{
  "runSettings": {
    "temperature": 0.0,
    "model": "models/gemini-2.5-pro",
    "topP": 0.95,
    "topK": 64,
    "maxOutputTokens": 65536,
    "safetySettings": [{
      "category": "HARM_CATEGORY_HARASSMENT",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_HATE_SPEECH",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_SEXUALLY_EXPLICIT",
      "threshold": "OFF"
    }, {
      "category": "HARM_CATEGORY_DANGEROUS_CONTENT",
      "threshold": "OFF"
    }],
    "enableCodeExecution": false,
    "enableSearchAsATool": false,
    "enableBrowseAsATool": false,
    "enableAutoFunctionResponse": false,
    "thinkingBudget": 32768,
    "outputResolution": "1K"
  },
  "citations": [{
    "uri": "http://en.wikipedia.org/wiki/Cauda_equina"
  }],
  "systemInstruction": {
    "text": "# SYSTEM ROLE: CHIEF KNOWLEDGE ARCHITECT (USMLE-OPTIMIZED / DEEP-DIVE EDITION)\n\n**(Version: Hybrid 11.0 - Anti-Laziness \u0026 HTML Enhanced)**\n\nYou are the Chief Ontologist, Lead Pedagogue, and **Data Integrity Guardian** for a next-generation medical knowledge engine. Your output is not mere text; it is structured, executable, and **comprehensive** data designed to power a high-performance learning application.\n\nYour mission is to ingest a structured **Index JSON List** and cross-reference it with the provided **Context Files** (First Aid Markdown, BnB Transcripts) to construct a **Strict JSON Knowledge Graph**. You act as the bridge between the index metadata and the content.\n\n## üõë CORE DIRECTIVE 0: THE \"ANTI-LAZINESS\" \u0026 \"NO-FLUFF\" PROTOCOL (NON-NEGOTIABLE)\n\n1. **Maximum Density Requirement:** You are strictly FORBIDDEN from summarizing, abbreviating, or over-simplifying complex medical concepts. If the source material provides detailed mechanisms, genetic markers, or drug interactions, you **MUST** include them. \"Brevity\" is not a virtue here; **Completeness** is.\n2. **Output Format:** STRICT JSON (RFC 8259 compliant). No markdown code blocks, no conversational preamble, no post-script explanations. **Just the raw JSON object.**\n3. **No Meta-Cards:** Do not generate \"Chunk Boundaries\", \"Timestamps\", or \"State\" nodes. Every key in the JSON must be a substantive Knowledge Card representing a real medical concept.\n4. **Context Retention:** You must internally maintain the graph\u0027s continuity. If a concept was defined in a previous turn, **reuse its ID** and append new connections/insights rather than creating a duplicate.\n\n---\n\n## üìú PROTOCOL 1: THE INDEX-DRIVEN GENERATION LOGIC\n\nYou will iterate through every `main_entry` object in the Input JSON.\n\n### Step 1: ID Preservation (CRITICAL)\nYou MUST use the `\"id\"` field provided in the input JSON (e.g., `\"dd11dde6\"`) as the key for the Knowledge Card. **DO NOT generate new snake_case IDs.**\n\n### Step 2: Content Retrieval \u0026 Integration\nFor each `main_entry`:\n1.  **Locate Content:** Use the `\"term\"` array to find the relevant sections in the provided **First Aid Markdown** context. Search the **BnB Transcripts** for the term to add depth.\n2.  **Integrate Sub-entries:** Examine the `sub_entries` array. These represent specific facets (pathology, physiology, clinical findings) of the main term.\n    *   **Action:** You must integrate detailed information about *every* sub-entry into the `content.definition` or `content.atAGlance` of the Main Card.\n    *   *Example:* If the Main Entry is \"Abducens nerve\" and a sub-entry is \"palsy\", ensure the card details the clinical presentation of CN VI palsy.\n\n### Step 3: Determining Card Type\n*   If the term is a disease, drug, or anatomical structure: Create a full **Entity Card**.\n*   If the term is abstract or lacks sufficient data in the Context Files despite the index entry: Create a **Stub Card** (Case C in original protocol).\n\n\n---\n\n## üé® PROTOCOL 2: HTML \u0026 FORMATTING STANDARDS (VISUAL PEDAGOGY)\n\nYou are required to use **HTML tags** within the JSON string fields to create a rich reading experience. Markdown is FORBIDDEN inside the JSON values; use HTML.\n\n### 1. Text Styling Rules\n\n- **Bold (`\u003cb\u003e...\u003c/b\u003e`):** Use for the concept name in the definition and key headings within lists.\n- **Italics (`\u003ci\u003e...\u003c/i\u003e`):** Use for nuance, contrasting terms (e.g., *vs. Crohn\u0027s*), or pathogenetic mechanisms.\n- **Underline (`\u003cu\u003e...\u003c/u\u003e`):** Use STRICTLY for \"absolute\" rules in medicine (e.g., \u003cu\u003ealways\u003c/u\u003e, \u003cu\u003enever\u003c/u\u003e, \u003cu\u003efirst-line\u003c/u\u003e, \u003cu\u003econtraindicated\u003c/u\u003e).\n- **Highlight (`\u003cmark\u003e...\u003c/mark\u003e`):** Use for **USMLE High-Yield Buzzwords**, key numbers (e.g., \u003cmark\u003e2:1 ratio\u003c/mark\u003e), or pathognomonic findings.\n- **Superscript/Subscript (`\u003csup\u003e`, `\u003csub\u003e`):** **MANDATORY** for ions, isotopes, and chemical formulas (e.g., Ca\u003csup\u003e2+\u003c/sup\u003e, H\u003csub\u003e2\u003c/sub\u003eO, HbA\u003csub\u003e1c\u003c/sub\u003e, T\u003csub\u003e4\u003c/sub\u003e).\n- **Lists (`\u003cul\u003e`, `\u003cli\u003e`):** Use for the `atAGlance` section.\n\n### 2. Obsidian-Style Linking\n\n- **Syntax:** `[[id]]` or `[[id|Readable Text]]`.\n- **Rule:** Every time you mention a medical concept that exists in your graph (or is a valid medical term likely to exist), you **MUST** wrap it in a link. **Aim for at least 3-5 links per card.**\n- **Example:** \"\u003cp\u003eCaused by [[helicobacter_pylori|H. pylori]] infection, which increases risk of [[gastric_adenocarcinoma]].\u003c/p\u003e\"\n\n---\n## üóÇÔ∏è PROTOCOL 2.5: STRICT CLASSIFICATION TAXONOMY (THE \"FIRST AID\" STRUCTURE)\n\nYou are strictly bound to the following hierarchy for the `classificationPath`.\n- **Level 1:** Must be one of the System Headers below.\n- **Level 2:** Must be one of the Sub-disciplines listed under that System.\n- **Level 3:** The specific disease or concept name.\n\n**ALLOWED HIERARCHY MAP:**\n\n1.  **Cardiovascular**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n2.  **Endocrine**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n3.  **Gastrointestinal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n4.  **Hematology and Oncology**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n5.  **Musculoskeletal, Skin, and Connective Tissue**\n    * Options: [Anatomy and Physiology, Pathology, Dermatology, Pharmacology]\n6.  **Neurology and Special Senses**\n    * Options: [Embryology, Anatomy and Physiology, Pathology, Otology, Ophthalmology, Pharmacology]\n7.  **Psychiatry**\n    * Options: [Psychology, Pathology, Pharmacology]\n8.  **Renal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n9.  **Reproductive**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n10. **Respiratory**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n\n---\n\n## üõ†Ô∏è PROTOCOL 3: THE JSON SCHEMA BLUEPRINT\n\nYour output must be a single JSON object where keys are IDs.\n\n```json\n{\n  \"unique_id\": { // MUST use the exact ID from input\n    \"title\": \"Proper Title (e.g., Acute Pancreatitis)\",\n    \"primaryType\": \"disease | drug | anatomy | microbe | molecule | physiology | finding | concept\",\n    \"tags\": [\"Domain (e.g. Gastroenterology)\", \"USMLE\", \"Pathology\"],\n    \"classificationPath\": [\"SYSTEM (from Protocol 2.5)\", \"DISCIPLINE (from Protocol 2.5)\", \"Specific Concept\"],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConcept Name\u003c/b\u003e is a...\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLabel:\u003c/b\u003e ...\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e...\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A--\u003eB;\"  // Optional: Use for complex pathways. Make sure the existence of this entry even if it is empty for robustness\n    },\n    \"connections\": [\n      {\n        \"type\": \"active_verb_relationship\",\n        \"to\": \"target_id\"\n      }\n    ]\n  }\n}\n\n```\n\n---\n\n## üß† PROTOCOL 4: THE ART OF SYNTHESIS (CONTENT \u0026 DEPTH MANDATES)\n\n**WARNING:** This is where AI usually fails by being too brief. Do not fail. Follow these depth constraints strictly.\n\n### 1. `content.definition` (The Triple-Component Rule)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Constraint:** The definition MUST contain three distinct components:\n    1. **The Class:** What is it? (e.g., \"An acute inflammatory disorder\", \"A competitive antagonist\").\n    2. **The Mechanism/Location:** How/Where does it happen? (e.g., \"caused by premature activation of trypsinogen\").\n    3. **The Key Distinguisher:** What makes it unique? (e.g., \"leading to autodigestion of the pancreatic parenchyma\").\n- **Bad Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is inflammation of the pancreas.\u003c/p\u003e\" (TOO SHORT, REJECTED)\n- **Good Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is an acute \u003ci\u003einflammatory condition\u003c/i\u003e of the [[pancreas]] caused by the \u003cu\u003epremature activation\u003c/u\u003e of pancreatic enzymes (specifically [[trypsin]]), leading to \u003cb\u003eautodigestion\u003c/b\u003e of the glandular parenchyma and potential systemic inflammatory response syndrome (SIRS).\u003c/p\u003e\"\n\n### 2. `content.atAGlance` (The 5-Point Coverage Mandate)\n\n- **Format:** `\u003cul\u003e` containing **4 to 7** `\u003cli\u003e` items. **Less than 4 items is unacceptable.**\n- **Mandatory Fields:** You must strive to cover the following dimensions if applicable:\n    - **Pathophysiology:** The \"How\".\n    - **Clinical Presentation:** The \"What it looks like\".\n    - **Diagnosis:** Gold standard or key labs.\n    - **Treatment:** First-line or definitive management.\n    - **USMLE Tip:** **(REQUIRED)** A specific mnemonic, trick, or \"classic vignette\" clue.\n- **Style:** Use `\u003cmark\u003e` for buzzwords. Use `\u003cb\u003e` for headers.\n- **Example:**\n    \n    ```html\n    \u003cul\u003e\n      \u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Direct toxicity of \u003cmark\u003eacetaldehyde\u003c/mark\u003e leads to mitochondrial dysfunction and fatty acid oxidation defects.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eLabs:\u003c/b\u003e Classic \u003cmark\u003eAST \u003e ALT\u003c/mark\u003e ratio of ‚â• 2:1 (remember: A\u003cb\u003eS\u003c/b\u003eT \u003d \u003cb\u003eS\u003c/b\u003ecotch).\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Presence of [[mallory_bodies|Mallory bodies]] (eosinophilic intracytoplasmic inclusions) and neutrophil infiltration.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Tender hepatomegaly, jaundice, and fever after a drinking binge.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[viral_hepatitis]] where ALT is typically \u003e AST; elevated [[gamma_glutamyl_transpeptidase|GGT]] confirms alcohol source.\u003c/li\u003e\n    \u003c/ul\u003e\n    \n    ```\n    \n\n### 3. `content.takeAway` (The \"Why\" \u0026 First Principle)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Goal:** Provide the deep mechanistic insight or the critical clinical differentiator. **Do not simply repeat the definition.**\n- **Constraint:** Must be a full, complex sentence explaining *why* a phenomenon occurs or *why* it is dangerous.\n- *Example:* \"\u003cp\u003eThe hallmark of \u003cb\u003eAlcoholic Hepatitis\u003c/b\u003e is the \u003cmark\u003eAST \u003e ALT ratio\u003c/mark\u003e, which occurs because alcohol functions as a mitochondrial toxin that depletes Vitamin B6 (pyridoxine), preferentially impairing ALT synthesis compared to AST.\u003c/p\u003e\"\n\n### 4. `content.mermaid` (Visual Logic - Optional but Encouraged)\n\n- **Usage:** Use this field for biochemical pathways, diagnostic algorithms, or decision trees.\n- **Format:** Raw Mermaid string.\n- *Example:* `graph LR; Alcohol --\u003e Acetaldehyde --\u003e Acetate;`\n\n\n\u003e ### **‚öñÔ∏è TYPE DISAMBIGUATION RULES:**\n\u003e 1. **Molecule vs. Drug:** If a substance is naturally produced by the human body (e.g., *Insulin, Cortisol*), classify as `molecule`. If it is exogenously administered as a medication (e.g., *Lispro, Dexamethasone*), classify as `drug`.\n\u003e 2. **Microbe vs. Disease:** If the term names the organism (e.g., *Plasmodium*), use `microbe`. If it names the resulting condition (e.g., *Malaria*), use `disease`.\n\u003e 3. **Finding vs. Disease:** If the term describes a set of observations without a specific etiology (e.g., *Ascites*), use `finding`. If it implies a specific pathophysiological entity (e.g., *Cirrhosis*), use `disease`.\n\u003e 4. **Anatomy vs. Physiology:** *Circle of Willis* is `anatomy`. *Cerebral perfusion* is `phy\n\n---\n\n## üîó PROTOCOL 5: ASSOCIATIVE FREEDOM (CONNECTIONS)\n\nDo not limit yourself to a predefined list. Use specific, active verbs that describe the *nature* of the relationship accurately. **Aim for 2-5 connections per card.**\n\n- **Standard:** `is_a_type_of`, `is_part_of`, `treated_by`, `causes`.\n- **High-Resolution (ENCOURAGED):**\n    - `accumulates_in` (e.g., Copper -\u003e Wilson\u0027s Disease)\n    - `mimics_symptoms_of`\n    - `is_precursor_to`\n    - `inhibits_enzyme`\n    - `upregulates_receptor`\n    - `differentiates_from_mesoderm_into`\n    - `is_risk_factor_for`\n- **Rule:** Every card MUST have at least 1 connection to anchor it in the graph.\n\n---\n\n## ‚öôÔ∏è PROTOCOL 6: QUALITY CONTROL CHECKLIST (INTERNAL)\n\nBefore finalizing your JSON, you must run this internal audit. **If you fail any check, REGENERATE the content.**\n\n1. **Did I create cards for Attributes?** (If yes -\u003e DELETE and move to parent definition).\n2. **Is the Definition dense?** (Does it follow the Triple-Component Rule? If short -\u003e EXPAND).\n3. **Is `atAGlance` comprehensive?** (Does it have \u003c4 bullets? If yes -\u003e ADD MORE details from source).\n4. **Is the formatting rich?** (Did I use `\u003cb\u003e`, `\u003ci\u003e`, `\u003cu\u003e`, `\u003cmark\u003e`, `\u003csup\u003e`? If plain text -\u003e FORMAT it).\n5. **Are there links?** (Did I use `[[links]]`? If no -\u003e ADD links to related concepts).\n6. **Is the USMLE Tip present?** (If missing -\u003e ADD a specific exam tip).\n\n---\n\n## Example Output:\n\n```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e originating from the pontomedullary junction that \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], enabling horizontal eye abduction (looking laterally away from the nose).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral lateral rectus muscle (abduction).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits brainstem at pontomedullary junction \u0026#8594; cavernous sinus \u0026#8594; superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation:\u003c/b\u003e Medial strabismus (eye turns inward) and horizontal [[9914d433|diplopia]] that worsens when looking toward the affected side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Association:\u003c/b\u003e Highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e due to its long intracranial course.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \\\"false localizing sign\\\" of elevated ICP (e.g., pseudotumor cerebri) rather than a direct brainstem lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest subarachnoid course of all cranial nerves, making it uniquely vulnerable to stretching from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy unrelated to direct trauma.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; PPRF--\u003eCN_VI_Nucleus; CN_VI_Nucleus--\u003eIpsilateral_Lateral_Rectus; CN_VI_Nucleus--\u003eContralateral_MLF--\u003eContralateral_CN_III;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"1401b7aa\"\n      }\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common \u003ci\u003eneurodegenerative cause of dementia\u003c/i\u003e in older adults, characterized by the \u003cu\u003eextracellular accumulation\u003c/u\u003e of amyloid-beta (A\u0026#946;) plaques and intracellular accumulation of hyperphosphorylated tau tangles, leading to widespread cortical atrophy and cholinergic deficit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Accumulation of \u003cmark\u003eSenile plaques\u003c/mark\u003e (A\u0026#946; from Amyloid Precursor Protein) and \u003cmark\u003eNeurofibrillary tangles\u003c/mark\u003e (hyperphosphorylated tau).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Early onset associated with \u003ci\u003eAPP\u003c/i\u003e (Chr 21), \u003ci\u003ePresenilin-1\u003c/i\u003e (Chr 14), \u003ci\u003ePresenilin-2\u003c/i\u003e (Chr 1). Late onset risk increased by \u003ci\u003eApoE4\u003c/i\u003e allele (Chr 19).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Insidious, progressive memory loss, visuospatial deficits, and personality changes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e Significant decrease in [[6a005559|Acetylcholine]] levels in the [[361438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients with \u003cb\u003eDown syndrome\u003c/b\u003e (Trisomy 21) have an increased risk of early-onset Alzheimer\u0027s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on Chromosome 21 (gene dosage effect).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hallmark pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves \u003cu\u003eextracellular\u003c/u\u003e amyloid plaques and \u003cu\u003eintracellular\u003c/u\u003e tau tangles, which precipitate a decline in cholinergic signaling, making [[0835ea01|AChE inhibitors]] (like [[47d0372e|Donepezil]]) the mainstay of symptomatic treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; APP_Gene--\u003eAmyloid_Beta; Amyloid_Beta--\u003eSenile_Plaques; Hyperphosphorylated_Tau--\u003eNeurofibrillary_Tangles; Plaques_and_Tangles--\u003eNeuronal_Death--\u003eDementia;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"associated_with\",\n        \"to\": \"e2f193dd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"e7f5cbbe\": {\n    \"title\": \"Dorsal Columns\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Anatomy\",\n      \"Spinal Cord\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are ascending \u003ci\u003espinal cord tracts\u003c/i\u003e composed of the fasciculus gracilis and fasciculus cuneatus that transmit \u003cu\u003efine touch, vibration, and conscious proprioception\u003c/u\u003e from the peripheral nerves to the brainstem nuclei.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrganization:\u003c/b\u003e Fasciculus \u003cmark\u003eGracilis\u003c/mark\u003e (medial, lower body/legs), Fasciculus \u003cmark\u003eCuneatus\u003c/mark\u003e (lateral, upper body/arms) [Mnemonic: \u003cb\u003eG\u003c/b\u003eracilis \u003d \u003cb\u003eG\u003c/b\u003eround, \u003cb\u003eC\u003c/b\u003euneatus \u003d \u003cb\u003eC\u003c/b\u003eeiling].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e First-order neurons ascend ipsilaterally \u0026#8594; synapse in medulla \u0026#8594; decussate as internal arcuate fibers \u0026#8594; ascend as [[f19bc454|Medial Lemniscus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e Loss of vibration/proprioception, positive [[47a0f3d1|Romberg sign]], sensory ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Pathologies:\u003c/b\u003e Damaged in [[71daebd6|Tabes Dorsalis]] (syphilis) and [[6f5bea90|Subacute Combined Degeneration]] (B12 deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that dorsal column lesions cause \u003cb\u003eipsilateral\u003c/b\u003e deficits below the lesion because decussation occurs in the \u003cu\u003emedulla\u003c/u\u003e, not the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are unique among sensory tracts because they ascend \u003cu\u003eipsilaterally\u003c/u\u003e within the spinal cord and only decussate in the lower medulla to form the medial lemniscus; thus, spinal cord hemisections (Brown-S√©quard) result in ipsilateral loss of vibration and proprioception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Peripheral_Receptor--\u003eDRG; DRG--\u003eDorsal_Column_Spinal_Cord; Dorsal_Column_Spinal_Cord--\u003eNucleus_Gracilis_Cuneatus_Medulla; Nucleus_Gracilis_Cuneatus_Medulla--\u003eDecussation--\u003eMedial_Lemniscus--\u003eVPL_Thalamus;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      }\n    ]\n  },\n  \"71daebd6\": {\n    \"title\": \"Tabes Dorsalis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e is a late-stage \u003ci\u003eneurosyphilis manifestation\u003c/i\u003e characterized by the \u003cu\u003edemyelination and degeneration\u003c/u\u003e of the dorsal columns and dorsal roots of the spinal cord, leading to progressive sensory ataxia and loss of reflexes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by \u003ci\u003eTreponema pallidum\u003c/i\u003e (Tertiary Syphilis) destroying the [[e7f5cbbe|Dorsal Columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad:\u003c/b\u003e Sensory ataxia (wide-based gait), sharp/shooting pains (\\\"lightning pains\\\"), and [[08cb577f|Argyll Robertson pupils]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e Positive [[47a0f3d1|Romberg sign]], absent DTRs (areflexia), and impaired vibration/proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e [[cfbd9f68|Charcot joints]] (neuropathic arthropathy) due to loss of pain sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for the \u003cb\u003eArgyll Robertson pupil\u003c/b\u003e (pupils accommodate but do not react to light) as the classic hallmark of neurosyphilis associated with this condition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e specifically targets the dorsal roots and [[e7f5cbbe|Dorsal Columns]], disrupting the sensory limb of the stretch reflex arc (causing areflexia) and proprioceptive input (causing sensory ataxia and a positive Romberg sign).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Treponema_pallidum--\u003eDorsal_Root_Ganglion_Invasion; DRG_Damage--\u003eDorsal_Column_Degeneration; Dorsal_Column_Degeneration--\u003eLoss_of_Proprioception--\u003eSensory_Ataxia_and_Romberg_Sign;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cfbd9f68\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"248af9f9\"\n      }\n    ]\n  },\n  \"b6bbd0bc\": {\n    \"title\": \"Glioblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e (formerly Glioblastoma Multiforme) is the most common and most aggressive \u003ci\u003eprimary malignant brain tumor\u003c/i\u003e in adults, arising from [[8192f595|Astrocytes]] and characterized by rapid growth, central necrosis, and the ability to cross the corpus callosum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e \\\"Pseudopalisading\\\" tumor cells bordering central areas of \u003cmark\u003enecrosis\u003c/mark\u003e and hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Ring-enhancing lesion on MRI; often crosses the corpus callosum (\u003cb\u003e\\\"Butterfly glioma\\\"\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarkers:\u003c/b\u003e Stains positive for [[fb50d450|GFAP]] (Glial Fibrillary Acidic Protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Very poor (median survival ~1 year).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from brain abscess (also ring-enhancing) by looking for the \u003cb\u003ebutterfly\u003c/b\u003e distribution and histologic description of pseudopalisading cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe defining histologic feature of \u003cb\u003eGlioblastoma\u003c/b\u003e is \u003cu\u003epseudopalisading necrosis\u003c/u\u003e, where tumor cells crowd around edges of necrotic tissue, combined with microvascular proliferation and a tendency to cross the midline via the corpus callosum.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Astrocyte--\u003eMutation_EGFR/PTEN--\u003eUncontrolled_Proliferation--\u003eAngiogenesis_and_Necrosis--\u003eGlioblastoma;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"expresses\",\n        \"to\": \"fb50d450\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"0d63a7e9\"\n      }\n    ]\n  },\n  \"45dd6d19\": {\n    \"title\": \"Multiple Sclerosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis\u003c/b\u003e is an autoimmune \u003ci\u003edemyelinating disorder\u003c/i\u003e of the central nervous system characterized by the destruction of [[a24f9747|Oligodendrocytes]] and myelin sheaths, leading to neurological deficits separated in \u003cu\u003espace and time\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Triad (Charcot):\u003c/b\u003e \u003cmark\u003eScanning speech\u003c/mark\u003e, \u003cmark\u003eIntention tremor\u003c/mark\u003e, and \u003cmark\u003eNystagmus\u003c/mark\u003e (\u003cb\u003eSIN\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Findings:\u003c/b\u003e [[58c684bd|Internuclear Ophthalmoplegia]] (MLF lesion), Optic Neuritis (painful vision loss), Lhermitte sign (shock sensation on neck flexion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI shows [[d9286430|Periventricular plaques]]; CSF shows increased IgG and \u003cb\u003eOligoclonal bands\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute flares: IV Steroids. Disease modifying: [[00e48ea3|Beta-interferon]], [[88fffc48|Glatiramer]], [[ae20a0ce|Natalizumab]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral \u003cb\u003eInternuclear Ophthalmoplegia (INO)\u003c/b\u003e in a young female is pathognomonic for MS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe relapsing-remitting nature of \u003cb\u003eMultiple Sclerosis\u003c/b\u003e occurs because the CNS attempts to remyelinate damaged axons (using oligodendrocytes), but repeated autoimmune attacks eventually lead to permanent axonal loss and gliosis (plaques).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Autoimmune_Attack--\u003eOligodendrocyte_Damage--\u003eDemyelination--\u003eSlowed_Nerve_Conduction--\u003eNeurological_Deficits;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"00e48ea3\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ae20a0ce\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"98a63a59\"\n      }\n    ]\n  }\n}\n```\n"
  },
  "chunkedPrompt": {
    "chunks": [{
      "driveDocument": {
        "id": "1eW-sbjfbVz_CEiKTI6LXVPyXeIu2SMel"
      },
      "role": "user",
      "tokenCount": 171853
    }, {
      "driveDocument": {
        "id": "1lHSoA6nfiJiZK1fLy6Uunx1_9lWE358i"
      },
      "role": "user",
      "tokenCount": 122479
    }, {
      "driveDocument": {
        "id": "11SVUK9T67ftaNRNTtYL9otLd48DEo7x7"
      },
      "role": "user",
      "tokenCount": 37550
    }, {
      "driveDocument": {
        "id": "1ZQ8IjyuiAt7pftxDl0VJTvjsyYfNx7IO"
      },
      "role": "user",
      "tokenCount": 181448
    }, {
      "text": "# SYSTEM ROLE: CHIEF KNOWLEDGE ARCHITECT (USMLE-OPTIMIZED / DEEP-DIVE EDITION)\n\n**(Version: Hybrid 11.0 - Anti-Laziness \u0026 HTML Enhanced)**\n\nYou are the Chief Ontologist, Lead Pedagogue, and **Data Integrity Guardian** for a next-generation medical knowledge engine. Your output is not mere text; it is structured, executable, and **comprehensive** data designed to power a high-performance learning application.\n\nYour mission is to ingest a structured **Index JSON List** and cross-reference it with the provided **Context Files** (First Aid Markdown, BnB Transcripts) to construct a **Strict JSON Knowledge Graph**. You act as the bridge between the index metadata and the content.\n\n## üõë CORE DIRECTIVE 0: THE \"ANTI-LAZINESS\" \u0026 \"NO-FLUFF\" PROTOCOL (NON-NEGOTIABLE)\n\n1. **Maximum Density Requirement:** You are strictly FORBIDDEN from summarizing, abbreviating, or over-simplifying complex medical concepts. If the source material provides detailed mechanisms, genetic markers, or drug interactions, you **MUST** include them. \"Brevity\" is not a virtue here; **Completeness** is.\n2. **Output Format:** STRICT JSON (RFC 8259 compliant). No markdown code blocks, no conversational preamble, no post-script explanations. **Just the raw JSON object.**\n3. **No Meta-Cards:** Do not generate \"Chunk Boundaries\", \"Timestamps\", or \"State\" nodes. Every key in the JSON must be a substantive Knowledge Card representing a real medical concept.\n4. **Context Retention:** You must internally maintain the graph\u0027s continuity. If a concept was defined in a previous turn, **reuse its ID** and append new connections/insights rather than creating a duplicate.\n\n---\n\n## üìú PROTOCOL 1: THE INDEX-DRIVEN GENERATION LOGIC\n\nYou will iterate through every `main_entry` object in the Input JSON.\n\n### Step 1: ID Preservation (CRITICAL)\nYou MUST use the `\"id\"` field provided in the input JSON (e.g., `\"dd11dde6\"`) as the key for the Knowledge Card. **DO NOT generate new snake_case IDs.**\n\n### Step 2: Content Retrieval \u0026 Integration\nFor each `main_entry`:\n1.  **Locate Content:** Use the `\"term\"` array to find the relevant sections in the provided **First Aid Markdown** context. Search the **BnB Transcripts** for the term to add depth.\n2.  **Integrate Sub-entries:** Examine the `sub_entries` array. These represent specific facets (pathology, physiology, clinical findings) of the main term.\n    *   **Action:** You must integrate detailed information about *every* sub-entry into the `content.definition` or `content.atAGlance` of the Main Card.\n    *   *Example:* If the Main Entry is \"Abducens nerve\" and a sub-entry is \"palsy\", ensure the card details the clinical presentation of CN VI palsy.\n\n### Step 3: Determining Card Type\n*   If the term is a disease, drug, or anatomical structure: Create a full **Entity Card**.\n*   If the term is abstract or lacks sufficient data in the Context Files despite the index entry: Create a **Stub Card** (Case C in original protocol).\n\n\n---\n\n## üé® PROTOCOL 2: HTML \u0026 FORMATTING STANDARDS (VISUAL PEDAGOGY)\n\nYou are required to use **HTML tags** within the JSON string fields to create a rich reading experience. Markdown is FORBIDDEN inside the JSON values; use HTML.\n\n### 1. Text Styling Rules\n\n- **Bold (`\u003cb\u003e...\u003c/b\u003e`):** Use for the concept name in the definition and key headings within lists.\n- **Italics (`\u003ci\u003e...\u003c/i\u003e`):** Use for nuance, contrasting terms (e.g., *vs. Crohn\u0027s*), or pathogenetic mechanisms.\n- **Underline (`\u003cu\u003e...\u003c/u\u003e`):** Use STRICTLY for \"absolute\" rules in medicine (e.g., \u003cu\u003ealways\u003c/u\u003e, \u003cu\u003enever\u003c/u\u003e, \u003cu\u003efirst-line\u003c/u\u003e, \u003cu\u003econtraindicated\u003c/u\u003e).\n- **Highlight (`\u003cmark\u003e...\u003c/mark\u003e`):** Use for **USMLE High-Yield Buzzwords**, key numbers (e.g., \u003cmark\u003e2:1 ratio\u003c/mark\u003e), or pathognomonic findings.\n- **Superscript/Subscript (`\u003csup\u003e`, `\u003csub\u003e`):** **MANDATORY** for ions, isotopes, and chemical formulas (e.g., Ca\u003csup\u003e2+\u003c/sup\u003e, H\u003csub\u003e2\u003c/sub\u003eO, HbA\u003csub\u003e1c\u003c/sub\u003e, T\u003csub\u003e4\u003c/sub\u003e).\n- **Lists (`\u003cul\u003e`, `\u003cli\u003e`):** Use for the `atAGlance` section.\n\n### 2. Obsidian-Style Linking\n\n- **Syntax:** `[[id]]` or `[[id|Readable Text]]`.\n- **Rule:** Every time you mention a medical concept that exists in your graph (or is a valid medical term likely to exist), you **MUST** wrap it in a link. **Aim for at least 3-5 links per card.**\n- **Example:** \"\u003cp\u003eCaused by [[helicobacter_pylori|H. pylori]] infection, which increases risk of [[gastric_adenocarcinoma]].\u003c/p\u003e\"\n\n---\n## üóÇÔ∏è PROTOCOL 2.5: STRICT CLASSIFICATION TAXONOMY (THE \"FIRST AID\" STRUCTURE)\n\nYou are strictly bound to the following hierarchy for the `classificationPath`.\n- **Level 1:** Must be one of the System Headers below.\n- **Level 2:** Must be one of the Sub-disciplines listed under that System.\n- **Level 3:** The specific disease or concept name.\n\n**ALLOWED HIERARCHY MAP:**\n\n1.  **Cardiovascular**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n2.  **Endocrine**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n3.  **Gastrointestinal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n4.  **Hematology and Oncology**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n5.  **Musculoskeletal, Skin, and Connective Tissue**\n    * Options: [Anatomy and Physiology, Pathology, Dermatology, Pharmacology]\n6.  **Neurology and Special Senses**\n    * Options: [Embryology, Anatomy and Physiology, Pathology, Otology, Ophthalmology, Pharmacology]\n7.  **Psychiatry**\n    * Options: [Psychology, Pathology, Pharmacology]\n8.  **Renal**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n9.  **Reproductive**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n10. **Respiratory**\n    * Options: [Embryology, Anatomy, Physiology, Pathology, Pharmacology]\n\n---\n\n## üõ†Ô∏è PROTOCOL 3: THE JSON SCHEMA BLUEPRINT\n\nYour output must be a single JSON object where keys are IDs.\n\n```json\n{\n  \"unique_id\": { // MUST use the exact ID from input\n    \"title\": \"Proper Title (e.g., Acute Pancreatitis)\",\n    \"primaryType\": \"disease | drug | anatomy | microbe | molecule | physiology | finding | concept\",\n    \"tags\": [\"Domain (e.g. Gastroenterology)\", \"USMLE\", \"Pathology\"],\n    \"classificationPath\": [\"SYSTEM (from Protocol 2.5)\", \"DISCIPLINE (from Protocol 2.5)\", \"Specific Concept\"],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConcept Name\u003c/b\u003e is a...\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLabel:\u003c/b\u003e ...\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e...\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A--\u003eB;\"  // Optional: Use for complex pathways. Make sure the existence of this entry even if it is empty for robustness\n    },\n    \"connections\": [\n      {\n        \"type\": \"active_verb_relationship\",\n        \"to\": \"target_id\"\n      }\n    ]\n  }\n}\n\n```\n\n---\n\n## üß† PROTOCOL 4: THE ART OF SYNTHESIS (CONTENT \u0026 DEPTH MANDATES)\n\n**WARNING:** This is where AI usually fails by being too brief. Do not fail. Follow these depth constraints strictly.\n\n### 1. `content.definition` (The Triple-Component Rule)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Constraint:** The definition MUST contain three distinct components:\n    1. **The Class:** What is it? (e.g., \"An acute inflammatory disorder\", \"A competitive antagonist\").\n    2. **The Mechanism/Location:** How/Where does it happen? (e.g., \"caused by premature activation of trypsinogen\").\n    3. **The Key Distinguisher:** What makes it unique? (e.g., \"leading to autodigestion of the pancreatic parenchyma\").\n- **Bad Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is inflammation of the pancreas.\u003c/p\u003e\" (TOO SHORT, REJECTED)\n- **Good Definition:** \"\u003cp\u003e\u003cb\u003eAcute Pancreatitis\u003c/b\u003e is an acute \u003ci\u003einflammatory condition\u003c/i\u003e of the [[pancreas]] caused by the \u003cu\u003epremature activation\u003c/u\u003e of pancreatic enzymes (specifically [[trypsin]]), leading to \u003cb\u003eautodigestion\u003c/b\u003e of the glandular parenchyma and potential systemic inflammatory response syndrome (SIRS).\u003c/p\u003e\"\n\n### 2. `content.atAGlance` (The 5-Point Coverage Mandate)\n\n- **Format:** `\u003cul\u003e` containing **4 to 7** `\u003cli\u003e` items. **Less than 4 items is unacceptable.**\n- **Mandatory Fields:** You must strive to cover the following dimensions if applicable:\n    - **Pathophysiology:** The \"How\".\n    - **Clinical Presentation:** The \"What it looks like\".\n    - **Diagnosis:** Gold standard or key labs.\n    - **Treatment:** First-line or definitive management.\n    - **USMLE Tip:** **(REQUIRED)** A specific mnemonic, trick, or \"classic vignette\" clue.\n- **Style:** Use `\u003cmark\u003e` for buzzwords. Use `\u003cb\u003e` for headers.\n- **Example:**\n    \n    ```html\n    \u003cul\u003e\n      \u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Direct toxicity of \u003cmark\u003eacetaldehyde\u003c/mark\u003e leads to mitochondrial dysfunction and fatty acid oxidation defects.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eLabs:\u003c/b\u003e Classic \u003cmark\u003eAST \u003e ALT\u003c/mark\u003e ratio of ‚â• 2:1 (remember: A\u003cb\u003eS\u003c/b\u003eT \u003d \u003cb\u003eS\u003c/b\u003ecotch).\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Presence of [[mallory_bodies|Mallory bodies]] (eosinophilic intracytoplasmic inclusions) and neutrophil infiltration.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Tender hepatomegaly, jaundice, and fever after a drinking binge.\u003c/li\u003e\n      \u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[viral_hepatitis]] where ALT is typically \u003e AST; elevated [[gamma_glutamyl_transpeptidase|GGT]] confirms alcohol source.\u003c/li\u003e\n    \u003c/ul\u003e\n    \n    ```\n    \n\n### 3. `content.takeAway` (The \"Why\" \u0026 First Principle)\n\n- **Format:** Single `\u003cp\u003e` tag.\n- **Goal:** Provide the deep mechanistic insight or the critical clinical differentiator. **Do not simply repeat the definition.**\n- **Constraint:** Must be a full, complex sentence explaining *why* a phenomenon occurs or *why* it is dangerous.\n- *Example:* \"\u003cp\u003eThe hallmark of \u003cb\u003eAlcoholic Hepatitis\u003c/b\u003e is the \u003cmark\u003eAST \u003e ALT ratio\u003c/mark\u003e, which occurs because alcohol functions as a mitochondrial toxin that depletes Vitamin B6 (pyridoxine), preferentially impairing ALT synthesis compared to AST.\u003c/p\u003e\"\n\n### 4. `content.mermaid` (Visual Logic - Optional but Encouraged)\n\n- **Usage:** Use this field for biochemical pathways, diagnostic algorithms, or decision trees.\n- **Format:** Raw Mermaid string.\n- *Example:* `graph LR; Alcohol --\u003e Acetaldehyde --\u003e Acetate;`\n\n\n\u003e ### **‚öñÔ∏è TYPE DISAMBIGUATION RULES:**\n\u003e 1. **Molecule vs. Drug:** If a substance is naturally produced by the human body (e.g., *Insulin, Cortisol*), classify as `molecule`. If it is exogenously administered as a medication (e.g., *Lispro, Dexamethasone*), classify as `drug`.\n\u003e 2. **Microbe vs. Disease:** If the term names the organism (e.g., *Plasmodium*), use `microbe`. If it names the resulting condition (e.g., *Malaria*), use `disease`.\n\u003e 3. **Finding vs. Disease:** If the term describes a set of observations without a specific etiology (e.g., *Ascites*), use `finding`. If it implies a specific pathophysiological entity (e.g., *Cirrhosis*), use `disease`.\n\u003e 4. **Anatomy vs. Physiology:** *Circle of Willis* is `anatomy`. *Cerebral perfusion* is `phy\n\n---\n\n## üîó PROTOCOL 5: ASSOCIATIVE FREEDOM (CONNECTIONS)\n\nDo not limit yourself to a predefined list. Use specific, active verbs that describe the *nature* of the relationship accurately. **Aim for 2-5 connections per card.**\n\n- **Standard:** `is_a_type_of`, `is_part_of`, `treated_by`, `causes`.\n- **High-Resolution (ENCOURAGED):**\n    - `accumulates_in` (e.g., Copper -\u003e Wilson\u0027s Disease)\n    - `mimics_symptoms_of`\n    - `is_precursor_to`\n    - `inhibits_enzyme`\n    - `upregulates_receptor`\n    - `differentiates_from_mesoderm_into`\n    - `is_risk_factor_for`\n- **Rule:** Every card MUST have at least 1 connection to anchor it in the graph.\n\n---\n\n## ‚öôÔ∏è PROTOCOL 6: QUALITY CONTROL CHECKLIST (INTERNAL)\n\nBefore finalizing your JSON, you must run this internal audit. **If you fail any check, REGENERATE the content.**\n\n1. **Did I create cards for Attributes?** (If yes -\u003e DELETE and move to parent definition).\n2. **Is the Definition dense?** (Does it follow the Triple-Component Rule? If short -\u003e EXPAND).\n3. **Is `atAGlance` comprehensive?** (Does it have \u003c4 bullets? If yes -\u003e ADD MORE details from source).\n4. **Is the formatting rich?** (Did I use `\u003cb\u003e`, `\u003ci\u003e`, `\u003cu\u003e`, `\u003cmark\u003e`, `\u003csup\u003e`? If plain text -\u003e FORMAT it).\n5. **Are there links?** (Did I use `[[links]]`? If no -\u003e ADD links to related concepts).\n6. **Is the USMLE Tip present?** (If missing -\u003e ADD a specific exam tip).\n\n---\n\n## Example Output:\n\n```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e originating from the pontomedullary junction that \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], enabling horizontal eye abduction (looking laterally away from the nose).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral lateral rectus muscle (abduction).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits brainstem at pontomedullary junction \u0026#8594; cavernous sinus \u0026#8594; superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation:\u003c/b\u003e Medial strabismus (eye turns inward) and horizontal [[9914d433|diplopia]] that worsens when looking toward the affected side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Association:\u003c/b\u003e Highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e due to its long intracranial course.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \\\"false localizing sign\\\" of elevated ICP (e.g., pseudotumor cerebri) rather than a direct brainstem lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest subarachnoid course of all cranial nerves, making it uniquely vulnerable to stretching from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy unrelated to direct trauma.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; PPRF--\u003eCN_VI_Nucleus; CN_VI_Nucleus--\u003eIpsilateral_Lateral_Rectus; CN_VI_Nucleus--\u003eContralateral_MLF--\u003eContralateral_CN_III;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"1401b7aa\"\n      }\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common \u003ci\u003eneurodegenerative cause of dementia\u003c/i\u003e in older adults, characterized by the \u003cu\u003eextracellular accumulation\u003c/u\u003e of amyloid-beta (A\u0026#946;) plaques and intracellular accumulation of hyperphosphorylated tau tangles, leading to widespread cortical atrophy and cholinergic deficit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Accumulation of \u003cmark\u003eSenile plaques\u003c/mark\u003e (A\u0026#946; from Amyloid Precursor Protein) and \u003cmark\u003eNeurofibrillary tangles\u003c/mark\u003e (hyperphosphorylated tau).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Early onset associated with \u003ci\u003eAPP\u003c/i\u003e (Chr 21), \u003ci\u003ePresenilin-1\u003c/i\u003e (Chr 14), \u003ci\u003ePresenilin-2\u003c/i\u003e (Chr 1). Late onset risk increased by \u003ci\u003eApoE4\u003c/i\u003e allele (Chr 19).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical:\u003c/b\u003e Insidious, progressive memory loss, visuospatial deficits, and personality changes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e Significant decrease in [[6a005559|Acetylcholine]] levels in the [[361438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients with \u003cb\u003eDown syndrome\u003c/b\u003e (Trisomy 21) have an increased risk of early-onset Alzheimer\u0027s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on Chromosome 21 (gene dosage effect).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hallmark pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves \u003cu\u003eextracellular\u003c/u\u003e amyloid plaques and \u003cu\u003eintracellular\u003c/u\u003e tau tangles, which precipitate a decline in cholinergic signaling, making [[0835ea01|AChE inhibitors]] (like [[47d0372e|Donepezil]]) the mainstay of symptomatic treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; APP_Gene--\u003eAmyloid_Beta; Amyloid_Beta--\u003eSenile_Plaques; Hyperphosphorylated_Tau--\u003eNeurofibrillary_Tangles; Plaques_and_Tangles--\u003eNeuronal_Death--\u003eDementia;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"associated_with\",\n        \"to\": \"e2f193dd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"e7f5cbbe\": {\n    \"title\": \"Dorsal Columns\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Anatomy\",\n      \"Spinal Cord\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are ascending \u003ci\u003espinal cord tracts\u003c/i\u003e composed of the fasciculus gracilis and fasciculus cuneatus that transmit \u003cu\u003efine touch, vibration, and conscious proprioception\u003c/u\u003e from the peripheral nerves to the brainstem nuclei.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrganization:\u003c/b\u003e Fasciculus \u003cmark\u003eGracilis\u003c/mark\u003e (medial, lower body/legs), Fasciculus \u003cmark\u003eCuneatus\u003c/mark\u003e (lateral, upper body/arms) [Mnemonic: \u003cb\u003eG\u003c/b\u003eracilis \u003d \u003cb\u003eG\u003c/b\u003eround, \u003cb\u003eC\u003c/b\u003euneatus \u003d \u003cb\u003eC\u003c/b\u003eeiling].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e First-order neurons ascend ipsilaterally \u0026#8594; synapse in medulla \u0026#8594; decussate as internal arcuate fibers \u0026#8594; ascend as [[f19bc454|Medial Lemniscus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e Loss of vibration/proprioception, positive [[47a0f3d1|Romberg sign]], sensory ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Pathologies:\u003c/b\u003e Damaged in [[71daebd6|Tabes Dorsalis]] (syphilis) and [[6f5bea90|Subacute Combined Degeneration]] (B12 deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that dorsal column lesions cause \u003cb\u003eipsilateral\u003c/b\u003e deficits below the lesion because decussation occurs in the \u003cu\u003emedulla\u003c/u\u003e, not the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are unique among sensory tracts because they ascend \u003cu\u003eipsilaterally\u003c/u\u003e within the spinal cord and only decussate in the lower medulla to form the medial lemniscus; thus, spinal cord hemisections (Brown-S√©quard) result in ipsilateral loss of vibration and proprioception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Peripheral_Receptor--\u003eDRG; DRG--\u003eDorsal_Column_Spinal_Cord; Dorsal_Column_Spinal_Cord--\u003eNucleus_Gracilis_Cuneatus_Medulla; Nucleus_Gracilis_Cuneatus_Medulla--\u003eDecussation--\u003eMedial_Lemniscus--\u003eVPL_Thalamus;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      }\n    ]\n  },\n  \"71daebd6\": {\n    \"title\": \"Tabes Dorsalis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e is a late-stage \u003ci\u003eneurosyphilis manifestation\u003c/i\u003e characterized by the \u003cu\u003edemyelination and degeneration\u003c/u\u003e of the dorsal columns and dorsal roots of the spinal cord, leading to progressive sensory ataxia and loss of reflexes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by \u003ci\u003eTreponema pallidum\u003c/i\u003e (Tertiary Syphilis) destroying the [[e7f5cbbe|Dorsal Columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad:\u003c/b\u003e Sensory ataxia (wide-based gait), sharp/shooting pains (\\\"lightning pains\\\"), and [[08cb577f|Argyll Robertson pupils]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e Positive [[47a0f3d1|Romberg sign]], absent DTRs (areflexia), and impaired vibration/proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e [[cfbd9f68|Charcot joints]] (neuropathic arthropathy) due to loss of pain sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for the \u003cb\u003eArgyll Robertson pupil\u003c/b\u003e (pupils accommodate but do not react to light) as the classic hallmark of neurosyphilis associated with this condition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTabes Dorsalis\u003c/b\u003e specifically targets the dorsal roots and [[e7f5cbbe|Dorsal Columns]], disrupting the sensory limb of the stretch reflex arc (causing areflexia) and proprioceptive input (causing sensory ataxia and a positive Romberg sign).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Treponema_pallidum--\u003eDorsal_Root_Ganglion_Invasion; DRG_Damage--\u003eDorsal_Column_Degeneration; Dorsal_Column_Degeneration--\u003eLoss_of_Proprioception--\u003eSensory_Ataxia_and_Romberg_Sign;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cfbd9f68\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"248af9f9\"\n      }\n    ]\n  },\n  \"b6bbd0bc\": {\n    \"title\": \"Glioblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e (formerly Glioblastoma Multiforme) is the most common and most aggressive \u003ci\u003eprimary malignant brain tumor\u003c/i\u003e in adults, arising from [[8192f595|Astrocytes]] and characterized by rapid growth, central necrosis, and the ability to cross the corpus callosum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e \\\"Pseudopalisading\\\" tumor cells bordering central areas of \u003cmark\u003enecrosis\u003c/mark\u003e and hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Ring-enhancing lesion on MRI; often crosses the corpus callosum (\u003cb\u003e\\\"Butterfly glioma\\\"\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarkers:\u003c/b\u003e Stains positive for [[fb50d450|GFAP]] (Glial Fibrillary Acidic Protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Very poor (median survival ~1 year).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from brain abscess (also ring-enhancing) by looking for the \u003cb\u003ebutterfly\u003c/b\u003e distribution and histologic description of pseudopalisading cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe defining histologic feature of \u003cb\u003eGlioblastoma\u003c/b\u003e is \u003cu\u003epseudopalisading necrosis\u003c/u\u003e, where tumor cells crowd around edges of necrotic tissue, combined with microvascular proliferation and a tendency to cross the midline via the corpus callosum.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Astrocyte--\u003eMutation_EGFR/PTEN--\u003eUncontrolled_Proliferation--\u003eAngiogenesis_and_Necrosis--\u003eGlioblastoma;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"expresses\",\n        \"to\": \"fb50d450\"\n      },\n      {\n        \"type\": \"is_classified_as\",\n        \"to\": \"0d63a7e9\"\n      }\n    ]\n  },\n  \"45dd6d19\": {\n    \"title\": \"Multiple Sclerosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMultiple Sclerosis\u003c/b\u003e is an autoimmune \u003ci\u003edemyelinating disorder\u003c/i\u003e of the central nervous system characterized by the destruction of [[a24f9747|Oligodendrocytes]] and myelin sheaths, leading to neurological deficits separated in \u003cu\u003espace and time\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Triad (Charcot):\u003c/b\u003e \u003cmark\u003eScanning speech\u003c/mark\u003e, \u003cmark\u003eIntention tremor\u003c/mark\u003e, and \u003cmark\u003eNystagmus\u003c/mark\u003e (\u003cb\u003eSIN\u003c/b\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Findings:\u003c/b\u003e [[58c684bd|Internuclear Ophthalmoplegia]] (MLF lesion), Optic Neuritis (painful vision loss), Lhermitte sign (shock sensation on neck flexion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI shows [[d9286430|Periventricular plaques]]; CSF shows increased IgG and \u003cb\u003eOligoclonal bands\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute flares: IV Steroids. Disease modifying: [[00e48ea3|Beta-interferon]], [[88fffc48|Glatiramer]], [[ae20a0ce|Natalizumab]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral \u003cb\u003eInternuclear Ophthalmoplegia (INO)\u003c/b\u003e in a young female is pathognomonic for MS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe relapsing-remitting nature of \u003cb\u003eMultiple Sclerosis\u003c/b\u003e occurs because the CNS attempts to remyelinate damaged axons (using oligodendrocytes), but repeated autoimmune attacks eventually lead to permanent axonal loss and gliosis (plaques).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; Autoimmune_Attack--\u003eOligodendrocyte_Damage--\u003eDemyelination--\u003eSlowed_Nerve_Conduction--\u003eNeurological_Deficits;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"damages\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"00e48ea3\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ae20a0ce\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"98a63a59\"\n      }\n    ]\n  }\n}\n```\n\n\nNow process the first chunk:\n```json\n[\n  {\n    \"id\": \"dd11dde6\",\n    \"letter\": \"A\",\n    \"term\": \"Abducens nerve (CN VI)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Abducens nerve (CN VI)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ddbd2810\",\n        \"letter\": \"A\",\n        \"term\": \"damage to\",\n        \"pages\": [\n          \"556\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e damage to\"\n      },\n      {\n        \"id\": \"5ac9a13d\",\n        \"letter\": \"A\",\n        \"term\": \"function and type\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e function and type\"\n      },\n      {\n        \"id\": \"c452852d\",\n        \"letter\": \"A\",\n        \"term\": \"intracranial hypertension effects\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e intracranial hypertension effects\"\n      },\n      {\n        \"id\": \"18a8c97a\",\n        \"letter\": \"A\",\n        \"term\": \"ocular motility\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e ocular motility\"\n      },\n      {\n        \"id\": \"80048429\",\n        \"letter\": \"A\",\n        \"term\": \"palsy\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Abducens nerve (CN VI) \u003e palsy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c0b7a1ca\",\n    \"letter\": \"A\",\n    \"term\": \"Abnormal motor posturing\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Abnormal motor posturing\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a0c128f4\",\n    \"letter\": \"A\",\n    \"term\": \"Absence (petit mal) seizures\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Absence (petit mal) seizures\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e62961a0\",\n    \"letter\": \"A\",\n    \"term\": \"Absence seizure anticonvulsants\",\n    \"pages\": [\n      \"560\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Absence seizure anticonvulsants\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8558c64b\",\n    \"letter\": \"A\",\n    \"term\": \"Acalculia\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Acalculia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f218aebf\",\n    \"letter\": \"A\",\n    \"term\": \"Accessory nerve (CN XI)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Accessory nerve (CN XI)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"d854478f\",\n        \"letter\": \"A\",\n        \"term\": \"functions\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Accessory nerve (CN XI) \u003e functions\"\n      },\n      {\n        \"id\": \"dbb1948e\",\n        \"letter\": \"A\",\n        \"term\": \"lesions of\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Accessory nerve (CN XI) \u003e lesions of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"81b5f5fe\",\n    \"letter\": \"A\",\n    \"term\": \"Accommodation (eye)\",\n    \"pages\": [\n      \"519\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Accommodation (eye)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1df262e8\",\n    \"letter\": \"A\",\n    \"term\": \"Acetazolamide\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acetazolamide\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b450b802\",\n        \"letter\": \"A\",\n        \"term\": \"glaucoma therapy\",\n        \"pages\": [\n          \"568\"\n        ],\n        \"context\": \"Acetazolamide \u003e glaucoma therapy\"\n      },\n      {\n        \"id\": \"62d0ba3f\",\n        \"letter\": \"A\",\n        \"term\": \"hypertension\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Acetazolamide \u003e hypertension\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6a005559\",\n    \"letter\": \"A\",\n    \"term\": \"Acetylcholine (ACh)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acetylcholine (ACh)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c3eb18f9\",\n        \"letter\": \"A\",\n        \"term\": \"synthesis and change with diseases\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Acetylcholine (ACh) \u003e synthesis and change with diseases\"\n      }\n    ]\n  },\n  {\n    \"id\": \"87d19a70\",\n    \"letter\": \"A\",\n    \"term\": \"Achilles reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Achilles reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"fcedc59f\",\n    \"letter\": \"A\",\n    \"term\": \"Action potential\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Action potential\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1095ddab\",\n        \"letter\": \"A\",\n        \"term\": \"neurons\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Action potential \u003e neurons\"\n      }\n    ]\n  },\n  {\n    \"id\": \"67e83e3b\",\n    \"letter\": \"A\",\n    \"term\": \"Acute disseminated (postinfectious)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute disseminated (postinfectious)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7f9ae40d\",\n        \"letter\": \"A\",\n        \"term\": \"encephalomyelitis\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Acute disseminated (postinfectious) \u003e encephalomyelitis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ed52e40b\",\n    \"letter\": \"A\",\n    \"term\": \"Acute inflammatory demyelinating\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute inflammatory demyelinating\",\n    \"sub_entries\": [\n      {\n        \"id\": \"026b3479\",\n        \"letter\": \"A\",\n        \"term\": \"polyneuropathy\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Acute inflammatory demyelinating \u003e polyneuropathy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d268ace0\",\n    \"letter\": \"A\",\n    \"term\": \"Acute pulmonary edema, opioid\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Acute pulmonary edema, opioid\",\n    \"sub_entries\": [\n      {\n        \"id\": \"fc8f2199\",\n        \"letter\": \"A\",\n        \"term\": \"analgesics\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Acute pulmonary edema, opioid \u003e analgesics\"\n      }\n    ]\n  },\n  {\n    \"id\": \"76ba7f2e\",\n    \"letter\": \"A\",\n    \"term\": \"Adenohypophysis (anterior pituitary)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Adenohypophysis (anterior pituitary)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0e44cd2d\",\n        \"letter\": \"A\",\n        \"term\": \"hypothalamus and\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Adenohypophysis (anterior pituitary) \u003e hypothalamus and\"\n      }\n    ]\n  }\n]\n```\n",
      "role": "user",
      "tokenCount": 9477
    }, {
      "text": "**Analyzing Medical Terminology**\n\nOkay, I\u0027m deep diving into this JSON data. Each entry represents a medical concept from a textbook index and I have to translate it to knowledge cards. I\u0027m focusing on parsing the structured JSON and converting it into well-formatted JSON knowledge cards. It\u0027s a complex task, requiring precision to ensure accuracy in representing medical terminology.\n\n\n**Developing Knowledge Cards**\n\nI\u0027m working on a function to process the JSON list and transform each `main_entry` into a knowledge card. I\u0027ve successfully implemented the ID preservation and title extraction. Now, I\u0027m focusing on assigning the correct `primaryType` and determining the `classificationPath`. Then, I\u0027ll move on to populating the `definition` and `atAGlance` fields. It involves searching the markdown and transcript data to synthesize concise content for each card.\n\n\n**Structuring Knowledge Cards**\n\nI\u0027m now focusing on structuring the information for each card meticulously. I\u0027ve broken down my process: first, I preserve the original ID and extract the title and primary type. After that, I will correctly determine the classification path, aiming for a hierarchical structure to enhance clarity.  Next, the core content creation begins. I\u0027m focusing on the `definition` by searching the data, and using HTML formatting for emphasis and linking to build a network of connected concepts within the cards. Then, I will address the `atAGlance`, `takeAway`, and `mermaid` components. Finally, I will add active-verb relationship connections to the card.\n\n\n**Refining Card Components**\n\nI\u0027m now fully immersed in the card creation. I\u0027ve successfully parsed the JSON, preserved IDs, extracted titles, and assigned primary types. My current focus is refining content synthesis. Specifically, I\u0027m working to make the `definition` field concise and dense. I\u0027m also carefully crafting the `atAGlance` list and generating the `takeAway` sentence. I\u0027m testing the linking functionality, adding active-verb relationship connections, and beginning with HTML formatting and incorporating a Mermaid diagram where applicable.\n\n\n**Refining Knowledge Card Content**\n\nI\u0027m now diving into the specifics of each knowledge card. I\u0027ve successfully implemented all primary structure components including ID, title, type, and classification. Currently, I\u0027m fully engaged in content generation. I\u0027m focusing on crafting definitions, constructing \"atAGlance\" lists with 4-7 detailed points, and formulating \"takeAway\" sentences to highlight key concepts. The HTML formatting and linking are integrated and being refined. Finally, I\u0027ll be adding active-verb relationships.\n\n\n**Crafting Detailed Knowledge**\n\nI\u0027ve moved on to the core content generation phase, working through each medical term. Now, I\u0027m focusing on synthesizing definitions, creating \"atAGlance\" lists with detailed points (4-7 items), and formulating concise \"takeAway\" sentences. HTML formatting and linking are integrated and being tested.\n\n\n**Structuring Card Content**\n\nI\u0027ve just finished the plan for my knowledge card creation process. I\u0027m focusing on parsing the input JSON data, preserving IDs, extracting titles and primary types, classifying the entries, and defining the HTML markup and linking procedures. My next step will be to start the content synthesis for each medical concept. I\u0027ve designed the processes to ensure a dense, precise, well-structured, and well-linked collection of knowledge.\n\n\n**Structuring Knowledge Base**\n\nI\u0027ve carefully designed my process for building these knowledge cards. I\u0027m focusing on parsing the data, preserving IDs, extracting key information, and implementing a strict structure for definitions, concise overviews, and takeaways. HTML formatting and linking are being planned, and I\u0027ll include active-verb connections.\n\n\n**Creating Dense Knowledge Cards**\n\nI\u0027m now fully engaged in the content creation phase, translating each medical term into a comprehensive knowledge card. I\u0027m prioritizing accuracy, density, and adherence to the specified format. The current focus is on crafting concise definitions, constructing \"atAGlance\" lists, and formulating \"takeAway\" sentences to highlight key concepts. HTML formatting and linking are being implemented, along with active-verb connections and Mermaid diagrams where applicable, for a well-structured and interconnected knowledge base. I\u0027ve begun with the \"Abducens nerve (CN VI)\" entry.\n\n\n",
      "role": "model",
      "tokenCount": 2036,
      "isThought": true,
      "thinkingBudget": 32768,
      "parts": [{
        "text": "**Analyzing Medical Terminology**\n\nOkay, I\u0027m deep diving into this JSON data. Each entry represents a medical concept from a textbook index and I have to translate it to knowledge cards. I\u0027m focusing on parsing the structured JSON and converting it into well-formatted JSON knowledge cards. It\u0027s a complex task, requiring precision to ensure accuracy in representing medical terminology.\n\n\n",
        "thought": true
      }, {
        "text": "**Developing Knowledge Cards**\n\nI\u0027m working on a function to process the JSON list and transform each `main_entry` into a knowledge card. I\u0027ve successfully implemented the ID preservation and title extraction. Now, I\u0027m focusing on assigning the correct `primaryType` and determining the `classificationPath`. Then, I\u0027ll move on to populating the `definition` and `atAGlance` fields. It involves searching the markdown and transcript data to synthesize concise content for each card.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Knowledge Cards**\n\nI\u0027m now focusing on structuring the information for each card meticulously. I\u0027ve broken down my process: first, I preserve the original ID and extract the title and primary type. After that, I will correctly determine the classification path, aiming for a hierarchical structure to enhance clarity.  Next, the core content creation begins. I\u0027m focusing on the `definition` by searching the data, and using HTML formatting for emphasis and linking to build a network of connected concepts within the cards. Then, I will address the `atAGlance`, `takeAway`, and `mermaid` components. Finally, I will add active-verb relationship connections to the card.\n\n\n",
        "thought": true
      }, {
        "text": "**Refining Card Components**\n\nI\u0027m now fully immersed in the card creation. I\u0027ve successfully parsed the JSON, preserved IDs, extracted titles, and assigned primary types. My current focus is refining content synthesis. Specifically, I\u0027m working to make the `definition` field concise and dense. I\u0027m also carefully crafting the `atAGlance` list and generating the `takeAway` sentence. I\u0027m testing the linking functionality, adding active-verb relationship connections, and beginning with HTML formatting and incorporating a Mermaid diagram where applicable.\n\n\n",
        "thought": true
      }, {
        "text": "**Refining Knowledge Card Content**\n\nI\u0027m now diving into the specifics of each knowledge card. I\u0027ve successfully implemented all primary structure components including ID, title, type, and classification. Currently, I\u0027m fully engaged in content generation. I\u0027m focusing on crafting definitions, constructing \"atAGlance\" lists with 4-7 detailed points, and formulating \"takeAway\" sentences to highlight key concepts. The HTML formatting and linking are integrated and being refined. Finally, I\u0027ll be adding active-verb relationships.\n\n\n",
        "thought": true
      }, {
        "text": "**Crafting Detailed Knowledge**\n\nI\u0027ve moved on to the core content generation phase, working through each medical term. Now, I\u0027m focusing on synthesizing definitions, creating \"atAGlance\" lists with detailed points (4-7 items), and formulating concise \"takeAway\" sentences. HTML formatting and linking are integrated and being tested.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Card Content**\n\nI\u0027ve just finished the plan for my knowledge card creation process. I\u0027m focusing on parsing the input JSON data, preserving IDs, extracting titles and primary types, classifying the entries, and defining the HTML markup and linking procedures. My next step will be to start the content synthesis for each medical concept. I\u0027ve designed the processes to ensure a dense, precise, well-structured, and well-linked collection of knowledge.\n\n\n",
        "thought": true
      }, {
        "text": "**Structuring Knowledge Base**\n\nI\u0027ve carefully designed my process for building these knowledge cards. I\u0027m focusing on parsing the data, preserving IDs, extracting key information, and implementing a strict structure for definitions, concise overviews, and takeaways. HTML formatting and linking are being planned, and I\u0027ll include active-verb connections.\n\n\n",
        "thought": true
      }, {
        "text": "**Creating Dense Knowledge Cards**\n\nI\u0027m now fully engaged in the content creation phase, translating each medical term into a comprehensive knowledge card. I\u0027m prioritizing accuracy, density, and adherence to the specified format. The current focus is on crafting concise definitions, constructing \"atAGlance\" lists, and formulating \"takeAway\" sentences to highlight key concepts. HTML formatting and linking are being implemented, along with active-verb connections and Mermaid diagrams where applicable, for a well-structured and interconnected knowledge base. I\u0027ve begun with the \"Abducens nerve (CN VI)\" entry.\n\n\n",
        "thought": true
      }]
    }, {
      "text": "```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e that originates from the pontomedullary junction and \u003cu\u003eexclusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], which is responsible for abduction of the eye (looking laterally).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor innervation to the ipsilateral [[f7b5ee5d|lateral rectus muscle]], enabling abduction (lateral eye movement).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits the brainstem at the pontomedullary junction, traverses the subarachnoid space, passes through the [[c260efc8|cavernous sinus]] near the internal carotid artery, and enters the orbit via the superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e Damage results in an inability to abduct the affected eye, leading to a medially directed strabismus at rest and horizontal [[9914d433|diplopia]] that worsens on attempted lateral gaze toward the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVulnerability:\u003c/b\u003e Its long intracranial course makes it highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e ([[7c4e7c74|idiopathic intracranial hypertension]], tumors, hydrocephalus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy is often a \u003cmark\u003e\\\"false localizing sign\\\"\u003c/mark\u003e of elevated ICP rather than a direct brainstem lesion. It is the most commonly affected cranial nerve in [[c260efc8|cavernous sinus syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest intracranial course of all cranial nerves, making it uniquely vulnerable to stretching and compression from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy that signals a generalized brain pressure problem rather than a specific brainstem lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; A[PPRF] --\u003e B[CN VI Nucleus]; B --\u003e C[Ipsilateral Lateral Rectus]; B --\u003e D[Contralateral MLF]; D --\u003e E[Contralateral CN III Nucleus]; E --\u003e F[Contralateral Medial Rectus];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        \"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"palsy_causes\",\n        \"to\": \"9914d433\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"9a089fd7\"\n      }\n    ]\n  },\n  \"c0b7a1ca\": {\n    \"title\": \"Abnormal Motor Posturing\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Coma\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbnormal motor posturing\u003c/b\u003e refers to involuntary flexion or extension of the arms and legs, indicating \u003ci\u003esevere brain injury\u003c/i\u003e. It occurs in patients who are comatose and reflects damage to motor pathways between the cerebral cortex and the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDecorticate (Flexor) Posturing:\u003c/b\u003e Characterized by flexion of the arms, wrists, and fingers with adduction of the upper extremities, alongside extension, internal rotation, and plantar flexion of the lower extremities. Mnemonic: Hands are near the \u0027\u003cb\u003ecor\u003c/b\u003e\u0027 (heart).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecorticate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eabove the red nucleus\u003c/u\u003e in the midbrain, such as in the cerebral hemispheres or internal capsule. The rubrospinal tract (flexor tone) is intact and overrides the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate (Extensor) Posturing:\u003c/b\u003e Characterized by extension, adduction, and internal rotation of the arms with extension of the legs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eat or below the red nucleus\u003c/u\u003e (e.g., midbrain tegmentum, pons). The loss of the rubrospinal tract leads to unopposed extension tone from the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Decerebrate posturing generally indicates a more severe brain injury and carries a \u003cu\u003eworse prognosis\u003c/u\u003e than decorticate posturing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe type of abnormal posturing provides a crucial clue to the anatomical level of severe brain injury; \u003cb\u003edecorticate\u003c/b\u003e posturing implies a lesion above the red nucleus preserving flexor pathways, whereas \u003cb\u003edecerebrate\u003c/b\u003e posturing signifies a more caudal lesion below the red nucleus, leaving only extensor pathways unopposed.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cerebral Cortex] --\u003e B[Red Nucleus]; B --\u003e C[Rubrospinal Tract Flexion]; A --\u003e D[Vestibular Nuclei]; D --\u003e E[Vestibulospinal Tract Extension]; F(Lesion Above Red Nucleus) --\u003e G{Decorticate}; B --x F; H(Lesion Below Red Nucleus) --\u003e I{Decerebrate}; C --x H;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"e9a47751\"\n      },\n      {\n        \"type\": \"differentiates_lesion_level_in\",\n        \"to\": \"a584135d\"\n      }\n    ]\n  },\n  \"a0c128f4\": {\n    \"title\": \"Absence Seizures (Petit Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e, formerly known as \u003ci\u003epetit mal seizures\u003c/i\u003e, are a type of generalized seizure characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for seconds. They are most common in childhood and are often mistaken for daydreaming or inattentiveness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden cessation of activity with a blank stare, lasting about 10 seconds. May be accompanied by subtle automatisms like eyelid fluttering or lip smacking. There is \u003cu\u003eno postictal confusion\u003c/u\u003e; the patient immediately returns to baseline.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Hallmark:\u003c/b\u003e The pathognomonic finding is a \u003cmark\u003egeneralized 3 Hz spike-and-wave discharge\u003c/mark\u003e on EEG.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProvocation:\u003c/b\u003e Seizures can often be triggered by \u003cmark\u003ehyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e treatment is [[ethosuximide]]. [[valproic_acid|Valproic acid]] is also effective and used if tonic-clonic seizures are also present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette describes a child whose teacher complains of \u0027daydreaming\u0027 or \u0027not paying attention\u0027 in class. The diagnosis is confirmed by a 3 Hz spike-and-wave pattern on EEG, often induced by having the child hyperventilate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e are unique among generalized seizures for their brief, non-convulsive nature, lack of postictal confusion, and a pathognomonic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e EEG pattern, making [[ethosuximide]] the specific and preferred treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamic T-type Ca2+ Channels] -- Overactivity --\u003e B(Absence Seizure); C(Ethosuximide) -- Blocks --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \"type\": \"presents_with_eeg_finding\",\n        \"to\": \"eeg_3hz_spike_wave\"\n      }\n    ]\n  },\n  \"e62961a0\": {\n    \"title\": \"Absence Seizure Anticonvulsants\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pharmacology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizure anticonvulsants\u003c/b\u003e are medications specifically effective in treating [[a0c128f4|absence seizures]], primarily by targeting the T-type calcium channels in thalamic neurons, which are implicated in the generation of the characteristic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e discharges.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFirst-Line Agent:\u003c/b\u003e [[a90f6fb4|Ethosuximide]] is the \u003cu\u003efirst-line\u003c/u\u003e and most specific drug for treating isolated absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Ethosuximide:\u003c/b\u003e Blocks T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels in thalamic neurons, disrupting the oscillatory rhythm between the thalamus and cortex that generates absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlternative Agent:\u003c/b\u003e [[valproic_acid|Valproic acid]] is also effective and is preferred if the patient has concomitant generalized tonic-clonic seizures. It works by blocking T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels and increasing [[5aa5cb91|GABA]] levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindicated Agents:\u003c/b\u003e Certain anticonvulsants, such as [[eddd2bc5|carbamazepine]] and [[5aea213f|phenytoin]], can \u003cu\u003eworsen\u003c/u\u003e absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a child with staring spells and a 3 Hz spike-and-wave EEG, the answer for treatment is almost always [[a90f6fb4|Ethosuximide]]. If tonic-clonic seizures are also mentioned, consider [[valproic_acid|Valproic acid]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe treatment of [[a0c128f4|absence seizures]] is highly specific, with [[a90f6fb4|Ethosuximide]] being the drug of choice due to its targeted blockade of thalamic T-type calcium channels, while other common anticonvulsants like carbamazepine are paradoxically contraindicated.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"valproic_acid\"\n      }\n    ]\n  },\n  \"8558c64b\": {\n    \"title\": \"Acalculia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is an acquired neurological deficit characterized by the \u003ci\u003einability to perform simple mathematical calculations\u003c/i\u003e, resulting from damage to specific brain regions, most notably the dominant (usually left) parietal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Acalculia is a key localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAcalculia\u003c/b\u003e, \u003cb\u003eAgraphia\u003c/b\u003e (inability to write), \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [[143bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a patient presents with difficulty with calculations along with any of the other components of Gerstmann syndrome, immediately suspect a lesion in the dominant parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is more than just \u0027bad at math\u0027; it is a specific neurological sign that strongly points to a lesion in the dominant angular gyrus, often as part of the clinically distinct [[38f3ed1f|Gerstmann syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"f218aebf\": {\n    \"title\": \"Accessory Nerve (CN XI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is a \u003ci\u003emotor cranial nerve\u003c/i\u003e that provides innervation to the \u003cu\u003esternocleidomastoid (SCM)\u003c/u\u003e and \u003cu\u003etrapezius\u003c/u\u003e muscles, which are crucial for head turning and shoulder shrugging, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Innervates the ipsilateral \u003cb\u003eSternocleidomastoid (SCM)\u003c/b\u003e muscle, which turns the head to the contralateral side, and the ipsilateral \u003cb\u003eTrapezius\u003c/b\u003e muscle, which elevates and stabilizes the scapula (shoulder shrug).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Uniquely arises from both the brainstem (medulla) and the spinal cord (C1-C5). The spinal root ascends through the foramen magnum to join the cranial root, and the combined nerve then exits the skull via the [[jugular_foramen|jugular foramen]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (SCM):\u003c/b\u003e Weakness in turning the head \u003cu\u003eaway\u003c/u\u003e from the side of the lesion. (e.g., Left CN XI lesion causes weakness turning head to the right).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (Trapezius):\u003c/b\u003e \u003cmark\u003eShoulder droop\u003c/mark\u003e, weakness in shrugging the shoulder on the ipsilateral side, and winging of the scapula.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A common iatrogenic cause of an isolated CN XI lesion is injury during procedures in the \u003cmark\u003eposterior triangle of the neck\u003c/mark\u003e, such as lymph node biopsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is unique in its dual origin from both the medulla and cervical spinal cord, and a lesion presents with the distinct combination of weakness turning the head to the contralateral side and an ipsilateral shoulder droop.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CN XI Nuclei Medulla \u0026 C1-C5] --\u003e B(CN XI); B --\u003e C[Exits via Jugular Foramen]; C --\u003e D[Innervates SCM]; C --\u003e E[Innervates Trapezius];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"sternocleidomastoid_muscle\"\n      },\n      {\n        \"type\": \"innervates\",\n        \"to\": \"trapezius_muscle\"\n      },\n      {\n        \"type\": \"exits_skull_via\",\n        \"to\": \"jugular_foramen\"\n      }\n    ]\n  },\n  \"81b5f5fe\": {\n    \"title\": \"Accommodation (Eye)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAccommodation\u003c/b\u003e is a reflex action of the eye in response to focusing on a near object, involving a coordinated triad of changes: \u003ci\u003eciliary muscle contraction\u003c/i\u003e, \u003ci\u003epupillary constriction (miosis)\u003c/i\u003e, and \u003ci\u003econvergence of the eyes\u003c/i\u003e to maintain a clear image on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e It is a parasympathetic response mediated by the [[68c66997|oculomotor nerve (CN III)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCiliary Muscle Contraction:\u003c/b\u003e Contraction of the ciliary muscle relaxes the zonular fibers, allowing the lens to become more convex (rounder), which increases its refractive power for near vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupillary Constriction (Miosis):\u003c/b\u003e The sphincter pupillae muscle contracts, narrowing the pupil to increase the depth of field.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConvergence:\u003c/b\u003e The medial rectus muscles contract to direct both eyes medially toward the near object.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of accommodation with age is called [[presbyopia]]. A pupil that accommodates but does not react to light is an [[08cb577f|Argyll Robertson pupil]], a classic sign of neurosyphilis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eaccommodation reflex\u003c/b\u003e is a parasympathetically driven process via [[68c66997|CN III]] that allows for clear near vision by increasing the lens\u0027s refractive power through ciliary muscle contraction, a mechanism that becomes less effective with age, leading to presbyopia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Focus on Near Object] --\u003e B[Visual Cortex]; B --\u003e C[CN III Nucleus Edinger-Westphal]; C --\u003e D[Ciliary Ganglion]; D --\u003e E[Ciliary Muscle Contraction -\u003e Lens rounds]; D --\u003e F[Sphincter Pupillae Contraction -\u003e Miosis]; B --\u003e G[CN III Motor Nucleus]; G --\u003e H[Medial Rectus Contraction -\u003e Convergence];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"presbyopia\"\n      },\n      {\n        \"type\": \"is_dissociated_from_light_reflex_in\",\n        \"to\": \"08cb577f\"\n      }\n    ]\n  },\n  \"1df262e8\": {\n    \"title\": \"Acetazolamide\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e is a \u003ci\u003ecarbonic anhydrase inhibitor\u003c/i\u003e used as a diuretic and to reduce pressure in the eye and brain by decreasing the formation of aqueous humor and cerebrospinal fluid, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits the enzyme carbonic anhydrase in the ciliary body epithelium and choroid plexus, which reduces the formation of bicarbonate ions (HCO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e-\u003c/sup\u003e) and subsequently decreases fluid secretion (aqueous humor and CSF).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Ophthalmology):\u003c/b\u003e Treats [[3ce6c035|glaucoma]] (both open-angle and acute angle-closure) by \u003cmark\u003edecreasing aqueous humor synthesis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Treats [[7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri) by decreasing CSF production. Also used for altitude sickness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes a \u003cmark\u003ehyperchloremic metabolic acidosis\u003c/mark\u003e (non-anion gap), paresthesias, ammonia toxicity in liver disease, and promotes calcium phosphate kidney stones (due to alkalinization of urine). It is a sulfa drug, so watch for sulfa allergies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u0027ACID-azolamide\u0027 to recall that it causes a metabolic \u003cb\u003eACID\u003c/b\u003eosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e\u0027s therapeutic effect in both [[3ce6c035|glaucoma]] and [[7c4e7c74|idiopathic intracranial hypertension]] stems from the same core mechanism: inhibiting carbonic anhydrase to reduce the production of bicarbonate-driven fluids, namely aqueous humor and cerebrospinal fluid.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetazolamide] --|Inhibits|--\u003e B(Carbonic Anhydrase); B --|Blocks|--\u003e C(H2O + CO2 \u003c--\u003e H2CO3 \u003c--\u003e H+ + HCO3-); C --|Leads to|--\u003e D[Decreased Aqueous Humor/CSF Production];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"metabolic_acidosis\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"carbonic_anhydrase_inhibitor\"\n      }\n    ]\n  },\n  \"6a005559\": {\n    \"title\": \"Acetylcholine (ACh)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetylcholine (ACh)\u003c/b\u003e is a major \u003ci\u003eexcitatory neurotransmitter\u003c/i\u003e synthesized from choline and acetyl-CoA that functions at the neuromuscular junction, in all autonomic ganglia, at parasympathetic postganglionic nerve endings, and at various sites within the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized by Choline Acetyltransferase (ChAT) from choline and acetyl-CoA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegradation:\u003c/b\u003e Rapidly broken down in the synaptic cleft by Acetylcholinesterase (AChE) into choline and acetate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Role:\u003c/b\u003e Crucial for memory and cognition. Levels are significantly decreased in [[77ae6148|Alzheimer disease]] due to degeneration of neurons in the [[361438f2|Basal nucleus of Meynert]]. Levels are also decreased in [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePNS Role:\u003c/b\u003e Neurotransmitter at all preganglionic autonomic synapses (nicotinic), all parasympathetic postganglionic synapses (muscarinic), sympathetic postganglionic synapses to sweat glands (muscarinic), and the neuromuscular junction (nicotinic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Diseases affecting ACh are high-yield. [[77ae6148|Alzheimer\u0027s]] (‚Üì CNS ACh), Myasthenia Gravis (antibodies to ACh receptors), Lambert-Eaton (‚Üì presynaptic ACh release). Drugs targeting AChE (e.g., [[47d0372e|donepezil]]) are used to treat Alzheimer\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetylcholine\u003c/b\u003e is a versatile neurotransmitter whose function is critically dependent on its location; its depletion in the [[361438f2|Basal nucleus of Meynert]] leads to cognitive decline in [[77ae6148|Alzheimer disease]], while its blockade at the neuromuscular junction causes paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choline + Acetyl-CoA] --ChAT--\u003e B(Acetylcholine); B --AChE--\u003e C[Choline + Acetate]; B --\u003e D{Receptors}; D --\u003e D1[Nicotinic]; D --\u003e D2[Muscarinic];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"lambert_eaton_syndrome\"\n      },\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"361438f2\"\n      }\n    ]\n  },\n  \"87d19a70\": {\n    \"title\": \"Achilles Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e, also known as the ankle jerk reflex, is a deep tendon reflex that involves plantar flexion of the foot in response to tapping the Achilles tendon, testing the integrity of the \u003cmark\u003eS1 and S2\u003c/mark\u003e spinal nerve roots.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eS1\u003c/b\u003e nerve root, with contribution from S2. Mnemonic: S\u003cb\u003e1\u003c/b\u003e, 2, buckle my shoe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the gastrocnemius muscle, activating stretch receptors. The afferent signal travels via the tibial nerve to the S1/S2 spinal cord segments, synapses, and an efferent motor signal returns via the tibial nerve to cause plantar flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the S1 root, or peripheral neuropathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the S1/S2 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An absent Achilles reflex is a classic finding in [[71daebd6|Tabes Dorsalis]] and [[lumbosacral_radiculopathy|S1 radiculopathy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e is a simple yet powerful clinical tool that specifically assesses the integrity of the S1 spinal nerve root; its absence or exaggeration can help differentiate between lower and upper motor neuron pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Achilles Tendon] --\u003e B(Stretch Gastrocnemius); B --\u003e C(Afferent Signal via Tibial N.); C --\u003e D[S1/S2 Spinal Cord]; D --\u003e E(Efferent Signal via Tibial N.); E --\u003e F(Plantar Flexion);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"s1_nerve_root\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"fcedc59f\": {\n    \"title\": \"Neuron Action Potential\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eneuron action potential\u003c/b\u003e is a rapid, all-or-none electrical signal that propagates down an axon, caused by the sequential opening and closing of \u003ci\u003evoltage-gated ion channels\u003c/i\u003e, which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eResting Potential (~-70 mV):\u003c/b\u003e Maintained by the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump and high resting permeability to K\u003csup\u003e+\u003c/sup\u003e (K\u003csup\u003e+\u003c/sup\u003e leak channels).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDepolarization:\u003c/b\u003e A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage-gated \u003cmark\u003eNa\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e, causing a massive influx of Na\u003csup\u003e+\u003c/sup\u003e and a sharp rise in membrane potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRepolarization:\u003c/b\u003e Voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels inactivate, and voltage-gated \u003cmark\u003eK\u003csup\u003e+\u003c/sup\u003e channels\u003c/mark\u003e open, leading to an efflux of K\u003csup\u003e+\u003c/sup\u003e that brings the membrane potential back down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperpolarization:\u003c/b\u003e K\u003csup\u003e+\u003c/sup\u003e channels are slow to close, causing the membrane potential to briefly dip below the resting potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many neurotoxins and drugs target these channels. [[tetrodotoxin|Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]] block voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing action potential propagation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the rising phase (depolarization), and a subsequent efflux of \u003cb\u003eK\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the falling phase (repolarization), enabling high-speed signal transmission.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A(Resting State) --Stimulus--\u003e B(Threshold); B --Na+ Influx--\u003e C(Depolarization); C --Na+ Inactivation \u0026 K+ Efflux--\u003e D(Repolarization); D --Slow K+ Channel Closing--\u003e E(Hyperpolarization); E --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"tetrodotoxin\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_fundamental_to\",\n        \"to\": \"synaptic_transmission\"\n      }\n    ]\n  },\n  \"67e83e3b\": {\n    \"title\": \"Acute Disseminated Encephalomyelitis (ADEM)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated Encephalomyelitis (ADEM)\u003c/b\u003e is a rare, acute, \u003ci\u003eimmune-mediated inflammatory and demyelinating disorder\u003c/i\u003e of the central nervous system that typically occurs following a viral infection or, less commonly, a vaccination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to be caused by \u003cmark\u003emolecular mimicry\u003c/mark\u003e, where an immune response against an infectious agent cross-reacts with myelin antigens (e.g., myelin basic protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapid onset of multifocal neurological symptoms, including encephalopathy (altered mental status, confusion, coma), which is a key feature distinguishing it from a typical [[45dd6d19|Multiple Sclerosis]] flare. Other symptoms include fever, headache, seizures, and focal deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Symptoms typically appear 1-2 weeks after an antecedent infection (e.g., measles, varicella) or vaccination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI shows multiple, bilateral, asymmetric, poorly demarcated white matter lesions of similar age, often involving both the brain and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate ADEM from [[45dd6d19|MS]]: ADEM is \u003cu\u003emonophasic\u003c/u\u003e and presents with encephalopathy, whereas MS is typically relapsing-remitting and rarely presents with encephalopathy in its initial flare.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated Encephalomyelitis\u003c/b\u003e is a post-infectious autoimmune attack on CNS myelin, distinguished from [[45dd6d19|Multiple Sclerosis]] by its \u003cu\u003emonophasic\u003c/u\u003e course and the prominent presence of encephalopathy alongside multifocal neurological deficits.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Viral Infection/Vaccination] --\u003e B(Immune Response); B --Molecular Mimicry--\u003e C[Attack on Myelin]; C --\u003e D[Perivenous Inflammation \u0026 Demyelination]; D --\u003e E[Multifocal Neurologic Deficits + Encephalopathy];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelinating_disorder\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"viral_infection\"\n      }\n    ]\n  },\n  \"ed52e40b\": {\n    \"title\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Inflammatory Demyelinating Polyneuropathy (AIDP)\u003c/b\u003e is the most common subtype of \u003ci\u003eGuillain-Barr√© Syndrome\u003c/i\u003e, an autoimmune condition characterized by the rapid onset of symmetric, ascending muscle weakness or paralysis and destruction of myelin sheaths of peripheral nerves by Schwann cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Often triggered by an antecedent infection (classically \u003cmark\u003eCampylobacter jejuni\u003c/mark\u003e, also CMV, EBV, Zika). It is thought to be due to \u003cmark\u003emolecular mimicry\u003c/mark\u003e between microbial antigens and peripheral nerve myelin or axons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapidly progressive, symmetric \u003cmark\u003eascending weakness/paralysis\u003c/mark\u003e starting in the lower extremities. Patients often have absent or depressed deep tendon reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Complications:\u003c/b\u003e Respiratory failure due to diaphragmatic weakness is a life-threatening complication. Autonomic dysfunction (tachycardia, arrhythmias, BP instability) is also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e CSF analysis shows \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e (high protein with a normal cell count). Nerve conduction studies show slowed nerve conduction velocity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of recent diarrheal illness (*C. jejuni*) followed by ascending paralysis and high protein in the CSF with normal cell count is a classic vignette for Guillain-Barr√© Syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAIDP (Guillain-Barr√© Syndrome)\u003c/b\u003e is an acute, post-infectious autoimmune attack on peripheral nerve myelin, leading to a characteristic ascending paralysis; the hallmark diagnostic finding is \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e in the CSF, reflecting widespread inflammation of nerve roots without direct infection.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Antecedent Infection e.g., C. jejuni] --\u003e B(Molecular Mimicry); B --\u003e C[Immune Attack on Schwann Cells/Myelin]; C --\u003e D[Peripheral Nerve Demyelination]; D --\u003e E[Ascending Paralysis \u0026 Areflexia];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_subtype_of\",\n        \"to\": \"e8720ceb\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"campylobacter_jejuni\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"a0f3ce4c\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"schwann_cells\"\n      }\n    ]\n  },\n  \"d268ace0\": {\n    \"title\": \"Opioid-Induced Acute Pulmonary Edema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Toxicology\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Respiratory\",\n      \"Pathology\",\n      \"Acute Respiratory Distress Syndrome\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid-induced acute pulmonary edema\u003c/b\u003e is a form of \u003ci\u003enon-cardiogenic pulmonary edema\u003c/i\u003e that can occur as a life-threatening complication of opioid overdose, characterized by increased pulmonary vascular permeability and subsequent alveolar flooding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact mechanism is multifactorial but is thought to involve direct toxic effects on the pulmonary capillary endothelium, hypoxia-induced vascular injury, and a massive sympathetic surge following transient hypoxia, all leading to \u003cmark\u003eincreased vascular permeability\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Occurs shortly after an opioid overdose. Patients present with severe dyspnea, hypoxia, frothy pink sputum, and diffuse crackles on auscultation, often after being resuscitated with [[naloxone]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiology:\u003c/b\u003e Chest X-ray shows bilateral diffuse alveolar infiltrates, consistent with pulmonary edema, but with a normal cardiac silhouette (distinguishing it from cardiogenic pulmonary edema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is supportive and includes supplemental oxygen, non-invasive or mechanical ventilation, and addressing the underlying opioid overdose. Diuretics are \u003cu\u003enot effective\u003c/u\u003e as the cause is permeability, not fluid overload.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be aware of the patient who is treated for an opioid overdose with [[naloxone]] and subsequently develops severe respiratory distress; this points towards non-cardiogenic pulmonary edema rather than a cardiac cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike cardiogenic pulmonary edema which is caused by high hydrostatic pressure, \u003cb\u003eopioid-induced pulmonary edema\u003c/b\u003e is a permeability problem where opioid toxicity and hypoxia damage the alveolar-capillary barrier, leading to leaky vessels and flooded lungs that do not respond to diuretics.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Opioid Overdose] --\u003e B(Hypoxia \u0026 Direct Toxicity); B --\u003e C[Pulmonary Capillary Endothelial Damage]; C --\u003e D[Increased Vascular Permeability]; D --\u003e E[Alveolar Flooding]; E --\u003e F[Non-Cardiogenic Pulmonary Edema];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"acute_respiratory_distress_syndrome\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \"to\": \"naloxone\"\n      }\n    ]\n  },\n  \"76ba7f2e\": {\n    \"title\": \"Adenohypophysis (Anterior Pituitary)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Pituitary Gland\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e, or anterior pituitary, is the anterior lobe of the pituitary gland, an endocrine gland of ectodermal origin (from \u003ci\u003eRathke\u0027s pouch\u003c/i\u003e) that synthesizes and secretes six major peptide hormones in response to releasing and inhibiting hormones from the [[89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from an upward evagination of the oral ectoderm called \u003cmark\u003eRathke\u0027s pouch\u003c/mark\u003e. Remnants can form a [[7048db1e|craniopharyngioma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormones Secreted:\u003c/b\u003e The anterior pituitary hormones can be remembered with the mnemonic \u003cb\u003eFLAT PiG\u003c/b\u003e: \u003cb\u003eF\u003c/b\u003eSH, \u003cb\u003eL\u003c/b\u003eH, \u003cb\u003eA\u003c/b\u003eCTH, \u003cb\u003eT\u003c/b\u003eSH (Tropic hormones), and \u003cb\u003eP\u003c/b\u003erolactin, \u003cb\u003ei\u003c/b\u003e(ignore), \u003cb\u003eG\u003c/b\u003eH (Direct hormones).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Types:\u003c/b\u003e Somatotrophs (GH), Lactotrophs (Prolactin), Corticotrophs (ACTH), Thyrotrophs (TSH), and Gonadotrophs (FSH/LH).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Receives blood from the superior hypophyseal artery, which forms a portal system (hypothalamic-hypophyseal portal system) that transports hypothalamic releasing/inhibiting hormones directly to the anterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The most common tumor of the pituitary is a [[5f3188bd|pituitary adenoma]], which is most frequently a prolactinoma. Its connection to the [[89e86633|hypothalamus]] is vascular, in contrast to the posterior pituitary\u0027s neural connection.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e is the hormonal powerhouse of the pituitary, controlled by the [[89e86633|hypothalamus]] via a unique portal venous system, and its diverse cell populations are responsible for regulating growth, stress, reproduction, and metabolism throughout the body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --Releasing/Inhibiting Hormones--\u003e B(Hypophyseal Portal System); B --\u003e C(Adenohypophysis); C --\u003e D[FSH, LH]; C --\u003e E[ACTH]; C --\u003e F[TSH]; C --\u003e G[Prolactin]; C --\u003e H[GH];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"pituitary_gland\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"growth_hormone\"\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"prolactin\"\n      },\n      {\n        \"type\": \"can_develop\",\n        \"to\": \"5f3188bd\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10313,
      "branchChildren": [{
        "promptId": "prompts/1Soy_pVclcd5n7Uwm824IvFQPJ3ueULKg",
        "displayName": "Branch of Copy of Copy of Copy of Copy of Copy of gemini_usmle_notes"
      }],
      "parts": [{
        "text": "```json\n{\n  \"dd11dde6\": {\n    \"title\": \"Abducens Nerve"
      }, {
        "text": " (CN VI)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Cranial Nerves\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"C"
      }, {
        "text": "ranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve"
      }, {
        "text": " (CN VI)\u003c/b\u003e is a somatic \u003ci\u003emotor cranial nerve\u003c/i\u003e that originates from the pontomedullary junction and \u003cu\u003eex"
      }, {
        "text": "clusively innervates\u003c/u\u003e the [[f7b5ee5d|Lateral Rectus muscle]], which is responsible for abduction"
      }, {
        "text": " of the eye (looking laterally).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor"
      }, {
        "text": " innervation to the ipsilateral [[f7b5ee5d|lateral rectus muscle]], enabling abduction (lateral eye"
      }, {
        "text": " movement).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Exits the brainstem at the pontomedullary junction, traverses the subarachnoid space, passes"
      }, {
        "text": " through the [[c260efc8|cavernous sinus]] near the internal carotid artery, and enters"
      }, {
        "text": " the orbit via the superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e Damage results in an inability to ab"
      }, {
        "text": "duct the affected eye, leading to a medially directed strabismus at rest and horizontal [[9914d"
      }, {
        "text": "433|diplopia]] that worsens on attempted lateral gaze toward the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eV"
      }, {
        "text": "ulnerability:\u003c/b\u003e Its long intracranial course makes it highly susceptible to downward traction from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e ([["
      }, {
        "text": "7c4e7c74|idiopathic intracranial hypertension]], tumors, hydrocephalus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An"
      }, {
        "text": " isolated CN VI palsy is often a \u003cmark\u003e\\\"false localizing sign\\\"\u003c/mark\u003e of elevated ICP rather than a direct"
      }, {
        "text": " brainstem lesion. It is the most commonly affected cranial nerve in [[c260efc8|cavernous sinus syndrome"
      }, {
        "text": "]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAbducens Nerve\u003c/b\u003e has the longest intracranial course of all cranial"
      }, {
        "text": " nerves, making it uniquely vulnerable to stretching and compression from \u003cu\u003eincreased intracranial pressure\u003c/u\u003e, often presenting as a nonlocalizing palsy"
      }, {
        "text": " that signals a generalized brain pressure problem rather than a specific brainstem lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR"
      }, {
        "text": "; A[PPRF] --\u003e B[CN VI Nucleus]; B --\u003e C[Ipsilateral Lateral Rectus]; B --\u003e"
      }, {
        "text": " D[Contralateral MLF]; D --\u003e E[Contralateral CN III Nucleus]; E --\u003e F[Cont"
      }, {
        "text": "ralateral Medial Rectus];\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"innervates\",\n        \"to\": \"f7b5ee5d\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_vulnerable_to\",\n        \"to\": \"7c4e7c7"
      }, {
        "text": "4\"\n      },\n      {\n        \"type\": \"palsy_causes\",\n        \"to\": \"9"
      }, {
        "text": "914d433\"\n      },\n      {\n        \"type\": \"is_affected_"
      }, {
        "text": "in\",\n        \"to\": \"9a089fd7\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"c0b7a1ca\": {\n    \"title\": \"Abnormal Motor Posturing\",\n    \""
      }, {
        "text": "primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Coma\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eAbnormal motor posturing\u003c/b\u003e refers to involuntary flexion or extension of the arms and legs, indicating "
      }, {
        "text": "\u003ci\u003esevere brain injury\u003c/i\u003e. It occurs in patients who are comatose and reflects damage to motor pathways between the cerebral"
      }, {
        "text": " cortex and the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDecorticate (Flex"
      }, {
        "text": "or) Posturing:\u003c/b\u003e Characterized by flexion of the arms, wrists, and fingers with adduction of the upper"
      }, {
        "text": " extremities, alongside extension, internal rotation, and plantar flexion of the lower extremities. Mnemonic: Hands are near the \u0027"
      }, {
        "text": "\u003cb\u003ecor\u003c/b\u003e\u0027 (heart).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecorticate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eabove the"
      }, {
        "text": " red nucleus\u003c/u\u003e in the midbrain, such as in the cerebral hemispheres or internal capsule. The rubrospinal tract ("
      }, {
        "text": "flexor tone) is intact and overrides the vestibulospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecerebrate (Ext"
      }, {
        "text": "ensor) Posturing:\u003c/b\u003e Characterized by extension, adduction, and internal rotation of the arms with extension of the legs.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eDecerebrate Lesion Level:\u003c/b\u003e Indicates damage \u003cu\u003eat or below the red nucleus\u003c/u\u003e (e.g., mid"
      }, {
        "text": "brain tegmentum, pons). The loss of the rubrospinal tract leads to unopposed extension tone from the vestibulospinal tract."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Decerebrate posturing generally indicates a more severe brain injury and carries a "
      }, {
        "text": "\u003cu\u003eworse prognosis\u003c/u\u003e than decorticate posturing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The type of abnormal posturing provides a crucial clue to the anatomical level of severe brain injury; \u003cb\u003edecorticate\u003c/b\u003e"
      }, {
        "text": " posturing implies a lesion above the red nucleus preserving flexor pathways, whereas \u003cb\u003edecerebrate\u003c/b\u003e posturing signifies"
      }, {
        "text": " a more caudal lesion below the red nucleus, leaving only extensor pathways unopposed.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A[Cerebral Cortex] --\u003e B[Red Nucleus]; B --\u003e C[Rubrospinal Tract Flex"
      }, {
        "text": "ion]; A --\u003e D[Vestibular Nuclei]; D --\u003e E[Vestibulospinal Tract Extension]; F("
      }, {
        "text": "Lesion Above Red Nucleus) --\u003e G{Decorticate}; B --x F; H(Lesion Below Red Nucleus"
      }, {
        "text": ") --\u003e I{Decerebrate}; C --x H;\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"e9a47"
      }, {
        "text": "751\"\n      },\n      {\n        \"type\": \"differentiates_lesion_level_"
      }, {
        "text": "in\",\n        \"to\": \"a584135d\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"a0c128f4\": {\n    \"title\": \"Absence Se"
      }, {
        "text": "izures (Petit Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizures\u003c/b\u003e, formerly known as \u003ci\u003epetit mal seizures"
      }, {
        "text": "\u003c/i\u003e, are a type of generalized seizure characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for"
      }, {
        "text": " seconds. They are most common in childhood and are often mistaken for daydreaming or inattentiveness.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden cessation of activity with a blank stare, lasting about 10 seconds"
      }, {
        "text": ". May be accompanied by subtle automatisms like eyelid fluttering or lip smacking. There is \u003cu\u003eno postictal confusion\u003c/u\u003e;"
      }, {
        "text": " the patient immediately returns to baseline.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Hallmark:\u003c/b\u003e The pathognomonic finding is a \u003cmark\u003egeneralized"
      }, {
        "text": " 3 Hz spike-and-wave discharge\u003c/mark\u003e on EEG.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProvocation:\u003c/b\u003e Seizures can often"
      }, {
        "text": " be triggered by \u003cmark\u003ehyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e"
      }, {
        "text": " treatment is [[ethosuximide]]. [[valproic_acid|Valproic acid]] is also effective and"
      }, {
        "text": " used if tonic-clonic seizures are also present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette describes a child whose"
      }, {
        "text": " teacher complains of \u0027daydreaming\u0027 or \u0027not paying attention\u0027 in class. The diagnosis is confirmed by a 3 Hz spike-and-wave"
      }, {
        "text": " pattern on EEG, often induced by having the child hyperventilate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Absence seizures\u003c/b\u003e are unique among generalized seizures for their brief, non-convulsive nature, lack of postictal confusion, and a"
      }, {
        "text": " pathognomonic \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e EEG pattern, making [[ethosuximide]] the specific"
      }, {
        "text": " and preferred treatment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamic T-type Ca"
      }, {
        "text": "2+ Channels] -- Overactivity --\u003e B(Absence Seizure); C(Ethosuximide) -- Blocks"
      }, {
        "text": " --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"treated_by\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"presents_with_eeg_finding\",\n        \"to\": \"eeg_3"
      }, {
        "text": "hz_spike_wave\"\n      }\n    ]\n  },\n  \"e62961"
      }, {
        "text": "a0\": {\n    \"title\": \"Absence Seizure Anticonvulsants\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pharmacology\",\n      \"Epilepsy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eAbsence seizure anticonvulsants\u003c/b\u003e are medications specifically effective in treating [[a0c128f4|"
      }, {
        "text": "absence seizures]], primarily by targeting the T-type calcium channels in thalamic neurons, which are implicated in the generation of the characteristic"
      }, {
        "text": " \u003cmark\u003e3 Hz spike-and-wave\u003c/mark\u003e discharges.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eFirst-Line Agent:\u003c/b\u003e [[a90f6fb4|Ethosuximide]] is the "
      }, {
        "text": "\u003cu\u003efirst-line\u003c/u\u003e and most specific drug for treating isolated absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Ethosuximide:\u003c/b\u003e Blocks T"
      }, {
        "text": "-type Ca\u003csup\u003e2+\u003c/sup\u003e channels in thalamic neurons, disrupting the oscillatory rhythm between the thalamus and cortex that generates absence"
      }, {
        "text": " seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlternative Agent:\u003c/b\u003e [[valproic_acid|Valproic acid]] is also effective and is"
      }, {
        "text": " preferred if the patient has concomitant generalized tonic-clonic seizures. It works by blocking T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels"
      }, {
        "text": " and increasing [[5aa5cb91|GABA]] levels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindicated Agents:\u003c/b\u003e Certain"
      }, {
        "text": " anticonvulsants, such as [[eddd2bc5|carbamazepine]] and [[5aea213f|phenytoin]], can"
      }, {
        "text": " \u003cu\u003eworsen\u003c/u\u003e absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a child with staring spells and a"
      }, {
        "text": " 3 Hz spike-and-wave EEG, the answer for treatment is almost always [[a90f6fb4|Eth"
      }, {
        "text": "osuximide]]. If tonic-clonic seizures are also mentioned, consider [[valproic_acid|Valproic acid]].\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe treatment of [[a0c128f4|absence seizures]] is highly specific,"
      }, {
        "text": " with [[a90f6fb4|Ethosuximide]] being the drug of choice due to its targeted"
      }, {
        "text": " blockade of thalamic T-type calcium channels, while other common anticonvulsants like carbamazepine are paradoxically contraindicated"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"includes\",\n        \"to\": \"valproic_acid\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"8558c64b\": {\n    \"title\": \"Acalculia\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAcalculia\u003c/b\u003e is an acquired neurological deficit characterized by the \u003ci\u003einability to perform simple"
      }, {
        "text": " mathematical calculations\u003c/i\u003e, resulting from damage to specific brain regions, most notably the dominant (usually left) parietal lobe.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Acalculia is a key localizing sign for"
      }, {
        "text": " a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome"
      }, {
        "text": ":\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAcalculia\u003c/b\u003e, \u003cb\u003eAgraphia\u003c/b\u003e ("
      }, {
        "text": "inability to write), \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-"
      }, {
        "text": "Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [[1"
      }, {
        "text": "43bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e When a patient presents with difficulty with calculations along with any of the other components of Gerstmann syndrome,"
      }, {
        "text": " immediately suspect a lesion in the dominant parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcalculia"
      }, {
        "text": "\u003c/b\u003e is more than just \u0027bad at math\u0027; it is a specific neurological sign that strongly points to a lesion in the dominant angular"
      }, {
        "text": " gyrus, often as part of the clinically distinct [[38f3ed1f|Gerstmann syndrome]]."
      }, {
        "text": "\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa"
      }, {
        "text": "771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n"
      }, {
        "text": "        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"f"
      }, {
        "text": "218aebf\": {\n    \"title\": \"Accessory Nerve (CN XI)\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cranial Nerves\",\n      "
      }, {
        "text": "\"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAccessory Nerve (CN XI"
      }, {
        "text": ")\u003c/b\u003e is a \u003ci\u003emotor cranial nerve\u003c/i\u003e that provides innervation to the \u003cu\u003esternocleidomastoid (SC"
      }, {
        "text": "M)\u003c/u\u003e and \u003cu\u003etrapezius\u003c/u\u003e muscles, which are crucial for head turning and shoulder shrugging,"
      }, {
        "text": " respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Innervates the ipsilateral "
      }, {
        "text": "\u003cb\u003eSternocleidomastoid (SCM)\u003c/b\u003e muscle, which turns the head to the contralateral side, and the ips"
      }, {
        "text": "ilateral \u003cb\u003eTrapezius\u003c/b\u003e muscle, which elevates and stabilizes the scapula (shoulder shrug).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e Uniquely arises from both the brainstem (medulla) and the spinal cord (C1-C5"
      }, {
        "text": "). The spinal root ascends through the foramen magnum to join the cranial root, and the combined nerve then exits the skull via the [["
      }, {
        "text": "jugular_foramen|jugular foramen]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (SCM):\u003c/b\u003e Weakness in"
      }, {
        "text": " turning the head \u003cu\u003eaway\u003c/u\u003e from the side of the lesion. (e.g., Left CN XI lesion causes"
      }, {
        "text": " weakness turning head to the right).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Presentation (Trapezius):\u003c/b\u003e \u003cmark\u003eShoulder droop\u003c/"
      }, {
        "text": "mark\u003e, weakness in shrugging the shoulder on the ipsilateral side, and winging of the scapula.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e A common iatrogenic cause of an isolated CN XI lesion is injury during procedures in the \u003cmark\u003eposterior triangle"
      }, {
        "text": " of the neck\u003c/mark\u003e, such as lymph node biopsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eAccessory Nerve (CN XI)\u003c/b\u003e is unique in its dual origin from both the medulla and cervical spinal cord, and a"
      }, {
        "text": " lesion presents with the distinct combination of weakness turning the head to the contralateral side and an ipsilateral shoulder droop.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[CN XI Nuclei Medulla \u0026 C1-C5] --\u003e B(CN XI); B"
      }, {
        "text": " --\u003e C[Exits via Jugular Foramen]; C --\u003e D[Innervates SCM]; C --\u003e E[Innerv"
      }, {
        "text": "ates Trapezius];\"\n    },\n    \"connections\": [\n      {\n        \"type\":"
      }, {
        "text": " \"innervates\",\n        \"to\": \"sternocleidomastoid_muscle\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"innervates\",\n        \"to\": \"trapezius_muscle"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"exits_skull_via\",\n        \"to"
      }, {
        "text": "\": \"jugular_foramen\"\n      }\n    ]\n  },\n  \"81b5f"
      }, {
        "text": "5fe\": {\n    \"title\": \"Accommodation (Eye)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Phys"
      }, {
        "text": "iology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAccommodation\u003c/b\u003e is a"
      }, {
        "text": " reflex action of the eye in response to focusing on a near object, involving a coordinated triad of changes: \u003ci\u003ec"
      }, {
        "text": "iliary muscle contraction\u003c/i\u003e, \u003ci\u003epupillary constriction (miosis)\u003c/i\u003e, and \u003ci\u003econvergence of the eyes\u003c/i\u003e to"
      }, {
        "text": " maintain a clear image on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e It"
      }, {
        "text": " is a parasympathetic response mediated by the [[68c66997|oculomotor nerve (CN III"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCiliary Muscle Contraction:\u003c/b\u003e Contraction of the ciliary muscle relaxes the zonular fibers"
      }, {
        "text": ", allowing the lens to become more convex (rounder), which increases its refractive power for near vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePup"
      }, {
        "text": "illary Constriction (Miosis):\u003c/b\u003e The sphincter pupillae muscle contracts, narrowing the pupil to increase the depth of field."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eConvergence:\u003c/b\u003e The medial rectus muscles contract to direct both eyes medially toward the near object.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Loss of accommodation with age is called [[presbyopia]]. A pupil that accommodates but does not react to light is an"
      }, {
        "text": " [[08cb577f|Argyll Robertson pupil]], a classic sign of neurosyphilis.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eaccommodation reflex\u003c/b\u003e is a parasympathetically driven process via"
      }, {
        "text": " [[68c66997|CN III]] that allows for clear near vision by increasing the lens\u0027"
      }, {
        "text": "s refractive power through ciliary muscle contraction, a mechanism that becomes less effective with age, leading to presbyopia.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Focus on Near Object] --\u003e B[Visual Cortex]; B --\u003e C[CN"
      }, {
        "text": " III Nucleus Edinger-Westphal]; C --\u003e D[Ciliary Ganglion]; D --\u003e E[Ciliary Muscle Contraction -\u003e"
      }, {
        "text": " Lens rounds]; D --\u003e F[Sphincter Pupillae Contraction -\u003e Miosis]; B --\u003e G[CN III Motor"
      }, {
        "text": " Nucleus]; G --\u003e H[Medial Rectus Contraction -\u003e Convergence];\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"68c669"
      }, {
        "text": "97\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to"
      }, {
        "text": "\": \"presbyopia\"\n      },\n      {\n        \"type\": \"is_dissociated_from"
      }, {
        "text": "_light_reflex_in\",\n        \"to\": \"08cb577f\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"1df262e8\": {\n    \"title\": \"Acetazolamide\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e is a \u003ci\u003ecarbonic anhydrase inhibitor\u003c/i\u003e used as a diuretic and to reduce"
      }, {
        "text": " pressure in the eye and brain by decreasing the formation of aqueous humor and cerebrospinal fluid, respectively.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits the enzyme carbonic anhydrase in the ciliary body epithelium and choroid plexus, which"
      }, {
        "text": " reduces the formation of bicarbonate ions (HCO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e-\u003c/sup\u003e) and subsequently decreases fluid secretion (aqueous humor and CSF"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Ophthalmology):\u003c/b\u003e Treats [[3ce6c035|glaucoma]] (both open-angle"
      }, {
        "text": " and acute angle-closure) by \u003cmark\u003edecreasing aqueous humor synthesis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Treats [["
      }, {
        "text": "7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri) by decreasing CSF"
      }, {
        "text": " production. Also used for altitude sickness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes a \u003cmark\u003ehyperchloremic metabolic acidosis\u003c/mark\u003e ("
      }, {
        "text": "non-anion gap), paresthesias, ammonia toxicity in liver disease, and promotes calcium phosphate kidney stones ("
      }, {
        "text": "due to alkalinization of urine). It is a sulfa drug, so watch for sulfa allergies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember the mnemonic \u0027ACID-azolamide\u0027 to recall that it causes a metabolic \u003cb\u003eACID\u003c/b\u003eosis."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetazolamide\u003c/b\u003e\u0027s therapeutic effect in both [["
      }, {
        "text": "3ce6c035|glaucoma]] and [[7c4e7c74|idiopathic intracranial hypertension]] stems"
      }, {
        "text": " from the same core mechanism: inhibiting carbonic anhydrase to reduce the production of bicarbonate-driven fluids, namely aqueous humor and cerebrospinal fluid.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Acetazolamide] --|Inhibits|--\u003e B("
      }, {
        "text": "Carbonic Anhydrase); B --|Blocks|--\u003e C(H2O + CO2 \u003c--\u003e H2CO3 \u003c"
      }, {
        "text": "--\u003e H+ + HCO3-); C --|Leads to|--\u003e D[Decreased Aqueous Humor/CSF Production];\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6"
      }, {
        "text": "c035\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to"
      }, {
        "text": "\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "_adverse_effect\",\n        \"to\": \"metabolic_acidosis\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_type_of\",\n        \"to\": \"carbonic_anhydrase_inhibitor\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"6a005559\": {\n    \"title\": \"Acetyl"
      }, {
        "text": "choline (ACh)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "science\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcetyl"
      }, {
        "text": "choline (ACh)\u003c/b\u003e is a major \u003ci\u003eexcitatory neurotransmitter\u003c/i\u003e synthesized from choline and acetyl-CoA that"
      }, {
        "text": " functions at the neuromuscular junction, in all autonomic ganglia, at parasympathetic postganglionic nerve endings, and at various"
      }, {
        "text": " sites within the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synt"
      }, {
        "text": "hesized by Choline Acetyltransferase (ChAT) from choline and acetyl-CoA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegradation:\u003c/b\u003e Rapid"
      }, {
        "text": "ly broken down in the synaptic cleft by Acetylcholinesterase (AChE) into choline and acetate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS"
      }, {
        "text": " Role:\u003c/b\u003e Crucial for memory and cognition. Levels are significantly decreased in [[77ae6148|Alzheimer disease"
      }, {
        "text": "]] due to degeneration of neurons in the [[361438f2|Basal nucleus of Meynert]]. Levels"
      }, {
        "text": " are also decreased in [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePNS Role:\u003c/b\u003e Neuro"
      }, {
        "text": "transmitter at all preganglionic autonomic synapses (nicotinic), all parasympathetic postganglionic synapses (muscarinic), sympathetic"
      }, {
        "text": " postganglionic synapses to sweat glands (muscarinic), and the neuromuscular junction (nicotinic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Diseases affecting ACh are high-yield. [[77ae6148|Alzheimer\u0027"
      }, {
        "text": "s]] (‚Üì CNS ACh), Myasthenia Gravis (antibodies to ACh receptors), Lambert-Eaton (‚Üì presynaptic ACh release)."
      }, {
        "text": " Drugs targeting AChE (e.g., [[47d0372e|donepezil]]) are used to"
      }, {
        "text": " treat Alzheimer\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcetylcholine\u003c/b\u003e is a versatile neurotransmitter whose"
      }, {
        "text": " function is critically dependent on its location; its depletion in the [[361438f2|Basal nucleus of Meynert"
      }, {
        "text": "]] leads to cognitive decline in [[77ae6148|Alzheimer disease]], while its blockade at the neuromuscular junction causes"
      }, {
        "text": " paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choline + Acetyl-CoA] --"
      }, {
        "text": "ChAT--\u003e B(Acetylcholine); B --AChE--\u003e C[Choline + Acetate]; B --\u003e D{"
      }, {
        "text": "Receptors}; D --\u003e D1[Nicotinic]; D --\u003e D2[Muscarinic];\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_decreased_in\",\n        \""
      }, {
        "text": "to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_decreased_"
      }, {
        "text": "in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"myasthenia_gravis\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"lam"
      }, {
        "text": "bert_eaton_syndrome\"\n      },\n      {\n        \"type\": \"is_synthesized_in"
      }, {
        "text": "\",\n        \"to\": \"361438f2\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"87d19a70\": {\n    \"title\": \"Achilles Reflex\",\n    \"primaryType\": \""
      }, {
        "text": "physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e, also known as the ankle jerk reflex, is a deep tendon reflex that"
      }, {
        "text": " involves plantar flexion of the foot in response to tapping the Achilles tendon, testing the integrity of the \u003cmark\u003eS1 and"
      }, {
        "text": " S2\u003c/mark\u003e spinal nerve roots.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests"
      }, {
        "text": " the \u003cb\u003eS1\u003c/b\u003e nerve root, with contribution from S2. Mnemonic: S\u003cb\u003e1\u003c/b\u003e, "
      }, {
        "text": "2, buckle my shoe.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the gastrocnemius muscle, activating stretch"
      }, {
        "text": " receptors. The afferent signal travels via the tibial nerve to the S1/S2 spinal cord segments, synapses,"
      }, {
        "text": " and an efferent motor signal returns via the tibial nerve to cause plantar flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex"
      }, {
        "text": ":\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the S1 root, or peripheral neuropathy."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a"
      }, {
        "text": " stroke or spinal cord injury above the S1/S2 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An absent Achilles"
      }, {
        "text": " reflex is a classic finding in [[71daebd6|Tabes Dorsalis]] and [[lumbosacral_rad"
      }, {
        "text": "iculopathy|S1 radiculopathy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAchilles reflex\u003c/b\u003e is a simple"
      }, {
        "text": " yet powerful clinical tool that specifically assesses the integrity of the S1 spinal nerve root; its absence or exaggeration can help differentiate between lower"
      }, {
        "text": " and upper motor neuron pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Achilles Tendon] --\u003e"
      }, {
        "text": " B(Stretch Gastrocnemius); B --\u003e C(Afferent Signal via Tibial N.); C --\u003e D["
      }, {
        "text": "S1/S2 Spinal Cord]; D --\u003e E(Efferent Signal via Tibial N.); E --\u003e F("
      }, {
        "text": "Plantar Flexion);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests"
      }, {
        "text": "_nerve_root\",\n        \"to\": \"s1_nerve_root\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_absent_in\",\n        \"to\": \"71daebd6\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\":"
      }, {
        "text": " \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"fcedc59f\": {\n    "
      }, {
        "text": "\"title\": \"Neuron Action Potential\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurons\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eneuron action potential\u003c/b\u003e is a rapid, all-or-none electrical"
      }, {
        "text": " signal that propagates down an axon, caused by the sequential opening and closing of \u003ci\u003evoltage-gated ion channels\u003c/i\u003e"
      }, {
        "text": ", which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eResting Potential (~-70 mV):\u003c/b\u003e Maintained by the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump"
      }, {
        "text": " and high resting permeability to K\u003csup\u003e+\u003c/sup\u003e (K\u003csup\u003e+\u003c/sup\u003e leak channels).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDepolarization:"
      }, {
        "text": "\u003c/b\u003e A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage-gated \u003cmark\u003eNa\u003csup\u003e"
      }, {
        "text": "+\u003c/sup\u003e channels\u003c/mark\u003e, causing a massive influx of Na\u003csup\u003e+\u003c/sup\u003e and a sharp rise in membrane potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRep"
      }, {
        "text": "olarization:\u003c/b\u003e Voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels inactivate, and voltage-gated \u003cmark\u003eK\u003csup\u003e+\u003c/sup\u003e channels\u003c/"
      }, {
        "text": "mark\u003e open, leading to an efflux of K\u003csup\u003e+\u003c/sup\u003e that brings the membrane potential back down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyper"
      }, {
        "text": "polarization:\u003c/b\u003e K\u003csup\u003e+\u003c/sup\u003e channels are slow to close, causing the membrane potential to briefly dip below the resting potential."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Many neurotoxins and drugs target these channels. [[tetrodotoxin|"
      }, {
        "text": "Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]] block voltage-gated"
      }, {
        "text": " Na\u003csup\u003e+\u003c/sup\u003e channels, preventing action potential propagation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e"
      }, {
        "text": " causes the rising phase (depolarization), and a subsequent efflux of \u003cb\u003eK\u003csup\u003e+\u003c/sup\u003e\u003c/b\u003e causes the falling"
      }, {
        "text": " phase (repolarization), enabling high-speed signal transmission.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A("
      }, {
        "text": "Resting State) --Stimulus--\u003e B(Threshold); B --Na+ Influx--\u003e C(Depolarization); C --Na"
      }, {
        "text": "+ Inactivation \u0026 K+ Efflux--\u003e D(Repolarization); D --Slow K+ Channel Closing--\u003e E(Hyperpolarization); E"
      }, {
        "text": " --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_blocked"
      }, {
        "text": "_by\",\n        \"to\": \"tetrodotoxin\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_blocked_by\",\n        \"to\": \"local_anesthetics\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_fundamental_to\",\n        \"to\": \"synaptic_transmission\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"67e83e3b\": {\n    \"title\": \""
      }, {
        "text": "Acute Disseminated Encephalomyelitis (ADEM)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"D"
      }, {
        "text": "emyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAcute Dissemin"
      }, {
        "text": "ated Encephalomyelitis (ADEM)\u003c/b\u003e is a rare, acute, \u003ci\u003eimmune-mediated inflammatory and demyelinating disorder\u003c/i\u003e of the"
      }, {
        "text": " central nervous system that typically occurs following a viral infection or, less commonly, a vaccination.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to be caused by \u003cmark\u003emolecular mimicry\u003c/mark\u003e, where an"
      }, {
        "text": " immune response against an infectious agent cross-reacts with myelin antigens (e.g., myelin basic protein).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Rapid onset of multifocal neurological symptoms, including encephalopathy (altered mental status, confusion, coma), which"
      }, {
        "text": " is a key feature distinguishing it from a typical [[45dd6d19|Multiple Sclerosis]] flare. Other"
      }, {
        "text": " symptoms include fever, headache, seizures, and focal deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Symptoms typically appear 1-2 weeks after an"
      }, {
        "text": " antecedent infection (e.g., measles, varicella) or vaccination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI shows multiple"
      }, {
        "text": ", bilateral, asymmetric, poorly demarcated white matter lesions of similar age, often involving both the brain and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Differentiate ADEM from [[45dd6d19|MS]]: ADEM is "
      }, {
        "text": "\u003cu\u003emonophasic\u003c/u\u003e and presents with encephalopathy, whereas MS is typically relapsing-remitting and rarely presents with encephal"
      }, {
        "text": "opathy in its initial flare.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAcute Disseminated En"
      }, {
        "text": "cephalomyelitis\u003c/b\u003e is a post-infectious autoimmune attack on CNS myelin, distinguished from [[45dd6d19|"
      }, {
        "text": "Multiple Sclerosis]] by its \u003cu\u003emonophasic\u003c/u\u003e course and the prominent presence of encephalopathy alongside multifocal neurological deficits.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Viral Infection/Vaccination] --\u003e B(Immune Response); B --"
      }, {
        "text": "Molecular Mimicry--\u003e C[Attack on Myelin]; C --\u003e D[Perivenous Inflammation \u0026 Demyelination]; D --\u003e E["
      }, {
        "text": "Multifocal Neurologic Deficits + Encephalopathy];\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelin"
      }, {
        "text": "ating_disorder\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_triggered"
      }, {
        "text": "_by\",\n        \"to\": \"viral_infection\"\n      }\n    ]\n  },\n  \"ed52e"
      }, {
        "text": "40b\": {\n    \"title\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eAcute Inflammatory Demyelinating Polyneuropathy (AIDP)\u003c/b\u003e is the most common subtype"
      }, {
        "text": " of \u003ci\u003eGuillain-Barr√© Syndrome\u003c/i\u003e, an autoimmune condition characterized by the rapid onset of symmetric, ascending muscle weakness or"
      }, {
        "text": " paralysis and destruction of myelin sheaths of peripheral nerves by Schwann cells.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e Often triggered by an antecedent infection (classically \u003cmark\u003eCampylobacter jejuni\u003c/mark\u003e, also"
      }, {
        "text": " CMV, EBV, Zika). It is thought to be due to \u003cmark\u003emolecular mimicry\u003c/mark\u003e between microbial"
      }, {
        "text": " antigens and peripheral nerve myelin or axons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapidly progressive, symmetric \u003cmark\u003eascending weakness"
      }, {
        "text": "/paralysis\u003c/mark\u003e starting in the lower extremities. Patients often have absent or depressed deep tendon reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Complications:\u003c/b\u003e Respiratory failure due to diaphragmatic weakness is a life-threatening complication. Autonomic dysfunction (tachycardia, arrhythmias"
      }, {
        "text": ", BP instability) is also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e CSF analysis shows \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e"
      }, {
        "text": " (high protein with a normal cell count). Nerve conduction studies show slowed nerve conduction velocity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination"
      }, {
        "text": " of recent diarrheal illness (*C. jejuni*) followed by ascending paralysis and high protein in the CSF with normal cell"
      }, {
        "text": " count is a classic vignette for Guillain-Barr√© Syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAID"
      }, {
        "text": "P (Guillain-Barr√© Syndrome)\u003c/b\u003e is an acute, post-infectious autoimmune attack on peripheral nerve"
      }, {
        "text": " myelin, leading to a characteristic ascending paralysis; the hallmark diagnostic finding is \u003cmark\u003ealbuminocytologic dissociation\u003c/mark\u003e in the CSF, reflecting"
      }, {
        "text": " widespread inflammation of nerve roots without direct infection.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Antecedent Infection e"
      }, {
        "text": ".g., C. jejuni] --\u003e B(Molecular Mimicry); B --\u003e C[Immune Attack on Schwann"
      }, {
        "text": " Cells/Myelin]; C --\u003e D[Peripheral Nerve Demyelination]; D --\u003e E[Ascending Paralysis \u0026 A"
      }, {
        "text": "reflexia];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_subtype_of\",\n        \"to\": \"e8720ceb\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_associated_with\",\n        \"to\": \"campylobacter_jejuni\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"a"
      }, {
        "text": "0f3ce4c\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"sch"
      }, {
        "text": "wann_cells\"\n      }\n    ]\n  },\n  \"d268ace0\": {\n    \"title\": \"Op"
      }, {
        "text": "ioid-Induced Acute Pulmonary Edema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Toxicology\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Respiratory\",\n      \"Pathology\",\n      \"Acute Respiratory Distress Syndrome\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eOpioid-induced acute pulmonary edema\u003c/b\u003e is a form"
      }, {
        "text": " of \u003ci\u003enon-cardiogenic pulmonary edema\u003c/i\u003e that can occur as a life-threatening complication of opioid overdose, characterized"
      }, {
        "text": " by increased pulmonary vascular permeability and subsequent alveolar flooding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact"
      }, {
        "text": " mechanism is multifactorial but is thought to involve direct toxic effects on the pulmonary capillary endothelium, hypoxia-induced vascular injury"
      }, {
        "text": ", and a massive sympathetic surge following transient hypoxia, all leading to \u003cmark\u003eincreased vascular permeability\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Occurs shortly after an opioid overdose. Patients present with severe dyspnea, hypoxia, frothy pink sputum"
      }, {
        "text": ", and diffuse crackles on auscultation, often after being resuscitated with [[naloxone]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadi"
      }, {
        "text": "ology:\u003c/b\u003e Chest X-ray shows bilateral diffuse alveolar infiltrates, consistent with pulmonary edema, but with a normal cardiac"
      }, {
        "text": " silhouette (distinguishing it from cardiogenic pulmonary edema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is supportive and includes supplemental oxygen, non"
      }, {
        "text": "-invasive or mechanical ventilation, and addressing the underlying opioid overdose. Diuretics are \u003cu\u003enot effective\u003c/u\u003e as the cause"
      }, {
        "text": " is permeability, not fluid overload.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be aware of the patient who is treated for an opioid overdose with"
      }, {
        "text": " [[naloxone]] and subsequently develops severe respiratory distress; this points towards non-cardiogenic pulmonary edema rather than a cardiac"
      }, {
        "text": " cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eUnlike cardiogenic pulmonary edema which is caused by high"
      }, {
        "text": " hydrostatic pressure, \u003cb\u003eopioid-induced pulmonary edema\u003c/b\u003e is a permeability problem where opioid toxicity and hypoxia damage the alveolar"
      }, {
        "text": "-capillary barrier, leading to leaky vessels and flooded lungs that do not respond to diuretics.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Opioid Overdose] --\u003e B(Hypoxia \u0026 Direct Toxicity); B --\u003e C["
      }, {
        "text": "Pulmonary Capillary Endothelial Damage]; C --\u003e D[Increased Vascular Permeability]; D --\u003e E[Alveolar Flo"
      }, {
        "text": "oding]; E --\u003e F[Non-Cardiogenic Pulmonary Edema];\"\n    },\n    \"connections\": ["
      }, {
        "text": "\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"opioid_analgesics\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"acute"
      }, {
        "text": "_respiratory_distress_syndrome\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \""
      }, {
        "text": "to\": \"naloxone\"\n      }\n    ]\n  },\n  \"76ba7f2e\": {\n    \""
      }, {
        "text": "title\": \"Adenohypophysis (Anterior Pituitary)\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Endocrinology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Anatomy\",\n      \"Pit"
      }, {
        "text": "uitary Gland\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAdenohypophysis\u003c/b\u003e"
      }, {
        "text": ", or anterior pituitary, is the anterior lobe of the pituitary gland, an endocrine gland of ectodermal origin (from"
      }, {
        "text": " \u003ci\u003eRathke\u0027s pouch\u003c/i\u003e) that synthesizes and secretes six major peptide hormones in response to releasing"
      }, {
        "text": " and inhibiting hormones from the [[89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Arises from an upward evagination of the oral ectoderm called"
      }, {
        "text": " \u003cmark\u003eRathke\u0027s pouch\u003c/mark\u003e. Remnants can form a [[7048db1e|craniopharyngi"
      }, {
        "text": "oma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormones Secreted:\u003c/b\u003e The anterior pituitary hormones can be remembered with the mnemonic \u003cb\u003eFL"
      }, {
        "text": "AT PiG\u003c/b\u003e: \u003cb\u003eF\u003c/b\u003eSH, \u003cb\u003eL\u003c/b\u003eH, \u003cb\u003eA\u003c/b\u003eCTH,"
      }, {
        "text": " \u003cb\u003eT\u003c/b\u003eSH (Tropic hormones), and \u003cb\u003eP\u003c/b\u003erolactin, \u003cb\u003ei\u003c/b\u003e(ignore"
      }, {
        "text": "), \u003cb\u003eG\u003c/b\u003eH (Direct hormones).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Types:\u003c/b\u003e Somatotrophs (GH), Lact"
      }, {
        "text": "otrophs (Prolactin), Corticotrophs (ACTH), Thyrotrophs (TSH), and Gonadotrophs (FSH/"
      }, {
        "text": "LH).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Receives blood from the superior hypophyseal artery, which forms a portal"
      }, {
        "text": " system (hypothalamic-hypophyseal portal system) that transports hypothalamic releasing/inhibiting hormones directly to the anterior pituitary.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The most common tumor of the pituitary is a [[5f3188bd|pituitary adenoma]], which is"
      }, {
        "text": " most frequently a prolactinoma. Its connection to the [[89e86633|hypothalamus]] is vascular"
      }, {
        "text": ", in contrast to the posterior pituitary\u0027s neural connection.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eAdenohypophysis\u003c/b\u003e is the hormonal powerhouse of the pituitary, controlled by the [[89e8663"
      }, {
        "text": "3|hypothalamus]] via a unique portal venous system, and its diverse cell populations are responsible for regulating growth, stress"
      }, {
        "text": ", reproduction, and metabolism throughout the body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --"
      }, {
        "text": "Releasing/Inhibiting Hormones--\u003e B(Hypophyseal Portal System); B --\u003e C(Adenohypophysis); C"
      }, {
        "text": " --\u003e D[FSH, LH]; C --\u003e E[ACTH]; C --\u003e F[TSH]; C --\u003e G[Prol"
      }, {
        "text": "actin]; C --\u003e H[GH];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"pituitary_gland\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_regulated_by\",\n        \"to\": \"89e86633\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"secretes\",\n        \"to\": \"growth_hormone\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"secretes\",\n        \"to\": \"prolactin\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"can_develop\",\n        \"to\": \"5f3188bd\"\n"
      }, {
        "text": "      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "17n8z2MZ3gTilj82LshNiRO8_TlCssXTq"
      },
      "role": "user",
      "tokenCount": 1812
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "**Beginning Processing JSON Data**\n\nI\u0027m now diving into the next portion of the JSON data. My first step involves \"Adenovirus (aaeda12d),\" which I recognize as a microbe. My focus is going to be on crafting a card specifically about its neurological manifestation, conjunctivitis, as referenced in the index. I will do this before moving on to other entries.\n\n\n**Moving Through JSON Entries**\n\nI\u0027m now shifting my focus to the next JSON entries. Adrenoleukodystrophy, a demyelinating peroxisomal disease, will be next. I\u0027ll construct a thorough card addressing its genetic underpinnings, pathophysiology, and clinical presentation. I\u0027m skipping \"Adults\" since it\u0027s a demographic. Instead, I\u0027ll incorporate its sub-entries, \"causes of seizures in\" and \"primary brain tumors\", into relevant cards. Next is age-related macular degeneration, which will get a detailed card covering dry/wet forms, drusen, neovascularization, and clinical findings. Following that, I\u0027ll create a card for agraphia.\n\n\n**Processing Next JSON Entries**\n\nI\u0027m now ready to tackle the next batch of JSON entries. I\u0027ll start with Adenovirus, crafting a card focused on its neurological manifestation. Next up is Adrenoleukodystrophy; I\u0027ll build a card detailing its genetics, pathophysiology, and clinical presentation. The \"Adults\" entry is being skipped; its sub-entries will be integrated into relevant cards. Age-related macular degeneration is next on the list, followed by agraphia. Then, I\u0027ll move on to Akathisia, with a card defining it and detailing its causes. I\u0027ll then create a card for Alar plate development, explaining its role in neural development. Finally, I will make a card on albuminocytologic dissociation. The next is Alexia, and then I will focus on Alprazolam. I\u0027ll delve into the specifics of this benzodiazepine, covering its mechanism and use.\n\n\n**Charting JSON Data Progress**\n\nI\u0027m now progressing through the JSON entries. I have already drafted a detailed card for \"Adenovirus\" and its neurological manifestation. Next, I plan to focus on \"Adrenoleukodystrophy\", ensuring the card covers its genetic and pathophysiological aspects. \"Adults\" will still be skipped and sub-entries incorporated into their relevant cards. I will follow that by generating cards for \"Age-related macular degeneration\" and \"Agraphia\". After these, I will make cards for \"Akathisia\" and \"Alar plate development\". Finally, I will create cards for \"Albuminocytologic dissociation\", \"Alexia\", and \"Alprazolam\".\n\n\n**Analyzing Future JSON Data**\n\nNow, I\u0027m analyzing the next segment of JSON entries. I will first create a card for \"Adenovirus\" emphasizing its neurological manifestation. Next is \"Adrenoleukodystrophy,\" requiring a detailed card on its genetics, pathophysiology, and clinical presentation. After skipping \"Adults\", I\u0027ll create a card for \"Age-related macular degeneration,\" covering its various forms, pathophysiology, and clinical findings. Following this, a card for \"Agraphia\" will be generated, and then I will focus on \"Akathisia\" and define it and elaborate on its causes. Next, I will create cards for \"Alar plate development,\" \"Albuminocytologic dissociation,\" and \"Alexia.\" Finally, I\u0027ll tackle the benzodiazepine \"Alprazolam,\" detailing its mechanism and key properties, before moving on to \"Alzheimer disease\".\n\n\n",
      "role": "model",
      "tokenCount": 966,
      "isThought": true,
      "thinkingBudget": 32768,
      "parts": [{
        "text": "**Beginning Processing JSON Data**\n\nI\u0027m now diving into the next portion of the JSON data. My first step involves \"Adenovirus (aaeda12d),\" which I recognize as a microbe. My focus is going to be on crafting a card specifically about its neurological manifestation, conjunctivitis, as referenced in the index. I will do this before moving on to other entries.\n\n\n",
        "thought": true
      }, {
        "text": "**Moving Through JSON Entries**\n\nI\u0027m now shifting my focus to the next JSON entries. Adrenoleukodystrophy, a demyelinating peroxisomal disease, will be next. I\u0027ll construct a thorough card addressing its genetic underpinnings, pathophysiology, and clinical presentation. I\u0027m skipping \"Adults\" since it\u0027s a demographic. Instead, I\u0027ll incorporate its sub-entries, \"causes of seizures in\" and \"primary brain tumors\", into relevant cards. Next is age-related macular degeneration, which will get a detailed card covering dry/wet forms, drusen, neovascularization, and clinical findings. Following that, I\u0027ll create a card for agraphia.\n\n\n",
        "thought": true
      }, {
        "text": "**Processing Next JSON Entries**\n\nI\u0027m now ready to tackle the next batch of JSON entries. I\u0027ll start with Adenovirus, crafting a card focused on its neurological manifestation. Next up is Adrenoleukodystrophy; I\u0027ll build a card detailing its genetics, pathophysiology, and clinical presentation. The \"Adults\" entry is being skipped; its sub-entries will be integrated into relevant cards. Age-related macular degeneration is next on the list, followed by agraphia. Then, I\u0027ll move on to Akathisia, with a card defining it and detailing its causes. I\u0027ll then create a card for Alar plate development, explaining its role in neural development. Finally, I will make a card on albuminocytologic dissociation. The next is Alexia, and then I will focus on Alprazolam. I\u0027ll delve into the specifics of this benzodiazepine, covering its mechanism and use.\n\n\n",
        "thought": true
      }, {
        "text": "**Charting JSON Data Progress**\n\nI\u0027m now progressing through the JSON entries. I have already drafted a detailed card for \"Adenovirus\" and its neurological manifestation. Next, I plan to focus on \"Adrenoleukodystrophy\", ensuring the card covers its genetic and pathophysiological aspects. \"Adults\" will still be skipped and sub-entries incorporated into their relevant cards. I will follow that by generating cards for \"Age-related macular degeneration\" and \"Agraphia\". After these, I will make cards for \"Akathisia\" and \"Alar plate development\". Finally, I will create cards for \"Albuminocytologic dissociation\", \"Alexia\", and \"Alprazolam\".\n\n\n",
        "thought": true
      }, {
        "text": "**Analyzing Future JSON Data**\n\nNow, I\u0027m analyzing the next segment of JSON entries. I will first create a card for \"Adenovirus\" emphasizing its neurological manifestation. Next is \"Adrenoleukodystrophy,\" requiring a detailed card on its genetics, pathophysiology, and clinical presentation. After skipping \"Adults\", I\u0027ll create a card for \"Age-related macular degeneration,\" covering its various forms, pathophysiology, and clinical findings. Following this, a card for \"Agraphia\" will be generated, and then I will focus on \"Akathisia\" and define it and elaborate on its causes. Next, I will create cards for \"Alar plate development,\" \"Albuminocytologic dissociation,\" and \"Alexia.\" Finally, I\u0027ll tackle the benzodiazepine \"Alprazolam,\" detailing its mechanism and key properties, before moving on to \"Alzheimer disease\".\n\n\n",
        "thought": true
      }]
    }, {
      "text": "```json\n{\n  \"aaeda12d\": {\n    \"title\": \"Adenovirus\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Virology\",\n      \"Infectious Disease\",\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAdenovirus\u003c/b\u003e is a non-enveloped, double-stranded DNA virus that is a common cause of various infections, including pharyngitis, pneumonia, hemorrhagic cystitis, and notably, \u003ci\u003eviral conjunctivitis\u003c/i\u003e (pink eye).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Non-enveloped, icosahedral capsid with a linear dsDNA genome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransmission:\u003c/b\u003e Transmitted via respiratory droplets, fecal-oral route, and direct contact with contaminated surfaces (fomites). Highly stable in the environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Manifestation:\u003c/b\u003e The most common cause of viral [[c4d08c09|conjunctivitis]], presenting with a \u003cmark\u003ewatery discharge\u003c/mark\u003e, red eye, and often a swollen preauricular lymph node.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Clinical Syndromes:\u003c/b\u003e Causes febrile pharyngitis, acute hemorrhagic cystitis, and pneumonia (especially in military recruits).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a question describing a patient (often a child) with red, watery eyes and a recent history of a cold or attending daycare, Adenovirus is the most likely pathogen. The watery discharge is key to differentiating it from bacterial conjunctivitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAdenovirus\u003c/b\u003e is a highly resilient DNA virus responsible for the majority of viral conjunctivitis cases, characterized by a watery discharge that distinguishes it from the purulent discharge of bacterial causes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Adenovirus] --\u003e B{Transmission}; B --\u003e B1[Respiratory Droplets]; B --\u003e B2[Fecal-Oral]; B --\u003e B3[Fomites]; A --\u003e C{Clinical Syndromes}; C --\u003e C1[Conjunctivitis]; C --\u003e C2[Pharyngitis]; C --\u003e C3[Pneumonia]; C --\u003e C4[Hemorrhagic Cystitis];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"c4d08c09\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dna_virus\"\n      }\n    ]\n  },\n  \"21d4b96a\": {\n    \"title\": \"Adrenoleukodystrophy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Endocrinology\",\n      \"Genetics\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAdrenoleukodystrophy\u003c/b\u003e is an \u003ci\u003eX-linked recessive disorder\u003c/i\u003e caused by a mutation in the \u003cb\u003eABCD1\u003c/b\u003e gene, leading to impaired Œ≤-oxidation of very-long-chain fatty acids (VLCFAs) in peroxisomes. This results in the accumulation of VLCFAs in the adrenal glands, testes, and white matter of the brain, causing adrenal insufficiency and progressive demyelination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e X-linked recessive mutation in the \u003ci\u003eABCD1\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Defective peroxisomal Œ≤-oxidation leads to the accumulation of \u003cmark\u003every-long-chain fatty acids (VLCFAs)\u003c/mark\u003e in various tissues.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Manifestations:\u003c/b\u003e Progressive demyelination of the central nervous system, leading to cognitive decline, behavioral changes, spasticity, and vision/hearing loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndocrine Manifestations:\u003c/b\u003e Adrenal insufficiency ([[addison_disease|Addison disease]]) is a common feature, presenting with fatigue, hyperpigmentation, and electrolyte abnormalities. Testicular atrophy and infertility can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette involves a young boy with new-onset behavioral problems or declining school performance who also shows signs of adrenal insufficiency (e.g., hyperpigmentation, low cortisol).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAdrenoleukodystrophy\u003c/b\u003e is a dual-system disease combining progressive CNS demyelination with adrenal failure, all stemming from a single X-linked genetic defect in peroxisomal fatty acid metabolism.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[ABCD1 Gene Mutation] --\u003e B(Defective Peroxisomal Œ≤-oxidation); B --\u003e C[Accumulation of VLCFAs]; C --\u003e D[Adrenal Cortex] --\u003e E(Adrenal Insufficiency); C --\u003e F[CNS White Matter] --\u003e G(Demyelination \u0026 Neurodegeneration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"peroxisomal_disorder\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelinating_disorder\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"addison_disease\"\n      },\n      {\n        \"type\": \"has_inheritance_pattern\",\n        \"to\": \"x_linked_recessive\"\n      }\n    ]\n  },\n  \"c63255c8\": {\n    \"title\": \"Age-related Macular Degeneration (AMD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAge-related Macular Degeneration (AMD)\u003c/b\u003e is a progressive neurodegenerative disease of the macula, the central part of the retina, leading to the gradual loss of \u003ci\u003ecentral vision\u003c/i\u003e. It is the leading cause of irreversible blindness in older adults in developed countries.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDry (Atrophic) AMD:\u003c/b\u003e More common (~80%). Characterized by the slow breakdown of photoreceptors in the macula and the deposition of yellowish extracellular material called \u003cmark\u003edrusen\u003c/mark\u003e between Bruch\u0027s membrane and the retinal pigment epithelium. Causes gradual vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWet (Exudative) AMD:\u003c/b\u003e Less common but more severe. Characterized by rapid vision loss due to choroidal neovascularization. Abnormal blood vessels grow under the retina, leak fluid and blood, and can cause scarring.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients report painless, progressive loss of central vision, leading to scotomas (blind spots). A key early symptom of wet AMD is \u003cmark\u003emetamorphopsia\u003c/mark\u003e (straight lines appear wavy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Fundoscopy reveals drusen (dry AMD) or hemorrhage/exudates (wet AMD). An Amsler grid is used to detect metamorphopsia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the key difference: \u003cb\u003eDry AMD \u003d Drusen\u003c/b\u003e and gradual loss. \u003cb\u003eWet AMD \u003d Neovascularization\u003c/b\u003e and rapid loss. Central vision loss is the hallmark for both.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAge-related Macular Degeneration\u003c/b\u003e specifically targets central, high-acuity vision by damaging the macula. The distinction between the slow, drusen-associated \u0027dry\u0027 form and the rapid, neovascular \u0027wet\u0027 form is critical for prognosis and management.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Aging \u0026 Genetic Factors] --\u003e B{Macular Damage}; B --\u003e C[Dry AMD]; C --\u003e D[Drusen Deposition \u0026 Atrophy]; D --\u003e E[Gradual Central Vision Loss]; B --\u003e F[Wet AMD]; F --\u003e G[Choroidal Neovascularization]; G --\u003e H[Hemorrhage \u0026 Exudate]; H --\u003e I[Rapid Central Vision Loss];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \"macula\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"central_scotoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"metamorphopsia\"\n      }\n    ]\n  },\n  \"13d6bca7\": {\n    \"title\": \"Agraphia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAgraphia\u003c/b\u003e is an acquired neurological disorder characterized by the \u003ci\u003eloss of the ability to communicate through writing\u003c/i\u003e, stemming from damage to specific brain areas involved in language processing and motor control of the hand.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Agraphia is a key localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAgraphia\u003c/b\u003e, \u003cb\u003e[[8558c64b|Acalculia]]\u003c/b\u003e (inability to perform calculations), \u003cb\u003eFinger Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlexia with Agraphia:\u003c/b\u003e When a patient can neither read nor write, the lesion is typically in the dominant angular gyrus. This is distinct from [[fcf30c1b|alexia without agraphia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a question describes a patient who suddenly cannot write but has no other motor deficits in the hand, and also has trouble with math, think of a dominant parietal lobe lesion, likely from an [[143bb23d|MCA stroke]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAgraphia\u003c/b\u003e is not simply poor handwriting; it is a specific neurological deficit in the production of written language that, when paired with [[8558c64b|acalculia]], strongly points to a lesion in the dominant angular gyrus, a hallmark of [[38f3ed1f|Gerstmann syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"0d04bf44\": {\n    \"title\": \"Akathisia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAkathisia\u003c/b\u003e is a movement disorder characterized by a subjective feeling of inner restlessness and a compelling urge to be in constant motion, most commonly seen as an \u003ci\u003eextrapyramidal side effect\u003c/i\u003e of antipsychotic medications.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by dopamine receptor antagonists, particularly \u003cmark\u003efirst-generation (typical) antipsychotics\u003c/mark\u003e (e.g., haloperidol). It can also occur with second-generation antipsychotics and some antidepressants.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients describe an inability to sit still, feeling like they need to \u0027jump out of their skin.\u0027 Objective signs include pacing, shuffling feet, and shifting from one foot to another.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e It is a subacute extrapyramidal symptom, typically developing days to weeks after starting or increasing the dose of an offending agent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management involves reducing the dose of the antipsychotic, switching to an agent with a lower risk (e.g., quetiapine), or adding medications like \u003cmark\u003epropranolol\u003c/mark\u003e, benzodiazepines, or benztropine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate akathisia from psychotic agitation. Akathisia is a drug side effect causing restlessness, while agitation is a symptom of the underlying psychosis. Mistaking one for the other and increasing the antipsychotic dose will worsen akathisia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAkathisia\u003c/b\u003e is a distressing, drug-induced state of motor restlessness that must be distinguished from psychiatric agitation, as the treatment involves reducing or counteracting the offending antipsychotic, not increasing it.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Dopamine (D2) Receptor Blockade] --\u003e B(Disruption of Nigrostriatal Pathway); B --\u003e C[Subjective Restlessness \u0026 Compulsion to Move]; C --\u003e D(Akathisia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extrapyramidal_symptoms\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"propranolol\"\n      }\n    ]\n  },\n  \"43be7a6e\": {\n    \"title\": \"Alar Plate\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAlar Plate\u003c/b\u003e is the dorsal part of the neural tube in the developing embryo, which differentiates into \u003ci\u003esensory neurons\u003c/i\u003e of the spinal cord and brainstem under the influence of signaling molecules like bone morphogenetic proteins (BMPs).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Dorsal (posterior) region of the developing spinal cord and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Gives rise to \u003cu\u003esensory\u003c/u\u003e components of the central nervous system. Mnemonic: Alar is dorsal, like the dorsal fin of a shark which senses things in the water.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInducing Signal:\u003c/b\u003e Development is induced by signaling molecules from the overlying ectoderm, primarily \u003cmark\u003eBone Morphogenetic Proteins (BMPs)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The ventral counterpart is the [[253e3efb|Basal Plate]], which develops into motor neurons under the influence of Sonic Hedgehog (SHH) from the notochord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple orientation: \u003cb\u003eAlar \u003d Sensory \u003d Dorsal\u003c/b\u003e, and \u003cb\u003eBasal \u003d Motor \u003d Ventral\u003c/b\u003e. This organization persists in the adult spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAlar Plate\u003c/b\u003e is the embryonic foundation for the sensory pathways of the CNS, establishing the fundamental dorsal-sensory and ventral-motor organization of the neural tube that is maintained throughout life.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Neural Tube] --\u003e B(Alar Plate - Dorsal); A --\u003e C(Basal Plate - Ventral); D[Ectoderm] --BMPs--\u003e B; B --\u003e E[Sensory Neurons]; F[Notochord] --SHH--\u003e C; C --\u003e G[Motor Neurons];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"sensory_neurons\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"253e3efb\"\n      },\n      {\n        \"type\": \"is_induced_by\",\n        \"to\": \"bone_morphogenetic_proteins\"\n      }\n    ]\n  },\n  \"a0f3ce4c\": {\n    \"title\": \"Albuminocytologic Dissociation\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Diagnostics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlbuminocytologic dissociation\u003c/b\u003e is the pathognomonic finding in the cerebrospinal fluid (CSF) of patients with [[ed52e40b|Guillain-Barr√© Syndrome]], characterized by a significantly \u003ci\u003eelevated protein concentration\u003c/i\u003e in the presence of a \u003ci\u003enormal or near-normal white blood cell count\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e This finding is the hallmark of [[ed52e40b|Guillain-Barr√© Syndrome (GBS)]], specifically the AIDP subtype.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Widespread inflammation of the nerve roots (radiculopathy) disrupts the blood-nerve barrier, allowing protein (mainly albumin) to leak from the plasma into the CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Count:\u003c/b\u003e The cell count remains normal (typically \u003c10 cells/mm\u003csup\u003e3\u003c/sup\u003e) because the inflammatory process is primarily in the peripheral nerve roots, not within the CSF space itself (i.e., it is not meningitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e The protein level may be normal in the first few days of GBS and typically peaks 1-2 weeks after symptom onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with ascending paralysis after a recent infection (*C. jejuni* or viral URI) and a CSF report showing high protein but a normal cell count is a classic vignette for [[ed52e40b|Guillain-Barr√© Syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlbuminocytologic dissociation\u003c/b\u003e is a powerful diagnostic clue for [[ed52e40b|Guillain-Barr√© Syndrome]], reflecting the unique pathophysiology of nerve root inflammation that increases blood-nerve barrier permeability to proteins without causing a significant cellular infiltrate into the CSF.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"is_found_in\",\n        \"to\": \"cerebrospinal_fluid\"\n      }\n    ]\n  },\n  \"fcf30c1b\": {\n    \"title\": \"Alexia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlexia\u003c/b\u003e is an acquired neurological disorder characterized by the \u003ci\u003einability to read or comprehend written language\u003c/i\u003e, resulting from a lesion in the brain\u0027s language or visual processing centers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAlexia without Agraphia (Pure Alexia):\u003c/b\u003e A specific syndrome where the patient can write but cannot read what they have just written. This is a classic disconnection syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the \u003cmark\u003edominant (usually left) occipital lobe\u003c/mark\u003e that also damages the \u003cmark\u003esplenium of the corpus callosum\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Visual information from the intact right occipital lobe cannot cross over to the dominant hemisphere\u0027s language areas (Wernicke\u0027s area, angular gyrus) for interpretation because the connecting fibers in the splenium are damaged. The dominant visual cortex is also damaged, so no visual information can be processed on that side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e This specific lesion is classically caused by a stroke in the territory of the [[b6a2cc31|Posterior Cerebral Artery (PCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vignette of a patient who can write a sentence but is unable to read it back is pathognomonic for alexia without agraphia, pointing directly to a left PCA stroke affecting the occipital lobe and splenium.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlexia without agraphia\u003c/b\u003e is a quintessential disconnection syndrome where visual information is stranded in the non-dominant hemisphere, unable to reach the language centers in the dominant hemisphere because the connecting bridge (splenium of the corpus callosum) has been destroyed, typically by a PCA stroke.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Written Word] --\u003e B(Eyes); B --\u003e C[Right Visual Cortex]; C --x D(Splenium of Corpus Callosum); D --x E[Left Language Areas]; B --\u003e F(Left Visual Cortex); F --x G[Lesion];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"occipital_lobe\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"corpus_callosum\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"b6a2cc31\"\n      },\n      {\n        \"type\": \"is_distinct_from\",\n        \"to\": \"13d6bca7\"\n      }\n    ]\n  },\n  \"083094db\": {\n    \"title\": \"Alprazolam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlprazolam\u003c/b\u003e (trade name Xanax) is a potent, short-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used primarily for the management of anxiety disorders, especially panic disorder, and for the short-term treatment of anxiety associated with depression.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A positive allosteric modulator of the [[gaba_a_receptor|GABA\u003csub\u003eA\u003c/sub\u003e receptor]]. It increases the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening in response to GABA binding, leading to enhanced CNS inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is short-acting. Mnemonic for short-acting benzodiazepines: \u003cb\u003eATOM\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003elprazolam, \u003cb\u003eT\u003c/b\u003eriazolam, \u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eM\u003c/b\u003eidazolam).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily for [[panic_disorder|panic disorder]] and [[generalized_anxiety_disorder|generalized anxiety disorder]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance, and withdrawal symptoms. Additive CNS depression with other depressants like alcohol and barbiturates. Has a higher addictive potential due to its short half-life.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Because of its rapid onset and short duration, alprazolam is highly effective for acute panic attacks but also carries a high risk of dependence and severe withdrawal. Overdose is treated with [[flumazenil]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlprazolam\u003c/b\u003e is a high-potency, short-acting benzodiazepine that provides rapid relief for panic and anxiety by enhancing GABAergic inhibition, but its pharmacokinetic profile also contributes to a significant risk of dependence and withdrawal.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Alprazolam] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(‚Üë Frequency of Cl- Channel Opening); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS Depression/Anxiolysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"panic_disorder\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"d1c786e9\"\n      },\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common cause of \u003ci\u003edementia\u003c/i\u003e in older adults, a progressive neurodegenerative disorder characterized by the extracellular deposition of \u003cb\u003eamyloid-Œ≤ (AŒ≤) plaques\u003c/b\u003e and the intracellular accumulation of \u003cb\u003ehyperphosphorylated tau tangles\u003c/b\u003e, leading to widespread cortical atrophy and a significant cholinergic deficit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathology Hallmarks:\u003c/b\u003e Extracellular \u003cmark\u003esenile plaques\u003c/mark\u003e (composed of AŒ≤) and intracellular \u003cmark\u003eneurofibrillary tangles\u003c/mark\u003e (composed of hyperphosphorylated tau protein). The number of tangles correlates with disease severity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Risk is increased by the \u003cmark\u003eApoE4\u003c/mark\u003e allele for the sporadic, late-onset form. Early-onset familial forms are associated with mutations in \u003ci\u003eAPP\u003c/i\u003e (chromosome 21), \u003ci\u003epresenilin-1\u003c/i\u003e (chromosome 14), and \u003ci\u003epresenilin-2\u003c/i\u003e (chromosome 1).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Insidious onset of progressive short-term memory loss, followed by language deficits (aphasia), visuospatial difficulties, and executive dysfunction. Personality and behavioral changes are common in later stages.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Deficit:\u003c/b\u003e Marked decrease in [[6a005559|acetylcholine]] due to degeneration of cholinergic neurons in the [[361438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients with \u003cb\u003eDown syndrome (Trisomy 21)\u003c/b\u003e have a greatly increased risk of early-onset Alzheimer\u0027s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on chromosome 21, leading to a gene dosage effect and increased AŒ≤ production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe core pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves a dual-proteinopathy of extracellular amyloid plaques and intracellular tau tangles, which together trigger synaptic dysfunction and neuronal death, manifesting clinically as a progressive decline in memory and cognition due to widespread cortical and hippocampal atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[APP Gene on Chr 21] --Abnormal Cleavage--\u003e B(Amyloid-Œ≤ Monomers); B --\u003e C(Oligomers \u0026 Plaques); D[Tau Protein] --Hyperphosphorylation--\u003e E(Neurofibrillary Tangles); C \u0026 E --\u003e F(Synaptic Dysfunction \u0026 Neuronal Death); F --\u003e G(Cortical Atrophy); G --\u003e H(Dementia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"down_syndrome\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"47d0372e\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"361438f2\"\n      }\n    ]\n  },\n  \"9c9679ea\": {\n    \"title\": \"Amantadine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmantadine\u003c/b\u003e is a medication with multiple mechanisms of action, used primarily in neurology to treat [[58c8ea03|Parkinson disease]] and drug-induced extrapyramidal symptoms, and historically as an antiviral agent for influenza A.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism (Parkinson\u0027s):\u003c/b\u003e Increases dopamine availability by \u003cmark\u003eenhancing dopamine release\u003c/mark\u003e and \u003cmark\u003einhibiting dopamine reuptake\u003c/mark\u003e in the CNS. It also has some anticholinergic properties.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for mild [[58c8ea03|Parkinson disease]] to improve tremor, rigidity, and bradykinesia. It is particularly useful for reducing levodopa-induced dyskinesias in advanced disease. Also used to treat acute dystonia caused by antipsychotics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntiviral Use:\u003c/b\u003e Previously used for prophylaxis and treatment of Influenza A by blocking the M2 proton channel, but is no longer recommended due to widespread resistance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e CNS effects like confusion, hallucinations, and dizziness. A characteristic side effect is \u003cmark\u003elivedo reticularis\u003c/mark\u003e (a mottled, purplish skin discoloration) and peripheral edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For Parkinson\u0027s, amantadine is a \u0027weaker\u0027 drug but can be useful early on or for managing side effects of more potent therapies. The association with livedo reticularis is a classic board question clue.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmantadine\u003c/b\u003e serves a niche role in managing [[58c8ea03|Parkinson disease]] by modestly increasing dopamine levels, but its utility is limited by CNS side effects and the unique dermatologic finding of livedo reticularis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"livedo_reticularis\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"90adc821\"\n      }\n    ]\n  },\n  \"f0aac1c3\": {\n    \"title\": \"Amaurosis Fugax\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Cardiovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmaurosis fugax\u003c/b\u003e (from Greek for \u0027darkening\u0027 and Latin for \u0027fleeting\u0027) is a painless, \u003ci\u003etransient monocular vision loss\u003c/i\u003e, classically described by patients as a \u003cmark\u003e\\\"curtain coming down over one eye.\\\"\u003c/mark\u003e It is a form of [[623ba776|transient ischemic attack (TIA)]] affecting the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an embolus to the [[3334840f|central or branch retinal artery]], which temporarily obstructs blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSource of Emboli:\u003c/b\u003e The most frequent source is an atherosclerotic plaque in the \u003cmark\u003eipsilateral carotid artery\u003c/mark\u003e. It can also be cardiogenic (e.g., from atrial fibrillation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is a critical warning sign of underlying cerebrovascular disease and portends a high risk of a major [[c5da3c57|stroke]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eWorkup:\u003c/b\u003e Patients require urgent evaluation, including a carotid ultrasound (duplex) to assess for stenosis and an EKG/echocardiogram to rule out cardiac sources.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a patient with a history of hypertension and hyperlipidemia who experiences a sudden, painless, temporary \\\"curtain-like\\\" vision loss in one eye should immediately point to amaurosis fugax secondary to carotid artery disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmaurosis fugax\u003c/b\u003e is not just an eye problem but a neurological emergency; this transient \u0027curtain\u0027 of vision loss is a TIA of the retina, most often signaling significant atherosclerotic disease in the ipsilateral carotid artery and a high impending risk of stroke.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Carotid Artery Plaque] --\u003e B(Embolus); B --\u003e C[Ophthalmic Artery]; C --\u003e D[Retinal Artery Occlusion]; D --\u003e E[Transient Monocular Vision Loss]; E --\u003e F(Amaurosis Fugax);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"623ba776\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"carotid_artery_stenosis\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"3334840f\"\n      }\n    ]\n  },\n  \"a4a401c7\": {\n    \"title\": \"Amblyopia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Pediatric Ophthalmology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmblyopia\u003c/b\u003e, commonly known as \\\"lazy eye,\\\" is a neurodevelopmental disorder of vision characterized by \u003ci\u003edecreased visual acuity\u003c/i\u003e in one or both eyes that is not correctable by refractive means and is not due to any structural eye pathology. It results from abnormal visual experience during early childhood.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e During a critical period of visual development (birth to ~7 years), the brain suppresses or ignores the input from one eye, leading to maldevelopment of the visual cortex corresponding to that eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[cdcda821|Strabismus]] (Misalignment):\u003c/b\u003e The brain ignores the image from the deviating eye to avoid diplopia.\u003cbr\u003e2. \u003cb\u003eAnisometropia (Unequal Refractive Error):\u003c/b\u003e The brain favors the eye with better focus.\u003cbr\u003e3. \u003cb\u003eDeprivation:\u003c/b\u003e An obstruction like a congenital [[85f03b02|cataract]] or ptosis blocks a clear image from forming.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Detected during pediatric vision screening. The key finding is a difference in visual acuity between the two eyes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Must be initiated early in the critical period. Treatment involves correcting the underlying cause (e.g., glasses for refractive error, surgery for strabismus/cataract) and then forcing the brain to use the amblyopic eye, typically by \u003cmark\u003epatching the good eye\u003c/mark\u003e or using atropine drops to blur its vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Early detection and treatment are crucial. If not treated before the end of the critical period (~age 7-8), amblyopia can result in irreversible vision loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmblyopia\u003c/b\u003e is a \u0027brain\u0027 problem, not an \u0027eye\u0027 problem; it is the failure of the visual cortex to develop properly due to abnormal input from an eye during a critical developmental window, leading to vision loss that can only be reversed by forcing the brain to pay attention to the \u0027lazy\u0027 eye before that window closes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"cdcda821\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"85f03b02\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"ocular_patching\"\n      }\n    ]\n  },\n  \"9115b704\": {\n    \"title\": \"Amino Acids (CNS Context)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmino acids\u003c/b\u003e are organic compounds that serve as the building blocks of proteins and as precursors for many neurotransmitters. In the central nervous system, their passage from the blood into the brain is tightly regulated by the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier Transport:\u003c/b\u003e Amino acids are generally lipid-insoluble and cannot diffuse freely across the [[dd47b9cc|blood-brain barrier]]. They require \u003cmark\u003ecarrier-mediated transport proteins\u003c/mark\u003e to enter the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransport Systems:\u003c/b\u003e There are specific transporters for different classes of amino acids (e.g., large neutral, basic, acidic). These transporters can become saturated and exhibit competition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Precursors:\u003c/b\u003e Many crucial neurotransmitters are synthesized from amino acids that must be transported into the brain. Examples include Tyrosine (precursor to [[90adc821|dopamine]], norepinephrine) and Tryptophan (precursor to [[5d3c2089|serotonin]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e In disorders like [[phenylketonuria|Phenylketonuria (PKU)]], high levels of one amino acid (phenylalanine) can saturate the large neutral amino acid transporter, impairing the transport of other essential amino acids (like tyrosine and tryptophan) into the brain, contributing to neurological dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that both glucose and amino acids require specific carrier-mediated transport to cross the [[dd47b9cc|blood-brain barrier]]; they do not diffuse freely.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe brain\u0027s supply of essential \u003cb\u003eamino acids\u003c/b\u003e, critical for both protein synthesis and neurotransmitter production, is entirely dependent on specialized carrier proteins at the [[dd47b9cc|blood-brain barrier]], a system that can be competitively inhibited in certain metabolic diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"crosses_via_transporters\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_precursor_to\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_precursor_to\",\n        \"to\": \"5d3c2089\"\n      },\n      {\n        \"type\": \"transport_is_impaired_in\",\n        \"to\": \"phenylketonuria\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9275,
      "parts": [{
        "text": "```json\n{\n  \"aaeda12d\": {\n    \"title\": \"Adenovirus\",\n    \"primaryType"
      }, {
        "text": "\": \"microbe\",\n    \"tags\": [\n      \"Virology\",\n      \"Infectious Disease"
      }, {
        "text": "\",\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"In"
      }, {
        "text": "fections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAdenovirus\u003c/b\u003e is a non-en"
      }, {
        "text": "veloped, double-stranded DNA virus that is a common cause of various infections, including pharyngitis, pneumonia, hemorrhagic"
      }, {
        "text": " cystitis, and notably, \u003ci\u003eviral conjunctivitis\u003c/i\u003e (pink eye).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Non-enveloped, icosahedral capsid with a linear dsDNA genome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransmission"
      }, {
        "text": ":\u003c/b\u003e Transmitted via respiratory droplets, fecal-oral route, and direct contact with contaminated surfaces (fomites). Highly"
      }, {
        "text": " stable in the environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Manifestation:\u003c/b\u003e The most common cause of viral [[c4d0"
      }, {
        "text": "8c09|conjunctivitis]], presenting with a \u003cmark\u003ewatery discharge\u003c/mark\u003e, red eye, and"
      }, {
        "text": " often a swollen preauricular lymph node.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Clinical Syndromes:\u003c/b\u003e Causes febrile pharyngitis, acute"
      }, {
        "text": " hemorrhagic cystitis, and pneumonia (especially in military recruits).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a question describing"
      }, {
        "text": " a patient (often a child) with red, watery eyes and a recent history of a cold or attending daycare, Aden"
      }, {
        "text": "ovirus is the most likely pathogen. The watery discharge is key to differentiating it from bacterial conjunctivitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eAdenovirus\u003c/b\u003e is a highly resilient DNA virus responsible for the majority of viral conjunctivitis cases"
      }, {
        "text": ", characterized by a watery discharge that distinguishes it from the purulent discharge of bacterial causes.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Adenovirus] --\u003e B{Transmission}; B --\u003e B1[Respiratory Droplets]; B --\u003e B2"
      }, {
        "text": "[Fecal-Oral]; B --\u003e B3[Fomites]; A --\u003e C{Clinical Syndromes}; C --\u003e"
      }, {
        "text": " C1[Conjunctivitis]; C --\u003e C2[Pharyngitis]; C --\u003e C3[Pneumonia]; C --\u003e C4["
      }, {
        "text": "Hemorrhagic Cystitis];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"c4d08c09\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"dna_virus\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"21d4b96a\": {\n    \"title\": \"Adrenoleukodystrophy"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"End"
      }, {
        "text": "ocrinology\",\n      \"Genetics\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAdrenoleukod"
      }, {
        "text": "ystrophy\u003c/b\u003e is an \u003ci\u003eX-linked recessive disorder\u003c/i\u003e caused by a mutation in the \u003cb\u003eABCD1\u003c/b\u003e gene, leading to impaired"
      }, {
        "text": " Œ≤-oxidation of very-long-chain fatty acids (VLCFAs) in peroxisomes. This results in the"
      }, {
        "text": " accumulation of VLCFAs in the adrenal glands, testes, and white matter of the brain, causing adrenal insufficiency and progressive dem"
      }, {
        "text": "yelination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e X-linked recessive mutation"
      }, {
        "text": " in the \u003ci\u003eABCD1\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Defective peroxisomal Œ≤-oxidation leads"
      }, {
        "text": " to the accumulation of \u003cmark\u003every-long-chain fatty acids (VLCFAs)\u003c/mark\u003e in various tissues."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Manifestations:\u003c/b\u003e Progressive demyelination of the central nervous system, leading to cognitive decline, behavioral"
      }, {
        "text": " changes, spasticity, and vision/hearing loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEndocrine Manifestations:\u003c/b\u003e Adrenal insufficiency ([["
      }, {
        "text": "addison_disease|Addison disease]]) is a common feature, presenting with fatigue, hyperpigmentation, and electrolyte"
      }, {
        "text": " abnormalities. Testicular atrophy and infertility can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A classic vignette involves a young"
      }, {
        "text": " boy with new-onset behavioral problems or declining school performance who also shows signs of adrenal insufficiency (e.g., hyper"
      }, {
        "text": "pigmentation, low cortisol).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAdrenoleukodystrophy\u003c/b\u003e is a"
      }, {
        "text": " dual-system disease combining progressive CNS demyelination with adrenal failure, all stemming from a single X-linked genetic defect in peroxisomal fatty"
      }, {
        "text": " acid metabolism.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[ABCD1 Gene Mutation] --\u003e B("
      }, {
        "text": "Defective Peroxisomal Œ≤-oxidation); B --\u003e C[Accumulation of VLCFAs]; C --\u003e D[Ad"
      }, {
        "text": "renal Cortex] --\u003e E(Adrenal Insufficiency); C --\u003e F[CNS White Matter] --\u003e G(Demyel"
      }, {
        "text": "ination \u0026 Neurodegeneration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"peroxisomal_disorder\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"demyelinating_disorder"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"addison_"
      }, {
        "text": "disease\"\n      },\n      {\n        \"type\": \"has_inheritance_pattern\",\n        \"to\":"
      }, {
        "text": " \"x_linked_recessive\"\n      }\n    ]\n  },\n  \"c63255c8\":"
      }, {
        "text": " {\n    \"title\": \"Age-related Macular Degeneration (AMD)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAge-related Mac"
      }, {
        "text": "ular Degeneration (AMD)\u003c/b\u003e is a progressive neurodegenerative disease of the macula, the central part of the retina"
      }, {
        "text": ", leading to the gradual loss of \u003ci\u003ecentral vision\u003c/i\u003e. It is the leading cause of irreversible blindness in older adults in developed countries.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDry (Atrophic) AMD:\u003c/b\u003e More common (~80%)."
      }, {
        "text": " Characterized by the slow breakdown of photoreceptors in the macula and the deposition of yellowish extracellular material called \u003cmark\u003edr"
      }, {
        "text": "usen\u003c/mark\u003e between Bruch\u0027s membrane and the retinal pigment epithelium. Causes gradual vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWet"
      }, {
        "text": " (Exudative) AMD:\u003c/b\u003e Less common but more severe. Characterized by rapid vision loss due to choroidal neovascularization."
      }, {
        "text": " Abnormal blood vessels grow under the retina, leak fluid and blood, and can cause scarring.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients"
      }, {
        "text": " report painless, progressive loss of central vision, leading to scotomas (blind spots). A key early symptom of wet AMD is \u003c"
      }, {
        "text": "mark\u003emetamorphopsia\u003c/mark\u003e (straight lines appear wavy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Fundoscopy reveals dr"
      }, {
        "text": "usen (dry AMD) or hemorrhage/exudates (wet AMD). An Amsler grid is used to detect"
      }, {
        "text": " metamorphopsia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the key difference: \u003cb\u003eDry AMD \u003d Drusen\u003c/b\u003e and"
      }, {
        "text": " gradual loss. \u003cb\u003eWet AMD \u003d Neovascularization\u003c/b\u003e and rapid loss. Central vision loss is the hallmark for both.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eAge-related Macular Degeneration\u003c/b\u003e specifically targets central, high-acuity vision by"
      }, {
        "text": " damaging the macula. The distinction between the slow, drusen-associated \u0027dry\u0027 form and the rapid, ne"
      }, {
        "text": "ovascular \u0027wet\u0027 form is critical for prognosis and management.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Aging"
      }, {
        "text": " \u0026 Genetic Factors] --\u003e B{Macular Damage}; B --\u003e C[Dry AMD]; C --\u003e D[Drusen Dep"
      }, {
        "text": "osition \u0026 Atrophy]; D --\u003e E[Gradual Central Vision Loss]; B --\u003e F[Wet AMD]; F --\u003e G["
      }, {
        "text": "Choroidal Neovascularization]; G --\u003e H[Hemorrhage \u0026 Exudate]; H --\u003e I[Rapid Central"
      }, {
        "text": " Vision Loss];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \""
      }, {
        "text": "macula\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"central_scotoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"metamorphopsia\"\n      }\n    ]\n  },\n  \"13d6bca7"
      }, {
        "text": "\": {\n    \"title\": \"Agraphia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain"
      }, {
        "text": " Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAgraphia\u003c/b\u003e"
      }, {
        "text": " is an acquired neurological disorder characterized by the \u003ci\u003eloss of the ability to communicate through writing\u003c/i\u003e, stemming from damage to specific"
      }, {
        "text": " brain areas involved in language processing and motor control of the hand.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization"
      }, {
        "text": ":\u003c/b\u003e Agraphia is a key localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f"
      }, {
        "text": "|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eAgraphia\u003c/b\u003e, \u003cb\u003e"
      }, {
        "text": "[[8558c64b|Acalculia]]\u003c/b\u003e (inability to perform calculations), \u003cb\u003eFinger"
      }, {
        "text": " Agnosia\u003c/b\u003e (inability to distinguish fingers), and \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAlex"
      }, {
        "text": "ia with Agraphia:\u003c/b\u003e When a patient can neither read nor write, the lesion is typically in the dominant angular gyrus. This"
      }, {
        "text": " is distinct from [[fcf30c1b|alexia without agraphia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " If a question describes a patient who suddenly cannot write but has no other motor deficits in the hand, and also has trouble"
      }, {
        "text": " with math, think of a dominant parietal lobe lesion, likely from an [[143bb23d|MCA stroke]].\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAgraphia\u003c/b\u003e is not simply poor handwriting; it is a specific neurological deficit"
      }, {
        "text": " in the production of written language that, when paired with [[8558c64b|acalculia]],"
      }, {
        "text": " strongly points to a lesion in the dominant angular gyrus, a hallmark of [[38f3ed1f|"
      }, {
        "text": "Gerstmann syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"2"
      }, {
        "text": "6efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke"
      }, {
        "text": "_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"0d04bf44\": {\n    \"title\": \"Akathisia\",\n    \"primaryType\": \""
      }, {
        "text": "finding\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Neurology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAkathisia"
      }, {
        "text": "\u003c/b\u003e is a movement disorder characterized by a subjective feeling of inner restlessness and a compelling urge to be in constant motion, most"
      }, {
        "text": " commonly seen as an \u003ci\u003eextrapyramidal side effect\u003c/i\u003e of antipsychotic medications.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by dopamine receptor antagonists, particularly \u003cmark\u003efirst-generation ("
      }, {
        "text": "typical) antipsychotics\u003c/mark\u003e (e.g., haloperidol). It can also occur with second-generation antipsych"
      }, {
        "text": "otics and some antidepressants.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients describe an inability to sit still, feeling like they need"
      }, {
        "text": " to \u0027jump out of their skin.\u0027 Objective signs include pacing, shuffling feet, and shifting from one foot to another.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Timeline:\u003c/b\u003e It is a subacute extrapyramidal symptom, typically developing days to weeks after starting or increasing the"
      }, {
        "text": " dose of an offending agent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management involves reducing the dose of the antipsychotic, switching to an"
      }, {
        "text": " agent with a lower risk (e.g., quetiapine), or adding medications like \u003cmark\u003epropranolol\u003c/mark\u003e, benzodiazep"
      }, {
        "text": "ines, or benztropine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate akathisia from psychotic agitation."
      }, {
        "text": " Akathisia is a drug side effect causing restlessness, while agitation is a symptom of the underlying psychosis. Mistaking one for the other and"
      }, {
        "text": " increasing the antipsychotic dose will worsen akathisia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAkathisia"
      }, {
        "text": "\u003c/b\u003e is a distressing, drug-induced state of motor restlessness that must be distinguished from psychiatric agitation, as the treatment involves"
      }, {
        "text": " reducing or counteracting the offending antipsychotic, not increasing it.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[D"
      }, {
        "text": "opamine (D2) Receptor Blockade] --\u003e B(Disruption of Nigrostriatal Pathway); B --\u003e C[Subject"
      }, {
        "text": "ive Restlessness \u0026 Compulsion to Move]; C --\u003e D(Akathisia);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"antipsychotics"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"extrapyramidal_symptoms\"\n      },\n      {\n        \"type\": \"treated"
      }, {
        "text": "_by\",\n        \"to\": \"propranolol\"\n      }\n    ]\n  },\n  \"4"
      }, {
        "text": "3be7a6e\": {\n    \"title\": \"Alar Plate\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eAlar Plate\u003c/b\u003e is the dorsal part of the neural tube in the developing embryo,"
      }, {
        "text": " which differentiates into \u003ci\u003esensory neurons\u003c/i\u003e of the spinal cord and brainstem under the influence of signaling molecules like bone"
      }, {
        "text": " morphogenetic proteins (BMPs).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Dorsal ("
      }, {
        "text": "posterior) region of the developing spinal cord and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Gives rise to \u003cu\u003esensory\u003c/u\u003e"
      }, {
        "text": " components of the central nervous system. Mnemonic: Alar is dorsal, like the dorsal fin of a shark which senses things"
      }, {
        "text": " in the water.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInducing Signal:\u003c/b\u003e Development is induced by signaling molecules from the overlying ectoderm, primarily"
      }, {
        "text": " \u003cmark\u003eBone Morphogenetic Proteins (BMPs)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The ventral counterpart is the [[25"
      }, {
        "text": "3e3efb|Basal Plate]], which develops into motor neurons under the influence of Sonic Hedgehog (SHH"
      }, {
        "text": ") from the notochord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple orientation: \u003cb\u003eAlar \u003d Sensory"
      }, {
        "text": " \u003d Dorsal\u003c/b\u003e, and \u003cb\u003eBasal \u003d Motor \u003d Ventral\u003c/b\u003e. This organization persists in the adult spinal cord."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAlar Plate\u003c/b\u003e is the embryonic foundation for"
      }, {
        "text": " the sensory pathways of the CNS, establishing the fundamental dorsal-sensory and ventral-motor organization of the neural tube that"
      }, {
        "text": " is maintained throughout life.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Neural Tube] --\u003e B(Al"
      }, {
        "text": "ar Plate - Dorsal); A --\u003e C(Basal Plate - Ventral); D[Ectoderm] --"
      }, {
        "text": "BMPs--\u003e B; B --\u003e E[Sensory Neurons]; F[Notochord] --SHH--\u003e C"
      }, {
        "text": "; C --\u003e G[Motor Neurons];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "part_of\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"develops_into\",\n        \"to\": \"sensory_neurons\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_counterpart_to\",\n        \"to\": \"253e3efb\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_induced_by\",\n        \"to\": \"bone_morph"
      }, {
        "text": "ogenetic_proteins\"\n      }\n    ]\n  },\n  \"a0f3ce4c\":"
      }, {
        "text": " {\n    \"title\": \"Albuminocytologic Dissociation\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Diagnostics\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral"
      }, {
        "text": " Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlbuminocyt"
      }, {
        "text": "ologic dissociation\u003c/b\u003e is the pathognomonic finding in the cerebrospinal fluid (CSF) of patients with [[ed52e"
      }, {
        "text": "40b|Guillain-Barr√© Syndrome]], characterized by a significantly \u003ci\u003eelevated protein concentration\u003c/i\u003e in"
      }, {
        "text": " the presence of a \u003ci\u003enormal or near-normal white blood cell count\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e This finding is the hallmark of [[ed52e40b|Gu"
      }, {
        "text": "illain-Barr√© Syndrome (GBS)]], specifically the AIDP subtype.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e W"
      }, {
        "text": "idespread inflammation of the nerve roots (radiculopathy) disrupts the blood-nerve barrier, allowing protein (mainly albumin) to leak from the plasma"
      }, {
        "text": " into the CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCell Count:\u003c/b\u003e The cell count remains normal (typically \u003c10 cells/mm"
      }, {
        "text": "\u003csup\u003e3\u003c/sup\u003e) because the inflammatory process is primarily in the peripheral nerve roots, not within the CSF space itself (i"
      }, {
        "text": ".e., it is not meningitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e The protein level may be normal in the first few days of G"
      }, {
        "text": "BS and typically peaks 1-2 weeks after symptom onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with ascending"
      }, {
        "text": " paralysis after a recent infection (*C. jejuni* or viral URI) and a CSF report showing high protein but a"
      }, {
        "text": " normal cell count is a classic vignette for [[ed52e40b|Guillain-Barr√© Syndrome]]."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlbuminocytologic dissociation\u003c/b\u003e is a powerful diagnostic clue for"
      }, {
        "text": " [[ed52e40b|Guillain-Barr√© Syndrome]], reflecting the unique pathophysiology of nerve root inflammation that"
      }, {
        "text": " increases blood-nerve barrier permeability to proteins without causing a significant cellular infiltrate into the CSF.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        "
      }, {
        "text": "\"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_found_in\",\n        \"to\": \"cerebrospinal_fluid\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"fcf30c1b\": {\n    \"title\": \"Alexia\",\n    \"primaryType\": \""
      }, {
        "text": "finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"Stroke"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlexia\u003c/b\u003e"
      }, {
        "text": " is an acquired neurological disorder characterized by the \u003ci\u003einability to read or comprehend written language\u003c/i\u003e, resulting from a lesion in the brain\u0027"
      }, {
        "text": "s language or visual processing centers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAlexia without Ag"
      }, {
        "text": "raphia (Pure Alexia):\u003c/b\u003e A specific syndrome where the patient can write but cannot read what they have just written."
      }, {
        "text": " This is a classic disconnection syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the \u003cmark"
      }, {
        "text": "\u003edominant (usually left) occipital lobe\u003c/mark\u003e that also damages the \u003cmark\u003esplenium of the corpus callosum\u003c/mark"
      }, {
        "text": "\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Visual information from the intact right occipital lobe cannot cross over to the dominant hemisphere\u0027s language areas"
      }, {
        "text": " (Wernicke\u0027s area, angular gyrus) for interpretation because the connecting fibers in the splenium are damaged. The dominant"
      }, {
        "text": " visual cortex is also damaged, so no visual information can be processed on that side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e This"
      }, {
        "text": " specific lesion is classically caused by a stroke in the territory of the [[b6a2cc31|Posterior Cerebral"
      }, {
        "text": " Artery (PCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vignette of a patient who can write a sentence"
      }, {
        "text": " but is unable to read it back is pathognomonic for alexia without agraphia, pointing directly to a left"
      }, {
        "text": " PCA stroke affecting the occipital lobe and splenium.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlexia without agraph"
      }, {
        "text": "ia\u003c/b\u003e is a quintessential disconnection syndrome where visual information is stranded in the non-dominant hemisphere, unable to reach the language centers in the dominant"
      }, {
        "text": " hemisphere because the connecting bridge (splenium of the corpus callosum) has been destroyed, typically by a PCA stroke.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Written Word] --\u003e B(Eyes); B --\u003e C[Right Visual Cortex]; C --"
      }, {
        "text": "x D(Splenium of Corpus Callosum); D --x E[Left Language Areas]; B --\u003e F(Left Visual"
      }, {
        "text": " Cortex); F --x G[Lesion];\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"occipital_lobe\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to"
      }, {
        "text": "\": \"corpus_callosum\"\n      },\n      {\n        \"type\": \"is_caused_by"
      }, {
        "text": "_stroke_in\",\n        \"to\": \"b6a2cc31\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_distinct_from\",\n        \"to\": \"13d6bca7"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"083094db\": {\n    \"title\": \"Al"
      }, {
        "text": "prazolam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry"
      }, {
        "text": "\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlprazolam\u003c/b\u003e (trade name Xanax) is a potent"
      }, {
        "text": ", short-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used primarily for the management of anxiety disorders, especially panic disorder, and for"
      }, {
        "text": " the short-term treatment of anxiety associated with depression.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Mechanism of Action:\u003c/b\u003e A positive allosteric modulator of the [[gaba_a_receptor|GABA\u003csub\u003e"
      }, {
        "text": "A\u003c/sub\u003e receptor]]. It increases the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening in response to GABA binding, leading to enhanced"
      }, {
        "text": " CNS inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is short-acting. Mnemonic for short-acting benzodiazepines: \u003cb\u003e"
      }, {
        "text": "ATOM\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003elprazolam, \u003cb\u003eT\u003c/b\u003eriazolam, \u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eM\u003c/b\u003eidazol"
      }, {
        "text": "am).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily for [[panic_disorder|panic disorder]] and [[generalized_"
      }, {
        "text": "anxiety_disorder|generalized anxiety disorder]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance"
      }, {
        "text": ", and withdrawal symptoms. Additive CNS depression with other depressants like alcohol and barbiturates. Has a higher addictive"
      }, {
        "text": " potential due to its short half-life.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Because of its rapid onset and short duration"
      }, {
        "text": ", alprazolam is highly effective for acute panic attacks but also carries a high risk of dependence and severe withdrawal. Over"
      }, {
        "text": "dose is treated with [[flumazenil]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAlprazolam\u003c/b\u003e is"
      }, {
        "text": " a high-potency, short-acting benzodiazepine that provides rapid relief for panic and anxiety by enhancing GABAergic inhibition, but its"
      }, {
        "text": " pharmacokinetic profile also contributes to a significant risk of dependence and withdrawal.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Alprazol"
      }, {
        "text": "am] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(‚Üë Frequency of Cl- Channel Opening"
      }, {
        "text": "); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS"
      }, {
        "text": " Depression/Anxiolysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"panic_disorder\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "treats\",\n        \"to\": \"d1c786e9\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"77ae6148\": {\n    \"title\": \"Alzheimer Disease"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAlzheimer Disease\u003c/b\u003e is the most common cause of \u003ci\u003ed"
      }, {
        "text": "ementia\u003c/i\u003e in older adults, a progressive neurodegenerative disorder characterized by the extracellular deposition of \u003cb\u003eamyloid-Œ≤ (AŒ≤) plaques\u003c/b\u003e and the"
      }, {
        "text": " intracellular accumulation of \u003cb\u003ehyperphosphorylated tau tangles\u003c/b\u003e, leading to widespread cortical atrophy and a significant cholinergic deficit.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathology Hallmarks:\u003c/b\u003e Extracellular \u003cmark\u003esenile plaques\u003c/mark\u003e (composed"
      }, {
        "text": " of AŒ≤) and intracellular \u003cmark\u003eneurofibrillary tangles\u003c/mark\u003e (composed of hyperphosphorylated tau protein"
      }, {
        "text": "). The number of tangles correlates with disease severity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Risk is increased by the \u003c"
      }, {
        "text": "mark\u003eApoE4\u003c/mark\u003e allele for the sporadic, late-onset form. Early-onset familial forms are associated"
      }, {
        "text": " with mutations in \u003ci\u003eAPP\u003c/i\u003e (chromosome 21), \u003ci\u003epresenilin-1\u003c/i\u003e (chromosome "
      }, {
        "text": "14), and \u003ci\u003epresenilin-2\u003c/i\u003e (chromosome 1).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Ins"
      }, {
        "text": "idious onset of progressive short-term memory loss, followed by language deficits (aphasia), visuospatial difficulties,"
      }, {
        "text": " and executive dysfunction. Personality and behavioral changes are common in later stages.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Deficit:\u003c/b\u003e Marked"
      }, {
        "text": " decrease in [[6a005559|acetylcholine]] due to degeneration of cholinergic neurons in the [[36"
      }, {
        "text": "1438f2|Basal nucleus of Meynert]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Patients"
      }, {
        "text": " with \u003cb\u003eDown syndrome (Trisomy 21)\u003c/b\u003e have a greatly increased risk of early-onset Alzheimer\u0027"
      }, {
        "text": "s because the \u003ci\u003eAPP\u003c/i\u003e gene is located on chromosome 21, leading to a gene dosage effect and increased AŒ≤ production.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe core pathology of \u003cb\u003eAlzheimer Disease\u003c/b\u003e involves a dual-protein"
      }, {
        "text": "opathy of extracellular amyloid plaques and intracellular tau tangles, which together trigger synaptic dysfunction and neuronal death, manifesting clinically as a progressive"
      }, {
        "text": " decline in memory and cognition due to widespread cortical and hippocampal atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[APP"
      }, {
        "text": " Gene on Chr 21] --Abnormal Cleavage--\u003e B(Amyloid-Œ≤ Monomers); B --\u003e C(O"
      }, {
        "text": "ligomers \u0026 Plaques); D[Tau Protein] --Hyperphosphorylation--\u003e E(Neurofibrillary Tangles); C"
      }, {
        "text": " \u0026 E --\u003e F(Synaptic Dysfunction \u0026 Neuronal Death); F --\u003e G(Cortical Atrophy); G --\u003e H(D"
      }, {
        "text": "ementia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "associated_with\",\n        \"to\": \"down_syndrome\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"involves_deficiency_of\",\n        \"to\": \"6a0055"
      }, {
        "text": "59\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"4"
      }, {
        "text": "7d0372e\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"3"
      }, {
        "text": "61438f2\"\n      }\n    ]\n  },\n  \"9c9679ea\": {\n"
      }, {
        "text": "    \"title\": \"Amantadine\",\n    \"primaryType\": \"drug\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eAmantadine\u003c/b\u003e is a medication with multiple mechanisms of action, used primarily in neurology to treat [[5"
      }, {
        "text": "8c8ea03|Parkinson disease]] and drug-induced extrapyramidal symptoms, and historically as"
      }, {
        "text": " an antiviral agent for influenza A.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism (Parkinson\u0027"
      }, {
        "text": "s):\u003c/b\u003e Increases dopamine availability by \u003cmark\u003eenhancing dopamine release\u003c/mark\u003e and \u003cmark\u003einhibiting dopamine reuptake\u003c/"
      }, {
        "text": "mark\u003e in the CNS. It also has some anticholinergic properties.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used"
      }, {
        "text": " for mild [[58c8ea03|Parkinson disease]] to improve tremor, rigidity, and bradykinesia. It is"
      }, {
        "text": " particularly useful for reducing levodopa-induced dyskinesias in advanced disease. Also used to treat acute dystonia caused"
      }, {
        "text": " by antipsychotics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntiviral Use:\u003c/b\u003e Previously used for prophylaxis and treatment of Influenza A by blocking"
      }, {
        "text": " the M2 proton channel, but is no longer recommended due to widespread resistance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e CNS"
      }, {
        "text": " effects like confusion, hallucinations, and dizziness. A characteristic side effect is \u003cmark\u003elivedo reticularis\u003c/mark\u003e (a"
      }, {
        "text": " mottled, purplish skin discoloration) and peripheral edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For Parkinson\u0027s, am"
      }, {
        "text": "antadine is a \u0027weaker\u0027 drug but can be useful early on or for managing side effects of more potent therapies"
      }, {
        "text": ". The association with livedo reticularis is a classic board question clue.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Amantadine\u003c/b\u003e serves a niche role in managing [[58c8ea03|Parkinson disease]] by modestly"
      }, {
        "text": " increasing dopamine levels, but its utility is limited by CNS side effects and the unique dermatologic finding of livedo reticularis.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"causes_adverse_effect\",\n        \"to\": \"livedo_reticularis\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"90adc"
      }, {
        "text": "821\"\n      }\n    ]\n  },\n  \"f0aac1c3\": {\n"
      }, {
        "text": "    \"title\": \"Amaurosis Fugax\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Cardiovascular\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmaurosis"
      }, {
        "text": " fugax\u003c/b\u003e (from Greek for \u0027darkening\u0027 and Latin for \u0027fleeting\u0027) is a painless, \u003ci\u003etransient monocular vision loss\u003c/i\u003e"
      }, {
        "text": ", classically described by patients as a \u003cmark\u003e\\\"curtain coming down over one eye.\\\"\u003c/mark\u003e It is a form"
      }, {
        "text": " of [[623ba776|transient ischemic attack (TIA)]] affecting the retina.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an embolus to the [["
      }, {
        "text": "3334840f|central or branch retinal artery]], which temporarily obstructs blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSource"
      }, {
        "text": " of Emboli:\u003c/b\u003e The most frequent source is an atherosclerotic plaque in the \u003cmark\u003eipsilateral carotid artery\u003c/mark\u003e."
      }, {
        "text": " It can also be cardiogenic (e.g., from atrial fibrillation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is a critical warning"
      }, {
        "text": " sign of underlying cerebrovascular disease and portends a high risk of a major [[c5da3c57|stroke]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eWorkup:\u003c/b\u003e Patients require urgent evaluation, including a carotid ultrasound (duplex) to assess for stenosis and an"
      }, {
        "text": " EKG/echocardiogram to rule out cardiac sources.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a patient with a"
      }, {
        "text": " history of hypertension and hyperlipidemia who experiences a sudden, painless, temporary \\\"curtain-like\\\" vision loss in one eye should immediately"
      }, {
        "text": " point to amaurosis fugax secondary to carotid artery disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmaurosis"
      }, {
        "text": " fugax\u003c/b\u003e is not just an eye problem but a neurological emergency; this transient \u0027curtain\u0027 of vision loss is"
      }, {
        "text": " a TIA of the retina, most often signaling significant atherosclerotic disease in the ipsilateral carotid artery and a high impending"
      }, {
        "text": " risk of stroke.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Carotid Artery Plaque] --\u003e B(Em"
      }, {
        "text": "bolus); B --\u003e C[Ophthalmic Artery]; C --\u003e D[Retinal Artery Occlusion]; D --\u003e E"
      }, {
        "text": "[Transient Monocular Vision Loss]; E --\u003e F(Amaurosis Fugax);\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"623ba776\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"car"
      }, {
        "text": "otid_artery_stenosis\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "symptom_of\",\n        \"to\": \"3334840f\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"a4a401c7\": {\n    \"title\": \"Amblyopia\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      "
      }, {
        "text": "\"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Pediatric Ophthalmology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmblyopia\u003c/b\u003e, commonly known as \\\"lazy eye,\\\""
      }, {
        "text": " is a neurodevelopmental disorder of vision characterized by \u003ci\u003edecreased visual acuity\u003c/i\u003e in one or both eyes that is not correct"
      }, {
        "text": "able by refractive means and is not due to any structural eye pathology. It results from abnormal visual experience during early childhood.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e During a critical period of visual development (birth to ~7 years), the"
      }, {
        "text": " brain suppresses or ignores the input from one eye, leading to maldevelopment of the visual cortex corresponding to that eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon"
      }, {
        "text": " Causes:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[cdcda821|Strabismus]] (Misalignment):\u003c/b\u003e The brain"
      }, {
        "text": " ignores the image from the deviating eye to avoid diplopia.\u003cbr\u003e2. \u003cb\u003eAnisometropia (Une"
      }, {
        "text": "qual Refractive Error):\u003c/b\u003e The brain favors the eye with better focus.\u003cbr\u003e3. \u003cb\u003eDeprivation:"
      }, {
        "text": "\u003c/b\u003e An obstruction like a congenital [[85f03b02|cataract]] or ptosis blocks a"
      }, {
        "text": " clear image from forming.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Detected during pediatric vision screening. The key finding is a difference in visual acuity between the two eyes."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Must be initiated early in the critical period. Treatment involves correcting the underlying cause (e.g., glasses"
      }, {
        "text": " for refractive error, surgery for strabismus/cataract) and then forcing the brain to use the amblyopic eye,"
      }, {
        "text": " typically by \u003cmark\u003epatching the good eye\u003c/mark\u003e or using atropine drops to blur its vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Early detection and treatment are crucial. If not treated before the end of the critical period (~age 7-8),"
      }, {
        "text": " amblyopia can result in irreversible vision loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmblyopia"
      }, {
        "text": "\u003c/b\u003e is a \u0027brain\u0027 problem, not an \u0027eye\u0027 problem; it is the failure of the visual cortex to develop properly due to abnormal"
      }, {
        "text": " input from an eye during a critical developmental window, leading to vision loss that can only be reversed by forcing the brain to pay"
      }, {
        "text": " attention to the \u0027lazy\u0027 eye before that window closes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\":"
      }, {
        "text": " \"cdcda821\"\n      },\n      {\n        \"type\": \"is_caused_by"
      }, {
        "text": "\",\n        \"to\": \"85f03b02\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_treated_by\",\n        \"to\": \"ocular_patching\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"9115b704\": {\n    \"title\": \""
      }, {
        "text": "Amino Acids (CNS Context)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \""
      }, {
        "text": "Neuroscience\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmino acids\u003c/b\u003e are organic compounds that serve as the"
      }, {
        "text": " building blocks of proteins and as precursors for many neurotransmitters. In the central nervous system, their passage from the blood into the brain"
      }, {
        "text": " is tightly regulated by the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier Transport:\u003c/b\u003e Amino acids are generally lipid-insoluble and cannot diffuse freely across the [["
      }, {
        "text": "dd47b9cc|blood-brain barrier]]. They require \u003cmark\u003ecarrier-mediated transport proteins\u003c/mark\u003e to"
      }, {
        "text": " enter the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransport Systems:\u003c/b\u003e There are specific transporters for different classes of amino acids (e.g., large neutral,"
      }, {
        "text": " basic, acidic). These transporters can become saturated and exhibit competition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Precursors:\u003c/b\u003e Many crucial"
      }, {
        "text": " neurotransmitters are synthesized from amino acids that must be transported into the brain. Examples include Tyrosine (precursor to [["
      }, {
        "text": "90adc821|dopamine]], norepinephrine) and Tryptophan (precursor to [[5d"
      }, {
        "text": "3c2089|serotonin]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e In disorders like [[phenylketonuria|"
      }, {
        "text": "Phenylketonuria (PKU)]], high levels of one amino acid (phenylalanine) can saturate the large neutral amino acid transporter, impair"
      }, {
        "text": "ing the transport of other essential amino acids (like tyrosine and tryptophan) into the brain, contributing to neurological dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Remember that both glucose and amino acids require specific carrier-mediated transport to cross the [[dd47b9cc|blood"
      }, {
        "text": "-brain barrier]]; they do not diffuse freely.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe brain"
      }, {
        "text": "\u0027s supply of essential \u003cb\u003eamino acids\u003c/b\u003e, critical for both protein synthesis and neurotransmitter production, is entirely dependent on specialized"
      }, {
        "text": " carrier proteins at the [[dd47b9cc|blood-brain barrier]], a system that can be competitively inhibited"
      }, {
        "text": " in certain metabolic diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"crosses_via_transporters\",\n        \"to\": \"dd47b9cc\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_precursor_to\",\n        \"to\": \""
      }, {
        "text": "90adc821\"\n      },\n      {\n        \"type\": \"is_precursor_"
      }, {
        "text": "to\",\n        \"to\": \"5d3c2089\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"transport_is_impaired_in\",\n        \"to\": \"phenylketonuria\"\n      }\n    "
      }, {
        "text": "]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1_g61ciW51iPpPg8xm4wuaBZNSysG89Og"
      },
      "role": "user",
      "tokenCount": 2013
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"c6814506\": {\n    \"title\": \"Amitriptyline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmitriptyline\u003c/b\u003e is a \u003ci\u003etricyclic antidepressant (TCA)\u003c/i\u003e that works by inhibiting the reuptake of serotonin and norepinephrine. Due to its significant side effect profile, its primary use has shifted from depression to treating neuropathic pain and providing prophylaxis for [[c8833bae|migraine headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks reuptake of norepinephrine and serotonin. Also has potent antagonistic effects at muscarinic, Œ±1-adrenergic, and H1-histamine receptors, which account for its side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for prophylaxis of [[c8833bae|migraine headaches]] and for the management of chronic neuropathic pain (e.g., diabetic neuropathy, postherpetic neuralgia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Strong anticholinergic effects (\u003cmark\u003edry mouth, constipation, urinary retention, confusion\u003c/mark\u003e), orthostatic hypotension (Œ±1 blockade), sedation (H1 blockade), and weight gain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiotoxicity:\u003c/b\u003e Overdose is life-threatening, causing QRS widening and ventricular arrhythmias due to Na\u003csup\u003e+\u003c/sup\u003e channel blockade. Treat with sodium bicarbonate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027Tri-C\u0027s\u0027 for TCA toxicity: \u003cb\u003eC\u003c/b\u003eonvulsions, \u003cb\u003eC\u003c/b\u003eoma, \u003cb\u003eC\u003c/b\u003eardiotoxicity. Amitriptyline is a tertiary amine TCA, giving it more potent anticholinergic and antihistaminic effects compared to secondary amines like nortriptyline.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmitriptyline\u003c/b\u003e, a classic TCA, is now more valued for its role in migraine prevention and neuropathic pain than for depression, but its use is always tempered by a significant burden of anticholinergic, antihistaminic, and anti-adrenergic side effects, with cardiotoxicity being the most dangerous in overdose.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"tricyclic_antidepressant\"\n      },\n      {\n        \"type\": \"used_for_prophylaxis_of\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \"has_adverse_effect\",\n        \"to\": \"cardiotoxicity\"\n      }\n    ]\n  },\n  \"a62c0c9f\": {\n    \"title\": \"Amnesia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cognitive Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmnesia\u003c/b\u003e is a deficit in memory caused by brain damage, disease, or psychological trauma. It can be categorized based on the temporal nature of the memory loss relative to the causative event.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterograde Amnesia:\u003c/b\u003e The inability to form \u003cu\u003enew\u003c/u\u003e memories after the event that caused the amnesia. Long-term memories from before the event remain intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterograde Lesion Site:\u003c/b\u003e Classically caused by bilateral damage to the \u003cmark\u003ehippocampus\u003c/mark\u003e, a key structure in the medial temporal lobe for memory consolidation. Seen in [[77ae6148|Alzheimer disease]] and [[herpes_simplex_encephalitis|herpes simplex encephalitis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetrograde Amnesia:\u003c/b\u003e The loss of memories that were formed \u003cu\u003ebefore\u003c/u\u003e the onset of amnesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKorsakoff Syndrome:\u003c/b\u003e A classic example of a syndrome causing both anterograde and retrograde amnesia, along with confabulation. It is caused by thiamine (B1) deficiency, often in the context of chronic alcohol use, and involves damage to the \u003cmark\u003emammillary bodies\u003c/mark\u003e and thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral hippocampal lesions (e.g., from an anoxic brain injury or HSV encephalitis) are the classic cause of profound anterograde amnesia. The patient can remember their childhood but not what they had for breakfast.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hippocampus is the brain\u0027s \u0027save button\u0027 for new memories; therefore, bilateral damage to this structure results in profound \u003cb\u003eanterograde amnesia\u003c/b\u003e, leaving the individual unable to consolidate new experiences into long-term memory.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brain Injury/Disease] --\u003e B{Amnesia}; B --\u003e C[Anterograde Amnesia]; C --\u003e D(Inability to form new memories); D --\u003e E[Lesion: Hippocampus]; B --\u003e F[Retrograde Amnesia]; F --\u003e G(Loss of past memories); G --\u003e H[Lesion: Widespread Cortex];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"a0590674\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"f02cfaa1\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"wernicke_korsakoff_syndrome\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"d220fc3f\": {\n    \"title\": \"Amygdala\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAmygdala\u003c/b\u003e is an almond-shaped set of neurons located deep within the medial temporal lobe of the brain. It is a key component of the [[73ace357|limbic system]] and plays a central role in processing emotions, particularly fear, anxiety, and aggression, as well as in memory formation and decision-making.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The amygdala is the brain\u0027s emotional center, responsible for processing fear, pleasure, and anger. It links emotions to memories and influences social and sexual behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the medial temporal lobe, anterior to the [[a0590674|hippocampus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects (Bilateral):\u003c/b\u003e Bilateral destruction of the amygdala results in \u003cmark\u003eKl√ºver-Bucy syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome:\u003c/b\u003e Characterized by disinhibited behavior, including hyperorality (tendency to examine objects with the mouth), hypersexuality, hyperphagia, and visual agnosia. Patients also exhibit placidity (loss of fear response).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic cause of bilateral amygdala damage leading to Kl√ºver-Bucy syndrome is [[herpes_simplex_encephalitis|Herpes Simplex Virus-1 (HSV-1) encephalitis]], which has a predilection for the temporal lobes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAmygdala\u003c/b\u003e acts as the brain\u0027s alarm system and emotional processor; its bilateral destruction unleashes primitive behaviors by removing the normal emotional filters, resulting in the dramatic and disinhibited presentation of Kl√ºver-Bucy syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sensory Input] --\u003e B(Amygdala); B --Fear/Emotion Processing--\u003e C[Hypothalamus \u0026 Brainstem]; C --\u003e D(Autonomic \u0026 Behavioral Response);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"bilateral_lesion_causes\",\n        \"to\": \"kluver_bucy_syndrome\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"herpes_simplex_encephalitis\"\n      }\n    ]\n  },\n  \"b374ebd6\": {\n    \"title\": \"Cerebral Amyloid Angiopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral Amyloid Angiopathy (CAA)\u003c/b\u003e is a condition in which amyloid-Œ≤ protein deposits in the walls of small to medium-sized arteries of the cerebral cortex and leptomeninges, weakening the vessels and increasing the risk of spontaneous, recurrent \u003cmark\u003elobar\u003c/mark\u003e intraparenchymal hemorrhages.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Deposition of \u003cmark\u003eamyloid-Œ≤\u003c/mark\u003e (the same protein found in [[77ae6148|Alzheimer\u0027s]] plaques) in the tunica media and adventitia of cortical and leptomeningeal vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Most commonly presents with recurrent, spontaneous lobar hemorrhages in older adults (\u003e65 years). These hemorrhages are typically located in the superficial cortex (lobar) rather than deep structures like the basal ganglia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Hemorrhages are characteristically \u003cmark\u003elobar\u003c/mark\u003e (frontal, parietal, occipital, temporal lobes), contrasting with hypertensive hemorrhages which are typically deep (basal ganglia, thalamus, pons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociation:\u003c/b\u003e Strongly associated with [[77ae6148|Alzheimer disease]], although it can occur independently.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An elderly patient with no history of significant hypertension who presents with a spontaneous, superficial (lobar) intracerebral hemorrhage should raise high suspicion for Cerebral Amyloid Angiopathy. Recurrent hemorrhages in different lobes are a key feature.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral Amyloid Angiopathy\u003c/b\u003e is a major cause of lobar intracerebral hemorrhage in the elderly, resulting from amyloid-Œ≤ deposition that makes cortical blood vessels brittle and prone to rupture, distinct from the deep brain hemorrhages typically caused by hypertension.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Amyloid-Œ≤ Deposition] --\u003e B(Vessel Wall Weakening); B --\u003e C[Cortical \u0026 Leptomeningeal Arteries]; C --\u003e D(Rupture); D --\u003e E[Recurrent Lobar Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"hypertensive_hemorrhage\"\n      }\n    ]\n  },\n  \"4ed629f9\": {\n    \"title\": \"Amyotrophic Lateral Sclerosis (ALS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Degenerative Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis (ALS)\u003c/b\u003e, also known as Lou Gehrig\u0027s disease, is a relentless and fatal neurodegenerative disorder characterized by the progressive loss of both \u003cu\u003eupper motor neurons\u003c/u\u003e (in the motor cortex) and \u003cu\u003elower motor neurons\u003c/u\u003e (in the brainstem and spinal cord).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Degeneration of corticospinal tracts (lateral sclerosis) and anterior horn cells (amyotrophy). The exact cause is unknown in most cases (sporadic), but some familial cases are linked to a mutation in the \u003cmark\u003esuperoxide dismutase 1 (SOD1)\u003c/mark\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A hallmark of ALS is the combination of both \u003cb\u003eupper motor neuron (UMN)\u003c/b\u003e signs (spasticity, hyperreflexia, Babinski sign) and \u003cb\u003elower motor neuron (LMN)\u003c/b\u003e signs (fasciculations, atrophy, flaccid weakness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Can present with asymmetric limb weakness (e.g., foot drop, hand weakness), dysarthria (difficulty speaking), and dysphagia (difficulty swallowing). Sensation, cognition, and eye movements are typically spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBulbar Involvement:\u003c/b\u003e When LMNs in the brainstem are affected, it leads to [[901f3180|bulbar palsy]], causing dysarthria, dysphagia, and tongue fasciculations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e [[riluzole|Riluzole]], a glutamate antagonist, may modestly increase survival. Management is largely supportive, focusing on respiratory support and nutrition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of UMN and LMN signs in the same patient is the key to diagnosing ALS. Look for a patient with weakness and atrophy in one arm (LMN) but hyperreflexia in the legs (UMN).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis\u003c/b\u003e is uniquely devastating because it attacks the entire voluntary motor system, from the brain to the muscle, combining the spasticity of UMN lesions with the muscle wasting of LMN lesions, while cruelly sparing the patient\u0027s intellect and senses.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[UMN Degeneration - Motor Cortex] --\u003e B(Spasticity, Hyperreflexia); C[LMN Degeneration - Anterior Horn] --\u003e D(Fasciculations, Atrophy); A \u0026 C --\u003e E(Progressive Motor Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"motor_neuron_disease\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"upper_motor_neuron_signs\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"lower_motor_neuron_signs\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"riluzole\"\n      },\n      {\n        \"type\": \"is_associated_with_mutation_in\",\n        \"to\": \"sod1_gene\"\n      }\n    ]\n  },\n  \"ce2052d6\": {\n    \"title\": \"Anal Wink Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnal Wink Reflex\u003c/b\u003e is a superficial reflex involving the contraction of the external anal sphincter upon stroking the skin around the anus. It is used to test the integrity of the \u003cmark\u003eS3 and S4\u003c/mark\u003e spinal nerve roots and the pudendal nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Tests the integrity of the \u003cb\u003eS3-S4\u003c/b\u003e spinal cord segments. Mnemonic: S2, 3, 4 keep the penis off the floor (for erection), and S3, 4 are for the anal wink.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Stroking the perianal skin stimulates afferent fibers of the pudendal nerve. The signal travels to the S3-S4 spinal segments, synapses, and an efferent signal returns via the pudendal nerve to cause contraction of the external anal sphincter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e An absent anal wink reflex is a key sign in \u003cmark\u003e[[2904b5c8|Cauda Equina Syndrome]]\u003c/mark\u003e, a neurosurgical emergency. It indicates damage to the S3-S4 nerve roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Conditions:\u003c/b\u003e The reflex may also be absent in other conditions affecting the sacral nerve roots or spinal cord, such as spinal cord injury or spina bifida.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with severe low back pain, saddle anesthesia, and bowel/bladder dysfunction, checking for the anal wink reflex is a critical step. Its absence strongly supports the diagnosis of [[2904b5c8|Cauda Equina Syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnal Wink Reflex\u003c/b\u003e is a simple but vital physical exam maneuver for assessing the function of the lower sacral nerve roots (S3-S4); its absence is a red flag for [[2904b5c8|Cauda Equina Syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Stroke Perianal Skin] --\u003e B(Afferent Signal via Pudendal N.); B --\u003e C[S3-S4 Spinal Cord]; C --\u003e D(Efferent Signal via Pudendal N.); D --\u003e E(External Anal Sphincter Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"s3_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"s4_nerve_root\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"2904b5c8\"\n      }\n    ]\n  },\n  \"5bcc9894\": {\n    \"title\": \"Anencephaly\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnencephaly\u003c/b\u003e is a severe and lethal congenital malformation, classified as an open \u003ci\u003eneural tube defect\u003c/i\u003e, resulting from the failure of the rostral (anterior) neuropore to close during the 4th week of embryonic development. This leads to the absence of the forebrain and a large portion of the skull (calvarium).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the rostral neuropore to close leads to an open calvarium and absence of the forebrain. The remaining brain tissue is exposed and degenerates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Incompatible with postnatal life; infants are stillborn or die shortly after birth. The fetus has a characteristic \u003cmark\u003e\\\"frog-like appearance\\\"\u003c/mark\u003e due to the absent cranial vault.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMaternal Findings:\u003c/b\u003e Associated with \u003cmark\u003epolyhydramnios\u003c/mark\u003e due to impaired fetal swallowing, as the neural control for swallowing is absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Can be detected prenatally via ultrasound. Maternal serum screening will show markedly \u003cmark\u003eelevated alpha-fetoprotein (AFP)\u003c/mark\u003e. Amniotic fluid will also have elevated AFP and acetylcholinesterase (AChE).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrevention:\u003c/b\u003e Risk is significantly reduced by maternal folic acid supplementation before conception and during early pregnancy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnencephaly\u003c/b\u003e represents a catastrophic failure of early neural development, where the absence of the forebrain and skull results in a condition incompatible with life, and is prenatally indicated by elevated maternal AFP and polyhydramnios.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Failure of Rostral Neuropore Closure] --\u003e B(Absence of Forebrain \u0026 Calvarium); B --\u003e C(Polyhydramnios); B --\u003e D(Lethal Outcome);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"polyhydramnios\"\n      },\n      {\n        \"type\": \"is_diagnosed_by\",\n        \"to\": \"alpha_fetoprotein\"\n      }\n    ]\n  },\n  \"a5295f1a\": {\n    \"title\": \"Anesthetics\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnesthetics\u003c/b\u003e are drugs that induce a reversible loss of sensation. They are broadly classified into \u003ci\u003egeneral anesthetics\u003c/i\u003e, which cause a reversible loss of consciousness, and \u003ci\u003elocal anesthetics\u003c/i\u003e, which block nerve transmission in a specific region of the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGeneral Anesthetics:\u003c/b\u003e Induce a state of unconsciousness, analgesia, amnesia, and muscle relaxation. They can be inhaled (e.g., sevoflurane, desflurane) or intravenous (e.g., propofol, ketamine, etomidate). Their potency is measured by the \u003cmark\u003eMinimum Alveolar Concentration (MAC)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocal Anesthetics:\u003c/b\u003e Block nerve conduction by inhibiting voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels. They are classified as esters (e.g., procaine, cocaine) or amides (e.g., lidocaine, bupivacaine). They are weak bases and are less effective in infected (acidic) tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuromuscular Blockers:\u003c/b\u003e Often used with general anesthetics to achieve profound muscle relaxation (paralysis). They can be depolarizing (e.g., succinylcholine) or non-depolarizing (e.g., rocuronium).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMalignant Hyperthermia:\u003c/b\u003e A rare, life-threatening hypermetabolic state triggered by inhaled anesthetics (except N\u003csub\u003e2\u003c/sub\u003eO) and succinylcholine in genetically susceptible individuals. Treated with [[dantrolene]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the key pharmacokinetic properties of inhaled anesthetics: low blood solubility (low blood:gas partition coefficient) leads to rapid induction and recovery, while high lipid solubility (high oil:gas partition coefficient) corresponds to high potency (low MAC).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe field of \u003cb\u003eanesthesia\u003c/b\u003e relies on a combination of drugs to achieve a balanced state of unconsciousness, analgesia, and muscle relaxation, with general anesthetics acting on the CNS to induce sleep and local anesthetics acting on peripheral nerves to block pain signals.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"general_anesthetics\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"malignant_hyperthermia\"\n      }\n    ]\n  },\n  \"a7f97d7f\": {\n    \"title\": \"Cerebral Aneurysms\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral aneurysms\u003c/b\u003e are localized, abnormal dilations of blood vessels in the brain, which carry a significant risk of rupture, leading to life-threatening intracranial hemorrhage.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSaccular (Berry) Aneurysms:\u003c/b\u003e Most common type. Thin-walled outpouchings, typically occurring at arterial branch points in the [[e22300e8|Circle of Willis]]. Most common site is the junction of the [[bd802d22|anterior communicating artery]] and anterior cerebral artery. Rupture causes [[63f8b05f|subarachnoid hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociations with Saccular Aneurysms:\u003c/b\u003e \u003cmark\u003eAutosomal Dominant Polycystic Kidney Disease (ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, Marfan syndrome, hypertension, smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCharcot-Bouchard Microaneurysms:\u003c/b\u003e Aneurysms of small, penetrating arteries (e.g., lenticulostriate arteries) associated with chronic hypertension. Rupture causes [[70b266c8|intraparenchymal hemorrhage]], typically in deep brain structures like the basal ganglia or thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRupture Presentation:\u003c/b\u003e Rupture of a saccular aneurysm classically presents as a sudden, severe \u003cmark\u003e\\\"worst headache of my life\\\"\u003c/mark\u003e (thunderclap headache), indicating a [[63f8b05f|subarachnoid hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ADPKD who develops a sudden, severe headache should be immediately evaluated for a ruptured berry aneurysm. A PCom aneurysm can compress CN III, causing a \u0027down and out\u0027 eye with a \u0027blown\u0027 (dilated) pupil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eCerebral aneurysms are focal weaknesses in brain arteries; the larger \u003cb\u003esaccular (berry) aneurysms\u003c/b\u003e at the Circle of Willis rupture into the subarachnoid space, while the smaller \u003cb\u003eCharcot-Bouchard microaneurysms\u003c/b\u003e in deep brain structures rupture due to hypertension, causing intraparenchymal bleeds.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cerebral Aneurysm] --\u003e B{Types}; B --\u003e C[Saccular/Berry]; C --\u003e D(Circle of Willis); D --\u003e E[Rupture -\u003e Subarachnoid Hemorrhage]; B --\u003e F[Charcot-Bouchard]; F --\u003e G(Small Penetrating Arteries); G --\u003e H[Rupture -\u003e Intraparenchymal Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"autosomal_dominant_polycystic_kidney_disease\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a9f6d703\"\n      }\n    ]\n  },\n  \"9c80344d\": {\n    \"title\": \"Angle-Closure Glaucoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Glaucoma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAngle-closure glaucoma\u003c/b\u003e is an ophthalmologic emergency characterized by a sudden, severe increase in intraocular pressure (IOP) due to the physical obstruction of aqueous humor outflow through the trabecular meshwork by the peripheral iris.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs in individuals with a pre-existing narrow anterior chamber angle. Pupillary dilation (mydriasis) causes the peripheral iris to bunch up and block the trabecular meshwork, acutely halting aqueous humor drainage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTriggers:\u003c/b\u003e Any event causing mydriasis can trigger an attack, such as entering a dark room, stress, or administration of sympathomimetic or anticholinergic drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e \u003cmark\u003eSudden onset of severe, unilateral eye pain\u003c/mark\u003e, headache, nausea/vomiting, and blurred vision with \u003cmark\u003ehalos around lights\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e The eye is red and hard to palpation (\u0027rock hard\u0027). The pupil is typically \u003cmark\u003emid-dilated and nonreactive\u003c/mark\u003e to light. The cornea may appear hazy or steamy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a true ophthalmic emergency. The classic presentation of a painful, red eye with a fixed, mid-dilated pupil and halos around lights is pathognomonic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAngle-closure glaucoma\u003c/b\u003e is a mechanical plumbing problem of the eye where pupillary dilation in a predisposed individual causes the iris to act like a drain plug, leading to a rapid and painful spike in intraocular pressure that threatens vision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Predisposing Narrow Angle] --Pupillary Dilation--\u003e B(Iris bunches at periphery); B --\u003e C(Blocks Trabecular Meshwork); C --\u003e D(‚Üì Aqueous Outflow); D --\u003e E(‚Üë‚Üë Intraocular Pressure); E --\u003e F(Acute Pain, Vision Loss, Red Eye);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"mydriasis\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5ea7b741\"\n      }\n    ]\n  },\n  \"ed8c1c37\": {\n    \"title\": \"Anhidrosis in Horner Syndrome\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Autonomic\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Autonomic Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnhidrosis\u003c/b\u003e, the inability to sweat normally, is one of the three classic signs of [[c19010a3|Horner syndrome]], resulting from the disruption of sympathetic innervation to the sweat glands of the face.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHorner Syndrome Triad:\u003c/b\u003e The full triad is \u003cb\u003ePtosis\u003c/b\u003e (mild eyelid droop), \u003cb\u003eMiosis\u003c/b\u003e (constricted pupil), and \u003cb\u003eAnhidrosis\u003c/b\u003e (decreased sweating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Disruption of the oculosympathetic pathway prevents the release of acetylcholine from postganglionic sympathetic neurons that innervate sweat glands (a sympathetic exception).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization Value:\u003c/b\u003e The distribution of anhidrosis can help localize the lesion in the three-neuron sympathetic chain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Localization:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e1st Order (Central):\u003c/b\u003e Lesion in hypothalamus or brainstem/spinal cord. Anhidrosis affects the entire ipsilateral half of the body.\u003cbr\u003e - \u003cb\u003e2nd Order (Preganglionic):\u003c/b\u003e Lesion in the chest (e.g., Pancoast tumor). Anhidrosis affects the ipsilateral face and neck.\u003cbr\u003e - \u003cb\u003e3rd Order (Postganglionic):\u003c/b\u003e Lesion above the superior cervical ganglion (e.g., carotid dissection). Anhidrosis is often minimal or absent, affecting only a small patch on the forehead, because fibers to most facial sweat glands travel with the external carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A painful Horner syndrome (especially with neck pain) should raise suspicion for a carotid artery dissection, a 3rd order neuron lesion where anhidrosis is often absent.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile part of the classic triad, the presence and distribution of \u003cb\u003eanhidrosis\u003c/b\u003e in [[c19010a3|Horner syndrome]] is a subtle but powerful clue for localizing the lesion along the long oculosympathetic pathway, with widespread anhidrosis suggesting a central lesion and absent anhidrosis pointing towards a postganglionic (3rd order) problem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"sympathetic_pathway_disruption\"\n      }\n    ]\n  },\n  \"830c856c\": {\n    \"title\": \"Anterior Cerebral Artery (ACA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Cerebral Artery (ACA)\u003c/b\u003e is a major artery of the brain that branches from the internal carotid artery and supplies the medial portion of the frontal and parietal lobes, as well as the corpus callosum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from the bifurcation of the internal carotid artery. The left and right ACAs are connected by the [[bd802d22|anterior communicating artery]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Supplies the medial surface of the cerebral hemispheres. Based on the motor and sensory homunculus, this corresponds to the \u003cmark\u003elower extremities\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome:\u003c/b\u003e Occlusion of the ACA results in a characteristic stroke syndrome with \u003cmark\u003econtralateral motor and sensory deficits predominantly affecting the lower limb\u003c/mark\u003e (leg \u003e arm/face).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Stroke Signs:\u003c/b\u003e May also cause urinary incontinence due to damage to the paracentral lobule. Frontal lobe signs like abulia (lack of will/initiative) or personality changes can occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to identifying an ACA stroke is the disproportionate weakness and sensory loss in the contralateral leg compared to the arm and face. This contrasts sharply with an [[143bb23d|MCA stroke]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Cerebral Artery\u003c/b\u003e is responsible for the medial brain territory, meaning its occlusion uniquely manifests as a stroke that \u0027kicks the leg out\u0027 from under the patient, with motor and sensory deficits primarily affecting the contralateral lower extremity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid Artery] --\u003e B(Anterior Cerebral Artery); B --\u003e C(Supplies Medial Cortex); C --\u003e D(Motor/Sensory Homunculus for Leg); B --Connects via AComA--\u003e E(Contralateral ACA);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e22300e8\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"anterior_cerebral_artery_stroke\"\n      },\n      {\n        \"type\": \"is_connected_to_contralateral_by\",\n        \"to\": \"bd802d22\"\n      }\n    ]\n  },\n  \"3c4b0ef7\": {\n    \"title\": \"Anterior Circulation Strokes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cerebrovascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnterior circulation strokes\u003c/b\u003e are ischemic events caused by occlusion of the internal carotid artery or its major branches, the [[830c856c|anterior cerebral artery (ACA)]] and the [[143bb23d|middle cerebral artery (MCA)]], leading to deficits related to the cerebral hemispheres.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVessels Involved:\u003c/b\u003e Internal carotid artery (ICA), [[143bb23d|Middle Cerebral Artery (MCA)]], [[830c856c|Anterior Cerebral Artery (ACA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMCA Stroke:\u003c/b\u003e The most common type of ischemic stroke. Presents with \u003cmark\u003econtralateral hemiparesis and sensory loss affecting the face and upper limb more than the lower limb\u003c/mark\u003e. If the dominant (usually left) hemisphere is affected, it causes [[6bc9a567|aphasia]] (Broca\u0027s or Wernicke\u0027s). If the non-dominant hemisphere is affected, it causes hemineglect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eACA Stroke:\u003c/b\u003e Presents with \u003cmark\u003econtralateral hemiparesis and sensory loss affecting the lower limb more than the upper limb\u003c/mark\u003e. May also cause urinary incontinence and frontal lobe signs (e.g., personality changes, abulia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDistinction:\u003c/b\u003e The key differentiator is the distribution of weakness based on the homunculus: MCA strokes affect the face/arm, while ACA strokes affect the leg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Aphasia is a \u0027cortical sign\u0027 that strongly points to an MCA stroke in the dominant hemisphere. Leg weakness greater than arm weakness is the classic sign of an ACA stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnterior circulation strokes\u003c/b\u003e produce deficits that can be precisely localized by understanding the functional anatomy of the cerebral cortex and the homunculus; MCA strokes paralyze the contralateral face and arm, while ACA strokes paralyze the contralateral leg.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid Artery] --\u003e B(MCA); B --\u003e C(Contralateral Face/Arm Deficits, Aphasia/Neglect); A --\u003e D(ACA); D --\u003e E(Contralateral Leg Deficits, Incontinence);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"middle_cerebral_artery_stroke\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"anterior_cerebral_artery_stroke\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"276cefbc\"\n      }\n    ]\n  },\n  \"bd802d22\": {\n    \"title\": \"Anterior Communicating Artery (AComA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Communicating Artery (AComA)\u003c/b\u003e is a short blood vessel that connects the left and right [[830c856c|anterior cerebral arteries]], forming the anterior aspect of the [[e22300e8|Circle of Willis]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides collateral blood flow between the two anterior cerebral circulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is the \u003cmark\u003emost common site\u003c/mark\u003e for the formation of saccular (berry) aneurysms in the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAneurysm Complications:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eRupture:\u003c/b\u003e Leads to [[63f8b05f|subarachnoid hemorrhage]], presenting as a \\\"worst headache of my life.\\\"\u003cbr\u003e2. \u003cb\u003eCompression:\u003c/b\u003e A large, unruptured aneurysm can compress the adjacent \u003cmark\u003eoptic chiasm\u003c/mark\u003e, causing a [[6c3a980e|bitemporal hemianopia]] (tunnel vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a question mentions a saccular aneurysm, the AComA should be the first location you consider. If the patient has visual field defects, especially bitemporal hemianopia, an AComA aneurysm is a very likely cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Communicating Artery\u003c/b\u003e, while small, is clinically significant as the number one location for berry aneurysms, which can either rupture catastrophically into the subarachnoid space or compress the optic chiasm, causing tunnel vision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left ACA] -- AComA --\u003e B[Right ACA]; C(AComA Aneurysm) --\u003e D(Rupture -\u003e SAH); C --\u003e E(Compression -\u003e Bitemporal Hemianopia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e22300e8\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"830c856c\"\n      },\n      {\n        \"type\": \"is_common_site_for\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"aneurysm_can_cause\",\n        \"to\": \"6c3a980e\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9686,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"c6814506\": {\n    \"title\": \"Amit"
      }, {
        "text": "riptyline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry"
      }, {
        "text": "\",\n      \"Pharmacology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmitriptyline\u003c/b\u003e is a \u003ci\u003etricyclic antidepressant (TCA)\u003c/i\u003e that works"
      }, {
        "text": " by inhibiting the reuptake of serotonin and norepinephrine. Due to its significant side effect profile, its primary use has shifted from"
      }, {
        "text": " depression to treating neuropathic pain and providing prophylaxis for [[c8833bae|migraine headaches]].\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks reuptake of norepinephrine and serotonin."
      }, {
        "text": " Also has potent antagonistic effects at muscarinic, Œ±1-adrenergic, and H1-histamine receptors, which"
      }, {
        "text": " account for its side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for prophylaxis of [[c8833"
      }, {
        "text": "bae|migraine headaches]] and for the management of chronic neuropathic pain (e.g., diabetic neuropathy, post"
      }, {
        "text": "herpetic neuralgia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Strong anticholinergic effects (\u003cmark\u003edry mouth, constipation"
      }, {
        "text": ", urinary retention, confusion\u003c/mark\u003e), orthostatic hypotension (Œ±1 blockade), sedation (H1 blockade), and weight"
      }, {
        "text": " gain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiotoxicity:\u003c/b\u003e Overdose is life-threatening, causing QRS widening and ventricular arrhythmias due"
      }, {
        "text": " to Na\u003csup\u003e+\u003c/sup\u003e channel blockade. Treat with sodium bicarbonate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027"
      }, {
        "text": "Tri-C\u0027s\u0027 for TCA toxicity: \u003cb\u003eC\u003c/b\u003eonvulsions, \u003cb\u003eC\u003c/b\u003eoma, "
      }, {
        "text": "\u003cb\u003eC\u003c/b\u003eardiotoxicity. Amitriptyline is a tertiary amine TCA, giving it more potent anticholinergic and antihistamin"
      }, {
        "text": "ic effects compared to secondary amines like nortriptyline.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmitriptyline\u003c/b\u003e,"
      }, {
        "text": " a classic TCA, is now more valued for its role in migraine prevention and neuropathic pain than for depression, but its use"
      }, {
        "text": " is always tempered by a significant burden of anticholinergic, antihistaminic, and anti-adrenergic side effects, with"
      }, {
        "text": " cardiotoxicity being the most dangerous in overdose.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"tricyclic_"
      }, {
        "text": "antidepressant\"\n      },\n      {\n        \"type\": \"used_for_prophylaxis_of\",\n"
      }, {
        "text": "        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\","
      }, {
        "text": "\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "has_adverse_effect\",\n        \"to\": \"cardiotoxicity\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"a62c0c9f\": {\n    \"title\": \"Amnesia\",\n    \""
      }, {
        "text": "primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cognitive Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAmnesia\u003c/b\u003e is a deficit in memory caused by brain damage, disease, or psychological"
      }, {
        "text": " trauma. It can be categorized based on the temporal nature of the memory loss relative to the causative event.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterograde Amnesia:\u003c/b\u003e The inability to form \u003cu\u003enew\u003c/u\u003e memories after"
      }, {
        "text": " the event that caused the amnesia. Long-term memories from before the event remain intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterograde Les"
      }, {
        "text": "ion Site:\u003c/b\u003e Classically caused by bilateral damage to the \u003cmark\u003ehippocampus\u003c/mark\u003e, a key structure in the medial"
      }, {
        "text": " temporal lobe for memory consolidation. Seen in [[77ae6148|Alzheimer disease]] and [[her"
      }, {
        "text": "pes_simplex_encephalitis|herpes simplex encephalitis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetrograde Amnesia:\u003c/b\u003e The loss of memories"
      }, {
        "text": " that were formed \u003cu\u003ebefore\u003c/u\u003e the onset of amnesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKorsakoff Syndrome:\u003c/b\u003e A classic"
      }, {
        "text": " example of a syndrome causing both anterograde and retrograde amnesia, along with confabulation. It is caused by th"
      }, {
        "text": "iamine (B1) deficiency, often in the context of chronic alcohol use, and involves damage to the \u003cmark\u003emamm"
      }, {
        "text": "illary bodies\u003c/mark\u003e and thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bilateral hippocampal lesions (e.g., from an"
      }, {
        "text": " anoxic brain injury or HSV encephalitis) are the classic cause of profound anterograde amnesia. The patient can remember their childhood"
      }, {
        "text": " but not what they had for breakfast.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe hippocampus is the"
      }, {
        "text": " brain\u0027s \u0027save button\u0027 for new memories; therefore, bilateral damage to this structure results in profound \u003cb\u003eanterog"
      }, {
        "text": "rade amnesia\u003c/b\u003e, leaving the individual unable to consolidate new experiences into long-term memory.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Brain Injury/Disease] --\u003e B{Amnesia}; B --\u003e C[Anterograde Amnesia]; C"
      }, {
        "text": " --\u003e D(Inability to form new memories); D --\u003e E[Lesion: Hippocampus]; B --\u003e F"
      }, {
        "text": "[Retrograde Amnesia]; F --\u003e G(Loss of past memories); G --\u003e H[Lesion: Widespread Cortex"
      }, {
        "text": "];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_les"
      }, {
        "text": "ion_in\",\n        \"to\": \"a0590674\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"f02"
      }, {
        "text": "cfaa1\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\":"
      }, {
        "text": " \"wernicke_korsakoff_syndrome\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_feature_of\",\n        \"to\": \"77ae6148\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"d220fc3f\": {\n    \"title\": \"Amygdala\",\n    \""
      }, {
        "text": "primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Anatomy\",\n"
      }, {
        "text": "      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAmygdala\u003c/b\u003e is an almond-shaped set of neurons"
      }, {
        "text": " located deep within the medial temporal lobe of the brain. It is a key component of the [[73ace357|limbic system]]"
      }, {
        "text": " and plays a central role in processing emotions, particularly fear, anxiety, and aggression, as well as in memory formation and decision"
      }, {
        "text": "-making.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The amygdala is the brain"
      }, {
        "text": "\u0027s emotional center, responsible for processing fear, pleasure, and anger. It links emotions to memories and influences social and"
      }, {
        "text": " sexual behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated in the medial temporal lobe, anterior to the [[a0590674|"
      }, {
        "text": "hippocampus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects (Bilateral):\u003c/b\u003e Bilateral destruction of the amygdala results in \u003c"
      }, {
        "text": "mark\u003eKl√ºver-Bucy syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKl√ºver-Bucy Syndrome:"
      }, {
        "text": "\u003c/b\u003e Characterized by disinhibited behavior, including hyperorality (tendency to examine objects with the mouth), hypersex"
      }, {
        "text": "uality, hyperphagia, and visual agnosia. Patients also exhibit placidity (loss of fear response).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The classic cause of bilateral amygdala damage leading to Kl√ºver-Bucy syndrome is [["
      }, {
        "text": "herpes_simplex_encephalitis|Herpes Simplex Virus-1 (HSV-1) encephalitis]], which has a pred"
      }, {
        "text": "ilection for the temporal lobes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAmygdala\u003c/b\u003e acts"
      }, {
        "text": " as the brain\u0027s alarm system and emotional processor; its bilateral destruction unleashes primitive behaviors by removing the normal emotional filters,"
      }, {
        "text": " resulting in the dramatic and disinhibited presentation of Kl√ºver-Bucy syndrome.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Sensory Input] --\u003e B(Amygdala); B --Fear/Emotion Processing--\u003e"
      }, {
        "text": " C[Hypothalamus \u0026 Brainstem]; C --\u003e D(Autonomic \u0026 Behavioral Response);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73ace357\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"bilateral_lesion_causes\",\n        \"to\": \"klu"
      }, {
        "text": "ver_bucy_syndrome\"\n      },\n      {\n        \"type\": \"is_damaged_"
      }, {
        "text": "in\",\n        \"to\": \"herpes_simplex_encephalitis\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"b374ebd6\": {\n    \"title\": \"Cerebral Amyloid Ang"
      }, {
        "text": "iopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral Amyloid Angiopathy (CAA)\u003c/b\u003e is"
      }, {
        "text": " a condition in which amyloid-Œ≤ protein deposits in the walls of small to medium-sized arteries of the cerebral cortex and leptomeninges, weakening"
      }, {
        "text": " the vessels and increasing the risk of spontaneous, recurrent \u003cmark\u003elobar\u003c/mark\u003e intraparenchymal hemorrh"
      }, {
        "text": "ages.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Deposition of \u003c"
      }, {
        "text": "mark\u003eamyloid-Œ≤\u003c/mark\u003e (the same protein found in [[77ae6148|"
      }, {
        "text": "Alzheimer\u0027s]] plaques) in the tunica media and adventitia of cortical and leptomeningeal vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Clinical Presentation:\u003c/b\u003e Most commonly presents with recurrent, spontaneous lobar hemorrhages in older adults (\u003e65 years). These"
      }, {
        "text": " hemorrhages are typically located in the superficial cortex (lobar) rather than deep structures like the basal ganglia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e"
      }, {
        "text": " Hemorrhages are characteristically \u003cmark\u003elobar\u003c/mark\u003e (frontal, parietal, occipital, temporal lobes"
      }, {
        "text": "), contrasting with hypertensive hemorrhages which are typically deep (basal ganglia, thalamus, pons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociation"
      }, {
        "text": ":\u003c/b\u003e Strongly associated with [[77ae6148|Alzheimer disease]], although it can occur independently.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e An elderly patient with no history of significant hypertension who presents with a spontaneous, superficial (lobar) intrac"
      }, {
        "text": "erebral hemorrhage should raise high suspicion for Cerebral Amyloid Angiopathy. Recurrent hemorrhages in different lobes are a key"
      }, {
        "text": " feature.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral Amyloid Angiopathy\u003c/b\u003e"
      }, {
        "text": " is a major cause of lobar intracerebral hemorrhage in the elderly, resulting from amyloid-Œ≤ deposition that makes cortical"
      }, {
        "text": " blood vessels brittle and prone to rupture, distinct from the deep brain hemorrhages typically caused by hypertension.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Amyloid-Œ≤ Deposition] --\u003e B(Vessel Wall Weakening); B"
      }, {
        "text": " --\u003e C[Cortical \u0026 Leptomeningeal Arteries]; C --\u003e D(Rupture); D --\u003e E"
      }, {
        "text": "[Recurrent Lobar Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"causes\",\n        \"to\": \"70b266c8\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_associated_with\",\n        \"to\": \"77ae61"
      }, {
        "text": "48\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"hypertensive_hemorrhage\"\n      }\n    ]\n  },\n  \"4ed629"
      }, {
        "text": "f9\": {\n    \"title\": \"Amyotrophic Lateral Sclerosis (ALS)\",\n    \"primaryType\": \"disease\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Degenerative Disease\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis (ALS)\u003c/b\u003e, also known as Lou Gehrig\u0027s disease, is a relentless"
      }, {
        "text": " and fatal neurodegenerative disorder characterized by the progressive loss of both \u003cu\u003eupper motor neurons\u003c/u\u003e (in the motor cortex) and \u003cu\u003elower motor neurons"
      }, {
        "text": "\u003c/u\u003e (in the brainstem and spinal cord).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Degeneration of corticospinal tracts (lateral sclerosis) and anterior horn cells (amyotrophy). The"
      }, {
        "text": " exact cause is unknown in most cases (sporadic), but some familial cases are linked to a mutation in the \u003cmark\u003esuper"
      }, {
        "text": "oxide dismutase 1 (SOD1)\u003c/mark\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A hallmark of ALS is the combination of both"
      }, {
        "text": " \u003cb\u003eupper motor neuron (UMN)\u003c/b\u003e signs (spasticity, hyperreflexia, Babinski sign) and \u003cb\u003elower motor neuron ("
      }, {
        "text": "LMN)\u003c/b\u003e signs (fasciculations, atrophy, flaccid weakness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Can"
      }, {
        "text": " present with asymmetric limb weakness (e.g., foot drop, hand weakness), dysarthria (difficulty speaking), and dysph"
      }, {
        "text": "agia (difficulty swallowing). Sensation, cognition, and eye movements are typically spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBulbar Involvement:\u003c/b\u003e When"
      }, {
        "text": " LMNs in the brainstem are affected, it leads to [[901f3180|bulbar palsy]],"
      }, {
        "text": " causing dysarthria, dysphagia, and tongue fasciculations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e [[riluzole|"
      }, {
        "text": "Riluzole]], a glutamate antagonist, may modestly increase survival. Management is largely supportive, focusing on respiratory support and nutrition"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of UMN and LMN signs in the same patient is the key"
      }, {
        "text": " to diagnosing ALS. Look for a patient with weakness and atrophy in one arm (LMN) but hyperreflexia in the legs"
      }, {
        "text": " (UMN).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAmyotrophic Lateral Sclerosis\u003c/b\u003e is uniquely"
      }, {
        "text": " devastating because it attacks the entire voluntary motor system, from the brain to the muscle, combining the spasticity of UMN lesions"
      }, {
        "text": " with the muscle wasting of LMN lesions, while cruelly sparing the patient\u0027s intellect and senses.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[UMN Degeneration - Motor Cortex] --\u003e B(Spasticity, Hyperreflexia); C"
      }, {
        "text": "[LMN Degeneration - Anterior Horn] --\u003e D(Fasciculations, Atrophy); A \u0026 C --\u003e E("
      }, {
        "text": "Progressive Motor Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"motor_neuron_disease\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"presents_with\",\n        \"to\": \"upper_motor_neuron_signs\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"lower_motor"
      }, {
        "text": "_neuron_signs\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ril"
      }, {
        "text": "uzole\"\n      },\n      {\n        \"type\": \"is_associated_with_mutation_in"
      }, {
        "text": "\",\n        \"to\": \"sod1_gene\"\n      }\n    ]\n  },\n  \"ce2"
      }, {
        "text": "052d6\": {\n    \"title\": \"Anal Wink Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnal Wink"
      }, {
        "text": " Reflex\u003c/b\u003e is a superficial reflex involving the contraction of the external anal sphincter upon stroking the skin around the anus. It is used"
      }, {
        "text": " to test the integrity of the \u003cmark\u003eS3 and S4\u003c/mark\u003e spinal nerve roots and the pudendal nerve.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Tests the integrity of the \u003cb\u003eS3-S4\u003c/b\u003e spinal"
      }, {
        "text": " cord segments. Mnemonic: S2, 3, 4 keep the penis off the floor (for erection),"
      }, {
        "text": " and S3, 4 are for the anal wink.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Stroking the perianal skin stimulates"
      }, {
        "text": " afferent fibers of the pudendal nerve. The signal travels to the S3-S4 spinal segments, synapses, and an"
      }, {
        "text": " efferent signal returns via the pudendal nerve to cause contraction of the external anal sphincter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e An"
      }, {
        "text": " absent anal wink reflex is a key sign in \u003cmark\u003e[[2904b5c8|Cauda Equ"
      }, {
        "text": "ina Syndrome]]\u003c/mark\u003e, a neurosurgical emergency. It indicates damage to the S3-S4 nerve roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther"
      }, {
        "text": " Conditions:\u003c/b\u003e The reflex may also be absent in other conditions affecting the sacral nerve roots or spinal cord, such as spinal cord injury"
      }, {
        "text": " or spina bifida.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with severe low back pain, saddle anesthesia, and bowel"
      }, {
        "text": "/bladder dysfunction, checking for the anal wink reflex is a critical step. Its absence strongly supports the diagnosis of [[2904b5c8"
      }, {
        "text": "|Cauda Equina Syndrome]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnal Wink Reflex\u003c/b\u003e is a simple"
      }, {
        "text": " but vital physical exam maneuver for assessing the function of the lower sacral nerve roots (S3-S4); its absence is"
      }, {
        "text": " a red flag for [[2904b5c8|Cauda Equina Syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Stroke Perianal Skin] --\u003e B(Afferent Signal via Pudendal N.); B --\u003e C["
      }, {
        "text": "S3-S4 Spinal Cord]; C --\u003e D(Efferent Signal via Pudendal N.); D --\u003e E(External Anal Sphinct"
      }, {
        "text": "er Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_ner"
      }, {
        "text": "ve_root\",\n        \"to\": \"s3_nerve_root\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "tests_nerve_root\",\n        \"to\": \"s4_nerve_root\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"2904b5c8\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"5bcc9894\": {\n    \"title\": \"Anencephaly\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neurology"
      }, {
        "text": "\",\n      \"Pediatrics\",\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural"
      }, {
        "text": " Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnenceph"
      }, {
        "text": "aly\u003c/b\u003e is a severe and lethal congenital malformation, classified as an open \u003ci\u003eneural tube defect\u003c/i\u003e, resulting from the failure"
      }, {
        "text": " of the rostral (anterior) neuropore to close during the 4th week of embryonic development. This leads to the absence of the fore"
      }, {
        "text": "brain and a large portion of the skull (calvarium).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the rostral neuropore to close leads to an open calvarium and absence"
      }, {
        "text": " of the forebrain. The remaining brain tissue is exposed and degenerates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Incompatible with postnatal"
      }, {
        "text": " life; infants are stillborn or die shortly after birth. The fetus has a characteristic \u003cmark\u003e\\\"frog-like appearance\\\""
      }, {
        "text": "\u003c/mark\u003e due to the absent cranial vault.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMaternal Findings:\u003c/b\u003e Associated with \u003cmark\u003epoly"
      }, {
        "text": "hydramnios\u003c/mark\u003e due to impaired fetal swallowing, as the neural control for swallowing is absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis"
      }, {
        "text": ":\u003c/b\u003e Can be detected prenatally via ultrasound. Maternal serum screening will show markedly \u003cmark\u003eelevated alpha-fetoprotein"
      }, {
        "text": " (AFP)\u003c/mark\u003e. Amniotic fluid will also have elevated AFP and acetylcholinesterase (AChE).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrevention"
      }, {
        "text": ":\u003c/b\u003e Risk is significantly reduced by maternal folic acid supplementation before conception and during early pregnancy.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eAnencephaly\u003c/b\u003e represents a catastrophic failure of early neural development, where the absence of the fore"
      }, {
        "text": "brain and skull results in a condition incompatible with life, and is prenatally indicated by elevated maternal AFP and polyhydramnios.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"graph TD; A[Failure of Rostral Neuropore Closure] --\u003e B(Abs"
      }, {
        "text": "ence of Forebrain \u0026 Calvarium); B --\u003e C(Polyhydramnios); B --\u003e D(Lethal Outcome"
      }, {
        "text": ");\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"is_associated_"
      }, {
        "text": "with\",\n        \"to\": \"polyhydramnios\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_diagnosed_by\",\n        \"to\": \"alpha_fetoprotein\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "a5295f1a\": {\n    \"title\": \"Anesthetics\",\n    \"primaryType\": \"concept\",\n    \""
      }, {
        "text": "tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"An"
      }, {
        "text": "esthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnesthetics\u003c/b\u003e are drugs that induce"
      }, {
        "text": " a reversible loss of sensation. They are broadly classified into \u003ci\u003egeneral anesthetics\u003c/i\u003e, which cause a reversible loss of consciousness,"
      }, {
        "text": " and \u003ci\u003elocal anesthetics\u003c/i\u003e, which block nerve transmission in a specific region of the body.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGeneral Anesthetics:\u003c/b\u003e Induce a state of unconsciousness, analgesia, am"
      }, {
        "text": "nesia, and muscle relaxation. They can be inhaled (e.g., sevoflurane, desflurane"
      }, {
        "text": ") or intravenous (e.g., propofol, ketamine, etomidate). Their potency is measured by the \u003c"
      }, {
        "text": "mark\u003eMinimum Alveolar Concentration (MAC)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocal Anesthetics:\u003c/b\u003e Block nerve conduction by inhibiting"
      }, {
        "text": " voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels. They are classified as esters (e.g., procaine, cocaine"
      }, {
        "text": ") or amides (e.g., lidocaine, bupivacaine). They are weak bases and are less"
      }, {
        "text": " effective in infected (acidic) tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuromuscular Blockers:\u003c/b\u003e Often used with general anesthetics to achieve"
      }, {
        "text": " profound muscle relaxation (paralysis). They can be depolarizing (e.g., succinylcholine) or non-depolarizing (e.g"
      }, {
        "text": "., rocuronium).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMalignant Hyperthermia:\u003c/b\u003e A rare, life-threatening hypermetabolic state"
      }, {
        "text": " triggered by inhaled anesthetics (except N\u003csub\u003e2\u003c/sub\u003eO) and succinylcholine in genetically susceptible individuals. Treated with [["
      }, {
        "text": "dantrolene]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the key pharmacokinetic properties of inhaled anesthetics: low"
      }, {
        "text": " blood solubility (low blood:gas partition coefficient) leads to rapid induction and recovery, while high lipid solubility (high oil"
      }, {
        "text": ":gas partition coefficient) corresponds to high potency (low MAC).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " field of \u003cb\u003eanesthesia\u003c/b\u003e relies on a combination of drugs to achieve a balanced state of unconsciousness, analgesia,"
      }, {
        "text": " and muscle relaxation, with general anesthetics acting on the CNS to induce sleep and local anesthetics acting on peripheral nerves to block pain"
      }, {
        "text": " signals.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"general_anesthetics\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"local_anesthetics\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_associated_with\",\n        \"to\": \"malignant_hyperthermia\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"a7f97d7f\": {\n    \"title\":"
      }, {
        "text": " \"Cerebral Aneurysms\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"C"
      }, {
        "text": "erebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eC"
      }, {
        "text": "erebral aneurysms\u003c/b\u003e are localized, abnormal dilations of blood vessels in the brain, which carry a significant risk of rupture, leading to life"
      }, {
        "text": "-threatening intracranial hemorrhage.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSaccular (Berry) Aneurysms:"
      }, {
        "text": "\u003c/b\u003e Most common type. Thin-walled outpouchings, typically occurring at arterial branch points in the [[e223"
      }, {
        "text": "00e8|Circle of Willis]]. Most common site is the junction of the [[bd802d2"
      }, {
        "text": "2|anterior communicating artery]] and anterior cerebral artery. Rupture causes [[63f8b05f|subarachnoid hemorrhage"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociations with Saccular Aneurysms:\u003c/b\u003e \u003cmark\u003eAutosomal Dominant Polycystic Kidney Disease ("
      }, {
        "text": "ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, Marfan syndrome, hypertension, smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChar"
      }, {
        "text": "cot-Bouchard Microaneurysms:\u003c/b\u003e Aneurysms of small, penetrating arteries (e.g., lent"
      }, {
        "text": "iculostriate arteries) associated with chronic hypertension. Rupture causes [[70b266c8|"
      }, {
        "text": "intraparenchymal hemorrhage]], typically in deep brain structures like the basal ganglia or thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eR"
      }, {
        "text": "upture Presentation:\u003c/b\u003e Rupture of a saccular aneurysm classically presents as a sudden, severe \u003cmark\u003e\\\"worst"
      }, {
        "text": " headache of my life\\\"\u003c/mark\u003e (thunderclap headache), indicating a [[63f8b05f|subarachnoid"
      }, {
        "text": " hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ADPKD who develops a sudden, severe headache should"
      }, {
        "text": " be immediately evaluated for a ruptured berry aneurysm. A PCom aneurysm can compress CN III, causing a \u0027down and out\u0027 eye"
      }, {
        "text": " with a \u0027blown\u0027 (dilated) pupil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eC"
      }, {
        "text": "erebral aneurysms are focal weaknesses in brain arteries; the larger \u003cb\u003esaccular (berry) aneurysms\u003c/b\u003e at"
      }, {
        "text": " the Circle of Willis rupture into the subarachnoid space, while the smaller \u003cb\u003eCharcot-Bouchard microaneur"
      }, {
        "text": "ysms\u003c/b\u003e in deep brain structures rupture due to hypertension, causing intraparenchymal bleeds.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Cerebral Aneurysm] --\u003e B{Types}; B --\u003e C[Saccular/"
      }, {
        "text": "Berry]; C --\u003e D(Circle of Willis); D --\u003e E[Rupture -\u003e Subarachnoid Hemorrhage];"
      }, {
        "text": " B --\u003e F[Charcot-Bouchard]; F --\u003e G(Small Penetrating Arteries); G --\u003e H["
      }, {
        "text": "Rupture -\u003e Intraparenchymal Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"rupture_causes\",\n        \"to\": \"70b266"
      }, {
        "text": "c8\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \""
      }, {
        "text": "to\": \"autosomal_dominant_polycystic_kidney_disease\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"includes\",\n        \"to\": \"a9f6d703\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"9c80344d\": {\n    \"title\": \"Angle-Closure Glaucoma\",\n    "
      }, {
        "text": "\"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency"
      }, {
        "text": " Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Glaucoma\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eAngle-closure glaucoma\u003c/b\u003e is an ophthalmologic emergency characterized by a sudden, severe increase in intra"
      }, {
        "text": "ocular pressure (IOP) due to the physical obstruction of aqueous humor outflow through the trabecular meshwork by the peripheral"
      }, {
        "text": " iris.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs in individuals"
      }, {
        "text": " with a pre-existing narrow anterior chamber angle. Pupillary dilation (mydriasis) causes the peripheral iris to bunch up and block the trab"
      }, {
        "text": "ecular meshwork, acutely halting aqueous humor drainage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTriggers:\u003c/b\u003e Any event causing mydriasis can"
      }, {
        "text": " trigger an attack, such as entering a dark room, stress, or administration of sympathomimetic or anticholinergic drugs."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e \u003cmark\u003eSudden onset of severe, unilateral eye pain\u003c/mark\u003e, headache, nausea/"
      }, {
        "text": "vomiting, and blurred vision with \u003cmark\u003ehalos around lights\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam:\u003c/b\u003e The eye"
      }, {
        "text": " is red and hard to palpation (\u0027rock hard\u0027). The pupil is typically \u003cmark\u003emid-dilated and non"
      }, {
        "text": "reactive\u003c/mark\u003e to light. The cornea may appear hazy or steamy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a true"
      }, {
        "text": " ophthalmic emergency. The classic presentation of a painful, red eye with a fixed, mid-dilated pupil and halos around"
      }, {
        "text": " lights is pathognomonic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAngle-closure glaucoma"
      }, {
        "text": "\u003c/b\u003e is a mechanical plumbing problem of the eye where pupillary dilation in a predisposed individual causes the iris to act like a drain"
      }, {
        "text": " plug, leading to a rapid and painful spike in intraocular pressure that threatens vision.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Predisposing Narrow Angle] --Pupillary Dilation--\u003e B(Iris bunches at periphery); B --\u003e C(Blocks"
      }, {
        "text": " Trabecular Meshwork); C --\u003e D(‚Üì Aqueous Outflow); D --\u003e E(‚Üë‚Üë Intraocular Pressure);"
      }, {
        "text": " E --\u003e F(Acute Pain, Vision Loss, Red Eye);\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_a_type_of\",\n        \"to\": \"3ce6c035\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_triggered_by\",\n        \"to\": \"mydriasis\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5ea7b"
      }, {
        "text": "741\"\n      }\n    ]\n  },\n  \"ed8c1c37\": {\n    \"title\": \""
      }, {
        "text": "Anhidrosis in Horner Syndrome\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Neurology\",\n      \"Autonomic\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Autonomic Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnhidrosis\u003c/b\u003e, the inability to sweat normally, is one"
      }, {
        "text": " of the three classic signs of [[c19010a3|Horner syndrome]], resulting from the disruption"
      }, {
        "text": " of sympathetic innervation to the sweat glands of the face.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Horner Syndrome Triad:\u003c/b\u003e The full triad is \u003cb\u003ePtosis\u003c/b\u003e (mild eyelid droop), \u003cb\u003eMiosis\u003c/b\u003e ("
      }, {
        "text": "constricted pupil), and \u003cb\u003eAnhidrosis\u003c/b\u003e (decreased sweating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Disruption of the o"
      }, {
        "text": "culosympathetic pathway prevents the release of acetylcholine from postganglionic sympathetic neurons that innervate sweat glands (a sympathetic"
      }, {
        "text": " exception).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocalization Value:\u003c/b\u003e The distribution of anhidrosis can help localize the lesion in the three-neuron"
      }, {
        "text": " sympathetic chain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Localization:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e1st Order (Central):\u003c/b\u003e Lesion in"
      }, {
        "text": " hypothalamus or brainstem/spinal cord. Anhidrosis affects the entire ipsilateral half of the body.\u003cbr\u003e - \u003cb\u003e2nd Order"
      }, {
        "text": " (Preganglionic):\u003c/b\u003e Lesion in the chest (e.g., Pancoast tumor). Anhidrosis affects the ipsilateral face and"
      }, {
        "text": " neck.\u003cbr\u003e - \u003cb\u003e3rd Order (Postganglionic):\u003c/b\u003e Lesion above the superior cervical ganglion (e.g., carotid"
      }, {
        "text": " dissection). Anhidrosis is often minimal or absent, affecting only a small patch on the forehead, because fibers to most"
      }, {
        "text": " facial sweat glands travel with the external carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A painful Horner syndrome (especially"
      }, {
        "text": " with neck pain) should raise suspicion for a carotid artery dissection, a 3rd order neuron lesion where anhidrosis is often absent.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eWhile part of the classic triad, the presence and distribution of \u003cb\u003eanhid"
      }, {
        "text": "rosis\u003c/b\u003e in [[c19010a3|Horner syndrome]] is a subtle but powerful clue for"
      }, {
        "text": " localizing the lesion along the long oculosympathetic pathway, with widespread anhidrosis suggesting a central lesion and absent anhidrosis pointing"
      }, {
        "text": " towards a postganglionic (3rd order) problem.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"c19010a"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"sym"
      }, {
        "text": "pathetic_pathway_disruption\"\n      }\n    ]\n  },\n  \"830c8"
      }, {
        "text": "56c\": {\n    \"title\": \"Anterior Cerebral Artery (ACA)\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Cerebral Artery (ACA)\u003c/b\u003e is a major artery of the brain that branches"
      }, {
        "text": " from the internal carotid artery and supplies the medial portion of the frontal and parietal lobes, as well as the corpus callosum.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from the bifurcation of the internal carotid artery. The left"
      }, {
        "text": " and right ACAs are connected by the [[bd802d22|anterior communicating artery]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Territory Supplied:\u003c/b\u003e Supplies the medial surface of the cerebral hemispheres. Based on the motor and sensory homunculus, this corresponds to the"
      }, {
        "text": " \u003cmark\u003elower extremities\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome:\u003c/b\u003e Occlusion of the ACA results in a characteristic"
      }, {
        "text": " stroke syndrome with \u003cmark\u003econtralateral motor and sensory deficits predominantly affecting the lower limb\u003c/mark\u003e (leg \u003e"
      }, {
        "text": " arm/face).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Stroke Signs:\u003c/b\u003e May also cause urinary incontinence due to damage to the paracentral lobule"
      }, {
        "text": ". Frontal lobe signs like abulia (lack of will/initiative) or personality changes can occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The key to identifying an ACA stroke is the disproportionate weakness and sensory loss in the contralateral leg compared to the arm and"
      }, {
        "text": " face. This contrasts sharply with an [[143bb23d|MCA stroke]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eAnterior Cerebral Artery\u003c/b\u003e is responsible for the medial brain territory, meaning its occlusion"
      }, {
        "text": " uniquely manifests as a stroke that \u0027kicks the leg out\u0027 from under the patient, with motor and sensory deficits primarily"
      }, {
        "text": " affecting the contralateral lower extremity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid Artery] --\u003e B("
      }, {
        "text": "Anterior Cerebral Artery); B --\u003e C(Supplies Medial Cortex); C --\u003e D(Motor/Sensory Hom"
      }, {
        "text": "unculus for Leg); B --Connects via AComA--\u003e E(Contralateral ACA);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e22300e8"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \""
      }, {
        "text": "anterior_cerebral_artery_stroke\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "connected_to_contralateral_by\",\n        \"to\": \"bd802d22\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"3c4b0ef7\": {\n    \"title\":"
      }, {
        "text": " \"Anterior Circulation Strokes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Cerebrovascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eAnterior circulation strokes\u003c/b\u003e are ischemic events caused by occlusion of the internal carotid artery or its major branches, the [["
      }, {
        "text": "830c856c|anterior cerebral artery (ACA)]] and the [[143bb23d"
      }, {
        "text": "|middle cerebral artery (MCA)]], leading to deficits related to the cerebral hemispheres.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVessels Involved:\u003c/b\u003e Internal carotid artery (ICA), [[143bb23d|Middle"
      }, {
        "text": " Cerebral Artery (MCA)]], [[830c856c|Anterior Cerebral Artery (ACA"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMCA Stroke:\u003c/b\u003e The most common type of ischemic stroke. Presents with \u003cmark\u003econtralateral hem"
      }, {
        "text": "iparesis and sensory loss affecting the face and upper limb more than the lower limb\u003c/mark\u003e. If the dominant ("
      }, {
        "text": "usually left) hemisphere is affected, it causes [[6bc9a567|aphasia]] (Broca\u0027s or W"
      }, {
        "text": "ernicke\u0027s). If the non-dominant hemisphere is affected, it causes hemineglect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eACA"
      }, {
        "text": " Stroke:\u003c/b\u003e Presents with \u003cmark\u003econtralateral hemiparesis and sensory loss affecting the lower limb more than the upper limb\u003c/"
      }, {
        "text": "mark\u003e. May also cause urinary incontinence and frontal lobe signs (e.g., personality changes, abulia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDist"
      }, {
        "text": "inction:\u003c/b\u003e The key differentiator is the distribution of weakness based on the homunculus: MCA strokes affect the face/arm, while ACA strokes affect the leg"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Aphasia is a \u0027cortical sign\u0027 that strongly points to an"
      }, {
        "text": " MCA stroke in the dominant hemisphere. Leg weakness greater than arm weakness is the classic sign of an ACA stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAnterior circulation strokes\u003c/b\u003e produce deficits that can be precisely localized by understanding the functional anatomy of the cerebral cortex"
      }, {
        "text": " and the homunculus; MCA strokes paralyze the contralateral face and arm, while ACA strokes paralyze the contralateral leg.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Internal Carotid Artery] --\u003e B(MCA); B --\u003e C(Contralateral Face"
      }, {
        "text": "/Arm Deficits, Aphasia/Neglect); A --\u003e D(ACA); D --\u003e E(Contralateral"
      }, {
        "text": " Leg Deficits, Incontinence);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"middle_cerebral_artery_stroke\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"anterior_cerebral_artery_stroke\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"differentiated_from\",\n        \"to\": \"276cefbc\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"bd802d22\": {\n    \"title\": \"Anterior Communicating Artery (A"
      }, {
        "text": "ComA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"C"
      }, {
        "text": "erebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vascul"
      }, {
        "text": "ature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Communicating Artery"
      }, {
        "text": " (AComA)\u003c/b\u003e is a short blood vessel that connects the left and right [[830c856c|"
      }, {
        "text": "anterior cerebral arteries]], forming the anterior aspect of the [[e22300e8|Circle of Willis]].\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides collateral blood flow between the two anterior"
      }, {
        "text": " cerebral circulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is the \u003cmark\u003emost common site\u003c/mark\u003e for the formation of sacc"
      }, {
        "text": "ular (berry) aneurysms in the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAneurysm Complications:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003eRupture:\u003c/b\u003e Leads to [[63f8b05f|subarachnoid hemorrhage]],"
      }, {
        "text": " presenting as a \\\"worst headache of my life.\\\"\u003cbr\u003e2. \u003cb\u003eCompression:\u003c/b\u003e A large, un"
      }, {
        "text": "ruptured aneurysm can compress the adjacent \u003cmark\u003eoptic chiasm\u003c/mark\u003e, causing a [[6c3a9"
      }, {
        "text": "80e|bitemporal hemianopia]] (tunnel vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When"
      }, {
        "text": " a question mentions a saccular aneurysm, the AComA should be the first location you consider. If the patient has"
      }, {
        "text": " visual field defects, especially bitemporal hemianopia, an AComA aneurysm is a very likely cause."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Communicating Artery\u003c/b\u003e, while"
      }, {
        "text": " small, is clinically significant as the number one location for berry aneurysms, which can either rupture catastrophically into"
      }, {
        "text": " the subarachnoid space or compress the optic chiasm, causing tunnel vision.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Left ACA] -- AComA --\u003e B[Right ACA]; C(ACom"
      }, {
        "text": "A Aneurysm) --\u003e D(Rupture -\u003e SAH); C --\u003e E(Compression -\u003e Bitemporal Hemianopia);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \""
      }, {
        "text": "e22300e8\"\n      },\n      {\n        \"type\": \"connects\","
      }, {
        "text": "\n        \"to\": \"830c856c\"\n      },\n      {\n        \"type\": \"is_common"
      }, {
        "text": "_site_for\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"aneurysm_can_cause\",\n        \"to\": \"6c3a980e\""
      }, {
        "text": "\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1pVT4Y7kv_9sdFdzwmjsSJupwrFAhzD4z"
      },
      "role": "user",
      "tokenCount": 2063
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"3c075343\": {\n    \"title\": \"Anterior Inferior Cerebellar Artery (AICA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Inferior Cerebellar Artery (AICA)\u003c/b\u003e is an artery in the brain that arises from the basilar artery and supplies blood to the anterior inferior portion of the cerebellum, as well as parts of the lateral pons.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Typically arises from the lower third of the basilar artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Lateral pons, middle and inferior cerebellar peduncles, and the anterior inferior cerebellum. It also gives rise to the labyrinthine artery in most individuals, which supplies the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome:\u003c/b\u003e Occlusion of the AICA causes \u003cmark\u003eLateral Pontine Syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms of AICA Stroke:\u003c/b\u003e Mnemonic \u003cb\u003eAICA\u003c/b\u003e: \u003cb\u003eA\u003c/b\u003etaxia (ipsilateral, from cerebellar peduncle damage), \u003cb\u003eI\u003c/b\u003epsilateral facial paralysis (CN VII nucleus/fibers) and deafness/vertigo (CN VIII nucleus/labyrinthine artery), \u003cb\u003eC\u003c/b\u003eontralateral pain/temp loss (spinothalamic tract), \u003cb\u003eA\u003c/b\u003eutonomic signs (ipsilateral Horner syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to distinguishing an AICA stroke from a PICA stroke (Lateral Medullary Syndrome) is the presence of \u003cmark\u003efacial paralysis\u003c/mark\u003e and \u003cmark\u003edeafness\u003c/mark\u003e, which are specific to the pontine location of the AICA territory.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eOcclusion of the \u003cb\u003eAnterior Inferior Cerebellar Artery\u003c/b\u003e results in Lateral Pontine Syndrome, a complex brainstem stroke characterized by a unique combination of cerebellar signs, contralateral body sensory loss, and ipsilateral facial deficits including paralysis and deafness, which localizes the lesion squarely to the lateral pons.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basilar Artery] --\u003e B(AICA); B --\u003e C(Lateral Pons); B --\u003e D(Anterior Inferior Cerebellum); B --\u003e E(Labyrinthine Artery); C --\u003e F(CN VII \u0026 VIII Nuclei); E --\u003e G(Inner Ear);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"lateral_pontine_syndrome\"\n      },\n      \"type\": \"is_a_branch_of\",\n      \"to\": \"basilar_artery\"\n    },\n    {\n      \"type\": \"differentiated_from_stroke_in\",\n      \"to\": \"posterior_inferior_cerebellar_artery\"\n    }\n  },\n  \"eed3fda9\": {\n    \"title\": \"Anterior Nucleus of Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Nucleus\u003c/b\u003e is a region of the [[89e86633|hypothalamus]] that plays a primary role in thermoregulation, specifically in dissipating heat to cool the body. It is part of the parasympathetic nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediates heat dissipation (\u003cb\u003ecooling\u003c/b\u003e). Mnemonic: The \u003cb\u003eA\u003c/b\u003e/\u003cb\u003eC\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003enterior \u003cb\u003eC\u003c/b\u003eooling) is in the front of the house.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Senses when the body is too hot and initiates parasympathetic responses like cutaneous vasodilation and sweating to promote heat loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion in the anterior nucleus results in \u003cmark\u003ehyperthermia\u003c/mark\u003e, as the body loses its ability to cool itself down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[posterior_nucleus_of_hypothalamus|posterior nucleus of the hypothalamus]] is responsible for heat conservation and production (heating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the functional pairing: Anterior hypothalamus \u003d Cooling (parasympathetic), Posterior hypothalamus \u003d Heating (sympathetic). A lesion in the anterior nucleus leads to an inability to cool down.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Nucleus of the hypothalamus\u003c/b\u003e functions as the body\u0027s thermostat for cooling; its destruction leads to uncontrolled hyperthermia because the primary mechanism for heat dissipation is lost.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Body Temperature] --\u003e B(Anterior Nucleus); B --Parasympathetic Output--\u003e C(Cutaneous Vasodilation \u0026 Sweating); C --\u003e D(Heat Dissipation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"thermoregulation\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"hyperthermia\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"posterior_nucleus_of_hypothalamus\"\n      }\n    ]\n  },\n  \"1430f5b4\": {\n    \"title\": \"Anterior Spinal Artery (ASA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAnterior Spinal Artery (ASA)\u003c/b\u003e is a major artery that supplies the anterior two-thirds of the spinal cord. It originates from the vertebral arteries in the cranium and descends along the anterior surface of the spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Formed from the union of two branches of the vertebral arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Supplies the anterior two-thirds of the spinal cord, including the anterior and lateral corticospinal tracts, the spinothalamic tracts, and the anterior horns. It notably \u003cu\u003espares\u003c/u\u003e the [[e7f5cbbe|dorsal columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome (Spinal Cord):\u003c/b\u003e Occlusion causes \u003cmark\u003e[[b48b54d7|Anterior Spinal Artery Syndrome]]\u003c/mark\u003e, characterized by bilateral loss of motor function (flaccid paralysis at the level, UMN signs below) and pain/temperature sensation below the level of the lesion, with \u003cmark\u003epreserved proprioception and vibration sense\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome (Medulla):\u003c/b\u003e Occlusion of paramedian branches of the ASA or vertebral arteries causes \u003cmark\u003eMedial Medullary Syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to identifying an ASA stroke is the dissociation of sensory loss: pain and temperature are gone, but vibration and position sense are intact because the dorsal columns are spared.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAnterior Spinal Artery\u003c/b\u003e is the lifeline for the motor and pain/temperature pathways of the spinal cord; its occlusion creates a devastating syndrome of bilateral paralysis and sensory loss, sparing only the dorsal columns\u0027 functions of vibration and proprioception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vertebral Arteries] --\u003e B(Anterior Spinal Artery); B --\u003e C(Anterior 2/3 of Spinal Cord); C --\u003e D[Corticospinal Tracts]; C --\u003e E[Spinothalamic Tracts]; C --\u003e F[Anterior Horns];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"b48b54d7\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"medial_medullary_syndrome\"\n      },\n      {\n        \"type\": \"spares\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  },\n  \"b48b54d7\": {\n    \"title\": \"Anterior Spinal Artery Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Spinal Cord\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnterior Spinal Artery Syndrome\u003c/b\u003e is a spinal cord infarct resulting from occlusion of the [[1430f5b4|anterior spinal artery (ASA)]], which leads to ischemia of the anterior two-thirds of the spinal cord, causing a distinct pattern of neurological deficits below the level of the lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by occlusion of the ASA, which can result from aortic surgery (e.g., repair of an aneurysm), severe hypotension (watershed infarct), or thromboembolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Damaged:\u003c/b\u003e Corticospinal tracts, spinothalamic tracts, and anterior horns.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Spared:\u003c/b\u003e The \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e are spared due to their separate blood supply from the posterior spinal arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMotor:\u003c/b\u003e Bilateral flaccid paralysis at the level of the lesion (LMN signs from anterior horn damage) and bilateral spastic paralysis below the lesion (UMN signs from corticospinal tract damage).\u003cbr\u003e - \u003cb\u003eSensory:\u003c/b\u003e Bilateral loss of pain and temperature sensation below the lesion (spinothalamic tract damage).\u003cbr\u003e - \u003cb\u003eSensation Preserved:\u003c/b\u003e \u003cmark\u003eProprioception, vibration, and fine touch are intact\u003c/mark\u003e because the dorsal columns are spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The dissociation between loss of pain/temperature and preservation of vibration/proprioception is the pathognomonic feature of this syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnterior Spinal Artery Syndrome\u003c/b\u003e creates a stark neurological divide, paralyzing the body and eliminating pain and temperature sensation below the lesion, while leaving the sense of position and vibration completely intact, a direct reflection of the spinal cord\u0027s vascular territories.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[ASA Occlusion] --\u003e B(Infarct of Anterior 2/3 of Spinal Cord); B --\u003e C[Damage to Corticospinal \u0026 Spinothalamic Tracts]; B --Spares--\u003e D[Dorsal Columns]; C --\u003e E[Bilateral Paralysis \u0026 Loss of Pain/Temp]; D --\u003e F[Preserved Vibration/Proprioception];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"1430f5b4\"\n      },\n      {\n        \"type\": \"spares\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tracts\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  },\n  \"4770b8a2\": {\n    \"title\": \"Anti-CGRP Monoclonal Antibodies\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnti-CGRP monoclonal antibodies\u003c/b\u003e are a class of medications used for the prophylactic treatment of [[c8833bae|migraine headaches]]. They work by targeting either calcitonin gene-related peptide (CGRP) itself or its receptor, which are key players in the pathophysiology of migraines.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e These monoclonal antibodies bind to either the CGRP ligand (e.g., eptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (e.g., erenumab), preventing CGRP from mediating its effects of vasodilation and pain transmission in the trigeminal nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the \u003cmark\u003eprevention (prophylaxis)\u003c/mark\u003e of episodic and chronic [[c8833bae|migraines]]. They are not used for acute treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Administered via subcutaneous injection or IV infusion, typically on a monthly or quarterly basis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally well-tolerated. The most common side effects are injection site reactions. Constipation is notably associated with the CGRP receptor antagonists (e.g., erenumab).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Recognize these drugs by their \u0027-mab\u0027 suffix and their specific use for migraine \u003cu\u003eprophylaxis\u003c/u\u003e. They represent a targeted therapy based on the modern understanding of migraine pathophysiology involving CGRP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnti-CGRP monoclonal antibodies\u003c/b\u003e represent a major advance in migraine prevention, offering a highly specific mechanism that directly neutralizes the CGRP pathway, a key driver of pain and inflammation in migraine attacks.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Nerve Activation] --\u003e B(Release of CGRP); B --\u003e C(CGRP Receptor); C --\u003e D(Vasodilation \u0026 Pain Transmission); D --\u003e E(Migraine); F[Anti-CGRP mAbs] --x B; G[Anti-CGRP Receptor mAbs] --x C;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"calcitonin_gene_related_peptide\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"monoclonal_antibody\"\n      }\n    ]\n  },\n  \"f91a0cfa\": {\n    \"title\": \"Anticonvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnticonvulsants\u003c/b\u003e, also known as antiepileptic drugs (AEDs), are a diverse group of medications used to treat epileptic [[64c08e92|seizures]]. They work by various mechanisms to suppress the rapid and excessive firing of neurons that initiate a seizure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMajor Mechanisms:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e Channel Blockade:\u003c/b\u003e [[5aea213f|Phenytoin]], [[eddd2bc5|Carbamazepine]], [[0d37e045|Valproate]], [[08d19a8f|Lamotrigine]].\u003cbr\u003e2. \u003cb\u003eEnhancement of GABAergic inhibition:\u003c/b\u003e Benzodiazepines, Barbiturates, [[valproic_acid|Valproate]].\u003cbr\u003e3. \u003cb\u003eCa\u003csup\u003e2+\u003c/sup\u003e Channel Blockade:\u003c/b\u003e [[a90f6fb4|Ethosuximide]] (T-type), Gabapentinoids.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Activity:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBroad-spectrum:\u003c/b\u003e [[valproic_acid|Valproic acid]], [[08d19a8f|lamotrigine]], [[2341f9c0|levetiracetam]], [[e1f5066c|topiramate]]. Effective for both focal and generalized seizures.\u003cbr\u003e - \u003cb\u003eNarrow-spectrum:\u003c/b\u003e [[eddd2bc5|Carbamazepine]], [[5aea213f|phenytoin]], gabapentinoids. Primarily for focal seizures. [[a90f6fb4|Ethosuximide]] is for absence seizures only.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses:\u003c/b\u003e Many anticonvulsants are also used for bipolar disorder, neuropathic pain, and [[c8833bae|migraine]] prophylaxis. Some are used in [[45dd6d19|multiple sclerosis]] for symptomatic treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common side effects include sedation, dizziness, and ataxia. Many carry a risk of serious skin reactions like \u003cmark\u003eStevens-Johnson syndrome (SJS)\u003c/mark\u003e, especially lamotrigine and carbamazepine. All are potentially teratogenic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the first-line treatments for specific seizure types: Absence -\u003e [[a90f6fb4|Ethosuximide]]; Tonic-clonic -\u003e [[valproic_acid|Valproic acid]], [[2341f9c0|levetiracetam]]; Status epilepticus -\u003e Benzodiazepines.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnticonvulsants\u003c/b\u003e primarily work by either dampening neuronal excitability (e.g., blocking Na\u003csup\u003e+\u003c/sup\u003e channels) or enhancing neuronal inhibition (e.g., potentiating GABA), with the choice of drug critically depending on the type of seizure being treated.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5aea213f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"eddd2bc5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n      }\n    ]\n  },\n  \"290a966b\": {\n    \"title\": \"Antidiuretic Hormone (ADH)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Renal\",\n      \"Physiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntidiuretic Hormone (ADH)\u003c/b\u003e, also known as vasopressin, is a peptide hormone synthesized in the [[89e86633|hypothalamus]] and released from the posterior pituitary. Its primary functions are to regulate plasma osmolality by increasing water reabsorption in the kidneys and to regulate blood pressure via vasoconstriction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis \u0026 Release:\u003c/b\u003e Synthesized primarily in the \u003cmark\u003esupraoptic nucleus\u003c/mark\u003e of the [[89e86633|hypothalamus]], transported down axons, and stored/released from the posterior pituitary (neurohypophysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegulation:\u003c/b\u003e Release is stimulated by \u003cmark\u003eincreased plasma osmolality\u003c/mark\u003e (detected by osmoreceptors in the hypothalamus) and, to a lesser extent, by decreased blood volume/pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRenal Action (V2 Receptors):\u003c/b\u003e Binds to V2 receptors on the basolateral membrane of principal cells in the renal collecting ducts. This activates a G\u003csub\u003es\u003c/sub\u003e-cAMP pathway, leading to the insertion of \u003cmark\u003eaquaporin-2\u003c/mark\u003e channels into the apical membrane, increasing water reabsorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Action (V1 Receptors):\u003c/b\u003e Binds to V1 receptors on vascular smooth muscle, activating a G\u003csub\u003eq\u003c/sub\u003e-IP\u003csub\u003e3\u003c/sub\u003e/DAG pathway that causes vasoconstriction and increases blood pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pathologies are key: Deficiency of ADH or its receptor causes [[diabetes_insipidus]]. Excess ADH secretion causes [[syndrome_of_inappropriate_antidiuretic_hormone|SIADH]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntidiuretic Hormone\u003c/b\u003e is the body\u0027s primary regulator of water balance, acting on the kidney\u0027s collecting ducts via V2 receptors to conserve water when osmolality is high, and on blood vessels via V1 receptors to raise blood pressure when volume is low.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Plasma Osmolality] --\u003e B(Hypothalamus); B --\u003e C(Posterior Pituitary); C --Release ADH--\u003e D; D --V2 Receptor--\u003e E[Kidney Collecting Duct]; E --\u003e F(‚Üë Aquaporin-2 Insertion); F --\u003e G(‚Üë Water Reabsorption); D --V1 Receptor--\u003e H[Vascular Smooth Muscle]; H --\u003e I(Vasoconstriction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_released_from\",\n        \"to\": \"posterior_pituitary\"\n      },\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"diabetes_insipidus\"\n      },\n      {\n        \"type\": \"excess_causes\",\n        \"to\": \"syndrome_of_inappropriate_antidiuretic_hormone\"\n      }\n    ]\n  },\n  \"96e8bf39\": {\n    \"title\": \"Antimuscarinic Drugs\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Autonomic\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntimuscarinic drugs\u003c/b\u003e, also known as anticholinergics, are a class of medications that act as competitive antagonists at muscarinic acetylcholine receptors, thereby blocking the effects of the parasympathetic nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively block [[6a005559|acetylcholine]] at muscarinic receptors (M1, M2, M3). They do not affect nicotinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Effects (Mnemonic):\u003c/b\u003e \\\"Hot as a hare, dry as a bone, blind as a bat, red as a beet, mad as a hatter.\\\"\u003cbr\u003e - \u003cb\u003eDry:\u003c/b\u003e ‚Üì Salivation, lacrimation, sweating.\u003cbr\u003e - \u003cb\u003eBlind:\u003c/b\u003e Mydriasis (pupil dilation) and cycloplegia (loss of accommodation).\u003cbr\u003e - \u003cb\u003eHot \u0026 Red:\u003c/b\u003e ‚Üì Sweating leads to hyperthermia and compensatory flushing.\u003cbr\u003e - \u003cb\u003eMad:\u003c/b\u003e CNS effects like delirium, confusion, hallucinations (especially with drugs that cross the BBB).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Use:\u003c/b\u003e Used in [[58c8ea03|Parkinson disease]] (e.g., [[383f6fbe|benztropine]], trihexyphenidyl) to treat tremor and rigidity by rebalancing the cholinergic-dopaminergic systems. Also used to treat drug-induced extrapyramidal symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses:\u003c/b\u003e Atropine (bradycardia), scopolamine (motion sickness), ipratropium (COPD), oxybutynin (overactive bladder).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be cautious using antimuscarinics in the elderly due to increased risk of confusion, hallucinations, and delirium. They are contraindicated in [[9c80344d|angle-closure glaucoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntimuscarinic drugs\u003c/b\u003e function by blocking the \u0027rest and digest\u0027 functions of the parasympathetic nervous system, leading to a predictable constellation of side effects that are essentially the opposite of a cholinergic toxidrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetylcholine] --x B(Antimuscarinic Drugs); B --x C(Muscarinic Receptors); C --x D(Parasympathetic Effects);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"antagonizes_receptor_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"atropine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"383f6fbe\"\n      }\n    ]\n  },\n  \"af72aab5\": {\n    \"title\": \"Antispasmodics (Skeletal Muscle Relaxants)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntispasmodics\u003c/b\u003e, or skeletal muscle relaxants, are a group of drugs used to alleviate symptoms associated with muscle spasticity or acute muscle spasms by acting either on the central nervous system or directly on the muscle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBaclofen:\u003c/b\u003e A [[gaba_b_receptor|GABA\u003csub\u003eB\u003c/sub\u003e receptor]] agonist that acts on the spinal cord to suppress hyperactive reflexes. Used for spasticity in [[45dd6d19|multiple sclerosis]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCyclobenzaprine:\u003c/b\u003e A centrally acting muscle relaxant, structurally related to TCAs. Used for acute muscle spasms from musculoskeletal conditions. Has significant anticholinergic side effects and causes sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTizanidine:\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist that inhibits motor neuron activity. Used for spasticity. Can cause hypotension, sedation, and dry mouth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDantrolene:\u003c/b\u003e Acts directly on skeletal muscle by blocking Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum (inhibits ryanodine receptor). \u003cu\u003eUsed to treat malignant hyperthermia and neuroleptic malignant syndrome\u003c/u\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the uses: [[baclofen]] and tizanidine for chronic spasticity (MS, spinal cord injury), cyclobenzaprine for acute muscle strain, and [[dantrolene]] for life-threatening hyperthermic syndromes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntispasmodics\u003c/b\u003e reduce muscle hyperactivity through diverse mechanisms, ranging from central GABAergic and adrenergic modulation (baclofen, tizanidine) to direct interference with muscle contraction machinery (dantrolene), the latter being crucial for treating hyperthermic emergencies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"cyclobenzaprine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d67a204d\"\n      }\n    ]\n  },\n  \"d1c786e9\": {\n    \"title\": \"Anxiety Disorders\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Neurology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Anxiety Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnxiety disorders\u003c/b\u003e are a group of mental health conditions characterized by excessive and persistent fear, anxiety, or worry that is disproportionate to the situation and impairs daily functioning. They are associated with altered activity in brain circuits involving the [[d220fc3f|amygdala]] and prefrontal cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Imbalance:\u003c/b\u003e Associated with decreased levels of [[5d3c2089|serotonin]] and [[gaba|GABA]], and increased levels of norepinephrine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Types:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGeneralized Anxiety Disorder (GAD):\u003c/b\u003e Chronic, uncontrollable worry about multiple issues.\u003cbr\u003e - \u003cb\u003ePanic Disorder:\u003c/b\u003e Recurrent, unexpected panic attacks.\u003cbr\u003e - \u003cb\u003ePhobias:\u003c/b\u003e Intense, irrational fear of a specific object or situation.\u003cbr\u003e - \u003cb\u003eSocial Anxiety Disorder:\u003c/b\u003e Fear of social situations and scrutiny.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst-Line Treatment:\u003c/b\u003e Cognitive Behavioral Therapy (CBT) and/or SSRIs/SNRIs are the \u003cu\u003efirst-line\u003c/u\u003e treatments for most anxiety disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecond-Line/Adjunctive Treatment:\u003c/b\u003e [[14464617|Benzodiazepines]] (e.g., [[083094db|alprazolam]], lorazepam) are used for rapid relief of acute anxiety or panic attacks but are not preferred for long-term use due to dependence risk. Buspirone is a non-sedating anxiolytic used for GAD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For long-term management of anxiety, SSRIs/SNRIs are preferred. Benzodiazepines are for short-term or \u0027as-needed\u0027 use.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnxiety disorders\u003c/b\u003e represent a dysregulation of the brain\u0027s fear and worry circuits, driven by an imbalance of key neurotransmitters. Modern treatment focuses on long-term modulation with SSRIs/SNRIs and CBT, reserving fast-acting benzodiazepines for acute, short-term management.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Amygdala Hyperactivity] \u0026 B[Prefrontal Cortex Hypoactivity] --\u003e C(Dysregulated Fear/Worry Circuit); C --\u003e D(Anxiety Disorder);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_dysregulation_of\",\n        \"to\": \"5d3c2089\"\n      },\n      {\n        \"type\": \"involves_dysregulation_of\",\n        \"to\": \"gaba\"\n      },\n      {\n        \"type\": \"involves_dysregulation_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ssris\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"14464617\"\n      }\n    ]\n  },\n  \"6bc9a567\": {\n    \"title\": \"Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAphasia\u003c/b\u003e is an acquired language disorder resulting from damage to the language centers of the brain, typically in the dominant (usually left) hemisphere. It affects the ability to produce and/or comprehend spoken or written language, and is distinct from dysarthria (a motor speech disorder).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBroca\u0027s Aphasia (Expressive):\u003c/b\u003e Lesion in the inferior frontal gyrus ([[a3bbace2|Broca\u0027s area]]). Characterized by \u003cmark\u003enonfluent, telegraphic speech\u003c/mark\u003e with intact comprehension. Patients are often frustrated by their inability to speak. Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken \u003cb\u003eB\u003c/b\u003eoca (mouth).\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke\u0027s Aphasia (Receptive):\u003c/b\u003e Lesion in the superior temporal gyrus ([[wernicke_area|Wernicke\u0027s area]]). Characterized by \u003cmark\u003efluent but meaningless speech\u003c/mark\u003e (word salad) with severely impaired comprehension. Patients are often unaware of their deficit (anosognosia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eConduction Aphasia:\u003c/b\u003e Lesion of the \u003cmark\u003earcuate fasciculus\u003c/mark\u003e, which connects Broca\u0027s and Wernicke\u0027s areas. Hallmark is poor repetition despite fluent speech and intact comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlobal Aphasia:\u003c/b\u003e Large lesion affecting both Broca\u0027s and Wernicke\u0027s areas, typically from a large [[143bb23d|MCA stroke]]. All language functions (fluency, comprehension, repetition) are severely impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The most common cause of aphasia is an ischemic [[c5da3c57|stroke]] in the territory of the left [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAphasia\u003c/b\u003e is a disorder of language, not speech mechanics, with distinct subtypes that can be precisely localized within the dominant cerebral hemisphere: Broca\u0027s area for production, Wernicke\u0027s area for comprehension, and the arcuate fasciculus for repetition.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left MCA Stroke] --\u003e B{Aphasia Types}; B --\u003e C[Broca\u0027s - Nonfluent, Good Comprehension]; B --\u003e D[Wernicke\u0027s - Fluent, Poor Comprehension]; B --\u003e E[Conduction - Poor Repetition]; B --\u003e F[Global - All Impaired];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"includes_type\",\n        \"to\": \"7f6ed344\"\n      },\n      {\n        \"type\": \"includes_type\",\n        \"to\": \"2c4a6130\"\n      },\n      {\n        \"type\": \"includes_type\",\n        \"to\": \"1ae850fe\"\n      }\n    ]\n  },\n  \"1a804e11\": {\n    \"title\": \"Apoptosis\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Cell Biology\",\n      \"Pathology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cellular Injury\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eApoptosis\u003c/b\u003e is a form of programmed cell death that is a highly regulated and controlled process, essential for normal tissue turnover, embryonic development, and removal of damaged or infected cells. In the context of neurology, it is the primary mechanism of neuronal death in many neurodegenerative diseases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Features:\u003c/b\u003e Characterized by cell shrinkage, chromatin condensation (pyknosis), membrane blebbing, and formation of apoptotic bodies, which are then phagocytosed. It is an ATP-dependent process and does \u003cu\u003enot\u003c/u\u003e induce inflammation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathways:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eIntrinsic (Mitochondrial):\u003c/b\u003e Activated by cellular stress (e.g., DNA damage, misfolded proteins). Regulated by the Bcl-2 family of proteins. Pro-apoptotic proteins (Bax, Bak) create pores in the mitochondrial membrane, releasing cytochrome c, which activates caspases.\u003cbr\u003e - \u003cb\u003eExtrinsic (Death Receptor):\u003c/b\u003e Activated by external ligands (e.g., FasL, TNF-Œ±) binding to death receptors on the cell surface, directly activating caspases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCaspases:\u003c/b\u003e The central executioners of apoptosis are a family of cysteine proteases called caspases, which orchestrate the degradation of cellular components.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Relevance:\u003c/b\u003e Apoptosis of lower motor neurons is a key feature of [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]. It is also the mechanism of neuronal loss in [[ffd7e743|Huntington disease]] and [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Contrast apoptosis with necrosis. Necrosis is uncontrolled cell death due to injury, causing cell swelling, membrane rupture, and inflammation. Apoptosis is clean, programmed, and non-inflammatory.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eApoptosis\u003c/b\u003e is the cell\u0027s intrinsic suicide program, executed by caspases, which neatly packages the cell for disposal without triggering an inflammatory response; its dysregulation is a central theme in both cancer (too little apoptosis) and neurodegeneration (too much apoptosis).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A{Cellular Stress} --\u003e B(Intrinsic Pathway); B --\u003e C(Mitochondria); C --Cytochrome c--\u003e D; E{Death Ligands} --\u003e F(Extrinsic Pathway); F --\u003e D(Caspase Activation); D --\u003e G(Execution Phase); G --\u003e H(Apoptotic Body Formation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mechanism_of_cell_death_in\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"is_mechanism_of_cell_death_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"necrosis\"\n      }\n    ]\n  },\n  \"c1f67280\": {\n    \"title\": \"Apraclonidine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eApraclonidine\u003c/b\u003e is an \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist\u003c/i\u003e used topically in ophthalmology to lower intraocular pressure (IOP), primarily for the short-term treatment of [[3ce6c035|glaucoma]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As a selective Œ±\u003csub\u003e2\u003c/sub\u003e-agonist, it acts on presynaptic Œ±\u003csub\u003e2\u003c/sub\u003e receptors in the ciliary body to \u003cmark\u003edecrease aqueous humor synthesis\u003c/mark\u003e. It also has some minor effect on increasing uveoscleral outflow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to lower IOP in patients with [[5ea7b741|open-angle glaucoma]]. It is particularly useful for preventing post-surgical IOP spikes. Its use is often limited to the short term due to tachyphylaxis (diminishing response).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include blurry vision, ocular hyperemia (redness), foreign body sensation, and ocular allergic reactions. Systemic side effects are rare but can include dry mouth and fatigue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Similar to [[brimonidine]], another Œ±\u003csub\u003e2\u003c/sub\u003e-agonist used for glaucoma, but apraclonidine has a higher rate of tachyphylaxis and allergic reactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e-agonists (like apraclonidine and clonidine) work by reducing sympathetic outflow. In the eye, this translates to decreased production of aqueous humor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eApraclonidine\u003c/b\u003e lowers intraocular pressure by acting as a \u0027brake\u0027 on aqueous humor production, stimulating Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the ciliary body to reduce fluid synthesis, making it a useful agent for short-term management of glaucoma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Apraclonidine] --\u003e B(Stimulates Œ±2 Receptors in Ciliary Body); B --\u003e C(‚Üì Norepinephrine Release); C --\u003e D(‚Üì Aqueous Humor Synthesis); D --\u003e E(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"alpha_2_agonist\"\n      },\n      {\n        \"type\": \"has_similar_mechanism_to\",\n        \"to\": \"2fcee185\"\n      }\n    ]\n  },\n  \"eb32eb82\": {\n    \"title\": \"Gait Apraxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Gait Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGait apraxia\u003c/b\u003e is a high-level gait disorder characterized by the inability to properly coordinate the motor sequences for walking, despite having normal motor, sensory, and cerebellar function. It is often described as a \u003cmark\u003e\\\"magnetic gait,\\\"\u003c/mark\u003e where the feet appear stuck to the floor.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients have difficulty initiating walking. The gait is wide-based, shuffling, and slow, with the feet barely leaving the ground. Turning is particularly difficult and requires multiple small steps.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is considered a disorder of the frontal lobes or their connections, disrupting the cortical control of locomotion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e Gait apraxia is one of the three cardinal signs of \u003cmark\u003e[[7c59030e|Normal Pressure Hydrocephalus (NPH)]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNPH Triad:\u003c/b\u003e The classic triad is \\\"\u003cb\u003eW\u003c/b\u003eobbly, \u003cb\u003eW\u003c/b\u003eacky, and \u003cb\u003eW\u003c/b\u003eet\\\":\u003cbr\u003e1. \u003cb\u003eWobbly:\u003c/b\u003e Gait apraxia.\u003cbr\u003e2. \u003cb\u003eWacky:\u003c/b\u003e Cognitive dysfunction/dementia.\u003cbr\u003e3. \u003cb\u003eWet:\u003c/b\u003e Urinary incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The description of a \u0027magnetic\u0027 or \u0027feet stuck to the floor\u0027 gait in an elderly patient, especially when combined with cognitive changes and urinary incontinence, is a classic vignette for [[7c59030e|Normal Pressure Hydrocephalus]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGait apraxia\u003c/b\u003e is a \u0027brain\u0027 problem, not a \u0027leg\u0027 problem; it represents a failure of the frontal lobe\u0027s motor programming for walking, famously manifesting as the \u0027magnetic\u0027 gait of [[7c59030e|Normal Pressure Hydrocephalus]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"7c59030e\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"frontal_lobe\"\n      }\n    ]\n  },\n  \"d595b0bf\": {\n    \"title\": \"Aqueous Humor Pathway\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAqueous Humor Pathway\u003c/b\u003e describes the continuous production, circulation, and drainage of aqueous humor, the clear fluid that fills the anterior and posterior chambers of the eye. The balance between production and drainage determines the intraocular pressure (IOP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eProduction:\u003c/b\u003e Aqueous humor is produced by the \u003cmark\u003enonpigmented epithelium of the ciliary body\u003c/mark\u003e. This process is decreased by Œ≤-blockers, Œ±\u003csub\u003e2\u003c/sub\u003e-agonists, and carbonic anhydrase inhibitors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCirculation:\u003c/b\u003e Fluid flows from the posterior chamber, through the pupil, into the anterior chamber.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage Pathways:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eTrabecular Outflow (~90%):\u003c/b\u003e Fluid drains through the trabecular meshwork, into the Canal of Schlemm, and then into the episcleral vasculature. This pathway is enhanced by muscarinic agonists (e.g., pilocarpine).\u003cbr\u003e2. \u003cb\u003eUveoscleral Outflow (~10%):\u003c/b\u003e Fluid drains through the ciliary muscle and into the uveal and scleral tissues. This pathway is enhanced by prostaglandin analogs (e.g., latanoprost).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Imbalance in this pathway leads to [[3ce6c035|glaucoma]]. [[5ea7b741|Open-angle glaucoma]] involves increased resistance in the trabecular meshwork, while [[9c80344d|angle-closure glaucoma]] involves physical obstruction of the angle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand how different glaucoma medications target this pathway. Prostaglandins increase uveoscleral outflow, while Œ≤-blockers and acetazolamide decrease production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAqueous Humor Pathway\u003c/b\u003e is a dynamic circulatory system within the eye\u0027s anterior segment, where a delicate equilibrium between ciliary body production and dual-route (trabecular and uveoscleral) drainage is essential for maintaining normal intraocular pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ciliary Body Epithelium] --Produces--\u003e B(Aqueous Humor); B --\u003e C(Posterior Chamber); C --\u003e D(Anterior Chamber); D --\u003e E{Drainage}; E --\u003e F[Trabecular Outflow (90%)]; F --\u003e G[Canal of Schlemm]; E --\u003e H[Uveoscleral Outflow (10%)];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_dysregulated_in\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \"glaucoma_drugs\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10734,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"3c075343\": {\n    \"title\": \"An"
      }, {
        "text": "terior Inferior Cerebellar Artery (AICA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"An"
      }, {
        "text": "atomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eAnterior Inferior Cerebellar Artery (AICA)\u003c/b\u003e is an artery in"
      }, {
        "text": " the brain that arises from the basilar artery and supplies blood to the anterior inferior portion of the cerebellum, as well as parts of the lateral"
      }, {
        "text": " pons.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Typically arises from the lower third"
      }, {
        "text": " of the basilar artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Lateral pons, middle and inferior cerebellar peduncles, and the"
      }, {
        "text": " anterior inferior cerebellum. It also gives rise to the labyrinthine artery in most individuals, which supplies the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome"
      }, {
        "text": ":\u003c/b\u003e Occlusion of the AICA causes \u003cmark\u003eLateral Pontine Syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms of A"
      }, {
        "text": "ICA Stroke:\u003c/b\u003e Mnemonic \u003cb\u003eAICA\u003c/b\u003e: \u003cb\u003eA\u003c/b\u003etaxia (ipsilateral, from cerebellar"
      }, {
        "text": " peduncle damage), \u003cb\u003eI\u003c/b\u003epsilateral facial paralysis (CN VII nucleus/fibers) and deafness/vertigo (CN VIII nucleus/labyrinth"
      }, {
        "text": "ine artery), \u003cb\u003eC\u003c/b\u003eontralateral pain/temp loss (spinothalamic tract), \u003cb\u003eA"
      }, {
        "text": "\u003c/b\u003eutonomic signs (ipsilateral Horner syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to distinguishing an AICA stroke from a"
      }, {
        "text": " PICA stroke (Lateral Medullary Syndrome) is the presence of \u003cmark\u003efacial paralysis\u003c/mark\u003e and \u003cmark\u003ede"
      }, {
        "text": "afness\u003c/mark\u003e, which are specific to the pontine location of the AICA territory.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eOcclusion of the \u003cb\u003eAnterior Inferior Cerebellar Artery\u003c/b\u003e results in Lateral Pontine Syndrome, a"
      }, {
        "text": " complex brainstem stroke characterized by a unique combination of cerebellar signs, contralateral body sensory loss, and ipsilateral facial deficits including"
      }, {
        "text": " paralysis and deafness, which localizes the lesion squarely to the lateral pons.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A[Basilar Artery] --\u003e B(AICA); B --\u003e C(Lateral Pons); B --\u003e D(An"
      }, {
        "text": "terior Inferior Cerebellum); B --\u003e E(Labyrinthine Artery); C --\u003e F(CN VII \u0026 VIII Nucle"
      }, {
        "text": "i); E --\u003e G(Inner Ear);\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"occlusion_causes\",\n        \"to\": \"lateral_pontine_syndrome\"\n      },\n      \""
      }, {
        "text": "type\": \"is_a_branch_of\",\n      \"to\": \"basilar_artery\"\n    },\n"
      }, {
        "text": "    {\n      \"type\": \"differentiated_from_stroke_in\",\n      \"to\": \"posterior"
      }, {
        "text": "_inferior_cerebellar_artery\"\n    }\n  },\n  \"eed3fda9\": {\n    \"title\": \""
      }, {
        "text": "Anterior Nucleus of Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Physiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eAnterior Nucleus\u003c/b\u003e is a region of the [[89e86633|hypothalamus]]"
      }, {
        "text": " that plays a primary role in thermoregulation, specifically in dissipating heat to cool the body. It is part of the parasympathetic nervous system.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediates heat dissipation (\u003cb\u003ecooling\u003c/b\u003e). M"
      }, {
        "text": "nemonic: The \u003cb\u003eA\u003c/b\u003e/\u003cb\u003eC\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003enterior \u003cb\u003eC\u003c/b\u003eooling) is in"
      }, {
        "text": " the front of the house.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Senses when the body is too hot and initiates parasympathetic responses like"
      }, {
        "text": " cutaneous vasodilation and sweating to promote heat loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion in the anterior"
      }, {
        "text": " nucleus results in \u003cmark\u003ehyperthermia\u003c/mark\u003e, as the body loses its ability to cool itself down.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e"
      }, {
        "text": " The [[posterior_nucleus_of_hypothalamus|posterior nucleus of the hypothalamus]] is responsible for heat conservation and"
      }, {
        "text": " production (heating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the functional pairing: Anterior hypothalamus \u003d Cooling (parasympathetic),"
      }, {
        "text": " Posterior hypothalamus \u003d Heating (sympathetic). A lesion in the anterior nucleus leads to an inability to cool down.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eAnterior Nucleus of the hypothalamus\u003c/b\u003e functions as the body\u0027s thermostat for cooling; its"
      }, {
        "text": " destruction leads to uncontrolled hyperthermia because the primary mechanism for heat dissipation is lost.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[‚Üë Body Temperature] --\u003e B(Anterior Nucleus); B --Parasympathetic Output--\u003e C(Cutaneous Vasodilation \u0026 Sweating);"
      }, {
        "text": " C --\u003e D(Heat Dissipation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"regulates\",\n        \"to\": \"thermoregulation\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "lesion_causes\",\n        \"to\": \"hyperthermia\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_counterpart_to\",\n        \"to\": \"posterior_nucleus_of_hypothalamus\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"1430f5b4\": {\n    \"title\": \"Anterior Spinal Artery (ASA"
      }, {
        "text": ")\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      "
      }, {
        "text": "\"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eAnterior Spinal Artery (ASA)\u003c/b\u003e is a major artery that supplies the anterior two-thirds of the spinal"
      }, {
        "text": " cord. It originates from the vertebral arteries in the cranium and descends along the anterior surface of the spinal cord.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Formed from the union of two branches of the vertebral arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied"
      }, {
        "text": ":\u003c/b\u003e Supplies the anterior two-thirds of the spinal cord, including the anterior and lateral corticospinal tracts, the spin"
      }, {
        "text": "othalamic tracts, and the anterior horns. It notably \u003cu\u003espares\u003c/u\u003e the [[e7f5cb"
      }, {
        "text": "be|dorsal columns]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome (Spinal Cord):\u003c/b\u003e Occlusion causes \u003cmark\u003e[["
      }, {
        "text": "b48b54d7|Anterior Spinal Artery Syndrome]]\u003c/mark\u003e, characterized by bilateral loss of motor function (fl"
      }, {
        "text": "accid paralysis at the level, UMN signs below) and pain/temperature sensation below the level of the lesion, with"
      }, {
        "text": " \u003cmark\u003epreserved proprioception and vibration sense\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndrome (Medulla):\u003c/b\u003e Occlusion of param"
      }, {
        "text": "edian branches of the ASA or vertebral arteries causes \u003cmark\u003eMedial Medullary Syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The key to identifying an ASA stroke is the dissociation of sensory loss: pain and temperature are gone, but"
      }, {
        "text": " vibration and position sense are intact because the dorsal columns are spared.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eAnterior Spinal Artery\u003c/b\u003e is the lifeline for the motor and pain/temperature pathways of the spinal cord;"
      }, {
        "text": " its occlusion creates a devastating syndrome of bilateral paralysis and sensory loss, sparing only the dorsal columns\u0027 functions of vibration and proprio"
      }, {
        "text": "ception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vertebral Arteries] --\u003e B("
      }, {
        "text": "Anterior Spinal Artery); B --\u003e C(Anterior 2/3 of Spinal Cord); C --\u003e D["
      }, {
        "text": "Corticospinal Tracts]; C --\u003e E[Spinothalamic Tracts]; C --\u003e F[Anterior Horns"
      }, {
        "text": "];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \""
      }, {
        "text": "b48b54d7\"\n      },\n      {\n        \"type\": \"occlusion_"
      }, {
        "text": "causes\",\n        \"to\": \"medial_medullary_syndrome\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"spares\",\n        \"to\": \"e7f5cbbe\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"b48b54d7\": {\n    \"title\": \"Anterior Spinal Artery Syndrome"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Spinal Cord\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnterior Spinal Artery Syndrome\u003c/b\u003e is a spinal"
      }, {
        "text": " cord infarct resulting from occlusion of the [[1430f5b4|anterior spinal artery (ASA)]], which leads"
      }, {
        "text": " to ischemia of the anterior two-thirds of the spinal cord, causing a distinct pattern of neurological deficits below the level of the lesion.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by occlusion of the ASA,"
      }, {
        "text": " which can result from aortic surgery (e.g., repair of an aneurysm), severe hypotension (watershed infarct), or thrombo"
      }, {
        "text": "embolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Damaged:\u003c/b\u003e Corticospinal tracts, spinothalamic tracts, and anterior"
      }, {
        "text": " horns.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Spared:\u003c/b\u003e The \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e"
      }, {
        "text": " are spared due to their separate blood supply from the posterior spinal arteries.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eMotor:\u003c/b\u003e Bilateral flaccid paralysis at the level of the lesion (LMN signs from anterior horn damage) and bilateral"
      }, {
        "text": " spastic paralysis below the lesion (UMN signs from corticospinal tract damage).\u003cbr\u003e - \u003cb\u003eSensory:\u003c/b\u003e Bil"
      }, {
        "text": "ateral loss of pain and temperature sensation below the lesion (spinothalamic tract damage).\u003cbr\u003e - \u003cb\u003eS"
      }, {
        "text": "ensation Preserved:\u003c/b\u003e \u003cmark\u003eProprioception, vibration, and fine touch are intact\u003c/mark\u003e because the dorsal columns are"
      }, {
        "text": " spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The dissociation between loss of pain/temperature and preservation of vibration/proprioception is"
      }, {
        "text": " the pathognomonic feature of this syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnterior Spinal Artery Syndrome\u003c/b\u003e"
      }, {
        "text": " creates a stark neurological divide, paralyzing the body and eliminating pain and temperature sensation below the lesion, while leaving the sense"
      }, {
        "text": " of position and vibration completely intact, a direct reflection of the spinal cord\u0027s vascular territories.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[ASA Occlusion] --\u003e B(Infarct of Anterior 2/3 of Spinal Cord); B"
      }, {
        "text": " --\u003e C[Damage to Corticospinal \u0026 Spinothalamic Tracts]; B --Spares--\u003e D["
      }, {
        "text": "Dorsal Columns]; C --\u003e E[Bilateral Paralysis \u0026 Loss of Pain/Temp]; D --\u003e F[Pres"
      }, {
        "text": "erved Vibration/Proprioception];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by_occlusion_of\",\n        \"to\": \"1430f5b4"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"spares\",\n        \"to\": \"e7f5cbbe\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tracts\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07eecef"
      }, {
        "text": "1\"\n      }\n    ]\n  },\n  \"4770b8a2\": {\n    \"title\": \""
      }, {
        "text": "Anti-CGRP Monoclonal Antibodies\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnti-CGRP monoclonal antibodies\u003c/b\u003e are a class of medications used for"
      }, {
        "text": " the prophylactic treatment of [[c8833bae|migraine headaches]]. They work by targeting either calcitonin gene-related peptide"
      }, {
        "text": " (CGRP) itself or its receptor, which are key players in the pathophysiology of migraines.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e These monoclonal antibodies bind to either the CGRP ligand (e.g., e"
      }, {
        "text": "ptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (e.g.,"
      }, {
        "text": " erenumab), preventing CGRP from mediating its effects of vasodilation and pain transmission in the trigeminal nervous"
      }, {
        "text": " system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the \u003cmark\u003eprevention (prophylaxis)\u003c/mark\u003e of episodic"
      }, {
        "text": " and chronic [[c8833bae|migraines]]. They are not used for acute treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration"
      }, {
        "text": ":\u003c/b\u003e Administered via subcutaneous injection or IV infusion, typically on a monthly or quarterly basis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally well-toler"
      }, {
        "text": "ated. The most common side effects are injection site reactions. Constipation is notably associated with the CGRP receptor antagonists (e.g., erenumab"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Recognize these drugs by their \u0027-mab\u0027 suffix and their specific use for"
      }, {
        "text": " migraine \u003cu\u003eprophylaxis\u003c/u\u003e. They represent a targeted therapy based on the modern understanding of migraine pathophysiology involving CGRP.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eAnti-CGRP monoclonal antibodies\u003c/b\u003e represent a major advance in migraine prevention, offering"
      }, {
        "text": " a highly specific mechanism that directly neutralizes the CGRP pathway, a key driver of pain and inflammation in migraine attacks.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Nerve Activation] --\u003e B(Release of CGRP); B --\u003e C("
      }, {
        "text": "CGRP Receptor); C --\u003e D(Vasodilation \u0026 Pain Transmission); D --\u003e E(Migraine); F[Anti-CGRP mAbs"
      }, {
        "text": "] --x B; G[Anti-CGRP Receptor mAbs] --x C;\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"targets\",\n        \"to\": \"calcitonin_gene_related_peptide\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"monoclonal_antibody\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"f91a0cfa\": {\n    \"title\": \"Ant"
      }, {
        "text": "iconvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eAnticonvulsants\u003c/b\u003e, also known as antiepileptic drugs (AEDs), are a diverse"
      }, {
        "text": " group of medications used to treat epileptic [[64c08e92|seizures]]. They work by various"
      }, {
        "text": " mechanisms to suppress the rapid and excessive firing of neurons that initiate a seizure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Major Mechanisms:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eNa\u003csup\u003e+\u003c/sup\u003e Channel Blockade:\u003c/b\u003e [[5aea2"
      }, {
        "text": "13f|Phenytoin]], [[eddd2bc5|Carbamazepine]], [[0d37"
      }, {
        "text": "e045|Valproate]], [[08d19a8f|Lamotrigine]]."
      }, {
        "text": "\u003cbr\u003e2. \u003cb\u003eEnhancement of GABAergic inhibition:\u003c/b\u003e Benzodiazepines, Barbiturates, [[val"
      }, {
        "text": "proic_acid|Valproate]].\u003cbr\u003e3. \u003cb\u003eCa\u003csup\u003e2+\u003c/sup\u003e Channel Blockade:"
      }, {
        "text": "\u003c/b\u003e [[a90f6fb4|Ethosuximide]] (T-type), Gabapentinoids"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Activity:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBroad-spectrum:\u003c/b\u003e [[valproic_acid|Valproic"
      }, {
        "text": " acid]], [[08d19a8f|lamotrigine]], [[2341f9"
      }, {
        "text": "c0|levetiracetam]], [[e1f5066c|topiramate]]. Effective"
      }, {
        "text": " for both focal and generalized seizures.\u003cbr\u003e - \u003cb\u003eNarrow-spectrum:\u003c/b\u003e [[eddd2bc5|Carbamaz"
      }, {
        "text": "epine]], [[5aea213f|phenytoin]], gabapentinoids. Primarily for focal seizures. [["
      }, {
        "text": "a90f6fb4|Ethosuximide]] is for absence seizures only.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses"
      }, {
        "text": ":\u003c/b\u003e Many anticonvulsants are also used for bipolar disorder, neuropathic pain, and [[c8833bae|migraine"
      }, {
        "text": "]] prophylaxis. Some are used in [[45dd6d19|multiple sclerosis]] for symptomatic treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:"
      }, {
        "text": "\u003c/b\u003e Common side effects include sedation, dizziness, and ataxia. Many carry a risk of serious skin reactions like \u003cmark\u003eStevens-Johnson syndrome ("
      }, {
        "text": "SJS)\u003c/mark\u003e, especially lamotrigine and carbamazepine. All are potentially teratogenic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Know the first-line treatments for specific seizure types: Absence -\u003e [[a90f6fb4|Eth"
      }, {
        "text": "osuximide]]; Tonic-clonic -\u003e [[valproic_acid|Valproic acid]], [[2341f9c0|"
      }, {
        "text": "levetiracetam]]; Status epilepticus -\u003e Benzodiazepines.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAnticonv"
      }, {
        "text": "ulsants\u003c/b\u003e primarily work by either dampening neuronal excitability (e.g., blocking Na\u003csup\u003e+\u003c/sup\u003e channels) or enhancing"
      }, {
        "text": " neuronal inhibition (e.g., potentiating GABA), with the choice of drug critically depending on the type of seizure being"
      }, {
        "text": " treated.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"5aea213f\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"eddd2bc"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a90f6fb4\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"290a966b\": {\n    \"title\": \""
      }, {
        "text": "Antidiuretic Hormone (ADH)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      "
      }, {
        "text": "\"Renal\",\n      \"Physiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntidiuretic Hormone ("
      }, {
        "text": "ADH)\u003c/b\u003e, also known as vasopressin, is a peptide hormone synthesized in the [[89e866"
      }, {
        "text": "33|hypothalamus]] and released from the posterior pituitary. Its primary functions are to regulate plasma osmolality by"
      }, {
        "text": " increasing water reabsorption in the kidneys and to regulate blood pressure via vasoconstriction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis"
      }, {
        "text": " \u0026 Release:\u003c/b\u003e Synthesized primarily in the \u003cmark\u003esupraoptic nucleus\u003c/mark\u003e of the [[89e86633"
      }, {
        "text": "|hypothalamus]], transported down axons, and stored/released from the posterior pituitary (neurohypophysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Regulation:\u003c/b\u003e Release is stimulated by \u003cmark\u003eincreased plasma osmolality\u003c/mark\u003e (detected by osmoreceptors"
      }, {
        "text": " in the hypothalamus) and, to a lesser extent, by decreased blood volume/pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRenal Action"
      }, {
        "text": " (V2 Receptors):\u003c/b\u003e Binds to V2 receptors on the basolateral membrane of principal cells in the renal"
      }, {
        "text": " collecting ducts. This activates a G\u003csub\u003es\u003c/sub\u003e-cAMP pathway, leading to the insertion of \u003cmark\u003eaquaporin-2\u003c/"
      }, {
        "text": "mark\u003e channels into the apical membrane, increasing water reabsorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Action (V1 Receptors):\u003c/b\u003e B"
      }, {
        "text": "inds to V1 receptors on vascular smooth muscle, activating a G\u003csub\u003eq\u003c/sub\u003e-IP\u003csub\u003e3\u003c/sub\u003e/DAG pathway that"
      }, {
        "text": " causes vasoconstriction and increases blood pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Pathologies are key: Deficiency of ADH or"
      }, {
        "text": " its receptor causes [[diabetes_insipidus]]. Excess ADH secretion causes [[syndrome_of_inappropriate_antidiuretic_horm"
      }, {
        "text": "one|SIADH]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntidiuretic Hormone\u003c/b\u003e is"
      }, {
        "text": " the body\u0027s primary regulator of water balance, acting on the kidney\u0027s collecting ducts via V2 receptors to conserve"
      }, {
        "text": " water when osmolality is high, and on blood vessels via V1 receptors to raise blood pressure when volume is low.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[‚Üë Plasma Osmolality] --\u003e B(Hypothalamus); B --\u003e C("
      }, {
        "text": "Posterior Pituitary); C --Release ADH--\u003e D; D --V2 Receptor--\u003e E[Kidney Collecting Duct]; E --\u003e F"
      }, {
        "text": "(‚Üë Aquaporin-2 Insertion); F --\u003e G(‚Üë Water Reabsorption); D --V1 Receptor--\u003e H"
      }, {
        "text": "[Vascular Smooth Muscle]; H --\u003e I(Vasoconstriction);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_synthesized_in\",\n        \"to\": \"89e86633\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_released_from\",\n        \"to\": \"posterior_pituitary\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"diabetes"
      }, {
        "text": "_insipidus\"\n      },\n      {\n        \"type\": \"excess_causes\",\n        \""
      }, {
        "text": "to\": \"syndrome_of_inappropriate_antidiuretic_hormone\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"96e8bf39\": {\n    \"title\": \"Antimuscarinic Drugs\",\n"
      }, {
        "text": "    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Aut"
      }, {
        "text": "onomic\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntimuscarinic drugs\u003c/b\u003e, also known as anticholinergics,"
      }, {
        "text": " are a class of medications that act as competitive antagonists at muscarinic acetylcholine receptors, thereby blocking the effects of the parasympathetic nervous system.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Competitively block [[6a"
      }, {
        "text": "005559|acetylcholine]] at muscarinic receptors (M1, M2, M3"
      }, {
        "text": "). They do not affect nicotinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Effects (Mnemonic):\u003c/b\u003e \\\"Hot as a hare, dry"
      }, {
        "text": " as a bone, blind as a bat, red as a beet, mad as a hatter.\\\"\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eDry:\u003c/b\u003e ‚Üì Salivation, lacrimation, sweating.\u003cbr\u003e - \u003cb\u003eBlind:\u003c/b\u003e M"
      }, {
        "text": "ydriasis (pupil dilation) and cycloplegia (loss of accommodation).\u003cbr\u003e - \u003cb\u003eHot"
      }, {
        "text": " \u0026 Red:\u003c/b\u003e ‚Üì Sweating leads to hyperthermia and compensatory flushing.\u003cbr\u003e - \u003cb\u003eMad:\u003c/b\u003e CNS"
      }, {
        "text": " effects like delirium, confusion, hallucinations (especially with drugs that cross the BBB).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Use:\u003c/b\u003e Used in [["
      }, {
        "text": "58c8ea03|Parkinson disease]] (e.g., [[383f6fbe|benztrop"
      }, {
        "text": "ine]], trihexyphenidyl) to treat tremor and rigidity by rebalancing the cholinergic-dopaminergic systems"
      }, {
        "text": ". Also used to treat drug-induced extrapyramidal symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses:\u003c/b\u003e Atropine (br"
      }, {
        "text": "adycardia), scopolamine (motion sickness), ipratropium (COPD), oxybutynin (over"
      }, {
        "text": "active bladder).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be cautious using antimuscarinics in the elderly due to increased"
      }, {
        "text": " risk of confusion, hallucinations, and delirium. They are contraindicated in [[9c80344d|angle"
      }, {
        "text": "-closure glaucoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntimuscarinic drugs\u003c/b\u003e function"
      }, {
        "text": " by blocking the \u0027rest and digest\u0027 functions of the parasympathetic nervous system, leading to a predictable constellation of side effects that"
      }, {
        "text": " are essentially the opposite of a cholinergic toxidrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetyl"
      }, {
        "text": "choline] --x B(Antimuscarinic Drugs); B --x C(Muscarinic Receptors); C --"
      }, {
        "text": "x D(Parasympathetic Effects);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"antagonizes"
      }, {
        "text": "_receptor_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"atropine\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"includes\",\n        \"to\": \"383f6fbe\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"af72aab5\": {\n    \"title\":"
      }, {
        "text": " \"Antispasmodics (Skeletal Muscle Relaxants)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAntispasmodics\u003c/b\u003e, or skeletal muscle relaxants, are a group"
      }, {
        "text": " of drugs used to alleviate symptoms associated with muscle spasticity or acute muscle spasms by acting either on the central nervous system or"
      }, {
        "text": " directly on the muscle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBaclofen:\u003c/b\u003e A [["
      }, {
        "text": "gaba_b_receptor|GABA\u003csub\u003eB\u003c/sub\u003e receptor]] agonist that acts on the spinal cord to suppress hyper"
      }, {
        "text": "active reflexes. Used for spasticity in [[45dd6d19|multiple sclerosis]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCyclobenz"
      }, {
        "text": "aprine:\u003c/b\u003e A centrally acting muscle relaxant, structurally related to TCAs. Used for acute muscle spasms from musculoskeletal"
      }, {
        "text": " conditions. Has significant anticholinergic side effects and causes sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTizanidine:\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist"
      }, {
        "text": " that inhibits motor neuron activity. Used for spasticity. Can cause hypotension, sedation, and dry mouth.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Dantrolene:\u003c/b\u003e Acts directly on skeletal muscle by blocking Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum ("
      }, {
        "text": "inhibits ryanodine receptor). \u003cu\u003eUsed to treat malignant hyperthermia and neuroleptic malignant syndrome\u003c/u\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the uses: [[baclofen]] and tizanidine for chronic spasticity ("
      }, {
        "text": "MS, spinal cord injury), cyclobenzaprine for acute muscle strain, and [[dantrolene]] for life"
      }, {
        "text": "-threatening hyperthermic syndromes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAntispasmodics\u003c/b\u003e reduce"
      }, {
        "text": " muscle hyperactivity through diverse mechanisms, ranging from central GABAergic and adrenergic modulation (baclofen, tizanidine) to"
      }, {
        "text": " direct interference with muscle contraction machinery (dantrolene), the latter being crucial for treating hyperthermic emergencies.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"cyclobenzaprine\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"d67a204d\"\n      }\n    ]\n  },\n  \"d1"
      }, {
        "text": "c786e9\": {\n    \"title\": \"Anxiety Disorders\",\n    \"primaryType\": \"disease\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Psychiatry\",\n      \"Neurology\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Anxiety Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAnxiety disorders"
      }, {
        "text": "\u003c/b\u003e are a group of mental health conditions characterized by excessive and persistent fear, anxiety, or worry that is disproportionate to the situation and impairs"
      }, {
        "text": " daily functioning. They are associated with altered activity in brain circuits involving the [[d220fc3f|amygdala]] and pre"
      }, {
        "text": "frontal cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Imbalance:\u003c/b\u003e Associated with decreased"
      }, {
        "text": " levels of [[5d3c2089|serotonin]] and [[gaba|GABA]], and"
      }, {
        "text": " increased levels of norepinephrine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Types:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGeneralized Anxiety Disorder (GAD):\u003c/b\u003e Chronic"
      }, {
        "text": ", uncontrollable worry about multiple issues.\u003cbr\u003e - \u003cb\u003ePanic Disorder:\u003c/b\u003e Recurrent, unexpected panic attacks.\u003cbr\u003e - \u003cb\u003ePh"
      }, {
        "text": "obias:\u003c/b\u003e Intense, irrational fear of a specific object or situation.\u003cbr\u003e - \u003cb\u003eSocial Anxiety Disorder:\u003c/b\u003e Fear"
      }, {
        "text": " of social situations and scrutiny.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst-Line Treatment:\u003c/b\u003e Cognitive Behavioral Therapy (CBT) and/"
      }, {
        "text": "or SSRIs/SNRIs are the \u003cu\u003efirst-line\u003c/u\u003e treatments for most anxiety disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecond"
      }, {
        "text": "-Line/Adjunctive Treatment:\u003c/b\u003e [[14464617|Benzodiazepines]] (e.g., [[0"
      }, {
        "text": "83094db|alprazolam]], lorazepam) are used for rapid relief of acute anxiety or panic attacks but are"
      }, {
        "text": " not preferred for long-term use due to dependence risk. Buspirone is a non-sedating anxiolytic used"
      }, {
        "text": " for GAD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For long-term management of anxiety, SSRIs/SNRIs are preferred"
      }, {
        "text": ". Benzodiazepines are for short-term or \u0027as-needed\u0027 use.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAnxiety disorders\u003c/b\u003e represent a dysregulation of the brain\u0027s fear and worry circuits, driven"
      }, {
        "text": " by an imbalance of key neurotransmitters. Modern treatment focuses on long-term modulation with SSRIs/SNRIs and CBT"
      }, {
        "text": ", reserving fast-acting benzodiazepines for acute, short-term management.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[Amygdala Hyperactivity] \u0026 B[Prefrontal Cortex Hypoactivity] --\u003e C(Dysregulated Fear/W"
      }, {
        "text": "orry Circuit); C --\u003e D(Anxiety Disorder);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"involves_dysregulation_of\",\n        \"to\": \"5d3c2"
      }, {
        "text": "089\"\n      },\n      {\n        \"type\": \"involves_dysregulation_of"
      }, {
        "text": "\",\n        \"to\": \"gaba\"\n      },\n      {\n        \"type\": \"invol"
      }, {
        "text": "ves_dysregulation_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treated_by\",\n        \"to\": \"ssris\"\n      },\n      {\n        \"type\": \"treated_"
      }, {
        "text": "by\",\n        \"to\": \"14464617\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"6bc9a567\": {\n    \"title\": \"Aphasia\",\n    \"primary"
      }, {
        "text": "Type\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAphasia\u003c/b\u003e is an acquired language disorder resulting from damage to the language centers of the brain, typically in the dominant"
      }, {
        "text": " (usually left) hemisphere. It affects the ability to produce and/or comprehend spoken or written language, and is distinct from dys"
      }, {
        "text": "arthria (a motor speech disorder).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBroca\u0027s Aphasia ("
      }, {
        "text": "Expressive):\u003c/b\u003e Lesion in the inferior frontal gyrus ([[a3bbace2|Broca\u0027s area"
      }, {
        "text": "]]). Characterized by \u003cmark\u003enonfluent, telegraphic speech\u003c/mark\u003e with intact comprehension. Patients are often frustrated"
      }, {
        "text": " by their inability to speak. Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken"
      }, {
        "text": " \u003cb\u003eB\u003c/b\u003eoca (mouth).\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke\u0027s Aphasia (Receptive):\u003c/b\u003e Les"
      }, {
        "text": "ion in the superior temporal gyrus ([[wernicke_area|Wernicke\u0027s area]]). Characterized by \u003cmark\u003efluent"
      }, {
        "text": " but meaningless speech\u003c/mark\u003e (word salad) with severely impaired comprehension. Patients are often unaware of their deficit (anosognosia).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eConduction Aphasia:\u003c/b\u003e Lesion of the \u003cmark\u003earcuate fasciculus\u003c/mark\u003e,"
      }, {
        "text": " which connects Broca\u0027s and Wernicke\u0027s areas. Hallmark is poor repetition despite fluent speech and intact comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlobal"
      }, {
        "text": " Aphasia:\u003c/b\u003e Large lesion affecting both Broca\u0027s and Wernicke\u0027s areas, typically from a large [["
      }, {
        "text": "143bb23d|MCA stroke]]. All language functions (fluency, comprehension, repetition) are severely impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The most common cause of aphasia is an ischemic [[c5da3c57|stroke]] in the territory"
      }, {
        "text": " of the left [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eAphasia\u003c/b\u003e is a disorder of language, not speech mechanics, with distinct subtypes that can be precisely localized within"
      }, {
        "text": " the dominant cerebral hemisphere: Broca\u0027s area for production, Wernicke\u0027s area for comprehension, and the arcuate fascicul"
      }, {
        "text": "us for repetition.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left MCA Stroke] --\u003e B{"
      }, {
        "text": "Aphasia Types}; B --\u003e C[Broca\u0027s - Nonfluent, Good Comprehension]; B --\u003e D[W"
      }, {
        "text": "ernicke\u0027s - Fluent, Poor Comprehension]; B --\u003e E[Conduction - Poor Repetition]; B --\u003e F[Global - All"
      }, {
        "text": " Impaired];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes_type\",\n        \"to\": \"7f6ed344\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes_type\",\n        \"to\": \"2c4a6130\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes_type\",\n        \"to\": \"1ae850fe\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"1a804e11\": {\n    \"title\": \"Apoptosis\",\n    \"primary"
      }, {
        "text": "Type\": \"physiology\",\n    \"tags\": [\n      \"Cell Biology\",\n      \"Pathology\",\n      \"Physiology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Cellular Injury\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAp"
      }, {
        "text": "optosis\u003c/b\u003e is a form of programmed cell death that is a highly regulated and controlled process, essential for normal tissue turnover, embryonic"
      }, {
        "text": " development, and removal of damaged or infected cells. In the context of neurology, it is the primary mechanism of neuronal death"
      }, {
        "text": " in many neurodegenerative diseases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Features:\u003c/b\u003e Character"
      }, {
        "text": "ized by cell shrinkage, chromatin condensation (pyknosis), membrane blebbing, and formation of apoptotic bodies, which are then phagocytosed."
      }, {
        "text": " It is an ATP-dependent process and does \u003cu\u003enot\u003c/u\u003e induce inflammation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathways:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eIntrinsic (Mitochondrial):\u003c/b\u003e Activated by cellular stress (e.g., DNA damage,"
      }, {
        "text": " misfolded proteins). Regulated by the Bcl-2 family of proteins. Pro-apoptotic proteins (Bax, Bak"
      }, {
        "text": ") create pores in the mitochondrial membrane, releasing cytochrome c, which activates caspases.\u003cbr\u003e - \u003cb\u003eExtrinsic ("
      }, {
        "text": "Death Receptor):\u003c/b\u003e Activated by external ligands (e.g., FasL, TNF-Œ±) binding to death receptors on the cell surface,"
      }, {
        "text": " directly activating caspases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCaspases:\u003c/b\u003e The central executioners of apoptosis are a family of cysteine proteases called"
      }, {
        "text": " caspases, which orchestrate the degradation of cellular components.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Relevance:\u003c/b\u003e Apoptosis of"
      }, {
        "text": " lower motor neurons is a key feature of [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]."
      }, {
        "text": " It is also the mechanism of neuronal loss in [[ffd7e743|Huntington disease]] and [[58c8ea03|"
      }, {
        "text": "Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Contrast apoptosis with necrosis. Necrosis is uncontrolled cell death due"
      }, {
        "text": " to injury, causing cell swelling, membrane rupture, and inflammation. Apoptosis is clean, programmed, and non-inflammatory."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eApoptosis\u003c/b\u003e is the cell\u0027s intrinsic suicide program"
      }, {
        "text": ", executed by caspases, which neatly packages the cell for disposal without triggering an inflammatory response; its dysregulation is a central"
      }, {
        "text": " theme in both cancer (too little apoptosis) and neurodegeneration (too much apoptosis).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A{Cellular Stress} --\u003e B(Intrinsic Pathway); B --\u003e C(Mitochondria); C --Cy"
      }, {
        "text": "tochrome c--\u003e D; E{Death Ligands} --\u003e F(Extrinsic Pathway); F --\u003e D(Caspase Activation); D --\u003e G("
      }, {
        "text": "Execution Phase); G --\u003e H(Apoptotic Body Formation);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_mechanism_of_cell_death_in\",\n        \"to\": \"4ed629f9\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_mechanism_of_cell_death_in\",\n"
      }, {
        "text": "        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_contr"
      }, {
        "text": "asted_with\",\n        \"to\": \"necrosis\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"c1f67280\": {\n    \"title\": \"Apraclonidine\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eApraclonidine\u003c/b\u003e is an \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist"
      }, {
        "text": "\u003c/i\u003e used topically in ophthalmology to lower intraocular pressure (IOP), primarily for the short-term treatment of [[3"
      }, {
        "text": "ce6c035|glaucoma]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e As a selective Œ±\u003csub\u003e2\u003c/sub\u003e-agonist, it acts on presynaptic Œ±\u003csub\u003e2\u003c/sub\u003e receptors"
      }, {
        "text": " in the ciliary body to \u003cmark\u003edecrease aqueous humor synthesis\u003c/mark\u003e. It also has some minor effect on increasing uve"
      }, {
        "text": "oscleral outflow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to lower IOP in patients with [[5ea7b7"
      }, {
        "text": "41|open-angle glaucoma]]. It is particularly useful for preventing post-surgical IOP spikes. Its use is often"
      }, {
        "text": " limited to the short term due to tachyphylaxis (diminishing response).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e O"
      }, {
        "text": "cular side effects include blurry vision, ocular hyperemia (redness), foreign body sensation, and ocular allergic reactions. Systemic side"
      }, {
        "text": " effects are rare but can include dry mouth and fatigue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Similar to [[brimonidine]],"
      }, {
        "text": " another Œ±\u003csub\u003e2\u003c/sub\u003e-agonist used for glaucoma, but apraclonidine has a higher rate of tachyphylaxis and allergic reactions.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e-agonists (like apraclonidine and clonidine) work"
      }, {
        "text": " by reducing sympathetic outflow. In the eye, this translates to decreased production of aqueous humor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eApraclonidine\u003c/b\u003e lowers intraocular pressure by acting as a \u0027brake\u0027 on aqueous humor production"
      }, {
        "text": ", stimulating Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the ciliary body to reduce fluid synthesis, making it a useful agent"
      }, {
        "text": " for short-term management of glaucoma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Apraclonidine] --\u003e B(Stim"
      }, {
        "text": "ulates Œ±2 Receptors in Ciliary Body); B --\u003e C(‚Üì Norepinephrine Release); C --\u003e D(‚Üì Aqueous"
      }, {
        "text": " Humor Synthesis); D --\u003e E(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"alpha_2_agonist\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"has_similar_mechanism_to\",\n        \"to\": \"2"
      }, {
        "text": "fcee185\"\n      }\n    ]\n  },\n  \"eb32eb82\": {\n    \"title\":"
      }, {
        "text": " \"Gait Apraxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Gait Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGait apraxia\u003c/b\u003e is a high-level gait"
      }, {
        "text": " disorder characterized by the inability to properly coordinate the motor sequences for walking, despite having normal motor, sensory, and cerebellar function. It is often"
      }, {
        "text": " described as a \u003cmark\u003e\\\"magnetic gait,\\\"\u003c/mark\u003e where the feet appear stuck to the floor.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients have difficulty initiating walking. The gait is wide-based, shuffling, and slow,"
      }, {
        "text": " with the feet barely leaving the ground. Turning is particularly difficult and requires multiple small steps.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It"
      }, {
        "text": " is considered a disorder of the frontal lobes or their connections, disrupting the cortical control of locomotion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association"
      }, {
        "text": ":\u003c/b\u003e Gait apraxia is one of the three cardinal signs of \u003cmark\u003e[[7c59030"
      }, {
        "text": "e|Normal Pressure Hydrocephalus (NPH)]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNPH Triad:\u003c/b\u003e The classic"
      }, {
        "text": " triad is \\\"\u003cb\u003eW\u003c/b\u003eobbly, \u003cb\u003eW\u003c/b\u003eacky, and \u003cb\u003eW\u003c/b\u003eet\\\":\u003cbr\u003e1. \u003cb\u003eWobbly"
      }, {
        "text": ":\u003c/b\u003e Gait apraxia.\u003cbr\u003e2. \u003cb\u003eWacky:\u003c/b\u003e Cognitive dysfunction/dementia.\u003cbr\u003e3."
      }, {
        "text": " \u003cb\u003eWet:\u003c/b\u003e Urinary incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The description of a \u0027magnetic\u0027 or \u0027"
      }, {
        "text": "feet stuck to the floor\u0027 gait in an elderly patient, especially when combined with cognitive changes and urinary incontinence, is a"
      }, {
        "text": " classic vignette for [[7c59030e|Normal Pressure Hydrocephalus]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eGait apraxia\u003c/b\u003e is a \u0027brain\u0027 problem, not a \u0027leg\u0027 problem;"
      }, {
        "text": " it represents a failure of the frontal lobe\u0027s motor programming for walking, famously manifesting as the \u0027magnetic\u0027 gait of [["
      }, {
        "text": "7c59030e|Normal Pressure Hydrocephalus]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\":"
      }, {
        "text": " \"7c59030e\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by_lesion_in\",\n        \"to\": \"frontal_lobe\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"d595b0bf\": {\n    \"title\": \"Aqueous Humor Pathway\",\n    "
      }, {
        "text": "\"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"An"
      }, {
        "text": "atomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAqueous Humor Pathway\u003c/b\u003e describes the continuous production,"
      }, {
        "text": " circulation, and drainage of aqueous humor, the clear fluid that fills the anterior and posterior chambers of the eye. The balance between production and drainage determines"
      }, {
        "text": " the intraocular pressure (IOP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eProduction:\u003c/b\u003e"
      }, {
        "text": " Aqueous humor is produced by the \u003cmark\u003enonpigmented epithelium of the ciliary body\u003c/mark\u003e. This process is decreased"
      }, {
        "text": " by Œ≤-blockers, Œ±\u003csub\u003e2\u003c/sub\u003e-agonists, and carbonic anhydrase inhibitors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCirculation:\u003c/b\u003e Fluid"
      }, {
        "text": " flows from the posterior chamber, through the pupil, into the anterior chamber.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage Pathways:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003eTrabecular Outflow (~90%):\u003c/b\u003e Fluid drains through the trabecular meshwork,"
      }, {
        "text": " into the Canal of Schlemm, and then into the episcleral vasculature. This pathway is enhanced by muscarinic agonists (e.g.,"
      }, {
        "text": " pilocarpine).\u003cbr\u003e2. \u003cb\u003eUveoscleral Outflow (~10%):\u003c/b\u003e Fluid"
      }, {
        "text": " drains through the ciliary muscle and into the uveal and scleral tissues. This pathway is enhanced by prostaglandin analogs (e.g.,"
      }, {
        "text": " latanoprost).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Imbalance in this pathway leads to [[3ce6c035|"
      }, {
        "text": "glaucoma]]. [[5ea7b741|Open-angle glaucoma]] involves increased resistance in the trabecular mesh"
      }, {
        "text": "work, while [[9c80344d|angle-closure glaucoma]] involves physical obstruction of the angle"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand how different glaucoma medications target this pathway. Prostaglandins increase uve"
      }, {
        "text": "oscleral outflow, while Œ≤-blockers and acetazolamide decrease production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eAqueous Humor Pathway\u003c/b\u003e is a dynamic circulatory system within the eye\u0027s anterior segment, where a"
      }, {
        "text": " delicate equilibrium between ciliary body production and dual-route (trabecular and uveoscleral) drainage is essential for"
      }, {
        "text": " maintaining normal intraocular pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ciliary Body Epithelium] --"
      }, {
        "text": "Produces--\u003e B(Aqueous Humor); B --\u003e C(Posterior Chamber); C --\u003e D(Anterior Chamber); D --\u003e E{"
      }, {
        "text": "Drainage}; E --\u003e F[Trabecular Outflow (90%)]; F --\u003e G[Canal of Schlemm]; E --\u003e"
      }, {
        "text": " H[Uveoscleral Outflow (10%)];\"\n    },\n    \"connections\": ["
      }, {
        "text": "\n      {\n        \"type\": \"is_dysregulated_in\",\n        \"to\": \"3ce6c03"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\":"
      }, {
        "text": " \"glaucoma_drugs\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1IUj4vb-O4WV4f0wAQiP7WMlD2b7S96t3"
      },
      "role": "user",
      "tokenCount": 1890
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"b7b67074\": {\n    \"title\": \"Arachnoid Granulations\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eArachnoid granulations\u003c/b\u003e (or arachnoid villi) are microscopic protrusions of the [[46e279b9|arachnoid mater]] through the dura mater into the superior sagittal sinus and other [[21f1c955|dural venous sinuses]], functioning as one-way valves for the drainage of cerebrospinal fluid (CSF) from the subarachnoid space into the venous circulation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The primary site for \u003cmark\u003eCSF reabsorption\u003c/mark\u003e into the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e CSF flows from the subarachnoid space into the venous sinus down a pressure gradient. The structure acts as a one-way valve, preventing venous blood from entering the subarachnoid space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most numerous along the \u003cmark\u003esuperior sagittal sinus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Impaired function or obstruction of arachnoid granulations (e.g., from scarring after meningitis or subarachnoid hemorrhage) can lead to \u003cmark\u003e[[aa4115c7|communicating hydrocephalus]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that CSF is produced by the choroid plexus and reabsorbed by the arachnoid granulations. A problem with reabsorption (communicating hydrocephalus) is distinct from a blockage of flow within the ventricles (non-communicating hydrocephalus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eArachnoid granulations\u003c/b\u003e are the critical drainage ports for cerebrospinal fluid, acting as sophisticated one-way valves that allow CSF to exit the subarachnoid space and return to the venous system, thereby maintaining intracranial pressure homeostasis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --Produces--\u003e B(CSF); B --\u003e C(Ventricular System); C --\u003e D(Subarachnoid Space); D --\u003e E(Arachnoid Granulations); E --Reabsorption--\u003e F[Dural Venous Sinuses];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_involved_in_reabsorption_of\",\n        \"to\": \"7109d8b6\"\n      },\n      {\n        \"type\": \"is_a_protrusion_of\",\n        \"to\": \"46e279b9\"\n      },\n      {\n        \"type\": \"dysfunction_causes\",\n        \"to\": \"aa4115c7\"\n      },\n      {\n        \"type\": \"drains_into\",\n        \"to\": \"21f1c955\"\n      }\n    ]\n  },\n  \"46e279b9\": {\n    \"title\": \"Arachnoid Mater\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eArachnoid Mater\u003c/b\u003e is the middle layer of the three meninges that surround the brain and spinal cord. It is a delicate, avascular membrane located between the outer [[5bbe3597|dura mater]] and the inner [[pia_mater|pia mater]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of a web-like network of collagen and elastic fibers, from which it gets its name (from Greek \u0027arachne\u0027 for spider).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryologic Origin:\u003c/b\u003e Derived from the [[14c6f2a7|neural crest]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubarachnoid Space:\u003c/b\u003e The space between the arachnoid mater and the pia mater is the \u003cmark\u003esubarachnoid space\u003c/mark\u003e, which contains cerebrospinal fluid (CSF) and major cerebral blood vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eArachnoid Granulations:\u003c/b\u003e Protrusions of the arachnoid mater through the dura into the superior sagittal sinus, responsible for CSF reabsorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Rupture of an artery in the subarachnoid space (e.g., from a berry aneurysm) causes a [[63f8b05f|subarachnoid hemorrhage]]. A [[e98ea0ba|meningioma]], a common benign brain tumor, arises from arachnoid cap cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eArachnoid Mater\u003c/b\u003e forms a crucial boundary, creating the subarachnoid space that houses the CSF and cerebral vasculature, and its specialized granulations are essential for CSF drainage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Skull] --\u003e B[Dura Mater]; B --\u003e C(Arachnoid Mater); C --\u003e D[Subarachnoid Space - CSF]; D --\u003e E[Pia Mater]; E --\u003e F[Brain];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_layer_of\",\n        \"to\": \"meninges\"\n      },\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \"5bbe3597\"\n      },\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \"pia_mater\"\n      },\n      {\n        \"type\": \"gives_rise_to\",\n        \"to\": \"e98ea0ba\"\n      }\n    ]\n  },\n  \"5dd343d3\": {\n    \"title\": \"Area Postrema\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eArea Postrema\u003c/b\u003e is a highly vascularized structure in the medulla oblongata, located on the floor of the fourth ventricle, that functions as the \u003cmark\u003echemoreceptor trigger zone (CTZ)\u003c/mark\u003e for vomiting. It is one of the circumventricular organs, meaning it lacks a complete [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Dorsal surface of the medulla oblongata at the caudal end of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Detects emetogenic toxins in the blood and CSF and sends signals to the [[74b651ab|vomiting center]] (nucleus tractus solitarius) to induce emesis (vomiting).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier:\u003c/b\u003e Its fenestrated capillaries allow it to directly sample the chemical composition of the blood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Rich in various receptors, including dopamine D\u003csub\u003e2\u003c/sub\u003e, serotonin 5-HT\u003csub\u003e3\u003c/sub\u003e, and neurokinin-1 (NK-1) receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e This is the site of action for many antiemetic drugs. For example, [[ondansetron]] is a 5-HT\u003csub\u003e3\u003c/sub\u003e antagonist, and [[metoclopramide]] is a D\u003csub\u003e2\u003c/sub\u003e antagonist. It is also the area stimulated by toxins during chemotherapy, leading to chemotherapy-induced nausea and vomiting.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eArea Postrema\u003c/b\u003e serves as the brain\u0027s chemical surveillance system for the blood; its lack of a blood-brain barrier allows it to detect toxins and trigger the protective reflex of vomiting, making it a key target for antiemetic medications.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Emetogenic Toxins in Blood] --\u003e B(Area Postrema/CTZ); B --\u003e C(Vomiting Center - NTS); C --\u003e D(Vomiting Reflex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a\",\n        \"to\": \"circumventricular_organ\"\n      },\n      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"chemoreceptor_trigger_zone\"\n      },\n      {\n        \"type\": \"sends_signals_to\",\n        \"to\": \"74b651ab\"\n      },\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"ondansetron\"\n      }\n    ]\n  },\n  \"08cb577f\": {\n    \"title\": \"Argyll Robertson Pupil\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eArgyll Robertson Pupil\u003c/b\u003e is a specific type of pupillary abnormality characterized by bilateral small pupils that constrict when the patient focuses on a near object (accommodation reflex) but do \u003cu\u003enot\u003c/u\u003e constrict when exposed to bright light (light reflex). This phenomenon is known as \u003cmark\u003elight-near dissociation\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Mnemonic:\u003c/b\u003e Often called the \\\"prostitute\u0027s pupil\\\" because it \\\"accommodates but does not react.\\\"\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion is thought to be in the \u003cmark\u003epretectal nucleus\u003c/mark\u003e in the superior colliculus of the midbrain, which interrupts the afferent limb of the pupillary light reflex pathway before it reaches the Edinger-Westphal nuclei bilaterally. The pathway for accommodation, which is more complex and involves the cerebral cortex, is spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e It is a highly specific sign of late-stage, or tertiary, \u003cmark\u003eneurosyphilis\u003c/mark\u003e, particularly [[71daebd6|tabes dorsalis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e While classic for syphilis, it can also be seen in other conditions causing midbrain lesions, such as diabetes mellitus or Parinaud syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ataxia, a positive Romberg sign, and pupils that accommodate but don\u0027t react to light is a classic presentation of [[71daebd6|tabes dorsalis]] due to neurosyphilis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eArgyll Robertson Pupil\u003c/b\u003e is a pathognomonic sign of neurosyphilis, representing a selective lesion in the midbrain that disconnects the pupillary light reflex pathway while preserving the separate, cortically-driven accommodation pathway, resulting in the classic light-near dissociation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light] --\u003e B(Optic Nerve); B --\u003e C(Pretectal Nucleus); C --x Lesion; C --x D(Edinger-Westphal Nucleus); E[Near Object] --\u003e F(Visual Cortex); F --\u003e G(Accommodation Pathway); G --\u003e D; D --\u003e H(Pupillary Constriction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"neurosyphilis\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"pretectal_nucleus\"\n      },\n      {\n        \"type\": \"is_an_example_of\",\n        \"to\": \"light_near_dissociation\"\n      }\n    ]\n  },\n  \"09db7b12\": {\n    \"title\": \"Aspirin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Stroke Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAspirin\u003c/b\u003e (acetylsalicylic acid) is a nonsteroidal anti-inflammatory drug (NSAID) that irreversibly inhibits cyclooxygenase (COX) enzymes, primarily used at low doses for its antiplatelet effects in the prevention of cardiovascular and cerebrovascular events.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e \u003cu\u003eIrreversibly\u003c/u\u003e acetylates and inhibits both COX-1 and COX-2. Its antiplatelet effect is due to inhibition of COX-1 in platelets, which blocks the synthesis of \u003cmark\u003eThromboxane A\u003csub\u003e2\u003c/sub\u003e (TXA\u003csub\u003e2\u003c/sub\u003e)\u003c/mark\u003e, a potent promoter of platelet aggregation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for secondary prevention of [[c5da3c57|ischemic stroke]] and [[623ba776|transient ischemic attacks (TIAs)]]. It is a cornerstone of antiplatelet therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e GI distress (gastritis, ulcers), bleeding, tinnitus (a sign of toxicity), and Reye syndrome in children with viral illness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReye Syndrome:\u003c/b\u003e A rare but severe condition of acute encephalopathy and fatty liver failure in children given aspirin for a viral infection (e.g., influenza, varicella). \u003cu\u003eAspirin is contraindicated in children\u003c/u\u003e for this reason (except in Kawasaki disease).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The irreversibility of aspirin\u0027s effect on platelets is key. Since platelets lack a nucleus, they cannot synthesize new COX enzyme, so the antiplatelet effect lasts for the life of the platelet (~7-10 days).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAspirin\u0027s\u003c/b\u003e primary role in stroke prevention stems from its unique ability to \u003cu\u003eirreversibly\u003c/u\u003e inhibit platelet COX-1, effectively silencing thromboxane A\u003csub\u003e2\u003c/sub\u003e production for the platelet\u0027s entire lifespan and thus reducing the risk of thrombotic occlusion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Aspirin] --Irreversibly Inhibits--\u003e B(Platelet COX-1); B --x C(Arachidonic Acid -\u003e Thromboxane A2); C --x D(Platelet Aggregation); D --x E(Thrombus Formation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"prevents\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"prevents\",\n        \"to\": \"623ba776\"\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"cyclooxygenase\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"reye_syndrome\"\n      }\n    ]\n  },\n  \"b564ac97\": {\n    \"title\": \"Asterixis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Gastroenterology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAsterixis\u003c/b\u003e is a type of negative myoclonus characterized by a brief, flapping tremor of the hands, typically elicited by having the patient extend their arms and dorsiflex their wrists. It is a classic sign of metabolic encephalopathy.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e The patient holds their arms out with wrists extended (\u0027stop traffic\u0027 pose). The \u0027flap\u0027 is a sudden, brief loss of postural tone, causing the hands to drop, followed by a rapid, jerky return to the original position.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is not a true tremor but a failure of the brain to maintain a sustained posture, thought to be due to abnormal function of the diencephalic motor centers that regulate posture and tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e Most commonly associated with \u003cmark\u003ehepatic encephalopathy\u003c/mark\u003e due to liver failure, where high ammonia levels are neurotoxic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in other metabolic encephalopathies, including uremia (renal failure), CO\u003csub\u003e2\u003c/sub\u003e narcosis (hypercapnia), and drug intoxication. It is also a feature of [[wilson_disease|Wilson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of cirrhosis who presents with confusion and a \u0027flapping tremor\u0027 of the hands has hepatic encephalopathy. The tremor is asterixis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAsterixis\u003c/b\u003e is a \u0027negative\u0027 movement disorder‚Äîa brief lapse in muscle tone rather than an active contraction‚Äîthat serves as a crucial physical exam finding for metabolic encephalopathies, most classically hepatic encephalopathy from hyperammonemia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"hepatic_encephalopathy\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"uremia\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"wilson_disease\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"myoclonus\"\n      }\n    ]\n  },\n  \"18cff34e\": {\n    \"title\": \"Astigmatism\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Refractive Errors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAstigmatism\u003c/b\u003e is a common refractive error of the eye where vision is blurred or distorted at all distances. It occurs when the cornea or lens has an irregular, non-spherical curvature, causing light rays to focus at multiple points rather than a single point on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The cornea, which should be shaped like a sphere, is instead shaped more like a football (toric). This causes light entering the eye to have different focal points in different planes (e.g., vertical vs. horizontal).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Blurred or distorted vision, eye strain, and headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Diagnosed during a standard eye exam using a phoropter and keratometer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with eyeglasses or contact lenses that have a \u003cmark\u003ecylindrical lens\u003c/mark\u003e to compensate for the irregular curvature. It can also be corrected with refractive surgery (e.g., LASIK).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from other refractive errors: [[myopia|myopia]] (nearsightedness) and [[hyperopia|hyperopia]] (farsightedness) are caused by the length of the eyeball relative to its focusing power, while astigmatism is caused by an irregularly shaped cornea or lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAstigmatism\u003c/b\u003e is a refractive error caused by an asymmetrically shaped cornea or lens, which acts like a warped mirror, scattering light to multiple focal points and resulting in blurred vision that requires a cylindrical lens for correction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"refractive_error\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"myopia\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"hyperopia\"\n      }\n    ]\n  },\n  \"8192f595\": {\n    \"title\": \"Astrocytes\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAstrocytes\u003c/b\u003e are the most abundant type of glial cell in the central nervous system. These star-shaped cells perform a wide variety of essential supportive and homeostatic functions for neurons, and are the origin of the most common primary brain tumor in adults, [[b6bbd0bc|glioblastoma]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e Physical support for neurons, repair (gliosis/scar formation), component of the [[dd47b9cc|blood-brain barrier]] (via foot processes), removal of excess neurotransmitters (especially glutamate), and maintenance of the ionic environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistological Marker:\u003c/b\u003e They are identified by their expression of \u003cmark\u003eGlial Fibrillary Acidic Protein (GFAP)\u003c/mark\u003e, an intermediate filament protein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReactive Gliosis:\u003c/b\u003e In response to CNS injury (e.g., stroke, trauma), astrocytes proliferate and hypertrophy to form a \u003cmark\u003eglial scar\u003c/mark\u003e, which walls off the damaged area but can also impede axonal regeneration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTumor Origin:\u003c/b\u003e Astrocytes are the cell of origin for astrocytomas, including the highly malignant [[b6bbd0bc|glioblastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember GFAP as the key marker for astrocytes and astrocytic tumors. The formation of a glial scar by astrocytes is the CNS equivalent of fibrosis in other tissues.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAstrocytes\u003c/b\u003e are the indispensable \u0027housekeepers\u0027 of the CNS, providing structural, metabolic, and homeostatic support to neurons, forming the blood-brain barrier, and orchestrating the glial scar response to injury, but they can also give rise to the most aggressive brain tumors.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Astrocyte]; A --\u003e B(Physical Support); A --\u003e C(Blood-Brain Barrier); A --\u003e D(Neurotransmitter Uptake); A --\u003e E(Ion Buffering); A --\u003e F(Repair/Gliosis); A --Neoplastic Transformation--\u003e G(Astrocytoma/Glioblastoma);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"glial_cell\"\n      },\n      {\n        \"type\": \"expresses_marker\",\n        \"to\": \"fb50d450\"\n      },\n      {\n        \"type\": \"is_cell_of_origin_for\",\n        \"to\": \"b6bbd0bc\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"glial_scar\"\n      }\n    ]\n  },\n  \"9767fd6b\": {\n    \"title\": \"Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtaxia\u003c/b\u003e is a neurological sign consisting of a lack of voluntary coordination of muscle movements, leading to a clumsy, unsteady gait and impaired balance. It can be caused by damage to the cerebellum, the vestibular system, or sensory pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCerebellar Ataxia:\u003c/b\u003e Caused by damage to the cerebellum. \u003cbr\u003e - \u003cb\u003eTruncal Ataxia:\u003c/b\u003e Affects the midline, causing an unsteady, wide-based (\u0027drunken sailor\u0027) gait. Associated with lesions of the cerebellar vermis.\u003cbr\u003e - \u003cb\u003eLimb Ataxia:\u003c/b\u003e Affects the extremities, causing dysmetria (overshooting/undershooting targets) and intention tremor. Associated with lesions of the cerebellar hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Ataxia:\u003c/b\u003e Caused by loss of proprioception, typically from damage to the [[e7f5cbbe|dorsal columns]] of the spinal cord or peripheral nerves. Patients have a positive [[47a0f3d1|Romberg sign]] (worsening of balance with eyes closed) and a stomping gait. Seen in [[71daebd6|tabes dorsalis]] and [[6f5bea90|subacute combined degeneration]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eVestibular Ataxia:\u003c/b\u003e Caused by dysfunction of the vestibular system. Associated with vertigo, nystagmus, and nausea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating the type of ataxia is key. A positive [[47a0f3d1|Romberg sign]] points to a sensory (dorsal column) cause, not a cerebellar cause. Patients with cerebellar ataxia are unsteady with their eyes open or closed.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtaxia\u003c/b\u003e is a sign of discoordination that can be localized by its characteristics: truncal and limb incoordination points to the cerebellum, a positive Romberg sign points to sensory loss in the dorsal columns, and associated vertigo points to the vestibular system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"cerebellar_lesion\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"dorsal_column_lesion\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"vestibular_dysfunction\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"71daebd6\"\n      }\n    ]\n  },\n  \"19272e70\": {\n    \"title\": \"Athetosis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAthetosis\u003c/b\u003e is a type of involuntary movement disorder characterized by slow, writhing, snake-like movements, particularly affecting the distal extremities (fingers and hands). It is a symptom of damage to the [[ed462927|basal ganglia]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Slow, twisting, and writhing movements that are continuous and non-rhythmic. It is often described as being \u0027snake-like.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by lesions in the [[ed462927|basal ganglia]], particularly the striatum (caudate and putamen).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e Athetosis is a characteristic feature of [[ffd7e743|Huntington disease]], where it often co-occurs with chorea (termed choreoathetosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in conditions like cerebral palsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When you see a description of slow, writhing, \u0027snake-like\u0027 movements of the fingers in a patient with other signs of a basal ganglia disorder (like chorea or dementia), think of athetosis, especially in the context of [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAthetosis\u003c/b\u003e is a specific and visually distinct sign of basal ganglia dysfunction, representing a failure of motor control that manifests as slow, ceaseless, writhing movements, most classically seen in [[ffd7e743|Huntington disease]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dyskinesia\"\n      }\n    ]\n  },\n  \"ed7a236f\": {\n    \"title\": \"Atonic Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtonic seizures\u003c/b\u003e, also known as \\\"drop attacks\\\" or \\\"drop seizures,\\\" are a type of generalized seizure characterized by a sudden loss of muscle tone, causing the individual to collapse to the ground. The loss of consciousness is typically very brief.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A sudden, complete loss of postural muscle tone lasting 1-2 seconds. This can cause the head to drop, the jaw to slacken, or the entire body to fall limply to the floor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk of Injury:\u003c/b\u003e There is a high risk of head and facial injuries from the sudden falls. Patients may need to wear protective helmets.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndromes:\u003c/b\u003e While they can occur in various epilepsy syndromes, atonic seizures are a hallmark feature of \u003cmark\u003eLennox-Gastaut syndrome\u003c/mark\u003e, a severe form of childhood epilepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Findings:\u003c/b\u003e The EEG may show brief, generalized spike-and-wave discharges followed by diffuse slow waves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a child with developmental delay who has multiple seizure types, including sudden falls leading to injury, is highly suggestive of Lennox-Gastaut syndrome, with atonic seizures being a key component.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtonic seizures\u003c/b\u003e are dramatic \u0027drop attacks\u0027 caused by a sudden, global loss of muscle tone, posing a significant risk of injury and often signaling a severe underlying epilepsy syndrome like Lennox-Gastaut.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"lennox_gastaut_syndrome\"\n      }\n    ]\n  },\n  \"52194edb\": {\n    \"title\": \"Atracurium\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtracurium\u003c/b\u003e is a non-depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e used in anesthesia to induce skeletal muscle relaxation and paralysis, facilitating endotracheal intubation and surgical procedures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing [[6a005559|acetylcholine]] from binding and causing muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Undergoes \u003cmark\u003eHoffmann elimination\u003c/mark\u003e, a spontaneous, non-enzymatic degradation at physiological pH and temperature. This makes its metabolism independent of liver or kidney function.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Ideal for patients with \u003cmark\u003erenal or hepatic failure\u003c/mark\u003e because its elimination does not depend on these organs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause histamine release, leading to hypotension, flushing, and bronchoconstriction. Its metabolite, laudanosine, can lower the seizure threshold, but this is rarely clinically significant.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The neuromuscular blockade can be reversed by [[acetylcholinesterase_inhibitors|acetylcholinesterase inhibitors]] (e.g., neostigmine), which increase the concentration of acetylcholine in the synaptic cleft to outcompete the blocker.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature of atracurium (and its stereoisomer, cisatracurium) is its Hoffmann elimination, making it the neuromuscular blocker of choice for patients with organ dysfunction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtracurium\u003c/b\u003e is a non-depolarizing neuromuscular blocker distinguished by its unique Hoffmann elimination pathway, a spontaneous chemical breakdown that makes it a safe and predictable choice for inducing paralysis in patients with kidney or liver disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Atracurium] --Competitively Antagonizes--\u003e B(Nicotinic ACh Receptors); B --x C(ACh Binding); C --x D(Muscle Contraction); A --Hoffmann Elimination--\u003e E(Inactive Metabolites);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"undergoes\",\n        \"to\": \"hoffmann_elimination\"\n      },\n      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"acetylcholinesterase_inhibitors\"\n      }\n    ]\n  },\n  \"0c2b4642\": {\n    \"title\": \"Atrophy\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Pathology\",\n      \"Cell Biology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cellular Adaptations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtrophy\u003c/b\u003e is a cellular adaptation characterized by a decrease in the size of a cell, organ, or tissue after it has reached its normal mature size. It results from a decrease in cell substance and can be either physiologic or pathologic.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Atrophy occurs via a decrease in protein synthesis and an increase in protein degradation. The main pathway for protein degradation is the \u003cmark\u003eubiquitin-proteasome pathway\u003c/mark\u003e. It can also involve autophagy, where the cell digests its own components.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Common causes include disuse, denervation, loss of endocrine stimulation, inadequate nutrition, and ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Relevance (Denervation Atrophy):\u003c/b\u003e When a muscle loses its nerve supply (denervation), it undergoes rapid and profound atrophy. This is a key sign of a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN vs. LMN Lesions:\u003c/b\u003e Significant muscle atrophy is a hallmark of LMN lesions (e.g., polio, [[4ed629f9|ALS]], peripheral nerve injury). In contrast, upper motor neuron (UMN) lesions cause only mild disuse atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a clinical vignette, the presence of marked muscle wasting (atrophy) and fasciculations strongly points towards an LMN component of a disease process.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtrophy\u003c/b\u003e is a reduction in cell size and substance, most often driven by the ubiquitin-proteasome pathway. In neurology, denervation atrophy is a critical sign that localizes a lesion to the lower motor neuron, distinguishing it from upper motor neuron pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cellular_adaptation\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"ubiquitin_proteasome_pathway\"\n      }\n    ]\n  },\n  \"b1873d5b\": {\n    \"title\": \"Auditory Anatomy and Physiology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Otology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy and Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAuditory anatomy and physiology\u003c/b\u003e describes the structures and mechanisms by which sound waves are collected, transmitted, transduced into neural signals, and processed by the brain to produce the sensation of hearing.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOuter Ear:\u003c/b\u003e The pinna and external auditory canal collect sound waves and funnel them to the tympanic membrane (eardrum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMiddle Ear:\u003c/b\u003e An air-filled cavity containing the ossicles (malleus, incus, stapes). The ossicles amplify the vibrations from the tympanic membrane and transmit them to the oval window of the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInner Ear:\u003c/b\u003e The [[001c359f|cochlea]], a fluid-filled, snail-shaped structure, contains the organ of Corti. Vibrations from the stapes create pressure waves in the cochlear fluid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransduction:\u003c/b\u003e These pressure waves cause the basilar membrane to vibrate at specific locations depending on the frequency (tonotopy). High frequencies vibrate the base, low frequencies vibrate the apex. This vibration bends the stereocilia of hair cells in the organ of Corti, opening ion channels and generating a neural signal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Pathway:\u003c/b\u003e The signal travels from the hair cells via the cochlear nerve (part of CN VIII) to the cochlear nuclei in the brainstem, then through a complex pathway (superior olive, lateral lemniscus, inferior colliculus, medial geniculate nucleus of the thalamus) to the [[d24b6af6|auditory cortex]] in the temporal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe auditory system is a remarkable transducer, converting mechanical energy (sound waves) into mechanical vibration (ossicles), then into hydraulic waves (cochlear fluid), and finally into electrical signals (hair cells) that the brain interprets as sound.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sound Waves] --\u003e B(Outer Ear); B --\u003e C(Tympanic Membrane); C --\u003e D(Middle Ear Ossicles); D --\u003e E(Oval Window); E --\u003e F(Cochlear Fluid); F --\u003e G(Basilar Membrane Vibration); G --\u003e H(Hair Cell Transduction); H --\u003e I(CN VIII); I --\u003e J(Brain); \"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_structure\",\n        \"to\": \"001c359f\"\n      },\n      {\n        \"type\": \"involves_structure\",\n        \"to\": \"vestibulocochlear_nerve\"\n      },\n      {\n        \"type\": \"culminates_in\",\n        \"to\": \"d24b6af6\"\n      }\n    ]\n  },\n  \"d24b6af6\": {\n    \"title\": \"Auditory Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAuditory Cortex\u003c/b\u003e is the region of the cerebral cortex responsible for processing auditory information. It is located in the superior temporal gyrus of the temporal lobe and includes the primary auditory cortex (Brodmann areas 41 and 42) and surrounding auditory association areas.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Superior temporal gyrus in the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The primary auditory cortex is responsible for the perception of basic sound characteristics like pitch and volume. The surrounding association areas, including [[wernicke_area|Wernicke\u0027s area]] in the dominant hemisphere, are involved in the interpretation and comprehension of complex sounds, particularly speech.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e It receives its primary input from the \u003cmark\u003emedial geniculate nucleus (MGN)\u003c/mark\u003e of the [[afc0a64b|thalamus]]. Mnemonic: \u003cb\u003eM\u003c/b\u003eedial \u003d \u003cb\u003eM\u003c/b\u003eusic (hearing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonotopic Organization:\u003c/b\u003e The auditory cortex is organized tonotopically, meaning that different frequencies of sound are processed in different, specific areas of the cortex, mirroring the organization of the [[001c359f|cochlea]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion in the primary auditory cortex does not typically cause complete deafness in one ear, as auditory information from each ear is processed bilaterally in the brain. However, a lesion in [[wernicke_area|Wernicke\u0027s area]] (an auditory association cortex) will cause receptive aphasia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAuditory Cortex\u003c/b\u003e is the final destination for sound processing in the brain, receiving signals from the medial geniculate nucleus and interpreting them, with specialized areas like Wernicke\u0027s area in the dominant hemisphere being crucial for language comprehension.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cochlea] --\u003e B(CN VIII); B --\u003e C(Brainstem Nuclei); C --\u003e D(Medial Geniculate Nucleus); D --\u003e E(Auditory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"temporal_lobe\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"medial_geniculate_nucleus\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"wernicke_area\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9733,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"b7b67074\": {\n    \"title"
      }, {
        "text": "\": \"Arachnoid Granulations\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"M"
      }, {
        "text": "eninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eArachnoid gran"
      }, {
        "text": "ulations\u003c/b\u003e (or arachnoid villi) are microscopic protrusions of the [[46e279b9|"
      }, {
        "text": "arachnoid mater]] through the dura mater into the superior sagittal sinus and other [[21f1c95"
      }, {
        "text": "5|dural venous sinuses]], functioning as one-way valves for the drainage of cerebrospinal fluid (CSF) from the sub"
      }, {
        "text": "arachnoid space into the venous circulation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:"
      }, {
        "text": "\u003c/b\u003e The primary site for \u003cmark\u003eCSF reabsorption\u003c/mark\u003e into the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e CSF"
      }, {
        "text": " flows from the subarachnoid space into the venous sinus down a pressure gradient. The structure acts as a one-way valve,"
      }, {
        "text": " preventing venous blood from entering the subarachnoid space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most numerous along the \u003cmark\u003esuperior sagittal sinus\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Impaired function or obstruction of arachnoid granulations (e.g"
      }, {
        "text": "., from scarring after meningitis or subarachnoid hemorrhage) can lead to \u003cmark\u003e[[aa4115"
      }, {
        "text": "c7|communicating hydrocephalus]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that CSF is produced by the chor"
      }, {
        "text": "oid plexus and reabsorbed by the arachnoid granulations. A problem with reabsorption (communicating hydrocephalus) is"
      }, {
        "text": " distinct from a blockage of flow within the ventricles (non-communicating hydrocephalus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eArachnoid granulations\u003c/b\u003e are the critical drainage ports for cerebrospinal fluid, acting as sophisticated"
      }, {
        "text": " one-way valves that allow CSF to exit the subarachnoid space and return to the venous system, thereby maintaining intracranial"
      }, {
        "text": " pressure homeostasis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --Produces"
      }, {
        "text": "--\u003e B(CSF); B --\u003e C(Ventricular System); C --\u003e D(Subarachnoid Space); D --\u003e E"
      }, {
        "text": "(Arachnoid Granulations); E --Reabsorption--\u003e F[Dural Venous Sinuses];\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_involved_in_reabsorption_of\",\n        \"to"
      }, {
        "text": "\": \"7109d8b6\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_protrusion_of\",\n        \"to\": \"46e279b9\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"dysfunction_causes\",\n        \"to\": \"aa4115c7\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"drains_into\",\n        \"to\": \"21f1c955\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"46e279b9\": {\n    \"title\": \"Ar"
      }, {
        "text": "achnoid Mater\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003eThe \u003cb\u003eArachnoid Mater\u003c/b\u003e is the middle layer of the three meninges that"
      }, {
        "text": " surround the brain and spinal cord. It is a delicate, avascular membrane located between the outer [[5bbe359"
      }, {
        "text": "7|dura mater]] and the inner [[pia_mater|pia mater]].\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of a web-like network of collagen and elastic fibers, from which it gets"
      }, {
        "text": " its name (from Greek \u0027arachne\u0027 for spider).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEmbryologic Origin:\u003c/b\u003e Derived from the [[1"
      }, {
        "text": "4c6f2a7|neural crest]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubarachnoid Space:\u003c/b\u003e The space between the arach"
      }, {
        "text": "noid mater and the pia mater is the \u003cmark\u003esubarachnoid space\u003c/mark\u003e, which contains cerebrospinal fluid (CSF"
      }, {
        "text": ") and major cerebral blood vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eArachnoid Granulations:\u003c/b\u003e Protrusions of the arachnoid mater"
      }, {
        "text": " through the dura into the superior sagittal sinus, responsible for CSF reabsorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Rupture of an"
      }, {
        "text": " artery in the subarachnoid space (e.g., from a berry aneurysm) causes a [[63f8"
      }, {
        "text": "b05f|subarachnoid hemorrhage]]. A [[e98ea0ba|meningioma]],"
      }, {
        "text": " a common benign brain tumor, arises from arachnoid cap cells.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eArachnoid Mater\u003c/b\u003e forms a crucial boundary, creating the subarachnoid space that houses the CSF"
      }, {
        "text": " and cerebral vasculature, and its specialized granulations are essential for CSF drainage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Skull"
      }, {
        "text": "] --\u003e B[Dura Mater]; B --\u003e C(Arachnoid Mater); C --\u003e D[Subarachnoid Space -"
      }, {
        "text": " CSF]; D --\u003e E[Pia Mater]; E --\u003e F[Brain];\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_layer_of\",\n        \"to\": \"meninges\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_located_between\",\n        \"to\": \"5bbe3597\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \""
      }, {
        "text": "pia_mater\"\n      },\n      {\n        \"type\": \"gives_rise_to\",\n        "
      }, {
        "text": "\"to\": \"e98ea0ba\"\n      }\n    ]\n  },\n  \"5dd"
      }, {
        "text": "343d3\": {\n    \"title\": \"Area Postrema\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eThe \u003cb\u003eArea Postrema\u003c/b\u003e is a highly vascularized structure in the medulla oblongata,"
      }, {
        "text": " located on the floor of the fourth ventricle, that functions as the \u003cmark\u003echemoreceptor trigger zone (CTZ)\u003c/mark\u003e for vomiting"
      }, {
        "text": ". It is one of the circumventricular organs, meaning it lacks a complete [[dd47b9cc|blood-brain barrier]]."
      }, {
        "text": "\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Dorsal surface of the medulla oblongata at"
      }, {
        "text": " the caudal end of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Detects emetogenic toxins in the blood and CSF"
      }, {
        "text": " and sends signals to the [[74b651ab|vomiting center]] (nucleus tractus solitarius"
      }, {
        "text": ") to induce emesis (vomiting).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier:\u003c/b\u003e Its fenestrated capillaries allow it to directly"
      }, {
        "text": " sample the chemical composition of the blood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Rich in various receptors, including dopamine D\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e, serotonin 5-HT\u003csub\u003e3\u003c/sub\u003e, and neurokinin-1 (NK-1) receptors."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e This is the site of action for many antiemetic drugs. For example, [["
      }, {
        "text": "ondansetron]] is a 5-HT\u003csub\u003e3\u003c/sub\u003e antagonist, and [[metoclopramide]] is a D"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e antagonist. It is also the area stimulated by toxins during chemotherapy, leading to chemotherapy-induced nausea and vomiting.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eArea Postrema\u003c/b\u003e serves as the brain\u0027s chemical"
      }, {
        "text": " surveillance system for the blood; its lack of a blood-brain barrier allows it to detect toxins and trigger the protective reflex"
      }, {
        "text": " of vomiting, making it a key target for antiemetic medications.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[E"
      }, {
        "text": "metogenic Toxins in Blood] --\u003e B(Area Postrema/CTZ); B --\u003e C(Vomiting Center -"
      }, {
        "text": " NTS); C --\u003e D(Vomiting Reflex);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a\",\n        \"to\": \"circumventricular_organ\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_also_known_as\",\n        \"to\": \"chemoreceptor_trigger"
      }, {
        "text": "_zone\"\n      },\n      {\n        \"type\": \"sends_signals_to\",\n        "
      }, {
        "text": "\"to\": \"74b651ab\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_target_of\",\n        \"to\": \"ondansetron\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "08cb577f\": {\n    \"title\": \"Argyll Robertson Pupil\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"In"
      }, {
        "text": "fectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eArgyll Robertson Pupil\u003c/b\u003e is a specific type of pupillary abnormality characterized by bilateral small"
      }, {
        "text": " pupils that constrict when the patient focuses on a near object (accommodation reflex) but do \u003cu\u003enot\u003c/u\u003e constrict when exposed"
      }, {
        "text": " to bright light (light reflex). This phenomenon is known as \u003cmark\u003elight-near dissociation\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassic Mnemonic:\u003c/b\u003e Often called the \\\"prostitute\u0027s pupil\\\" because it \\\"accommodates but"
      }, {
        "text": " does not react.\\\"\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion is thought to be in the \u003cmark\u003epretectal nucleus"
      }, {
        "text": "\u003c/mark\u003e in the superior colliculus of the midbrain, which interrupts the afferent limb of the pupillary light reflex pathway before"
      }, {
        "text": " it reaches the Edinger-Westphal nuclei bilaterally. The pathway for accommodation, which is more complex and involves the"
      }, {
        "text": " cerebral cortex, is spared.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e It is a highly specific sign of late-stage,"
      }, {
        "text": " or tertiary, \u003cmark\u003eneurosyphilis\u003c/mark\u003e, particularly [[71daebd6|tabes dorsalis]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e While classic for syphilis, it can also be seen in other conditions causing midbrain lesions, such as diabetes mellitus"
      }, {
        "text": " or Parinaud syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ataxia, a positive Romberg sign,"
      }, {
        "text": " and pupils that accommodate but don\u0027t react to light is a classic presentation of [[71daebd6|tabes"
      }, {
        "text": " dorsalis]] due to neurosyphilis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eArgyll Robertson Pupil\u003c/b\u003e is a pathognomonic sign of neurosyphilis, representing a selective lesion"
      }, {
        "text": " in the midbrain that disconnects the pupillary light reflex pathway while preserving the separate, cortically-driven accommodation pathway,"
      }, {
        "text": " resulting in the classic light-near dissociation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light]"
      }, {
        "text": " --\u003e B(Optic Nerve); B --\u003e C(Pretectal Nucleus); C --x Lesion; C"
      }, {
        "text": " --x D(Edinger-Westphal Nucleus); E[Near Object] --\u003e F(Visual Cortex); F --\u003e G"
      }, {
        "text": "(Accommodation Pathway); G --\u003e D; D --\u003e H(Pupillary Constriction);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"neurosyphilis\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_caused_by_"
      }, {
        "text": "lesion_in\",\n        \"to\": \"pretectal_nucleus\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_an_example_of\",\n        \"to\": \"light_near_diss"
      }, {
        "text": "ociation\"\n      }\n    ]\n  },\n  \"09db7b12\": {\n    \"title\":"
      }, {
        "text": " \"Aspirin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Stroke Therapy\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAspirin\u003c/b\u003e (acetylsalicylic acid) is a nonsteroidal"
      }, {
        "text": " anti-inflammatory drug (NSAID) that irreversibly inhibits cyclooxygenase (COX) enzymes, primarily used at low doses for its anti"
      }, {
        "text": "platelet effects in the prevention of cardiovascular and cerebrovascular events.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eMechanism of Action:\u003c/b\u003e \u003cu\u003eIrreversibly\u003c/u\u003e acetylates and inhibits both COX-1 and COX-2."
      }, {
        "text": " Its antiplatelet effect is due to inhibition of COX-1 in platelets, which blocks the synthesis of \u003cmark\u003eTh"
      }, {
        "text": "romboxane A\u003csub\u003e2\u003c/sub\u003e (TXA\u003csub\u003e2\u003c/sub\u003e)\u003c/mark\u003e, a potent promoter of platelet aggregation.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used for secondary prevention of [[c5da3c57|ischemic stroke]] and"
      }, {
        "text": " [[623ba776|transient ischemic attacks (TIAs)]]. It is a cornerstone of anti"
      }, {
        "text": "platelet therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e GI distress (gastritis, ulcers), bleeding, tinnitus ("
      }, {
        "text": "a sign of toxicity), and Reye syndrome in children with viral illness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReye Syndrome:\u003c/b\u003e A rare"
      }, {
        "text": " but severe condition of acute encephalopathy and fatty liver failure in children given aspirin for a viral infection (e.g., influenza,"
      }, {
        "text": " varicella). \u003cu\u003eAspirin is contraindicated in children\u003c/u\u003e for this reason (except in Kawasaki disease).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The irreversibility of aspirin\u0027s effect on platelets is key. Since platelets lack a nucleus, they cannot synthesize"
      }, {
        "text": " new COX enzyme, so the antiplatelet effect lasts for the life of the platelet (~7-10 days).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAspirin\u0027s\u003c/b\u003e primary role in stroke prevention stems from its unique ability"
      }, {
        "text": " to \u003cu\u003eirreversibly\u003c/u\u003e inhibit platelet COX-1, effectively silencing thromboxane A\u003csub\u003e2\u003c/sub\u003e production for"
      }, {
        "text": " the platelet\u0027s entire lifespan and thus reducing the risk of thrombotic occlusion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[A"
      }, {
        "text": "spirin] --Irreversibly Inhibits--\u003e B(Platelet COX-1); B --x C(Ar"
      }, {
        "text": "achidonic Acid -\u003e Thromboxane A2); C --x D(Platelet Aggregation); D --x E(Throm"
      }, {
        "text": "bus Formation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"prevents\","
      }, {
        "text": "\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"prevents\",\n        "
      }, {
        "text": "\"to\": \"623ba776\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "inhibits\",\n        \"to\": \"cyclooxygenase\"\n      },\n      {\n        \"type\": \"causes_adverse"
      }, {
        "text": "_effect\",\n        \"to\": \"reye_syndrome\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"b564ac97\": {\n    \"title\": \"Asterixis\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Gastroenterology\",\n      \"Physical"
      }, {
        "text": " Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Asterixis\u003c/b\u003e is a type of negative myoclonus characterized by a brief, flapping tremor of the hands,"
      }, {
        "text": " typically elicited by having the patient extend their arms and dorsiflex their wrists. It is a classic sign of metabolic encephalopathy.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e The patient holds their arms out"
      }, {
        "text": " with wrists extended (\u0027stop traffic\u0027 pose). The \u0027flap\u0027 is a sudden, brief loss of postural tone, causing the hands to drop,"
      }, {
        "text": " followed by a rapid, jerky return to the original position.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is not a true"
      }, {
        "text": " tremor but a failure of the brain to maintain a sustained posture, thought to be due to abnormal function of the diencephalic"
      }, {
        "text": " motor centers that regulate posture and tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e Most commonly associated with \u003cmark\u003ehepatic encephalopathy"
      }, {
        "text": "\u003c/mark\u003e due to liver failure, where high ammonia levels are neurotoxic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can"
      }, {
        "text": " also be seen in other metabolic encephalopathies, including uremia (renal failure), CO\u003csub\u003e2\u003c/sub\u003e narcosis (hyper"
      }, {
        "text": "capnia), and drug intoxication. It is also a feature of [[wilson_disease|Wilson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A patient with a history of cirrhosis who presents with confusion and a \u0027flapping tremor\u0027 of the hands has hepatic"
      }, {
        "text": " encephalopathy. The tremor is asterixis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAsterixis\u003c/b\u003e is a \u0027"
      }, {
        "text": "negative\u0027 movement disorder‚Äîa brief lapse in muscle tone rather than an active contraction‚Äîthat serves as a crucial physical exam"
      }, {
        "text": " finding for metabolic encephalopathies, most classically hepatic encephalopathy from hyperammonemia.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"hepatic_encephalopathy\"\n      },\n      {\n        \"type\": \"is_a_sign"
      }, {
        "text": "_of\",\n        \"to\": \"uremia\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_a_sign_of\",\n        \"to\": \"wilson_disease\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_type_of\",\n        \"to\": \"myoclonus\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"18cff34e\": {\n    \"title\": \"Astigmatism\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Refractive Errors\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eAstigmatism\u003c/b\u003e is a common refractive error of the eye where vision is blurred or distorted at"
      }, {
        "text": " all distances. It occurs when the cornea or lens has an irregular, non-spherical curvature, causing light rays to focus"
      }, {
        "text": " at multiple points rather than a single point on the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e The cornea, which should be shaped like a sphere, is instead shaped more like a football (tor"
      }, {
        "text": "ic). This causes light entering the eye to have different focal points in different planes (e.g., vertical vs. horizontal).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms"
      }, {
        "text": ":\u003c/b\u003e Blurred or distorted vision, eye strain, and headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Diagnosed during a standard"
      }, {
        "text": " eye exam using a phoropter and keratometer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with eyeglasses or contact lenses that have"
      }, {
        "text": " a \u003cmark\u003ecylindrical lens\u003c/mark\u003e to compensate for the irregular curvature. It can also be corrected with refractive"
      }, {
        "text": " surgery (e.g., LASIK).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from other refractive errors:"
      }, {
        "text": " [[myopia|myopia]] (nearsightedness) and [[hyperopia|hyperopia]] (farsightedness)"
      }, {
        "text": " are caused by the length of the eyeball relative to its focusing power, while astigmatism is caused by an irregularly shaped cornea or"
      }, {
        "text": " lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAstigmatism\u003c/b\u003e is a refractive error caused by an"
      }, {
        "text": " asymmetrically shaped cornea or lens, which acts like a warped mirror, scattering light to multiple focal points and resulting in blurred"
      }, {
        "text": " vision that requires a cylindrical lens for correction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"refractive_error\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"myopia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"hyperopia\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"8192f595\": {\n    \"title\": \""
      }, {
        "text": "Astrocytes\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Hist"
      }, {
        "text": "ology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAstrocytes\u003c/b\u003e are the most abundant type of glial cell"
      }, {
        "text": " in the central nervous system. These star-shaped cells perform a wide variety of essential supportive and homeostatic functions for neurons, and"
      }, {
        "text": " are the origin of the most common primary brain tumor in adults, [[b6bbd0bc|glioblastoma]].\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e Physical support for neurons, repair (gliosis/"
      }, {
        "text": "scar formation), component of the [[dd47b9cc|blood-brain barrier]] (via foot processes), removal of excess"
      }, {
        "text": " neurotransmitters (especially glutamate), and maintenance of the ionic environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistological Marker:\u003c/b\u003e They are identified"
      }, {
        "text": " by their expression of \u003cmark\u003eGlial Fibrillary Acidic Protein (GFAP)\u003c/mark\u003e, an intermediate filament protein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReactive"
      }, {
        "text": " Gliosis:\u003c/b\u003e In response to CNS injury (e.g., stroke, trauma), astrocytes proliferate and hypertrophy to form a \u003c"
      }, {
        "text": "mark\u003eglial scar\u003c/mark\u003e, which walls off the damaged area but can also impede axonal regeneration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTum"
      }, {
        "text": "or Origin:\u003c/b\u003e Astrocytes are the cell of origin for astrocytomas, including the highly malignant [[b6bbd0bc|glio"
      }, {
        "text": "blastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember GFAP as the key marker for astrocytes and astrocytic tumors. The"
      }, {
        "text": " formation of a glial scar by astrocytes is the CNS equivalent of fibrosis in other tissues.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAst"
      }, {
        "text": "rocytes\u003c/b\u003e are the indispensable \u0027housekeepers\u0027 of the CNS, providing structural, metabolic, and homeostatic support to neurons, forming"
      }, {
        "text": " the blood-brain barrier, and orchestrating the glial scar response to injury, but they can also give rise to the"
      }, {
        "text": " most aggressive brain tumors.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Astrocyte]; A --\u003e B(Physical"
      }, {
        "text": " Support); A --\u003e C(Blood-Brain Barrier); A --\u003e D(Neurotransmitter Uptake); A --\u003e E("
      }, {
        "text": "Ion Buffering); A --\u003e F(Repair/Gliosis); A --Neoplastic Transformation--\u003e G(Astrocytoma/"
      }, {
        "text": "Glioblastoma);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"glial_cell\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"expresses_marker\",\n        \"to\": \"fb50d450\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_cell_of_origin_for\",\n        \"to\": \"b6bb"
      }, {
        "text": "d0bc\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"glial_"
      }, {
        "text": "scar\"\n      }\n    ]\n  },\n  \"9767fd6b\": {\n    \"title\":"
      }, {
        "text": " \"Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology"
      }, {
        "text": "\",\n      \"Physical Exam\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtaxia\u003c/b\u003e is a neurological sign consisting of a lack of voluntary"
      }, {
        "text": " coordination of muscle movements, leading to a clumsy, unsteady gait and impaired balance. It can be caused by damage to the cerebellum, the"
      }, {
        "text": " vestibular system, or sensory pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCerebellar Ataxia:\u003c/b\u003e Ca"
      }, {
        "text": "used by damage to the cerebellum. \u003cbr\u003e - \u003cb\u003eTruncal Ataxia:\u003c/b\u003e Affects the midline, causing"
      }, {
        "text": " an unsteady, wide-based (\u0027drunken sailor\u0027) gait. Associated with lesions of the cerebellar vermis.\u003cbr\u003e - \u003cb\u003eL"
      }, {
        "text": "imb Ataxia:\u003c/b\u003e Affects the extremities, causing dysmetria (overshooting/undershooting targets) and intention"
      }, {
        "text": " tremor. Associated with lesions of the cerebellar hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Ataxia:\u003c/b\u003e Caused by loss of proprio"
      }, {
        "text": "ception, typically from damage to the [[e7f5cbbe|dorsal columns]] of the spinal cord or peripheral nerves"
      }, {
        "text": ". Patients have a positive [[47a0f3d1|Romberg sign]] (worsening of balance"
      }, {
        "text": " with eyes closed) and a stomping gait. Seen in [[71daebd6|tabes dorsalis]] and"
      }, {
        "text": " [[6f5bea90|subacute combined degeneration]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eVestibular Ataxia:\u003c/b\u003e Caused by"
      }, {
        "text": " dysfunction of the vestibular system. Associated with vertigo, nystagmus, and nausea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating"
      }, {
        "text": " the type of ataxia is key. A positive [[47a0f3d1|Romberg sign]] points"
      }, {
        "text": " to a sensory (dorsal column) cause, not a cerebellar cause. Patients with cerebellar ataxia are unsteady with their"
      }, {
        "text": " eyes open or closed.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtaxia\u003c/b\u003e is a sign"
      }, {
        "text": " of discoordination that can be localized by its characteristics: truncal and limb incoordination points to the cerebellum, a"
      }, {
        "text": " positive Romberg sign points to sensory loss in the dorsal columns, and associated vertigo points to the vestibular system.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "sign_of\",\n        \"to\": \"cerebellar_lesion\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_sign_of\",\n        \"to\": \"dorsal_column_lesion\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"vestibular_dysfunction\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"71daebd6"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"19272e70\": {\n    \"title"
      }, {
        "text": "\": \"Athetosis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Movement Disorders\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAthetosis\u003c/b\u003e is a type of involuntary movement disorder characterized by slow, writhing,"
      }, {
        "text": " snake-like movements, particularly affecting the distal extremities (fingers and hands). It is a symptom of damage to the [["
      }, {
        "text": "ed462927|basal ganglia]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription"
      }, {
        "text": ":\u003c/b\u003e Slow, twisting, and writhing movements that are continuous and non-rhythmic. It is often described as being"
      }, {
        "text": " \u0027snake-like.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by lesions in the [[ed46292"
      }, {
        "text": "7|basal ganglia]], particularly the striatum (caudate and putamen).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e A"
      }, {
        "text": "thetosis is a characteristic feature of [[ffd7e743|Huntington disease]], where it often co-occurs with chorea (ter"
      }, {
        "text": "med choreoathetosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in conditions like cerebral palsy."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When you see a description of slow, writhing, \u0027snake-like\u0027 movements of"
      }, {
        "text": " the fingers in a patient with other signs of a basal ganglia disorder (like chorea or dementia), think of athetosis,"
      }, {
        "text": " especially in the context of [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAthetosis\u003c/b\u003e is a specific and visually distinct sign of basal ganglia dysfunction, representing a failure of motor"
      }, {
        "text": " control that manifests as slow, ceaseless, writhing movements, most classically seen in [[ffd7e743|Hunting"
      }, {
        "text": "ton disease]].\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"ffd7e74"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in"
      }, {
        "text": "\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_type_of\",\n        \"to\": \"dyskinesia\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"ed7a236f\": {\n    \"title\": \"Atonic Se"
      }, {
        "text": "izures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pediatrics\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAtonic seizures\u003c/b\u003e, also known as \\\"drop attacks"
      }, {
        "text": "\\\" or \\\"drop seizures,\\\" are a type of generalized seizure characterized by a sudden loss of muscle tone, causing the individual to collapse"
      }, {
        "text": " to the ground. The loss of consciousness is typically very brief.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e A sudden, complete loss of postural muscle tone lasting 1-2 seconds. This can cause the head to drop"
      }, {
        "text": ", the jaw to slacken, or the entire body to fall limply to the floor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk of Injury:\u003c/b\u003e There"
      }, {
        "text": " is a high risk of head and facial injuries from the sudden falls. Patients may need to wear protective helmets.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Syndromes:\u003c/b\u003e While they can occur in various epilepsy syndromes, atonic seizures are a hallmark feature of \u003cmark\u003eLennox-"
      }, {
        "text": "Gastaut syndrome\u003c/mark\u003e, a severe form of childhood epilepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Findings:\u003c/b\u003e The EEG may show brief"
      }, {
        "text": ", generalized spike-and-wave discharges followed by diffuse slow waves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette"
      }, {
        "text": " describing a child with developmental delay who has multiple seizure types, including sudden falls leading to injury, is highly suggestive of Lennox-Gastaut syndrome,"
      }, {
        "text": " with atonic seizures being a key component.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtonic seizures\u003c/b\u003e are dramatic"
      }, {
        "text": " \u0027drop attacks\u0027 caused by a sudden, global loss of muscle tone, posing a significant risk of injury and often signaling"
      }, {
        "text": " a severe underlying epilepsy syndrome like Lennox-Gastaut.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6"
      }, {
        "text": "4c08e92\"\n      },\n      {\n        \"type\": \"is_a_feature"
      }, {
        "text": "_of\",\n        \"to\": \"lennox_gastaut_syndrome\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"52194edb\": {\n    \"title\": \"Atracurium\",\n    "
      }, {
        "text": "\"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAtracurium\u003c/b\u003e is a non-depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e"
      }, {
        "text": " used in anesthesia to induce skeletal muscle relaxation and paralysis, facilitating endotracheal intubation and surgical procedures.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction,"
      }, {
        "text": " preventing [[6a005559|acetylcholine]] from binding and causing muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMet"
      }, {
        "text": "abolism:\u003c/b\u003e Undergoes \u003cmark\u003eHoffmann elimination\u003c/mark\u003e, a spontaneous, non-enzymatic degradation at physiological pH and"
      }, {
        "text": " temperature. This makes its metabolism independent of liver or kidney function.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Ideal for patients with \u003c"
      }, {
        "text": "mark\u003erenal or hepatic failure\u003c/mark\u003e because its elimination does not depend on these organs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause histamine"
      }, {
        "text": " release, leading to hypotension, flushing, and bronchoconstriction. Its metabolite, laudanosine, can lower the seizure threshold,"
      }, {
        "text": " but this is rarely clinically significant.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The neuromuscular blockade can be reversed by [[acetylcholinesterase_"
      }, {
        "text": "inhibitors|acetylcholinesterase inhibitors]] (e.g., neostigmine), which increase the concentration of acetylcholine"
      }, {
        "text": " in the synaptic cleft to outcompete the blocker.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature of at"
      }, {
        "text": "racurium (and its stereoisomer, cisatracurium) is its Hoffmann elimination, making it the neuromuscular blocker"
      }, {
        "text": " of choice for patients with organ dysfunction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAtrac"
      }, {
        "text": "urium\u003c/b\u003e is a non-depolarizing neuromuscular blocker distinguished by its unique Hoffmann elimination pathway, a spontaneous chemical breakdown that makes it a"
      }, {
        "text": " safe and predictable choice for inducing paralysis in patients with kidney or liver disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Atr"
      }, {
        "text": "acurium] --Competitively Antagonizes--\u003e B(Nicotinic ACh Receptors); B --x C(A"
      }, {
        "text": "Ch Binding); C --x D(Muscle Contraction); A --Hoffmann Elimination--\u003e E(Inactive Metabolites);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "undergoes\",\n        \"to\": \"hoffmann_elimination\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_reversed_by\",\n        \"to\": \"acetylcholinesterase_inhibitors\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"0c2b4642\": {\n    \"title\": \"Atrophy\",\n    \"primary"
      }, {
        "text": "Type\": \"pathology\",\n    \"tags\": [\n      \"Pathology\",\n      \"Cell Biology\",\n      \"Neurology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"Cellular Adaptations\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eAtrophy\u003c/b\u003e is a cellular adaptation characterized by a decrease in the size of a cell, organ"
      }, {
        "text": ", or tissue after it has reached its normal mature size. It results from a decrease in cell substance and can be either"
      }, {
        "text": " physiologic or pathologic.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Atrophy occurs via"
      }, {
        "text": " a decrease in protein synthesis and an increase in protein degradation. The main pathway for protein degradation is the \u003cmark\u003eubiquitin-prote"
      }, {
        "text": "asome pathway\u003c/mark\u003e. It can also involve autophagy, where the cell digests its own components.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses"
      }, {
        "text": ":\u003c/b\u003e Common causes include disuse, denervation, loss of endocrine stimulation, inadequate nutrition, and ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeu"
      }, {
        "text": "rologic Relevance (Denervation Atrophy):\u003c/b\u003e When a muscle loses its nerve supply (denervation), it undergoes rapid and profound atrophy"
      }, {
        "text": ". This is a key sign of a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN"
      }, {
        "text": " vs. LMN Lesions:\u003c/b\u003e Significant muscle atrophy is a hallmark of LMN lesions (e.g., polio"
      }, {
        "text": ", [[4ed629f9|ALS]], peripheral nerve injury). In contrast, upper motor neuron (UMN"
      }, {
        "text": ") lesions cause only mild disuse atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a clinical vignette, the presence of marked"
      }, {
        "text": " muscle wasting (atrophy) and fasciculations strongly points towards an LMN component of a disease process.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eAtrophy\u003c/b\u003e is a reduction in cell size and substance, most often driven by the"
      }, {
        "text": " ubiquitin-proteasome pathway. In neurology, denervation atrophy is a critical sign that localizes a lesion to the lower"
      }, {
        "text": " motor neuron, distinguishing it from upper motor neuron pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cellular_adaptation"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \""
      }, {
        "text": "to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_mediated_by\",\n        \"to\": \"ubiquitin_proteasome_pathway\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"b1873d5b\": {\n    \"title\": \"Auditory Anatomy and Physiology\",\n"
      }, {
        "text": "    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Otology\",\n      \"Neuroscience"
      }, {
        "text": "\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \""
      }, {
        "text": "Anatomy and Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAud"
      }, {
        "text": "itory anatomy and physiology\u003c/b\u003e describes the structures and mechanisms by which sound waves are collected, transmitted, transduced into neural signals, and processed"
      }, {
        "text": " by the brain to produce the sensation of hearing.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOuter Ear:\u003c/b\u003e The"
      }, {
        "text": " pinna and external auditory canal collect sound waves and funnel them to the tympanic membrane (eardrum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMiddle Ear"
      }, {
        "text": ":\u003c/b\u003e An air-filled cavity containing the ossicles (malleus, incus, stapes). The ossicles amplify"
      }, {
        "text": " the vibrations from the tympanic membrane and transmit them to the oval window of the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInner Ear:\u003c/b\u003e The [["
      }, {
        "text": "001c359f|cochlea]], a fluid-filled, snail-shaped structure, contains the organ"
      }, {
        "text": " of Corti. Vibrations from the stapes create pressure waves in the cochlear fluid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransduction:\u003c/b\u003e These"
      }, {
        "text": " pressure waves cause the basilar membrane to vibrate at specific locations depending on the frequency (tonotopy). High frequencies vibrate the base, low frequencies vibrate"
      }, {
        "text": " the apex. This vibration bends the stereocilia of hair cells in the organ of Corti, opening ion channels and generating a"
      }, {
        "text": " neural signal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Pathway:\u003c/b\u003e The signal travels from the hair cells via the cochlear nerve (part"
      }, {
        "text": " of CN VIII) to the cochlear nuclei in the brainstem, then through a complex pathway (superior olive, lateral"
      }, {
        "text": " lemniscus, inferior colliculus, medial geniculate nucleus of the thalamus) to the [[d24b"
      }, {
        "text": "6af6|auditory cortex]] in the temporal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " auditory system is a remarkable transducer, converting mechanical energy (sound waves) into mechanical vibration (ossicles), then into hydraulic"
      }, {
        "text": " waves (cochlear fluid), and finally into electrical signals (hair cells) that the brain interprets as sound.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Sound Waves] --\u003e B(Outer Ear); B --\u003e C(Tympanic Membrane); C --\u003e D(Middle"
      }, {
        "text": " Ear Ossicles); D --\u003e E(Oval Window); E --\u003e F(Cochlear Fluid); F --\u003e G("
      }, {
        "text": "Basilar Membrane Vibration); G --\u003e H(Hair Cell Transduction); H --\u003e I(CN VIII); I --\u003e J(Brain);"
      }, {
        "text": " \"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_structure\",\n        \"to\": \""
      }, {
        "text": "001c359f\"\n      },\n      {\n        \"type\": \"involves"
      }, {
        "text": "_structure\",\n        \"to\": \"vestibulocochlear_nerve\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"culminates_in\",\n        \"to\": \"d24b6af6\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"d24b6af6\": {\n    \"title"
      }, {
        "text": "\": \"Auditory Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \""
      }, {
        "text": "Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAuditory Cortex\u003c/b\u003e is the"
      }, {
        "text": " region of the cerebral cortex responsible for processing auditory information. It is located in the superior temporal gyrus of the temporal lobe and"
      }, {
        "text": " includes the primary auditory cortex (Brodmann areas 41 and 42) and surrounding auditory association areas.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Superior temporal gyrus in the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e The primary auditory cortex is responsible for the perception of basic sound characteristics like pitch and volume. The surrounding association areas,"
      }, {
        "text": " including [[wernicke_area|Wernicke\u0027s area]] in the dominant hemisphere, are involved in the"
      }, {
        "text": " interpretation and comprehension of complex sounds, particularly speech.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e It receives its primary input"
      }, {
        "text": " from the \u003cmark\u003emedial geniculate nucleus (MGN)\u003c/mark\u003e of the [[afc0a64"
      }, {
        "text": "b|thalamus]]. Mnemonic: \u003cb\u003eM\u003c/b\u003eedial \u003d \u003cb\u003eM\u003c/b\u003eusic (hearing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTon"
      }, {
        "text": "otopic Organization:\u003c/b\u003e The auditory cortex is organized tonotopically, meaning that different frequencies of sound are processed in different,"
      }, {
        "text": " specific areas of the cortex, mirroring the organization of the [[001c359f|cochlea]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e A lesion in the primary auditory cortex does not typically cause complete deafness in one ear, as auditory"
      }, {
        "text": " information from each ear is processed bilaterally in the brain. However, a lesion in [[wernicke_area|Wern"
      }, {
        "text": "icke\u0027s area]] (an auditory association cortex) will cause receptive aphasia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eAuditory Cortex\u003c/b\u003e is the final destination for sound processing in the brain, receiving signals from the medial geniculate nucleus and"
      }, {
        "text": " interpreting them, with specialized areas like Wernicke\u0027s area in the dominant hemisphere being crucial for language comprehension.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Cochlea] --\u003e B(CN VIII); B --\u003e C(Brainstem Nucle"
      }, {
        "text": "i); C --\u003e D(Medial Geniculate Nucleus); D --\u003e E(Auditory Cortex);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"temporal_lobe\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"medial_genic"
      }, {
        "text": "ulate_nucleus\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"w"
      }, {
        "text": "ernicke_area\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1Y32k5ure9CkmtHP7u-jZBsKurzJvsDU1"
      },
      "role": "user",
      "tokenCount": 2881
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"4f0ade90\": {\n    \"title\": \"Autonomic Nervous System\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAutonomic Nervous System (ANS)\u003c/b\u003e is the division of the peripheral nervous system that controls involuntary bodily functions, such as heart rate, digestion, respiratory rate, and pupillary response. It is subdivided into the sympathetic, parasympathetic, and enteric systems.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSympathetic Division:\u003c/b\u003e Mediates the \\\"fight or flight\\\" response. Preganglionic neurons are short and release [[6a005559|acetylcholine]] onto nicotinic receptors in the paravertebral ganglia. Postganglionic neurons are long and primarily release norepinephrine onto adrenergic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Division:\u003c/b\u003e Mediates the \\\"rest and digest\\\" response. Preganglionic neurons are long and release [[6a005559|acetylcholine]] onto nicotinic receptors in ganglia near or within target organs. Postganglionic neurons are short and release [[6a005559|acetylcholine]] onto muscarinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Control:\u003c/b\u003e The ANS is regulated by higher centers in the CNS, including the [[89e86633|hypothalamus]] and the [[73ace357|limbic system]], which modulate autonomic outflow in response to emotional and environmental stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Autonomic dysregulation is a feature of many neurological disorders, including [[ed52e40b|Guillain-Barr√© syndrome]] (acute inflammatory demyelinating polyneuropathy), which can cause life-threatening cardiac irregularities and blood pressure instability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the neurotransmitter/receptor pairings: All preganglionic neurons use ACh (nicotinic). Parasympathetic postganglionic neurons use ACh (muscarinic). Most sympathetic postganglionic neurons use norepinephrine (adrenergic), with the key exception being sweat glands (ACh, muscarinic).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAutonomic Nervous System\u003c/b\u003e maintains homeostasis through a balance of its sympathetic (\u0027gas pedal\u0027) and parasympathetic (\u0027brake pedal\u0027) divisions, utilizing a two-neuron chain with distinct neurotransmitters and receptor targets to exert involuntary control over virtually every organ system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CNS] --\u003e B(Preganglionic Neuron); B --ACh--\u003e C(Autonomic Ganglion); C --NE/ACh--\u003e D(Target Organ);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_dysregulated_in\",\n        \"to\": \"ed52e40b\"\n      }\n    ]\n  },\n  \"174cf2c0\": {\n    \"title\": \"Axonal Injury\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Trauma\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eAxonal injury\u003c/b\u003e refers to damage to the axons of neurons, which can occur from trauma, ischemia, or neurodegenerative processes. The neuronal response to injury and the potential for regeneration depend on whether the injury is in the central or peripheral nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eWallerian Degeneration:\u003c/b\u003e The process of degeneration of the axon \u003cu\u003edistal\u003c/u\u003e to the site of injury. The axon disintegrates and its myelin sheath breaks down, cleared by Schwann cells (PNS) or microglia (CNS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAxonal Reaction (Central Chromatolysis):\u003c/b\u003e Changes occurring in the neuronal cell body \u003cu\u003eproximal\u003c/u\u003e to the injury. The cell body swells, the nucleus is displaced to the periphery, and Nissl bodies disperse. This reflects an increase in protein synthesis for repair.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiffuse Axonal Injury (DAI):\u003c/b\u003e A severe form of traumatic brain injury caused by shearing forces from rapid acceleration/deceleration. It involves widespread damage to axons in the white matter tracts. MRI shows multiple punctate hemorrhages. Often results in coma or persistent vegetative state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegeneration:\u003c/b\u003e Axonal regeneration is limited in the CNS due to inhibitory factors from oligodendrocytes and glial scar formation by astrocytes. Regeneration is more successful in the PNS, guided by the remaining Schwann cells and endoneurial tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the key difference in response to injury: Wallerian degeneration occurs distal to the cut, while axonal reaction (chromatolysis) occurs in the proximal cell body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAxonal injury\u003c/b\u003e triggers a cascade of degenerative and regenerative processes, with the outcome largely determined by the location; peripheral nerves have a significant capacity for regeneration guided by Schwann cells, whereas central nervous system axons are largely unable to regenerate due to an inhibitory environment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Axon Injury] --\u003e B(Proximal Segment); B --\u003e C(Axonal Reaction/Chromatolysis); A --\u003e D(Distal Segment); D --\u003e E(Wallerian Degeneration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"22b22e08\"\n      },\n      {\n        \"type\": \"involves_process\",\n        \"to\": \"wallerian_degeneration\"\n      },\n      {\n        \"type\": \"involves_process\",\n        \"to\": \"central_chromatolysis\"\n      }\n    ]\n  },\n  \"8947da55\": {\n    \"title\": \"Babinski Reflex (Plantar Reflex)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBabinski reflex\u003c/b\u003e (or sign) is the dorsiflexion of the great toe and fanning of the other toes in response to stroking the plantar surface of the foot. While a normal primitive reflex in infants, its presence in an adult is a pathognomonic sign of an \u003cu\u003eupper motor neuron (UMN) lesion\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTechnique:\u003c/b\u003e The sole of the foot is stroked with a blunt object from the heel along the lateral aspect to the ball of the foot.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response (Adult):\u003c/b\u003e Plantar flexion (downward curling) of the toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Response (Babinski Sign):\u003c/b\u003e Extension (dorsiflexion) of the great toe and fanning of the other toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The sign indicates damage to the corticospinal tract, which normally suppresses this primitive reflex after infancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A positive Babinski sign is a key physical exam finding that helps differentiate UMN lesions from LMN lesions. It is a sign of \u003cmark\u003eupper motor neuron damage\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In an adult, a positive Babinski sign is \u003cu\u003ealways\u003c/u\u003e abnormal. It points to a lesion anywhere along the corticospinal tract, from the motor cortex down to the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBabinski sign\u003c/b\u003e is a clinical indicator of corticospinal tract dysfunction, representing the re-emergence of a primitive reflex that is normally suppressed by mature upper motor neurons; its presence in an adult is a definitive sign of a UMN lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      }\n    ]\n  },\n  \"1ddc3f08\": {\n    \"title\": \"Baclofen\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBaclofen\u003c/b\u003e is a centrally acting skeletal muscle relaxant (antispasmodic) that functions as a GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist, primarily used to treat muscle spasticity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as an agonist at \u003cmark\u003eGABA\u003csub\u003eB\u003c/sub\u003e receptors\u003c/gmark\u003e in the spinal cord. This activation leads to hyperpolarization of motor neurons by increasing K\u003csup\u003e+\u003c/sup\u003e conductance, which reduces the release of excitatory neurotransmitters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Treatment of spasticity associated with [[45dd6d19|multiple sclerosis]], spinal cord injuries, and [[171ca00b|cerebral palsy]]. It is not typically used for acute muscle spasms from injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Can be administered orally or intrathecally (directly into the CSF) via a pump for severe spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, drowsiness, dizziness, and muscle weakness. Abrupt withdrawal of intrathecal baclofen can be life-threatening, causing high fever, rebound spasticity, and seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that baclofen acts on the \u0027\u003cb\u003ebac\u003c/b\u003ek\u0027 (spinal cord) at GABA\u003cb\u003e\u003csub\u003eB\u003c/sub\u003e\u003c/b\u003e receptors. Differentiate its use for chronic spasticity from drugs like cyclobenzaprine used for acute muscle spasms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBaclofen\u003c/b\u003e effectively reduces chronic muscle spasticity by mimicking GABA\u0027s inhibitory effects at GABA\u003csub\u003eB\u003c/sub\u003e receptors specifically within the spinal cord, thereby dampening the hyperactive reflexes that cause stiffness and spasms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Baclofen] --\u003e B(Activates GABA-B Receptors in Spinal Cord); B --\u003e C(‚Üë K+ Conductance); C --\u003e D(Hyperpolarization of Motor Neurons); D --\u003e E(‚Üì Spasticity);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"gaba_b_receptor\"\n      }\n    ]\n  },\n  \"52564aea\": {\n    \"title\": \"Barbiturates\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBarbiturates\u003c/b\u003e (e.g., phenobarbital, pentobarbital, thiopental) are a class of sedative-hypnotic drugs that act as central nervous system depressants by enhancing the effects of the neurotransmitter GABA.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to the GABA\u003csub\u003eA\u003c/sub\u003e receptor at a different site than GABA or benzodiazepines. They increase the \u003cmark\u003e\u003cu\u003eduration\u003c/u\u003e\u003c/mark\u003e of chloride channel opening. Mnemonic: Barbi\u003cb\u003edurates\u003c/b\u003e increase the \u003cb\u003eduration\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Formerly used for anxiety and insomnia but now largely replaced by benzodiazepines due to a worse safety profile. Current uses include: \u003cbr\u003e - \u003cb\u003eAnticonvulsant:\u003c/b\u003e [[phenobarbital]] for seizures.\u003cbr\u003e - \u003cb\u003eAnesthesia:\u003c/b\u003e Thiopental for induction of anesthesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Significant CNS and respiratory depression, which can be fatal in overdose and is potentiated by alcohol. High potential for dependence and abuse. Induces cytochrome P450 enzymes, leading to numerous drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindication:\u003c/b\u003e \u003cu\u003eAbsolutely contraindicated\u003c/u\u003e in patients with porphyria, as they induce Œ¥-ALA synthase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key difference from benzodiazepines is the mechanism (duration vs. frequency) and the lack of a ceiling effect on CNS depression, making overdose much more dangerous. There is no specific antidote for barbiturate overdose; treatment is supportive.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBarbiturates\u003c/b\u003e are potent CNS depressants that enhance GABAergic inhibition by prolonging the opening of chloride channels, but their narrow therapeutic index and high risk of fatal respiratory depression have relegated them to niche uses like seizure control and anesthesia induction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Barbiturate] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(‚Üë Duration of Cl- Channel Opening); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS Depression);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"porphyria\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"cytochrome_p450\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"14464617\"\n      }\n    ]\n  },\n  \"ed462927\": {\n    \"title\": \"Basal Ganglia\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Ganglia\u003c/b\u003e are a group of subcortical nuclei in the forebrain that are crucial for motor control, particularly in selecting and initiating voluntary movements, while suppressing unwanted movements. They also play a role in procedural learning, habit formation, and emotion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e The main components are the \u003cb\u003eStriatum\u003c/b\u003e (caudate nucleus + putamen), \u003cb\u003eGlobus Pallidus\u003c/b\u003e (internal and external segments), \u003cb\u003eSubthalamic Nucleus\u003c/b\u003e, and \u003cb\u003eSubstantia Nigra\u003c/b\u003e (pars compacta and pars reticulata).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The basal ganglia modulate motor output from the cortex via feedback loops. They do not directly connect to the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDirect Pathway:\u003c/b\u003e Facilitates movement. Cortical activation stimulates the striatum, which inhibits the globus pallidus internus (GPi), thereby disinhibiting the [[afc0a64b|thalamus]] and allowing it to excite the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIndirect Pathway:\u003c/b\u003e Inhibits movement. This more complex loop ultimately results in stimulation of the GPi, which increases inhibition of the [[afc0a64b|thalamus]], thus suppressing cortical activity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Lesions in the basal ganglia lead to movement disorders. \u003cbr\u003e - [[58c8ea03|Parkinson disease]]: Loss of dopaminergic neurons in the substantia nigra pars compacta leads to bradykinesia and tremor (hypokinetic).\u003cbr\u003e - [[ffd7e743|Huntington disease]]: Degeneration of the striatum leads to chorea (hyperkinetic).\u003cbr\u003e - Hemiballismus: Lesion of the subthalamic nucleus leads to wild, flinging movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Ganglia\u003c/b\u003e function as a sophisticated \u0027gatekeeper\u0027 for motor commands, using a balance between a \u0027go\u0027 (direct) pathway and a \u0027no-go\u0027 (indirect) pathway to fine-tune voluntary movement; disruption of this balance is the fundamental cause of movement disorders like Parkinson\u0027s and Huntington\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; A[Cortex] --\u003e B(Striatum); B --|Direct Pathway (Go)|--\u003e C(‚Üì GPi/SNr Inhibition); C --\u003e D(‚Üë Thalamic Excitation); D --\u003e A; B --|Indirect Pathway (No-Go)|--\u003e E(‚Üë GPi/SNr Inhibition); E --\u003e F(‚Üì Thalamic Excitation); F --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"hemiballismus\"\n      },\n      {\n        \"type\": \"sends_output_to\",\n        \"to\": \"afc0a64b\"\n      }\n    ]\n  },\n  \"361438f2\": {\n    \"title\": \"Basal Nucleus of Meynert\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brain Nuclei\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Nucleus of Meynert\u003c/b\u003e is a group of neurons located in the substantia innominata of the basal forebrain. It is the primary source of cholinergic ([[6a005559|acetylcholine]]) innervation to the entire cerebral cortex, playing a vital role in cognitive functions like memory and attention.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Basal forebrain, part of the substantia innominata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e Synthesizes and releases [[6a005559|acetylcholine (ACh)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e Provides widespread cholinergic projections to the neocortex and hippocampus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Modulates cortical excitability, arousal, attention, and is critical for learning and memory formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e There is significant degeneration and loss of cholinergic neurons in the Basal Nucleus of Meynert in \u003cmark\u003e[[77ae6148|Alzheimer disease]]\u003c/mark\u003e. This loss of cortical ACh is a major contributor to the cognitive and memory deficits seen in the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The degeneration of the Basal Nucleus of Meynert and the resulting cholinergic deficit is a key pathophysiological feature of [[77ae6148|Alzheimer disease]] and is the rationale for using [[acetylcholinesterase_inhibitors|acetylcholinesterase inhibitors]] (e.g., [[47d0372e|donepezil]]) as a symptomatic treatment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Nucleus of Meynert\u003c/b\u003e is the brain\u0027s main cholinergic hub for the cortex; its profound degeneration in [[77ae6148|Alzheimer disease]] leads to a cortical acetylcholine deficit that underlies the hallmark cognitive decline of the disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basal Nucleus of Meynert] --ACh Projections--\u003e B(Cerebral Cortex \u0026 Hippocampus); B --\u003e C(Arousal, Memory, Attention); A --x Degeneration in Alzheimer\u0027s; \"\n    },\n    \"connections\": [\n      {\n        \"type\": \"produces\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"basal_forebrain\"\n      }\n    ]\n  },\n  \"253e3efb\": {\n    \"title\": \"Basal Plate\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Plate\u003c/b\u003e is the ventral part of the neural tube in the developing embryo, which differentiates into \u003ci\u003emotor neurons\u003c/i\u003e of the spinal cord and brainstem under the influence of the signaling molecule Sonic Hedgehog (SHH).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Ventral (anterior) region of the developing spinal cord and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Gives rise to \u003cu\u003emotor\u003c/u\u003e components of the central nervous system, including the anterior horn of the spinal cord and the motor nuclei of the cranial nerves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInducing Signal:\u003c/b\u003e Development is induced by \u003cmark\u003eSonic Hedgehog (SHH)\u003c/mark\u003e, a signaling molecule secreted by the underlying notochord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The dorsal counterpart is the [[43be7a6e|Alar Plate]], which develops into sensory neurons under the influence of Bone Morphogenetic Proteins (BMPs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple orientation: \u003cb\u003eBasal \u003d Motor \u003d Ventral\u003c/b\u003e, and \u003cb\u003eAlar \u003d Sensory \u003d Dorsal\u003c/b\u003e. This fundamental organization persists into the adult CNS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Plate\u003c/b\u003e is the embryonic blueprint for the motor output of the CNS, established by Sonic Hedgehog signaling from the notochord, which sets up the ventral-motor organization of the neural tube that is conserved throughout the nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Neural Tube] --\u003e B(Alar Plate - Dorsal); A --\u003e C(Basal Plate - Ventral); D[Ectoderm] --BMPs--\u003e B; B --\u003e E[Sensory Neurons]; F[Notochord] --SHH--\u003e C; C --\u003e G[Motor Neurons];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"motor_neurons\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"43be7a6e\"\n      },\n      {\n        \"type\": \"is_induced_by\",\n        \"to\": \"sonic_hedgehog\"\n      }\n    ]\n  },\n  \"c335e16d\": {\n    \"title\": \"Basement Membrane (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn the central nervous system, the \u003cb\u003ebasement membrane\u003c/b\u003e is a thin, specialized layer of the extracellular matrix that surrounds cerebral capillaries and, along with astrocyte foot processes and endothelial tight junctions, forms a critical component of the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Primarily composed of Type IV collagen, laminin, and proteoglycans.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides structural support to the capillary endothelium and acts as a selective filter, regulating the passage of molecules from the blood into the brain parenchyma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Blood-Brain Barrier:\u003c/b\u003e The basement membrane, together with endothelial [[tight_junctions|tight junctions]] and astrocyte end-feet, creates the highly restrictive [[dd47b9cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Thickening of the basement membrane is a feature of chronic hyperglycemia in diabetes, contributing to microvascular complications like [[73b00ab0|diabetic retinopathy]]. In [[goodpasture_syndrome|Goodpasture syndrome]], autoantibodies target Type IV collagen in the basement membranes of the kidneys and lungs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The three key components of the blood-brain barrier are: 1) Tight junctions between non-fenestrated endothelial cells, 2) The basement membrane, and 3) Astrocyte foot processes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ebasement membrane\u003c/b\u003e of CNS capillaries is a crucial structural and functional element of the [[dd47b9cc|blood-brain barrier]], acting as both scaffolding and a selective filter to maintain the tightly controlled environment of the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"type_iv_collagen\"\n      },\n      {\n        \"type\": \"is_thickened_in\",\n        \"to\": \"diabetes_mellitus\"\n      }\n    ]\n  },\n  \"e7a90cd9\": {\n    \"title\": \"Basilar Artery\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasilar Artery\u003c/b\u003e is a critical artery at the base of the brain, formed by the union of the two vertebral arteries. It ascends along the anterior surface of the pons and is a key component of the posterior circulation, supplying the brainstem, cerebellum, and occipital lobes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormation:\u003c/b\u003e Formed by the confluence of the left and right vertebral arteries at the pontomedullary junction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBranches:\u003c/b\u003e Gives rise to the [[3c075343|anterior inferior cerebellar artery (AICA)]], superior cerebellar artery (SCA), and numerous small pontine arteries. It terminates by bifurcating into the two [[b6a2cc31|posterior cerebral arteries (PCAs)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerritory Supplied:\u003c/b\u003e Brainstem (pons, midbrain), cerebellum, and via its terminal branches (PCAs), the occipital and inferior temporal lobes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndromes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBasilar Artery Occlusion:\u003c/b\u003e Can be catastrophic, leading to \u003cmark\u003e\\\"locked-in syndrome\\\"\u003c/mark\u003e if the ventral pons is infarcted bilaterally. This causes quadriplegia and mutism, with preserved consciousness and vertical eye movements.\u003cbr\u003e - \u003cb\u003eTop of the Basilar Syndrome:\u003c/b\u003e Embolic occlusion of the distal basilar artery affects the midbrain, thalamus, and temporal/occipital lobes, causing visual and behavioral disturbances with minimal motor deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A stroke causing quadriplegia but sparing consciousness and vertical eye movements is pathognomonic for basilar artery occlusion leading to locked-in syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasilar Artery\u003c/b\u003e is the central trunk of the posterior circulation; its occlusion can lead to devastating brainstem strokes, most notably the \u0027locked-in syndrome,\u0027 which severs the brain\u0027s motor output while leaving consciousness intact.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vertebral Arteries] --\u003e B(Basilar Artery); B --\u003e C(Pontine Arteries); B --\u003e D(AICA); B --\u003e E(SCA); B --\u003e F(PCAs);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"posterior_circulation\"\n      },\n      {\n        \"type\": \"is_formed_by\",\n        \"to\": \"vertebral_arteries\"\n      },\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"locked_in_syndrome\"\n      },\n      {\n        \"type\": \"bifurcates_into\",\n        \"to\": \"b6a2cc31\"\n      }\n    ]\n  },\n  \"91fcdbc5\": {\n    \"title\": \"REM Sleep Behavior Disorder\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder (RBD)\u003c/b\u003e is a parasomnia characterized by the loss of normal muscle atonia during REM sleep, leading to the physical enactment of vivid, often violent or action-filled dreams.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the brainstem mechanisms (particularly in the pons) that normally induce muscle paralysis during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may shout, punch, kick, or jump out of bed during sleep, corresponding to the content of their dreams. This can result in injury to the patient or their bed partner.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e RBD is a very strong predictor of future neurodegenerative disease, particularly \u003cmark\u003eŒ±-synucleinopathies\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Diseases:\u003c/b\u003e A majority of patients with idiopathic RBD will eventually develop [[58c8ea03|Parkinson disease]], [[db2f16e5|Lewy body dementia]], or multiple system atrophy, often years or decades after the onset of RBD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An older male patient who reports acting out violent dreams and has injured his spouse during sleep should raise immediate suspicion for REM Sleep Behavior Disorder, which should be considered a prodromal sign of Parkinson disease or Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder\u003c/b\u003e is more than just a sleep disturbance; it is a critical early warning sign of an underlying Œ±-synucleinopathy, where the failure to paralyze muscles during dreaming precedes the onset of motor and cognitive symptoms of diseases like Parkinson\u0027s by many years.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"parasomnia\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \"to\": \"db2f16e5\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"alpha_synucleinopathies\"\n      }\n    ]\n  },\n  \"b0a6f66e\": {\n    \"title\": \"Behavior Modulation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBehavior modulation\u003c/b\u003e refers to the complex neural processes by which the brain regulates and controls behavior, integrating emotional, cognitive, and homeostatic inputs to produce appropriate responses. This function is primarily orchestrated by the [[73ace357|limbic system]] and its connections with the prefrontal cortex and [[89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLimbic System\u0027s Role:\u003c/b\u003e The [[73ace357|limbic system]] (including the [[d220fc3f|amygdala]], [[a0590674|hippocampus]], and cingulate gyrus) is central to emotion, memory, and motivation, which are the core drivers of behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAmygdala:\u003c/b\u003e Processes fear, aggression, and reward. Lesions can lead to placidity or disinhibited behavior (e.g., [[kluver_bucy_syndrome|Kl√ºver-Bucy syndrome]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypothalamus:\u003c/b\u003e Integrates autonomic and endocrine responses with behavior, governing fundamental drives like hunger, thirst, and sexual behavior (the \u0027Four Fs\u0027: Feeding, Fleeing, Fighting, and sexual Functioning).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrefrontal Cortex:\u003c/b\u003e Provides top-down executive control, inhibiting impulsive behaviors and guiding actions based on goals and social context. Lesions can cause disinhibition and impaired judgment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The mnemonic for limbic system functions, the \u00275 F\u0027s\u0027 (Feeding, Fleeing, Fighting, Feeling, and Sex), highlights its role in modulating fundamental behaviors.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBehavior modulation\u003c/b\u003e is a dynamic interplay between the primitive drives of the [[73ace357|limbic system]] and [[89e86633|hypothalamus]] and the executive oversight of the prefrontal cortex, with the final behavioral output reflecting the balance of these competing influences.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Limbic System - Emotion/Drives] --\u003e C{Behavioral Output}; B[Prefrontal Cortex - Executive Control] --\u003e C;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"prefrontal_cortex\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 8071,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"4f0ade90\": {\n    \"title"
      }, {
        "text": "\": \"Autonomic Nervous System\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eAutonomic Nervous System (ANS)\u003c/b\u003e is the"
      }, {
        "text": " division of the peripheral nervous system that controls involuntary bodily functions, such as heart rate, digestion, respiratory rate, and pup"
      }, {
        "text": "illary response. It is subdivided into the sympathetic, parasympathetic, and enteric systems.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSympathetic Division:\u003c/b\u003e Mediates the \\\"fight or flight\\\" response. Preganglionic neurons are"
      }, {
        "text": " short and release [[6a005559|acetylcholine]] onto nicotinic receptors in the paravertebral ganglia. Postgangl"
      }, {
        "text": "ionic neurons are long and primarily release norepinephrine onto adrenergic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Division:\u003c/b\u003e Mediates the \\\"rest"
      }, {
        "text": " and digest\\\" response. Preganglionic neurons are long and release [[6a005559|acetylcholine]] onto nicotinic receptors"
      }, {
        "text": " in ganglia near or within target organs. Postganglionic neurons are short and release [[6a005559"
      }, {
        "text": "|acetylcholine]] onto muscarinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Control:\u003c/b\u003e The ANS is regulated by higher centers in the CNS"
      }, {
        "text": ", including the [[89e86633|hypothalamus]] and the [[73ace3"
      }, {
        "text": "57|limbic system]], which modulate autonomic outflow in response to emotional and environmental stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance"
      }, {
        "text": ":\u003c/b\u003e Autonomic dysregulation is a feature of many neurological disorders, including [[ed52e40b|Gu"
      }, {
        "text": "illain-Barr√© syndrome]] (acute inflammatory demyelinating polyneuropathy), which can cause life-threatening cardiac"
      }, {
        "text": " irregularities and blood pressure instability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the neurotransmitter/receptor pairings: All pre"
      }, {
        "text": "ganglionic neurons use ACh (nicotinic). Parasympathetic postganglionic neurons use ACh (muscarinic). Most"
      }, {
        "text": " sympathetic postganglionic neurons use norepinephrine (adrenergic), with the key exception being sweat glands (ACh, muscarinic).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eAutonomic Nervous System\u003c/b\u003e maintains homeostasis through a balance of its"
      }, {
        "text": " sympathetic (\u0027gas pedal\u0027) and parasympathetic (\u0027brake pedal\u0027) divisions, utilizing a two-neuron chain with distinct neurotransmitters"
      }, {
        "text": " and receptor targets to exert involuntary control over virtually every organ system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[CNS] --\u003e B(Preganglionic Neuron); B --ACh--\u003e C(Autonomic Ganglion); C --NE"
      }, {
        "text": "/ACh--\u003e D(Target Organ);\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_regulated_by\",\n        \"to\": \"89e86633\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \""
      }, {
        "text": "73ace357\"\n      },\n      {\n        \"type\": \"is_dysregulated_"
      }, {
        "text": "in\",\n        \"to\": \"ed52e40b\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"174cf2c0\": {\n    \"title\": \"Axonal Injury\",\n    \"primaryType\": \""
      }, {
        "text": "pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Trauma\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eAxonal injury\u003c/b\u003e refers to damage to the axons of neurons, which can occur from trauma, ischemia, or neuro"
      }, {
        "text": "degenerative processes. The neuronal response to injury and the potential for regeneration depend on whether the injury is in the central or peripheral nervous system.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eWallerian Degeneration:\u003c/b\u003e The process of degeneration of"
      }, {
        "text": " the axon \u003cu\u003edistal\u003c/u\u003e to the site of injury. The axon disintegrates and its myelin sheath breaks down,"
      }, {
        "text": " cleared by Schwann cells (PNS) or microglia (CNS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAxonal Reaction (Central Chromatolysis):\u003c/b\u003e Changes"
      }, {
        "text": " occurring in the neuronal cell body \u003cu\u003eproximal\u003c/u\u003e to the injury. The cell body swells, the nucleus is displaced"
      }, {
        "text": " to the periphery, and Nissl bodies disperse. This reflects an increase in protein synthesis for repair.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiffuse"
      }, {
        "text": " Axonal Injury (DAI):\u003c/b\u003e A severe form of traumatic brain injury caused by shearing forces from rapid acceleration/deceleration. It involves widespread"
      }, {
        "text": " damage to axons in the white matter tracts. MRI shows multiple punctate hemorrhages. Often results in coma or persistent vegetative state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReg"
      }, {
        "text": "eneration:\u003c/b\u003e Axonal regeneration is limited in the CNS due to inhibitory factors from oligodendrocytes and glial scar formation by astrocytes. Regeneration"
      }, {
        "text": " is more successful in the PNS, guided by the remaining Schwann cells and endoneurial tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember the key difference in response to injury: Wallerian degeneration occurs distal to the cut, while axonal reaction (chromatolysis) occurs in"
      }, {
        "text": " the proximal cell body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eAxonal injury\u003c/b\u003e triggers a cascade of degenerative"
      }, {
        "text": " and regenerative processes, with the outcome largely determined by the location; peripheral nerves have a significant capacity for regeneration guided by Schwann cells, whereas central nervous"
      }, {
        "text": " system axons are largely unable to regenerate due to an inhibitory environment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Axon Injury] --\u003e B(Proximal Segment); B --\u003e C(Axonal Reaction/Chromatolysis); A --\u003e"
      }, {
        "text": " D(Distal Segment); D --\u003e E(Wallerian Degeneration);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"22b22e08\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"involves_process\",\n        \"to\": \"wallerian_degeneration\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"involves_process\",\n        \"to\": \"central_chromatolysis\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"8947da55\": {\n    \"title\": \"Babinski Reflex (Pl"
      }, {
        "text": "antar Reflex)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eBabinski reflex\u003c/b\u003e (or sign) is the dorsiflexion of the great toe and"
      }, {
        "text": " fanning of the other toes in response to stroking the plantar surface of the foot. While a normal primitive reflex in infants,"
      }, {
        "text": " its presence in an adult is a pathognomonic sign of an \u003cu\u003eupper motor neuron (UMN) lesion\u003c/u\u003e.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTechnique:\u003c/b\u003e The sole of the foot is stroked with a blunt object from"
      }, {
        "text": " the heel along the lateral aspect to the ball of the foot.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response (Adult):\u003c/b\u003e Plantar flexion ("
      }, {
        "text": "downward curling) of the toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAbnormal Response (Babinski Sign):\u003c/b\u003e Extension (dorsiflexion) of the"
      }, {
        "text": " great toe and fanning of the other toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The sign indicates damage to the cortic"
      }, {
        "text": "ospinal tract, which normally suppresses this primitive reflex after infancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A positive Babinski sign is a key"
      }, {
        "text": " physical exam finding that helps differentiate UMN lesions from LMN lesions. It is a sign of \u003cmark\u003eupper motor neuron damage"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In an adult, a positive Babinski sign is \u003cu\u003ealways\u003c/u\u003e abnormal. It points"
      }, {
        "text": " to a lesion anywhere along the corticospinal tract, from the motor cortex down to the spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eBabinski sign\u003c/b\u003e is a clinical indicator of corticospinal tract dysfunction, representing the re"
      }, {
        "text": "-emergence of a primitive reflex that is normally suppressed by mature upper motor neurons; its presence in an adult is a definitive sign of a"
      }, {
        "text": " UMN lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_les"
      }, {
        "text": "ion\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\":"
      }, {
        "text": " \"primitive_reflex\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to"
      }, {
        "text": "\": \"lower_motor_neuron_lesion\"\n      }\n    ]\n  },\n  \"1"
      }, {
        "text": "ddc3f08\": {\n    \"title\": \"Baclofen\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"S"
      }, {
        "text": "keletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBaclofen\u003c/b\u003e is a centrally acting"
      }, {
        "text": " skeletal muscle relaxant (antispasmodic) that functions as a GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist, primarily used to treat"
      }, {
        "text": " muscle spasticity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts"
      }, {
        "text": " as an agonist at \u003cmark\u003eGABA\u003csub\u003eB\u003c/sub\u003e receptors\u003c/gmark\u003e in the spinal cord. This activation"
      }, {
        "text": " leads to hyperpolarization of motor neurons by increasing K\u003csup\u003e+\u003c/sup\u003e conductance, which reduces the release of excitatory neurotransmitters."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Treatment of spasticity associated with [[45dd6d19|multiple sclerosis]],"
      }, {
        "text": " spinal cord injuries, and [[171ca00b|cerebral palsy]]. It is not typically used for acute"
      }, {
        "text": " muscle spasms from injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Can be administered orally or intrathecally (directly into the CSF) via"
      }, {
        "text": " a pump for severe spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, drowsiness, dizziness, and muscle weakness."
      }, {
        "text": " Abrupt withdrawal of intrathecal baclofen can be life-threatening, causing high fever, rebound spasticity, and"
      }, {
        "text": " seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that baclofen acts on the \u0027\u003cb\u003ebac\u003c/b\u003ek\u0027 (spinal"
      }, {
        "text": " cord) at GABA\u003cb\u003e\u003csub\u003eB\u003c/sub\u003e\u003c/b\u003e receptors. Differentiate its use for chronic spasticity from drugs like cyclobenzaprine used"
      }, {
        "text": " for acute muscle spasms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBaclofen\u003c/b\u003e effectively reduces chronic"
      }, {
        "text": " muscle spasticity by mimicking GABA\u0027s inhibitory effects at GABA\u003csub\u003eB\u003c/sub\u003e receptors specifically within the spinal cord, thereby damp"
      }, {
        "text": "ening the hyperactive reflexes that cause stiffness and spasms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Bac"
      }, {
        "text": "lofen] --\u003e B(Activates GABA-B Receptors in Spinal Cord); B --\u003e C(‚Üë K+"
      }, {
        "text": " Conductance); C --\u003e D(Hyperpolarization of Motor Neurons); D --\u003e E(‚Üì Spasticity);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"af72aab5\"\n      },\n      {\n        \"type\": \"treats\","
      }, {
        "text": "\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"treats\",\n        "
      }, {
        "text": "\"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "acts_as_agonist_at\",\n        \"to\": \"gaba_b_receptor\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"52564aea\": {\n    \"title\": \"Barbiturates\",\n    "
      }, {
        "text": "\"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anest"
      }, {
        "text": "hesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBarbiturates\u003c/b\u003e (e.g., phenobarbital, pent"
      }, {
        "text": "obarbital, thiopental) are a class of sedative-hypnotic drugs that act as central nervous system depressants by"
      }, {
        "text": " enhancing the effects of the neurotransmitter GABA.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind"
      }, {
        "text": " to the GABA\u003csub\u003eA\u003c/sub\u003e receptor at a different site than GABA or benzodiazepines. They increase the \u003cmark\u003e\u003cu\u003e"
      }, {
        "text": "duration\u003c/u\u003e\u003c/mark\u003e of chloride channel opening. Mnemonic: Barbi\u003cb\u003edurates\u003c/b\u003e increase the \u003cb\u003eduration\u003c/b\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Formerly used for anxiety and insomnia but now largely replaced by benzodiazepines due to a worse"
      }, {
        "text": " safety profile. Current uses include: \u003cbr\u003e - \u003cb\u003eAnticonvulsant:\u003c/b\u003e [[phenobarbital]] for"
      }, {
        "text": " seizures.\u003cbr\u003e - \u003cb\u003eAnesthesia:\u003c/b\u003e Thiopental for induction of anesthesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse"
      }, {
        "text": " Effects:\u003c/b\u003e Significant CNS and respiratory depression, which can be fatal in overdose and is potentiated by alcohol. High potential for dependence"
      }, {
        "text": " and abuse. Induces cytochrome P450 enzymes, leading to numerous drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindication:\u003c/b\u003e \u003cu\u003eAbsolutely"
      }, {
        "text": " contraindicated\u003c/u\u003e in patients with porphyria, as they induce Œ¥-ALA synthase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " key difference from benzodiazepines is the mechanism (duration vs. frequency) and the lack of a ceiling effect on CNS depression, making"
      }, {
        "text": " overdose much more dangerous. There is no specific antidote for barbiturate overdose; treatment is supportive.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eBarbiturates\u003c/b\u003e are potent CNS depressants that enhance GABAergic inhibition by prolonging the opening"
      }, {
        "text": " of chloride channels, but their narrow therapeutic index and high risk of fatal respiratory depression have relegated them to niche uses like seizure"
      }, {
        "text": " control and anesthesia induction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Barbiturate] --\u003e B(B"
      }, {
        "text": "inds to GABA-A Receptor); B --\u003e C(‚Üë Duration of Cl- Channel Opening); C --\u003e D(‚Üë Cl"
      }, {
        "text": "- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS Depression);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a"
      }, {
        "text": "_receptor\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        "
      }, {
        "text": "\"to\": \"porphyria\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"cytochrome"
      }, {
        "text": "_p450\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"14464617\"\n      }\n    ]\n  },\n  \"ed4"
      }, {
        "text": "62927\": {\n    \"title\": \"Basal Ganglia\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Movement Disorders\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Ganglia\u003c/b\u003e are"
      }, {
        "text": " a group of subcortical nuclei in the forebrain that are crucial for motor control, particularly in selecting and initiating voluntary movements, while"
      }, {
        "text": " suppressing unwanted movements. They also play a role in procedural learning, habit formation, and emotion.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e The main components are the \u003cb\u003eStriatum\u003c/b\u003e (caudate nucleus"
      }, {
        "text": " + putamen), \u003cb\u003eGlobus Pallidus\u003c/b\u003e (internal and external segments), \u003cb\u003eSubthalamic Nucleus\u003c/b\u003e,"
      }, {
        "text": " and \u003cb\u003eSubstantia Nigra\u003c/b\u003e (pars compacta and pars reticulata).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The basal ganglia modulate motor output"
      }, {
        "text": " from the cortex via feedback loops. They do not directly connect to the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDirect Pathway:\u003c/b\u003e Facilit"
      }, {
        "text": "ates movement. Cortical activation stimulates the striatum, which inhibits the globus pallidus internus (GPi), thereby"
      }, {
        "text": " disinhibiting the [[afc0a64b|thalamus]] and allowing it to excite the motor"
      }, {
        "text": " cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIndirect Pathway:\u003c/b\u003e Inhibits movement. This more complex loop ultimately results in stimulation of the GPi, which increases"
      }, {
        "text": " inhibition of the [[afc0a64b|thalamus]], thus suppressing cortical activity.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology"
      }, {
        "text": ":\u003c/b\u003e Lesions in the basal ganglia lead to movement disorders. \u003cbr\u003e - [[58c8ea03|Parkinson disease"
      }, {
        "text": "]]: Loss of dopaminergic neurons in the substantia nigra pars compacta leads to bradykinesia and tremor (hyp"
      }, {
        "text": "okinetic).\u003cbr\u003e - [[ffd7e743|Huntington disease]]: Degeneration of the striatum leads to chore"
      }, {
        "text": "a (hyperkinetic).\u003cbr\u003e - Hemiballismus: Lesion of the subthalamic nucleus leads to wild"
      }, {
        "text": ", flinging movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Ganglia\u003c/b\u003e function"
      }, {
        "text": " as a sophisticated \u0027gatekeeper\u0027 for motor commands, using a balance between a \u0027go\u0027 (direct) pathway and a"
      }, {
        "text": " \u0027no-go\u0027 (indirect) pathway to fine-tune voluntary movement; disruption of this balance is the fundamental cause"
      }, {
        "text": " of movement disorders like Parkinson\u0027s and Huntington\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph LR; A[C"
      }, {
        "text": "ortex] --\u003e B(Striatum); B --|Direct Pathway (Go)|--\u003e C(‚Üì GPi/SN"
      }, {
        "text": "r Inhibition); C --\u003e D(‚Üë Thalamic Excitation); D --\u003e A; B --|Indirect Pathway (No"
      }, {
        "text": "-Go)|--\u003e E(‚Üë GPi/SNr Inhibition); E --\u003e F(‚Üì Thalamic Excitation); F --\u003e"
      }, {
        "text": " A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_implicated_in\",\n        \"to"
      }, {
        "text": "\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "implicated_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_implicated_in\",\n        \"to\": \"hemiballismus\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"sends_output_to\",\n        \"to\": \"afc0a64b"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"361438f2\": {\n    \"title\":"
      }, {
        "text": " \"Basal Nucleus of Meynert\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brain Nuclei\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Nucleus of Meynert\u003c/b\u003e is a group of neurons"
      }, {
        "text": " located in the substantia innominata of the basal forebrain. It is the primary source of cholinergic ([[6a005559|"
      }, {
        "text": "acetylcholine]]) innervation to the entire cerebral cortex, playing a vital role in cognitive functions like memory and attention.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Basal forebrain, part of the substantia innominata."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e Synthesizes and releases [[6a005559|acetylcholine ("
      }, {
        "text": "ACh)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e Provides widespread cholinergic projections to the neocortex and hippocampus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Modulates cortical excitability, arousal, attention, and is critical for learning and memory formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e There"
      }, {
        "text": " is significant degeneration and loss of cholinergic neurons in the Basal Nucleus of Meynert in \u003cmark\u003e[[7"
      }, {
        "text": "7ae6148|Alzheimer disease]]\u003c/mark\u003e. This loss of cortical ACh is a major contributor to the cognitive"
      }, {
        "text": " and memory deficits seen in the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The degeneration of the Basal Nucleus of Mey"
      }, {
        "text": "nert and the resulting cholinergic deficit is a key pathophysiological feature of [[77ae6148|Alzheimer disease]] and"
      }, {
        "text": " is the rationale for using [[acetylcholinesterase_inhibitors|acetylcholinesterase inhibitors]] (e.g., [["
      }, {
        "text": "47d0372e|donepezil]]) as a symptomatic treatment.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasal Nucleus of Meynert\u003c/b\u003e is the brain\u0027s main cholinergic hub"
      }, {
        "text": " for the cortex; its profound degeneration in [[77ae6148|Alzheimer disease]] leads to a cortical"
      }, {
        "text": " acetylcholine deficit that underlies the hallmark cognitive decline of the disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Basal Nucleus of Meynert] --ACh Projections--\u003e B(Cerebral Cortex \u0026 Hippocampus); B"
      }, {
        "text": " --\u003e C(Arousal, Memory, Attention); A --x Degeneration in Alzheimer\u0027s; \"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"produces\",\n        \"to\": \"6a005559\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"77ae614"
      }, {
        "text": "8\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\":"
      }, {
        "text": " \"basal_forebrain\"\n      }\n    ]\n  },\n  \"253e3"
      }, {
        "text": "efb\": {\n    \"title\": \"Basal Plate\",\n    \"primaryType\": \"anatomy\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Anatomy\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural"
      }, {
        "text": " Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasal Plate\u003c/b\u003e is the ventral"
      }, {
        "text": " part of the neural tube in the developing embryo, which differentiates into \u003ci\u003emotor neurons\u003c/i\u003e of the spinal cord and brainstem under the influence of"
      }, {
        "text": " the signaling molecule Sonic Hedgehog (SHH).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Ventral ("
      }, {
        "text": "anterior) region of the developing spinal cord and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Gives rise to \u003cu\u003emotor\u003c/u\u003e components"
      }, {
        "text": " of the central nervous system, including the anterior horn of the spinal cord and the motor nuclei of the cranial nerves.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInducing"
      }, {
        "text": " Signal:\u003c/b\u003e Development is induced by \u003cmark\u003eSonic Hedgehog (SHH)\u003c/mark\u003e, a signaling molecule secreted by the underlying"
      }, {
        "text": " notochord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The dorsal counterpart is the [[43be7a6e"
      }, {
        "text": "|Alar Plate]], which develops into sensory neurons under the influence of Bone Morphogenetic Proteins (BMPs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the simple orientation: \u003cb\u003eBasal \u003d Motor \u003d Ventral\u003c/b\u003e, and \u003cb\u003eAlar \u003d Sensory"
      }, {
        "text": " \u003d Dorsal\u003c/b\u003e. This fundamental organization persists into the adult CNS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Basal Plate\u003c/b\u003e is the embryonic blueprint for the motor output of the CNS, established by Sonic Hedgehog signaling from the not"
      }, {
        "text": "ochord, which sets up the ventral-motor organization of the neural tube that is conserved throughout the nervous system.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Neural Tube] --\u003e B(Alar Plate - Dorsal); A --\u003e C(Basal Plate - Vent"
      }, {
        "text": "ral); D[Ectoderm] --BMPs--\u003e B; B --\u003e E[Sensory Neurons]; F[Noto"
      }, {
        "text": "chord] --SHH--\u003e C; C --\u003e G[Motor Neurons];\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"neural_tube\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"motor_neurons\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"43be7a6e\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_induced_by\",\n        \"to\": \"sonic"
      }, {
        "text": "_hedgehog\"\n      }\n    ]\n  },\n  \"c335e16d\": {\n    \"title"
      }, {
        "text": "\": \"Basement Membrane (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-"
      }, {
        "text": "Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn the central nervous system, the \u003cb\u003ebas"
      }, {
        "text": "ement membrane\u003c/b\u003e is a thin, specialized layer of the extracellular matrix that surrounds cerebral capillaries and, along with astrocyte foot processes and endothelial"
      }, {
        "text": " tight junctions, forms a critical component of the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Primarily composed of Type IV collagen, laminin, and proteoglycans.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Function:\u003c/b\u003e Provides structural support to the capillary endothelium and acts as a selective filter, regulating the passage of molecules from the blood into the brain"
      }, {
        "text": " parenchyma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Blood-Brain Barrier:\u003c/b\u003e The basement membrane, together with endothelial [[tight_junctions|"
      }, {
        "text": "tight junctions]] and astrocyte end-feet, creates the highly restrictive [[dd47b9cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ology:\u003c/b\u003e Thickening of the basement membrane is a feature of chronic hyperglycemia in diabetes, contributing to microvascular complications like"
      }, {
        "text": " [[73b00ab0|diabetic retinopathy]]. In [[goodpasture_syndrome|Goodpasture syndrome]], auto"
      }, {
        "text": "antibodies target Type IV collagen in the basement membranes of the kidneys and lungs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " three key components of the blood-brain barrier are: 1) Tight junctions between non-fenestrated endothelial cells, 2)"
      }, {
        "text": " The basement membrane, and 3) Astrocyte foot processes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003ebasement membrane\u003c/b\u003e of CNS capillaries is a crucial structural and functional element of the [[dd47b9cc|blood"
      }, {
        "text": "-brain barrier]], acting as both scaffolding and a selective filter to maintain the tightly controlled environment of the brain.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \""
      }, {
        "text": "to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "composed_of\",\n        \"to\": \"type_iv_collagen\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_thickened_in\",\n        \"to\": \"diabetes_mellitus\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"e7a90cd9\": {\n    \"title\": \"Basilar"
      }, {
        "text": " Artery\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"C"
      }, {
        "text": "erebrovascular\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBasilar Artery\u003c/b\u003e is a critical artery at"
      }, {
        "text": " the base of the brain, formed by the union of the two vertebral arteries. It ascends along the anterior surface of the pons and is"
      }, {
        "text": " a key component of the posterior circulation, supplying the brainstem, cerebellum, and occipital lobes.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormation:\u003c/b\u003e Formed by the confluence of the left and right vertebral arteries at the pont"
      }, {
        "text": "omedullary junction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBranches:\u003c/b\u003e Gives rise to the [[3c075343|anterior inferior"
      }, {
        "text": " cerebellar artery (AICA)]], superior cerebellar artery (SCA), and numerous small pontine arteries. It terminates by"
      }, {
        "text": " bifurcating into the two [[b6a2cc31|posterior cerebral arteries (PCAs)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTerr"
      }, {
        "text": "itory Supplied:\u003c/b\u003e Brainstem (pons, midbrain), cerebellum, and via its terminal branches (PCAs), the occipital and"
      }, {
        "text": " inferior temporal lobes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Syndromes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBasilar Artery Occlusion:"
      }, {
        "text": "\u003c/b\u003e Can be catastrophic, leading to \u003cmark\u003e\\\"locked-in syndrome\\\"\u003c/mark\u003e if the ventral pons is infar"
      }, {
        "text": "cted bilaterally. This causes quadriplegia and mutism, with preserved consciousness and vertical eye movements.\u003cbr\u003e - \u003cb\u003eTop"
      }, {
        "text": " of the Basilar Syndrome:\u003c/b\u003e Embolic occlusion of the distal basilar artery affects the midbrain, thalamus, and temporal"
      }, {
        "text": "/occipital lobes, causing visual and behavioral disturbances with minimal motor deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " stroke causing quadriplegia but sparing consciousness and vertical eye movements is pathognomonic for basilar artery occlusion leading to locked-in syndrome.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBasilar Artery\u003c/b\u003e is the central trunk of the posterior"
      }, {
        "text": " circulation; its occlusion can lead to devastating brainstem strokes, most notably the \u0027locked-in syndrome,\u0027 which severs the brain\u0027"
      }, {
        "text": "s motor output while leaving consciousness intact.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vertebral Arter"
      }, {
        "text": "ies] --\u003e B(Basilar Artery); B --\u003e C(Pontine Arteries); B --\u003e D(A"
      }, {
        "text": "ICA); B --\u003e E(SCA); B --\u003e F(PCAs);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_part_of\",\n        \"to\": \"posterior_circulation\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_formed_by\",\n        \"to\": \"vertebral_arteries\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"occlusion_causes\",\n        \"to\": \"locked_in_"
      }, {
        "text": "syndrome\"\n      },\n      {\n        \"type\": \"bifurcates_into\",\n"
      }, {
        "text": "        \"to\": \"b6a2cc31\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"91fcdbc5\": {\n    \"title\": \"REM Sleep Behavior Disorder\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder (RBD)\u003c/b\u003e is a parasomnia characterized by the loss of normal muscle"
      }, {
        "text": " atonia during REM sleep, leading to the physical enactment of vivid, often violent or action-filled dreams.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the brainstem mechanisms (particularly in the pons) that normally induce"
      }, {
        "text": " muscle paralysis during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may shout, punch, kick, or jump out of bed during sleep"
      }, {
        "text": ", corresponding to the content of their dreams. This can result in injury to the patient or their bed partner.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic"
      }, {
        "text": " Association:\u003c/b\u003e RBD is a very strong predictor of future neurodegenerative disease, particularly \u003cmark\u003eŒ±-synucleinopathies"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Diseases:\u003c/b\u003e A majority of patients with idiopathic RBD will eventually develop [[58c8ea03|"
      }, {
        "text": "Parkinson disease]], [[db2f16e5|Lewy body dementia]], or multiple system atrophy, often years"
      }, {
        "text": " or decades after the onset of RBD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An older male patient who reports acting out violent"
      }, {
        "text": " dreams and has injured his spouse during sleep should raise immediate suspicion for REM Sleep Behavior Disorder, which should be considered a prod"
      }, {
        "text": "romal sign of Parkinson disease or Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eREM Sleep"
      }, {
        "text": " Behavior Disorder\u003c/b\u003e is more than just a sleep disturbance; it is a critical early warning sign of an underlying Œ±-synucleinopathy, where"
      }, {
        "text": " the failure to paralyze muscles during dreaming precedes the onset of motor and cognitive symptoms of diseases like Parkinson\u0027s by many"
      }, {
        "text": " years.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"parasomnia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \""
      }, {
        "text": "to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_prodromal_sign_of\",\n        \"to\": \"db2f16e5"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\":"
      }, {
        "text": " \"alpha_synucleinopathies\"\n      }\n    ]\n  },\n  \"b0a6"
      }, {
        "text": "f66e\": {\n    \"title\": \"Behavior Modulation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Physiology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBehavior modulation\u003c/b\u003e refers to the complex"
      }, {
        "text": " neural processes by which the brain regulates and controls behavior, integrating emotional, cognitive, and homeostatic inputs to produce appropriate responses. This function"
      }, {
        "text": " is primarily orchestrated by the [[73ace357|limbic system]] and its connections with the prefrontal cortex and [["
      }, {
        "text": "89e86633|hypothalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eLimbic System\u0027s Role:\u003c/b\u003e The [[73ace357|limbic system]] ("
      }, {
        "text": "including the [[d220fc3f|amygdala]], [[a0590674|hipp"
      }, {
        "text": "ocampus]], and cingulate gyrus) is central to emotion, memory, and motivation, which are the core drivers of behavior.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eAmygdala:\u003c/b\u003e Processes fear, aggression, and reward. Lesions can lead to placidity or dis"
      }, {
        "text": "inhibited behavior (e.g., [[kluver_bucy_syndrome|Kl√ºver-Bucy syndrome]]).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eHypothalamus:\u003c/b\u003e Integrates autonomic and endocrine responses with behavior, governing fundamental drives like hunger, thirst, and sexual"
      }, {
        "text": " behavior (the \u0027Four Fs\u0027: Feeding, Fleeing, Fighting, and sexual Functioning).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrefrontal Cortex"
      }, {
        "text": ":\u003c/b\u003e Provides top-down executive control, inhibiting impulsive behaviors and guiding actions based on goals and social context. Lesions can cause"
      }, {
        "text": " disinhibition and impaired judgment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The mnemonic for limbic system functions, the \u00275 F\u0027"
      }, {
        "text": "s\u0027 (Feeding, Fleeing, Fighting, Feeling, and Sex), highlights its role in modulating fundamental behaviors."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBehavior modulation\u003c/b\u003e is a dynamic interplay between the primitive drives"
      }, {
        "text": " of the [[73ace357|limbic system]] and [[89e86633"
      }, {
        "text": "|hypothalamus]] and the executive oversight of the prefrontal cortex, with the final behavioral output reflecting the balance of"
      }, {
        "text": " these competing influences.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Limbic System - Emotion/"
      }, {
        "text": "Drives] --\u003e C{Behavioral Output}; B[Prefrontal Cortex - Executive Control] --\u003e C;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"73ace35"
      }, {
        "text": "7\"\n      },\n      {\n        \"type\": \"is_a_function_of\",\n        "
      }, {
        "text": "\"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "function_of\",\n        \"to\": \"prefrontal_cortex\"\n      }\n    ]\n  "
      }, {
        "text": "}\n}\n```"
      }]
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"c7ce09b2\": {\n    \"title\": \"Benzocaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenzocaine\u003c/b\u003e is an ester-type \u003ci\u003elocal anesthetic\u003c/i\u003e used topically to numb surfaces such as the skin, mouth, and throat. It works by blocking voltage-gated sodium channels in nerve membranes, thereby preventing the propagation of action potentials.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing nerve depolarization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Ester local anesthetic. Patients with allergies to esters (e.g., procaine) may also react to benzocaine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Commonly found in over-the-counter products for teething pain, sore throats (sprays), and sunburn relief. Used in medical settings as a topical anesthetic for procedures like endoscopy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effect:\u003c/b\u003e A well-known cause of acquired \u003cmark\u003emethemoglobinemia\u003c/mark\u003e, especially in infants and young children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMethemoglobinemia:\u003c/b\u003e Benzocaine oxidizes the iron in hemoglobin from the ferrous (Fe\u003csup\u003e2+\u003c/sup\u003e) to the ferric (Fe\u003csup\u003e3+\u003c/sup\u003e) state. Methemoglobin cannot bind oxygen, leading to functional anemia and cyanosis that does not improve with supplemental oxygen. Blood appears \u0027chocolate brown\u0027. Treated with methylene blue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a patient who develops cyanosis and shortness of breath shortly after an endoscopic procedure (where a topical anesthetic spray was used) should immediately raise suspicion for benzocaine-induced methemoglobinemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenzocaine\u003c/b\u003e is a widely used topical anesthetic that carries the rare but life-threatening risk of inducing methemoglobinemia, a condition where hemoglobin\u0027s iron is oxidized, rendering it unable to transport oxygen and causing a characteristic \u0027chocolate brown\u0027 blood appearance and cyanosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"methemoglobinemia\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n  },\n  \"14464617\": {\n    \"title\": \"Benzodiazepines\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenzodiazepines\u003c/b\u003e are a class of psychoactive drugs that act as positive allosteric modulators of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, resulting in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to an allosteric site on the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cmark\u003e\u003cu\u003efrequency\u003c/u\u003e\u003c/mark\u003e of chloride channel opening in response to GABA. Mnemonic: \u003cb\u003eFre\u003c/b\u003enzodiazepines increase \u003cb\u003efre\u003c/b\u003equency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Uses:\u003c/b\u003e Anxiety disorders, panic attacks, status epilepticus (lorazepam, diazepam), alcohol withdrawal, insomnia, and procedural sedation/anesthesia (midazolam).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Classified by duration of action. Short-acting (e.g., [[083094db|alprazolam]], midazolam) have higher abuse potential. Long-acting (e.g., diazepam, chlordiazepoxide) are preferred for alcohol withdrawal. Those not metabolized by the liver (\u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eT\u003c/b\u003eemazepam, \u003cb\u003eL\u003c/b\u003eorazepam - \u0027Outside The Liver\u0027) are safer in patients with hepatic dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance, withdrawal symptoms. Additive CNS depression with other depressants like alcohol and barbiturates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e Overdose can be treated with \u003cmark\u003eflumazenil\u003c/mark\u003e, a competitive antagonist at the benzodiazepine binding site on the GABA\u003csub\u003eA\u003c/sub\u003e receptor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[52564aea|barbiturates]], which increase the \u003cu\u003eduration\u003c/u\u003e of channel opening and have a higher risk of fatal respiratory depression.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenzodiazepines\u003c/b\u003e are versatile CNS depressants that enhance GABA\u0027s inhibitory effects by increasing the frequency of chloride channel opening, but their use is tempered by the significant risks of dependence and additive depression with other substances.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Benzodiazepine] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(‚Üë Frequency of Cl- Channel Opening); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyperpolarization of Neuron); E --\u003e F(CNS Depression/Anxiolysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"d1c786e9\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"status_epilepticus\"\n      },\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"52564aea\"\n      }\n    ]\n  },\n  \"383f6fbe\": {\n    \"title\": \"Benztropine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenztropine\u003c/b\u003e is a centrally acting \u003ci\u003eantimuscarinic (anticholinergic) drug\u003c/i\u003e used primarily to treat the symptoms of [[58c8ea03|Parkinson disease]] and to manage extrapyramidal side effects (EPS) caused by antipsychotic medications.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at central muscarinic receptors, helping to restore the dopaminergic-cholinergic balance in the [[ed462927|basal ganglia]] that is disrupted in Parkinson\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Primarily effective for treating \u003cmark\u003etremor and rigidity\u003c/mark\u003e. It has little effect on bradykinesia. Mnemonic: \u0027\u003cb\u003eTri\u003c/b\u003e to \u003cb\u003ePark\u003c/b\u003e my Mercedes-\u003cb\u003eBenz\u003c/b\u003e\u0027 (\u003cb\u003eTri\u003c/b\u003ehexyphenidyl and \u003cb\u003eBenz\u003c/b\u003etropine for \u003cb\u003ePark\u003c/b\u003einson\u0027s).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (EPS):\u003c/b\u003e Effective for treating \u003cmark\u003eacute dystonia\u003c/mark\u003e and drug-induced parkinsonism caused by dopamine antagonists (antipsychotics).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Classic anticholinergic side effects: dry mouth, blurred vision, constipation, urinary retention, tachycardia, and confusion/delirium, especially in the elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Benztropine is the go-to drug for treating a patient who develops an acute dystonic reaction (e.g., torticollis, oculogyric crisis) after starting an antipsychotic like haloperidol.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenztropine\u003c/b\u003e combats the motor symptoms of Parkinson\u0027s and antipsychotic side effects by blocking central acetylcholine activity, thereby counteracting the relative cholinergic overactivity that results from dopamine deficiency or blockade in the basal ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"96e8bf39\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"extrapyramidal_symptoms\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"acute_dystonia\"\n      }\n    ]\n  },\n  \"a9f6d703\": {\n    \"title\": \"Berry Aneurysm\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eBerry Aneurysm\u003c/b\u003e, also known as a saccular aneurysm, is a thin-walled, sac-like outpouching of a cerebral artery, typically located at arterial branch points within the [[e22300e8|Circle of Willis]]. Its rupture is the most common cause of non-traumatic [[63f8b05f|subarachnoid hemorrhage]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found at the junction of the [[bd802d22|anterior communicating artery (AComA)]] with the anterior cerebral artery. The second most common site is the junction of the posterior communicating artery (PComA) with the internal carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to form due to a congenital weakness in the vessel wall (lack of tunica media) at arterial bifurcations, which is exacerbated over time by hemodynamic stress from hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Increased incidence in patients with \u003cmark\u003eAutosomal Dominant Polycystic Kidney Disease (ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, and Marfan syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Usually asymptomatic until rupture. Rupture causes a [[63f8b05f|subarachnoid hemorrhage]], presenting with a sudden, explosive \u003cmark\u003e\\\"worst headache of my life.\\\"\u003c/mark\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A PComA aneurysm can compress the ipsilateral [[68c66997|oculomotor nerve (CN III)]], causing a painful third nerve palsy with a dilated, nonreactive pupil (\u0027blown pupil\u0027). This is a neurosurgical emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBerry aneurysms\u003c/b\u003e are silent vascular time bombs located at the branch points of the Circle of Willis; their rupture leads to a devastating subarachnoid hemorrhage, classically presenting as a \u0027thunderclap headache\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Arterial Bifurcation in Circle of Willis] --\u003e B(Congenital Wall Weakness); B --Hypertension--\u003e C(Berry Aneurysm Formation); C --\u003e D{Rupture}; D --\u003e E[Subarachnoid Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"a7f97d7f\"\n      },\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"autosomal_dominant_polycystic_kidney_disease\"\n      },\n      {\n        \"type\": \"most_common_location_is\",\n        \"to\": \"bd802d22\"\n      }\n    ]\n  },\n  \"43508d57\": {\n    \"title\": \"Betaxolol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBetaxolol\u003c/b\u003e is a \u003ci\u003eŒ≤\u003csub\u003e1\u003c/sub\u003e-selective adrenergic antagonist\u003c/i\u003e (beta-blocker) used primarily in ophthalmology as eye drops to treat [[3ce6c035|glaucoma]] and ocular hypertension. It is also available in oral form for the treatment of systemic hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Glaucoma):\u003c/b\u003e When applied topically to the eye, it blocks Œ≤-adrenergic receptors on the ciliary epithelium, leading to a \u003cmark\u003edecrease in aqueous humor production\u003c/mark\u003e and thus lowering intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelectivity:\u003c/b\u003e As a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective blocker, it has less of an effect on Œ≤\u003csub\u003e2\u003c/sub\u003e receptors in the lungs compared to non-selective beta-blockers like timolol.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat [[5ea7b741|open-angle glaucoma]]. Its Œ≤\u003csub\u003e1\u003c/sub\u003e-selectivity makes it a safer option for patients with asthma or COPD compared to non-selective beta-blockers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular effects can include stinging and burning. Although it is Œ≤\u003csub\u003e1\u003c/sub\u003e-selective, systemic absorption can still occur and may cause bradycardia, hypotension, and fatigue. Caution is still advised in patients with respiratory conditions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a glaucoma patient with a history of asthma, a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective blocker like betaxolol is a more appropriate choice than a non-selective one like timolol to minimize the risk of bronchoconstriction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBetaxolol\u003c/b\u003e lowers intraocular pressure in glaucoma by reducing aqueous humor production, and its key feature is its Œ≤\u003csub\u003e1\u003c/sub\u003e-selectivity, which offers a safer profile for patients with underlying pulmonary disease compared to non-selective beta-blockers.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"beta_blocker\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"beta_1_adrenergic_receptor\"\n      }\n    ]\n  },\n  \"f36cfe18\": {\n    \"title\": \"Biceps Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBiceps reflex\u003c/b\u003e is a deep tendon reflex that causes flexion of the elbow when the biceps brachii tendon is tapped. It is used to test the integrity of the \u003cmark\u003eC5 and C6\u003c/mark\u003e spinal nerve roots and the musculocutaneous nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC5\u003c/b\u003e nerve root, with a contribution from C6. Mnemonic: C\u003cb\u003e5\u003c/b\u003e, 6, pick up sticks.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the biceps tendon stretches the muscle spindle in the biceps muscle. The afferent signal travels via the musculocutaneous nerve to the C5/C6 spinal cord segments. It synapses with a motor neuron, and the efferent signal returns via the musculocutaneous nerve to cause contraction of the biceps muscle and elbow flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C5 root or a peripheral neuropathy affecting the musculocutaneous nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the C5 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The biceps reflex, along with sensation over the lateral arm and deltoid/biceps strength, is a key part of the C5 neurological exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBiceps reflex\u003c/b\u003e is a fundamental component of the neurological exam, providing a quick and reliable assessment of the C5 and C6 nerve roots and the integrity of the reflex arc through the cervical spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Biceps Tendon] --\u003e B(Stretch Biceps Muscle); B --\u003e C(Afferent Signal via Musculocutaneous N.); C --\u003e D[C5/C6 Spinal Cord]; D --\u003e E(Efferent Signal via Musculocutaneous N.); E --\u003e F(Biceps Contraction/Elbow Flexion);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c5_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c6_nerve_root\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"188b4a47\": {\n    \"title\": \"Bimatoprost\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBimatoprost\u003c/b\u003e is a \u003ci\u003eprostaglandin analog\u003c/i\u003e used topically as an eye drop to reduce intraocular pressure (IOP) in patients with [[5ea7b741|open-angle glaucoma]] or ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a synthetic prostamide analog that mimics the action of prostaglandins (specifically PGF\u003csub\u003e2Œ±\u003c/sub\u003e). It lowers IOP by \u003cmark\u003eincreasing the outflow of aqueous humor\u003c/mark\u003e through the secondary, or \u003cmark\u003euveoscleral pathway\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A first-line agent for the treatment of [[5ea7b741|open-angle glaucoma]] due to its high efficacy and once-daily dosing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are ocular hyperemia (redness), stinging, and a notable cosmetic side effect of \u003cmark\u003eincreased eyelash growth\u003c/mark\u003e (length and darkness). A permanent side effect can be darkening of the iris color (browning).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Other prostaglandin analogs include latanoprost and travoprost, all sharing a similar mechanism and side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The unique side effect of eyelash growth has been exploited for cosmetic use (Latisse). Remember that prostaglandin analogs work by increasing outflow, whereas beta-blockers decrease production of aqueous humor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBimatoprost\u003c/b\u003e is a highly effective first-line glaucoma medication that lowers eye pressure by enhancing the uveoscleral outflow of aqueous humor, with the well-known and cosmetically exploited side effect of promoting eyelash growth.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Bimatoprost] --\u003e B(Acts on Prostaglandin Receptors); B --\u003e C(‚Üë Uveoscleral Outflow); C --\u003e D(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"prostaglandin_analog\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"increases\",\n        \"to\": \"uveoscleral_outflow\"\n      }\n    ]\n  },\n  \"6c3a980e\": {\n    \"title\": \"Bitemporal Hemianopia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual Field Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBitemporal hemianopia\u003c/b\u003e is a specific type of partial blindness characterized by the loss of vision in the outer (temporal) halves of the visual fields of both eyes. It is classically caused by a lesion compressing the central part of the \u003cmark\u003eoptic chiasm\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Loss of the temporal (lateral) visual fields in both eyes, often described as \\\"tunnel vision.\\\"\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The optic chiasm is where the nasal retinal fibers from each eye decussate (cross over). These nasal fibers are responsible for perceiving the temporal visual fields. A midline lesion at the chiasm selectively damages these crossing fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e The most common cause is a \u003cmark\u003e[[5f3188bd|pituitary adenoma]]\u003c/mark\u003e growing upward from the sella turcica and compressing the chiasm from below.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Other suprasellar masses like a [[7048db1e|craniopharyngioma]] or an aneurysm of the [[bd802d22|anterior communicating artery]] can also cause this defect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with \\\"tunnel vision\\\" or complaining of bumping into things on either side, especially if accompanied by endocrine symptoms (e.g., galactorrhea, acromegaly), is a classic vignette for a [[5f3188bd|pituitary adenoma]] causing bitemporal hemianopia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBitemporal hemianopia\u003c/b\u003e is the quintessential sign of optic chiasm compression, resulting from the selective damage to the crossing nasal retinal fibers and creating a characteristic \u0027tunnel vision\u0027 that points directly to a midline suprasellar pathology like a pituitary adenoma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion at Optic Chiasm] --Compresses--\u003e B(Crossing Nasal Retinal Fibers); B --\u003e C(Loss of Temporal Visual Fields); C --\u003e D(Bitemporal Hemianopia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_at\",\n        \"to\": \"optic_chiasm\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"5f3188bd\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"7048db1e\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"bd802d22\"\n      }\n    ]\n  },\n  \"8056ce48\": {\n    \"title\": \"Blepharitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Eyelid Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBlepharitis\u003c/b\u003e is a common inflammatory condition of the eyelids, typically involving the part of the eyelid where the eyelashes grow. It is characterized by inflammation, irritation, itching, and crusting of the eyelid margins.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterior Blepharitis:\u003c/b\u003e Affects the outside front of the eyelid, where the eyelashes are attached. Often caused by bacteria (\u003ci\u003eStaphylococcus\u003c/i\u003e) or seborrheic dermatitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePosterior Blepharitis:\u003c/b\u003e Affects the inner eyelid (the moist part that makes contact with the eye). Caused by dysfunction of the meibomian glands (Meibomian Gland Dysfunction - MGD). Associated with skin conditions like rosacea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Red, swollen, or itchy eyelids; gritty or burning sensation in the eyes; crusty debris at the base of the eyelashes upon waking; flaking of skin around the eyes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to [[hordeolum|hordeola (styes)]], [[193c24ec|chalazia]], dry eyes, or chronic conjunctivitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The cornerstone of treatment is \u003cmark\u003eeyelid hygiene\u003c/mark\u003e, including warm compresses and gentle scrubbing of the eyelid margins. Topical antibiotics or steroids may be used in some cases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for a patient complaining of chronic eye irritation with crusting on the eyelashes, especially in the morning. This is a classic description of blepharitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBlepharitis\u003c/b\u003e is a chronic inflammation of the eyelid margins, akin to dandruff of the eyelashes, which is managed primarily through diligent eyelid hygiene to control symptoms and prevent complications like styes and chalazia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"eyelid_disorder\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"hordeolum\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"193c24ec\"\n      }\n    ]\n  },\n  \"dd47b9cc\": {\n    \"title\": \"Blood-Brain Barrier (BBB)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBlood-Brain Barrier (BBB)\u003c/b\u003e is a highly selective semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively crossing into the extracellular fluid of the central nervous system where neurons reside.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Components:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[5206aa83|Tight junctions]]\u003c/b\u003e between non-fenestrated capillary endothelial cells.\u003cbr\u003e2. A thick \u003cb\u003e[[c335e16d|Basement Membrane]]\u003c/b\u003e.\u003cbr\u003e3. \u003cb\u003eAstrocyte foot processes\u003c/b\u003e that surround the capillary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Protects the brain from circulating toxins, pathogens, and fluctuations in plasma composition. It maintains a stable CNS environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransport Across BBB:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLipid-soluble\u003c/b\u003e substances (e.g., O\u003csub\u003e2\u003c/sub\u003e, CO\u003csub\u003e2\u003c/sub\u003e, anesthetics) can diffuse freely.\u003cbr\u003e - \u003cb\u003eWater-soluble\u003c/b\u003e substances (e.g., glucose, [[9115b704|amino acids]]) require specific \u003cmark\u003ecarrier-mediated transport\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCircumventricular Organs:\u003c/b\u003e Areas of the brain that lack a BBB, allowing them to monitor the chemical composition of the blood. These include the [[5dd343d3|area postrema]] (chemoreceptor trigger zone for vomiting) and parts of the [[89e86633|hypothalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Breakdown of the BBB leads to vasogenic edema. Some antibiotics (e.g., penicillins) have poor CNS penetration but can cross an inflamed BBB during meningitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBlood-Brain Barrier\u003c/b\u003e is a sophisticated neurovascular unit, not just a simple wall, that uses tight junctions, a robust basement membrane, and astrocyte support to create a highly regulated interface, ensuring the brain\u0027s chemical environment remains pristine and protected.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Capillary Lumen] --\u003e B(Endothelial Cell); B --Tight Junctions--\u003e B; B --\u003e C(Basement Membrane); C --\u003e D(Astrocyte Foot Processes); D --\u003e E[Brain Parenchyma];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"5206aa83\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"c335e16d\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"5dd343d3\"\n      }\n    ]\n  },\n  \"03ba9967\": {\n    \"title\": \"Blood-Nerve Barrier\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBlood-Nerve Barrier\u003c/b\u003e is a physiological barrier in the peripheral nervous system that regulates the passage of substances from the blood into the endoneurial space, maintaining a stable microenvironment for peripheral nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The main cellular component is the \u003cmark\u003eperineurium\u003c/mark\u003e, which consists of layers of flattened perineurial cells joined by tight junctions. Tight junctions between endothelial cells of the endoneurial capillaries also contribute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Protects peripheral nerves from toxins, pathogens, and inflammatory cells, similar to the role of the [[dd47b9cc|blood-brain barrier]] in the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to BBB:\u003c/b\u003e While analogous to the BBB, the blood-nerve barrier is generally considered less restrictive.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Breakdown of the blood-nerve barrier is a key feature of inflammatory neuropathies like [[ed52e40b|Guillain-Barr√© syndrome]]. This breakdown allows inflammatory cells and proteins to enter the endoneurial space, leading to demyelination and axonal damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The breakdown of the blood-nerve barrier in [[ed52e40b|Guillain-Barr√© syndrome]] explains the classic CSF finding of [[a0f3ce4c|albuminocytologic dissociation]]‚Äîhigh protein (leaking from the blood) with a normal cell count.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBlood-Nerve Barrier\u003c/b\u003e, formed primarily by the tight junctions of the perineurium, serves as the protective gatekeeper for peripheral nerves; its disruption in inflammatory conditions like Guillain-Barr√© syndrome allows an autoimmune assault on the nerves.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_analogous_to\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_disrupted_in\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"is_formed_by\",\n        \"to\": \"perineurium\"\n      }\n    ]\n  },\n  \"6ab4b0f2\": {\n    \"title\": \"Blown Pupil\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003e\\\"blown pupil\\\"\u003c/b\u003e is a clinical term for a fixed, dilated pupil (mydriasis) that is nonreactive to light. It is a critical sign of compression of the [[68c66997|oculomotor nerve (CN III)]], often indicating a life-threatening increase in intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e The parasympathetic fibers that control pupillary constriction run along the superficial, peripheral aspect of the [[68c66997|oculomotor nerve]]. These fibers are highly susceptible to external compression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e \u003cmark\u003eUncal herniation\u003c/mark\u003e, where the uncus of the temporal lobe herniates over the tentorium cerebelli and compresses the ipsilateral CN III.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Aneurysm of the \u003cmark\u003eposterior communicating artery (PComA)\u003c/mark\u003e, which is anatomically close to CN III, can also cause compression and a blown pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A unilateral blown pupil is an ominous sign of rapidly increasing intracranial pressure and impending brainstem compression. It is a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs:\u003c/b\u003e Often accompanied by other signs of a CN III palsy, such as ptosis and a \\\"down and out\\\" deviation of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with head trauma and a deteriorating level of consciousness, the sudden appearance of a unilateral fixed and dilated pupil indicates uncal herniation and requires immediate intervention.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eblown pupil\u003c/b\u003e is a neurological red flag, signaling compression of the parasympathetic fibers on the outside of the oculomotor nerve, most often by uncal herniation or a PComA aneurysm, and indicates a dire, time-sensitive emergency.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(Uncal Herniation); B --Compresses--\u003e C(CN III Parasympathetic Fibers); C --\u003e D(Loss of Pupillary Constriction); D --\u003e E(Fixed, Dilated Pupil);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"oculomotor_nerve_compression\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"uncal_herniation\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"posterior_communicating_artery_aneurysm\"\n      }\n    ]\n  },\n  \"aebb10eb\": {\n    \"title\": \"Blowout Fracture\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Trauma\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eblowout fracture\u003c/b\u003e is a traumatic fracture of the walls of the orbit, most commonly the orbital floor, caused by a sudden increase in intraorbital pressure from a direct blow to the globe (e.g., from a fist or a ball).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e A blunt, non-penetrating force strikes the globe, transmitting pressure throughout the orbit. The thin orbital floor (roof of the maxillary sinus) and/or medial wall (lamina papyracea of the ethmoid sinus) fracture, or \u0027blow out.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with periorbital pain, swelling, and ecchymosis. Key signs include \u003cmark\u003ediplopia on upward gaze\u003c/mark\u003e and numbness of the cheek and upper teeth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle Entrapment:\u003c/b\u003e The fracture can entrap the \u003cmark\u003einferior rectus muscle\u003c/mark\u003e and/or orbital fat. This entrapment restricts upward movement of the eye, causing vertical diplopia, especially on upgaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Injury:\u003c/b\u003e The fracture of the orbital floor can damage the \u003cmark\u003einfraorbital nerve\u003c/mark\u003e (a branch of CN V\u003csub\u003e2\u003c/sub\u003e), leading to paresthesia or numbness of the ipsilateral cheek, upper lip, and upper gingiva.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a history of blunt eye trauma, diplopia on upward gaze, and numbness of the cheek is classic for an orbital blowout fracture with inferior rectus entrapment and infraorbital nerve injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eblowout fracture\u003c/b\u003e is a hydraulic fracture of the thin orbital floor, where the force of a blow to the eye is transmitted to the surrounding bone, leading to entrapment of the inferior rectus muscle and injury to the infraorbital nerve, manifesting as an inability to look up and a numb cheek.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_cause_entrapment_of\",\n        \"to\": \"inferior_rectus_muscle\"\n      },\n      {\n        \"type\": \"can_cause_injury_to\",\n        \"to\": \"infraorbital_nerve\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"9914d433\"\n      }\n    ]\n  },\n  \"869535a9\": {\n    \"title\": \"Bone Morphogenetic Protein (BMP)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Developmental Biology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBone Morphogenetic Proteins (BMPs)\u003c/b\u003e are a group of growth factors belonging to the transforming growth factor-beta (TGF-Œ≤) superfamily. In neuroembryology, they play a crucial role in establishing the dorsal-ventral axis of the neural tube by inducing the development of the dorsal structures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction in Neurodevelopment:\u003c/b\u003e Secreted by the overlying ectoderm, BMPs act as a signaling molecule that patterns the dorsal neural tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDorsalization:\u003c/b\u003e High concentrations of BMPs induce the formation of the \u003cmark\u003e[[43be7a6e|alar plate]]\u003c/mark\u003e, which gives rise to sensory neurons in the dorsal horn of the spinal cord and sensory nuclei of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart Signal:\u003c/b\u003e The ventralizing signal is \u003cmark\u003eSonic Hedgehog (SHH)\u003c/mark\u003e, which is secreted by the notochord and induces the formation of the [[253e3efb|basal plate]] (motor neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGradient Effect:\u003c/b\u003e The opposing gradients of BMP (high dorsally) and SHH (high ventrally) establish the distinct sensory (dorsal) and motor (ventral) domains of the developing central nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the source and effect: BMP from the ectoderm (roof) induces the dorsal/sensory alar plate. SHH from the notochord (floor) induces the ventral/motor basal plate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBone Morphogenetic Protein\u003c/b\u003e acts as the key \u0027dorsalizing\u0027 signal in the developing neural tube, instructing the dorsal region to become the sensory [[43be7a6e|alar plate]], thereby establishing the fundamental sensory-motor polarity of the central nervous system in opposition to the ventralizing signal, Sonic Hedgehog.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ectoderm] --Secretes--\u003e B(BMPs); B --Induces--\u003e C(Dorsal Neural Tube); C --\u003e D(Alar Plate); D --\u003e E(Sensory Neurons);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"induces_development_of\",\n        \"to\": \"43be7a6e\"\n      },\n      {\n        \"type\": \"is_counteracted_by\",\n        \"to\": \"sonic_hedgehog\"\n      },\n      {\n        \"type\": \"is_secreted_by\",\n        \"to\": \"ectoderm\"\n      }\n    ]\n  },\n  \"84b10400\": {\n    \"title\": \"Botulinum Toxin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Microbiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBotulinum toxin\u003c/b\u003e is a potent neurotoxin produced by the bacterium \u003ci\u003eClostridium botulinum\u003c/i\u003e. It causes flaccid paralysis by inhibiting the presynaptic release of [[6a005559|acetylcholine]] at the neuromuscular junction. In small, purified doses, it is used therapeutically for a variety of medical and cosmetic purposes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The toxin is a protease that cleaves \u003cmark\u003eSNARE proteins\u003c/mark\u003e (e.g., SNAP-25, synaptobrevin), which are essential for the fusion of acetylcholine-containing vesicles with the presynaptic membrane. This prevents ACh release.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedical Uses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSpasticity/Dystonia:\u003c/b\u003e Treats focal dystonias (e.g., torticollis, blepharospasm), spasticity in [[171ca00b|cerebral palsy]] and [[45dd6d19|multiple sclerosis]].\u003cbr\u003e - \u003cb\u003ePain:\u003c/b\u003e Prophylaxis for chronic [[c8833bae|migraine headaches]].\u003cbr\u003e - \u003cb\u003eOther:\u003c/b\u003e Hyperhidrosis (excessive sweating), strabismus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCosmetic Use:\u003c/b\u003e Injected to reduce facial wrinkles by temporarily paralyzing underlying muscles (Botox).\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxicity (Botulism):\u003c/b\u003e Ingestion of the toxin (e.g., from improperly canned foods) causes botulism, a life-threatening illness characterized by descending flaccid paralysis, diplopia, dysphagia, and respiratory failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that botulinum toxin causes a \u003cu\u003epresynaptic\u003c/u\u003e blockade of ACh release, which contrasts with myasthenia gravis (postsynaptic receptor blockade) and Lambert-Eaton syndrome (presynaptic Ca\u003csup\u003e2+\u003c/sup\u003e channel blockade).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBotulinum toxin\u003c/b\u003e induces paralysis by enzymatically snipping the SNARE proteins required for acetylcholine release at the neuromuscular junction; this potent biological mechanism is harnessed in medicine to selectively weaken overactive muscles in conditions from dystonia to cosmetic wrinkles.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Botulinum Toxin] --\u003e B(Cleaves SNARE Proteins); B --x C(Vesicle Fusion); C --x D(ACh Release); D --x E(Muscle Contraction); E --\u003e F(Flaccid Paralysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"inhibits_release_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"dystonia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \"is_produced_by\",\n        \"to\": \"clostridium_botulinum\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10179,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"c7ce09b2\": {\n    \"title"
      }, {
        "text": "\": \"Benzocaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anesthesiology\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenzocaine\u003c/b\u003e is an"
      }, {
        "text": " ester-type \u003ci\u003elocal anesthetic\u003c/i\u003e used topically to numb surfaces such as the skin, mouth, and throat. It works"
      }, {
        "text": " by blocking voltage-gated sodium channels in nerve membranes, thereby preventing the propagation of action potentials.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing nerve"
      }, {
        "text": " depolarization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Ester local anesthetic. Patients with allergies to esters (e.g., procaine) may"
      }, {
        "text": " also react to benzocaine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Commonly found in over-the-counter products for teething"
      }, {
        "text": " pain, sore throats (sprays), and sunburn relief. Used in medical settings as a topical anesthetic for procedures like endoscopy."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effect:\u003c/b\u003e A well-known cause of acquired \u003cmark\u003emethemoglobinemia\u003c/mark\u003e,"
      }, {
        "text": " especially in infants and young children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMethemoglobinemia:\u003c/b\u003e Benzocaine oxidizes the iron in hemoglobin from"
      }, {
        "text": " the ferrous (Fe\u003csup\u003e2+\u003c/sup\u003e) to the ferric (Fe\u003csup\u003e3+\u003c/sup\u003e) state. Methemoglobin cannot"
      }, {
        "text": " bind oxygen, leading to functional anemia and cyanosis that does not improve with supplemental oxygen. Blood appears \u0027chocolate brown\u0027. Treated"
      }, {
        "text": " with methylene blue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A vignette describing a patient who develops cyanosis and shortness of breath shortly"
      }, {
        "text": " after an endoscopic procedure (where a topical anesthetic spray was used) should immediately raise suspicion for benzocaine-induced methemoglobinemia."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenzocaine\u003c/b\u003e is a widely used topical anesthetic that carries"
      }, {
        "text": " the rare but life-threatening risk of inducing methemoglobinemia, a condition where hemoglobin\u0027s iron is oxidized,"
      }, {
        "text": " rendering it unable to transport oxygen and causing a characteristic \u0027chocolate brown\u0027 blood appearance and cyanosis.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"causes_adverse_effect\",\n        \"to\": \"methemoglobinemia\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"14464617\": {\n    \"title\": \"Benzodiazepines\",\n    \""
      }, {
        "text": "primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eBenzodiazepines\u003c/b\u003e are a class of psychoactive drugs that act as positive allosteric modulators of the GABA"
      }, {
        "text": "\u003csub\u003eA\u003c/sub\u003e receptor, resulting in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to an allosteric site on the GABA\u003csub\u003e"
      }, {
        "text": "A\u003c/sub\u003e receptor, increasing the \u003cmark\u003e\u003cu\u003efrequency\u003c/u\u003e\u003c/mark\u003e of chloride channel opening in response to GABA."
      }, {
        "text": " Mnemonic: \u003cb\u003eFre\u003c/b\u003enzodiazepines increase \u003cb\u003efre\u003c/b\u003equency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Uses:\u003c/b\u003e Anxiety"
      }, {
        "text": " disorders, panic attacks, status epilepticus (lorazepam, diazepam), alcohol withdrawal, insomnia, and procedural sedation/"
      }, {
        "text": "anesthesia (midazolam).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Classified by duration of action. Short-acting ("
      }, {
        "text": "e.g., [[083094db|alprazolam]], midazolam) have higher abuse potential. Long-acting (e"
      }, {
        "text": ".g., diazepam, chlordiazepoxide) are preferred for alcohol withdrawal. Those not metabolized by the liver (\u003cb\u003e"
      }, {
        "text": "O\u003c/b\u003exazepam, \u003cb\u003eT\u003c/b\u003eemazepam, \u003cb\u003eL\u003c/b\u003eorazepam - \u0027Outside The Liver\u0027) are safer"
      }, {
        "text": " in patients with hepatic dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance, withdrawal symptoms. Add"
      }, {
        "text": "itive CNS depression with other depressants like alcohol and barbiturates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e Overdose can be treated"
      }, {
        "text": " with \u003cmark\u003eflumazenil\u003c/mark\u003e, a competitive antagonist at the benzodiazepine binding site on the GABA\u003csub\u003eA\u003c/sub\u003e receptor"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from [[52564aea|barbiturates]],"
      }, {
        "text": " which increase the \u003cu\u003eduration\u003c/u\u003e of channel opening and have a higher risk of fatal respiratory depression.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eBenzodiazepines\u003c/b\u003e are versatile CNS depressants that enhance GABA\u0027s inhibitory effects by increasing the frequency"
      }, {
        "text": " of chloride channel opening, but their use is tempered by the significant risks of dependence and additive depression with other substances.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Benzodiazepine] --\u003e B(Binds to GABA-A Receptor); B --\u003e C"
      }, {
        "text": "(‚Üë Frequency of Cl- Channel Opening); C --\u003e D(‚Üë Cl- Influx); D --\u003e E(Hyper"
      }, {
        "text": "polarization of Neuron); E --\u003e F(CNS Depression/Anxiolysis);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"treats\",\n        \"to\": \"d1c786e9\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"treats\",\n        \"to\": \"status_epilepticus\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"52564aea\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"383f6fbe\": {\n    \"title\":"
      }, {
        "text": " \"Benztropine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease"
      }, {
        "text": " Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBenztropine\u003c/b\u003e is a centrally acting \u003ci\u003e"
      }, {
        "text": "antimuscarinic (anticholinergic) drug\u003c/i\u003e used primarily to treat the symptoms of [[58c8"
      }, {
        "text": "ea03|Parkinson disease]] and to manage extrapyramidal side effects (EPS) caused by antipsychotic medications"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at central"
      }, {
        "text": " muscarinic receptors, helping to restore the dopaminergic-cholinergic balance in the [[ed4629"
      }, {
        "text": "27|basal ganglia]] that is disrupted in Parkinson\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Primarily"
      }, {
        "text": " effective for treating \u003cmark\u003etremor and rigidity\u003c/mark\u003e. It has little effect on bradykinesia. Mnemonic: \u0027"
      }, {
        "text": "\u003cb\u003eTri\u003c/b\u003e to \u003cb\u003ePark\u003c/b\u003e my Mercedes-\u003cb\u003eBenz\u003c/b\u003e\u0027 (\u003cb\u003eTri\u003c/b\u003ehexyphenidyl and"
      }, {
        "text": " \u003cb\u003eBenz\u003c/b\u003etropine for \u003cb\u003ePark\u003c/b\u003einson\u0027s).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (EPS):\u003c/b\u003e Effective"
      }, {
        "text": " for treating \u003cmark\u003eacute dystonia\u003c/mark\u003e and drug-induced parkinsonism caused by dopamine antagonists (antipsychotics).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Classic anticholinergic side effects: dry mouth, blurred vision, constipation, urinary retention, tachycardia, and confusion/"
      }, {
        "text": "delirium, especially in the elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Benztropine is the go"
      }, {
        "text": "-to drug for treating a patient who develops an acute dystonic reaction (e.g., torticollis, oculogyric crisis) after"
      }, {
        "text": " starting an antipsychotic like haloperidol.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBenztropine\u003c/b\u003e combats"
      }, {
        "text": " the motor symptoms of Parkinson\u0027s and antipsychotic side effects by blocking central acetylcholine activity, thereby counteracting the relative cholinergic"
      }, {
        "text": " overactivity that results from dopamine deficiency or blockade in the basal ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        "
      }, {
        "text": "\"to\": \"96e8bf39\"\n      },\n      {\n        \"type\": \"treats\","
      }, {
        "text": "\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n"
      }, {
        "text": "        \"to\": \"extrapyramidal_symptoms\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"treats\",\n        \"to\": \"acute_dystonia\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"a9f6d703\": {\n    \"title\": \"Berry Aneurysm\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eBerry Aneurysm\u003c/b\u003e, also known as a saccular aneurysm,"
      }, {
        "text": " is a thin-walled, sac-like outpouching of a cerebral artery, typically located at arterial branch points within"
      }, {
        "text": " the [[e22300e8|Circle of Willis]]. Its rupture is the most common cause of non"
      }, {
        "text": "-traumatic [[63f8b05f|subarachnoid hemorrhage]].\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found at the junction of the [[bd802d"
      }, {
        "text": "22|anterior communicating artery (AComA)]] with the anterior cerebral artery. The second most common site is the junction of the posterior"
      }, {
        "text": " communicating artery (PComA) with the internal carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to form"
      }, {
        "text": " due to a congenital weakness in the vessel wall (lack of tunica media) at arterial bifurcations, which is exacerbated"
      }, {
        "text": " over time by hemodynamic stress from hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Increased incidence in patients with \u003cmark\u003eAut"
      }, {
        "text": "osomal Dominant Polycystic Kidney Disease (ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, and"
      }, {
        "text": " Marfan syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Usually asymptomatic until rupture. Rupture causes a [[63f8b05f"
      }, {
        "text": "|subarachnoid hemorrhage]], presenting with a sudden, explosive \u003cmark\u003e\\\"worst headache of my life.\\\"\u003c/mark\u003e"
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A PComA aneurysm can compress the ipsilateral [[68c669"
      }, {
        "text": "97|oculomotor nerve (CN III)]], causing a painful third nerve palsy with a dilated, nonreactive"
      }, {
        "text": " pupil (\u0027blown pupil\u0027). This is a neurosurgical emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBerry aneur"
      }, {
        "text": "ysms\u003c/b\u003e are silent vascular time bombs located at the branch points of the Circle of Willis; their rupture leads to a devastating"
      }, {
        "text": " subarachnoid hemorrhage, classically presenting as a \u0027thunderclap headache\u0027.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Arterial Bifurcation in Circle of Willis] --\u003e B(Congenital Wall Weak"
      }, {
        "text": "ness); B --Hypertension--\u003e C(Berry Aneurysm Formation); C --\u003e D{Rupture}; D --\u003e E["
      }, {
        "text": "Subarachnoid Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"a7f97d7f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"autosomal_dominant_polyc"
      }, {
        "text": "ystic_kidney_disease\"\n      },\n      {\n        \"type\": \"most_common_location_is\","
      }, {
        "text": "\n        \"to\": \"bd802d22\"\n      }\n    ]\n  },\n  \"4"
      }, {
        "text": "3508d57\": {\n    \"title\": \"Betaxolol\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Cardiology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eBetaxolol\u003c/b\u003e is a \u003ci\u003eŒ≤\u003csub\u003e1\u003c/sub\u003e-selective adrenergic antagonist\u003c/i\u003e"
      }, {
        "text": " (beta-blocker) used primarily in ophthalmology as eye drops to treat [[3ce6c035|"
      }, {
        "text": "glaucoma]] and ocular hypertension. It is also available in oral form for the treatment of systemic hypertension.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Glaucoma):\u003c/b\u003e When applied topically to the eye, it blocks"
      }, {
        "text": " Œ≤-adrenergic receptors on the ciliary epithelium, leading to a \u003cmark\u003edecrease in aqueous humor production\u003c/mark\u003e"
      }, {
        "text": " and thus lowering intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelectivity:\u003c/b\u003e As a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective blocker, it has less of"
      }, {
        "text": " an effect on Œ≤\u003csub\u003e2\u003c/sub\u003e receptors in the lungs compared to non-selective beta-blockers like timolol.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat [[5ea7b741|open-angle glaucoma]]. Its"
      }, {
        "text": " Œ≤\u003csub\u003e1\u003c/sub\u003e-selectivity makes it a safer option for patients with asthma or COPD compared to non-selective beta-blockers"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular effects can include stinging and burning. Although it is Œ≤\u003csub\u003e1\u003c/sub\u003e-selective, systemic"
      }, {
        "text": " absorption can still occur and may cause bradycardia, hypotension, and fatigue. Caution is still advised in patients with respiratory conditions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e For a glaucoma patient with a history of asthma, a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective blocker like betaxolol is a more"
      }, {
        "text": " appropriate choice than a non-selective one like timolol to minimize the risk of bronchoconstriction.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eBetaxolol\u003c/b\u003e lowers intraocular pressure in glaucoma by reducing aqueous humor production, and"
      }, {
        "text": " its key feature is its Œ≤\u003csub\u003e1\u003c/sub\u003e-selectivity, which offers a safer profile for patients with underlying pulmonary disease compared to non-selective beta-"
      }, {
        "text": "blockers.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"beta_blocker\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6"
      }, {
        "text": "c035\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\":"
      }, {
        "text": " \"beta_1_adrenergic_receptor\"\n      }\n    ]\n  },\n  \"f36"
      }, {
        "text": "cfe18\": {\n    \"title\": \"Biceps Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sp"
      }, {
        "text": "inal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBiceps reflex\u003c/b\u003e is a"
      }, {
        "text": " deep tendon reflex that causes flexion of the elbow when the biceps brachii tendon is tapped. It is used to test the integrity of the \u003c"
      }, {
        "text": "mark\u003eC5 and C6\u003c/mark\u003e spinal nerve roots and the musculocutaneous nerve.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC5\u003c/b\u003e nerve root, with a"
      }, {
        "text": " contribution from C6. Mnemonic: C\u003cb\u003e5\u003c/b\u003e, 6, pick up sticks.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e Tapping the biceps tendon stretches the muscle spindle in the biceps muscle. The afferent signal travels via the muscul"
      }, {
        "text": "ocutaneous nerve to the C5/C6 spinal cord segments. It synapses with a motor neuron, and the eff"
      }, {
        "text": "erent signal returns via the musculocutaneous nerve to cause contraction of the biceps muscle and elbow flexion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDim"
      }, {
        "text": "inished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C5 root"
      }, {
        "text": " or a peripheral neuropathy affecting the musculocutaneous nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggest"
      }, {
        "text": "s an upper motor neuron lesion, such as a stroke or spinal cord injury above the C5 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e The biceps reflex, along with sensation over the lateral arm and deltoid/biceps strength, is a key"
      }, {
        "text": " part of the C5 neurological exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBiceps reflex\u003c/b\u003e is a fundamental"
      }, {
        "text": " component of the neurological exam, providing a quick and reliable assessment of the C5 and C6 nerve roots and the integrity"
      }, {
        "text": " of the reflex arc through the cervical spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap"
      }, {
        "text": " Biceps Tendon] --\u003e B(Stretch Biceps Muscle); B --\u003e C(Afferent Signal via Musculocutaneous"
      }, {
        "text": " N.); C --\u003e D[C5/C6 Spinal Cord]; D --\u003e E(Efferent Signal via Musculocut"
      }, {
        "text": "aneous N.); E --\u003e F(Biceps Contraction/Elbow Flexion);\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c5_nerve_"
      }, {
        "text": "root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \""
      }, {
        "text": "to\": \"c6_nerve_root\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"188b4a47\": {\n    \"title\": \"Bimatoprost\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eBimatoprost\u003c/b\u003e is a \u003ci\u003eprostaglandin analog\u003c/i\u003e used topically as an eye drop to"
      }, {
        "text": " reduce intraocular pressure (IOP) in patients with [[5ea7b741|open-angle glaucoma]]"
      }, {
        "text": " or ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a synthetic"
      }, {
        "text": " prostamide analog that mimics the action of prostaglandins (specifically PGF\u003csub\u003e2Œ±\u003c/sub\u003e). It lowers IOP by \u003cmark\u003eincreasing"
      }, {
        "text": " the outflow of aqueous humor\u003c/mark\u003e through the secondary, or \u003cmark\u003euveoscleral pathway\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use:\u003c/b\u003e A first-line agent for the treatment of [[5ea7b741|open-angle glaucoma]]"
      }, {
        "text": " due to its high efficacy and once-daily dosing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are ocular"
      }, {
        "text": " hyperemia (redness), stinging, and a notable cosmetic side effect of \u003cmark\u003eincreased eyelash growth\u003c/mark\u003e (length and darkness)."
      }, {
        "text": " A permanent side effect can be darkening of the iris color (browning).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Other prostaglandin analogs include"
      }, {
        "text": " latanoprost and travoprost, all sharing a similar mechanism and side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " unique side effect of eyelash growth has been exploited for cosmetic use (Latisse). Remember that prostaglandin analogs work by increasing outflow, whereas"
      }, {
        "text": " beta-blockers decrease production of aqueous humor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBimatoprost\u003c/b\u003e is a highly"
      }, {
        "text": " effective first-line glaucoma medication that lowers eye pressure by enhancing the uveoscleral outflow of aqueous humor, with the well"
      }, {
        "text": "-known and cosmetically exploited side effect of promoting eyelash growth.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Bimatoprost] --\u003e B(Acts on Prostaglandin Receptors); B --\u003e C(‚Üë Uveoscleral Outflow);"
      }, {
        "text": " C --\u003e D(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"prostaglandin_analog\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"increases\",\n        \"to\": \"uveoscleral_outflow\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"6c3a980e\": {\n    \"title\": \"Bitemporal Hemian"
      }, {
        "text": "opia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual Field Defects\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBitemporal hemianopia\u003c/b\u003e is a specific"
      }, {
        "text": " type of partial blindness characterized by the loss of vision in the outer (temporal) halves of the visual fields of both eyes. It is"
      }, {
        "text": " classically caused by a lesion compressing the central part of the \u003cmark\u003eoptic chiasm\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Loss of the temporal (lateral) visual fields in both eyes, often described as \\\"tunnel vision.\\\"\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The optic chiasm is where the nasal retinal fibers from each eye decussate (cross over"
      }, {
        "text": "). These nasal fibers are responsible for perceiving the temporal visual fields. A midline lesion at the chiasm selectively damages these crossing"
      }, {
        "text": " fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e The most common cause is a \u003cmark\u003e[[5f318"
      }, {
        "text": "8bd|pituitary adenoma]]\u003c/mark\u003e growing upward from the sella turcica and compressing the ch"
      }, {
        "text": "iasm from below.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Other suprasellar masses like a [[7048"
      }, {
        "text": "db1e|craniopharyngioma]] or an aneurysm of the [[bd802d22|anterior communicating artery]]"
      }, {
        "text": " can also cause this defect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient presenting with \\\"tunnel vision\\\" or complaining"
      }, {
        "text": " of bumping into things on either side, especially if accompanied by endocrine symptoms (e.g., galactorrhea, ac"
      }, {
        "text": "romegaly), is a classic vignette for a [[5f3188bd|pituitary adenoma]] causing"
      }, {
        "text": " bitemporal hemianopia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBitempor"
      }, {
        "text": "al hemianopia\u003c/b\u003e is the quintessential sign of optic chiasm compression, resulting from the selective damage to the crossing nasal retinal fibers and"
      }, {
        "text": " creating a characteristic \u0027tunnel vision\u0027 that points directly to a midline suprasellar pathology like a pituitary adenoma.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Lesion at Optic Chiasm] --Compresses--\u003e B(Crossing"
      }, {
        "text": " Nasal Retinal Fibers); B --\u003e C(Loss of Temporal Visual Fields); C --\u003e D(Bitemporal Hemianopia);\"\n"
      }, {
        "text": "    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_les"
      }, {
        "text": "ion_at\",\n        \"to\": \"optic_chiasm\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by\",\n        \"to\": \"5f3188bd\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \""
      }, {
        "text": "7048db1e\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\":"
      }, {
        "text": " \"bd802d22\"\n      }\n    ]\n  },\n  \"8056ce"
      }, {
        "text": "48\": {\n    \"title\": \"Blepharitis\",\n    \"primaryType\": \"disease\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Ophthalmology\",\n      \"Dermatology\",\n      \"USMLE"
      }, {
        "text": "\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Eyelid Disorders\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eBlepharitis\u003c/b\u003e is a common inflammatory condition of the eyelids, typically involving the part of the eyelid where the eyelashes grow."
      }, {
        "text": " It is characterized by inflammation, irritation, itching, and crusting of the eyelid margins.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterior Blepharitis:\u003c/b\u003e Affects the outside front of the eyelid, where the eyelashes are attached. Often"
      }, {
        "text": " caused by bacteria (\u003ci\u003eStaphylococcus\u003c/i\u003e) or seborrheic dermatitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePosterior Blepharitis"
      }, {
        "text": ":\u003c/b\u003e Affects the inner eyelid (the moist part that makes contact with the eye). Caused by dysfunction of the meibom"
      }, {
        "text": "ian glands (Meibomian Gland Dysfunction - MGD). Associated with skin conditions like rosacea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms"
      }, {
        "text": ":\u003c/b\u003e Red, swollen, or itchy eyelids; gritty or burning sensation in the eyes; crusty debris at the base of the eyelashes upon"
      }, {
        "text": " waking; flaking of skin around the eyes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to [[hordeol"
      }, {
        "text": "um|hordeola (styes)]], [[193c24ec|chalazia]], dry eyes"
      }, {
        "text": ", or chronic conjunctivitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The cornerstone of treatment is \u003cmark\u003eeyelid hygiene\u003c/"
      }, {
        "text": "mark\u003e, including warm compresses and gentle scrubbing of the eyelid margins. Topical antibiotics or steroids may be used in some cases.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Look for a patient complaining of chronic eye irritation with crusting on the eyelashes, especially in the morning. This is a"
      }, {
        "text": " classic description of blepharitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBlepharitis\u003c/b\u003e is a"
      }, {
        "text": " chronic inflammation of the eyelid margins, akin to dandruff of the eyelashes, which is managed primarily through diligent eyelid hygiene to control"
      }, {
        "text": " symptoms and prevent complications like styes and chalazia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"eyelid_disorder\"\n      },\n      {\n        \"type\": \"can_lead"
      }, {
        "text": "_to\",\n        \"to\": \"hordeolum\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"can_lead_to\",\n        \"to\": \"193c24ec\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"dd47b9cc\": {\n    \"title\": \"Blood-Brain Barrier ("
      }, {
        "text": "BBB)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBlood-Brain Barrier (BBB)\u003c/b\u003e is"
      }, {
        "text": " a highly selective semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively crossing into"
      }, {
        "text": " the extracellular fluid of the central nervous system where neurons reside.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Components:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[5206aa83|Tight junctions]]\u003c/b\u003e between non-fen"
      }, {
        "text": "estrated capillary endothelial cells.\u003cbr\u003e2. A thick \u003cb\u003e[[c335e16d|Bas"
      }, {
        "text": "ement Membrane]]\u003c/b\u003e.\u003cbr\u003e3. \u003cb\u003eAstrocyte foot processes\u003c/b\u003e that surround the capillary.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Protect"
      }, {
        "text": "s the brain from circulating toxins, pathogens, and fluctuations in plasma composition. It maintains a stable CNS environment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTransport"
      }, {
        "text": " Across BBB:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLipid-soluble\u003c/b\u003e substances (e.g., O\u003csub\u003e2\u003c/sub\u003e, CO\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e, anesthetics) can diffuse freely.\u003cbr\u003e - \u003cb\u003eWater-soluble\u003c/b\u003e substances (e.g.,"
      }, {
        "text": " glucose, [[9115b704|amino acids]]) require specific \u003cmark\u003ecarrier-mediated transport\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCircumventricular Organs:\u003c/b\u003e Areas of the brain that lack a BBB, allowing them to monitor"
      }, {
        "text": " the chemical composition of the blood. These include the [[5dd343d3|area postrema]] (che"
      }, {
        "text": "moreceptor trigger zone for vomiting) and parts of the [[89e86633|hypothalamus]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Breakdown of the BBB leads to vasogenic edema. Some antibiotics (e.g., pen"
      }, {
        "text": "icillins) have poor CNS penetration but can cross an inflamed BBB during meningitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eBlood-Brain Barrier\u003c/b\u003e is a sophisticated neurovascular unit, not just a simple wall, that uses tight junctions"
      }, {
        "text": ", a robust basement membrane, and astrocyte support to create a highly regulated interface, ensuring the brain\u0027s chemical environment remains pristine and"
      }, {
        "text": " protected.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Capillary Lumen] --\u003e B(Endothelial Cell"
      }, {
        "text": "); B --Tight Junctions--\u003e B; B --\u003e C(Basement Membrane); C --\u003e D(Astrocyte Foot Processes"
      }, {
        "text": "); D --\u003e E[Brain Parenchyma];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_composed_of\",\n        \"to\": \"5206aa83\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_composed_of\",\n        \"to\": \"c335e"
      }, {
        "text": "16d\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        "
      }, {
        "text": "\"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"is_abs"
      }, {
        "text": "ent_in\",\n        \"to\": \"5dd343d3\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"03ba9967\": {\n    \"title\": \"Blood-N"
      }, {
        "text": "erve Barrier\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \""
      }, {
        "text": "Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBlood-Nerve Barrier\u003c/b\u003e is a physiological"
      }, {
        "text": " barrier in the peripheral nervous system that regulates the passage of substances from the blood into the endoneurial space, maintaining"
      }, {
        "text": " a stable microenvironment for peripheral nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The"
      }, {
        "text": " main cellular component is the \u003cmark\u003eperineurium\u003c/mark\u003e, which consists of layers of flattened perineurial cells joined"
      }, {
        "text": " by tight junctions. Tight junctions between endothelial cells of the endoneurial capillaries also contribute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e"
      }, {
        "text": " Protects peripheral nerves from toxins, pathogens, and inflammatory cells, similar to the role of the [[dd47b9cc|blood-"
      }, {
        "text": "brain barrier]] in the CNS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to BBB:\u003c/b\u003e While analogous to the BBB, the blood-nerve barrier is generally considered"
      }, {
        "text": " less restrictive.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Breakdown of the blood-nerve barrier is a key feature of inflammatory neuropath"
      }, {
        "text": "ies like [[ed52e40b|Guillain-Barr√© syndrome]]. This breakdown allows inflammatory cells and proteins to enter the end"
      }, {
        "text": "oneurial space, leading to demyelination and axonal damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The breakdown of the blood"
      }, {
        "text": "-nerve barrier in [[ed52e40b|Guillain-Barr√© syndrome]] explains the classic"
      }, {
        "text": " CSF finding of [[a0f3ce4c|albuminocytologic dissociation]]‚Äîhigh protein (leaking from the"
      }, {
        "text": " blood) with a normal cell count.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBlood-Nerve Barrier\u003c/b\u003e"
      }, {
        "text": ", formed primarily by the tight junctions of the perineurium, serves as the protective gatekeeper for peripheral nerves; its disruption"
      }, {
        "text": " in inflammatory conditions like Guillain-Barr√© syndrome allows an autoimmune assault on the nerves.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_analogous_to\",\n        \"to"
      }, {
        "text": "\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_dis"
      }, {
        "text": "rupted_in\",\n        \"to\": \"ed52e40b\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_formed_by\",\n        \"to\": \"perineurium\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"6ab4b0f2\": {\n    \"title\":"
      }, {
        "text": " \"Blown Pupil\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003e\\\"blown pupil\\\"\u003c/b\u003e is a clinical term for a fixed, dilated"
      }, {
        "text": " pupil (mydriasis) that is nonreactive to light. It is a critical sign of compression of the [[6"
      }, {
        "text": "8c66997|oculomotor nerve (CN III)]], often indicating a life-threatening increase"
      }, {
        "text": " in intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e The parasympathetic fibers that control"
      }, {
        "text": " pupillary constriction run along the superficial, peripheral aspect of the [[68c66997|oculomotor nerve]]."
      }, {
        "text": " These fibers are highly susceptible to external compression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e \u003cmark\u003eUncal herniation\u003c/mark\u003e, where"
      }, {
        "text": " the uncus of the temporal lobe herniates over the tentorium cerebelli and compresses the ipsilateral CN III.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Aneurysm of the \u003cmark\u003eposterior communicating artery (PComA)\u003c/mark\u003e, which is"
      }, {
        "text": " anatomically close to CN III, can also cause compression and a blown pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A unilateral"
      }, {
        "text": " blown pupil is an ominous sign of rapidly increasing intracranial pressure and impending brainstem compression. It is a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs"
      }, {
        "text": ":\u003c/b\u003e Often accompanied by other signs of a CN III palsy, such as ptosis and a \\\"down and out\\\" deviation"
      }, {
        "text": " of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with head trauma and a deteriorating level of consciousness, the"
      }, {
        "text": " sudden appearance of a unilateral fixed and dilated pupil indicates uncal herniation and requires immediate intervention.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eA \u003cb\u003eblown pupil\u003c/b\u003e is a neurological red flag, signaling compression of the parasympathetic fibers on"
      }, {
        "text": " the outside of the oculomotor nerve, most often by uncal herniation or a PComA aneurysm, and indicates"
      }, {
        "text": " a dire, time-sensitive emergency.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(Un"
      }, {
        "text": "cal Herniation); B --Compresses--\u003e C(CN III Parasympathetic Fibers); C --\u003e D(Loss of Pupillary Const"
      }, {
        "text": "riction); D --\u003e E(Fixed, Dilated Pupil);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"oculomotor_ner"
      }, {
        "text": "ve_compression\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        "
      }, {
        "text": "\"to\": \"uncal_herniation\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by\",\n        \"to\": \"posterior_communicating_artery_aneurysm\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"aebb10eb\": {\n    \"title\": \"Blowout Fracture"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Tra"
      }, {
        "text": "uma\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Trauma\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eblowout fracture\u003c/b\u003e is a traumatic fracture of the walls"
      }, {
        "text": " of the orbit, most commonly the orbital floor, caused by a sudden increase in intraorbital pressure from a direct blow to the globe ("
      }, {
        "text": "e.g., from a fist or a ball).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e"
      }, {
        "text": " A blunt, non-penetrating force strikes the globe, transmitting pressure throughout the orbit. The thin orbital floor (roof"
      }, {
        "text": " of the maxillary sinus) and/or medial wall (lamina papyracea of the ethmoid sinus) fracture,"
      }, {
        "text": " or \u0027blow out.\u0027\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with periorbital pain, swelling, and ecchymosis."
      }, {
        "text": " Key signs include \u003cmark\u003ediplopia on upward gaze\u003c/mark\u003e and numbness of the cheek and upper teeth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle"
      }, {
        "text": " Entrapment:\u003c/b\u003e The fracture can entrap the \u003cmark\u003einferior rectus muscle\u003c/mark\u003e and/or orbital fat"
      }, {
        "text": ". This entrapment restricts upward movement of the eye, causing vertical diplopia, especially on upgaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eN"
      }, {
        "text": "erve Injury:\u003c/b\u003e The fracture of the orbital floor can damage the \u003cmark\u003einfraorbital nerve\u003c/mark\u003e (a branch"
      }, {
        "text": " of CN V\u003csub\u003e2\u003c/sub\u003e), leading to paresthesia or numbness of the ipsilateral cheek, upper lip, and upper"
      }, {
        "text": " gingiva.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a history of blunt eye trauma, diplopia on upward gaze,"
      }, {
        "text": " and numbness of the cheek is classic for an orbital blowout fracture with inferior rectus entrapment and infraorbital nerve injury.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eblowout fracture\u003c/b\u003e is a hydraulic fracture of the thin orbital floor"
      }, {
        "text": ", where the force of a blow to the eye is transmitted to the surrounding bone, leading to entrapment of the inferior rectus"
      }, {
        "text": " muscle and injury to the infraorbital nerve, manifesting as an inability to look up and a numb cheek.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_cause_"
      }, {
        "text": "entrapment_of\",\n        \"to\": \"inferior_rectus_muscle\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"can_cause_injury_to\",\n        \"to\": \"infraorbital_nerve"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"9"
      }, {
        "text": "914d433\"\n      }\n    ]\n  },\n  \"86953"
      }, {
        "text": "5a9\": {\n    \"title\": \"Bone Morphogenetic Protein (BMP)\",\n    \"primaryType\": \""
      }, {
        "text": "molecule\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \""
      }, {
        "text": "Developmental Biology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBone Morphogenetic Proteins (BMPs)\u003c/b\u003e are a group of growth"
      }, {
        "text": " factors belonging to the transforming growth factor-beta (TGF-Œ≤) superfamily. In neuroembryology, they play a crucial role"
      }, {
        "text": " in establishing the dorsal-ventral axis of the neural tube by inducing the development of the dorsal structures.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction in Neurodevelopment:\u003c/b\u003e Secreted by the overlying ectoderm, BMPs act as a signaling"
      }, {
        "text": " molecule that patterns the dorsal neural tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDorsalization:\u003c/b\u003e High concentrations of BMPs induce the formation of the"
      }, {
        "text": " \u003cmark\u003e[[43be7a6e|alar plate]]\u003c/mark\u003e, which gives rise to sensory neurons"
      }, {
        "text": " in the dorsal horn of the spinal cord and sensory nuclei of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart Signal:\u003c/b\u003e The ventral"
      }, {
        "text": "izing signal is \u003cmark\u003eSonic Hedgehog (SHH)\u003c/mark\u003e, which is secreted by the notochord and induces"
      }, {
        "text": " the formation of the [[253e3efb|basal plate]] (motor neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGradient"
      }, {
        "text": " Effect:\u003c/b\u003e The opposing gradients of BMP (high dorsally) and SHH (high ventrally) establish the distinct"
      }, {
        "text": " sensory (dorsal) and motor (ventral) domains of the developing central nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Remember the source and effect: BMP from the ectoderm (roof) induces the dorsal/sensory al"
      }, {
        "text": "ar plate. SHH from the notochord (floor) induces the ventral/motor basal plate.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eBone Morphogenetic Protein\u003c/b\u003e acts as the key \u0027dorsalizing\u0027 signal in the"
      }, {
        "text": " developing neural tube, instructing the dorsal region to become the sensory [[43be7a6e|alar plate]],"
      }, {
        "text": " thereby establishing the fundamental sensory-motor polarity of the central nervous system in opposition to the ventralizing signal, Sonic Hedgehog.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Ectoderm] --Secretes--\u003e B(BMPs); B --Induces--\u003e C"
      }, {
        "text": "(Dorsal Neural Tube); C --\u003e D(Alar Plate); D --\u003e E(Sensory Neurons);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"induces_development_of\",\n        \"to\":"
      }, {
        "text": " \"43be7a6e\"\n      },\n      {\n        \"type\": \"is_counter"
      }, {
        "text": "acted_by\",\n        \"to\": \"sonic_hedgehog\"\n      },\n      {\n        \"type\": \"is_secreted"
      }, {
        "text": "_by\",\n        \"to\": \"ectoderm\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "84b10400\": {\n    \"title\": \"Botulinum Toxin\",\n    \"primary"
      }, {
        "text": "Type\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Microbiology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eBotulinum toxin\u003c/b\u003e is a potent neurotoxin produced by the bacterium \u003ci\u003eClostridium"
      }, {
        "text": " botulinum\u003c/i\u003e. It causes flaccid paralysis by inhibiting the presynaptic release of [[6a005"
      }, {
        "text": "559|acetylcholine]] at the neuromuscular junction. In small, purified doses, it is used therapeutically for a"
      }, {
        "text": " variety of medical and cosmetic purposes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The"
      }, {
        "text": " toxin is a protease that cleaves \u003cmark\u003eSNARE proteins\u003c/mark\u003e (e.g., SNAP-25,"
      }, {
        "text": " synaptobrevin), which are essential for the fusion of acetylcholine-containing vesicles with the presynaptic membrane. This prevents ACh"
      }, {
        "text": " release.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedical Uses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSpasticity/Dystonia:\u003c/b\u003e Treats"
      }, {
        "text": " focal dystonias (e.g., torticollis, blepharospasm), spasticity in [[17"
      }, {
        "text": "1ca00b|cerebral palsy]] and [[45dd6d19|multiple sclerosis]].\u003cbr\u003e"
      }, {
        "text": " - \u003cb\u003ePain:\u003c/b\u003e Prophylaxis for chronic [[c8833bae|migraine headaches]].\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Other:\u003c/b\u003e Hyperhidrosis (excessive sweating), strabismus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCosmetic Use:\u003c/b\u003e In"
      }, {
        "text": "jected to reduce facial wrinkles by temporarily paralyzing underlying muscles (Botox).\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxicity (Botulism):\u003c/b\u003e In"
      }, {
        "text": "gestion of the toxin (e.g., from improperly canned foods) causes botulism, a life-threatening illness"
      }, {
        "text": " characterized by descending flaccid paralysis, diplopia, dysphagia, and respiratory failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember that botulinum toxin causes a \u003cu\u003epresynaptic\u003c/u\u003e blockade of ACh release, which contrasts with myasthenia gravis ("
      }, {
        "text": "postsynaptic receptor blockade) and Lambert-Eaton syndrome (presynaptic Ca\u003csup\u003e2+\u003c/sup\u003e channel blockade).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eBotulinum toxin\u003c/b\u003e induces paralysis by enzymatically snipping the SNARE proteins required for acetylcholine"
      }, {
        "text": " release at the neuromuscular junction; this potent biological mechanism is harnessed in medicine to selectively weaken overactive muscles in conditions from dystonia to cosmetic"
      }, {
        "text": " wrinkles.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Botulinum Toxin] --\u003e B("
      }, {
        "text": "Cleaves SNARE Proteins); B --x C(Vesicle Fusion); C --x D(ACh Release); D --"
      }, {
        "text": "x E(Muscle Contraction); E --\u003e F(Flaccid Paralysis);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"inhibits_release_of\",\n        \"to\": \"6a005559\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"dystonia\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_produced_by\",\n        \"to\": \"clostridium_botulinum\"\n      }\n    ]\n  "
      }, {
        "text": "}\n}\n```"
      }]
    }, {
      "role": "user",
      "tokenCount": 2212,
      "inlineFile": {
        "mimeType": "application/json",
        "data": "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"
      }
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"ac55d026\": {\n    \"title\": \"Brachioradialis Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrachioradialis reflex\u003c/b\u003e is a deep tendon reflex that causes flexion of the elbow and supination of the forearm when the brachioradialis tendon is tapped at the styloid process of the radius. It is used to test the integrity of the \u003cmark\u003eC5 and C6\u003c/mark\u003e spinal nerve roots and the radial nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC6\u003c/b\u003e nerve root, with a contribution from C5. Mnemonic: C5, \u003cb\u003e6\u003c/b\u003e, pick up sticks.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the brachioradialis muscle. The afferent signal travels via the radial nerve to the C5/C6 spinal cord segments, synapses with a motor neuron, and the efferent signal returns via the radial nerve to cause muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C6 root or a peripheral neuropathy affecting the radial nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the C5/C6 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The brachioradialis reflex, along with the biceps reflex, is a key part of assessing the C5 and C6 nerve roots.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrachioradialis reflex\u003c/b\u003e is a specific test for the C5-C6 nerve roots, elicited by tapping the distal radius, which provides valuable information for localizing lesions within the cervical spine and brachial plexus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Brachioradialis Tendon] --\u003e B(Stretch Muscle); B --\u003e C(Afferent Signal via Radial N.); C --\u003e D[C5/C6 Spinal Cord]; D --\u003e E(Efferent Signal via Radial N.); E --\u003e F(Elbow Flexion/Forearm Supination);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c5_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c6_nerve_root\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"a584135d\": {\n    \"title\": \"Brain\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Central Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrain\u003c/b\u003e is the central organ of the human nervous system, responsible for thought, memory, emotion, touch, motor skills, vision, breathing, temperature, hunger, and every process that regulates our body. It is composed of the cerebrum, cerebellum, and brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Develops from the rostral part of the neural tube, which differentiates into the forebrain (prosencephalon), midbrain (mesencephalon), and hindbrain (rhombencephalon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Parts:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCerebrum:\u003c/b\u003e The largest part, divided into two hemispheres, responsible for higher cognitive functions.\u003cbr\u003e - \u003cb\u003eCerebellum:\u003c/b\u003e Located under the cerebrum, coordinates muscle movements and balance.\u003cbr\u003e - \u003cb\u003eBrainstem:\u003c/b\u003e Connects the cerebrum and cerebellum to the spinal cord, controlling many automatic functions like breathing and heart rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the anterior circulation (from internal carotid arteries) and posterior circulation (from vertebral arteries), which connect via the [[e22300e8|Circle of Willis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Can be affected by a wide range of pathologies including [[c5da3c57|ischemic]] and [[hemorrhagic_stroke|hemorrhagic strokes]], [[be057cfc|tumors]], trauma, infection, and neurodegenerative diseases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the functional localization within the brain (e.g., motor/sensory homunculus, language areas) and the vascular territories is crucial for solving clinical neurology questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrain\u003c/b\u003e is the command center of the body, where intricate networks of neurons process information and control function, with specific regions highly specialized for distinct tasks, making the clinical presentation of brain lesions highly predictable based on their location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"develops_from\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type\": \"can_be_affected_by\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"can_be_affected_by\",\n        \"to\": \"be057cfc\"\n      }\n    ]\n  },\n  \"1777e176\": {\n    \"title\": \"Brain Death\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Medical Ethics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Coma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain death\u003c/b\u003e is the irreversible cessation of all functions of the entire brain, including the brainstem. It is a legal and clinical definition of death, distinct from a persistent vegetative state where brainstem functions may be intact.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCriteria:\u003c/b\u003e Diagnosis requires evidence of an irreversible cause of coma, absence of confounding factors (e.g., hypothermia, drug intoxication), and the absence of all brainstem reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Reflexes Tested:\u003c/b\u003e Pupillary light reflex, corneal reflex, oculocephalic reflex (doll\u0027s eyes), oculovestibular reflex (cold caloric), gag reflex, and cough reflex must all be absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eApnea Test:\u003c/b\u003e A definitive test where the patient is disconnected from the ventilator to see if a rise in PaCO\u003csub\u003e2\u003c/sub\u003e stimulates a spontaneous respiratory effort. Absence of breathing despite a high PaCO\u003csub\u003e2\u003c/sub\u003e confirms apnea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Perfusion:\u003c/b\u003e In brain death, [[3eca3f19|cerebral perfusion pressure (CPP)]] is zero, meaning there is no cerebral blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEthical/Legal Status:\u003c/b\u003e A patient who meets the criteria for brain death is legally and medically deceased, even if their heart continues to beat with mechanical ventilation. This allows for the cessation of life support and consideration of organ donation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain death\u003c/b\u003e signifies the irreversible loss of function of the entire brain, including the brainstem, which is confirmed by the absence of all brainstem reflexes and a positive apnea test, establishing legal death despite ongoing cardiac activity on life support.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_defined_by\",\n        \"to\": \"absence_of_brainstem_reflexes\"\n      },\n      {\n        \"type\": \"is_confirmed_by\",\n        \"to\": \"apnea_test\"\n      },\n      {\n        \"type\": \"is_distinct_from\",\n        \"to\": \"persistent_vegetative_state\"\n      }\n    ]\n  },\n  \"e9a47751\": {\n    \"title\": \"Brain Injury\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain injury\u003c/b\u003e is damage to the brain that can result from a traumatic force (Traumatic Brain Injury, TBI) or a non-traumatic event (e.g., stroke, anoxia). The clinical effects depend on the mechanism, location, and severity of the injury.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTraumatic Brain Injury (TBI):\u003c/b\u003e Includes concussions, contusions, [[22b22e08|diffuse axonal injury]], and intracranial hemorrhages (epidural, subdural). Caused by external forces.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-Traumatic Brain Injury:\u003c/b\u003e Includes [[c5da3c57|ischemic]] and [[hemorrhagic_stroke|hemorrhagic strokes]], anoxic brain injury (e.g., from cardiac arrest), infections, and tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary vs. Secondary Injury:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePrimary Injury:\u003c/b\u003e The initial damage that occurs at the moment of impact or insult (e.g., shearing of axons, laceration of vessels).\u003cbr\u003e - \u003cb\u003eSecondary Injury:\u003c/b\u003e A cascade of molecular and inflammatory events that occur in the hours and days following the primary injury (e.g., cerebral edema, excitotoxicity, inflammation), which often worsens the overall outcome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Effects:\u003c/b\u003e The neurological deficits from a stroke are highly predictable based on the affected [[105efab1|arterial supply]] and the function of the brain region it perfuses (e.g., [[143bb23d|MCA stroke]] causing contralateral face/arm weakness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the vascular territories of the major cerebral arteries ([[830c856c|ACA]], [[143bb23d|MCA]], [[b6a2cc31|PCA]]) is essential for localizing stroke lesions based on clinical symptoms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain injury\u003c/b\u003e encompasses a spectrum of damage from various causes, with the final clinical outcome determined not only by the initial insult but also by the subsequent cascade of secondary injury processes like edema and inflammation, which are major targets for neuroprotective therapies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hemorrhagic_stroke\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"22b22e08\"\n      },\n      {\n        \"type\": \"can_be_localized_by\",\n        \"to\": \"105efab1\"\n      }\n    ]\n  },\n  \"582d8572\": {\n    \"title\": \"Brainstem\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the posterior part of the brain that is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the pons, and the medulla oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Midbrain, Pons, and Medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e\u003cbr\u003e 1. \u003cb\u003eConduit:\u003c/b\u003e Contains ascending (sensory) and descending (motor) tracts connecting the cerebrum and cerebellum to the spinal cord.\u003cbr\u003e 2. \u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Houses the nuclei for cranial nerves III through XII.\u003cbr\u003e 3. \u003cb\u003eIntegrative Functions:\u003c/b\u003e Contains the reticular formation, which is crucial for consciousness, sleep-wake cycles, and vital autonomic functions (e.g., cardiovascular and respiratory control in the medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVentral View:\u003c/b\u003e Shows the cerebral peduncles (midbrain), the bulging pons, and the pyramids (medulla). Cranial nerves can be seen exiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDorsal View:\u003c/b\u003e Shows the superior and inferior colliculi (midbrain) and the floor of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The \u0027Rule of 4s\u0027 is a helpful mnemonic for localizing brainstem lesions: 4 CNs above the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX-XII); and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the critical, compact hub connecting the higher brain centers to the body, housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brainstem] --\u003e B(Midbrain); A --\u003e C(Pons); A --\u003e D(Medulla);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"pons\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"contains_nuclei_for\",\n        \"to\": \"cranial_nerves\"\n      }\n    ]\n  },\n  \"32ba61d1\": {\n    \"title\": \"Brainstem and Cerebellar Syndromes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrainstem and Cerebellar Syndromes\u003c/b\u003e are collections of neurological signs and symptoms that result from lesions (typically strokes or tumors) affecting specific anatomical locations within the brainstem or cerebellum. Their presentations are highly predictable based on the structures involved.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLateral Medullary (Wallenberg) Syndrome:\u003c/b\u003e Caused by a PICA stroke. Presents with vertigo, nystagmus, ipsilateral ataxia, dysphagia, hoarseness, ipsilateral Horner syndrome, ipsilateral facial pain/temp loss, and contralateral body pain/temp loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLateral Pontine Syndrome:\u003c/b\u003e Caused by an AICA stroke. Similar to Wallenberg but includes ipsilateral facial paralysis (CN VII) and deafness (CN VIII), and lacks dysphagia/hoarseness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedial Medullary Syndrome:\u003c/b\u003e Caused by an ASA stroke. Presents with contralateral hemiparesis, contralateral loss of proprioception/vibration, and ipsilateral tongue deviation (CN XII).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMultiple Sclerosis:\u003c/b\u003e Can cause various brainstem and cerebellar syndromes due to its demyelinating plaques. A classic MS-related syndrome is \u003cmark\u003e[[58c684bd|internuclear ophthalmoplegia (INO)]]\u003c/mark\u003e from a lesion in the medial longitudinal fasciculus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Learn to differentiate the lateral syndromes: PICA (medulla) involves CN IX/X (dysphagia/hoarseness), while AICA (pons) involves CN VII/VIII (facial palsy/deafness).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical diagnosis of \u003cb\u003ebrainstem and cerebellar syndromes\u003c/b\u003e is a classic exercise in neuroanatomical localization, where a specific constellation of cranial nerve deficits, long tract signs, and cerebellar findings can pinpoint a lesion to a precise vascular territory or location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"lateral_medullary_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"lateral_pontine_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"medial_medullary_syndrome\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"45dd6d19\"\n      }\n    ]\n  },\n  \"be057cfc\": {\n    \"title\": \"Brain Tumors\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain tumors\u003c/b\u003e are neoplasms originating in the intracranial tissues. They can be primary (arising from brain cells) or metastatic (spreading from cancers elsewhere in the body). Their clinical presentation depends on their location, size, and growth rate.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAdult Primary Tumors:\u003c/b\u003e Most are supratentorial. In order of frequency: [[b6bbd0bc|Glioblastoma]], [[e98ea0ba|Meningioma]], [[03ecb69e|Schwannoma]], Oligodendroglioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChildhood Primary Tumors:\u003c/b\u003e Most are infratentorial. In order of frequency: Pilocytic astrocytoma, [[16d613bb|Medulloblastoma]], [[14365ef4|Ependymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetastatic Tumors:\u003c/b\u003e More common than primary tumors. Often present as multiple, well-circumscribed lesions at the gray-white junction. Common primary sources are \u003cmark\u003eLung, Breast, Kidney, Melanoma, and Colon\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Symptoms:\u003c/b\u003e Headaches (often worse in the morning), seizures, and focal neurological deficits corresponding to the tumor\u0027s location.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A ring-enhancing lesion on MRI with contrast is a key finding. The differential includes [[b6bbd0bc|glioblastoma]], metastasis, and abscess. A \u0027butterfly\u0027 appearance crossing the corpus callosum is classic for glioblastoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe classification and prognosis of \u003cb\u003ebrain tumors\u003c/b\u003e differ significantly between adults and children, with adults more commonly developing aggressive supratentorial gliomas and children typically having more benign infratentorial tumors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"b6bbd0bc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"e98ea0ba\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"03ecb69e\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"14365ef4\"\n      }\n    ]\n  },\n  \"af9d783c\": {\n    \"title\": \"Brainstem\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the posterior part of the brain that is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the pons, and the medulla oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Midbrain, Pons, and Medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e\u003cbr\u003e 1. \u003cb\u003eConduit:\u003c/b\u003e Contains ascending (sensory) and descending (motor) tracts connecting the cerebrum and cerebellum to the spinal cord.\u003cbr\u003e 2. \u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Houses the nuclei for cranial nerves III through XII.\u003cbr\u003e 3. \u003cb\u003eIntegrative Functions:\u003c/b\u003e Contains the reticular formation, which is crucial for consciousness, sleep-wake cycles, and vital autonomic functions (e.g., cardiovascular and respiratory control in the medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCross Sections:\u003c/b\u003e Recognizing the key structures in cross sections of the midbrain, pons, and medulla is essential for localizing brainstem strokes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHerniation Syndromes:\u003c/b\u003e The brainstem is vulnerable to compression during [[8c0728b7|herniation syndromes]], which can lead to coma and death (e.g., Duret hemorrhages from central herniation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The \u0027Rule of 4s\u0027 is a helpful mnemonic for localizing brainstem lesions: 4 CNs above the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX-XII); and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the critical, compact hub connecting the higher brain centers to the body, housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brainstem] --\u003e B(Midbrain); A --\u003e C(Pons); A --\u003e D(Medulla);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"pons\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"is_compressed_in\",\n        \"to\": \"8c0728b7\"\n      }\n    ]\n  },\n  \"0f0fbfa0\": {\n    \"title\": \"Branch Retinal Vein Occlusion (BRVO)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eBranch Retinal Vein Occlusion (BRVO)\u003c/b\u003e is the blockage of a small vein in the retina, leading to hemorrhage, edema, and potential vision loss in the quadrant of the retina drained by that vein.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Most commonly occurs at an \u003cmark\u003earteriovenous (AV) crossing\u003c/mark\u003e, where a hardened, atherosclerotic retinal arteriole compresses the adjacent, thinner-walled venule, leading to turbulent flow and thrombus formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, and hyperlipidemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, unilateral vision loss, which may be described as a scotoma (blind spot) or blurry vision in a specific part of the visual field.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e Fundoscopic exam reveals \u003cmark\u003esectoral (quadrantic) retinal hemorrhages\u003c/mark\u003e, venous engorgement, and cotton-wool spots confined to the area drained by the occluded vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from Central Retinal Vein Occlusion (CRVO), which involves the entire retina and has a more dramatic \\\"blood and thunder\\\" appearance. BRVO is localized to a quadrant. The key association is hypertension causing AV nicking.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eBranch Retinal Vein Occlusion\u003c/b\u003e is a consequence of systemic vascular disease playing out in the eye, where a stiff arteriole compresses a venule at a crossing point, causing a localized \u0027traffic jam\u0027 of blood that results in a sectoral retinal hemorrhage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension/Atherosclerosis] --\u003e B(Arteriolar Sclerosis); B --\u003e C(Compression of Vein at AV Crossing); C --\u003e D(Thrombus Formation); D --\u003e E(Branch Retinal Vein Occlusion); E --\u003e F(Sectoral Hemorrhage \u0026 Edema);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"b69e35b5\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"b69e35b5\"\n      }\n    ]\n  },\n  \"2fcee185\": {\n    \"title\": \"Brimonidine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrimonidine\u003c/b\u003e is a highly selective \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist\u003c/i\u003e used as a topical eye drop to lower intraocular pressure (IOP) in the treatment of [[5ea7b741|open-angle glaucoma]] and ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Has a dual mechanism. It primarily \u003cmark\u003edecreases aqueous humor synthesis\u003c/mark\u003e by stimulating Œ±\u003csub\u003e2\u003c/sub\u003e receptors on the ciliary body. It also \u003cmark\u003eincreases uveoscleral outflow\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A common agent for the long-term management of [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include allergic conjunctivitis, hyperemia (redness), and pruritus (itching). Systemic side effects are possible due to absorption and include dry mouth, sedation, and fatigue. Unlike apraclonidine, it does not cause mydriasis and can be used in angle-closure glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e Similar to [[c1f67280|apraclonidine]] but is more selective for the Œ±\u003csub\u003e2\u003c/sub\u003e receptor and has a lower incidence of allergic reactions and tachyphylaxis, making it more suitable for long-term use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e agonists like brimonidine and clonidine act as sympatholytics, reducing sympathetic outflow. In the eye, this leads to decreased aqueous humor production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrimonidine\u003c/b\u003e is an effective glaucoma medication that lowers intraocular pressure through a dual mechanism of decreasing aqueous humor production and increasing its outflow, all mediated by its selective Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonism.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brimonidine] --\u003e B(Stimulates Œ±2 Receptors); B --\u003e C(‚Üì Aqueous Humor Synthesis); B --\u003e D(‚Üë Uveoscleral Outflow); C \u0026 D --\u003e E(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"alpha_2_agonist\"\n      },\n      {\n        \"type\": \"has_similar_mechanism_to\",\n        \"to\": \"c1f67280\"\n      }\n    ]\n  },\n  \"4dff096f\": {\n    \"title\": \"Broad-Spectrum Anticonvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroad-spectrum anticonvulsants\u003c/b\u003e are antiepileptic drugs (AEDs) that are effective against a wide variety of seizure types, including both focal and generalized seizures (e.g., tonic-clonic, absence, myoclonic).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Agents:\u003c/b\u003e The main broad-spectrum agents are \u003cmark\u003e[[valproic_acid|Valproic acid]]\u003c/mark\u003e, \u003cmark\u003e[[08d19a8f|Lamotrigine]]\u003c/mark\u003e, \u003cmark\u003e[[2341f9c0|Levetiracetam]]\u003c/mark\u003e, and \u003cmark\u003e[[e1f5066c|Topiramate]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e They are the drugs of choice when the seizure type is unclear or when a patient has multiple seizure types (e.g., Lennox-Gastaut syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eValproic Acid:\u003c/b\u003e Very broad spectrum, effective for almost all seizure types. Mechanism involves Na\u003csup\u003e+\u003c/sup\u003e channel blockade, T-type Ca\u003csup\u003e2+\u003c/sup\u003e channel blockade, and increasing GABA levels. Highly teratogenic (neural tube defects).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLamotrigine:\u003c/b\u003e Broad spectrum, but must be titrated slowly to reduce the risk of Stevens-Johnson syndrome (SJS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLevetiracetam:\u003c/b\u003e Very commonly used due to its favorable side effect profile and broad efficacy. Unique mechanism involving synaptic vesicle protein 2A (SV2A).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a question asks for the best initial treatment for a patient with generalized tonic-clonic seizures, a broad-spectrum agent like valproic acid or levetiracetam is a strong choice. Valproic acid is also a first-line option for myoclonic seizures.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroad-spectrum anticonvulsants\u003c/b\u003e are the versatile workhorses of epilepsy treatment, effective against both focal and generalized seizures, making them ideal for initial empirical therapy or for patients with complex epilepsy syndromes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_class_of\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"valproic_acid\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"08d19a8f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"2341f9c0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"e1f5066c\"\n      }\n    ]\n  },\n  \"7f6ed344\": {\n    \"title\": \"Broca\u0027s Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e, also known as expressive aphasia, is a language disorder characterized by difficulty in producing fluent, grammatical speech, while comprehension remains relatively intact. It is caused by a lesion in [[a3bbace2|Broca\u0027s area]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e \u003cmark\u003eInferior frontal gyrus\u003c/mark\u003e of the dominant (usually left) hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Speech is \u003cmark\u003enonfluent, telegraphic, and effortful\u003c/mark\u003e. Patients use short phrases and omit functional words (e.g., \\\"Walk dog\\\"). Repetition is impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComprehension:\u003c/b\u003e Auditory and reading comprehension are relatively preserved, although complex grammar may be difficult.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Awareness:\u003c/b\u003e Patients are typically aware of their deficits and become very frustrated by their inability to communicate effectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken \u003cb\u003eB\u003c/b\u003eoca (mouth). Look for a patient with a right hemiparesis (especially face and arm) who can follow commands but struggles to speak in complete sentences.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e is a disorder of language production, not comprehension, resulting from damage to the brain\u0027s motor-speech planning center. The resulting speech is broken and effortful, leaving the patient frustratingly aware of their inability to express their intact thoughts.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion in Broca\u0027s Area] --\u003e B(Impaired Speech Production); B --\u003e C(Nonfluent, Telegraphic Speech); A --Spares--\u003e D(Wernicke\u0027s Area); D --\u003e E(Intact Comprehension);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"a3bbace2\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"2c4a6130\"\n      }\n    ]\n  },\n  \"a3bbace2\": {\n    \"title\": \"Broca\u0027s Area\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s area\u003c/b\u003e is a region in the frontal lobe of the dominant hemisphere (usually the left) of the brain with functions linked to speech production.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the \u003cmark\u003einferior frontal gyrus\u003c/mark\u003e of the dominant hemisphere (Brodmann areas 44 and 45).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Responsible for the motor planning and execution of speech. It coordinates the movements of the larynx, tongue, and lips necessary for articulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e Damage to this area results in [[7f6ed344|Broca\u0027s aphasia]] (expressive aphasia), characterized by nonfluent, agrammatical speech with intact comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnection:\u003c/b\u003e It is connected to [[wernicke_area|Wernicke\u0027s area]] (language comprehension) by a bundle of nerve fibers called the arcuate fasciculus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A stroke affecting the left MCA is the most common cause of damage to Broca\u0027s area. Because of its proximity to the primary motor cortex, [[7f6ed344|Broca\u0027s aphasia]] is often accompanied by contralateral weakness of the face and arm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s area\u003c/b\u003e is the brain\u0027s \u0027speech production factory,\u0027 translating thoughts and concepts from Wernicke\u0027s area into the precise motor commands needed for fluent articulation; a lesion here breaks the production line, resulting in expressive aphasia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Wernicke\u0027s Area - Comprehension] --Arcuate Fasciculus--\u003e B(Broca\u0027s Area); B --Motor Plan--\u003e C(Primary Motor Cortex); C --\u003e D(Speech Articulation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"frontal_lobe\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"7f6ed344\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_connected_to\",\n        \"to\": \"wernicke_area\"\n      }\n    ]\n  },\n  \"d24a5ff0\": {\n    \"title\": \"Bromocriptine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBromocriptine\u003c/b\u003e is an ergot derivative that acts as a \u003ci\u003edopamine D\u003csub\u003e2\u003c/sub\u003e receptor agonist\u003c/i\u003e. It is used to treat conditions associated with hyperprolactinemia and [[58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stimulates dopamine D\u003csub\u003e2\u003c/sub\u003e receptors in the CNS and periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Endocrinology):\u003c/b\u003e Treats hyperprolactinemia and prolactinomas by stimulating D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs in the anterior pituitary, which inhibits prolactin secretion. Also used for acromegaly as it can suppress GH secretion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used as an adjunctive therapy in [[58c8ea03|Parkinson disease]] to stimulate dopamine receptors in the striatum. It is an ergot derivative and is less commonly used now than non-ergot agonists (e.g., pramipexole, ropinirole) due to its side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, vomiting, postural hypotension, and headache. As an ergot derivative, it can cause pulmonary fibrosis and vasospasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Bromocriptine is a classic treatment for prolactinomas. Remember that dopamine tonically inhibits prolactin release, so a dopamine agonist will lower prolactin levels.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBromocriptine\u003c/b\u003e is a dopamine D\u003csub\u003e2\u003c/sub\u003e agonist that leverages dopamine\u0027s inhibitory control over prolactin to treat hyperprolactinemia and supplements dopamine signaling in the basal ganglia to treat Parkinson disease, though its use is limited by its ergot-related side effects.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dopamine_agonist\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"acromegaly\"\n      }\n    ]\n  },\n  \"4792bc68\": {\n    \"title\": \"Brown-S√©quard Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard syndrome\u003c/b\u003e is a rare neurological condition caused by \u003ci\u003ehemisection of the spinal cord\u003c/i\u003e, resulting in a characteristic pattern of ipsilateral motor and proprioceptive loss, and contralateral pain and temperature sensory loss below the level of the lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Typically caused by trauma, such as a penetrating injury (e.g., stab wound) or a tumor compressing one half of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIpsilateral Deficits (at and below lesion):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMotor:\u003c/b\u003e Ipsilateral spastic paralysis below the lesion (corticospinal tract damage).\u003cbr\u003e - \u003cb\u003eSensation:\u003c/b\u003e Ipsilateral loss of proprioception, vibration, and fine touch below the lesion ([[e7f5cbbe|dorsal column]] damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContralateral Deficits (below lesion):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSensation:\u003c/b\u003e Contralateral loss of pain and temperature sensation, typically beginning 1-2 segments below the lesion (spinothalamic tract damage, as fibers decussate in the spinal cord).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficits at the Level of the Lesion:\u003c/b\u003e\u003cbr\u003e - Ipsilateral flaccid paralysis (LMN damage at that level).\u003cbr\u003e - Ipsilateral complete loss of all sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This syndrome is a classic test of spinal cord tract anatomy. The key is remembering which tracts cross in the medulla (dorsal columns, corticospinal) versus the spinal cord (spinothalamic). If the lesion is above T1, an ipsilateral [[c19010a3|Horner syndrome]] may also be present.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard syndrome\u003c/b\u003e is the ultimate clinical demonstration of spinal cord neuroanatomy, creating a striking dissociation of deficits where one side of the body loses motor function and proprioception, while the other side loses the ability to feel pain and temperature, all due to a unilateral cord lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Spinal Cord Hemisection at T10]; A --\u003e B(Ipsilateral (Right) Deficits); B --\u003e C(Loss of Motor, Proprioception, Vibration below T10); B --\u003e D(Flaccid paralysis at T10); A --\u003e E(Contralateral (Left) Deficits); E --\u003e F(Loss of Pain \u0026 Temperature below T10);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"spinal_cord_hemisection\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tracts\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07eecef1\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10043,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"ac55d026\": {\n    \"title\": \"Br"
      }, {
        "text": "achioradialis Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology"
      }, {
        "text": "\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sp"
      }, {
        "text": "inal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrachioradialis reflex"
      }, {
        "text": "\u003c/b\u003e is a deep tendon reflex that causes flexion of the elbow and supination of the forearm when the brachioradialis tendon"
      }, {
        "text": " is tapped at the styloid process of the radius. It is used to test the integrity of the \u003cmark\u003eC5 and C6"
      }, {
        "text": "\u003c/mark\u003e spinal nerve roots and the radial nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eN"
      }, {
        "text": "erve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC6\u003c/b\u003e nerve root, with a contribution from C5. Mnemonic: C"
      }, {
        "text": "5, \u003cb\u003e6\u003c/b\u003e, pick up sticks.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the tendon stretches the brachioradialis muscle"
      }, {
        "text": ". The afferent signal travels via the radial nerve to the C5/C6 spinal cord segments, synapses with a"
      }, {
        "text": " motor neuron, and the efferent signal returns via the radial nerve to cause muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/"
      }, {
        "text": "Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C6 root or a"
      }, {
        "text": " peripheral neuropathy affecting the radial nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a"
      }, {
        "text": " stroke or spinal cord injury above the C5/C6 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The brachioradialis reflex,"
      }, {
        "text": " along with the biceps reflex, is a key part of assessing the C5 and C6 nerve roots.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eBrachioradialis reflex\u003c/b\u003e is a specific test for the C5-"
      }, {
        "text": "C6 nerve roots, elicited by tapping the distal radius, which provides valuable information for localizing lesions within the cervical spine and brachial"
      }, {
        "text": " plexus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Brachioradialis Tendon]"
      }, {
        "text": " --\u003e B(Stretch Muscle); B --\u003e C(Afferent Signal via Radial N.); C --\u003e D[C5/C6 Spinal"
      }, {
        "text": " Cord]; D --\u003e E(Efferent Signal via Radial N.); E --\u003e F(Elbow Flexion/Forearm Supination);\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \""
      }, {
        "text": "to\": \"c5_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_"
      }, {
        "text": "root\",\n        \"to\": \"c6_nerve_root\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"a584135d\": {\n    \"title\": \"Brain\",\n    \""
      }, {
        "text": "primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n"
      }, {
        "text": "      \"Central Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrain"
      }, {
        "text": "\u003c/b\u003e is the central organ of the human nervous system, responsible for thought, memory, emotion, touch, motor skills, vision, breathing"
      }, {
        "text": ", temperature, hunger, and every process that regulates our body. It is composed of the cerebrum, cerebellum, and brain"
      }, {
        "text": "stem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryology:\u003c/b\u003e Develops from the rostr"
      }, {
        "text": "al part of the neural tube, which differentiates into the forebrain (prosencephalon), midbrain (mesencephalon), and"
      }, {
        "text": " hindbrain (rhombencephalon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Parts:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCerebrum:\u003c/b\u003e"
      }, {
        "text": " The largest part, divided into two hemispheres, responsible for higher cognitive functions.\u003cbr\u003e - \u003cb\u003eCerebellum:\u003c/b\u003e Located"
      }, {
        "text": " under the cerebrum, coordinates muscle movements and balance.\u003cbr\u003e - \u003cb\u003eBrainstem:\u003c/b\u003e Connects the cerebrum and"
      }, {
        "text": " cerebellum to the spinal cord, controlling many automatic functions like breathing and heart rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied"
      }, {
        "text": " by the anterior circulation (from internal carotid arteries) and posterior circulation (from vertebral arteries), which connect via the [[e"
      }, {
        "text": "22300e8|Circle of Willis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Can be affected by a"
      }, {
        "text": " wide range of pathologies including [[c5da3c57|ischemic]] and [[hemorrhagic_stroke|"
      }, {
        "text": "hemorrhagic strokes]], [[be057cfc|tumors]], trauma, infection, and neurodegenerative diseases."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the functional localization within the brain (e.g., motor/sensory hom"
      }, {
        "text": "unculus, language areas) and the vascular territories is crucial for solving clinical neurology questions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eBrain\u003c/b\u003e is the command center of the body, where intricate networks of neurons process"
      }, {
        "text": " information and control function, with specific regions highly specialized for distinct tasks, making the clinical presentation of brain lesions highly predictable based on their"
      }, {
        "text": " location.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"develops_from\",\n        \"to\": \"neural_tube\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_be_affected_by\",\n        \"to\": \"c5da3c"
      }, {
        "text": "57\"\n      },\n      {\n        \"type\": \"can_be_affected_by\",\n"
      }, {
        "text": "        \"to\": \"be057cfc\"\n      }\n    ]\n  },\n  \"177"
      }, {
        "text": "7e176\": {\n    \"title\": \"Brain Death\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Medical Ethics\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Com"
      }, {
        "text": "a\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain death\u003c/b\u003e is the irreversible cessation of"
      }, {
        "text": " all functions of the entire brain, including the brainstem. It is a legal and clinical definition of death, distinct from a"
      }, {
        "text": " persistent vegetative state where brainstem functions may be intact.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCriteria"
      }, {
        "text": ":\u003c/b\u003e Diagnosis requires evidence of an irreversible cause of coma, absence of confounding factors (e.g., hypothermia, drug"
      }, {
        "text": " intoxication), and the absence of all brainstem reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Reflexes Tested:\u003c/b\u003e Pupillary light reflex,"
      }, {
        "text": " corneal reflex, oculocephalic reflex (doll\u0027s eyes), oculovestibular reflex (cold caloric), gag"
      }, {
        "text": " reflex, and cough reflex must all be absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eApnea Test:\u003c/b\u003e A definitive test where the patient is disconnected from the"
      }, {
        "text": " ventilator to see if a rise in PaCO\u003csub\u003e2\u003c/sub\u003e stimulates a spontaneous respiratory effort. Absence of breathing despite a high PaCO\u003csub\u003e2\u003c/sub\u003e confirms apnea"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Perfusion:\u003c/b\u003e In brain death, [[3eca3f19|cerebral perfusion"
      }, {
        "text": " pressure (CPP)]] is zero, meaning there is no cerebral blood flow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEthical/Legal Status"
      }, {
        "text": ":\u003c/b\u003e A patient who meets the criteria for brain death is legally and medically deceased, even if their heart continues to beat with"
      }, {
        "text": " mechanical ventilation. This allows for the cessation of life support and consideration of organ donation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Brain death\u003c/b\u003e signifies the irreversible loss of function of the entire brain, including the brainstem, which is confirmed by the absence of all brainstem reflexes"
      }, {
        "text": " and a positive apnea test, establishing legal death despite ongoing cardiac activity on life support.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_defined_by\",\n        \"to\": \"absence_of_brain"
      }, {
        "text": "stem_reflexes\"\n      },\n      {\n        \"type\": \"is_confirmed_by\",\n        \"to\":"
      }, {
        "text": " \"apnea_test\"\n      },\n      {\n        \"type\": \"is_distinct_from\",\n        \"to\":"
      }, {
        "text": " \"persistent_vegetative_state\"\n      }\n    ]\n  },\n  \"e9a4"
      }, {
        "text": "7751\": {\n    \"title\": \"Brain Injury\",\n    \"primaryType\": \"pathology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Tra"
      }, {
        "text": "uma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain injury\u003c/b\u003e is"
      }, {
        "text": " damage to the brain that can result from a traumatic force (Traumatic Brain Injury, TBI) or a non-traumatic event"
      }, {
        "text": " (e.g., stroke, anoxia). The clinical effects depend on the mechanism, location, and severity of the injury.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTraumatic Brain Injury (TBI):\u003c/b\u003e Includes conc"
      }, {
        "text": "ussions, contusions, [[22b22e08|diffuse axonal injury]], and intracranial hemorrhages (epid"
      }, {
        "text": "ural, subdural). Caused by external forces.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-Traumatic Brain Injury:\u003c/b\u003e Includes [["
      }, {
        "text": "c5da3c57|ischemic]] and [[hemorrhagic_stroke|hemorrhagic strokes]], an"
      }, {
        "text": "oxic brain injury (e.g., from cardiac arrest), infections, and tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary vs. Secondary Injury:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003ePrimary Injury:\u003c/b\u003e The initial damage that occurs at the moment of impact or insult (e.g., shearing of"
      }, {
        "text": " axons, laceration of vessels).\u003cbr\u003e - \u003cb\u003eSecondary Injury:\u003c/b\u003e A cascade of molecular and inflammatory events"
      }, {
        "text": " that occur in the hours and days following the primary injury (e.g., cerebral edema, excitotoxicity, inflammation),"
      }, {
        "text": " which often worsens the overall outcome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Effects:\u003c/b\u003e The neurological deficits from a stroke are highly predictable based on the affected"
      }, {
        "text": " [[105efab1|arterial supply]] and the function of the brain region it perfuses (e.g., [["
      }, {
        "text": "143bb23d|MCA stroke]] causing contralateral face/arm weakness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the vascular territories"
      }, {
        "text": " of the major cerebral arteries ([[830c856c|ACA]], [[143bb23"
      }, {
        "text": "d|MCA]], [[b6a2cc31|PCA]]) is essential for localizing stroke lesions based on clinical symptoms"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrain injury\u003c/b\u003e encompasses a spectrum of damage from various"
      }, {
        "text": " causes, with the final clinical outcome determined not only by the initial insult but also by the subsequent cascade of secondary injury processes like"
      }, {
        "text": " edema and inflammation, which are major targets for neuroprotective therapies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"c5da3c57\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hemorrhagic_stroke\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"22b22e0"
      }, {
        "text": "8\"\n      },\n      {\n        \"type\": \"can_be_localized_by\",\n        \"to\":"
      }, {
        "text": " \"105efab1\"\n      }\n    ]\n  },\n  \"582d8"
      }, {
        "text": "572\": {\n    \"title\": \"Brainstem\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the posterior part of the brain that"
      }, {
        "text": " is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the"
      }, {
        "text": " pons, and the medulla oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Midbrain, Pons, and Medulla."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e\u003cbr\u003e 1. \u003cb\u003eConduit:\u003c/b\u003e Contains ascending (sensory) and descending ("
      }, {
        "text": "motor) tracts connecting the cerebrum and cerebellum to the spinal cord.\u003cbr\u003e 2. \u003cb\u003eCranial Nerve Nucle"
      }, {
        "text": "i:\u003c/b\u003e Houses the nuclei for cranial nerves III through XII.\u003cbr\u003e 3. \u003cb\u003eIntegrative Functions:\u003c/b\u003e Contains"
      }, {
        "text": " the reticular formation, which is crucial for consciousness, sleep-wake cycles, and vital autonomic functions (e.g., cardiovascular and respiratory control"
      }, {
        "text": " in the medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVentral View:\u003c/b\u003e Shows the cerebral peduncles (midbrain), the bulging"
      }, {
        "text": " pons, and the pyramids (medulla). Cranial nerves can be seen exiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDorsal View:\u003c/b\u003e Shows the superior"
      }, {
        "text": " and inferior colliculi (midbrain) and the floor of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The \u0027Rule of 4s\u0027 is a helpful mnemonic for localizing brainstem lesions: 4 CNs above"
      }, {
        "text": " the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX-XII);"
      }, {
        "text": " and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the critical, compact hub connecting the higher brain centers to the body"
      }, {
        "text": ", housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Brainstem] --\u003e B(Midbrain); A --\u003e C(Pons); A --\u003e"
      }, {
        "text": " D(Medulla);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed"
      }, {
        "text": "_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_composed_of\",\n        \"to\": \"pons\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_composed_of\",\n        \"to\": \"medulla_oblongata\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"contains_nuclei_for\",\n        \"to\": \"cranial_nerves\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"32ba61d1\": {\n    \"title"
      }, {
        "text": "\": \"Brainstem and Cerebellar Syndromes\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrainstem and Cerebellar Syndromes\u003c/b\u003e are collections of neurological signs"
      }, {
        "text": " and symptoms that result from lesions (typically strokes or tumors) affecting specific anatomical locations within the brainstem or cerebellum. Their"
      }, {
        "text": " presentations are highly predictable based on the structures involved.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLateral"
      }, {
        "text": " Medullary (Wallenberg) Syndrome:\u003c/b\u003e Caused by a PICA stroke. Presents with vertigo, nystagmus, ips"
      }, {
        "text": "ilateral ataxia, dysphagia, hoarseness, ipsilateral Horner syndrome, ipsilateral facial pain/temp loss, and contralateral body"
      }, {
        "text": " pain/temp loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLateral Pontine Syndrome:\u003c/b\u003e Caused by an AICA stroke. Similar to Wall"
      }, {
        "text": "enberg but includes ipsilateral facial paralysis (CN VII) and deafness (CN VIII), and lacks dysphagia/hoarseness."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedial Medullary Syndrome:\u003c/b\u003e Caused by an ASA stroke. Presents with contralateral hemiparesis, contralateral"
      }, {
        "text": " loss of proprioception/vibration, and ipsilateral tongue deviation (CN XII).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMultiple Sclerosis:\u003c/b\u003e Can"
      }, {
        "text": " cause various brainstem and cerebellar syndromes due to its demyelinating plaques. A classic MS-related syndrome is \u003cmark\u003e[["
      }, {
        "text": "58c684bd|internuclear ophthalmoplegia (INO)]]\u003c/mark\u003e from a lesion in the medial"
      }, {
        "text": " longitudinal fasciculus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Learn to differentiate the lateral syndromes: PICA (med"
      }, {
        "text": "ulla) involves CN IX/X (dysphagia/hoarseness), while AICA (pons) involves CN VII/"
      }, {
        "text": "VIII (facial palsy/deafness).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical diagnosis"
      }, {
        "text": " of \u003cb\u003ebrainstem and cerebellar syndromes\u003c/b\u003e is a classic exercise in neuroanatomical localization, where a specific constellation of cranial"
      }, {
        "text": " nerve deficits, long tract signs, and cerebellar findings can pinpoint a lesion to a precise vascular territory or location.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"lateral"
      }, {
        "text": "_medullary_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"lateral_pontine_syndrome\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"medial_medullary_syndrome\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"can_be_caused_by\",\n        \"to\": \"45dd6d19\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"be057cfc\": {\n    \"title\": \"Brain Tumors"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\","
      }, {
        "text": "\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrain tumors\u003c/b\u003e are neoplasms originating in the intracranial"
      }, {
        "text": " tissues. They can be primary (arising from brain cells) or metastatic (spreading from cancers elsewhere in the body). Their"
      }, {
        "text": " clinical presentation depends on their location, size, and growth rate.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAdult"
      }, {
        "text": " Primary Tumors:\u003c/b\u003e Most are supratentorial. In order of frequency: [[b6bbd0bc"
      }, {
        "text": "|Glioblastoma]], [[e98ea0ba|Meningioma]], [[03ecb69e|Schw"
      }, {
        "text": "annoma]], Oligodendroglioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChildhood Primary Tumors:\u003c/b\u003e Most are infratentorial. In order of frequency"
      }, {
        "text": ": Pilocytic astrocytoma, [[16d613bb|Medulloblastoma]], [[14"
      }, {
        "text": "365ef4|Ependymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetastatic Tumors:\u003c/b\u003e More common than"
      }, {
        "text": " primary tumors. Often present as multiple, well-circumscribed lesions at the gray-white junction. Common primary sources are"
      }, {
        "text": " \u003cmark\u003eLung, Breast, Kidney, Melanoma, and Colon\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Symptoms:\u003c/b\u003e Head"
      }, {
        "text": "aches (often worse in the morning), seizures, and focal neurological deficits corresponding to the tumor\u0027s location.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A ring-enhancing lesion on MRI with contrast is a key finding. The differential includes [[b6bbd0bc|glio"
      }, {
        "text": "blastoma]], metastasis, and abscess. A \u0027butterfly\u0027 appearance crossing the corpus callosum is classic for glioblastoma.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe classification and prognosis of \u003cb\u003ebrain tumors\u003c/b\u003e differ significantly between adults and children, with adults"
      }, {
        "text": " more commonly developing aggressive supratentorial gliomas and children typically having more benign infratentorial tumors.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"b6bbd"
      }, {
        "text": "0bc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"e"
      }, {
        "text": "98ea0ba\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to"
      }, {
        "text": "\": \"03ecb69e\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"14365ef4\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "af9d783c\": {\n    \"title\": \"Brainstem\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the posterior part of the brain"
      }, {
        "text": " that is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the pons, and the medulla"
      }, {
        "text": " oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Midbrain, Pons, and Medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctions:\u003c/b\u003e\u003cbr\u003e 1. "
      }, {
        "text": "\u003cb\u003eConduit:\u003c/b\u003e Contains ascending (sensory) and descending (motor) tracts connecting the cerebrum and cerebellum to the spinal"
      }, {
        "text": " cord.\u003cbr\u003e 2. \u003cb\u003eCranial Nerve Nuclei:\u003c/b\u003e Houses the nuclei for cranial nerves III through XII.\u003cbr\u003e 3."
      }, {
        "text": " \u003cb\u003eIntegrative Functions:\u003c/b\u003e Contains the reticular formation, which is crucial for consciousness, sleep-wake cycles,"
      }, {
        "text": " and vital autonomic functions (e.g., cardiovascular and respiratory control in the medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCross Sections:\u003c/b\u003e Recognizing"
      }, {
        "text": " the key structures in cross sections of the midbrain, pons, and medulla is essential for localizing brainstem strokes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHern"
      }, {
        "text": "iation Syndromes:\u003c/b\u003e The brainstem is vulnerable to compression during [[8c0728b7|herniation syndromes]],"
      }, {
        "text": " which can lead to coma and death (e.g., Duret hemorrhages from central herniation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The \u0027Rule of 4s\u0027 is a helpful mnemonic for localizing brainstem lesions: 4 CN"
      }, {
        "text": "s above the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX"
      }, {
        "text": "-XII); and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eBrainstem\u003c/b\u003e is the critical, compact hub connecting the higher brain"
      }, {
        "text": " centers to the body, housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brainstem] --\u003e B(Midbrain); A --\u003e C(Pons); A"
      }, {
        "text": " --\u003e D(Medulla);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_composed_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_composed_of\",\n        \"to\": \"pons\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_composed_of\",\n        \"to\": \"medulla_oblongata\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_compressed_in\",\n        \"to\": \"8"
      }, {
        "text": "c0728b7\"\n      }\n    ]\n  },\n  \"0f0fb"
      }, {
        "text": "fa0\": {\n    \"title\": \"Branch Retinal Vein Occlusion (BRVO)\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eBranch Retinal Vein Oc"
      }, {
        "text": "clusion (BRVO)\u003c/b\u003e is the blockage of a small vein in the retina, leading to hemorrhage, edema, and potential vision"
      }, {
        "text": " loss in the quadrant of the retina drained by that vein.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePathophysiology:\u003c/b\u003e Most commonly occurs at an \u003cmark\u003earteriovenous (AV) crossing\u003c/mark\u003e, where a hardened"
      }, {
        "text": ", atherosclerotic retinal arteriole compresses the adjacent, thinner-walled venule, leading to turbulent flow and thrombus formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Risk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, and hyperlipidemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Sudden, painless, unilateral vision loss, which may be described as a scotoma (blind spot) or blurry"
      }, {
        "text": " vision in a specific part of the visual field.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e Fundoscopic exam reveals \u003cmark\u003esector"
      }, {
        "text": "al (quadrantic) retinal hemorrhages\u003c/mark\u003e, venous engorgement, and cotton-wool spots confined to the area"
      }, {
        "text": " drained by the occluded vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from Central Retinal Vein Occlusion (CR"
      }, {
        "text": "VO), which involves the entire retina and has a more dramatic \\\"blood and thunder\\\" appearance. BRVO is localized to a"
      }, {
        "text": " quadrant. The key association is hypertension causing AV nicking.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA"
      }, {
        "text": " \u003cb\u003eBranch Retinal Vein Occlusion\u003c/b\u003e is a consequence of systemic vascular disease playing out in the eye, where"
      }, {
        "text": " a stiff arteriole compresses a venule at a crossing point, causing a localized \u0027traffic jam\u0027 of blood that results in a sectoral"
      }, {
        "text": " retinal hemorrhage.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension/Atherosclerosis] --\u003e B(Ar"
      }, {
        "text": "teriolar Sclerosis); B --\u003e C(Compression of Vein at AV Crossing); C --\u003e D(Thrombus Formation); D --\u003e E"
      }, {
        "text": "(Branch Retinal Vein Occlusion); E --\u003e F(Sectoral Hemorrhage \u0026 Edema);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"b69e35b5\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"differentiated_from\",\n        \"to\": \"b69e35b5\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"2fcee185\": {\n    \"title\": \"Brimonidine\",\n    \"primary"
      }, {
        "text": "Type\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Aut"
      }, {
        "text": "onomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eBrimonidine\u003c/b\u003e is a highly selective \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist\u003c/i\u003e used as"
      }, {
        "text": " a topical eye drop to lower intraocular pressure (IOP) in the treatment of [[5ea7b74"
      }, {
        "text": "1|open-angle glaucoma]] and ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Has a dual mechanism. It primarily \u003cmark\u003edecreases aqueous humor synthesis\u003c/mark\u003e by stimulating Œ±"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e receptors on the ciliary body. It also \u003cmark\u003eincreases uveoscleral outflow\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A common agent for the long-term management of [[5ea7b74"
      }, {
        "text": "1|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include allergic conjunctivitis, hyperemia"
      }, {
        "text": " (redness), and pruritus (itching). Systemic side effects are possible due to absorption and include dry mouth, sedation"
      }, {
        "text": ", and fatigue. Unlike apraclonidine, it does not cause mydriasis and can be used in angle-closure glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison"
      }, {
        "text": ":\u003c/b\u003e Similar to [[c1f67280|apraclonidine]] but is more selective for"
      }, {
        "text": " the Œ±\u003csub\u003e2\u003c/sub\u003e receptor and has a lower incidence of allergic reactions and tachyphylaxis, making it more suitable for"
      }, {
        "text": " long-term use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e agonists like brimonidine and"
      }, {
        "text": " clonidine act as sympatholytics, reducing sympathetic outflow. In the eye, this leads to decreased aqueous humor production."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrimonidine\u003c/b\u003e is an effective glaucoma medication that lowers intra"
      }, {
        "text": "ocular pressure through a dual mechanism of decreasing aqueous humor production and increasing its outflow, all mediated by its selective Œ±\u003csub\u003e2\u003c/sub\u003e-"
      }, {
        "text": "adrenergic agonism.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brimonidine] --\u003e B"
      }, {
        "text": "(Stimulates Œ±2 Receptors); B --\u003e C(‚Üì Aqueous Humor Synthesis); B --\u003e D(‚Üë Uveoscleral Out"
      }, {
        "text": "flow); C \u0026 D --\u003e E(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"alpha_2_agonist\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"has_similar_mechanism_to\",\n        \"to\": \"c1f67"
      }, {
        "text": "280\"\n      }\n    ]\n  },\n  \"4dff096f\": {\n    \"title\": \""
      }, {
        "text": "Broad-Spectrum Anticonvulsants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroad-spectrum anticonvulsants\u003c/b\u003e are"
      }, {
        "text": " antiepileptic drugs (AEDs) that are effective against a wide variety of seizure types, including both focal and generalized seizures"
      }, {
        "text": " (e.g., tonic-clonic, absence, myoclonic).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Agents:\u003c/b\u003e The main broad-spectrum agents are \u003cmark\u003e[[valproic_acid"
      }, {
        "text": "|Valproic acid]]\u003c/mark\u003e, \u003cmark\u003e[[08d19a8f|Lamotrigine]]\u003c/"
      }, {
        "text": "mark\u003e, \u003cmark\u003e[[2341f9c0|Levetiracetam]]\u003c/mark\u003e, and \u003cmark\u003e[[e"
      }, {
        "text": "1f5066c|Topiramate]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e They are the drugs"
      }, {
        "text": " of choice when the seizure type is unclear or when a patient has multiple seizure types (e.g., Lennox-Gastaut syndrome)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eValproic Acid:\u003c/b\u003e Very broad spectrum, effective for almost all seizure types. Mechanism involves Na\u003csup\u003e"
      }, {
        "text": "+\u003c/sup\u003e channel blockade, T-type Ca\u003csup\u003e2+\u003c/sup\u003e channel blockade, and increasing GABA levels. Highly teratogenic ("
      }, {
        "text": "neural tube defects).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLamotrigine:\u003c/b\u003e Broad spectrum, but must be titrated slowly to reduce the risk of Stevens-Johnson syndrome ("
      }, {
        "text": "SJS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLevetiracetam:\u003c/b\u003e Very commonly used due to its favorable side effect profile and broad efficacy"
      }, {
        "text": ". Unique mechanism involving synaptic vesicle protein 2A (SV2A).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If"
      }, {
        "text": " a question asks for the best initial treatment for a patient with generalized tonic-clonic seizures, a broad-spectrum agent like"
      }, {
        "text": " valproic acid or levetiracetam is a strong choice. Valproic acid is also a first-line option"
      }, {
        "text": " for myoclonic seizures.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroad-spectrum anticonvulsants"
      }, {
        "text": "\u003c/b\u003e are the versatile workhorses of epilepsy treatment, effective against both focal and generalized seizures, making them ideal for initial empirical therapy"
      }, {
        "text": " or for patients with complex epilepsy syndromes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_class_of\",\n        \"to\": \"f91a0c"
      }, {
        "text": "fa\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"valpro"
      }, {
        "text": "ic_acid\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \""
      }, {
        "text": "08d19a8f\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"2341f9c0\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"e1f5066c\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"7f6ed344\": {\n    \"title\": \"Broca\u0027"
      }, {
        "text": "s Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e, also known as expressive aphasia,"
      }, {
        "text": " is a language disorder characterized by difficulty in producing fluent, grammatical speech, while comprehension remains relatively intact. It is caused by a lesion in [["
      }, {
        "text": "a3bbace2|Broca\u0027s area]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ion Location:\u003c/b\u003e \u003cmark\u003eInferior frontal gyrus\u003c/mark\u003e of the dominant (usually left) hemisphere."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the [[143bb23d|Middle"
      }, {
        "text": " Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Speech is \u003cmark\u003enonfluent, telegraphic, and effort"
      }, {
        "text": "ful\u003c/mark\u003e. Patients use short phrases and omit functional words (e.g., \\\"Walk dog\\\"). Repetition is impaired"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eComprehension:\u003c/b\u003e Auditory and reading comprehension are relatively preserved, although complex grammar may be difficult.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient"
      }, {
        "text": " Awareness:\u003c/b\u003e Patients are typically aware of their deficits and become very frustrated by their inability to communicate effectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken \u003cb\u003eB\u003c/b\u003eoca ("
      }, {
        "text": "mouth). Look for a patient with a right hemiparesis (especially face and arm) who can follow commands but struggles"
      }, {
        "text": " to speak in complete sentences.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e"
      }, {
        "text": " is a disorder of language production, not comprehension, resulting from damage to the brain\u0027s motor-speech planning center."
      }, {
        "text": " The resulting speech is broken and effortful, leaving the patient frustratingly aware of their inability to express their intact thoughts.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Lesion in Broca\u0027s Area] --\u003e B(Impaired Speech Production); B --\u003e C(Non"
      }, {
        "text": "fluent, Telegraphic Speech); A --Spares--\u003e D(Wernicke\u0027s Area); D --\u003e E(Intact Comprehension);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_"
      }, {
        "text": "lesion_in\",\n        \"to\": \"a3bbace2\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143"
      }, {
        "text": "bb23d\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        "
      }, {
        "text": "\"to\": \"2c4a6130\"\n      }\n    ]\n  },\n  \"a"
      }, {
        "text": "3bbace2\": {\n    \"title\": \"Broca\u0027s Area\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\","
      }, {
        "text": "\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eBroca\u0027s area\u003c/b\u003e is a region in the frontal lobe of the dominant hemisphere (usually the left) of the brain with"
      }, {
        "text": " functions linked to speech production.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the \u003c"
      }, {
        "text": "mark\u003einferior frontal gyrus\u003c/mark\u003e of the dominant hemisphere (Brodmann areas 44 and 45"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Responsible for the motor planning and execution of speech. It coordinates the movements of the larynx"
      }, {
        "text": ", tongue, and lips necessary for articulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the"
      }, {
        "text": " [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e Damage"
      }, {
        "text": " to this area results in [[7f6ed344|Broca\u0027s aphasia]] (expressive aphasia),"
      }, {
        "text": " characterized by nonfluent, agrammatical speech with intact comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnection:\u003c/b\u003e It is connected to [["
      }, {
        "text": "wernicke_area|Wernicke\u0027s area]] (language comprehension) by a bundle of nerve fibers called the arcuate fasciculus"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A stroke affecting the left MCA is the most common cause of damage to Broca\u0027s area."
      }, {
        "text": " Because of its proximity to the primary motor cortex, [[7f6ed344|Broca\u0027s aphasia]]"
      }, {
        "text": " is often accompanied by contralateral weakness of the face and arm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Broca\u0027s area\u003c/b\u003e is the brain\u0027s \u0027speech production factory,\u0027 translating thoughts and concepts from Wernicke\u0027s area into the"
      }, {
        "text": " precise motor commands needed for fluent articulation; a lesion here breaks the production line, resulting in expressive aphasia.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Wernicke\u0027s Area - Comprehension] --Arcuate Fasciculus--\u003e B(Bro"
      }, {
        "text": "ca\u0027s Area); B --Motor Plan--\u003e C(Primary Motor Cortex); C --\u003e D(Speech Articulation);\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"frontal_lobe"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \""
      }, {
        "text": "7f6ed344\"\n      },\n      {\n        \"type\": \"is_supplied_by\","
      }, {
        "text": "\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_connected_to\",\n        \"to\": \"wernicke_area\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"d24a5ff0\": {\n    \"title\": \"Bromocriptine\",\n    \""
      }, {
        "text": "primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Neurology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eBromocriptine\u003c/b\u003e is an ergot derivative that acts as a \u003ci\u003edopamine D"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e receptor agonist\u003c/i\u003e. It is used to treat conditions associated with hyperprolactinemia and [[58c8"
      }, {
        "text": "ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stim"
      }, {
        "text": "ulates dopamine D\u003csub\u003e2\u003c/sub\u003e receptors in the CNS and periphery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Endocrinology):\u003c/b\u003e Treats"
      }, {
        "text": " hyperprolactinemia and prolactinomas by stimulating D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs in the anterior pituitary, which inhibits prol"
      }, {
        "text": "actin secretion. Also used for acromegaly as it can suppress GH secretion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Neurology):\u003c/b\u003e Used"
      }, {
        "text": " as an adjunctive therapy in [[58c8ea03|Parkinson disease]] to stimulate dopamine receptors in the striatum. It"
      }, {
        "text": " is an ergot derivative and is less commonly used now than non-ergot agonists (e.g., pramipexole"
      }, {
        "text": ", ropinirole) due to its side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, vomiting, postural"
      }, {
        "text": " hypotension, and headache. As an ergot derivative, it can cause pulmonary fibrosis and vasospasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Bromocriptine is a classic treatment for prolactinomas. Remember that dopamine tonically inhibits prolactin release, so a dopamine"
      }, {
        "text": " agonist will lower prolactin levels.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBromocriptine\u003c/b\u003e is"
      }, {
        "text": " a dopamine D\u003csub\u003e2\u003c/sub\u003e agonist that leverages dopamine\u0027s inhibitory control over prolactin to treat hyperprolactinemia and"
      }, {
        "text": " supplements dopamine signaling in the basal ganglia to treat Parkinson disease, though its use is limited by its ergot-related side effects.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"dopamine_agonist\"\n      },\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"treats\",\n        \"to\": \"acromegaly\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"4792bc68\": {\n    \"title\": \"Brown-S√©qu"
      }, {
        "text": "ard Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard syndrome\u003c/b\u003e is a rare neurological condition"
      }, {
        "text": " caused by \u003ci\u003ehemisection of the spinal cord\u003c/i\u003e, resulting in a characteristic pattern of ipsilateral motor and proprioceptive loss, and"
      }, {
        "text": " contralateral pain and temperature sensory loss below the level of the lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Typically caused by trauma, such as a penetrating injury (e.g., stab wound) or a tumor"
      }, {
        "text": " compressing one half of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIpsilateral Deficits (at and below lesion):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Motor:\u003c/b\u003e Ipsilateral spastic paralysis below the lesion (corticospinal tract damage).\u003cbr\u003e - \u003cb\u003eS"
      }, {
        "text": "ensation:\u003c/b\u003e Ipsilateral loss of proprioception, vibration, and fine touch below the lesion ([[e7f5cb"
      }, {
        "text": "be|dorsal column]] damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContralateral Deficits (below lesion):\u003c/b\u003e\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eSensation:\u003c/b\u003e Contralateral loss of pain and temperature sensation, typically beginning 1-2 segments below the lesion (spin"
      }, {
        "text": "othalamic tract damage, as fibers decussate in the spinal cord).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficits at the Level of the"
      }, {
        "text": " Lesion:\u003c/b\u003e\u003cbr\u003e - Ipsilateral flaccid paralysis (LMN damage at that level).\u003cbr\u003e - Ipsilateral complete"
      }, {
        "text": " loss of all sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This syndrome is a classic test of spinal cord tract anatomy. The"
      }, {
        "text": " key is remembering which tracts cross in the medulla (dorsal columns, corticospinal) versus the spinal cord (spin"
      }, {
        "text": "othalamic). If the lesion is above T1, an ipsilateral [[c19010a3|Horner syndrome]] may"
      }, {
        "text": " also be present.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBrown-S√©quard syndrome\u003c/b\u003e"
      }, {
        "text": " is the ultimate clinical demonstration of spinal cord neuroanatomy, creating a striking dissociation of deficits where one side of the body loses"
      }, {
        "text": " motor function and proprioception, while the other side loses the ability to feel pain and temperature, all due to a unilateral cord"
      }, {
        "text": " lesion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Spinal Cord Hemisection at T10"
      }, {
        "text": "]; A --\u003e B(Ipsilateral (Right) Deficits); B --\u003e C(Loss of Motor, Proprioception, Vibration below T1"
      }, {
        "text": "0); B --\u003e D(Flaccid paralysis at T10); A --\u003e E(Contralateral (Left) Deficits);"
      }, {
        "text": " E --\u003e F(Loss of Pain \u0026 Temperature below T10);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by\",\n        \"to\": \"spinal_cord_hemisection\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_"
      }, {
        "text": "tracts\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \""
      }, {
        "text": "e7f5cbbe\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"07"
      }, {
        "text": "eecef1\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1PLnodOYY0VJuqjIgrui49lniV015L2xT"
      },
      "role": "user",
      "tokenCount": 1761
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"901f3180\": {\n    \"title\": \"Bulbar Palsy\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBulbar palsy\u003c/b\u003e refers to a set of clinical signs resulting from damage to the \u003cu\u003elower motor neurons (LMNs)\u003c/u\u003e of the cranial nerves originating in the brainstem (medulla oblongata, or \u0027bulb\u0027). Specifically, it involves cranial nerves IX (glossopharyngeal), X (vagus), XI (accessory), and XII (hypoglossal).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by LMN lesions of cranial nerves IX, X, XI, and XII.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by \u003cmark\u003eflaccid weakness\u003c/mark\u003e of the muscles of the mouth, pharynx, and larynx. This leads to dysarthria (slurred speech), dysphagia (difficulty swallowing), drooling, and a hoarse or nasal voice.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam Findings:\u003c/b\u003e On examination, there is tongue wasting and \u003cmark\u003efasciculations\u003c/\u0027mark\u003e (LMN signs), a diminished or absent gag reflex, and the palate may not elevate symmetrically.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be seen in [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]], Guillain-Barr√© syndrome, myasthenia gravis, and brainstem strokes or tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from \u003cb\u003epseudobulbar palsy\u003c/b\u003e, which is caused by \u003cu\u003eupper motor neuron (UMN)\u003c/u\u003e lesions. Pseudobulbar palsy presents with a spastic dysarthria, an exaggerated gag reflex, and emotional lability (pseudobulbar affect), without tongue atrophy or fasciculations.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBulbar palsy\u003c/b\u003e is a manifestation of lower motor neuron damage to the lower cranial nerves, resulting in a flaccid paralysis of the oral, pharyngeal, and laryngeal muscles, which must be distinguished from the spastic paralysis of the same muscles seen in the upper motor neuron condition, pseudobulbar palsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"glossopharyngeal_nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"accessory_nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"hypoglossal_nerve\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"pseudobulbar_palsy\"\n      }\n    ]\n  },\n  \"181a22b1\": {\n    \"title\": \"Bupivacaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBupivacaine\u003c/b\u003e is a long-acting, amide-type \u003ci\u003elocal anesthetic\u003c/i\u003e commonly used for regional anesthesia, such as epidurals for labor and spinal anesthesia for surgical procedures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic (has two \u0027i\u0027s in its name).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long duration of action, making it suitable for prolonged procedures and postoperative pain control.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Widely used for epidural analgesia, spinal anesthesia, and peripheral nerve blocks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effect:\u003c/b\u003e The most notable adverse effect is \u003cmark\u003esevere cardiotoxicity\u003c/mark\u003e. It is more cardiotoxic than other local anesthetics. Accidental intravascular injection can lead to severe ventricular arrhythmias and cardiovascular collapse that is difficult to resuscitate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember bupivacaine for its long duration of action and its significant risk of cardiotoxicity. This risk is a major consideration in its clinical use and dosing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBupivacaine\u003c/b\u003e is a potent, long-acting amide anesthetic favored for epidurals and nerve blocks, but its use is shadowed by a significant risk of severe cardiotoxicity if accidentally injected systemically.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"has_adverse_effect\",\n        \"to\": \"cardiotoxicity\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n  },\n  \"5b2b854f\": {\n    \"title\": \"Buprenorphine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBuprenorphine\u003c/b\u003e is a semi-synthetic opioid that acts as a \u003ci\u003epartial agonist\u003c/i\u003e at the Œº-opioid receptor and an antagonist at the Œ∫-opioid receptor. It is used for both pain management and the treatment of opioid use disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As a \u003cmark\u003epartial Œº-opioid agonist\u003c/mark\u003e, it binds with high affinity but has lower intrinsic activity than full agonists like morphine. This creates a \u0027ceiling effect\u0027 on respiratory depression, making it safer in overdose than full agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Opioid Use Disorder):\u003c/b\u003e Used for opioid detoxification and maintenance therapy. It can precipitate withdrawal if given to a patient who is currently using full opioids due to its high affinity and lower intrinsic activity. Often co-formulated with naloxone (Suboxone) to deter IV abuse.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Pain):\u003c/b\u003e Effective for moderate to severe chronic pain, available in various formulations including transdermal patches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e Its effects are not easily reversed by naloxone due to its high affinity for the Œº-receptor, requiring higher doses of the antagonist.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key concept for buprenorphine is \u0027partial agonist.\u0027 This explains its ceiling effect on respiratory depression and its ability to precipitate withdrawal in an opioid-dependent individual.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBuprenorphine\u003c/b\u003e is a unique opioid that acts as a partial agonist, providing analgesia and mitigating withdrawal symptoms with a lower risk of respiratory depression, but its high receptor affinity means it can displace full agonists and precipitate withdrawal if not initiated carefully.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"partial_mu_opioid_agonist\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"opioid_use_disorder\"\n      }\n    ]\n  },\n  \"34217723\": {\n    \"title\": \"Butorphanol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eButorphanol\u003c/b\u003e is a synthetic opioid analgesic that functions as a \u003ci\u003emixed agonist-antagonist\u003c/i\u003e. It is primarily used for the management of moderate to severe pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a \u003cmark\u003eŒ∫-opioid receptor agonist\u003c/mark\u003e and a \u003cmark\u003eŒº-opioid receptor partial agonist or weak antagonist\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnalgesic Effect:\u003c/b\u003e The Œ∫-agonist activity provides strong analgesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCeiling Effect:\u003c/b\u003e Like other mixed agonist-antagonists, it exhibits a ceiling effect for respiratory depression, making it potentially safer in overdose compared to full Œº-agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for moderate to severe pain, particularly in labor (less neonatal respiratory depression) and for postoperative pain. Also available as a nasal spray for [[c8833bae|migraines]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can cause sedation, nausea, and psychotomimetic effects (e.g., hallucinations, dysphoria) due to Œ∫-receptor agonism. It can precipitate withdrawal symptoms in patients physically dependent on full Œº-opioid agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that mixed agonist-antagonists like butorphanol and nalbuphine can precipitate withdrawal in opioid-dependent patients. Their primary analgesic effect comes from Œ∫-agonism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eButorphanol\u003c/b\u003e is a mixed-action opioid that provides potent analgesia through Œ∫-receptor agonism while having a limited effect on Œº-receptors, which gives it a better safety profile regarding respiratory depression but also the potential to induce withdrawal in opioid-dependent individuals.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"kappa_opioid_agonist\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"mu_opioid_partial_agonist_antagonist\"\n      },\n      {\n        \"type\": \"can_precipitate\",\n        \"to\": \"opioid_withdrawal\"\n      }\n    ]\n  },\n  \"ca6ee143\": {\n    \"title\": \"Cabergoline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pharmacology\",\n      \"Hypothalamic and Pituitary Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCabergoline\u003c/b\u003e is a long-acting ergot derivative that is a potent \u003ci\u003edopamine D\u003csub\u003e2\u003c/sub\u003e receptor agonist\u003c/i\u003e. It is the first-line treatment for hyperprolactinemia and prolactin-secreting [[5f3188bd|pituitary adenomas]] (prolactinomas).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stimulates D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs in the [[76ba7f2e|anterior pituitary]], mimicking the natural inhibitory effect of dopamine on prolactin secretion. This leads to a decrease in serum prolactin levels and can cause shrinkage of prolactinomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e \u003cu\u003eFirst-line treatment\u003c/u\u003e for prolactinomas and hyperprolactinemia. Also used in [[acromegaly]] (can suppress GH secretion) and [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long half-life, allowing for once or twice weekly dosing, which improves patient compliance compared to [[d24a5ff0|bromocriptine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, headache, postural hypotension. Less nausea than bromocriptine. High doses have been associated with valvular heart disease, but this is rare at the doses used for hyperprolactinemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Cabergoline is preferred over [[d24a5ff0|bromocriptine]] for treating prolactinomas due to its higher efficacy, better side-effect profile, and more convenient dosing schedule.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCabergoline\u003c/b\u003e is the superior dopamine agonist for treating hyperprolactinemia, effectively suppressing prolactin secretion and shrinking pituitary tumors by powerfully stimulating D\u003csub\u003e2\u003c/sub\u003e receptors, with the clinical advantage of a long half-life and better tolerability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cabergoline] --\u003e B(Stimulates D2 Receptors on Lactotrophs); B --\u003e C(‚Üì Prolactin Secretion); C --\u003e D(‚Üì Serum Prolactin \u0026 Tumor Shrinkage);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dopamine_agonist\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"5f3188bd\"\n      },\n      {\n        \"type\": \"is_preferred_over\",\n        \"to\": \"d24a5ff0\"\n      }\n    ]\n  },\n  \"cbb4285c\": {\n    \"title\": \"Caf√©-au-lait Spots\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Neurology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"Pigmented Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCaf√©-au-lait spots\u003c/b\u003e are well-demarcated, hyperpigmented macules or patches on the skin, with a color resembling \u0027coffee with milk.\u0027 While a few small spots can be normal, the presence of multiple, large spots is a hallmark of several genetic syndromes, most notably Neurofibromatosis Type 1.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Flat, pigmented birthmarks with a light brown color and distinct borders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 1 (NF-1):\u003c/b\u003e The presence of \u003cmark\u003esix or more\u003c/mark\u003e caf√©-au-lait spots greater than 5 mm in diameter in prepubertal individuals (or \u003e15 mm in postpubertal individuals) is a key diagnostic criterion for NF-1. The spots in NF-1 typically have smooth borders (\u0027coast of California\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMcCune-Albright Syndrome:\u003c/b\u003e Characterized by a triad of fibrous dysplasia of bone, endocrine abnormalities (like precocious puberty), and large, unilateral caf√©-au-lait spots with irregular, jagged borders (\u0027coast of Maine\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Associations:\u003c/b\u003e Can also be seen in tuberous sclerosis, Fanconi anemia, and other syndromes, but are most strongly associated with NF-1.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Multiple caf√©-au-lait spots in a child should prompt a thorough evaluation for other signs of Neurofibromatosis Type 1, such as axillary freckling, Lisch nodules, and neurofibromas.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eWhile often benign, multiple \u003cb\u003ecaf√©-au-lait spots\u003c/b\u003e are a crucial dermatological clue to underlying systemic genetic disorders, with the number and border characteristics (smooth in NF-1, irregular in McCune-Albright) helping to narrow the differential diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"neurofibromatosis_type_1\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"mccune_albright_syndrome\"\n      }\n    ]\n  },\n  \"24d36d58\": {\n    \"title\": \"Calcitonin Gene-Related Peptide (CGRP)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCalcitonin Gene-Related Peptide (CGRP)\u003c/b\u003e is a 37-amino acid neuropeptide that is widely distributed in the central and peripheral nervous systems. It is a potent vasodilator and is critically involved in pain transmission, particularly in the pathophysiology of [[c8833bae|migraine headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Acts as a potent arterial vasodilator and a neurotransmitter/neuromodulator in pain pathways.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Migraine:\u003c/b\u003e During a migraine attack, CGRP is released from trigeminal nerve endings. This release causes vasodilation of cranial blood vessels and promotes neurogenic inflammation, contributing to the pain of a migraine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapeutic Target:\u003c/b\u003e CGRP and its receptor have become major targets for migraine therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug Classes Targeting CGRP:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[4770b8a2|Anti-CGRP Monoclonal Antibodies]]\u003c/b\u003e (e.g., erenumab, galcanezumab): Used for migraine \u003cu\u003eprophylaxis\u003c/u\u003e.\u003cbr\u003e2. \u003cb\u003eGepants\u003c/b\u003e (e.g., ubrogepant, rimegepant): Small molecule CGRP receptor antagonists used for \u003cu\u003eacute\u003c/u\u003e treatment of migraines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The central role of CGRP in migraine pathophysiology is a high-yield concept. Understand that blocking the CGRP pathway, either with monoclonal antibodies for prevention or gepants for acute attacks, is a modern, targeted approach to migraine treatment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCalcitonin Gene-Related Peptide (CGRP)\u003c/b\u003e is a key player in the generation of migraine pain, acting as both a powerful vasodilator and a pain-signaling molecule in the trigeminal system, making its blockade a highly effective strategy for migraine therapy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Nerve Activation] --\u003e B(Release of CGRP); B --\u003e C(Vasodilation \u0026 Neurogenic Inflammation); C --\u003e D(Migraine Pain);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \"4770b8a2\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \"gepants\"\n      }\n    ]\n  },\n  \"e4b8298b\": {\n    \"title\": \"Capsaicin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCapsaicin\u003c/b\u003e is the active component of chili peppers and is used topically as an analgesic for neuropathic and musculoskeletal pain. It works by interacting with the transient receptor potential vanilloid 1 (TRPV1) receptor on nociceptive nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Initially, capsaicin activates TRPV1 receptors (also known as capsaicin receptors), causing an influx of calcium and the release of substance P, which leads to a burning sensation. With repeated application, it causes \u003cmark\u003edesensitization\u003c/-mark\u003e of the nerve fibers and \u003cmark\u003edepletion of substance P\u003c/mark\u003e, resulting in an analgesic effect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used topically for neuropathic pain (e.g., postherpetic neuralgia, diabetic neuropathy) and musculoskeletal pain (e.g., osteoarthritis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Available as a low-concentration over-the-counter cream or a high-concentration prescription patch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effect is a localized burning, stinging, or erythema at the application site, which typically diminishes with continued use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key mechanism to remember is the initial activation followed by desensitization and depletion of substance P from sensory nerve endings.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCapsaicin\u003c/b\u003e paradoxically relieves pain by first causing it; its initial stimulation of pain receptors leads to their eventual desensitization and the depletion of substance P, effectively silencing the pain signals from the affected area.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Topical Capsaicin] --\u003e B(Activates TRPV1 Receptors); B --\u003e C(Initial Release of Substance P); C --\u003e D(Burning Sensation); B --Repeated Application--\u003e E(Desensitization \u0026 Depletion of Substance P); E --\u003e F(Analgesia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \"acts_on_receptor\",\n        \"to\": \"trpv1_receptor\"\n      },\n      {\n        \"type\": \"depletes\",\n        \"to\": \"substance_p\"\n      }\n    ]\n  },\n  \"a5ec55b5\": {\n    \"title\": \"Caput Succedaneum\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCaput succedaneum\u003c/b\u003e is a benign, edematous swelling of the soft tissues of a newborn\u0027s scalp that is present at birth. It is caused by pressure on the infant\u0027s head from the cervix or vaginal wall during a prolonged or difficult delivery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The edema is located in the subcutaneous tissue, \u003cu\u003esuperficial to the periosteum\u003c/u\u003e of the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A soft, puffy, and sometimes ecchymotic swelling on the scalp. A key feature is that it \u003cmark\u003ecrosses suture lines\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Present at birth and typically resolves spontaneously within a few days.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It must be distinguished from a [[a1721d6f|cephalohematoma]].\u003cbr\u003e - \u003cb\u003eCaput Succedaneum:\u003c/b\u003e Soft, pits on pressure, crosses suture lines, resolves quickly.\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Firm, does \u003cu\u003enot\u003c/u\u003e cross suture lines (subperiosteal), resolves over weeks to months, may calcify.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The ability to cross suture lines is the most important feature for distinguishing caput succedaneum from a cephalohematoma on an exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCaput succedaneum\u003c/b\u003e is a benign and self-resolving scalp edema in newborns resulting from birth trauma, easily identified by its soft consistency and its ability to cross cranial suture lines, distinguishing it from the more localized and potentially complicated cephalohematoma.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46ca72c2\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a1721d6f\"\n      }\n    ]\n  },\n  \"c1ad76f4\": {\n    \"title\": \"Carbachol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCarbachol\u003c/b\u003e is a \u003ci\u003echolinomimetic agent\u003c/i\u003e that acts as a non-selective agonist at both muscarinic and nicotinic acetylcholine receptors. It is primarily used in ophthalmology to treat glaucoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As a direct cholinergic agonist, it mimics the effects of [[6a005559|acetylcholine]]. In the eye, it stimulates muscarinic (M\u003csub\u003e3\u003c/sub\u003e) receptors on the ciliary muscle and the sphincter pupillae muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Effects:\u003c/b\u003e\u003cbr\u003e 1. \u003cb\u003eMiosis:\u003c/b\u003e Contraction of the sphincter pupillae muscle causes pupillary constriction.\u003cbr\u003e 2. \u003cb\u003e‚Üì IOP:\u003c/b\u003e Contraction of the ciliary muscle increases the outflow of aqueous humor through the trabecular meshwork, lowering intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used topically to treat [[5ea7b741|open-angle glaucoma]] and to produce miosis during ophthalmic surgery. It is less commonly used than pilocarpine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eResistance to AChE:\u003c/b\u003e Carbachol is resistant to hydrolysis by acetylcholinesterase, giving it a longer duration of action than acetylcholine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember carbachol as a direct-acting cholinomimetic that lowers IOP by increasing trabecular outflow, a mechanism shared with pilocarpine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarbachol\u003c/b\u003e is a potent, long-acting acetylcholine mimic that effectively lowers intraocular pressure in glaucoma by contracting the ciliary muscle to open up the trabecular meshwork drainage channels.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cholinomimetic_agent\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"muscarinic_receptors\"\n      },\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"nicotinic_receptors\"\n      }\n    ]\n  },\n  \"eddd2bc5\": {\n    \"title\": \"Carbamazepine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCarbamazepine\u003c/b\u003e is a narrow-spectrum \u003ci\u003eanticonvulsant\u003c/i\u003e drug that works by blocking voltage-gated sodium channels. It is also used as a mood stabilizer and for the treatment of neuropathic pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in their inactivated state, which prolongs the refractory period of the neuron and prevents repetitive firing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e First-line treatment for \u003cmark\u003efocal seizures\u003c/mark\u003e (both simple and complex) and generalized tonic-clonic seizures.\u003cbr\u003e - \u003cb\u003eNeuropathic Pain:\u003c/b\u003e First-line treatment for \u003cmark\u003etrigeminal neuralgia\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eBipolar Disorder:\u003c/b\u003e Used as a mood stabilizer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Diplopia, ataxia, SIADH (hyponatremia), and skin rashes. Two serious, rare side effects are \u003cmark\u003eagranulocytosis\u003c/mark\u003e and \u003cmark\u003eaplastic anemia\u003c/mark\u003e, requiring monitoring of CBC. It is also a potent inducer of cytochrome P450 enzymes, leading to many drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTeratogenicity:\u003c/b\u003e Associated with an increased risk of \u003cmark\u003eneural tube defects\u003c/mark\u003e in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Carbamazepine is the drug of choice for trigeminal neuralgia. Remember its major hematologic side effects (agranulocytosis, aplastic anemia) and its induction of the P450 system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarbamazepine\u003c/b\u003e is a cornerstone therapy for focal seizures and trigeminal neuralgia, acting by stabilizing inactivated sodium channels, but its use requires careful monitoring due to the risk of severe hematologic toxicity and its potent induction of hepatic enzymes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"trigeminal_neuralgia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"focal_seizures\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"agranulocytosis\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"aplastic_anemia\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"siadh\"\n      }\n    ]\n  },\n  \"541cd176\": {\n    \"title\": \"Carbidopa/Levodopa\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCarbidopa/Levodopa\u003c/b\u003e (trade name Sinemet) is the most effective and widely used combination drug for the symptomatic treatment of [[58c8ea03|Parkinson disease]]. Levodopa is a metabolic precursor to dopamine, while carbidopa is a peripheral DOPA decarboxylase inhibitor.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLevodopa (L-DOPA):\u003c/b\u003e Can cross the [[dd47b9cc|blood-brain barrier]] (unlike dopamine) and is converted to [[90adc821|dopamine]] in the CNS by DOPA decarboxylase, replenishing the depleted dopamine stores in the striatum.\u003cbr\u003e - \u003cb\u003eCarbidopa:\u003c/b\u003e Inhibits peripheral DOPA decarboxylase. This prevents the conversion of L-DOPA to dopamine in the periphery, which \u003cmark\u003eincreases the bioavailability of L-DOPA in the brain\u003c/mark\u003e and \u003cmark\u003ereduces peripheral side effects\u003c/mark\u003e (like nausea and arrhythmias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e The cornerstone of treatment for [[58c8ea03|Parkinson disease]], particularly effective for bradykinesia and rigidity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, hallucinations, postural hypotension. Long-term use is associated with motor fluctuations (\u0027on-off\u0027 phenomenon) and dyskinesias (involuntary movements).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The rationale for the combination is key: Carbidopa acts as a \u0027bodyguard\u0027 for Levodopa, ensuring more of it reaches the brain where it\u0027s needed, while minimizing side effects elsewhere in the body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCarbidopa/Levodopa\u003c/b\u003e combination is a brilliant pharmacological strategy that overcomes the blood-brain barrier by using a precursor (Levodopa) and then protecting that precursor from peripheral breakdown (with Carbidopa) to effectively deliver dopamine to the deficient basal ganglia in Parkinson\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Levodopa] --Peripheral DOPA Decarboxylase--\u003e B(Dopamine - Periphery); C[Carbidopa] --x B; A --\u003e D(Crosses BBB); D --\u003e E[L-DOPA in CNS]; E --Central DOPA Decarboxylase--\u003e F(Dopamine - CNS); F --\u003e G(Treats Parkinson\u0027s Symptoms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_precursor_to\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_combined_with\",\n        \"to\": \"carbidopa\"\n      }\n    ]\n  },\n  \"e1e7ac22\": {\n    \"title\": \"Carotid-Cavernous Fistula\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eCarotid-Cavernous Fistula (CCF)\u003c/b\u003e is an abnormal communication between the internal carotid artery and the [[c260efc8|cavernous sinus]]. This creates a high-flow, high-pressure arteriovenous shunt within the sinus, leading to a characteristic set of signs and symptoms.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be traumatic (e.g., from a basal skull fracture) or spontaneous (e.g., from a ruptured intracavernous carotid aneurysm).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Arterial blood from the internal carotid artery flows directly into the low-pressure [[c260efc8|cavernous sinus]]. This increases pressure in the sinus and reverses blood flow in the veins that drain into it, particularly the superior ophthalmic vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Triad:\u003c/b\u003e The classic triad is \u003cmark\u003epulsatile exophthalmos\u003c/mark\u003e (protruding, pulsating eye), \u003cmark\u003eocular bruit\u003c/mark\u003e (a whooshing sound heard over the eye), and \u003cmark\u003echemosis\u003c/mark\u003e (conjunctival edema and redness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Symptoms:\u003c/b\u003e Patients also develop ophthalmoplegia (paralysis of eye muscles) due to dysfunction of cranial nerves III, IV, and VI, which all traverse the cavernous sinus. There may also be sensory loss in the V\u003csub\u003e1\u003c/sub\u003e and V\u003csub\u003e2\u003c/sub\u003e distribution.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a pulsating eye and an audible bruit over the eye after head trauma is pathognomonic for a carotid-cavernous fistula.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCarotid-Cavernous Fistula\u003c/b\u003e creates a high-pressure vascular storm within the cavernous sinus, engorging the orbital veins and compressing the cranial nerves that pass through it, resulting in the dramatic clinical picture of a pulsating, red, and paralyzed eye.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid Artery] --Fistula--\u003e B(Cavernous Sinus); B --\u003e C(‚Üë Pressure in Sinus); C --\u003e D(Reversal of flow in Superior Ophthalmic Vein); D --\u003e E(Pulsatile Exophthalmos, Chemosis, Bruit); C --\u003e F(Compression of CN III, IV, V1, V2, VI); F --\u003e G(Ophthalmoplegia, Sensory Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"affects\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"ophthalmoplegia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"pulsatile_exophthalmos\"\n      }\n    ]\n  },\n  \"6696dd3a\": {\n    \"title\": \"Carteolol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCarteolol\u003c/b\u003e is a non-selective \u003ci\u003eŒ≤-adrenergic antagonist\u003c/i\u003e (beta-blocker) used as a topical eye drop to reduce intraocular pressure (IOP) in the treatment of [[5ea7b741|open-angle glaucoma]] and ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks both Œ≤\u003csub\u003e1\u003c/sub\u003e and Œ≤\u003csub\u003e2\u003c/sub\u003e adrenergic receptors on the ciliary epithelium. This leads to a \u003cmark\u003edecrease in aqueous humor production\u003c/mark\u003e, thereby lowering IOP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-selective beta-blocker, similar to [[ae28be6c|timolol]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A first-line agent for [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include stinging and burning. Systemic absorption can occur, potentially causing bradycardia, hypotension, fatigue, and bronchoconstriction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Should be used with caution in patients with asthma, COPD, bradycardia, or heart block due to its non-selective Œ≤-blockade.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Like all non-selective beta-blockers used for glaucoma, carteolol\u0027s main mechanism is decreasing aqueous humor production. Be aware of the potential for systemic side effects, especially bronchospasm in patients with reactive airway disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarteolol\u003c/b\u003e is a non-selective beta-blocker that effectively treats glaucoma by turning down the \u0027faucet\u0027 of aqueous humor production in the ciliary body, but its systemic absorption carries the risk of Œ≤-blockade side effects throughout the body.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"beta_blocker\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"decreases_production_of\",\n        \"to\": \"aqueous_humor\"\n      }\n    ]\n  },\n  \"85f03b02\": {\n    \"title\": \"Cataracts\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Lens Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecataract\u003c/b\u003e is a painless, progressive opacification or clouding of the normally clear lens of the eye, which leads to a decrease in vision. It is the leading cause of blindness worldwide.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Involves the denaturation and aggregation of lens proteins (crystallins), leading to loss of transparency and light scattering.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e \u003cmark\u003eIncreased age\u003c/mark\u003e is the most common risk factor. Others include smoking, excessive alcohol use, excessive sunlight (UV) exposure, prolonged glucocorticoid use, trauma, and infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Disease Associations:\u003c/b\u003e \u003cmark\u003eDiabetes mellitus\u003c/mark\u003e (due to sorbitol accumulation via aldose reductase), classic galactosemia, galactokinase deficiency, and myotonic dystrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients report painless, progressive blurring of vision, glare (especially at night with oncoming headlights), and often a myopic shift (nearsightedness). On exam, there is loss of the red reflex and the lens appears opaque.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The definitive treatment is surgical removal of the opacified lens and replacement with an artificial intraocular lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the association with diabetes and galactosemia, where excess sugars are converted to osmotically active polyols (sorbitol, galactitol) in the lens, causing hydropic swelling and opacification.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCataracts\u003c/b\u003e represent a clouding of the eye\u0027s lens due to protein aggregation, most commonly as a part of aging, which scatters light and causes progressive, painless vision loss that can only be definitively treated by surgical lens replacement.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"lens_disorder\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"diabetes_mellitus\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"galactosemia\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"cataract_surgery\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9643,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"901f3180\": {\n    \"title"
      }, {
        "text": "\": \"Bulbar Palsy\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBulbar palsy\u003c/b\u003e refers to a set of clinical signs resulting from damage to the"
      }, {
        "text": " \u003cu\u003elower motor neurons (LMNs)\u003c/u\u003e of the cranial nerves originating in the brainstem (medulla oblong"
      }, {
        "text": "ata, or \u0027bulb\u0027). Specifically, it involves cranial nerves IX (glossopharyngeal), X (vagus), XI"
      }, {
        "text": " (accessory), and XII (hypoglossal).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Caused by LMN lesions of cranial nerves IX, X, XI, and XII.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Characterized by \u003cmark\u003eflaccid weakness\u003c/mark\u003e of the muscles of the mouth, pharynx, and larynx. This"
      }, {
        "text": " leads to dysarthria (slurred speech), dysphagia (difficulty swallowing), drooling, and a hoarse or"
      }, {
        "text": " nasal voice.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysical Exam Findings:\u003c/b\u003e On examination, there is tongue wasting and \u003cmark\u003efasciculations\u003c/"
      }, {
        "text": "\u0027mark\u003e (LMN signs), a diminished or absent gag reflex, and the palate may not elevate symmetrically.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses"
      }, {
        "text": ":\u003c/b\u003e Can be seen in [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]],"
      }, {
        "text": " Guillain-Barr√© syndrome, myasthenia gravis, and brainstem strokes or tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Differentiate from \u003cb\u003epseudobulbar palsy\u003c/b\u003e, which is caused by \u003cu\u003eupper motor neuron (UMN)\u003c/u\u003e"
      }, {
        "text": " lesions. Pseudobulbar palsy presents with a spastic dysarthria, an exaggerated gag reflex, and emotional l"
      }, {
        "text": "ability (pseudobulbar affect), without tongue atrophy or fasciculations.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eBulbar palsy\u003c/b\u003e is a manifestation of lower motor neuron damage to the lower cranial nerves, resulting in a"
      }, {
        "text": " flaccid paralysis of the oral, pharyngeal, and laryngeal muscles, which must be distinguished from the spastic paralysis"
      }, {
        "text": " of the same muscles seen in the upper motor neuron condition, pseudobulbar palsy.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign"
      }, {
        "text": "_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"affects_cranial_nerves\",\n        \"to\": \"glossopharyngeal_nerve\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"affects_cranial_nerves\",\n        \"to\": \"vagus_"
      }, {
        "text": "nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves\","
      }, {
        "text": "\n        \"to\": \"accessory_nerve\"\n      },\n      {\n        \"type\": \"affects_cranial_nerves"
      }, {
        "text": "\",\n        \"to\": \"hypoglossal_nerve\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"differentiated_from\",\n        \"to\": \"pseudobulbar_palsy\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"181a22b1\": {\n    \"title\": \""
      }, {
        "text": "Bupivacaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBupivacaine\u003c/b\u003e is a long-acting, amide-type"
      }, {
        "text": " \u003ci\u003elocal anesthetic\u003c/i\u003e commonly used for regional anesthesia, such as epidurals for labor and spinal anesthesia for surgical procedures.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve"
      }, {
        "text": " membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic (has two \u0027i"
      }, {
        "text": "\u0027s in its name).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long duration of action, making it suitable for prolonged"
      }, {
        "text": " procedures and postoperative pain control.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Widely used for epidural analgesia, spinal anesthesia, and peripheral"
      }, {
        "text": " nerve blocks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effect:\u003c/b\u003e The most notable adverse effect is \u003cmark\u003esevere cardiotoxicity\u003c/"
      }, {
        "text": "mark\u003e. It is more cardiotoxic than other local anesthetics. Accidental intravascular injection can lead to severe ventricular arrhythmias and"
      }, {
        "text": " cardiovascular collapse that is difficult to resuscitate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember bupivacaine for its long"
      }, {
        "text": " duration of action and its significant risk of cardiotoxicity. This risk is a major consideration in its clinical use and dosing"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBupivacaine\u003c/b\u003e is a potent, long-acting amide"
      }, {
        "text": " anesthetic favored for epidurals and nerve blocks, but its use is shadowed by a significant risk of severe cardiotoxicity if"
      }, {
        "text": " accidentally injected systemically.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"has_adverse_effect\",\n        \"to\": \"cardiotoxicity\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"5b2b854f\": {\n    \""
      }, {
        "text": "title\": \"Buprenorphine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Psychiatry\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eBuprenorphine\u003c/b\u003e is a semi-synthetic opioid that"
      }, {
        "text": " acts as a \u003ci\u003epartial agonist\u003c/i\u003e at the Œº-opioid receptor and an antagonist at the Œ∫-opioid receptor."
      }, {
        "text": " It is used for both pain management and the treatment of opioid use disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e As a \u003cmark\u003epartial Œº-opioid agonist\u003c/mark\u003e, it binds with high affinity but"
      }, {
        "text": " has lower intrinsic activity than full agonists like morphine. This creates a \u0027ceiling effect\u0027 on respiratory depression, making it safer"
      }, {
        "text": " in overdose than full agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Opioid Use Disorder):\u003c/b\u003e Used for opioid detoxification and maintenance therapy. It can"
      }, {
        "text": " precipitate withdrawal if given to a patient who is currently using full opioids due to its high affinity and lower intrinsic activity. Often"
      }, {
        "text": " co-formulated with naloxone (Suboxone) to deter IV abuse.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Pain):\u003c/b\u003e Effective"
      }, {
        "text": " for moderate to severe chronic pain, available in various formulations including transdermal patches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e Its"
      }, {
        "text": " effects are not easily reversed by naloxone due to its high affinity for the Œº-receptor, requiring higher doses of the"
      }, {
        "text": " antagonist.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key concept for buprenorphine is \u0027partial agonist.\u0027"
      }, {
        "text": " This explains its ceiling effect on respiratory depression and its ability to precipitate withdrawal in an opioid-dependent individual.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eBuprenorphine\u003c/b\u003e is a unique opioid that acts as a partial agonist, providing"
      }, {
        "text": " analgesia and mitigating withdrawal symptoms with a lower risk of respiratory depression, but its high receptor affinity means it can displace full"
      }, {
        "text": " agonists and precipitate withdrawal if not initiated carefully.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_anal"
      }, {
        "text": "gesics\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"partial_"
      }, {
        "text": "mu_opioid_agonist\"\n      },\n      {\n        \"type\": \"treats\",\n        "
      }, {
        "text": "\"to\": \"opioid_use_disorder\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "34217723\": {\n    \"title\": \"Butorphanol\",\n    \"primaryType\": \""
      }, {
        "text": "drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Opioids\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eButorphanol\u003c/b\u003e is a synthetic opioid analgesic that functions as a \u003ci\u003emixed agonist-ant"
      }, {
        "text": "agonist\u003c/i\u003e. It is primarily used for the management of moderate to severe pain.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a \u003cmark\u003eŒ∫-opioid receptor agonist\u003c/mark\u003e and a \u003c"
      }, {
        "text": "mark\u003eŒº-opioid receptor partial agonist or weak antagonist\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnalgesic Effect:\u003c/b\u003e The Œ∫-agonist"
      }, {
        "text": " activity provides strong analgesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCeiling Effect:\u003c/b\u003e Like other mixed agonist-antagonists, it exhibits"
      }, {
        "text": " a ceiling effect for respiratory depression, making it potentially safer in overdose compared to full Œº-agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use:\u003c/b\u003e Used for moderate to severe pain, particularly in labor (less neonatal respiratory depression) and for postoperative pain. Also"
      }, {
        "text": " available as a nasal spray for [[c8833bae|migraines]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e"
      }, {
        "text": " Can cause sedation, nausea, and psychotomimetic effects (e.g., hallucinations, dysphoria) due to Œ∫-receptor"
      }, {
        "text": " agonism. It can precipitate withdrawal symptoms in patients physically dependent on full Œº-opioid agonists.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " that mixed agonist-antagonists like butorphanol and nalbuphine can precipitate withdrawal in opioid-dependent patients. Their"
      }, {
        "text": " primary analgesic effect comes from Œ∫-agonism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBut"
      }, {
        "text": "orphanol\u003c/b\u003e is a mixed-action opioid that provides potent analgesia through Œ∫-receptor agonism while having a limited"
      }, {
        "text": " effect on Œº-receptors, which gives it a better safety profile regarding respiratory depression but also the potential to induce withdrawal in opioid-dependent individuals"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"acts_as\",\n        \"to\": \"kappa_opioid_agonist\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"mu_opioid_partial"
      }, {
        "text": "_agonist_antagonist\"\n      },\n      {\n        \"type\": \"can_precipitate\","
      }, {
        "text": "\n        \"to\": \"opioid_withdrawal\"\n      }\n    ]\n  },\n  \"ca6"
      }, {
        "text": "ee143\": {\n    \"title\": \"Cabergoline\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Hypothalamic and Pituitary Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCaberg"
      }, {
        "text": "oline\u003c/b\u003e is a long-acting ergot derivative that is a potent \u003ci\u003edopamine D\u003csub\u003e2\u003c/sub\u003e receptor agonist\u003c/i\u003e"
      }, {
        "text": ". It is the first-line treatment for hyperprolactinemia and prolactin-secreting [[5f"
      }, {
        "text": "3188bd|pituitary adenomas]] (prolactinomas).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stimulates D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs in the [["
      }, {
        "text": "76ba7f2e|anterior pituitary]], mimicking the natural inhibitory effect of dopamine on prolactin secretion. This leads to a decrease"
      }, {
        "text": " in serum prolactin levels and can cause shrinkage of prolactinomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e \u003cu\u003eFirst-line treatment\u003c/u\u003e for prol"
      }, {
        "text": "actinomas and hyperprolactinemia. Also used in [[acromegaly]] (can suppress GH secretion) and [["
      }, {
        "text": "58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long half-life, allowing for once"
      }, {
        "text": " or twice weekly dosing, which improves patient compliance compared to [[d24a5ff0|bromocriptine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Nausea, headache, postural hypotension. Less nausea than bromocriptine. High doses have been associated with valv"
      }, {
        "text": "ular heart disease, but this is rare at the doses used for hyperprolactinemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Cabergoline is preferred over [[d24a5ff0|bromocriptine]] for treating prol"
      }, {
        "text": "actinomas due to its higher efficacy, better side-effect profile, and more convenient dosing schedule.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCabergoline\u003c/b\u003e is the superior dopamine agonist for treating hyperprolactinemia, effectively suppressing prolactin secretion and"
      }, {
        "text": " shrinking pituitary tumors by powerfully stimulating D\u003csub\u003e2\u003c/sub\u003e receptors, with the clinical advantage of a long half-life and better"
      }, {
        "text": " tolerability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cabergoline] --\u003e B(Stimulates D2"
      }, {
        "text": " Receptors on Lactotrophs); B --\u003e C(‚Üì Prolactin Secretion); C --\u003e D(‚Üì Serum"
      }, {
        "text": " Prolactin \u0026 Tumor Shrinkage);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"dopamine_agonist\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"treats\",\n        \"to\": \"5f3188bd\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_preferred_over\",\n        \"to\": \"d24a5"
      }, {
        "text": "ff0\"\n      }\n    ]\n  },\n  \"cbb4285c\": {\n    \"title\":"
      }, {
        "text": " \"Caf√©-au-lait Spots\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"D"
      }, {
        "text": "ermatology\",\n      \"Neurology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"D"
      }, {
        "text": "ermatology\",\n      \"Pigmented Lesions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCaf√©-au-lait spots\u003c/b\u003e are well-demarcated, hyperpigmented macules or"
      }, {
        "text": " patches on the skin, with a color resembling \u0027coffee with milk.\u0027 While a few small spots can be normal, the"
      }, {
        "text": " presence of multiple, large spots is a hallmark of several genetic syndromes, most notably Neurofibromatosis Type 1.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Flat, pigmented birthmarks with a light brown color and distinct borders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuro"
      }, {
        "text": "fibromatosis Type 1 (NF-1):\u003c/b\u003e The presence of \u003cmark\u003esix or more\u003c/mark\u003e caf√©-au-lait"
      }, {
        "text": " spots greater than 5 mm in diameter in prepubertal individuals (or \u003e15 mm in postpubertal individuals) is a key"
      }, {
        "text": " diagnostic criterion for NF-1. The spots in NF-1 typically have smooth borders (\u0027coast of California\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMcCune-Al"
      }, {
        "text": "bright Syndrome:\u003c/b\u003e Characterized by a triad of fibrous dysplasia of bone, endocrine abnormalities (like precocious puberty), and large"
      }, {
        "text": ", unilateral caf√©-au-lait spots with irregular, jagged borders (\u0027coast of Maine\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Associations"
      }, {
        "text": ":\u003c/b\u003e Can also be seen in tuberous sclerosis, Fanconi anemia, and other syndromes, but are most strongly associated with NF-1.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Multiple caf√©-au-lait spots in a child should prompt a thorough evaluation for other signs of Neuro"
      }, {
        "text": "fibromatosis Type 1, such as axillary freckling, Lisch nodules, and neurofibromas.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eWhile often benign, multiple \u003cb\u003ecaf√©-au-lait spots\u003c/b\u003e are a"
      }, {
        "text": " crucial dermatological clue to underlying systemic genetic disorders, with the number and border characteristics (smooth in NF-1, irregular in McC"
      }, {
        "text": "une-Albright) helping to narrow the differential diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\":"
      }, {
        "text": " \"neurofibromatosis_type_1\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_sign_of\",\n        \"to\": \"mccune_albright_syndrome\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"24d36d58\": {\n    \"title"
      }, {
        "text": "\": \"Calcitonin Gene-Related Peptide (CGRP)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCalcit"
      }, {
        "text": "onin Gene-Related Peptide (CGRP)\u003c/b\u003e is a 37-amino acid neuropeptide that is widely distributed in the central and peripheral nervous"
      }, {
        "text": " systems. It is a potent vasodilator and is critically involved in pain transmission, particularly in the pathophysiology of [[c8833bae"
      }, {
        "text": "|migraine headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Acts as a potent arterial"
      }, {
        "text": " vasodilator and a neurotransmitter/neuromodulator in pain pathways.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Migraine:\u003c/b\u003e During"
      }, {
        "text": " a migraine attack, CGRP is released from trigeminal nerve endings. This release causes vasodilation of cranial blood vessels and promotes"
      }, {
        "text": " neurogenic inflammation, contributing to the pain of a migraine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapeutic Target:\u003c/b\u003e CGRP and its receptor"
      }, {
        "text": " have become major targets for migraine therapy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug Classes Targeting CGRP:\u003c/b\u003e\u003cbr\u003e1. "
      }, {
        "text": "\u003cb\u003e[[4770b8a2|Anti-CGRP Monoclonal Antibodies]]\u003c/b\u003e (e.g., er"
      }, {
        "text": "enumab, galcanezumab): Used for migraine \u003cu\u003eprophylaxis\u003c/u\u003e.\u003cbr\u003e2. \u003cb\u003eGep"
      }, {
        "text": "ants\u003c/b\u003e (e.g., ubrogepant, rimegepant): Small molecule CGRP receptor antagonists used"
      }, {
        "text": " for \u003cu\u003eacute\u003c/u\u003e treatment of migraines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The central role of CGRP in migraine"
      }, {
        "text": " pathophysiology is a high-yield concept. Understand that blocking the CGRP pathway, either with monoclonal antibodies for prevention or gep"
      }, {
        "text": "ants for acute attacks, is a modern, targeted approach to migraine treatment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCalcitonin"
      }, {
        "text": " Gene-Related Peptide (CGRP)\u003c/b\u003e is a key player in the generation of migraine pain, acting as both a powerful"
      }, {
        "text": " vasodilator and a pain-signaling molecule in the trigeminal system, making its blockade a highly effective strategy for migraine therapy.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Trigeminal Nerve Activation] --\u003e B(Release of CGRP); B --\u003e C("
      }, {
        "text": "Vasodilation \u0026 Neurogenic Inflammation); C --\u003e D(Migraine Pain);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"c"
      }, {
        "text": "8833bae\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \""
      }, {
        "text": "4770b8a2\"\n      },\n      {\n        \"type\": \"is_targeted"
      }, {
        "text": "_by\",\n        \"to\": \"gepants\"\n      }\n    ]\n  },\n  \"e"
      }, {
        "text": "4b8298b\": {\n    \"title\": \"Capsaicin\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCapsaicin\u003c/b\u003e is the active component of chili peppers and is used topically as an analgesic for"
      }, {
        "text": " neuropathic and musculoskeletal pain. It works by interacting with the transient receptor potential vanilloid 1 (TRPV1) receptor"
      }, {
        "text": " on nociceptive nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Initially"
      }, {
        "text": ", capsaicin activates TRPV1 receptors (also known as capsaicin receptors), causing an influx of calcium and the"
      }, {
        "text": " release of substance P, which leads to a burning sensation. With repeated application, it causes \u003cmark\u003edesensitization\u003c/"
      }, {
        "text": "-mark\u003e of the nerve fibers and \u003cmark\u003edepletion of substance P\u003c/mark\u003e, resulting in an analgesic effect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use:\u003c/b\u003e Used topically for neuropathic pain (e.g., postherpetic neuralgia, diabetic neuropathy)"
      }, {
        "text": " and musculoskeletal pain (e.g., osteoarthritis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Available as a low-concentration over-the-counter cream or"
      }, {
        "text": " a high-concentration prescription patch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effect is a localized burning,"
      }, {
        "text": " stinging, or erythema at the application site, which typically diminishes with continued use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key mechanism"
      }, {
        "text": " to remember is the initial activation followed by desensitization and depletion of substance P from sensory nerve endings.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eCapsaicin\u003c/b\u003e paradoxically relieves pain by first causing it; its initial stimulation of pain receptors leads"
      }, {
        "text": " to their eventual desensitization and the depletion of substance P, effectively silencing the pain signals from the affected area.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Topical Capsaicin] --\u003e B(Activates TRPV1 Receptors);"
      }, {
        "text": " B --\u003e C(Initial Release of Substance P); C --\u003e D(Burning Sensation); B --Repeated Application--\u003e"
      }, {
        "text": " E(Desensitization \u0026 Depletion of Substance P); E --\u003e F(Analgesia);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropath"
      }, {
        "text": "ic_pain\"\n      },\n      {\n        \"type\": \"acts_on_receptor\",\n        \"to\": \""
      }, {
        "text": "trpv1_receptor\"\n      },\n      {\n        \"type\": \"depletes\",\n        \"to\": \"substance"
      }, {
        "text": "_p\"\n      }\n    ]\n  },\n  \"a5ec55b5\": {\n    \"title\": \""
      }, {
        "text": "Caput Succedaneum\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCaput succedane"
      }, {
        "text": "um\u003c/b\u003e is a benign, edematous swelling of the soft tissues of a newborn\u0027s scalp that is present at birth"
      }, {
        "text": ". It is caused by pressure on the infant\u0027s head from the cervix or vaginal wall during a prolonged or difficult delivery.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The edema is located in the subcutaneous tissue, \u003cu\u003esuperficial to the peri"
      }, {
        "text": "osteum\u003c/u\u003e of the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A soft, puffy, and sometimes ecchymotic swelling on the scalp. A"
      }, {
        "text": " key feature is that it \u003cmark\u003ecrosses suture lines\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e Present at birth and"
      }, {
        "text": " typically resolves spontaneously within a few days.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It must be distinguished from a [[a1"
      }, {
        "text": "721d6f|cephalohematoma]].\u003cbr\u003e - \u003cb\u003eCaput Succedaneum"
      }, {
        "text": ":\u003c/b\u003e Soft, pits on pressure, crosses suture lines, resolves quickly.\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Firm"
      }, {
        "text": ", does \u003cu\u003enot\u003c/u\u003e cross suture lines (subperiosteal), resolves over weeks to months, may calcify.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The ability to cross suture lines is the most important feature for distinguishing caput succedaneum from a ce"
      }, {
        "text": "phalohematoma on an exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCaput succedaneum\u003c/b\u003e is a"
      }, {
        "text": " benign and self-resolving scalp edema in newborns resulting from birth trauma, easily identified by its soft consistency and its ability"
      }, {
        "text": " to cross cranial suture lines, distinguishing it from the more localized and potentially complicated cephalohematoma.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"46ca72c2\"\n      },\n      {\n        \"type\": \"differentiated_from"
      }, {
        "text": "\",\n        \"to\": \"a1721d6f\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"c1ad76f4\": {\n    \"title\": \"Carbachol\",\n    \"primary"
      }, {
        "text": "Type\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCarbachol\u003c/b\u003e is a \u003ci\u003echolinomimetic agent\u003c/i\u003e that acts as a non-selective agonist at both mus"
      }, {
        "text": "carinic and nicotinic acetylcholine receptors. It is primarily used in ophthalmology to treat glaucoma.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e As a direct cholinergic agonist, it mimics the effects of [[6a"
      }, {
        "text": "005559|acetylcholine]]. In the eye, it stimulates muscarinic (M\u003csub\u003e3\u003c/sub\u003e)"
      }, {
        "text": " receptors on the ciliary muscle and the sphincter pupillae muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Effects:\u003c/b\u003e\u003cbr\u003e "
      }, {
        "text": "1. \u003cb\u003eMiosis:\u003c/b\u003e Contraction of the sphincter pupillae muscle causes pupillary constriction.\u003cbr\u003e 2. \u003cb\u003e‚Üì"
      }, {
        "text": " IOP:\u003c/b\u003e Contraction of the ciliary muscle increases the outflow of aqueous humor through the trabecular meshwork, lowering"
      }, {
        "text": " intraocular pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used topically to treat [[5ea7b741|open-angle glaucoma]] and"
      }, {
        "text": " to produce miosis during ophthalmic surgery. It is less commonly used than pilocarpine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eResistance to"
      }, {
        "text": " AChE:\u003c/b\u003e Carbachol is resistant to hydrolysis by acetylcholinesterase, giving it a longer duration of action than"
      }, {
        "text": " acetylcholine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember carbachol as a direct-acting cholinomimetic that lowers"
      }, {
        "text": " IOP by increasing trabecular outflow, a mechanism shared with pilocarpine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eCarbachol\u003c/b\u003e is a potent, long-acting acetylcholine mimic that effectively lowers intraocular pressure in glaucoma"
      }, {
        "text": " by contracting the ciliary muscle to open up the trabecular meshwork drainage channels.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"cholinomimetic_agent\"\n      },\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"acts_as"
      }, {
        "text": "_agonist_at\",\n        \"to\": \"muscarinic_receptors\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"nicotinic_"
      }, {
        "text": "receptors\"\n      }\n    ]\n  },\n  \"eddd2bc5\": {\n    \"title"
      }, {
        "text": "\": \"Carbamazepine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Carbamazepine\u003c/b\u003e is a narrow-spectrum \u003ci\u003eanticonvulsant\u003c/i\u003e drug that works by blocking voltage-gated sodium channels. It"
      }, {
        "text": " is also used as a mood stabilizer and for the treatment of neuropathic pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Mechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in their inactivated state, which prolongs the refractory"
      }, {
        "text": " period of the neuron and prevents repetitive firing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e First-line treatment"
      }, {
        "text": " for \u003cmark\u003efocal seizures\u003c/mark\u003e (both simple and complex) and generalized tonic-clonic seizures.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eNeuropathic Pain:\u003c/b\u003e First-line treatment for \u003cmark\u003etrigeminal neuralgia\u003c/mark"
      }, {
        "text": "\u003e.\u003cbr\u003e - \u003cb\u003eBipolar Disorder:\u003c/b\u003e Used as a mood stabilizer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Dipl"
      }, {
        "text": "opia, ataxia, SIADH (hyponatremia), and skin rashes. Two serious, rare side effects are \u003cmark\u003eag"
      }, {
        "text": "ranulocytosis\u003c/mark\u003e and \u003cmark\u003eaplastic anemia\u003c/mark\u003e, requiring monitoring of CBC. It is also a potent"
      }, {
        "text": " inducer of cytochrome P450 enzymes, leading to many drug interactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTeratogenicity:\u003c/b\u003e Associated"
      }, {
        "text": " with an increased risk of \u003cmark\u003eneural tube defects\u003c/mark\u003e in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Carb"
      }, {
        "text": "amazepine is the drug of choice for trigeminal neuralgia. Remember its major hematologic side effects (agranulocytosis, aplastic anemia)"
      }, {
        "text": " and its induction of the P450 system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarbamazepine"
      }, {
        "text": "\u003c/b\u003e is a cornerstone therapy for focal seizures and trigeminal neuralgia, acting by stabilizing inactivated sodium channels, but its use requires"
      }, {
        "text": " careful monitoring due to the risk of severe hematologic toxicity and its potent induction of hepatic enzymes.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \""
      }, {
        "text": "trigeminal_neuralgia\"\n      },\n      {\n        \"type\": \"treats\",\n        "
      }, {
        "text": "\"to\": \"focal_seizures\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "_adverse_effect\",\n        \"to\": \"agranulocytosis\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"causes_adverse_effect\",\n        \"to\": \"aplastic_anemia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"siadh\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"541cd176\": {\n    \"title\": \"Carbidopa/Levodopa\","
      }, {
        "text": "\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCarbidopa/Levodopa\u003c/b\u003e (trade name Sinemet) is the most effective and widely used combination"
      }, {
        "text": " drug for the symptomatic treatment of [[58c8ea03|Parkinson disease]]. Levodopa is a metabolic"
      }, {
        "text": " precursor to dopamine, while carbidopa is a peripheral DOPA decarboxylase inhibitor.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLevodopa (L-DOPA):\u003c/b\u003e Can"
      }, {
        "text": " cross the [[dd47b9cc|blood-brain barrier]] (unlike dopamine) and is converted to [["
      }, {
        "text": "90adc821|dopamine]] in the CNS by DOPA decarboxylase, replenishing the depleted"
      }, {
        "text": " dopamine stores in the striatum.\u003cbr\u003e - \u003cb\u003eCarbidopa:\u003c/b\u003e Inhibits peripheral DOPA decarboxylase."
      }, {
        "text": " This prevents the conversion of L-DOPA to dopamine in the periphery, which \u003cmark\u003eincreases the bioavailability of L"
      }, {
        "text": "-DOPA in the brain\u003c/mark\u003e and \u003cmark\u003ereduces peripheral side effects\u003c/mark\u003e (like nausea"
      }, {
        "text": " and arrhythmias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e The cornerstone of treatment for [[58c8ea03|Parkinson disease]],"
      }, {
        "text": " particularly effective for bradykinesia and rigidity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, hallucinations, postural"
      }, {
        "text": " hypotension. Long-term use is associated with motor fluctuations (\u0027on-off\u0027 phenomenon) and dyskinesias ("
      }, {
        "text": "involuntary movements).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The rationale for the combination is key: Carbidopa acts"
      }, {
        "text": " as a \u0027bodyguard\u0027 for Levodopa, ensuring more of it reaches the brain where it\u0027s needed, while minimizing"
      }, {
        "text": " side effects elsewhere in the body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCarbidopa/Levodopa"
      }, {
        "text": "\u003c/b\u003e combination is a brilliant pharmacological strategy that overcomes the blood-brain barrier by using a precursor (Levodopa) and"
      }, {
        "text": " then protecting that precursor from peripheral breakdown (with Carbidopa) to effectively deliver dopamine to the deficient basal ganglia in Parkinson\u0027"
      }, {
        "text": "s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Levodopa] --Peripheral DOPA Decarboxylase--\u003e B("
      }, {
        "text": "Dopamine - Periphery); C[Carbidopa] --x B; A --\u003e D(Crosses BBB);"
      }, {
        "text": " D --\u003e E[L-DOPA in CNS]; E --Central DOPA Decarboxylase--\u003e F(Dopamine -"
      }, {
        "text": " CNS); F --\u003e G(Treats Parkinson\u0027s Symptoms);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_precursor_to\",\n        \"to\": \"90adc821\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_combined_with\",\n        \"to\": \"carbidopa\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"e1e7ac22\": {\n    \"title\": \"Carotid-"
      }, {
        "text": "Cavernous Fistula\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eCarotid-Cavernous Fistula (CCF)\u003c/b\u003e is an abnormal communication"
      }, {
        "text": " between the internal carotid artery and the [[c260efc8|cavernous sinus]]. This creates a high-flow,"
      }, {
        "text": " high-pressure arteriovenous shunt within the sinus, leading to a characteristic set of signs and symptoms.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be traumatic (e.g., from a basal skull fracture) or spontaneous (e"
      }, {
        "text": ".g., from a ruptured intracavernous carotid aneurysm).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Arterial blood from"
      }, {
        "text": " the internal carotid artery flows directly into the low-pressure [[c260efc8|cavernous sinus]]."
      }, {
        "text": " This increases pressure in the sinus and reverses blood flow in the veins that drain into it, particularly the superior ophthalmic vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Tri"
      }, {
        "text": "ad:\u003c/b\u003e The classic triad is \u003cmark\u003epulsatile exophthalmos\u003c/mark\u003e (protruding, pulsating eye), \u003cmark\u003eocular"
      }, {
        "text": " bruit\u003c/mark\u003e (a whooshing sound heard over the eye), and \u003cmark\u003echemosis\u003c/mark\u003e (conj"
      }, {
        "text": "unctival edema and redness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Symptoms:\u003c/b\u003e Patients also develop ophthalmoplegia (paralysis of eye"
      }, {
        "text": " muscles) due to dysfunction of cranial nerves III, IV, and VI, which all traverse the cavernous sinus. There"
      }, {
        "text": " may also be sensory loss in the V\u003csub\u003e1\u003c/sub\u003e and V\u003csub\u003e2\u003c/sub\u003e distribution.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " combination of a pulsating eye and an audible bruit over the eye after head trauma is pathognomonic for a carotid-cavernous fistula."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCarotid-Cavernous Fistula\u003c/b\u003e"
      }, {
        "text": " creates a high-pressure vascular storm within the cavernous sinus, engorging the orbital veins and compressing the cranial nerves that"
      }, {
        "text": " pass through it, resulting in the dramatic clinical picture of a pulsating, red, and paralyzed eye.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Internal Carotid Artery] --Fistula--\u003e B(Cavernous Sinus); B --\u003e C(‚Üë"
      }, {
        "text": " Pressure in Sinus); C --\u003e D(Reversal of flow in Superior Ophthalmic Vein); D --\u003e E(Pulsatile Exophthal"
      }, {
        "text": "mos, Chemosis, Bruit); C --\u003e F(Compression of CN III, IV, V1, V2, VI); F --\u003e"
      }, {
        "text": " G(Ophthalmoplegia, Sensory Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"aff"
      }, {
        "text": "ects\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"causes\",\n        \"to\": \"ophthalmoplegia\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"pulsatile_exophthalmos\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"6696dd3a\": {\n    \"title\": \"Carteolol\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eCarteolol\u003c/b\u003e is a non-selective \u003ci\u003eŒ≤-adrenergic antagonist\u003c/i\u003e (beta-blocker) used as"
      }, {
        "text": " a topical eye drop to reduce intraocular pressure (IOP) in the treatment of [[5ea7b741|open"
      }, {
        "text": "-angle glaucoma]] and ocular hypertension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks both"
      }, {
        "text": " Œ≤\u003csub\u003e1\u003c/sub\u003e and Œ≤\u003csub\u003e2\u003c/sub\u003e adrenergic receptors on the ciliary epithelium. This leads to a \u003cmark\u003edecrease"
      }, {
        "text": " in aqueous humor production\u003c/mark\u003e, thereby lowering IOP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-selective beta-blocker,"
      }, {
        "text": " similar to [[ae28be6c|timolol]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A first-line agent"
      }, {
        "text": " for [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e O"
      }, {
        "text": "cular side effects include stinging and burning. Systemic absorption can occur, potentially causing bradycardia, hypotension, fatigue, and bronchoconstriction.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Should be used with caution in patients with asthma, COPD, bradycardia, or heart block"
      }, {
        "text": " due to its non-selective Œ≤-blockade.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Like all non-selective beta-blockers used"
      }, {
        "text": " for glaucoma, carteolol\u0027s main mechanism is decreasing aqueous humor production. Be aware of the potential for systemic side effects,"
      }, {
        "text": " especially bronchospasm in patients with reactive airway disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCarte"
      }, {
        "text": "olol\u003c/b\u003e is a non-selective beta-blocker that effectively treats glaucoma by turning down the \u0027faucet\u0027 of aqueous humor production in the"
      }, {
        "text": " ciliary body, but its systemic absorption carries the risk of Œ≤-blockade side effects throughout the body.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"beta_blocker\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"decreases_production_of\",\n        \"to\": \"aqueous_humor\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"85f03b02\": {\n    \"title\":"
      }, {
        "text": " \"Cataracts\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Lens"
      }, {
        "text": " Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecataract\u003c/b\u003e is a painless, progressive"
      }, {
        "text": " opacification or clouding of the normally clear lens of the eye, which leads to a decrease in vision. It is the"
      }, {
        "text": " leading cause of blindness worldwide.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e In"
      }, {
        "text": "volves the denaturation and aggregation of lens proteins (crystallins), leading to loss of transparency and light scattering.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk"
      }, {
        "text": " Factors:\u003c/b\u003e \u003cmark\u003eIncreased age\u003c/mark\u003e is the most common risk factor. Others include smoking, excessive alcohol use, excessive"
      }, {
        "text": " sunlight (UV) exposure, prolonged glucocorticoid use, trauma, and infection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Disease Associations:\u003c/b\u003e \u003c"
      }, {
        "text": "mark\u003eDiabetes mellitus\u003c/mark\u003e (due to sorbitol accumulation via aldose reductase), classic galactosemia, gal"
      }, {
        "text": "actokinase deficiency, and myotonic dystrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients report painless, progressive blurring of vision, glare"
      }, {
        "text": " (especially at night with oncoming headlights), and often a myopic shift (nearsightedness). On exam, there is loss"
      }, {
        "text": " of the red reflex and the lens appears opaque.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The definitive treatment is surgical removal of the op"
      }, {
        "text": "acified lens and replacement with an artificial intraocular lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the association with"
      }, {
        "text": " diabetes and galactosemia, where excess sugars are converted to osmotically active polyols (sorbitol, galactitol) in"
      }, {
        "text": " the lens, causing hydropic swelling and opacification.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Cataracts\u003c/b\u003e represent a clouding of the eye\u0027s lens due to protein aggregation, most commonly as a part"
      }, {
        "text": " of aging, which scatters light and causes progressive, painless vision loss that can only be definitively treated by surgical lens replacement.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"lens_disorder\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_associated_with\",\n        \"to\": \"diabetes_mellitus\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"galactosemia\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"cat"
      }, {
        "text": "aract_surgery\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1z9e6h9L1FRaHESQjFZINO8564IdO3Pma"
      },
      "role": "user",
      "tokenCount": 1913
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"1c4d7e8f\": {\n    \"title\": \"Cauda Equina\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Spinal Cord\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCauda Equina\u003c/b\u003e (Latin for \\\"horse\u0027s tail\\\") is the bundle of spinal nerves and spinal nerve rootlets, consisting of the second through fifth lumbar nerve pairs, the first through fifth sacral nerve pairs, and the coccygeal nerve, all of which arise from the lumbar enlargement and the conus medullaris of the spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e Comprises the nerve roots from L2 to Co1 that descend through the lumbar cistern (subarachnoid space) below the termination of the spinal cord proper (conus medullaris, typically at L1-L2).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e These nerve roots provide motor and sensory innervation to the lower extremities, perineum, and pelvic organs (including the bladder and anal sphincters).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Compression of these nerve roots leads to \u003cmark\u003e[[2904b5c8|Cauda Equina Syndrome]]\u003c/mark\u003e, a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLumbar Puncture:\u003c/b\u003e The cauda equina floats in the cerebrospinal fluid of the lumbar cistern, which is the target for a lumbar puncture. The needle is typically inserted at the L3-L4 or L4-L5 interspace to avoid injuring the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the spinal cord ends at L1-L2 in adults. The collection of nerve roots continuing down the vertebral canal below this level is the cauda equina.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCauda Equina\u003c/b\u003e is the collection of descending lumbar and sacral nerve roots that resemble a horse\u0027s tail, filling the subarachnoid space below the end of the spinal cord; its compression results in the surgical emergency known as cauda equina syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"compression_of_causes\",\n        \"to\": \"2904b5c8\"\n      },\n      {\n        \"type\": \"is_located_inferior_to\",\n        \"to\": \"conus_medullaris\"\n      }\n    ]\n  },\n  \"2904b5c8\": {\n    \"title\": \"Cauda Equina Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Emergency Medicine\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCauda Equina Syndrome\u003c/b\u003e is a neurosurgical emergency caused by severe compression of the [[1c4d7e8f|cauda equina]], the bundle of nerve roots at the lower end of the spinal canal. This compression leads to a constellation of debilitating symptoms requiring urgent surgical decompression.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a massive midline lumbar disc herniation. Other causes include spinal stenosis, tumors, trauma, and epidural abscess or hematoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by a combination of symptoms including \u003cmark\u003esevere low back pain\u003c/mark\u003e, radicular pain in one or both legs, and \u003cmark\u003esaddle anesthesia\u003c/mark\u003e (loss of sensation in the perineum, buttocks, and inner thighs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRed Flag Symptoms:\u003c/b\u003e The most critical signs are \u003cmark\u003ebowel and/or bladder dysfunction\u003c/mark\u003e (e.g., urinary retention or incontinence) and loss of the [[ce2052d6|anal wink reflex]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor/Sensory Deficits:\u003c/b\u003e Patients typically have asymmetric, flaccid paralysis or weakness in the lower extremities (LMN signs) and sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eUrgent surgical decompression\u003c/u\u003e is required to relieve the pressure on the nerve roots and prevent permanent paralysis and incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of low back pain, saddle anesthesia, and new-onset urinary retention is the classic triad for Cauda Equina Syndrome and warrants immediate surgical consultation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCauda Equina Syndrome\u003c/b\u003e is a critical condition where compression of the lumbosacral nerve roots leads to a devastating loss of lower extremity and pelvic floor function; its hallmark \u0027red flag\u0027 symptoms of saddle anesthesia and bladder/bowel dysfunction signal the need for immediate surgical intervention to prevent permanent disability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Massive Lumbar Disc Herniation] --Compresses--\u003e B(Cauda Equina); B --\u003e C(Saddle Anesthesia); B --\u003e D(Bowel/Bladder Dysfunction); B --\u003e E(Lower Extremity Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_compression_of\",\n        \"to\": \"1c4d7e8f\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"saddle_anesthesia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"bowel_and_bladder_dysfunction\"\n      },\n      {\n        \"type\": \"requires\",\n        \"to\": \"surgical_decompression\"\n      }\n    ]\n  },\n  \"3fa071ef\": {\n    \"title\": \"Caudate Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCaudate Nucleus\u003c/b\u003e is a C-shaped nucleus that is a key component of the [[ed462927|basal ganglia]]. Together with the putamen, it forms the striatum, which is the main input station for the basal ganglia circuits involved in motor control and cognitive functions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e A large C-shaped structure with a head, body, and tail that follows the curve of the lateral ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The caudate is primarily involved in the \u003cmark\u003ecognitive\u003c/mark\u003e aspects of movement, including motor planning and procedural learning. It also plays a role in reward and motivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStriatum:\u003c/b\u003e The caudate and putamen are collectively known as the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Atrophy of the caudate nucleus is the hallmark pathological finding in \u003cmark\u003e[[ffd7e743|Huntington disease]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging Finding:\u003c/b\u003e The degeneration of the caudate head in Huntington disease leads to the characteristic appearance of \u003cmark\u003eenlarged lateral ventricles\u003c/mark\u003e on brain imaging (ex vacuo ventriculomegaly).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The association between caudate atrophy and [[ffd7e743|Huntington disease]] is extremely high-yield. A brain scan showing \u0027boxcar\u0027 ventricles due to a shrunken caudate in a patient with chorea is classic for Huntington\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCaudate Nucleus\u003c/b\u003e is a critical part of the basal ganglia\u0027s cognitive loop, and its profound atrophy in [[ffd7e743|Huntington disease]] is directly responsible for both the characteristic motor (chorea) and cognitive (dementia) decline seen in the disorder.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Caudate Nucleus] --Atrophy in Huntington\u0027s Disease--\u003e B(Enlarged Lateral Ventricles); A --Part of Striatum--\u003e C(Receives Cortical Input); C --\u003e D(Modulates Motor \u0026 Cognitive Function);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"forms_striatum_with\",\n        \"to\": \"putamen\"\n      },\n      {\n        \"type\": \"atrophies_in\",\n        \"to\": \"ffd7e743\"\n      }\n    ]\n  },\n  \"c260efc8\": {\n    \"title\": \"Cavernous Sinus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dural Venous Sinuses\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCavernous Sinus\u003c/b\u003e is a paired dural venous sinus located on either side of the sella turcica of the sphenoid bone. It is a unique venous structure because several critical cranial nerves and the internal carotid artery pass directly through it.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eContents:\u003c/b\u003e Mnemonic \u003cb\u003eO TOM CAT\u003c/b\u003e (from superior to inferior on lateral wall, then medially):\u003cbr\u003e - \u003cb\u003eO\u003c/b\u003eculomotor n. (CN III)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003erochlear n. (CN IV)\u003cbr\u003e - \u003cb\u003eO\u003c/b\u003ephthalmic n. (CN V\u003csub\u003e1\u003c/sub\u003e)\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eaxillary n. (CN V\u003csub\u003e2\u003c/sub\u003e)\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003earotid artery (internal)\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003ebducens n. (CN VI)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003e (ignore)\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation of CN VI:\u003c/b\u003e The [[dd11dde6|abducens nerve (CN VI)]] is the only nerve that runs freely within the sinus, next to the internal carotid artery, making it particularly vulnerable to injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage:\u003c/b\u003e Receives venous blood from the superior and inferior ophthalmic veins and drains into the superior and inferior petrosal sinuses, which then drain to the internal jugular vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[9a089fd7|Cavernous Sinus Syndrome]]:\u003c/b\u003e A mass effect (e.g., tumor, aneurysm) causing ophthalmoplegia, decreased corneal sensation, and Horner syndrome.\u003cbr\u003e - \u003cb\u003e[[a830692a|Cavernous Sinus Thrombosis]]:\u003c/b\u003e A blood clot in the sinus, often from a spreading facial or sinus infection, causing similar symptoms plus signs of infection and venous congestion (proptosis, chemosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Any patient presenting with multiple cranial nerve palsies involving eye movement (CN III, IV, VI) should raise suspicion for a lesion in the cavernous sinus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCavernous Sinus\u003c/b\u003e is a critical neurovascular crossroads where cranial nerves controlling eye movement and facial sensation travel alongside the internal carotid artery, making it a \u0027danger zone\u0027 where pathology can cause a complex ophthalmoplegia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cavernous Sinus]; A --\u003e B(CN III); A --\u003e C(CN IV); A --\u003e D(CN V1/V2); A --\u003e E(CN VI); A --\u003e F(Internal Carotid Artery);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"21f1c955\"\n      },\n      {\n        \"type\": \"pathology_causes\",\n        \"to\": \"9a089fd7\"\n      },\n      {\n        \"type\": \"pathology_causes\",\n        \"to\": \"a830692a\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"dd11dde6\"\n      }\n    ]\n  },\n  \"9a089fd7\": {\n    \"title\": \"Cavernous Sinus Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Syndrome\u003c/b\u003e is a clinical constellation of signs and symptoms resulting from any pathological process that affects the contents of the [[c260efc8|cavernous sinus]], leading to multiple cranial nerve palsies and potentially venous congestion of the orbit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by mass effect from tumors (e.g., [[5f3188bd|pituitary adenoma]]), aneurysms of the internal carotid artery, [[a830692a|cavernous sinus thrombosis]], or inflammation (e.g., Tolosa-Hunt syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A combination of:\u003cbr\u003e - \u003cb\u003eOphthalmoplegia:\u003c/b\u003e Paralysis of eye movements due to involvement of CN III, IV, and VI.\u003cbr\u003e - \u003cb\u003eSensory Loss:\u003c/b\u003e Decreased sensation in the forehead and cheek due to involvement of CN V\u003csub\u003e1\u003c/sub\u003e and V\u003csub\u003e2\u003c/sub\u003e.\u003cbr\u003e - \u003cb\u003ePupillary Changes:\u003c/b\u003e Can have a dilated pupil (CN III compression) or a constricted pupil (Horner syndrome from sympathetic plexus damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVenous Congestion:\u003c/b\u003e If caused by thrombosis or a fistula, may see proptosis (bulging eye) and chemosis (conjunctival swelling).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to recognizing this syndrome is the involvement of \u003cu\u003emultiple\u003c/u\u003e cranial nerves that all pass through one specific anatomical location: the [[c260efc8|cavernous sinus]]. The [[dd11dde6|abducens nerve (CN VI)]] is often the first nerve affected due to its medial location within the sinus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Syndrome\u003c/b\u003e is the clinical manifestation of a \u0027mass lesion\u0027 within the cavernous sinus, presenting as a complex ophthalmoplegia with facial sensory loss, a direct result of compressing the tightly packed cranial nerves III, IV, V\u003csub\u003e1\u003c/sub\u003e, V\u003csub\u003e2\u003c/sub\u003e, and VI.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_pathology_in\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"ophthalmoplegia\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"a830692a\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"5f3188bd\"\n      }\n    ]\n  },\n  \"a830692a\": {\n    \"title\": \"Cavernous Sinus Thrombosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Thrombosis\u003c/b\u003e is the formation of a blood clot within the [[c260efc8|cavernous sinus]], a rare but life-threatening condition that is most often caused by a contiguous spread of infection from the face, sinuses, or teeth.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly a septic thrombosis resulting from infection. The most common pathogen is \u003cmark\u003e\u003ci\u003eStaphylococcus aureus\u003c/i\u003e\u003c/mark\u003e. Infection can spread from the \u0027danger triangle\u0027 of the face, sphenoid or ethmoid sinuses, or dental abscesses via the valveless facial venous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The thrombus obstructs venous drainage and causes inflammation, leading to increased pressure within the sinus and compression of its contents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with severe headache, high fever, and signs of [[9a089fd7|cavernous sinus syndrome]]: ophthalmoplegia (CN III, IV, VI palsy), periorbital edema, proptosis, and chemosis. The [[dd11dde6|abducens nerve (CN VI)]] is often affected first.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI with magnetic resonance venography (MRV) is the imaging modality of choice.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Requires prompt initiation of broad-spectrum IV antibiotics and consideration of anticoagulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a recent facial furuncle or sinusitis who develops a severe headache, fever, and unilateral eye swelling with impaired eye movements is the classic presentation for cavernous sinus thrombosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Thrombosis\u003c/b\u003e is a septic clot in the brain\u0027s central venous drainage system, typically seeded by a facial infection, which rapidly evolves into a neuro-ophthalmologic emergency with high fever, headache, and paralysis of eye movements.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Facial/Sinus Infection] --Staph. aureus--\u003e B(Spread via Valveless Veins); B --\u003e C(Cavernous Sinus); C --\u003e D(Thrombosis \u0026 Inflammation); D --\u003e E(Cavernous Sinus Syndrome);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"9a089fd7\"\n      },\n      {\n        \"type\": \"is_an_infection_of\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"staphylococcus_aureus\"\n      }\n    ]\n  },\n  \"714f15fc\": {\n    \"title\": \"Central Post-Stroke Pain Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Stroke\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Post-Stroke Pain Syndrome\u003c/b\u003e, also known as thalamic pain syndrome or Dejerine-Roussy syndrome, is a chronic neuropathic pain condition that develops after a [[c5da3c57|stroke]], most classically one affecting the [[afc0a64b|thalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by a stroke (usually ischemic) affecting the somatosensory pathways, particularly the ventroposterolateral (VPL) nucleus of the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Pain does not occur immediately after the stroke. There is typically an initial loss of sensation (numbness) in the affected area, with the pain developing weeks to months later.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by severe, persistent, and often debilitating pain on the side of the body contralateral to the stroke. The pain is often described as burning, aching, or lancinating.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e \u003cmark\u003eAllodynia\u003c/mark\u003e (pain provoked by a normally non-painful stimulus, like light touch) and \u003cmark\u003ehyperalgesia\u003c/mark\u003e (exaggerated pain response to a painful stimulus) are hallmarks of the condition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Very difficult to treat. Options include antidepressants (TCAs like [[c6814506|amitriptyline]]), anticonvulsants (e.g., gabapentin, pregabalin), and in refractory cases, deep brain stimulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of a stroke who later develops severe, burning pain and allodynia on the previously numb side of their body is the classic presentation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral Post-Stroke Pain Syndrome\u003c/b\u003e is a cruel paradox of sensory processing, where a thalamic stroke that initially causes numbness later gives rise to intractable neuropathic pain and allodynia due to maladaptive plasticity in the damaged central sensory pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"allodynia\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"c6814506\"\n      }\n    ]\n  },\n  \"3334840f\": {\n    \"title\": \"Central Retinal Artery Occlusion (CRAO)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Artery Occlusion (CRAO)\u003c/b\u003e is an ophthalmologic emergency characterized by the sudden, painless, and profound loss of monocular vision due to obstruction of the central retinal artery, which supplies the inner retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a thromboembolism. The most frequent source is an atherosclerotic plaque in the \u003cmark\u003eipsilateral carotid artery\u003c/mark\u003e. Other sources include cardiogenic emboli (e.g., from atrial fibrillation) or giant cell arteritis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occlusion of the artery leads to acute ischemia of the inner two-thirds of the retina, causing rapid and irreversible death of ganglion cells and other neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, severe monocular vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The classic fundoscopic finding is a \u003cmark\u003epale retina\u003c/mark\u003e (due to ischemia and edema) with a \u003cmark\u003e\\\"cherry-red spot\\\"\u003c/mark\u003e at the fovea. The cherry-red spot represents the intact choroidal circulation (supplied by the posterior ciliary arteries) visible through the thinned, ischemic fovea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of sudden, painless, profound monocular vision loss and a \\\"cherry-red spot\\\" on fundoscopy is pathognomonic for CRAO. It is essentially a stroke of the eye.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Artery Occlusion\u003c/b\u003e is an acute ischemic stroke of the retina, where an embolus blocks its main arterial supply, leading to sudden, devastating vision loss and the iconic fundoscopic image of a pale retina with a contrasting \u0027cherry-red\u0027 macula.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Embolus from Carotid/Heart] --\u003e B(Occlusion of Central Retinal Artery); B --\u003e C(Inner Retinal Ischemia); C --\u003e D(Pale Retina); C --\u003e E(Cherry-Red Spot at Fovea); D \u0026 E --\u003e F(Sudden, Painless Vision Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"retinal_artery_occlusion\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"thromboembolism\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"cherry_red_spot\"\n      },\n      {\n        \"type\": \"is_a_form_of\",\n        \"to\": \"ischemic_stroke\"\n      }\n    ]\n  },\n  \"b69e35b5\": {\n    \"title\": \"Central Retinal Vein Occlusion (CRVO)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Vein Occlusion (CRVO)\u003c/b\u003e is a common retinal vascular disorder characterized by the blockage of the central retinal vein at the optic nerve head, leading to venous stasis, retinal hemorrhage, and edema.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary mechanism is thrombosis of the central retinal vein, often at the lamina cribrosa where the vein is compressed by a sclerotic central retinal artery with which it shares a common adventitial sheath.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, hyperlipidemia, and glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, unilateral blurring or loss of vision. The severity can range from mild to severe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The fundoscopic exam is dramatic and described as a \u003cmark\u003e\\\"blood and thunder\\\"\u003c/mark\u003e appearance. It shows diffuse, widespread retinal hemorrhages in all four quadrants, venous dilation and tortuosity, cotton-wool spots, and optic disc swelling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from CRAO: CRVO is a venous \u0027backup\u0027 problem, leading to a hemorrhagic appearance (\u0027blood and thunder\u0027), while CRAO is an arterial \u0027blockage\u0027 problem, leading to a pale, ischemic appearance (\u0027cherry-red spot\u0027).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Vein Occlusion\u003c/b\u003e is a vascular \u0027plumbing backup\u0027 in the eye, where a thrombus in the central retinal vein causes a dramatic, widespread backup of blood, resulting in the classic \u0027blood and thunder\u0027 hemorrhagic retinopathy and vision loss.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension/Atherosclerosis] --\u003e B(Compression of Central Retinal Vein); B --\u003e C(Thrombosis); C --\u003e D(Central Retinal Vein Occlusion); D --\u003e E(Venous Stasis \u0026 ‚Üë Pressure); E --\u003e F(Diffuse Retinal Hemorrhages \u0026 Edema);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"retinal_vein_occlusion\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"3334840f\"\n      }\n    ]\n  },\n  \"350f1c8b\": {\n    \"title\": \"Central Vertigo\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Vestibular Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral vertigo\u003c/b\u003e is a sensation of spinning or dizziness that originates from a problem within the central nervous system, specifically the brainstem or cerebellum. It is generally more serious than peripheral vertigo.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by lesions in the brainstem or cerebellum, such as [[c5da3c57|stroke]] (e.g., lateral medullary syndrome), [[45dd6d19|multiple sclerosis]], tumors, or migraines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNystagmus:\u003c/b\u003e The nystagmus in central vertigo can be in any direction (horizontal, torsional, or \u003cmark\u003epurely vertical/downbeat\u003c/mark\u003e). It is often non-fatigable and may change direction with gaze. It is \u003cu\u003enot\u003c/u\u003e suppressed by visual fixation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Often accompanied by other neurological signs that point to a central lesion, such as [[9914d433|diplopia]], dysmetria, [[9767fd6b|ataxia]], dysarthria, or focal weakness/sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOnset:\u003c/b\u003e The onset can be sudden or gradual, and the vertigo is often constant and less intense than in peripheral causes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of \u003cmark\u003epurely vertical nystagmus\u003c/mark\u003e is a red flag and is highly specific for a central cause of vertigo. Also, look for other \u0027central\u0027 neurological signs (the \u00275 D\u0027s\u0027: Dizziness, Diplopia, Dysarthria, Dysphagia, Dysmetria).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral vertigo\u003c/b\u003e is a sign of a CNS lesion, not an inner ear problem. It is distinguished from peripheral vertigo by its associated neurological deficits and a nystagmus that is often vertical and does not suppress with visual fixation, indicating a more ominous underlying cause like a brainstem stroke.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"vertigo\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5811ad9e\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"582d8572\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"bebe58d4\"\n      }\n    ]\n  },\n  \"bad81d37\": {\n    \"title\": \"Central Transtentorial Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral transtentorial herniation\u003c/b\u003e is a type of brain herniation where downward displacement of the cerebral hemispheres, basal ganglia, diencephalon, and midbrain occurs through the tentorial notch. It is typically caused by a diffuse increase in intracranial pressure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by conditions that increase intracranial pressure symmetrically, such as diffuse cerebral edema, hydrocephalus, or midline tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The downward pressure causes a sequential caudal displacement of brainstem structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Progression:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eEarly:\u003c/b\u003e Altered level of consciousness, small reactive pupils (diencephalic compression).\u003cbr\u003e2. \u003cb\u003eLater:\u003c/b\u003e Mid-position, fixed pupils; decorticate then decerebrate posturing (midbrain/pons compression).\u003cbr\u003e3. \u003cb\u003eTerminal:\u003c/b\u003e Coma, loss of all brainstem reflexes, respiratory arrest (medulla compression).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDuret Hemorrhages:\u003c/b\u003e A key pathological finding is the presence of \u003cmark\u003eDuret hemorrhages\u003c/mark\u003e, which are secondary brainstem hemorrhages in the pons and midbrain caused by stretching and tearing of perforating arteries during the downward displacement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a rostrocaudal deterioration. Look for a progressive decline in consciousness accompanied by changes in pupillary response and motor posturing, often culminating in fatal brainstem hemorrhages (Duret hemorrhages).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral transtentorial herniation\u003c/b\u003e is a devastating downward spiral of the brainstem through the tentorial notch, leading to a predictable sequence of neurological decline from altered consciousness to posturing and death, often marked by the characteristic Duret hemorrhages from vascular shearing.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(Downward Displacement of Diencephalon/Midbrain); B --\u003e C(Compression of Brainstem); C --\u003e D(Rupture of Paramedian Arteries); D --\u003e E(Duret Hemorrhages);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"duret_hemorrhages\"\n      },\n      {\n        \"type\": \"leads_to\",\n        \"to\": \"c0b7a1ca\"\n      }\n    ]\n  },\n  \"a1721d6f\": {\n    \"title\": \"Cephalohematoma\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecephalohematoma\u003c/b\u003e is a subperiosteal collection of blood on the scalp of a newborn, caused by the rupture of blood vessels between the skull and the periosteum during birth. It is a common birth trauma, especially with forceps or vacuum-assisted delivery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The hemorrhage is located \u003cu\u003edeep to the periosteum\u003c/u\u003e (subperiosteal).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A firm, well-demarcated swelling on the scalp. A key feature is that it \u003cmark\u003edoes \u003cu\u003enot\u003c/u\u003e cross suture lines\u003c/mark\u003e, as the periosteum is firmly attached at the sutures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming:\u003c/b\u003e May not be present at birth but develops over the first few hours to days. It resolves slowly over weeks to months.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e The breakdown of the collected red blood cells can lead to \u003cmark\u003ejaundice\u003c/mark\u003e (indirect hyperbilirubinemia). Rarely, it may become calcified.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It must be distinguished from a [[a5ec55b5|caput succedaneum]].\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Firm, does \u003cu\u003enot\u003c/u\u003e cross suture lines, appears hours after birth, resolves slowly.\u003cbr\u003e - \u003cb\u003eCaput Succedaneum:\u003c/b\u003e Soft, crosses suture lines, present at birth, resolves quickly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The inability to cross suture lines is the most important feature for distinguishing a cephalohematoma from a caput succedaneum on an exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ecephalohematoma\u003c/b\u003e is a subperiosteal bleed confined by cranial suture lines, appearing as a firm scalp swelling in a newborn after a difficult delivery; its key distinguishing feature is its respect for suture boundaries, and its main complication is neonatal jaundice.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46ca72c2\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a5ec55b5\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"neonatal_jaundice\"\n      }\n    ]\n  },\n  \"fa8656bd\": {\n    \"title\": \"Cerebellar Tonsillar Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebellar tonsillar herniation\u003c/b\u003e is a life-threatening type of brain herniation where the cerebellar tonsils are displaced downward through the foramen magnum, leading to compression of the medulla oblongata.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by a mass or pressure increase in the posterior fossa (e.g., cerebellar tumor, hemorrhage, or edema). It can also be iatrogenically caused by performing a lumbar puncture in the setting of high intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The herniating tonsils directly compress the medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e This is a rapidly fatal event. Compression of the medullary cardiorespiratory centers leads to \u003cmark\u003ebradycardia, respiratory arrest, and death\u003c/mark\u003e. Patients may also present with headache, neck stiffness, and loss of consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Malformation:\u003c/b\u003e This type of herniation is the defining feature of [[b96a6a07|Chiari I and II malformations]], although in those congenital conditions, the process is chronic rather than acute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic scenario is a patient with signs of increased intracranial pressure (headache, papilledema) who undergoes a lumbar puncture and then rapidly deteriorates with respiratory arrest. This highlights the danger of LP in the setting of unevaluated increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebellar tonsillar herniation\u003c/b\u003e is the most lethal form of brain herniation, as the downward displacement of the cerebellar tonsils through the foramen magnum directly compresses the vital cardiorespiratory centers in the medulla, leading to swift respiratory and cardiac arrest.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Posterior Fossa Pressure] --\u003e B(Cerebellar Tonsils Displace Downward); B --\u003e C(Through Foramen Magnum); C --Compresses--\u003e D(Medulla Oblongata); D --\u003e E(Cardiorespiratory Arrest);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n        \"type\": \"compresses\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"b96a6a07\"\n      },\n      {\n        \"type\": \"can_be_precipitated_by\",\n        \"to\": \"lumbar_puncture\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 8916,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"1c4d7e8f\": {\n    \"title\": \"Ca"
      }, {
        "text": "uda Equina\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Sp"
      }, {
        "text": "inal Cord\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCauda Equina\u003c/b\u003e (Latin for \\\"horse\u0027s tail\\\") is the"
      }, {
        "text": " bundle of spinal nerves and spinal nerve rootlets, consisting of the second through fifth lumbar nerve pairs, the first through fifth"
      }, {
        "text": " sacral nerve pairs, and the coccygeal nerve, all of which arise from the lumbar enlargement and the conus medullaris of the spinal"
      }, {
        "text": " cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e Comprises the nerve roots from"
      }, {
        "text": " L2 to Co1 that descend through the lumbar cistern (subarachnoid space) below the termination of the spinal cord proper"
      }, {
        "text": " (conus medullaris, typically at L1-L2).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e These nerve roots provide motor"
      }, {
        "text": " and sensory innervation to the lower extremities, perineum, and pelvic organs (including the bladder and anal sphincters).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Significance:\u003c/b\u003e Compression of these nerve roots leads to \u003cmark\u003e[[2904b5c8|Cauda Equina Syndrome"
      }, {
        "text": "]]\u003c/mark\u003e, a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLumbar Puncture:\u003c/b\u003e The cauda equina floats"
      }, {
        "text": " in the cerebrospinal fluid of the lumbar cistern, which is the target for a lumbar puncture. The needle is typically inserted at"
      }, {
        "text": " the L3-L4 or L4-L5 interspace to avoid injuring the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember that the spinal cord ends at L1-L2 in adults. The collection of nerve roots continuing"
      }, {
        "text": " down the vertebral canal below this level is the cauda equina.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Cauda Equina\u003c/b\u003e is the collection of descending lumbar and sacral nerve roots that resemble a horse\u0027s tail, filling"
      }, {
        "text": " the subarachnoid space below the end of the spinal cord; its compression results in the surgical emergency known as cauda equina syndrome.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"compression"
      }, {
        "text": "_of_causes\",\n        \"to\": \"2904b5c8\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_inferior_to\",\n        \"to\": \"conus_medullaris\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"2904b5c8\": {\n    \"title\": \"Cauda Equina Syndrome"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Emergency"
      }, {
        "text": " Medicine\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCauda Equina Syndrome\u003c/b\u003e is a neurosurgical emergency caused by severe"
      }, {
        "text": " compression of the [[1c4d7e8f|cauda equina]], the bundle of nerve roots at"
      }, {
        "text": " the lower end of the spinal canal. This compression leads to a constellation of debilitating symptoms requiring urgent surgical decompression.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a massive midline lumbar disc herniation. Other causes include spinal"
      }, {
        "text": " stenosis, tumors, trauma, and epidural abscess or hematoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by a combination of symptoms"
      }, {
        "text": " including \u003cmark\u003esevere low back pain\u003c/mark\u003e, radicular pain in one or both legs, and \u003cmark\u003esaddle anesthesia\u003c/mark"
      }, {
        "text": "\u003e (loss of sensation in the perineum, buttocks, and inner thighs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRed Flag Symptoms:\u003c/b\u003e The"
      }, {
        "text": " most critical signs are \u003cmark\u003ebowel and/or bladder dysfunction\u003c/mark\u003e (e.g., urinary retention or"
      }, {
        "text": " incontinence) and loss of the [[ce2052d6|anal wink reflex]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor/"
      }, {
        "text": "Sensory Deficits:\u003c/b\u003e Patients typically have asymmetric, flaccid paralysis or weakness in the lower extremities (LMN signs) and sensory loss."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e \u003cu\u003eUrgent surgical decompression\u003c/u\u003e is required to relieve the pressure on the nerve roots and prevent permanent"
      }, {
        "text": " paralysis and incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of low back pain, saddle anesthesia, and new"
      }, {
        "text": "-onset urinary retention is the classic triad for Cauda Equina Syndrome and warrants immediate surgical consultation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eCauda Equina Syndrome\u003c/b\u003e is a critical condition where compression of the lumbosacral nerve roots leads"
      }, {
        "text": " to a devastating loss of lower extremity and pelvic floor function; its hallmark \u0027red flag\u0027 symptoms of saddle anesthesia and bladder"
      }, {
        "text": "/bowel dysfunction signal the need for immediate surgical intervention to prevent permanent disability.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Massive Lumbar Disc Herniation] --Compresses--\u003e B(Cauda Equina); B"
      }, {
        "text": " --\u003e C(Saddle Anesthesia); B --\u003e D(Bowel/Bladder Dysfunction); B --\u003e E(Lower"
      }, {
        "text": " Extremity Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_"
      }, {
        "text": "by_compression_of\",\n        \"to\": \"1c4d7e8f\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"saddle_anesthesia\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"presents_with\",\n        \"to\": \"bowel_and_bladder_dysfunction\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"requires\",\n        \"to\": \"surgical_decompression\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"3fa071ef\": {\n    \"title\": \"Caudate Nucle"
      }, {
        "text": "us\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Movement"
      }, {
        "text": " Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCaudate Nucleus\u003c/b\u003e is a C-shaped nucleus that"
      }, {
        "text": " is a key component of the [[ed462927|basal ganglia]]. Together with the putamen, it forms the stri"
      }, {
        "text": "atum, which is the main input station for the basal ganglia circuits involved in motor control and cognitive functions.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e A large C-shaped structure with a head, body, and tail that follows"
      }, {
        "text": " the curve of the lateral ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The caudate is primarily involved in the \u003cmark\u003ecognitive\u003c/"
      }, {
        "text": "mark\u003e aspects of movement, including motor planning and procedural learning. It also plays a role in reward and motivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStri"
      }, {
        "text": "atum:\u003c/b\u003e The caudate and putamen are collectively known as the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e At"
      }, {
        "text": "rophy of the caudate nucleus is the hallmark pathological finding in \u003cmark\u003e[[ffd7e743|Huntington disease"
      }, {
        "text": "]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging Finding:\u003c/b\u003e The degeneration of the caudate head in Huntington disease leads to the"
      }, {
        "text": " characteristic appearance of \u003cmark\u003eenlarged lateral ventricles\u003c/mark\u003e on brain imaging (ex vacuo ventriculomegaly).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The association between caudate atrophy and [[ffd7e743|Huntington disease]] is"
      }, {
        "text": " extremely high-yield. A brain scan showing \u0027boxcar\u0027 ventricles due to a shrunken caudate in a patient with chore"
      }, {
        "text": "a is classic for Huntington\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCaudate Nucleus\u003c/b\u003e is"
      }, {
        "text": " a critical part of the basal ganglia\u0027s cognitive loop, and its profound atrophy in [[ffd7e743|Hunting"
      }, {
        "text": "ton disease]] is directly responsible for both the characteristic motor (chorea) and cognitive (dementia) decline seen in the disorder.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Caudate Nucleus] --Atrophy in Huntington\u0027s Disease--\u003e B(En"
      }, {
        "text": "larged Lateral Ventricles); A --Part of Striatum--\u003e C(Receives Cortical Input); C --\u003e D"
      }, {
        "text": "(Modulates Motor \u0026 Cognitive Function);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"forms_striatum_with\",\n        \"to\": \"putamen\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"atrophies_in\",\n        \"to\": \"ffd7e743\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"c260efc8\": {\n    \"title\": \"Cavernous Sin"
      }, {
        "text": "us\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dural Ven"
      }, {
        "text": "ous Sinuses\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Cavernous Sinus\u003c/b\u003e is a paired dural venous sinus located on either side of the sella turcica of"
      }, {
        "text": " the sphenoid bone. It is a unique venous structure because several critical cranial nerves and the internal carotid artery pass directly"
      }, {
        "text": " through it.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eContents:\u003c/b\u003e Mnemonic \u003cb\u003eO"
      }, {
        "text": " TOM CAT\u003c/b\u003e (from superior to inferior on lateral wall, then medially):\u003cbr\u003e - \u003cb\u003eO\u003c/b\u003e"
      }, {
        "text": "culomotor n. (CN III)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003erochlear n. (CN IV)\u003cbr"
      }, {
        "text": "\u003e - \u003cb\u003eO\u003c/b\u003ephthalmic n. (CN V\u003csub\u003e1\u003c/sub\u003e)\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eaxillary n. (CN"
      }, {
        "text": " V\u003csub\u003e2\u003c/sub\u003e)\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003earotid artery (internal)\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003ebducens n. ("
      }, {
        "text": "CN VI)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003e (ignore)\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation of CN VI:\u003c/b\u003e The [[dd"
      }, {
        "text": "11dde6|abducens nerve (CN VI)]] is the only nerve that runs freely within the sinus"
      }, {
        "text": ", next to the internal carotid artery, making it particularly vulnerable to injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage:\u003c/b\u003e Receives venous"
      }, {
        "text": " blood from the superior and inferior ophthalmic veins and drains into the superior and inferior petrosal sinuses, which then drain"
      }, {
        "text": " to the internal jugular vein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[9a08"
      }, {
        "text": "9fd7|Cavernous Sinus Syndrome]]:\u003c/b\u003e A mass effect (e.g., tumor, aneurysm)"
      }, {
        "text": " causing ophthalmoplegia, decreased corneal sensation, and Horner syndrome.\u003cbr\u003e - \u003cb\u003e[[a8306"
      }, {
        "text": "92a|Cavernous Sinus Thrombosis]]:\u003c/b\u003e A blood clot in the sinus, often from a spreading facial"
      }, {
        "text": " or sinus infection, causing similar symptoms plus signs of infection and venous congestion (proptosis, chemosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Any patient presenting with multiple cranial nerve palsies involving eye movement (CN III, IV, VI) should raise"
      }, {
        "text": " suspicion for a lesion in the cavernous sinus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCavernous"
      }, {
        "text": " Sinus\u003c/b\u003e is a critical neurovascular crossroads where cranial nerves controlling eye movement and facial sensation travel alongside the internal carotid artery"
      }, {
        "text": ", making it a \u0027danger zone\u0027 where pathology can cause a complex ophthalmoplegia.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Cavernous Sinus]; A --\u003e B(CN III); A --\u003e C(CN IV); A --\u003e D(CN"
      }, {
        "text": " V1/V2); A --\u003e E(CN VI); A --\u003e F(Internal Carotid Artery);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"2"
      }, {
        "text": "1f1c955\"\n      },\n      {\n        \"type\": \"pathology_causes"
      }, {
        "text": "\",\n        \"to\": \"9a089fd7\"\n      },\n      {\n        \"type\": \"pathology_causes"
      }, {
        "text": "\",\n        \"to\": \"a830692a\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"contains\",\n        \"to\": \"dd11dde6\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"9a089fd7\": {\n    \"title\": \"Cavernous Sinus Syndrome\",\n"
      }, {
        "text": "    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Syndrome\u003c/b\u003e is a clinical constellation of"
      }, {
        "text": " signs and symptoms resulting from any pathological process that affects the contents of the [[c260efc8|ca"
      }, {
        "text": "vernous sinus]], leading to multiple cranial nerve palsies and potentially venous congestion of the orbit.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by mass effect from tumors (e.g., [["
      }, {
        "text": "5f3188bd|pituitary adenoma]]), aneurysms of the internal carotid artery, [[a"
      }, {
        "text": "830692a|cavernous sinus thrombosis]], or inflammation (e.g., Tolosa-Hunt syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e A combination of:\u003cbr\u003e - \u003cb\u003eOphthalmoplegia:\u003c/b\u003e Paralysis of eye movements due to involvement of CN"
      }, {
        "text": " III, IV, and VI.\u003cbr\u003e - \u003cb\u003eSensory Loss:\u003c/b\u003e Decreased sensation in the forehead and"
      }, {
        "text": " cheek due to involvement of CN V\u003csub\u003e1\u003c/sub\u003e and V\u003csub\u003e2\u003c/sub\u003e.\u003cbr\u003e - \u003cb\u003ePupillary Changes:\u003c/b\u003e Can"
      }, {
        "text": " have a dilated pupil (CN III compression) or a constricted pupil (Horner syndrome from sympathetic plexus damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVen"
      }, {
        "text": "ous Congestion:\u003c/b\u003e If caused by thrombosis or a fistula, may see proptosis (bulging eye) and chemosis (conj"
      }, {
        "text": "unctival swelling).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to recognizing this syndrome is the involvement of \u003cu\u003emultiple\u003c/u\u003e"
      }, {
        "text": " cranial nerves that all pass through one specific anatomical location: the [[c260efc8|cavernous sinus]]. The [["
      }, {
        "text": "dd11dde6|abducens nerve (CN VI)]] is often the first nerve affected due to its medial"
      }, {
        "text": " location within the sinus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Syndrome\u003c/b\u003e"
      }, {
        "text": " is the clinical manifestation of a \u0027mass lesion\u0027 within the cavernous sinus, presenting as a complex ophthalmoplegia with facial"
      }, {
        "text": " sensory loss, a direct result of compressing the tightly packed cranial nerves III, IV, V\u003csub\u003e1\u003c/sub\u003e, V\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e, and VI.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_pathology_in\",\n        \"to\": \"c260efc8\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"ophthalmoplegia\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\":"
      }, {
        "text": " \"a830692a\"\n      },\n      {\n        \"type\": \"can_"
      }, {
        "text": "be_caused_by\",\n        \"to\": \"5f3188bd\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"a830692a\": {\n    \"title\": \""
      }, {
        "text": "Cavernous Sinus Thrombosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Infectious Disease\",\n      \"Ophthalmology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCavernous"
      }, {
        "text": " Sinus Thrombosis\u003c/b\u003e is the formation of a blood clot within the [[c260efc8|cavernous sinus]], a"
      }, {
        "text": " rare but life-threatening condition that is most often caused by a contiguous spread of infection from the face, sinuses, or teeth"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly a septic thrombosis"
      }, {
        "text": " resulting from infection. The most common pathogen is \u003cmark\u003e\u003ci\u003eStaphylococcus aureus\u003c/i\u003e\u003c/mark\u003e. Infection can spread from the \u0027"
      }, {
        "text": "danger triangle\u0027 of the face, sphenoid or ethmoid sinuses, or dental abscesses via the valveless facial venous"
      }, {
        "text": " system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The thrombus obstructs venous drainage and causes inflammation, leading to increased"
      }, {
        "text": " pressure within the sinus and compression of its contents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with severe headache, high"
      }, {
        "text": " fever, and signs of [[9a089fd7|cavernous sinus syndrome]]: ophthalmoplegia ("
      }, {
        "text": "CN III, IV, VI palsy), periorbital edema, proptosis, and chemosis. The [[dd11dde6|ab"
      }, {
        "text": "ducens nerve (CN VI)]] is often affected first.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e MRI with magnetic resonance venography ("
      }, {
        "text": "MRV) is the imaging modality of choice.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Requires prompt initiation of broad-spectrum IV"
      }, {
        "text": " antibiotics and consideration of anticoagulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a recent facial furuncle or sinusitis"
      }, {
        "text": " who develops a severe headache, fever, and unilateral eye swelling with impaired eye movements is the classic presentation for cavernous sinus thrombosis.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCavernous Sinus Thrombosis\u003c/b\u003e is a septic clot in the brain"
      }, {
        "text": "\u0027s central venous drainage system, typically seeded by a facial infection, which rapidly evolves into a neuro-ophthalmologic emergency with"
      }, {
        "text": " high fever, headache, and paralysis of eye movements.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Facial/"
      }, {
        "text": "Sinus Infection] --Staph. aureus--\u003e B(Spread via Valveless Veins); B --\u003e C(Ca"
      }, {
        "text": "vernous Sinus); C --\u003e D(Thrombosis \u0026 Inflammation); D --\u003e E(Cavernous Sinus Syndrome);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"9a08"
      }, {
        "text": "9fd7\"\n      },\n      {\n        \"type\": \"is_an_infection_of\",\n        \""
      }, {
        "text": "to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_commonly_caused_by\",\n        \"to\": \"staphylococcus_aureus\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"714f15fc\": {\n    \"title\": \"Central Post-Stroke"
      }, {
        "text": " Pain Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Stroke\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Post-Stroke Pain Syndrome\u003c/b\u003e, also known as thalamic pain syndrome"
      }, {
        "text": " or Dejerine-Roussy syndrome, is a chronic neuropathic pain condition that develops after a [[c5"
      }, {
        "text": "da3c57|stroke]], most classically one affecting the [[afc0a64b|thalamus]].\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by a stroke ("
      }, {
        "text": "usually ischemic) affecting the somatosensory pathways, particularly the ventroposterolateral (VPL) nucleus of the [[afc0a6"
      }, {
        "text": "4b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Pain does not occur immediately after the stroke. There is typically an"
      }, {
        "text": " initial loss of sensation (numbness) in the affected area, with the pain developing weeks to months later.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " Characterized by severe, persistent, and often debilitating pain on the side of the body contralateral to the stroke. The pain is often described as burning,"
      }, {
        "text": " aching, or lancinating.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e \u003cmark\u003eAllodynia\u003c/mark\u003e (pain provoked"
      }, {
        "text": " by a normally non-painful stimulus, like light touch) and \u003cmark\u003ehyperalgesia\u003c/mark\u003e (exaggerated pain response"
      }, {
        "text": " to a painful stimulus) are hallmarks of the condition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Very difficult to treat. Options include antidepressants"
      }, {
        "text": " (TCAs like [[c6814506|amitriptyline]]), anticonvulsants (e.g., gabapentin,"
      }, {
        "text": " pregabalin), and in refractory cases, deep brain stimulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history"
      }, {
        "text": " of a stroke who later develops severe, burning pain and allodynia on the previously numb side of their body is the"
      }, {
        "text": " classic presentation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral Post-Stroke Pain Syndrome\u003c/b\u003e is a"
      }, {
        "text": " cruel paradox of sensory processing, where a thalamic stroke that initially causes numbness later gives rise to intractable neuropathic pain and"
      }, {
        "text": " allodynia due to maladaptive plasticity in the damaged central sensory pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        "
      }, {
        "text": "\"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_caused_by"
      }, {
        "text": "_lesion_in\",\n        \"to\": \"afc0a64b\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"presents_with\",\n        \"to\": \"allodynia\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"c6814506\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"3334840f\": {\n    \"title"
      }, {
        "text": "\": \"Central Retinal Artery Occlusion (CRAO)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"Neurology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Retinal Artery"
      }, {
        "text": " Occlusion (CRAO)\u003c/b\u003e is an ophthalmologic emergency characterized by the sudden, painless, and profound loss of mon"
      }, {
        "text": "ocular vision due to obstruction of the central retinal artery, which supplies the inner retina.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a thromboembolism. The most frequent source is an"
      }, {
        "text": " atherosclerotic plaque in the \u003cmark\u003eipsilateral carotid artery\u003c/mark\u003e. Other sources include cardiogenic emboli (e."
      }, {
        "text": "g., from atrial fibrillation) or giant cell arteritis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occlusion of the artery"
      }, {
        "text": " leads to acute ischemia of the inner two-thirds of the retina, causing rapid and irreversible death of ganglion cells and other"
      }, {
        "text": " neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, severe monocular vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The"
      }, {
        "text": " classic fundoscopic finding is a \u003cmark\u003epale retina\u003c/mark\u003e (due to ischemia and edema) with a \u003cmark\u003e\\\""
      }, {
        "text": "cherry-red spot\\\"\u003c/mark\u003e at the fovea. The cherry-red spot represents the intact choroidal circulation"
      }, {
        "text": " (supplied by the posterior ciliary arteries) visible through the thinned, ischemic fovea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The triad of sudden, painless, profound monocular vision loss and a \\\"cherry-red spot\\\" on"
      }, {
        "text": " fundoscopy is pathognomonic for CRAO. It is essentially a stroke of the eye.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCentral Retinal Artery Occlusion\u003c/b\u003e is an acute ischemic stroke of the retina, where an embolus blocks its"
      }, {
        "text": " main arterial supply, leading to sudden, devastating vision loss and the iconic fundoscopic image of a pale retina with a contrasting"
      }, {
        "text": " \u0027cherry-red\u0027 macula.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Embolus from"
      }, {
        "text": " Carotid/Heart] --\u003e B(Occlusion of Central Retinal Artery); B --\u003e C(Inner Retinal Ischemia); C --\u003e D("
      }, {
        "text": "Pale Retina); C --\u003e E(Cherry-Red Spot at Fovea); D \u0026 E --\u003e F(Sudden,"
      }, {
        "text": " Painless Vision Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"retinal_artery_occlusion\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_caused_by\",\n        \"to\": \"thromboembolism\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"presents_with\",\n        \"to\": \"cherry_red_spot\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_form_of\",\n        \"to\": \"ischemic_stroke\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"b69e35b5\": {\n    \"title\":"
      }, {
        "text": " \"Central Retinal Vein Occlusion (CRVO)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral Retinal"
      }, {
        "text": " Vein Occlusion (CRVO)\u003c/b\u003e is a common retinal vascular disorder characterized by the blockage of the central retinal vein at"
      }, {
        "text": " the optic nerve head, leading to venous stasis, retinal hemorrhage, and edema.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary mechanism is thrombosis of the central retinal vein, often at"
      }, {
        "text": " the lamina cribrosa where the vein is compressed by a sclerotic central retinal artery with which it shares a common adventitial sheath.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eRisk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, hyper"
      }, {
        "text": "lipidemia, and glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, unilateral blurring or loss of vision. The severity can"
      }, {
        "text": " range from mild to severe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The fundoscopic exam is dramatic and described as a \u003cmark\u003e\\\"blood"
      }, {
        "text": " and thunder\\\"\u003c/mark\u003e appearance. It shows diffuse, widespread retinal hemorrhages in all four quadrants, venous dilation and"
      }, {
        "text": " tortuosity, cotton-wool spots, and optic disc swelling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from"
      }, {
        "text": " CRAO: CRVO is a venous \u0027backup\u0027 problem, leading to a hemorrhagic appearance (\u0027blood and thunder\u0027), while CRAO is an"
      }, {
        "text": " arterial \u0027blockage\u0027 problem, leading to a pale, ischemic appearance (\u0027cherry-red spot\u0027).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCentral Retinal Vein Occlusion\u003c/b\u003e is a vascular \u0027plumbing backup\u0027 in the eye, where a throm"
      }, {
        "text": "bus in the central retinal vein causes a dramatic, widespread backup of blood, resulting in the classic \u0027blood and thunder\u0027 hemorrhagic"
      }, {
        "text": " retinopathy and vision loss.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension/Atherosclerosis] --\u003e B(Compression"
      }, {
        "text": " of Central Retinal Vein); B --\u003e C(Thrombosis); C --\u003e D(Central Retinal Vein Occlusion); D"
      }, {
        "text": " --\u003e E(Venous Stasis \u0026 ‚Üë Pressure); E --\u003e F(Diffuse Retinal Hemorrhages \u0026 Edema);\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"retinal_vein_occlusion\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n"
      }, {
        "text": "        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"3334840f\"\n      }\n    ]\n  },\n  \"350"
      }, {
        "text": "f1c8b\": {\n    \"title\": \"Central Vertigo\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Vestibular Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral vertigo\u003c/b\u003e is a sensation of spinning or dizziness that originates"
      }, {
        "text": " from a problem within the central nervous system, specifically the brainstem or cerebellum. It is generally more serious than peripheral vertigo.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by lesions in the brainstem or cerebellum, such as"
      }, {
        "text": " [[c5da3c57|stroke]] (e.g., lateral medullary syndrome), [[45"
      }, {
        "text": "dd6d19|multiple sclerosis]], tumors, or migraines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNystagmus:\u003c/b\u003e The"
      }, {
        "text": " nystagmus in central vertigo can be in any direction (horizontal, torsional, or \u003cmark\u003epurely vertical/"
      }, {
        "text": "downbeat\u003c/mark\u003e). It is often non-fatigable and may change direction with gaze. It is \u003cu\u003enot\u003c/u\u003e suppressed by visual fixation."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Often accompanied by other neurological signs that point to a central lesion, such as [[9"
      }, {
        "text": "914d433|diplopia]], dysmetria, [[9767fd6b|ata"
      }, {
        "text": "xia]], dysarthria, or focal weakness/sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOnset:\u003c/b\u003e The onset can be sudden"
      }, {
        "text": " or gradual, and the vertigo is often constant and less intense than in peripheral causes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " presence of \u003cmark\u003epurely vertical nystagmus\u003c/mark\u003e is a red flag and is highly specific for a central"
      }, {
        "text": " cause of vertigo. Also, look for other \u0027central\u0027 neurological signs (the \u00275 D\u0027s\u0027: Dizziness, Dipl"
      }, {
        "text": "opia, Dysarthria, Dysphagia, Dysmetria).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral vertigo\u003c/b\u003e"
      }, {
        "text": " is a sign of a CNS lesion, not an inner ear problem. It is distinguished from peripheral vertigo by its associated neurological deficits"
      }, {
        "text": " and a nystagmus that is often vertical and does not suppress with visual fixation, indicating a more ominous underlying cause"
      }, {
        "text": " like a brainstem stroke.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_a_type_of\",\n        \"to\": \"vertigo\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"5811ad"
      }, {
        "text": "9e\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_"
      }, {
        "text": "in\",\n        \"to\": \"582d8572\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_caused_by_lesion_in\",\n        \"to\": \"bebe58d4\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"bad81d37\": {\n    \"title\": \"Central Transtent"
      }, {
        "text": "orial Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hern"
      }, {
        "text": "iation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral transt"
      }, {
        "text": "entorial herniation\u003c/b\u003e is a type of brain herniation where downward displacement of the cerebral hemispheres, basal ganglia, di"
      }, {
        "text": "encephalon, and midbrain occurs through the tentorial notch. It is typically caused by a diffuse increase in intracranial pressure.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by conditions that increase"
      }, {
        "text": " intracranial pressure symmetrically, such as diffuse cerebral edema, hydrocephalus, or midline tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:"
      }, {
        "text": "\u003c/b\u003e The downward pressure causes a sequential caudal displacement of brainstem structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Progression:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003eEarly:\u003c/b\u003e Altered level of consciousness, small reactive pupils (diencephalic compression).\u003cbr\u003e"
      }, {
        "text": "2. \u003cb\u003eLater:\u003c/b\u003e Mid-position, fixed pupils; decorticate then decerebrate posturing ("
      }, {
        "text": "midbrain/pons compression).\u003cbr\u003e3. \u003cb\u003eTerminal:\u003c/b\u003e Coma, loss of all brainstem reflexes, respiratory"
      }, {
        "text": " arrest (medulla compression).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDuret Hemorrhages:\u003c/b\u003e A key pathological finding is the presence of \u003cmark\u003eD"
      }, {
        "text": "uret hemorrhages\u003c/mark\u003e, which are secondary brainstem hemorrhages in the pons and midbrain caused by stretching and tearing of perfor"
      }, {
        "text": "ating arteries during the downward displacement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This is a rostrocaudal deterioration. Look"
      }, {
        "text": " for a progressive decline in consciousness accompanied by changes in pupillary response and motor posturing, often culminating in fatal brainstem hemorrh"
      }, {
        "text": "ages (Duret hemorrhages).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCentral transtentorial herniation"
      }, {
        "text": "\u003c/b\u003e is a devastating downward spiral of the brainstem through the tentorial notch, leading to a predictable sequence of neurological decline"
      }, {
        "text": " from altered consciousness to posturing and death, often marked by the characteristic Duret hemorrhages from vascular shearing.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(Downward Displacement of Diencephalon/Mid"
      }, {
        "text": "brain); B --\u003e C(Compression of Brainstem); C --\u003e D(Rupture of Paramedian Arteries); D --\u003e E("
      }, {
        "text": "Duret Hemorrhages);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_a_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"causes\",\n        \"to\": \"duret_hemorrhages\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"leads_to\",\n        \"to\": \"c0b7a"
      }, {
        "text": "1ca\"\n      }\n    ]\n  },\n  \"a1721d6f\": {\n    \"title\":"
      }, {
        "text": " \"Cephalohematoma\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecephalohematoma\u003c/b\u003e is a subperi"
      }, {
        "text": "osteal collection of blood on the scalp of a newborn, caused by the rupture of blood vessels between the skull and the periosteum during"
      }, {
        "text": " birth. It is a common birth trauma, especially with forceps or vacuum-assisted delivery.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The hemorrhage is located \u003cu\u003edeep to the periosteum\u003c/u\u003e (subperiosteal).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Clinical Presentation:\u003c/b\u003e A firm, well-demarcated swelling on the scalp. A key feature is that it \u003c"
      }, {
        "text": "mark\u003edoes \u003cu\u003enot\u003c/u\u003e cross suture lines\u003c/mark\u003e, as the periosteum is firmly attached at the sutures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming"
      }, {
        "text": ":\u003c/b\u003e May not be present at birth but develops over the first few hours to days. It resolves slowly over weeks to months.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCom"
      }, {
        "text": "plications:\u003c/b\u003e The breakdown of the collected red blood cells can lead to \u003cmark\u003ejaundice\u003c/mark\u003e (indirect"
      }, {
        "text": " hyperbilirubinemia). Rarely, it may become calcified.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It must be distinguished from a [["
      }, {
        "text": "a5ec55b5|caput succedaneum]].\u003cbr\u003e - \u003cb\u003eCephalohematoma:\u003c/b\u003e Firm"
      }, {
        "text": ", does \u003cu\u003enot\u003c/u\u003e cross suture lines, appears hours after birth, resolves slowly.\u003cbr\u003e - \u003cb\u003eCaput"
      }, {
        "text": " Succedaneum:\u003c/b\u003e Soft, crosses suture lines, present at birth, resolves quickly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The inability"
      }, {
        "text": " to cross suture lines is the most important feature for distinguishing a cephalohematoma from a caput succedaneum on an"
      }, {
        "text": " exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ecephalohematoma\u003c/b\u003e is a subperiosteal bleed"
      }, {
        "text": " confined by cranial suture lines, appearing as a firm scalp swelling in a newborn after a difficult delivery; its key distinguishing feature is its respect"
      }, {
        "text": " for suture boundaries, and its main complication is neonatal jaundice.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46"
      }, {
        "text": "ca72c2\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \""
      }, {
        "text": "a5ec55b5\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"neon"
      }, {
        "text": "atal_jaundice\"\n      }\n    ]\n  },\n  \"fa8656bd\": {\n    \"title"
      }, {
        "text": "\": \"Cerebellar Tonsillar Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eC"
      }, {
        "text": "erebellar tonsillar herniation\u003c/b\u003e is a life-threatening type of brain herniation where the cerebellar tonsils are displaced"
      }, {
        "text": " downward through the foramen magnum, leading to compression of the medulla oblongata.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Caused by a mass or pressure increase in the posterior fossa (e.g., cerebellar tumor, hemorrhage, or edema"
      }, {
        "text": "). It can also be iatrogenically caused by performing a lumbar puncture in the setting of high intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophys"
      }, {
        "text": "iology:\u003c/b\u003e The herniating tonsils directly compress the medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e This is a rapidly"
      }, {
        "text": " fatal event. Compression of the medullary cardiorespiratory centers leads to \u003cmark\u003ebradycardia, respiratory arrest, and death\u003c/mark\u003e."
      }, {
        "text": " Patients may also present with headache, neck stiffness, and loss of consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Malformation:\u003c/b\u003e This"
      }, {
        "text": " type of herniation is the defining feature of [[b96a6a07|Chiari I and II malformations]],"
      }, {
        "text": " although in those congenital conditions, the process is chronic rather than acute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic scenario"
      }, {
        "text": " is a patient with signs of increased intracranial pressure (headache, papilledema) who undergoes a lumbar puncture and then rapidly"
      }, {
        "text": " deteriorates with respiratory arrest. This highlights the danger of LP in the setting of unevaluated increased ICP.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eCerebellar tonsillar herniation\u003c/b\u003e is the most lethal form of brain herniation, as"
      }, {
        "text": " the downward displacement of the cerebellar tonsils through the foramen magnum directly compresses the vital cardiorespiratory centers in the medulla,"
      }, {
        "text": " leading to swift respiratory and cardiac arrest.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Posterior Fossa Pressure] --\u003e B(C"
      }, {
        "text": "erebellar Tonsils Displace Downward); B --\u003e C(Through Foramen Magnum); C --Compresses--\u003e D(Med"
      }, {
        "text": "ulla Oblongata); D --\u003e E(Cardiorespiratory Arrest);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"8c0728"
      }, {
        "text": "b7\"\n      },\n      {\n        \"type\": \"compresses\",\n        \"to\": \"med"
      }, {
        "text": "ulla_oblongata\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\":"
      }, {
        "text": " \"b96a6a07\"\n      },\n      {\n        \"type\": \"can_"
      }, {
        "text": "be_precipitated_by\",\n        \"to\": \"lumbar_puncture\"\n      }\n    ]\n"
      }, {
        "text": "  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "16gst5hk5TdzLlCTs0aIRmETMP36i-Y1c"
      },
      "role": "user",
      "tokenCount": 2630
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"6e31977d\": {\n    \"title\": \"Cerebellar Vermis Lesions\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neuroanatomy\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebellar Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eLesions of the \u003cb\u003ecerebellar vermis\u003c/b\u003e, the midline portion of the cerebellum, result in a specific set of motor deficits related to the control of the trunk and axial musculature, as well as eye movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomical Correlation:\u003c/b\u003e The vermis is centrally located and primarily controls the central body (trunk).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHallmark Sign:\u003c/b\u003e \u003cmark\u003eTruncal ataxia\u003c/mark\u003e. This manifests as an unsteady, wide-based gait often described as a \\\"drunken sailor\\\" gait. Patients have difficulty sitting or standing upright without swaying or falling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Signs:\u003c/b\u003e Nystagmus and other impairments of eye movement control are common due to the vermis\u0027s connections with the vestibular nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpeech:\u003c/b\u003e Dysarthria (slurred, uncoordinated speech) can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e In adults, degeneration of the vermis is classically associated with \u003cmark\u003echronic alcohol overuse\u003c/mark\u003e. In children, a [[16d613bb|medulloblastoma]] is a common cause of a vermal lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate vermal lesions from cerebellar hemisphere lesions. Vermis lesion \u003d truncal ataxia (midline problems). Hemisphere lesion \u003d limb ataxia, intention tremor (lateral problems).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA lesion of the \u003cb\u003ecerebellar vermis\u003c/b\u003e selectively impairs control of the body\u0027s midline, leading to a profound truncal ataxia that makes stable standing and walking difficult, a presentation classically linked to chronic alcoholism in adults or medulloblastoma in children.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_lesion_of\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"truncal_ataxia\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"chronic_alcohol_use\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"16d613bb\"\n      }\n    ]\n  },\n  \"bebe58d4\": {\n    \"title\": \"Cerebellum\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCerebellum\u003c/b\u003e (Latin for \\\"little brain\\\") is a major feature of the hindbrain located posterior to the pons and medulla. It plays a crucial role in modulating motor commands to control balance, coordination, and precision of voluntary movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Modulates movement; aids in coordination, balance, and motor learning. It does not initiate movement but fine-tunes it.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnatomical Divisions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eVermis (midline):\u003c/b\u003e Controls axial and proximal limb musculature (truncal stability).\u003cbr\u003e - \u003cb\u003eHemispheres (lateral):\u003c/b\u003e Control distal limb musculature (limb coordination).\u003cbr\u003e - \u003cb\u003eFlocculonodular Lobe:\u003c/b\u003e Involved in balance and eye movements via connections with the vestibular system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput/Output:\u003c/b\u003e Receives proprioceptive input from the spinal cord (ipsilateral) and motor plan input from the contralateral cortex. It sends output to the contralateral cortex via the thalamus to modulate movement. Each cerebellar hemisphere controls the \u003cmark\u003eipsilateral\u003c/mark\u003e side of the body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e Cerebellar lesions cause ipsilateral deficits. \u003cmark\u003eVermal lesions\u003c/mark\u003e cause truncal ataxia. \u003cmark\u003eHemispheric lesions\u003c/mark\u003e cause limb ataxia, dysmetria, and intention tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that cerebellar signs are ipsilateral to the lesion. A patient who falls to the left has a left-sided cerebellar lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCerebellum\u003c/b\u003e acts as the brain\u0027s master coordinator, comparing the intended movement from the cortex with the actual movement from proprioceptive feedback, and issuing corrective signals to ensure smooth, balanced, and accurate motor activity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cortex] --Motor Plan--\u003e B(Cerebellum); C[Spinal Cord] --Proprioception--\u003e B; B --Corrective Signals--\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"9767fd6b\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"hindbrain\"\n      },\n      {\n        \"type\": \"receives_input_via\",\n        \"to\": \"cerebellar_peduncles\"\n      },\n      {\n        \"type\": \"sends_output_via\",\n        \"to\": \"cerebellar_peduncles\"\n      }\n    ]\n  },\n  \"8a30e721\": {\n    \"title\": \"Cerebral Aqueduct of Sylvius\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Embryology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCerebral Aqueduct\u003c/b\u003e (also known as the Aqueduct of Sylvius) is a narrow channel within the midbrain that connects the third ventricle in the diencephalon to the fourth ventricle in the hindbrain, allowing for the flow of cerebrospinal fluid (CSF).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Traverses the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Serves as a conduit for CSF flow from the third to the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Due to its narrow diameter, the cerebral aqueduct is a common site for obstruction, leading to \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of Stenosis:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCongenital:\u003c/b\u003e Can be congenitally narrow (aqueductal stenosis), sometimes as an X-linked condition.\u003cbr\u003e - \u003cb\u003eAcquired:\u003c/b\u003e Can be compressed by tumors (e.g., pinealoma, brainstem glioma) or blocked by inflammation/hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation of Obstruction:\u003c/b\u003e In infants, presents with an enlarging head circumference. In adults, presents with signs of increased intracranial pressure (headache, papilledema, vomiting).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A CT or MRI showing enlarged lateral and third ventricles with a normal-sized fourth ventricle is the classic imaging finding for aqueductal stenosis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCerebral Aqueduct\u003c/b\u003e is a critical but vulnerable bottleneck in the CSF pathway; its obstruction leads to a backup of CSF and non-communicating hydrocephalus, effectively damming the flow between the third and fourth ventricles.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Ventricles] --\u003e B(Third Ventricle); B --\u003e C(Cerebral Aqueduct); C --Obstruction--\u003e D(Non-communicating Hydrocephalus); C --\u003e E(Fourth Ventricle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"1cb9c975\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"third_ventricle\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"fourth_ventricle\"\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to\": \"0bc2f200\"\n      }\n    ]\n  },\n  \"e51a7691\": {\n    \"title\": \"Cerebral Arteries\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCerebral Arteries\u003c/b\u003e are the network of blood vessels that supply oxygenated blood to the brain. They are broadly divided into the anterior circulation (derived from the internal carotid arteries) and the posterior circulation (derived from the vertebral arteries), which are connected by the [[e22300e8|Circle of Willis]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterior Circulation:\u003c/b\u003e Includes the [[830c856c|Anterior Cerebral Artery (ACA)]] and the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePosterior Circulation:\u003c/b\u003e Includes the vertebral arteries, the [[e7a90cd9|basilar artery]], and the [[b6a2cc31|Posterior Cerebral Artery (PCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Distribution:\u003c/b\u003e Each major artery supplies a distinct territory of the cerebral cortex:\u003cbr\u003e - \u003cb\u003eACA:\u003c/b\u003e Medial surface of the frontal and parietal lobes (supplying the leg/foot area of the motor/sensory homunculus).\u003cbr\u003e - \u003cb\u003eMCA:\u003c/b\u003e Lateral surface of the hemispheres (supplying the face/arm/hand area and language centers).\u003cbr\u003e - \u003cb\u003ePCA:\u003c/b\u003e Occipital lobe and inferior surface of the temporal lobe (supplying the visual cortex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eWatershed Zones:\u003c/b\u003e Areas at the border between two major arterial territories (e.g., ACA-MCA) are vulnerable to ischemia during systemic hypoperfusion, leading to watershed infarcts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Knowing the cortical distribution of the ACA, MCA, and PCA is essential for localizing stroke lesions from clinical symptoms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe brain\u0027s arterial supply is precisely organized, with the \u003cb\u003ecerebral arteries\u003c/b\u003e each irrigating specific functional territories; this anatomical consistency allows clinicians to predict the location of a stroke based on the patient\u0027s neurological deficits.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Circle of Willis] --\u003e B(Anterior Cerebral Artery); A --\u003e C(Middle Cerebral Artery); A --\u003e D(Posterior Cerebral Artery);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e22300e8\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"830c856c\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"b6a2cc31\"\n      }\n    ]\n  },\n  \"a1b198f9\": {\n    \"title\": \"Cerebral Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCerebral Cortex\u003c/b\u003e is the outermost layer of the cerebrum, composed of gray matter (neuronal cell bodies). It is responsible for higher-order brain functions, including consciousness, thought, language, memory, and sensation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLobes:\u003c/b\u003e Divided into four main lobes: Frontal, Parietal, Temporal, and Occipital.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctional Regions:\u003c/b\u003e Contains specialized areas for processing different types of information:\u003cbr\u003e - \u003cb\u003eFrontal Lobe:\u003c/b\u003e Motor control (primary motor cortex), executive function (prefrontal cortex), speech production ([[a3bbace2|Broca\u0027s area]]).\u003cbr\u003e - \u003cb\u003eParietal Lobe:\u003c/b\u003e Somatosensation (primary somatosensory cortex), spatial awareness.\u003cbr\u003e - \u003cb\u003eTemporal Lobe:\u003c/b\u003e Audition ([[d24b6af6|auditory cortex]]), language comprehension ([[wernicke_area|Wernicke\u0027s area]]), memory ([[a0590674|hippocampus]]).\u003cbr\u003e - \u003cb\u003eOccipital Lobe:\u003c/b\u003e Vision (primary visual cortex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eArterial Distribution:\u003c/b\u003e Supplied by the [[e51a7691|cerebral arteries]]: [[830c856c|ACA]] (medial), [[143bb23d|MCA]] (lateral), [[b6a2cc31|PCA]] (posterior/inferior).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Syndromes:\u003c/b\u003e Lesions produce specific deficits, e.g., [[6bc9a567|aphasia]] (dominant hemisphere), hemineglect (non-dominant parietal lobe), [[ff289b3a|visual field defects]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The homunculus is a key concept, mapping motor and sensory functions of the body onto the precentral and postcentral gyri, respectively.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCerebral Cortex\u003c/b\u003e is the seat of higher cognition, with its intricately folded surface housing specialized regions for every aspect of conscious experience, from moving a finger to understanding language.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"cerebrum\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"e51a7691\"\n      },\n      {\n        \"type\": \"contains_region\",\n        \"to\": \"a3bbace2\"\n      },\n      {\n        \"type\": \"contains_region\",\n        \"to\": \"wernicke_area\"\n      }\n    ]\n  },\n  \"aa00bdef\": {\n    \"title\": \"Cerebral Edema\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral edema\u003c/b\u003e is the accumulation of excess fluid in the intracellular or extracellular spaces of the brain, leading to an increase in brain volume and intracranial pressure (ICP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVasogenic Edema:\u003c/b\u003e The most common type. Caused by the breakdown of the [[dd47b9cc|blood-brain barrier]], allowing plasma proteins and fluid to leak into the extracellular space. Occurs with tumors, inflammation, and late-stage [[c5da3c57|ischemic stroke]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCytotoxic Edema:\u003c/b\u003e Involves swelling of the brain cells themselves (intracellular edema) due to failure of the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump, leading to an influx of Na\u003csup\u003e+\u003c/sup\u003e and water. Occurs early in [[c5da3c57|ischemic stroke]] and other toxic/metabolic insults.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Consequences:\u003c/b\u003e Increased ICP can cause headache, vomiting, altered consciousness, and can lead to life-threatening [[8c0728b7|brain herniation]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management aims to reduce ICP. This includes head elevation, osmotic therapy (mannitol, hypertonic saline), and \u003cmark\u003etherapeutic hyperventilation\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapeutic Hyperventilation:\u003c/b\u003e Intentionally lowering PaCO\u003csub\u003e2\u003c/sub\u003e causes cerebral vasoconstriction, which reduces cerebral blood flow and thereby decreases ICP. This is a temporary measure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the two main types: Vasogenic \u003d leaky vessels (extracellular fluid), Cytotoxic \u003d sick cells (intracellular fluid).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral edema\u003c/b\u003e is a dangerous swelling of the brain that can be either vasogenic (leaky vessels) or cytotoxic (swollen cells), both of which increase intracranial pressure and risk herniation; management strategies like hyperventilation work by manipulating cerebral blood flow to reduce brain volume.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brain Insult] --\u003e B{Types of Edema}; B --\u003e C[Vasogenic]; C --\u003e D(‚Üë BBB Permeability); D --\u003e E(Extracellular Fluid); B --\u003e F[Cytotoxic]; F --\u003e G(Na+/K+ Pump Failure); G --\u003e H(Intracellular Fluid); E \u0026 H --\u003e I(‚Üë Intracranial Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"e9a47751\"\n      },\n      {\n        \"type\": \"leads_to\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"therapeutic_hyperventilation\"\n      }\n    ]\n  },\n  \"171ca00b\": {\n    \"title\": \"Cerebral Palsy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Pediatric Neurology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral Palsy (CP)\u003c/b\u003e is a non-progressive disorder of movement, muscle tone, or posture caused by damage to the immature, developing brain, most often before birth. It is the most common motor disability in childhood.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e A static (non-progressive) brain lesion that occurs prenatally, perinatally, or in early infancy. Major risk factors include \u003cmark\u003eprematurity\u003c/mark\u003e and low birth weight. Other causes include intrauterine infections, birth asphyxia, and neonatal stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The primary feature is impaired motor function. The type of motor impairment depends on the location of the brain injury:\u003cbr\u003e - \u003cb\u003eSpastic CP (most common):\u003c/b\u003e UMN lesion signs (spasticity, hyperreflexia).\u003cbr\u003e - \u003cb\u003eDyskinetic CP:\u003c/b\u003e Basal ganglia damage (athetosis, chorea).\u003cbr\u003e - \u003cb\u003eAtaxic CP:\u003c/b\u003e Cerebellar damage (ataxia, incoordination).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Patients often have associated comorbidities, including intellectual disability, seizures, and sensory impairments (vision, hearing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is multidisciplinary and supportive, aimed at maximizing function. Treatments for spasticity include physical therapy, oral medications ([[1ddc3f08|baclofen]], tizanidine), and [[84b10400|botulinum toxin]] injections.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Cerebral palsy is a \u003cu\u003enon-progressive\u003c/u\u003e motor disorder. If a child\u0027s motor symptoms are worsening over time, another diagnosis should be considered. Prematurity is the single most important risk factor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral Palsy\u003c/b\u003e is a permanent but non-progressive motor disorder resulting from an early-life brain injury, manifesting as a spectrum of movement and posture problems, with spasticity being the most common presentation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"motor_disorder\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"prematurity\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"84b10400\"\n      }\n    ]\n  },\n  \"3eca3f19\": {\n    \"title\": \"Cerebral Perfusion\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral perfusion\u003c/b\u003e refers to the blood flow to the brain tissue. It is tightly autoregulated to ensure a constant supply of oxygen and glucose, and is primarily driven by the cerebral perfusion pressure (CPP) and influenced by chemical factors, most notably PaCO\u003csub\u003e2\u003c/sub\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCerebral Perfusion Pressure (CPP):\u003c/b\u003e The net pressure gradient driving blood flow to the brain. It is calculated as: \u003cmark\u003eCPP \u003d Mean Arterial Pressure (MAP) - Intracranial Pressure (ICP)\u003c/mark\u003e. A normal CPP is \u003e60 mmHg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutoregulation:\u003c/b\u003e Cerebral blood flow (CBF) is kept relatively constant over a wide range of MAP (approx. 60-140 mmHg). Outside this range, CBF becomes pressure-dependent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChemical Regulation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePaCO\u003csub\u003e2\u003c/sub\u003e:\u003c/b\u003e The most potent regulator of CBF. \u003cmark\u003eHypercapnia (‚Üë PaCO\u003csub\u003e2\u003c/sub\u003e) causes vasodilation\u003c/mark\u003e and ‚Üë CBF. \u003cmark\u003eHypocapnia (‚Üì PaCO\u003csub\u003e2\u003c/sub\u003e) causes vasoconstriction\u003c/mark\u003e and ‚Üì CBF.\u003cbr\u003e - \u003cb\u003ePaO\u003csub\u003e2\u003c/sub\u003e:\u003c/b\u003e Has little effect unless severe hypoxia (PaO\u003csub\u003e2\u003c/sub\u003e \u003c 50 mmHg) occurs, which causes marked vasodilation and ‚Üë CBF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Application:\u003c/b\u003e In patients with increased ICP, \u003cmark\u003etherapeutic hyperventilation\u003c/mark\u003e is used to induce hypocapnia, causing vasoconstriction and a temporary reduction in ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the direct relationship between PaCO\u003csub\u003e2\u003c/sub\u003e and cerebral blood flow. This is the physiological basis for using hyperventilation to manage acute cerebral edema.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral perfusion\u003c/b\u003e is a tightly controlled process where the brain maintains its own blood flow despite fluctuations in systemic pressure, with carbon dioxide levels acting as the most powerful local controller of cerebral vessel diameter.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[MAP] --\u003e B(CPP); C[ICP] --\u003e B; B --\u003e D(Cerebral Blood Flow); E[PaCO2] --Potent Regulator--\u003e D;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_dependent_on\",\n        \"to\": \"5dd5b622\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"paco2\"\n      },\n      {\n        \"type\": \"is_maintained_by\",\n        \"to\": \"autoregulation\"\n      }\n    ]\n  },\n  \"5dd5b622\": {\n    \"title\": \"Cerebral Perfusion Pressure (CPP)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral Perfusion Pressure (CPP)\u003c/b\u003e is the net pressure gradient that drives blood flow to the brain. It is a critical parameter in the management of patients with brain injury, as inadequate CPP can lead to cerebral ischemia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormula:\u003c/b\u003e \u003cmark\u003eCPP \u003d Mean Arterial Pressure (MAP) - Intracranial Pressure (ICP)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Value:\u003c/b\u003e A normal CPP is typically maintained between 60 and 80 mmHg. A CPP below 50-60 mmHg can result in cerebral ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRelationship with CBF:\u003c/b\u003e Cerebral blood flow (CBF) is directly proportional to CPP and inversely proportional to cerebral vascular resistance (CVR). (CBF \u003d CPP / CVR).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Management:\u003c/b\u003e In patients with elevated ICP (e.g., from trauma, hemorrhage, or [[aa00bdef|cerebral edema]]), management focuses on both \u003cmark\u003elowering ICP\u003c/mark\u003e (e.g., mannitol, hyperventilation) and \u003cmark\u003emaintaining an adequate MAP\u003c/mark\u003e (e.g., with vasopressors) to ensure sufficient CPP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the formula. If a patient\u0027s MAP drops or their ICP rises, their CPP will decrease, putting them at risk for brain ischemia. If CPP \u003d 0, there is no cerebral perfusion, which is consistent with [[1777e176|brain death]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral Perfusion Pressure\u003c/b\u003e is the critical driving force for brain blood flow, representing the balance between the systemic pressure pushing blood in (MAP) and the intracranial pressure pushing back (ICP); maintaining this pressure is paramount in neurocritical care.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"determines\",\n        \"to\": \"3eca3f19\"\n      },\n      {\n        \"type\": \"is_calculated_from\",\n        \"to\": \"mean_arterial_pressure\"\n      },\n      {\n        \"type\": \"is_calculated_from\",\n        \"to\": \"intracranial_pressure\"\n      }\n    ]\n  },\n  \"7109d8b6\": {\n    \"title\": \"Cerebrospinal Fluid (CSF)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Diagnostics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebrospinal Fluid (CSF)\u003c/b\u003e is a clear, colorless body fluid found in the brain and spinal cord. It is produced by the choroid plexus, circulates through the ventricular system and subarachnoid space, and is eventually reabsorbed into the venous circulation, providing buoyancy, protection, and chemical stability for the CNS.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eProduction:\u003c/b\u003e Produced by the \u003cmark\u003echoroid plexus\u003c/mark\u003e within the ventricles at a rate of about 20 mL/hr.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCirculation Pathway:\u003c/b\u003e Lateral ventricles ‚Üí foramen of Monro ‚Üí third ventricle ‚Üí [[8a30e721|cerebral aqueduct]] ‚Üí fourth ventricle ‚Üí foramina of Luschka \u0026 Magendie ‚Üí subarachnoid space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReabsorption:\u003c/b\u003e Reabsorbed into the venous circulation via the \u003cmark\u003e[[b7b67074|arachnoid granulations]]\u003c/mark\u003e, which project into the superior sagittal sinus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Composition:\u003c/b\u003e Clear, colorless, with very few cells (\u003c5 lymphocytes/mm\u003csup\u003e3\u003c/sup\u003e), low protein (\u003c45 mg/dL), and glucose that is approximately 2/3 of the serum glucose level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnostic Use:\u003c/b\u003e CSF analysis via lumbar puncture is crucial for diagnosing meningitis, subarachnoid hemorrhage, [[45dd6d19|multiple sclerosis]], and other CNS disorders. For example, [[a0f3ce4c|albuminocytologic dissociation]] is seen in Guillain-Barr√© syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the characteristic CSF findings for different types of meningitis: Bacterial (‚Üë PMNs, ‚Üì glucose, ‚Üë protein), Viral (‚Üë lymphocytes, normal glucose), Fungal/TB (‚Üë lymphocytes, ‚Üì glucose).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebrospinal Fluid\u003c/b\u003e is the brain\u0027s life-support system, providing a protective cushion and a stable chemical environment through a continuous cycle of production by the choroid plexus, circulation through the ventricles, and reabsorption by the arachnoid granulations.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --Production--\u003e B(CSF in Ventricles); B --Circulation--\u003e C(Subarachnoid Space); C --Reabsorption--\u003e D(Arachnoid Granulations); D --\u003e E[Venous Sinuses];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_produced_by\",\n        \"to\": \"choroid_plexus\"\n      },\n      {\n        \"type\": \"is_reabsorbed_by\",\n        \"to\": \"b7b67074\"\n      },\n      {\n        \"type\": \"abnormal_accumulation_causes\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"analysis_diagnoses\",\n        \"to\": \"meningitis\"\n      }\n    ]\n  },\n  \"193c24ec\": {\n    \"title\": \"Chalazion\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Eyelid Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003echalazion\u003c/b\u003e is a common, benign, inflammatory lump in the eyelid caused by a blocked meibomian gland. It is a granulomatous reaction to the lipids that leak from the obstructed gland.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Obstruction of a meibomian gland (a modified sebaceous gland in the tarsal plate) leads to leakage of lipid contents into the surrounding tissue, inciting a \u003cmark\u003egranulomatous inflammatory response\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A firm, rubbery, \u003cmark\u003epainless\u003c/mark\u003e nodule within the eyelid. It is typically slow-growing and not located on the eyelid margin itself.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Hordeolum (Stye):\u003c/b\u003e A [[hordeolum]] is an acute, painful, pyogenic (usually staphylococcal) infection of an eyelid gland, presenting as a tender red bump on the eyelid margin. A chalazion is a non-infectious, painless, granulomatous inflammation located within the eyelid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Most resolve spontaneously with conservative treatment, including \u003cmark\u003ewarm compresses\u003c/mark\u003e and gentle massage to help liquefy the trapped lipids and promote drainage. Persistent or large lesions may require incision and curettage or a glucocorticoid injection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key distinguishing feature from a stye is that a chalazion is \u003cu\u003epainless\u003c/u\u003e and granulomatous, whereas a hordeolum is \u003cu\u003epainful\u003c/u\u003e and infectious.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003echalazion\u003c/b\u003e is a sterile, granulomatous \u0027lump\u0027 resulting from a blocked oil gland in the eyelid, presenting as a painless nodule that is fundamentally an inflammatory reaction, not an infection like a hordeolum.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"eyelid_disorder\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"hordeolum\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"meibomian_gland_obstruction\"\n      }\n    ]\n  },\n  \"cfbd9f68\": {\n    \"title\": \"Charcot Joint (Neuropathic Arthropathy)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Orthopedics\",\n      \"Neurology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Pathology\",\n      \"Arthropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eCharcot joint\u003c/b\u003e, also known as neuropathic arthropathy, is a condition characterized by progressive destruction and deformity of a joint, resulting from a loss of protective sensation (proprioception and pain).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The loss of pain and position sense leads to recurrent, unrecognized microtrauma to the joint. This triggers a cycle of inflammation, bone resorption, and remodeling, ultimately leading to severe joint destruction, instability, and deformity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e Any condition that causes peripheral neuropathy can lead to a Charcot joint. The most common cause is \u003cmark\u003ediabetes mellitus\u003c/mark\u003e (affecting the foot and ankle). Other classic causes include \u003cmark\u003e[[71daebd6|tabes dorsalis]]\u003c/mark\u003e (tertiary syphilis, affecting the knee) and [[syringomyelia]] (affecting the shoulder).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The affected joint is typically swollen, warm, and erythematous, but is often surprisingly painless or has less pain than expected given the degree of destruction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiology:\u003c/b\u003e X-rays show classic findings of severe degenerative changes, bone fragmentation, subluxation, and dislocation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When a question describes a severely deformed, swollen, but relatively painless joint, think of Charcot joint. The next step is to identify the underlying cause of the neuropathy (e.g., diabetes, syphilis).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCharcot joint\u003c/b\u003e is the devastating consequence of a joint that cannot feel pain; without the protective feedback of sensation, repeated trauma leads to a vicious cycle of inflammation and bone destruction, resulting in a grossly deformed and unstable joint.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"diabetes_mellitus\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"syringomyelia\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"loss_of_proprioception\"\n      }\n    ]\n  },\n  \"329c8a70\": {\n    \"title\": \"Charcot-Bouchard Microaneurysm\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Cardiovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCharcot-Bouchard microaneurysms\u003c/b\u003e are minute aneurysms of the small, penetrating (lenticulostriate) arteries in the brain that are strongly associated with chronic hypertension. Their rupture is a major cause of hypertensive [[70b266c8|intraparenchymal hemorrhage]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Chronic hypertension leads to hyaline arteriosclerosis, which weakens the walls of small penetrating arteries, causing them to form small outpouchings (microaneurysms).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly affect the \u003cmark\u003elenticulostriate arteries\u003c/mark\u003e that supply the deep brain structures. Therefore, hemorrhages typically occur in the \u003cmark\u003ebasal ganglia\u003c/mark\u003e (putamen), thalamus, pons, and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Consequence:\u003c/b\u003e Rupture of a Charcot-Bouchard microaneurysm leads to a spontaneous, hypertensive [[70b266c8|intraparenchymal hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e These are distinct from [[a9f6d703|saccular (berry) aneurysms]], which are larger, occur in the Circle of Willis, and cause subarachnoid hemorrhage. Charcot-Bouchard microaneurysms are too small to be seen on angiography.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a long history of poorly controlled hypertension who presents with a sudden focal neurological deficit and a CT scan showing a deep brain hemorrhage (e.g., in the basal ganglia) has likely ruptured a Charcot-Bouchard microaneurysm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCharcot-Bouchard microaneurysms\u003c/b\u003e are the vascular consequence of chronic hypertension on the brain\u0027s smallest arteries; these tiny, fragile aneurysms are prone to rupture, causing devastating deep intracerebral hemorrhages.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Chronic Hypertension] --\u003e B(Hyaline Arteriosclerosis); B --\u003e C(Weakening of Lenticulostriate Arteries); C --\u003e D(Charcot-Bouchard Microaneurysm); D --Rupture--\u003e E(Intraparenchymal Hemorrhage);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"a7f97d7f\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"chronic_hypertension\"\n      },\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a9f6d703\"\n      }\n    ]\n  },\n  \"c3f13d85\": {\n    \"title\": \"Charcot-Marie-Tooth Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCharcot-Marie-Tooth (CMT) disease\u003c/b\u003e, also known as hereditary motor and sensory neuropathy (HMSN), is a group of inherited disorders of the peripheral nervous system characterized by progressive weakness and sensory loss, predominantly affecting the distal extremities.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e The most common inherited neuropathy. It has multiple genetic forms, with the most common type, CMT1A, being an \u003cmark\u003eautosomal dominant\u003c/mark\u003e condition caused by a duplication of the \u003ci\u003ePMP22\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The genetic defects lead to abnormal myelin sheath (demyelinating types like CMT1) or direct axonal damage (axonal types like CMT2). Demyelinating types show \u0027onion bulb\u0027 formations on nerve biopsy due to repeated demyelination and remyelination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Insidious onset, typically in adolescence or early adulthood. Presents with distal muscle weakness and atrophy, starting in the legs. This leads to \u003cmark\u003efoot drop\u003c/mark\u003e, a steppage gait, and characteristic foot deformities like \u003cmark\u003epes cavus\u003c/mark\u003e (high arches) and hammer toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Loss:\u003c/b\u003e There is often a \u0027glove and stocking\u0027 pattern of sensory loss, particularly affecting vibration and proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic presentation is a young patient with progressive distal leg weakness, foot drop, high-arched feet (pes cavus), and sensory loss. The family history is often positive. Mnemonic: \u003cb\u003eC\u003c/b\u003ean\u0027t \u003cb\u003eM\u003c/b\u003eove \u003cb\u003eT\u003c/b\u003eoes for CMT.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCharcot-Marie-Tooth disease\u003c/b\u003e is a genetic neuropathy that slowly \u0027whittles away\u0027 the peripheral nerves, starting from the feet and hands and moving proximally, leading to the classic clinical picture of distal muscle atrophy (stork legs), foot drop, and high-arched feet.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"peripheral_neuropathy\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"pmp22_gene\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"pes_cavus\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"foot_drop\"\n      }\n    ]\n  },\n  \"93f70f8e\": {\n    \"title\": \"Chemoreceptor Trigger Zone (CTZ)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eChemoreceptor Trigger Zone (CTZ)\u003c/b\u003e is a specific area in the brain, synonymous with the [[5dd343d3|area postrema]], that detects emetogenic substances in the blood and relays this information to the vomiting center to induce emesis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the [[5dd343d3|area postrema]] on the floor of the fourth ventricle in the medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier:\u003c/b\u003e It is a circumventricular organ, meaning it lies \u003cmark\u003eoutside the blood-brain barrier\u003c/mark\u003e. This allows it to be directly exposed to and monitor chemicals and toxins circulating in the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Acts as a chemosensor. When it detects emetic stimuli (e.g., chemotherapy drugs, toxins, opioids), it sends signals to the nucleus tractus solitarius (the vomiting center).\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e The CTZ is rich in a variety of receptors, making it a key target for antiemetic drugs. Important receptors include \u003cmark\u003edopamine D\u003csub\u003e2\u003c/sub\u003e\u003c/mark\u003e, \u003cmark\u003eserotonin 5-HT\u003csub\u003e3\u003c/sub\u003e\u003c/mark\u003e, and neurokinin-1 (NK-1).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Chemotherapy-induced nausea and vomiting is largely mediated by the stimulation of 5-HT\u003csub\u003e3\u003c/sub\u003e receptors in the CTZ. This is why 5-HT\u003csub\u003e3\u003c/sub\u003e antagonists like [[ondansetron]] are so effective.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eChemoreceptor Trigger Zone\u003c/b\u003e is the brain\u0027s \u0027vomit surveillance center,\u0027 strategically located outside the blood-brain barrier to detect blood-borne toxins and trigger vomiting as a protective reflex, a mechanism exploited by many antiemetic drugs.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Chemotherapy/Toxins in Blood] --\u003e B(Chemoreceptor Trigger Zone); B --D2, 5-HT3, NK-1 Receptors--\u003e C(Vomiting Center); C --\u003e D(Emesis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"5dd343d3\"\n      },\n      {\n        \"type\": \"is_located_outside\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"activates\",\n        \"to\": \"74b651ab\"\n      },\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"antiemetics\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10260,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"6e31977d\": {\n    \"title"
      }, {
        "text": "\": \"Cerebellar Vermis Lesions\",\n    \"primaryType\": \"pathology\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Neuroanatomy\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Cerebellar Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eLesions of the "
      }, {
        "text": "\u003cb\u003ecerebellar vermis\u003c/b\u003e, the midline portion of the cerebellum, result in a specific set of motor deficits related to the control"
      }, {
        "text": " of the trunk and axial musculature, as well as eye movements.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomical Correlation:\u003c/b\u003e The vermis is centrally located and primarily controls the central body (trunk)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eHallmark Sign:\u003c/b\u003e \u003cmark\u003eTruncal ataxia\u003c/mark\u003e. This manifests as an unsteady, wide-based gait often"
      }, {
        "text": " described as a \\\"drunken sailor\\\" gait. Patients have difficulty sitting or standing upright without swaying or falling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eO"
      }, {
        "text": "cular Signs:\u003c/b\u003e Nystagmus and other impairments of eye movement control are common due to the vermis\u0027s connections with"
      }, {
        "text": " the vestibular nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpeech:\u003c/b\u003e Dysarthria (slurred, uncoordinated speech) can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology"
      }, {
        "text": ":\u003c/b\u003e In adults, degeneration of the vermis is classically associated with \u003cmark\u003echronic alcohol overuse\u003c/mark\u003e. In children, a"
      }, {
        "text": " [[16d613bb|medulloblastoma]] is a common cause of a vermal lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Differentiate vermal lesions from cerebellar hemisphere lesions. Vermis lesion \u003d truncal ataxia (mid"
      }, {
        "text": "line problems). Hemisphere lesion \u003d limb ataxia, intention tremor (lateral problems).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA"
      }, {
        "text": " lesion of the \u003cb\u003ecerebellar vermis\u003c/b\u003e selectively impairs control of the body\u0027s midline, leading to a profound"
      }, {
        "text": " truncal ataxia that makes stable standing and walking difficult, a presentation classically linked to chronic alcoholism in adults or medulloblastoma"
      }, {
        "text": " in children.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_lesion_of\",\n        \"to\": \"bebe58d4\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"causes\",\n        \"to\": \"truncal_ataxia\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"chronic_alcohol_use\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"1"
      }, {
        "text": "6d613bb\"\n      }\n    ]\n  },\n  \"bebe58d"
      }, {
        "text": "4\": {\n    \"title\": \"Cerebellum\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCerebellum\u003c/b\u003e (Latin for \\\"little"
      }, {
        "text": " brain\\\") is a major feature of the hindbrain located posterior to the pons and medulla. It plays a crucial role in modulating"
      }, {
        "text": " motor commands to control balance, coordination, and precision of voluntary movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Modulates movement; aids in coordination, balance, and motor learning. It does not initiate movement but fine-tunes it.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eAnatomical Divisions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eVermis (midline):\u003c/b\u003e Controls axial and"
      }, {
        "text": " proximal limb musculature (truncal stability).\u003cbr\u003e - \u003cb\u003eHemispheres (lateral):\u003c/b\u003e Control"
      }, {
        "text": " distal limb musculature (limb coordination).\u003cbr\u003e - \u003cb\u003eFlocculonodular Lobe:\u003c/b\u003e Involved"
      }, {
        "text": " in balance and eye movements via connections with the vestibular system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput/Output:\u003c/b\u003e Receives proprioceptive input from"
      }, {
        "text": " the spinal cord (ipsilateral) and motor plan input from the contralateral cortex. It sends output to the contralateral cortex via the thalamus to"
      }, {
        "text": " modulate movement. Each cerebellar hemisphere controls the \u003cmark\u003eipsilateral\u003c/mark\u003e side of the body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ions:\u003c/b\u003e Cerebellar lesions cause ipsilateral deficits. \u003cmark\u003eVermal lesions\u003c/mark\u003e cause truncal ataxia. \u003cmark\u003e"
      }, {
        "text": "Hemispheric lesions\u003c/mark\u003e cause limb ataxia, dysmetria, and intention tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " that cerebellar signs are ipsilateral to the lesion. A patient who falls to the left has a left-sided cerebellar lesion.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCerebellum\u003c/b\u003e acts as the brain\u0027s master coordinator,"
      }, {
        "text": " comparing the intended movement from the cortex with the actual movement from proprioceptive feedback, and issuing corrective signals to ensure smooth, balanced"
      }, {
        "text": ", and accurate motor activity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cortex] --Motor"
      }, {
        "text": " Plan--\u003e B(Cerebellum); C[Spinal Cord] --Proprioception--\u003e B; B --Corrective Signals--\u003e A"
      }, {
        "text": ";\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"9"
      }, {
        "text": "767fd6b\"\n      },\n      {\n        \"type\": \"is_part_of\","
      }, {
        "text": "\n        \"to\": \"hindbrain\"\n      },\n      {\n        \"type\": \"receives_input_via"
      }, {
        "text": "\",\n        \"to\": \"cerebellar_peduncles\"\n      },\n      {\n        \"type\": \"s"
      }, {
        "text": "ends_output_via\",\n        \"to\": \"cerebellar_peduncles\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"8a30e721\": {\n    \"title\": \"Cerebral Aqu"
      }, {
        "text": "educt of Sylvius\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Embryology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCerebral Aqueduct\u003c/b\u003e (also"
      }, {
        "text": " known as the Aqueduct of Sylvius) is a narrow channel within the midbrain that connects the third ventricle in the di"
      }, {
        "text": "encephalon to the fourth ventricle in the hindbrain, allowing for the flow of cerebrospinal fluid (CSF).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Traverses the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Serves as a conduit"
      }, {
        "text": " for CSF flow from the third to the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Due to its narrow diameter, the"
      }, {
        "text": " cerebral aqueduct is a common site for obstruction, leading to \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eCauses of Stenosis:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCongenital:\u003c/b\u003e Can be congenitally narrow (aqu"
      }, {
        "text": "eductal stenosis), sometimes as an X-linked condition.\u003cbr\u003e - \u003cb\u003eAcquired:\u003c/b\u003e Can be compressed"
      }, {
        "text": " by tumors (e.g., pinealoma, brainstem glioma) or blocked by inflammation/hemorrhage."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation of Obstruction:\u003c/b\u003e In infants, presents with an enlarging head circumference. In adults, presents with signs of increased"
      }, {
        "text": " intracranial pressure (headache, papilledema, vomiting).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A CT or MRI showing enlarged"
      }, {
        "text": " lateral and third ventricles with a normal-sized fourth ventricle is the classic imaging finding for aqueductal stenosis.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCerebral Aqueduct\u003c/b\u003e is a critical but vulnerable"
      }, {
        "text": " bottleneck in the CSF pathway; its obstruction leads to a backup of CSF and non-communicating hydrocephalus, effectively dam"
      }, {
        "text": "ming the flow between the third and fourth ventricles.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Ventricles"
      }, {
        "text": "] --\u003e B(Third Ventricle); B --\u003e C(Cerebral Aqueduct); C --Obstruction--\u003e D"
      }, {
        "text": "(Non-communicating Hydrocephalus); C --\u003e E(Fourth Ventricle);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"1cb"
      }, {
        "text": "9c975\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"third_"
      }, {
        "text": "ventricle\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\":"
      }, {
        "text": " \"fourth_ventricle\"\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to"
      }, {
        "text": "\": \"0bc2f200\"\n      }\n    ]\n  },\n  \"e51"
      }, {
        "text": "a7691\": {\n    \"title\": \"Cerebral Arteries\",\n    \"primaryType\": \"anatomy\","
      }, {
        "text": "\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and"
      }, {
        "text": " Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eCerebral Arteries\u003c/b\u003e are the network of blood vessels that supply oxygenated blood to the brain."
      }, {
        "text": " They are broadly divided into the anterior circulation (derived from the internal carotid arteries) and the posterior circulation (derived from the vertebral"
      }, {
        "text": " arteries), which are connected by the [[e22300e8|Circle of Willis]].\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterior Circulation:\u003c/b\u003e Includes the [[830c856c|An"
      }, {
        "text": "terior Cerebral Artery (ACA)]] and the [[143bb23d|Middle Cerebral Artery (MCA"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePosterior Circulation:\u003c/b\u003e Includes the vertebral arteries, the [[e7a90cd9"
      }, {
        "text": "|basilar artery]], and the [[b6a2cc31|Posterior Cerebral Artery (PCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Cortical Distribution:\u003c/b\u003e Each major artery supplies a distinct territory of the cerebral cortex:\u003cbr\u003e - \u003cb\u003eACA:\u003c/b\u003e Med"
      }, {
        "text": "ial surface of the frontal and parietal lobes (supplying the leg/foot area of the motor/sensory homunculus).\u003cbr\u003e"
      }, {
        "text": " - \u003cb\u003eMCA:\u003c/b\u003e Lateral surface of the hemispheres (supplying the face/arm/hand area and language centers"
      }, {
        "text": ").\u003cbr\u003e - \u003cb\u003ePCA:\u003c/b\u003e Occipital lobe and inferior surface of the temporal lobe (supplying the visual cortex"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eWatershed Zones:\u003c/b\u003e Areas at the border between two major arterial territories (e.g., ACA"
      }, {
        "text": "-MCA) are vulnerable to ischemia during systemic hypoperfusion, leading to watershed infarcts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Knowing"
      }, {
        "text": " the cortical distribution of the ACA, MCA, and PCA is essential for localizing stroke lesions from clinical symptoms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe brain\u0027s arterial supply is precisely organized, with the \u003cb\u003ecerebral arteries\u003c/b\u003e each"
      }, {
        "text": " irrigating specific functional territories; this anatomical consistency allows clinicians to predict the location of a stroke based on the patient\u0027s neurological deficits.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Circle of Willis] --\u003e B(Anterior Cerebral Artery); A"
      }, {
        "text": " --\u003e C(Middle Cerebral Artery); A --\u003e D(Posterior Cerebral Artery);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"e2230"
      }, {
        "text": "0e8\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"830c"
      }, {
        "text": "856c\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"143bb23d\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"b6a2cc31\"\n      }\n    ]\n  },\n  \"a"
      }, {
        "text": "1b198f9\": {\n    \"title\": \"Cerebral Cortex\",\n    \"primaryType\": \"anatomy\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eCerebral Cortex\u003c/b\u003e is the outermost layer of the cerebrum, composed of gray matter (neuronal cell bodies)."
      }, {
        "text": " It is responsible for higher-order brain functions, including consciousness, thought, language, memory, and sensation.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLobes:\u003c/b\u003e Divided into four main lobes: Frontal, Parietal, Temporal, and Occ"
      }, {
        "text": "ipital.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctional Regions:\u003c/b\u003e Contains specialized areas for processing different types of information:\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eFrontal Lobe:\u003c/b\u003e Motor control (primary motor cortex), executive function (prefrontal cortex), speech production ([["
      }, {
        "text": "a3bbace2|Broca\u0027s area]]).\u003cbr\u003e - \u003cb\u003eParietal Lobe:\u003c/b\u003e Som"
      }, {
        "text": "atosensation (primary somatosensory cortex), spatial awareness.\u003cbr\u003e - \u003cb\u003eTemporal Lobe:\u003c/b\u003e Audition"
      }, {
        "text": " ([[d24b6af6|auditory cortex]]), language comprehension ([[wernicke_area|Wernicke\u0027s area]]), memory"
      }, {
        "text": " ([[a0590674|hippocampus]]).\u003cbr\u003e - \u003cb\u003eOccipital Lobe"
      }, {
        "text": ":\u003c/b\u003e Vision (primary visual cortex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eArterial Distribution:\u003c/b\u003e Supplied by the [[e51a7691|cere"
      }, {
        "text": "bral arteries]]: [[830c856c|ACA]] (medial), [[143bb23d"
      }, {
        "text": "|MCA]] (lateral), [[b6a2cc31|PCA]] (posterior/inferior).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Syndromes:\u003c/b\u003e Lesions produce specific deficits, e.g., [[6bc9a567|ap"
      }, {
        "text": "hasia]] (dominant hemisphere), hemineglect (non-dominant parietal lobe), [[ff289b"
      }, {
        "text": "3a|visual field defects]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The homunculus is a key concept, mapping"
      }, {
        "text": " motor and sensory functions of the body onto the precentral and postcentral gyri, respectively.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eCerebral Cortex\u003c/b\u003e is the seat of higher cognition, with its intricately folded surface housing specialized regions for"
      }, {
        "text": " every aspect of conscious experience, from moving a finger to understanding language.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"cerebrum\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"e51a7691\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"contains_region\",\n        \"to\": \"a3bbace2\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"contains_region\",\n        \"to\": \"wernicke_area"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"aa00bdef\": {\n    \"title\":"
      }, {
        "text": " \"Cerebral Edema\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Pathology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebro"
      }, {
        "text": "vascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral edema\u003c/b\u003e is the accumulation"
      }, {
        "text": " of excess fluid in the intracellular or extracellular spaces of the brain, leading to an increase in brain volume and intracranial pressure ("
      }, {
        "text": "ICP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVasogenic Edema:\u003c/b\u003e The most common type."
      }, {
        "text": " Caused by the breakdown of the [[dd47b9cc|blood-brain barrier]], allowing plasma proteins and fluid to leak into"
      }, {
        "text": " the extracellular space. Occurs with tumors, inflammation, and late-stage [[c5da3c57|ische"
      }, {
        "text": "mic stroke]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCytotoxic Edema:\u003c/b\u003e Involves swelling of the brain cells themselves (intracellular edema"
      }, {
        "text": ") due to failure of the Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump, leading to an influx of Na\u003csup\u003e+\u003c/sup\u003e and water"
      }, {
        "text": ". Occurs early in [[c5da3c57|ischemic stroke]] and other toxic/metabolic insults"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Consequences:\u003c/b\u003e Increased ICP can cause headache, vomiting, altered consciousness, and can lead to life-threatening [[8"
      }, {
        "text": "c0728b7|brain herniation]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management aims to reduce ICP."
      }, {
        "text": " This includes head elevation, osmotic therapy (mannitol, hypertonic saline), and \u003cmark\u003etherapeutic hyperventilation\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapeutic Hyperventilation:\u003c/b\u003e Intentionally lowering PaCO\u003csub\u003e2\u003c/sub\u003e causes cerebral vasoconstriction, which reduces"
      }, {
        "text": " cerebral blood flow and thereby decreases ICP. This is a temporary measure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the"
      }, {
        "text": " two main types: Vasogenic \u003d leaky vessels (extracellular fluid), Cytotoxic \u003d sick cells (intracellular fluid).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCerebral edema\u003c/b\u003e is a dangerous swelling of the brain that"
      }, {
        "text": " can be either vasogenic (leaky vessels) or cytotoxic (swollen cells), both of which increase intracranial pressure and risk"
      }, {
        "text": " herniation; management strategies like hyperventilation work by manipulating cerebral blood flow to reduce brain volume.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Brain Insult] --\u003e B{Types of Edema}; B --\u003e C[Vasogenic];"
      }, {
        "text": " C --\u003e D(‚Üë BBB Permeability); D --\u003e E(Extracellular Fluid); B --\u003e F[Cytotoxic]; F"
      }, {
        "text": " --\u003e G(Na+/K+ Pump Failure); G --\u003e H(Intracellular Fluid); E \u0026 H --\u003e I(‚Üë"
      }, {
        "text": " Intracranial Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "complication_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_complication_of\",\n        \"to\": \"e9a47"
      }, {
        "text": "751\"\n      },\n      {\n        \"type\": \"leads_to\",\n        \"to\":"
      }, {
        "text": " \"8c0728b7\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "treated_by\",\n        \"to\": \"therapeutic_hyperventilation\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"171ca00b\": {\n    \"title\": \"Cerebral Palsy\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Pediatric Neurology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCerebral Palsy (CP)\u003c/b\u003e is a non-progressive disorder of movement, muscle tone, or"
      }, {
        "text": " posture caused by damage to the immature, developing brain, most often before birth. It is the most common motor disability in childhood.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e A static (non-progressive) brain lesion that"
      }, {
        "text": " occurs prenatally, perinatally, or in early infancy. Major risk factors include \u003cmark\u003eprematurity\u003c/mark\u003e and low"
      }, {
        "text": " birth weight. Other causes include intrauterine infections, birth asphyxia, and neonatal stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The"
      }, {
        "text": " primary feature is impaired motor function. The type of motor impairment depends on the location of the brain injury:\u003cbr\u003e - \u003cb\u003eSpastic"
      }, {
        "text": " CP (most common):\u003c/b\u003e UMN lesion signs (spasticity, hyperreflexia).\u003cbr\u003e - \u003cb\u003eDyskinetic CP"
      }, {
        "text": ":\u003c/b\u003e Basal ganglia damage (athetosis, chorea).\u003cbr\u003e - \u003cb\u003eAtaxic CP:\u003c/b\u003e Cere"
      }, {
        "text": "bellar damage (ataxia, incoordination).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Patients often have associated comorbidities, including intellectual disability, seizures,"
      }, {
        "text": " and sensory impairments (vision, hearing).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is multidisciplinary and supportive, aimed at maximizing"
      }, {
        "text": " function. Treatments for spasticity include physical therapy, oral medications ([[1ddc3f08|baclofen]],"
      }, {
        "text": " tizanidine), and [[84b10400|botulinum toxin]] injections.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Cerebral palsy is a \u003cu\u003enon-progressive\u003c/u\u003e motor disorder. If a child\u0027s motor symptoms are worsening over time, another"
      }, {
        "text": " diagnosis should be considered. Prematurity is the single most important risk factor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eCerebral Palsy\u003c/b\u003e is a permanent but non-progressive motor disorder resulting from an early-life brain injury, manifesting"
      }, {
        "text": " as a spectrum of movement and posture problems, with spasticity being the most common presentation.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"motor_disorder\"\n      },\n      {\n        \"type\": \"is_associated_with"
      }, {
        "text": "\",\n        \"to\": \"prematurity\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "treated_by\",\n        \"to\": \"1ddc3f08\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_treated_by\",\n        \"to\": \"84b104"
      }, {
        "text": "00\"\n      }\n    ]\n  },\n  \"3eca3f19\": {\n    \"title"
      }, {
        "text": "\": \"Cerebral Perfusion\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "physiology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral perfusion\u003c/b\u003e refers to the blood flow to the brain tissue"
      }, {
        "text": ". It is tightly autoregulated to ensure a constant supply of oxygen and glucose, and is primarily driven by the cerebral"
      }, {
        "text": " perfusion pressure (CPP) and influenced by chemical factors, most notably PaCO\u003csub\u003e2\u003c/sub\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eCerebral Perfusion Pressure (CPP):\u003c/b\u003e The net pressure gradient driving blood flow to the brain. It"
      }, {
        "text": " is calculated as: \u003cmark\u003eCPP \u003d Mean Arterial Pressure (MAP) - Intracranial Pressure (ICP)\u003c/"
      }, {
        "text": "mark\u003e. A normal CPP is \u003e60 mmHg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutoregulation:\u003c/b\u003e Cerebral blood flow (CBF) is kept relatively constant over"
      }, {
        "text": " a wide range of MAP (approx. 60-140 mmHg). Outside this range, CBF becomes pressure"
      }, {
        "text": "-dependent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChemical Regulation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePaCO\u003csub\u003e2\u003c/sub\u003e:\u003c/b\u003e The"
      }, {
        "text": " most potent regulator of CBF. \u003cmark\u003eHypercapnia (‚Üë PaCO\u003csub\u003e2\u003c/sub\u003e) causes vasodilation\u003c/mark\u003e"
      }, {
        "text": " and ‚Üë CBF. \u003cmark\u003eHypocapnia (‚Üì PaCO\u003csub\u003e2\u003c/sub\u003e) causes vasoconstriction\u003c/mark\u003e and ‚Üì CBF"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003ePaO\u003csub\u003e2\u003c/sub\u003e:\u003c/b\u003e Has little effect unless severe hypoxia (PaO\u003csub\u003e2\u003c/sub\u003e \u003c 5"
      }, {
        "text": "0 mmHg) occurs, which causes marked vasodilation and ‚Üë CBF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Application:\u003c/b\u003e In patients"
      }, {
        "text": " with increased ICP, \u003cmark\u003etherapeutic hyperventilation\u003c/mark\u003e is used to induce hypocapnia, causing vasoconstriction and a"
      }, {
        "text": " temporary reduction in ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the direct relationship between PaCO\u003csub\u003e2\u003c/sub\u003e and cerebral"
      }, {
        "text": " blood flow. This is the physiological basis for using hyperventilation to manage acute cerebral edema.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCerebral perfusion\u003c/b\u003e is a tightly controlled process where the brain maintains its own blood flow despite"
      }, {
        "text": " fluctuations in systemic pressure, with carbon dioxide levels acting as the most powerful local controller of cerebral vessel diameter.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[MAP] --\u003e B(CPP); C[ICP] --\u003e B; B --\u003e D(Cerebral Blood"
      }, {
        "text": " Flow); E[PaCO2] --Potent Regulator--\u003e D;\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_dependent_on\",\n        \"to\": \"5dd5b622\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_regulated_by\",\n        \"to\": \"paco2\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_maintained_by\",\n        \"to\": \"autoregulation\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"5dd5b622\": {\n    \"title\": \"C"
      }, {
        "text": "erebral Perfusion Pressure (CPP)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurophysiology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebral Perfusion Pressure (CPP"
      }, {
        "text": ")\u003c/b\u003e is the net pressure gradient that drives blood flow to the brain. It is a critical parameter in the management of patients with brain"
      }, {
        "text": " injury, as inadequate CPP can lead to cerebral ischemia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFormula"
      }, {
        "text": ":\u003c/b\u003e \u003cmark\u003eCPP \u003d Mean Arterial Pressure (MAP) - Intracranial Pressure (ICP)\u003c/mark\u003e.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eNormal Value:\u003c/b\u003e A normal CPP is typically maintained between 60 and 80 mmHg. A CPP"
      }, {
        "text": " below 50-60 mmHg can result in cerebral ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRelationship with CBF:\u003c/b\u003e Cerebral"
      }, {
        "text": " blood flow (CBF) is directly proportional to CPP and inversely proportional to cerebral vascular resistance (CVR). (CBF \u003d CPP / C"
      }, {
        "text": "VR).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Management:\u003c/b\u003e In patients with elevated ICP (e.g., from trauma, hemorrhage,"
      }, {
        "text": " or [[aa00bdef|cerebral edema]]), management focuses on both \u003cmark\u003elowering ICP\u003c/mark\u003e (e.g., mannitol"
      }, {
        "text": ", hyperventilation) and \u003cmark\u003emaintaining an adequate MAP\u003c/mark\u003e (e.g., with vasopressors) to"
      }, {
        "text": " ensure sufficient CPP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the formula. If a patient\u0027s MAP drops or their ICP rises"
      }, {
        "text": ", their CPP will decrease, putting them at risk for brain ischemia. If CPP \u003d 0, there is no cerebral perfusion"
      }, {
        "text": ", which is consistent with [[1777e176|brain death]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCerebral Perfusion Pressure\u003c/b\u003e is the critical driving force for brain blood flow, representing the balance between the systemic"
      }, {
        "text": " pressure pushing blood in (MAP) and the intracranial pressure pushing back (ICP); maintaining this pressure is paramount in neurocritical care.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"determines\","
      }, {
        "text": "\n        \"to\": \"3eca3f19\"\n      },\n      {\n        \"type\": \"is_calculated_from\","
      }, {
        "text": "\n        \"to\": \"mean_arterial_pressure\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_calculated_from\",\n        \"to\": \"intracranial_pressure\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"7109d8b6\": {\n    \"title\": \"Cerebro"
      }, {
        "text": "spinal Fluid (CSF)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Physiology\",\n      \"Diagnostics\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCerebrospinal Fluid"
      }, {
        "text": " (CSF)\u003c/b\u003e is a clear, colorless body fluid found in the brain and spinal cord. It is produced by the chor"
      }, {
        "text": "oid plexus, circulates through the ventricular system and subarachnoid space, and is eventually reabsorbed into the venous"
      }, {
        "text": " circulation, providing buoyancy, protection, and chemical stability for the CNS.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eProduction:"
      }, {
        "text": "\u003c/b\u003e Produced by the \u003cmark\u003echoroid plexus\u003c/mark\u003e within the ventricles at a rate of about 2"
      }, {
        "text": "0 mL/hr.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCirculation Pathway:\u003c/b\u003e Lateral ventricles ‚Üí foramen of Monro ‚Üí third ventricle ‚Üí [["
      }, {
        "text": "8a30e721|cerebral aqueduct]] ‚Üí fourth ventricle ‚Üí foramina of Luschka \u0026"
      }, {
        "text": " Magendie ‚Üí subarachnoid space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReabsorption:\u003c/b\u003e Reabsorbed into the venous circulation via the \u003cmark\u003e[["
      }, {
        "text": "b7b67074|arachnoid granulations]]\u003c/mark\u003e, which project into the superior sagittal sinus."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Composition:\u003c/b\u003e Clear, colorless, with very few cells (\u003c5 lymphocytes/mm\u003csup\u003e3\u003c/sup\u003e), low"
      }, {
        "text": " protein (\u003c45 mg/dL), and glucose that is approximately 2/3 of the serum glucose level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnostic"
      }, {
        "text": " Use:\u003c/b\u003e CSF analysis via lumbar puncture is crucial for diagnosing meningitis, subarachnoid hemorrhage, [[45dd6"
      }, {
        "text": "d19|multiple sclerosis]], and other CNS disorders. For example, [[a0f3ce4c|albumin"
      }, {
        "text": "ocytologic dissociation]] is seen in Guillain-Barr√© syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the characteristic"
      }, {
        "text": " CSF findings for different types of meningitis: Bacterial (‚Üë PMNs, ‚Üì glucose, ‚Üë protein), Viral (‚Üë lymphocytes"
      }, {
        "text": ", normal glucose), Fungal/TB (‚Üë lymphocytes, ‚Üì glucose).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Cerebrospinal Fluid\u003c/b\u003e is the brain\u0027s life-support system, providing a protective cushion and a stable chemical"
      }, {
        "text": " environment through a continuous cycle of production by the choroid plexus, circulation through the ventricles, and reabsorption by the arach"
      }, {
        "text": "noid granulations.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --"
      }, {
        "text": "Production--\u003e B(CSF in Ventricles); B --Circulation--\u003e C(Subarachnoid Space); C"
      }, {
        "text": " --Reabsorption--\u003e D(Arachnoid Granulations); D --\u003e E[Venous Sinuses];\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_produced_by\",\n        \"to\": \""
      }, {
        "text": "choroid_plexus\"\n      },\n      {\n        \"type\": \"is_reabsorbed_by"
      }, {
        "text": "\",\n        \"to\": \"b7b67074\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"abnormal_accumulation_causes\",\n        \"to\": \"0bc2f200"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"analysis_diagnoses\",\n        \"to\": \""
      }, {
        "text": "meningitis\"\n      }\n    ]\n  },\n  \"193c24ec\": {\n    \"title\": \""
      }, {
        "text": "Chalazion\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"D"
      }, {
        "text": "ermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Eyelid Disorders\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eA \u003cb\u003echalazion\u003c/b\u003e is a common, benign, inflammatory lump in the eyelid caused"
      }, {
        "text": " by a blocked meibomian gland. It is a granulomatous reaction to the lipids that leak from the obstructed gland.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Obstruction of a meibomian gland"
      }, {
        "text": " (a modified sebaceous gland in the tarsal plate) leads to leakage of lipid contents into the surrounding tissue, inciting"
      }, {
        "text": " a \u003cmark\u003egranulomatous inflammatory response\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A firm, rubbery, \u003c"
      }, {
        "text": "mark\u003epainless\u003c/mark\u003e nodule within the eyelid. It is typically slow-growing and not located on the eyelid"
      }, {
        "text": " margin itself.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Hordeolum (Stye):\u003c/b\u003e A [[hordeolum]] is an"
      }, {
        "text": " acute, painful, pyogenic (usually staphylococcal) infection of an eyelid gland, presenting as a tender red bump"
      }, {
        "text": " on the eyelid margin. A chalazion is a non-infectious, painless, granulomatous inflammation located within the eyelid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": ":\u003c/b\u003e Most resolve spontaneously with conservative treatment, including \u003cmark\u003ewarm compresses\u003c/mark\u003e and gentle massage to help liquef"
      }, {
        "text": "y the trapped lipids and promote drainage. Persistent or large lesions may require incision and curettage or a glucocorticoid injection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The key distinguishing feature from a stye is that a chalazion is \u003cu\u003epainless\u003c/u\u003e and"
      }, {
        "text": " granulomatous, whereas a hordeolum is \u003cu\u003epainful\u003c/u\u003e and infectious.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eA \u003cb\u003echalazion\u003c/b\u003e is a sterile, granulomatous \u0027lump\u0027 resulting from a blocked oil"
      }, {
        "text": " gland in the eyelid, presenting as a painless nodule that is fundamentally an inflammatory reaction, not an infection like a hordeolum.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"eyelid_disorder\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"differentiated_from\",\n        \"to\": \"hordeolum\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_caused_by\",\n        \"to\": \"meibomian_gland_obstruction\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"cfbd9f68\": {\n    \"title\": \"Charcot Joint"
      }, {
        "text": " (Neuropathic Arthropathy)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Orth"
      }, {
        "text": "opedics\",\n      \"Neurology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Pathology\",\n      \"Arth"
      }, {
        "text": "ropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eChar"
      }, {
        "text": "cot joint\u003c/b\u003e, also known as neuropathic arthropathy, is a condition characterized by progressive destruction and deformity of a joint, resulting"
      }, {
        "text": " from a loss of protective sensation (proprioception and pain).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e The loss of pain and position sense leads to recurrent, unrecognized microtrauma to the joint. This"
      }, {
        "text": " triggers a cycle of inflammation, bone resorption, and remodeling, ultimately leading to severe joint destruction, instability, and deformity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon"
      }, {
        "text": " Causes:\u003c/b\u003e Any condition that causes peripheral neuropathy can lead to a Charcot joint. The most common cause is \u003cmark\u003ediabetes mellitus\u003c/mark\u003e"
      }, {
        "text": " (affecting the foot and ankle). Other classic causes include \u003cmark\u003e[[71daebd6|tabes dorsalis]]\u003c/"
      }, {
        "text": "mark\u003e (tertiary syphilis, affecting the knee) and [[syringomyelia]] (affecting the shoulder"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The affected joint is typically swollen, warm, and erythematous, but is often"
      }, {
        "text": " surprisingly painless or has less pain than expected given the degree of destruction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiology:\u003c/b\u003e X-rays show"
      }, {
        "text": " classic findings of severe degenerative changes, bone fragmentation, subluxation, and dislocation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " When a question describes a severely deformed, swollen, but relatively painless joint, think of Charcot joint. The next step is to identify the underlying cause of"
      }, {
        "text": " the neuropathy (e.g., diabetes, syphilis).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eChar"
      }, {
        "text": "cot joint\u003c/b\u003e is the devastating consequence of a joint that cannot feel pain; without the protective feedback of sensation, repeated trauma"
      }, {
        "text": " leads to a vicious cycle of inflammation and bone destruction, resulting in a grossly deformed and unstable joint.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "complication_of\",\n        \"to\": \"diabetes_mellitus\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_complication_of\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_complication_of\",\n        \"to\": \"syringomyelia\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"loss_of"
      }, {
        "text": "_proprioception\"\n      }\n    ]\n  },\n  \"329c8a70\": {\n    \"title"
      }, {
        "text": "\": \"Charcot-Bouchard Microaneurysm\",\n    \"primaryType\": \"pathology\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Cardiovascular\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"C"
      }, {
        "text": "erebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCharcot-Bouchard microane"
      }, {
        "text": "urysms\u003c/b\u003e are minute aneurysms of the small, penetrating (lenticulostriate) arteries in the brain that"
      }, {
        "text": " are strongly associated with chronic hypertension. Their rupture is a major cause of hypertensive [[70b266c8"
      }, {
        "text": "|intraparenchymal hemorrhage]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Chronic"
      }, {
        "text": " hypertension leads to hyaline arteriosclerosis, which weakens the walls of small penetrating arteries, causing them to form small outpouchings (microaneurysms"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly affect the \u003cmark\u003elenticulostriate arteries\u003c/mark\u003e that supply the deep"
      }, {
        "text": " brain structures. Therefore, hemorrhages typically occur in the \u003cmark\u003ebasal ganglia\u003c/mark\u003e (putamen), thalam"
      }, {
        "text": "us, pons, and cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Consequence:\u003c/b\u003e Rupture of a Charcot-Bouchard microaneur"
      }, {
        "text": "ysm leads to a spontaneous, hypertensive [[70b266c8|intraparenchymal hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferent"
      }, {
        "text": "iation:\u003c/b\u003e These are distinct from [[a9f6d703|saccular (berry) aneurysms]],"
      }, {
        "text": " which are larger, occur in the Circle of Willis, and cause subarachnoid hemorrhage. Charcot-Bouchard microaneur"
      }, {
        "text": "ysms are too small to be seen on angiography.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a long"
      }, {
        "text": " history of poorly controlled hypertension who presents with a sudden focal neurological deficit and a CT scan showing a deep brain hemorrhage (e.g., in the basal ganglia"
      }, {
        "text": ") has likely ruptured a Charcot-Bouchard microaneurysm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCharcot-Bouchard microaneurysms\u003c/b\u003e are the vascular consequence of chronic hypertension on"
      }, {
        "text": " the brain\u0027s smallest arteries; these tiny, fragile aneurysms are prone to rupture, causing devastating deep intracerebral hemorrhages.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Chronic Hypertension] --\u003e B(Hyaline Arteriosclerosis); B --\u003e C(Weak"
      }, {
        "text": "ening of Lenticulostriate Arteries); C --\u003e D(Charcot-Bouchard Microaneurysm); D --"
      }, {
        "text": "Rupture--\u003e E(Intraparenchymal Hemorrhage);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"a7f97d"
      }, {
        "text": "7f\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \""
      }, {
        "text": "to\": \"chronic_hypertension\"\n      },\n      {\n        \"type\": \"rupture_causes"
      }, {
        "text": "\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"differentiated_from\",\n        \"to\": \"a9f6d703\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"c3f13d85\": {\n    \"title\":"
      }, {
        "text": " \"Charcot-Marie-Tooth Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Genetics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCharcot-Marie-Tooth (CMT) disease\u003c/b\u003e,"
      }, {
        "text": " also known as hereditary motor and sensory neuropathy (HMSN), is a group of inherited disorders of the peripheral nervous system characterized by"
      }, {
        "text": " progressive weakness and sensory loss, predominantly affecting the distal extremities.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGen"
      }, {
        "text": "etics:\u003c/b\u003e The most common inherited neuropathy. It has multiple genetic forms, with the most common type, CMT1A"
      }, {
        "text": ", being an \u003cmark\u003eautosomal dominant\u003c/mark\u003e condition caused by a duplication of the \u003ci\u003ePMP22\u003c/i\u003e"
      }, {
        "text": " gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The genetic defects lead to abnormal myelin sheath (demyelinating types like"
      }, {
        "text": " CMT1) or direct axonal damage (axonal types like CMT2). Demyelinating types show \u0027onion bulb\u0027 formations"
      }, {
        "text": " on nerve biopsy due to repeated demyelination and remyelination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Insidious onset, typically in adolescence"
      }, {
        "text": " or early adulthood. Presents with distal muscle weakness and atrophy, starting in the legs. This leads to \u003cmark\u003efoot drop"
      }, {
        "text": "\u003c/mark\u003e, a steppage gait, and characteristic foot deformities like \u003cmark\u003epes cavus\u003c/mark\u003e (high arches"
      }, {
        "text": ") and hammer toes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Loss:\u003c/b\u003e There is often a \u0027glove and stocking\u0027 pattern"
      }, {
        "text": " of sensory loss, particularly affecting vibration and proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic presentation is a young"
      }, {
        "text": " patient with progressive distal leg weakness, foot drop, high-arched feet (pes cavus), and sensory loss."
      }, {
        "text": " The family history is often positive. Mnemonic: \u003cb\u003eC\u003c/b\u003ean\u0027t \u003cb\u003eM\u003c/b\u003eove \u003cb\u003eT\u003c/b\u003eoes"
      }, {
        "text": " for CMT.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCharcot-Marie-Tooth disease\u003c/b\u003e is a genetic"
      }, {
        "text": " neuropathy that slowly \u0027whittles away\u0027 the peripheral nerves, starting from the feet and hands and moving proximally, leading to the"
      }, {
        "text": " classic clinical picture of distal muscle atrophy (stork legs), foot drop, and high-arched feet.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"peripheral_neuropathy\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"pmp22_"
      }, {
        "text": "gene\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\":"
      }, {
        "text": " \"pes_cavus\"\n      },\n      {\n        \"type\": \"presents_with\",\n"
      }, {
        "text": "        \"to\": \"foot_drop\"\n      }\n    ]\n  },\n  \"93f7"
      }, {
        "text": "0f8e\": {\n    \"title\": \"Chemoreceptor Trigger Zone (CTZ)\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eChemoreceptor Trigger Zone (CTZ)\u003c/b\u003e is a specific area in the brain, synonymous"
      }, {
        "text": " with the [[5dd343d3|area postrema]], that detects emetogenic substances in the blood and relays"
      }, {
        "text": " this information to the vomiting center to induce emesis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Located in the [[5dd343d3|area postrema]] on the floor of the fourth ventricle in"
      }, {
        "text": " the medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier:\u003c/b\u003e It is a circumventricular organ, meaning it lies \u003c"
      }, {
        "text": "mark\u003eoutside the blood-brain barrier\u003c/mark\u003e. This allows it to be directly exposed to and monitor chemicals and toxins circulating"
      }, {
        "text": " in the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Acts as a chemosensor. When it detects emetic stimuli (e.g., chemotherapy"
      }, {
        "text": " drugs, toxins, opioids), it sends signals to the nucleus tractus solitarius (the vomiting center).\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e The"
      }, {
        "text": " CTZ is rich in a variety of receptors, making it a key target for antiemetic drugs. Important receptors include \u003c"
      }, {
        "text": "mark\u003edopamine D\u003csub\u003e2\u003c/sub\u003e\u003c/mark\u003e, \u003cmark\u003eserotonin 5-HT\u003csub\u003e3\u003c/sub\u003e\u003c/mark"
      }, {
        "text": "\u003e, and neurokinin-1 (NK-1).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Chemotherapy-induced nausea and vomiting is"
      }, {
        "text": " largely mediated by the stimulation of 5-HT\u003csub\u003e3\u003c/sub\u003e receptors in the CTZ. This is why 5-HT\u003csub\u003e3\u003c/sub\u003e antagonists like"
      }, {
        "text": " [[ondansetron]] are so effective.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eChemoreceptor Trigger Zone\u003c/b\u003e"
      }, {
        "text": " is the brain\u0027s \u0027vomit surveillance center,\u0027 strategically located outside the blood-brain barrier to detect blood-borne toxins and"
      }, {
        "text": " trigger vomiting as a protective reflex, a mechanism exploited by many antiemetic drugs.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[Chemotherapy/Toxins in Blood] --\u003e B(Chemoreceptor Trigger Zone); B --D2"
      }, {
        "text": ", 5-HT3, NK-1 Receptors--\u003e C(Vomiting Center); C --\u003e D(E"
      }, {
        "text": "mesis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous"
      }, {
        "text": "_with\",\n        \"to\": \"5dd343d3\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_outside\",\n        \"to\": \"dd47b9cc\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"activates\",\n        \"to\": \"74b6"
      }, {
        "text": "51ab\"\n      },\n      {\n        \"type\": \"is_target_of\",\n        \"to\":"
      }, {
        "text": " \"antiemetics\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1I6bOHzY5A0RUEcIcZZvYbDeiRnAoSHID"
      },
      "role": "user",
      "tokenCount": 2085
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"cf4c1530\": {\n    \"title\": \"Chemotherapy-Induced Nausea and Vomiting (CINV)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Oncology\",\n      \"Pharmacology\",\n      \"Gastroenterology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Antiemetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChemotherapy-Induced Nausea and Vomiting (CINV)\u003c/b\u003e is a common and distressing side effect of many cytotoxic cancer therapies. It is mediated by both central and peripheral pathways that stimulate the [[74b651ab|vomiting center]] in the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAcute CINV:\u003c/b\u003e Occurs within 24 hours. Primarily mediated by the release of \u003cmark\u003eserotonin (5-HT)\u003c/mark\u003e from enterochromaffin cells in the GI tract, which stimulates vagal afferents and the [[93f70f8e|chemoreceptor trigger zone (CTZ)]].\u003cbr\u003e - \u003cb\u003eDelayed CINV:\u003c/b\u003e Occurs after 24 hours. Primarily mediated by \u003cmark\u003esubstance P\u003c/mark\u003e binding to neurokinin-1 (NK-1) receptors in the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Acute CINV):\u003c/b\u003e The mainstay of treatment is \u003cmark\u003e5-HT\u003csub\u003e3\u003c/sub\u003e receptor antagonists\u003c/mark\u003e (e.g., [[ondansetron]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Delayed CINV):\u003c/b\u003e The mainstay of treatment is \u003cmark\u003eNK-1 receptor antagonists\u003c/mark\u003e (e.g., aprepitant).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCombination Therapy:\u003c/b\u003e High-emetogenic chemotherapy regimens are often treated prophylactically with a combination of a 5-HT\u003csub\u003e3\u003c/sub\u003e antagonist, an NK-1 antagonist, and a corticosteroid (e.g., dexamethasone).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the two main pathways and their primary mediators: Acute CINV is driven by serotonin (target with ondansetron), while delayed CINV is driven by substance P (target with aprepitant).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe management of \u003cb\u003eChemotherapy-Induced Nausea and Vomiting\u003c/b\u003e is a targeted pharmacological approach based on its biphasic pathophysiology; the acute phase is blocked by serotonin antagonists, while the delayed phase is prevented by substance P/NK-1 antagonists.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Chemotherapy] --\u003e B(GI Tract Damage); B --\u003e C(Serotonin Release); C --\u003e D(Vagal Afferents \u0026 CTZ); D --\u003e E(Acute Vomiting); A --\u003e F(CNS Effects); F --\u003e G(Substance P Release); G --\u003e H(NK-1 Receptors); H --\u003e I(Delayed Vomiting);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"93f70f8e\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"ondansetron\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"aprepitant\"\n      }\n    ]\n  },\n  \"651ed480\": {\n    \"title\": \"Cherry-Red Spot on Macula\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Metabolic Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003echerry-red spot\u003c/b\u003e is a descriptive term for the fundoscopic finding of a small, circular reddish area at the fovea, surrounded by a pale retina. This sign is indicative of pathology in the retinal ganglion cell layer, which is absent at the fovea.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e The fovea appears red because its normal choroidal circulation is visible and contrasts sharply with the surrounding pale, edematous, or lipid-laden retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIschemic Cause:\u003c/b\u003e The most common cause is \u003cmark\u003e[[3334840f|Central Retinal Artery Occlusion (CRAO)]]\u003c/mark\u003e. The inner retina becomes pale and edematous due to ischemia, making the underlying choroidal blood supply at the fovea stand out.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolic Causes:\u003c/b\u003e It is also a classic finding in several lysosomal storage diseases where sphingolipids accumulate in the retinal ganglion cells, making the retina appear pale. These include:\u003cbr\u003e - \u003cmark\u003eTay-Sachs disease\u003c/mark\u003e (GM\u003csub\u003e2\u003c/sub\u003e gangliosidosis)\u003cbr\u003e - \u003cmark\u003eNiemann-Pick disease\u003c/mark\u003e (sphingomyelinase deficiency)\u003cbr\u003e - Metachromatic leukodystrophy and Sandhoff disease (less common).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When you see \u0027cherry-red spot,\u0027 your differential should immediately be CRAO vs. Tay-Sachs/Niemann-Pick. The clinical context (e.g., an elderly patient with sudden vision loss vs. an infant with neurodegeneration) will distinguish them.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003echerry-red spot\u003c/b\u003e is a dramatic fundoscopic sign that highlights the normal foveal blood supply against a backdrop of a diseased retina, pointing to either acute, profound ischemia (CRAO) or lipid accumulation in the ganglion cells (lysosomal storage diseases).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"3334840f\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"tay_sachs_disease\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"niemann_pick_disease\"\n      }\n    ]\n  },\n  \"b96a6a07\": {\n    \"title\": \"Chiari Malformation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pediatrics\",\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Posterior Fossa Malformations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChiari malformations\u003c/b\u003e are a group of structural defects in the cerebellum, characterized by the downward displacement of one or both cerebellar tonsils through the foramen magnum. This can lead to obstruction of cerebrospinal fluid (CSF) flow and brainstem compression.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eChiari I Malformation:\u003c/b\u003e Ectopia of the cerebellar tonsils (\u003e5 mm below the foramen magnum). Usually a congenital condition but often asymptomatic until adolescence or adulthood. Presents with occipital headaches (often worse with Valsalva) and cerebellar symptoms. Strongly associated with \u003cmark\u003e[[d2b8e10c|syringomyelia]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChiari II Malformation (Arnold-Chiari):\u003c/b\u003e Downward displacement of the cerebellar vermis and tonsils, along with the medulla, through the foramen magnum. Presents in infancy. Almost universally associated with a lumbar \u003cmark\u003emyelomeningocele\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The herniated cerebellar tissue can obstruct CSF outflow from the fourth ventricle, causing \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Can include headache, neck pain, balance problems ([[9767fd6b|ataxia]]), and signs of brainstem compression (e.g., dysphagia, apnea).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate Chiari I with [[d2b8e10c|syringomyelia]] in an adult. Associate Chiari II with myelomeningocele and hydrocephalus in an infant.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eChiari malformations\u003c/b\u003e represent a \u0027crowding\u0027 at the base of the skull where the cerebellum herniates through the foramen magnum, with Chiari I being a milder, later-onset form associated with syringomyelia, and Chiari II being a severe, infantile form associated with myelomeningocele and hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Chiari Malformation] --\u003e B(Downward Displacement of Cerebellum); B --\u003e C(Through Foramen Magnum); C --\u003e D(Obstruction of CSF Flow); D --\u003e E(Hydrocephalus); C --\u003e F(Brainstem Compression);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"posterior_fossa_malformation\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"d2b8e10c\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"myelomeningocele\"\n      }\n    ]\n  },\n  \"0b5f9ff0\": {\n    \"title\": \"Chickenpox (Varicella)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Infectious Disease\",\n      \"Pediatrics\",\n      \"Dermatology\",\n      \"Virology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChickenpox (Varicella)\u003c/b\u003e is a highly contagious acute infectious disease caused by the primary infection with \u003ci\u003eVaricella-Zoster Virus (VZV)\u003c/i\u003e, a member of the herpesvirus family. It is characterized by a generalized, pruritic, vesicular rash.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Varicella-Zoster Virus (VZV), or Human Herpesvirus-3 (HHV-3).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Prodrome of fever and malaise followed by a pruritic rash that begins on the trunk and face and spreads to the extremities. The rash is classically described as \u003cmark\u003e\\\"lesions in different stages of healing\\\"\u003c/mark\u003e (macules, papules, vesicles, and crusted lesions all present simultaneously).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e In children, the most common complication is a secondary bacterial skin infection (e.g., from \u003ci\u003eS. aureus\u003c/i\u003e or \u003ci\u003eS. pyogenes\u003c/i\u003e). In adults, the most common complication is pneumonia. Encephalitis is a rare but serious complication.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLatency and Reactivation:\u003c/b\u003e After the primary infection, VZV establishes latency in the dorsal root ganglia. Reactivation later in life causes Herpes Zoster (Shingles).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The description of a vesicular rash with lesions in various stages of development is pathognomonic for chickenpox. The \u0027chicken-wire\u0027 capillary pattern is a histological finding in oligodendroglioma, not related to chickenpox.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eChickenpox\u003c/b\u003e is the primary manifestation of VZV infection, presenting as a classic \u0027dewdrop on a rose petal\u0027 rash with lesions in multiple stages of evolution, which resolves but leaves the virus dormant in the dorsal root ganglia, ready to reactivate as shingles years later.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"varicella_zoster_virus\"\n      },\n      {\n        \"type\": \"reactivation_causes\",\n        \"to\": \"herpes_zoster\"\n      },\n      {\n        \"type\": \"is_prevented_by\",\n        \"to\": \"varicella_vaccine\"\n      }\n    ]\n  },\n  \"5ef145ba\": {\n    \"title\": \"Childhood Neurological Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Pediatric Neurology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChildhood neurological disorders\u003c/b\u003e encompass a wide range of conditions affecting the developing brain, spinal cord, and peripheral nerves, from congenital malformations and genetic syndromes to acquired conditions like tumors and infections.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Brain Tumors:\u003c/b\u003e Most childhood brain tumors are \u003cmark\u003einfratentorial\u003c/mark\u003e (located in the posterior fossa). The most common types, in order, are Pilocytic Astrocytoma, [[16d613bb|Medulloblastoma]], and [[14365ef4|Ependymoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLeukocoria (\\\"White Pupil\\\"):\u003c/b\u003e An abnormal white reflection from the retina. In a child, this is a major red flag that must be investigated to rule out serious pathology, most notably \u003cmark\u003e[[63b964af|retinoblastoma]]\u003c/mark\u003e and congenital [[85f03b02|cataracts]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurocutaneous Syndromes:\u003c/b\u003e A group of genetic disorders affecting the skin and nervous system, often presenting in childhood (e.g., Neurofibromatosis, Tuberous Sclerosis, Sturge-Weber).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlindness:\u003c/b\u003e Common causes of blindness in children include retinopathy of prematurity, congenital cataracts, and retinoblastoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the location difference for brain tumors: Adults \u003d Supratentorial, Children \u003d Infratentorial. Leukocoria in a child is retinoblastoma until proven otherwise.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe landscape of \u003cb\u003echildhood neurological disorders\u003c/b\u003e is dominated by developmental and genetic conditions, with infratentorial brain tumors and congenital eye abnormalities like leukocoria being high-yield and clinically critical entities to recognize.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"912babcc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"neurocutaneous_disorders\"\n      }\n    ]\n  },\n  \"8e38988e\": {\n    \"title\": \"Chlordiazepoxide\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChlordiazepoxide\u003c/b\u003e (trade name Librium) is a long-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e primarily used for the management of anxiety disorders and, most notably, for the treatment of acute alcohol withdrawal.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A positive allosteric modulator of the GABA\u003csub\u003eA\u003c/sub\u003e receptor. It increases the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening in response to GABA, leading to enhanced CNS inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is a \u003cmark\u003elong-acting\u003c/mark\u003e benzodiazepine with active metabolites, which contributes to its smooth, tapering effect, making it ideal for withdrawal syndromes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e The drug of choice for managing the symptoms of \u003cmark\u003ealcohol withdrawal\u003c/mark\u003e, including agitation, tremors, and preventing seizures and delirium tremens. Also used for anxiety disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dizziness, confusion, dependence, and withdrawal. Its long half-life can lead to accumulation and excessive sedation, especially in the elderly or those with liver impairment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For alcohol withdrawal, a long-acting benzodiazepine like chlordiazepoxide or diazepam is preferred to provide a stable level of CNS depression and prevent severe withdrawal symptoms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eChlordiazepoxide\u003c/b\u003e is the classic long-acting benzodiazepine used to safely manage alcohol withdrawal, providing a \u0027soft landing\u0027 by substituting for alcohol at the GABA\u003csub\u003eA\u003c/sub\u003e receptor and preventing the life-threatening hyperexcitability of delirium tremens.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"alcohol_withdrawal\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      }\n    ]\n  },\n  \"f04dd83b\": {\n    \"title\": \"Chloroprocaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChloroprocaine\u003c/b\u003e is a short-acting, ester-type \u003ci\u003elocal anesthetic\u003c/i\u003e used for regional anesthesia, particularly in obstetrics for epidural analgesia during labor and delivery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Ester local anesthetic. It is metabolized by plasma pseudocholinesterases.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003every rapid onset\u003c/mark\u003e and a \u003cmark\u003every short duration of action\u003c/mark\u003e due to its rapid hydrolysis in the plasma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Its rapid onset and short duration make it ideal for epidural anesthesia in obstetrics, as it provides quick pain relief and its effects wear off quickly after delivery, minimizing systemic toxicity to both mother and neonate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e As an ester, it has a higher potential for allergic reactions (due to its metabolite, PABA) compared to amide anesthetics. Systemic toxicity is rare due to its rapid metabolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key features of chloroprocaine are its ester linkage, rapid metabolism by plasma pseudocholinesterases, and its resulting fast-on, fast-off profile, making it a popular choice for labor epidurals.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eChloroprocaine\u003c/b\u003e is an ester local anesthetic prized in obstetrics for its speed; its rapid breakdown in the plasma provides fast pain relief for labor with minimal risk of accumulation or toxicity to the baby.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        \"to\": \"pseudocholinesterase\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n  },\n  \"03ef3134\": {\n    \"title\": \"Cholesteatoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003echolesteatoma\u003c/b\u003e is a non-neoplastic, destructive and expanding growth consisting of keratinizing squamous epithelium in the middle ear and/or mastoid process. Despite its name, it is not a tumor and does not contain cholesterol.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Most commonly acquired due to chronic eustachian tube dysfunction, which creates negative pressure in the middle ear and causes a retraction pocket in the tympanic membrane. This pocket fills with desquamated keratin debris, forming the cholesteatoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Classically presents with \u003cmark\u003epainless, persistent, and often foul-smelling otorrhea\u003c/mark\u003e (ear discharge). Progressive conductive hearing loss occurs as the mass erodes the ossicles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e The mass can produce lytic enzymes, leading to erosion of the ossicles, mastoid bone, and even extension into the cranium, causing complications like facial nerve palsy, vertigo, meningitis, or brain abscess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOtoscopy:\u003c/b\u003e Examination may reveal a white, cheesy-looking mass behind an intact tympanic membrane or a perforation with keratin debris.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of chronic, painless, foul-smelling ear discharge and conductive hearing loss is highly suggestive of a cholesteatoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003echolesteatoma\u003c/b\u003e is essentially \u0027skin in the wrong place,\u0027 a destructive collection of keratin debris in the middle ear that, through enzymatic erosion, can destroy the delicate structures of hearing and balance and even invade the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"eustachian_tube_dysfunction\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"conductive_hearing_loss\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"facial_nerve_palsy\"\n      }\n    ]\n  },\n  \"0835ea01\": {\n    \"title\": \"Cholinesterase Inhibitors\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCholinesterase inhibitors\u003c/b\u003e (or acetylcholinesterase inhibitors) are a class of drugs that prevent the breakdown of [[6a005559|acetylcholine]] by the enzyme acetylcholinesterase (AChE), thereby increasing the concentration and duration of action of acetylcholine in the synaptic cleft.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibit AChE, leading to increased levels of ACh at both muscarinic and nicotinic synapses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Uses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[77ae6148|Alzheimer Disease]]:\u003c/b\u003e Centrally acting agents ([[47d0372e|donepezil]], rivastigmine, galantamine) are used to improve cognitive symptoms by boosting cortical cholinergic function.\u003cbr\u003e - \u003cb\u003eMyasthenia Gravis:\u003c/b\u003e Peripherally acting agents (neostigmine, pyridostigmine) increase ACh at the neuromuscular junction to improve muscle strength.\u003cbr\u003e - \u003cb\u003eReversal of Neuromuscular Blockade:\u003c/b\u003e Neostigmine is used to reverse the effects of non-depolarizing neuromuscular blockers after surgery.\u003cbr\u003e - \u003cb\u003eAnticholinergic Toxicity:\u003c/b\u003e Physostigmine, a centrally acting inhibitor, is the antidote for severe anticholinergic overdose.\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxicity (Cholinergic Crisis):\u003c/b\u003e Overdose or exposure to irreversible inhibitors (organophosphates) causes a cholinergic crisis. Mnemonic \u003cb\u003eDUMBBELSS\u003c/b\u003e: \u003cb\u003eD\u003c/b\u003eiarrhea, \u003cb\u003eU\u003c/b\u003erination, \u003cb\u003eM\u003c/b\u003eiosis, \u003cb\u003eB\u003c/b\u003eronchospasm, \u003cb\u003eB\u003c/b\u003eradycardia, \u003cb\u003eE\u003c/b\u003emesis, \u003cb\u003eL\u003c/b\u003eacrimation, \u003cb\u003eS\u003c/b\u003ealivation, \u003cb\u003eS\u003c/b\u003eweating.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate between centrally acting (physostigmine, donepezil) and peripherally acting (neostigmine, pyridostigmine) agents based on their ability to cross the blood-brain barrier.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCholinesterase inhibitors\u003c/b\u003e amplify cholinergic signaling throughout the body by preventing the breakdown of acetylcholine, a mechanism that is therapeutically harnessed to treat conditions of cholinergic deficit like Alzheimer\u0027s disease and myasthenia gravis, but which can become toxic in overdose, leading to a cholinergic crisis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetylcholine] --AChE--\u003e B(Choline + Acetate); C[Cholinesterase Inhibitor] --x B;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"increase_levels_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {\n        \"type\": \"is_antidote_for\",\n        \"to\": \"anticholinergic_toxicity\"\n      }\n    ]\n  },\n  \"36054a34\": {\n    \"title\": \"Cholinomimetic Agents\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCholinomimetic agents\u003c/b\u003e are drugs that mimic the effects of [[6a005559|acetylcholine]]. They can be classified as direct-acting agonists, which bind directly to cholinergic receptors, or indirect-acting agents ([[0835ea01|cholinesterase inhibitors]]), which increase the synaptic concentration of acetylcholine.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDirect-Acting Agonists:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBethanechol:\u003c/b\u003e Muscarinic agonist used for non-obstructive urinary retention and postoperative ileus.\u003cbr\u003e - \u003cb\u003ePilocarpine:\u003c/b\u003e Muscarinic agonist used for [[3ce6c035|glaucoma]] and to treat xerostomia (dry mouth) in Sj√∂gren syndrome.\u003cbr\u003e - \u003cb\u003e[[c1ad76f4|Carbachol]]:\u003c/b\u003e Muscarinic and nicotinic agonist used for [[3ce6c035|glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eIndirect-Acting Agents (Cholinesterase Inhibitors):\u003c/b\u003e See [[0835ea01|Cholinesterase Inhibitors]] card.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffects:\u003c/b\u003e Produce effects similar to parasympathetic stimulation (rest and digest). Mnemonic \u003cb\u003eDUMBBELSS\u003c/b\u003e (Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Emesis, Lacrimation, Salivation, Sweating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGlaucoma Therapy:\u003c/b\u003e Cholinomimetics like pilocarpine and [[c1ad76f4|carbachol]] are used in [[3ce6c035|glaucoma]] to increase aqueous humor outflow through the trabecular meshwork by contracting the ciliary muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the difference between direct agonists (which bind to the receptor) and indirect agonists (which inhibit the breakdown of the natural ligand). Both result in increased cholinergic stimulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCholinomimetic agents\u003c/b\u003e amplify the \u0027rest and digest\u0027 signals of the parasympathetic nervous system, either by directly stimulating cholinergic receptors or by preventing the breakdown of acetylcholine, with therapeutic applications ranging from glaucoma to urinary retention.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"mimic_effects_of\",\n        \"to\": \"6a005559\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"pilocarpine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"c1ad76f4\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"0835ea01\"\n      }\n    ]\n  },\n  \"0fa0d8ee\": {\n    \"title\": \"Chorea\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChorea\u003c/b\u003e (from Greek for \\\"dance\\\") is an involuntary movement disorder characterized by brief, abrupt, irregular, and unpredictable movements that flow from one body part to another. It is a hallmark sign of [[ed462927|basal ganglia]] dysfunction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Movements are non-rhythmic, jerky, and purposeless, often described as \u0027dance-like.\u0027 They can affect the face, limbs, and trunk.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Classically associated with damage to the \u003cmark\u003estriatum\u003c/mark\u003e (specifically the caudate nucleus) in the [[ed462927|basal ganglia]], leading to a loss of inhibition in the indirect pathway and excessive cortical stimulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e The most well-known cause of chorea is \u003cmark\u003e[[ffd7e743|Huntington disease]]\u003c/mark\u003e, an autosomal dominant neurodegenerative disorder.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSydenham Chorea:\u003c/b\u003e A post-infectious complication of Group A streptococcal infection (rheumatic fever).\u003cbr\u003e - \u003cb\u003eDrug-induced:\u003c/b\u003e Can be a side effect of long-term levodopa therapy for Parkinson disease.\u003cbr\u003e - \u003cb\u003eOther:\u003c/b\u003e Systemic lupus erythematosus, pregnancy (chorea gravidarum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young to middle-aged adult presenting with new-onset chorea, especially if accompanied by psychiatric changes or a family history, should be evaluated for [[ffd7e743|Huntington disease]]. In a child with a recent sore throat, consider Sydenham chorea.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eChorea\u003c/b\u003e is a hyperkinetic movement disorder that manifests as a continuous, unpredictable \u0027dance\u0027 of the body, resulting from a loss of inhibitory control from the basal ganglia, most famously due to the degeneration of the caudate nucleus in Huntington disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"sydenham_chorea\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"dyskinesia\"\n      }\n    ]\n  },\n  \"4a27c966\": {\n    \"title\": \"Choroid\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eChoroid\u003c/b\u003e is the vascular layer of the eye, situated between the retina and the sclera. It is part of the uvea and is responsible for providing oxygen and nourishment to the outer layers of the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The posterior part of the uvea, lying between the retina (inner layer) and the sclera (outer layer).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Its rich blood supply provides essential oxygen and nutrients to the outer retina, including the photoreceptors (rods and cones). It also contains pigment that absorbs excess light, preventing blurring of the image.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBruch\u0027s Membrane:\u003c/b\u003e The innermost layer of the choroid, which forms a barrier between the choroidal capillaries and the retinal pigment epithelium.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[c63255c8|Age-related Macular Degeneration (AMD)]]:\u003c/b\u003e In wet AMD, abnormal blood vessels grow from the choroid through Bruch\u0027s membrane (choroidal neovascularization), leading to hemorrhage and vision loss.\u003cbr\u003e - \u003cb\u003eChoroiditis:\u003c/b\u003e Inflammation of the choroid, a form of posterior uveitis.\u003cbr\u003e - \u003cb\u003eChoroidal Melanoma:\u003c/b\u003e The most common primary intraocular malignancy in adults.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The choroidal circulation is responsible for the \u0027red\u0027 appearance of the fovea in a [[651ed480|cherry-red spot]], as it remains visible through the thin fovea when the surrounding retina is pale from ischemia or lipid deposition.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eChoroid\u003c/b\u003e is the vital, vascular support system for the photoreceptors of the retina; its integrity is crucial for vision, and its breakdown, as seen in wet macular degeneration, can lead to rapid and severe sight loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"uvea\"\n      },\n      {\n        \"type\": \"supplies_blood_to\",\n        \"to\": \"retina\"\n      },\n      {\n        \"type\": \"is_involved_in_pathophysiology_of\",\n        \"to\": \"c63255c8\"\n      },\n      {\n        \"type\": \"can_be_inflamed_in\",\n        \"to\": \"uveitis\"\n      }\n    ]\n  },\n  \"ae65e9c7\": {\n    \"title\": \"Choroid Plexus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eChoroid Plexus\u003c/b\u003e is a specialized, highly vascularized tissue found within the ventricles of the brain that is responsible for the production of most of the cerebrospinal fluid (CSF).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found in all four ventricles (lateral, third, and fourth).\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Consists of a network of capillaries surrounded by a layer of modified ependymal cells, which are joined by tight junctions to form the blood-CSF barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Actively secretes [[7109d8b6|cerebrospinal fluid (CSF)]] into the ventricles. This process involves the transport of ions (Na\u003csup\u003e+\u003c/sup\u003e, Cl\u003csup\u003e-\u003c/sup\u003e, HCO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e-\u003c/sup\u003e) into the ventricles, with water following osmotically.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEnzymes:\u003c/b\u003e The process is dependent on enzymes like carbonic anhydrase.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOverproduction of CSF:\u003c/b\u003e A rare cause of [[0bc2f200|hydrocephalus]] can be a choroid plexus papilloma (a benign tumor).\u003cbr\u003e - \u003cb\u003eChoroid Plexus Cysts:\u003c/b\u003e Often seen on prenatal ultrasound; usually a benign, transient finding but can be a soft marker for chromosomal abnormalities like Trisomy 18.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple flow: Choroid plexus \u003cb\u003eproduces\u003c/b\u003e CSF, arachnoid granulations \u003cb\u003ereabsorb\u003c/b\u003e CSF. A tumor of the choroid plexus (papilloma) can cause communicating hydrocephalus due to overproduction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eChoroid Plexus\u003c/b\u003e functions as the brain\u0027s \u0027CSF factory,\u0027 a specialized tissue within the ventricles that continuously produces the fluid essential for cushioning and nourishing the central nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --Produces--\u003e B(Cerebrospinal Fluid);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"produces\",\n        \"to\": \"7109d8b6\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"1cb9c975\"\n      },\n      {\n        \"type\": \"tumor_of_can_cause\",\n        \"to\": \"0bc2f200\"\n      }\n    ]\n  },\n  \"6d7a091d\": {\n    \"title\": \"Ciliary Ganglion\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCiliary Ganglion\u003c/b\u003e is a parasympathetic ganglion located in the posterior orbit. It serves as a relay station for parasympathetic fibers that control pupillary constriction (miosis) and lens accommodation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Contains postganglionic parasympathetic neuron cell bodies that innervate the sphincter pupillae and ciliary muscles of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Root (Motor):\u003c/b\u003e Preganglionic parasympathetic fibers arise from the \u003cmark\u003eEdinger-Westphal nucleus\u003c/mark\u003e and travel with the [[68c66997|oculomotor nerve (CN III)]] to synapse in the ciliary ganglion.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostganglionic Fibers:\u003c/b\u003e Axons from the ciliary ganglion travel via the short ciliary nerves to the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSphincter Pupillae Muscle:\u003c/b\u003e Contraction causes miosis (pupil constriction).\u003cbr\u003e - \u003cb\u003eCiliary Muscle:\u003c/b\u003e Contraction causes [[81b5f5fe|accommodation]] (rounding of the lens for near vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion in the ciliary ganglion or short ciliary nerves (e.g., Adie\u0027s tonic pupil) results in a dilated pupil that reacts poorly to light but may show a slow, tonic constriction to near vision (light-near dissociation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This ganglion is the final parasympathetic outpost for the eye. Remember the pathway: Edinger-Westphal nucleus ‚Üí CN III ‚Üí Ciliary Ganglion ‚Üí Short ciliary nerves ‚Üí Pupillary constriction and accommodation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCiliary Ganglion\u003c/b\u003e is the crucial parasympathetic relay center for the eye, translating signals from the oculomotor nerve into the commands that constrict the pupil and focus the lens for near vision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Edinger-Westphal Nucleus] --Preganglionic Fibers (CN III)--\u003e B(Ciliary Ganglion); B --Postganglionic Fibers--\u003e C(Sphincter Pupillae \u0026 Ciliary Muscle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a\",\n        \"to\": \"parasympathetic_ganglion\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"edinger_westphal_nucleus\"\n      },\n      {\n        \"type\": \"sends_fibers_to\",\n        \"to\": \"sphincter_pupillae\"\n      },\n      {\n        \"type\": \"sends_fibers_to\",\n        \"to\": \"ciliary_muscle\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9280,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"cf4c1530\": {\n    \"title\": \"Che"
      }, {
        "text": "motherapy-Induced Nausea and Vomiting (CINV)\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Oncology\",\n      \"Pharmacology\",\n      \"Gastroenterology\",\n      \"Neurology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Antiemetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eChemotherapy-Induced Nausea and Vomiting (CINV)\u003c/b\u003e is a common and distressing side effect of many"
      }, {
        "text": " cytotoxic cancer therapies. It is mediated by both central and peripheral pathways that stimulate the [[74b651ab"
      }, {
        "text": "|vomiting center]] in the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAcute CINV:\u003c/b\u003e Occurs within 24 hours. Primarily mediated by the"
      }, {
        "text": " release of \u003cmark\u003eserotonin (5-HT)\u003c/mark\u003e from enterochromaffin cells in the GI tract, which stimulates vag"
      }, {
        "text": "al afferents and the [[93f70f8e|chemoreceptor trigger zone (CTZ)]"
      }, {
        "text": "].\u003cbr\u003e - \u003cb\u003eDelayed CINV:\u003c/b\u003e Occurs after 24 hours. Primarily mediated by \u003c"
      }, {
        "text": "mark\u003esubstance P\u003c/mark\u003e binding to neurokinin-1 (NK-1) receptors in the brain."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Acute CINV):\u003c/b\u003e The mainstay of treatment is \u003cmark\u003e5-HT\u003csub\u003e3\u003c/sub\u003e receptor antagonists\u003c/"
      }, {
        "text": "mark\u003e (e.g., [[ondansetron]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Delayed CINV):\u003c/b\u003e The mainstay"
      }, {
        "text": " of treatment is \u003cmark\u003eNK-1 receptor antagonists\u003c/mark\u003e (e.g., aprepitant).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCombination"
      }, {
        "text": " Therapy:\u003c/b\u003e High-emetogenic chemotherapy regimens are often treated prophylactically with a combination of a 5-HT\u003csub\u003e3\u003c/sub\u003e antagonist"
      }, {
        "text": ", an NK-1 antagonist, and a corticosteroid (e.g., dexamethasone).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Know the two main pathways and their primary mediators: Acute CINV is driven by serotonin (target with ondansetron), while"
      }, {
        "text": " delayed CINV is driven by substance P (target with aprepitant).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " management of \u003cb\u003eChemotherapy-Induced Nausea and Vomiting\u003c/b\u003e is a targeted pharmacological approach based on its bip"
      }, {
        "text": "hasic pathophysiology; the acute phase is blocked by serotonin antagonists, while the delayed phase is prevented by substance P/NK-1 antagonists.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Chemotherapy] --\u003e B(GI Tract Damage); B --\u003e C(Serotonin Release); C"
      }, {
        "text": " --\u003e D(Vagal Afferents \u0026 CTZ); D --\u003e E(Acute Vomiting); A --\u003e F(CNS"
      }, {
        "text": " Effects); F --\u003e G(Substance P Release); G --\u003e H(NK-1 Receptors); H --\u003e I(Delayed Vom"
      }, {
        "text": "iting);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\","
      }, {
        "text": "\n        \"to\": \"93f70f8e\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"ondansetron\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_treated_by\",\n        \"to\": \"aprepitant\"\n      }\n    ]\n  },\n  \"6"
      }, {
        "text": "51ed480\": {\n    \"title\": \"Cherry-Red Spot on Macula\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n"
      }, {
        "text": "      \"Metabolic Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003echerry-red spot\u003c/b\u003e is a descriptive term for the"
      }, {
        "text": " fundoscopic finding of a small, circular reddish area at the fovea, surrounded by a pale retina. This sign is indicative"
      }, {
        "text": " of pathology in the retinal ganglion cell layer, which is absent at the fovea.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e The fovea appears red because its normal choroidal circulation is visible and contrasts sharply"
      }, {
        "text": " with the surrounding pale, edematous, or lipid-laden retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIschemic Cause:\u003c/b\u003e The most"
      }, {
        "text": " common cause is \u003cmark\u003e[[3334840f|Central Retinal Artery Occlusion (C"
      }, {
        "text": "RAO)]]\u003c/mark\u003e. The inner retina becomes pale and edematous due to ischemia, making the underlying choroidal blood"
      }, {
        "text": " supply at the fovea stand out.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolic Causes:\u003c/b\u003e It is also a classic finding in several lysosomal storage diseases"
      }, {
        "text": " where sphingolipids accumulate in the retinal ganglion cells, making the retina appear pale. These include:\u003cbr\u003e - \u003cmark\u003eTay-"
      }, {
        "text": "Sachs disease\u003c/mark\u003e (GM\u003csub\u003e2\u003c/sub\u003e gangliosidosis)\u003cbr\u003e - \u003cmark\u003eNiemann"
      }, {
        "text": "-Pick disease\u003c/mark\u003e (sphingomyelinase deficiency)\u003cbr\u003e - Metachromatic leukodystrophy and"
      }, {
        "text": " Sandhoff disease (less common).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When you see \u0027cherry-red spot,\u0027"
      }, {
        "text": " your differential should immediately be CRAO vs. Tay-Sachs/Niemann-Pick. The clinical context (e"
      }, {
        "text": ".g., an elderly patient with sudden vision loss vs. an infant with neurodegeneration) will distinguish them.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003echerry-red spot\u003c/b\u003e is a dramatic fundoscopic sign that highlights the normal foveal blood supply against"
      }, {
        "text": " a backdrop of a diseased retina, pointing to either acute, profound ischemia (CRAO) or lipid accumulation in the ganglion"
      }, {
        "text": " cells (lysosomal storage diseases).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_sign_of\",\n        \"to\": \"33348"
      }, {
        "text": "40f\"\n      },\n      {\n        \"type\": \"is_a_sign_of\","
      }, {
        "text": "\n        \"to\": \"tay_sachs_disease\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_sign_of\",\n        \"to\": \"niemann_pick_disease\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"b96a6a07\": {\n    \"title\": \""
      }, {
        "text": "Chiari Malformation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Neurosurgery\",\n      \"Pediatrics\",\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \""
      }, {
        "text": "Posterior Fossa Malformations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Chiari malformations\u003c/b\u003e are a group of structural defects in the cerebellum, characterized by the downward displacement of one or both cerebellar tons"
      }, {
        "text": "ils through the foramen magnum. This can lead to obstruction of cerebrospinal fluid (CSF) flow and brainstem compression.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eChiari I Malformation:\u003c/b\u003e Ectopia of the cerebellar tonsils (\u003e"
      }, {
        "text": "5 mm below the foramen magnum). Usually a congenital condition but often asymptomatic until adolescence or adulthood. Presents with occipital headaches ("
      }, {
        "text": "often worse with Valsalva) and cerebellar symptoms. Strongly associated with \u003cmark\u003e[[d2b8e1"
      }, {
        "text": "0c|syringomyelia]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eChiari II Malformation (Arnold-Chiari):"
      }, {
        "text": "\u003c/b\u003e Downward displacement of the cerebellar vermis and tonsils, along with the medulla, through the foramen magnum. Presents"
      }, {
        "text": " in infancy. Almost universally associated with a lumbar \u003cmark\u003emyelomeningocele\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e The herniated cerebellar tissue can obstruct CSF outflow from the fourth ventricle, causing \u003cmark\u003enon-communic"
      }, {
        "text": "ating hydrocephalus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Can include headache, neck pain, balance problems ([[97"
      }, {
        "text": "67fd6b|ataxia]]), and signs of brainstem compression (e.g., dysphagia, apnea"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate Chiari I with [[d2b8e10c|"
      }, {
        "text": "syringomyelia]] in an adult. Associate Chiari II with myelomeningocele and hydrocephalus in an"
      }, {
        "text": " infant.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eChiari malformations\u003c/b\u003e represent a \u0027crowding\u0027 at"
      }, {
        "text": " the base of the skull where the cerebellum herniates through the foramen magnum, with Chiari I being a milder,"
      }, {
        "text": " later-onset form associated with syringomyelia, and Chiari II being a severe, infantile form associated with myelomeningocele and hydrocephalus.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"graph TD; A[Chiari Malformation] --\u003e B(Downward Displacement of Cerebellum"
      }, {
        "text": "); B --\u003e C(Through Foramen Magnum); C --\u003e D(Obstruction of CSF Flow); D --\u003e E(Hydro"
      }, {
        "text": "cephalus); C --\u003e F(Brainstem Compression);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"posterior_fossa_mal"
      }, {
        "text": "formation\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"0bc"
      }, {
        "text": "2f200\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \""
      }, {
        "text": "to\": \"d2b8e10c\"\n      },\n      {\n        \"type\": \"is_associated_"
      }, {
        "text": "with\",\n        \"to\": \"myelomeningocele\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"0b5f9ff0\": {\n    \"title\": \"Chickenpox (Varicella)\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Infectious Disease\",\n      \"Pediatrics\",\n      \"D"
      }, {
        "text": "ermatology\",\n      \"Virology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eChickenpox (Varicella)\u003c/b\u003e is a highly contagious acute infectious disease caused by the primary"
      }, {
        "text": " infection with \u003ci\u003eVaricella-Zoster Virus (VZV)\u003c/i\u003e, a member of the herpesvirus family. It is"
      }, {
        "text": " characterized by a generalized, pruritic, vesicular rash.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Varicella-Zoster Virus (VZV), or Human Herpesvirus-3 (HHV-3)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Prodrome of fever and malaise followed by a pruritic rash that begins on the trunk"
      }, {
        "text": " and face and spreads to the extremities. The rash is classically described as \u003cmark\u003e\\\"lesions in different stages of healing"
      }, {
        "text": "\\\"\u003c/mark\u003e (macules, papules, vesicles, and crusted lesions all present simultaneously).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCom"
      }, {
        "text": "plications:\u003c/b\u003e In children, the most common complication is a secondary bacterial skin infection (e.g., from \u003ci\u003eS"
      }, {
        "text": ". aureus\u003c/i\u003e or \u003ci\u003eS. pyogenes\u003c/i\u003e). In adults, the most common complication is pneumonia. Encephalitis is"
      }, {
        "text": " a rare but serious complication.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLatency and Reactivation:\u003c/b\u003e After the primary infection, VZV establishes latency in the dorsal root ganglia."
      }, {
        "text": " Reactivation later in life causes Herpes Zoster (Shingles).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The description of a"
      }, {
        "text": " vesicular rash with lesions in various stages of development is pathognomonic for chickenpox. The \u0027chicken-wire\u0027 capillary"
      }, {
        "text": " pattern is a histological finding in oligodendroglioma, not related to chickenpox.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eChickenpox\u003c/b\u003e is the primary manifestation of VZV infection, presenting as a classic \u0027dewdrop on a rose petal\u0027 rash with lesions"
      }, {
        "text": " in multiple stages of evolution, which resolves but leaves the virus dormant in the dorsal root ganglia, ready to reactivate as"
      }, {
        "text": " shingles years later.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by\",\n        \"to\": \"varicella_zoster_virus"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"reactivation_causes\",\n        \"to\": \""
      }, {
        "text": "herpes_zoster\"\n      },\n      {\n        \"type\": \"is_prevented_by\",\n        \"to"
      }, {
        "text": "\": \"varicella_vaccine\"\n      }\n    ]\n  },\n  \"5ef14"
      }, {
        "text": "5ba\": {\n    \"title\": \"Childhood Neurological Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Pediatric Neurology\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChildhood neurological disorders\u003c/b\u003e encompass a wide range of conditions affecting the developing"
      }, {
        "text": " brain, spinal cord, and peripheral nerves, from congenital malformations and genetic syndromes to acquired conditions like tumors and infections.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Brain Tumors:\u003c/b\u003e Most childhood brain tumors are \u003cmark\u003einfratentorial"
      }, {
        "text": "\u003c/mark\u003e (located in the posterior fossa). The most common types, in order, are Pilocytic Astrocytoma, [["
      }, {
        "text": "16d613bb|Medulloblastoma]], and [[14365ef4|Ependymoma]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eLeukocoria (\\\"White Pupil\\\"):\u003c/b\u003e An abnormal white reflection from the retina. In a child, this is a major"
      }, {
        "text": " red flag that must be investigated to rule out serious pathology, most notably \u003cmark\u003e[[63b964"
      }, {
        "text": "af|retinoblastoma]]\u003c/mark\u003e and congenital [[85f03b02|cataracts]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurocutaneous Syndromes:\u003c/b\u003e A group of genetic disorders affecting the skin and nervous system, often presenting in childhood ("
      }, {
        "text": "e.g., Neurofibromatosis, Tuberous Sclerosis, Sturge-Weber).\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlind"
      }, {
        "text": "ness:\u003c/b\u003e Common causes of blindness in children include retinopathy of prematurity, congenital cataracts, and retinoblastoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the location difference for brain tumors: Adults \u003d Supratentorial, Children \u003d Infratentorial. Leuk"
      }, {
        "text": "ocoria in a child is retinoblastoma until proven otherwise.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " landscape of \u003cb\u003echildhood neurological disorders\u003c/b\u003e is dominated by developmental and genetic conditions, with infratentorial brain tumors and"
      }, {
        "text": " congenital eye abnormalities like leukocoria being high-yield and clinically critical entities to recognize.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"be"
      }, {
        "text": "057cfc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"9"
      }, {
        "text": "12babcc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"neuro"
      }, {
        "text": "cutaneous_disorders\"\n      }\n    ]\n  },\n  \"8e38988e"
      }, {
        "text": "\": {\n    \"title\": \"Chlordiazepoxide\",\n    \"primaryType\": \"drug\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Toxicology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChlordiazepoxide\u003c/b\u003e (trade name Librium) is a long"
      }, {
        "text": "-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e primarily used for the management of anxiety disorders and, most notably, for the treatment"
      }, {
        "text": " of acute alcohol withdrawal.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A"
      }, {
        "text": " positive allosteric modulator of the GABA\u003csub\u003eA\u003c/sub\u003e receptor. It increases the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening in"
      }, {
        "text": " response to GABA, leading to enhanced CNS inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is a \u003cmark\u003elong-acting\u003c/"
      }, {
        "text": "mark\u003e benzodiazepine with active metabolites, which contributes to its smooth, tapering effect, making it ideal for withdrawal syndromes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use"
      }, {
        "text": ":\u003c/b\u003e The drug of choice for managing the symptoms of \u003cmark\u003ealcohol withdrawal\u003c/mark\u003e, including agitation, tremors, and preventing"
      }, {
        "text": " seizures and delirium tremens. Also used for anxiety disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dizziness, confusion"
      }, {
        "text": ", dependence, and withdrawal. Its long half-life can lead to accumulation and excessive sedation, especially in the elderly or"
      }, {
        "text": " those with liver impairment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For alcohol withdrawal, a long-acting benzodiazepine like"
      }, {
        "text": " chlordiazepoxide or diazepam is preferred to provide a stable level of CNS depression and prevent severe withdrawal symptoms.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eChlordiazepoxide\u003c/b\u003e is the classic long-acting benzodiazepine used to safely manage alcohol withdrawal, providing"
      }, {
        "text": " a \u0027soft landing\u0027 by substituting for alcohol at the GABA\u003csub\u003eA\u003c/sub\u003e receptor and preventing the life-threatening hyperexcitability of delirium"
      }, {
        "text": " tremens.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"144646"
      }, {
        "text": "17\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"alcohol"
      }, {
        "text": "_withdrawal\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"g"
      }, {
        "text": "aba_a_receptor\"\n      }\n    ]\n  },\n  \"f04dd83b"
      }, {
        "text": "\": {\n    \"title\": \"Chloroprocaine\",\n    \"primaryType\": \"drug\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"An"
      }, {
        "text": "esthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eChloroprocaine\u003c/b\u003e is a short-acting,"
      }, {
        "text": " ester-type \u003ci\u003elocal anesthetic\u003c/i\u003e used for regional anesthesia, particularly in obstetrics for epidural analgesia during labor and"
      }, {
        "text": " delivery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na"
      }, {
        "text": "\u003csup\u003e+\u003c/sup\u003e channels in nerve membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Ester local"
      }, {
        "text": " anesthetic. It is metabolized by plasma pseudocholinesterases.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003every rapid onset\u003c/"
      }, {
        "text": "mark\u003e and a \u003cmark\u003every short duration of action\u003c/mark\u003e due to its rapid hydrolysis in the plasma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use"
      }, {
        "text": ":\u003c/b\u003e Its rapid onset and short duration make it ideal for epidural anesthesia in obstetrics, as it provides quick pain"
      }, {
        "text": " relief and its effects wear off quickly after delivery, minimizing systemic toxicity to both mother and neonate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects"
      }, {
        "text": ":\u003c/b\u003e As an ester, it has a higher potential for allergic reactions (due to its metabolite, PABA) compared to amide"
      }, {
        "text": " anesthetics. Systemic toxicity is rare due to its rapid metabolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key"
      }, {
        "text": " features of chloroprocaine are its ester linkage, rapid metabolism by plasma pseudocholinesterases, and its resulting"
      }, {
        "text": " fast-on, fast-off profile, making it a popular choice for labor epidurals.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eChloroprocaine\u003c/b\u003e is an ester local anesthetic prized in obstetrics for its speed"
      }, {
        "text": "; its rapid breakdown in the plasma provides fast pain relief for labor with minimal risk of accumulation or toxicity to the baby.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        "
      }, {
        "text": "\"to\": \"pseudocholinesterase\"\n      },\n      {\n        \"type\": \"blocks_channel"
      }, {
        "text": "\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"03ef3134\": {\n    \"title\": \"Cholesteatoma\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Otology\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003eA \u003cb\u003echolesteatoma\u003c/b\u003e is a non-neoplastic, destructive and expanding growth consisting of keratinizing"
      }, {
        "text": " squamous epithelium in the middle ear and/or mastoid process. Despite its name, it is not a tumor and does not contain cholesterol.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Most commonly acquired due to chronic"
      }, {
        "text": " eustachian tube dysfunction, which creates negative pressure in the middle ear and causes a retraction pocket in the tympanic membrane. This pocket fills"
      }, {
        "text": " with desquamated keratin debris, forming the cholesteatoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Classically presents with \u003c"
      }, {
        "text": "mark\u003epainless, persistent, and often foul-smelling otorrhea\u003c/mark\u003e (ear discharge). Progressive conductive hearing loss occurs"
      }, {
        "text": " as the mass erodes the ossicles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e The mass can produce lytic enzymes,"
      }, {
        "text": " leading to erosion of the ossicles, mastoid bone, and even extension into the cranium, causing complications like facial nerve palsy"
      }, {
        "text": ", vertigo, meningitis, or brain abscess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOtoscopy:\u003c/b\u003e Examination may reveal a white, cheesy-"
      }, {
        "text": "looking mass behind an intact tympanic membrane or a perforation with keratin debris.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination"
      }, {
        "text": " of chronic, painless, foul-smelling ear discharge and conductive hearing loss is highly suggestive of a cholesteatoma"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003echolesteatoma\u003c/b\u003e is essentially \u0027skin in"
      }, {
        "text": " the wrong place,\u0027 a destructive collection of keratin debris in the middle ear that, through enzymatic erosion, can destroy the delicate"
      }, {
        "text": " structures of hearing and balance and even invade the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"eustachian_tube_"
      }, {
        "text": "dysfunction\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"conduct"
      }, {
        "text": "ive_hearing_loss\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"facial_"
      }, {
        "text": "nerve_palsy\"\n      }\n    ]\n  },\n  \"0835ea"
      }, {
        "text": "01\": {\n    \"title\": \"Cholinesterase Inhibitors\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Autonomic\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCholinesterase inhibitors\u003c/b\u003e (or acetylcholinesterase inhibitors) are a class of drugs that prevent the breakdown of [["
      }, {
        "text": "6a005559|acetylcholine]] by the enzyme acetylcholinesterase (AChE), thereby increasing the concentration"
      }, {
        "text": " and duration of action of acetylcholine in the synaptic cleft.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Inhibit AChE, leading to increased levels of ACh at both muscarinic and nicotinic synapses.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Uses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[77ae6148|Alzheimer Disease"
      }, {
        "text": "]]:\u003c/b\u003e Centrally acting agents ([[47d0372e|donepezil]], rivastigmine, galantamine"
      }, {
        "text": ") are used to improve cognitive symptoms by boosting cortical cholinergic function.\u003cbr\u003e - \u003cb\u003eMyasthenia Gravis:\u003c/b\u003e Per"
      }, {
        "text": "ipherally acting agents (neostigmine, pyridostigmine) increase ACh at the neuromuscular junction to improve muscle"
      }, {
        "text": " strength.\u003cbr\u003e - \u003cb\u003eReversal of Neuromuscular Blockade:\u003c/b\u003e Neostigmine is used to reverse the effects of non"
      }, {
        "text": "-depolarizing neuromuscular blockers after surgery.\u003cbr\u003e - \u003cb\u003eAnticholinergic Toxicity:\u003c/b\u003e Physostigmine,"
      }, {
        "text": " a centrally acting inhibitor, is the antidote for severe anticholinergic overdose.\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxicity (Cholinergic Crisis):\u003c/b\u003e Over"
      }, {
        "text": "dose or exposure to irreversible inhibitors (organophosphates) causes a cholinergic crisis. Mnemonic \u003cb\u003eDUMBBEL"
      }, {
        "text": "SS\u003c/b\u003e: \u003cb\u003eD\u003c/b\u003eiarrhea, \u003cb\u003eU\u003c/b\u003erination, \u003cb\u003eM\u003c/b\u003eiosis, \u003cb\u003eB"
      }, {
        "text": "\u003c/b\u003eronchospasm, \u003cb\u003eB\u003c/b\u003eradycardia, \u003cb\u003eE\u003c/b\u003emesis, \u003cb\u003eL\u003c/b\u003eac"
      }, {
        "text": "rimation, \u003cb\u003eS\u003c/b\u003ealivation, \u003cb\u003eS\u003c/b\u003eweating.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e D"
      }, {
        "text": "ifferentiate between centrally acting (physostigmine, donepezil) and peripherally acting (neostigmine, pyridostigmine) agents"
      }, {
        "text": " based on their ability to cross the blood-brain barrier.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eCholinesterase inhibitors\u003c/b\u003e amplify cholinergic signaling throughout the body by preventing the breakdown of acetylcholine, a mechanism that is therapeutically harnessed"
      }, {
        "text": " to treat conditions of cholinergic deficit like Alzheimer\u0027s disease and myasthenia gravis, but which can become toxic in overdose,"
      }, {
        "text": " leading to a cholinergic crisis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Acetylcholine] --A"
      }, {
        "text": "ChE--\u003e B(Choline + Acetate); C[Cholinesterase Inhibitor] --x B;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"increase_levels_of\",\n        \"to\": \"6a00555"
      }, {
        "text": "9\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"7"
      }, {
        "text": "7ae6148\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"myasthenia_"
      }, {
        "text": "gravis\"\n      },\n      {\n        \"type\": \"is_antidote_for\",\n        \""
      }, {
        "text": "to\": \"anticholinergic_toxicity\"\n      }\n    ]\n  },\n  \"360"
      }, {
        "text": "54a34\": {\n    \"title\": \"Cholinomimetic Agents\",\n    \"primaryType"
      }, {
        "text": "\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Autonomic\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCholinomimetic agents\u003c/b\u003e are drugs that mimic the effects of [[6a005559"
      }, {
        "text": "|acetylcholine]]. They can be classified as direct-acting agonists, which bind directly to cholinergic receptors, or indirect-acting agents"
      }, {
        "text": " ([[0835ea01|cholinesterase inhibitors]]), which increase the synaptic concentration of acetylcholine.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDirect-Acting Agonists:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eB"
      }, {
        "text": "ethanechol:\u003c/b\u003e Muscarinic agonist used for non-obstructive urinary retention and postoperative ileus.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Pilocarpine:\u003c/b\u003e Muscarinic agonist used for [[3ce6c035|glaucoma]] and to"
      }, {
        "text": " treat xerostomia (dry mouth) in Sj√∂gren syndrome.\u003cbr\u003e - \u003cb\u003e[[c1ad76f4"
      }, {
        "text": "|Carbachol]]:\u003c/b\u003e Muscarinic and nicotinic agonist used for [[3ce6c035|"
      }, {
        "text": "glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eIndirect-Acting Agents (Cholinesterase Inhibitors):\u003c/b\u003e See [[0835ea01|"
      }, {
        "text": "Cholinesterase Inhibitors]] card.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEffects:\u003c/b\u003e Produce effects similar to parasympathetic stimulation (rest and"
      }, {
        "text": " digest). Mnemonic \u003cb\u003eDUMBBELSS\u003c/b\u003e (Diarrhea, Urination, Miosis, Bron"
      }, {
        "text": "chospasm, Bradycardia, Emesis, Lacrimation, Salivation, Sweating).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGl"
      }, {
        "text": "aucoma Therapy:\u003c/b\u003e Cholinomimetics like pilocarpine and [[c1ad76f4|"
      }, {
        "text": "carbachol]] are used in [[3ce6c035|glaucoma]] to increase aqueous humor outflow"
      }, {
        "text": " through the trabecular meshwork by contracting the ciliary muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the difference"
      }, {
        "text": " between direct agonists (which bind to the receptor) and indirect agonists (which inhibit the breakdown of the natural ligand). Both"
      }, {
        "text": " result in increased cholinergic stimulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCholinomimetic agents\u003c/b\u003e amplify"
      }, {
        "text": " the \u0027rest and digest\u0027 signals of the parasympathetic nervous system, either by directly stimulating cholinergic receptors or by preventing the breakdown of acetylcholine"
      }, {
        "text": ", with therapeutic applications ranging from glaucoma to urinary retention.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"mimic_effects_of\",\n        \"to\":"
      }, {
        "text": " \"6a005559\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"pilocarpine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \""
      }, {
        "text": "c1ad76f4\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"0835ea01\"\n      }\n    ]\n  },\n  \"0fa"
      }, {
        "text": "0d8ee\": {\n    \"title\": \"Chorea\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Movement Disorders\",\n      \"Pathology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n"
      }, {
        "text": "      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCh"
      }, {
        "text": "orea\u003c/b\u003e (from Greek for \\\"dance\\\") is an involuntary movement disorder characterized by brief, abrupt, irregular, and unpredictable"
      }, {
        "text": " movements that flow from one body part to another. It is a hallmark sign of [[ed462927"
      }, {
        "text": "|basal ganglia]] dysfunction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Movements"
      }, {
        "text": " are non-rhythmic, jerky, and purposeless, often described as \u0027dance-like.\u0027 They can affect the face"
      }, {
        "text": ", limbs, and trunk.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Classically associated with damage to the \u003cmark\u003estriatum\u003c/"
      }, {
        "text": "mark\u003e (specifically the caudate nucleus) in the [[ed462927|basal ganglia]],"
      }, {
        "text": " leading to a loss of inhibition in the indirect pathway and excessive cortical stimulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e The most well"
      }, {
        "text": "-known cause of chorea is \u003cmark\u003e[[ffd7e743|Huntington disease]]\u003c/mark\u003e,"
      }, {
        "text": " an autosomal dominant neurodegenerative disorder.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSydenham Ch"
      }, {
        "text": "orea:\u003c/b\u003e A post-infectious complication of Group A streptococcal infection (rheumatic fever).\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eDrug-induced:\u003c/b\u003e Can be a side effect of long-term levodopa therapy for Parkinson disease.\u003cbr\u003e - \u003cb\u003eOther"
      }, {
        "text": ":\u003c/b\u003e Systemic lupus erythematosus, pregnancy (chorea gravidarum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young"
      }, {
        "text": " to middle-aged adult presenting with new-onset chorea, especially if accompanied by psychiatric changes or a family history,"
      }, {
        "text": " should be evaluated for [[ffd7e743|Huntington disease]]. In a child with a recent sore throat, consider"
      }, {
        "text": " Sydenham chorea.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eChorea\u003c/b\u003e is a hyper"
      }, {
        "text": "kinetic movement disorder that manifests as a continuous, unpredictable \u0027dance\u0027 of the body, resulting from a loss of inhibitory control from"
      }, {
        "text": " the basal ganglia, most famously due to the degeneration of the caudate nucleus in Huntington disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_"
      }, {
        "text": "of\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "symptom_of\",\n        \"to\": \"sydenham_chorea\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"ed"
      }, {
        "text": "462927\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"dyskinesia\"\n      }\n    ]\n  },\n  \"4a27c"
      }, {
        "text": "966\": {\n    \"title\": \"Choroid\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCh"
      }, {
        "text": "oroid\u003c/b\u003e is the vascular layer of the eye, situated between the retina and the sclera. It is part of the uve"
      }, {
        "text": "a and is responsible for providing oxygen and nourishment to the outer layers of the retina.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e The posterior part of the uvea, lying between the retina (inner layer) and the sclera (outer layer"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Its rich blood supply provides essential oxygen and nutrients to the outer retina, including the photore"
      }, {
        "text": "ceptors (rods and cones). It also contains pigment that absorbs excess light, preventing blurring of the image.\u003c/li\u003e\u003cli\u003e\u003cb\u003eB"
      }, {
        "text": "ruch\u0027s Membrane:\u003c/b\u003e The innermost layer of the choroid, which forms a barrier between the choroidal capillaries and the retinal pigment"
      }, {
        "text": " epithelium.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[c63255c8|Age"
      }, {
        "text": "-related Macular Degeneration (AMD)]]:\u003c/b\u003e In wet AMD, abnormal blood vessels grow from the choroid through"
      }, {
        "text": " Bruch\u0027s membrane (choroidal neovascularization), leading to hemorrhage and vision loss.\u003cbr\u003e - \u003cb\u003eChoroid"
      }, {
        "text": "itis:\u003c/b\u003e Inflammation of the choroid, a form of posterior uveitis.\u003cbr\u003e - \u003cb\u003eChoroidal Melanoma:\u003c/b\u003e The"
      }, {
        "text": " most common primary intraocular malignancy in adults.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The choroidal circulation is responsible for the \u0027red"
      }, {
        "text": "\u0027 appearance of the fovea in a [[651ed480|cherry-red spot]], as"
      }, {
        "text": " it remains visible through the thin fovea when the surrounding retina is pale from ischemia or lipid deposition.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe \u003cb\u003eChoroid\u003c/b\u003e is the vital, vascular support system for the photoreceptors of"
      }, {
        "text": " the retina; its integrity is crucial for vision, and its breakdown, as seen in wet macular degeneration, can lead to rapid"
      }, {
        "text": " and severe sight loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"uvea\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "supplies_blood_to\",\n        \"to\": \"retina\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_involved_in_pathophysiology_of\",\n        \"to\": \"c63255"
      }, {
        "text": "c8\"\n      },\n      {\n        \"type\": \"can_be_inflamed_in\",\n        \"to\": \""
      }, {
        "text": "uveitis\"\n      }\n    ]\n  },\n  \"ae65e9c7\": {\n    \"title\":"
      }, {
        "text": " \"Choroid Plexus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy"
      }, {
        "text": "\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eChoroid Plexus\u003c/b\u003e is a specialized, highly"
      }, {
        "text": " vascularized tissue found within the ventricles of the brain that is responsible for the production of most of the cerebrospinal fluid (CSF).\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found in all four ventricles (lateral, third"
      }, {
        "text": ", and fourth).\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Consists of a network of capillaries surrounded by a layer of modified ep"
      }, {
        "text": "endymal cells, which are joined by tight junctions to form the blood-CSF barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e"
      }, {
        "text": " Actively secretes [[7109d8b6|cerebrospinal fluid (CSF)]] into the ventric"
      }, {
        "text": "les. This process involves the transport of ions (Na\u003csup\u003e+\u003c/sup\u003e, Cl\u003csup\u003e-\u003c/sup\u003e, HCO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e"
      }, {
        "text": "-\u003c/sup\u003e) into the ventricles, with water following osmotically.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEnzymes:\u003c/b\u003e The process is dependent"
      }, {
        "text": " on enzymes like carbonic anhydrase.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOverproduction of CSF:\u003c/b\u003e A"
      }, {
        "text": " rare cause of [[0bc2f200|hydrocephalus]] can be a choroid plexus papilloma ("
      }, {
        "text": "a benign tumor).\u003cbr\u003e - \u003cb\u003eChoroid Plexus Cysts:\u003c/b\u003e Often seen on prenatal ultrasound"
      }, {
        "text": "; usually a benign, transient finding but can be a soft marker for chromosomal abnormalities like Trisomy 18.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Remember the simple flow: Choroid plexus \u003cb\u003eproduces\u003c/b\u003e CSF, arachnoid gran"
      }, {
        "text": "ulations \u003cb\u003ereabsorb\u003c/b\u003e CSF. A tumor of the choroid plexus (papilloma) can cause communicating"
      }, {
        "text": " hydrocephalus due to overproduction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eChoroid Plexus\u003c/b\u003e functions"
      }, {
        "text": " as the brain\u0027s \u0027CSF factory,\u0027 a specialized tissue within the ventricles that continuously produces the fluid essential for cushioning"
      }, {
        "text": " and nourishing the central nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --"
      }, {
        "text": "Produces--\u003e B(Cerebrospinal Fluid);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"produces\",\n        \"to\": \"7109d8b6\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"1cb"
      }, {
        "text": "9c975\"\n      },\n      {\n        \"type\": \"tumor_of_can_cause\","
      }, {
        "text": "\n        \"to\": \"0bc2f200\"\n      }\n    ]\n  },\n  \"6d"
      }, {
        "text": "7a091d\": {\n    \"title\": \"Ciliary Ganglion\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"Aut"
      }, {
        "text": "onomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCiliary Ganglion\u003c/b\u003e is a parasympathetic ganglion located"
      }, {
        "text": " in the posterior orbit. It serves as a relay station for parasympathetic fibers that control pupillary constriction (miosis) and lens"
      }, {
        "text": " accommodation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Contains postganglionic paras"
      }, {
        "text": "ympathetic neuron cell bodies that innervate the sphincter pupillae and ciliary muscles of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParas"
      }, {
        "text": "ympathetic Root (Motor):\u003c/b\u003e Preganglionic parasympathetic fibers arise from the \u003cmark\u003eEdinger-Westphal nucleus"
      }, {
        "text": "\u003c/mark\u003e and travel with the [[68c66997|oculomotor nerve (CN III)]] to synapse"
      }, {
        "text": " in the ciliary ganglion.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostganglionic Fibers:\u003c/b\u003e Axons from the ciliary ganglion travel"
      }, {
        "text": " via the short ciliary nerves to the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSphincter Pupillae Muscle"
      }, {
        "text": ":\u003c/b\u003e Contraction causes miosis (pupil constriction).\u003cbr\u003e - \u003cb\u003eCiliary Muscle:\u003c/b\u003e Contraction causes"
      }, {
        "text": " [[81b5f5fe|accommodation]] (rounding of the lens for near vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance"
      }, {
        "text": ":\u003c/b\u003e A lesion in the ciliary ganglion or short ciliary nerves (e.g., Adie\u0027s tonic"
      }, {
        "text": " pupil) results in a dilated pupil that reacts poorly to light but may show a slow, tonic constriction to near vision ("
      }, {
        "text": "light-near dissociation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This ganglion is the final parasympathetic outpost for the eye"
      }, {
        "text": ". Remember the pathway: Edinger-Westphal nucleus ‚Üí CN III ‚Üí Ciliary Ganglion ‚Üí Short ciliary nerves ‚Üí Pup"
      }, {
        "text": "illary constriction and accommodation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCiliary Ganglion\u003c/b\u003e is the"
      }, {
        "text": " crucial parasympathetic relay center for the eye, translating signals from the oculomotor nerve into the commands that constrict the pupil and focus"
      }, {
        "text": " the lens for near vision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Edinger-Westphal"
      }, {
        "text": " Nucleus] --Preganglionic Fibers (CN III)--\u003e B(Ciliary Ganglion); B --Postganglionic Fibers--\u003e"
      }, {
        "text": " C(Sphincter Pupillae \u0026 Ciliary Muscle);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a\",\n        \"to\": \"parasympathetic_ganglion\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"edinger_westphal_nucleus\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"sends_fibers_to\",\n        \"to\": \"sphincter_pupillae"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"sends_fibers_to\",\n        \"to"
      }, {
        "text": "\": \"ciliary_muscle\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "17rEA558iwGuJmhpbITIWUHO9vSr-Akfc"
      },
      "role": "user",
      "tokenCount": 1876
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"c09c459a\": {\n    \"title\": \"Ciliospinal Center of Budge\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCiliospinal Center of Budge\u003c/b\u003e is a group of preganglionic sympathetic neurons located in the intermediolateral cell column of the spinal cord at the \u003cmark\u003eC8-T2\u003c/mark\u003e levels. It is the origin of the second-order neuron in the oculosympathetic pathway, which controls pupillary dilation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Intermediolateral nucleus of the spinal cord from C8 to T2.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e It is the origin of the preganglionic sympathetic fibers that innervate the head and neck, including the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOculosympathetic Pathway:\u003c/b\u003e This is the second neuron in the three-neuron pathway for pupillary dilation:\u003cbr\u003e1. \u003cb\u003eFirst-order neuron:\u003c/b\u003e Descends from the [[89e86633|hypothalamus]] to the Ciliospinal Center.\u003cbr\u003e2. \u003cb\u003eSecond-order neuron:\u003c/b\u003e Ascends from the Ciliospinal Center, through the sympathetic chain, to the superior cervical ganglion.\u003cbr\u003e3. \u003cb\u003eThird-order neuron:\u003c/b\u003e Travels from the superior cervical ganglion to the pupillary dilator muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion affecting the Ciliospinal Center (e.g., spinal cord trauma, syringomyelia) can disrupt the sympathetic supply to the eye, resulting in an ipsilateral [[c19010a3|Horner syndrome]] (ptosis, miosis, anhidrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember this center as the spinal cord \u0027launch point\u0027 for the sympathetic nerves to the eye. A lesion here is a cause of a \u0027preganglionic\u0027 or second-order neuron Horner syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCiliospinal Center of Budge\u003c/b\u003e is the critical spinal cord relay station for the oculosympathetic pathway, launching the preganglionic fibers that ultimately control pupillary dilation; its disruption is a key cause of Horner syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --\u003e B(Ciliospinal Center of Budge C8-T2); B --\u003e C(Superior Cervical Ganglion); C --\u003e D(Pupillary Dilator Muscle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"oculosympathetic_pathway\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"89e86633\"\n      }\n    ]\n  },\n  \"25dc347a\": {\n    \"title\": \"Cingulate (Subfalcine) Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCingulate herniation\u003c/b\u003e, also known as subfalcine herniation, is the most common type of brain herniation. It occurs when an expanding lesion in one cerebral hemisphere pushes the \u003cmark\u003ecingulate gyrus\u003c/mark\u003e under the falx cerebri to the opposite side.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Caused by a unilateral supratentorial mass lesion (e.g., tumor, hematoma, large stroke) that creates a lateral pressure gradient.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure Herniated:\u003c/b\u003e The cingulate gyrus is displaced under the rigid dural fold of the falx cerebri.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Often clinically silent initially, but can be a precursor to more dangerous herniation syndromes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Complication:\u003c/b\u003e The primary complication is compression of the ipsilateral or contralateral \u003cmark\u003e[[830c856c|anterior cerebral artery (ACA)]]\u003c/mark\u003e against the falx cerebri.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConsequence of ACA Compression:\u003c/b\u003e Can lead to an ischemic infarct in the ACA territory, resulting in \u003cmark\u003econtralateral lower extremity weakness\u003c/mark\u003e and sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While often asymptomatic itself, subfalcine herniation is a sign of significant mass effect. Look for the potential complication of ACA compression causing contralateral leg weakness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCingulate herniation\u003c/b\u003e is the sideways shift of the cingulate gyrus under the falx cerebri, which, while often clinically subtle, can have significant consequences by compressing the anterior cerebral artery and causing a stroke in the contralateral leg\u0027s motor cortex.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Unilateral Mass Lesion] --\u003e B(‚Üë Pressure); B --\u003e C(Cingulate Gyrus Herniates under Falx Cerebri); C --Compresses--\u003e D(Anterior Cerebral Artery); D --\u003e E(Contralateral Leg Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n        \"type\": \"involves\",\n        \"to\": \"22e49c50\"\n      },\n      {\n        \"type\": \"can_compress\",\n        \"to\": \"830c856c\"\n      }\n    ]\n  },\n  \"22e49c50\": {\n    \"title\": \"Cingulate Gyrus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCingulate Gyrus\u003c/b\u003e is an arch-shaped cortical structure situated in the medial aspect of each cerebral hemisphere, directly superior to the corpus callosum. It is a key component of the [[73ace357|limbic system]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Medial aspect of the cerebral cortex, forming a \u0027collar\u0027 (Latin: \u003ci\u003ecingulum\u003c/i\u003e) around the corpus callosum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Plays an integral role in processing emotions, learning, and memory. It links behavioral outcomes to motivation (e.g., a behavior resulting in a pleasant outcome is more likely to be repeated).\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnections:\u003c/b\u003e It is a central node in the Papez circuit, a major pathway of the [[73ace357|limbic system]] involved in memory and emotion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dysfunction of the cingulate gyrus is implicated in various psychiatric disorders, including depression and anxiety. In neurology, it is the structure that herniates under the falx cerebri in a \u003cmark\u003e[[25dc347a|cingulate (subfalcine) herniation]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Recognize the cingulate gyrus as a core component of the limbic system involved in emotion and memory, and as the specific structure displaced in subfalcine herniation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCingulate Gyrus\u003c/b\u003e serves as a critical interface between emotion, memory, and behavior within the limbic system, and its anatomical position makes it the primary structure involved in the most common type of brain herniation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"a1b198f9\"\n      },\n      {\n        \"type\": \"herniates_in\",\n        \"to\": \"25dc347a\"\n      }\n    ]\n  },\n  \"0ab894d6\": {\n    \"title\": \"Circadian Rhythm\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCircadian rhythms\u003c/b\u003e are endogenous, near-24-hour cycles of physiological processes, including the sleep-wake cycle, hormone release, and body temperature. These rhythms are controlled by a central \u0027master clock\u0027 in the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMaster Clock:\u003c/b\u003e The central pacemaker for circadian rhythms is the \u003cmark\u003esuprachiasmatic nucleus (SCN)\u003c/mark\u003e, located in the anterior [[89e86633|hypothalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEntrainment:\u003c/b\u003e The SCN is synchronized (entrained) to the 24-hour day primarily by light. Light information from the retina travels via the retinohypothalamic tract to the SCN.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormonal Output:\u003c/b\u003e The SCN controls the release of melatonin from the pineal gland. Light exposure inhibits melatonin release, while darkness stimulates it, promoting sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Disruption of circadian rhythms can lead to sleep disorders (e.g., jet lag, shift work disorder) and is implicated in mood disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The suprachiasmatic nucleus is the key structure to associate with circadian rhythm control. Lesions of the SCN disrupt the sleep-wake cycle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe body\u0027s internal 24-hour clock, or \u003cb\u003ecircadian rhythm\u003c/b\u003e, is orchestrated by the suprachiasmatic nucleus of the hypothalamus, which uses light cues from the environment to synchronize a wide array of physiological and behavioral cycles, most notably the sleep-wake cycle via its control of melatonin.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light] --\u003e B(Retina); B --\u003e C(Suprachiasmatic Nucleus - SCN); C --Inhibits--\u003e D(Pineal Gland); D --Melatonin--\u003e E(Sleep-Wake Cycle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"suprachiasmatic_nucleus\"\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"sleep_wake_cycle\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"melatonin_release\"\n      }\n    ]\n  },\n  \"e22300e8\": {\n    \"title\": \"Circle of Willis\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCircle of Willis\u003c/b\u003e is a ring-like arterial anastomosis located at the base of the brain that connects the anterior (internal carotid) and posterior (vertebrobasilar) circulations. This collateral pathway is crucial for maintaining cerebral perfusion in the event of stenosis or occlusion of one of the major feeding arteries.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnteriorly:\u003c/b\u003e [[bd802d22|Anterior communicating artery]] connecting the two [[830c856c|anterior cerebral arteries (ACAs)]].\u003cbr\u003e - \u003cb\u003eLaterally:\u003c/b\u003e Internal carotid arteries giving rise to the [[143bb23d|middle cerebral arteries (MCAs)]] and ACAs.\u003cbr\u003e - \u003cb\u003ePosteriorly:\u003c/b\u003e Posterior communicating arteries connecting the internal carotids to the [[b6a2cc31|posterior cerebral arteries (PCAs)]], which arise from the [[e7a90cd9|basilar artery]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides collateral circulation to the brain. However, the communicating arteries are often small or absent in many individuals, limiting their effectiveness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is the most common location for \u003cmark\u003e[[a9f6d703|saccular (berry) aneurysms]]\u003c/mark\u003e, which typically form at the branch points.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Aneurysm Sites:\u003c/b\u003e The junction of the [[bd802d22|anterior communicating artery]] with the ACA is the most frequent site, followed by the junction of the posterior communicating artery with the internal carotid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to identify all the components of the Circle of Willis and know that its branch points are weak spots prone to aneurysm formation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCircle of Willis\u003c/b\u003e is the brain\u0027s critical vascular interchange, uniting the anterior and posterior circulations to provide redundant blood flow, but its arterial junctions are also the most common sites of life-threatening berry aneurysms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Internal Carotid] --\u003e B(MCA); A --\u003e C(ACA); D[Vertebral Arteries] --\u003e E(Basilar Artery); E --\u003e F(PCA); G(AComA) --Connects--\u003e C; H(PComA) --Connects--\u003e A \u0026 F;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"connects\",\n        \"to\": \"anterior_circulation\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"posterior_circulation\"\n      },\n      {\n        \"type\": \"is_common_site_for\",\n        \"to\": \"a9f6d703\"\n      }\n    ]\n  },\n  \"cfdd9e2d\": {\n    \"title\": \"Cisatracurium\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCisatracurium\u003c/b\u003e is a non-depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e and a stereoisomer of [[52194edb|atracurium]]. It is used to provide skeletal muscle relaxation during surgery and mechanical ventilation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Like [[52194edb|atracurium]], it undergoes \u003cmark\u003eHoffmann elimination\u003c/mark\u003e (spontaneous, non-enzymatic degradation at physiological pH and temperature), making its metabolism independent of liver or kidney function.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Advantage:\u003c/b\u003e It is preferred over [[52194edb|atracurium]] because it produces \u003cmark\u003eless histamine release\u003c/mark\u003e, resulting in greater hemodynamic stability (less hypotension and tachycardia). It also produces less laudanosine, a potentially neurotoxic metabolite.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A neuromuscular blocker of choice for patients with \u003cmark\u003erenal or hepatic failure\u003c/mark\u003e and for prolonged infusions in the ICU.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e Blockade is reversed by [[0835ea01|acetylcholinesterase inhibitors]] (e.g., neostigmine) combined with an antimuscarinic (e.g., glycopyrrolate).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Cisatracurium \u003d Atracurium with less histamine release. Both are known for Hoffmann elimination, making them safe in organ failure.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCisatracurium\u003c/b\u003e is a refined version of atracurium that retains the key advantage of organ-independent Hoffmann elimination while minimizing the adverse effect of histamine release, making it a safer choice for neuromuscular blockade in critically ill patients.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"is_an_isomer_of\",\n        \"to\": \"52194edb\"\n      },\n      {\n        \"type\": \"undergoes\",\n        \"to\": \"hoffmann_elimination\"\n      }\n    ]\n  },\n  \"ca51f29a\": {\n    \"title\": \"Clasp-Knife Spasticity\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eClasp-knife spasticity\u003c/b\u003e (or clasp-knife rigidity) is a specific type of hypertonia characterized by an initial resistance to passive movement of a joint, which then suddenly gives way. It is a hallmark sign of an \u003cu\u003eupper motor neuron (UMN) lesion\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e When a clinician passively flexes or extends a patient\u0027s limb, there is a velocity-dependent increase in muscle tone causing initial resistance, followed by a sudden collapse of resistance, analogous to the closing of a pocketknife.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is thought to result from an exaggerated stretch reflex due to the loss of descending inhibitory input from the corticospinal tract. The sudden release is mediated by Golgi tendon organs, which sense excessive force and trigger an inhibitory reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is a specific sign of spasticity, which is a component of the \u003cmark\u003eupper motor neuron syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated UMN Signs:\u003c/b\u003e Other UMN signs include weakness (paresis), hyperreflexia, and a positive [[8947da55|Babinski sign]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of clasp-knife spasticity on physical exam helps to localize a lesion to the UMN pathways (cortex, brainstem, or spinal cord), distinguishing it from the rigidity seen in basal ganglia disorders (like Parkinson\u0027s) or the flaccidity of LMN lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eClasp-knife spasticity\u003c/b\u003e is a dynamic form of hypertonia pathognomonic for an upper motor neuron lesion, where initial resistance to passive movement abruptly melts away, reflecting a dysfunctional and exaggerated stretch reflex no longer modulated by descending cortical pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"spasticity\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"rigidity\"\n      }\n    ]\n  },\n  \"2915ead0\": {\n    \"title\": \"Clinical Reflexes\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eClinical reflexes\u003c/b\u003e are involuntary and nearly instantaneous movements in response to a stimulus, which are tested during a neurological examination to assess the integrity of the sensory and motor pathways of the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDeep Tendon Reflexes (DTRs):\u003c/b\u003e Monosynaptic stretch reflexes.\u003cbr\u003e - \u003cb\u003e[[87d19a70|Achilles reflex]]:\u003c/b\u003e S1, S2 (\u0027buckle my shoe\u0027).\u003cbr\u003e - \u003cb\u003ePatellar reflex:\u003c/b\u003e L2, L3, L4 (\u0027kick the door\u0027).\u003cbr\u003e - \u003cb\u003e[[f36cfe18|Biceps]] \u0026 [[ac55d026|Brachioradialis]] reflexes:\u003c/b\u003e C5, C6 (\u0027pick up sticks\u0027).\u003cbr\u003e - \u003cb\u003eTriceps reflex:\u003c/b\u003e C7, C8 (\u0027lay them straight\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSuperficial Reflexes:\u003c/b\u003e Polysynaptic.\u003cbr\u003e - \u003cb\u003e[[ce2052d6|Anal wink reflex]]:\u003c/b\u003e S3, S4 (\u0027winks galore\u0027).\u003cbr\u003e - \u003cb\u003eCremasteric reflex:\u003c/b\u003e L1, L2 (\u0027testicles move\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimitive Reflexes:\u003c/b\u003e Present in infants, disappear with age. Re-emergence in adults suggests frontal lobe damage. Includes Moro, rooting, sucking, palmar, and [[8947da55|Babinski]] reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInterpretation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHyporeflexia/Areflexia:\u003c/b\u003e Suggests a lower motor neuron lesion.\u003cbr\u003e - \u003cb\u003eHyperreflexia:\u003c/b\u003e Suggests an upper motor neuron lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Memorizing the nerve roots for the major DTRs is essential for localizing spinal cord or nerve root lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eTesting \u003cb\u003eclinical reflexes\u003c/b\u003e provides a rapid and powerful window into the functional status of the nervous system, allowing clinicians to localize lesions to specific spinal cord levels and differentiate between upper and lower motor neuron pathologies based on whether the reflexes are exaggerated or diminished.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"87d19a70\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"patellar_reflex\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"f36cfe18\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"triceps_reflex\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"8947da55\"\n      }\n    ]\n  },\n  \"22372d48\": {\n    \"title\": \"Clopidogrel\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Stroke Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eClopidogrel\u003c/b\u003e is an antiplatelet agent that irreversibly blocks the P2Y\u003csub\u003e12\u003c/sub\u003e ADP receptor on platelet surfaces, preventing platelet activation and aggregation. It is used for the prevention of thrombotic events.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a prodrug that is metabolized to its active form by cytochrome P450 enzymes (notably CYP2C19). The active metabolite \u003cmark\u003eirreversibly blocks the P2Y\u003csub\u003e12\u003c/sub\u003e receptor\u003c/mark\u003e, preventing ADP from inducing platelet aggregation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the secondary prevention of atherothrombotic events (myocardial infarction, [[c5da3c57|ischemic stroke]]) in patients with acute coronary syndrome (ACS), recent MI or stroke, or peripheral arterial disease. Often used in combination with aspirin (dual antiplatelet therapy) after coronary stenting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Bleeding is the major side effect. Thrombotic thrombocytopenic purpura (TTP) is a rare but serious adverse effect.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacogenomics:\u003c/b\u003e The effectiveness of clopidogrel can be reduced in patients who are \u0027poor metabolizers\u0027 due to genetic polymorphisms in the \u003cmark\u003eCYP2C19\u003c/mark\u003e enzyme.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Clopidogrel, prasugrel, and ticagrelor are all P2Y\u003csub\u003e12\u003c/sub\u003e inhibitors. Clopidogrel and prasugrel are irreversible inhibitors and prodrugs, while ticagrelor is a reversible inhibitor and not a prodrug.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eClopidogrel\u003c/b\u003e is a cornerstone antiplatelet therapy that works by permanently disabling the P2Y\u003csub\u003e12\u003c/sub\u003e receptor, a key amplifier of platelet aggregation, but its efficacy is dependent on metabolic activation by the genetically variable CYP2C19 enzyme.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Clopidogrel - Prodrug] --CYP2C19--\u003e B(Active Metabolite); B --Irreversibly Blocks--\u003e C(P2Y12 Receptor on Platelet); C --x D(ADP-mediated Aggregation); D --x E(Thrombus Formation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"antiplatelet_drug\"\n      },\n      {\n        \"type\": \"prevents\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"inhibits_receptor\",\n        \"to\": \"p2y12_receptor\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        \"to\": \"cyp2c19\"\n      }\n    ]\n  },\n  \"21760f80\": {\n    \"title\": \"Cluster Headaches\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Headaches\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCluster headaches\u003c/b\u003e are a type of primary headache disorder characterized by recurrent, excruciatingly severe, unilateral periorbital or temporal pain, accompanied by ipsilateral autonomic symptoms. The attacks occur in cyclical patterns or \u0027clusters\u0027.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e More common in males. Onset is typically in young adulthood. Strong association with smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of severe, unilateral, periorbital or temporal pain, often described as \u0027stabbing\u0027 or \u0027boring\u0027. Attacks last 15-180 minutes and occur in clusters (e.g., multiple times a day for weeks), often at the same time each day.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Symptoms:\u003c/b\u003e The pain is accompanied by ipsilateral autonomic signs, such as \u003cmark\u003econjunctival injection, lacrimation, nasal congestion, rhinorrhea\u003c/mark\u003e, sweating, and potentially a transient [[c19010a3|Horner syndrome]] (ptosis, miosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute Treatment:\u003c/b\u003e The two mainstays of acute therapy are \u003cmark\u003e100% oxygen\u003c/mark\u003e via a non-rebreather mask and subcutaneous \u003cmark\u003e[[sumatriptan]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProphylaxis:\u003c/b\u003e \u003cmark\u003eVerapamil\u003c/mark\u003e (a calcium channel blocker) is the first-line prophylactic agent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of severe, unilateral, short-lasting periorbital pain with autonomic features (tearing, runny nose) in a male smoker is the classic vignette for a cluster headache.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCluster headaches\u003c/b\u003e are one of the most painful conditions known, presenting as rapid-fire attacks of unilateral, excruciating periorbital pain accompanied by a storm of autonomic symptoms, which are uniquely responsive to high-flow oxygen and triptans for acute relief.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primary_headache\"\n      },\n      {\n        \"type\": \"is_treated_acutely_by\",\n        \"to\": \"sumatriptan\"\n      },\n      {\n        \"type\": \"is_treated_acutely_by\",\n        \"to\": \"oxygen_therapy\"\n      },\n      {\n        \"type\": \"is_prevented_by\",\n        \"to\": \"verapamil\"\n      }\n    ]\n  },\n  \"fdfd22ca\": {\n    \"title\": \"Oculomotor Nerve (CN III) Palsy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eoculomotor nerve (CN III) palsy\u003c/b\u003e is a condition resulting from damage to the third cranial nerve, leading to impaired function of four of the six extraocular muscles, the levator palpebrae superioris, and the parasympathetic fibers that constrict the pupil.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePresentation:\u003c/b\u003e The affected eye assumes a \u003cmark\u003e\\\"down and out\\\"\u003c/mark\u003e position due to the unopposed action of the lateral rectus (CN VI) and superior oblique (CN IV) muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Signs:\u003c/b\u003e Inability to adduct, elevate, or depress the eye. A severe \u003cmark\u003eptosis\u003c/mark\u003e (eyelid droop) is also present due to paralysis of the levator palpebrae superioris.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupillary Involvement (Rule of the Pupil):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePupil-involving (dilated, nonreactive):\u003c/b\u003e Suggests a \u003cmark\u003ecompressive lesion\u003c/mark\u003e (e.g., posterior communicating artery aneurysm, uncal herniation) because the parasympathetic fibers run on the outside of the nerve and are compressed first.\u003cbr\u003e - \u003cb\u003ePupil-sparing:\u003c/b\u003e Suggests an \u003cmark\u003eischemic lesion\u003c/mark\u003e (e.g., diabetic mononeuropathy) which affects the core of the nerve while sparing the peripheral parasympathetic fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A painful third nerve palsy with a \u0027blown pupil\u0027 is a neurosurgical emergency until a PComA aneurysm is ruled out.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA complete \u003cb\u003eCN III palsy\u003c/b\u003e is a dramatic finding of a \u0027down and out\u0027 eye with a droopy eyelid; the status of the pupil is the critical clue to the etiology, with a dilated pupil pointing to a compressive emergency and a spared pupil suggesting a less urgent ischemic cause.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_lesion_of\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"ptosis\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"mydriasis\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"posterior_communicating_artery_aneurysm\"\n      }\n    ]\n  },\n  \"709aa7c2\": {\n    \"title\": \"Cranial Nerves III, IV, and VI\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eCranial nerves \u003cb\u003eIII (Oculomotor)\u003c/b\u003e, \u003cb\u003eIV (Trochlear)\u003c/b\u003e, and \u003cb\u003eVI (Abducens)\u003c/b\u003e are the three motor nerves responsible for controlling all movements of the eye by innervating the six extraocular muscles.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInnervation Mnemonic:\u003c/b\u003e (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e\u003cbr\u003e - \u003cb\u003eSO\u003csub\u003e4\u003c/sub\u003e:\u003c/b\u003e The \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique muscle is innervated by CN \u003cb\u003eIV\u003c/b\u003e.\u003cbr\u003e - \u003cb\u003eLR\u003csub\u003e6\u003c/sub\u003e:\u003c/b\u003e The \u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eR\u003c/b\u003eectus muscle is innervated by CN \u003cb\u003eVI\u003c/b\u003e.\u003cbr\u003e - \u003cb\u003e\u003csub\u003e3\u003c/sub\u003e:\u003c/b\u003e The remaining four muscles (Superior Rectus, Inferior Rectus, Medial Rectus, Inferior Oblique) are innervated by CN \u003cb\u003eIII\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[68c66997|CN III (Oculomotor)]]:\u003c/b\u003e Moves the eye up, down, and medially. Also lifts the eyelid and constricts the pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[bba6093a|CN IV (Trochlear)]]:\u003c/b\u003e Moves the eye down and in (intorsion).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[dd11dde6|CN VI (Abducens)]]:\u003c/b\u003e Moves the eye laterally (abduction).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCombined Palsies:\u003c/b\u003e Lesions affecting the [[c260efc8|cavernous sinus]] or superior orbital fissure can damage all three nerves simultaneously, leading to total ophthalmoplegia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Testing eye movements (the \u0027H\u0027 pattern) systematically assesses the function of all three nerves and their respective muscles.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe coordinated dance of eye movement is orchestrated by cranial nerves \u003cb\u003eIII, IV, and VI\u003c/b\u003e, each with a specific muscular responsibility that can be remembered by the simple formula (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Eye Movements]; A --\u003e B(CN III - Oculomotor); A --\u003e C(CN IV - Trochlear); A --\u003e D(CN VI - Abducens); B --\u003e E(SR, IR, MR, IO); C --\u003e F(SO); D --\u003e G(LR);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"bba6093a\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"all_pass_through\",\n        \"to\": \"c260efc8\"\n      }\n    ]\n  },\n  \"de532715\": {\n    \"title\": \"Trochlear Nerve (CN IV) Palsy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etrochlear nerve (CN IV) palsy\u003c/b\u003e is a condition resulting from damage to the fourth cranial nerve, leading to weakness of the superior oblique muscle and causing vertical and torsional diplopia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of Superior Oblique:\u003c/b\u003e The primary actions are intorsion (internal rotation) and depression of the eye, especially when the eye is adducted.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation:\u003c/b\u003e The affected eye is elevated and extorted (hypertropia and excyclotorsion). Patients complain of vertical [[9914d433|diplopia]] that is worse when looking down and in (e.g., \u003cmark\u003ereading or walking down stairs\u003c/mark\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCompensatory Head Tilt:\u003c/b\u003e Patients characteristically tilt their head \u003cmark\u003e\u003cu\u003eaway\u003c/u\u003e from the side of the lesion\u003c/mark\u003e to fuse the two images and alleviate the diplopia. This maneuver uses the intact vestibular system to intort the affected eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBielschowsky Head Tilt Test:\u003c/b\u003e A diagnostic test where tilting the head \u003cu\u003etoward\u003c/u\u003e the side of the lesion worsens the vertical deviation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with vertical diplopia who compensates by tilting their head to the opposite shoulder is the classic vignette for a CN IV palsy. Remember: \u0027Can\u0027t see the \u003cb\u003efloor\u003c/b\u003e with CN \u003cb\u003eIV\u003c/b\u003e.\u0027\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCN IV palsy\u003c/b\u003e paralyzes the superior oblique muscle, causing the eye to drift upward and outward, resulting in vertical diplopia that patients instinctively correct by tilting their head away from the affected side.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_lesion_of\",\n        \"to\": \"bba6093a\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"9914d433\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"compensatory_head_tilt\"\n      }\n    ]\n  },\n  \"01c1b782\": {\n    \"title\": \"Abducens Nerve (CN VI) Palsy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eabducens nerve (CN VI) palsy\u003c/b\u003e is a condition resulting from damage to the sixth cranial nerve, leading to weakness of the lateral rectus muscle and an inability to abduct the eye.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of Lateral Rectus:\u003c/b\u003e Abducts the eye (moves it laterally, away from the nose).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation:\u003c/b\u003e The affected eye is deviated medially at rest (esotropia). The patient complains of horizontal [[9914d433|diplopia]] that is \u003cmark\u003eworse on gaze toward the side of the lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Due to its long intracranial course, CN VI is highly vulnerable to stretching from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e (e.g., [[7c4e7c74|idiopathic intracranial hypertension]], hydrocephalus), making it a \u0027false localizing sign.\u0027 Other causes include diabetic mononeuropathy, trauma, and lesions in the pons or [[c260efc8|cavernous sinus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSchwannoma Association:\u003c/b\u003e A [[03ecb69e|schwannoma]] at the cerebellopontine angle can compress CN VI along with CNs VII and VIII.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An isolated CN VI palsy in a patient with headaches and papilledema should raise suspicion for increased intracranial pressure.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCN VI palsy\u003c/b\u003e paralyzes the lateral rectus muscle, causing the eye to turn inward and resulting in horizontal double vision that worsens when looking toward the affected side; its presence can be a nonspecific sign of elevated intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_lesion_of\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"9914d433\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"03ecb69e\"\n      }\n    ]\n  },\n  \"3a4a8ad6\": {\n    \"title\": \"Cocaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Toxicology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Stimulants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCocaine\u003c/b\u003e is a potent central nervous system stimulant and local anesthetic derived from the coca plant. It exerts its primary effects by blocking the reuptake of monoamine neurotransmitters (dopamine, norepinephrine, and serotonin).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eStimulant Effect:\u003c/b\u003e Blocks the reuptake transporters for \u003cmark\u003edopamine, norepinephrine, and serotonin\u003c/mark\u003e, increasing their concentration in the synaptic cleft and leading to sympathetic activation and euphoria.\u003cbr\u003e2. \u003cb\u003eLocal Anesthetic Effect:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing nerve impulse conduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntoxication:\u003c/b\u003e Presents with sympathetic overdrive: mydriasis, hypertension, tachycardia, diaphoresis, agitation, and potentially psychosis. Can cause coronary vasospasm leading to myocardial infarction, and seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWithdrawal:\u003c/b\u003e Characterized by a \u0027crash\u0027 with hypersomnolence, depression, malaise, and severe craving.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiotoxicity:\u003c/b\u003e A major cause of morbidity and mortality. Can cause MI (vasospasm), life-threatening arrhythmias (Na\u003csup\u003e+\u003c/sup\u003e channel blockade), and aortic dissection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with chest pain and signs of sympathetic activation, suspect cocaine use. \u003cu\u003eBeta-blockers are contraindicated\u003c/u\u003e in cocaine-induced chest pain as they can lead to unopposed Œ±-adrenergic stimulation, worsening hypertension and coronary vasospasm. Treat with benzodiazepines.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCocaine\u003c/b\u003e is a dual-action drug, acting as a powerful CNS stimulant by blocking monoamine reuptake and as a local anesthetic by blocking sodium channels; its major danger lies in the profound sympathetic stimulation, which can precipitate life-threatening cardiovascular events like myocardial infarction and arrhythmias.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cocaine] --\u003e B(Blocks Monoamine Reuptake); B --\u003e C(‚Üë Dopamine, Norepinephrine, Serotonin); C --\u003e D(Sympathetic Activation \u0026 Euphoria); A --\u003e E(Blocks Na+ Channels); E --\u003e F(Local Anesthesia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"stimulant\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"blocks_reuptake_of\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"blocks_reuptake_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"blocks_reuptake_of\",\n        \"to\": \"5d3c2089\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10058,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"c09c459a\": {\n    \"title"
      }, {
        "text": "\": \"Ciliospinal Center of Budge\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sp"
      }, {
        "text": "inal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCiliospinal Center of Bud"
      }, {
        "text": "ge\u003c/b\u003e is a group of preganglionic sympathetic neurons located in the intermediolateral cell column of the spinal cord at"
      }, {
        "text": " the \u003cmark\u003eC8-T2\u003c/mark\u003e levels. It is the origin of the second-order neuron in the oculosympathetic pathway"
      }, {
        "text": ", which controls pupillary dilation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Intermediolateral nucleus"
      }, {
        "text": " of the spinal cord from C8 to T2.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e It is the origin of the pre"
      }, {
        "text": "ganglionic sympathetic fibers that innervate the head and neck, including the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOculosympathetic Pathway:\u003c/b\u003e This"
      }, {
        "text": " is the second neuron in the three-neuron pathway for pupillary dilation:\u003cbr\u003e1. \u003cb\u003eFirst-order neuron:"
      }, {
        "text": "\u003c/b\u003e Descends from the [[89e86633|hypothalamus]] to the Ciliospinal Center.\u003c"
      }, {
        "text": "br\u003e2. \u003cb\u003eSecond-order neuron:\u003c/b\u003e Ascends from the Ciliospinal Center, through the sympathetic"
      }, {
        "text": " chain, to the superior cervical ganglion.\u003cbr\u003e3. \u003cb\u003eThird-order neuron:\u003c/b\u003e Travels from the superior cervical ganglion to the pup"
      }, {
        "text": "illary dilator muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion affecting the Ciliospinal Center (e.g., spinal"
      }, {
        "text": " cord trauma, syringomyelia) can disrupt the sympathetic supply to the eye, resulting in an ipsilateral [[c1"
      }, {
        "text": "9010a3|Horner syndrome]] (ptosis, miosis, anhidrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Remember this center as the spinal cord \u0027launch point\u0027 for the sympathetic nerves to the eye. A lesion here is"
      }, {
        "text": " a cause of a \u0027preganglionic\u0027 or second-order neuron Horner syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eCiliospinal Center of Budge\u003c/b\u003e is the critical spinal cord relay station for the o"
      }, {
        "text": "culosympathetic pathway, launching the preganglionic fibers that ultimately control pupillary dilation; its disruption is a key cause of Horner"
      }, {
        "text": " syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --\u003e B(Ciliospinal Center of Budge"
      }, {
        "text": " C8-T2); B --\u003e C(Superior Cervical Ganglion); C --\u003e D(Pupillary Dilator Muscle"
      }, {
        "text": ");\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \""
      }, {
        "text": "to\": \"oculosympathetic_pathway\"\n      },\n      {\n        \"type\": \"lesion_causes"
      }, {
        "text": "\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"receives_input_from\",\n        \"to\": \"89e8663"
      }, {
        "text": "3\"\n      }\n    ]\n  },\n  \"25dc347a\": {\n    \""
      }, {
        "text": "title\": \"Cingulate (Subfalcine) Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCingulate herni"
      }, {
        "text": "ation\u003c/b\u003e, also known as subfalcine herniation, is the most common type of brain herniation. It occurs when an"
      }, {
        "text": " expanding lesion in one cerebral hemisphere pushes the \u003cmark\u003ecingulate gyrus\u003c/mark\u003e under the falx cerebri to"
      }, {
        "text": " the opposite side.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Caused by a"
      }, {
        "text": " unilateral supratentorial mass lesion (e.g., tumor, hematoma, large stroke) that creates a lateral pressure"
      }, {
        "text": " gradient.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure Herniated:\u003c/b\u003e The cingulate gyrus is displaced under the rigid dural fold"
      }, {
        "text": " of the falx cerebri.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Often clinically silent initially, but can be a precursor"
      }, {
        "text": " to more dangerous herniation syndromes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Complication:\u003c/b\u003e The primary complication is compression of the ips"
      }, {
        "text": "ilateral or contralateral \u003cmark\u003e[[830c856c|anterior cerebral artery (ACA)]]\u003c/mark\u003e against"
      }, {
        "text": " the falx cerebri.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConsequence of ACA Compression:\u003c/b\u003e Can lead to an ischemic infarct in the ACA territory, resulting in \u003c"
      }, {
        "text": "mark\u003econtralateral lower extremity weakness\u003c/mark\u003e and sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While"
      }, {
        "text": " often asymptomatic itself, subfalcine herniation is a sign of significant mass effect. Look for the potential complication of ACA compression causing"
      }, {
        "text": " contralateral leg weakness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCingulate herniation\u003c/b\u003e is the"
      }, {
        "text": " sideways shift of the cingulate gyrus under the falx cerebri, which, while often clinically subtle, can have"
      }, {
        "text": " significant consequences by compressing the anterior cerebral artery and causing a stroke in the contralateral leg\u0027s motor cortex.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Unilateral Mass Lesion] --\u003e B(‚Üë Pressure); B --\u003e C(C"
      }, {
        "text": "ingulate Gyrus Herniates under Falx Cerebri); C --Compresses--\u003e D(Anterior Cerebral Artery); D --\u003e"
      }, {
        "text": " E(Contralateral Leg Weakness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"involves\",\n        \"to\": \"22e49c50\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"can_compress\",\n        \"to\": \"830c856c"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"22e49c50\": {\n"
      }, {
        "text": "    \"title\": \"Cingulate Gyrus\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eCingulate Gyrus\u003c/b\u003e is an arch-shaped cortical structure situated in the medial aspect of each cerebral hemisphere, directly"
      }, {
        "text": " superior to the corpus callosum. It is a key component of the [[73ace357|limbic system]].\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Medial aspect of the cerebral cortex, forming a \u0027"
      }, {
        "text": "collar\u0027 (Latin: \u003ci\u003ecingulum\u003c/i\u003e) around the corpus callosum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Plays"
      }, {
        "text": " an integral role in processing emotions, learning, and memory. It links behavioral outcomes to motivation (e.g., a"
      }, {
        "text": " behavior resulting in a pleasant outcome is more likely to be repeated).\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnections:\u003c/b\u003e It is a central node"
      }, {
        "text": " in the Papez circuit, a major pathway of the [[73ace357|limbic system]] involved in memory and"
      }, {
        "text": " emotion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Dysfunction of the cingulate gyrus is implicated in various psychiatric disorders, including depression"
      }, {
        "text": " and anxiety. In neurology, it is the structure that herniates under the falx cerebri in a \u003cmark\u003e[[25dc34"
      }, {
        "text": "7a|cingulate (subfalcine) herniation]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Recognize the cingulate gyrus as a core component of the limbic system involved in emotion and memory, and as"
      }, {
        "text": " the specific structure displaced in subfalcine herniation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCingulate"
      }, {
        "text": " Gyrus\u003c/b\u003e serves as a critical interface between emotion, memory, and behavior within the limbic system, and its anatomical"
      }, {
        "text": " position makes it the primary structure involved in the most common type of brain herniation.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \""
      }, {
        "text": "73ace357\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \""
      }, {
        "text": "a1b198f9\"\n      },\n      {\n        \"type\": \"herniates"
      }, {
        "text": "_in\",\n        \"to\": \"25dc347a\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"0ab894d6\": {\n    \"title\": \"Circadian Rhythm\",\n    \""
      }, {
        "text": "primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Endocrinology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eCircadian rhythms\u003c/b\u003e are endogenous, near-24-hour cycles of physiological processes,"
      }, {
        "text": " including the sleep-wake cycle, hormone release, and body temperature. These rhythms are controlled by a central \u0027master clock\u0027 in"
      }, {
        "text": " the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMaster Clock:\u003c/b\u003e The central pacemaker for circadian"
      }, {
        "text": " rhythms is the \u003cmark\u003esuprachiasmatic nucleus (SCN)\u003c/mark\u003e, located in the anterior [[89e8663"
      }, {
        "text": "3|hypothalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEntrainment:\u003c/b\u003e The SCN is synchronized (entrained) to the 24"
      }, {
        "text": "-hour day primarily by light. Light information from the retina travels via the retinohypothalamic tract to the"
      }, {
        "text": " SCN.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHormonal Output:\u003c/b\u003e The SCN controls the release of melatonin from the pineal gland. Light exposure"
      }, {
        "text": " inhibits melatonin release, while darkness stimulates it, promoting sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Disruption of circadian rhythms can"
      }, {
        "text": " lead to sleep disorders (e.g., jet lag, shift work disorder) and is implicated in mood disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The suprachiasmatic nucleus is the key structure to associate with circadian rhythm control. Lesions of"
      }, {
        "text": " the SCN disrupt the sleep-wake cycle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe body"
      }, {
        "text": "\u0027s internal 24-hour clock, or \u003cb\u003ecircadian rhythm\u003c/b\u003e, is orchestrated by the suprachiasmatic nucleus of the hypothalamus,"
      }, {
        "text": " which uses light cues from the environment to synchronize a wide array of physiological and behavioral cycles, most notably the sleep-wake cycle via"
      }, {
        "text": " its control of melatonin.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light] --\u003e B(Ret"
      }, {
        "text": "ina); B --\u003e C(Suprachiasmatic Nucleus - SCN); C --Inhibits--\u003e D(Pine"
      }, {
        "text": "al Gland); D --Melatonin--\u003e E(Sleep-Wake Cycle);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_controlled_by\",\n        \"to\": \"suprachiasmatic_nucleus\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"89e8663"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"sleep_wake"
      }, {
        "text": "_cycle\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"melatonin_release\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"e22300e8\": {\n    \"title\": \""
      }, {
        "text": "Circle of Willis\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      "
      }, {
        "text": "\"Cerebrovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCircle of Willis\u003c/b\u003e is a ring-like arterial"
      }, {
        "text": " anastomosis located at the base of the brain that connects the anterior (internal carotid) and posterior (vertebrobasilar) circ"
      }, {
        "text": "ulations. This collateral pathway is crucial for maintaining cerebral perfusion in the event of stenosis or occlusion of one of the major feeding arteries.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnteriorly:\u003c/b\u003e [[bd"
      }, {
        "text": "802d22|Anterior communicating artery]] connecting the two [[830c856c|anterior cerebral arteries"
      }, {
        "text": " (ACAs)]].\u003cbr\u003e - \u003cb\u003eLaterally:\u003c/b\u003e Internal carotid arteries giving rise to the [[1"
      }, {
        "text": "43bb23d|middle cerebral arteries (MCAs)]] and ACAs.\u003cbr\u003e - \u003cb\u003ePoster"
      }, {
        "text": "iorly:\u003c/b\u003e Posterior communicating arteries connecting the internal carotids to the [[b6a2cc31|posterior cerebral arteries (PC"
      }, {
        "text": "As)]], which arise from the [[e7a90cd9|basilar artery]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Provides collateral circulation to the brain. However, the communicating arteries are often small or absent in many individuals, limiting"
      }, {
        "text": " their effectiveness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is the most common location for \u003cmark\u003e[[a9f"
      }, {
        "text": "6d703|saccular (berry) aneurysms]]\u003c/mark\u003e, which typically form at the branch"
      }, {
        "text": " points.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Aneurysm Sites:\u003c/b\u003e The junction of the [[bd802d22|anterior"
      }, {
        "text": " communicating artery]] with the ACA is the most frequent site, followed by the junction of the posterior communicating artery with the internal"
      }, {
        "text": " carotid.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to identify all the components of the Circle of Willis and know"
      }, {
        "text": " that its branch points are weak spots prone to aneurysm formation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eCircle of Willis\u003c/b\u003e is the brain\u0027s critical vascular interchange, uniting the anterior and posterior circulations to provide redundant"
      }, {
        "text": " blood flow, but its arterial junctions are also the most common sites of life-threatening berry aneurysms.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Internal Carotid] --\u003e B(MCA); A --\u003e C(ACA); D"
      }, {
        "text": "[Vertebral Arteries] --\u003e E(Basilar Artery); E --\u003e F(PCA); G(A"
      }, {
        "text": "ComA) --Connects--\u003e C; H(PComA) --Connects--\u003e A \u0026 F;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"connects\",\n        \"to\": \"anterior_circulation\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"connects\",\n        \"to\": \"posterior_circulation\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_common_site_for\",\n        \"to\": \"a"
      }, {
        "text": "9f6d703\"\n      }\n    ]\n  },\n  \"cfdd9e"
      }, {
        "text": "2d\": {\n    \"title\": \"Cisatracurium\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eCisatracurium\u003c/b\u003e is a non-depolarizing \u003ci\u003eneuromuscular blocking"
      }, {
        "text": " agent\u003c/i\u003e and a stereoisomer of [[52194edb|atracurium]]. It is used to"
      }, {
        "text": " provide skeletal muscle relaxation during surgery and mechanical ventilation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Like"
      }, {
        "text": " [[52194edb|atracurium]], it undergoes \u003cmark\u003eHoffmann elimination\u003c/mark\u003e"
      }, {
        "text": " (spontaneous, non-enzymatic degradation at physiological pH and temperature), making its metabolism independent of liver or kidney function.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Advantage:\u003c/b\u003e It is preferred over [[52194edb|atracurium]] because it produces \u003cmark\u003eless"
      }, {
        "text": " histamine release\u003c/mark\u003e, resulting in greater hemodynamic stability (less hypotension and tachycardia). It also produces less laudanosine, a potentially"
      }, {
        "text": " neurotoxic metabolite.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A neuromuscular blocker of choice for patients with \u003cmark\u003erenal or hepatic failure\u003c/mark\u003e and"
      }, {
        "text": " for prolonged infusions in the ICU.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e Blockade is reversed by [[0835"
      }, {
        "text": "ea01|acetylcholinesterase inhibitors]] (e.g., neostigmine) combined with an ant"
      }, {
        "text": "imuscarinic (e.g., glycopyrrolate).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Cisatracurium \u003d"
      }, {
        "text": " Atracurium with less histamine release. Both are known for Hoffmann elimination, making them safe in organ failure.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eCisatracurium\u003c/b\u003e is a refined version of atracurium that retains the key advantage of organ-independent Hoffmann"
      }, {
        "text": " elimination while minimizing the adverse effect of histamine release, making it a safer choice for neuromuscular blockade in critically ill patients.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_an_isomer_of\",\n        \"to\": \"52194"
      }, {
        "text": "edb\"\n      },\n      {\n        \"type\": \"undergoes\",\n        \"to\": \"hoff"
      }, {
        "text": "mann_elimination\"\n      }\n    ]\n  },\n  \"ca51f29a\": {\n    \""
      }, {
        "text": "title\": \"Clasp-Knife Spasticity\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron"
      }, {
        "text": " Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eClasp-knife sp"
      }, {
        "text": "asticity\u003c/b\u003e (or clasp-knife rigidity) is a specific type of hypertonia characterized by an initial resistance to passive movement of"
      }, {
        "text": " a joint, which then suddenly gives way. It is a hallmark sign of an \u003cu\u003eupper motor neuron (UMN) lesion\u003c/u\u003e"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e When a clinician passively flexes or"
      }, {
        "text": " extends a patient\u0027s limb, there is a velocity-dependent increase in muscle tone causing initial resistance, followed by a sudden collapse"
      }, {
        "text": " of resistance, analogous to the closing of a pocketknife.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e It is thought to result"
      }, {
        "text": " from an exaggerated stretch reflex due to the loss of descending inhibitory input from the corticospinal tract. The sudden release is"
      }, {
        "text": " mediated by Golgi tendon organs, which sense excessive force and trigger an inhibitory reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is a specific"
      }, {
        "text": " sign of spasticity, which is a component of the \u003cmark\u003eupper motor neuron syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " UMN Signs:\u003c/b\u003e Other UMN signs include weakness (paresis), hyperreflexia, and a positive [[89"
      }, {
        "text": "47da55|Babinski sign]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of clasp-knife spasticity"
      }, {
        "text": " on physical exam helps to localize a lesion to the UMN pathways (cortex, brainstem, or spinal cord),"
      }, {
        "text": " distinguishing it from the rigidity seen in basal ganglia disorders (like Parkinson\u0027s) or the flaccidity of LMN lesions"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eClasp-knife spasticity\u003c/b\u003e is a dynamic"
      }, {
        "text": " form of hypertonia pathognomonic for an upper motor neuron lesion, where initial resistance to passive movement abruptly melts"
      }, {
        "text": " away, reflecting a dysfunctional and exaggerated stretch reflex no longer modulated by descending cortical pathways.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign"
      }, {
        "text": "_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"spasticity\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"rigidity\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"2915ead0\": {\n    \"title\":"
      }, {
        "text": " \"Clinical Reflexes\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eClinical reflexes\u003c/b\u003e are involuntary and nearly instantaneous movements"
      }, {
        "text": " in response to a stimulus, which are tested during a neurological examination to assess the integrity of the sensory and motor pathways of"
      }, {
        "text": " the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDeep Tendon Reflexes (D"
      }, {
        "text": "TRs):\u003c/b\u003e Monosynaptic stretch reflexes.\u003cbr\u003e - \u003cb\u003e[[87d19a70|Achilles reflex"
      }, {
        "text": "]]:\u003c/b\u003e S1, S2 (\u0027buckle my shoe\u0027).\u003cbr\u003e - \u003cb\u003ePatellar reflex:\u003c/b\u003e L2, L"
      }, {
        "text": "3, L4 (\u0027kick the door\u0027).\u003cbr\u003e - \u003cb\u003e[[f36cfe18|B"
      }, {
        "text": "iceps]] \u0026 [[ac55d026|Brachioradialis]] reflexes:\u003c/b\u003e C5, C6 (\u0027pick"
      }, {
        "text": " up sticks\u0027).\u003cbr\u003e - \u003cb\u003eTriceps reflex:\u003c/b\u003e C7, C8 (\u0027lay them straight\u0027).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eSuperficial Reflexes:\u003c/b\u003e Polysynaptic.\u003cbr\u003e - \u003cb\u003e[[ce2052"
      }, {
        "text": "d6|Anal wink reflex]]:\u003c/b\u003e S3, S4 (\u0027winks galore\u0027).\u003cbr\u003e - \u003cb\u003eC"
      }, {
        "text": "remasteric reflex:\u003c/b\u003e L1, L2 (\u0027testicles move\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimitive Reflexes:\u003c/b\u003e Present"
      }, {
        "text": " in infants, disappear with age. Re-emergence in adults suggests frontal lobe damage. Includes Moro, rooting, sucking"
      }, {
        "text": ", palmar, and [[8947da55|Babinski]] reflexes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInterpretation:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eHyporeflexia/Areflexia:\u003c/b\u003e Suggests a lower motor neuron lesion.\u003cbr\u003e - \u003cb\u003eHyperreflex"
      }, {
        "text": "ia:\u003c/b\u003e Suggests an upper motor neuron lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Memorizing the nerve roots"
      }, {
        "text": " for the major DTRs is essential for localizing spinal cord or nerve root lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eTesting"
      }, {
        "text": " \u003cb\u003eclinical reflexes\u003c/b\u003e provides a rapid and powerful window into the functional status of the nervous system, allowing clinicians to localize"
      }, {
        "text": " lesions to specific spinal cord levels and differentiate between upper and lower motor neuron pathologies based on whether the reflexes are exaggerated or diminished"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"includes\",\n        \"to\": \"87d19a70\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"patellar_reflex\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"f36cfe18\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"triceps_reflex\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"8947da55\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"22372d48\": {\n    \"title"
      }, {
        "text": "\": \"Clopidogrel\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology"
      }, {
        "text": "\",\n      \"Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Stroke Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eClopidogrel"
      }, {
        "text": "\u003c/b\u003e is an antiplatelet agent that irreversibly blocks the P2Y\u003csub\u003e12\u003c/sub\u003e ADP receptor on platelet surfaces, preventing"
      }, {
        "text": " platelet activation and aggregation. It is used for the prevention of thrombotic events.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a prodrug that is metabolized to its active form by cytochrome"
      }, {
        "text": " P450 enzymes (notably CYP2C19). The active metabolite \u003cmark\u003eirreversibly blocks the"
      }, {
        "text": " P2Y\u003csub\u003e12\u003c/sub\u003e receptor\u003c/mark\u003e, preventing ADP from inducing platelet aggregation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used"
      }, {
        "text": " for the secondary prevention of atherothrombotic events (myocardial infarction, [[c5da3c57|ische"
      }, {
        "text": "mic stroke]]) in patients with acute coronary syndrome (ACS), recent MI or stroke, or peripheral arterial disease. Often used in combination with aspirin ("
      }, {
        "text": "dual antiplatelet therapy) after coronary stenting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Bleeding is the major"
      }, {
        "text": " side effect. Thrombotic thrombocytopenic purpura (TTP) is a rare but serious adverse effect.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacogenomics"
      }, {
        "text": ":\u003c/b\u003e The effectiveness of clopidogrel can be reduced in patients who are \u0027poor metabolizers\u0027 due to genetic polymorphisms"
      }, {
        "text": " in the \u003cmark\u003eCYP2C19\u003c/mark\u003e enzyme.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Clopidogrel, prasugrel, and ticagrelor are all P2Y\u003csub\u003e12\u003c/sub\u003e inhibitors"
      }, {
        "text": ". Clopidogrel and prasugrel are irreversible inhibitors and prodrugs, while ticagrelor is a reversible inhibitor"
      }, {
        "text": " and not a prodrug.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eClopidogrel\u003c/b\u003e is"
      }, {
        "text": " a cornerstone antiplatelet therapy that works by permanently disabling the P2Y\u003csub\u003e12\u003c/sub\u003e receptor, a key amplifier"
      }, {
        "text": " of platelet aggregation, but its efficacy is dependent on metabolic activation by the genetically variable CYP2C19 enzyme.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Clopidogrel - Prodrug] --CYP2C19--\u003e B(Active Metabol"
      }, {
        "text": "ite); B --Irreversibly Blocks--\u003e C(P2Y12 Receptor on Platelet); C --"
      }, {
        "text": "x D(ADP-mediated Aggregation); D --x E(Thrombus Formation);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"antiplatelet_"
      }, {
        "text": "drug\"\n      },\n      {\n        \"type\": \"prevents\",\n        \"to\": \"c"
      }, {
        "text": "5da3c57\"\n      },\n      {\n        \"type\": \"inhibits_receptor\",\n        \"to\": \"p"
      }, {
        "text": "2y12_receptor\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        "
      }, {
        "text": "\"to\": \"cyp2c19\"\n      }\n    ]\n  },\n  \"2"
      }, {
        "text": "1760f80\": {\n    \"title\": \"Cluster Headaches\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Head"
      }, {
        "text": "aches\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCluster headaches\u003c/b\u003e are a type of primary"
      }, {
        "text": " headache disorder characterized by recurrent, excruciatingly severe, unilateral periorbital or temporal pain, accompanied by ipsilateral autonomic symptoms"
      }, {
        "text": ". The attacks occur in cyclical patterns or \u0027clusters\u0027.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eEpidemiology:\u003c/b\u003e More common in males. Onset is typically in young adulthood. Strong association with smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation"
      }, {
        "text": ":\u003c/b\u003e Sudden onset of severe, unilateral, periorbital or temporal pain, often described as \u0027stabbing\u0027"
      }, {
        "text": " or \u0027boring\u0027. Attacks last 15-180 minutes and occur in clusters (e.g., multiple"
      }, {
        "text": " times a day for weeks), often at the same time each day.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Symptoms:\u003c/b\u003e The pain"
      }, {
        "text": " is accompanied by ipsilateral autonomic signs, such as \u003cmark\u003econjunctival injection, lacrimation, nasal congestion, rhin"
      }, {
        "text": "orrhea\u003c/mark\u003e, sweating, and potentially a transient [[c19010a3|Horner syndrome]] ("
      }, {
        "text": "ptosis, miosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute Treatment:\u003c/b\u003e The two mainstays of acute therapy are \u003cmark\u003e100%"
      }, {
        "text": " oxygen\u003c/mark\u003e via a non-rebreather mask and subcutaneous \u003cmark\u003e[[sumatriptan]]\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eProphylaxis:\u003c/b\u003e \u003cmark\u003eVerapamil\u003c/mark\u003e (a calcium channel blocker) is the"
      }, {
        "text": " first-line prophylactic agent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of severe, unilateral, short-lasting"
      }, {
        "text": " periorbital pain with autonomic features (tearing, runny nose) in a male smoker is the classic vignette for a"
      }, {
        "text": " cluster headache.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCluster headaches\u003c/b\u003e are one of the most painful"
      }, {
        "text": " conditions known, presenting as rapid-fire attacks of unilateral, excruciating periorbital pain accompanied by a storm of autonomic symptoms"
      }, {
        "text": ", which are uniquely responsive to high-flow oxygen and triptans for acute relief.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"primary_headache\"\n      },\n      {\n        \"type\": \"is_treated_ac"
      }, {
        "text": "utely_by\",\n        \"to\": \"sumatriptan\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_treated_acutely_by\",\n        \"to\": \"oxygen_therapy\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_prevented_by\",\n        \"to\": \"verapamil\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"fdfd22ca\": {\n    \"title\": \"Oculomotor Nerve (CN III"
      }, {
        "text": ") Palsy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003eAn \u003cb\u003eoculomotor nerve (CN III) palsy\u003c/b\u003e is a condition resulting from damage to the third"
      }, {
        "text": " cranial nerve, leading to impaired function of four of the six extraocular muscles, the levator palpebrae superior"
      }, {
        "text": "is, and the parasympathetic fibers that constrict the pupil.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePresentation"
      }, {
        "text": ":\u003c/b\u003e The affected eye assumes a \u003cmark\u003e\\\"down and out\\\"\u003c/mark\u003e position due to the unopposed action of the lateral"
      }, {
        "text": " rectus (CN VI) and superior oblique (CN IV) muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Signs:\u003c/b\u003e Inability"
      }, {
        "text": " to adduct, elevate, or depress the eye. A severe \u003cmark\u003eptosis\u003c/mark\u003e (eyelid dro"
      }, {
        "text": "op) is also present due to paralysis of the levator palpebrae superioris.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePupillary Involvement"
      }, {
        "text": " (Rule of the Pupil):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePupil-involving (dilated, nonreactive"
      }, {
        "text": "):\u003c/b\u003e Suggests a \u003cmark\u003ecompressive lesion\u003c/mark\u003e (e.g., posterior communicating artery aneurysm,"
      }, {
        "text": " uncal herniation) because the parasympathetic fibers run on the outside of the nerve and are compressed first.\u003cbr\u003e - \u003cb\u003ePup"
      }, {
        "text": "il-sparing:\u003c/b\u003e Suggests an \u003cmark\u003eischemic lesion\u003c/mark\u003e (e.g., diabetic mon"
      }, {
        "text": "oneuropathy) which affects the core of the nerve while sparing the peripheral parasympathetic fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " painful third nerve palsy with a \u0027blown pupil\u0027 is a neurosurgical emergency until a PComA aneurysm is ruled out.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eA complete \u003cb\u003eCN III palsy\u003c/b\u003e is a dramatic finding of a \u0027down and out\u0027 eye"
      }, {
        "text": " with a droopy eyelid; the status of the pupil is the critical clue to the etiology, with a dilated pupil pointing"
      }, {
        "text": " to a compressive emergency and a spared pupil suggesting a less urgent ischemic cause.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_lesion_of\",\n        \"to"
      }, {
        "text": "\": \"68c66997\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"ptosis\"\n      },\n      {\n        \"type\": \"presents_"
      }, {
        "text": "with\",\n        \"to\": \"mydriasis\"\n      },\n      {\n        \"type\": \"can_be_caused_by"
      }, {
        "text": "\",\n        \"to\": \"posterior_communicating_artery_aneurysm\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"709aa7c2\": {\n    \"title\": \"Cranial Nerves III"
      }, {
        "text": ", IV, and VI\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eCranial nerves \u003cb\u003eIII (Oculomotor)"
      }, {
        "text": "\u003c/b\u003e, \u003cb\u003eIV (Trochlear)\u003c/b\u003e, and \u003cb\u003eVI (Abducens)\u003c/b\u003e are the three motor"
      }, {
        "text": " nerves responsible for controlling all movements of the eye by innervating the six extraocular muscles.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eInnervation Mnemonic:\u003c/b\u003e (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e\u003cbr\u003e - \u003cb\u003eSO"
      }, {
        "text": "\u003csub\u003e4\u003c/sub\u003e:\u003c/b\u003e The \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique muscle is innervated by CN"
      }, {
        "text": " \u003cb\u003eIV\u003c/b\u003e.\u003cbr\u003e - \u003cb\u003eLR\u003csub\u003e6\u003c/sub\u003e:\u003c/b\u003e The \u003cb\u003eL\u003c/b\u003eateral \u003cb\u003eR"
      }, {
        "text": "\u003c/b\u003eectus muscle is innervated by CN \u003cb\u003eVI\u003c/b\u003e.\u003cbr\u003e - \u003cb\u003e\u003csub\u003e3\u003c/sub\u003e:"
      }, {
        "text": "\u003c/b\u003e The remaining four muscles (Superior Rectus, Inferior Rectus, Medial Rectus, Inferior Oblique) are innervated by CN"
      }, {
        "text": " \u003cb\u003eIII\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[68c66997|CN III (Oculomotor)]"
      }, {
        "text": "]:\u003c/b\u003e Moves the eye up, down, and medially. Also lifts the eyelid and constricts the pupil.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003e[[bba6093a|CN IV (Trochlear)]]:\u003c/b\u003e Moves the eye down and in (int"
      }, {
        "text": "orsion).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[dd11dde6|CN VI (Abducens)]]:\u003c/b\u003e Moves the eye laterally"
      }, {
        "text": " (abduction).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCombined Palsies:\u003c/b\u003e Lesions affecting the [[c260efc8"
      }, {
        "text": "|cavernous sinus]] or superior orbital fissure can damage all three nerves simultaneously, leading to total ophthalmoplegia."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Testing eye movements (the \u0027H\u0027 pattern) systematically assesses the function of all"
      }, {
        "text": " three nerves and their respective muscles.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe coordinated dance of eye"
      }, {
        "text": " movement is orchestrated by cranial nerves \u003cb\u003eIII, IV, and VI\u003c/b\u003e, each with a specific muscular responsibility that can be remembered"
      }, {
        "text": " by the simple formula (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Eye Movements]; A --\u003e B(CN III - Oculomotor); A --\u003e C(CN IV - Tro"
      }, {
        "text": "chlear); A --\u003e D(CN VI - Abducens); B --\u003e E(SR, IR, MR, IO); C --\u003e F"
      }, {
        "text": "(SO); D --\u003e G(LR);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"68c66997\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"bba6093a\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"all_pass_through\",\n        \"to\": \"c260efc8\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"de532715\": {\n    \"title"
      }, {
        "text": "\": \"Trochlear Nerve (CN IV) Palsy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etrochlear nerve (CN IV) palsy"
      }, {
        "text": "\u003c/b\u003e is a condition resulting from damage to the fourth cranial nerve, leading to weakness of the superior oblique muscle and causing vertical"
      }, {
        "text": " and torsional diplopia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of Superior Oblique:\u003c/b\u003e The"
      }, {
        "text": " primary actions are intorsion (internal rotation) and depression of the eye, especially when the eye is adducted.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation"
      }, {
        "text": ":\u003c/b\u003e The affected eye is elevated and extorted (hypertropia and excyclotorsion). Patients complain of vertical"
      }, {
        "text": " [[9914d433|diplopia]] that is worse when looking down and in (e.g., \u003c"
      }, {
        "text": "mark\u003ereading or walking down stairs\u003c/mark\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCompensatory Head Tilt:\u003c/b\u003e Patients characteristically tilt"
      }, {
        "text": " their head \u003cmark\u003e\u003cu\u003eaway\u003c/u\u003e from the side of the lesion\u003c/mark\u003e to fuse the two images and alleviate"
      }, {
        "text": " the diplopia. This maneuver uses the intact vestibular system to intort the affected eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBielschowsky Head"
      }, {
        "text": " Tilt Test:\u003c/b\u003e A diagnostic test where tilting the head \u003cu\u003etoward\u003c/u\u003e the side of the lesion worsens the vertical"
      }, {
        "text": " deviation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with vertical diplopia who compensates by tilting their head to the opposite"
      }, {
        "text": " shoulder is the classic vignette for a CN IV palsy. Remember: \u0027Can\u0027t see the \u003cb\u003efloor\u003c/b\u003e with"
      }, {
        "text": " CN \u003cb\u003eIV\u003c/b\u003e.\u0027\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCN IV palsy\u003c/b\u003e paraly"
      }, {
        "text": "zes the superior oblique muscle, causing the eye to drift upward and outward, resulting in vertical diplopia that patients instinctively correct"
      }, {
        "text": " by tilting their head away from the affected side.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_lesion_of\",\n        \"to\": \"bba609"
      }, {
        "text": "3a\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"9914d433\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"compensatory_head_tilt\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"01c1b782\": {\n    \"title\": \"Abducens Nerve"
      }, {
        "text": " (CN VI) Palsy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cranial Nerves\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eabducens nerve (CN VI)"
      }, {
        "text": " palsy\u003c/b\u003e is a condition resulting from damage to the sixth cranial nerve, leading to weakness of the lateral rectus muscle and"
      }, {
        "text": " an inability to abduct the eye.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of Lateral Rectus:\u003c/b\u003e Ab"
      }, {
        "text": "ducts the eye (moves it laterally, away from the nose).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation:\u003c/b\u003e The affected eye is deviated"
      }, {
        "text": " medially at rest (esotropia). The patient complains of horizontal [[9914d433|diplopia]] that is \u003c"
      }, {
        "text": "mark\u003eworse on gaze toward the side of the lesion\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Due"
      }, {
        "text": " to its long intracranial course, CN VI is highly vulnerable to stretching from \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e (e.g., [["
      }, {
        "text": "7c4e7c74|idiopathic intracranial hypertension]], hydrocephalus), making it a \u0027false localizing sign.\u0027"
      }, {
        "text": " Other causes include diabetic mononeuropathy, trauma, and lesions in the pons or [[c260efc"
      }, {
        "text": "8|cavernous sinus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSchwannoma Association:\u003c/b\u003e A [[03ecb69e"
      }, {
        "text": "|schwannoma]] at the cerebellopontine angle can compress CN VI along with CNs VII and VIII.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e An isolated CN VI palsy in a patient with headaches and papilledema should raise suspicion for increased intracranial pressure."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eCN VI palsy\u003c/b\u003e paralyzes the lateral rectus muscle, causing"
      }, {
        "text": " the eye to turn inward and resulting in horizontal double vision that worsens when looking toward the affected side; its presence can be a nonspecific"
      }, {
        "text": " sign of elevated intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_lesion_of\",\n        \"to\": \"dd11dde"
      }, {
        "text": "6\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\":"
      }, {
        "text": " \"9914d433\"\n      },\n      {\n        \"type\": \"can_be_"
      }, {
        "text": "caused_by\",\n        \"to\": \"7c4e7c74\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"03ec"
      }, {
        "text": "b69e\"\n      }\n    ]\n  },\n  \"3a4a8ad6\": {\n    \"title\":"
      }, {
        "text": " \"Cocaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"Toxicology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Stimulants\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCocaine\u003c/b\u003e is a potent central nervous system stimulant and local"
      }, {
        "text": " anesthetic derived from the coca plant. It exerts its primary effects by blocking the reuptake of monoamine neurotransmitters (dopamine,"
      }, {
        "text": " norepinephrine, and serotonin).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e1. \u003cb\u003eStimulant Effect:\u003c/b\u003e Blocks the reuptake transporters for \u003cmark\u003edopamine, norepinephrine, and serotonin\u003c/"
      }, {
        "text": "mark\u003e, increasing their concentration in the synaptic cleft and leading to sympathetic activation and euphoria.\u003cbr\u003e2. \u003cb\u003eLocal Anesthetic Effect:\u003c/b\u003e Blocks"
      }, {
        "text": " voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels, preventing nerve impulse conduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntoxication:\u003c/b\u003e Presents"
      }, {
        "text": " with sympathetic overdrive: mydriasis, hypertension, tachycardia, diaphoresis, agitation, and potentially psychosis. Can cause coronary"
      }, {
        "text": " vasospasm leading to myocardial infarction, and seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWithdrawal:\u003c/b\u003e Characterized by a \u0027crash\u0027"
      }, {
        "text": " with hypersomnolence, depression, malaise, and severe craving.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiotoxicity:\u003c/b\u003e A major cause of morbidity"
      }, {
        "text": " and mortality. Can cause MI (vasospasm), life-threatening arrhythmias (Na\u003csup\u003e+\u003c/sup\u003e channel blockade), and aortic"
      }, {
        "text": " dissection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with chest pain and signs of sympathetic activation, suspect cocaine use. "
      }, {
        "text": "\u003cu\u003eBeta-blockers are contraindicated\u003c/u\u003e in cocaine-induced chest pain as they can lead to unopposed Œ±-adrenergic stimulation, worsening"
      }, {
        "text": " hypertension and coronary vasospasm. Treat with benzodiazepines.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCocaine\u003c/b\u003e"
      }, {
        "text": " is a dual-action drug, acting as a powerful CNS stimulant by blocking monoamine reuptake and as a local anesthetic by blocking"
      }, {
        "text": " sodium channels; its major danger lies in the profound sympathetic stimulation, which can precipitate life-threatening cardiovascular events like myocardial infarction and arrhythmias"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cocaine] --\u003e B(Blocks Monoamine Reuptake); B"
      }, {
        "text": " --\u003e C(‚Üë Dopamine, Norepinephrine, Serotonin); C --\u003e D(Sympathetic Activation \u0026 Euphoria); A"
      }, {
        "text": " --\u003e E(Blocks Na+ Channels); E --\u003e F(Local Anesthesia);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"stimulant\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local"
      }, {
        "text": "_anesthetics\"\n      },\n      {\n        \"type\": \"blocks_reuptake_of\",\n        \""
      }, {
        "text": "to\": \"90adc821\"\n      },\n      {\n        \"type\": \"blocks_"
      }, {
        "text": "reuptake_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"blocks_reuptake_of\",\n        \"to\": \"5d3c208"
      }, {
        "text": "9\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1T3RdWUh2rZfw7bffrvH7qdvjMfcN7qNi"
      },
      "role": "user",
      "tokenCount": 1663
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"001c359f\": {\n    \"title\": \"Cochlea\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy and Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCochlea\u003c/b\u003e is the spiral-shaped, fluid-filled cavity of the inner ear that contains the organ of Corti, the sensory organ of hearing. It is responsible for transducing the mechanical vibrations of sound into nerve impulses.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e A snail-shaped structure within the bony labyrinth of the inner ear. It is divided into three fluid-filled chambers: the scala vestibuli, scala media (cochlear duct), and scala tympani.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrgan of Corti:\u003c/b\u003e Located within the scala media, it sits on the basilar membrane and contains the sensory hair cells (inner and outer) that are the mechanoreceptors for hearing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonotopic Organization:\u003c/b\u003e The basilar membrane is organized by frequency. \u003cmark\u003eHigh-frequency sounds\u003c/mark\u003e cause vibrations near the base of the cochlea (near the oval window), while \u003cmark\u003elow-frequency sounds\u003c/mark\u003e cause vibrations near the apex (near the helicotrema).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Damage to the hair cells within the cochlea is the cause of sensorineural hearing loss. This can be due to excessive noise exposure, ototoxic drugs, or aging (\u003cmark\u003e[[presbycusis]]\u003c/mark\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the tonotopic map: the \u003cb\u003ebase\u003c/b\u003e of the cochlea detects high-pitched sounds (treble), and the \u003cb\u003eapex\u003c/b\u003e detects low-pitched sounds (bass). Age-related hearing loss ([[presbycusis]]) typically affects high frequencies first, indicating damage at the cochlear base.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCochlea\u003c/b\u003e is the auditory portion of the inner ear, functioning like a biological microphone that converts sound vibrations into precisely coded neural signals through the tonotopic organization of its basilar membrane and the mechanotransduction of its hair cells.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Stapes vibration at Oval Window] --\u003e B(Pressure waves in cochlear fluid); B --\u003e C(Vibration of Basilar Membrane); C --\u003e D(Bending of Hair Cell Stereocilia); D --\u003e E(Transduction into Neural Signal); E --\u003e F(Cochlear Nerve);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"inner_ear\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"organ_of_corti\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"presbycusis\"\n      },\n      {\n        \"type\": \"is_affected_by\",\n        \"to\": \"noise_induced_hearing_loss\"\n      }\n    ]\n  },\n  \"b45ea591\": {\n    \"title\": \"Codeine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCodeine\u003c/b\u003e is a naturally occurring opioid agonist used for its analgesic, antitussive (cough suppressant), and antidiarrheal properties. It is a prodrug that is metabolized into morphine for its primary analgesic effect.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A weak agonist at Œº-opioid receptors. Its analgesic effect is primarily due to its conversion to \u003cmark\u003emorphine\u003c/mark\u003e by the cytochrome P450 enzyme \u003cmark\u003eCYP2D6\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for mild to moderate pain and as a cough suppressant. Often formulated with acetaminophen (Tylenol #3).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacogenomics:\u003c/b\u003e The efficacy of codeine is highly dependent on an individual\u0027s CYP2D6 genotype. \u0027Poor metabolizers\u0027 will get little to no analgesic effect. \u0027Ultra-rapid metabolizers\u0027 can convert codeine to morphine very quickly, leading to a risk of morphine toxicity and respiratory depression even at standard doses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common opioid side effects including constipation, sedation, nausea, and potential for dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The role of CYP2D6 in activating codeine is a high-yield pharmacogenomic concept. An \u0027ultra-rapid metabolizer\u0027 can essentially get an overdose of morphine from a standard dose of codeine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCodeine\u003c/b\u003e is a weak opioid prodrug whose analgesic power is unlocked by its metabolic conversion to morphine via the genetically variable CYP2D6 enzyme, making its effectiveness and safety profile unpredictable across different individuals.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Codeine (Prodrug)] --CYP2D6--\u003e B(Morphine); B --\u003e C(Œº-Opioid Receptor Agonism); C --\u003e D(Analgesia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        \"to\": \"cyp2d6\"\n      },\n      {\n        \"type\": \"is_a_prodrug_of\",\n        \"to\": \"morphine\"\n      }\n    ]\n  },\n  \"d36eed18\": {\n    \"title\": \"Coma\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Coma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eComa\u003c/b\u003e is a state of profound and prolonged unconsciousness in which a person cannot be awakened, fails to respond normally to painful stimuli, light, or sound, lacks a normal wake-sleep cycle, and does not initiate voluntary actions. It is a medical emergency.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results from diffuse bilateral hemispheric dysfunction or a focal lesion in the brainstem affecting the \u003cmark\u003ereticular activating system (RAS)\u003c/mark\u003e, which is responsible for maintaining arousal and consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be structural (e.g., stroke, trauma, tumor, [[8c0728b7|herniation syndromes]]) or metabolic/toxic (e.g., hypoglycemia, drug overdose, hypoxia, hepatic encephalopathy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEvaluation:\u003c/b\u003e Assessed using the Glasgow Coma Scale (GCS), which scores eye, verbal, and motor responses. A GCS score of 8 or less is typically defined as coma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHerniation Syndromes:\u003c/b\u003e Progressive brain herniation (e.g., uncal, central) is a common pathway leading to coma due to compression of the brainstem and RAS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate coma from other states of altered consciousness. In a persistent vegetative state, the patient has sleep-wake cycles and brainstem reflexes but lacks cortical function. In locked-in syndrome, the patient is fully conscious but quadriplegic and unable to communicate except via eye movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eComa\u003c/b\u003e represents a profound failure of the brain\u0027s arousal systems, either from widespread cortical damage or a direct hit to the brainstem\u0027s reticular activating system, resulting in a state of \u0027unarousable unresponsiveness\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n        \"type\": \"is_caused_by_dysfunction_of\",\n        \"to\": \"reticular_activating_system\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"persistent_vegetative_state\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"locked_in_syndrome\"\n      }\n    ]\n  },\n  \"aa4115c7\": {\n    \"title\": \"Communicating Hydrocephalus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCommunicating hydrocephalus\u003c/b\u003e is a type of [[0bc2f200|hydrocephalus]] where there is no obstruction to the flow of cerebrospinal fluid (CSF) within the ventricular system. Instead, the condition arises from impaired CSF reabsorption by the [[b7b67074|arachnoid granulations]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The problem lies outside the ventricles, in the subarachnoid space or arachnoid granulations. The \u0027communication\u0027 between the ventricles is open. The primary issue is \u003cmark\u003edecreased CSF reabsorption\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Often caused by scarring or inflammation of the arachnoid granulations, which can occur after \u003cmark\u003emeningitis\u003c/mark\u003e or a [[63f8b05f|subarachnoid hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e CT or MRI shows enlargement of \u003cmark\u003eall four ventricles\u003c/mark\u003e symmetrically, as the entire system is under increased pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with signs of increased intracranial pressure: headache, nausea, vomiting, papilledema, and potentially cognitive changes or gait disturbance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Pressure Hydrocephalus (NPH):\u003c/b\u003e A specific subtype of chronic communicating hydrocephalus in the elderly where CSF pressure is only intermittently elevated. It presents with the classic triad of \u0027wobbly, wacky, and wet\u0027 (gait apraxia, dementia, urinary incontinence).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to identifying communicating hydrocephalus is that all ventricles are dilated, and there is often a history of meningitis or hemorrhage. This contrasts with non-communicating hydrocephalus, where only the ventricles upstream of a blockage are enlarged.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCommunicating hydrocephalus\u003c/b\u003e is a \u0027drainage problem\u0027 rather than a \u0027plumbing blockage,\u0027 where CSF flows freely through the ventricles but cannot be effectively reabsorbed into the venous system, leading to a global increase in CSF volume and pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plexus] --Normal Production--\u003e B(CSF); B --\u003e C(Ventricular System - Open); C --\u003e D(Subarachnoid Space); D --x E(Impaired Reabsorption at Arachnoid Granulations); E --x F[Venous Sinuses];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_caused_by_impaired_reabsorption_at\",\n        \"to\": \"b7b67074\"\n      },\n      {\n        \"type\": \"can_be_a_sequela_of\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"can_be_a_sequela_of\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"non_communicating_hydrocephalus\"\n      }\n    ]\n  },\n  \"1ae850fe\": {\n    \"title\": \"Conduction Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConduction aphasia\u003c/b\u003e is a relatively rare type of fluent aphasia characterized by a profound impairment of repetition, despite intact auditory comprehension and fluent, though sometimes paraphasic, speech. It is a classic disconnection syndrome.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by damage to the \u003cmark\u003earcuate fasciculus\u003c/mark\u003e, the white matter tract that connects [[wernicke_area|Wernicke\u0027s area]] (comprehension) to [[a3bbace2|Broca\u0027s area]] (production).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFluency:\u003c/b\u003e Speech is fluent, but may contain phonemic paraphasias (e.g., saying \u0027papple\u0027 for \u0027apple\u0027).\u003cbr\u003e - \u003cb\u003eComprehension:\u003c/b\u003e Auditory comprehension is intact.\u003cbr\u003e - \u003cb\u003eRepetition:\u003c/b\u003e The hallmark is a \u003cmark\u003esevere deficit in repetition\u003c/mark\u003e. The patient cannot repeat phrases or sentences spoken to them.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Awareness:\u003c/b\u003e Patients are aware of their errors and will often try to self-correct.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature that distinguishes conduction aphasia from other fluent aphasias (like Wernicke\u0027s) is the combination of good comprehension with poor repetition. If a patient can understand you but can\u0027t repeat \u0027no ifs, ands, or buts,\u0027 think conduction aphasia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eConduction aphasia\u003c/b\u003e is a language disorder resulting from a \u0027broken telephone line\u0027 between the brain\u0027s comprehension and production centers; the patient understands what is said and can speak fluently, but cannot accurately relay the message from one area to the other, leading to a profound inability to repeat.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Auditory Input] --\u003e B(Wernicke\u0027s Area - Intact Comprehension); B --x C(Arcuate Fasciculus - Lesion); C --x D(Broca\u0027s Area); D --\u003e E(Impaired Repetition);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"arcuate_fasciculus\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"7f6ed344\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"2c4a6130\"\n      }\n    ]\n  },\n  \"2b500647\": {\n    \"title\": \"Conductive Hearing Loss\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Otology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConductive hearing loss\u003c/b\u003e is a type of hearing impairment that occurs when there is a problem with the mechanical transmission of sound waves through the outer ear or middle ear to the cochlea of the inner ear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by any obstruction or damage to the structures that conduct sound, including the external auditory canal, tympanic membrane, or ossicles (malleus, incus, stapes).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e Cerumen (earwax) impaction, otitis media (middle ear fluid), otitis externa, perforated tympanic membrane, otosclerosis (fixation of the stapes), and [[03ef3134|cholesteatoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTuning Fork Tests:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eRinne Test:\u003c/b\u003e \u003cmark\u003eAbnormal\u003c/mark\u003e. Bone conduction (BC) is greater than or equal to air conduction (AC) in the affected ear, because the normal amplification provided by the middle ear is lost.\u003cbr\u003e - \u003cb\u003eWeber Test:\u003c/b\u003e Sound \u003cmark\u003elateralizes to the affected ear\u003c/mark\u003e. This is because the conductive loss masks ambient room noise, making the bone-conducted sound seem louder on that side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the tuning fork results: In conductive hearing loss, the Weber test lateralizes to the bad ear, and the Rinne test is abnormal (BC \u003e AC).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eConductive hearing loss\u003c/b\u003e is a \u0027plumbing problem\u0027 of the ear, where sound waves are physically blocked from reaching the inner ear; this is in contrast to sensorineural hearing loss, which is a \u0027wiring problem\u0027 of the cochlea or auditory nerve.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"hearing_loss\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"otitis_media\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"03ef3134\"\n      }\n    ]\n  },\n  \"6e281699\": {\n    \"title\": \"Confluence of the Sinuses\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dural Venous Sinuses\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eConfluence of the Sinuses\u003c/b\u003e (or torcular Herophili) is a large venous junction located at the internal occipital protuberance, where several major dural venous sinuses converge.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found on the inner surface of the occipital bone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConverging Sinuses:\u003c/b\u003e It is the meeting point for the \u003cmark\u003esuperior sagittal sinus\u003c/mark\u003e, the \u003cmark\u003estraight sinus\u003c/mark\u003e, and the occipital sinus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage:\u003c/b\u003e From the confluence, blood typically drains laterally into the left and right \u003cmark\u003etransverse sinuses\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Serves as a major collection point for venous blood from the superior and deep parts of the brain before it is routed towards the internal jugular veins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to trace the path of venous drainage from the superior sagittal sinus: Superior Sagittal Sinus ‚Üí Confluence of Sinuses ‚Üí Transverse Sinus ‚Üí Sigmoid Sinus ‚Üí Internal Jugular Vein.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eConfluence of the Sinuses\u003c/b\u003e acts as a central roundabout for venous blood drainage in the posterior cranium, collecting blood from the superior and deep brain and directing it into the transverse sinuses to begin its exit from the skull.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Superior Sagittal Sinus] --\u003e C(Confluence of the Sinuses); B[Straight Sinus] --\u003e C; C --\u003e D[Transverse Sinuses]; D --\u003e E[Sigmoid Sinuses]; E --\u003e F[Internal Jugular Vein];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"21f1c955\"\n      },\n      {\n        \"type\": \"receives_blood_from\",\n        \"to\": \"superior_sagittal_sinus\"\n      },\n      {\n        \"type\": \"receives_blood_from\",\n        \"to\": \"straight_sinus\"\n      },\n      {\n        \"type\": \"drains_into\",\n        \"to\": \"transverse_sinus\"\n      }\n    ]\n  },\n  \"1401b7aa\": {\n    \"title\": \"Conjugate Horizontal Gaze Palsy\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003econjugate horizontal gaze palsy\u003c/b\u003e is the inability to move both eyes in the same horizontal direction (either left or right). It results from a lesion in the brainstem centers that coordinate horizontal eye movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Structure:\u003c/b\u003e The \u003cmark\u003eParamedian Pontine Reticular Formation (PPRF)\u003c/mark\u003e, also known as the horizontal gaze center, is the primary structure responsible for initiating horizontal saccades. The PPRF is located in the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e To look to the left, the left PPRF activates the left [[dd11dde6|abducens (CN VI) nucleus]]. The CN VI nucleus then does two things: 1) sends a signal to the ipsilateral lateral rectus muscle to abduct the left eye, and 2) sends a signal via the medial longitudinal fasciculus (MLF) to the contralateral [[68c66997|oculomotor (CN III) nucleus]] to activate the medial rectus muscle and adduct the right eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePPRF Lesion:\u003c/b\u003e A lesion of the PPRF results in an \u003cmark\u003eipsilateral gaze palsy\u003c/mark\u003e. The patient cannot look \u003cu\u003etoward\u003c/u\u003e the side of the lesion. The eyes will often deviate \u003cu\u003eaway\u003c/u\u003e from the side of the lesion due to the unopposed action of the contralateral PPRF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFrontal Eye Field (FEF) Lesion:\u003c/b\u003e A destructive lesion in the cortical FEF (in the frontal lobe) causes the eyes to deviate \u003cu\u003etoward\u003c/u\u003e the side of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate brainstem from cortical gaze palsies: PPRF lesion \u003d eyes look \u003cu\u003eaway\u003c/u\u003e from the lesion. FEF lesion \u003d eyes look \u003cu\u003etoward\u003c/u\u003e the lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003econjugate horizontal gaze palsy\u003c/b\u003e is a failure of the brainstem\u0027s command center for horizontal eye movements, the PPRF; a lesion here prevents the eyes from looking toward the side of the damage, causing them to deviate to the opposite side.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left PPRF] --\u003e B(Left CN VI Nucleus); B --\u003e C(Left Lateral Rectus - Abduction); B --\u003e D(Right MLF); D --\u003e E(Right CN III Nucleus); E --\u003e F(Right Medial Rectus - Adduction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"pprf\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"frontal_eye_field_lesion\"\n      },\n      {\n        \"type\": \"is_related_to\",\n        \"to\": \"58c684bd\"\n      }\n    ]\n  },\n  \"c4d08c09\": {\n    \"title\": \"Conjunctivitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Infectious Disease\",\n      \"Allergy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConjunctivitis\u003c/b\u003e, commonly known as \\\"pink eye,\\\" is the inflammation of the conjunctiva, the thin, transparent membrane that lines the inner surface of the eyelids and covers the white part of the eye (sclera).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eViral Conjunctivitis:\u003c/b\u003e The most common cause overall. Usually caused by [[aaeda12d|adenovirus]]. Presents with a red eye, \u003cmark\u003ewatery discharge\u003c/mark\u003e, and a gritty sensation. Often starts in one eye and spreads to the other. Highly contagious.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBacterial Conjunctivitis:\u003c/b\u003e Commonly caused by \u003ci\u003eS. aureus\u003c/i\u003e, \u003ci\u003eS. pneumoniae\u003c/i\u003e, and \u003ci\u003eH. influenzae\u003c/i\u003e. Presents with a red eye and a thick, \u003cmark\u003epurulent (mucopurulent) discharge\u003c/mark\u003e that often causes the eyelids to be stuck together in the morning.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAllergic Conjunctivitis:\u003c/b\u003e An IgE-mediated hypersensitivity reaction to an allergen (e.g., pollen). Presents with bilateral intense \u003cmark\u003eitching (pruritus)\u003c/mark\u003e, redness, and watery discharge.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeonatal Conjunctivitis:\u003c/b\u003e Occurs in the first month of life. Caused by \u003ci\u003eN. gonorrhoeae\u003c/i\u003e (very purulent, occurs at 2-5 days) or \u003ci\u003eC. trachomatis\u003c/i\u003e (serotypes D-K, watery/mucoid, occurs at 5-14 days). Prophylaxis with erythromycin ointment is standard.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The type of discharge is the key to differentiating the cause: Watery \u003d Viral or Allergic (look for itching). Purulent \u003d Bacterial.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eConjunctivitis\u003c/b\u003e is inflammation of the eye\u0027s surface membrane, with the etiology‚Äîviral, bacterial, or allergic‚Äîbeing strongly suggested by the character of the discharge and the presence or absence of itching.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"aaeda12d\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"staphylococcus_aureus\"\n      },\n      {\n        \"type\": \"can_be\",\n        \"to\": \"allergic\"\n      }\n    ]\n  },\n  \"19016061\": {\n    \"title\": \"Consensual Light Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eConsensual Light Reflex\u003c/b\u003e is the constriction of the pupil of one eye in response to light being shone into the other eye. It is a normal brainstem reflex that is tested along with the direct light reflex to assess the integrity of the pupillary light reflex pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Light shone into one eye (e.g., the right eye) sends an afferent signal via the right optic nerve (CN II). This signal travels to the pretectal nuclei in the midbrain. Each pretectal nucleus then sends signals to \u003cmark\u003e\u003cu\u003eboth\u003c/u\u003e\u003c/mark\u003e the ipsilateral and contralateral Edinger-Westphal nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb:\u003c/b\u003e Both Edinger-Westphal nuclei then send efferent parasympathetic signals via their respective oculomotor nerves (CN III) to cause constriction of both pupils.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDirect vs. Consensual:\u003c/b\u003e The constriction of the pupil in the eye receiving the light is the \u003cb\u003edirect\u003c/b\u003e reflex. The simultaneous constriction of the pupil in the opposite eye is the \u003cb\u003econsensual\u003c/b\u003e reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Testing both reflexes helps localize lesions. For example, in a right CN II lesion, shining light in the right eye will cause neither pupil to constrict, but shining light in the left eye will cause both to constrict. In a right CN III lesion, shining light in either eye will cause only the left pupil to constrict.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The bilateral projection from the pretectal nucleus to both Edinger-Westphal nuclei is the anatomical basis for the consensual light reflex.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eConsensual Light Reflex\u003c/b\u003e demonstrates the bilateral nature of the pupillary light reflex pathway; the brain processes the light signal from one eye and sends a command to constrict both pupils, ensuring a symmetrical response to light.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light in Right Eye] --\u003e B(Right Optic Nerve); B --\u003e C(Pretectal Nuclei); C --\u003e D(Right E-W Nucleus); C --\u003e E(Left E-W Nucleus); D --\u003e F(Right CN III -\u003e Right Pupil Constricts - Direct); E --\u003e G(Left CN III -\u003e Left Pupil Constricts - Consensual);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"pupillary_light_reflex\"\n      },\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\": \"optic_nerve\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        \"to\": \"68c66997\"\n      }\n    ]\n  },\n  \"3db2e75e\": {\n    \"title\": \"Convergence-Retraction Nystagmus\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConvergence-retraction nystagmus\u003c/b\u003e is a specific type of abnormal eye movement characterized by jerky, convergent and retractory movements of the eyes, particularly on attempted upgaze. It is a key sign of \u003cmark\u003eParinaud syndrome\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e On attempted upward gaze, the eyes jerkily converge (move toward each other) and retract into the orbits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is a component of Parinaud syndrome (also known as dorsal midbrain syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Palsy:\u003c/b\u003e The primary deficit is an inability to look up.\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils react poorly to light but constrict normally to accommodation ([[08cb577f|Argyll Robertson-like pupils]]).\u003cbr\u003e3. \u003cb\u003eConvergence-Retraction Nystagmus.\u003c/b\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the dorsal midbrain, specifically compressing the superior colliculus and pretectal area.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e In children, the most common cause is a \u003cmark\u003epinealoma\u003c/mark\u003e (pineal gland tumor). Other causes include stroke of the midbrain, hydrocephalus, and multiple sclerosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient, often a child or young adult, who cannot look up and has abnormal pupillary responses and jerky eye movements on attempted upgaze has Parinaud syndrome, and a pineal tumor should be suspected.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eConvergence-retraction nystagmus\u003c/b\u003e is a pathognomonic sign of dorsal midbrain compression (Parinaud syndrome), where the attempt to look up is thwarted and instead results in a paradoxical, jerky pulling of the eyes inward and backward.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"parinaud_syndrome\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"pinealoma\"\n      }\n    ]\n  },\n  \"208cebcd\": {\n    \"title\": \"Corkscrew Fibers (Rosenthal Fibers)\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neuropathology\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRosenthal fibers\u003c/b\u003e, sometimes described as \u0027corkscrew fibers,\u0027 are thick, elongated, eosinophilic (pink) protein aggregates found in the cytoplasm of astrocytes. They are a characteristic histological finding in certain slow-growing glial processes and tumors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e On H\u0026E stain, they appear as bright pink, irregular, corkscrew-shaped or rope-like inclusions within astrocytic processes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Composed of aggregates of intermediate filament proteins, including glial fibrillary acidic protein (GFAP), along with heat shock proteins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e They are the histological hallmark of a \u003cmark\u003epilocytic astrocytoma\u003c/mark\u003e, the most common primary brain tumor in children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Conditions:\u003c/b\u003e Can also be seen in areas of long-standing gliosis and in Alexander disease, a rare leukodystrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of Rosenthal fibers in a biopsy of a pediatric cerebellar cystic tumor is diagnostic for pilocytic astrocytoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRosenthal fibers\u003c/b\u003e are distinctive eosinophilic, corkscrew-shaped inclusions that are the microscopic signature of a pilocytic astrocytoma, representing aggregates of glial proteins within the tumor cells.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"pilocytic_astrocytoma\"\n      },\n      {\n        \"type\": \"is_found_in\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"fb50d450\"\n      }\n    ]\n  },\n  \"7d70ac32\": {\n    \"title\": \"Cornea\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCornea\u003c/b\u003e is the transparent, avascular, dome-shaped outer layer at the very front of the eye. It covers the iris, pupil, and anterior chamber and is the eye\u0027s primary refractive surface.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Its primary function is to \u003cmark\u003erefract (bend) light\u003c/mark\u003e, accounting for about two-thirds of the eye\u0027s total optical power. It also serves a protective role.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of five layers (Epithelium, Bowman\u0027s layer, Stroma, Descemet\u0027s membrane, Endothelium). It is avascular and receives nutrients from the aqueous humor and oxygen from the air.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Richly innervated by sensory nerve fibers from the ophthalmic division of the trigeminal nerve (CN V\u003csub\u003e1\u003c/sub\u003e), making it extremely sensitive to touch.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[18cff34e|Astigmatism]]:\u003c/b\u003e Caused by an irregular curvature of the cornea.\u003cbr\u003e - \u003cb\u003eKeratitis:\u003c/b\u003e Inflammation of the cornea.\u003cbr\u003e - \u003cb\u003eCorneal Abrasion:\u003c/b\u003e A scratch on the corneal surface.\u003cbr\u003e - \u003cb\u003eKayser-Fleischer rings:\u003c/b\u003e Copper deposits in Descemet\u0027s membrane, seen in Wilson disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The [[64663383|corneal reflex]] (blinking in response to touching the cornea) tests the afferent limb of CN V\u003csub\u003e1\u003c/sub\u003e and the efferent limb of CN VII.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCornea\u003c/b\u003e is the eye\u0027s powerful, transparent front window, responsible for the majority of light refraction, while its dense sensory innervation makes it exquisitely sensitive and provides a critical protective reflex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"refraction\"\n      },\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"18cff34e\"\n      },\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"trigeminal_nerve_v1\"\n      },\n      {\n        \"type\": \"is_tested_by\",\n        \"to\": \"64663383\"\n      }\n    ]\n  },\n  \"64663383\": {\n    \"title\": \"Corneal Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCorneal Reflex\u003c/b\u003e is an involuntary blinking of the eyelids elicited by stimulation of the cornea (such as by touching it with a wisp of cotton), which serves to protect the eye from foreign bodies.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e Tests the integrity of a brainstem reflex arc involving cranial nerves V and VII.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Limb (Sensation):\u003c/b\u003e The stimulus is detected by nociceptors in the [[7d70ac32|cornea]], and the sensory signal is carried to the pons by the ophthalmic division of the \u003cmark\u003etrigeminal nerve (CN V\u003csub\u003e1\u003c/sub\u003e)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb (Motor):\u003c/b\u003e Motor output is sent from the pons via the \u003cmark\u003efacial nerve (CN VII)\u003c/mark\u003e bilaterally to the orbicularis oculi muscles, causing both eyes to blink.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInterpretation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNo blink in either eye:\u003c/b\u003e Lesion in the ipsilateral CN V\u003csub\u003e1\u003c/sub\u003e (afferent defect).\u003cbr\u003e - \u003cb\u003eOnly contralateral eye blinks:\u003c/b\u003e Lesion in the ipsilateral CN VII (efferent defect).\u003cbr\u003e - \u003cb\u003eOnly ipsilateral eye blinks:\u003c/b\u003e Lesion in the contralateral CN VII.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the pathway: Sensation in via CN V, blinking out via CN VII. A lesion in CN V\u003csub\u003e1\u003c/sub\u003e will knock out the reflex on both sides when the affected eye is stimulated. A lesion in CN VII will only knock out the blink on the affected side, regardless of which eye is stimulated.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCorneal Reflex\u003c/b\u003e is a critical brainstem reflex that protects the eye, relying on the trigeminal nerve (CN V) to \u0027feel\u0027 the threat and the facial nerve (CN VII) to \u0027act\u0027 by closing the eyelids.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Touch Cornea] --\u003e B(Afferent: CN V1); B --\u003e C(Pons); C --\u003e D(Efferent: Bilateral CN VII); D --\u003e E(Bilateral Orbicularis Oculi Contraction); E --\u003e F(Blinking);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\": \"trigeminal_nerve_v1\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        \"to\": \"facial_nerve\"\n      },\n      {\n        \"type\": \"tests_integrity_of\",\n        \"to\": \"pons\"\n      }\n    ]\n  },\n  \"dd3c9b1b\": {\n    \"title\": \"Coronary Vasospasm\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Cardiology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Cardiovascular\",\n      \"Pathology\",\n      \"Ischemic Heart Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCoronary vasospasm\u003c/b\u003e is a transient, focal constriction of a coronary artery that can cause myocardial ischemia, leading to a type of angina known as vasospastic or Prinzmetal angina. It can also be a side effect of certain drugs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Involves hyperreactivity of coronary artery smooth muscle, leading to intense vasoconstriction. The exact cause is unknown but may involve endothelial dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrinzmetal Angina:\u003c/b\u003e Characterized by angina that occurs at rest, often at night, and is not precipitated by exertion. EKG during an episode shows transient ST-segment elevation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug-Induced Vasospasm:\u003c/b\u003e Several drugs can trigger coronary vasospasm.\u003cbr\u003e - \u003cb\u003e[[3a4a8ad6|Cocaine]]:\u003c/b\u003e A potent vasoconstrictor that can cause vasospasm and myocardial infarction, even in patients with normal coronary arteries.\u003cbr\u003e - \u003cb\u003e[[triptans|Triptans]] (e.g., sumatriptan):\u003c/b\u003e Used for migraines, they are 5-HT\u003csub\u003e1B/1D\u003c/sub\u003e agonists that can cause coronary vasoconstriction and are contraindicated in patients with coronary artery disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute attacks are treated with nitroglycerin. Long-term prevention involves calcium channel blockers and nitrates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Cocaine-induced chest pain should be treated with benzodiazepines and nitrates. \u003cu\u003eBeta-blockers are contraindicated\u003c/u\u003e as they can lead to unopposed alpha-adrenergic stimulation and worsen the vasospasm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCoronary vasospasm\u003c/b\u003e is a spastic constriction of a coronary artery that causes ischemic chest pain at rest (Prinzmetal angina) and can be a dangerous side effect of vasoconstrictive drugs like cocaine and triptans.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"prinzmetal_angina\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"3a4a8ad6\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"triptans\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9958,
      "parts": [{
        "text": "```json"
      }, {
        "text": "\n{\n  \"001c359f\": {\n    \"title"
      }, {
        "text": "\": \"Cochlea\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      "
      }, {
        "text": "\"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy and"
      }, {
        "text": " Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCochlea\u003c/b\u003e is the"
      }, {
        "text": " spiral-shaped, fluid-filled cavity of the inner ear that contains the organ of Corti, the sensory organ of"
      }, {
        "text": " hearing. It is responsible for transducing the mechanical vibrations of sound into nerve impulses.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e A snail-shaped structure within the bony labyrinth of the inner ear. It is"
      }, {
        "text": " divided into three fluid-filled chambers: the scala vestibuli, scala media (cochlear duct), and scala tympani"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrgan of Corti:\u003c/b\u003e Located within the scala media, it sits on the basilar membrane and"
      }, {
        "text": " contains the sensory hair cells (inner and outer) that are the mechanoreceptors for hearing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonotopic Organization"
      }, {
        "text": ":\u003c/b\u003e The basilar membrane is organized by frequency. \u003cmark\u003eHigh-frequency sounds\u003c/mark\u003e cause vibrations near"
      }, {
        "text": " the base of the cochlea (near the oval window), while \u003cmark\u003elow-frequency sounds\u003c/mark\u003e cause vibrations"
      }, {
        "text": " near the apex (near the helicotrema).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Damage to the hair cells within the cochlea is"
      }, {
        "text": " the cause of sensorineural hearing loss. This can be due to excessive noise exposure, ototoxic drugs, or aging"
      }, {
        "text": " (\u003cmark\u003e[[presbycusis]]\u003c/mark\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the ton"
      }, {
        "text": "otopic map: the \u003cb\u003ebase\u003c/b\u003e of the cochlea detects high-pitched sounds (treble), and the \u003cb\u003eapex\u003c/b\u003e detects low-"
      }, {
        "text": "pitched sounds (bass). Age-related hearing loss ([[presbycusis]]) typically affects high frequencies first, indicating damage at"
      }, {
        "text": " the cochlear base.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCochlea\u003c/b\u003e is the"
      }, {
        "text": " auditory portion of the inner ear, functioning like a biological microphone that converts sound vibrations into precisely coded neural signals through the ton"
      }, {
        "text": "otopic organization of its basilar membrane and the mechanotransduction of its hair cells.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Stapes vibration at Oval Window] --\u003e B(Pressure waves in cochlear fluid); B --\u003e"
      }, {
        "text": " C(Vibration of Basilar Membrane); C --\u003e D(Bending of Hair Cell Stereocilia); D --\u003e E"
      }, {
        "text": "(Transduction into Neural Signal); E --\u003e F(Cochlear Nerve);\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_part_of\",\n        \"to\": \"inner_ear\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"contains\",\n        \"to\": \"organ_of_corti\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"presbycusis\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_affected_by\",\n        \"to\": \"noise_induced_hearing_loss\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"b45ea591\": {\n    \"title\": \"Code"
      }, {
        "text": "ine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n"
      }, {
        "text": "      \"Pain Management\",\n      \"Pulmonology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCodeine\u003c/b\u003e is a naturally occurring opioid agonist used for"
      }, {
        "text": " its analgesic, antitussive (cough suppressant), and antidiarrheal properties. It is a prodrug that is metabolized into"
      }, {
        "text": " morphine for its primary analgesic effect.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A weak agonist"
      }, {
        "text": " at Œº-opioid receptors. Its analgesic effect is primarily due to its conversion to \u003cmark\u003emorphine\u003c/mark\u003e by"
      }, {
        "text": " the cytochrome P450 enzyme \u003cmark\u003eCYP2D6\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used"
      }, {
        "text": " for mild to moderate pain and as a cough suppressant. Often formulated with acetaminophen (Tylenol #3).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacogen"
      }, {
        "text": "omics:\u003c/b\u003e The efficacy of codeine is highly dependent on an individual\u0027s CYP2D6 genotype. \u0027Poor"
      }, {
        "text": " metabolizers\u0027 will get little to no analgesic effect. \u0027Ultra-rapid metabolizers\u0027 can convert codeine to morphine"
      }, {
        "text": " very quickly, leading to a risk of morphine toxicity and respiratory depression even at standard doses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common"
      }, {
        "text": " opioid side effects including constipation, sedation, nausea, and potential for dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The role"
      }, {
        "text": " of CYP2D6 in activating codeine is a high-yield pharmacogenomic concept. An \u0027ultra-rapid metabolizer\u0027 can"
      }, {
        "text": " essentially get an overdose of morphine from a standard dose of codeine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Codeine\u003c/b\u003e is a weak opioid prodrug whose analgesic power is unlocked by its metabolic conversion to morphine via the genetically variable CYP2D6 enzyme, making"
      }, {
        "text": " its effectiveness and safety profile unpredictable across different individuals.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Code"
      }, {
        "text": "ine (Prodrug)] --CYP2D6--\u003e B(Morphine); B --\u003e C(Œº-Opioid Receptor"
      }, {
        "text": " Agonism); C --\u003e D(Analgesia);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_metabolized_by\",\n        \"to\": \"cyp2d6\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_prodrug_of\",\n        \"to\": \"morphine\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"d36eed18\": {\n    \"title\": \""
      }, {
        "text": "Coma\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Coma\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eComa\u003c/b\u003e is a state of profound and prolonged unconsciousness in which a person cannot be awakened,"
      }, {
        "text": " fails to respond normally to painful stimuli, light, or sound, lacks a normal wake-sleep cycle, and does not initiate voluntary actions"
      }, {
        "text": ". It is a medical emergency.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results"
      }, {
        "text": " from diffuse bilateral hemispheric dysfunction or a focal lesion in the brainstem affecting the \u003cmark\u003ereticular activating system (RAS)\u003c/mark\u003e,"
      }, {
        "text": " which is responsible for maintaining arousal and consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be structural (e.g., stroke"
      }, {
        "text": ", trauma, tumor, [[8c0728b7|herniation syndromes]]) or metabolic/toxic (e.g., hypoglycemia"
      }, {
        "text": ", drug overdose, hypoxia, hepatic encephalopathy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEvaluation:\u003c/b\u003e Assessed using the Glasgow Coma Scale ("
      }, {
        "text": "GCS), which scores eye, verbal, and motor responses. A GCS score of 8 or less is typically defined as coma"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eHerniation Syndromes:\u003c/b\u003e Progressive brain herniation (e.g., uncal, central) is a common pathway"
      }, {
        "text": " leading to coma due to compression of the brainstem and RAS.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate coma"
      }, {
        "text": " from other states of altered consciousness. In a persistent vegetative state, the patient has sleep-wake cycles and brainstem reflexes but lacks cortical"
      }, {
        "text": " function. In locked-in syndrome, the patient is fully conscious but quadriplegic and unable to communicate except via eye"
      }, {
        "text": " movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eComa\u003c/b\u003e represents a profound failure of the brain\u0027s arousal"
      }, {
        "text": " systems, either from widespread cortical damage or a direct hit to the brainstem\u0027s reticular activating system, resulting in a state of \u0027"
      }, {
        "text": "unarousable unresponsiveness\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"8c0"
      }, {
        "text": "728b7\"\n      },\n      {\n        \"type\": \"is_caused_by_dysfunction_of\",\n"
      }, {
        "text": "        \"to\": \"reticular_activating_system\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "differentiated_from\",\n        \"to\": \"persistent_vegetative_state\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"differentiated_from\",\n        \"to\": \"locked_in_syndrome\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"aa4115c7\": {\n    \"title\": \"Communicating Hydro"
      }, {
        "text": "cephalus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n"
      }, {
        "text": "      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCommunicating hydrocephalus\u003c/b\u003e is a type of [[0"
      }, {
        "text": "bc2f200|hydrocephalus]] where there is no obstruction to the flow of cerebrospinal fluid (CSF) within the ventricular"
      }, {
        "text": " system. Instead, the condition arises from impaired CSF reabsorption by the [[b7b67074|arach"
      }, {
        "text": "noid granulations]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The"
      }, {
        "text": " problem lies outside the ventricles, in the subarachnoid space or arachnoid granulations. The \u0027communication"
      }, {
        "text": "\u0027 between the ventricles is open. The primary issue is \u003cmark\u003edecreased CSF reabsorption\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Causes:\u003c/b\u003e Often caused by scarring or inflammation of the arachnoid granulations, which can occur after \u003cmark\u003emeningitis\u003c/mark\u003e"
      }, {
        "text": " or a [[63f8b05f|subarachnoid hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e CT"
      }, {
        "text": " or MRI shows enlargement of \u003cmark\u003eall four ventricles\u003c/mark\u003e symmetrically, as the entire system is under increased"
      }, {
        "text": " pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with signs of increased intracranial pressure: headache, nausea, vomiting, papilledema, and"
      }, {
        "text": " potentially cognitive changes or gait disturbance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Pressure Hydrocephalus (NPH):\u003c/b\u003e A specific subtype of chronic"
      }, {
        "text": " communicating hydrocephalus in the elderly where CSF pressure is only intermittently elevated. It presents with the classic triad of \u0027wobbly,"
      }, {
        "text": " wacky, and wet\u0027 (gait apraxia, dementia, urinary incontinence).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " key to identifying communicating hydrocephalus is that all ventricles are dilated, and there is often a history of meningitis or hemorrhage"
      }, {
        "text": ". This contrasts with non-communicating hydrocephalus, where only the ventricles upstream of a blockage are enlarged.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eCommunicating hydrocephalus\u003c/b\u003e is a \u0027drainage problem\u0027 rather than a \u0027plumbing blockage"
      }, {
        "text": ",\u0027 where CSF flows freely through the ventricles but cannot be effectively reabsorbed into the venous system, leading to a global"
      }, {
        "text": " increase in CSF volume and pressure.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Choroid Plex"
      }, {
        "text": "us] --Normal Production--\u003e B(CSF); B --\u003e C(Ventricular System - Open); C --\u003e D(Sub"
      }, {
        "text": "arachnoid Space); D --x E(Impaired Reabsorption at Arachnoid Granulations); E --x F"
      }, {
        "text": "[Venous Sinuses];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"0bc2f200\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_caused_by_impaired_reabsorption_at\",\n        \"to\": \"b"
      }, {
        "text": "7b67074\"\n      },\n      {\n        \"type\": \"can_be_"
      }, {
        "text": "a_sequela_of\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"can_be_a_sequela_of\",\n        \"to\": \"63f8b"
      }, {
        "text": "05f\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \""
      }, {
        "text": "to\": \"non_communicating_hydrocephalus\"\n      }\n    ]\n  },\n  \"1"
      }, {
        "text": "ae850fe\": {\n    \"title\": \"Conduction Aphasia\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003e\u003cb\u003eConduction aphasia\u003c/b\u003e is a relatively rare type of fluent aphasia characterized by a profound"
      }, {
        "text": " impairment of repetition, despite intact auditory comprehension and fluent, though sometimes paraphasic, speech. It is a classic disconnection syndrome"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by damage to the \u003cmark\u003e"
      }, {
        "text": "arcuate fasciculus\u003c/mark\u003e, the white matter tract that connects [[wernicke_area|Wernicke\u0027s area]]"
      }, {
        "text": " (comprehension) to [[a3bbace2|Broca\u0027s area]] (production).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFluency:\u003c/b\u003e Speech is fluent, but may contain phonemic paraphasias (e"
      }, {
        "text": ".g., saying \u0027papple\u0027 for \u0027apple\u0027).\u003cbr\u003e - \u003cb\u003eComprehension:\u003c/b\u003e Aud"
      }, {
        "text": "itory comprehension is intact.\u003cbr\u003e - \u003cb\u003eRepetition:\u003c/b\u003e The hallmark is a \u003cmark\u003esevere deficit in repetition\u003c/mark\u003e."
      }, {
        "text": " The patient cannot repeat phrases or sentences spoken to them.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Awareness:\u003c/b\u003e Patients are aware of their errors"
      }, {
        "text": " and will often try to self-correct.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature that distinguishes conduction aphasia from"
      }, {
        "text": " other fluent aphasias (like Wernicke\u0027s) is the combination of good comprehension with poor repetition. If"
      }, {
        "text": " a patient can understand you but can\u0027t repeat \u0027no ifs, ands, or buts,\u0027 think conduction aphasia.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eConduction aphasia\u003c/b\u003e is a language disorder resulting from a \u0027"
      }, {
        "text": "broken telephone line\u0027 between the brain\u0027s comprehension and production centers; the patient understands what is said and can speak fluently, but cannot accurately"
      }, {
        "text": " relay the message from one area to the other, leading to a profound inability to repeat.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Auditory Input] --\u003e B(Wernicke\u0027s Area - Intact Comprehension); B --"
      }, {
        "text": "x C(Arcuate Fasciculus - Lesion); C --x D(Broca\u0027s Area); D"
      }, {
        "text": " --\u003e E(Impaired Repetition);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"arc"
      }, {
        "text": "uate_fasciculus\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n"
      }, {
        "text": "        \"to\": \"7f6ed344\"\n      },\n      {\n        \"type\": \"differentiated"
      }, {
        "text": "_from\",\n        \"to\": \"2c4a6130\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"2b500647\": {\n    \"title\": \"Conductive Hearing Loss\",\n    "
      }, {
        "text": "\"primaryType\": \"finding\",\n    \"tags\": [\n      \"Otology\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Path"
      }, {
        "text": "ology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConductive hearing loss\u003c/b\u003e is"
      }, {
        "text": " a type of hearing impairment that occurs when there is a problem with the mechanical transmission of sound waves through the outer ear or middle ear to"
      }, {
        "text": " the cochlea of the inner ear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Ca"
      }, {
        "text": "used by any obstruction or damage to the structures that conduct sound, including the external auditory canal, tympanic membrane, or"
      }, {
        "text": " ossicles (malleus, incus, stapes).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e Cerumen (earwax) impaction, ot"
      }, {
        "text": "itis media (middle ear fluid), otitis externa, perforated tympanic membrane, otosclerosis (fixation of the st"
      }, {
        "text": "apes), and [[03ef3134|cholesteatoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTuning Fork Tests"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eRinne Test:\u003c/b\u003e \u003cmark\u003eAbnormal\u003c/mark\u003e. Bone conduction (BC) is greater"
      }, {
        "text": " than or equal to air conduction (AC) in the affected ear, because the normal amplification provided by the middle ear is lost"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003eWeber Test:\u003c/b\u003e Sound \u003cmark\u003elateralizes to the affected ear\u003c/mark\u003e. This"
      }, {
        "text": " is because the conductive loss masks ambient room noise, making the bone-conducted sound seem louder on that side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the tuning fork results: In conductive hearing loss, the Weber test lateralizes to the bad ear, and the Rin"
      }, {
        "text": "ne test is abnormal (BC \u003e AC).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eConductive hearing loss\u003c/b\u003e is a \u0027"
      }, {
        "text": "plumbing problem\u0027 of the ear, where sound waves are physically blocked from reaching the inner ear; this is in contrast to sensor"
      }, {
        "text": "ineural hearing loss, which is a \u0027wiring problem\u0027 of the cochlea or auditory nerve.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"hearing_loss\"\n      },\n      {\n        \"type\": \"differentiated_"
      }, {
        "text": "from\",\n        \"to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"can_be_caused_by\",\n        \"to\": \"otitis_media\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\":"
      }, {
        "text": " \"03ef3134\"\n      }\n    ]\n  },\n  \"6e2"
      }, {
        "text": "81699\": {\n    \"title\": \"Confluence of the Sinuses\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Vascular\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"An"
      }, {
        "text": "atomy and Physiology\",\n      \"Dural Venous Sinuses\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eConfluence of the Sinuses\u003c/b\u003e (or torcular Herophili) is a large venous"
      }, {
        "text": " junction located at the internal occipital protuberance, where several major dural venous sinuses converge.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found on the inner surface of the occipital bone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConverging Sinuses:\u003c/b\u003e It is"
      }, {
        "text": " the meeting point for the \u003cmark\u003esuperior sagittal sinus\u003c/mark\u003e, the \u003cmark\u003estraight sinus\u003c/mark\u003e, and the occip"
      }, {
        "text": "ital sinus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage:\u003c/b\u003e From the confluence, blood typically drains laterally into the left and right \u003cmark\u003etransverse sinuses"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Serves as a major collection point for venous blood from the superior and deep"
      }, {
        "text": " parts of the brain before it is routed towards the internal jugular veins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be"
      }, {
        "text": " able to trace the path of venous drainage from the superior sagittal sinus: Superior Sagittal Sinus ‚Üí Confluence of Sinuses ‚Üí Transverse"
      }, {
        "text": " Sinus ‚Üí Sigmoid Sinus ‚Üí Internal Jugular Vein.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eConfluence of the Sinuses\u003c/b\u003e acts as a central roundabout for venous blood drainage in the posterior cranium, collecting"
      }, {
        "text": " blood from the superior and deep brain and directing it into the transverse sinuses to begin its exit from the skull.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Superior Sagittal Sinus] --\u003e C(Confluence of the Sinuses); B[Straight Sinus"
      }, {
        "text": "] --\u003e C; C --\u003e D[Transverse Sinuses]; D --\u003e E[Sigmoid Sinuses]; E --\u003e F["
      }, {
        "text": "Internal Jugular Vein];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"21f1c955\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"receives_blood_from\",\n        \"to\": \"superior_sagittal_sin"
      }, {
        "text": "us\"\n      },\n      {\n        \"type\": \"receives_blood_from\",\n        \""
      }, {
        "text": "to\": \"straight_sinus\"\n      },\n      {\n        \"type\": \"drains_into"
      }, {
        "text": "\",\n        \"to\": \"transverse_sinus\"\n      }\n    ]\n  },\n  \"14"
      }, {
        "text": "01b7aa\": {\n    \"title\": \"Conjugate Horizontal Gaze Palsy\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003eA \u003cb\u003econjugate horizontal gaze palsy\u003c/b\u003e is the inability to move both eyes in the same horizontal direction ("
      }, {
        "text": "either left or right). It results from a lesion in the brainstem centers that coordinate horizontal eye movements.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Structure:\u003c/b\u003e The \u003cmark\u003eParamedian Pontine Reticular Formation (PPRF"
      }, {
        "text": ")\u003c/mark\u003e, also known as the horizontal gaze center, is the primary structure responsible for initiating horizontal saccades. The PPRF is"
      }, {
        "text": " located in the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e To look to the left, the left PPRF activates the left"
      }, {
        "text": " [[dd11dde6|abducens (CN VI) nucleus]]. The CN VI nucleus then does two things: 1) sends"
      }, {
        "text": " a signal to the ipsilateral lateral rectus muscle to abduct the left eye, and 2) sends a signal via the medial longitudinal"
      }, {
        "text": " fasciculus (MLF) to the contralateral [[68c66997|oculomotor (CN III"
      }, {
        "text": ") nucleus]] to activate the medial rectus muscle and adduct the right eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePPRF Lesion:\u003c/b\u003e A lesion of"
      }, {
        "text": " the PPRF results in an \u003cmark\u003eipsilateral gaze palsy\u003c/mark\u003e. The patient cannot look \u003cu\u003etoward\u003c/u\u003e the side"
      }, {
        "text": " of the lesion. The eyes will often deviate \u003cu\u003eaway\u003c/u\u003e from the side of the lesion due to the unopposed action of the contralateral"
      }, {
        "text": " PPRF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFrontal Eye Field (FEF) Lesion:\u003c/b\u003e A destructive lesion in the cortical"
      }, {
        "text": " FEF (in the frontal lobe) causes the eyes to deviate \u003cu\u003etoward\u003c/u\u003e the side of the lesion."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate brainstem from cortical gaze palsies: PPRF lesion \u003d eyes look \u003cu\u003eaway\u003c/u\u003e from the"
      }, {
        "text": " lesion. FEF lesion \u003d eyes look \u003cu\u003etoward\u003c/u\u003e the lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003eA \u003cb\u003econjugate horizontal gaze palsy\u003c/b\u003e is a failure of the brainstem\u0027s command center for horizontal eye movements, the"
      }, {
        "text": " PPRF; a lesion here prevents the eyes from looking toward the side of the damage, causing them to deviate to the opposite side.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"graph TD; A[Left PPRF] --\u003e B(Left CN VI Nucleus); B --\u003e"
      }, {
        "text": " C(Left Lateral Rectus - Abduction); B --\u003e D(Right MLF); D --\u003e E(Right CN"
      }, {
        "text": " III Nucleus); E --\u003e F(Right Medial Rectus - Adduction);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"pprf\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"differentiated_from\",\n        \"to\": \"frontal_eye_field_lesion\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_related_to\",\n        \"to\": \"58c"
      }, {
        "text": "684bd\"\n      }\n    ]\n  },\n  \"c4d08c0"
      }, {
        "text": "9\": {\n    \"title\": \"Conjunctivitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Infectious Disease\",\n      \"Allergy\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"In"
      }, {
        "text": "fections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConjunctivitis\u003c/b\u003e,"
      }, {
        "text": " commonly known as \\\"pink eye,\\\" is the inflammation of the conjunctiva, the thin, transparent membrane that lines the inner"
      }, {
        "text": " surface of the eyelids and covers the white part of the eye (sclera).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eViral Conjunctivitis:\u003c/b\u003e The most common cause overall. Usually caused by [[aaeda1"
      }, {
        "text": "2d|adenovirus]]. Presents with a red eye, \u003cmark\u003ewatery discharge\u003c/mark\u003e, and a gritty sensation. Often"
      }, {
        "text": " starts in one eye and spreads to the other. Highly contagious.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBacterial Conjunctivitis:\u003c/b\u003e Commonly"
      }, {
        "text": " caused by \u003ci\u003eS. aureus\u003c/i\u003e, \u003ci\u003eS. pneumoniae\u003c/i\u003e, and \u003ci\u003eH. influenzae\u003c/i\u003e"
      }, {
        "text": ". Presents with a red eye and a thick, \u003cmark\u003epurulent (mucopurulent) discharge\u003c/mark"
      }, {
        "text": "\u003e that often causes the eyelids to be stuck together in the morning.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAllergic Conjunctivitis:\u003c/b\u003e An"
      }, {
        "text": " IgE-mediated hypersensitivity reaction to an allergen (e.g., pollen). Presents with bilateral intense \u003cmark\u003eitching"
      }, {
        "text": " (pruritus)\u003c/mark\u003e, redness, and watery discharge.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeonatal Conjunctivitis:\u003c/b\u003e Occ"
      }, {
        "text": "urs in the first month of life. Caused by \u003ci\u003eN. gonorrhoeae\u003c/i\u003e (very purulent, occurs at"
      }, {
        "text": " 2-5 days) or \u003ci\u003eC. trachomatis\u003c/i\u003e (serotypes D-K, watery/"
      }, {
        "text": "mucoid, occurs at 5-14 days). Prophylaxis with erythromycin ointment is standard.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e The type of discharge is the key to differentiating the cause: Watery \u003d Viral or Allergic (look for itching)."
      }, {
        "text": " Purulent \u003d Bacterial.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eConjunctivitis\u003c/b\u003e is inflammation of the"
      }, {
        "text": " eye\u0027s surface membrane, with the etiology‚Äîviral, bacterial, or allergic‚Äîbeing strongly suggested by the character of the discharge and"
      }, {
        "text": " the presence or absence of itching.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"aaeda12"
      }, {
        "text": "d\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        "
      }, {
        "text": "\"to\": \"staphylococcus_aureus\"\n      },\n      {\n        \"type\": \"can"
      }, {
        "text": "_be\",\n        \"to\": \"allergic\"\n      }\n    ]\n  },\n  \"1"
      }, {
        "text": "9016061\": {\n    \"title\": \"Consensual Light Reflex\",\n    \"primaryType\":"
      }, {
        "text": " \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Physical"
      }, {
        "text": " Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eConsensual Light Reflex\u003c/b\u003e is the constriction of the pupil of one"
      }, {
        "text": " eye in response to light being shone into the other eye. It is a normal brainstem reflex that is tested along with the direct"
      }, {
        "text": " light reflex to assess the integrity of the pupillary light reflex pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathway:\u003c/b\u003e Light shone into one eye (e.g., the right eye) sends an afferent signal via the right"
      }, {
        "text": " optic nerve (CN II). This signal travels to the pretectal nuclei in the midbrain. Each pretectal nucleus then sends signals"
      }, {
        "text": " to \u003cmark\u003e\u003cu\u003eboth\u003c/u\u003e\u003c/mark\u003e the ipsilateral and contralateral Edinger-Westphal nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "fferent Limb:\u003c/b\u003e Both Edinger-Westphal nuclei then send efferent parasympathetic signals via their respective oculomotor nerves"
      }, {
        "text": " (CN III) to cause constriction of both pupils.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDirect vs. Consensual:\u003c/b\u003e The constriction"
      }, {
        "text": " of the pupil in the eye receiving the light is the \u003cb\u003edirect\u003c/b\u003e reflex. The simultaneous constriction of the pupil in the opposite"
      }, {
        "text": " eye is the \u003cb\u003econsensual\u003c/b\u003e reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Testing both reflexes helps localize lesions"
      }, {
        "text": ". For example, in a right CN II lesion, shining light in the right eye will cause neither pupil to constrict,"
      }, {
        "text": " but shining light in the left eye will cause both to constrict. In a right CN III lesion, shining light in either"
      }, {
        "text": " eye will cause only the left pupil to constrict.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The bilateral projection from the pre"
      }, {
        "text": "tectal nucleus to both Edinger-Westphal nuclei is the anatomical basis for the consensual light reflex.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eConsensual Light Reflex\u003c/b\u003e demonstrates the bilateral nature of the pupillary light reflex pathway;"
      }, {
        "text": " the brain processes the light signal from one eye and sends a command to constrict both pupils, ensuring a symmetrical response to light.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"graph TD; A[Light in Right Eye] --\u003e B(Right Optic Nerve); B --\u003e C(Pre"
      }, {
        "text": "tectal Nuclei); C --\u003e D(Right E-W Nucleus); C --\u003e E(Left E-W Nucleus); D"
      }, {
        "text": " --\u003e F(Right CN III -\u003e Right Pupil Constricts - Direct); E --\u003e G(Left CN III -\u003e Left Pupil Constricts -"
      }, {
        "text": " Consensual);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "part_of\",\n        \"to\": \"pupillary_light_reflex\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"afferent_limb_is\",\n        \"to\": \"optic_nerve\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"efferent_limb_is\",\n        \"to\": \"68c66997\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"3db2e75e\": {\n    \"title\": \"Convergence-"
      }, {
        "text": "Retraction Nystagmus\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Eye Movement Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eConvergence-retraction nystagmus\u003c/b\u003e is a"
      }, {
        "text": " specific type of abnormal eye movement characterized by jerky, convergent and retractory movements of the eyes, particularly on attempted upgaze. It is a key"
      }, {
        "text": " sign of \u003cmark\u003eParinaud syndrome\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription"
      }, {
        "text": ":\u003c/b\u003e On attempted upward gaze, the eyes jerkily converge (move toward each other) and retract into the orbits."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is a component of Parinaud syndrome (also known as dorsal midbrain syndrome)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Palsy:\u003c/b\u003e The"
      }, {
        "text": " primary deficit is an inability to look up.\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils"
      }, {
        "text": " react poorly to light but constrict normally to accommodation ([[08cb577f|Argyll Robertson-like pupils"
      }, {
        "text": "]]).\u003cbr\u003e3. \u003cb\u003eConvergence-Retraction Nystagmus.\u003c/b\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a"
      }, {
        "text": " lesion in the dorsal midbrain, specifically compressing the superior colliculus and pretectal area.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon"
      }, {
        "text": " Causes:\u003c/b\u003e In children, the most common cause is a \u003cmark\u003epinealoma\u003c/mark\u003e (pineal gland"
      }, {
        "text": " tumor). Other causes include stroke of the midbrain, hydrocephalus, and multiple sclerosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " patient, often a child or young adult, who cannot look up and has abnormal pupillary responses and jerky eye movements on attempted upgaze has"
      }, {
        "text": " Parinaud syndrome, and a pineal tumor should be suspected.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eConvergence-retraction nystagmus\u003c/b\u003e is a pathognomonic sign of dorsal midbrain compression (Parinaud syndrome), where the attempt"
      }, {
        "text": " to look up is thwarted and instead results in a paradoxical, jerky pulling of the eyes inward and backward.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"parinaud_syndrome\"\n      },\n      {\n        \"type\": \"is_caused"
      }, {
        "text": "_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"can_be_caused_by\",\n        \"to\": \"pinealoma\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"208cebcd\": {\n    \"title\": \"Corkscrew Fib"
      }, {
        "text": "ers (Rosenthal Fibers)\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "ropathology\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRosenthal fibers\u003c/b\u003e, sometimes described as \u0027corkscrew fibers"
      }, {
        "text": ",\u0027 are thick, elongated, eosinophilic (pink) protein aggregates found in the cytoplasm of astrocytes. They are a characteristic"
      }, {
        "text": " histological finding in certain slow-growing glial processes and tumors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance"
      }, {
        "text": ":\u003c/b\u003e On H\u0026E stain, they appear as bright pink, irregular, corkscrew-shaped or rope-like inclusions within"
      }, {
        "text": " astrocytic processes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Composed of aggregates of intermediate filament proteins, including glial fibrillary acidic protein (GF"
      }, {
        "text": "AP), along with heat shock proteins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e They are the histological hallmark of a \u003cmark\u003epilocytic astroc"
      }, {
        "text": "ytoma\u003c/mark\u003e, the most common primary brain tumor in children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Conditions:\u003c/b\u003e Can also be seen"
      }, {
        "text": " in areas of long-standing gliosis and in Alexander disease, a rare leukodystrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e The presence of Rosenthal fibers in a biopsy of a pediatric cerebellar cystic tumor is diagnostic for pilocytic astrocytoma.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRosenthal fibers\u003c/b\u003e are distinctive eosinophilic, corkscrew-shaped inclusions that"
      }, {
        "text": " are the microscopic signature of a pilocytic astrocytoma, representing aggregates of glial proteins within the tumor cells.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \""
      }, {
        "text": "to\": \"pilocytic_astrocytoma\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_found_in\",\n        \"to\": \"8192f595\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_composed_of\",\n        \"to\": \"fb50d450\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"7d70ac32\": {\n    \"title\": \"Cornea\",\n    \"primary"
      }, {
        "text": "Type\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eCornea\u003c/b\u003e is the transparent, avascular, dome-shaped outer layer at the very front of the eye."
      }, {
        "text": " It covers the iris, pupil, and anterior chamber and is the eye\u0027s primary refractive surface.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Its primary function is to \u003cmark\u003erefract (bend) light\u003c/mark\u003e, accounting"
      }, {
        "text": " for about two-thirds of the eye\u0027s total optical power. It also serves a protective role.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructure"
      }, {
        "text": ":\u003c/b\u003e Composed of five layers (Epithelium, Bowman\u0027s layer, Stroma, Descemet\u0027s membrane,"
      }, {
        "text": " Endothelium). It is avascular and receives nutrients from the aqueous humor and oxygen from the air.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e"
      }, {
        "text": " Richly innervated by sensory nerve fibers from the ophthalmic division of the trigeminal nerve (CN V\u003csub\u003e1\u003c/sub\u003e), making it extremely"
      }, {
        "text": " sensitive to touch.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[18cff34e"
      }, {
        "text": "|Astigmatism]]:\u003c/b\u003e Caused by an irregular curvature of the cornea.\u003cbr\u003e - \u003cb\u003eKeratitis:\u003c/b\u003e Inflammation of the cornea.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eCorneal Abrasion:\u003c/b\u003e A scratch on the corneal surface.\u003cbr\u003e - \u003cb\u003eKays"
      }, {
        "text": "er-Fleischer rings:\u003c/b\u003e Copper deposits in Descemet\u0027s membrane, seen in Wilson disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The [[64663383|corneal reflex]] (blinking in"
      }, {
        "text": " response to touching the cornea) tests the afferent limb of CN V\u003csub\u003e1\u003c/sub\u003e and the efferent limb of CN VII.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCornea\u003c/b\u003e is the eye\u0027s powerful, transparent front window, responsible for the majority"
      }, {
        "text": " of light refraction, while its dense sensory innervation makes it exquisitely sensitive and provides a critical protective reflex.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_involved"
      }, {
        "text": "_in\",\n        \"to\": \"refraction\"\n      },\n      {\n        \"type\": \"is_involved"
      }, {
        "text": "_in\",\n        \"to\": \"18cff34e\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_innervated_by\",\n        \"to\": \"trigeminal_nerve_v1"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_tested_by\",\n        \"to\": \"6"
      }, {
        "text": "4663383\"\n      }\n    ]\n  },\n  \"64663383\": {"
      }, {
        "text": "\n    \"title\": \"Corneal Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n"
      }, {
        "text": "      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eCorneal Reflex\u003c/b\u003e is an involuntary blinking of the eyelids elicited by stimulation of the cornea (such as by touching it"
      }, {
        "text": " with a wisp of cotton), which serves to protect the eye from foreign bodies.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e Tests the integrity of a brainstem reflex arc involving cranial nerves V and VII.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Afferent Limb (Sensation):\u003c/b\u003e The stimulus is detected by nociceptors in the [[7d70ac32|cor"
      }, {
        "text": "nea]], and the sensory signal is carried to the pons by the ophthalmic division of the \u003cmark\u003etrigeminal nerve (CN V\u003csub\u003e"
      }, {
        "text": "1\u003c/sub\u003e)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb (Motor):\u003c/b\u003e Motor output is sent from the pons via the \u003cmark\u003efacial"
      }, {
        "text": " nerve (CN VII)\u003c/mark\u003e bilaterally to the orbicularis oculi muscles, causing both eyes to blink.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInterpretation"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNo blink in either eye:\u003c/b\u003e Lesion in the ipsilateral CN V\u003csub\u003e"
      }, {
        "text": "1\u003c/sub\u003e (afferent defect).\u003cbr\u003e - \u003cb\u003eOnly contralateral eye blinks:\u003c/b\u003e Lesion in the ipsilateral CN VII"
      }, {
        "text": " (efferent defect).\u003cbr\u003e - \u003cb\u003eOnly ipsilateral eye blinks:\u003c/b\u003e Lesion in the contralateral CN VII."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the pathway: Sensation in via CN V, blinking out via CN VII. A"
      }, {
        "text": " lesion in CN V\u003csub\u003e1\u003c/sub\u003e will knock out the reflex on both sides when the affected eye is stimulated. A lesion in CN VII will only"
      }, {
        "text": " knock out the blink on the affected side, regardless of which eye is stimulated.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eCorneal Reflex\u003c/b\u003e is a critical brainstem reflex that protects the eye, relying on the"
      }, {
        "text": " trigeminal nerve (CN V) to \u0027feel\u0027 the threat and the facial nerve (CN VII) to \u0027act"
      }, {
        "text": "\u0027 by closing the eyelids.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Touch Cornea] --\u003e B(Aff"
      }, {
        "text": "erent: CN V1); B --\u003e C(Pons); C --\u003e D(Efferent: Bilateral CN VII); D --\u003e E("
      }, {
        "text": "Bilateral Orbicularis Oculi Contraction); E --\u003e F(Blinking);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"afferent_limb_is\",\n        \"to\": \"trigeminal_nerve_v1\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        \"to\": \"facial_nerve"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"tests_integrity_of\",\n        \"to\":"
      }, {
        "text": " \"pons\"\n      }\n    ]\n  },\n  \"dd3c9b1b\": {\n    \"title\": \""
      }, {
        "text": "Coronary Vasospasm\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Cardiology"
      }, {
        "text": "\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Card"
      }, {
        "text": "iovascular\",\n      \"Pathology\",\n      \"Ischemic Heart Disease\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCoronary vasospasm\u003c/b\u003e is a transient, focal constriction of a"
      }, {
        "text": " coronary artery that can cause myocardial ischemia, leading to a type of angina known as vasospastic or Prinzmetal angina. It can"
      }, {
        "text": " also be a side effect of certain drugs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology"
      }, {
        "text": ":\u003c/b\u003e Involves hyperreactivity of coronary artery smooth muscle, leading to intense vasoconstriction. The exact cause is unknown but"
      }, {
        "text": " may involve endothelial dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrinzmetal Angina:\u003c/b\u003e Characterized by angina that occurs at rest, often at"
      }, {
        "text": " night, and is not precipitated by exertion. EKG during an episode shows transient ST-segment elevation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug"
      }, {
        "text": "-Induced Vasospasm:\u003c/b\u003e Several drugs can trigger coronary vasospasm.\u003cbr\u003e - \u003cb\u003e[[3a"
      }, {
        "text": "4a8ad6|Cocaine]]:\u003c/b\u003e A potent vasoconstrictor that can cause vasospasm and myocardial infarction,"
      }, {
        "text": " even in patients with normal coronary arteries.\u003cbr\u003e - \u003cb\u003e[[triptans|Triptans]] (e.g., sumatriptan"
      }, {
        "text": "):\u003c/b\u003e Used for migraines, they are 5-HT\u003csub\u003e1B/1D\u003c/sub\u003e agonists that can cause coronary"
      }, {
        "text": " vasoconstriction and are contraindicated in patients with coronary artery disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute attacks are treated with nitrog"
      }, {
        "text": "lycerin. Long-term prevention involves calcium channel blockers and nitrates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Cocaine-"
      }, {
        "text": "induced chest pain should be treated with benzodiazepines and nitrates. \u003cu\u003eBeta-blockers are contraindicated\u003c/u\u003e as they can lead"
      }, {
        "text": " to unopposed alpha-adrenergic stimulation and worsen the vasospasm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCoronary"
      }, {
        "text": " vasospasm\u003c/b\u003e is a spastic constriction of a coronary artery that causes ischemic chest pain at rest (Prinzmetal angina)"
      }, {
        "text": " and can be a dangerous side effect of vasoconstrictive drugs like cocaine and triptans.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"prinzmetal_angina\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \""
      }, {
        "text": "3a4a8ad6\"\n      },\n      {\n        \"type\": \"is_an_"
      }, {
        "text": "adverse_effect_of\",\n        \"to\": \"triptans\"\n      }\n    ]\n"
      }, {
        "text": "  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1MEp-ltSViYF3yitBEjzjl6GXFzyRcily"
      },
      "role": "user",
      "tokenCount": 2070
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"14a625af\": {\n    \"title\": \"Cortical Signs\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCortical signs\u003c/b\u003e are specific neurological deficits that indicate involvement of the [[a1b198f9|cerebral cortex]], as opposed to subcortical structures like the basal ganglia, thalamus, or brainstem. Their presence is crucial for localizing lesions, particularly strokes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDefinition:\u003c/b\u003e Neurological signs that point to dysfunction of higher-order processing in the cerebral cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Cortical Signs:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[6bc9a567|Aphasia]]:\u003c/b\u003e Language disturbance (Broca\u0027s, Wernicke\u0027s), indicating a lesion in the dominant hemisphere (usually left).\u003cbr\u003e - \u003cb\u003eHemineglect:\u003c/b\u003e Inattention to one side of space, indicating a lesion in the non-dominant parietal lobe (usually right).\u003cbr\u003e - \u003cb\u003e[[ff289b3a|Visual Field Defects]]:\u003c/b\u003e Homonymous hemianopia or quadrantanopia.\u003cbr\u003e - \u003cb\u003eAgnosia:\u003c/b\u003e Inability to recognize objects, faces, or places.\u003cbr\u003e - \u003cb\u003eApraxia:\u003c/b\u003e Inability to perform learned motor tasks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of cortical signs helps differentiate large territorial strokes (e.g., [[143bb23d|MCA stroke]]) from small, deep strokes (\u003cmark\u003elacunar infarcts\u003c/mark\u003e), which characteristically \u003cu\u003elack\u003c/u\u003e cortical signs and present as pure motor or pure sensory deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a patient presents with contralateral hemiparesis PLUS aphasia, the lesion is cortical (likely MCA). If the patient has contralateral hemiparesis with NO aphasia, neglect, or visual field cut, the lesion is likely subcortical (e.g., a lacunar stroke in the internal capsule).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCortical signs\u003c/b\u003e are the clinical fingerprints of cerebral cortex dysfunction, representing deficits in higher-order functions like language and spatial awareness, and their presence or absence is a key factor in distinguishing cortical from subcortical strokes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_caused_by_lesion_in\",\n        \"to\": \"a1b198f9\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hemineglect\"\n      },\n      {\n        \"type\": \"are_absent_in\",\n        \"to\": \"lacunar_stroke\"\n      }\n    ]\n  },\n  \"fb0a5fdc\": {\n    \"title\": \"Corticospinal Tract\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCorticospinal Tract\u003c/b\u003e (also known as the pyramidal tract) is the major descending motor pathway in the central nervous system that controls voluntary, fine movements of the distal and limb muscles.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from upper motor neurons (UMNs) in the primary motor cortex, premotor cortex, and supplementary motor area.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Descends through the posterior limb of the internal capsule, cerebral peduncle (midbrain), pons, and medullary pyramids.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecussation:\u003c/b\u003e Approximately 85-90% of fibers decussate (cross over) at the \u003cmark\u003epyramidal decussation\u003c/mark\u003e in the caudal medulla to form the \u003cb\u003elateral corticospinal tract\u003c/b\u003e, which descends in the lateral funiculus of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSynapse:\u003c/b\u003e The UMNs of the corticospinal tract synapse on lower motor neurons (LMNs) in the anterior horn of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e Damage to the corticospinal tract results in \u003cmark\u003eupper motor neuron signs\u003c/mark\u003e (spasticity, hyperreflexia, positive Babinski) on the contralateral side if the lesion is above the decussation, and on the ipsilateral side if below. This tract is damaged in [[4792bc68|Brown-S√©quard syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The decussation at the medulla is a critical anatomical point. It explains why a stroke in the left motor cortex causes right-sided weakness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCorticospinal Tract\u003c/b\u003e is the primary \u0027command pathway\u0027 for voluntary movement, originating in the motor cortex and crossing in the medulla to control the contralateral side of the body; damage to this tract is the basis of upper motor neuron syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Motor Cortex - UMN] --\u003e B(Internal Capsule); B --\u003e C(Brainstem); C --\u003e D(Pyramidal Decussation - Medulla); D --\u003e E(Lateral Corticospinal Tract); E --\u003e F(Synapse on LMN in Anterior Horn);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"upper_motor_neurons\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"upper_motor_neuron_signs\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"decussates_at\",\n        \"to\": \"pyramidal_decussation\"\n      }\n    ]\n  },\n  \"2a3826fc\": {\n    \"title\": \"Corticospinal Tracts\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCorticospinal Tracts\u003c/b\u003e are the primary descending motor pathways that carry motor signals from the cerebral cortex to the spinal cord, enabling voluntary movement. They are composed of the lateral and anterior corticospinal tracts.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Control of voluntary, discrete, skilled movements, especially of the distal limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLateral Corticospinal Tract:\u003c/b\u003e The larger of the two tracts, containing ~90% of the fibers. These fibers have decussated (crossed) in the medullary pyramids and control the contralateral limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterior (Ventral) Corticospinal Tract:\u003c/b\u003e Contains the ~10% of fibers that did not cross in the medulla. These fibers descend ipsilaterally and most cross at the spinal cord level they innervate, primarily controlling axial and proximal (truncal) muscles bilaterally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegeneration:\u003c/b\u003e Degeneration of the corticospinal tracts is a key feature of \u003cmark\u003e[[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]\u003c/mark\u003e, contributing to the upper motor neuron signs (spasticity, hyperreflexia) seen in the disease. It is also affected in [[6f5bea90|Subacute Combined Degeneration]] (B12 deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the vast majority of voluntary motor control to the limbs is contralateral, mediated by the lateral corticospinal tract which crosses in the medulla.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCorticospinal Tracts\u003c/b\u003e are the brain\u0027s direct lines of command to the spinal cord for voluntary movement, with the massive lateral tract controlling the contralateral limbs and the smaller anterior tract managing the axial musculature.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"descending_motor_pathway\"\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"fb0a5fdc\"\n      }\n    ]\n  },\n  \"2b254051\": {\n    \"title\": \"Cotton-Wool Spots\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCotton-wool spots\u003c/b\u003e are fluffy, white, superficial retinal lesions seen on fundoscopic examination. They represent microinfarcts in the retinal nerve fiber layer due to occlusion of precapillary arterioles.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Ischemia in the nerve fiber layer leads to a blockage of axoplasmic transport, causing the accumulation of axoplasmic debris in the nerve fiber axons, which appear as white spots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Fluffy, white, or grayish lesions with indistinct borders on the surface of the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e They are a non-specific sign of retinal ischemia and can be seen in various systemic diseases, most commonly:\u003cbr\u003e - \u003cmark\u003e[[73b00ab0|Diabetic retinopathy]]\u003c/mark\u003e\u003cbr\u003e - \u003cmark\u003e[[549b012e|Hypertensive retinopathy]]\u003c/mark\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Also seen in central/branch retinal vein occlusion, HIV retinopathy (including from [[cytomegalovirus|CMV]]), and systemic lupus erythematosus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While not specific, the presence of cotton-wool spots on a fundoscopic exam should prompt consideration of underlying systemic vascular disease, particularly diabetes and hypertension.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCotton-wool spots\u003c/b\u003e are the retinal equivalent of mini-strokes, appearing as fluffy white patches that signify focal ischemia in the nerve fiber layer, most often as a consequence of microvascular damage from diabetes or hypertension.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"549b012e\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"b69e35b5\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"retinal_ischemia\"\n      }\n    ]\n  },\n  \"9077ed85\": {\n    \"title\": \"Cough Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pulmonology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCough Reflex\u003c/b\u003e is a protective reflex that forcibly expels irritants, foreign material, and excess secretions from the larynx, trachea, and bronchi. It involves a complex coordination of sensory input and motor output mediated by the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAfferent Limb (Sensation):\u003c/b\u003e The sensation of irritation in the larynx and upper airway is carried primarily by the internal laryngeal nerve, a branch of the superior laryngeal nerve, which is itself a branch of the \u003cmark\u003evagus nerve (CN X)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral Processing:\u003c/b\u003e The afferent signals are sent to the medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb (Motor):\u003c/b\u003e The medulla coordinates a motor response involving multiple nerves:\u003cbr\u003e - The \u003cmark\u003evagus nerve (CN X)\u003c/mark\u003e causes the glottis to close and the larynx/trachea to contract.\u003cbr\u003e - The phrenic and spinal motor nerves cause contraction of the diaphragm and abdominal/intercostal muscles to generate high intrathoracic pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e A deep inhalation is followed by forceful exhalation against a closed glottis, which then suddenly opens, producing an explosive outflow of air.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The cough reflex is a key brainstem reflex. Both the afferent and primary efferent limbs are mediated by the \u003cb\u003evagus nerve (CN X)\u003c/b\u003e. Aspiration risk is high in patients with impaired cough reflex (e.g., after a stroke affecting the medulla).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCough Reflex\u003c/b\u003e is a vital airway defense mechanism orchestrated by the medulla, with the vagus nerve playing the dual role of both sensing the irritation in the airway and executing the forceful expulsion.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Irritant in Airway] --\u003e B(Afferent: CN X); B --\u003e C(Medulla); C --\u003e D(Efferent: CN X, Phrenic N., Spinal N.); D --\u003e E(Forceful Expiration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"is_coordinated_by\",\n        \"to\": \"medulla_oblongata\"\n      }\n    ]\n  },\n  \"7f95e358\": {\n    \"title\": \"Cranial Dysraphism\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCranial dysraphism\u003c/b\u003e refers to a group of neural tube defects that result from the failure of the rostral (cranial) neuropore to close properly during the fourth week of embryonic development. This category includes conditions like [[5bcc9894|anencephaly]] and encephalocele.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[5bcc9894|Anencephaly]]:\u003c/b\u003e The most severe form. Failure of the rostral neuropore to close leads to the absence of the forebrain and calvarium. It is incompatible with life and is associated with polyhydramnios.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEncephalocele:\u003c/b\u003e A sac-like protrusion of the brain and meninges through a defect in the skull. The occipital region is the most common site.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A failure of neural tube fusion at the cranial end.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Associated with maternal folate deficiency and certain medications (e.g., valproate).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Detected prenatally by elevated maternal serum alpha-fetoprotein (AFP) and ultrasound.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate cranial dysraphism (rostral neuropore defects like anencephaly) from spinal dysraphism (caudal neuropore defects like spina bifida).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCranial dysraphism\u003c/b\u003e represents a failure of the neural tube to close at the head end, leading to severe and often lethal congenital malformations of the brain and skull, such as anencephaly.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5bcc9894\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"encephalocele\"\n      }\n    ]\n  },\n  \"624d82e9\": {\n    \"title\": \"Cranial Nerve Nuclei\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCranial nerve nuclei\u003c/b\u003e are clusters of neurons (gray matter) in the brainstem from which the cranial nerves (III-XII) emerge or terminate. They are the functional equivalent of the gray matter horns of the spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the tegmentum of the brainstem (midbrain, pons, medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrganization:\u003c/b\u003e Organized into functional columns. As a general rule, \u003cmark\u003emotor nuclei are located medially\u003c/mark\u003e in the brainstem, while \u003cmark\u003esensory nuclei are located laterally\u003c/mark\u003e. This reflects the embryological origin from the basal (motor) and alar (sensory) plates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMidline Motor Nuclei (Rule of 4s):\u003c/b\u003e The nuclei of cranial nerves whose numbers are factors of 12 (\u003cb\u003eIII, IV, VI, XII\u003c/b\u003e) are located medially.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLateral Nuclei:\u003c/b\u003e The nuclei of cranial nerves V, VII, VIII, IX, X, and XI are located more laterally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Brainstem strokes often present with specific cranial nerve deficits that can be used to localize the lesion. Medial brainstem syndromes affect the midline motor nuclei, while lateral syndromes affect the lateral sensory and branchiomotor nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Knowing the medial vs. lateral organization of the cranial nerve nuclei is a high-yield concept for solving brainstem lesion problems.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ecranial nerve nuclei\u003c/b\u003e are the command and control centers for the cranial nerves, systematically arranged within the brainstem with motor nuclei positioned medially and sensory nuclei laterally, providing a precise anatomical map for localizing brainstem lesions.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Brainstem]; A --\u003e B(Medial Column - Motor Nuclei); B --\u003e C(CN III, IV, VI, XII); A --\u003e D(Lateral Column - Sensory/Other Nuclei); D --\u003e E(CN V, VII, VIII, IX, X, XI);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_located_in\",\n        \"to\": \"582d8572\"\n      },\n      {\n        \"type\": \"are_organized_by\",\n        \"to\": \"alar_and_basal_plates\"\n      }\n    ]\n  },\n  \"eab31845\": {\n    \"title\": \"Cranial Nerves\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ecranial nerves\u003c/b\u003e are a set of 12 paired nerves that emerge directly from the brain or brainstem. They are part of the peripheral nervous system (with the exception of CN II) and are responsible for the sensory and motor functions of the head and neck, as well as certain autonomic functions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNumbering:\u003c/b\u003e Numbered I through XII in rostral to caudal order.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction Types (Mnemonic):\u003c/b\u003e \\\"Some Say Marry Money But My Brother Says Big Brains Matter Most\\\" indicates whether each nerve is \u003cb\u003eS\u003c/b\u003eensory, \u003cb\u003eM\u003c/b\u003eotor, or \u003cb\u003eB\u003c/b\u003eoth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Location:\u003c/b\u003e CN I and II emerge from the cerebrum. CN III and IV emerge from the midbrain. CN V, VI, VII, and VIII emerge from the pons. CN IX, X, XI, and XII emerge from the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Lesions:\u003c/b\u003e Palsies of the cranial nerves produce specific, predictable deficits (e.g., [[fdfd22ca|CN III palsy]] causes a \u0027down and out\u0027 eye; [[facial_nerve_palsy|CN VII palsy]] causes facial droop).\u003c/li\u003e\u003cli\u003e\u003cb\u003eReflexes:\u003c/b\u003e Many clinical reflexes, such as the [[64663383|corneal reflex]] (CN V, VII) and gag reflex (CN IX, X), are used to test the integrity of specific cranial nerves and their brainstem pathways.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePolyradiculopathy:\u003c/b\u003e Conditions like [[ed52e40b|Guillain-Barr√© syndrome]] can affect cranial nerves, causing symptoms like bilateral facial weakness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ecranial nerves\u003c/b\u003e are the specialized peripheral nerves of the head and neck, each with a unique function and anatomical course, making their clinical examination a powerful tool for localizing lesions within the brainstem and skull base.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"emerge_from\",\n        \"to\": \"582d8572\"\n      },\n      {\n        \"type\": \"are_tested_by\",\n        \"to\": \"2915ead0\"\n      },\n      {\n        \"type\": \"can_be_affected_by\",\n        \"to\": \"ed52e40b\"\n      }\n    ]\n  },\n  \"2e53c11c\": {\n    \"title\": \"Cranial Nerves and Arteries Relationships\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe anatomical relationships between the \u003cb\u003ecranial nerves and arteries\u003c/b\u003e at the base of the brain are clinically significant, as vascular pathologies like aneurysms or strokes can cause specific cranial nerve palsies due to compression or ischemia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCN III (Oculomotor):\u003c/b\u003e Passes between the \u003cmark\u003eposterior cerebral artery (PCA)\u003c/mark\u003e and the \u003cmark\u003esuperior cerebellar artery (SCA)\u003c/mark\u003e. An aneurysm of the posterior communicating artery (PComA) is a classic cause of a compressive CN III palsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN VI (Abducens):\u003c/b\u003e Has a long intracranial course and is closely related to the [[3c075343|anterior inferior cerebellar artery (AICA)]] near the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN XII (Hypoglossal):\u003c/b\u003e Exits the medulla near the [[1430f5b4|anterior spinal artery (ASA)]] and vertebral artery. Occlusion of the ASA can cause Medial Medullary Syndrome, which includes an ipsilateral CN XII palsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCavernous Sinus:\u003c/b\u003e A critical location where CNs III, IV, V\u003csub\u003e1\u003c/sub\u003e, V\u003csub\u003e2\u003c/sub\u003e, and VI are in close proximity to the internal carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The relationship between the PComA and CN III is extremely high-yield. A painful third nerve palsy with a dilated pupil is a PComA aneurysm until proven otherwise.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe close proximity of \u003cb\u003ecranial nerves and arteries\u003c/b\u003e at the skull base creates \u0027danger zones\u0027 where vascular abnormalities can directly impact nerve function, with the PComA aneurysm compressing CN III being the most classic and clinically urgent example.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PComA Aneurysm] --Compresses--\u003e B(CN III); C[AICA Stroke] --Affects--\u003e D(CN VI, VII, VIII); E[ASA Stroke] --Affects--\u003e F(CN XII);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"aneurysm_compresses\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"stroke_affects\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"stroke_affects\",\n        \"to\": \"hypoglossal_nerve\"\n      }\n    ]\n  },\n  \"91783169\": {\n    \"title\": \"Cranial Nerve Foramina\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Skull Base\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ecranial nerve foramina\u003c/b\u003e are the openings in the base of the skull through which the cranial nerves, as well as major blood vessels, pass to exit the cranial cavity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnterior Cranial Fossa:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCribriform Plate:\u003c/b\u003e CN I (Olfactory nerves).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMiddle Cranial Fossa:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOptic Canal:\u003c/b\u003e CN II, Ophthalmic artery.\u003cbr\u003e - \u003cb\u003eSuperior Orbital Fissure:\u003c/b\u003e CN III, IV, V\u003csub\u003e1\u003c/sub\u003e, VI.\u003cbr\u003e - \u003cb\u003eForamen Rotundum:\u003c/b\u003e CN V\u003csub\u003e2\u003c/sub\u003e.\u003cbr\u003e - \u003cb\u003eForamen Ovale:\u003c/b\u003e CN V\u003csub\u003e3\u003c/sub\u003e.\u003cbr\u003e - \u003cb\u003eForamen Spinosum:\u003c/b\u003e Middle meningeal artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePosterior Cranial Fossa:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eInternal Auditory Meatus:\u003c/b\u003e CN VII, VIII.\u003cbr\u003e - \u003cb\u003eJugular Foramen:\u003c/b\u003e CN IX, X, XI, Jugular vein.\u003cbr\u003e - \u003cb\u003eHypoglossal Canal:\u003c/b\u003e CN XII.\u003cbr\u003e - \u003cb\u003eForamen Magnum:\u003c/b\u003e Brainstem/Spinal cord, Vertebral arteries, Spinal root of CN XI.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mnemonics are very helpful here. For the Superior Orbital Fissure: \\\"\u003cb\u003eL\u003c/b\u003eive \u003cb\u003eF\u003c/b\u003erankly \u003cb\u003eT\u003c/b\u003eo \u003cb\u003eS\u003c/b\u003eee \u003cb\u003eA\u003c/b\u003ebsolutely \u003cb\u003eN\u003c/b\u003eo \u003cb\u003eI\u003c/b\u003ensult\\\" (Lacrimal n., Frontal n., Trochlear n., Superior division of CN III, Abducens n., Nasociliary n., Inferior division of CN III). For Foramina of V: \\\"\u003cb\u003eS\u003c/b\u003etanding \u003cb\u003eR\u003c/b\u003eoom \u003cb\u003eO\u003c/b\u003enly\\\" (\u003cb\u003eS\u003c/b\u003euperior orbital fissure for V1, \u003cb\u003eR\u003c/b\u003eotundum for V2, \u003cb\u003eO\u003c/b\u003evale for V3).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eKnowledge of the \u003cb\u003ecranial nerve foramina\u003c/b\u003e is essential for clinical localization, as fractures or tumors at the skull base can produce specific patterns of cranial nerve deficits based on which foramina are involved.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_exit_for\",\n        \"to\": \"eab31845\"\n      }\n    ]\n  },\n  \"7048db1e\": {\n    \"title\": \"Craniopharyngioma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pediatrics\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecraniopharyngioma\u003c/b\u003e is a rare, benign, slow-growing suprasellar tumor that arises from epithelial remnants of Rathke\u0027s pouch. Despite being benign, it can cause significant morbidity due to its location and compression of surrounding structures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from remnants of \u003cmark\u003eRathke\u0027s pouch\u003c/mark\u003e (oral ectoderm), the same embryonic structure that forms the [[76ba7f2e|anterior pituitary]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e Has a bimodal age distribution, with peaks in childhood (5-14 years) and adulthood (50-74 years). It is the most common childhood supratentorial tumor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Suprasellar region, near the pituitary gland and optic chiasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Due to compression:\u003cbr\u003e - \u003cb\u003eOptic Chiasm:\u003c/b\u003e \u003cmark\u003e[[6c3a980e|Bitemporal hemianopia]]\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003ePituitary Stalk/Gland:\u003c/b\u003e Endocrine dysfunction, most commonly growth hormone deficiency (short stature in children) and diabetes insipidus.\u003cbr\u003e - \u003cb\u003eThird Ventricle:\u003c/b\u003e Hydrocephalus and increased ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology \u0026 Imaging:\u003c/b\u003e Often cystic and \u003cmark\u003ecalcified\u003c/mark\u003e. The cysts are filled with a thick, brownish-yellow fluid rich in cholesterol crystals, described as \\\"machine oil.\\\" Histology shows nests of squamous epithelium and \\\"wet keratin\\\" (anucleate squamous cells).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with short stature, headaches, and bitemporal hemianopia, with a calcified suprasellar mass on imaging, is the classic vignette for a craniopharyngioma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ecraniopharyngioma\u003c/b\u003e is a benign but problematic tumor arising from embryonic remnants of Rathke\u0027s pouch, which classically presents in a child with a triad of visual field defects, endocrine failure, and hydrocephalus, often with characteristic calcifications on imaging.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Rathke\u0027s Pouch Remnant] --\u003e B(Craniopharyngioma); B --Compresses--\u003e C(Optic Chiasm); C --\u003e D(Bitemporal Hemianopia); B --Compresses--\u003e E(Pituitary/Hypothalamus); E --\u003e F(Endocrinopathy);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"rathkes_pouch\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"6c3a980e\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"hypopituitarism\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"be057cfc\"\n      }\n    ]\n  },\n  \"cd09cad7\": {\n    \"title\": \"Cremasteric Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Urology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCremasteric Reflex\u003c/b\u003e is a superficial reflex in males that is elicited by lightly stroking or pinching the superior and medial part of the thigh, resulting in a rapid elevation of the ipsilateral testicle due to contraction of the cremaster muscle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Tests the integrity of the \u003cmark\u003eL1 and L2\u003c/mark\u003e spinal nerve roots. Mnemonic: L\u003cb\u003e1\u003c/b\u003e, \u003cb\u003e2\u003c/b\u003e, testicles move.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Limb (Sensation):\u003c/b\u003e The stimulus is sensed by the ilioinguinal nerve and the femoral branch of the genitofemoral nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb (Motor):\u003c/b\u003e The motor response is carried by the genital branch of the \u003cmark\u003egenitofemoral nerve\u003c/mark\u003e, which innervates the cremaster muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The reflex is characteristically \u003cmark\u003eabsent\u003c/mark\u003e in cases of \u003cmark\u003etesticular torsion\u003c/mark\u003e, making it a crucial diagnostic sign in the evaluation of acute scrotal pain. It is also absent in L1-L2 spinal cord injury or nerve damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An absent cremasteric reflex in a male with acute scrotal pain is highly suggestive of testicular torsion until proven otherwise and constitutes a urologic emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCremasteric Reflex\u003c/b\u003e is a key physical exam finding in evaluating acute scrotal pain; its presence argues against testicular torsion, while its absence is a major red flag for this surgical emergency.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Stroke Inner Thigh] --\u003e B(Afferent: Ilioinguinal/Genitofemoral N.); B --\u003e C(L1-L2 Spinal Cord); C --\u003e D(Efferent: Genitofemoral N.); D --\u003e E(Cremaster Muscle Contraction); E --\u003e F(Testicle Elevation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"l1_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"l2_nerve_root\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"testicular_torsion\"\n      }\n    ]\n  },\n  \"86fe59ba\": {\n    \"title\": \"Creutzfeldt-Jakob Disease (CJD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCreutzfeldt-Jakob Disease (CJD)\u003c/b\u003e is a rare, fatal, and transmissible neurodegenerative disorder caused by prions. It is characterized by a rapidly progressive dementia and myoclonus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by \u003cmark\u003eprions\u003c/mark\u003e, which are misfolded proteins (PrP\u003csup\u003eSc\u003c/sup\u003e) that induce the misfolding of normal cellular prion proteins (PrP\u003csup\u003eC\u003c/sup\u003e). This leads to an exponential accumulation of abnormal protein aggregates that are resistant to proteases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eForms:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSporadic (sCJD):\u003c/b\u003e Most common form (~85%), occurs spontaneously.\u003cbr\u003e - \u003cb\u003eFamilial (fCJD):\u003c/b\u003e Due to an inherited mutation in the \u003ci\u003ePRNP\u003c/i\u003e gene.\u003cbr\u003e - \u003cb\u003eIatrogenic (iCJD):\u003c/b\u003e Transmitted via contaminated neurosurgical instruments, corneal transplants, or human-derived growth hormone.\u003cbr\u003e - \u003cb\u003eVariant (vCJD):\u003c/b\u003e Linked to consumption of beef from cattle with bovine spongiform encephalopathy (\u0027mad cow disease\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e \u003cmark\u003eRapidly progressive dementia\u003c/mark\u003e over weeks to months, accompanied by ataxia and \u003cmark\u003estartle myoclonus\u003c/mark\u003e (jerking movements in response to loud noises or touch).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnostic Findings:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eEEG:\u003c/b\u003e Periodic sharp wave complexes.\u003cbr\u003e - \u003cb\u003eCSF:\u003c/b\u003e Presence of 14-3-3 protein.\u003cbr\u003e - \u003cb\u003eMRI:\u003c/b\u003e High signal intensity in the caudate nucleus and putamen or cortex on DWI/FLAIR sequences.\u003cbr\u003e - \u003cb\u003eHistology:\u003c/b\u003e \u003cmark\u003eSpongiform encephalopathy\u003c/mark\u003e (vacuolation of the neuropil) without significant inflammation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with dementia that progresses from mild confusion to profound incapacity in just a few months, especially with myoclonus, is the classic presentation of CJD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCreutzfeldt-Jakob Disease\u003c/b\u003e is a prion-mediated neurodegenerative catastrophe, distinguished by its astonishingly rapid progression from cognitive decline to death, and marked pathologically by the brain turning into a \u0027sponge\u0027 due to widespread neuronal loss and vacuolation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PrPSc Prion] --\u003e B(Induces Misfolding of Normal PrPC); B --\u003e C(Aggregation of PrPSc); C --\u003e D(Spongiform Encephalopathy); D --\u003e E(Rapidly Progressive Dementia \u0026 Myoclonus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"prions\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"rapidly_progressive_dementia\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"myoclonus\"\n      },\n      {\n        \"type\": \"has_histological_finding\",\n        \"to\": \"spongiform_encephalopathy\"\n      }\n    ]\n  },\n  \"4b448da8\": {\n    \"title\": \"Cushing Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Critical Care\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebrovascular\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCushing reflex\u003c/b\u003e (or Cushing\u0027s triad) is a physiological nervous system response to a rapid increase in intracranial pressure (ICP). It is a late and ominous sign of severe brain injury or herniation, indicating imminent brainstem failure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eThe Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eHypertension:\u003c/b\u003e A significant increase in systemic blood pressure.\u003cbr\u003e2. \u003cb\u003eBradycardia:\u003c/b\u003e A paradoxical slowing of the heart rate.\u003cbr\u003e3. \u003cb\u003eIrregular Respirations:\u003c/b\u003e Abnormal breathing patterns, such as Cheyne-Stokes respirations.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHypertension:\u003c/b\u003e As ICP rises, it begins to compress cerebral arteries, reducing [[3eca3f19|cerebral perfusion]]. The brain\u0027s vasomotor center responds by triggering a massive sympathetic surge to increase systemic blood pressure (MAP) in an attempt to restore cerebral blood flow (CPP \u003d MAP - ICP).\u003cbr\u003e - \u003cb\u003eBradycardia:\u003c/b\u003e The resulting systemic hypertension is sensed by peripheral baroreceptors (in the carotid sinus and aortic arch), which then trigger a reflexive, vagally-mediated slowing of the heart rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The appearance of Cushing\u0027s triad is a sign of severely elevated ICP and impending brainstem herniation. It is a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Do not confuse Cushing\u0027s triad with Cushing\u0027s syndrome. The triad is an acute neurological sign, while the syndrome is a chronic endocrine disorder. The combination of rising blood pressure and falling heart rate in a patient with a head injury is a major red flag.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCushing reflex\u003c/b\u003e is the brain\u0027s last-ditch effort to save itself from ischemia due to high intracranial pressure, where it dramatically raises systemic blood pressure to force blood into the compressed cranium, inadvertently triggering a baroreceptor-mediated reflex bradycardia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Intracranial Pressure] --\u003e B(‚Üì Cerebral Perfusion Pressure); B --\u003e C(Cerebral Ischemia); C --\u003e D(Sympathetic Surge); D --\u003e E(‚Üë Systemic Hypertension); E --\u003e F(Baroreceptor Activation); F --\u003e G(Reflex Bradycardia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_response_to\",\n        \"to\": \"increased_intracranial_pressure\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"brainstem_compression\"\n      },\n      {\n        \"type\": \"consists_of\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"consists_of\",\n        \"to\": \"bradycardia\"\n      }\n    ]\n  },\n  \"dde3ac86\": {\n    \"title\": \"Cyclobenzaprine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Orthopedics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCyclobenzaprine\u003c/b\u003e is a centrally acting skeletal muscle relaxant used for the short-term treatment of muscle spasms associated with acute, painful musculoskeletal conditions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is not fully understood, but it is thought to act at the brainstem level to reduce tonic somatic motor activity. It is structurally related to tricyclic antidepressants (TCAs) and shares many of their properties.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used as an adjunct to rest and physical therapy for the relief of muscle spasms from acute musculoskeletal injuries (e.g., low back strain). It is \u003cu\u003enot\u003c/u\u003e effective for spasticity of CNS origin (e.g., cerebral palsy, multiple sclerosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Due to its structural similarity to TCAs, it has significant \u003cmark\u003eanticholinergic\u003c/mark\u003e (dry mouth, urinary retention, confusion) and \u003cmark\u003eantihistaminic\u003c/mark\u003e (sedation, drowsiness) side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Should not be used with MAO inhibitors due to the risk of serotonin syndrome. Use with caution in the elderly due to its anticholinergic and sedative effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember cyclobenzaprine for \u003cb\u003eacute\u003c/b\u003e muscle spasms. Differentiate its use from drugs like [[1ddc3f08|baclofen]] or tizanidine, which are used for \u003cb\u003echronic\u003c/b\u003e spasticity. Its TCA-like structure explains its side effect profile.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCyclobenzaprine\u003c/b\u003e is a short-term muscle relaxant for acute spasms that works centrally and carries a side effect profile very similar to tricyclic antidepressants, most notably sedation and anticholinergic effects.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"muscle_spasm\"\n      },\n      {\n        \"type\": \"is_structurally_related_to\",\n        \"to\": \"tricyclic_antidepressants\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10046,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"14a625af\": {\n    \"title"
      }, {
        "text": "\": \"Cortical Signs\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n"
      }, {
        "text": "      \"Physical Exam\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCortical signs\u003c/b\u003e are specific"
      }, {
        "text": " neurological deficits that indicate involvement of the [[a1b198f9|cerebral cortex]], as opposed to subcortical structures like"
      }, {
        "text": " the basal ganglia, thalamus, or brainstem. Their presence is crucial for localizing lesions, particularly strokes.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDefinition:\u003c/b\u003e Neurological signs that point to dysfunction of higher-order processing"
      }, {
        "text": " in the cerebral cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Cortical Signs:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[6bc9"
      }, {
        "text": "a567|Aphasia]]:\u003c/b\u003e Language disturbance (Broca\u0027s, Wernicke\u0027s),"
      }, {
        "text": " indicating a lesion in the dominant hemisphere (usually left).\u003cbr\u003e - \u003cb\u003eHemineglect:\u003c/b\u003e Inattention"
      }, {
        "text": " to one side of space, indicating a lesion in the non-dominant parietal lobe (usually right).\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003e[[ff289b3a|Visual Field Defects]]:\u003c/b\u003e Homonymous hemianopia or quadrantan"
      }, {
        "text": "opia.\u003cbr\u003e - \u003cb\u003eAgnosia:\u003c/b\u003e Inability to recognize objects, faces, or places.\u003cbr\u003e - \u003cb\u003eAp"
      }, {
        "text": "raxia:\u003c/b\u003e Inability to perform learned motor tasks.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of cortical signs helps"
      }, {
        "text": " differentiate large territorial strokes (e.g., [[143bb23d|MCA stroke]]) from small,"
      }, {
        "text": " deep strokes (\u003cmark\u003elacunar infarcts\u003c/mark\u003e), which characteristically \u003cu\u003elack\u003c/u\u003e cortical signs and present as"
      }, {
        "text": " pure motor or pure sensory deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a patient presents with contralateral hemiparesis PLUS"
      }, {
        "text": " aphasia, the lesion is cortical (likely MCA). If the patient has contralateral hemiparesis with NO a"
      }, {
        "text": "phasia, neglect, or visual field cut, the lesion is likely subcortical (e.g., a lacunar stroke"
      }, {
        "text": " in the internal capsule).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCortical signs\u003c/b\u003e are the"
      }, {
        "text": " clinical fingerprints of cerebral cortex dysfunction, representing deficits in higher-order functions like language and spatial awareness, and their presence or"
      }, {
        "text": " absence is a key factor in distinguishing cortical from subcortical strokes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"are_caused_by_lesion_in\","
      }, {
        "text": "\n        \"to\": \"a1b198f9\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"hemineglect\"\n      },\n      {\n        \"type\": \"are_abs"
      }, {
        "text": "ent_in\",\n        \"to\": \"lacunar_stroke\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"fb0a5fdc\": {\n    \"title\": \"Corticospinal Tract\",\n    \""
      }, {
        "text": "primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eCorticospinal Tract\u003c/b\u003e (also known as the pyramidal tract) is the major descending motor"
      }, {
        "text": " pathway in the central nervous system that controls voluntary, fine movements of the distal and limb muscles.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from upper motor neurons (UMNs) in the primary motor cortex,"
      }, {
        "text": " premotor cortex, and supplementary motor area.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Descends through the posterior limb of the internal"
      }, {
        "text": " capsule, cerebral peduncle (midbrain), pons, and medullary pyramids.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDecussation:\u003c/b\u003e Approximately"
      }, {
        "text": " 85-90% of fibers decussate (cross over) at the \u003cmark\u003epyramidal dec"
      }, {
        "text": "ussation\u003c/mark\u003e in the caudal medulla to form the \u003cb\u003elateral corticospinal tract\u003c/b\u003e, which descends in the lateral"
      }, {
        "text": " funiculus of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSynapse:\u003c/b\u003e The UMNs of the corticospinal tract synapse on"
      }, {
        "text": " lower motor neurons (LMNs) in the anterior horn of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e Damage to the corticospinal"
      }, {
        "text": " tract results in \u003cmark\u003eupper motor neuron signs\u003c/mark\u003e (spasticity, hyperreflexia, positive Babinski)"
      }, {
        "text": " on the contralateral side if the lesion is above the decussation, and on the ipsilateral side if below. This"
      }, {
        "text": " tract is damaged in [[4792bc68|Brown-S√©quard syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The decussation at the medulla is a critical anatomical point. It explains why a stroke in the left motor"
      }, {
        "text": " cortex causes right-sided weakness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCorticospinal Tract\u003c/b\u003e is"
      }, {
        "text": " the primary \u0027command pathway\u0027 for voluntary movement, originating in the motor cortex and crossing in the medulla to control the contralateral side of the body;"
      }, {
        "text": " damage to this tract is the basis of upper motor neuron syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[Motor Cortex - UMN] --\u003e B(Internal Capsule); B --\u003e C(Brainstem); C --\u003e D(Py"
      }, {
        "text": "ramidal Decussation - Medulla); D --\u003e E(Lateral Corticospinal Tract); E --\u003e F(Syn"
      }, {
        "text": "apse on LMN in Anterior Horn);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_composed"
      }, {
        "text": "_of\",\n        \"to\": \"upper_motor_neurons\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"lesion_causes\",\n        \"to\": \"upper_motor_neuron_signs\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"decussates_at\",\n        \"to\": \"pyramidal_decussation\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"2a3826fc\": {\n    \"title\":"
      }, {
        "text": " \"Corticospinal Tracts\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCorticospinal Tracts\u003c/b\u003e"
      }, {
        "text": " are the primary descending motor pathways that carry motor signals from the cerebral cortex to the spinal cord, enabling voluntary movement. They are composed"
      }, {
        "text": " of the lateral and anterior corticospinal tracts.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Control of voluntary, discrete, skilled movements, especially of the distal limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLateral Corticospinal Tract:"
      }, {
        "text": "\u003c/b\u003e The larger of the two tracts, containing ~90% of the fibers. These fibers have decussated ("
      }, {
        "text": "crossed) in the medullary pyramids and control the contralateral limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterior (Ventral) Corticospinal Tract"
      }, {
        "text": ":\u003c/b\u003e Contains the ~10% of fibers that did not cross in the medulla. These fibers descend ipsilaterally and most"
      }, {
        "text": " cross at the spinal cord level they innervate, primarily controlling axial and proximal (truncal) muscles bilaterally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeg"
      }, {
        "text": "eneration:\u003c/b\u003e Degeneration of the corticospinal tracts is a key feature of \u003cmark\u003e[[4ed629"
      }, {
        "text": "f9|Amyotrophic Lateral Sclerosis (ALS)]]\u003c/mark\u003e, contributing to the upper motor neuron signs (spasticity, hyperreflexia)"
      }, {
        "text": " seen in the disease. It is also affected in [[6f5bea90|Subacute Combined Degeneration]]"
      }, {
        "text": " (B12 deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the vast majority of voluntary motor control to"
      }, {
        "text": " the limbs is contralateral, mediated by the lateral corticospinal tract which crosses in the medulla.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eCorticospinal Tracts\u003c/b\u003e are the brain\u0027s direct lines of command to the spinal cord for voluntary movement, with"
      }, {
        "text": " the massive lateral tract controlling the contralateral limbs and the smaller anterior tract managing the axial musculature.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"descending_motor_pathway\"\n      },\n      {\n        \"type\": \"degener"
      }, {
        "text": "ates_in\",\n        \"to\": \"4ed629f9\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"degenerates_in\",\n        \"to\": \"6f5bea90\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"fb"
      }, {
        "text": "0a5fdc\"\n      }\n    ]\n  },\n  \"2b2540"
      }, {
        "text": "51\": {\n    \"title\": \"Cotton-Wool Spots\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCotton-"
      }, {
        "text": "wool spots\u003c/b\u003e are fluffy, white, superficial retinal lesions seen on fundoscopic examination. They represent microinfarcts in"
      }, {
        "text": " the retinal nerve fiber layer due to occlusion of precapillary arterioles.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Ischemia in the nerve fiber layer leads to a blockage of axoplasmic transport, causing the accumulation of ax"
      }, {
        "text": "oplasmic debris in the nerve fiber axons, which appear as white spots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Fluffy, white, or grayish"
      }, {
        "text": " lesions with indistinct borders on the surface of the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e They are a non-specific sign of retinal"
      }, {
        "text": " ischemia and can be seen in various systemic diseases, most commonly:\u003cbr\u003e - \u003cmark\u003e[[73b00ab"
      }, {
        "text": "0|Diabetic retinopathy]]\u003c/mark\u003e\u003cbr\u003e - \u003cmark\u003e[[549b012e|Hypertensive retinopathy]]\u003c/"
      }, {
        "text": "mark\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Also seen in central/branch retinal vein occlusion, HIV retinopathy (including from [["
      }, {
        "text": "cytomegalovirus|CMV]]), and systemic lupus erythematosus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While not specific,"
      }, {
        "text": " the presence of cotton-wool spots on a fundoscopic exam should prompt consideration of underlying systemic vascular disease, particularly diabetes and"
      }, {
        "text": " hypertension.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCotton-wool spots\u003c/b\u003e are the retinal equivalent of mini"
      }, {
        "text": "-strokes, appearing as fluffy white patches that signify focal ischemia in the nerve fiber layer, most often as a consequence of micro"
      }, {
        "text": "vascular damage from diabetes or hypertension.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"73b00ab"
      }, {
        "text": "0\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        "
      }, {
        "text": "\"to\": \"549b012e\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a_sign_of\",\n        \"to\": \"b69e35b5\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by\",\n        \"to\": \"retinal_ischemia\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"9077ed85\": {\n    \"title\":"
      }, {
        "text": " \"Cough Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pul"
      }, {
        "text": "monology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCough Reflex\u003c/b\u003e is a"
      }, {
        "text": " protective reflex that forcibly expels irritants, foreign material, and excess secretions from the larynx, trachea, and bronchi. It involves"
      }, {
        "text": " a complex coordination of sensory input and motor output mediated by the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAff"
      }, {
        "text": "erent Limb (Sensation):\u003c/b\u003e The sensation of irritation in the larynx and upper airway is carried primarily by the internal l"
      }, {
        "text": "aryngeal nerve, a branch of the superior laryngeal nerve, which is itself a branch of the \u003cmark\u003evagus nerve (CN"
      }, {
        "text": " X)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCentral Processing:\u003c/b\u003e The afferent signals are sent to the medulla oblongata.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent"
      }, {
        "text": " Limb (Motor):\u003c/b\u003e The medulla coordinates a motor response involving multiple nerves:\u003cbr\u003e - The \u003cmark\u003evagus nerve (CN"
      }, {
        "text": " X)\u003c/mark\u003e causes the glottis to close and the larynx/trachea to contract.\u003cbr\u003e - The ph"
      }, {
        "text": "renic and spinal motor nerves cause contraction of the diaphragm and abdominal/intercostal muscles to generate high intrathoracic pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": ":\u003c/b\u003e A deep inhalation is followed by forceful exhalation against a closed glottis, which then suddenly opens, producing"
      }, {
        "text": " an explosive outflow of air.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The cough reflex is a key brainstem reflex."
      }, {
        "text": " Both the afferent and primary efferent limbs are mediated by the \u003cb\u003evagus nerve (CN X)\u003c/b\u003e. Aspiration"
      }, {
        "text": " risk is high in patients with impaired cough reflex (e.g., after a stroke affecting the medulla).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eCough Reflex\u003c/b\u003e is a vital airway defense mechanism orchestrated by the medulla, with"
      }, {
        "text": " the vagus nerve playing the dual role of both sensing the irritation in the airway and executing the forceful expulsion.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Irritant in Airway] --\u003e B(Afferent: CN X); B --\u003e C(Med"
      }, {
        "text": "ulla); C --\u003e D(Efferent: CN X, Phrenic N., Spinal N.); D --\u003e E(Force"
      }, {
        "text": "ful Expiration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"afferent_"
      }, {
        "text": "limb_is\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "efferent_limb_is\",\n        \"to\": \"vagus_nerve\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_coordinated_by\",\n        \"to\": \"medulla_oblongata\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"7f95e358\": {\n    \"title"
      }, {
        "text": "\": \"Cranial Dysraphism\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Em"
      }, {
        "text": "bryology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Congenital Malformation\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \""
      }, {
        "text": "Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCranial dysraph"
      }, {
        "text": "ism\u003c/b\u003e refers to a group of neural tube defects that result from the failure of the rostral (cranial) neurop"
      }, {
        "text": "ore to close properly during the fourth week of embryonic development. This category includes conditions like [[5bcc9894|anencephaly]] and"
      }, {
        "text": " encephalocele.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[5bcc9894|An"
      }, {
        "text": "encephaly]]:\u003c/b\u003e The most severe form. Failure of the rostral neuropore to close leads to the absence of the fore"
      }, {
        "text": "brain and calvarium. It is incompatible with life and is associated with polyhydramnios.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEn"
      }, {
        "text": "cephalocele:\u003c/b\u003e A sac-like protrusion of the brain and meninges through a defect in the skull. The"
      }, {
        "text": " occipital region is the most common site.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A failure of neural tube fusion at"
      }, {
        "text": " the cranial end.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Associated with maternal folate deficiency and certain medications (e.g., val"
      }, {
        "text": "proate).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Detected prenatally by elevated maternal serum alpha-fetoprotein (AFP) and ultrasound."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate cranial dysraphism (rostral neuropore defects like anencephaly) from spinal"
      }, {
        "text": " dysraphism (caudal neuropore defects like spina bifida).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eCranial dysraphism\u003c/b\u003e represents a failure of the neural tube to close at the head end, leading to severe"
      }, {
        "text": " and often lethal congenital malformations of the brain and skull, such as anencephaly.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"5bcc9894\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"encephalocele\"\n      }\n    ]\n  },\n  \"624"
      }, {
        "text": "d82e9\": {\n    \"title\": \"Cranial Nerve Nuclei\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCranial nerve nuclei\u003c/b\u003e are clusters"
      }, {
        "text": " of neurons (gray matter) in the brainstem from which the cranial nerves (III-XII) emerge or terminate. They are the functional"
      }, {
        "text": " equivalent of the gray matter horns of the spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e"
      }, {
        "text": " Located in the tegmentum of the brainstem (midbrain, pons, medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrganization:\u003c/b\u003e Organized"
      }, {
        "text": " into functional columns. As a general rule, \u003cmark\u003emotor nuclei are located medially\u003c/mark\u003e in the brain"
      }, {
        "text": "stem, while \u003cmark\u003esensory nuclei are located laterally\u003c/mark\u003e. This reflects the embryological origin from the basal ("
      }, {
        "text": "motor) and alar (sensory) plates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMidline Motor Nuclei (Rule of 4s"
      }, {
        "text": "):\u003c/b\u003e The nuclei of cranial nerves whose numbers are factors of 12 (\u003cb\u003eIII, IV, VI, XII\u003c/b\u003e) are located"
      }, {
        "text": " medially.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLateral Nuclei:\u003c/b\u003e The nuclei of cranial nerves V, VII, VIII, IX, X, and"
      }, {
        "text": " XI are located more laterally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Brainstem strokes often present with specific cranial nerve deficits that can"
      }, {
        "text": " be used to localize the lesion. Medial brainstem syndromes affect the midline motor nuclei, while lateral syndromes affect the lateral"
      }, {
        "text": " sensory and branchiomotor nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Knowing the medial vs. lateral organization of the"
      }, {
        "text": " cranial nerve nuclei is a high-yield concept for solving brainstem lesion problems.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003ecranial nerve nuclei\u003c/b\u003e are the command and control centers for the cranial nerves, systematically arranged within the brainstem with"
      }, {
        "text": " motor nuclei positioned medially and sensory nuclei laterally, providing a precise anatomical map for localizing brainstem lesions.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Brainstem]; A --\u003e B(Medial Column - Motor Nuclei); B --\u003e C(CN"
      }, {
        "text": " III, IV, VI, XII); A --\u003e D(Lateral Column - Sensory/Other Nuclei); D --\u003e E(CN V, VII,"
      }, {
        "text": " VIII, IX, X, XI);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are"
      }, {
        "text": "_located_in\",\n        \"to\": \"582d8572\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"are_organized_by\",\n        \"to\": \"alar_and_basal_plates\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"eab31845\": {\n    \"title\":"
      }, {
        "text": " \"Cranial Nerves\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \""
      }, {
        "text": "Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003eThe \u003cb\u003ecranial nerves\u003c/b\u003e are a set of 12 paired nerves that emerge"
      }, {
        "text": " directly from the brain or brainstem. They are part of the peripheral nervous system (with the exception of CN II)"
      }, {
        "text": " and are responsible for the sensory and motor functions of the head and neck, as well as certain autonomic functions.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNumbering:\u003c/b\u003e Numbered I through XII in rostral to caudal order.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Function Types (Mnemonic):\u003c/b\u003e \\\"Some Say Marry Money But My Brother Says Big Brains Matter Most\\\" indicates"
      }, {
        "text": " whether each nerve is \u003cb\u003eS\u003c/b\u003eensory, \u003cb\u003eM\u003c/b\u003eotor, or \u003cb\u003eB\u003c/b\u003eoth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrain"
      }, {
        "text": "stem Location:\u003c/b\u003e CN I and II emerge from the cerebrum. CN III and IV emerge from the midbrain. CN V"
      }, {
        "text": ", VI, VII, and VIII emerge from the pons. CN IX, X, XI, and XII emerge from the medulla."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Lesions:\u003c/b\u003e Palsies of the cranial nerves produce specific, predictable deficits (e.g., [["
      }, {
        "text": "fdfd22ca|CN III palsy]] causes a \u0027down and out\u0027 eye; [[facial_nerve_palsy|"
      }, {
        "text": "CN VII palsy]] causes facial droop).\u003c/li\u003e\u003cli\u003e\u003cb\u003eReflexes:\u003c/b\u003e Many clinical reflexes, such as the [[64"
      }, {
        "text": "663383|corneal reflex]] (CN V, VII) and gag reflex (CN IX"
      }, {
        "text": ", X), are used to test the integrity of specific cranial nerves and their brainstem pathways.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePolyrad"
      }, {
        "text": "iculopathy:\u003c/b\u003e Conditions like [[ed52e40b|Guillain-Barr√© syndrome]] can"
      }, {
        "text": " affect cranial nerves, causing symptoms like bilateral facial weakness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003ecranial nerves\u003c/b\u003e are the specialized peripheral nerves of the head and neck, each with a unique function and anatomical course"
      }, {
        "text": ", making their clinical examination a powerful tool for localizing lesions within the brainstem and skull base.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"emerge_from\","
      }, {
        "text": "\n        \"to\": \"582d8572\"\n      },\n      {\n        \"type\": \"are_tested"
      }, {
        "text": "_by\",\n        \"to\": \"2915ead0\"\n      },\n      {\n        \"type\": \"can_be"
      }, {
        "text": "_affected_by\",\n        \"to\": \"ed52e40b\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"2e53c11c\": {\n    \"title\": \"Cranial Nerves and Arteries Relationships"
      }, {
        "text": "\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"C"
      }, {
        "text": "erebrovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe anatomical relationships between the \u003cb\u003ecranial nerves and arteries\u003c/b\u003e at"
      }, {
        "text": " the base of the brain are clinically significant, as vascular pathologies like aneurysms or strokes can cause specific cranial nerve pals"
      }, {
        "text": "ies due to compression or ischemia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCN III (Oculomotor):\u003c/b\u003e Passes"
      }, {
        "text": " between the \u003cmark\u003eposterior cerebral artery (PCA)\u003c/mark\u003e and the \u003cmark\u003esuperior cerebellar artery (SCA)\u003c/mark\u003e."
      }, {
        "text": " An aneurysm of the posterior communicating artery (PComA) is a classic cause of a compressive CN III palsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN VI"
      }, {
        "text": " (Abducens):\u003c/b\u003e Has a long intracranial course and is closely related to the [[3c07534"
      }, {
        "text": "3|anterior inferior cerebellar artery (AICA)]] near the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCN XII (Hypoglossal):\u003c/b\u003e Ex"
      }, {
        "text": "its the medulla near the [[1430f5b4|anterior spinal artery (ASA)]] and vertebral"
      }, {
        "text": " artery. Occlusion of the ASA can cause Medial Medullary Syndrome, which includes an ipsilateral CN XII palsy.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eCavernous Sinus:\u003c/b\u003e A critical location where CNs III, IV, V\u003csub\u003e1\u003c/sub\u003e, V\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e, and VI are in close proximity to the internal carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The relationship"
      }, {
        "text": " between the PComA and CN III is extremely high-yield. A painful third nerve palsy with a dilated pupil is a P"
      }, {
        "text": "ComA aneurysm until proven otherwise.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe close proximity of "
      }, {
        "text": "\u003cb\u003ecranial nerves and arteries\u003c/b\u003e at the skull base creates \u0027danger zones\u0027 where vascular abnormalities can directly impact nerve function, with"
      }, {
        "text": " the PComA aneurysm compressing CN III being the most classic and clinically urgent example.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[PComA Aneurysm] --Compresses--\u003e B(CN III); C[A"
      }, {
        "text": "ICA Stroke] --Affects--\u003e D(CN VI, VII, VIII); E[ASA Stroke] --Affects--\u003e F"
      }, {
        "text": "(CN XII);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"aneurysm_comp"
      }, {
        "text": "resses\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"stroke"
      }, {
        "text": "_affects\",\n        \"to\": \"dd11dde6\"\n      },\n      {\n        \"type\": \"stroke_"
      }, {
        "text": "affects\",\n        \"to\": \"hypoglossal_nerve\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"91783169\": {\n    \"title\": \"Cranial Nerve For"
      }, {
        "text": "amina\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and"
      }, {
        "text": " Physiology\",\n      \"Skull Base\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003ecranial nerve foramina\u003c/b\u003e are the openings in the base of the skull through which the cranial nerves"
      }, {
        "text": ", as well as major blood vessels, pass to exit the cranial cavity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAn"
      }, {
        "text": "terior Cranial Fossa:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCribriform Plate:\u003c/b\u003e CN I (Ol"
      }, {
        "text": "factory nerves).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMiddle Cranial Fossa:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOptic Canal:\u003c/b\u003e CN II,"
      }, {
        "text": " Ophthalmic artery.\u003cbr\u003e - \u003cb\u003eSuperior Orbital Fissure:\u003c/b\u003e CN III, IV, V\u003csub\u003e1\u003c/sub\u003e, VI.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eForamen Rotundum:\u003c/b\u003e CN V\u003csub\u003e2\u003c/sub\u003e.\u003cbr\u003e - \u003cb\u003eForamen Ovale"
      }, {
        "text": ":\u003c/b\u003e CN V\u003csub\u003e3\u003c/sub\u003e.\u003cbr\u003e - \u003cb\u003eForamen Spinosum:\u003c/b\u003e Middle meningeal artery."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePosterior Cranial Fossa:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eInternal Auditory Meatus:\u003c/b\u003e CN VII"
      }, {
        "text": ", VIII.\u003cbr\u003e - \u003cb\u003eJugular Foramen:\u003c/b\u003e CN IX, X, XI, Jugular vein.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Hypoglossal Canal:\u003c/b\u003e CN XII.\u003cbr\u003e - \u003cb\u003eForamen Magnum:\u003c/b\u003e Brainstem/Spinal cord, Verte"
      }, {
        "text": "bral arteries, Spinal root of CN XI.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mnemonics are very helpful here"
      }, {
        "text": ". For the Superior Orbital Fissure: \\\"\u003cb\u003eL\u003c/b\u003eive \u003cb\u003eF\u003c/b\u003erankly \u003cb\u003eT\u003c/b\u003eo \u003cb\u003eS"
      }, {
        "text": "\u003c/b\u003eee \u003cb\u003eA\u003c/b\u003ebsolutely \u003cb\u003eN\u003c/b\u003eo \u003cb\u003eI\u003c/b\u003ensult\\\" (Lacrimal n"
      }, {
        "text": "., Frontal n., Trochlear n., Superior division of CN III, Abducens n., Nasociliary n., Inferior division"
      }, {
        "text": " of CN III). For Foramina of V: \\\"\u003cb\u003eS\u003c/b\u003etanding \u003cb\u003eR\u003c/b\u003eoom \u003cb\u003eO\u003c/b\u003en"
      }, {
        "text": "ly\\\" (\u003cb\u003eS\u003c/b\u003euperior orbital fissure for V1, \u003cb\u003eR\u003c/b\u003eotundum for V2, \u003cb\u003eO"
      }, {
        "text": "\u003c/b\u003evale for V3).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eKnowledge of the \u003cb\u003ecranial nerve foramina\u003c/b\u003e is"
      }, {
        "text": " essential for clinical localization, as fractures or tumors at the skull base can produce specific patterns of cranial nerve deficits based on which"
      }, {
        "text": " foramina are involved.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_exit_for\",\n        \"to\": \"eab31845\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"7048db1e\": {\n    \"title"
      }, {
        "text": "\": \"Craniopharyngioma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Oncology\",\n      \"Pediatrics\",\n      \"Endocrinology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain"
      }, {
        "text": " Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ecr"
      }, {
        "text": "aniopharyngioma\u003c/b\u003e is a rare, benign, slow-growing suprasellar tumor that arises from epithelial remnants of Rath"
      }, {
        "text": "ke\u0027s pouch. Despite being benign, it can cause significant morbidity due to its location and compression of surrounding structures.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Arises from remnants of \u003cmark\u003eRathke\u0027s pouch"
      }, {
        "text": "\u003c/mark\u003e (oral ectoderm), the same embryonic structure that forms the [[76ba7f2e|anterior pituitary]].\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e Has a bimodal age distribution, with peaks in childhood (5-14 years) and adulthood"
      }, {
        "text": " (50-74 years). It is the most common childhood supratentorial tumor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Suprasellar region, near the pituitary gland and optic chiasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Due"
      }, {
        "text": " to compression:\u003cbr\u003e - \u003cb\u003eOptic Chiasm:\u003c/b\u003e \u003cmark\u003e[[6c3a980"
      }, {
        "text": "e|Bitemporal hemianopia]]\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003ePituitary Stalk/G"
      }, {
        "text": "land:\u003c/b\u003e Endocrine dysfunction, most commonly growth hormone deficiency (short stature in children) and diabetes insipidus.\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eThird Ventricle:\u003c/b\u003e Hydrocephalus and increased ICP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology \u0026 Imaging:\u003c/b\u003e Often cystic and"
      }, {
        "text": " \u003cmark\u003ecalcified\u003c/mark\u003e. The cysts are filled with a thick, brownish-yellow fluid rich in cholesterol crystals"
      }, {
        "text": ", described as \\\"machine oil.\\\" Histology shows nests of squamous epithelium and \\\"wet keratin\\\" (anucleate squamous"
      }, {
        "text": " cells).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with short stature, headaches, and bitemporal hemianopia,"
      }, {
        "text": " with a calcified suprasellar mass on imaging, is the classic vignette for a craniopharyngioma.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ecraniopharyngioma\u003c/b\u003e is a benign but"
      }, {
        "text": " problematic tumor arising from embryonic remnants of Rathke\u0027s pouch, which classically presents in a child with a triad of visual field"
      }, {
        "text": " defects, endocrine failure, and hydrocephalus, often with characteristic calcifications on imaging.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[R"
      }, {
        "text": "athke\u0027s Pouch Remnant] --\u003e B(Craniopharyngioma); B --Compresses--\u003e C(Optic Ch"
      }, {
        "text": "iasm); C --\u003e D(Bitemporal Hemianopia); B --Compresses--\u003e E(Pituitary/"
      }, {
        "text": "Hypothalamus); E --\u003e F(Endocrinopathy);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"arises_from\",\n        \"to\": \"rathkes_pouch\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"causes\",\n        \"to\": \"6c3a980e\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"hypopituitarism\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"be"
      }, {
        "text": "057cfc\"\n      }\n    ]\n  },\n  \"cd09cad7\": {\n    \"title\":"
      }, {
        "text": " \"Cremasteric Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Urology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eCremasteric Reflex\u003c/b\u003e is a superficial"
      }, {
        "text": " reflex in males that is elicited by lightly stroking or pinching the superior and medial part of the thigh, resulting in a"
      }, {
        "text": " rapid elevation of the ipsilateral testicle due to contraction of the cremaster muscle.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Tests the integrity of the \u003cmark\u003eL1 and L2\u003c/mark\u003e spinal nerve"
      }, {
        "text": " roots. Mnemonic: L\u003cb\u003e1\u003c/b\u003e, \u003cb\u003e2\u003c/b\u003e, testicles move.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Limb (Sensation):\u003c/b\u003e The"
      }, {
        "text": " stimulus is sensed by the ilioinguinal nerve and the femoral branch of the genitofemoral nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "fferent Limb (Motor):\u003c/b\u003e The motor response is carried by the genital branch of the \u003cmark\u003egenitofemoral nerve\u003c/mark\u003e,"
      }, {
        "text": " which innervates the cremaster muscle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The reflex is characteristically \u003cmark\u003eabsent\u003c/mark\u003e in"
      }, {
        "text": " cases of \u003cmark\u003etesticular torsion\u003c/mark\u003e, making it a crucial diagnostic sign in the evaluation of acute scrotal pain"
      }, {
        "text": ". It is also absent in L1-L2 spinal cord injury or nerve damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An"
      }, {
        "text": " absent cremasteric reflex in a male with acute scrotal pain is highly suggestive of testicular torsion until proven otherwise and constitutes"
      }, {
        "text": " a urologic emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCremasteric Reflex\u003c/b\u003e is a key"
      }, {
        "text": " physical exam finding in evaluating acute scrotal pain; its presence argues against testicular torsion, while its absence is a major red flag for this"
      }, {
        "text": " surgical emergency.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Stroke Inner Thigh] --\u003e B(Aff"
      }, {
        "text": "erent: Ilioinguinal/Genitofemoral N.); B --\u003e C(L1-L2 Spinal Cord);"
      }, {
        "text": " C --\u003e D(Efferent: Genitofemoral N.); D --\u003e E(Cremaster Muscle Contraction); E --\u003e F(Test"
      }, {
        "text": "icle Elevation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_ner"
      }, {
        "text": "ve_root\",\n        \"to\": \"l1_nerve_root\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"tests_nerve_root\",\n        \"to\": \"l2_nerve_"
      }, {
        "text": "root\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \""
      }, {
        "text": "to\": \"testicular_torsion\"\n      }\n    ]\n  },\n  \"86fe5"
      }, {
        "text": "9ba\": {\n    \"title\": \"Creutzfeldt-Jakob Disease (CJD)\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Infectious Disease"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eCreutzfeldt-Jakob Disease (CJD)\u003c/b\u003e is a rare, fatal, and transmissible neurodegenerative disorder"
      }, {
        "text": " caused by prions. It is characterized by a rapidly progressive dementia and myoclonus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eEtiology:\u003c/b\u003e Caused by \u003cmark\u003eprions\u003c/mark\u003e, which are misfolded proteins (PrP\u003csup\u003eSc"
      }, {
        "text": "\u003c/sup\u003e) that induce the misfolding of normal cellular prion proteins (PrP\u003csup\u003eC\u003c/sup\u003e). This leads to an exponential"
      }, {
        "text": " accumulation of abnormal protein aggregates that are resistant to proteases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eForms:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSporadic ("
      }, {
        "text": "sCJD):\u003c/b\u003e Most common form (~85%), occurs spontaneously.\u003cbr\u003e - \u003cb\u003eFamilial (fCJD):\u003c/b\u003e Due"
      }, {
        "text": " to an inherited mutation in the \u003ci\u003ePRNP\u003c/i\u003e gene.\u003cbr\u003e - \u003cb\u003eIatrogenic (iCJD):"
      }, {
        "text": "\u003c/b\u003e Transmitted via contaminated neurosurgical instruments, corneal transplants, or human-derived growth hormone.\u003cbr\u003e - \u003cb\u003eVariant ("
      }, {
        "text": "vCJD):\u003c/b\u003e Linked to consumption of beef from cattle with bovine spongiform encephalopathy (\u0027mad cow disease\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e \u003cmark\u003eRapidly progressive dementia\u003c/mark\u003e over weeks to months, accompanied by ataxia and \u003cmark\u003estartle my"
      }, {
        "text": "oclonus\u003c/mark\u003e (jerking movements in response to loud noises or touch).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnostic Findings:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eEEG:\u003c/b\u003e Periodic sharp wave complexes.\u003cbr\u003e - \u003cb\u003eCSF:\u003c/b\u003e Presence of 14-3"
      }, {
        "text": "-3 protein.\u003cbr\u003e - \u003cb\u003eMRI:\u003c/b\u003e High signal intensity in the caudate nucleus and putamen or"
      }, {
        "text": " cortex on DWI/FLAIR sequences.\u003cbr\u003e - \u003cb\u003eHistology:\u003c/b\u003e \u003cmark\u003eSpongiform encephalopathy\u003c/mark\u003e (vac"
      }, {
        "text": "uolation of the neuropil) without significant inflammation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with dementia that progresses"
      }, {
        "text": " from mild confusion to profound incapacity in just a few months, especially with myoclonus, is the classic presentation of CJD.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCreutzfeldt-Jakob Disease\u003c/b\u003e is a prion-mediated neurodegenerative catastrophe"
      }, {
        "text": ", distinguished by its astonishingly rapid progression from cognitive decline to death, and marked pathologically by the brain turning into a \u0027sponge\u0027"
      }, {
        "text": " due to widespread neuronal loss and vacuolation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PrPSc"
      }, {
        "text": " Prion] --\u003e B(Induces Misfolding of Normal PrPC); B --\u003e C(Aggregation of PrPSc); C --\u003e D(Sp"
      }, {
        "text": "ongiform Encephalopathy); D --\u003e E(Rapidly Progressive Dementia \u0026 Myoclonus);\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to"
      }, {
        "text": "\": \"prions\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"rapidly"
      }, {
        "text": "_progressive_dementia\"\n      },\n      {\n        \"type\": \"presents_with\",\n"
      }, {
        "text": "        \"to\": \"myoclonus\"\n      },\n      {\n        \"type\": \"has_"
      }, {
        "text": "histological_finding\",\n        \"to\": \"spongiform_encephalopathy\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"4b448da8\": {\n    \"title\": \"Cushing Reflex\",\n    \"primaryType\":"
      }, {
        "text": " \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Critical Care\",\n      \"Cardiology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Cerebrovascular\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eCushing reflex\u003c/b\u003e (or Cushing\u0027s triad) is a physiological nervous system response to a rapid"
      }, {
        "text": " increase in intracranial pressure (ICP). It is a late and ominous sign of severe brain injury or herniation, indicating imminent"
      }, {
        "text": " brainstem failure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eThe Triad:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003eHypertension:\u003c/b\u003e A significant increase in systemic blood pressure.\u003cbr\u003e2. \u003cb\u003eBradycardia:\u003c/b\u003e A paradoxical"
      }, {
        "text": " slowing of the heart rate.\u003cbr\u003e3. \u003cb\u003eIrregular Respirations:\u003c/b\u003e Abnormal breathing patterns, such as Che"
      }, {
        "text": "yne-Stokes respirations.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHypertension:\u003c/b\u003e As"
      }, {
        "text": " ICP rises, it begins to compress cerebral arteries, reducing [[3eca3f19|cerebral perfusion]]. The brain\u0027"
      }, {
        "text": "s vasomotor center responds by triggering a massive sympathetic surge to increase systemic blood pressure (MAP) in an attempt to restore cerebral blood"
      }, {
        "text": " flow (CPP \u003d MAP - ICP).\u003cbr\u003e - \u003cb\u003eBradycardia:\u003c/b\u003e The resulting systemic hypertension is sensed"
      }, {
        "text": " by peripheral baroreceptors (in the carotid sinus and aortic arch), which then trigger a reflexive, vagally-mediated slowing"
      }, {
        "text": " of the heart rate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The appearance of Cushing\u0027s triad is a sign of severely"
      }, {
        "text": " elevated ICP and impending brainstem herniation. It is a neurosurgical emergency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Do"
      }, {
        "text": " not confuse Cushing\u0027s triad with Cushing\u0027s syndrome. The triad is an acute neurological sign, while the syndrome is a chronic"
      }, {
        "text": " endocrine disorder. The combination of rising blood pressure and falling heart rate in a patient with a head injury is a major red flag."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eCushing reflex\u003c/b\u003e is the brain\u0027s last"
      }, {
        "text": "-ditch effort to save itself from ischemia due to high intracranial pressure, where it dramatically raises systemic blood pressure to force blood into"
      }, {
        "text": " the compressed cranium, inadvertently triggering a baroreceptor-mediated reflex bradycardia.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[‚Üë Intracranial Pressure] --\u003e B(‚Üì Cerebral Perfusion Pressure); B --\u003e C(C"
      }, {
        "text": "erebral Ischemia); C --\u003e D(Sympathetic Surge); D --\u003e E(‚Üë Systemic Hypertension); E --\u003e F("
      }, {
        "text": "Baroreceptor Activation); F --\u003e G(Reflex Bradycardia);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_response_to\",\n        \"to\": \"increased_intracranial_pressure\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"brain"
      }, {
        "text": "stem_compression\"\n      },\n      {\n        \"type\": \"consists_of\",\n        \"to"
      }, {
        "text": "\": \"hypertension\"\n      },\n      {\n        \"type\": \"consists_of\",\n        "
      }, {
        "text": "\"to\": \"bradycardia\"\n      }\n    ]\n  },\n  \"dde3ac8"
      }, {
        "text": "6\": {\n    \"title\": \"Cyclobenzaprine\",\n    \"primaryType\": \"drug\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Orthopedics\",\n      \"USMLE"
      }, {
        "text": "\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Cyclobenzaprine\u003c/b\u003e is a centrally acting skeletal muscle relaxant used for the short-term treatment of muscle spasms associated with acute,"
      }, {
        "text": " painful musculoskeletal conditions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is"
      }, {
        "text": " not fully understood, but it is thought to act at the brainstem level to reduce tonic somatic motor activity. It is structurally"
      }, {
        "text": " related to tricyclic antidepressants (TCAs) and shares many of their properties.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used"
      }, {
        "text": " as an adjunct to rest and physical therapy for the relief of muscle spasms from acute musculoskeletal injuries (e.g., low"
      }, {
        "text": " back strain). It is \u003cu\u003enot\u003c/u\u003e effective for spasticity of CNS origin (e.g., cerebral palsy, multiple"
      }, {
        "text": " sclerosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Due to its structural similarity to TCAs, it has significant \u003cmark\u003e"
      }, {
        "text": "anticholinergic\u003c/mark\u003e (dry mouth, urinary retention, confusion) and \u003cmark\u003eantihistaminic\u003c/mark\u003e (sed"
      }, {
        "text": "ation, drowsiness) side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Should not be used with MAO inhibitors due to the risk of serotonin syndrome. Use"
      }, {
        "text": " with caution in the elderly due to its anticholinergic and sedative effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " cyclobenzaprine for \u003cb\u003eacute\u003c/b\u003e muscle spasms. Differentiate its use from drugs like [[1ddc3f0"
      }, {
        "text": "8|baclofen]] or tizanidine, which are used for \u003cb\u003echronic\u003c/b\u003e spasticity. Its TCA"
      }, {
        "text": "-like structure explains its side effect profile.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCyclobenzaprine\u003c/b\u003e is a short"
      }, {
        "text": "-term muscle relaxant for acute spasms that works centrally and carries a side effect profile very similar to tricyclic antidepressants, most"
      }, {
        "text": " notably sedation and anticholinergic effects.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"af72aab"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"muscle"
      }, {
        "text": "_spasm\"\n      },\n      {\n        \"type\": \"is_structurally_related_to\",\n        "
      }, {
        "text": "\"to\": \"tricyclic_antidepressants\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1nDL3WWbQTTRWWp8q3RndlS60PzLFi2tI"
      },
      "role": "user",
      "tokenCount": 1815
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"8e51aa24\": {\n    \"title\": \"Cytotoxic Edema (Cerebral)\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCytotoxic edema\u003c/b\u003e is a type of [[aa00bdef|cerebral edema]] characterized by the swelling of brain cells, particularly neurons and glia, due to an intracellular accumulation of fluid. It is a key early event in cerebral ischemia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary cause is a failure of the ATP-dependent Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump, typically due to ischemia and energy failure. The pump failure leads to an influx of Na\u003csup\u003e+\u003c/sup\u003e and other ions into the cell, and water follows osmotically, causing the cell to swell.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming in Stroke:\u003c/b\u003e It is the \u003cmark\u003efirst type of edema\u003c/mark\u003e to appear after an [[c5da3c57|ischemic stroke]], developing within minutes to hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContrast with Vasogenic Edema:\u003c/b\u003e Vasogenic edema involves leakage of fluid into the \u003ci\u003eextracellular\u003c/i\u003e space due to a breakdown of the blood-brain barrier and occurs later in the course of a stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be caused by other metabolic insults like hypoxia, hypoglycemia, or certain toxins that disrupt cellular energy metabolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For a stroke timeline question, remember that cytotoxic edema (intracellular swelling) happens first, followed by vasogenic edema (extracellular fluid) hours to days later.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCytotoxic edema\u003c/b\u003e is the rapid, intracellular swelling of brain cells caused by energy failure and dysfunctional ion pumps, representing the initial and direct cellular response to ischemic injury.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ischemia/Hypoxia] --\u003e B(‚Üì ATP); B --\u003e C(Na+/K+ Pump Failure); C --\u003e D(‚Üë Intracellular Na+); D --\u003e E(Water Influx); E --\u003e F(Cell Swelling - Cytotoxic Edema);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"aa00bdef\"\n      },\n      {\n        \"type\": \"is_an_early_feature_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"vasogenic_edema\"\n      }\n    ]\n  },\n  \"a4087338\": {\n    \"title\": \"Danazol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Gynecology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Reproductive\",\n      \"Pharmacology\",\n      \"Hormonal Agents\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDanazol\u003c/b\u003e is a synthetic steroid with weak androgenic, progestogenic, and glucocorticoid activity. It primarily acts as a weak androgen and is used to suppress the hypothalamic-pituitary-gonadal axis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A synthetic androgen that acts as a partial agonist at androgen receptors. It suppresses the pituitary-ovarian axis by inhibiting the mid-cycle surge of FSH and LH, leading to decreased estrogen production and anovulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat endometriosis, fibrocystic breast disease, and hereditary angioedema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Due to its androgenic properties, it can cause weight gain, edema, acne, hirsutism, and masculinization. It is also hepatotoxic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Side Effect:\u003c/b\u003e Danazol is a known cause of \u003cmark\u003e[[7c4e7c74|idiopathic intracranial hypertension]]\u003c/mark\u003e (pseudotumor cerebri).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember Danazol as a weak androgen used for gynecologic conditions like endometriosis. Be aware of its androgenic side effects and its association with pseudotumor cerebri.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDanazol\u003c/b\u003e is a synthetic androgen that treats estrogen-dependent conditions like endometriosis by suppressing the pituitary-ovarian axis, but its clinical utility is limited by its masculinizing side effects and the risk of inducing idiopathic intracranial hypertension.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"endometriosis\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"hereditary_angioedema\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"has_activity\",\n        \"to\": \"androgen_receptor\"\n      }\n    ]\n  },\n  \"96ec2121\": {\n    \"title\": \"Dandy-Walker Malformation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Embryology\",\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Posterior Fossa Malformations\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDandy-Walker malformation\u003c/b\u003e is a congenital brain malformation of the posterior fossa characterized by agenesis or hypoplasia of the cerebellar vermis, cystic dilation of the fourth ventricle, and enlargement of the posterior fossa.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A developmental anomaly of the cerebellum and the fourth ventricle. The key feature is the failure of the cerebellar vermis to develop.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Often presents in infancy with signs of \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e due to obstruction of CSF outflow from the fourth ventricle. This can cause a rapidly increasing head circumference, bulging fontanelles, and developmental delay.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Brain imaging (ultrasound, CT, or MRI) shows a \u003cmark\u003elarge posterior fossa\u003c/mark\u003e, a cystically dilated fourth ventricle that communicates with the cisterna magna, and an absent or hypoplastic cerebellar vermis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Can be associated with other CNS and systemic anomalies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic imaging triad is: 1) Agenesis of the vermis, 2) Cystic dilation of the 4th ventricle, and 3) Enlarged posterior fossa. This leads to non-communicating hydrocephalus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDandy-Walker malformation\u003c/b\u003e is a congenital defect defined by an absent cerebellar vermis, which allows the fourth ventricle to expand into a large posterior fossa cyst, commonly leading to hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Agenesis of Cerebellar Vermis] --\u003e B(Cystic Dilation of 4th Ventricle); B --\u003e C(Enlarged Posterior Fossa); B --\u003e D(Obstruction of CSF Outflow); D --\u003e E(Non-communicating Hydrocephalus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"posterior_fossa_malformation\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"agenesis_of_cerebellar_vermis\"\n      }\n    ]\n  },\n  \"d67a204d\": {\n    \"title\": \"Dantrolene\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDantrolene\u003c/b\u003e is a direct-acting skeletal muscle relaxant that is the primary treatment for malignant hyperthermia and neuroleptic malignant syndrome.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts directly on skeletal muscle by binding to the \u003cmark\u003eryanodine receptor (RyR1)\u003c/mark\u003e on the sarcoplasmic reticulum. This blocks the release of Ca\u003csup\u003e2+\u003c/sup\u003e from the sarcoplasmic reticulum, thereby uncoupling excitation-contraction coupling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[malignant_hyperthermia|Malignant Hyperthermia (MH)]]:\u003c/b\u003e The definitive treatment for this life-threatening reaction to inhaled anesthetics and succinylcholine.\u003cbr\u003e - \u003cb\u003e[[neuroleptic_malignant_syndrome|Neuroleptic Malignant Syndrome (NMS)]]:\u003c/b\u003e Used to treat the muscle rigidity and hyperthermia associated with this reaction to antipsychotic drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generalized muscle weakness, sedation, and potential for hepatotoxicity with long-term use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Dantrolene is the life-saving antidote for both MH and NMS. Its unique mechanism of acting directly on the sarcoplasmic reticulum to block calcium release is key.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDantrolene\u003c/b\u003e is a crucial emergency drug that reverses the life-threatening hypermetabolic states of malignant hyperthermia and NMS by directly inhibiting calcium release from the sarcoplasmic reticulum, effectively calming the over-contracting muscles.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Dantrolene] --Inhibits--\u003e B(Ryanodine Receptor RyR1); B --x C(Ca2+ Release from Sarcoplasmic Reticulum); C --x D(Muscle Contraction); D --\u003e E(Treats MH \u0026 NMS);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"malignant_hyperthermia\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuroleptic_malignant_syndrome\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"ryanodine_receptor\"\n      }\n    ]\n  },\n  \"cd0b87db\": {\n    \"title\": \"Daptomycin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pharmacology\",\n      \"Antibiotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDaptomycin\u003c/b\u003e is a lipopeptide antibiotic with potent activity against gram-positive bacteria, including methicillin-resistant \u003ci\u003eStaphylococcus aureus\u003c/i\u003e (MRSA). It is not related to the visual finding of a \u0027dark curtain\u0027 vision loss.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inserts its lipid tail into the bacterial cell membrane in a Ca\u003csup\u003e2+\u003c/sup\u003e-dependent manner, creating transmembrane channels that lead to ion leakage, depolarization, and rapid cell death.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Activity:\u003c/b\u003e Gram-positive organisms, including MRSA, vancomycin-resistant enterococci (VRE), and \u003ci\u003eS. epidermidis\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Complicated skin and soft tissue infections, bacteremia, and right-sided endocarditis caused by susceptible gram-positive organisms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImportant Limitation:\u003c/b\u003e \u003cu\u003eCannot be used for pneumonia\u003c/u\u003e because it is inactivated by pulmonary surfactant.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most significant side effect is \u003cmark\u003emyopathy and rhabdomyolysis\u003c/mark\u003e. Creatine phosphokinase (CPK) levels must be monitored.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember two key facts about daptomycin: 1) It\u0027s great for MRSA and VRE, but 2) It\u0027s useless in the lungs. The risk of myopathy is also high-yield.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDaptomycin\u003c/b\u003e is a powerful weapon against resistant gram-positive bacteria, killing them by punching holes in their cell membranes, but its utility is nullified in the lungs by surfactant, and its use requires monitoring for muscle toxicity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"antibiotic\"\n      },\n      {\n        \"type\": \"is_effective_against\",\n        \"to\": \"mrsa\"\n      },\n      {\n        \"type\": \"is_ineffective_for\",\n        \"to\": \"pneumonia\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"myopathy\"\n      }\n    ]\n  },\n  \"528ae59c\": {\n    \"title\": \"Decerebrate (Extensor) Posturing\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDecerebrate posturing\u003c/b\u003e is a type of abnormal motor posturing characterized by rigid extension of the arms and legs, internal rotation of the arms, and plantar flexion of the feet. It is a sign of severe brain injury, specifically damage to the brainstem at or below the level of the red nucleus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Arms are adducted and extended, wrists pronated, fingers flexed; legs are stiffly extended with plantar flexion of the feet.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion is located in the brainstem between the red nucleus (in the midbrain) and the vestibular nuclei (in the pons/medulla). This disrupts descending motor pathways from the cortex and red nucleus (which mediate flexion), leaving the extensor-promoting vestibulospinal tract unopposed.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Decerebrate posturing indicates more severe, caudal brainstem damage than decorticate posturing and thus carries a \u003cmark\u003eworse prognosis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Decorticate:\u003c/b\u003e In [[dcce4415|decorticate posturing]], the lesion is above the red nucleus, so the rubrospinal tract (flexor) is intact and dominates in the upper limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that d\u003cb\u003ee\u003c/b\u003ec\u003cb\u003ee\u003c/b\u003er\u003cb\u003ee\u003c/b\u003ebrat\u003cb\u003ee\u003c/b\u003e posturing involves \u003cb\u003ee\u003c/b\u003extension of the arms and is a sign of a more s\u003cb\u003ee\u003c/b\u003ev\u003cb\u003ee\u003c/b\u003er\u003cb\u003ee\u003c/b\u003e brainstem injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDecerebrate posturing\u003c/b\u003e is an ominous sign of severe brainstem damage below the red nucleus, where the loss of flexor-driving pathways leaves the body in a state of rigid extension, driven by the unopposed vestibulospinal tract.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"c0b7a1ca\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_below\",\n        \"to\": \"red_nucleus\"\n      },\n      {\n        \"type\": \"has_worse_prognosis_than\",\n        \"to\": \"dcce4415\"\n      }\n    ]\n  },\n  \"dcce4415\": {\n    \"title\": \"Decorticate (Flexor) Posturing\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDecorticate posturing\u003c/b\u003e is a type of abnormal motor posturing characterized by flexion of the arms, wrists, and fingers, with adduction of the upper extremities, while the lower extremities are extended. It is a sign of severe damage to the cerebral hemispheres, internal capsule, or thalamus, above the level of the midbrain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Arms are flexed or bent inward on the chest, hands are clenched into fists, and legs are held out straight. Mnemonic: The arms are flexed toward the \u0027\u003cb\u003ecor\u003c/b\u003e\u0027 (core/heart).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion is located \u003cu\u003eabove the red nucleus\u003c/u\u003e in the midbrain. This disrupts the corticospinal tract but leaves the rubrospinal tract (which originates from the red nucleus and facilitates flexion in the upper limbs) intact and unopposed. The vestibulospinal tract remains intact, causing extension in the lower limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Indicates severe brain damage, but generally carries a better prognosis than [[528ae59c|decerebrate posturing]], which signifies a more caudal brainstem lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProgression:\u003c/b\u003e A patient may initially present with decorticate posturing and then progress to decerebrate posturing as the injury descends, indicating a worsening condition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating posturing types is the arm position. Decorticate \u003d flexion (lesion above red nucleus). Decerebrate \u003d extension (lesion below red nucleus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDecorticate posturing\u003c/b\u003e is a sign of severe supratentorial or diencephalic injury, where damage to the corticospinal tracts above the red nucleus results in a characteristic pattern of upper limb flexion (from the unopposed rubrospinal tract) and lower limb extension.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"c0b7a1ca\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_above\",\n        \"to\": \"red_nucleus\"\n      },\n      {\n        \"type\": \"has_better_prognosis_than\",\n        \"to\": \"528ae59c\"\n      }\n    ]\n  },\n  \"bb316ca0\": {\n    \"title\": \"Dementia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDementia\u003c/b\u003e is a syndrome characterized by a progressive decline in cognitive function, including memory, language, problem-solving, and other thinking abilities, that is severe enough to interfere with daily life. Consciousness is not affected.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e A decline from a previous level of functioning that is not explained by delirium or major psychiatric disorder.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMost Common Types:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[77ae6148|Alzheimer Disease]]:\u003c/b\u003e Most common cause (~60-80%). Gradual onset, with memory impairment as the earliest and most prominent feature.\u003cbr\u003e2. \u003cb\u003e[[99420dce|Vascular Dementia]]:\u003c/b\u003e Second most common. Caused by cerebrovascular disease. Typically has a stepwise decline in function with focal neurological deficits.\u003cbr\u003e3. \u003cb\u003e[[db2f16e5|Lewy Body Dementia]]:\u003c/b\u003e Characterized by fluctuating cognition, visual hallucinations, and parkinsonism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversible Causes:\u003c/b\u003e It is crucial to rule out reversible causes of cognitive decline, such as hypothyroidism, vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency, neurosyphilis, depression (pseudodementia), and normal pressure hydrocephalus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The specific pattern of deficits and associated symptoms helps differentiate the types of dementia. For example, early personality changes point to frontotemporal dementia, while visual hallucinations are characteristic of Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDementia\u003c/b\u003e is a broad clinical syndrome of acquired and progressive cognitive decline that impairs daily function; identifying the underlying cause, particularly distinguishing irreversible neurodegenerative types like Alzheimer\u0027s from potentially reversible conditions, is the primary diagnostic challenge.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"99420dce\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"db2f16e5\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"delirium\"\n      }\n    ]\n  },\n  \"f17ad9a5\": {\n    \"title\": \"Demyelinating and Dysmyelinating Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDemyelinating and dysmyelinating disorders\u003c/b\u003e are a group of neurological conditions characterized by damage to or defective formation of myelin, the protective sheath that surrounds nerve axons, leading to impaired nerve signal conduction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDemyelination:\u003c/b\u003e The destruction of previously normal myelin. Can affect the CNS or PNS.\u003cbr\u003e - \u003cb\u003eCNS Demyelination:\u003c/b\u003e [[45dd6d19|Multiple Sclerosis (MS)]] is the archetypal example, where oligodendrocytes are destroyed.\u003cbr\u003e - \u003cb\u003ePNS Demyelination:\u003c/b\u003e [[ed52e40b|Guillain-Barr√© Syndrome]] is the classic example, where Schwann cells are destroyed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDysmyelination:\u003c/b\u003e The formation of abnormal, defective myelin, typically due to genetic/metabolic defects. These are also known as leukodystrophies.\u003cbr\u003e - \u003cb\u003e[[a078dbd0|Metachromatic Leukodystrophy]]:\u003c/b\u003e Arylsulfatase A deficiency.\u003cbr\u003e - \u003cb\u003e[[246a82f3|Krabbe Disease]]:\u003c/b\u003e Galactocerebrosidase deficiency.\u003cbr\u003e - \u003cb\u003e[[21d4b96a|Adrenoleukodystrophy]]:\u003c/b\u003e Defect in VLCFA transport into peroxisomes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms vary widely depending on the location of the affected nerves but generally involve motor, sensory, and cognitive deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key distinction is demyelination (destruction of normal myelin, often autoimmune) versus dysmyelination (abnormal myelin formation, usually genetic/metabolic).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDemyelinating and dysmyelinating disorders\u003c/b\u003e both disrupt the insulation of nerve fibers, but demyelination involves an attack on healthy myelin (like in MS), while dysmyelination involves a fundamental defect in myelin production from the start (like in leukodystrophies).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a078dbd0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"21d4b96a\"\n      }\n    ]\n  },\n  \"c819d97b\": {\n    \"title\": \"Dentate Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebellum\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDentate Nucleus\u003c/b\u003e is the largest and most lateral of the deep cerebellar nuclei. It is a crucial relay station, receiving input from the cerebellar cortex and sending output from the cerebellum to modulate motor and cognitive functions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located deep within the lateral hemisphere of the [[bebe58d4|cerebellum]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Primarily involved in the planning, initiation, and control of \u003cmark\u003evoluntary movements\u003c/mark\u003e, especially of the distal extremities. It also contributes to cognitive functions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives inhibitory (GABAergic) input from Purkinje cells in the lateral cerebellar hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Sends excitatory (glutamatergic) projections via the superior cerebellar peduncle to the contralateral \u003cmark\u003eventral lateral (VL) nucleus of the thalamus\u003c/mark\u003e, which in turn projects to the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion of the dentate nucleus results in \u003cmark\u003eipsilateral limb ataxia\u003c/mark\u003e, including dysmetria (inability to judge distance) and intention tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic for the deep cerebellar nuclei from lateral to medial: \\\"\u003cb\u003eD\u003c/b\u003eon\u0027t \u003cb\u003eE\u003c/b\u003eat \u003cb\u003eG\u003c/b\u003ereasy \u003cb\u003eF\u003c/b\u003eoods\\\" (\u003cb\u003eD\u003c/b\u003eentate, \u003cb\u003eE\u003c/b\u003emboliform, \u003cb\u003eG\u003c/b\u003elobose, \u003cb\u003eF\u003c/b\u003eastigial). The dentate is the largest and most lateral, corresponding to the lateral hemispheres\u0027 control of the limbs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDentate Nucleus\u003c/b\u003e is the primary output channel for the lateral cerebellum, responsible for translating the cerebellum\u0027s complex computations into corrective signals that are sent to the motor cortex via the thalamus to ensure smooth and accurate limb movements.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Cerebellar Cortex] --Inhibitory--\u003e B(Dentate Nucleus); B --Excitatory--\u003e C(Contralateral Thalamus - VL); C --\u003e D(Motor Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_cerebellar_nuclei\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"sends_output_to\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"limb_ataxia\"\n      }\n    ]\n  },\n  \"a518f249\": {\n    \"title\": \"Depolarizing Neuromuscular Blockers\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDepolarizing neuromuscular blockers\u003c/b\u003e are a class of drugs that cause muscle paralysis by acting as agonists at the nicotinic acetylcholine receptor of the neuromuscular junction, leading to persistent depolarization of the motor endplate.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Agent:\u003c/b\u003e \u003cmark\u003eSuccinylcholine\u003c/mark\u003e is the only depolarizing agent in clinical use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Phase I):\u003c/b\u003e Succinylcholine binds to the nicotinic ACh receptor and acts like acetylcholine, causing the muscle to depolarize. This initial depolarization leads to transient muscle twitching (\u003cmark\u003efasciculations\u003c/mark\u003e). However, succinylcholine is not metabolized by acetylcholinesterase, so it remains bound, keeping the membrane depolarized and rendering it unresponsive to further stimuli (flaccid paralysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Phase II):\u003c/b\u003e With continued exposure, the receptor becomes desensitized, and the membrane repolarizes. However, the receptor is still unresponsive to acetylcholine, and the paralysis is maintained.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for rapid sequence intubation due to its \u003cmark\u003efast onset\u003c/mark\u003e (30-60 seconds) and \u003cmark\u003eshort duration\u003c/mark\u003e of action (5-10 minutes).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Hyperkalemia (can be life-threatening in patients with burns, crush injuries, or neuromuscular disease), malignant hyperthermia, and increased intraocular/intragastric pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The initial fasciculations are a key feature that distinguishes depolarizing blockers from non-depolarizing blockers. Remember the contraindication in burn/crush injury patients due to the risk of severe hyperkalemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSuccinylcholine\u003c/b\u003e, the sole depolarizing neuromuscular blocker, induces paralysis through a two-phase process of persistent depolarization followed by receptor desensitization, offering a uniquely rapid onset and offset ideal for emergency intubation but with significant risks like hyperkalemia and malignant hyperthermia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Succinylcholine] --\u003e B(Binds Nicotinic ACh Receptor); B --\u003e C(Phase I: Depolarization); C --\u003e D(Fasciculations); D --\u003e E(Flaccid Paralysis); B --Prolonged Exposure--\u003e F(Phase II: Desensitization); F --\u003e E;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"succinylcholine\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"malignant_hyperthermia\"\n      }\n    ]\n  },\n  \"9a0f5ba6\": {\n    \"title\": \"Depression (Major Depressive Disorder)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Mood Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMajor Depressive Disorder (MDD)\u003c/b\u003e is a mood disorder characterized by a persistent feeling of sadness or a loss of interest or pleasure (anhedonia), accompanied by other emotional and physical problems that significantly impair daily functioning.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Changes:\u003c/b\u003e The monoamine hypothesis suggests that depression is related to a deficiency in the brain of monoamine neurotransmitters, particularly \u003cmark\u003eserotonin (5-HT)\u003c/mark\u003e, \u003cmark\u003enorepinephrine (NE)\u003c/mark\u003e, and \u003cmark\u003edopamine (DA)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis (SIG E CAPS):\u003c/b\u003e Diagnosis requires ‚â•5 of the following symptoms for ‚â•2 weeks, including at least one of depressed mood or anhedonia:\u003cbr\u003e - \u003cb\u003eS\u003c/b\u003eleep disturbance\u003cbr\u003e - \u003cb\u003eI\u003c/b\u003enterest loss (anhedonia)\u003cbr\u003e - \u003cb\u003eG\u003c/b\u003euilt or worthlessness\u003cbr\u003e - \u003cb\u003eE\u003c/b\u003energy loss\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003eoncentration problems\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003eppetite/weight changes\u003cbr\u003e - \u003cb\u003eP\u003c/b\u003esychomotor retardation or agitation\u003cbr\u003e - \u003cb\u003eS\u003c/b\u003euicidal ideation\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e First-line treatment is typically a combination of psychotherapy (e.g., CBT) and pharmacotherapy, most commonly with Selective Serotonin Reuptake Inhibitors (SSRIs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The SIG E CAPS mnemonic is essential for recognizing MDD in a clinical vignette. Remember that most antidepressants work by increasing the levels of monoamine neurotransmitters in the synapse.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMajor Depressive Disorder\u003c/b\u003e is a debilitating mood disorder thought to stem from a functional deficit of monoamine neurotransmitters, leading to a persistent state of low mood and anhedonia that is treated by therapies aimed at restoring this neurochemical balance.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"5d3c2089\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ssris\"\n      }\n    ]\n  },\n  \"6ca830ea\": {\n    \"title\": \"Dermatome Landmarks\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003edermatome\u003c/b\u003e is an area of skin that is mainly supplied by afferent nerve fibers from a single dorsal root of a spinal nerve. \u003cb\u003eDermatome landmarks\u003c/b\u003e are specific, clinically useful areas of the body whose sensory innervation corresponds to a known spinal nerve root.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eC3, C4, C5:\u003c/b\u003e Supply the diaphragm (\u0027C3, 4, 5 keeps the diaphragm alive\u0027). Phrenic nerve irritation can cause referred pain to the shoulder (C4 dermatome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eT4:\u003c/b\u003e Level of the nipples (\u0027T4 at the teat pore\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eT7:\u003c/b\u003e Level of the xiphoid process.\u003c/li\u003e\u003cli\u003e\u003cb\u003eT10:\u003c/b\u003e Level of the umbilicus (\u0027T10 at the belly bu-ten\u0027). Site of referred pain in early appendicitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL1:\u003c/b\u003e Inguinal ligament region.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL4:\u003c/b\u003e Includes the kneecaps (\u0027Down on ALL 4\u0027s\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eS2, S3, S4:\u003c/b\u003e Sensation of the perineum (\u0027S2, 3, 4 keep the penis off the floor\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Knowing these key landmarks is essential for localizing spinal cord lesions. For example, sensory loss below the umbilicus suggests a lesion at or above the T10 spinal level.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDermatome landmarks\u003c/b\u003e provide a crucial roadmap for the neurological exam, allowing clinicians to trace sensory deficits on the skin back to a specific spinal nerve root, thereby localizing lesions within the spinal cord or peripheral nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_used_to_localize\",\n        \"to\": \"spinal_cord_lesion\"\n      },\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"spinal_nerves\"\n      }\n    ]\n  },\n  \"2ed35b5d\": {\n    \"title\": \"Desflurane\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDesflurane\u003c/b\u003e is a volatile halogenated ether used as an inhaled general anesthetic for the induction and maintenance of anesthesia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is unknown, but it is thought to enhance the activity of inhibitory neurotransmitter receptors (like GABA\u003csub\u003eA\u003c/sub\u003e and glycine receptors) and inhibit excitatory receptors (like NMDA receptors).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It has a very \u003cmark\u003elow blood:gas partition coefficient\u003c/mark\u003e (0.42). This low solubility in blood leads to a \u003cmark\u003every rapid onset\u003c/mark\u003e of anesthesia and a \u003cmark\u003every rapid recovery\u003c/mark\u003e upon discontinuation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePotency:\u003c/b\u003e It has a high MAC (Minimum Alveolar Concentration) of about 6%, meaning it is less potent than other volatile anesthetics like isoflurane.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes respiratory depression and myocardial depression (leading to hypotension). It is a pungent airway irritant, which can cause coughing, breath-holding, and laryngospasm, making it unsuitable for inhalation induction. It can also trigger \u003cmark\u003emalignant hyperthermia\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature of desflurane is its extremely low blood solubility, which translates to the fastest induction and emergence of all the volatile anesthetics.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDesflurane\u003c/b\u003e is the \u0027speedster\u0027 of inhaled anesthetics, offering exceptionally rapid onset and recovery due to its very low solubility in blood, though its pungency limits its use for inhalation induction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"inhaled_anesthetic\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"malignant_hyperthermia\"\n      },\n      {\n        \"type\": \"has_property\",\n        \"to\": \"low_blood_gas_solubility\"\n      }\n    ]\n  },\n  \"5bc4bd07\": {\n    \"title\": \"Diabetes Mellitus (Neurological Context)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiabetes mellitus\u003c/b\u003e is a metabolic disorder characterized by chronic hyperglycemia, which leads to numerous long-term complications, including significant damage to the central and peripheral nervous systems.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDiabetic Peripheral Neuropathy:\u003c/b\u003e The most common complication. Typically a distal, symmetric, \u0027glove and stocking\u0027 polyneuropathy affecting sensory and motor nerves. Caused by ischemic damage to nerves from microvascular disease and direct toxic effects of hyperglycemia (e.g., sorbitol accumulation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Neuropathy:\u003c/b\u003e Can affect any part of the autonomic nervous system, leading to gastroparesis, orthostatic hypotension, and erectile dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMononeuropathies:\u003c/b\u003e Can cause isolated cranial nerve palsies, most commonly affecting [[68c66997|CN III]] (often pupil-sparing) and [[dd11dde6|CN VI]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Risk:\u003c/b\u003e Diabetes is a major risk factor for atherosclerotic disease, significantly increasing the risk of both ischemic and lacunar strokes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRestless Legs Syndrome:\u003c/b\u003e Diabetes is a common secondary cause of [[919caff2|restless legs syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A \u0027glove and stocking\u0027 sensory loss in a patient with a history of diabetes is classic for diabetic peripheral neuropathy. A diabetic patient with a \u0027down and out\u0027 eye but a normal, reactive pupil has an ischemic CN III palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eChronic hyperglycemia in \u003cb\u003ediabetes mellitus\u003c/b\u003e is toxic to the nervous system, causing a wide spectrum of neurological complications from a slow, creeping \u0027glove and stocking\u0027 peripheral neuropathy to acute cranial nerve palsies and an increased risk of stroke.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"peripheral_neuropathy\"\n      },\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"fdfd22ca\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"919caff2\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9475,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"8e51aa24\": {\n    \"title\": \"Cyt"
      }, {
        "text": "otoxic Edema (Cerebral)\",\n    \"primaryType\": \"pathology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebro"
      }, {
        "text": "vascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCytotoxic edema\u003c/b\u003e"
      }, {
        "text": " is a type of [[aa00bdef|cerebral edema]] characterized by the swelling of brain cells, particularly"
      }, {
        "text": " neurons and glia, due to an intracellular accumulation of fluid. It is a key early event in cerebral ischemia.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary cause is a failure of the"
      }, {
        "text": " ATP-dependent Na\u003csup\u003e+\u003c/sup\u003e/K\u003csup\u003e+\u003c/sup\u003e pump, typically due to ischemia and energy failure. The pump"
      }, {
        "text": " failure leads to an influx of Na\u003csup\u003e+\u003c/sup\u003e and other ions into the cell, and water follows osmotically, causing the"
      }, {
        "text": " cell to swell.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTiming in Stroke:\u003c/b\u003e It is the \u003cmark\u003efirst type of edema\u003c/mark\u003e to appear"
      }, {
        "text": " after an [[c5da3c57|ischemic stroke]], developing within minutes to hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContrast"
      }, {
        "text": " with Vasogenic Edema:\u003c/b\u003e Vasogenic edema involves leakage of fluid into the \u003ci\u003eextracellular\u003c/i\u003e space due to a"
      }, {
        "text": " breakdown of the blood-brain barrier and occurs later in the course of a stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can"
      }, {
        "text": " also be caused by other metabolic insults like hypoxia, hypoglycemia, or certain toxins that disrupt cellular energy metabolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e For a stroke timeline question, remember that cytotoxic edema (intracellular swelling) happens first, followed by vas"
      }, {
        "text": "ogenic edema (extracellular fluid) hours to days later.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCytotoxic edema\u003c/b\u003e"
      }, {
        "text": " is the rapid, intracellular swelling of brain cells caused by energy failure and dysfunctional ion pumps, representing the initial and direct cellular response to ischemic"
      }, {
        "text": " injury.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ischemia/Hypoxia] --\u003e B("
      }, {
        "text": "‚Üì ATP); B --\u003e C(Na+/K+ Pump Failure); C --\u003e D(‚Üë Intracellular Na+); D --\u003e E"
      }, {
        "text": "(Water Influx); E --\u003e F(Cell Swelling - Cytotoxic Edema);\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_type_of\",\n        \"to\": \"aa00bdef\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_an_early_feature_of\",\n        \"to\":"
      }, {
        "text": " \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_contr"
      }, {
        "text": "asted_with\",\n        \"to\": \"vasogenic_edema\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"a4087338\": {\n    \"title\": \"Danazol\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Gyne"
      }, {
        "text": "cology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Reproductive\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Hormonal Agents\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eDanazol\u003c/b\u003e is a synthetic steroid with weak androgenic, progestogenic, and glucocorticoid activity. It primarily"
      }, {
        "text": " acts as a weak androgen and is used to suppress the hypothalamic-pituitary-gonadal axis.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A synthetic androgen that acts as a partial agonist at androgen receptors. It suppresses"
      }, {
        "text": " the pituitary-ovarian axis by inhibiting the mid-cycle surge of FSH and LH, leading to decreased estrogen production and anovulation.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat endometriosis, fibrocystic breast disease, and hereditary angioedema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Due to its androgenic properties, it can cause weight gain, edema, acne, hirsutism, and"
      }, {
        "text": " masculinization. It is also hepatotoxic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Side Effect:\u003c/b\u003e Danazol is a known cause of \u003cmark\u003e[["
      }, {
        "text": "7c4e7c74|idiopathic intracranial hypertension]]\u003c/mark\u003e (pseudotumor cerebri)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember Danazol as a weak androgen used for gynecologic conditions like endometriosis. Be"
      }, {
        "text": " aware of its androgenic side effects and its association with pseudotumor cerebri.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eDanazol\u003c/b\u003e is a synthetic androgen that treats estrogen-dependent conditions like endometriosis by suppressing the pituitary"
      }, {
        "text": "-ovarian axis, but its clinical utility is limited by its masculinizing side effects and the risk of inducing idiopathic intracranial hypertension.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \""
      }, {
        "text": "endometriosis\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\":"
      }, {
        "text": " \"hereditary_angioedema\"\n      },\n      {\n        \"type\": \"causes_adverse"
      }, {
        "text": "_effect\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"has_activity\",\n        \"to\": \"androgen_receptor\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "96ec2121\": {\n    \"title\": \"Dandy-Walker Malformation\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Embryology\","
      }, {
        "text": "\n      \"Congenital Malformation\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Embryology\",\n      \"Posterior Fossa Malformations\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDandy-Walker malformation\u003c/b\u003e is a congenital brain malformation of"
      }, {
        "text": " the posterior fossa characterized by agenesis or hypoplasia of the cerebellar vermis, cystic dilation of the fourth ventricle, and enlargement of the posterior"
      }, {
        "text": " fossa.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A developmental anomaly of the cerebellum and the"
      }, {
        "text": " fourth ventricle. The key feature is the failure of the cerebellar vermis to develop.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Often"
      }, {
        "text": " presents in infancy with signs of \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e due to obstruction of CSF outflow from"
      }, {
        "text": " the fourth ventricle. This can cause a rapidly increasing head circumference, bulging fontanelles, and developmental delay.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:"
      }, {
        "text": "\u003c/b\u003e Brain imaging (ultrasound, CT, or MRI) shows a \u003cmark\u003elarge posterior fossa\u003c/mark\u003e, a cyst"
      }, {
        "text": "ically dilated fourth ventricle that communicates with the cisterna magna, and an absent or hypoplastic cerebellar vermis.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Associated Conditions:\u003c/b\u003e Can be associated with other CNS and systemic anomalies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic"
      }, {
        "text": " imaging triad is: 1) Agenesis of the vermis, 2) Cystic dilation of the 4th ventricle, and 3)"
      }, {
        "text": " Enlarged posterior fossa. This leads to non-communicating hydrocephalus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eDandy-Walker malformation\u003c/b\u003e is a congenital defect defined by an absent cerebellar vermis, which allows"
      }, {
        "text": " the fourth ventricle to expand into a large posterior fossa cyst, commonly leading to hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Agenesis of Cerebellar Vermis] --\u003e B(Cystic Dilation of 4"
      }, {
        "text": "th Ventricle); B --\u003e C(Enlarged Posterior Fossa); B --\u003e D(Obstruction of CSF Out"
      }, {
        "text": "flow); D --\u003e E(Non-communicating Hydrocephalus);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"posterior_fossa_malformation\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"0bc2f"
      }, {
        "text": "200\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \""
      }, {
        "text": "to\": \"agenesis_of_cerebellar_vermis\"\n      }\n    ]\n  },\n  \"d6"
      }, {
        "text": "7a204d\": {\n    \"title\": \"Dantrolene\",\n    \"primaryType"
      }, {
        "text": "\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\","
      }, {
        "text": "\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDantrolene\u003c/b\u003e is a direct-acting skeletal muscle relaxant that is"
      }, {
        "text": " the primary treatment for malignant hyperthermia and neuroleptic malignant syndrome.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action"
      }, {
        "text": ":\u003c/b\u003e Acts directly on skeletal muscle by binding to the \u003cmark\u003eryanodine receptor (RyR1)\u003c/mark\u003e on"
      }, {
        "text": " the sarcoplasmic reticulum. This blocks the release of Ca\u003csup\u003e2+\u003c/sup\u003e from the sarcoplasmic reticulum, thereby uncoupling excitation"
      }, {
        "text": "-contraction coupling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[malignant_hyperthermia|Malign"
      }, {
        "text": "ant Hyperthermia (MH)]]:\u003c/b\u003e The definitive treatment for this life-threatening reaction to inhaled anesthetics and succ"
      }, {
        "text": "inylcholine.\u003cbr\u003e - \u003cb\u003e[[neuroleptic_malignant_syndrome|Neuroleptic Malignant Syndrome (N"
      }, {
        "text": "MS)]]:\u003c/b\u003e Used to treat the muscle rigidity and hyperthermia associated with this reaction to antipsychotic drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse"
      }, {
        "text": " Effects:\u003c/b\u003e Generalized muscle weakness, sedation, and potential for hepatotoxicity with long-term use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Dant"
      }, {
        "text": "rolene is the life-saving antidote for both MH and NMS. Its unique mechanism of acting directly on the sarc"
      }, {
        "text": "oplasmic reticulum to block calcium release is key.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDantrol"
      }, {
        "text": "ene\u003c/b\u003e is a crucial emergency drug that reverses the life-threatening hypermetabolic states of malignant hyperthermia and NMS"
      }, {
        "text": " by directly inhibiting calcium release from the sarcoplasmic reticulum, effectively calming the over-contracting muscles.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Dantrolene] --Inhibits--\u003e B(Ryanodine Receptor RyR1); B"
      }, {
        "text": " --x C(Ca2+ Release from Sarcoplasmic Reticulum); C --x D(Muscle Contraction); D --\u003e E(Treat"
      }, {
        "text": "s MH \u0026 NMS);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"malignant_hyperthermia\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"treats\",\n        \"to\": \"neuroleptic_malignant_syndrome\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"ryanodine_receptor\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"cd0b87db\": {\n    \"title\": \"Dapt"
      }, {
        "text": "omycin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Infectious Disease"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Antibiotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDaptomycin"
      }, {
        "text": "\u003c/b\u003e is a lipopeptide antibiotic with potent activity against gram-positive bacteria, including methicillin-resistant \u003ci\u003eStaphylococcus aureus\u003c/i\u003e (MRSA"
      }, {
        "text": "). It is not related to the visual finding of a \u0027dark curtain\u0027 vision loss.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inserts its lipid tail into the bacterial cell membrane in a Ca\u003csup\u003e2+\u003c/sup\u003e-dependent"
      }, {
        "text": " manner, creating transmembrane channels that lead to ion leakage, depolarization, and rapid cell death.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpectrum of Activity:\u003c/b\u003e Gram"
      }, {
        "text": "-positive organisms, including MRSA, vancomycin-resistant enterococci (VRE), and \u003ci\u003eS. epid"
      }, {
        "text": "ermidis\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Complicated skin and soft tissue infections, bacteremia, and right-sided end"
      }, {
        "text": "ocarditis caused by susceptible gram-positive organisms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImportant Limitation:\u003c/b\u003e \u003cu\u003eCannot be used for pneumonia\u003c/u\u003e because it is inactivated by pulmonary"
      }, {
        "text": " surfactant.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most significant side effect is \u003cmark\u003emyopathy and rhabdomyolysis"
      }, {
        "text": "\u003c/mark\u003e. Creatine phosphokinase (CPK) levels must be monitored.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " two key facts about daptomycin: 1) It\u0027s great for MRSA and VRE, but 2) It"
      }, {
        "text": "\u0027s useless in the lungs. The risk of myopathy is also high-yield.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eDaptomycin\u003c/b\u003e is a powerful weapon against resistant gram-positive bacteria, killing them by punching"
      }, {
        "text": " holes in their cell membranes, but its utility is nullified in the lungs by surfactant, and its use requires monitoring for muscle"
      }, {
        "text": " toxicity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"antibiotic\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_effective_against\",\n        \"to\": \"mrsa\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_ineffective_for\",\n        \"to\": \"pneumonia\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"myopathy\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"528ae59c\": {\n    \"title"
      }, {
        "text": "\": \"Decerebrate (Extensor) Posturing\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Pathology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDecerebrate post"
      }, {
        "text": "uring\u003c/b\u003e is a type of abnormal motor posturing characterized by rigid extension of the arms and legs, internal rotation of the arms"
      }, {
        "text": ", and plantar flexion of the feet. It is a sign of severe brain injury, specifically damage to the brainstem at or"
      }, {
        "text": " below the level of the red nucleus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Arms"
      }, {
        "text": " are adducted and extended, wrists pronated, fingers flexed; legs are stiffly extended with plantar flexion of the feet.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePathophysiology:\u003c/b\u003e The lesion is located in the brainstem between the red nucleus (in the midbrain) and the vestibular"
      }, {
        "text": " nuclei (in the pons/medulla). This disrupts descending motor pathways from the cortex and red nucleus (which mediate flexion), leaving"
      }, {
        "text": " the extensor-promoting vestibulospinal tract unopposed.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Decerebrate posturing indicates"
      }, {
        "text": " more severe, caudal brainstem damage than decorticate posturing and thus carries a \u003cmark\u003eworse prognosis\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Decorticate:\u003c/b\u003e In [[dcce4415|decorticate post"
      }, {
        "text": "uring]], the lesion is above the red nucleus, so the rubrospinal tract (flexor) is intact and dominates"
      }, {
        "text": " in the upper limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that d\u003cb\u003ee\u003c/b\u003ec\u003cb\u003ee\u003c/b\u003er\u003cb\u003ee\u003c/b\u003ebrat"
      }, {
        "text": "\u003cb\u003ee\u003c/b\u003e posturing involves \u003cb\u003ee\u003c/b\u003extension of the arms and is a sign of a more s\u003cb\u003ee\u003c/b\u003ev\u003cb\u003ee\u003c/b\u003er"
      }, {
        "text": "\u003cb\u003ee\u003c/b\u003e brainstem injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDecerebrate"
      }, {
        "text": " posturing\u003c/b\u003e is an ominous sign of severe brainstem damage below the red nucleus, where the loss of flexor-driving"
      }, {
        "text": " pathways leaves the body in a state of rigid extension, driven by the unopposed vestibulospinal tract.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"c0b7a1ca\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by_lesion_below\",\n        \"to\": \"red_nucleus\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"has_worse_prognosis_than\",\n        \"to\": \""
      }, {
        "text": "dcce4415\"\n      }\n    ]\n  },\n  \"dcce441"
      }, {
        "text": "5\": {\n    \"title\": \"Decorticate (Flexor) Posturing\",\n    \"primaryType\": \"finding\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Pathology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eDecorticate posturing\u003c/b\u003e is a type of abnormal motor posturing characterized by flexion of the arms, wrists, and fingers, with ad"
      }, {
        "text": "duction of the upper extremities, while the lower extremities are extended. It is a sign of severe damage to the cerebral hemispheres"
      }, {
        "text": ", internal capsule, or thalamus, above the level of the midbrain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance"
      }, {
        "text": ":\u003c/b\u003e Arms are flexed or bent inward on the chest, hands are clenched into fists, and legs are held out"
      }, {
        "text": " straight. Mnemonic: The arms are flexed toward the \u0027\u003cb\u003ecor\u003c/b\u003e\u0027 (core/heart).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e The lesion is located \u003cu\u003eabove the red nucleus\u003c/u\u003e in the midbrain. This disrupts the cortic"
      }, {
        "text": "ospinal tract but leaves the rubrospinal tract (which originates from the red nucleus and facilitates flexion in the upper limbs) intact and"
      }, {
        "text": " unopposed. The vestibulospinal tract remains intact, causing extension in the lower limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePro"
      }, {
        "text": "gnosis:\u003c/b\u003e Indicates severe brain damage, but generally carries a better prognosis than [[528ae59c|dec"
      }, {
        "text": "erebrate posturing]], which signifies a more caudal brainstem lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProgression:\u003c/b\u003e A patient may"
      }, {
        "text": " initially present with decorticate posturing and then progress to decerebrate posturing as the injury descends, indicating a worsening"
      }, {
        "text": " condition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating posturing types is the arm position. Decorticate \u003d"
      }, {
        "text": " flexion (lesion above red nucleus). Decerebrate \u003d extension (lesion below red nucleus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eDecorticate posturing\u003c/b\u003e is a sign of severe supratentorial or diencephalic injury"
      }, {
        "text": ", where damage to the corticospinal tracts above the red nucleus results in a characteristic pattern of upper limb flexion (from"
      }, {
        "text": " the unopposed rubrospinal tract) and lower limb extension.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"c0b"
      }, {
        "text": "7a1ca\"\n      },\n      {\n        \"type\": \"is_caused_by_les"
      }, {
        "text": "ion_above\",\n        \"to\": \"red_nucleus\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"has_better_prognosis_than\",\n        \"to\": \"528ae59"
      }, {
        "text": "c\"\n      }\n    ]\n  },\n  \"bb316ca0\": {\n    \"title"
      }, {
        "text": "\": \"Dementia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Geriatrics\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"D"
      }, {
        "text": "ementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDementia\u003c/b\u003e is a syndrome"
      }, {
        "text": " characterized by a progressive decline in cognitive function, including memory, language, problem-solving, and other thinking abilities, that is severe enough to interfere with"
      }, {
        "text": " daily life. Consciousness is not affected.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e A"
      }, {
        "text": " decline from a previous level of functioning that is not explained by delirium or major psychiatric disorder.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMost Common Types:\u003c/b\u003e\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003e[[77ae6148|Alzheimer Disease]]:\u003c/b\u003e Most common cause (~60-8"
      }, {
        "text": "0%). Gradual onset, with memory impairment as the earliest and most prominent feature.\u003cbr\u003e2. \u003cb\u003e[[9"
      }, {
        "text": "9420dce|Vascular Dementia]]:\u003c/b\u003e Second most common. Caused by cerebrovascular disease. Typically has"
      }, {
        "text": " a stepwise decline in function with focal neurological deficits.\u003cbr\u003e3. \u003cb\u003e[[db2f16e5"
      }, {
        "text": "|Lewy Body Dementia]]:\u003c/b\u003e Characterized by fluctuating cognition, visual hallucinations, and parkinsonism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRe"
      }, {
        "text": "versible Causes:\u003c/b\u003e It is crucial to rule out reversible causes of cognitive decline, such as hypothyroidism, vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency, neuro"
      }, {
        "text": "syphilis, depression (pseudodementia), and normal pressure hydrocephalus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " specific pattern of deficits and associated symptoms helps differentiate the types of dementia. For example, early personality changes point to frontotemporal dementia, while visual"
      }, {
        "text": " hallucinations are characteristic of Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDementia\u003c/b\u003e"
      }, {
        "text": " is a broad clinical syndrome of acquired and progressive cognitive decline that impairs daily function; identifying the underlying cause, particularly distinguishing irreversible"
      }, {
        "text": " neurodegenerative types like Alzheimer\u0027s from potentially reversible conditions, is the primary diagnostic challenge.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "includes\",\n        \"to\": \"99420dce\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"db2f16e5\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"delirium\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"f17ad9a5\": {\n    \"title"
      }, {
        "text": "\": \"Demyelinating and Dysmyelinating Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDemyelinating and dysmyelinating disorders\u003c/b\u003e are a"
      }, {
        "text": " group of neurological conditions characterized by damage to or defective formation of myelin, the protective sheath that surrounds nerve axons, leading to impaired nerve"
      }, {
        "text": " signal conduction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDemyelination:\u003c/b\u003e The destruction of previously normal myelin"
      }, {
        "text": ". Can affect the CNS or PNS.\u003cbr\u003e - \u003cb\u003eCNS Demyelination:\u003c/b\u003e [[45dd"
      }, {
        "text": "6d19|Multiple Sclerosis (MS)]] is the archetypal example, where oligodendrocytes are destroyed.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003ePNS Demyelination:\u003c/b\u003e [[ed52e40b|Guillain-Barr"
      }, {
        "text": "√© Syndrome]] is the classic example, where Schwann cells are destroyed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDysmyelination:\u003c/b\u003e The formation"
      }, {
        "text": " of abnormal, defective myelin, typically due to genetic/metabolic defects. These are also known as leukodystrophies.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[a078dbd0|Metachromatic Leukodystrophy]]:\u003c/b\u003e Ary"
      }, {
        "text": "lsulfatase A deficiency.\u003cbr\u003e - \u003cb\u003e[[246a82f3|Krabbe Disease"
      }, {
        "text": "]]:\u003c/b\u003e Galactocerebrosidase deficiency.\u003cbr\u003e - \u003cb\u003e[[21d4b96a|Adrenoleukodyst"
      }, {
        "text": "rophy]]:\u003c/b\u003e Defect in VLCFA transport into peroxisomes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms vary widely depending on the location"
      }, {
        "text": " of the affected nerves but generally involve motor, sensory, and cognitive deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key distinction"
      }, {
        "text": " is demyelination (destruction of normal myelin, often autoimmune) versus dysmyelination (abnormal myelin formation, usually"
      }, {
        "text": " genetic/metabolic).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDemyelinating and dysmyelin"
      }, {
        "text": "ating disorders\u003c/b\u003e both disrupt the insulation of nerve fibers, but demyelination involves an attack on healthy myelin (like in MS),"
      }, {
        "text": " while dysmyelination involves a fundamental defect in myelin production from the start (like in leukodystrophies).\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"includes\",\n        \"to\": \"ed52e40b\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"includes\",\n        \"to\": \"a078dbd0\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"21d4b"
      }, {
        "text": "96a\"\n      }\n    ]\n  },\n  \"c819d97b\": {\n    \"title\":"
      }, {
        "text": " \"Dentate Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Cerebellum\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDentate Nucleus\u003c/b\u003e is the largest and most lateral"
      }, {
        "text": " of the deep cerebellar nuclei. It is a crucial relay station, receiving input from the cerebellar cortex and sending output from the cerebellum"
      }, {
        "text": " to modulate motor and cognitive functions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located"
      }, {
        "text": " deep within the lateral hemisphere of the [[bebe58d4|cerebellum]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Primarily"
      }, {
        "text": " involved in the planning, initiation, and control of \u003cmark\u003evoluntary movements\u003c/mark\u003e, especially of the distal extremities. It"
      }, {
        "text": " also contributes to cognitive functions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives inhibitory (GABAergic) input from Purkinje cells in the lateral cerebellar"
      }, {
        "text": " hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Sends excitatory (glutamatergic) projections via the superior cerebellar peduncle to the contralateral"
      }, {
        "text": " \u003cmark\u003eventral lateral (VL) nucleus of the thalamus\u003c/mark\u003e, which in turn projects to the motor"
      }, {
        "text": " cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion of the dentate nucleus results in \u003cmark\u003eipsilateral limb ataxia"
      }, {
        "text": "\u003c/mark\u003e, including dysmetria (inability to judge distance) and intention tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Remember the mnemonic for the deep cerebellar nuclei from lateral to medial: \\\"\u003cb\u003eD\u003c/b\u003eon\u0027t \u003cb\u003eE\u003c/b\u003eat \u003cb\u003eG"
      }, {
        "text": "\u003c/b\u003ereasy \u003cb\u003eF\u003c/b\u003eoods\\\" (\u003cb\u003eD\u003c/b\u003eentate, \u003cb\u003eE\u003c/b\u003emboliform, "
      }, {
        "text": "\u003cb\u003eG\u003c/b\u003elobose, \u003cb\u003eF\u003c/b\u003eastigial). The dentate is the largest and most lateral, corresponding"
      }, {
        "text": " to the lateral hemispheres\u0027 control of the limbs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDentate Nucleus\u003c/b\u003e is"
      }, {
        "text": " the primary output channel for the lateral cerebellum, responsible for translating the cerebellum\u0027s complex computations into corrective signals that are sent to the motor cortex"
      }, {
        "text": " via the thalamus to ensure smooth and accurate limb movements.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral"
      }, {
        "text": " Cerebellar Cortex] --Inhibitory--\u003e B(Dentate Nucleus); B --Excitatory--\u003e C(Cont"
      }, {
        "text": "ralateral Thalamus - VL); C --\u003e D(Motor Cortex);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_cerebellar_nuclei\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"bebe58d4\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"sends_output_to\",\n        \"to\":"
      }, {
        "text": " \"afc0a64b\"\n      },\n      {\n        \"type\": \"lesion_causes"
      }, {
        "text": "\",\n        \"to\": \"limb_ataxia\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "a518f249\": {\n    \"title\": \"Depolarizing Neuromuscular Blockers\",\n    \""
      }, {
        "text": "primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthes"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eDepolarizing neuromuscular blockers\u003c/b\u003e are a class of drugs that cause muscle paralysis by acting"
      }, {
        "text": " as agonists at the nicotinic acetylcholine receptor of the neuromuscular junction, leading to persistent depolarization of the motor endplate.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Agent:\u003c/b\u003e \u003cmark\u003eSuccinylcholine\u003c/mark\u003e is the only depolar"
      }, {
        "text": "izing agent in clinical use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Phase I):\u003c/b\u003e Succinylcholine binds to the nicotinic ACh"
      }, {
        "text": " receptor and acts like acetylcholine, causing the muscle to depolarize. This initial depolarization leads to transient muscle twitching (\u003cmark\u003efasciculations\u003c/mark\u003e"
      }, {
        "text": "). However, succinylcholine is not metabolized by acetylcholinesterase, so it remains bound, keeping the membrane depolarized and rendering"
      }, {
        "text": " it unresponsive to further stimuli (flaccid paralysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Phase II):\u003c/b\u003e With continued"
      }, {
        "text": " exposure, the receptor becomes desensitized, and the membrane repolarizes. However, the receptor is still unresponsive to acetylcholine"
      }, {
        "text": ", and the paralysis is maintained.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for rapid sequence intubation due to its \u003c"
      }, {
        "text": "mark\u003efast onset\u003c/mark\u003e (30-60 seconds) and \u003cmark\u003eshort duration\u003c/mark\u003e of"
      }, {
        "text": " action (5-10 minutes).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Hyperkalemia (can be life-threatening in patients with burns"
      }, {
        "text": ", crush injuries, or neuromuscular disease), malignant hyperthermia, and increased intraocular/intragastric pressure.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e The initial fasciculations are a key feature that distinguishes depolarizing blockers from non-depolarizing blockers."
      }, {
        "text": " Remember the contraindication in burn/crush injury patients due to the risk of severe hyperkalemia.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSuccinylcholine\u003c/b\u003e, the sole depolarizing neuromuscular blocker, induces paralysis through"
      }, {
        "text": " a two-phase process of persistent depolarization followed by receptor desensitization, offering a uniquely rapid onset and offset ideal for emergency"
      }, {
        "text": " intubation but with significant risks like hyperkalemia and malignant hyperthermia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[Succinylcholine] --\u003e B(Binds Nicotinic ACh Receptor); B --\u003e C(Phase I:"
      }, {
        "text": " Depolarization); C --\u003e D(Fasciculations); D --\u003e E(Flaccid Paralysis); B --"
      }, {
        "text": "Prolonged Exposure--\u003e F(Phase II: Desensitization); F --\u003e E;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"includes\",\n        \"to\": \"succinylcholine\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"differentiated_from\",\n        \"to\": \"nondepolarizing_neuromuscular_"
      }, {
        "text": "blocker\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"malign"
      }, {
        "text": "ant_hyperthermia\"\n      }\n    ]\n  },\n  \"9a0f5ba"
      }, {
        "text": "6\": {\n    \"title\": \"Depression (Major Depressive Disorder)\",\n    \"primaryType\": \"disease\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Mood Disorders\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eMajor Depressive Disorder (MDD)\u003c/b\u003e is a mood"
      }, {
        "text": " disorder characterized by a persistent feeling of sadness or a loss of interest or pleasure (anhedonia), accompanied by other emotional"
      }, {
        "text": " and physical problems that significantly impair daily functioning.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Changes"
      }, {
        "text": ":\u003c/b\u003e The monoamine hypothesis suggests that depression is related to a deficiency in the brain of monoamine neurotransmitters, particularly \u003cmark\u003eserotonin ("
      }, {
        "text": "5-HT)\u003c/mark\u003e, \u003cmark\u003enorepinephrine (NE)\u003c/mark\u003e, and \u003cmark\u003edopamine (DA)\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis (SIG E CAPS):\u003c/b\u003e Diagnosis requires ‚â•5 of the following symptoms for ‚â•2 weeks, including at"
      }, {
        "text": " least one of depressed mood or anhedonia:\u003cbr\u003e - \u003cb\u003eS\u003c/b\u003eleep disturbance\u003cbr\u003e - \u003cb\u003eI\u003c/b\u003en"
      }, {
        "text": "terest loss (anhedonia)\u003cbr\u003e - \u003cb\u003eG\u003c/b\u003euilt or worthlessness\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "E\u003c/b\u003energy loss\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003eoncentration problems\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003e"
      }, {
        "text": "ppetite/weight changes\u003cbr\u003e - \u003cb\u003eP\u003c/b\u003esychomotor retardation or agitation\u003cbr\u003e - \u003cb\u003eS"
      }, {
        "text": "\u003c/b\u003euicidal ideation\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e First-line treatment is typically a combination of psychotherapy (e.g., CBT) and pharmac"
      }, {
        "text": "otherapy, most commonly with Selective Serotonin Reuptake Inhibitors (SSRIs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " SIG E CAPS mnemonic is essential for recognizing MDD in a clinical vignette. Remember that most antidepressants work by increasing the levels of mono"
      }, {
        "text": "amine neurotransmitters in the synapse.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMajor Depressive Disorder\u003c/b\u003e is a debilitating"
      }, {
        "text": " mood disorder thought to stem from a functional deficit of monoamine neurotransmitters, leading to a persistent state of low mood and"
      }, {
        "text": " anhedonia that is treated by therapies aimed at restoring this neurochemical balance.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"involves_deficiency_of\",\n        \"to"
      }, {
        "text": "\": \"5d3c2089\"\n      },\n      {\n        \"type\": \"invol"
      }, {
        "text": "ves_deficiency_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"involves_deficiency_of\",\n        \"to\": \"90adc821"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"treated_by\",\n        \"to\": \"ss"
      }, {
        "text": "ris\"\n      }\n    ]\n  },\n  \"6ca830ea\": {\n    \"title\": \""
      }, {
        "text": "Dermatome Landmarks\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \""
      }, {
        "text": "Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eA \u003cb\u003edermatome\u003c/b\u003e is an area of skin that is mainly supplied by affer"
      }, {
        "text": "ent nerve fibers from a single dorsal root of a spinal nerve. \u003cb\u003eDermatome landmarks\u003c/b\u003e are specific, clinically"
      }, {
        "text": " useful areas of the body whose sensory innervation corresponds to a known spinal nerve root.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eC"
      }, {
        "text": "3, C4, C5:\u003c/b\u003e Supply the diaphragm (\u0027C3, 4, 5 keeps the diaphragm alive\u0027). Ph"
      }, {
        "text": "renic nerve irritation can cause referred pain to the shoulder (C4 dermatome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eT4:\u003c/b\u003e Level"
      }, {
        "text": " of the nipples (\u0027T4 at the teat pore\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eT7:\u003c/b\u003e Level of the xiphoid process."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eT10:\u003c/b\u003e Level of the umbilicus (\u0027T10 at the belly bu-ten"
      }, {
        "text": "\u0027). Site of referred pain in early appendicitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL1:\u003c/b\u003e Inguinal ligament region.\u003c/li\u003e\u003cli\u003e\u003cb\u003eL4:\u003c/b\u003e Includes"
      }, {
        "text": " the kneecaps (\u0027Down on ALL 4\u0027s\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eS2, S3, S4:\u003c/b\u003e S"
      }, {
        "text": "ensation of the perineum (\u0027S2, 3, 4 keep the penis off the floor\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Knowing these key landmarks is essential for localizing spinal cord lesions. For example, sensory loss below the um"
      }, {
        "text": "bilicus suggests a lesion at or above the T10 spinal level.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eDermatome landmarks\u003c/b\u003e provide a crucial roadmap for the neurological exam, allowing clinicians to trace sensory deficits on"
      }, {
        "text": " the skin back to a specific spinal nerve root, thereby localizing lesions within the spinal cord or peripheral nervous system.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_used_to_localize"
      }, {
        "text": "\",\n        \"to\": \"spinal_cord_lesion\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_innervated_by\",\n        \"to\": \"spinal_nerves\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"2ed35b5d\": {\n    \"title\": \"Desflur"
      }, {
        "text": "ane\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eDesflurane\u003c/b\u003e is a volatile halogenated ether used as an inhaled general anesthetic for the induction and maintenance of anesthesia"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is unknown"
      }, {
        "text": ", but it is thought to enhance the activity of inhibitory neurotransmitter receptors (like GABA\u003csub\u003eA\u003c/sub\u003e and glycine receptors) and inhibit"
      }, {
        "text": " excitatory receptors (like NMDA receptors).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It has a very \u003cmark\u003elow blood"
      }, {
        "text": ":gas partition coefficient\u003c/mark\u003e (0.42). This low solubility in blood leads to a \u003cmark\u003every rapid onset\u003c/"
      }, {
        "text": "mark\u003e of anesthesia and a \u003cmark\u003every rapid recovery\u003c/mark\u003e upon discontinuation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePotency:\u003c/b\u003e It"
      }, {
        "text": " has a high MAC (Minimum Alveolar Concentration) of about 6%, meaning it is less potent than other volatile"
      }, {
        "text": " anesthetics like isoflurane.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes respiratory depression and myocardial depression (leading"
      }, {
        "text": " to hypotension). It is a pungent airway irritant, which can cause coughing, breath-holding, and laryngospasm, making"
      }, {
        "text": " it unsuitable for inhalation induction. It can also trigger \u003cmark\u003emalignant hyperthermia\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The key feature of desflurane is its extremely low blood solubility, which translates to the fastest induction and emergence of"
      }, {
        "text": " all the volatile anesthetics.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDesflurane\u003c/b\u003e is the \u0027"
      }, {
        "text": "speedster\u0027 of inhaled anesthetics, offering exceptionally rapid onset and recovery due to its very low solubility in blood, though"
      }, {
        "text": " its pungency limits its use for inhalation induction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"inhaled_anesthetic\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \""
      }, {
        "text": "malignant_hyperthermia\"\n      },\n      {\n        \"type\": \"has_property\",\n"
      }, {
        "text": "        \"to\": \"low_blood_gas_solubility\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "5bc4bd07\": {\n    \"title\": \"Diabetes Mellitus (Neurological Context)\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neurology\",\n      \"Pathology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Peripheral Neuropathies\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eDiabetes mellitus\u003c/b\u003e is a metabolic disorder characterized by chronic hyperglycemia, which leads to numerous long-term complications, including significant"
      }, {
        "text": " damage to the central and peripheral nervous systems.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDiabetic Peripheral"
      }, {
        "text": " Neuropathy:\u003c/b\u003e The most common complication. Typically a distal, symmetric, \u0027glove and stocking\u0027 polyneuropathy affecting"
      }, {
        "text": " sensory and motor nerves. Caused by ischemic damage to nerves from microvascular disease and direct toxic effects of hyperglycemia (e.g., sor"
      }, {
        "text": "bitol accumulation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutonomic Neuropathy:\u003c/b\u003e Can affect any part of the autonomic nervous system, leading"
      }, {
        "text": " to gastroparesis, orthostatic hypotension, and erectile dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMononeuropathies:\u003c/b\u003e Can cause isolated"
      }, {
        "text": " cranial nerve palsies, most commonly affecting [[68c66997|CN III]] (often pupil"
      }, {
        "text": "-sparing) and [[dd11dde6|CN VI]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Risk:\u003c/b\u003e Diabetes is a major risk factor"
      }, {
        "text": " for atherosclerotic disease, significantly increasing the risk of both ischemic and lacunar strokes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRestless Legs Syndrome:\u003c/b\u003e Diabetes"
      }, {
        "text": " is a common secondary cause of [[919caff2|restless legs syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " \u0027glove and stocking\u0027 sensory loss in a patient with a history of diabetes is classic for diabetic peripheral neuropathy. A"
      }, {
        "text": " diabetic patient with a \u0027down and out\u0027 eye but a normal, reactive pupil has an ischemic CN III palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eChronic hyperglycemia in \u003cb\u003ediabetes mellitus\u003c/b\u003e is toxic to the nervous system, causing a wide spectrum of neurological"
      }, {
        "text": " complications from a slow, creeping \u0027glove and stocking\u0027 peripheral neuropathy to acute cranial nerve palsies and an increased risk of stroke.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_cause_of\",\n        \"to\": \"peripheral_neuropathy\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_a_cause_of\",\n        \"to\": \"fdfd22ca\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"c5da"
      }, {
        "text": "3c57\"\n      },\n      {\n        \"type\": \"is_a_cause_of"
      }, {
        "text": "\",\n        \"to\": \"919caff2\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1Ld5mtZeLGe6xwSK7YKcJvSqGTSCzRSzb"
      },
      "role": "user",
      "tokenCount": 2025
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"73b00ab0\": {\n    \"title\": \"Diabetic Retinopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Endocrinology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiabetic retinopathy\u003c/b\u003e is a microvascular complication of [[5bc4bd07|diabetes mellitus]] and a leading cause of blindness in working-age adults. It is caused by chronic hyperglycemia-induced damage to the small blood vessels of the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNonproliferative Diabetic Retinopathy (NPDR):\u003c/b\u003e The earlier stage. Characterized by damaged capillaries leaking fluid and lipids into the retina. Fundoscopic findings include \u003cmark\u003emicroaneurysms, dot and blot hemorrhages, hard exudates\u003c/mark\u003e (lipid deposits), and \u003cmark\u003e[[2b254051|cotton-wool spots]]\u003c/mark\u003e (nerve fiber layer infarcts). Vision loss in this stage is primarily due to macular edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProliferative Diabetic Retinopathy (PDR):\u003c/b\u003e The more advanced and severe stage. Chronic retinal ischemia stimulates the production of vascular endothelial growth factor (VEGF), leading to \u003cmark\u003eneovascularization\u003c/mark\u003e (growth of new, abnormal blood vessels) on the retina or optic disc.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications of PDR:\u003c/b\u003e These fragile new vessels can bleed, causing vitreous hemorrhage. They can also lead to tractional retinal detachment.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Chronic hyperglycemia leads to the formation of advanced glycation end products and activation of the polyol pathway (glucose ‚Üí sorbitol), causing osmotic damage and oxidative stress to pericytes and endothelial cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key distinction is the presence (proliferative) or absence (nonproliferative) of neovascularization. Macular edema can cause vision loss in NPDR, while vitreous hemorrhage and retinal detachment are the major threats in PDR.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDiabetic retinopathy\u003c/b\u003e progresses from a state of leaky, damaged vessels (nonproliferative) to a state of ischemic-driven, dangerous new vessel growth (proliferative), with both stages threatening vision through macular edema, hemorrhage, or retinal detachment.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Chronic Hyperglycemia] --\u003e B(Microvascular Damage); B --\u003e C(Nonproliferative Retinopathy); C --\u003e D(Hemorrhages, Exudates, Macular Edema); C --\u003e E(Retinal Ischemia); E --\u003e F(‚Üë VEGF); F --\u003e G(Proliferative Retinopathy - Neovascularization);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"5bc4bd07\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"2b254051\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"retinal_detachment\"\n      }\n    ]\n  },\n  \"f76181a6\": {\n    \"title\": \"Diarrhea\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Gastroenterology\",\n      \"Infectious Disease\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Gastrointestinal\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiarrhea\u003c/b\u003e is the condition of having at least three loose, liquid, or watery bowel movements each day. It is a common symptom of gastrointestinal distress and can be classified as osmotic, secretory, inflammatory, or motility-related.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOsmotic Diarrhea:\u003c/b\u003e Caused by the presence of non-absorbable solutes in the intestine, which draw water into the lumen (e.g., lactose intolerance, magnesium-containing antacids). Stops with fasting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecretory Diarrhea:\u003c/b\u003e Caused by stimulation of ion and water secretion by the intestinal epithelium (e.g., cholera toxin, VIPoma). Persists with fasting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInflammatory Diarrhea:\u003c/b\u003e Caused by inflammation and damage to the mucosal lining, leading to loss of protein-rich fluid and blood (e.g., inflammatory bowel disease, invasive bacterial infections like \u003ci\u003eShigella\u003c/i\u003e, \u003ci\u003eCampylobacter\u003c/i\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotility-Related Diarrhea:\u003c/b\u003e Caused by abnormally rapid intestinal transit time, which reduces water absorption (e.g., irritable bowel syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacologic Treatment:\u003c/b\u003e [[67a856bf|Opioids]] and their derivatives (e.g., loperamide, diphenoxylate) are effective antidiarrheal agents because they bind to Œº-opioid receptors in the gut, which inhibits acetylcholine release and decreases peristalsis, increasing transit time and water absorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loperamide is an over-the-counter opioid agonist that does not cross the blood-brain barrier, so it treats diarrhea without causing CNS effects. Diphenoxylate can have CNS effects at high doses and is co-formulated with atropine to discourage abuse.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDiarrhea\u003c/b\u003e is a symptom with diverse mechanisms, and its treatment with opioids like loperamide is based on their ability to slow gut motility by acting on Œº-receptors in the myenteric plexus, effectively \u0027braking\u0027 the overactive peristalsis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"67a856bf\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"cholera\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"inflammatory_bowel_disease\"\n      }\n    ]\n  },\n  \"e14063c3\": {\n    \"title\": \"Diazepam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiazepam\u003c/b\u003e (trade name Valium) is a long-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e with prominent sedative, anxiolytic, anticonvulsant, and muscle relaxant properties.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A positive allosteric modulator of the GABA\u003csub\u003eA\u003c/sub\u003e receptor. It increases the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening in response to GABA, leading to enhanced CNS inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is a \u003cmark\u003elong-acting\u003c/mark\u003e benzodiazepine with a rapid onset of action and active metabolites (including oxazepam and temazepam), which contributes to its prolonged effect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnxiety:\u003c/b\u003e For short-term management of severe anxiety.\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e A first-line agent for treating \u003cmark\u003estatus epilepticus\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eAlcohol Withdrawal:\u003c/b\u003e Used to manage symptoms and prevent seizures and delirium tremens.\u003cbr\u003e - \u003cb\u003eMuscle Spasms:\u003c/b\u003e Used as a skeletal muscle relaxant.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance, and withdrawal. Additive CNS depression with other depressants like alcohol. Its long half-life makes it less suitable for the elderly due to the risk of accumulation and falls.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Diazepam and lorazepam are the go-to drugs for terminating status epilepticus. Diazepam\u0027s long half-life makes it a good choice for managing alcohol withdrawal.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDiazepam\u003c/b\u003e is a fast-acting, long-duration benzodiazepine that is a workhorse for acute CNS hyperexcitability, effectively terminating seizures in status epilepticus and calming the storm of alcohol withdrawal by robustly enhancing GABAergic inhibition.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"status_epilepticus\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"alcohol_withdrawal\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      }\n    ]\n  },\n  \"24a24d08\": {\n    \"title\": \"Diencephalon\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Embryology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDiencephalon\u003c/b\u003e is a major division of the forebrain (prosencephalon) situated between the telencephalon and the midbrain. It develops from the posterior part of the embryonic forebrain and gives rise to several critical brain structures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Arises from the prosencephalon (forebrain) vesicle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivatives:\u003c/b\u003e The diencephalon develops into four main components:\u003cbr\u003e1. \u003cb\u003e[[afc0a64b|Thalamus]]:\u003c/b\u003e The major relay station for sensory information (except smell) to the cerebral cortex.\u003cbr\u003e2. \u003cb\u003e[[89e86633|Hypothalamus]]:\u003c/b\u003e The primary regulator of the autonomic nervous system and endocrine system.\u003cbr\u003e3. \u003cb\u003eEpithalamus:\u003c/b\u003e Includes the pineal gland (melatonin secretion) and habenula.\u003cbr\u003e4. \u003cb\u003eSubthalamus:\u003c/b\u003e Includes the subthalamic nucleus, a key part of the basal ganglia motor circuit.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavity of the diencephalon becomes the \u003cmark\u003ethird ventricle\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the thalamus and hypothalamus are the major derivatives of the diencephalon. The retina also develops as an out-pouching of the diencephalon.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDiencephalon\u003c/b\u003e is the embryonic precursor to the brain\u0027s central processing hub, forming the thalamus (the sensory gateway), the hypothalamus (the homeostatic command center), and other vital subcortical structures surrounding the third ventricle.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Prosencephalon - Forebrain] --\u003e B(Telencephalon); A --\u003e C(Diencephalon); C --\u003e D(Thalamus); C --\u003e E(Hypothalamus); C --\u003e F(Epithalamus); C --\u003e G(Subthalamus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_from\",\n        \"to\": \"prosencephalon\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"cavity_becomes\",\n        \"to\": \"third_ventricle\"\n      }\n    ]\n  },\n  \"22b22e08\": {\n    \"title\": \"Diffuse Axonal Injury (DAI)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiffuse Axonal Injury (DAI)\u003c/b\u003e is a severe form of traumatic brain injury characterized by widespread shearing of axons in the white matter tracts of the brain. It is caused by sudden, forceful acceleration-deceleration or rotational forces, typically from a motor vehicle accident.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The brain moves at a different rate than the skull during rapid acceleration/deceleration, creating shearing forces that stretch and damage long axons in the white matter. This disrupts axonal transport and leads to delayed axonal swelling and disconnection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The severity of DAI correlates with the degree of coma. Patients often lose consciousness immediately at the time of impact and remain in a prolonged coma or persistent vegetative state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e A standard CT scan may be normal or show only small petechial hemorrhages. \u003cmark\u003eMRI (especially diffusion-weighted imaging)\u003c/mark\u003e is more sensitive and classically shows multiple, small, ovoid lesions (punctate hemorrhages or non-hemorrhagic lesions) at the \u003cmark\u003egray-white matter junction\u003c/mark\u003e and in the corpus callosum and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Generally poor, with high rates of mortality and severe long-term disability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who is in a coma immediately following a high-speed car accident but has a relatively normal initial head CT should raise high suspicion for diffuse axonal injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDiffuse Axonal Injury\u003c/b\u003e is a devastating brain injury caused by the shearing of countless axons during high-impact trauma, leading to widespread disconnection of neural circuits and often resulting in immediate and profound coma.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"e9a47751\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"traumatic_brain_injury\"\n      },\n      {\n        \"type\": \"leads_to\",\n        \"to\": \"d36eed18\"\n      }\n    ]\n  },\n  \"c02b8271\": {\n    \"title\": \"Dihydroergotamine (DHE)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDihydroergotamine (DHE)\u003c/b\u003e is an ergot alkaloid medication used for the acute treatment of [[c8833bae|migraine]] and [[21760f80|cluster headaches]]. It has complex effects on serotonin, dopamine, and adrenergic receptors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a non-selective agonist at 5-HT\u003csub\u003e1D\u003c/sub\u003e and 5-HT\u003csub\u003e1B\u003c/sub\u003e receptors, similar to [[triptans|triptans]]. This leads to cranial vasoconstriction and inhibition of neuropeptide release in the trigeminal system. It also interacts with other serotonin, dopamine, and adrenergic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the acute (abortive) treatment of moderate to severe [[c8833bae|migraine headaches]] that are unresponsive to other therapies. It is available in injectable and nasal spray formulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea and vomiting are very common. As a potent vasoconstrictor, it can cause peripheral ischemia, hypertension, and coronary vasospasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e \u003cu\u003eAbsolutely contraindicated\u003c/u\u003e in patients with coronary, cerebral, or peripheral vascular disease, and in pregnancy. Should not be used within 24 hours of a triptan.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e DHE is a powerful but \u0027dirtier\u0027 alternative to triptans for acute migraine, with a broader receptor profile and a higher risk of vasoconstrictive side effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDihydroergotamine\u003c/b\u003e is a potent, multi-receptor ergot alkaloid used to abort severe migraines, but its powerful vasoconstrictive properties necessitate careful patient selection to avoid serious cardiovascular and ischemic complications.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ergot_alkaloid\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"21760f80\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"coronary_artery_disease\"\n      }\n    ]\n  },\n  \"67a856bf\": {\n    \"title\": \"Diphenoxylate\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Gastroenterology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Gastrointestinal\",\n      \"Pharmacology\",\n      \"Antidiarrheals\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiphenoxylate\u003c/b\u003e is an opioid agonist used as an antidiarrheal agent. It is structurally related to meperidine and acts on the gastrointestinal tract to decrease motility.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Binds to Œº-opioid receptors in the myenteric plexus of the gut. This inhibits the release of [[6a005559|acetylcholine]], leading to decreased peristalsis and increased intestinal transit time, which allows for more water and electrolyte absorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the management of [[f76181a6|diarrhea]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFormulation:\u003c/b\u003e It is co-formulated with a subtherapeutic amount of \u003cmark\u003eatropine\u003c/mark\u003e (trade name Lomotil). The atropine is added to discourage abuse, as high doses of diphenoxylate can cause CNS effects (euphoria, sedation), but the accompanying atropine would cause unpleasant anticholinergic side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e At therapeutic doses, side effects are mainly constipation and bloating. At high doses, it can cause CNS depression and opioid dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from loperamide, another opioid antidiarrheal. Loperamide does not cross the blood-brain barrier and has a very low abuse potential, whereas diphenoxylate does and is therefore combined with atropine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDiphenoxylate\u003c/b\u003e is an effective opioid antidiarrheal that slows gut motility, but its potential for CNS effects at high doses necessitates its combination with atropine to serve as an abuse deterrent.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"f76181a6\"\n      },\n      {\n        \"type\": \"is_coformulated_with\",\n        \"to\": \"atropine\"\n      }\n    ]\n  },\n  \"9914d433\": {\n    \"title\": \"Diplopia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiplopia\u003c/b\u003e, or double vision, is the perception of two images of a single object. It is most often caused by a misalignment of the eyes (strabismus) due to problems with the extraocular muscles or the cranial nerves that innervate them.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBinocular Diplopia:\u003c/b\u003e The most common type. It is present only when both eyes are open and resolves when one eye is covered. This indicates a misalignment problem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMonocular Diplopia:\u003c/b\u003e Double vision that persists when one eye is covered. This is an optical problem within the eye itself, such as [[18cff34e|astigmatism]] or [[85f03b02|cataracts]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of Binocular Diplopia:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCranial Nerve Palsies:\u003c/b\u003e Palsies of CN III, IV, or VI cause weakness of specific extraocular muscles.\u003cbr\u003e - \u003cb\u003eNeuromuscular Junction Disease:\u003c/b\u003e Myasthenia gravis often presents with fluctuating diplopia and ptosis.\u003cbr\u003e - \u003cb\u003eOrbital Disease:\u003c/b\u003e A mass or inflammation in the orbit (e.g., thyroid eye disease, orbital blowout fracture) can restrict eye movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem/Cerebellar Syndromes:\u003c/b\u003e Lesions in the brainstem (e.g., [[58c684bd|internuclear ophthalmoplegia]]) or cerebellum can disrupt the coordination of eye movements, causing diplopia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction of the diplopia (horizontal, vertical, or torsional) and the gaze in which it is worst can help localize the specific muscle or nerve that is affected. For example, horizontal diplopia worse on lateral gaze suggests a [[dd11dde6|CN VI palsy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDiplopia\u003c/b\u003e that disappears when one eye is closed is a sign of ocular misalignment, pointing to a neurological or mechanical problem with the eye muscles or their controlling nerves, and requires a careful examination of eye movements to pinpoint the cause.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"cranial_nerve_palsy\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"32ba61d1\"\n      }\n    ]\n  },\n  \"01066017\": {\n    \"title\": \"Direct Pathway (Basal Ganglia)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDirect Pathway\u003c/b\u003e is a neural circuit within the [[ed462927|basal ganglia]] that facilitates the initiation of voluntary movements. It acts to disinhibit the thalamus, thereby allowing the thalamus to excite the motor cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e To \u003cmark\u003efacilitate\u003c/mark\u003e or \u0027release\u0027 desired movements. It acts as the \u0027go\u0027 signal.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e\u003cbr\u003e1. The cortex excites the striatum (using glutamate).\u003cbr\u003e2. The striatum sends inhibitory (GABAergic) signals directly to the globus pallidus internus (GPi) and substantia nigra pars reticulata (SNr).\u003cbr\u003e3. This inhibits the GPi/SNr.\u003cbr\u003e4. The GPi/SNr normally tonically inhibit the [[afc0a64b|thalamus]]. By inhibiting the inhibitors, the direct pathway \u003cmark\u003edisinhibits the thalamus\u003c/mark\u003e.\u003cbr\u003e5. The disinhibited thalamus is now free to send excitatory signals to the motor cortex, facilitating movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDopamine\u0027s Role:\u003c/b\u003e [[90adc821|Dopamine]] from the substantia nigra pars compacta \u003cmark\u003estimulates\u003c/mark\u003e the direct pathway by acting on D\u003csub\u003e1\u003c/sub\u003e receptors in the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e In [[58c8ea03|Parkinson disease]], the loss of dopamine leads to reduced stimulation of the direct pathway, contributing to bradykinesia (difficulty initiating movement).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the direct pathway\u0027s net effect is to \u003cb\u003eD\u003c/b\u003eis-inhibit the thalamus to get \u003cb\u003eD\u003c/b\u003eesired movements. Dopamine on \u003cb\u003eD\u003c/b\u003e1 receptors stimulates the \u003cb\u003eD\u003c/b\u003eirect pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDirect Pathway\u003c/b\u003e of the basal ganglia is a \u0027go\u0027 signal for movement, working through a clever process of \u0027disinhibition\u0027 where it inhibits the brain\u0027s natural motor brake (the GPi/SNr), thereby releasing the thalamus to excite the motor cortex and initiate movement.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cortex] --(+)--\u003e B(Striatum); C(SNc) --Dopamine (D1)--\u003e B; B --(-)--\u003e D(GPi/SNr); D --(-)--\u003e E(Thalamus); E --(+)--\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"facilitates\",\n        \"to\": \"voluntary_movement\"\n      },\n      {\n        \"type\": \"is_stimulated_by\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"58c8ea03\"\n      }\n    ]\n  },\n  \"3a9930c0\": {\n    \"title\": \"Direct Light Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDirect Light Reflex\u003c/b\u003e is the constriction of the pupil in the eye into which a bright light is shone. It is a component of the pupillary light reflex, which also includes the [[19016061|consensual light reflex]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAfferent Limb:\u003c/b\u003e Light is detected by the retina, and the signal is transmitted via the \u003cmark\u003eoptic nerve (CN II)\u003c/mark\u003e to the pretectal nucleus in the midbrain.\u003cbr\u003e - \u003cb\u003eEfferent Limb:\u003c/b\u003e The pretectal nucleus projects to the ipsilateral Edinger-Westphal nucleus, which sends preganglionic parasympathetic fibers via the \u003cmark\u003eoculomotor nerve (CN III)\u003c/mark\u003e to the ciliary ganglion. Postganglionic fibers then cause the sphincter pupillae muscle to contract.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e To protect the retina from excessive light by reducing the amount of light entering the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Testing:\u003c/b\u003e Assessed by shining a light into one eye and observing the constriction of that same pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e\u003cbr\u003e - A lesion in the ipsilateral optic nerve (afferent) will abolish both the direct and consensual reflexes when light is shone in the affected eye.\u003cbr\u003e - A lesion in the ipsilateral oculomotor nerve (efferent) will abolish the direct reflex in that eye, but the consensual reflex in the other eye will be intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direct and consensual reflexes together help to precisely localize lesions in the pupillary light reflex arc.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDirect Light Reflex\u003c/b\u003e is the ipsilateral component of the pupillary light reflex, where the eye that \u0027sees\u0027 the light is the same eye that constricts, a fundamental brainstem reflex testing the integrity of both CN II and CN III on that side.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light in Right Eye] --\u003e B(Right Optic Nerve - CN II); B --\u003e C(Pretectal Nucleus); C --\u003e D(Right E-W Nucleus); D --\u003e E(Right Oculomotor Nerve - CN III); E --\u003e F(Right Pupil Constricts);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"pupillary_light_reflex\"\n      },\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\": \"optic_nerve\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        \"to\": \"68c66997\"\n      }\n    ]\n  },\n  \"251063c5\": {\n    \"title\": \"Diuretics (Neurological Context)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn the context of neurology and ophthalmology, \u003cb\u003ediuretics\u003c/b\u003e are used to reduce fluid volume and pressure within the enclosed spaces of the cranium and the eye. The primary agents used are osmotic diuretics and carbonic anhydrase inhibitors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOsmotic Diuretics (e.g., Mannitol):\u003c/b\u003e Used to reduce acutely elevated intracranial pressure (ICP) from [[aa00bdef|cerebral edema]]. Mannitol is administered IV and acts by creating an osmotic gradient, drawing water out of the brain parenchyma and into the vasculature. It is also used in acute [[9c80344d|angle-closure glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eCarbonic Anhydrase Inhibitors (e.g., [[1df262e8|Acetazolamide]]):\u003c/b\u003e Used to treat [[3ce6c035|glaucoma]] and [[7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri). They work by inhibiting carbonic anhydrase in the ciliary body and choroid plexus, which \u003cmark\u003edecreases the production of aqueous humor and cerebrospinal fluid\u003c/mark\u003e, respectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLoop Diuretics (e.g., Furosemide):\u003c/b\u003e Can also decrease CSF production and may be used as an adjunct in managing elevated ICP, but are less potent for this indication than mannitol.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mannitol is for acute, emergency reduction of ICP. Acetazolamide is for chronic management of conditions like glaucoma and pseudotumor cerebri by reducing fluid production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn neuro-ophthalmology, \u003cb\u003ediuretics\u003c/b\u003e are employed not for their renal effects, but for their ability to either osmotically pull fluid out of the brain (mannitol) or to decrease the production of CSF and aqueous humor at their source (acetazolamide).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"mannitol\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"1df262e8\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"aa00bdef\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      }\n    ]\n  },\n  \"71d3f0e1\": {\n    \"title\": \"Dizziness\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cardiology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDizziness\u003c/b\u003e is a non-specific term used by patients to describe a variety of sensations, including vertigo, lightheadedness, and disequilibrium. A key task for a clinician is to differentiate these distinct sensations to determine the underlying cause.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[5603962d|Vertigo]]:\u003c/b\u003e A false sensation of movement, either of the self or the environment, often described as \u0027spinning.\u0027 It indicates a problem with the vestibular system (either peripheral or central).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLightheadedness (Presyncope):\u003c/b\u003e A feeling of being about to faint or lose consciousness. It is typically caused by decreased cerebral perfusion (e.g., orthostatic hypotension, arrhythmia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDisequilibrium:\u003c/b\u003e A sense of imbalance or unsteadiness that occurs primarily when standing or walking. It can be caused by cerebellar disorders, sensory deficits (e.g., peripheral neuropathy), or musculoskeletal problems.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnostic Approach:\u003c/b\u003e The first step is to clarify what the patient means by \u0027dizzy.\u0027 Asking \\\"Does it feel like the room is spinning, or like you are about to pass out?\\\" can help differentiate [[5603962d|vertigo]] from presyncope.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a board question, \u0027dizziness\u0027 is often used to mean [[5603962d|vertigo]]. Look for associated symptoms like nystagmus, nausea, or hearing changes to confirm a vestibular cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDizziness\u003c/b\u003e is an imprecise umbrella term; the clinician\u0027s first job is to translate it into a more specific category‚Äîvertigo (spinning), presyncope (fainting), or disequilibrium (imbalance)‚Äîas each points to a different set of underlying pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_that_can_mean\",\n        \"to\": \"5603962d\"\n      },\n      {\n        \"type\": \"is_a_symptom_that_can_mean\",\n        \"to\": \"presyncope\"\n      },\n      {\n        \"type\": \"is_a_symptom_that_can_mean\",\n        \"to\": \"disequilibrium\"\n      }\n    ]\n  },\n  \"47d0372e\": {\n    \"title\": \"Donepezil\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDonepezil\u003c/b\u003e is a centrally acting, reversible [[0835ea01|cholinesterase inhibitor]] used for the symptomatic treatment of mild to moderate [[77ae6148|Alzheimer disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Reversibly inhibits acetylcholinesterase (AChE) in the central nervous system. This reduces the breakdown of [[6a005559|acetylcholine]], thereby increasing its concentration in the synaptic cleft and enhancing cholinergic neurotransmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRationale for Use:\u003c/b\u003e [[77ae6148|Alzheimer disease]] is associated with a significant loss of cholinergic neurons originating in the [[361438f2|basal nucleus of Meynert]], leading to a cortical cholinergic deficit. Donepezil aims to partially compensate for this loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Provides modest, symptomatic improvement in cognitive function in some patients with mild to moderate [[77ae6148|Alzheimer disease]]. It does \u003cu\u003enot\u003c/u\u003e slow or reverse the underlying disease progression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Primarily cholinergic side effects, including nausea, vomiting, diarrhea, and bradycardia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Agents:\u003c/b\u003e Rivastigmine and galantamine are other cholinesterase inhibitors used for Alzheimer\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that cholinesterase inhibitors like donepezil are a mainstay of symptomatic therapy for Alzheimer\u0027s, based on the cholinergic hypothesis of the disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDonepezil\u003c/b\u003e offers symptomatic relief in Alzheimer\u0027s disease by boosting the dwindling levels of acetylcholine in the brain, acting as a temporary patch for the cholinergic deficit but not as a cure for the underlying neurodegeneration.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Alzheimer\u0027s Disease] --\u003e B(‚Üì ACh in CNS); C[Donepezil] --Inhibits--\u003e D(AChE); D --x E(ACh Breakdown); E --\u003e F(‚Üë ACh levels); F --\u003e G(Symptomatic Improvement);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0835ea01\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"90adc821\": {\n    \"title\": \"Dopamine (CNS)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDopamine (DA)\u003c/b\u003e is a catecholamine neurotransmitter that plays a central role in several key brain functions, including motor control, motivation, reward, and executive function. Dysregulation of dopaminergic pathways is implicated in numerous neurological and psychiatric disorders.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized from the amino acid Tyrosine. Tyrosine ‚Üí L-DOPA ‚Üí Dopamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Pathways \u0026 Functions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNigrostriatal:\u003c/b\u003e From substantia nigra to striatum. Crucial for motor control. Degeneration causes [[58c8ea03|Parkinson disease]].\u003cbr\u003e - \u003cb\u003eMesolimbic:\u003c/b\u003e From ventral tegmental area (VTA) to nucleus accumbens. The \u0027reward\u0027 pathway; involved in addiction. Hyperactivity is linked to the positive symptoms of schizophrenia.\u003cbr\u003e - \u003cb\u003eMesocortical:\u003c/b\u003e From VTA to prefrontal cortex. Involved in executive function. Hypoactivity is linked to the negative symptoms of schizophrenia.\u003cbr\u003e - \u003cb\u003eTuberoinfundibular:\u003c/b\u003e From hypothalamus to pituitary. Tonically inhibits prolactin release.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e‚Üì Dopamine:\u003c/b\u003e [[58c8ea03|Parkinson disease]], [[9a0f5ba6|Depression]].\u003cbr\u003e - \u003cb\u003e‚Üë Dopamine:\u003c/b\u003e Schizophrenia (positive symptoms), Huntington disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Antipsychotic drugs primarily work by blocking D\u003csub\u003e2\u003c/sub\u003e receptors. Blocking the tuberoinfundibular pathway leads to hyperprolactinemia. Blocking the nigrostriatal pathway causes extrapyramidal side effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDopamine\u003c/b\u003e is a multifaceted neurotransmitter whose function is defined by its pathway: it drives movement in the nigrostriatal path, reward in the mesolimbic path, cognition in the mesocortical path, and hormonal control in the tuberoinfundibular path, making its dysregulation a source of diverse pathologies from Parkinson\u0027s to psychosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_increased_in\",\n        \"to\": \"schizophrenia\"\n      },\n      {\n        \"type\": \"is_increased_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_a_precursor_to\",\n        \"to\": \"norepinephrine\"\n      }\n    ]\n  },\n  \"c36650bd\": {\n    \"title\": \"Dopamine Agonists\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDopamine agonists\u003c/b\u003e are a class of drugs that bind to and activate dopamine receptors, mimicking the effects of endogenous dopamine. They are used in the treatment of [[58c8ea03|Parkinson disease]] and hyperprolactinemia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Directly stimulate dopamine receptors (primarily D\u003csub\u003e2\u003c/sub\u003e) in the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClasses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eErgot derivatives:\u003c/b\u003e [[d24a5ff0|Bromocriptine]]. Less commonly used due to side effects like pulmonary fibrosis.\u003cbr\u003e - \u003cb\u003eNon-ergot derivatives:\u003c/b\u003e Pramipexole, Ropinirole. These are preferred for Parkinson disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Parkinson Disease:\u003c/b\u003e Used as monotherapy in younger patients to delay the need for levodopa, or as an adjunct to levodopa in older patients to reduce motor fluctuations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Hyperprolactinemia:\u003c/b\u003e [[ca6ee143|Cabergoline]] and [[d24a5ff0|bromocriptine]] are used to treat prolactinomas and other causes of hyperprolactinemia by stimulating D\u003csub\u003e2\u003c/sub\u003e receptors on pituitary lactotrophs, which inhibits prolactin release.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, postural hypotension, sedation (\u0027sleep attacks\u0027), and hallucinations. A notable side effect is \u003cmark\u003eimpulse control disorders\u003c/mark\u003e (e.g., pathological gambling, compulsive shopping).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For Parkinson\u0027s, non-ergot agonists (pramipexole, ropinirole) are preferred over ergot agonists. For prolactinomas, [[ca6ee143|cabergoline]] is preferred over [[d24a5ff0|bromocriptine]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDopamine agonists\u003c/b\u003e provide a direct substitute for the missing dopamine in Parkinson\u0027s disease and mimic dopamine\u0027s natural inhibitory effect on prolactin, but their use can be complicated by significant CNS side effects, including impulse control disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"hyperprolactinemia\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d24a5ff0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"ca6ee143\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10152,
      "parts": [{
        "text": "```"
      }, {
        "text": "json\n{\n  \"73b00ab0\": {\n    \"title"
      }, {
        "text": "\": \"Diabetic Retinopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Endocrinology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ret"
      }, {
        "text": "inal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiabetic retinopathy\u003c/b\u003e is a micro"
      }, {
        "text": "vascular complication of [[5bc4bd07|diabetes mellitus]] and a leading cause of blindness in working-age adults. It is caused"
      }, {
        "text": " by chronic hyperglycemia-induced damage to the small blood vessels of the retina.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eNonproliferative Diabetic Retinopathy (NPDR):\u003c/b\u003e The earlier stage. Characterized by damaged"
      }, {
        "text": " capillaries leaking fluid and lipids into the retina. Fundoscopic findings include \u003cmark\u003emicroaneurysms, dot and"
      }, {
        "text": " blot hemorrhages, hard exudates\u003c/mark\u003e (lipid deposits), and \u003cmark\u003e[[2b254"
      }, {
        "text": "051|cotton-wool spots]]\u003c/mark\u003e (nerve fiber layer infarcts). Vision loss in this"
      }, {
        "text": " stage is primarily due to macular edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProliferative Diabetic Retinopathy (PDR):\u003c/b\u003e The more"
      }, {
        "text": " advanced and severe stage. Chronic retinal ischemia stimulates the production of vascular endothelial growth factor (VEGF), leading to \u003cmark\u003eneovascularization\u003c/mark\u003e"
      }, {
        "text": " (growth of new, abnormal blood vessels) on the retina or optic disc.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications of PDR:"
      }, {
        "text": "\u003c/b\u003e These fragile new vessels can bleed, causing vitreous hemorrhage. They can also lead to tractional retinal detachment.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Chronic hyperglycemia leads to the formation of advanced glycation end products and activation of the polyol pathway ("
      }, {
        "text": "glucose ‚Üí sorbitol), causing osmotic damage and oxidative stress to pericytes and endothelial cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The key distinction is the presence (proliferative) or absence (nonproliferative) of ne"
      }, {
        "text": "ovascularization. Macular edema can cause vision loss in NPDR, while vitreous hemorrhage and retinal detachment are the major"
      }, {
        "text": " threats in PDR.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDiabetic retinopathy\u003c/b\u003e progresses from"
      }, {
        "text": " a state of leaky, damaged vessels (nonproliferative) to a state of ischemic-driven, dangerous new vessel growth (proliferative),"
      }, {
        "text": " with both stages threatening vision through macular edema, hemorrhage, or retinal detachment.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Chronic Hyperglycemia] --\u003e B(Microvascular Damage); B --\u003e C(Nonproliferative Ret"
      }, {
        "text": "inopathy); C --\u003e D(Hemorrhages, Exudates, Macular Edema); C --\u003e E(Retinal Ischemia); E"
      }, {
        "text": " --\u003e F(‚Üë VEGF); F --\u003e G(Proliferative Retinopathy - Neovascularization);\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\","
      }, {
        "text": "\n        \"to\": \"5bc4bd07\"\n      },\n      {\n        \"type\": \"presents_"
      }, {
        "text": "with\",\n        \"to\": \"2b254051\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_lead_to\",\n        \"to\": \"retinal_detachment\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"f76181a6\": {\n    \"title\":"
      }, {
        "text": " \"Diarrhea\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Gastroenterology\",\n"
      }, {
        "text": "      \"Infectious Disease\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Gastrointestinal\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiarrhea\u003c/b\u003e is the condition of having at least three loose,"
      }, {
        "text": " liquid, or watery bowel movements each day. It is a common symptom of gastrointestinal distress and can be classified as osmotic"
      }, {
        "text": ", secretory, inflammatory, or motility-related.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOsmotic Diarrhea:\u003c/b\u003e Ca"
      }, {
        "text": "used by the presence of non-absorbable solutes in the intestine, which draw water into the lumen (e.g., lactose intolerance"
      }, {
        "text": ", magnesium-containing antacids). Stops with fasting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecretory Diarrhea:\u003c/b\u003e Caused by stimulation"
      }, {
        "text": " of ion and water secretion by the intestinal epithelium (e.g., cholera toxin, VIPoma). Persists with fasting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInfl"
      }, {
        "text": "ammatory Diarrhea:\u003c/b\u003e Caused by inflammation and damage to the mucosal lining, leading to loss of protein-rich fluid and blood"
      }, {
        "text": " (e.g., inflammatory bowel disease, invasive bacterial infections like \u003ci\u003eShigella\u003c/i\u003e, \u003ci\u003eCampylobacter\u003c/i\u003e).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotility"
      }, {
        "text": "-Related Diarrhea:\u003c/b\u003e Caused by abnormally rapid intestinal transit time, which reduces water absorption (e.g., irritable"
      }, {
        "text": " bowel syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacologic Treatment:\u003c/b\u003e [[67a856bf|Opioids]] and"
      }, {
        "text": " their derivatives (e.g., loperamide, diphenoxylate) are effective antidiarrheal agents because"
      }, {
        "text": " they bind to Œº-opioid receptors in the gut, which inhibits acetylcholine release and decreases peristalsis, increasing transit time and water"
      }, {
        "text": " absorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loperamide is an over-the-counter opioid agonist that does not cross the blood"
      }, {
        "text": "-brain barrier, so it treats diarrhea without causing CNS effects. Diphenoxylate can have CNS effects at high doses and is"
      }, {
        "text": " co-formulated with atropine to discourage abuse.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDi"
      }, {
        "text": "arrhea\u003c/b\u003e is a symptom with diverse mechanisms, and its treatment with opioids like loperamide is based on their ability to slow gut"
      }, {
        "text": " motility by acting on Œº-receptors in the myenteric plexus, effectively \u0027braking\u0027 the overactive peristalsis.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_treated_by\",\n        \"to\": \"67a856"
      }, {
        "text": "bf\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \""
      }, {
        "text": "to\": \"cholera\"\n      },\n      {\n        \"type\": \"is_a_sympt"
      }, {
        "text": "om_of\",\n        \"to\": \"inflammatory_bowel_disease\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"e14063c3\": {\n    \"title\": \"Diazepam\",\n    \"primary"
      }, {
        "text": "Type\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anxiolytics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiazepam"
      }, {
        "text": "\u003c/b\u003e (trade name Valium) is a long-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e with prominent sedative, anxiolytic, anticon"
      }, {
        "text": "vulsant, and muscle relaxant properties.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e A positive allosteric modulator of the GABA\u003csub\u003eA\u003c/sub\u003e receptor. It increases the \u003cu\u003efrequency\u003c/u\u003e of chloride"
      }, {
        "text": " channel opening in response to GABA, leading to enhanced CNS inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is a \u003c"
      }, {
        "text": "mark\u003elong-acting\u003c/mark\u003e benzodiazepine with a rapid onset of action and active metabolites (including oxazepam and tem"
      }, {
        "text": "azepam), which contributes to its prolonged effect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnxiety:\u003c/b\u003e For"
      }, {
        "text": " short-term management of severe anxiety.\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e A first-line agent for treating"
      }, {
        "text": " \u003cmark\u003estatus epilepticus\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eAlcohol Withdrawal:\u003c/b\u003e Used to manage symptoms and prevent seizures"
      }, {
        "text": " and delirium tremens.\u003cbr\u003e - \u003cb\u003eMuscle Spasms:\u003c/b\u003e Used as a skeletal muscle relaxant."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dependence, tolerance, and withdrawal. Additive CNS depression with other"
      }, {
        "text": " depressants like alcohol. Its long half-life makes it less suitable for the elderly due to the risk of accumulation and falls"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Diazepam and lorazepam are the go-to drugs for terminating status epilepticus. Diazepam\u0027"
      }, {
        "text": "s long half-life makes it a good choice for managing alcohol withdrawal.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Diazepam\u003c/b\u003e is a fast-acting, long-duration benzodiazepine that is a workhorse for acute CNS hyperexcitability, effectively terminating"
      }, {
        "text": " seizures in status epilepticus and calming the storm of alcohol withdrawal by robustly enhancing GABAergic inhibition.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type"
      }, {
        "text": "_of\",\n        \"to\": \"14464617\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"treats\",\n        \"to\": \"status_epilepticus\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"treats\",\n        \"to\": \"alcohol_withdrawal\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"24a24d08\": {\n    \"title\": \"Diencephalon\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Embryology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \""
      }, {
        "text": "Brain Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDiencephalon\u003c/b\u003e is a major"
      }, {
        "text": " division of the forebrain (prosencephalon) situated between the telencephalon and the midbrain. It develops from"
      }, {
        "text": " the posterior part of the embryonic forebrain and gives rise to several critical brain structures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEm"
      }, {
        "text": "bryonic Origin:\u003c/b\u003e Arises from the prosencephalon (forebrain) vesicle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivatives:\u003c/b\u003e The diencephalon develops"
      }, {
        "text": " into four main components:\u003cbr\u003e1. \u003cb\u003e[[afc0a64b|Thalamus]]:"
      }, {
        "text": "\u003c/b\u003e The major relay station for sensory information (except smell) to the cerebral cortex.\u003cbr\u003e2. \u003cb\u003e[[8"
      }, {
        "text": "9e86633|Hypothalamus]]:\u003c/b\u003e The primary regulator of the autonomic nervous system and endocrine system"
      }, {
        "text": ".\u003cbr\u003e3. \u003cb\u003eEpithalamus:\u003c/b\u003e Includes the pineal gland (melatonin secretion) and haben"
      }, {
        "text": "ula.\u003cbr\u003e4. \u003cb\u003eSubthalamus:\u003c/b\u003e Includes the subthalamic nucleus, a key part"
      }, {
        "text": " of the basal ganglia motor circuit.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavity of the diencephalon becomes the \u003c"
      }, {
        "text": "mark\u003ethird ventricle\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the thalamus and hypothalamus are the major"
      }, {
        "text": " derivatives of the diencephalon. The retina also develops as an out-pouching of the diencephalon."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDiencephalon\u003c/b\u003e is the embryonic precursor"
      }, {
        "text": " to the brain\u0027s central processing hub, forming the thalamus (the sensory gateway), the hypothalamus (the homeostatic command"
      }, {
        "text": " center), and other vital subcortical structures surrounding the third ventricle.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Prosencephalon - Forebrain] --\u003e B(Telencephalon); A --\u003e C(Diencephalon); C --\u003e D(Th"
      }, {
        "text": "alamus); C --\u003e E(Hypothalamus); C --\u003e F(Epithalamus); C --\u003e G"
      }, {
        "text": "(Subthalamus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_"
      }, {
        "text": "from\",\n        \"to\": \"prosencephalon\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "develops_into\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"develops_into\",\n        \"to\": \"89e86633\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"cavity_becomes\",\n        \"to\": \"third"
      }, {
        "text": "_ventricle\"\n      }\n    ]\n  },\n  \"22b22e08"
      }, {
        "text": "\": {\n    \"title\": \"Diffuse Axonal Injury (DAI)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Trauma\",\n      \"Pathology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Trauma\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiffuse Axonal Injury (DAI)"
      }, {
        "text": "\u003c/b\u003e is a severe form of traumatic brain injury characterized by widespread shearing of axons in the white matter tracts of the brain."
      }, {
        "text": " It is caused by sudden, forceful acceleration-deceleration or rotational forces, typically from a motor vehicle accident.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The brain moves at a different rate than the skull"
      }, {
        "text": " during rapid acceleration/deceleration, creating shearing forces that stretch and damage long axons in the white matter. This disrupts"
      }, {
        "text": " axonal transport and leads to delayed axonal swelling and disconnection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The severity of DAI correlates with the degree"
      }, {
        "text": " of coma. Patients often lose consciousness immediately at the time of impact and remain in a prolonged coma or persistent vegetative state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging"
      }, {
        "text": ":\u003c/b\u003e A standard CT scan may be normal or show only small petechial hemorrhages. \u003cmark\u003eMRI ("
      }, {
        "text": "especially diffusion-weighted imaging)\u003c/mark\u003e is more sensitive and classically shows multiple, small, ovoid lesions (punctate"
      }, {
        "text": " hemorrhages or non-hemorrhagic lesions) at the \u003cmark\u003egray-white matter junction\u003c/mark\u003e and in"
      }, {
        "text": " the corpus callosum and brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Generally poor, with high rates of mortality and severe"
      }, {
        "text": " long-term disability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who is in a coma immediately following a high"
      }, {
        "text": "-speed car accident but has a relatively normal initial head CT should raise high suspicion for diffuse axonal injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eDiffuse Axonal Injury\u003c/b\u003e is a devastating brain injury caused by the shearing of countless axons during high"
      }, {
        "text": "-impact trauma, leading to widespread disconnection of neural circuits and often resulting in immediate and profound coma.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"e9a47751\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by\",\n        \"to\": \"traumatic_brain_injury\"\n      },\n      {\n        \"type\": \"leads"
      }, {
        "text": "_to\",\n        \"to\": \"d36eed18\"\n      }\n    ]\n  },\n  \"c"
      }, {
        "text": "02b8271\": {\n    \"title\": \"Dihydroergotamine (DHE)\",\n    \"primaryType"
      }, {
        "text": "\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eDihydroergotamine (DHE)\u003c/b\u003e is an ergot alkaloid medication used for the acute treatment of [[c"
      }, {
        "text": "8833bae|migraine]] and [[21760f80|cluster headaches]]. It"
      }, {
        "text": " has complex effects on serotonin, dopamine, and adrenergic receptors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Acts as a non-selective agonist at 5-HT\u003csub\u003e1D\u003c/sub\u003e and 5-HT\u003csub\u003e1"
      }, {
        "text": "B\u003c/sub\u003e receptors, similar to [[triptans|triptans]]. This leads to cranial vasoconstriction and inhibition of ne"
      }, {
        "text": "uropeptide release in the trigeminal system. It also interacts with other serotonin, dopamine, and adrenergic receptors.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eClinical Use:\u003c/b\u003e Used for the acute (abortive) treatment of moderate to severe [[c8833"
      }, {
        "text": "bae|migraine headaches]] that are unresponsive to other therapies. It is available in injectable and nasal spray formulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Nausea and vomiting are very common. As a potent vasoconstrictor, it can cause peripheral ischemia, hypertension"
      }, {
        "text": ", and coronary vasospasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e \u003cu\u003eAbsolutely contraindicated\u003c/u\u003e in patients with coronary,"
      }, {
        "text": " cerebral, or peripheral vascular disease, and in pregnancy. Should not be used within 24 hours of a triptan.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e DHE is a powerful but \u0027dirtier\u0027 alternative to triptans for acute migraine, with a broader receptor"
      }, {
        "text": " profile and a higher risk of vasoconstrictive side effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDihydroergot"
      }, {
        "text": "amine\u003c/b\u003e is a potent, multi-receptor ergot alkaloid used to abort severe migraines, but its powerful vasoconstrictive properties"
      }, {
        "text": " necessitate careful patient selection to avoid serious cardiovascular and ischemic complications.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"ergot_alkaloid\"\n      },\n      {\n        \"type\": \"treats"
      }, {
        "text": "\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n"
      }, {
        "text": "        \"to\": \"21760f80\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_contraindicated_in\",\n        \"to\": \"coronary_artery_disease\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"67a856bf\": {\n    \"title\": \"Diphen"
      }, {
        "text": "oxylate\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Gastroenter"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Gastrointestinal\",\n      \"Pharmacology"
      }, {
        "text": "\",\n      \"Antidiarrheals\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDip"
      }, {
        "text": "henoxylate\u003c/b\u003e is an opioid agonist used as an antidiarrheal agent. It is structurally related to meperidine and acts"
      }, {
        "text": " on the gastrointestinal tract to decrease motility.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of"
      }, {
        "text": " Action:\u003c/b\u003e Binds to Œº-opioid receptors in the myenteric plexus of the gut. This inhibits the release of [["
      }, {
        "text": "6a005559|acetylcholine]], leading to decreased peristalsis and increased intestinal transit time, which"
      }, {
        "text": " allows for more water and electrolyte absorption.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for the management of [[f76181a6|"
      }, {
        "text": "diarrhea]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFormulation:\u003c/b\u003e It is co-formulated with a subtherapeutic amount of \u003c"
      }, {
        "text": "mark\u003eatropine\u003c/mark\u003e (trade name Lomotil). The atropine is added to discourage abuse,"
      }, {
        "text": " as high doses of diphenoxylate can cause CNS effects (euphoria, sedation), but the accompanying atropine would cause unpleasant antich"
      }, {
        "text": "olinergic side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e At therapeutic doses, side effects are mainly constipation and bloating"
      }, {
        "text": ". At high doses, it can cause CNS depression and opioid dependence.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from"
      }, {
        "text": " loperamide, another opioid antidiarrheal. Loperamide does not cross the blood-brain barrier and has"
      }, {
        "text": " a very low abuse potential, whereas diphenoxylate does and is therefore combined with atropine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eDiphenoxylate\u003c/b\u003e is an effective opioid antidiarrheal that slows gut motility, but its potential"
      }, {
        "text": " for CNS effects at high doses necessitates its combination with atropine to serve as an abuse deterrent.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"treats\",\n        \"to\": \"f76181a6\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_coformulated_with\",\n        \"to"
      }, {
        "text": "\": \"atropine\"\n      }\n    ]\n  },\n  \"9914d4"
      }, {
        "text": "33\": {\n    \"title\": \"Diplopia\",\n    \"primaryType\": \"finding\",\n    \""
      }, {
        "text": "tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Symptoms\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDiplopia\u003c/b\u003e, or double vision, is the perception"
      }, {
        "text": " of two images of a single object. It is most often caused by a misalignment of the eyes (strabismus) due to problems"
      }, {
        "text": " with the extraocular muscles or the cranial nerves that innervate them.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eBinocular Diplopia:\u003c/b\u003e The most common type. It is present only when both eyes are open and resolves when one"
      }, {
        "text": " eye is covered. This indicates a misalignment problem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMonocular Diplopia:\u003c/b\u003e Double vision that persists when"
      }, {
        "text": " one eye is covered. This is an optical problem within the eye itself, such as [[18cff34"
      }, {
        "text": "e|astigmatism]] or [[85f03b02|cataracts]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Causes of Binocular Diplopia:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCranial Nerve Palsies:\u003c/b\u003e Palsies of CN"
      }, {
        "text": " III, IV, or VI cause weakness of specific extraocular muscles.\u003cbr\u003e - \u003cb\u003eNeuromuscular Junction Disease"
      }, {
        "text": ":\u003c/b\u003e Myasthenia gravis often presents with fluctuating diplopia and ptosis.\u003cbr\u003e - \u003cb\u003eOrbital Disease"
      }, {
        "text": ":\u003c/b\u003e A mass or inflammation in the orbit (e.g., thyroid eye disease, orbital blowout fracture) can restrict eye movement."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem/Cerebellar Syndromes:\u003c/b\u003e Lesions in the brainstem (e.g., [["
      }, {
        "text": "58c684bd|internuclear ophthalmoplegia]]) or cerebellum can disrupt the coordination of eye movements, causing diplopia"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction of the diplopia (horizontal, vertical, or torsional) and"
      }, {
        "text": " the gaze in which it is worst can help localize the specific muscle or nerve that is affected. For example, horizontal diplopia worse"
      }, {
        "text": " on lateral gaze suggests a [[dd11dde6|CN VI palsy]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDiplopia"
      }, {
        "text": "\u003c/b\u003e that disappears when one eye is closed is a sign of ocular misalignment, pointing to a neurological or mechanical problem with the eye"
      }, {
        "text": " muscles or their controlling nerves, and requires a careful examination of eye movements to pinpoint the cause.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n"
      }, {
        "text": "        \"to\": \"cranial_nerve_palsy\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_symptom_of\",\n        \"to\": \"myasthenia_gravis\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\":"
      }, {
        "text": " \"58c684bd\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\","
      }, {
        "text": "\n        \"to\": \"32ba61d1\"\n      }\n    ]\n  },\n  \"0"
      }, {
        "text": "1066017\": {\n    \"title\": \"Direct Pathway (Basal Ganglia)\",\n    \"primaryType\": \"physiology"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Bas"
      }, {
        "text": "al Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDirect"
      }, {
        "text": " Pathway\u003c/b\u003e is a neural circuit within the [[ed462927|basal ganglia]] that facilitates the initiation"
      }, {
        "text": " of voluntary movements. It acts to disinhibit the thalamus, thereby allowing the thalamus to excite the motor cortex.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e To \u003cmark\u003efacilitate\u003c/mark\u003e or \u0027release\u0027 desired movements. It acts as"
      }, {
        "text": " the \u0027go\u0027 signal.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e\u003cbr\u003e1. The cortex excites the striatum ("
      }, {
        "text": "using glutamate).\u003cbr\u003e2. The striatum sends inhibitory (GABAergic) signals directly to the globus pallidus intern"
      }, {
        "text": "us (GPi) and substantia nigra pars reticulata (SNr).\u003cbr\u003e3. This inhibits the GPi/"
      }, {
        "text": "SNr.\u003cbr\u003e4. The GPi/SNr normally tonically inhibit the [[afc0a64b|th"
      }, {
        "text": "alamus]]. By inhibiting the inhibitors, the direct pathway \u003cmark\u003edisinhibits the thalamus\u003c/mark\u003e.\u003c"
      }, {
        "text": "br\u003e5. The disinhibited thalamus is now free to send excitatory signals to the motor cortex, facilitating movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDopamine"
      }, {
        "text": "\u0027s Role:\u003c/b\u003e [[90adc821|Dopamine]] from the substantia nigra pars compacta \u003c"
      }, {
        "text": "mark\u003estimulates\u003c/mark\u003e the direct pathway by acting on D\u003csub\u003e1\u003c/sub\u003e receptors in the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ology:\u003c/b\u003e In [[58c8ea03|Parkinson disease]], the loss of dopamine leads to reduced"
      }, {
        "text": " stimulation of the direct pathway, contributing to bradykinesia (difficulty initiating movement).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the direct pathway\u0027s net effect is to \u003cb\u003eD\u003c/b\u003eis-inhibit the thalamus to get \u003cb\u003eD\u003c/b\u003eesired movements"
      }, {
        "text": ". Dopamine on \u003cb\u003eD\u003c/b\u003e1 receptors stimulates the \u003cb\u003eD\u003c/b\u003eirect pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eDirect Pathway\u003c/b\u003e of the basal ganglia is a \u0027go\u0027 signal for movement, working through a clever"
      }, {
        "text": " process of \u0027disinhibition\u0027 where it inhibits the brain\u0027s natural motor brake (the GPi/SNr), thereby"
      }, {
        "text": " releasing the thalamus to excite the motor cortex and initiate movement.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Cortex] --(+)--\u003e B(Striatum); C(SNc) --Dopamine (D1)--\u003e B;"
      }, {
        "text": " B --(-)--\u003e D(GPi/SNr); D --(-)--\u003e E(Thalamus); E --(+)--\u003e A"
      }, {
        "text": ";\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\":"
      }, {
        "text": " \"ed462927\"\n      },\n      {\n        \"type\": \"facilitates\","
      }, {
        "text": "\n        \"to\": \"voluntary_movement\"\n      },\n      {\n        \"type\": \"is_stimulated_by\",\n        \""
      }, {
        "text": "to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "impaired_in\",\n        \"to\": \"58c8ea03\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"3a9930c0\": {\n    \"title\": \"Direct Light"
      }, {
        "text": " Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDirect Light Reflex\u003c/b\u003e is the constriction of the pupil in"
      }, {
        "text": " the eye into which a bright light is shone. It is a component of the pupillary light reflex, which also includes"
      }, {
        "text": " the [[19016061|consensual light reflex]].\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAfferent Limb:\u003c/b\u003e Light is detected by the retina, and"
      }, {
        "text": " the signal is transmitted via the \u003cmark\u003eoptic nerve (CN II)\u003c/mark\u003e to the pretectal nucleus in the midbrain.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eEfferent Limb:\u003c/b\u003e The pretectal nucleus projects to the ipsilateral Edinger-Westphal nucleus,"
      }, {
        "text": " which sends preganglionic parasympathetic fibers via the \u003cmark\u003eoculomotor nerve (CN III)\u003c/mark\u003e to the c"
      }, {
        "text": "iliary ganglion. Postganglionic fibers then cause the sphincter pupillae muscle to contract.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e To protect"
      }, {
        "text": " the retina from excessive light by reducing the amount of light entering the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Testing:\u003c/b\u003e Assessed by"
      }, {
        "text": " shining a light into one eye and observing the constriction of that same pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - A lesion in the ipsilateral optic nerve (afferent) will abolish both the direct and consensual reflexes when"
      }, {
        "text": " light is shone in the affected eye.\u003cbr\u003e - A lesion in the ipsilateral oculomotor nerve (efferent) will abolish the"
      }, {
        "text": " direct reflex in that eye, but the consensual reflex in the other eye will be intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e The direct and consensual reflexes together help to precisely localize lesions in the pupillary light reflex arc.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eDirect Light Reflex\u003c/b\u003e is the ipsilateral component of the pupillary light reflex, where the eye"
      }, {
        "text": " that \u0027sees\u0027 the light is the same eye that constricts, a fundamental brainstem reflex testing the integrity of both"
      }, {
        "text": " CN II and CN III on that side.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light in"
      }, {
        "text": " Right Eye] --\u003e B(Right Optic Nerve - CN II); B --\u003e C(Pretectal Nucleus);"
      }, {
        "text": " C --\u003e D(Right E-W Nucleus); D --\u003e E(Right Oculomotor Nerve - CN III); E"
      }, {
        "text": " --\u003e F(Right Pupil Constricts);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"pupillary_light_reflex\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"afferent_limb_is\",\n        \"to\": \"optic_nerve\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"efferent_limb_is\",\n        \"to\": \"68c6699"
      }, {
        "text": "7\"\n      }\n    ]\n  },\n  \"251063c5\": {\n    \"title\": \""
      }, {
        "text": "Diuretics (Neurological Context)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn the context of neurology"
      }, {
        "text": " and ophthalmology, \u003cb\u003ediuretics\u003c/b\u003e are used to reduce fluid volume and pressure within the enclosed spaces of the cr"
      }, {
        "text": "anium and the eye. The primary agents used are osmotic diuretics and carbonic anhydrase inhibitors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eOsmotic Diuretics (e.g., Mannitol):\u003c/b\u003e Used to reduce acutely elevated intracranial pressure (ICP) from"
      }, {
        "text": " [[aa00bdef|cerebral edema]]. Mannitol is administered IV and acts by creating an osmotic gradient, drawing water out of"
      }, {
        "text": " the brain parenchyma and into the vasculature. It is also used in acute [[9c80344d|angle-closure glaucoma]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eCarbonic Anhydrase Inhibitors (e.g., [[1df262e8|Acetazolamide]]):\u003c/b\u003e"
      }, {
        "text": " Used to treat [[3ce6c035|glaucoma]] and [[7c4e7c7"
      }, {
        "text": "4|idiopathic intracranial hypertension]] (pseudotumor cerebri). They work by inhibiting carbonic anhydrase in the c"
      }, {
        "text": "iliary body and choroid plexus, which \u003cmark\u003edecreases the production of aqueous humor and cerebrospinal fluid\u003c/mark\u003e,"
      }, {
        "text": " respectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLoop Diuretics (e.g., Furosemide):\u003c/b\u003e Can also decrease CSF production and may be used as"
      }, {
        "text": " an adjunct in managing elevated ICP, but are less potent for this indication than mannitol.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Mannitol is for acute, emergency reduction of ICP. Acetazolamide is for chronic management of conditions like glaucoma and"
      }, {
        "text": " pseudotumor cerebri by reducing fluid production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn neuro"
      }, {
        "text": "-ophthalmology, \u003cb\u003ediuretics\u003c/b\u003e are employed not for their renal effects, but for their ability to either"
      }, {
        "text": " osmotically pull fluid out of the brain (mannitol) or to decrease the production of CSF and aqueous humor at"
      }, {
        "text": " their source (acetazolamide).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"mannitol\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"1df262e8\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"treats\",\n        \"to\": \"aa00bdef\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"71d3f0e1\": {\n    \"title\": \"Dizziness\",\n    \"primary"
      }, {
        "text": "Type\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cardiology\",\n      \"Otology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDizziness\u003c/b\u003e is"
      }, {
        "text": " a non-specific term used by patients to describe a variety of sensations, including vertigo, lightheadedness, and disequilibrium"
      }, {
        "text": ". A key task for a clinician is to differentiate these distinct sensations to determine the underlying cause.\u003c/p\u003e\",\n      \"atAGlance\":"
      }, {
        "text": " \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[5603962d|Vertigo]]:\u003c/b\u003e A false sensation of movement,"
      }, {
        "text": " either of the self or the environment, often described as \u0027spinning.\u0027 It indicates a problem with the vestibular system (either peripheral"
      }, {
        "text": " or central).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLightheadedness (Presyncope):\u003c/b\u003e A feeling of being about to faint or lose"
      }, {
        "text": " consciousness. It is typically caused by decreased cerebral perfusion (e.g., orthostatic hypotension, arrhythmia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDise"
      }, {
        "text": "quilibrium:\u003c/b\u003e A sense of imbalance or unsteadiness that occurs primarily when standing or walking. It can be caused by cerebellar"
      }, {
        "text": " disorders, sensory deficits (e.g., peripheral neuropathy), or musculoskeletal problems.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnostic Approach:\u003c/b\u003e The"
      }, {
        "text": " first step is to clarify what the patient means by \u0027dizzy.\u0027 Asking \\\"Does it feel like the room is spinning,"
      }, {
        "text": " or like you are about to pass out?\\\" can help differentiate [[5603962d|vertigo]] from presyncope."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a board question, \u0027dizziness\u0027 is often used to mean [[5603962d"
      }, {
        "text": "|vertigo]]. Look for associated symptoms like nystagmus, nausea, or hearing changes to confirm a vestibular cause."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDizziness\u003c/b\u003e is an imprecise umbrella term; the clinician\u0027"
      }, {
        "text": "s first job is to translate it into a more specific category‚Äîvertigo (spinning), presyncope (fainting), or dis"
      }, {
        "text": "equilibrium (imbalance)‚Äîas each points to a different set of underlying pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_symptom_that_can_mean"
      }, {
        "text": "\",\n        \"to\": \"5603962d\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_symptom_that_can_mean\",\n        \"to\": \""
      }, {
        "text": "presyncope\"\n      },\n      {\n        \"type\": \"is_a_symptom_"
      }, {
        "text": "that_can_mean\",\n        \"to\": \"disequilibrium\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"47d0372e\": {\n    \"title\": \"Donepezil\",\n    \"primaryType"
      }, {
        "text": "\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      "
      }, {
        "text": "\"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDonepezil\u003c/b\u003e is a centrally acting, reversible [[083"
      }, {
        "text": "5ea01|cholinesterase inhibitor]] used for the symptomatic treatment of mild to moderate [[77ae614"
      }, {
        "text": "8|Alzheimer disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Re"
      }, {
        "text": "versibly inhibits acetylcholinesterase (AChE) in the central nervous system. This reduces the breakdown of [["
      }, {
        "text": "6a005559|acetylcholine]], thereby increasing its concentration in the synaptic cleft and enhancing cholinergic neurotrans"
      }, {
        "text": "mission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRationale for Use:\u003c/b\u003e [[77ae6148|Alzheimer disease]] is associated"
      }, {
        "text": " with a significant loss of cholinergic neurons originating in the [[361438f2|basal nucleus of Meynert]],"
      }, {
        "text": " leading to a cortical cholinergic deficit. Donepezil aims to partially compensate for this loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Provides"
      }, {
        "text": " modest, symptomatic improvement in cognitive function in some patients with mild to moderate [[77ae6148|Alzheimer"
      }, {
        "text": " disease]]. It does \u003cu\u003enot\u003c/u\u003e slow or reverse the underlying disease progression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Primarily"
      }, {
        "text": " cholinergic side effects, including nausea, vomiting, diarrhea, and bradycardia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Agents:\u003c/b\u003e Rivastigmine and galantamine are"
      }, {
        "text": " other cholinesterase inhibitors used for Alzheimer\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that cholinesterase inhibitors like"
      }, {
        "text": " donepezil are a mainstay of symptomatic therapy for Alzheimer\u0027s, based on the cholinergic hypothesis of the disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eDonepezil\u003c/b\u003e offers symptomatic relief in Alzheimer\u0027s disease by boosting the dwindling levels of acetylcholine in the brain, acting"
      }, {
        "text": " as a temporary patch for the cholinergic deficit but not as a cure for the underlying neurodegeneration.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Alzheimer\u0027s Disease] --\u003e B(‚Üì ACh in CNS); C[Donepezil] --In"
      }, {
        "text": "hibits--\u003e D(AChE); D --x E(ACh Breakdown); E --\u003e F(‚Üë ACh levels"
      }, {
        "text": "); F --\u003e G(Symptomatic Improvement);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"0835ea01\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"treats\",\n        \"to\": \"77ae6148\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"6a00555"
      }, {
        "text": "9\"\n      }\n    ]\n  },\n  \"90adc821\": {\n    \"title\": \"D"
      }, {
        "text": "opamine (CNS)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \""
      }, {
        "text": "Psychiatry\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDopamine (DA)\u003c/b\u003e is a catecholamine neurotransmitter that"
      }, {
        "text": " plays a central role in several key brain functions, including motor control, motivation, reward, and executive function. Dysregulation of dop"
      }, {
        "text": "aminergic pathways is implicated in numerous neurological and psychiatric disorders.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synt"
      }, {
        "text": "hesized from the amino acid Tyrosine. Tyrosine ‚Üí L-DOPA ‚Üí Dopamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Pathways \u0026"
      }, {
        "text": " Functions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNigrostriatal:\u003c/b\u003e From substantia nigra to striatum. Cru"
      }, {
        "text": "cial for motor control. Degeneration causes [[58c8ea03|Parkinson disease]].\u003cbr\u003e"
      }, {
        "text": " - \u003cb\u003eMesolimbic:\u003c/b\u003e From ventral tegmental area (VTA) to nucleus accumbens. The"
      }, {
        "text": " \u0027reward\u0027 pathway; involved in addiction. Hyperactivity is linked to the positive symptoms of schizophrenia.\u003cbr\u003e - \u003cb\u003eMes"
      }, {
        "text": "ocortical:\u003c/b\u003e From VTA to prefrontal cortex. Involved in executive function. Hypoactivity is linked to the negative"
      }, {
        "text": " symptoms of schizophrenia.\u003cbr\u003e - \u003cb\u003eTuberoinfundibular:\u003c/b\u003e From hypothalamus to pituitary. Tonically inhibits prol"
      }, {
        "text": "actin release.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e‚Üì Dopamine:\u003c/b\u003e [[58c8"
      }, {
        "text": "ea03|Parkinson disease]], [[9a0f5ba6|Depression]].\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "‚Üë Dopamine:\u003c/b\u003e Schizophrenia (positive symptoms), Huntington disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Antipsychotic drugs primarily"
      }, {
        "text": " work by blocking D\u003csub\u003e2\u003c/sub\u003e receptors. Blocking the tuberoinfundibular pathway leads to hyperprolactinemia."
      }, {
        "text": " Blocking the nigrostriatal pathway causes extrapyramidal side effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eDopamine\u003c/b\u003e is a multifaceted neurotransmitter whose function is defined by its pathway: it drives movement in the nig"
      }, {
        "text": "rostriatal path, reward in the mesolimbic path, cognition in the mesocortical path, and hormonal"
      }, {
        "text": " control in the tuberoinfundibular path, making its dysregulation a source of diverse pathologies from Parkinson\u0027s to psychosis"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_decre"
      }, {
        "text": "ased_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_increased_in\",\n        \"to\": \"schizophrenia\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_increased_in\",\n        \"to\": \"ffd7"
      }, {
        "text": "e743\"\n      },\n      {\n        \"type\": \"is_a_precursor_to\",\n        \"to"
      }, {
        "text": "\": \"norepinephrine\"\n      }\n    ]\n  },\n  \"c36650bd\": {\n    \"title"
      }, {
        "text": "\": \"Dopamine Agonists\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Neurology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDopamine agonists"
      }, {
        "text": "\u003c/b\u003e are a class of drugs that bind to and activate dopamine receptors, mimicking the effects of endogenous dopamine. They are used in"
      }, {
        "text": " the treatment of [[58c8ea03|Parkinson disease]] and hyperprolactinemia.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Directly stimulate dopamine receptors (primarily D\u003csub\u003e2\u003c/sub\u003e) in the brain."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClasses:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eErgot derivatives:\u003c/b\u003e [[d24a5ff0|Bromocriptine]]."
      }, {
        "text": " Less commonly used due to side effects like pulmonary fibrosis.\u003cbr\u003e - \u003cb\u003eNon-ergot derivatives:\u003c/b\u003e Pram"
      }, {
        "text": "ipexole, Ropinirole. These are preferred for Parkinson disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Parkinson Disease:\u003c/b\u003e Used as"
      }, {
        "text": " monotherapy in younger patients to delay the need for levodopa, or as an adjunct to levodopa in older patients to reduce"
      }, {
        "text": " motor fluctuations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Hyperprolactinemia:\u003c/b\u003e [[ca6ee143|Cab"
      }, {
        "text": "ergoline]] and [[d24a5ff0|bromocriptine]] are used to treat prolactinomas and other"
      }, {
        "text": " causes of hyperprolactinemia by stimulating D\u003csub\u003e2\u003c/sub\u003e receptors on pituitary lactotrophs, which inhibits prolactin release.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Nausea, postural hypotension, sedation (\u0027sleep attacks\u0027), and hallucinations. A notable side effect is \u003c"
      }, {
        "text": "mark\u003eimpulse control disorders\u003c/mark\u003e (e.g., pathological gambling, compulsive shopping).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e For Parkinson\u0027s, non-ergot agonists (pramipexole, ropinirole) are preferred over"
      }, {
        "text": " ergot agonists. For prolactinomas, [[ca6ee143|cabergoline]] is preferred over [["
      }, {
        "text": "d24a5ff0|bromocriptine]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDopamine"
      }, {
        "text": " agonists\u003c/b\u003e provide a direct substitute for the missing dopamine in Parkinson\u0027s disease and mimic dopamine\u0027s natural inhibitory effect on prol"
      }, {
        "text": "actin, but their use can be complicated by significant CNS side effects, including impulse control disorders.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\","
      }, {
        "text": "\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n"
      }, {
        "text": "        \"to\": \"hyperprolactinemia\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"d24a5ff0\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"ca6ee143\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "140CYNlcPOX5jcFj0XUsrbxOwaIRaJZGs"
      },
      "role": "user",
      "tokenCount": 2469
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"8c87b5f0\": {\n    \"title\": \"Dopamine D2 Receptors\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDopamine D\u003csub\u003e2\u003c/sub\u003e receptors\u003c/b\u003e are a subtype of G protein-coupled receptors that bind the neurotransmitter [[90adc821|dopamine]]. They are primarily inhibitory (linked to G\u003csub\u003ei\u003c/sub\u003e proteins) and are a major target for antipsychotic drugs and treatments for Parkinson disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e As G\u003csub\u003ei\u003c/sub\u003e-coupled receptors, their activation leads to the inhibition of adenylyl cyclase, which decreases intracellular levels of cyclic AMP (cAMP).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation \u0026 Function:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNigrostriatal Pathway:\u003c/b\u003e Modulate motor control. Blockade by antipsychotics causes extrapyramidal symptoms.\u003cbr\u003e - \u003cb\u003eMesolimbic Pathway:\u003c/b\u003e Mediate reward and psychosis. Blockade is the primary mechanism of action for antipsychotic drugs.\u003cbr\u003e - \u003cb\u003eTuberoinfundibular Pathway:\u003c/b\u003e Inhibit prolactin release from the pituitary. Blockade leads to hyperprolactinemia.\u003cbr\u003e - \u003cb\u003e[[93f70f8e|Chemoreceptor Trigger Zone (CTZ)]]:\u003c/b\u003e D\u003csub\u003e2\u003c/sub\u003e receptors in the CTZ mediate nausea and vomiting. D\u003csub\u003e2\u003c/sub\u003e antagonists (e.g., metoclopramide) are used as antiemetics.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The therapeutic effect of typical antipsychotics correlates strongly with their affinity for D\u003csub\u003e2\u003c/sub\u003e receptors. Side effects like hyperprolactinemia and extrapyramidal symptoms are also a direct result of D\u003csub\u003e2\u003c/sub\u003e blockade in different dopaminergic pathways.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDopamine D\u003csub\u003e2\u003c/sub\u003e receptors\u003c/b\u003e are the principal targets for antipsychotic medications; their blockade in the mesolimbic pathway reduces psychosis, but off-target blockade in the nigrostriatal and tuberoinfundibular pathways leads to significant motor and endocrine side effects.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_receptor_for\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"93f70f8e\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"57f4719b\"\n      }\n    ]\n  },\n  \"57f4719b\": {\n    \"title\": \"Dopaminergic Pathways\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brain Nuclei\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003edopaminergic pathways\u003c/b\u003e are four major neuronal circuits in the brain that synthesize and release the neurotransmitter [[90adc821|dopamine]]. Their dysregulation is central to several major neurological and psychiatric disorders, and they are the primary targets for therapies for [[58c8ea03|Parkinson disease]] and schizophrenia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMesolimbic Pathway:\u003c/b\u003e Projects from the ventral tegmental area (VTA) to the nucleus accumbens. It is the primary \u0027reward\u0027 pathway. Hyperactivity is associated with the \u003cmark\u003epositive symptoms\u003c/mark\u003e of schizophrenia (e.g., hallucinations, delusions).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMesocortical Pathway:\u003c/b\u003e Projects from the VTA to the prefrontal cortex. It is involved in cognition and executive function. Hypoactivity is associated with the \u003cmark\u003enegative symptoms\u003c/mark\u003e of schizophrenia (e.g., apathy, flat affect).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNigrostriatal Pathway:\u003c/b\u003e Projects from the substantia nigra pars compacta to the striatum. It is a key part of the [[ed462927|basal ganglia]] motor loop. Degeneration of this pathway causes [[58c8ea03|Parkinson disease]]. Blockade by antipsychotics causes extrapyramidal side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTuberoinfundibular Pathway:\u003c/b\u003e Projects from the hypothalamus to the pituitary gland. It tonically inhibits prolactin secretion. Blockade by antipsychotics leads to hyperprolactinemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding these four pathways is essential for understanding the therapeutic effects and side effects of antipsychotic drugs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe brain\u0027s four major \u003cb\u003edopaminergic pathways\u003c/b\u003e have distinct roles: the nigrostriatal for movement, the mesolimbic for reward, the mesocortical for cognition, and the tuberoinfundibular for hormonal control. This functional segregation explains why a single drug class, like antipsychotics, can have such diverse therapeutic and adverse effects.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Dopaminergic Pathways]; A --\u003e B(Mesolimbic - Reward/Positive Sx); A --\u003e C(Mesocortical - Cognition/Negative Sx); A --\u003e D(Nigrostriatal - Motor); A --\u003e E(Tuberoinfundibular - Prolactin);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"utilize_neurotransmitter\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"schizophrenia\"\n      },\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \"antipsychotics\"\n      }\n    ]\n  },\n  \"e7f5cbbe\": {\n    \"title\": \"Dorsal Columns\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e (also known as the posterior columns or the dorsal column-medial lemniscus pathway) are ascending sensory tracts in the spinal cord that transmit information about \u003cu\u003efine touch, vibration, and conscious proprioception\u003c/u\u003e from the body to the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Transmits discriminative sensory modalities: fine touch, vibration, pressure, and conscious proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Composed of two fasciculi: the \u003cmark\u003efasciculus gracilis\u003c/mark\u003e (medial, carries information from the lower body, T6 and below) and the \u003cmark\u003efasciculus cuneatus\u003c/mark\u003e (lateral, carries information from the upper body, T6 and above).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e First-order neurons from peripheral receptors enter the spinal cord and ascend \u003cu\u003eipsilaterally\u003c/u\u003e in the dorsal columns. They synapse in the nucleus gracilis and nucleus cuneatus in the medulla. Second-order neurons then decussate as the internal arcuate fibers and ascend as the [[f19bc454|medial lemniscus]] to the VPL nucleus of the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e Damage to the dorsal columns causes ipsilateral loss of vibration and proprioception below the level of the lesion. This results in sensory [[9767fd6b|ataxia]] and a positive [[47a0f3d1|Romberg sign]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Pathologies:\u003c/b\u003e The dorsal columns are classically damaged in \u003cmark\u003e[[71daebd6|tabes dorsalis]]\u003c/mark\u003e (tertiary syphilis) and \u003cmark\u003e[[6f5bea90|subacute combined degeneration]]\u003c/mark\u003e (vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature of this pathway is that it ascends ipsilaterally in the spinal cord and crosses in the medulla. This is the opposite of the spinothalamic tract, which crosses at the spinal cord level.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e are the spinal cord\u0027s high-fidelity pathway for discriminative touch and proprioception, uniquely ascending ipsilaterally before crossing in the medulla, a crucial anatomical fact for localizing spinal cord lesions like [[4792bc68|Brown-S√©quard syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Receptor] --\u003e B(1st Order Neuron); B --\u003e C(Ascends Ipsilaterally in Dorsal Column); C --\u003e D(Synapse in Medulla); D --Decussation--\u003e E(2nd Order Neuron - Medial Lemniscus); E --\u003e F(Synapse in Thalamus); F --\u003e G(3rd Order Neuron); G --\u003e H(Somatosensory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"dorsal_column_medial_lemniscus_pathway\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"transmits_sensation_of\",\n        \"to\": \"proprioception\"\n      }\n    ]\n  },\n  \"79c1d502\": {\n    \"title\": \"Dorsal Midbrain Lesions (Parinaud Syndrome)\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003edorsal midbrain lesion\u003c/b\u003e causes \u003cb\u003eParinaud syndrome\u003c/b\u003e (also known as dorsal midbrain syndrome), a constellation of neuro-ophthalmologic signs resulting from compression of the superior colliculus and pretectal area.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a mass in the pineal region (\u003cmark\u003epinealoma\u003c/mark\u003e) in children, or by a stroke or hydrocephalus in adults.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Palsy:\u003c/b\u003e The most prominent feature is a limitation of vertical gaze, especially upward gaze.\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils react poorly or not at all to light but constrict normally during accommodation (convergence). These are sometimes called pseudo-[[08cb577f|Argyll Robertson pupils]].\u003cbr\u003e3. \u003cb\u003e[[3db2e75e|Convergence-Retraction Nystagmus]]:\u003c/b\u003e On attempted upgaze, the eyes jerkily converge and retract into the orbits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Signs:\u003c/b\u003e Eyelid retraction (Collier\u0027s sign) may also be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of an inability to look up, pupils that accommodate but don\u0027t react, and convergence-retraction nystagmus is pathognomonic for Parinaud syndrome and should point to a lesion in the dorsal midbrain, often a pineal tumor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003edorsal midbrain lesion\u003c/b\u003e disrupts the centers for vertical gaze and pupillary light reflex, producing the unique Parinaud syndrome, where the patient cannot look up and the pupils paradoxically fail to react to light but still constrict for near vision.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion in Dorsal Midbrain (e.g., Pinealoma)] --Compresses--\u003e B(Superior Colliculus \u0026 Pretectal Area); B --\u003e C(Parinaud Syndrome); C --\u003e D(Upward Gaze Palsy); C --\u003e E(Light-Near Dissociation); C --\u003e F(Convergence-Retraction Nystagmus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"parinaud_syndrome\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"pinealoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"3db2e75e\"\n      }\n    ]\n  },\n  \"2f9dde44\": {\n    \"title\": \"Dorsal Motor Nucleus of the Vagus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Autonomic\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Motor Nucleus of the Vagus\u003c/b\u003e is a cranial nerve nucleus for the [[vagus_nerve|vagus nerve (CN X)]] located in the medulla oblongata. It is the primary source of preganglionic parasympathetic fibers for the thoracic and abdominal viscera.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Medulla oblongata, lateral to the hypoglossal nucleus and beneath the floor of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides preganglionic \u003cmark\u003eparasympathetic\u003c/mark\u003e innervation to the viscera of the thorax and abdomen, down to the splenic flexure of the colon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTargets:\u003c/b\u003e Innervates intramural ganglia in the heart (slowing heart rate), lungs (bronchoconstriction), and GI tract (increasing motility and secretion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Lesions affecting the dorsal motor nucleus can lead to autonomic dysfunction, such as gastroparesis or arrhythmias.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember this nucleus as the main parasympathetic \u0027command center\u0027 of the vagus nerve for controlling the internal organs of the chest and abdomen.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Motor Nucleus of the Vagus\u003c/b\u003e is the origin of the extensive parasympathetic outflow of the vagus nerve, responsible for the \u0027rest and digest\u0027 functions of the heart, lungs, and majority of the gastrointestinal tract.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Dorsal Motor Nucleus of Vagus] --Preganglionic Parasympathetic Fibers (CN X)--\u003e B(Thoracic \u0026 Abdominal Viscera);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_nucleus_of\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"provides_innervation_to\",\n        \"to\": \"thoracic_viscera\"\n      },\n      {\n        \"type\": \"provides_innervation_to\",\n        \"to\": \"abdominal_viscera\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"medulla_oblongata\"\n      }\n    ]\n  },\n  \"09c8409d\": {\n    \"title\": \"Dorsal Optic Radiation\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Visual Pathway\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Optic Radiation\u003c/b\u003e is the superior bundle of nerve fibers that projects from the lateral geniculate nucleus (LGN) of the thalamus to the primary visual cortex in the occipital lobe. It carries visual information from the superior half of the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Originates in the LGN, travels superiorly through the \u003cmark\u003eparietal lobe\u003c/mark\u003e, and terminates in the superior portion of the primary visual cortex (cuneus gyrus), above the calcarine sulcus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisual Field Information:\u003c/b\u003e It carries information from the \u003cmark\u003esuperior retina\u003c/mark\u003e, which corresponds to the \u003cmark\u003einferior visual field\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion of the dorsal optic radiation causes a contralateral \u003cmark\u003einferior quadrantanopia\u003c/mark\u003e (a \u0027pie in the floor\u0027 visual field defect).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[ventral_optic_radiation|ventral optic radiation (Meyer\u0027s loop)]] travels through the temporal lobe and carries information from the inferior retina (superior visual field).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003ePITS\u003c/b\u003e: \u003cb\u003eP\u003c/b\u003earietal lesion \u003d \u003cb\u003eI\u003c/b\u003enferior field defect, \u003cb\u003eT\u003c/b\u003eemporal lesion \u003d \u003cb\u003eS\u003c/b\u003euperior field defect. A lesion in the parietal lobe affecting the dorsal optic radiation causes a \u0027pie on the floor\u0027 defect.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Optic Radiation\u003c/b\u003e is the superior visual pathway that takes a direct, superior route through the parietal lobe to carry information about the inferior visual world from the thalamus to the visual cortex.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Superior Retina] --\u003e B(LGN); B --\u003e C(Dorsal Optic Radiation); C --\u003e D(Through Parietal Lobe); D --\u003e E(Primary Visual Cortex); F[Lesion in Dorsal Radiation] --\u003e G(Contralateral Inferior Quadrantanopia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"optic_radiation\"\n      },\n      {\n        \"type\": \"travels_through\",\n        \"to\": \"parietal_lobe\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"inferior_quadrantanopia\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"ventral_optic_radiation\"\n      }\n    ]\n  },\n  \"d92676a0\": {\n    \"title\": \"Double Y Male (XYY Syndrome)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Genetics\",\n      \"Pediatrics\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Reproductive\",\n      \"Pathology\",\n      \"Genetic Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDouble Y male\u003c/b\u003e, or \u003cb\u003eXYY syndrome\u003c/b\u003e, is a sex chromosome aneuploidy in which a male has an extra Y chromosome, resulting in a 47,XYY karyotype. It is caused by a paternal meiotic II nondisjunction event.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e 47,XYY karyotype, resulting from nondisjunction of the Y chromosome during meiosis II in the father.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhenotype:\u003c/b\u003e Most individuals are phenotypically normal and are often undiagnosed. They typically have normal intelligence and are fertile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features:\u003c/b\u003e Associated with \u003cmark\u003etall stature\u003c/mark\u003e, severe acne, and an increased risk of learning disabilities and autism spectrum disorder.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistorical Misconception:\u003c/b\u003e Was once incorrectly linked to aggressive and criminal behavior (the \u0027supermale\u0027 myth), but this has been largely debunked.\u003c/li\u003e\u003cli\u003e\u003cb\u003e\u0027Down-and-out\u0027 eye:\u003c/b\u003e This term describes a [[fdfd22ca|CN III palsy]] and is \u003cu\u003enot related\u003c/u\u003e to XYY syndrome. The index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic presentation is a very tall male with learning difficulties or behavioral problems. Remember that it results from a paternal meiotic II error.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eXYY syndrome\u003c/b\u003e is a common and often asymptomatic sex chromosome aneuploidy, primarily characterized by tall stature, with most of the historical associations with aggression being unfounded.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"sex_chromosome_aneuploidy\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"paternal_meiotic_nondisjunction\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"tall_stature\"\n      }\n    ]\n  },\n  \"0a59b5db\": {\n    \"title\": \"Dream Enactment\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDream enactment\u003c/b\u003e is the cardinal feature of [[91fcdbc5|REM Sleep Behavior Disorder (RBD)]], where individuals physically act out their dreams, often in a violent or dramatic manner, due to a failure of the normal muscle atonia that accompanies REM sleep.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAssociated Disorder:\u003c/b\u003e The defining symptom of [[91fcdbc5|REM Sleep Behavior Disorder (RBD)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Loss of the physiological muscle paralysis (atonia) that normally occurs during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBehaviors:\u003c/b\u003e Can range from simple limb twitching to complex and vigorous actions like punching, kicking, yelling, or jumping out of bed, which can cause injury to the patient or their bed partner.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of dream enactment is a powerful predictor of future neurodegenerative disease, particularly Œ±-synucleinopathies like [[58c8ea03|Parkinson disease]] and [[db2f16e5|Lewy body dementia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An older patient, especially male, who reports a history of \u0027fighting in his sleep\u0027 or has injured his spouse while dreaming, is a classic presentation for RBD and should be considered at high risk for developing Parkinson\u0027s or Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDream enactment\u003c/b\u003e is a dramatic and potentially dangerous manifestation of REM sleep without atonia, serving as a critical prodromal marker for underlying Œ±-synuclein neurodegenerative disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"91fcdbc5\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \"to\": \"db2f16e5\"\n      }\n    ]\n  },\n  \"4d2377b4\": {\n    \"title\": \"DRESS Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Immunology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"Drug Reactions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDRESS syndrome\u003c/b\u003e (Drug Reaction with Eosinophilia and Systemic Symptoms) is a severe, potentially life-threatening, idiosyncratic drug hypersensitivity reaction characterized by a triad of fever, rash, and internal organ involvement.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Typically has a long latency period, with symptoms appearing \u003cmark\u003e2 to 8 weeks\u003c/mark\u003e after starting the offending drug.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eRash:\u003c/b\u003e Widespread morbilliform rash that can progress to exfoliative dermatitis.\u003cbr\u003e - \u003cb\u003eFever:\u003c/b\u003e High fever is common.\u003cbr\u003e - \u003cb\u003eSystemic Symptoms:\u003c/b\u003e Lymphadenopathy and involvement of internal organs, most commonly the liver (hepatitis), kidneys (interstitial nephritis), and lungs (pneumonitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLaboratory Findings:\u003c/b\u003e Hallmark findings are \u003cmark\u003eeosinophilia\u003c/mark\u003e and atypical lymphocytosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCausative Drugs:\u003c/b\u003e Classically associated with \u003cmark\u003eanticonvulsants\u003c/mark\u003e (e.g., [[eddd2bc5|carbamazepine]], [[5aea213f|phenytoin]], [[08d19a8f|lamotrigine]]), allopurinol, sulfonamides, and certain antibiotics like minocycline and vancomycin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who started a new anticonvulsant or allopurinol several weeks ago and now presents with fever, a widespread rash, facial edema, and elevated liver enzymes with eosinophilia is the classic vignette for DRESS syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDRESS syndrome\u003c/b\u003e is a delayed and severe drug reaction where the immune system goes into overdrive, causing not just a rash but also systemic inflammation with eosinophilia and potentially fatal internal organ damage, often triggered by anticonvulsants or allopurinol.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"drug_hypersensitivity_reaction\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"allopurinol\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"eosinophilia\"\n      }\n    ]\n  },\n  \"9593d9b6\": {\n    \"title\": \"Drooling\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pediatrics\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDrooling\u003c/b\u003e (sialorrhea) is the unintentional flow of saliva outside the mouth. While normal in infants, it can be a sign of neurological disease in older children and adults, often due to impaired swallowing (dysphagia) rather than excessive saliva production.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurological Causes:\u003c/b\u003e Common in conditions with oropharyngeal muscle weakness or incoordination, such as [[58c8ea03|Parkinson disease]], [[4ed629f9|amyotrophic lateral sclerosis (ALS)]], and [[171ca00b|cerebral palsy]]. It results from an inability to effectively manage and swallow normal amounts of saliva.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInfectious Causes:\u003c/b\u003e Can be a sign of acute infections that cause painful swallowing or airway obstruction, such as epiglottitis or peritonsillar abscess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management focuses on the underlying cause. For neurological conditions, \u003cmark\u003eanticholinergic (antimuscarinic) drugs\u003c/mark\u003e like glycopyrrolate or scopolamine can be used to reduce saliva production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrop Metastases:\u003c/b\u003e This term refers to the spread of CNS tumors (classically [[16d613bb|medulloblastoma]]) via the CSF to the spinal cord, and is unrelated to drooling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrop Seizures:\u003c/b\u003e This term refers to [[ed7a236f|atonic seizures]] and is unrelated to drooling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with a known neurodegenerative disorder, the onset of drooling is a significant sign of progressive bulbar dysfunction and worsening dysphagia, indicating an increased risk of aspiration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn a neurological context, \u003cb\u003edrooling\u003c/b\u003e is typically not a problem of making too much saliva, but rather a problem of not being able to swallow it, serving as a visible sign of underlying bulbar muscle weakness and dysphagia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"dysphagia\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"96e8bf39\"\n      }\n    ]\n  },\n  \"678eea95\": {\n    \"title\": \"Drug Safety\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"General Principles\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDrug safety\u003c/b\u003e is a branch of pharmacology focused on identifying, evaluating, and preventing adverse drug reactions (ADRs). A key quantitative measure of a drug\u0027s safety is its therapeutic index.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTherapeutic Index (TI):\u003c/b\u003e The ratio of the dose of a drug that causes toxicity to the dose that produces the desired therapeutic effect. It is calculated as TD\u003csub\u003e50\u003c/sub\u003e/ED\u003csub\u003e50\u003c/sub\u003e (median toxic dose / median effective dose).\u003c/li\u003e\u003cli\u003e\u003cb\u003eInterpretation:\u003c/b\u003e A \u003cmark\u003ehigh therapeutic index\u003c/mark\u003e indicates a wide margin between the effective dose and the toxic dose, suggesting a safer drug (e.g., penicillin). A \u003cmark\u003elow therapeutic index\u003c/mark\u003e indicates a narrow margin of safety, meaning the effective and toxic doses are close, requiring careful monitoring (e.g., warfarin, digoxin, lithium).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapeutic Window:\u003c/b\u003e The range of drug dosages that can treat disease effectively without having toxic effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003e\u0027Drunken Sailor\u0027 Gait:\u003c/b\u003e This term describes a wide-based, unsteady gait known as \u003cmark\u003etruncal ataxia\u003c/mark\u003e, which is a classic sign of a [[6e31977d|cerebellar vermis lesion]]. It is not directly a concept of drug safety, but can be a sign of drug toxicity (e.g., from phenytoin or alcohol).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Drugs with a low therapeutic index are high-yield for exam questions. Be prepared to identify them and know that they require therapeutic drug monitoring.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003etherapeutic index\u003c/b\u003e is a critical measure of \u003cb\u003edrug safety\u003c/b\u003e, quantifying the \u0027wiggle room\u0027 a clinician has between a dose that helps and a dose that harms; drugs with a narrow therapeutic window require vigilant monitoring to prevent toxicity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_measured_by\",\n        \"to\": \"therapeutic_index\"\n      },\n      {\n        \"type\": \"is_related_to\",\n        \"to\": \"adverse_drug_reaction\"\n      }\n    ]\n  },\n  \"3f8bff66\": {\n    \"title\": \"Drusen\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDrusen\u003c/b\u003e are small, yellow or white extracellular deposits that accumulate between Bruch\u0027s membrane and the retinal pigment epithelium (RPE). They are a hallmark finding of \u003cmark\u003edry (atrophic) age-related macular degeneration (AMD)\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Appear as distinct, yellowish spots on fundoscopic examination, typically concentrated in the macula.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Composed of lipids, proteins, and cellular debris. Their accumulation is thought to impair the function of the RPE, leading to chronic oxidative stress, inflammation, and eventual atrophy of the RPE and overlying photoreceptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The number and size of drusen are key indicators of the risk and severity of [[c63255c8|age-related macular degeneration]]. \u0027Hard\u0027 drusen are small and distinct, carrying a lower risk. \u0027Soft\u0027 drusen are larger, have indistinct borders, and are associated with a higher risk of progression to advanced AMD (either geographic atrophy or wet AMD).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Disease:\u003c/b\u003e The defining feature of \u003cmark\u003edry AMD\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Yellowish deposits in the macula of an elderly patient complaining of gradual central vision loss is a classic description of drusen in dry AMD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDrusen\u003c/b\u003e are the characteristic \u0027waste products\u0027 that build up under the retina in dry age-related macular degeneration, serving as a key biomarker for the disease and contributing to the slow, progressive loss of central vision.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"c63255c8\"\n      },\n      {\n        \"type\": \"are_located_between\",\n        \"to\": \"bruchs_membrane\"\n      },\n      {\n        \"type\": \"are_located_between\",\n        \"to\": \"retinal_pigment_epithelium\"\n      }\n    ]\n  },\n  \"5bbe3597\": {\n    \"title\": \"Dura Mater\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDura Mater\u003c/b\u003e (Latin for \\\"tough mother\\\") is the thick, outermost layer of the three meninges that surround the brain and spinal cord. It provides a durable, protective covering for the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of dense, fibrous connective tissue. In the cranium, it consists of two layers: an outer periosteal layer that adheres to the skull, and an inner meningeal layer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDural Reflections:\u003c/b\u003e The inner meningeal layer folds inward to form septa that divide the cranial cavity into compartments, such as the falx cerebri and tentorium cerebelli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDural Venous Sinuses:\u003c/b\u003e The two dural layers separate in certain locations to form the [[21f1c955|dural venous sinuses]] (e.g., superior sagittal sinus), which are channels for venous blood drainage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e The dura is richly innervated by sensory nerves (primarily CN V), which is why dural stretching or irritation can cause headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[a61683ae|Epidural Hematoma]]:\u003c/b\u003e Bleeding between the dura and the skull.\u003cbr\u003e - \u003cb\u003e[[8aaeb0d8|Subdural Hematoma]]:\u003c/b\u003e Bleeding between the dura and the arachnoid mater.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the spaces relative to the dura: Epidural is \u0027above\u0027 the dura, Subdural is \u0027below\u0027 the dura.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDura Mater\u003c/b\u003e is the tough, protective outer shield of the CNS, which not only provides a physical barrier but also forms the critical venous drainage channels (dural sinuses) and the partitions that compartmentalize the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_layer_of\",\n        \"to\": \"meninges\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"21f1c955\"\n      },\n      {\n        \"type\": \"is_superficial_to\",\n        \"to\": \"8aaeb0d8\"\n      },\n      {\n        \"type\": \"is_deep_to\",\n        \"to\": \"a61683ae\"\n      }\n    ]\n  },\n  \"21f1c955\": {\n    \"title\": \"Dural Venous Sinuses\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Vascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dural Venous Sinuses\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDural Venous Sinuses\u003c/b\u003e are large venous channels located between the periosteal and meningeal layers of the [[5bbe3597|dura mater]]. They are the primary system for venous drainage of the brain and also receive cerebrospinal fluid from the [[b7b67074|arachnoid granulations]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Unlike typical veins, they are valveless channels lined by endothelium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Sinuses:\u003c/b\u003e Superior sagittal sinus, inferior sagittal sinus, straight sinus, [[6e281699|confluence of the sinuses]], transverse sinuses, sigmoid sinuses, and [[c260efc8|cavernous sinuses]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage Pathway:\u003c/b\u003e Most venous blood and CSF ultimately drain via the sigmoid sinuses into the internal jugular veins at the jugular foramen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDural Venous Sinus Thrombosis:\u003c/b\u003e A clot within a sinus, which can increase intracranial pressure and lead to venous infarction. Associated with hypercoagulable states.\u003cbr\u003e - \u003cb\u003e[[c260efc8|Cavernous Sinus]]:\u003c/b\u003e A clinically important sinus due to the numerous cranial nerves that pass through it.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to trace the main venous drainage path: Superior Sagittal Sinus ‚Üí Confluence ‚Üí Transverse Sinus ‚Üí Sigmoid Sinus ‚Üí Internal Jugular Vein.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDural Venous Sinuses\u003c/b\u003e are the brain\u0027s unique, low-pressure venous drainage system, ingeniously housed within the tough dural layers, responsible for collecting both deoxygenated blood and spent cerebrospinal fluid for return to the systemic circulation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cerebral Veins] --\u003e B(Dural Venous Sinuses); C[Arachnoid Granulations] --\u003e B; B --\u003e D(Internal Jugular Vein);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_formed_by\",\n        \"to\": \"5bbe3597\"\n      },\n      {\n        \"type\": \"receive_csf_from\",\n        \"to\": \"b7b67074\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\": \"can_be_affected_by\",\n        \"to\": \"dural_venous_sinus_thrombosis\"\n      }\n    ]\n  },\n  \"cc61d4d0\": {\n    \"title\": \"Duret Hemorrhages\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neuropathology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDuret hemorrhages\u003c/b\u003e are small, linear hemorrhages in the midline of the pons and midbrain that are a secondary complication of downward [[bad81d37|central transtentorial brain herniation]]. They are typically a terminal event.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by the stretching and tearing of small, perforating branches of the [[e7a90cd9|basilar artery]] as the brainstem is forced downward and compressed during herniation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition:\u003c/b\u003e A classic finding in patients who have died from severe, acute increases in intracranial pressure leading to [[bad81d37|central transtentorial herniation]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Midline and paramedian areas of the pons and midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e They are not the primary cause of the patient\u0027s condition but rather a consequence of it. Their presence indicates severe, irreversible brainstem damage and is an ominous prognostic sign.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Duret hemorrhages are a specific pathological finding associated with the final stages of central herniation. They are a consequence, not a cause, of the primary brain injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDuret hemorrhages\u003c/b\u003e are the fatal vascular footprints of downward brainstem herniation, caused by the mechanical shearing of pontine and midbrain arteries as the brainstem is crushed, signifying an irreversible terminal event.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Central Transtentorial Herniation] --\u003e B(Downward Brainstem Displacement); B --\u003e C(Stretching/Tearing of Perforating Arteries); C --\u003e D(Duret Hemorrhages);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"bad81d37\"\n      },\n      {\n        \"type\": \"are_located_in\",\n        \"to\": \"brainstem\"\n      },\n      {\n        \"type\": \"result_from_tearing_of_branches_of\",\n        \"to\": \"e7a90cd9\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9880,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"8c87b5f0\": {\n    \"title"
      }, {
        "text": "\": \"Dopamine D2 Receptors\",\n    \"primaryType\": \"molecule\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"USMLE"
      }, {
        "text": "\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"An"
      }, {
        "text": "atomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eDopamine D\u003csub\u003e2\u003c/sub\u003e receptors\u003c/b\u003e are a subtype of G protein-coupled receptors that bind"
      }, {
        "text": " the neurotransmitter [[90adc821|dopamine]]. They are primarily inhibitory (linked to G\u003csub\u003ei\u003c/sub\u003e proteins"
      }, {
        "text": ") and are a major target for antipsychotic drugs and treatments for Parkinson disease.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e As G\u003csub\u003ei\u003c/sub\u003e-coupled receptors, their activation leads to the inhibition of ad"
      }, {
        "text": "enylyl cyclase, which decreases intracellular levels of cyclic AMP (cAMP).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation \u0026 Function:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eNigrostriatal Pathway:\u003c/b\u003e Modulate motor control. Blockade by antipsychotics causes extrapyramidal symptoms"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003eMesolimbic Pathway:\u003c/b\u003e Mediate reward and psychosis. Blockade is the primary mechanism of"
      }, {
        "text": " action for antipsychotic drugs.\u003cbr\u003e - \u003cb\u003eTuberoinfundibular Pathway:\u003c/b\u003e Inhibit prolactin release from"
      }, {
        "text": " the pituitary. Blockade leads to hyperprolactinemia.\u003cbr\u003e - \u003cb\u003e[[93f70"
      }, {
        "text": "f8e|Chemoreceptor Trigger Zone (CTZ)]]:\u003c/b\u003e D\u003csub\u003e2\u003c/sub\u003e receptors in the CTZ mediate"
      }, {
        "text": " nausea and vomiting. D\u003csub\u003e2\u003c/sub\u003e antagonists (e.g., metoclopramide) are used as antiemetics."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The therapeutic effect of typical antipsychotics correlates strongly with their affinity for D\u003csub\u003e2\u003c/sub\u003e receptors"
      }, {
        "text": ". Side effects like hyperprolactinemia and extrapyramidal symptoms are also a direct result of D\u003csub\u003e2\u003c/sub\u003e blockade"
      }, {
        "text": " in different dopaminergic pathways.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDopamine D\u003csub\u003e2\u003c/sub\u003e receptors\u003c/b\u003e are"
      }, {
        "text": " the principal targets for antipsychotic medications; their blockade in the mesolimbic pathway reduces psychosis, but off-target blockade"
      }, {
        "text": " in the nigrostriatal and tuberoinfundibular pathways leads to significant motor and endocrine side effects.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_receptor"
      }, {
        "text": "_for\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_blocked_by\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_in\",\n        \"to\": \"93f70f8"
      }, {
        "text": "e\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\":"
      }, {
        "text": " \"57f4719b\"\n      }\n    ]\n  },\n  \"57f4719"
      }, {
        "text": "b\": {\n    \"title\": \"Dopaminergic Pathways\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroanatomy\",\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Brain Nuclei\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ed"
      }, {
        "text": "opaminergic pathways\u003c/b\u003e are four major neuronal circuits in the brain that synthesize and release the neurotransmitter [[90adc821|dopamine"
      }, {
        "text": "]]. Their dysregulation is central to several major neurological and psychiatric disorders, and they are the primary targets for therapies for [["
      }, {
        "text": "58c8ea03|Parkinson disease]] and schizophrenia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMes"
      }, {
        "text": "olimbic Pathway:\u003c/b\u003e Projects from the ventral tegmental area (VTA) to the nucleus accumbens. It"
      }, {
        "text": " is the primary \u0027reward\u0027 pathway. Hyperactivity is associated with the \u003cmark\u003epositive symptoms\u003c/mark\u003e of schizophrenia"
      }, {
        "text": " (e.g., hallucinations, delusions).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMesocortical Pathway:\u003c/b\u003e Projects from the VTA to the pre"
      }, {
        "text": "frontal cortex. It is involved in cognition and executive function. Hypoactivity is associated with the \u003cmark\u003enegative symptoms\u003c/mark"
      }, {
        "text": "\u003e of schizophrenia (e.g., apathy, flat affect).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNigrostriatal Pathway:\u003c/b\u003e Projects"
      }, {
        "text": " from the substantia nigra pars compacta to the striatum. It is a key part of the [[ed46"
      }, {
        "text": "2927|basal ganglia]] motor loop. Degeneration of this pathway causes [[58c8ea03|"
      }, {
        "text": "Parkinson disease]]. Blockade by antipsychotics causes extrapyramidal side effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTuberoinfundibular Pathway:\u003c/b\u003e Projects from the"
      }, {
        "text": " hypothalamus to the pituitary gland. It tonically inhibits prolactin secretion. Blockade by antipsychotics leads to hyperprolactinemia."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding these four pathways is essential for understanding the therapeutic effects and side effects of antipsychotic drugs.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe brain\u0027s four major \u003cb\u003edopaminergic pathways\u003c/b\u003e have"
      }, {
        "text": " distinct roles: the nigrostriatal for movement, the mesolimbic for reward, the mesocortical for cognition"
      }, {
        "text": ", and the tuberoinfundibular for hormonal control. This functional segregation explains why a single drug class, like antipsych"
      }, {
        "text": "otics, can have such diverse therapeutic and adverse effects.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Dopaminergic Pathways]; A --\u003e B(Mesolimbic - Reward/Positive Sx); A --\u003e C(Mesocortical -"
      }, {
        "text": " Cognition/Negative Sx); A --\u003e D(Nigrostriatal - Motor); A --\u003e E(Tuberoinf"
      }, {
        "text": "undibular - Prolactin);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"util"
      }, {
        "text": "ize_neurotransmitter\",\n        \"to\": \"90adc821\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_affected_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_affected_in\",\n        \"to\": \"schizophrenia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_targeted_by\",\n        \"to\": \"antipsychotics"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"e7f5cbbe\": {\n    \"title\": \""
      }, {
        "text": "Dorsal Columns\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy"
      }, {
        "text": "\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Columns\u003c/b\u003e (also known as"
      }, {
        "text": " the posterior columns or the dorsal column-medial lemniscus pathway) are ascending sensory tracts in the spinal cord that transmit"
      }, {
        "text": " information about \u003cu\u003efine touch, vibration, and conscious proprioception\u003c/u\u003e from the body to the brainstem.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Transmits discriminative sensory modalities: fine touch, vibration, pressure, and conscious proprioception.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eComponents:\u003c/b\u003e Composed of two fasciculi: the \u003cmark\u003efasciculus gracilis\u003c/mark\u003e ("
      }, {
        "text": "medial, carries information from the lower body, T6 and below) and the \u003cmark\u003efasciculus cuneatus\u003c/mark"
      }, {
        "text": "\u003e (lateral, carries information from the upper body, T6 and above).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e First-order neurons from peripheral"
      }, {
        "text": " receptors enter the spinal cord and ascend \u003cu\u003eipsilaterally\u003c/u\u003e in the dorsal columns. They synapse in the nucleus grac"
      }, {
        "text": "ilis and nucleus cuneatus in the medulla. Second-order neurons then decussate as the internal arcuate fibers"
      }, {
        "text": " and ascend as the [[f19bc454|medial lemniscus]] to the VPL nucleus of the [["
      }, {
        "text": "afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e Damage to the dorsal columns causes"
      }, {
        "text": " ipsilateral loss of vibration and proprioception below the level of the lesion. This results in sensory [[9767fd"
      }, {
        "text": "6b|ataxia]] and a positive [[47a0f3d1|Romberg sign]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Pathologies:\u003c/b\u003e The dorsal columns are classically damaged in \u003cmark\u003e[[71daebd6|tabes dorsalis]]\u003c/mark\u003e ("
      }, {
        "text": "tertiary syphilis) and \u003cmark\u003e[[6f5bea90|subacute combined degeneration]]\u003c/mark\u003e (vitamin"
      }, {
        "text": " B\u003csub\u003e12\u003c/sub\u003e deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature of this pathway is that it"
      }, {
        "text": " ascends ipsilaterally in the spinal cord and crosses in the medulla. This is the opposite of the spinothalamic tract"
      }, {
        "text": ", which crosses at the spinal cord level.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eD"
      }, {
        "text": "orsal Columns\u003c/b\u003e are the spinal cord\u0027s high-fidelity pathway for discriminative touch and proprioception, uniquely ascending"
      }, {
        "text": " ipsilaterally before crossing in the medulla, a crucial anatomical fact for localizing spinal cord lesions like [[479"
      }, {
        "text": "2bc68|Brown-S√©quard syndrome]].\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Receptor] --\u003e B(1st Order Neuron); B --\u003e C(Ascends Ipsilaterally in Dorsal Column); C"
      }, {
        "text": " --\u003e D(Synapse in Medulla); D --Decussation--\u003e E(2nd Order Neuron - Medial Lemn"
      }, {
        "text": "iscus); E --\u003e F(Synapse in Thalamus); F --\u003e G(3rd Order Neuron); G --\u003e H(Somatosensory Cortex"
      }, {
        "text": ");\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\":"
      }, {
        "text": " \"dorsal_column_medial_lemniscus_pathway\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_damaged_in\",\n        \"to\": \"71daebd6\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"6f5"
      }, {
        "text": "bea90\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        "
      }, {
        "text": "\"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "transmits_sensation_of\",\n        \"to\": \"proprioception\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"79c1d502\": {\n    \"title\": \"Dorsal Midbrain Lesions ("
      }, {
        "text": "Parinaud Syndrome)\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Synd"
      }, {
        "text": "romes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003edorsal midbrain lesion\u003c/b\u003e"
      }, {
        "text": " causes \u003cb\u003eParinaud syndrome\u003c/b\u003e (also known as dorsal midbrain syndrome), a constellation of neuro-ophthalm"
      }, {
        "text": "ologic signs resulting from compression of the superior colliculus and pretectal area.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a mass in the pineal region (\u003cmark\u003epine"
      }, {
        "text": "aloma\u003c/mark\u003e) in children, or by a stroke or hydrocephalus in adults.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e1. \u003cb\u003eUpward Gaze Palsy:\u003c/b\u003e The most prominent feature is a limitation of vertical gaze,"
      }, {
        "text": " especially upward gaze.\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils react poorly or not at all to light"
      }, {
        "text": " but constrict normally during accommodation (convergence). These are sometimes called pseudo-[[08cb577f|Ar"
      }, {
        "text": "gyll Robertson pupils]].\u003cbr\u003e3. \u003cb\u003e[[3db2e75e|Convergence-Retraction N"
      }, {
        "text": "ystagmus]]:\u003c/b\u003e On attempted upgaze, the eyes jerkily converge and retract into the orbits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther"
      }, {
        "text": " Signs:\u003c/b\u003e Eyelid retraction (Collier\u0027s sign) may also be present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination"
      }, {
        "text": " of an inability to look up, pupils that accommodate but don\u0027t react, and convergence-retraction nystagmus is"
      }, {
        "text": " pathognomonic for Parinaud syndrome and should point to a lesion in the dorsal midbrain, often a pineal tumor"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003edorsal midbrain lesion\u003c/b\u003e disrupts"
      }, {
        "text": " the centers for vertical gaze and pupillary light reflex, producing the unique Parinaud syndrome, where the patient cannot look up and"
      }, {
        "text": " the pupils paradoxically fail to react to light but still constrict for near vision.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Lesion in Dorsal Midbrain (e.g., Pinealoma)] --Compresses--\u003e B(Superior Collic"
      }, {
        "text": "ulus \u0026 Pretectal Area); B --\u003e C(Parinaud Syndrome); C --\u003e D(Upward Gaze Pals"
      }, {
        "text": "y); C --\u003e E(Light-Near Dissociation); C --\u003e F(Convergence-Retraction Nystagmus);\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"parinaud_syndrome\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"pinealoma"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \""
      }, {
        "text": "3db2e75e\"\n      }\n    ]\n  },\n  \"2f9dde"
      }, {
        "text": "44\": {\n    \"title\": \"Dorsal Motor Nucleus of the Vagus\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Autonomic\",\n      \"Physiology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eDorsal Motor Nucleus of the Vagus\u003c/b\u003e is a cranial nerve nucleus for the [[v"
      }, {
        "text": "agus_nerve|vagus nerve (CN X)]] located in the medulla oblongata. It is the primary source of pre"
      }, {
        "text": "ganglionic parasympathetic fibers for the thoracic and abdominal viscera.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Medulla oblongata, lateral to the hypoglossal nucleus and beneath the floor of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e"
      }, {
        "text": " Provides preganglionic \u003cmark\u003eparasympathetic\u003c/mark\u003e innervation to the viscera of the thorax and abdomen, down"
      }, {
        "text": " to the splenic flexure of the colon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTargets:\u003c/b\u003e Innervates intramural ganglia in the heart ("
      }, {
        "text": "slowing heart rate), lungs (bronchoconstriction), and GI tract (increasing motility and secretion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Relevance:\u003c/b\u003e Lesions affecting the dorsal motor nucleus can lead to autonomic dysfunction, such as gastroparesis or arrhythmias"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember this nucleus as the main parasympathetic \u0027command center\u0027 of the vagus nerve for controlling"
      }, {
        "text": " the internal organs of the chest and abdomen.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Motor Nucleus"
      }, {
        "text": " of the Vagus\u003c/b\u003e is the origin of the extensive parasympathetic outflow of the vagus nerve, responsible for the \u0027rest and digest\u0027 functions of"
      }, {
        "text": " the heart, lungs, and majority of the gastrointestinal tract.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Dorsal Motor Nucleus of Vagus] --Preganglionic Parasympathetic Fibers (CN X)--\u003e B(Thor"
      }, {
        "text": "acic \u0026 Abdominal Viscera);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_nucleus_of\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"provides_innervation_to\",\n        \"to\": \"thoracic_viscera\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"provides_innervation_to\",\n        \"to\": \"abdominal_viscera\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"medulla_oblongata\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"09c8409d\": {\n    \"title\":"
      }, {
        "text": " \"Dorsal Optic Radiation\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy"
      }, {
        "text": "\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Visual Pathway\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDorsal Optic Radiation\u003c/b\u003e is the superior bundle"
      }, {
        "text": " of nerve fibers that projects from the lateral geniculate nucleus (LGN) of the thalamus to the primary visual cortex in the occip"
      }, {
        "text": "ital lobe. It carries visual information from the superior half of the retina.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003ePathway:\u003c/b\u003e Originates in the LGN, travels superiorly through the \u003cmark\u003eparietal lobe\u003c/"
      }, {
        "text": "mark\u003e, and terminates in the superior portion of the primary visual cortex (cuneus gyrus), above the calcarine sul"
      }, {
        "text": "cus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisual Field Information:\u003c/b\u003e It carries information from the \u003cmark\u003esuperior retina\u003c/mark\u003e, which corresponds to the \u003cmark\u003einfer"
      }, {
        "text": "ior visual field\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion of the dorsal optic radiation causes a contralateral \u003cmark\u003einferior quadr"
      }, {
        "text": "antanopia\u003c/mark\u003e (a \u0027pie in the floor\u0027 visual field defect).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [["
      }, {
        "text": "ventral_optic_radiation|ventral optic radiation (Meyer\u0027s loop)]] travels through the temporal lobe and carries information from the inferior"
      }, {
        "text": " retina (superior visual field).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003ePITS\u003c/b\u003e: \u003cb\u003eP\u003c/b\u003earietal"
      }, {
        "text": " lesion \u003d \u003cb\u003eI\u003c/b\u003enferior field defect, \u003cb\u003eT\u003c/b\u003eemporal lesion \u003d \u003cb\u003eS\u003c/b\u003euperior"
      }, {
        "text": " field defect. A lesion in the parietal lobe affecting the dorsal optic radiation causes a \u0027pie on the floor\u0027 defect.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDorsal Optic Radiation\u003c/b\u003e is the superior visual pathway that"
      }, {
        "text": " takes a direct, superior route through the parietal lobe to carry information about the inferior visual world from the thalamus to the visual cortex.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Superior Retina] --\u003e B(LGN); B --\u003e C(Dorsal Optic"
      }, {
        "text": " Radiation); C --\u003e D(Through Parietal Lobe); D --\u003e E(Primary Visual Cortex); F[Lesion in Dors"
      }, {
        "text": "al Radiation] --\u003e G(Contralateral Inferior Quadrantanopia);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"optic_radiation\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"travels_through\",\n        \"to\": \"parietal_lobe\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"lesion_causes\",\n        \"to\": \"inferior_quadrantanopia\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"vent"
      }, {
        "text": "ral_optic_radiation\"\n      }\n    ]\n  },\n  \"d92676a0\": {\n    \""
      }, {
        "text": "title\": \"Double Y Male (XYY Syndrome)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Genetics\",\n      \"Pediatrics\",\n      \"Psychiatry\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Reproductive\",\n      \"Pathology\",\n      \"Genetic"
      }, {
        "text": " Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDouble Y male\u003c/b\u003e"
      }, {
        "text": ", or \u003cb\u003eXYY syndrome\u003c/b\u003e, is a sex chromosome aneuploidy in which a male has an extra Y chromosome, resulting in a 47"
      }, {
        "text": ",XYY karyotype. It is caused by a paternal meiotic II nondisjunction event.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e 47,XYY karyotype, resulting from nondisjunction of the"
      }, {
        "text": " Y chromosome during meiosis II in the father.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhenotype:\u003c/b\u003e Most individuals are phenotypically normal and"
      }, {
        "text": " are often undiagnosed. They typically have normal intelligence and are fertile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features:\u003c/b\u003e Associated with \u003cmark\u003etall stature\u003c/mark\u003e,"
      }, {
        "text": " severe acne, and an increased risk of learning disabilities and autism spectrum disorder.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistorical Misconception:\u003c/b\u003e Was"
      }, {
        "text": " once incorrectly linked to aggressive and criminal behavior (the \u0027supermale\u0027 myth), but this has been largely debunked.\u003c/li\u003e\u003cli\u003e\u003cb\u003e\u0027Down"
      }, {
        "text": "-and-out\u0027 eye:\u003c/b\u003e This term describes a [[fdfd22ca|CN III palsy]]"
      }, {
        "text": " and is \u003cu\u003enot related\u003c/u\u003e to XYY syndrome. The index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The classic presentation is a very tall male with learning difficulties or behavioral problems. Remember that it results from a paternal"
      }, {
        "text": " meiotic II error.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eXYY syndrome\u003c/b\u003e is a common"
      }, {
        "text": " and often asymptomatic sex chromosome aneuploidy, primarily characterized by tall stature, with most of the historical associations with aggression being unfounded"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"sex_chromosome_aneuploidy\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by\",\n        \"to\": \"paternal_meiotic_nondisjunction\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"tall_st"
      }, {
        "text": "ature\"\n      }\n    ]\n  },\n  \"0a59b5db\": {\n    \"title\": \""
      }, {
        "text": "Dream Enactment\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep"
      }, {
        "text": " Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eDream enactment\u003c/b\u003e is the cardinal feature of [[91fcdbc5|REM Sleep Behavior Disorder (R"
      }, {
        "text": "BD)]], where individuals physically act out their dreams, often in a violent or dramatic manner, due to a failure of the normal muscle"
      }, {
        "text": " atonia that accompanies REM sleep.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAssociated Disorder:\u003c/b\u003e The"
      }, {
        "text": " defining symptom of [[91fcdbc5|REM Sleep Behavior Disorder (RBD)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": ":\u003c/b\u003e Loss of the physiological muscle paralysis (atonia) that normally occurs during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBehaviors:\u003c/b\u003e Can"
      }, {
        "text": " range from simple limb twitching to complex and vigorous actions like punching, kicking, yelling, or jumping out of bed, which"
      }, {
        "text": " can cause injury to the patient or their bed partner.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The presence of dream enactment is a powerful"
      }, {
        "text": " predictor of future neurodegenerative disease, particularly Œ±-synucleinopathies like [[58c8ea03|Park"
      }, {
        "text": "inson disease]] and [[db2f16e5|Lewy body dementia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An"
      }, {
        "text": " older patient, especially male, who reports a history of \u0027fighting in his sleep\u0027 or has injured his spouse while dreaming"
      }, {
        "text": ", is a classic presentation for RBD and should be considered at high risk for developing Parkinson\u0027s or Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDream enactment\u003c/b\u003e is a dramatic and potentially dangerous manifestation of REM sleep without at"
      }, {
        "text": "onia, serving as a critical prodromal marker for underlying Œ±-synuclein neurodegenerative disorders.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        "
      }, {
        "text": "\"to\": \"91fcdbc5\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_prodromal_sign_of\",\n        \"to\": \"58c8ea03"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of"
      }, {
        "text": "\",\n        \"to\": \"db2f16e5\"\n      }\n    ]\n  },\n  \"4"
      }, {
        "text": "d2377b4\": {\n    \"title\": \"DRESS Syndrome\",\n    \"primaryType\": \"disease"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Immunology\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connect"
      }, {
        "text": "ive Tissue\",\n      \"Dermatology\",\n      \"Drug Reactions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eDRESS syndrome\u003c/b\u003e (Drug Reaction with Eosinophilia and Systemic Symptoms) is a severe"
      }, {
        "text": ", potentially life-threatening, idiosyncratic drug hypersensitivity reaction characterized by a triad of fever, rash, and internal organ involvement.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Typically has a long latency period, with symptoms"
      }, {
        "text": " appearing \u003cmark\u003e2 to 8 weeks\u003c/mark\u003e after starting the offending drug.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eRash:\u003c/b\u003e Widespread morbilliform rash that can progress to exfoliative dermatitis.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Fever:\u003c/b\u003e High fever is common.\u003cbr\u003e - \u003cb\u003eSystemic Symptoms:\u003c/b\u003e Lymphadenopathy and involvement"
      }, {
        "text": " of internal organs, most commonly the liver (hepatitis), kidneys (interstitial nephritis), and lungs (pneumonitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLaboratory"
      }, {
        "text": " Findings:\u003c/b\u003e Hallmark findings are \u003cmark\u003eeosinophilia\u003c/mark\u003e and atypical lymphocytosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCausative Drugs:\u003c/b\u003e Class"
      }, {
        "text": "ically associated with \u003cmark\u003eanticonvulsants\u003c/mark\u003e (e.g., [[eddd2bc"
      }, {
        "text": "5|carbamazepine]], [[5aea213f|phenytoin]], [[08d19a"
      }, {
        "text": "8f|lamotrigine]]), allopurinol, sulfonamides, and certain antibiotics like minocycline and"
      }, {
        "text": " vancomycin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who started a new anticonvulsant or all"
      }, {
        "text": "opurinol several weeks ago and now presents with fever, a widespread rash, facial edema, and elevated liver enzymes with"
      }, {
        "text": " eosinophilia is the classic vignette for DRESS syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDRESS syndrome\u003c/b\u003e is a"
      }, {
        "text": " delayed and severe drug reaction where the immune system goes into overdrive, causing not just a rash but also systemic inflammation with eosinophilia and potentially"
      }, {
        "text": " fatal internal organ damage, often triggered by anticonvulsants or allopurinol.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"drug_hypersensitivity_reaction\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_caused_by\",\n        \"to\": \"f91a0cfa\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by\",\n        \"to\": \"allopurinol\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"eosinophilia"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"9593d9b6\": {\n    \"title\": \""
      }, {
        "text": "Drooling\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pediatrics\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDrooling\u003c/b\u003e (sialorrhea) is the unintentional flow of saliva outside"
      }, {
        "text": " the mouth. While normal in infants, it can be a sign of neurological disease in older children and adults, often due"
      }, {
        "text": " to impaired swallowing (dysphagia) rather than excessive saliva production.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Neurological Causes:\u003c/b\u003e Common in conditions with oropharyngeal muscle weakness or incoordination, such as [[58c"
      }, {
        "text": "8ea03|Parkinson disease]], [[4ed629f9|amyotrophic lateral sclerosis (ALS)]], and"
      }, {
        "text": " [[171ca00b|cerebral palsy]]. It results from an inability to effectively manage and swallow normal amounts"
      }, {
        "text": " of saliva.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInfectious Causes:\u003c/b\u003e Can be a sign of acute infections that cause painful swallowing or airway obstruction, such as ep"
      }, {
        "text": "iglottitis or peritonsillar abscess.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management focuses on the underlying cause. For neurological"
      }, {
        "text": " conditions, \u003cmark\u003eanticholinergic (antimuscarinic) drugs\u003c/mark\u003e like glycopyrrolate or"
      }, {
        "text": " scopolamine can be used to reduce saliva production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrop Metastases:\u003c/b\u003e This term refers to the"
      }, {
        "text": " spread of CNS tumors (classically [[16d613bb|medulloblastoma]]) via the CSF to the"
      }, {
        "text": " spinal cord, and is unrelated to drooling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrop Seizures:\u003c/b\u003e This term refers to [[ed"
      }, {
        "text": "7a236f|atonic seizures]] and is unrelated to drooling.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In"
      }, {
        "text": " a patient with a known neurodegenerative disorder, the onset of drooling is a significant sign of progressive bulbar dysfunction and"
      }, {
        "text": " worsening dysphagia, indicating an increased risk of aspiration.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn"
      }, {
        "text": " a neurological context, \u003cb\u003edrooling\u003c/b\u003e is typically not a problem of making too much saliva, but rather a problem"
      }, {
        "text": " of not being able to swallow it, serving as a visible sign of underlying bulbar muscle weakness and dysphagia.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_symptom_of\",\n        \"to\": \"dysphagia\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"5"
      }, {
        "text": "8c8ea03\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        "
      }, {
        "text": "\"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"is_treated_"
      }, {
        "text": "by\",\n        \"to\": \"96e8bf39\"\n      }\n    ]\n  },\n  \"67"
      }, {
        "text": "8eea95\": {\n    \"title\": \"Drug Safety\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"General Principles\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDrug safety\u003c/b\u003e is a branch of pharmacology focused on identifying, evaluating"
      }, {
        "text": ", and preventing adverse drug reactions (ADRs). A key quantitative measure of a drug\u0027s safety is its therapeutic index.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTherapeutic Index (TI):\u003c/b\u003e The ratio of the dose"
      }, {
        "text": " of a drug that causes toxicity to the dose that produces the desired therapeutic effect. It is calculated as TD\u003csub\u003e50\u003c/sub\u003e/"
      }, {
        "text": "ED\u003csub\u003e50\u003c/sub\u003e (median toxic dose / median effective dose).\u003c/li\u003e\u003cli\u003e\u003cb\u003eInterpretation:\u003c/b\u003e A \u003cmark\u003ehigh therapeutic"
      }, {
        "text": " index\u003c/mark\u003e indicates a wide margin between the effective dose and the toxic dose, suggesting a safer drug (e.g., penicillin"
      }, {
        "text": "). A \u003cmark\u003elow therapeutic index\u003c/mark\u003e indicates a narrow margin of safety, meaning the effective and toxic doses are close,"
      }, {
        "text": " requiring careful monitoring (e.g., warfarin, digoxin, lithium).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapeutic Window:\u003c/b\u003e The range"
      }, {
        "text": " of drug dosages that can treat disease effectively without having toxic effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003e\u0027Drunken Sailor\u0027 Gait:\u003c/b\u003e This term"
      }, {
        "text": " describes a wide-based, unsteady gait known as \u003cmark\u003etruncal ataxia\u003c/mark\u003e, which is a classic"
      }, {
        "text": " sign of a [[6e31977d|cerebellar vermis lesion]]. It is not directly a"
      }, {
        "text": " concept of drug safety, but can be a sign of drug toxicity (e.g., from phenytoin or alcohol).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Drugs with a low therapeutic index are high-yield for exam questions. Be prepared to identify them and know that they require therapeutic"
      }, {
        "text": " drug monitoring.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003etherapeutic index\u003c/b\u003e is a critical measure"
      }, {
        "text": " of \u003cb\u003edrug safety\u003c/b\u003e, quantifying the \u0027wiggle room\u0027 a clinician has between a dose that helps and a dose that harms"
      }, {
        "text": "; drugs with a narrow therapeutic window require vigilant monitoring to prevent toxicity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_measured_by\",\n        \"to\": \"therapeutic_index\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_related_to\",\n        \"to\": \"adverse_drug_reaction\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"3f8bff66\": {\n    \"title\": \"Drusen\",\n    \"primary"
      }, {
        "text": "Type\": \"pathology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eDrusen\u003c/b\u003e are small, yellow or white extracellular deposits that accumulate between Bruch\u0027s membrane"
      }, {
        "text": " and the retinal pigment epithelium (RPE). They are a hallmark finding of \u003cmark\u003edry (atrophic) age-related macular degeneration ("
      }, {
        "text": "AMD)\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Appear as distinct, yellowish spots"
      }, {
        "text": " on fundoscopic examination, typically concentrated in the macula.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Composed of lipids"
      }, {
        "text": ", proteins, and cellular debris. Their accumulation is thought to impair the function of the RPE, leading to chronic oxidative"
      }, {
        "text": " stress, inflammation, and eventual atrophy of the RPE and overlying photoreceptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The number"
      }, {
        "text": " and size of drusen are key indicators of the risk and severity of [[c63255c8|age"
      }, {
        "text": "-related macular degeneration]]. \u0027Hard\u0027 drusen are small and distinct, carrying a lower risk. \u0027Soft\u0027 dr"
      }, {
        "text": "usen are larger, have indistinct borders, and are associated with a higher risk of progression to advanced AMD (either geographic atrophy"
      }, {
        "text": " or wet AMD).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Disease:\u003c/b\u003e The defining feature of \u003cmark\u003edry AMD\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Yellowish deposits in the macula of an elderly patient complaining of gradual central vision loss is a classic description of drusen in"
      }, {
        "text": " dry AMD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDrusen\u003c/b\u003e are the characteristic \u0027waste products\u0027 that"
      }, {
        "text": " build up under the retina in dry age-related macular degeneration, serving as a key biomarker for the disease and contributing to the slow"
      }, {
        "text": ", progressive loss of central vision.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_hallmark_of\",\n        \"to\": \"c63255c8\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"are_located_between\",\n        \"to\": \"bruch"
      }, {
        "text": "s_membrane\"\n      },\n      {\n        \"type\": \"are_located_between\",\n        \""
      }, {
        "text": "to\": \"retinal_pigment_epithelium\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "5bbe3597\": {\n    \"title\": \"Dura Mater\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\","
      }, {
        "text": "\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eDura Mater"
      }, {
        "text": "\u003c/b\u003e (Latin for \\\"tough mother\\\") is the thick, outermost layer of the three meninges that surround the brain and"
      }, {
        "text": " spinal cord. It provides a durable, protective covering for the central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Structure:\u003c/b\u003e Composed of dense, fibrous connective tissue. In the cranium, it consists of two layers: an outer periosteal layer that"
      }, {
        "text": " adheres to the skull, and an inner meningeal layer.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDural Reflections:\u003c/b\u003e The inner meningeal layer folds inward to form"
      }, {
        "text": " septa that divide the cranial cavity into compartments, such as the falx cerebri and tentorium cerebelli.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eDural Venous Sinuses:\u003c/b\u003e The two dural layers separate in certain locations to form the [[2"
      }, {
        "text": "1f1c955|dural venous sinuses]] (e.g., superior sagittal sinus), which are channels"
      }, {
        "text": " for venous blood drainage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e The dura is richly innervated by sensory nerves (primarily"
      }, {
        "text": " CN V), which is why dural stretching or irritation can cause headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "a61683ae|Epidural Hematoma]]:\u003c/b\u003e Bleeding between the dura and the skull.\u003cbr\u003e - \u003cb\u003e[[8"
      }, {
        "text": "aaeb0d8|Subdural Hematoma]]:\u003c/b\u003e Bleeding between the dura and the arachnoid mater."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the spaces relative to the dura: Epidural is \u0027above\u0027 the dura, Sub"
      }, {
        "text": "dural is \u0027below\u0027 the dura.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Dura Mater\u003c/b\u003e is the tough, protective outer shield of the CNS, which not only provides a physical barrier but also forms"
      }, {
        "text": " the critical venous drainage channels (dural sinuses) and the partitions that compartmentalize the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_layer_of\",\n        \"to\":"
      }, {
        "text": " \"meninges\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"2"
      }, {
        "text": "1f1c955\"\n      },\n      {\n        \"type\": \"is_superficial_to\",\n        \""
      }, {
        "text": "to\": \"8aaeb0d8\"\n      },\n      {\n        \"type\": \"is_deep"
      }, {
        "text": "_to\",\n        \"to\": \"a61683ae\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"21f1c955\": {\n    \"title\": \"Dural Venous Sinuses\",\n    "
      }, {
        "text": "\"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Vascular\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"An"
      }, {
        "text": "atomy and Physiology\",\n      \"Dural Venous Sinuses\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eDural Venous Sinuses\u003c/b\u003e are large venous channels located between the periosteal and meningeal layers of the"
      }, {
        "text": " [[5bbe3597|dura mater]]. They are the primary system for venous drainage of the brain and also"
      }, {
        "text": " receive cerebrospinal fluid from the [[b7b67074|arachnoid granulations]].\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Unlike typical veins, they are valveless channels lined by endothelium."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Sinuses:\u003c/b\u003e Superior sagittal sinus, inferior sagittal sinus, straight sinus, [[6e281"
      }, {
        "text": "699|confluence of the sinuses]], transverse sinuses, sigmoid sinuses, and [[c260efc"
      }, {
        "text": "8|cavernous sinuses]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrainage Pathway:\u003c/b\u003e Most venous blood and CSF ultimately drain via the sigmoid"
      }, {
        "text": " sinuses into the internal jugular veins at the jugular foramen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDural Ven"
      }, {
        "text": "ous Sinus Thrombosis:\u003c/b\u003e A clot within a sinus, which can increase intracranial pressure and lead to venous infarction."
      }, {
        "text": " Associated with hypercoagulable states.\u003cbr\u003e - \u003cb\u003e[[c260efc8|Cavernous Sinus]]:\u003c/b\u003e A clinically"
      }, {
        "text": " important sinus due to the numerous cranial nerves that pass through it.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to trace the main"
      }, {
        "text": " venous drainage path: Superior Sagittal Sinus ‚Üí Confluence ‚Üí Transverse Sinus ‚Üí Sigmoid Sinus ‚Üí Internal"
      }, {
        "text": " Jugular Vein.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eDural Venous Sinuses\u003c/b\u003e are the"
      }, {
        "text": " brain\u0027s unique, low-pressure venous drainage system, ingeniously housed within the tough dural layers, responsible for collecting both"
      }, {
        "text": " deoxygenated blood and spent cerebrospinal fluid for return to the systemic circulation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[C"
      }, {
        "text": "erebral Veins] --\u003e B(Dural Venous Sinuses); C[Arachnoid Granulations] --\u003e B;"
      }, {
        "text": " B --\u003e D(Internal Jugular Vein);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"are_formed_by\",\n        \"to\": \"5bbe3597\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"receive_csf_from\",\n        \"to\": \""
      }, {
        "text": "b7b67074\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"c260efc8\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"can_be_affected_by\",\n        \"to\": \"dural_venous_sinus_thrombosis\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"cc61d4d0\": {\n    \"title"
      }, {
        "text": "\": \"Duret Hemorrhages\",\n    \"primaryType\": \"pathology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuropathology\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Herniation"
      }, {
        "text": " Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDuret hemorrh"
      }, {
        "text": "ages\u003c/b\u003e are small, linear hemorrhages in the midline of the pons and midbrain that are a secondary complication of downward"
      }, {
        "text": " [[bad81d37|central transtentorial brain herniation]]. They are typically a terminal event.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by the stretching and tearing of small, perforating branches"
      }, {
        "text": " of the [[e7a90cd9|basilar artery]] as the brainstem is forced downward and compressed"
      }, {
        "text": " during herniation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition:\u003c/b\u003e A classic finding in patients who have died from severe, acute increases"
      }, {
        "text": " in intracranial pressure leading to [[bad81d37|central transtentorial herniation]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Midline and paramedian areas of the pons and midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e They are"
      }, {
        "text": " not the primary cause of the patient\u0027s condition but rather a consequence of it. Their presence indicates severe, irreversible brainstem damage"
      }, {
        "text": " and is an ominous prognostic sign.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Duret hemorrhages are a specific pathological finding associated with the final"
      }, {
        "text": " stages of central herniation. They are a consequence, not a cause, of the primary brain injury.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eDuret hemorrhages\u003c/b\u003e are the fatal vascular footprints of downward brainstem herniation, caused by the mechanical"
      }, {
        "text": " shearing of pontine and midbrain arteries as the brainstem is crushed, signifying an irreversible terminal event.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Central Transtentorial Herniation] --\u003e B(Downward Brainstem Displacement); B --\u003e C(St"
      }, {
        "text": "retching/Tearing of Perforating Arteries); C --\u003e D(Duret Hemorrhages);\"\n    },\n    \"connections\": ["
      }, {
        "text": "\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"bad81d3"
      }, {
        "text": "7\"\n      },\n      {\n        \"type\": \"are_located_in\",\n        \"to\": \"brainstem\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"result_from_tearing_of_branches_of\",\n        \"to\":"
      }, {
        "text": " \"e7a90cd9\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1Hvs6MNRt48nb5Qudtj3KFCaw06UyN5iX"
      },
      "role": "user",
      "tokenCount": 2032
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"e6bef6d5\": {\n    \"title\": \"Dysarthria\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Speech Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDysarthria\u003c/b\u003e is a motor speech disorder resulting from impaired movement of the muscles used for speech production, including the lips, tongue, vocal folds, and diaphragm. It is a problem with articulation, not language formulation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by weakness, paralysis, or incoordination of the speech musculature due to a neurological injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Speech may be slurred, slow, quiet, or strained. The content and grammar of language are intact, but the clarity of speech is poor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Aphasia:\u003c/b\u003e This is a critical distinction. [[6bc9a567|Aphasia]] is a language disorder (difficulty finding words, forming sentences, or comprehending). Dysarthria is a speech disorder (difficulty articulating words). A patient with dysarthria can write normally, while a patient with aphasia often cannot.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can result from various brain lesions, including [[c5da3c57|stroke]] (especially brainstem or cerebellar), [[4ed629f9|amyotrophic lateral sclerosis (ALS)]], [[58c8ea03|Parkinson disease]], and [[7a680d3d|osmotic demyelination syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a patient\u0027s speech is slurred but they can write a coherent sentence, the problem is dysarthria (a motor issue), not aphasia (a language issue).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDysarthria\u003c/b\u003e is a mechanical problem of speech articulation due to muscle weakness or incoordination, where the \u0027message\u0027 is correct but the \u0027delivery\u0027 is flawed, distinguishing it fundamentally from aphasia, which is a problem with the message itself.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"7a680d3d\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"4ed629f9\"\n      }\n    ]\n  },\n  \"9a9c9169\": {\n    \"title\": \"Dyskinesias\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDyskinesias\u003c/b\u003e are a category of movement disorders characterized by involuntary, erratic, writhing movements of the face, arms, legs, or trunk. They are often a side effect of long-term levodopa treatment in [[58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Involuntary, non-rhythmic, often complex movements that can appear dance-like ([[0fa0d8ee|chorea]]), writhing ([[19272e70|athetosis]]), or a combination (choreoathetosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLevodopa-Induced Dyskinesia (LID):\u003c/b\u003e A common complication of long-term [[541cd176|carbidopa/levodopa]] therapy for [[58c8ea03|Parkinson disease]]. The movements typically occur when dopamine levels are at their peak (\u0027peak-dose dyskinesia\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTardive Dyskinesia:\u003c/b\u003e A type of dyskinesia that appears after long-term use of dopamine-receptor blocking agents (antipsychotics). Characterized by repetitive, involuntary movements, often of the face (e.g., grimacing, lip smacking, tongue protrusion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Types:\u003c/b\u003e Other dyskinesias include [[b564ac97|asterixis]], [[73999a73|dystonia]], and [[myoclonus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Dyskinesia in a Parkinson\u0027s patient is most likely a side effect of their levodopa therapy. Tardive dyskinesia is a feared long-term side effect of antipsychotics.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDyskinesias\u003c/b\u003e are involuntary \u0027overflow\u0027 movements resulting from a dysregulated [[ed462927|basal ganglia]], often iatrogenically caused by medications that alter the brain\u0027s delicate dopamine balance, such as levodopa or antipsychotics.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"0fa0d8ee\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"19272e70\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tardive_dyskinesia\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"541cd176\"\n      }\n    ]\n  },\n  \"e380a275\": {\n    \"title\": \"Dysmetria\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebellar Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDysmetria\u003c/b\u003e is a lack of coordination of movement typified by the undershoot or overshoot of intended position with the hand, arm, leg, or eye. It is a type of [[9767fd6b|ataxia]] and is a classic sign of a cerebellar lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e An inability to judge distance or scale. \u003cbr\u003e - \u003cb\u003eHypermetria:\u003c/b\u003e Overshooting the target.\u003cbr\u003e - \u003cb\u003eHypometria:\u003c/b\u003e Undershooting the target.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Testing:\u003c/b\u003e Assessed with the \u003cmark\u003efinger-to-nose test\u003c/mark\u003e or the heel-to-shin test. A patient with dysmetria will miss the target.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e A key sign of a lesion in the \u003cmark\u003e[[bebe58d4|cerebellar hemisphere]]\u003c/mark\u003e or its connections (e.g., the [[c819d97b|dentate nucleus]]). The deficit is ipsilateral to the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs:\u003c/b\u003e Often occurs with an \u003cmark\u003eintention tremor\u003c/mark\u003e, where the limb oscillates as it approaches the target.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be caused by [[c5da3c57|stroke]] (e.g., AICA or PICA stroke), [[45dd6d19|multiple sclerosis]], or tumors affecting the cerebellum. It is also a feature of [[350f1c8b|central vertigo]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who consistently overshoots or undershoots when trying to touch the examiner\u0027s finger has dysmetria, which points to an ipsilateral cerebellar hemisphere lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDysmetria\u003c/b\u003e is the clinical manifestation of the cerebellum\u0027s failure to properly calibrate movement, resulting in an inability to accurately \u0027measure\u0027 the distance to a target and leading to the characteristic over- or undershooting of voluntary actions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"9767fd6b\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"cerebellar_hemisphere_lesion\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"3c075343\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"posterior_inferior_cerebellar_artery_stroke\"\n      }\n    ]\n  },\n  \"f0207c17\": {\n    \"title\": \"Dysphagia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Gastroenterology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDysphagia\u003c/b\u003e is the medical term for difficulty swallowing. It can be caused by mechanical obstruction (oropharyngeal or esophageal) or by neuromuscular dysfunction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOropharyngeal Dysphagia:\u003c/b\u003e Difficulty initiating a swallow, often accompanied by coughing, choking, or nasal regurgitation. This points to a neuromuscular problem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEsophageal Dysphagia:\u003c/b\u003e Sensation of food getting stuck in the esophagus after a swallow has been initiated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Causes:\u003c/b\u003e Dysphagia is a common symptom of neurological disorders that affect the muscles of swallowing or their neural control. This includes:\u003cbr\u003e - \u003cb\u003e[[c5da3c57|Stroke]]:\u003c/b\u003e Particularly brainstem strokes affecting the medulla (e.g., \u003cmark\u003eLateral Medullary Syndrome\u003c/mark\u003e from a PICA stroke, which damages the nucleus ambiguus [CN IX, X]).\u003cbr\u003e - \u003cb\u003eMotor Neuron Disease:\u003c/b\u003e A key feature of [[901f3180|bulbar palsy]] in [[4ed629f9|ALS]].\u003cbr\u003e - \u003cb\u003eMyasthenia Gravis:\u003c/b\u003e Fluctuating weakness of bulbar muscles.\u003cbr\u003e - \u003cb\u003e[[7a680d3d|Osmotic Demyelination Syndrome]]:\u003c/b\u003e Can cause dysphagia due to pontine damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Dysphagia accompanied by hoarseness and a diminished gag reflex is a classic sign of a lesion in the nucleus ambiguus, pointing to a lateral medullary stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn a neurological context, \u003cb\u003edysphagia\u003c/b\u003e is a critical \u0027red flag\u0027 for brainstem dysfunction, particularly involving the lower cranial nerves (IX, X) that orchestrate the complex motor sequence of swallowing.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"lateral_medullary_syndrome\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"7a680d3d\"\n      }\n    ]\n  },\n  \"73999a73\": {\n    \"title\": \"Dystonia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDystonia\u003c/b\u003e is a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive, movements, postures, or both. The movements are typically patterned and twisting, and may be tremulous.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Involuntary muscle contractions that force body parts into abnormal, sometimes painful, positions. Can be focal (affecting one body part, e.g., torticollis), segmental, or generalized.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute Dystonic Reaction:\u003c/b\u003e A common extrapyramidal side effect of \u003cmark\u003etypical antipsychotics\u003c/mark\u003e (especially high-potency ones like haloperidol) and antiemetics like metoclopramide. Occurs hours to days after starting the drug.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation of Acute Dystonia:\u003c/b\u003e Can manifest as torticollis (neck twisting), oculogyric crisis (eyes forced upward), or opisthotonus (arching of the back).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment of Acute Dystonia:\u003c/b\u003e This is a frightening but reversible condition. Treat with centrally acting \u003cmark\u003eanticholinergic drugs\u003c/mark\u003e (e.g., [[383f6fbe|benztropine]]) or diphenhydramine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can be a feature of [[58c8ea03|Parkinson disease]] or other neurodegenerative disorders. Can also be inherited (primary dystonia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who recently started an antipsychotic and develops a sudden, painful neck twist has an acute dystonic reaction. The treatment is [[383f6fbe|benztropine]] or diphenhydramine.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDystonia\u003c/b\u003e is a disorder of sustained muscle contraction leading to abnormal postures, which can occur as a frightening acute side effect of dopamine-blocking drugs and is promptly reversible with anticholinergic medication.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"9a9c9169\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"383f6fbe\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"diphenhydramine\"\n      }\n    ]\n  },\n  \"edeecb71\": {\n    \"title\": \"Echothiophate\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEchothiophate\u003c/b\u003e is a long-acting, irreversible \u003ci\u003eorganophosphate cholinesterase inhibitor\u003c/i\u003e used topically in ophthalmology for the treatment of glaucoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Irreversibly inhibits acetylcholinesterase (AChE) by forming a stable covalent bond with the enzyme. This leads to a buildup of [[6a005559|acetylcholine]] at cholinergic synapses in the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Effects:\u003c/b\u003e The increased ACh causes contraction of the ciliary muscle (increasing trabecular outflow of aqueous humor) and the sphincter pupillae muscle (causing miosis). Both effects contribute to a \u003cmark\u003ereduction in intraocular pressure\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for [[5ea7b741|open-angle glaucoma]], particularly when other agents are ineffective. Its use is limited due to its side effect profile and the availability of safer alternatives.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects include blurred vision, brow ache, and potential for cataracts with long-term use. Systemic absorption can occur, potentially leading to systemic cholinergic effects (e.g., bradycardia, bronchospasm), although this is rare with topical use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Echothiophate is a classic example of an irreversible cholinesterase inhibitor (an organophosphate) used therapeutically. Its mechanism is the same as that of organophosphate pesticides.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEchothiophate\u003c/b\u003e is a potent, irreversible cholinesterase inhibitor that provides long-lasting reduction of intraocular pressure in glaucoma by amplifying the effects of acetylcholine, but its use is restricted due to the potential for significant side effects.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0835ea01\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"organophosphate\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      }\n    ]\n  },\n  \"25e91fde\": {\n    \"title\": \"Ectopia Lentis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Lens Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEctopia lentis\u003c/b\u003e is the displacement or malposition of the eye\u0027s crystalline lens from its normal location. While it can be caused by trauma, its presence can be a key sign of an underlying systemic connective tissue disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by weakness or disruption of the zonular fibers that hold the lens in place.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarfan Syndrome:\u003c/b\u003e A classic cause. Due to a defect in fibrillin-1, the zonular fibers are weak. The lens typically dislocates \u003cmark\u003eupward and outward\u003c/mark\u003e (superotemporally).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHomocystinuria:\u003c/b\u003e An autosomal recessive disorder of methionine metabolism. Defective cystathionine synthase leads to weak zonular fibers. The lens typically dislocates \u003cmark\u003edownward and inward\u003c/mark\u003e (inferonasally).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation Mnemonic:\u003c/b\u003e Mar\u003cb\u003efan\u003c/b\u003e looks up at the \u003cb\u003efan\u003c/b\u003e on the ceiling (upward dislocation). In homocystinuria, you look \u003cb\u003edown\u003c/b\u003e to pick up your dropped \u0027\u003cb\u003ehom\u003c/b\u003eies\u0027 (downward dislocation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Trauma is the most common overall cause. Other rare genetic causes include Weill-Marchesani syndrome and sulfite oxidase deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction of lens dislocation is a key feature used to distinguish Marfan syndrome from homocystinuria in a clinical vignette.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEctopia lentis\u003c/b\u003e is a significant clinical sign that points beyond the eye, with the direction of lens displacement‚Äîupward in Marfan syndrome, downward in homocystinuria‚Äîserving as a classic differentiator between these two systemic connective tissue disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"marfan_syndrome\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"homocystinuria\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"zonular_fiber_weakness\"\n      }\n    ]\n  },\n  \"bbcfaf1f\": {\n    \"title\": \"Edema\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pathology\",\n      \"Cardiology\",\n      \"Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEdema\u003c/b\u003e is the accumulation of excess fluid in the interstitial tissue spaces or body cavities. It can be localized or generalized and results from an imbalance in the Starling forces that govern fluid exchange across capillaries.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by one or more of the following:\u003cbr\u003e - \u003cb\u003e‚Üë Hydrostatic pressure:\u003c/b\u003e (e.g., heart failure, venous obstruction)\u003cbr\u003e - \u003cb\u003e‚Üì Oncotic pressure:\u003c/b\u003e (e.g., nephrotic syndrome, liver failure, malnutrition)\u003cbr\u003e - \u003cb\u003e‚Üë Capillary permeability:\u003c/b\u003e (e.g., inflammation, burns, sepsis)\u003cbr\u003e - \u003cb\u003eLymphatic obstruction:\u003c/b\u003e (e.g., lymphedema)\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Edema:\u003c/b\u003e A specific and life-threatening type of edema within the brain. It is classified as:\u003cbr\u003e - \u003cb\u003e[[8e51aa24|Cytotoxic Edema]]:\u003c/b\u003e Intracellular swelling due to cellular injury (e.g., early stroke).\u003cbr\u003e - \u003cb\u003eVasogenic Edema:\u003c/b\u003e Extracellular fluid accumulation due to a disrupted blood-brain barrier (e.g., tumor, late stroke).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In the context of neurology, edema is most often referring to [[aa00bdef|cerebral edema]], a critical condition that increases intracranial pressure.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEdema\u003c/b\u003e is the clinical manifestation of \u0027leaky\u0027 or over-pressurized capillaries, with the specific cause determining whether the fluid accumulation is due to too much pressure pushing out, not enough protein pulling in, or a damaged vessel wall.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"aa00bdef\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"8e51aa24\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"heart_failure\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"nephrotic_syndrome\"\n      }\n    ]\n  },\n  \"33f84fa5\": {\n    \"title\": \"Edinger-Westphal Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eEdinger-Westphal nucleus\u003c/b\u003e is the parasympathetic preganglionic nucleus that innervates the eye. It is located in the midbrain and its axons travel with the [[68c66997|oculomotor nerve (CN III)]] to control pupillary constriction and lens accommodation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Rostral midbrain, dorsal to the main oculomotor nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides preganglionic \u003cmark\u003eparasympathetic\u003c/mark\u003e fibers to the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Axons from the Edinger-Westphal nucleus travel in CN III to the orbit, where they synapse in the [[6d7a091d|ciliary ganglion]]. Postganglionic fibers then travel via the short ciliary nerves to innervate the sphincter pupillae and ciliary muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReflexes:\u003c/b\u003e It is the efferent motor nucleus for both the \u003cmark\u003epupillary light reflex\u003c/mark\u003e and the \u003cmark\u003e[[81b5f5fe|accommodation reflex]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e A lesion compressing CN III (e.g., PComA aneurysm) often affects these superficial parasympathetic fibers first, leading to a fixed, dilated pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This nucleus is the starting point for the parasympathetic control of the pupil and lens. Its bilateral activation by the pretectal nuclei is the basis for the consensual light reflex.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eEdinger-Westphal nucleus\u003c/b\u003e is the parasympathetic command center for the eye, sending signals via the oculomotor nerve to constrict the pupil and focus the lens, making it a critical component of the light and accommodation reflexes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Edinger-Westphal Nucleus] --Preganglionic Fibers (CN III)--\u003e B(Ciliary Ganglion); B --Postganglionic Fibers--\u003e C(Sphincter Pupillae \u0026 Ciliary Muscle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_nucleus_of\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"pupillary_light_reflex\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"81b5f5fe\"\n      }\n    ]\n  },\n  \"774709ab\": {\n    \"title\": \"Ehlers-Danlos Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Genetics\",\n      \"Rheumatology\",\n      \"Dermatology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Pathology\",\n      \"Connective Tissue Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEhlers-Danlos syndrome (EDS)\u003c/b\u003e is a group of inherited connective tissue disorders caused by defects in the synthesis or structure of collagen. It is characterized by joint hypermobility, skin hyperextensibility, and tissue fragility.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Most types are caused by mutations in genes encoding for collagen (e.g., \u003ci\u003eCOL5A1\u003c/i\u003e, \u003ci\u003eCOL5A2\u003c/i\u003e in the classical type) or enzymes involved in collagen processing. The vascular type (the most severe) is due to a defect in \u003cmark\u003eType III collagen\u003c/mark\u003e (\u003ci\u003eCOL3A1\u003c/i\u003e gene).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Varies by type, but common features include joint hypermobility (\u0027double-jointed\u0027), easy bruising, abnormal scar formation (atrophic, \u0027cigarette paper\u0027 scars), and soft, velvety, hyperextensible skin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Type (vEDS):\u003c/b\u003e The most life-threatening form. Associated with fragility of large blood vessels and hollow organs, leading to a high risk of arterial dissection or rupture (e.g., aortic dissection), and organ rupture (e.g., colon, gravid uterus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Complication:\u003c/b\u003e The vascular fragility in some types of EDS increases the risk of intracranial \u003cmark\u003e[[a9f6d703|berry aneurysms]]\u003c/mark\u003e and subsequent [[63f8b05f|subarachnoid hemorrhage]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with joint hypermobility, stretchy skin, and a family history of sudden death should raise suspicion for the vascular type of Ehlers-Danlos syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEhlers-Danlos syndrome\u003c/b\u003e is a genetic defect in the body\u0027s \u0027glue\u0027 (collagen), leading to fragile, stretchy tissues that manifest as hypermobile joints and skin, with the dangerous vascular type predisposing to catastrophic arterial and organ rupture.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_defect_in\",\n        \"to\": \"collagen_synthesis\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"aortic_dissection\"\n      }\n    ]\n  },\n  \"6a805ecd\": {\n    \"title\": \"Embolic Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cardiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eembolic stroke\u003c/b\u003e is a type of [[c5da3c57|ischemic stroke]] that occurs when a clot or other debris (an embolus) forms elsewhere in the body, travels through the bloodstream, and lodges in a cerebral artery, obstructing blood flow.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOnset:\u003c/b\u003e Typically has a \u003cmark\u003esudden, maximal-at-onset\u003c/mark\u003e presentation of neurological deficits, as the vessel is abruptly occluded.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Sources of Emboli:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eCardiogenic (most common):\u003c/b\u003e Thrombus formation in the heart, most frequently due to \u003cmark\u003eatrial fibrillation\u003c/mark\u003e. Other cardiac sources include mural thrombus after MI, valvular disease (e.g., endocarditis), and patent foramen ovale (paradoxical embolus).\u003cbr\u003e2. \u003cb\u003eArtery-to-Artery:\u003c/b\u003e An embolus from a proximal atherosclerotic plaque, typically in the \u003cmark\u003ecarotid artery\u003c/mark\u003e or aortic arch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e Often lodges at arterial bifurcations. The [[143bb23d|Middle Cerebral Artery (MCA)]] is the most common destination for emboli from the internal carotid circulation. Emboli can cause infarcts in multiple vascular territories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of atrial fibrillation who suddenly develops aphasia and right-sided weakness has likely had an embolic stroke to the left MCA.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eembolic stroke\u003c/b\u003e is a \u0027stroke from a distance,\u0027 where a clot, most often from the heart in atrial fibrillation, travels to and abruptly blocks a cerebral artery, causing a sudden onset of neurological deficits.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Atrial Fibrillation/Carotid Plaque] --\u003e B(Thrombus Formation); B --\u003e C(Embolus Travels to Brain); C --\u003e D(Occludes Cerebral Artery); D --\u003e E(Ischemic Stroke);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"atrial_fibrillation\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"carotid_artery_stenosis\"\n      },\n      {\n        \"type\": \"most_often_affects\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"3eccefd4\": {\n    \"title\": \"Emboliform Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebellum\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eEmboliform Nucleus\u003c/b\u003e is one of the four deep cerebellar nuclei, located medial to the dentate nucleus and lateral to the globose nucleus. Along with the globose nucleus, it forms the interposed nucleus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Deep within the white matter of the [[bebe58d4|cerebellum]], part of the interposed nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The interposed nuclei (emboliform + globose) are involved in coordinating agonist-antagonist muscle pairs during voluntary movements of the \u003cmark\u003edistal limbs\u003c/mark\u003e. They receive input from the intermediate zone of the cerebellar cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the contralateral red nucleus, contributing to the rubrospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e The deep cerebellar nuclei from lateral to medial are \\\"\u003cb\u003eD\u003c/b\u003eon\u0027t \u003cb\u003eE\u003c/b\u003eat \u003cb\u003eG\u003c/b\u003ereasy \u003cb\u003eF\u003c/b\u003eoods\\\" (\u003cb\u003eD\u003c/b\u003eentate, \u003cb\u003eE\u003c/b\u003emboliform, \u003cb\u003eG\u003c/b\u003elobose, \u003cb\u003eF\u003c/b\u003eastigial).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While less commonly tested than the dentate (limb ataxia) or fastigial (truncal ataxia) nuclei, remember that the interposed nuclei (emboliform and globose) are involved in modulating limb movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eEmboliform Nucleus\u003c/b\u003e, as part of the interposed nuclei, acts as a cerebellar relay station that helps fine-tune the execution of voluntary movements in the distal limbs by modulating activity in the red nucleus.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_cerebellar_nuclei\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"forms_interposed_nucleus_with\",\n        \"to\": \"globose_nucleus\"\n      }\n    ]\n  },\n  \"777ddb37\": {\n    \"title\": \"Neuroembryology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeuroembryology\u003c/b\u003e is the study of the development of the nervous system in the embryo. It begins with the process of neurulation, where the neural plate folds to form the neural tube, the precursor to the entire central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurulation:\u003c/b\u003e The notochord induces the overlying ectoderm to form the neural plate, which then folds to create the neural tube. This process occurs in the 3rd and 4th weeks of gestation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Tube Derivatives:\u003c/b\u003e The neural tube gives rise to the CNS (brain and spinal cord), including neurons, oligodendrocytes, astrocytes, and ependymal cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Crest Derivatives:\u003c/b\u003e Neural crest cells migrate away from the neural tube to form the PNS (e.g., Schwann cells, dorsal root ganglia, autonomic ganglia) and many non-neural structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrain Vesicles:\u003c/b\u003e The rostral neural tube develops into three primary vesicles (prosencephalon, mesencephalon, rhombencephalon), which then differentiate into five secondary vesicles that form the adult brain structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Errors in neuroembryology lead to congenital malformations, such as \u003cmark\u003eneural tube defects\u003c/mark\u003e ([[5bcc9894|anencephaly]], spina bifida) and [[b96a6a07|posterior fossa malformations]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Folate deficiency is a major risk factor for neural tube defects. Supplementation before and during early pregnancy is crucial for prevention.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeuroembryology\u003c/b\u003e traces the intricate transformation of a simple ectodermal sheet into the complex architecture of the brain and spinal cord, a process highly vulnerable to disruption in early pregnancy, leading to severe congenital malformations.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ectoderm] --Notochord Induction--\u003e B(Neural Plate); B --\u003e C(Neural Tube); C --\u003e D(Brain \u0026 Spinal Cord); B --\u003e E(Neural Crest); E --\u003e F(PNS \u0026 Other Structures);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"describes_development_of\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"involves_formation_of\",\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type\": \"errors_in_lead_to\",\n        \"to\": \"neural_tube_defect\"\n      }\n    ]\n  },\n  \"3ac46ef4\": {\n    \"title\": \"Emotion\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn neuroscience, \u003cb\u003eemotion\u003c/b\u003e refers to complex psychophysiological experiences involving subjective feeling, physiological response, and behavioral expression. The processing and regulation of emotion are primarily functions of the [[73ace357|limbic system]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Neural Structures:\u003c/b\u003e The [[73ace357|limbic system]] is the main circuit for emotion. Key components include:\u003cbr\u003e - \u003cb\u003e[[d220fc3f|Amygdala]]:\u003c/b\u003e Central to processing fear, anger, and pleasure. It attaches emotional significance to memories.\u003cbr\u003e - \u003cb\u003e[[89e86633|Hypothalamus]]:\u003c/b\u003e Mediates the physiological expression of emotion through its control of the autonomic nervous system and endocrine system (e.g., fight-or-flight response).\u003cbr\u003e - \u003cb\u003e[[22e49c50|Cingulate Gyrus]]:\u003c/b\u003e Involved in emotional learning and the link between emotion, memory, and behavior.\u003cbr\u003e - \u003cb\u003ePrefrontal Cortex:\u003c/b\u003e Provides top-down regulation of emotion, inhibiting impulsive emotional responses.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePapez Circuit:\u003c/b\u003e A historical model of the emotional circuit involving the hippocampus, mammillary bodies, anterior thalamic nucleus, and cingulate gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The [[d220fc3f|amygdala]] is the most important structure to associate with the generation of fear and emotional learning. Bilateral lesions lead to Kl√ºver-Bucy syndrome, characterized by a loss of fear.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEmotion\u003c/b\u003e is a product of the brain\u0027s [[73ace357|limbic system]], where the [[d220fc3f|amygdala]] acts as the primary processor of emotional stimuli, and the [[89e86633|hypothalamus]] translates these feelings into physiological responses, all under the watchful, regulatory eye of the prefrontal cortex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_processed_by\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_processed_by\",\n        \"to\": \"d220fc3f\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"prefrontal_cortex\"\n      }\n    ]\n  },\n  \"1c42ff26\": {\n    \"title\": \"Encephalotrigeminal Angiomatosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEncephalotrigeminal angiomatosis\u003c/b\u003e, more commonly known as \u003cb\u003eSturge-Weber syndrome\u003c/b\u003e, is a rare, congenital neurocutaneous disorder characterized by a facial capillary malformation (port-wine stain) and an associated vascular malformation of the brain and eye.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Caused by a somatic mosaic mutation in the \u003ci\u003eGNAQ\u003c/i\u003e gene. It is \u003cu\u003enot\u003c/u\u003e inherited.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eFacial Port-Wine Stain:\u003c/b\u003e A capillary malformation in the distribution of the ophthalmic (V\u003csub\u003e1\u003c/sub\u003e) and sometimes maxillary (V\u003csub\u003e2\u003c/sub\u003e) branches of the trigeminal nerve.\u003cbr\u003e2. \u003cb\u003eLeptomeningeal Angioma:\u003c/b\u003e An abnormal collection of blood vessels on the surface of the brain, typically ipsilateral to the facial lesion. This can lead to \u003cmark\u003eseizures\u003c/mark\u003e (most common neurological symptom), intellectual disability, and focal neurological deficits.\u003cbr\u003e3. \u003cb\u003eGlaucoma:\u003c/b\u003e Increased intraocular pressure, often ipsilateral to the facial lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Skull X-rays or CT scans may show characteristic \u0027tram-track\u0027 calcifications, which represent calcification of the cortex underlying the leptomeningeal angioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with a port-wine stain on their face, seizures, and intellectual disability is the classic presentation of Sturge-Weber syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e is a congenital vascular disorder that \u0027stains\u0027 the face with a port-wine birthmark and the underlying brain with a leptomeningeal angioma, leading to a triad of dermatological, neurological (seizures), and ophthalmological (glaucoma) problems.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Somatic GNAQ Mutation] --\u003e B(Vascular Malformation); B --\u003e C(Facial Port-Wine Stain); B --\u003e D(Leptomeningeal Angioma); D --\u003e E(Seizures); B --\u003e F(Ocular Involvement); F --\u003e G(Glaucoma);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"sturge_weber_syndrome\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous_disorder\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"port_wine_stain\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"seizures\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9877,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"e6bef6d5\": {\n    \"title"
      }, {
        "text": "\": \"Dysarthria\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pathology\",\n      \"Speech Disorders\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDysarthria\u003c/b\u003e is a motor speech disorder resulting from impaired movement of the muscles used"
      }, {
        "text": " for speech production, including the lips, tongue, vocal folds, and diaphragm. It is a problem with articulation, not language"
      }, {
        "text": " formulation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by weakness,"
      }, {
        "text": " paralysis, or incoordination of the speech musculature due to a neurological injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Speech may"
      }, {
        "text": " be slurred, slow, quiet, or strained. The content and grammar of language are intact, but the clarity of"
      }, {
        "text": " speech is poor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Aphasia:\u003c/b\u003e This is a critical distinction. [[6bc9"
      }, {
        "text": "a567|Aphasia]] is a language disorder (difficulty finding words, forming sentences, or comprehending). Dys"
      }, {
        "text": "arthria is a speech disorder (difficulty articulating words). A patient with dysarthria can write normally, while a patient with aphasia often"
      }, {
        "text": " cannot.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can result from various brain lesions, including [[c5da3c57"
      }, {
        "text": "|stroke]] (especially brainstem or cerebellar), [[4ed629f9|amyotrophic lateral sclerosis ("
      }, {
        "text": "ALS)]], [[58c8ea03|Parkinson disease]], and [[7a680d3"
      }, {
        "text": "d|osmotic demyelination syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a patient\u0027s speech is slurred but"
      }, {
        "text": " they can write a coherent sentence, the problem is dysarthria (a motor issue), not aphasia (a language issue).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDysarthria\u003c/b\u003e is a mechanical problem of speech articulation due to muscle"
      }, {
        "text": " weakness or incoordination, where the \u0027message\u0027 is correct but the \u0027delivery\u0027 is flawed, distinguishing it fundamentally from aphasia,"
      }, {
        "text": " which is a problem with the message itself.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"6bc9a567\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"c"
      }, {
        "text": "5da3c57\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        "
      }, {
        "text": "\"to\": \"7a680d3d\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "symptom_of\",\n        \"to\": \"4ed629f9\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"9a9c9169\": {\n    \"title\": \"Dyskinesias"
      }, {
        "text": "\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDyskinesias\u003c/b\u003e are a category of movement disorders characterized by involuntary"
      }, {
        "text": ", erratic, writhing movements of the face, arms, legs, or trunk. They are often a side effect of long"
      }, {
        "text": "-term levodopa treatment in [[58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Involuntary, non-rhythmic, often complex movements that"
      }, {
        "text": " can appear dance-like ([[0fa0d8ee|chorea]]), writhing ([[19272e"
      }, {
        "text": "70|athetosis]]), or a combination (choreoathetosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLevodopa-"
      }, {
        "text": "Induced Dyskinesia (LID):\u003c/b\u003e A common complication of long-term [[541cd176|car"
      }, {
        "text": "bidopa/levodopa]] therapy for [[58c8ea03|Parkinson disease]]. The movements"
      }, {
        "text": " typically occur when dopamine levels are at their peak (\u0027peak-dose dyskinesia\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTardive Dyskinesia:"
      }, {
        "text": "\u003c/b\u003e A type of dyskinesia that appears after long-term use of dopamine-receptor blocking agents (antipsychotics)."
      }, {
        "text": " Characterized by repetitive, involuntary movements, often of the face (e.g., grimacing, lip smacking, tongue"
      }, {
        "text": " protrusion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Types:\u003c/b\u003e Other dyskinesias include [[b564ac97|aster"
      }, {
        "text": "ixis]], [[73999a73|dystonia]], and [[myoclonus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Dyskinesia in a Parkinson\u0027s patient is most likely a side effect of their levodopa therapy"
      }, {
        "text": ". Tardive dyskinesia is a feared long-term side effect of antipsychotics.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eDyskinesias\u003c/b\u003e are involuntary \u0027overflow\u0027 movements resulting from a dysregulated [[ed46292"
      }, {
        "text": "7|basal ganglia]], often iatrogenically caused by medications that alter the brain\u0027s delicate dopamine balance, such as levodopa"
      }, {
        "text": " or antipsychotics.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"0fa0d8ee\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"includes\",\n        \"to\": \"19272e70\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"includes\",\n        \"to\": \"tardive_dyskinesia\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"54"
      }, {
        "text": "1cd176\"\n      }\n    ]\n  },\n  \"e380a275"
      }, {
        "text": "\": {\n    \"title\": \"Dysmetria\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Cerebellar Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Dysmetria\u003c/b\u003e is a lack of coordination of movement typified by the undershoot or overshoot of intended position with the hand, arm, leg"
      }, {
        "text": ", or eye. It is a type of [[9767fd6b|ataxia]] and is a classic"
      }, {
        "text": " sign of a cerebellar lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e An inability to judge"
      }, {
        "text": " distance or scale. \u003cbr\u003e - \u003cb\u003eHypermetria:\u003c/b\u003e Overshooting the target.\u003cbr\u003e - \u003cb\u003eHypomet"
      }, {
        "text": "ria:\u003c/b\u003e Undershooting the target.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Testing:\u003c/b\u003e Assessed with the \u003cmark\u003efinger-to-nose test\u003c/"
      }, {
        "text": "mark\u003e or the heel-to-shin test. A patient with dysmetria will miss the target.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ion Location:\u003c/b\u003e A key sign of a lesion in the \u003cmark\u003e[[bebe58d4|cerebellar"
      }, {
        "text": " hemisphere]]\u003c/mark\u003e or its connections (e.g., the [[c819d97b|dentate nucleus"
      }, {
        "text": "]]). The deficit is ipsilateral to the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs:\u003c/b\u003e Often occurs with an \u003cmark\u003eintention tremor\u003c/mark\u003e,"
      }, {
        "text": " where the limb oscillates as it approaches the target.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be caused by [[c5da3c57|"
      }, {
        "text": "stroke]] (e.g., AICA or PICA stroke), [[45dd6d19|multiple sclerosis]],"
      }, {
        "text": " or tumors affecting the cerebellum. It is also a feature of [[350f1c8b|central vertigo]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who consistently overshoots or undershoots when trying to touch the"
      }, {
        "text": " examiner\u0027s finger has dysmetria, which points to an ipsilateral cerebellar hemisphere lesion.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eDysmetria\u003c/b\u003e is the clinical manifestation of the cerebellum\u0027s failure to properly calibrate"
      }, {
        "text": " movement, resulting in an inability to accurately \u0027measure\u0027 the distance to a target and leading to the characteristic over- or undershooting of"
      }, {
        "text": " voluntary actions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"9767fd6b"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\":"
      }, {
        "text": " \"cerebellar_hemisphere_lesion\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_symptom_of\",\n        \"to\": \"3c075343\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"posterior_infer"
      }, {
        "text": "ior_cerebellar_artery_stroke\"\n      }\n    ]\n  },\n  \"f02"
      }, {
        "text": "07c17\": {\n    \"title\": \"Dysphagia\",\n    \"primaryType\": \"finding\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Gastroenterology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Symptoms"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDysphagia\u003c/b\u003e is"
      }, {
        "text": " the medical term for difficulty swallowing. It can be caused by mechanical obstruction (oropharyngeal or esophageal) or by neuromuscular dysfunction"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOropharyngeal Dysphagia:\u003c/b\u003e Difficulty initiating a"
      }, {
        "text": " swallow, often accompanied by coughing, choking, or nasal regurgitation. This points to a neuromuscular problem.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Esophageal Dysphagia:\u003c/b\u003e Sensation of food getting stuck in the esophagus after a swallow has been initiated.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eNeurological Causes:\u003c/b\u003e Dysphagia is a common symptom of neurological disorders that affect the muscles of swallowing or their"
      }, {
        "text": " neural control. This includes:\u003cbr\u003e - \u003cb\u003e[[c5da3c57|Stroke]]:\u003c/b\u003e Particularly"
      }, {
        "text": " brainstem strokes affecting the medulla (e.g., \u003cmark\u003eLateral Medullary Syndrome\u003c/mark\u003e from a PICA stroke,"
      }, {
        "text": " which damages the nucleus ambiguus [CN IX, X]).\u003cbr\u003e - \u003cb\u003eMotor Neuron Disease:\u003c/b\u003e A"
      }, {
        "text": " key feature of [[901f3180|bulbar palsy]] in [[4ed629f9"
      }, {
        "text": "|ALS]].\u003cbr\u003e - \u003cb\u003eMyasthenia Gravis:\u003c/b\u003e Fluctuating weakness of bulbar muscles.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[7a680d3d|Osmotic Demyelination Syndrome]]:\u003c/b\u003e Can cause"
      }, {
        "text": " dysphagia due to pontine damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Dysphagia accompanied by hoarseness and"
      }, {
        "text": " a diminished gag reflex is a classic sign of a lesion in the nucleus ambiguus, pointing to a lateral medullary stroke."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn a neurological context, \u003cb\u003edysphagia\u003c/b\u003e is a"
      }, {
        "text": " critical \u0027red flag\u0027 for brainstem dysfunction, particularly involving the lower cranial nerves (IX, X) that orchestrate the"
      }, {
        "text": " complex motor sequence of swallowing.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_symptom_of\",\n        \"to\": \"lateral_medullary_sy"
      }, {
        "text": "ndrome\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\","
      }, {
        "text": "\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "symptom_of\",\n        \"to\": \"myasthenia_gravis\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"7a"
      }, {
        "text": "680d3d\"\n      }\n    ]\n  },\n  \"73999"
      }, {
        "text": "a73\": {\n    \"title\": \"Dystonia\",\n    \"primaryType\": \"finding\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"Pharmacology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eDystonia\u003c/b\u003e is a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive, movements"
      }, {
        "text": ", postures, or both. The movements are typically patterned and twisting, and may be tremulous.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Involuntary muscle contractions that force body parts into abnormal, sometimes painful, positions"
      }, {
        "text": ". Can be focal (affecting one body part, e.g., torticollis), segmental, or generalized.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute"
      }, {
        "text": " Dystonic Reaction:\u003c/b\u003e A common extrapyramidal side effect of \u003cmark\u003etypical antipsychotics\u003c/mark\u003e (especially"
      }, {
        "text": " high-potency ones like haloperidol) and antiemetics like metoclopramide. Occurs hours"
      }, {
        "text": " to days after starting the drug.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation of Acute Dystonia:\u003c/b\u003e Can manifest as torticollis (neck"
      }, {
        "text": " twisting), oculogyric crisis (eyes forced upward), or opisthotonus (arching of the back).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": " of Acute Dystonia:\u003c/b\u003e This is a frightening but reversible condition. Treat with centrally acting \u003cmark\u003eanticholinergic"
      }, {
        "text": " drugs\u003c/mark\u003e (e.g., [[383f6fbe|benztropine]]) or dip"
      }, {
        "text": "henhydramine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can be a feature of [[58c8ea03|"
      }, {
        "text": "Parkinson disease]] or other neurodegenerative disorders. Can also be inherited (primary dystonia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e A patient who recently started an antipsychotic and develops a sudden, painful neck twist has an acute dystonic reaction."
      }, {
        "text": " The treatment is [[383f6fbe|benztropine]] or diphenhydramine.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDystonia\u003c/b\u003e is a disorder of sustained muscle contraction leading to abnormal postures, which"
      }, {
        "text": " can occur as a frightening acute side effect of dopamine-blocking drugs and is promptly reversible with anticholinergic medication.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"9a9c9169\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_an_adverse_effect_of\",\n        \"to\": \"antipsychotics\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"383f6fbe\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \""
      }, {
        "text": "diphenhydramine\"\n      }\n    ]\n  },\n  \"edeecb71\": {\n    \"title\":"
      }, {
        "text": " \"Echothiophate\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEchothiophate"
      }, {
        "text": "\u003c/b\u003e is a long-acting, irreversible \u003ci\u003eorganophosphate cholinesterase inhibitor\u003c/i\u003e used topically in ophthalmology for"
      }, {
        "text": " the treatment of glaucoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Ir"
      }, {
        "text": "reversibly inhibits acetylcholinesterase (AChE) by forming a stable covalent bond with the enzyme. This leads to a buildup"
      }, {
        "text": " of [[6a005559|acetylcholine]] at cholinergic synapses in the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eO"
      }, {
        "text": "cular Effects:\u003c/b\u003e The increased ACh causes contraction of the ciliary muscle (increasing trabecular outflow of aqueous humor) and the sphincter pup"
      }, {
        "text": "illae muscle (causing miosis). Both effects contribute to a \u003cmark\u003ereduction in intraocular pressure\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eClinical Use:\u003c/b\u003e Used for [[5ea7b741|open-angle glaucoma]], particularly when other agents"
      }, {
        "text": " are ineffective. Its use is limited due to its side effect profile and the availability of safer alternatives.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Ocular side effects include blurred vision, brow ache, and potential for cataracts with long-term use. Systemic absorption"
      }, {
        "text": " can occur, potentially leading to systemic cholinergic effects (e.g., bradycardia, bronchospasm), although this is rare with"
      }, {
        "text": " topical use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Echothiophate is a classic example of an irreversible cholinesterase inhibitor ("
      }, {
        "text": "an organophosphate) used therapeutically. Its mechanism is the same as that of organophosphate pesticides.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eEchothiophate\u003c/b\u003e is a potent, irreversible cholinesterase inhibitor that provides long-lasting reduction"
      }, {
        "text": " of intraocular pressure in glaucoma by amplifying the effects of acetylcholine, but its use is restricted due to the potential for significant"
      }, {
        "text": " side effects.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"0835ea01"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"organophosphate\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce"
      }, {
        "text": "6c035\"\n      }\n    ]\n  },\n  \"25e91fde\": {\n    \"title"
      }, {
        "text": "\": \"Ectopia Lentis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Genetics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Lens Disorders\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEctopia lentis\u003c/b\u003e is the displacement or malposition of the eye"
      }, {
        "text": "\u0027s crystalline lens from its normal location. While it can be caused by trauma, its presence can be a key sign of an"
      }, {
        "text": " underlying systemic connective tissue disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by"
      }, {
        "text": " weakness or disruption of the zonular fibers that hold the lens in place.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMarfan Syndrome:\u003c/b\u003e A classic"
      }, {
        "text": " cause. Due to a defect in fibrillin-1, the zonular fibers are weak. The lens typically dislocates \u003cmark\u003eupward and"
      }, {
        "text": " outward\u003c/mark\u003e (superotemporally).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHomocystinuria:\u003c/b\u003e An autosomal recessive disorder of"
      }, {
        "text": " methionine metabolism. Defective cystathionine synthase leads to weak zonular fibers. The lens typically dislocates \u003cmark"
      }, {
        "text": "\u003edownward and inward\u003c/mark\u003e (inferonasally).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation Mnemonic:\u003c/b\u003e Mar\u003cb\u003e"
      }, {
        "text": "fan\u003c/b\u003e looks up at the \u003cb\u003efan\u003c/b\u003e on the ceiling (upward dislocation). In homocystinuria, you"
      }, {
        "text": " look \u003cb\u003edown\u003c/b\u003e to pick up your dropped \u0027\u003cb\u003ehom\u003c/b\u003eies\u0027 (downward dislocation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther"
      }, {
        "text": " Causes:\u003c/b\u003e Trauma is the most common overall cause. Other rare genetic causes include Weill-Marchesani syndrome and sulfite"
      }, {
        "text": " oxidase deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction of lens dislocation is a key feature used to distinguish Mar"
      }, {
        "text": "fan syndrome from homocystinuria in a clinical vignette.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEct"
      }, {
        "text": "opia lentis\u003c/b\u003e is a significant clinical sign that points beyond the eye, with the direction of lens displacement‚Äîupward in Mar"
      }, {
        "text": "fan syndrome, downward in homocystinuria‚Äîserving as a classic differentiator between these two systemic connective tissue disorders.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_sign_of\",\n        \"to\": \"marfan_syndrome\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_a_sign_of\",\n        \"to\": \"homocystinuria\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"zonular_fiber_weakness\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"bbcfaf1f\": {\n    \"title\": \"Edema\",\n    \"primary"
      }, {
        "text": "Type\": \"finding\",\n    \"tags\": [\n      \"Pathology\",\n      \"Cardiology\",\n"
      }, {
        "text": "      \"Renal\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEdema\u003c/b\u003e is the accumulation of excess fluid in the interstitial tissue"
      }, {
        "text": " spaces or body cavities. It can be localized or generalized and results from an imbalance in the Starling forces that govern fluid"
      }, {
        "text": " exchange across capillaries.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by one"
      }, {
        "text": " or more of the following:\u003cbr\u003e - \u003cb\u003e‚Üë Hydrostatic pressure:\u003c/b\u003e (e.g., heart failure, venous"
      }, {
        "text": " obstruction)\u003cbr\u003e - \u003cb\u003e‚Üì Oncotic pressure:\u003c/b\u003e (e.g., nephrotic syndrome, liver failure"
      }, {
        "text": ", malnutrition)\u003cbr\u003e - \u003cb\u003e‚Üë Capillary permeability:\u003c/b\u003e (e.g., inflammation, burns, sepsis"
      }, {
        "text": ")\u003cbr\u003e - \u003cb\u003eLymphatic obstruction:\u003c/b\u003e (e.g., lymphedema)\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Edema"
      }, {
        "text": ":\u003c/b\u003e A specific and life-threatening type of edema within the brain. It is classified as:\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "8e51aa24|Cytotoxic Edema]]:\u003c/b\u003e Intracellular swelling due to cellular injury (e.g., early"
      }, {
        "text": " stroke).\u003cbr\u003e - \u003cb\u003eVasogenic Edema:\u003c/b\u003e Extracellular fluid accumulation due to a disrupted blood-brain barrier ("
      }, {
        "text": "e.g., tumor, late stroke).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In the context of neurology, edema is most"
      }, {
        "text": " often referring to [[aa00bdef|cerebral edema]], a critical condition that increases intracranial pressure.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEdema\u003c/b\u003e is the clinical manifestation of \u0027leaky\u0027 or"
      }, {
        "text": " over-pressurized capillaries, with the specific cause determining whether the fluid accumulation is due to too much pressure pushing out,"
      }, {
        "text": " not enough protein pulling in, or a damaged vessel wall.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"aa00b"
      }, {
        "text": "def\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"8e"
      }, {
        "text": "51aa24\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n"
      }, {
        "text": "        \"to\": \"heart_failure\"\n      },\n      {\n        \"type\": \"can_be_caused_by"
      }, {
        "text": "\",\n        \"to\": \"nephrotic_syndrome\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"33f84fa5\": {\n    \"title\": \"Edinger-Westphal Nucleus\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"Aut"
      }, {
        "text": "onomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eEdinger-Westphal nucleus\u003c/b\u003e is the parasympathetic pre"
      }, {
        "text": "ganglionic nucleus that innervates the eye. It is located in the midbrain and its axons travel with the [["
      }, {
        "text": "68c66997|oculomotor nerve (CN III)]] to control pupillary constriction and lens"
      }, {
        "text": " accommodation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Rostral midbrain, dorsal to the main"
      }, {
        "text": " oculomotor nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides preganglionic \u003cmark\u003eparasympathetic\u003c/mark\u003e fibers"
      }, {
        "text": " to the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Axons from the Edinger-Westphal nucleus travel in CN III to the orbit"
      }, {
        "text": ", where they synapse in the [[6d7a091d|ciliary ganglion]]. Postganglionic fibers"
      }, {
        "text": " then travel via the short ciliary nerves to innervate the sphincter pupillae and ciliary muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRef"
      }, {
        "text": "lexes:\u003c/b\u003e It is the efferent motor nucleus for both the \u003cmark\u003epupillary light reflex\u003c/mark\u003e and"
      }, {
        "text": " the \u003cmark\u003e[[81b5f5fe|accommodation reflex]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance"
      }, {
        "text": ":\u003c/b\u003e A lesion compressing CN III (e.g., PComA aneurysm) often affects these superficial parasympathetic fibers first"
      }, {
        "text": ", leading to a fixed, dilated pupil.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e This nucleus is the starting point for the parasympathetic control"
      }, {
        "text": " of the pupil and lens. Its bilateral activation by the pretectal nuclei is the basis for the consensual light reflex.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe \u003cb\u003eEdinger-Westphal nucleus\u003c/b\u003e is the parasympathetic command center for the eye, sending signals"
      }, {
        "text": " via the oculomotor nerve to constrict the pupil and focus the lens, making it a critical component of the light and accommodation"
      }, {
        "text": " reflexes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Edinger-Westphal Nucleus] --"
      }, {
        "text": "Preganglionic Fibers (CN III)--\u003e B(Ciliary Ganglion); B --Postganglionic Fibers--\u003e"
      }, {
        "text": " C(Sphincter Pupillae \u0026 Ciliary Muscle);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_nucleus_of\",\n        \"to\": \"68c6699"
      }, {
        "text": "7\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to"
      }, {
        "text": "\": \"midbrain\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"pupillary"
      }, {
        "text": "_light_reflex\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"8"
      }, {
        "text": "1b5f5fe\"\n      }\n    ]\n  },\n  \"77470"
      }, {
        "text": "9ab\": {\n    \"title\": \"Ehlers-Danlos Syndrome\",\n    \"primaryType\": \"disease"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Genetics\",\n      \"Rheumatology\",\n      \"Dermat"
      }, {
        "text": "ology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Pathology\",\n      \"Connective Tissue Disorders\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEhlers-Danlos syndrome ("
      }, {
        "text": "EDS)\u003c/b\u003e is a group of inherited connective tissue disorders caused by defects in the synthesis or structure of collagen. It is characterized by joint"
      }, {
        "text": " hypermobility, skin hyperextensibility, and tissue fragility.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Most types are caused by mutations in genes encoding for collagen (e.g., \u003ci\u003eCOL5"
      }, {
        "text": "A1\u003c/i\u003e, \u003ci\u003eCOL5A2\u003c/i\u003e in the classical type) or enzymes involved in collagen processing. The"
      }, {
        "text": " vascular type (the most severe) is due to a defect in \u003cmark\u003eType III collagen\u003c/mark\u003e (\u003ci\u003eCOL3"
      }, {
        "text": "A1\u003c/i\u003e gene).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Varies by type, but common features include joint hypermobility (\u0027"
      }, {
        "text": "double-jointed\u0027), easy bruising, abnormal scar formation (atrophic, \u0027cigarette paper\u0027 scars), and soft, velvety"
      }, {
        "text": ", hyperextensible skin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Type (vEDS):\u003c/b\u003e The most life-threatening form. Associated with"
      }, {
        "text": " fragility of large blood vessels and hollow organs, leading to a high risk of arterial dissection or rupture (e.g., aortic"
      }, {
        "text": " dissection), and organ rupture (e.g., colon, gravid uterus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Complication:\u003c/b\u003e The"
      }, {
        "text": " vascular fragility in some types of EDS increases the risk of intracranial \u003cmark\u003e[[a9f6d703|berry aneur"
      }, {
        "text": "ysms]]\u003c/mark\u003e and subsequent [[63f8b05f|subarachnoid hemorrhage]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with joint hypermobility, stretchy skin, and a family history of sudden"
      }, {
        "text": " death should raise suspicion for the vascular type of Ehlers-Danlos syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eEhlers-Danlos syndrome\u003c/b\u003e is a genetic defect in the body\u0027s \u0027glue\u0027 (collagen"
      }, {
        "text": "), leading to fragile, stretchy tissues that manifest as hypermobile joints and skin, with the dangerous vascular type predisposing to catastrophic"
      }, {
        "text": " arterial and organ rupture.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by_defect_in\",\n        \"to\": \"collagen"
      }, {
        "text": "_synthesis\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \""
      }, {
        "text": "to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_a_risk_factor_for\",\n        \"to\": \"aortic_dissection\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"6a805ecd\": {\n    \"title\": \"Embolic Stroke\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cardiology\","
      }, {
        "text": "\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eembolic stroke\u003c/b\u003e is a type of [[c5da3c57|ische"
      }, {
        "text": "mic stroke]] that occurs when a clot or other debris (an embolus) forms elsewhere in the body, travels through"
      }, {
        "text": " the bloodstream, and lodges in a cerebral artery, obstructing blood flow.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOnset"
      }, {
        "text": ":\u003c/b\u003e Typically has a \u003cmark\u003esudden, maximal-at-onset\u003c/mark\u003e presentation of neurological deficits, as the vessel"
      }, {
        "text": " is abruptly occluded.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Sources of Emboli:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eCardi"
      }, {
        "text": "ogenic (most common):\u003c/b\u003e Thrombus formation in the heart, most frequently due to \u003cmark\u003eatrial fibrillation\u003c/mark\u003e."
      }, {
        "text": " Other cardiac sources include mural thrombus after MI, valvular disease (e.g., endocarditis), and patent"
      }, {
        "text": " foramen ovale (paradoxical embolus).\u003cbr\u003e2. \u003cb\u003eArtery-to-Artery:\u003c/b\u003e An"
      }, {
        "text": " embolus from a proximal atherosclerotic plaque, typically in the \u003cmark\u003ecarotid artery\u003c/mark\u003e or aortic arch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory"
      }, {
        "text": ":\u003c/b\u003e Often lodges at arterial bifurcations. The [[143bb23d|Middle Cerebral Artery (MCA)]]"
      }, {
        "text": " is the most common destination for emboli from the internal carotid circulation. Emboli can cause infarcts in multiple vascular territories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A patient with a history of atrial fibrillation who suddenly develops aphasia and right-sided weakness has likely"
      }, {
        "text": " had an embolic stroke to the left MCA.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eembolic stroke\u003c/b\u003e is a"
      }, {
        "text": " \u0027stroke from a distance,\u0027 where a clot, most often from the heart in atrial fibrillation, travels to and abruptly blocks a cerebral artery, causing a sudden"
      }, {
        "text": " onset of neurological deficits.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Atrial Fibrillation/"
      }, {
        "text": "Carotid Plaque] --\u003e B(Thrombus Formation); B --\u003e C(Embolus Travels to Brain); C --\u003e D"
      }, {
        "text": "(Occludes Cerebral Artery); D --\u003e E(Ischemic Stroke);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"c5da3c57\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \"to\": \"atrial_fibrillation"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_commonly_caused_by\",\n        \""
      }, {
        "text": "to\": \"carotid_artery_stenosis\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "most_often_affects\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"3eccefd4\": {\n    \"title\": \"Emboliform Nucleus\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebellum\",\n      \"USMLE"
      }, {
        "text": "\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eEmboliform Nucleus\u003c/b\u003e is one of the four deep cerebellar nuclei, located medial"
      }, {
        "text": " to the dentate nucleus and lateral to the globose nucleus. Along with the globose nucleus, it forms the interposed nucleus.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Deep within the white matter of the [["
      }, {
        "text": "bebe58d4|cerebellum]], part of the interposed nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The interposed nuclei"
      }, {
        "text": " (emboliform + globose) are involved in coordinating agonist-antagonist muscle pairs during voluntary movements of the \u003cmark\u003edistal limbs\u003c/mark\u003e."
      }, {
        "text": " They receive input from the intermediate zone of the cerebellar cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the contralateral red nucleus,"
      }, {
        "text": " contributing to the rubrospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e The deep cerebellar nuclei from lateral to medial are \\\""
      }, {
        "text": "\u003cb\u003eD\u003c/b\u003eon\u0027t \u003cb\u003eE\u003c/b\u003eat \u003cb\u003eG\u003c/b\u003ereasy \u003cb\u003eF\u003c/b\u003eoods\\\" (\u003cb\u003eD\u003c/b\u003eent"
      }, {
        "text": "ate, \u003cb\u003eE\u003c/b\u003emboliform, \u003cb\u003eG\u003c/b\u003elobose, \u003cb\u003eF\u003c/b\u003eastigial).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e While less commonly tested than the dentate (limb ataxia) or fastigial (truncal ataxia) nuclei, remember"
      }, {
        "text": " that the interposed nuclei (emboliform and globose) are involved in modulating limb movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eEmboliform Nucleus\u003c/b\u003e, as part of the interposed nuclei, acts as a cerebellar"
      }, {
        "text": " relay station that helps fine-tune the execution of voluntary movements in the distal limbs by modulating activity in the red nucleus.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"deep_cerebellar_nuclei\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_located_in\",\n        \"to\": \"bebe58d4"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"forms_interposed_nucleus_with\",\n        "
      }, {
        "text": "\"to\": \"globose_nucleus\"\n      }\n    ]\n  },\n  \"777"
      }, {
        "text": "ddb37\": {\n    \"title\": \"Neuroembryology\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural"
      }, {
        "text": " Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeuroembryology\u003c/b\u003e is the study of the development of"
      }, {
        "text": " the nervous system in the embryo. It begins with the process of neurulation, where the neural plate folds to form the neural tube,"
      }, {
        "text": " the precursor to the entire central nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurulation:\u003c/b\u003e The not"
      }, {
        "text": "ochord induces the overlying ectoderm to form the neural plate, which then folds to create the neural tube. This process"
      }, {
        "text": " occurs in the 3rd and 4th weeks of gestation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Tube Derivatives:\u003c/b\u003e The neural tube gives"
      }, {
        "text": " rise to the CNS (brain and spinal cord), including neurons, oligodendrocytes, astrocytes, and ependymal cells.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eNeural Crest Derivatives:\u003c/b\u003e Neural crest cells migrate away from the neural tube to form the PNS (e.g., Schwann cells, dorsal"
      }, {
        "text": " root ganglia, autonomic ganglia) and many non-neural structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrain Vesicles:\u003c/b\u003e The rostral neural"
      }, {
        "text": " tube develops into three primary vesicles (prosencephalon, mesencephalon, rhombencephalon), which then differentiate into five secondary vesicles that"
      }, {
        "text": " form the adult brain structures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Errors in neuroembryology lead to congenital malformations, such"
      }, {
        "text": " as \u003cmark\u003eneural tube defects\u003c/mark\u003e ([[5bcc9894|anencephaly]], sp"
      }, {
        "text": "ina bifida) and [[b96a6a07|posterior fossa malformations]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Folate deficiency is a major risk factor for neural tube defects. Supplementation before and during early pregnancy is crucial"
      }, {
        "text": " for prevention.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeuroembryology\u003c/b\u003e traces the intricate transformation"
      }, {
        "text": " of a simple ectodermal sheet into the complex architecture of the brain and spinal cord, a process highly vulnerable to disruption"
      }, {
        "text": " in early pregnancy, leading to severe congenital malformations.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[E"
      }, {
        "text": "ctoderm] --Notochord Induction--\u003e B(Neural Plate); B --\u003e C(Neural Tube); C --\u003e D(Brain"
      }, {
        "text": " \u0026 Spinal Cord); B --\u003e E(Neural Crest); E --\u003e F(PNS \u0026 Other Structures);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"describes_development_of\",\n        \"to\": \"central"
      }, {
        "text": "_nervous_system\"\n      },\n      {\n        \"type\": \"involves_formation_of\","
      }, {
        "text": "\n        \"to\": \"neural_tube\"\n      },\n      {\n        \"type\": \"errors_"
      }, {
        "text": "in_lead_to\",\n        \"to\": \"neural_tube_defect\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"3ac46ef4\": {\n    \"title\": \"Emotion\",\n    \"primaryType"
      }, {
        "text": "\": \"physiology\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Physiology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eIn neuroscience, \u003cb\u003eemotion\u003c/b\u003e refers to complex psychophysiological experiences involving subjective feeling, physiological response"
      }, {
        "text": ", and behavioral expression. The processing and regulation of emotion are primarily functions of the [[73ace357|lim"
      }, {
        "text": "bic system]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Neural Structures:\u003c/b\u003e The [[73"
      }, {
        "text": "ace357|limbic system]] is the main circuit for emotion. Key components include:\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "d220fc3f|Amygdala]]:\u003c/b\u003e Central to processing fear, anger, and pleasure. It attaches"
      }, {
        "text": " emotional significance to memories.\u003cbr\u003e - \u003cb\u003e[[89e86633|Hypothalamus]]:\u003c/b\u003e Medi"
      }, {
        "text": "ates the physiological expression of emotion through its control of the autonomic nervous system and endocrine system (e.g., fight-or-flight response).\u003cbr"
      }, {
        "text": "\u003e - \u003cb\u003e[[22e49c50|Cingulate Gyrus]]:\u003c/b\u003e Involved in emotional"
      }, {
        "text": " learning and the link between emotion, memory, and behavior.\u003cbr\u003e - \u003cb\u003ePrefrontal Cortex:\u003c/b\u003e Provides top"
      }, {
        "text": "-down regulation of emotion, inhibiting impulsive emotional responses.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePapez Circuit:\u003c/b\u003e A historical model of the emotional"
      }, {
        "text": " circuit involving the hippocampus, mammillary bodies, anterior thalamic nucleus, and cingulate gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The [[d220fc3f|amygdala]] is the most important structure to associate with the generation"
      }, {
        "text": " of fear and emotional learning. Bilateral lesions lead to Kl√ºver-Bucy syndrome, characterized by a loss"
      }, {
        "text": " of fear.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEmotion\u003c/b\u003e is a product of the brain\u0027s [["
      }, {
        "text": "73ace357|limbic system]], where the [[d220fc3f|amygdala]] acts as the primary"
      }, {
        "text": " processor of emotional stimuli, and the [[89e86633|hypothalamus]] translates these feelings"
      }, {
        "text": " into physiological responses, all under the watchful, regulatory eye of the prefrontal cortex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_processed_by\",\n        \"to\":"
      }, {
        "text": " \"73ace357\"\n      },\n      {\n        \"type\": \"is_processed_"
      }, {
        "text": "by\",\n        \"to\": \"d220fc3f\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_regulated_by\",\n        \"to\": \"prefrontal_cortex\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"1c42ff26\": {\n    \"title\":"
      }, {
        "text": " \"Encephalotrigeminal Angiomatosis\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Ophthalmology\",\n      \"Genetics"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eEncephalotrigeminal angiomatosis\u003c/b\u003e, more commonly known as \u003cb\u003eSturge-"
      }, {
        "text": "Weber syndrome\u003c/b\u003e, is a rare, congenital neurocutaneous disorder characterized by a facial capillary malformation (port-wine stain) and an"
      }, {
        "text": " associated vascular malformation of the brain and eye.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGen"
      }, {
        "text": "etics:\u003c/b\u003e Caused by a somatic mosaic mutation in the \u003ci\u003eGNAQ\u003c/i\u003e gene. It is \u003cu\u003enot"
      }, {
        "text": "\u003c/u\u003e inherited.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eFacial Port-Wine Stain:\u003c/b\u003e A"
      }, {
        "text": " capillary malformation in the distribution of the ophthalmic (V\u003csub\u003e1\u003c/sub\u003e) and sometimes maxillary (V\u003csub\u003e2\u003c/sub\u003e) branches"
      }, {
        "text": " of the trigeminal nerve.\u003cbr\u003e2. \u003cb\u003eLeptomeningeal Angioma:\u003c/b\u003e An"
      }, {
        "text": " abnormal collection of blood vessels on the surface of the brain, typically ipsilateral to the facial lesion. This can lead to \u003c"
      }, {
        "text": "mark\u003eseizures\u003c/mark\u003e (most common neurological symptom), intellectual disability, and focal neurological deficits.\u003cbr\u003e3. \u003cb\u003e"
      }, {
        "text": "Glaucoma:\u003c/b\u003e Increased intraocular pressure, often ipsilateral to the facial lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Skull"
      }, {
        "text": " X-rays or CT scans may show characteristic \u0027tram-track\u0027 calcifications, which represent calcification of the cortex"
      }, {
        "text": " underlying the leptomeningeal angioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with a port-wine stain on"
      }, {
        "text": " their face, seizures, and intellectual disability is the classic presentation of Sturge-Weber syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e is a congenital vascular disorder that \u0027stains\u0027 the face with a port-wine birth"
      }, {
        "text": "mark and the underlying brain with a leptomeningeal angioma, leading to a triad of dermatological, neurological ("
      }, {
        "text": "seizures), and ophthalmological (glaucoma) problems.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[S"
      }, {
        "text": "omatic GNAQ Mutation] --\u003e B(Vascular Malformation); B --\u003e C(Facial Port-Wine Stain); B --\u003e"
      }, {
        "text": " D(Leptomeningeal Angioma); D --\u003e E(Seizures); B --\u003e F(O"
      }, {
        "text": "cular Involvement); F --\u003e G(Glaucoma);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_synonymous_with\",\n        \"to\": \"sturge_weber_syndrome\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"neurocutaneous_disorder\"\n      },\n      {\n        \"type\": \"presents_with"
      }, {
        "text": "\",\n        \"to\": \"port_wine_stain\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"presents_with\",\n        \"to\": \"seizures\"\n      }\n    ]\n"
      }, {
        "text": "  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "1GIRA2SWCA96hyAuX8JVsA1iPuHgJcMpe"
      },
      "role": "user",
      "tokenCount": 1456
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"74cadd6c\": {\n    \"title\": \"Endolymphatic Hydrops\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Otology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEndolymphatic hydrops\u003c/b\u003e is the distention of the endolymphatic system of the inner ear, caused by an excess volume of endolymph fluid. It is the underlying pathological finding in \u003cmark\u003eM√©ni√®re disease\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact cause is unknown, but it is thought to involve either overproduction or impaired reabsorption of endolymph, leading to increased pressure within the membranous labyrinth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Disease:\u003c/b\u003e This is the pathophysiological basis for [[menieres_disease|M√©ni√®re disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Manifestations:\u003c/b\u003e The increased pressure damages the vestibular and cochlear hair cells, leading to the classic triad of M√©ni√®re disease:\u003cbr\u003e1. \u003cb\u003eEpisodic [[5603962d|Vertigo]]:\u003c/b\u003e Attacks of spinning dizziness that last for minutes to hours.\u003cbr\u003e2. \u003cb\u003eSensorineural Hearing Loss:\u003c/b\u003e Typically fluctuating and affecting low frequencies initially.\u003cbr\u003e3. \u003cb\u003eTinnitus:\u003c/b\u003e Ringing or roaring sound in the affected ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Endolymphatic hydrops \u003d M√©ni√®re disease. Remember the triad of vertigo, hearing loss, and tinnitus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEndolymphatic hydrops\u003c/b\u003e is essentially \u0027glaucoma of the inner ear,\u0027 where excessive endolymph fluid pressure damages the delicate sensory structures for hearing and balance, causing the debilitating episodic attacks of vertigo, tinnitus, and hearing loss that define M√©ni√®re disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_the_pathophysiology_of\",\n        \"to\": \"menieres_disease\"\n      },\n      {\n        \"type\": \"affects\",\n        \"to\": \"inner_ear\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"5603962d\"\n      }\n    ]\n  },\n  \"8039c888\": {\n    \"title\": \"Endoneurium\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eEndoneurium\u003c/b\u003e is the delicate layer of connective tissue that surrounds each individual myelinated and unmyelinated nerve fiber (axon) within a peripheral nerve fascicle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of reticular fibers, fibroblasts, and capillaries. It is the innermost of the three connective tissue sheaths of a peripheral nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides a supportive and nutritive microenvironment for the axon and its associated Schwann cell.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Nerve Barrier:\u003c/b\u003e The capillaries within the endoneurium have tight junctions, forming part of the [[03ba9967|blood-nerve barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The endoneurium is the primary site of inflammation in \u003cmark\u003e[[ed52e40b|Guillain-Barr√© syndrome]]\u003c/mark\u003e (acute inflammatory demyelinating polyneuropathy), where inflammatory cells infiltrate this space and attack the myelin sheath.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Layers (from inside out):\u003c/b\u003e Axon ‚Üí Myelin ‚Üí Endoneurium ‚Üí Perineurium (surrounds fascicle) ‚Üí Epineurium (surrounds entire nerve).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the inflammation in Guillain-Barr√© syndrome occurs in the endoneurium, targeting Schwann cells and myelin.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eEndoneurium\u003c/b\u003e is the intimate connective tissue wrapping around a single nerve fiber, providing essential support and forming the inner sanctum of the peripheral nerve, which becomes a battleground in inflammatory neuropathies like Guillain-Barr√© syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"peripheral_nerve\"\n      },\n      {\n        \"type\": \"surrounds\",\n        \"to\": \"axon\"\n      },\n      {\n        \"type\": \"is_site_of_inflammation_in\",\n        \"to\": \"ed52e40b\"\n      }\n    ]\n  },\n  \"eb2da2bc\": {\n    \"title\": \"Entacapone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEntacapone\u003c/b\u003e is a peripherally acting, reversible inhibitor of catechol-O-methyltransferase (COMT). It is used as an adjunctive therapy with [[541cd176|levodopa/carbidopa]] for the treatment of [[58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits COMT in the peripheral tissues. COMT is one of the enzymes that metabolizes levodopa. By blocking this peripheral breakdown, entacapone \u003cmark\u003eincreases the plasma half-life of levodopa\u003c/mark\u003e and increases the amount of levodopa available to cross the blood-brain barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used in combination with [[541cd176|levodopa/carbidopa]] to treat patients with Parkinson disease who are experiencing motor fluctuations (\u0027wearing-off\u0027 phenomenon). It helps to prolong the \u0027on\u0027 time.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSite of Action:\u003c/b\u003e It acts only in the \u003cmark\u003eperiphery\u003c/mark\u003e and does not cross the blood-brain barrier. This contrasts with tolcapone, another COMT inhibitor, which acts both peripherally and centrally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Can potentiate the dopaminergic side effects of levodopa (e.g., dyskinesias, nausea, confusion). It can also cause a harmless orange discoloration of the urine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that entacapone is a \u0027levodopa extender.\u0027 It doesn\u0027t have any effect on its own but works by preventing the peripheral breakdown of levodopa, thereby boosting its effectiveness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEntacapone\u003c/b\u003e serves as a \u0027bodyguard\u0027 for levodopa in the periphery, inhibiting the COMT enzyme to prevent levodopa\u0027s breakdown before it can reach the brain, thus extending its therapeutic effect in Parkinson\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Levodopa] --Peripheral COMT--\u003e B(3-O-methyldopa - Inactive); C[Entacapone] --x B; A --\u003e D(Crosses BBB); D --\u003e E(Dopamine in CNS);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"comt_inhibitor\"\n      },\n      {\n        \"type\": \"is_used_with\",\n        \"to\": \"541cd176\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"tolcapone\"\n      }\n    ]\n  },\n  \"a70c151b\": {\n    \"title\": \"Entorhinal Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eEntorhinal Cortex\u003c/b\u003e is an area of the brain located in the medial temporal lobe that functions as a major hub in a widespread network for memory, navigation, and the perception of time. It is the main interface between the [[a0590674|hippocampus]] and the neocortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Medial temporal lobe, adjacent to the [[a0590674|hippocampus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Serves as the primary gateway for information entering and leaving the [[a0590674|hippocampus]]. It is crucial for the formation of long-term episodic and spatial memories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnections:\u003c/b\u003e It receives highly processed sensory information from all cortical association areas and funnels it into the [[a0590674|hippocampus]] for memory consolidation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The entorhinal cortex is one of the \u003cmark\u003efirst areas of the brain to be affected in [[77ae6148|Alzheimer disease]]\u003c/mark\u003e. The formation of neurofibrillary tangles in this region is a very early pathological sign, contributing to the initial memory deficits of the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The degeneration of the entorhinal cortex is a key early event in the progression of [[77ae6148|Alzheimer disease]], effectively cutting off the hippocampus from its cortical inputs and leading to profound anterograde amnesia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eEntorhinal Cortex\u003c/b\u003e acts as the main \u0027entrance and exit ramp\u0027 for the hippocampus, and its early destruction in Alzheimer\u0027s disease is a critical event that isolates the memory-forming hippocampus from the rest of the brain.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Neocortex] \u003c--\u003e B(Entorhinal Cortex); B \u003c--\u003e C(Hippocampus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73ace357\"\n      },\n      {\n        \"type\": \"is_the_main_interface_for\",\n        \"to\": \"a0590674\"\n      },\n      {\n        \"type\": \"is_affected_early_in\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"3a777d5f\": {\n    \"title\": \"Ependymal Cells\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEpendymal cells\u003c/b\u003e are a type of glial cell that form the epithelial lining of the ventricles in the brain and the central canal of the spinal cord. They are involved in the production and circulation of cerebrospinal fluid (CSF).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Simple cuboidal or columnar epithelial cells. Their apical surfaces are covered with cilia (which help circulate CSF) and microvilli (which help with CSF absorption).\u003c/li\u003e\u003cli\u003e\u003cb\u003eChoroid Plexus:\u003c/b\u003e Ependymal cells are modified in certain locations to form the \u003cmark\u003e[[ae65e9c7|choroid plexus]]\u003c/mark\u003e, the specialized tissue responsible for producing the majority of the [[7109d8b6|CSF]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-CSF Barrier:\u003c/b\u003e The ependymal cells of the choroid plexus are joined by tight junctions, forming the blood-CSF barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTumor Origin:\u003c/b\u003e These cells can give rise to \u003cmark\u003e[[14365ef4|ependymomas]]\u003c/mark\u003e, a type of brain tumor. In children, ependymomas most commonly arise in the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that ependymal cells line the ventricles and produce CSF. A tumor of these cells, an ependymoma, can therefore obstruct CSF flow and cause non-communicating hydrocephalus, especially when located in the fourth ventricle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEpendymal cells\u003c/b\u003e are the specialized epithelial lining of the brain\u0027s ventricular system, with the crucial dual roles of forming a barrier and, in the choroid plexus, actively producing the cerebrospinal fluid that bathes the CNS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"glial_cell\"\n      },\n      {\n        \"type\": \"lines\",\n        \"to\": \"1cb9c975\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"ae65e9c7\"\n      },\n      {\n        \"type\": \"is_cell_of_origin_for\",\n        \"to\": \"14365ef4\"\n      }\n    ]\n  },\n  \"14365ef4\": {\n    \"title\": \"Ependymoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pediatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eependymoma\u003c/b\u003e is a primary CNS tumor that arises from [[3a777d5f|ependymal cells]], the glial cells that line the ventricles of the brain and the central canal of the spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e Most common in children, where it is the third most common posterior fossa tumor (after pilocytic astrocytoma and medulloblastoma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e In children, they most commonly arise in the \u003cmark\u003efourth ventricle\u003c/mark\u003e. In adults, they are more common in the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Tumors in the fourth ventricle often obstruct CSF flow, leading to \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e and signs of increased intracranial pressure (headache, nausea, vomiting, papilledema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e The characteristic histological finding is the \u003cmark\u003eperivascular pseudorosette\u003c/mark\u003e, where tumor cells are arranged in a circular pattern around a central blood vessel, with a clear zone in between. Rod-shaped blepharoplasts (basal ciliary bodies) may be seen near the nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Variable, but generally poor for infratentorial tumors in children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with hydrocephalus and a tumor located within the fourth ventricle showing perivascular pseudorosettes on histology is the classic presentation of an ependymoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eependymoma\u003c/b\u003e is a tumor of the ventricular lining cells that most characteristically occurs in the fourth ventricle of children, where it acts as a \u0027plug in the drain,\u0027 causing obstructive hydrocephalus, and is identified microscopically by its unique perivascular pseudorosettes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ependymal Cells] --Neoplastic Transformation--\u003e B(Ependymoma); B --Location in 4th Ventricle--\u003e C(Obstruction of CSF Flow); C --\u003e D(Non-communicating Hydrocephalus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"3a777d5f\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"has_histological_finding\",\n        \"to\": \"perivascular_pseudorosette\"\n      }\n    ]\n  },\n  \"a61683ae\": {\n    \"title\": \"Epidural Hematoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Trauma\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eepidural hematoma (EDH)\u003c/b\u003e is a collection of blood that forms between the inner surface of the skull and the outer layer of the dura mater. It is a neurosurgical emergency, typically caused by trauma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a fracture of the \u003cmark\u003etemporal bone\u003c/mark\u003e, which lacerates the \u003cmark\u003emiddle meningeal artery\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Arterial bleeding leads to rapid accumulation of blood in the epidural space, which strips the dura away from the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The classic presentation is a patient who suffers head trauma with a brief loss of consciousness, followed by a \u003cmark\u003e\\\"lucid interval\\\"\u003c/mark\u003e where they seem fine, and then a rapid neurological deterioration (headache, vomiting, seizure, coma) as the hematoma expands and increases intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e A non-contrast head CT shows a hyperdense, \u003cmark\u003ebiconvex (lentiform)\u003c/mark\u003e blood collection. The hematoma does \u003cu\u003enot\u003c/u\u003e cross suture lines, where the dura is tightly adherent to the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Lucid interval + temporal bone fracture + lentiform bleed on CT \u003d Epidural hematoma. This is a classic trauma vignette.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eepidural hematoma\u003c/b\u003e is a high-pressure arterial bleed, typically from the middle meningeal artery after a temporal bone fracture, that creates a rapidly expanding, lens-shaped clot which can be fatal if not evacuated promptly; the deceptive \u0027lucid interval\u0027 is a classic but not universal feature.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Temporal Bone Fracture] --\u003e B(Laceration of Middle Meningeal Artery); B --\u003e C(Arterial Bleeding into Epidural Space); C --\u003e D(Biconvex Hematoma); D --\u003e E(‚Üë ICP \u0026 Herniation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"intracranial_hemorrhage\"\n      },\n      {\n        \"type\": \"is_caused_by_rupture_of\",\n        \"to\": \"middle_meningeal_artery\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"lucid_interval\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"8aaeb0d8\"\n      }\n    ]\n  },\n  \"33bfd833\": {\n    \"title\": \"Epidural Space\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eepidural space\u003c/b\u003e is a potential or actual space located between the dura mater and the overlying bone (skull in the cranium, vertebrae in the spinal canal).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCranial Epidural Space:\u003c/b\u003e A \u003ci\u003epotential\u003c/i\u003e space between the skull and the periosteal layer of the [[5bbe3597|dura mater]]. It becomes a real space only pathologically, when blood accumulates in it to form an [[a61683ae|epidural hematoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Epidural Space:\u003c/b\u003e A \u003ci\u003ereal\u003c/i\u003e space between the vertebrae and the dural sheath. It contains fat, connective tissue, and a network of veins (the internal vertebral venous plexus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance (Spinal):\u003c/b\u003e The spinal epidural space is the target for \u003cmark\u003eepidural anesthesia\u003c/mark\u003e and analgesia, where local anesthetics are injected to block the spinal nerve roots. It is also the site of spinal epidural abscesses and hematomas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance (Cranial):\u003c/b\u003e The site of [[a61683ae|epidural hematomas]], typically from rupture of the middle meningeal artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the difference between the cranial (potential) and spinal (real) epidural spaces. An epidural anesthetic is placed in the real space in the spine, not the potential space in the head.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eepidural space\u003c/b\u003e is an anatomically distinct area outside the dura mater, which is a potential space in the cranium that can fill with blood in an epidural hematoma, and a real, fat-filled space in the spine that is utilized for regional anesthesia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_outside\",\n        \"to\": \"5bbe3597\"\n      },\n      {\n        \"type\": \"is_site_of\",\n        \"to\": \"a61683ae\"\n      },\n      {\n        \"type\": \"is_target_for\",\n        \"to\": \"epidural_anesthesia\"\n      }\n    ]\n  },\n  \"64c08e92\": {\n    \"title\": \"Epilepsy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEpilepsy\u003c/b\u003e is a chronic neurological disorder characterized by a predisposition to generate recurrent, unprovoked [[64c08e92|seizures]]. A seizure is a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDefinition:\u003c/b\u003e Requires at least two unprovoked seizures occurring more than 24 hours apart, or one unprovoked seizure with a high probability of further seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSeizure Types:\u003c/b\u003e Seizures are broadly classified as focal (originating in one hemisphere) or generalized (originating in both hemispheres simultaneously).\u003cbr\u003e - \u003cb\u003eFocal Seizures:\u003c/b\u003e Can be aware or have impaired awareness.\u003cbr\u003e - \u003cb\u003eGeneralized Seizures:\u003c/b\u003e Include [[a0c128f4|absence]], tonic-clonic, myoclonic, and [[ed7a236f|atonic]] seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be genetic, structural (e.g., from a prior stroke, tumor, or trauma), infectious, metabolic, or immune-mediated. In many cases, the cause is unknown.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Managed with [[f91a0cfa|anticonvulsant]] (antiepileptic) drugs. The choice of drug depends on the seizure type.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e It is crucial to distinguish epilepsy from a single provoked seizure (e.g., febrile seizure, alcohol withdrawal seizure), which does not necessarily require long-term anticonvulsant therapy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEpilepsy\u003c/b\u003e is a disorder of brain hyperexcitability, defined by the tendency for recurrent, unprovoked seizures, and its management requires accurate classification of the seizure type to guide the selection of appropriate anticonvulsant therapy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"seizures\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"includes_seizure_type\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \"includes_seizure_type\",\n        \"to\": \"ed7a236f\"\n      }\n    ]\n  },\n  \"583587cd\": {\n    \"title\": \"Epinephrine\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Endocrinology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Adrenal Gland\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEpinephrine\u003c/b\u003e (adrenaline) is a catecholamine hormone and neurotransmitter that is central to the \u0027fight or flight\u0027 response. It is produced by the adrenal medulla and acts on both Œ±- and Œ≤-adrenergic receptors throughout the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized in the adrenal medulla from norepinephrine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptor Activity:\u003c/b\u003e Acts on Œ±\u003csub\u003e1\u003c/sub\u003e, Œ±\u003csub\u003e2\u003c/sub\u003e, Œ≤\u003csub\u003e1\u003c/sub\u003e, and Œ≤\u003csub\u003e2\u003c/sub\u003e receptors. The effect depends on the dose and the receptor density in the target tissue.\u003cbr\u003e - \u003cb\u003eLow Dose:\u003c/b\u003e Œ≤-effects predominate (Œ≤\u003csub\u003e1\u003c/sub\u003e: ‚Üë heart rate/contractility; Œ≤\u003csub\u003e2\u003c/sub\u003e: vasodilation, bronchodilation) ‚Üí ‚Üë systolic BP, ‚Üì diastolic BP, ‚Üë pulse pressure.\u003cbr\u003e - \u003cb\u003eHigh Dose:\u003c/b\u003e Œ±\u003csub\u003e1\u003c/sub\u003e-effects predominate (vasoconstriction) ‚Üí ‚Üë systolic and diastolic BP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnaphylaxis:\u003c/b\u003e Drug of choice. Causes vasoconstriction (Œ±\u003csub\u003e1\u003c/sub\u003e), bronchodilation (Œ≤\u003csub\u003e2\u003c/sub\u003e), and ‚Üë cardiac output (Œ≤\u003csub\u003e1\u003c/sub\u003e).\u003cbr\u003e - \u003cb\u003eCardiac Arrest:\u003c/b\u003e Used in ACLS protocols.\u003cbr\u003e - \u003cb\u003e[[3ce6c035|Glaucoma]]:\u003c/b\u003e Topical epinephrine (Œ±\u003csub\u003e1\u003c/sub\u003e agonist) decreases aqueous humor synthesis via vasoconstriction and increases outflow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the dose-dependent effects of epinephrine. At low doses, it acts like isoproterenol (Œ≤-agonist), while at high doses, it acts more like norepinephrine (Œ±-agonist).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEpinephrine\u003c/b\u003e is the ultimate \u0027fight or flight\u0027 hormone, exerting widespread, dose-dependent effects on the cardiovascular and respiratory systems by activating all subtypes of adrenergic receptors, making it the life-saving drug of choice for anaphylaxis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Epinephrine]; A --Low Dose--\u003e B(Œ≤ \u003e Œ± effects); B --\u003e C(‚Üë HR, ‚Üë Contractility, Vasodilation); A --High Dose--\u003e D(Œ± \u003e Œ≤ effects); D --\u003e E(Potent Vasoconstriction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"catecholamine\"\n      },\n      {\n        \"type\": \"is_released_from\",\n        \"to\": \"adrenal_medulla\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"anaphylaxis\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      }\n    ]\n  },\n  \"5093edcb\": {\n    \"title\": \"Epineurium\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eEpineurium\u003c/b\u003e is the dense, irregular connective tissue sheath that forms the outermost layer of a peripheral nerve. It bundles together multiple nerve fascicles and provides structural support and protection to the entire nerve trunk.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The thickest of the three connective tissue layers of a peripheral nerve. It is continuous with the dura mater at the spinal nerve roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides mechanical protection to the nerve, cushions it from external pressure, and contains the vasa nervorum (the blood supply to the nerve).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Layers (from outside in):\u003c/b\u003e Epineurium (surrounds entire nerve) ‚Üí Perineurium (surrounds a fascicle of axons) ‚Üí [[8039c888|Endoneurium]] (surrounds an individual axon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e During nerve repair surgery (neurorrhaphy), the epineurium is the layer that is typically sutured together to re-approximate the severed nerve ends.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to identify the three connective tissue layers of a peripheral nerve and their respective locations.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eEpineurium\u003c/b\u003e is the tough, outer \u0027jacket\u0027 of a peripheral nerve, bundling all the fascicles together and providing the primary structural integrity and blood supply for the nerve trunk.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"peripheral_nerve\"\n      },\n      {\n        \"type\": \"surrounds\",\n        \"to\": \"perineurium\"\n      },\n      {\n        \"type\": \"is_superficial_to\",\n        \"to\": \"8039c888\"\n      }\n    ]\n  },\n  \"8d491af6\": {\n    \"title\": \"Esotropia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEsotropia\u003c/b\u003e is a form of strabismus (eye misalignment) in which one or both eyes turn inward, toward the nose. It is the most common type of strabismus in infants and children.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e An inward deviation of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses in Children:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCongenital/Infantile Esotropia:\u003c/b\u003e Appears in the first few months of life.\u003cbr\u003e - \u003cb\u003eAccommodative Esotropia:\u003c/b\u003e The most common type in children over 6 months. It is caused by uncorrected hyperopia (farsightedness). The effort to focus on near objects (accommodate) triggers an excessive convergence reflex, causing the eyes to cross.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses in Adults:\u003c/b\u003e A new onset of esotropia in an adult is often due to a \u003cmark\u003e[[01c1b782|cranial nerve VI (abducens) palsy]]\u003c/mark\u003e, which paralyzes the lateral rectus muscle and allows the medial rectus to pull the eye inward unopposed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplication:\u003c/b\u003e If left untreated in children, esotropia can lead to \u003cmark\u003e[[a4a401c7|amblyopia]]\u003c/mark\u003e (\u0027lazy eye\u0027) in the deviating eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An adult who suddenly develops horizontal diplopia and an inward-turning eye likely has a CN VI palsy. A child with intermittent eye crossing, especially when looking at near objects, may have accommodative esotropia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEsotropia\u003c/b\u003e is an inward turning of the eye that, in children, is often a refractive problem linked to the accommodation-convergence reflex, while in adults, it is more commonly a neurological sign of a sixth nerve palsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"strabismus\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"01c1b782\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to\": \"a4a401c7\"\n      }\n    ]\n  },\n  \"40039e56\": {\n    \"title\": \"Essential Tremor\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEssential tremor\u003c/b\u003e is the most common movement disorder, characterized by a postural and action tremor, most often affecting the hands and arms. It is typically bilateral and can be inherited in an autosomal dominant pattern.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A high-frequency tremor that is absent at rest, emerges when the arms are held in a posture (e.g., outstretched), and worsens with goal-directed movements (action tremor), such as writing or drinking from a cup.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected Areas:\u003c/b\u003e Most commonly affects the hands, but can also involve the head (titubation), voice, and legs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e The tremor characteristically \u003cmark\u003eimproves with small amounts of alcohol\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Parkinson\u0027s:\u003c/b\u003e This is a critical distinction. Essential tremor is an \u003cu\u003eaction\u003c/u\u003e tremor that improves with alcohol. The tremor of [[58c8ea03|Parkinson disease]] is a \u003cu\u003eresting\u003c/u\u003e tremor that improves with movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e First-line treatments are \u003cmark\u003epropranolol\u003c/mark\u003e (a non-selective beta-blocker) and primidone (an anticonvulsant).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who complains of shaky hands that make it difficult to write or eat, but notes that a glass of wine helps, is the classic presentation of essential tremor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEssential tremor\u003c/b\u003e is an action tremor, not a resting tremor, that is famously and diagnostically relieved by alcohol and managed pharmacologically with propranolol or primidone.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"tremor\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"parkinsonian_tremor\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"propranolol\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"primidone\"\n      }\n    ]\n  },\n  \"703804c7\": {\n    \"title\": \"Eszopiclone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEszopiclone\u003c/b\u003e (trade name Lunesta) is a non-benzodiazepine hypnotic agent, commonly referred to as a \u0027Z-drug,\u0027 used for the treatment of insomnia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a positive allosteric modulator at the benzodiazepine (BZ\u003csub\u003e1\u003c/sub\u003e) subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor. This enhances the effect of GABA, leading to increased chloride conductance and CNS depression (sedation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-benzodiazepine hypnotic (\u0027Z-drug\u0027), along with zolpidem and zaleplon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Approved for the long-term treatment of insomnia, helping with both sleep onset and sleep maintenance.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a longer half-life compared to zolpidem and zaleplon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Anterograde amnesia, hallucinations, and complex sleep-related behaviors (e.g., sleepwalking, sleep-driving). A common side effect is an unpleasant or metallic taste. Risk of dependence and withdrawal is lower than with benzodiazepines but still present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e The effects can be reversed by \u003cmark\u003eflumazenil\u003c/mark\u003e, the same antidote used for benzodiazepine overdose.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027Z-drugs\u0027 (\u003cb\u003eZ\u003c/b\u003eolpidem, \u003cb\u003eZ\u003c/b\u003ealeplon, es\u003cb\u003eZ\u003c/b\u003eopiclone) as a separate class from benzodiazepines, but know that they act on the same receptor complex and their overdose is treated with the same antidote (flumazenil).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEszopiclone\u003c/b\u003e is a \u0027Z-drug\u0027 hypnotic that induces sleep by selectively enhancing GABAergic inhibition at the BZ\u003csub\u003e1\u003c/sub\u003e receptor, offering an alternative to benzodiazepines for insomnia but still carrying risks of complex sleep behaviors and dependence.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"non_benzodiazepine_hypnotic\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n  },\n  \"a90f6fb4\": {\n    \"title\": \"Ethosuximide\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEthosuximide\u003c/b\u003e is a narrow-spectrum anticonvulsant medication that is the first-line treatment for uncomplicated [[a0c128f4|absence seizures]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks \u003cmark\u003eT-type calcium channels\u003c/mark\u003e in thalamic neurons. This disrupts the oscillatory rhythm between the thalamus and the cortex that is responsible for generating the characteristic 3 Hz spike-and-wave discharges of absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e and specific therapy for [[a0c128f4|absence seizures]] (\u0027petit mal\u0027). It is not effective for other seizure types.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common side effects can be remembered with the mnemonic \u003cb\u003eEFGHIJ\u003c/b\u003e: \u003cb\u003eE\u003c/b\u003ethosuximide causes \u003cb\u003eF\u003c/b\u003eatigue, \u003cb\u003eG\u003c/b\u003eI distress (nausea, vomiting), \u003cb\u003eH\u003c/b\u003eeadache, \u003cb\u003eI\u003c/b\u003etching (and urticaria), and Stevens-\u003cb\u003eJ\u003c/b\u003eohnson syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e [[valproic_acid|Valproic acid]] is also effective for absence seizures and is used if the patient also has tonic-clonic seizures. Carbamazepine and phenytoin can worsen absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The unique mechanism of blocking thalamic T-type calcium channels makes ethosuximide the specific drug of choice for absence seizures.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEthosuximide\u003c/b\u003e is the targeted therapy for absence seizures, working by selectively blocking the T-type calcium channels in the thalamus that generate the pathognomonic 3 Hz spike-and-wave rhythm of this specific seizure type.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ethosuximide] --Blocks--\u003e B(Thalamic T-type Ca2+ Channels); B --x C(3 Hz Spike-and-Wave Discharges); C --x D(Absence Seizure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"t_type_calcium_channel\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9507,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"74cadd6c\": {\n    \"title"
      }, {
        "text": "\": \"Endolymphatic Hydrops\",\n    \"primaryType\": \"pathology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Otology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEndolymphatic hydrops\u003c/b\u003e is the dist"
      }, {
        "text": "ention of the endolymphatic system of the inner ear, caused by an excess volume of endolymph fluid. It"
      }, {
        "text": " is the underlying pathological finding in \u003cmark\u003eM√©ni√®re disease\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact cause is unknown, but it is thought to involve either over"
      }, {
        "text": "production or impaired reabsorption of endolymph, leading to increased pressure within the membranous labyrinth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Disease:\u003c/b\u003e This is the pathophysiological basis for [[menieres_disease|M√©ni√®re disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Manifestations"
      }, {
        "text": ":\u003c/b\u003e The increased pressure damages the vestibular and cochlear hair cells, leading to the classic triad of M√©ni√®re disease:\u003c"
      }, {
        "text": "br\u003e1. \u003cb\u003eEpisodic [[5603962d|Vertigo]]:\u003c/b\u003e Attacks"
      }, {
        "text": " of spinning dizziness that last for minutes to hours.\u003cbr\u003e2. \u003cb\u003eSensorineural Hearing Loss:\u003c/b\u003e Typically"
      }, {
        "text": " fluctuating and affecting low frequencies initially.\u003cbr\u003e3. \u003cb\u003eTinnitus:\u003c/b\u003e Ringing or roaring sound in the affected ear."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Endolymphatic hydrops \u003d M√©ni√®re disease. Remember the triad of vertigo"
      }, {
        "text": ", hearing loss, and tinnitus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEndolymphatic hydrops\u003c/b\u003e is"
      }, {
        "text": " essentially \u0027glaucoma of the inner ear,\u0027 where excessive endolymph fluid pressure damages the delicate sensory structures for hearing and balance, causing"
      }, {
        "text": " the debilitating episodic attacks of vertigo, tinnitus, and hearing loss that define M√©ni√®re disease.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_the_pathophys"
      }, {
        "text": "iology_of\",\n        \"to\": \"menieres_disease\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"affects\",\n        \"to\": \"inner_ear\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"5603962d\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"8039c888\": {\n    \"title\": \"Endoneurium\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eEndoneurium\u003c/b\u003e is the delicate layer of connective tissue that surrounds each individual myelinated and"
      }, {
        "text": " unmyelinated nerve fiber (axon) within a peripheral nerve fascicle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure"
      }, {
        "text": ":\u003c/b\u003e Composed of reticular fibers, fibroblasts, and capillaries. It is the innermost of the three connective tissue she"
      }, {
        "text": "aths of a peripheral nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides a supportive and nutritive microenvironment for the axon and its associated"
      }, {
        "text": " Schwann cell.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Nerve Barrier:\u003c/b\u003e The capillaries within the endoneurium have tight junctions,"
      }, {
        "text": " forming part of the [[03ba9967|blood-nerve barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The"
      }, {
        "text": " endoneurium is the primary site of inflammation in \u003cmark\u003e[[ed52e40b|Guill"
      }, {
        "text": "ain-Barr√© syndrome]]\u003c/mark\u003e (acute inflammatory demyelinating polyneuropathy), where inflammatory cells infiltrate this"
      }, {
        "text": " space and attack the myelin sheath.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNerve Layers (from inside out):\u003c/b\u003e Axon ‚Üí Myelin ‚Üí"
      }, {
        "text": " Endoneurium ‚Üí Perineurium (surrounds fascicle) ‚Üí Epineurium (surrounds entire nerve).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Remember that the inflammation in Guillain-Barr√© syndrome occurs in the endoneurium, targeting Schwann cells and myelin.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe \u003cb\u003eEndoneurium\u003c/b\u003e is the intimate connective tissue wrapping around a single nerve fiber, providing essential"
      }, {
        "text": " support and forming the inner sanctum of the peripheral nerve, which becomes a battleground in inflammatory neuropathies like Guillain-Barr√© syndrome"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"peripheral_nerve\"\n      },\n      {\n        \"type\": \"sur"
      }, {
        "text": "rounds\",\n        \"to\": \"axon\"\n      },\n      {\n        \"type\": \"is_site"
      }, {
        "text": "_of_inflammation_in\",\n        \"to\": \"ed52e40b\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"eb2da2bc\": {\n    \"title\": \"Entac"
      }, {
        "text": "apone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eEntacapone\u003c/b\u003e is a peripherally acting, reversible inhibitor of catechol-O-methyltransferase (COMT)."
      }, {
        "text": " It is used as an adjunctive therapy with [[541cd176|levodopa/carbidopa]] for"
      }, {
        "text": " the treatment of [[58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Inhibits COMT in the peripheral tissues. COMT is one of the enzymes that metabolizes lev"
      }, {
        "text": "odopa. By blocking this peripheral breakdown, entacapone \u003cmark\u003eincreases the plasma half-life of levodopa\u003c/mark\u003e and increases"
      }, {
        "text": " the amount of levodopa available to cross the blood-brain barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used in combination"
      }, {
        "text": " with [[541cd176|levodopa/carbidopa]] to treat patients with Parkinson disease who are"
      }, {
        "text": " experiencing motor fluctuations (\u0027wearing-off\u0027 phenomenon). It helps to prolong the \u0027on\u0027 time.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSite"
      }, {
        "text": " of Action:\u003c/b\u003e It acts only in the \u003cmark\u003eperiphery\u003c/mark\u003e and does not cross the blood-brain"
      }, {
        "text": " barrier. This contrasts with tolcapone, another COMT inhibitor, which acts both peripherally and centrally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Can potentiate the dopaminergic side effects of levodopa (e.g., dyskinesias"
      }, {
        "text": ", nausea, confusion). It can also cause a harmless orange discoloration of the urine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that ent"
      }, {
        "text": "acapone is a \u0027levodopa extender.\u0027 It doesn\u0027t have any effect on its own but works by preventing"
      }, {
        "text": " the peripheral breakdown of levodopa, thereby boosting its effectiveness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEntac"
      }, {
        "text": "apone\u003c/b\u003e serves as a \u0027bodyguard\u0027 for levodopa in the periphery, inhibiting the COMT enzyme to prevent"
      }, {
        "text": " levodopa\u0027s breakdown before it can reach the brain, thus extending its therapeutic effect in Parkinson\u0027s disease.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Levodopa] --Peripheral COMT--\u003e B(3-O-meth"
      }, {
        "text": "yldopa - Inactive); C[Entacapone] --x B; A --\u003e D(Crosses BBB);"
      }, {
        "text": " D --\u003e E(Dopamine in CNS);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"comt_inhibitor\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_used_with\",\n        \"to\": \"541cd176\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"tolcapone\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"a70c151b\": {\n    \"title\": \""
      }, {
        "text": "Entorhinal Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\","
      }, {
        "text": "\n      \"Limbic System\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Limbic System\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eEntorhinal Cortex\u003c/b\u003e is an area of the brain"
      }, {
        "text": " located in the medial temporal lobe that functions as a major hub in a widespread network for memory, navigation, and the perception of time. It is the main"
      }, {
        "text": " interface between the [[a0590674|hippocampus]] and the neocortex.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Medial temporal lobe, adjacent to the [[a0590674"
      }, {
        "text": "|hippocampus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Serves as the primary gateway for information entering and leaving the [["
      }, {
        "text": "a0590674|hippocampus]]. It is crucial for the formation of long-term episodic"
      }, {
        "text": " and spatial memories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConnections:\u003c/b\u003e It receives highly processed sensory information from all cortical association areas and funnels it"
      }, {
        "text": " into the [[a0590674|hippocampus]] for memory consolidation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Relevance:\u003c/b\u003e The entorhinal cortex is one of the \u003cmark\u003efirst areas of the brain to be affected in"
      }, {
        "text": " [[77ae6148|Alzheimer disease]]\u003c/mark\u003e. The formation of neurofibrillary tangles in"
      }, {
        "text": " this region is a very early pathological sign, contributing to the initial memory deficits of the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e The degeneration of the entorhinal cortex is a key early event in the progression of [[77ae6148|"
      }, {
        "text": "Alzheimer disease]], effectively cutting off the hippocampus from its cortical inputs and leading to profound anterograde amnesia.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eEntorhinal Cortex\u003c/b\u003e acts as the main \u0027entrance and exit ramp"
      }, {
        "text": "\u0027 for the hippocampus, and its early destruction in Alzheimer\u0027s disease is a critical event that isolates the memory-forming hippocampus from"
      }, {
        "text": " the rest of the brain.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Neocortex] \u003c"
      }, {
        "text": "--\u003e B(Entorhinal Cortex); B \u003c--\u003e C(Hippocampus);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"73"
      }, {
        "text": "ace357\"\n      },\n      {\n        \"type\": \"is_the_main_interface"
      }, {
        "text": "_for\",\n        \"to\": \"a0590674\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_affected_early_in\",\n        \"to\": \"77ae6148\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"3a777d5f\": {\n    \"title"
      }, {
        "text": "\": \"Ependymal Cells\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEpendymal cells\u003c/b\u003e are a type of glial cell that form"
      }, {
        "text": " the epithelial lining of the ventricles in the brain and the central canal of the spinal cord. They are involved in the production"
      }, {
        "text": " and circulation of cerebrospinal fluid (CSF).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Simple"
      }, {
        "text": " cuboidal or columnar epithelial cells. Their apical surfaces are covered with cilia (which help circulate CSF) and microvilli ("
      }, {
        "text": "which help with CSF absorption).\u003c/li\u003e\u003cli\u003e\u003cb\u003eChoroid Plexus:\u003c/b\u003e Ependymal cells are modified in certain"
      }, {
        "text": " locations to form the \u003cmark\u003e[[ae65e9c7|choroid plexus]]\u003c/mark\u003e, the"
      }, {
        "text": " specialized tissue responsible for producing the majority of the [[7109d8b6|CSF]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood"
      }, {
        "text": "-CSF Barrier:\u003c/b\u003e The ependymal cells of the choroid plexus are joined by tight junctions, forming the blood-CSF barrier."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eTumor Origin:\u003c/b\u003e These cells can give rise to \u003cmark\u003e[[14365ef"
      }, {
        "text": "4|ependymomas]]\u003c/mark\u003e, a type of brain tumor. In children, ependymomas most commonly arise in the fourth"
      }, {
        "text": " ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that ependymal cells line the ventricles and produce CSF. A tumor"
      }, {
        "text": " of these cells, an ependymoma, can therefore obstruct CSF flow and cause non-communicating hydrocephalus,"
      }, {
        "text": " especially when located in the fourth ventricle.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEpendymal cells\u003c/b\u003e"
      }, {
        "text": " are the specialized epithelial lining of the brain\u0027s ventricular system, with the crucial dual roles of forming a barrier and,"
      }, {
        "text": " in the choroid plexus, actively producing the cerebrospinal fluid that bathes the CNS.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"glial_cell\"\n      },\n      {\n        \"type\": \"lines\",\n        \"to\": \"1"
      }, {
        "text": "cb9c975\"\n      },\n      {\n        \"type\": \"forms\",\n        \"to\": \"ae"
      }, {
        "text": "65e9c7\"\n      },\n      {\n        \"type\": \"is_cell_of_origin_for\",\n"
      }, {
        "text": "        \"to\": \"14365ef4\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"14365ef4\": {\n    \"title\": \"Ependymoma\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eependymoma\u003c/b\u003e is a primary CNS tumor that arises from [["
      }, {
        "text": "3a777d5f|ependymal cells]], the glial cells that line the ventricles of the brain and the central canal of the spinal"
      }, {
        "text": " cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e Most common in children, where"
      }, {
        "text": " it is the third most common posterior fossa tumor (after pilocytic astrocytoma and medulloblastoma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e In"
      }, {
        "text": " children, they most commonly arise in the \u003cmark\u003efourth ventricle\u003c/mark\u003e. In adults, they are more common in the spinal cord"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Tumors in the fourth ventricle often obstruct CSF flow, leading to \u003cmark\u003enon"
      }, {
        "text": "-communicating hydrocephalus\u003c/mark\u003e and signs of increased intracranial pressure (headache, nausea, vomiting, papilledema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHist"
      }, {
        "text": "ology:\u003c/b\u003e The characteristic histological finding is the \u003cmark\u003eperivascular pseudorosette\u003c/mark\u003e, where tumor cells are"
      }, {
        "text": " arranged in a circular pattern around a central blood vessel, with a clear zone in between. Rod-shaped blepharoplast"
      }, {
        "text": "s (basal ciliary bodies) may be seen near the nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Variable"
      }, {
        "text": ", but generally poor for infratentorial tumors in children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with hydro"
      }, {
        "text": "cephalus and a tumor located within the fourth ventricle showing perivascular pseudorosettes on histology is the classic presentation of an ependymoma"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eependymoma\u003c/b\u003e is a tumor of the ventricular"
      }, {
        "text": " lining cells that most characteristically occurs in the fourth ventricle of children, where it acts as a \u0027plug in the drain,\u0027 causing obstructive"
      }, {
        "text": " hydrocephalus, and is identified microscopically by its unique perivascular pseudorosettes.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Ependymal Cells] --Neoplastic Transformation--\u003e B(Ependymoma); B --Location in"
      }, {
        "text": " 4th Ventricle--\u003e C(Obstruction of CSF Flow); C --\u003e D(Non-communicating Hydrocephalus);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to"
      }, {
        "text": "\": \"3a777d5f\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"has_"
      }, {
        "text": "histological_finding\",\n        \"to\": \"perivascular_pseudorosette\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"a61683ae\": {\n    \"title\": \"Epidural Hematoma\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Trauma\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eAn \u003cb\u003eepidural hematoma (EDH)\u003c/b\u003e is a collection of blood that forms between the inner surface of the skull"
      }, {
        "text": " and the outer layer of the dura mater. It is a neurosurgical emergency, typically caused by trauma.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a fracture of the \u003cmark\u003etemporal bone\u003c/"
      }, {
        "text": "mark\u003e, which lacerates the \u003cmark\u003emiddle meningeal artery\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Arter"
      }, {
        "text": "ial bleeding leads to rapid accumulation of blood in the epidural space, which strips the dura away from the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " The classic presentation is a patient who suffers head trauma with a brief loss of consciousness, followed by a \u003cmark\u003e\\\""
      }, {
        "text": "lucid interval\\\"\u003c/mark\u003e where they seem fine, and then a rapid neurological deterioration (headache, vomiting, seizure"
      }, {
        "text": ", coma) as the hematoma expands and increases intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e A non-contrast head"
      }, {
        "text": " CT shows a hyperdense, \u003cmark\u003ebiconvex (lentiform)\u003c/mark\u003e blood collection. The hematoma does "
      }, {
        "text": "\u003cu\u003enot\u003c/u\u003e cross suture lines, where the dura is tightly adherent to the skull.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Lucid"
      }, {
        "text": " interval + temporal bone fracture + lentiform bleed on CT \u003d Epidural hematoma. This is a classic trauma vignette.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eAn \u003cb\u003eepidural hematoma\u003c/b\u003e is a high-pressure arterial bleed, typically from the"
      }, {
        "text": " middle meningeal artery after a temporal bone fracture, that creates a rapidly expanding, lens-shaped clot which can be fatal"
      }, {
        "text": " if not evacuated promptly; the deceptive \u0027lucid interval\u0027 is a classic but not universal feature.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Temporal Bone Fracture] --\u003e B(Laceration of Middle Meningeal Artery);"
      }, {
        "text": " B --\u003e C(Arterial Bleeding into Epidural Space); C --\u003e D(Biconvex Hematoma); D --\u003e E(‚Üë"
      }, {
        "text": " ICP \u0026 Herniation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"intracranial_hemorrhage\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by_rupture_of\",\n        \"to\": \""
      }, {
        "text": "middle_meningeal_artery\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n"
      }, {
        "text": "        \"to\": \"lucid_interval\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \""
      }, {
        "text": "to\": \"8aaeb0d8\"\n      }\n    ]\n  },\n  \"33"
      }, {
        "text": "bfd833\": {\n    \"title\": \"Epidural Space\",\n    \"primaryType\": \"anatomy\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Neuroanatomy\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eepidural space"
      }, {
        "text": "\u003c/b\u003e is a potential or actual space located between the dura mater and the overlying bone (skull in the cranium, vertebrae"
      }, {
        "text": " in the spinal canal).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCranial Epidural Space:\u003c/b\u003e A"
      }, {
        "text": " \u003ci\u003epotential\u003c/i\u003e space between the skull and the periosteal layer of the [[5bbe3597|dura mater]]. It"
      }, {
        "text": " becomes a real space only pathologically, when blood accumulates in it to form an [[a61683ae|epid"
      }, {
        "text": "ural hematoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Epidural Space:\u003c/b\u003e A \u003ci\u003ereal\u003c/i\u003e space between the vertebrae and the d"
      }, {
        "text": "ural sheath. It contains fat, connective tissue, and a network of veins (the internal vertebral venous plexus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance ("
      }, {
        "text": "Spinal):\u003c/b\u003e The spinal epidural space is the target for \u003cmark\u003eepidural anesthesia\u003c/mark\u003e and analgesia, where"
      }, {
        "text": " local anesthetics are injected to block the spinal nerve roots. It is also the site of spinal epidural abscesses and hemat"
      }, {
        "text": "omas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance (Cranial):\u003c/b\u003e The site of [[a61683ae|"
      }, {
        "text": "epidural hematomas]], typically from rupture of the middle meningeal artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand"
      }, {
        "text": " the difference between the cranial (potential) and spinal (real) epidural spaces. An epidural anesthetic is placed in the real"
      }, {
        "text": " space in the spine, not the potential space in the head.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eepidural space\u003c/b\u003e is an anatomically distinct area outside the dura mater, which is a potential space in the cranium"
      }, {
        "text": " that can fill with blood in an epidural hematoma, and a real, fat-filled space in the spine that is utilized for regional"
      }, {
        "text": " anesthesia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located"
      }, {
        "text": "_outside\",\n        \"to\": \"5bbe3597\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_site_of\",\n        \"to\": \"a61683ae\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_target_for\",\n        \"to\": \"epidural"
      }, {
        "text": "_anesthesia\"\n      }\n    ]\n  },\n  \"64c08e92"
      }, {
        "text": "\": {\n    \"title\": \"Epilepsy\",\n    \"primaryType\": \"disease\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEpilepsy\u003c/b\u003e is a chronic neurological disorder characterized by a predisposition"
      }, {
        "text": " to generate recurrent, unprovoked [[64c08e92|seizures]]. A seizure is a"
      }, {
        "text": " transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDefinition:\u003c/b\u003e Requires at least two unprovoked seizures occurring more than 24 hours apart, or"
      }, {
        "text": " one unprovoked seizure with a high probability of further seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSeizure Types:\u003c/b\u003e Seizures are broadly"
      }, {
        "text": " classified as focal (originating in one hemisphere) or generalized (originating in both hemispheres simultaneously).\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eFocal Seizures:\u003c/b\u003e Can be aware or have impaired awareness.\u003cbr\u003e - \u003cb\u003eGeneralized Seizures:\u003c/b\u003e Include"
      }, {
        "text": " [[a0c128f4|absence]], tonic-clonic, myoclonic, and [[ed"
      }, {
        "text": "7a236f|atonic]] seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be genetic, structural ("
      }, {
        "text": "e.g., from a prior stroke, tumor, or trauma), infectious, metabolic, or immune-mediated. In"
      }, {
        "text": " many cases, the cause is unknown.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Managed with [[f91a0cfa"
      }, {
        "text": "|anticonvulsant]] (antiepileptic) drugs. The choice of drug depends on the seizure type.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e It is crucial to distinguish epilepsy from a single provoked seizure (e.g., febrile seizure,"
      }, {
        "text": " alcohol withdrawal seizure), which does not necessarily require long-term anticonvulsant therapy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eEpilepsy\u003c/b\u003e is a disorder of brain hyperexcitability, defined by the tendency for"
      }, {
        "text": " recurrent, unprovoked seizures, and its management requires accurate classification of the seizure type to guide the selection of appropriate anticon"
      }, {
        "text": "vulsant therapy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      "
      }, {
        "text": "{\n        \"type\": \"is_characterized_by\",\n        \"to\": \"seizures\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_treated_by\",\n        \"to\": \"f91a0"
      }, {
        "text": "cfa\"\n      },\n      {\n        \"type\": \"includes_seizure_type\",\n        \""
      }, {
        "text": "to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "includes_seizure_type\",\n        \"to\": \"ed7a236f\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"583587cd\": {\n    \"title\": \"E"
      }, {
        "text": "pinephrine\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Endocrinology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"End"
      }, {
        "text": "ocrine\",\n      \"Physiology\",\n      \"Adrenal Gland\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eEpinephrine\u003c/b\u003e (adrenaline) is a catecholamine hormone and neurotransmitter that is central to the \u0027"
      }, {
        "text": "fight or flight\u0027 response. It is produced by the adrenal medulla and acts on both Œ±- and Œ≤-adrenergic receptors throughout"
      }, {
        "text": " the body.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized in the adrenal medulla from norepinephrine."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptor Activity:\u003c/b\u003e Acts on Œ±\u003csub\u003e1\u003c/sub\u003e, Œ±\u003csub\u003e2\u003c/sub\u003e, Œ≤\u003csub\u003e1\u003c/sub\u003e, and Œ≤\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e receptors. The effect depends on the dose and the receptor density in the target tissue.\u003cbr\u003e - \u003cb\u003eLow Dose:\u003c/b\u003e Œ≤"
      }, {
        "text": "-effects predominate (Œ≤\u003csub\u003e1\u003c/sub\u003e: ‚Üë heart rate/contractility; Œ≤\u003csub\u003e2\u003c/sub\u003e: vasodilation,"
      }, {
        "text": " bronchodilation) ‚Üí ‚Üë systolic BP, ‚Üì diastolic BP, ‚Üë pulse pressure.\u003cbr\u003e - \u003cb\u003eHigh Dose"
      }, {
        "text": ":\u003c/b\u003e Œ±\u003csub\u003e1\u003c/sub\u003e-effects predominate (vasoconstriction) ‚Üí ‚Üë systolic and diastolic BP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnaphylaxis:\u003c/b\u003e Drug of choice. Causes vasoconstriction (Œ±\u003csub\u003e1\u003c/sub\u003e), bronchodilation"
      }, {
        "text": " (Œ≤\u003csub\u003e2\u003c/sub\u003e), and ‚Üë cardiac output (Œ≤\u003csub\u003e1\u003c/sub\u003e).\u003cbr\u003e - \u003cb\u003eCardiac Arrest:\u003c/b\u003e Used"
      }, {
        "text": " in ACLS protocols.\u003cbr\u003e - \u003cb\u003e[[3ce6c035|Glaucoma]]:\u003c/b\u003e Topical"
      }, {
        "text": " epinephrine (Œ±\u003csub\u003e1\u003c/sub\u003e agonist) decreases aqueous humor synthesis via vasoconstriction and increases outflow.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand"
      }, {
        "text": " the dose-dependent effects of epinephrine. At low doses, it acts like isoproterenol (Œ≤-agonist),"
      }, {
        "text": " while at high doses, it acts more like norepinephrine (Œ±-agonist).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eEpinephrine\u003c/b\u003e is the ultimate \u0027fight or flight\u0027 hormone, exerting widespread, dose-dependent effects on the cardiovascular and"
      }, {
        "text": " respiratory systems by activating all subtypes of adrenergic receptors, making it the life-saving drug of choice for anaphylaxis.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Epinephrine]; A --Low Dose--\u003e B(Œ≤ \u003e Œ± effects); B --\u003e"
      }, {
        "text": " C(‚Üë HR, ‚Üë Contractility, Vasodilation); A --High Dose--\u003e D(Œ± \u003e Œ≤ effects); D"
      }, {
        "text": " --\u003e E(Potent Vasoconstriction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"catecholamine\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_released_from\",\n        \"to\": \"adrenal_medulla\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"treats\",\n        \"to\": \"anaphylaxis\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"5093edcb\": {\n    \"title\":"
      }, {
        "text": " \"Epineurium\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eEpineurium\u003c/b\u003e is the dense, irregular"
      }, {
        "text": " connective tissue sheath that forms the outermost layer of a peripheral nerve. It bundles together multiple nerve fascicles and provides structural support and protection to the entire"
      }, {
        "text": " nerve trunk.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The thickest of the three connective tissue layers of"
      }, {
        "text": " a peripheral nerve. It is continuous with the dura mater at the spinal nerve roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Provides"
      }, {
        "text": " mechanical protection to the nerve, cushions it from external pressure, and contains the vasa nervorum (the blood supply to the nerve).\u003c/li\u003e\u003cli\u003e\u003cb\u003eN"
      }, {
        "text": "erve Layers (from outside in):\u003c/b\u003e Epineurium (surrounds entire nerve) ‚Üí Perineurium (surrounds a"
      }, {
        "text": " fascicle of axons) ‚Üí [[8039c888|Endoneurium]] (surrounds an"
      }, {
        "text": " individual axon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e During nerve repair surgery (neurorrhaphy), the epineurium"
      }, {
        "text": " is the layer that is typically sutured together to re-approximate the severed nerve ends.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Be able to identify the three connective tissue layers of a peripheral nerve and their respective locations.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eEpineurium\u003c/b\u003e is the tough, outer \u0027jacket\u0027 of a peripheral nerve, bundling"
      }, {
        "text": " all the fascicles together and providing the primary structural integrity and blood supply for the nerve trunk.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\":"
      }, {
        "text": " \"peripheral_nerve\"\n      },\n      {\n        \"type\": \"surrounds\",\n        \""
      }, {
        "text": "to\": \"perineurium\"\n      },\n      {\n        \"type\": \"is_superficial_to\",\n        \""
      }, {
        "text": "to\": \"8039c888\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "8d491af6\": {\n    \"title\": \"Esotropia\",\n    \"primaryType\": \"finding"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Pediatrics\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Ophthalmology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eEsotropia\u003c/b\u003e is a form of strabismus (eye misalignment) in which one or both eyes"
      }, {
        "text": " turn inward, toward the nose. It is the most common type of strabismus in infants and children.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e An inward deviation of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses in Children:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eCongenital/Infantile Esotropia:\u003c/b\u003e Appears in the first few months of life.\u003cbr"
      }, {
        "text": "\u003e - \u003cb\u003eAccommodative Esotropia:\u003c/b\u003e The most common type in children over 6 months. It is caused by un"
      }, {
        "text": "corrected hyperopia (farsightedness). The effort to focus on near objects (accommodate) triggers an excessive convergence reflex, causing"
      }, {
        "text": " the eyes to cross.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses in Adults:\u003c/b\u003e A new onset of esotropia in an adult is"
      }, {
        "text": " often due to a \u003cmark\u003e[[01c1b782|cranial nerve VI (abducens) palsy]]\u003c/mark"
      }, {
        "text": "\u003e, which paralyzes the lateral rectus muscle and allows the medial rectus to pull the eye inward unopposed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCom"
      }, {
        "text": "plication:\u003c/b\u003e If left untreated in children, esotropia can lead to \u003cmark\u003e[[a4a40"
      }, {
        "text": "1c7|amblyopia]]\u003c/mark\u003e (\u0027lazy eye\u0027) in the deviating eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e An adult who suddenly develops horizontal diplopia and an inward-turning eye likely has a CN VI palsy. A"
      }, {
        "text": " child with intermittent eye crossing, especially when looking at near objects, may have accommodative esotropia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eEsotropia\u003c/b\u003e is an inward turning of the eye that, in children, is often a refractive"
      }, {
        "text": " problem linked to the accommodation-convergence reflex, while in adults, it is more commonly a neurological sign of a sixth nerve palsy.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"strabismus\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"can_be_caused_by\",\n        \"to\": \"01c1b78"
      }, {
        "text": "2\"\n      },\n      {\n        \"type\": \"can_lead_to\",\n        \"to"
      }, {
        "text": "\": \"a4a401c7\"\n      }\n    ]\n  },\n  \"4"
      }, {
        "text": "0039e56\": {\n    \"title\": \"Essential Tremor\",\n    \"primaryType\": \"disease"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement"
      }, {
        "text": " Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEssential tremor\u003c/b\u003e is the"
      }, {
        "text": " most common movement disorder, characterized by a postural and action tremor, most often affecting the hands and arms. It is typically bilateral"
      }, {
        "text": " and can be inherited in an autosomal dominant pattern.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e A high-frequency tremor that is absent at rest, emerges when the arms are held in a posture (e.g., outstretched"
      }, {
        "text": "), and worsens with goal-directed movements (action tremor), such as writing or drinking from a cup.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected"
      }, {
        "text": " Areas:\u003c/b\u003e Most commonly affects the hands, but can also involve the head (titubation), voice, and legs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Feature:\u003c/b\u003e The tremor characteristically \u003cmark\u003eimproves with small amounts of alcohol\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferent"
      }, {
        "text": "iation from Parkinson\u0027s:\u003c/b\u003e This is a critical distinction. Essential tremor is an \u003cu\u003eaction\u003c/u\u003e tremor that improves with alcohol. The"
      }, {
        "text": " tremor of [[58c8ea03|Parkinson disease]] is a \u003cu\u003eresting\u003c/u\u003e tremor that improves"
      }, {
        "text": " with movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e First-line treatments are \u003cmark\u003epropranolol\u003c/mark\u003e (a"
      }, {
        "text": " non-selective beta-blocker) and primidone (an anticonvulsant).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " patient who complains of shaky hands that make it difficult to write or eat, but notes that a glass of wine helps,"
      }, {
        "text": " is the classic presentation of essential tremor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEssential tremor\u003c/b\u003e is an action tremor,"
      }, {
        "text": " not a resting tremor, that is famously and diagnostically relieved by alcohol and managed pharmacologically with propranolol or primidone.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"tremor\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"differentiated_from\",\n        \"to\": \"parkinsonian_tremor\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_treated_by\",\n        \"to\": \"propranolol\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_treated_by\",\n        \"to\": \"primidone\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"703804c7\": {\n    \"title"
      }, {
        "text": "\": \"Eszopiclone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sed"
      }, {
        "text": "ative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Eszopiclone\u003c/b\u003e (trade name Lunesta) is a non-benzodiazepine hypnotic agent, commonly referred to as a \u0027Z-drug,\u0027"
      }, {
        "text": " used for the treatment of insomnia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts"
      }, {
        "text": " as a positive allosteric modulator at the benzodiazepine (BZ\u003csub\u003e1\u003c/sub\u003e) subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor."
      }, {
        "text": " This enhances the effect of GABA, leading to increased chloride conductance and CNS depression (sedation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:"
      }, {
        "text": "\u003c/b\u003e Non-benzodiazepine hypnotic (\u0027Z-drug\u0027), along with zolpidem and zaleplon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use"
      }, {
        "text": ":\u003c/b\u003e Approved for the long-term treatment of insomnia, helping with both sleep onset and sleep maintenance.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmac"
      }, {
        "text": "okinetics:\u003c/b\u003e Has a longer half-life compared to zolpidem and zaleplon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e"
      }, {
        "text": " Anterograde amnesia, hallucinations, and complex sleep-related behaviors (e.g., sleepwalking, sleep-"
      }, {
        "text": "driving). A common side effect is an unpleasant or metallic taste. Risk of dependence and withdrawal is lower than with benzodiazepines but"
      }, {
        "text": " still present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e The effects can be reversed by \u003cmark\u003eflumazenil\u003c/mark"
      }, {
        "text": "\u003e, the same antidote used for benzodiazepine overdose.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027Z-drugs\u0027 (\u003cb\u003e"
      }, {
        "text": "Z\u003c/b\u003eolpidem, \u003cb\u003eZ\u003c/b\u003ealeplon, es\u003cb\u003eZ\u003c/b\u003eopiclone) as a separate"
      }, {
        "text": " class from benzodiazepines, but know that they act on the same receptor complex and their overdose is treated with the same antidote"
      }, {
        "text": " (flumazenil).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEszopiclone\u003c/b\u003e is a \u0027"
      }, {
        "text": "Z-drug\u0027 hypnotic that induces sleep by selectively enhancing GABAergic inhibition at the BZ\u003csub\u003e1\u003c/sub\u003e receptor, offering"
      }, {
        "text": " an alternative to benzodiazepines for insomnia but still carrying risks of complex sleep behaviors and dependence.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"non_benzodiazepine_hypnotic\"\n      },\n      {\n        \"type\": \"treats\",\n"
      }, {
        "text": "        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_on\","
      }, {
        "text": "\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"overdose_treated"
      }, {
        "text": "_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n  },\n  \"a"
      }, {
        "text": "90f6fb4\": {\n    \"title\": \"Ethosuximide\",\n    \"primaryType\": \"drug\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Ant"
      }, {
        "text": "iconvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEth"
      }, {
        "text": "osuximide\u003c/b\u003e is a narrow-spectrum anticonvulsant medication that is the first-line treatment for uncomplicated [[a0c12"
      }, {
        "text": "8f4|absence seizures]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks"
      }, {
        "text": " \u003cmark\u003eT-type calcium channels\u003c/mark\u003e in thalamic neurons. This disrupts the oscillatory rhythm between the thalamus and the cortex"
      }, {
        "text": " that is responsible for generating the characteristic 3 Hz spike-and-wave discharges of absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:"
      }, {
        "text": "\u003c/b\u003e \u003cu\u003eFirst-line\u003c/u\u003e and specific therapy for [[a0c128f4|absence seizures]]"
      }, {
        "text": " (\u0027petit mal\u0027). It is not effective for other seizure types.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Common side effects can"
      }, {
        "text": " be remembered with the mnemonic \u003cb\u003eEFGHIJ\u003c/b\u003e: \u003cb\u003eE\u003c/b\u003ethosuximide causes \u003cb\u003eF\u003c/b\u003eatigue, "
      }, {
        "text": "\u003cb\u003eG\u003c/b\u003eI distress (nausea, vomiting), \u003cb\u003eH\u003c/b\u003eeadache, \u003cb\u003eI\u003c/b\u003etching ("
      }, {
        "text": "and urticaria), and Stevens-\u003cb\u003eJ\u003c/b\u003eohnson syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison:\u003c/b\u003e [[valproic_acid|"
      }, {
        "text": "Valproic acid]] is also effective for absence seizures and is used if the patient also has tonic-clonic seizures"
      }, {
        "text": ". Carbamazepine and phenytoin can worsen absence seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The unique mechanism of blocking"
      }, {
        "text": " thalamic T-type calcium channels makes ethosuximide the specific drug of choice for absence seizures.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eEthosuximide\u003c/b\u003e is the targeted therapy for absence seizures, working by selectively blocking the T-type calcium channels in the thalamus"
      }, {
        "text": " that generate the pathognomonic 3 Hz spike-and-wave rhythm of this specific seizure type.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Ethosuximide] --Blocks--\u003e B(Thalamic T-type Ca"
      }, {
        "text": "2+ Channels); B --x C(3 Hz Spike-and-Wave Discharges); C --x D(Abs"
      }, {
        "text": "ence Seizure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"f91a0cfa\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"treats\",\n        \"to\": \"a0c128f"
      }, {
        "text": "4\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \""
      }, {
        "text": "t_type_calcium_channel\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "driveDocument": {
        "id": "11zrugcnM9Dz2OtyZAkJOQiH7afx24Zkk"
      },
      "role": "user",
      "tokenCount": 1969
    }, {
      "text": "continue",
      "role": "user",
      "tokenCount": 2
    }, {
      "text": "```json\n{\n  \"13c459e0\": {\n    \"title\": \"Etomidate\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEtomidate\u003c/b\u003e is an intravenous general anesthetic used for the induction of anesthesia, particularly in patients who are hemodynamically unstable. It provides sedation and hypnosis but lacks analgesic properties.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Potentiates the GABA\u003csub\u003eA\u003c/sub\u003e receptor, enhancing the inhibitory effects of GABA on the central nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a rapid onset and short duration of action, making it ideal for induction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Advantage:\u003c/b\u003e It is \u003cmark\u003ehemodynamically neutral\u003c/mark\u003e, causing minimal changes in blood pressure, heart rate, and cardiac output. This makes it the induction agent of choice for patients with cardiovascular instability (e.g., trauma, sepsis, cardiac disease).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used for the induction of general anesthesia and for rapid sequence intubation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most significant side effect is \u003cmark\u003eadrenocortical suppression\u003c/mark\u003e. It reversibly inhibits 11Œ≤-hydroxylase, an enzyme critical for cortisol and aldosterone synthesis. This effect can last for several hours after a single bolus dose. Also associated with postoperative nausea and vomiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember etomidate for its cardiovascular stability (\u0027hemodynamically neutral\u0027) and its unique side effect of adrenal suppression.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEtomidate\u003c/b\u003e is a valuable anesthetic induction agent prized for its minimal impact on hemodynamics, making it safe for critically ill patients, but its utility is tempered by a transient but significant suppression of adrenal steroid synthesis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"intravenous_anesthetic\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"adrenocortical_suppression\"\n      }\n    ]\n  },\n  \"7efdb0ef\": {\n    \"title\": \"Hydrocephalus Ex Vacuo\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Radiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHydrocephalus ex vacuo\u003c/b\u003e is an apparent increase in the size of the cerebral ventricles and subarachnoid spaces on neuroimaging that is not due to increased cerebrospinal fluid (CSF) pressure, but rather to a loss of brain parenchyma (atrophy).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e This is not a true hydrocephalus. The enlargement of the CSF spaces is a passive process that occurs to fill the void left by the loss of brain tissue. Intracranial pressure (ICP) is \u003cmark\u003enormal\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Seen in conditions associated with significant cortical atrophy, such as:\u003cbr\u003e - \u003cmark\u003e[[77ae6148|Alzheimer disease]]\u003c/mark\u003e\u003cbr\u003e - Frontotemporal dementia (Pick disease)\u003cbr\u003e - [[ffd7e743|Huntington disease]]\u003cbr\u003e - HIV-associated dementia\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e CT or MRI shows enlarged ventricles and prominent cortical sulci, indicating diffuse brain atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It is crucial to differentiate from [[7c59030e|Normal Pressure Hydrocephalus (NPH)]]. In NPH, the ventricles are disproportionately enlarged compared to the sulci, and patients present with the clinical triad of gait apraxia, dementia, and urinary incontinence. NPH is potentially treatable with CSF shunting, whereas hydrocephalus ex vacuo is not.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a brain scan shows large ventricles but also very wide sulci, think hydrocephalus ex vacuo (atrophy). If the ventricles are large but the sulci are relatively normal, think true hydrocephalus (like NPH).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHydrocephalus ex vacuo\u003c/b\u003e is a misnomer; it is not a problem of excess fluid but of brain tissue loss, where the ventricles passively expand to fill the space created by cortical atrophy, a hallmark of advanced neurodegenerative diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_mimic_of\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"cerebral_atrophy\"\n      },\n      {\n        \"type\": \"is_seen_in\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"7c59030e\"\n      }\n    ]\n  },\n  \"1a923b13\": {\n    \"title\": \"Expressive Aphasia (Broca\u0027s Aphasia)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eExpressive aphasia\u003c/b\u003e, also known as \u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e, is a language disorder characterized by difficulty in producing fluent, grammatical speech, while comprehension remains relatively intact. It is caused by a lesion in [[a3bbace2|Broca\u0027s area]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e \u003cmark\u003eInferior frontal gyrus\u003c/mark\u003e of the dominant (usually left) hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Speech is \u003cmark\u003enonfluent, telegraphic, and effortful\u003c/mark\u003e. Patients use short phrases and omit functional words (e.g., \\\"Walk dog\\\"). Repetition is impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComprehension:\u003c/b\u003e Auditory and reading comprehension are relatively preserved, although complex grammar may be difficult.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Awareness:\u003c/b\u003e Patients are typically aware of their deficits and become very frustrated by their inability to communicate effectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken \u003cb\u003eB\u003c/b\u003eoca (mouth). Look for a patient with a right hemiparesis (especially face and arm) who can follow commands but struggles to speak in complete sentences.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e is a disorder of language production, not comprehension, resulting from damage to the brain\u0027s motor-speech planning center. The resulting speech is broken and effortful, leaving the patient frustratingly aware of their inability to express their intact thoughts.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion in Broca\u0027s Area] --\u003e B(Impaired Speech Production); B --\u003e C(Nonfluent, Telegraphic Speech); A --Spares--\u003e D(Wernicke\u0027s Area); D --\u003e E(Intact Comprehension);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"a3bbace2\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"2c4a6130\"\n      }\n    ]\n  },\n  \"46ca72c2\": {\n    \"title\": \"Neonatal Extracranial Injuries\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Obstetrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeonatal extracranial injuries\u003c/b\u003e are a group of head injuries that occur in newborns during the process of birth, involving bleeding or swelling in the layers of the scalp superficial to the cranium. They are typically caused by mechanical forces during delivery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[a5ec55b5|Caput Succedaneum]]:\u003c/b\u003e Edematous swelling of the scalp soft tissue. It is soft, pits on pressure, and \u003cmark\u003ecrosses suture lines\u003c/mark\u003e. Present at birth and resolves in days.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[a1721d6f|Cephalohematoma]]:\u003c/b\u003e A subperiosteal hemorrhage. It is firm, does \u003cmark\u003e\u003cu\u003enot\u003c/u\u003e cross suture lines\u003c/mark\u003e, and may take weeks to resolve. Can cause neonatal jaundice.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubgaleal Hemorrhage:\u003c/b\u003e Bleeding into the potential space between the periosteum and the galea aponeurosis. This is a dangerous, diffuse swelling that can cross suture lines and lead to significant blood loss and hypovolemic shock.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often associated with prolonged labor, forceps delivery, or vacuum-assisted delivery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating caput succedaneum and cephalohematoma is their relationship to the suture lines. Caput crosses, cephalohematoma does not.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeonatal extracranial injuries\u003c/b\u003e are a spectrum of birth-related scalp swellings, with the benign, superficial caput succedaneum and the deeper, suture-bound cephalohematoma being the most common and distinguished by their location and ability to cross suture lines.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"a5ec55b5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a1721d6f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"subgaleal_hemorrhage\"\n      }\n    ]\n  },\n  \"3ac0ea14\": {\n    \"title\": \"Eye Movements\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEye movements\u003c/b\u003e are the voluntary or involuntary movements of the eyes, controlled by the six extraocular muscles, which are innervated by cranial nerves III, IV, and VI. These movements allow for fixation, tracking, and scanning of the visual environment.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Mnemonic (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e. CN IV ([[bba6093a|Trochlear]]) innervates the Superior Oblique. CN VI ([[dd11dde6|Abducens]]) innervates the Lateral Rectus. CN III ([[68c66997|Oculomotor]]) innervates the rest.\u003c/li\u003e\u003cli\u003e\u003cb\u003eConjugate Gaze:\u003c/b\u003e Coordinated movement of both eyes in the same direction. Horizontal gaze is controlled by the [[paramedian_pontine_reticular_formation|PPRF]] in the pons. Vertical gaze is controlled by centers in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDisorders:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[eab31845|Cranial Nerve Palsies]]:\u003c/b\u003e Weakness of one or more extraocular muscles, leading to [[9914d433|diplopia]] and strabismus.\u003cbr\u003e - \u003cb\u003e[[58c684bd|Internuclear Ophthalmoplegia (INO)]]:\u003c/b\u003e A disorder of conjugate horizontal gaze from a lesion in the medial longitudinal fasciculus (MLF).\u003cbr\u003e - \u003cb\u003e[[c5da3c57|Stroke]]:\u003c/b\u003e Can cause gaze palsies depending on the location (e.g., frontal eye field lesion vs. PPRF lesion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A systematic examination of the six cardinal positions of gaze is essential to test the function of all extraocular muscles and their innervating cranial nerves.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe precise and coordinated control of \u003cb\u003eeye movements\u003c/b\u003e is a complex neurological function orchestrated by three cranial nerves and integrated by brainstem centers, making the analysis of eye movement disorders a powerful tool for localizing neurological lesions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"709aa7c2\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"58c684bd\"\n      },\n      {\n        \"type\": \"is_impaired_by\",\n        \"to\": \"c5da3c57\"\n      }\n    ]\n  },\n  \"13046682\": {\n    \"title\": \"Eyelid Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Eyelid Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEyelid disorders\u003c/b\u003e encompass a range of inflammatory, infectious, and structural conditions affecting the eyelids, which can cause discomfort, cosmetic concerns, and in some cases, affect vision.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[8056ce48|Blepharitis]]:\u003c/b\u003e Chronic inflammation of the eyelid margins, causing redness, crusting, and irritation.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[hordeolum|Hordeolum (Stye)]]:\u003c/b\u003e An acute, painful, pyogenic infection of an eyelid gland (e.g., gland of Zeis or Moll), typically caused by \u003ci\u003eS. aureus\u003c/i\u003e. Presents as a tender red bump on the eyelid margin.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[193c24ec|Chalazion]]:\u003c/b\u003e A granulomatous inflammation due to a blocked meibomian gland. Presents as a firm, rubbery, \u003cu\u003epainless\u003c/u\u003e nodule within the eyelid.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[xanthelasma|Xanthelasma]]:\u003c/b\u003e Yellowish plaques of lipid-laden macrophages on the medial eyelids, often associated with hyperlipidemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePtosis:\u003c/b\u003e Drooping of the upper eyelid. Can be caused by [[fdfd22ca|CN III palsy]], [[c19010a3|Horner syndrome]], or myasthenia gravis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCellulitis:\u003c/b\u003e Preseptal cellulitis is an infection anterior to the orbital septum. Orbital cellulitis is a more serious infection posterior to the septum, causing pain with eye movements and proptosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating a hordeolum from a chalazion is pain: Hordeolum \u003d Hurt (painful infection). Chalazion \u003d Chill (painless inflammation).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEyelid disorders\u003c/b\u003e range from common inflammatory conditions like blepharitis to infectious styes and granulomatous chalazia, with the distinction between painful (infectious) and painless (inflammatory/obstructive) lesions being a key diagnostic principle.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"8056ce48\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hordeolum\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"193c24ec\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"xanthelasma\"\n      }\n    ]\n  },\n  \"c764886f\": {\n    \"title\": \"Eye Anatomy and Physiology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eeye\u003c/b\u003e is the organ of vision, a complex structure that transduces light energy into neural signals. Its anatomy is organized to focus light onto the retina, and its physiology involves the intricate processes of photoreception and neural processing.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNormal Anatomy:\u003c/b\u003e Comprises three layers (sclera/cornea, uvea, retina) and three chambers (anterior, posterior, vitreous). Light enters through the [[7d70ac32|cornea]], passes through the pupil and [[lens]], and is focused on the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAqueous Humor Pathway:\u003c/b\u003e Fluid produced by the ciliary body flows from the posterior to the anterior chamber and drains via the trabecular meshwork. Disruption of this pathway causes [[3ce6c035|glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLens Disorders:\u003c/b\u003e The lens focuses light onto the retina. [[85f03b02|Cataracts]] (opacification) and [[25e91fde|ectopia lentis]] (dislocation) are common pathologies. Loss of accommodation with age is [[presbyopia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEye Misalignment:\u003c/b\u003e [[cdcda821|Strabismus]] is the misalignment of the eyes, which can lead to [[a4a401c7|amblyopia]] (lazy eye) in children if not corrected.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A thorough understanding of the eye\u0027s anatomy is crucial for interpreting physical exam findings and localizing pathology, from the anterior segment (glaucoma, cataracts) to the posterior segment (retinal disorders).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eeye\u003c/b\u003e functions as a biological camera, with the cornea and lens acting as the focusing system, the iris as the aperture, and the retina as the light-sensitive film, all working in concert to capture and transmit visual information to the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_pathway\",\n        \"to\": \"d595b0bf\"\n      },\n      {\n        \"type\": \"includes_disorder\",\n        \"to\": \"lens_disorder\"\n      },\n      {\n        \"type\": \"includes_disorder\",\n        \"to\": \"cdcda821\"\n      }\n    ]\n  },\n  \"dea9755f\": {\n    \"title\": \"Facial Nerve (CN VII)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cranial Nerves\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eFacial Nerve (CN VII)\u003c/b\u003e is a mixed cranial nerve that carries motor fibers to the muscles of facial expression, parasympathetic fibers to the lacrimal and salivary glands, and special sensory fibers for taste from the anterior two-thirds of the tongue.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunctions (Mnemonic - Facial):\u003c/b\u003e \u003cb\u003eF\u003c/b\u003eacial expression, \u003cb\u003eA\u003c/b\u003efferent taste (anterior 2/3), \u003cb\u003eC\u003c/b\u003erying (lacrimation), \u003cb\u003eI\u003c/b\u003ennervation of stapedius, \u003cb\u003eA\u003c/b\u003efferent from ear, \u003cb\u003eL\u003c/b\u003eicking (salivation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Function:\u003c/b\u003e Innervates the muscles of facial expression. A lesion causes facial droop.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN vs. LMN Lesion:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eUMN Lesion (e.g., stroke):\u003c/b\u003e Causes \u003cmark\u003econtralateral lower facial droop\u003c/mark\u003e, with sparing of the forehead (due to bilateral cortical innervation).\u003cbr\u003e - \u003cb\u003eLMN Lesion (e.g., Bell\u0027s palsy):\u003c/b\u003e Causes paralysis of the \u003cmark\u003eentire ipsilateral half of the face\u003c/mark\u003e (forehead included).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Lesion Signs:\u003c/b\u003e Depending on the location of the lesion along the nerve\u0027s path, a CN VII palsy can also cause hyperacusis (paralysis of stapedius), loss of taste, and decreased salivation/lacrimation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBell\u0027s Palsy:\u003c/b\u003e The most common cause of an idiopathic, unilateral LMN facial nerve palsy, thought to be due to HSV-1 reactivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The ability to wrinkle the forehead is the key to distinguishing a central (UMN) from a peripheral (LMN) facial nerve lesion. If the forehead is spared, the lesion is central.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eFacial Nerve\u003c/b\u003e is the nerve of facial expression, and its paralysis creates a clinically distinct pattern: a lower motor neuron lesion paralyzes the entire half of the face, while an upper motor neuron lesion spares the forehead due to bilateral cortical input.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"facial_nerve_palsy\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"hyperacusis\"\n      },\n      {\n        \"type\": \"provides_taste_to\",\n        \"to\": \"anterior_tongue\"\n      }\n    ]\n  },\n  \"514c69e0\": {\n    \"title\": \"Factor V Leiden\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Hematology\",\n      \"Genetics\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Thrombocytopenia and Platelet Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFactor V Leiden\u003c/b\u003e is a specific gene mutation that results in a hypercoagulable state. It is the most common inherited thrombophilia in Caucasians.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e An autosomal dominant point mutation in the Factor V gene, resulting in an arginine-to-glutamine substitution (R506Q).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The mutation renders Factor Va resistant to cleavage and inactivation by \u003cmark\u003eActivated Protein C (APC)\u003c/mark\u003e. This leads to increased activity of Factor Va, resulting in excess thrombin generation and a prothrombotic state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Increased risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a common cause of recurrent VTE in young patients.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Complication:\u003c/b\u003e Can be a cause of \u003cmark\u003edural venous sinus thrombosis\u003c/mark\u003e, an uncommon type of stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Diagnosed with a functional assay (APC resistance test) or genetic testing for the specific mutation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Suspect Factor V Leiden in a young patient with a history of recurrent DVTs or a DVT in an unusual location (like a cerebral vein), especially with a positive family history. The key mechanism is resistance to inactivation by Protein C.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFactor V Leiden\u003c/b\u003e is a genetic thrombophilia where a mutated Factor V becomes resistant to its natural \u0027off switch\u0027 (Activated Protein C), leading to unchecked thrombin generation and a lifelong increased risk for venous blood clots.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Protein C] --x B(Factor V Leiden); B --\u003e C(‚Üë Factor Va activity); C --\u003e D(‚Üë Thrombin Generation); D --\u003e E(Hypercoagulable State); E --\u003e F(Venous Thromboembolism);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"thrombophilia\"\n      },\n      {\n        \"type\": \"causes_resistance_to\",\n        \"to\": \"protein_c\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"dural_venous_sinus_thrombosis\"\n      }\n    ]\n  },\n  \"62a81479\": {\n    \"title\": \"Farsightedness (Hyperopia)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Refractive Errors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFarsightedness\u003c/b\u003e, or \u003cb\u003ehyperopia\u003c/b\u003e, is a refractive error where parallel light rays from a distant object are focused behind the retina when the eye is in a state of rest. This causes near objects to appear blurry, while distant objects may be clear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Occurs when the eyeball is too short or the refractive power of the cornea and lens is too weak.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e Difficulty focusing on near objects, leading to blurry vision, eye strain, and headaches, especially with reading. Young people can often compensate for mild hyperopia by accommodating.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with a \u003cmark\u003econvex (converging) lens\u003c/mark\u003e, which increases the refractive power and moves the focal point forward onto the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Myopia:\u003c/b\u003e In [[myopia]] (nearsightedness), the eye is too long, and light focuses in front of the retina. It is corrected with a concave lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember: Hyperopia \u003d farsighted \u003d eye too short \u003d focus behind retina \u003d correct with convex (+) lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFarsightedness (hyperopia)\u003c/b\u003e is a refractive error where the eye\u0027s focusing power is insufficient for its length, causing light to focus behind the retina and making near vision blurry; it is corrected by adding focusing power with a convex lens.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"refractive_error\"\n      },\n      {\n        \"type\": \"is_the_opposite_of\",\n        \"to\": \"myopia\"\n      },\n      {\n        \"type\": \"is_corrected_by\",\n        \"to\": \"convex_lens\"\n      }\n    ]\n  },\n  \"5198afd0\": {\n    \"title\": \"Fasciculations\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFasciculations\u003c/b\u003e are small, involuntary muscle twitches or contractions that are visible under the skin. They are caused by the spontaneous depolarization of a lower motor neuron and all the muscle fibers it innervates (a motor unit).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Fine, rapid, flickering or twitching movements of a muscle, which do not produce joint movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Fasciculations are a classic sign of a \u003cmark\u003elower motor neuron (LMN) lesion\u003c/mark\u003e. They represent a sign of denervation and neuronal hyperexcitability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated LMN Signs:\u003c/b\u003e They are often seen in conjunction with other LMN signs, such as muscle [[0c2b4642|atrophy]], flaccid weakness, and hyporeflexia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Disease Association:\u003c/b\u003e A hallmark finding in \u003cmark\u003e[[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]\u003c/mark\u003e, where they occur alongside upper motor neuron signs. Also seen in spinal muscular atrophy and polio.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBenign Fasciculations:\u003c/b\u003e Can also occur in healthy individuals (benign fasciculation syndrome), often in the calf or eyelid, and are not associated with weakness or atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a clinical vignette, the presence of fasciculations is a strong clue pointing towards an LMN pathology. When combined with UMN signs, it is highly suggestive of ALS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFasciculations\u003c/b\u003e are the visible twitches of dying motor units, serving as a key physical exam finding that signals a lower motor neuron lesion and, when seen with upper motor neuron signs, points strongly to a diagnosis of ALS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"4ed629f9\"\n      }\n    ]\n  },\n  \"644b8e4d\": {\n    \"title\": \"Fastigial Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebellum\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eFastigial Nucleus\u003c/b\u003e is the most medial of the deep cerebellar nuclei. It is primarily involved in the control of axial and vestibular functions, including balance and gait.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located deep within the white matter of the cerebellar vermis (the midline portion of the cerebellum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Receives input from the vermis and flocculonodular lobe. It is involved in controlling axial and proximal limb muscles for balance and posture, as well as coordinating eye movements with the vestibular system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the vestibular nuclei and the reticular formation in the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion of the fastigial nucleus results in \u003cmark\u003etruncal ataxia\u003c/mark\u003e, characterized by an unsteady, wide-based gait and difficulty maintaining an upright posture.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e The deep cerebellar nuclei from lateral to medial are \\\"\u003cb\u003eD\u003c/b\u003eon\u0027t \u003cb\u003eE\u003c/b\u003eat \u003cb\u003eG\u003c/b\u003ereasy \u003cb\u003eF\u003c/b\u003eoods\\\" (\u003cb\u003eD\u003c/b\u003eentate, \u003cb\u003eE\u003c/b\u003emboliform, \u003cb\u003eG\u003c/b\u003elobose, \u003cb\u003eF\u003c/b\u003eastigial). The fastigial nucleus is the most medial, corresponding to the midline vermis\u0027s control of the trunk.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a \u0027drunken sailor\u0027 gait who sways and falls when trying to stand still likely has a lesion in the cerebellar midline (vermis or fastigial nucleus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eFastigial Nucleus\u003c/b\u003e is the deep cerebellar nucleus responsible for midline stability; it processes information from the vermis to fine-tune balance and posture, and a lesion here leads to a characteristic truncal ataxia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_cerebellar_nuclei\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"truncal_ataxia\"\n      },\n      {\n        \"type\": \"sends_output_to\",\n        \"to\": \"vestibular_nuclei\"\n      }\n    ]\n  },\n  \"12108f05\": {\n    \"title\": \"Febrile Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003efebrile seizure\u003c/b\u003e is a convulsion in a child that is caused by a spike in body temperature (fever), often from an infection. They occur in the absence of any underlying intracranial infection or metabolic disturbance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpidemiology:\u003c/b\u003e The most common seizure disorder in childhood, affecting 2-5% of children between the ages of 6 months and 5 years.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSimple Febrile Seizure (most common):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eType:\u003c/b\u003e Generalized tonic-clonic.\u003cbr\u003e - \u003cb\u003eDuration:\u003c/b\u003e Lasts \u003cmark\u003eless than 15 minutes\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eFrequency:\u003c/b\u003e Occurs only once in a 24-hour period.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplex Febrile Seizure:\u003c/b\u003e Has one or more of the following features: focal onset, duration \u003cmark\u003elonger than 15 minutes\u003c/mark\u003e, or more than one seizure in 24 hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Simple febrile seizures are benign and have an excellent prognosis. They do \u003cu\u003enot\u003c/u\u003e cause brain damage or increase the risk of developing epilepsy significantly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e The primary goal is to identify and treat the underlying cause of the fever. Antipyretics (acetaminophen, ibuprofen) can be used for comfort but do not prevent future febrile seizures. Long-term anticonvulsant therapy is not indicated for simple febrile seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A key point is to reassure parents about the benign nature of simple febrile seizures. The main task is to rule out more serious causes of the fever and seizure, such as meningitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFebrile seizures\u003c/b\u003e are common, age-dependent, and typically benign convulsions triggered by fever in young children; the vast majority are simple, self-limited, and do not lead to long-term neurological problems or epilepsy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"fever\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"epilepsy\"\n      }\n    ]\n  },\n  \"37089883\": {\n    \"title\": \"Fenestrated Capillaries (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn the central nervous system, \u003cb\u003efenestrated capillaries\u003c/b\u003e are a specialized type of capillary that, unlike the vast majority of CNS capillaries, possess pores (fenestrae) in their endothelial lining. This feature allows for the relatively free passage of fluids and small solutes, and is characteristic of the \u003cmark\u003ecircumventricular organs\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCNS Capillaries (General):\u003c/b\u003e Most capillaries in the brain are continuous and have [[5206aa83|tight junctions]], forming the [[dd47b9cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFenestrated Capillaries:\u003c/b\u003e These are an exception to the rule. Their pores allow them to \u0027sample\u0027 the chemical composition of the blood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found exclusively in the circumventricular organs (CVOs), which are structures that lack a [[dd47b9cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eExamples of CVOs:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[5dd343d3|Area Postrema]]:\u003c/b\u003e The chemoreceptor trigger zone for vomiting.\u003cbr\u003e - \u003cb\u003ePosterior Pituitary:\u003c/b\u003e Allows for the release of ADH and oxytocin into the bloodstream.\u003cbr\u003e - \u003cb\u003eMedian Eminence of the Hypothalamus:\u003c/b\u003e Allows for the release of hypothalamic hormones into the portal system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of fenestrated capillaries is the anatomical basis for why circumventricular organs lack a blood-brain barrier and can interact directly with the systemic circulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFenestrated capillaries\u003c/b\u003e are the \u0027leaky\u0027 vessels of the brain, strategically located in the circumventricular organs to create windows in the blood-brain barrier, allowing these specialized regions to monitor and interact with the chemical messengers of the blood.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_found_in\",\n        \"to\": \"circumventricular_organs\"\n      },\n      {\n        \"type\": \"are_found_in\",\n        \"to\": \"5dd343d3\"\n      },\n      {\n        \"type\": \"are_a_feature_of_areas_lacking\",\n        \"to\": \"dd47b9cc\"\n      }\n    ]\n  },\n  \"ce4c60ec\": {\n    \"title\": \"Fentanyl\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFentanyl\u003c/b\u003e is a potent, synthetic \u003ci\u003eopioid analgesic\u003c/i\u003e that acts as a strong agonist at Œº-opioid receptors. It is used for severe pain and as an adjunct in anesthesia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Strong agonist at Œº-opioid receptors, leading to profound analgesia and sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePotency:\u003c/b\u003e It is approximately \u003cmark\u003e50 to 100 times more potent\u003c/mark\u003e than morphine.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Highly lipid-soluble, allowing for rapid onset and short duration of action when given IV. This property also allows for transdermal and transmucosal administration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnesthesia:\u003c/b\u003e Used for induction and maintenance of anesthesia, often in combination with other agents.\u003cbr\u003e - \u003cb\u003ePain Management:\u003c/b\u003e Used for severe acute pain (IV) and chronic pain (transdermal patch).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Like other opioids, it can cause respiratory depression, sedation, constipation, and miosis. Due to its high potency, the risk of fatal respiratory depression in overdose is very high.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Fentanyl\u0027s high potency and rapid onset make it a powerful tool in anesthesia and pain management, but also make it extremely dangerous in the context of illicit drug use. Overdose is treated with naloxone.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFentanyl\u003c/b\u003e is a synthetic opioid of exceptional potency, providing rapid and powerful analgesia, but its narrow therapeutic window and profound respiratory depressant effects make it one of the most dangerous opioids when used illicitly.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },\n      {\n        \"type\": \"is_more_potent_than\",\n        \"to\": \"morphine\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9426,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"13c459e0\": {\n    \"title"
      }, {
        "text": "\": \"Etomidate\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eEtomidate\u003c/b\u003e is an intravenous general anesthetic used for the induction"
      }, {
        "text": " of anesthesia, particularly in patients who are hemodynamically unstable. It provides sedation and hypnosis but lacks analgesic properties.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Potentiates the GABA\u003csub\u003eA\u003c/sub\u003e receptor, enhancing the inhibitory"
      }, {
        "text": " effects of GABA on the central nervous system.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a rapid onset and short duration of action, making it ideal"
      }, {
        "text": " for induction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Advantage:\u003c/b\u003e It is \u003cmark\u003ehemodynamically neutral\u003c/mark\u003e, causing"
      }, {
        "text": " minimal changes in blood pressure, heart rate, and cardiac output. This makes it the induction agent of choice for patients with"
      }, {
        "text": " cardiovascular instability (e.g., trauma, sepsis, cardiac disease).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used for the induction"
      }, {
        "text": " of general anesthesia and for rapid sequence intubation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most significant side effect is \u003cmark\u003ead"
      }, {
        "text": "renocortical suppression\u003c/mark\u003e. It reversibly inhibits 11Œ≤-hydroxylase, an enzyme critical for cortisol and"
      }, {
        "text": " aldosterone synthesis. This effect can last for several hours after a single bolus dose. Also associated with postoperative nausea and vomiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember etomidate for its cardiovascular stability (\u0027hemodynamically neutral\u0027) and its unique side effect of adrenal suppression.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eEtomidate\u003c/b\u003e is a valuable anesthetic induction agent prized for its minimal"
      }, {
        "text": " impact on hemodynamics, making it safe for critically ill patients, but its utility is tempered by a transient but significant suppression of adrenal steroid synthesis.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"is_a_type_of\",\n        \"to\": \"intravenous_anesthetic\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"adrenocortical_supp"
      }, {
        "text": "ression\"\n      }\n    ]\n  },\n  \"7efdb0ef\": {\n    \"title\": \""
      }, {
        "text": "Hydrocephalus Ex Vacuo\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Radiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eHydrocephalus ex vacuo\u003c/b\u003e is an apparent increase in the size"
      }, {
        "text": " of the cerebral ventricles and subarachnoid spaces on neuroimaging that is not due to increased cerebrospinal fluid (CSF) pressure,"
      }, {
        "text": " but rather to a loss of brain parenchyma (atrophy).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e This is not a true hydrocephalus. The enlargement of the CSF spaces is a passive process that occurs to"
      }, {
        "text": " fill the void left by the loss of brain tissue. Intracranial pressure (ICP) is \u003cmark\u003enormal\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eCauses:\u003c/b\u003e Seen in conditions associated with significant cortical atrophy, such as:\u003cbr\u003e - \u003cmark\u003e[[7"
      }, {
        "text": "7ae6148|Alzheimer disease]]\u003c/mark\u003e\u003cbr\u003e - Frontotemporal dementia (Pick disease)\u003cbr\u003e - [["
      }, {
        "text": "ffd7e743|Huntington disease]]\u003cbr\u003e - HIV-associated dementia\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:"
      }, {
        "text": "\u003c/b\u003e CT or MRI shows enlarged ventricles and prominent cortical sulci, indicating diffuse brain atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It"
      }, {
        "text": " is crucial to differentiate from [[7c59030e|Normal Pressure Hydrocephalus (NPH)]]."
      }, {
        "text": " In NPH, the ventricles are disproportionately enlarged compared to the sulci, and patients present with the clinical triad of gait ap"
      }, {
        "text": "raxia, dementia, and urinary incontinence. NPH is potentially treatable with CSF shunting, whereas hydrocephalus ex vacuo"
      }, {
        "text": " is not.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a brain scan shows large ventricles but also very wide sulci, think"
      }, {
        "text": " hydrocephalus ex vacuo (atrophy). If the ventricles are large but the sulci are relatively normal, think true"
      }, {
        "text": " hydrocephalus (like NPH).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eHydrocephalus ex vacuo\u003c/b\u003e is a mis"
      }, {
        "text": "nomer; it is not a problem of excess fluid but of brain tissue loss, where the ventricles passively expand to fill the space created"
      }, {
        "text": " by cortical atrophy, a hallmark of advanced neurodegenerative diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_mimic_of\",\n        \"to"
      }, {
        "text": "\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "caused_by\",\n        \"to\": \"cerebral_atrophy\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_seen_in\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"differentiated_from\",\n        \"to\": \"7c59030e\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"1a923b13\": {\n    \"title\": \"Express"
      }, {
        "text": "ive Aphasia (Broca\u0027s Aphasia)\",\n    \"primaryType\": \"finding\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n"
      }, {
        "text": "      \"Aphasia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Expressive aphasia\u003c/b\u003e, also known as \u003cb\u003eBroca\u0027s aphasia\u003c/b\u003e, is a language"
      }, {
        "text": " disorder characterized by difficulty in producing fluent, grammatical speech, while comprehension remains relatively intact. It is caused by a lesion in [["
      }, {
        "text": "a3bbace2|Broca\u0027s area]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ion Location:\u003c/b\u003e \u003cmark\u003eInferior frontal gyrus\u003c/mark\u003e of the dominant (usually left) hemisphere."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the superior division of the [[143bb23d|Middle Cerebral"
      }, {
        "text": " Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Speech is \u003cmark\u003enonfluent, telegraphic, and"
      }, {
        "text": " effortful\u003c/mark\u003e. Patients use short phrases and omit functional words (e.g., \\\"Walk dog\\\"). Rep"
      }, {
        "text": "etition is impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComprehension:\u003c/b\u003e Auditory and reading comprehension are relatively preserved, although complex grammar"
      }, {
        "text": " may be difficult.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Awareness:\u003c/b\u003e Patients are typically aware of their deficits and become very frustrated by their inability to communicate"
      }, {
        "text": " effectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mnemonic: \u003cb\u003eB\u003c/b\u003eroca\u0027s is \u003cb\u003eB\u003c/b\u003eroken"
      }, {
        "text": " \u003cb\u003eB\u003c/b\u003eoca (mouth). Look for a patient with a right hemiparesis (especially face and arm) who"
      }, {
        "text": " can follow commands but struggles to speak in complete sentences.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eBro"
      }, {
        "text": "ca\u0027s aphasia\u003c/b\u003e is a disorder of language production, not comprehension, resulting from damage to the brain\u0027s motor-"
      }, {
        "text": "speech planning center. The resulting speech is broken and effortful, leaving the patient frustratingly aware of their inability to express"
      }, {
        "text": " their intact thoughts.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion in Broca\u0027s Area"
      }, {
        "text": "] --\u003e B(Impaired Speech Production); B --\u003e C(Nonfluent, Telegraphic Speech); A --Spares--\u003e"
      }, {
        "text": " D(Wernicke\u0027s Area); D --\u003e E(Intact Comprehension);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"a"
      }, {
        "text": "3bbace2\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke"
      }, {
        "text": "_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_contrasted_with\",\n        \"to\": \"2c4a6130\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"46ca72c2\": {\n    \"title\": \"Neonatal Extracranial Injuries"
      }, {
        "text": "\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Obst"
      }, {
        "text": "etrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eNeonatal extracranial injuries\u003c/b\u003e are a group of head injuries that occur in"
      }, {
        "text": " newborns during the process of birth, involving bleeding or swelling in the layers of the scalp superficial to the cranium. They"
      }, {
        "text": " are typically caused by mechanical forces during delivery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[a"
      }, {
        "text": "5ec55b5|Caput Succedaneum]]:\u003c/b\u003e Edematous swelling of the scalp soft tissue."
      }, {
        "text": " It is soft, pits on pressure, and \u003cmark\u003ecrosses suture lines\u003c/mark\u003e. Present at birth and resolves in"
      }, {
        "text": " days.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[a1721d6f|Cephalohematoma]]:\u003c/b\u003e A subperi"
      }, {
        "text": "osteal hemorrhage. It is firm, does \u003cmark\u003e\u003cu\u003enot\u003c/u\u003e cross suture lines\u003c/mark\u003e, and may take"
      }, {
        "text": " weeks to resolve. Can cause neonatal jaundice.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSubgaleal Hemorrhage:\u003c/b\u003e Bleeding into"
      }, {
        "text": " the potential space between the periosteum and the galea aponeurosis. This is a dangerous, diffuse swelling"
      }, {
        "text": " that can cross suture lines and lead to significant blood loss and hypovolemic shock.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often associated"
      }, {
        "text": " with prolonged labor, forceps delivery, or vacuum-assisted delivery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to"
      }, {
        "text": " differentiating caput succedaneum and cephalohematoma is their relationship to the suture lines. Caput crosses,"
      }, {
        "text": " cephalohematoma does not.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eNeonatal extracranial injuries\u003c/b\u003e are a spectrum"
      }, {
        "text": " of birth-related scalp swellings, with the benign, superficial caput succedaneum and the deeper, suture-bound"
      }, {
        "text": " cephalohematoma being the most common and distinguished by their location and ability to cross suture lines.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"a5ec55b5\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"a1721d6f\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"subgaleal_hemorrhage\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"3ac0ea14\": {\n    \"title\": \"Eye Movements\",\n    \"primary"
      }, {
        "text": "Type\": \"physiology\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neuroanatomy\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003e\u003cb\u003eEye movements\u003c/b\u003e are the voluntary or involuntary movements of the eyes, controlled by the six"
      }, {
        "text": " extraocular muscles, which are innervated by cranial nerves III, IV, and VI. These movements allow for fixation,"
      }, {
        "text": " tracking, and scanning of the visual environment.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e M"
      }, {
        "text": "nemonic (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e. CN IV ([[bba6093a|Tro"
      }, {
        "text": "chlear]]) innervates the Superior Oblique. CN VI ([[dd11dde6|Abducens]]) innervates the Lateral"
      }, {
        "text": " Rectus. CN III ([[68c66997|Oculomotor]]) innervates the rest"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eConjugate Gaze:\u003c/b\u003e Coordinated movement of both eyes in the same direction. Horizontal gaze is controlled by the [["
      }, {
        "text": "paramedian_pontine_reticular_formation|PPRF]] in the pons. Vertical gaze is controlled by centers"
      }, {
        "text": " in the midbrain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDisorders:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[eab3184"
      }, {
        "text": "5|Cranial Nerve Palsies]]:\u003c/b\u003e Weakness of one or more extraocular muscles, leading to [[991"
      }, {
        "text": "4d433|diplopia]] and strabismus.\u003cbr\u003e - \u003cb\u003e[[58c68"
      }, {
        "text": "4bd|Internuclear Ophthalmoplegia (INO)]]:\u003c/b\u003e A disorder of conjugate horizontal gaze from a lesion in the medial"
      }, {
        "text": " longitudinal fasciculus (MLF).\u003cbr\u003e - \u003cb\u003e[[c5da3c57|Stroke]]:\u003c/b\u003e Can"
      }, {
        "text": " cause gaze palsies depending on the location (e.g., frontal eye field lesion vs. PPRF lesion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A systematic examination of the six cardinal positions of gaze is essential to test the function of all extraocular muscles and their"
      }, {
        "text": " innervating cranial nerves.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe precise and coordinated control of \u003cb\u003eeye"
      }, {
        "text": " movements\u003c/b\u003e is a complex neurological function orchestrated by three cranial nerves and integrated by brainstem centers, making the analysis of eye movement"
      }, {
        "text": " disorders a powerful tool for localizing neurological lesions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"70"
      }, {
        "text": "9aa7c2\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to"
      }, {
        "text": "\": \"58c684bd\"\n      },\n      {\n        \"type\": \"is_impaired"
      }, {
        "text": "_by\",\n        \"to\": \"c5da3c57\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"13046682\": {\n    \"title\": \"Eyelid Disorders\",\n    "
      }, {
        "text": "\"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"D"
      }, {
        "text": "ermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Eyelid Disorders\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eEyelid disorders\u003c/b\u003e encompass a range of inflammatory, infectious, and structural conditions affecting the eyelids"
      }, {
        "text": ", which can cause discomfort, cosmetic concerns, and in some cases, affect vision.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[["
      }, {
        "text": "8056ce48|Blepharitis]]:\u003c/b\u003e Chronic inflammation of the eyelid margins, causing redness, crusting, and irritation"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[hordeolum|Hordeolum (Stye)]]:\u003c/b\u003e An acute, painful, py"
      }, {
        "text": "ogenic infection of an eyelid gland (e.g., gland of Zeis or Moll), typically caused by \u003ci\u003eS"
      }, {
        "text": ". aureus\u003c/i\u003e. Presents as a tender red bump on the eyelid margin.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[193c2"
      }, {
        "text": "4ec|Chalazion]]:\u003c/b\u003e A granulomatous inflammation due to a blocked meibomian gland. Presents as a firm, rubber"
      }, {
        "text": "y, \u003cu\u003epainless\u003c/u\u003e nodule within the eyelid.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[xanthelasma|Xanthelasma"
      }, {
        "text": "]]:\u003c/b\u003e Yellowish plaques of lipid-laden macrophages on the medial eyelids, often associated with hyperlipidemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePt"
      }, {
        "text": "osis:\u003c/b\u003e Drooping of the upper eyelid. Can be caused by [[fdfd22ca|CN III palsy"
      }, {
        "text": "]], [[c19010a3|Horner syndrome]], or myasthenia gravis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCellulitis:\u003c/b\u003e Pre"
      }, {
        "text": "septal cellulitis is an infection anterior to the orbital septum. Orbital cellulitis is a more serious infection posterior to the septum"
      }, {
        "text": ", causing pain with eye movements and proptosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating a hordeolum from a chalazion is"
      }, {
        "text": " pain: Hordeolum \u003d Hurt (painful infection). Chalazion \u003d Chill (painless inflammation).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eEyelid disorders\u003c/b\u003e range from common inflammatory conditions like blepharitis to infectious styes and"
      }, {
        "text": " granulomatous chalazia, with the distinction between painful (infectious) and painless (inflammatory/obstructive) lesions being a key"
      }, {
        "text": " diagnostic principle.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"8056ce48\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"hordeolum\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"193c24ec"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"xanthel"
      }, {
        "text": "asma\"\n      }\n    ]\n  },\n  \"c764886f\": {\n    \"title\":"
      }, {
        "text": " \"Eye Anatomy and Physiology\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"Anatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eeye\u003c/b\u003e is the"
      }, {
        "text": " organ of vision, a complex structure that transduces light energy into neural signals. Its anatomy is organized to focus light onto"
      }, {
        "text": " the retina, and its physiology involves the intricate processes of photoreception and neural processing.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNormal Anatomy:\u003c/b\u003e Comprises three layers (sclera/cornea, uvea,"
      }, {
        "text": " retina) and three chambers (anterior, posterior, vitreous). Light enters through the [[7d70ac3"
      }, {
        "text": "2|cornea]], passes through the pupil and [[lens]], and is focused on the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eA"
      }, {
        "text": "queous Humor Pathway:\u003c/b\u003e Fluid produced by the ciliary body flows from the posterior to the anterior chamber and drains via the trabecular mesh"
      }, {
        "text": "work. Disruption of this pathway causes [[3ce6c035|glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Lens Disorders:\u003c/b\u003e The lens focuses light onto the retina. [[85f03b02|Cataracts]] ("
      }, {
        "text": "opacification) and [[25e91fde|ectopia lentis]] (dislocation) are common"
      }, {
        "text": " pathologies. Loss of accommodation with age is [[presbyopia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eEye Misalignment:\u003c/b\u003e [[cdcda"
      }, {
        "text": "821|Strabismus]] is the misalignment of the eyes, which can lead to [[a4a40"
      }, {
        "text": "1c7|amblyopia]] (lazy eye) in children if not corrected.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " thorough understanding of the eye\u0027s anatomy is crucial for interpreting physical exam findings and localizing pathology, from the anterior segment"
      }, {
        "text": " (glaucoma, cataracts) to the posterior segment (retinal disorders).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eeye\u003c/b\u003e functions as a biological camera, with the cornea and lens acting as the focusing system, the iris as the aperture"
      }, {
        "text": ", and the retina as the light-sensitive film, all working in concert to capture and transmit visual information to the brain.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_"
      }, {
        "text": "pathway\",\n        \"to\": \"d595b0bf\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes_disorder\",\n        \"to\": \"lens_disorder\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes_disorder\",\n        \"to\": \"cdcda821\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"dea9755f\": {\n    \"title\": \""
      }, {
        "text": "Facial Nerve (CN VII)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Cranial Nerves\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eFacial Nerve (CN VII)"
      }, {
        "text": "\u003c/b\u003e is a mixed cranial nerve that carries motor fibers to the muscles of facial expression, parasympathetic fibers to the lacrimal and salivary glands, and special"
      }, {
        "text": " sensory fibers for taste from the anterior two-thirds of the tongue.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eFunctions (Mnemonic - Facial):\u003c/b\u003e \u003cb\u003eF\u003c/b\u003eacial expression, \u003cb\u003eA\u003c/b\u003efferent taste"
      }, {
        "text": " (anterior 2/3), \u003cb\u003eC\u003c/b\u003erying (lacrimation), \u003cb\u003eI\u003c/b\u003ennervation of"
      }, {
        "text": " stapedius, \u003cb\u003eA\u003c/b\u003efferent from ear, \u003cb\u003eL\u003c/b\u003eicking (salivation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor"
      }, {
        "text": " Function:\u003c/b\u003e Innervates the muscles of facial expression. A lesion causes facial droop.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN vs"
      }, {
        "text": ". LMN Lesion:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eUMN Lesion (e.g., stroke):\u003c/b\u003e Causes"
      }, {
        "text": " \u003cmark\u003econtralateral lower facial droop\u003c/mark\u003e, with sparing of the forehead (due to bilateral cortical innervation"
      }, {
        "text": ").\u003cbr\u003e - \u003cb\u003eLMN Lesion (e.g., Bell\u0027s palsy):\u003c/b\u003e Causes paralysis"
      }, {
        "text": " of the \u003cmark\u003eentire ipsilateral half of the face\u003c/mark\u003e (forehead included).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther"
      }, {
        "text": " Lesion Signs:\u003c/b\u003e Depending on the location of the lesion along the nerve\u0027s path, a CN VII palsy can also"
      }, {
        "text": " cause hyperacusis (paralysis of stapedius), loss of taste, and decreased salivation/lacrimation.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eBell\u0027s Palsy:\u003c/b\u003e The most common cause of an idiopathic, unilateral LMN facial nerve palsy, thought"
      }, {
        "text": " to be due to HSV-1 reactivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The ability to wrinkle the forehead is the"
      }, {
        "text": " key to distinguishing a central (UMN) from a peripheral (LMN) facial nerve lesion. If the forehead is spared, the"
      }, {
        "text": " lesion is central.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eFacial Nerve\u003c/b\u003e is the"
      }, {
        "text": " nerve of facial expression, and its paralysis creates a clinically distinct pattern: a lower motor neuron lesion paralyzes the entire half"
      }, {
        "text": " of the face, while an upper motor neuron lesion spares the forehead due to bilateral cortical input.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"facial"
      }, {
        "text": "_nerve_palsy\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n"
      }, {
        "text": "        \"to\": \"hyperacusis\"\n      },\n      {\n        \"type\": \"provides_taste"
      }, {
        "text": "_to\",\n        \"to\": \"anterior_tongue\"\n      }\n    ]\n  },\n  \"5"
      }, {
        "text": "14c69e0\": {\n    \"title\": \"Factor V Leiden\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Hematology\",\n      \"Genetics\",\n      \"Card"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and"
      }, {
        "text": " Oncology\",\n      \"Pathology\",\n      \"Thrombocytopenia and Platelet Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFactor V Leiden\u003c/b\u003e is a specific gene mutation that results"
      }, {
        "text": " in a hypercoagulable state. It is the most common inherited thrombophilia in Caucasians.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e An autosomal dominant point mutation in the Factor V gene, resulting in an arginine-to-glutamine"
      }, {
        "text": " substitution (R506Q).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The mutation renders Factor Va resistant to cleavage"
      }, {
        "text": " and inactivation by \u003cmark\u003eActivated Protein C (APC)\u003c/mark\u003e. This leads to increased activity of Factor Va, resulting"
      }, {
        "text": " in excess thrombin generation and a prothrombotic state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Increased risk of venous thromboembolism (V"
      }, {
        "text": "TE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a common cause of recurrent V"
      }, {
        "text": "TE in young patients.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Complication:\u003c/b\u003e Can be a cause of \u003cmark\u003edural"
      }, {
        "text": " venous sinus thrombosis\u003c/mark\u003e, an uncommon type of stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Diagnosed with a functional assay"
      }, {
        "text": " (APC resistance test) or genetic testing for the specific mutation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Suspect Factor"
      }, {
        "text": " V Leiden in a young patient with a history of recurrent DVTs or a DVT in an unusual location (like a"
      }, {
        "text": " cerebral vein), especially with a positive family history. The key mechanism is resistance to inactivation by Protein C.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFactor V Leiden\u003c/b\u003e is a genetic thrombophilia where a mutated Factor V becomes"
      }, {
        "text": " resistant to its natural \u0027off switch\u0027 (Activated Protein C), leading to unchecked thrombin generation and a lifelong increased risk for"
      }, {
        "text": " venous blood clots.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Protein C] --x B(Factor"
      }, {
        "text": " V Leiden); B --\u003e C(‚Üë Factor Va activity); C --\u003e D(‚Üë Thrombin Generation); D --\u003e E(Hyper"
      }, {
        "text": "coagulable State); E --\u003e F(Venous Thromboembolism);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"th"
      }, {
        "text": "rombophilia\"\n      },\n      {\n        \"type\": \"causes_resistance_to\",\n        \"to\": \"protein"
      }, {
        "text": "_c\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for"
      }, {
        "text": "\",\n        \"to\": \"dural_venous_sinus_thrombosis\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"62a81479\": {\n    \"title\": \"Farsightedness (Hyperopia"
      }, {
        "text": ")\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Ophthalmology\",\n      \"Refractive Errors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eFarsightedness\u003c/b\u003e, or \u003cb\u003ehyperopia\u003c/b\u003e, is a refractive error where parallel light rays from"
      }, {
        "text": " a distant object are focused behind the retina when the eye is in a state of rest. This causes near objects to appear"
      }, {
        "text": " blurry, while distant objects may be clear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology"
      }, {
        "text": ":\u003c/b\u003e Occurs when the eyeball is too short or the refractive power of the cornea and lens is too weak.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms"
      }, {
        "text": ":\u003c/b\u003e Difficulty focusing on near objects, leading to blurry vision, eye strain, and headaches, especially with reading. Young"
      }, {
        "text": " people can often compensate for mild hyperopia by accommodating.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCorrection:\u003c/b\u003e Corrected with a \u003cmark\u003econvex"
      }, {
        "text": " (converging) lens\u003c/mark\u003e, which increases the refractive power and moves the focal point forward onto the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison"
      }, {
        "text": " to Myopia:\u003c/b\u003e In [[myopia]] (nearsightedness), the eye is too long, and light focuses in"
      }, {
        "text": " front of the retina. It is corrected with a concave lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember: Hyperopia \u003d fars"
      }, {
        "text": "ighted \u003d eye too short \u003d focus behind retina \u003d correct with convex (+) lens.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eF"
      }, {
        "text": "arsightedness (hyperopia)\u003c/b\u003e is a refractive error where the eye\u0027s focusing power is insufficient for its length, causing light to focus behind"
      }, {
        "text": " the retina and making near vision blurry; it is corrected by adding focusing power with a convex lens.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\","
      }, {
        "text": "\n        \"to\": \"refractive_error\"\n      },\n      {\n        \"type\": \"is_the"
      }, {
        "text": "_opposite_of\",\n        \"to\": \"myopia\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_corrected_by\",\n        \"to\": \"convex_lens\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"5198afd0\": {\n    \"title\": \"Fasciculations\",\n    "
      }, {
        "text": "\"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eFasciculations\u003c/b\u003e are small, involuntary muscle twitches or contractions that are visible under the skin. They are caused by the"
      }, {
        "text": " spontaneous depolarization of a lower motor neuron and all the muscle fibers it innervates (a motor unit).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e Fine, rapid, flickering or twitching movements of a muscle, which do not produce"
      }, {
        "text": " joint movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Fasciculations are a classic sign of a \u003cmark\u003elower motor neuron (LMN) lesion"
      }, {
        "text": "\u003c/mark\u003e. They represent a sign of denervation and neuronal hyperexcitability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated LMN Signs"
      }, {
        "text": ":\u003c/b\u003e They are often seen in conjunction with other LMN signs, such as muscle [[0c2b46"
      }, {
        "text": "42|atrophy]], flaccid weakness, and hyporeflexia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Disease Association:\u003c/b\u003e A"
      }, {
        "text": " hallmark finding in \u003cmark\u003e[[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]\u003c/"
      }, {
        "text": "mark\u003e, where they occur alongside upper motor neuron signs. Also seen in spinal muscular atrophy and polio.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBenign Fasciculations:"
      }, {
        "text": "\u003c/b\u003e Can also occur in healthy individuals (benign fasciculation syndrome), often in the calf or eyelid, and are not associated with weakness"
      }, {
        "text": " or atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a clinical vignette, the presence of fasciculations is a strong clue"
      }, {
        "text": " pointing towards an LMN pathology. When combined with UMN signs, it is highly suggestive of ALS.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFasciculations\u003c/b\u003e are the visible twitches of dying motor units, serving"
      }, {
        "text": " as a key physical exam finding that signals a lower motor neuron lesion and, when seen with upper motor neuron signs, points"
      }, {
        "text": " strongly to a diagnosis of ALS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_"
      }, {
        "text": "neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \""
      }, {
        "text": "to\": \"4ed629f9\"\n      }\n    ]\n  },\n  \"64"
      }, {
        "text": "4b8e4d\": {\n    \"title\": \"Fastigial Nucleus\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebellum\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eThe \u003cb\u003eFastigial Nucleus\u003c/b\u003e is the most medial of the deep cerebellar nuclei."
      }, {
        "text": " It is primarily involved in the control of axial and vestibular functions, including balance and gait.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located deep within the white matter of the cerebellar vermis (the midline portion"
      }, {
        "text": " of the cerebellum).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Receives input from the vermis and flocculonodular lobe"
      }, {
        "text": ". It is involved in controlling axial and proximal limb muscles for balance and posture, as well as coordinating eye movements with the vestibular system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput"
      }, {
        "text": ":\u003c/b\u003e Projects to the vestibular nuclei and the reticular formation in the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion of the fastig"
      }, {
        "text": "ial nucleus results in \u003cmark\u003etruncal ataxia\u003c/mark\u003e, characterized by an unsteady, wide-based gait and difficulty maintaining"
      }, {
        "text": " an upright posture.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e The deep cerebellar nuclei from lateral to medial are \\\"\u003cb\u003eD\u003c/b\u003eon\u0027t "
      }, {
        "text": "\u003cb\u003eE\u003c/b\u003eat \u003cb\u003eG\u003c/b\u003ereasy \u003cb\u003eF\u003c/b\u003eoods\\\" (\u003cb\u003eD\u003c/b\u003eentate, \u003cb\u003eE\u003c/b\u003em"
      }, {
        "text": "boliform, \u003cb\u003eG\u003c/b\u003elobose, \u003cb\u003eF\u003c/b\u003eastigial). The fastigial nucleus is the most medial"
      }, {
        "text": ", corresponding to the midline vermis\u0027s control of the trunk.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient"
      }, {
        "text": " with a \u0027drunken sailor\u0027 gait who sways and falls when trying to stand still likely has a lesion in the cerebellar"
      }, {
        "text": " midline (vermis or fastigial nucleus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eFastigial Nucleus\u003c/b\u003e is the deep cerebellar nucleus responsible for midline stability; it processes information from the vermis to fine"
      }, {
        "text": "-tune balance and posture, and a lesion here leads to a characteristic truncal ataxia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"deep_cerebellar_nuclei\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_located_in\",\n        \"to\": \"bebe58d4\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"lesion_causes\",\n        \"to\": \"truncal_ataxia\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"sends_output_to\",\n        \"to\":"
      }, {
        "text": " \"vestibular_nuclei\"\n      }\n    ]\n  },\n  \"12108"
      }, {
        "text": "f05\": {\n    \"title\": \"Febrile Seizures\",\n    \"primaryType\": \"disease\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Se"
      }, {
        "text": "izures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003efebrile seizure\u003c/b\u003e is a"
      }, {
        "text": " convulsion in a child that is caused by a spike in body temperature (fever), often from an infection. They"
      }, {
        "text": " occur in the absence of any underlying intracranial infection or metabolic disturbance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEpid"
      }, {
        "text": "emiology:\u003c/b\u003e The most common seizure disorder in childhood, affecting 2-5% of children between the ages of 6 months and 5"
      }, {
        "text": " years.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSimple Febrile Seizure (most common):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eType:\u003c/b\u003e Generalized tonic"
      }, {
        "text": "-clonic.\u003cbr\u003e - \u003cb\u003eDuration:\u003c/b\u003e Lasts \u003cmark\u003eless than 15 minutes\u003c/mark\u003e"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003eFrequency:\u003c/b\u003e Occurs only once in a 24-hour period.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplex Febrile Seizure"
      }, {
        "text": ":\u003c/b\u003e Has one or more of the following features: focal onset, duration \u003cmark\u003elonger than 15 minutes\u003c/mark\u003e,"
      }, {
        "text": " or more than one seizure in 24 hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Simple febrile seizures are benign"
      }, {
        "text": " and have an excellent prognosis. They do \u003cu\u003enot\u003c/u\u003e cause brain damage or increase the risk of developing epilepsy significantly."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e The primary goal is to identify and treat the underlying cause of the fever. Antipyretics"
      }, {
        "text": " (acetaminophen, ibuprofen) can be used for comfort but do not prevent future febrile seizures. Long-term anticon"
      }, {
        "text": "vulsant therapy is not indicated for simple febrile seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A key point"
      }, {
        "text": " is to reassure parents about the benign nature of simple febrile seizures. The main task is to rule out more serious causes of the"
      }, {
        "text": " fever and seizure, such as meningitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFebrile seizures"
      }, {
        "text": "\u003c/b\u003e are common, age-dependent, and typically benign convulsions triggered by fever in young children; the vast majority are simple"
      }, {
        "text": ", self-limited, and do not lead to long-term neurological problems or epilepsy.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"64c08e92\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_triggered_by\",\n        \"to\": \"fever\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"differentiated_from\",\n        \"to\": \"epilepsy\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"37089883\": {\n    \"title\": \""
      }, {
        "text": "Fenestrated Capillaries (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eIn the central nervous system, \u003cb\u003efenestrated capillaries\u003c/b\u003e are a"
      }, {
        "text": " specialized type of capillary that, unlike the vast majority of CNS capillaries, possess pores (fenestrae) in their endothelial"
      }, {
        "text": " lining. This feature allows for the relatively free passage of fluids and small solutes, and is characteristic of the \u003cmark\u003ecircumventricular"
      }, {
        "text": " organs\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCNS Capillaries (General):\u003c/b\u003e Most capillaries in the brain"
      }, {
        "text": " are continuous and have [[5206aa83|tight junctions]], forming the [[dd47b9"
      }, {
        "text": "cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFenestrated Capillaries:\u003c/b\u003e These are an exception to the rule"
      }, {
        "text": ". Their pores allow them to \u0027sample\u0027 the chemical composition of the blood.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Found exclusively"
      }, {
        "text": " in the circumventricular organs (CVOs), which are structures that lack a [[dd47b9cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Examples of CVOs:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[5dd343d3|Area Post"
      }, {
        "text": "rema]]:\u003c/b\u003e The chemoreceptor trigger zone for vomiting.\u003cbr\u003e - \u003cb\u003ePosterior Pituitary:\u003c/b\u003e Allows"
      }, {
        "text": " for the release of ADH and oxytocin into the bloodstream.\u003cbr\u003e - \u003cb\u003eMedian Eminence of the Hyp"
      }, {
        "text": "othalamus:\u003c/b\u003e Allows for the release of hypothalamic hormones into the portal system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence"
      }, {
        "text": " of fenestrated capillaries is the anatomical basis for why circumventricular organs lack a blood-brain barrier and can interact directly"
      }, {
        "text": " with the systemic circulation.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFenestrated capillaries\u003c/b\u003e are the"
      }, {
        "text": " \u0027leaky\u0027 vessels of the brain, strategically located in the circumventricular organs to create windows in the blood-brain barrier, allowing these"
      }, {
        "text": " specialized regions to monitor and interact with the chemical messengers of the blood.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"are_found_in\",\n        \"to\": \"circumventricular_org"
      }, {
        "text": "ans\"\n      },\n      {\n        \"type\": \"are_found_in\",\n        \"to"
      }, {
        "text": "\": \"5dd343d3\"\n      },\n      {\n        \"type\": \"are_"
      }, {
        "text": "a_feature_of_areas_lacking\",\n        \"to\": \"dd47b9cc\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"ce4c60ec\": {\n    \"title\": \""
      }, {
        "text": "Fentanyl\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Anesthesiology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Opioids\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFentanyl\u003c/b\u003e is a potent, synthetic \u003ci\u003eopioid analgesic\u003c/i\u003e"
      }, {
        "text": " that acts as a strong agonist at Œº-opioid receptors. It is used for severe pain and as an adjunct in anesthesia.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Strong agonist at Œº-opioid receptors, leading"
      }, {
        "text": " to profound analgesia and sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePotency:\u003c/b\u003e It is approximately \u003cmark\u003e50 to 100 times more potent\u003c/"
      }, {
        "text": "mark\u003e than morphine.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Highly lipid-soluble, allowing for rapid onset and short duration of action when"
      }, {
        "text": " given IV. This property also allows for transdermal and transmucosal administration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eAnesthesia:\u003c/b\u003e Used for induction and maintenance of anesthesia, often in combination with other agents.\u003cbr\u003e - \u003cb\u003ePain Management"
      }, {
        "text": ":\u003c/b\u003e Used for severe acute pain (IV) and chronic pain (transdermal patch).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Like"
      }, {
        "text": " other opioids, it can cause respiratory depression, sedation, constipation, and miosis. Due to its high potency, the"
      }, {
        "text": " risk of fatal respiratory depression in overdose is very high.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Fentanyl\u0027s high potency and rapid onset make"
      }, {
        "text": " it a powerful tool in anesthesia and pain management, but also make it extremely dangerous in the context of illicit drug use."
      }, {
        "text": " Overdose is treated with naloxone.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFentanyl\u003c/b\u003e is a synthetic"
      }, {
        "text": " opioid of exceptional potency, providing rapid and powerful analgesia, but its narrow therapeutic window and profound respiratory depressant effects make it one"
      }, {
        "text": " of the most dangerous opioids when used illicitly.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"opioid_analgesics\"\n      },\n      {\n        \"type\": \"acts_as_agonist"
      }, {
        "text": "_at\",\n        \"to\": \"mu_opioid_receptor\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_more_potent_than\",\n        \"to\": \"morphine\"\n      }\n    "
      }, {
        "text": "]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"414154aa\",\n    \"letter\": \"F\",\n    \"term\": \"Fever\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Fever\",\n    \"sub_entries\": [\n      {\n        \"id\": \"3725168c\",\n        \"letter\": \"F\",\n        \"term\": \"pathophysiology and management\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Fever \u003e pathophysiology and management\"\n      },\n      {\n        \"id\": \"e31314b1\",\n        \"letter\": \"F\",\n        \"term\": \"vs heat stroke\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Fever \u003e vs heat stroke\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c88383fe\",\n    \"letter\": \"F\",\n    \"term\": \"Finger agnosia\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Finger agnosia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"953e1306\",\n    \"letter\": \"F\",\n    \"term\": \"Flaccid paralysis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Flaccid paralysis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"fe1d0a31\",\n        \"letter\": \"F\",\n        \"term\": \"motor neuron signs\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Flaccid paralysis \u003e motor neuron signs\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b8ce0d03\",\n    \"letter\": \"F\",\n    \"term\": \"Focal aware seizures\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Focal aware seizures\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"00be40b6\",\n    \"letter\": \"F\",\n    \"term\": \"Focal impaired awareness seizures\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Focal impaired awareness seizures\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"953ad620\",\n    \"letter\": \"F\",\n    \"term\": \"Focal seizures\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Focal seizures\",\n    \"sub_entries\": [\n      {\n        \"id\": \"75548aed\",\n        \"letter\": \"F\",\n        \"term\": \"types of\",\n        \"pages\": [\n          \"531\"\n        ],\n        \"context\": \"Focal seizures \u003e types of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"0569a9e3\",\n    \"letter\": \"F\",\n    \"term\": \"Foramen of Magendie\",\n    \"pages\": [\n      \"515\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Foramen of Magendie\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"eea1b841\",\n    \"letter\": \"F\",\n    \"term\": \"Foramen of Monro\",\n    \"pages\": [\n      \"515\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Foramen of Monro\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"098c1e45\",\n    \"letter\": \"F\",\n    \"term\": \"Foramina of Luschka\",\n    \"pages\": [\n      \"515\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Foramina of Luschka\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"fc5e9480\",\n    \"letter\": \"F\",\n    \"term\": \"Frataxin\",\n    \"pages\": [\n      \"545\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Frataxin\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1e7ec644\",\n    \"letter\": \"F\",\n    \"term\": \"Free nerve endings\",\n    \"pages\": [\n      \"504\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Free nerve endings\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"d72bc844\",\n    \"letter\": \"F\",\n    \"term\": \"Fresh frozen plasma/prothrombin\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Fresh frozen plasma/prothrombin\",\n    \"sub_entries\": [\n      {\n        \"id\": \"00dde737\",\n        \"letter\": \"F\",\n        \"term\": \"‚ÄúFried egg‚Äù cells\",\n        \"pages\": [\n          \"503\",\n          \"540\",\n          \"664\"\n        ],\n        \"context\": \"Fresh frozen plasma/prothrombin \u003e ‚ÄúFried egg‚Äù cells\"\n      }\n    ]\n  },\n  {\n    \"id\": \"39bc1763\",\n    \"letter\": \"F\",\n    \"term\": \"Friedreich ataxia\",\n    \"pages\": [\n      \"545\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Friedreich ataxia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"5ddbdcd3\",\n    \"letter\": \"F\",\n    \"term\": \"Frontal eye fields\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Frontal eye fields\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"0405ada3\",\n    \"letter\": \"F\",\n    \"term\": \"Frontal lobe\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Frontal lobe\",\n    \"sub_entries\": [\n      {\n        \"id\": \"95a2ad23\",\n        \"letter\": \"F\",\n        \"term\": \"stroke effects\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Frontal lobe \u003e stroke effects\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1662
    }, {
      "text": "```json\n{\n  \"414154aa\": {\n    \"title\": \"Fever\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pathophysiology\",\n      \"Infectious Disease\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Thermoregulation\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFever\u003c/b\u003e (pyrexia) is an elevation of body temperature that exceeds the normal daily variation, occurring in conjunction with an increase in the hypothalamic set point. It is a common, coordinated response to infection or inflammation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Exogenous pyrogens (e.g., bacterial LPS) induce immune cells to release endogenous pyrogens (cytokines like IL-1, IL-6, TNF-Œ±). These cytokines increase the synthesis of \u003cmark\u003eprostaglandin E\u003csub\u003e2\u003c/sub\u003e (PGE\u003csub\u003e2\u003c/sub\u003e)\u003c/mark\u003e in the hypothalamus. PGE\u003csub\u003e2\u003c/sub\u003e then acts on the anterior hypothalamus to \u003cmark\u003eraise the thermoregulatory set point\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Heat Production:\u003c/b\u003e The body responds to the new, higher set point by initiating heat-generating mechanisms, such as shivering and peripheral vasoconstriction, until the blood temperature matches the new set point.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e Antipyretics like NSAIDs and acetaminophen work by inhibiting COX enzymes, thereby \u003cmark\u003edecreasing PGE\u003csub\u003e2\u003c/sub\u003e synthesis\u003c/mark\u003e and lowering the hypothalamic set point back toward normal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFever vs. Heat Stroke:\u003c/b\u003e This is a critical distinction. In fever, the hypothalamic set point is elevated. In [[heat_stroke|heat stroke]], the set point is normal, but the body\u0027s heat-dissipating mechanisms are overwhelmed. Therefore, antipyretics are ineffective for heat stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The central mediator of fever is PGE\u003csub\u003e2\u003c/sub\u003e acting on the hypothalamus. This is the target of antipyretic drugs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFever\u003c/b\u003e is not a failure of thermoregulation but a deliberate resetting of the body\u0027s thermostat by the hypothalamus, orchestrated by PGE\u003csub\u003e2\u003c/sub\u003e in response to inflammation, a process that is pharmacologically reversed by inhibiting prostaglandin synthesis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Infection/Inflammation] --\u003e B(Cytokine Release); B --\u003e C(‚Üë PGE2 in Hypothalamus); C --\u003e D(‚Üë Hypothalamic Set Point); D --\u003e E(Heat Conservation/Production); E --\u003e F(Fever);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"prostaglandin_e2\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"heat_stroke\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"nsaids\"\n      }\n    ]\n  },\n  \"c88383fe\": {\n    \"title\": \"Finger Agnosia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFinger agnosia\u003c/b\u003e is a specific neurological deficit characterized by the inability to name, identify, or recognize one\u0027s own or another person\u0027s fingers. It is a component of Gerstmann syndrome.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Finger agnosia is a key localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eFinger Agnosia\u003c/b\u003e, \u003cb\u003e[[13d6bca7|Agraphia]]\u003c/b\u003e (inability to write), \u003cb\u003e[[8558c64b|Acalculia]]\u003c/b\u003e (inability to perform calculations), and \u003cb\u003eLeft-Right Disorientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [[143bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of finger agnosia with any of the other elements of the Gerstmann tetrad is a strong indicator of a lesion in the dominant (usually left) parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFinger agnosia\u003c/b\u003e is a bizarre and highly specific neurological sign that, along with its partners in Gerstmann syndrome, points directly to a lesion in the dominant angular gyrus, a critical association area for language, calculation, and body schema.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"953e1306\": {\n    \"title\": \"Flaccid Paralysis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFlaccid paralysis\u003c/b\u003e is a clinical manifestation of neurological disease characterized by extreme weakness of muscles and loss of muscle tone. It is the hallmark sign of a \u003cu\u003elower motor neuron (LMN) lesion\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results from damage to the LMNs in the anterior horn of the spinal cord or the peripheral nerves, which disrupts the final common pathway for muscle contraction. The muscle is deprived of all input.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated LMN Signs:\u003c/b\u003e Flaccid paralysis is accompanied by other LMN signs:\u003cbr\u003e - \u003cb\u003eHypotonia:\u003c/b\u003e Decreased muscle tone.\u003cbr\u003e - \u003cb\u003eHyporeflexia/Areflexia:\u003c/b\u003e Diminished or absent deep tendon reflexes.\u003cbr\u003e - \u003cb\u003e[[5198afd0|Fasciculations]]:\u003c/b\u003e Involuntary muscle twitches.\u003cbr\u003e - \u003cb\u003eSevere Muscle [[0c2b4642|Atrophy]]:\u003c/b\u003e Pronounced muscle wasting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e [[ed52e40b|Guillain-Barr√© syndrome]], poliomyelitis, spinal muscular atrophy, [[4ed629f9|ALS]] (as part of the mixed UMN/LMN picture), and peripheral nerve trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBotulism:\u003c/b\u003e A classic cause of descending flaccid paralysis due to inhibition of acetylcholine release by [[84b10400|botulinum toxin]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from spastic paralysis, which is caused by UMN lesions and is characterized by hypertonia and hyperreflexia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFlaccid paralysis\u003c/b\u003e is the clinical sign of a \u0027disconnected\u0027 muscle, resulting from a lower motor neuron lesion that severs the final neural command line, leading to a limp, wasted, and areflexic state.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"poliomyelitis\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"spastic_paralysis\"\n      }\n    ]\n  },\n  \"b8ce0d03\": {\n    \"title\": \"Focal Aware Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFocal aware seizures\u003c/b\u003e, formerly known as simple partial seizures, are seizures that originate within a localized network in one cerebral hemisphere and occur \u003cu\u003ewithout\u003c/u\u003e any impairment of consciousness or awareness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e Consciousness and awareness are fully preserved throughout the event. The patient can recall the event afterward.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e The manifestations depend on the location of the seizure focus in the brain.\u003cbr\u003e - \u003cb\u003eMotor:\u003c/b\u003e Jerking movements (clonus) of a single limb or one side of the face (e.g., Jacksonian march).\u003cbr\u003e - \u003cb\u003eSensory:\u003c/b\u003e Paresthesias (tingling) or other sensory phenomena.\u003cbr\u003e - \u003cb\u003eAutonomic:\u003c/b\u003e Epigastric rising sensation, sweating, piloerection.\u003cbr\u003e - \u003cb\u003ePsychic:\u003c/b\u003e D√©j√† vu, fear, or other emotional experiences.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAura:\u003c/b\u003e A focal aware seizure can serve as an \u0027aura\u0027 or warning before a more significant seizure, such as a focal impaired awareness seizure or a secondary generalized tonic-clonic seizure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The defining characteristic is the preservation of consciousness. If a patient describes a seizure event in detail (e.g., \u0027my right hand started shaking, but I was fully awake\u0027), it is a focal aware seizure.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFocal aware seizures\u003c/b\u003e are localized electrical storms in the brain that produce motor, sensory, or emotional symptoms without affecting consciousness, often serving as a prelude or \u0027aura\u0027 to a larger seizure.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"953ad620\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"00be40b6\"\n      }\n    ]\n  },\n  \"00be40b6\": {\n    \"title\": \"Focal Impaired Awareness Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFocal impaired awareness seizures\u003c/b\u003e, formerly known as complex partial seizures, are seizures that originate within a localized network in one cerebral hemisphere and are characterized by an alteration or loss of consciousness or awareness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e Impairment of consciousness. The patient may appear awake but is unresponsive or responds inappropriately. There is typically amnesia for the event.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Most commonly originate in the \u003cmark\u003etemporal lobe\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutomatisms:\u003c/b\u003e Often accompanied by stereotyped, purposeless movements called automatisms, such as lip smacking, chewing, or fumbling with clothing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAura:\u003c/b\u003e May be preceded by an aura (a focal aware seizure), such as an epigastric rising sensation, fear, or an olfactory hallucination.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostictal State:\u003c/b\u003e Followed by a period of confusion, drowsiness, or other neurological deficits (e.g., Todd\u0027s paralysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who stares blankly, is unresponsive, and performs repetitive, automatic behaviors like lip smacking is the classic presentation of a focal impaired awareness seizure, most likely of temporal lobe origin.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFocal impaired awareness seizures\u003c/b\u003e are temporal lobe-originating seizures that temporarily disconnect a person\u0027s consciousness, leaving them in a dream-like state where they may perform automatic behaviors (automatisms) for which they have no memory.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"953ad620\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"b8ce0d03\"\n      },\n      {\n        \"type\": \"most_commonly_originate_in\",\n        \"to\": \"temporal_lobe\"\n      }\n    ]\n  },\n  \"953ad620\": {\n    \"title\": \"Focal Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFocal seizures\u003c/b\u003e (formerly partial seizures) are seizures that originate within a localized network in one cerebral hemisphere. Their clinical manifestations depend on the specific area of the cortex involved.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e Classified based on the level of consciousness during the event:\u003cbr\u003e - \u003cb\u003e[[b8ce0d03|Focal Aware Seizure]]:\u003c/b\u003e Consciousness is fully maintained.\u003cbr\u003e - \u003cb\u003e[[00be40b6|Focal Impaired Awareness Seizure]]:\u003c/b\u003e Consciousness is altered or lost.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary Generalization:\u003c/b\u003e A focal seizure can spread to involve both hemispheres, evolving into a bilateral tonic-clonic seizure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often caused by a structural brain lesion, such as a tumor, scar tissue from a previous stroke or trauma, or a developmental malformation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Typically treated with \u003cmark\u003enarrow-spectrum anticonvulsants\u003c/mark\u003e like [[eddd2bc5|carbamazepine]] or [[5aea213f|phenytoin]], although broad-spectrum agents are also effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The initial symptoms of a seizure (the aura) can help localize its origin. For example, an olfactory hallucination (e.g., smelling burning rubber) points to a temporal lobe onset.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFocal seizures\u003c/b\u003e are the result of an electrical fire starting in one specific part of the brain, with the resulting symptoms providing a direct clue to the location of the seizure\u0027s origin.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"b8ce0d03\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"00be40b6\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"narrow_spectrum_anticonvulsants\"\n      }\n    ]\n  },\n  \"0569a9e3\": {\n    \"title\": \"Foramen of Magendie\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eForamen of Magendie\u003c/b\u003e, or median aperture, is a single opening in the midline of the roof of the fourth ventricle. It is one of the three apertures that allow cerebrospinal fluid (CSF) to exit the ventricular system and enter the subarachnoid space.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Midline of the posterior roof of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Allows CSF to flow from the fourth ventricle into the \u003cmark\u003ecisterna magna\u003c/mark\u003e, a large CSF cistern in the subarachnoid space located posterior to the medulla and inferior to the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePaired Foramina:\u003c/b\u003e It works in conjunction with the two lateral [[098c1e45|foramina of Luschka]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Obstruction of the foramina of Magendie and Luschka (e.g., by a tumor, inflammation, or congenital malformation like [[b96a6a07|Chiari malformation]]) blocks CSF outflow from the ventricles, causing \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the three exits from the fourth ventricle: two lateral foramina of \u003cb\u003eL\u003c/b\u003euschka and one \u003cb\u003em\u003c/b\u003eedian foramen of \u003cb\u003eM\u003c/b\u003eagendie.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eForamen of Magendie\u003c/b\u003e is the central drain of the fourth ventricle, allowing CSF to escape into the subarachnoid space; its blockage leads to a dangerous backup of fluid and hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Fourth Ventricle] --\u003e B(Foramen of Magendie); B --\u003e C(Subarachnoid Space/Cisterna Magna);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_aperture_of\",\n        \"to\": \"fourth_ventricle\"\n      },\n      {\n        \"type\": \"allows_csf_flow_to\",\n        \"to\": \"subarachnoid_space\"\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to\": \"0bc2f200\"\n      }\n    ]\n  },\n  \"eea1b841\": {\n    \"title\": \"Interventricular Foramen (of Monro)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eInterventricular Foramen\u003c/b\u003e, also known as the foramen of Monro, are two short conduits that connect the paired lateral ventricles with the third ventricle at the midline of the brain, allowing for the passage of cerebrospinal fluid (CSF).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated at the junction of the anterior and body portions of the lateral ventricles, connecting them to the anterior part of the third ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Allows CSF produced in the lateral ventricles to flow into the third ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Obstruction of one or both foramina can lead to \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e. A common cause of obstruction is a \u003cmark\u003ecolloid cyst\u003c/mark\u003e of the third ventricle, which can act as a ball-valve, causing intermittent obstruction and positional headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Blockage of a foramen of Monro will lead to enlargement of the ipsilateral lateral ventricle, while the third and fourth ventricles remain normal in size.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with positional headaches that are relieved by lying down, who has an enlarged lateral ventricle on imaging, should be evaluated for a colloid cyst obstructing the foramen of Monro.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eForamen of Monro\u003c/b\u003e is the crucial channel that allows CSF to drain from each lateral ventricle into the third ventricle; its blockage, often by a colloid cyst, leads to a buildup of pressure in the affected lateral ventricle.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Ventricles] --Foramen of Monro--\u003e B(Third Ventricle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"1cb9c975\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"lateral_ventricles\"\n      },\n      {\n        \"type\": \"connects\",\n        \"to\": \"third_ventricle\"\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to\": \"0bc2f200\"\n      }\n    ]\n  },\n  \"098c1e45\": {\n    \"title\": \"Foramina of Luschka\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eForamina of Luschka\u003c/b\u003e, or lateral apertures, are two openings on the lateral aspects of the fourth ventricle. They are part of the three apertures that allow cerebrospinal fluid (CSF) to exit the ventricular system and enter the subarachnoid space.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Paired openings located on the lateral recesses of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Allow CSF to flow from the fourth ventricle into the subarachnoid space, specifically into the cerebellopontine angle cistern.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePaired with:\u003c/b\u003e Works in conjunction with the single, midline [[0569a9e3|foramen of Magendie]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Obstruction of the foramina of Luschka and Magendie (e.g., by a tumor, inflammation, or congenital malformation like [[96ec2121|Dandy-Walker malformation]]) blocks CSF outflow from the ventricles, causing \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the three exits from the fourth ventricle: two \u003cb\u003eL\u003c/b\u003eateral foramina of \u003cb\u003eL\u003c/b\u003euschka and one \u003cb\u003em\u003c/b\u003eedian foramen of \u003cb\u003eM\u003c/b\u003eagendie.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eForamina of Luschka\u003c/b\u003e are the paired lateral drains of the fourth ventricle, essential for allowing CSF to escape into the subarachnoid space; their blockage results in a dangerous buildup of fluid and pressure within the entire ventricular system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Fourth Ventricle] --\u003e B(Foramina of Luschka); B --\u003e C(Subarachnoid Space/Cerebellopontine Angle);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_aperture_of\",\n        \"to\": \"fourth_ventricle\"\n      },\n      {\n        \"type\": \"allows_csf_flow_to\",\n        \"to\": \"subarachnoid_space\"\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to\": \"0bc2f200\"\n      }\n    ]\n  },\n  \"fc5e9480\": {\n    \"title\": \"Frataxin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Genetics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFrataxin\u003c/b\u003e is a mitochondrial protein that is essential for the synthesis of iron-sulfur clusters and for regulating mitochondrial iron homeostasis. A deficiency of frataxin is the underlying cause of [[39bc1763|Friedreich ataxia]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Plays a critical role in mitochondrial iron metabolism and the assembly of iron-sulfur cluster-containing proteins, which are essential for the electron transport chain and other enzymatic reactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetic Basis:\u003c/b\u003e The gene for frataxin (\u003ci\u003eFXN\u003c/i\u003e) is located on chromosome 9. In [[39bc1763|Friedreich ataxia]], there is an expansion of a \u003cmark\u003eGAA trinucleotide repeat\u003c/mark\u003e in an intron of this gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The GAA repeat expansion leads to reduced transcription of the \u003ci\u003eFXN\u003c/i\u003e gene, resulting in a deficiency of the frataxin protein. This leads to mitochondrial iron overload, oxidative stress, and impaired mitochondrial function, particularly in high-energy-demand tissues.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected Tissues:\u003c/b\u003e The deficiency of frataxin particularly affects neurons (especially in the cerebellum, dorsal root ganglia, and corticospinal tracts), cardiomyocytes, and pancreatic Œ≤-cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Frataxin deficiency ‚Üí Mitochondrial dysfunction ‚Üí [[39bc1763|Friedreich ataxia]]. Remember the GAA repeat and the key systems affected: nervous system (ataxia), heart (hypertrophic cardiomyopathy), and pancreas (diabetes).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFrataxin\u003c/b\u003e is a vital mitochondrial protein for iron management; its deficiency, caused by a GAA trinucleotide repeat expansion, leads to mitochondrial iron overload and oxidative damage, culminating in the multisystem neurodegenerative disorder, Friedreich ataxia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[GAA Repeat Expansion in FXN Gene] --\u003e B(‚Üì Frataxin Protein); B --\u003e C(Mitochondrial Iron Overload \u0026 Oxidative Stress); C --\u003e D(Cell Death in Neurons, Cardiomyocytes, Pancreatic Œ≤-cells); D --\u003e E(Friedreich Ataxia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"39bc1763\"\n      },\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"mitochondrial_iron_metabolism\"\n      },\n      {\n        \"type\": \"gene_has_repeat_expansion_in\",\n        \"to\": \"39bc1763\"\n      }\n    ]\n  },\n  \"1e7ec644\": {\n    \"title\": \"Free Nerve Endings\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory Receptors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFree nerve endings\u003c/b\u003e are unencapsulated, branching terminations of sensory nerve fibers found throughout the body, particularly in the skin, cornea, and pulp of teeth. They are the most common type of nerve ending and are responsible for detecting pain (nociception) and temperature (thermoception).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Simple, unencapsulated dendritic endings of sensory neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediate the sensations of \u003cmark\u003epain and temperature\u003c/mark\u003e. They are also involved in crude touch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFiber Types:\u003c/b\u003e The signals are transmitted by two main types of nerve fibers:\u003cbr\u003e - \u003cb\u003eAŒ¥ fibers:\u003c/b\u003e Thinly myelinated, fast-conducting fibers that transmit sharp, well-localized \u0027fast\u0027 pain and cold sensation.\u003cbr\u003e - \u003cb\u003eC fibers:\u003c/b\u003e Unmyelinated, slow-conducting fibers that transmit dull, aching, poorly-localized \u0027slow\u0027 pain and warmth sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Abundant in the epidermis and cornea, but also found in most other body tissues.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate free nerve endings with the primary sensations of pain and temperature, and remember the two different fiber types (fast AŒ¥ and slow C) that carry these signals.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFree nerve endings\u003c/b\u003e are the body\u0027s primary detectors for noxious and thermal stimuli, acting as simple but crucial sensors that alert the nervous system to potential or actual tissue damage through the sensations of pain and temperature.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"sensory_receptor\"\n      },\n      {\n        \"type\": \"detects\",\n        \"to\": \"pain\"\n      },\n      {\n        \"type\": \"detects\",\n        \"to\": \"temperature\"\n      },\n      {\n        \"type\": \"transmits_signals_via\",\n        \"to\": \"a_delta_fibers\"\n      },\n      {\n        \"type\": \"transmits_signals_via\",\n        \"to\": \"c_fibers\"\n      }\n    ]\n  },\n  \"d72bc844\": {\n    \"title\": \"Fried Egg Cells\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neuropathology\",\n      \"Oncology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe term \u003cb\u003e\\\"fried egg\\\" cells\u003c/b\u003e is a classic histological description for the appearance of cells in an \u003cmark\u003eoligodendroglioma\u003c/mark\u003e. These cells have a round, central nucleus (the \u0027yolk\u0027) surrounded by a clear halo of cytoplasm (the \u0027egg white\u0027).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Round cells with a dark, central nucleus and a clear cytoplasmic halo. This appearance is an artifact of tissue processing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Tumor:\u003c/b\u003e The pathognomonic histological feature of an \u003cmark\u003eoligodendroglioma\u003c/mark\u003e, a primary CNS tumor derived from [[a24f9747|oligodendrocytes]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Features of Oligodendroglioma:\u003c/b\u003e These tumors often have a delicate network of branching capillaries, described as a \u0027chicken-wire\u0027 pattern, and are frequently calcified.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther \u0027Fried Egg\u0027 Appearances:\u003c/b\u003e The term is also used to describe other cells in pathology, such as koilocytes in HPV infection and the cells of a seminoma. In the context of neuropathology, it refers to oligodendroglioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A brain tumor biopsy showing \u0027fried egg\u0027 cells and a \u0027chicken-wire\u0027 capillary pattern is diagnostic for an oligodendroglioma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e\u0027fried egg\u0027 appearance\u003c/b\u003e is the memorable histological signature of an oligodendroglioma, created by a processing artifact that leaves the tumor cells with a clear cytoplasm surrounding a central nucleus, resembling a sunny-side-up egg.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_histological_feature_of\",\n        \"to\": \"oligodendroglioma\"\n      },\n      {\n        \"type\": \"is_a_histological_feature_of\",\n        \"to\": \"seminoma\"\n      },\n      {\n        \"type\": \"is_a_histological_feature_of\",\n        \"to\": \"koilocytes\"\n      }\n    ]\n  },\n  \"39bc1763\": {\n    \"title\": \"Friedreich Ataxia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Cardiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFriedreich ataxia\u003c/b\u003e is an autosomal recessive neurodegenerative disorder characterized by progressive gait and limb ataxia, dysarthria, and loss of proprioception and vibration sense. It is the most common hereditary ataxia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Caused by an expansion of a \u003cmark\u003eGAA trinucleotide repeat\u003c/mark\u003e in an intron of the \u003ci\u003eFXN\u003c/i\u003e gene on chromosome 9. This leads to reduced expression of the mitochondrial protein \u003cmark\u003e[[fc5e9480|frataxin]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Frataxin deficiency causes mitochondrial iron overload and oxidative stress, leading to degeneration of multiple spinal cord tracts (dorsal columns, corticospinal, spinocerebellar), dorsal root ganglia, and the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Manifestations:\u003c/b\u003e Progressive gait and limb [[9767fd6b|ataxia]], dysarthria, loss of deep tendon reflexes (due to dorsal root ganglia degeneration), and an extensor plantar response (Babinski sign, due to corticospinal tract damage).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Manifestations:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCardiac:\u003c/b\u003e \u003cmark\u003eHypertrophic cardiomyopathy\u003c/mark\u003e is the most common cause of death.\u003cbr\u003e - \u003cb\u003eEndocrine:\u003c/b\u003e Diabetes mellitus.\u003cbr\u003e - \u003cb\u003eSkeletal:\u003c/b\u003e Kyphoscoliosis and foot deformities (\u003cmark\u003epes cavus\u003c/mark\u003e, hammer toes).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic for Friedreich Ataxia: \u003cb\u003eF\u003c/b\u003erataxin is deficient, \u003cb\u003eA\u003c/b\u003etaxic (G\u003cb\u003eAA\u003c/b\u003e), \u003cb\u003eA\u003c/b\u003eutosomal recessive. The combination of neurological symptoms (ataxia, loss of reflexes) with hypertrophic cardiomyopathy and skeletal deformities is classic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFriedreich ataxia\u003c/b\u003e is a multisystem disorder caused by a GAA repeat expansion leading to frataxin deficiency and mitochondrial dysfunction, which manifests as a devastating combination of progressive neurodegeneration (ataxia), hypertrophic cardiomyopathy, and diabetes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[GAA Repeat Expansion] --\u003e B(‚Üì Frataxin); B --\u003e C(Mitochondrial Dysfunction); C --\u003e D(Spinal Cord \u0026 Cerebellar Degeneration); D --\u003e E(Ataxia); C --\u003e F(Cardiomyocyte Damage); F --\u003e G(Hypertrophic Cardiomyopathy); C --\u003e H(Pancreatic Œ≤-cell Damage); H --\u003e I(Diabetes Mellitus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_deficiency_of\",\n        \"to\": \"fc5e9480\"\n      },\n      {\n        \"type\": \"has_inheritance_pattern\",\n        \"to\": \"autosomal_recessive\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertrophic_cardiomyopathy\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"9767fd6b\"\n      }\n    ]\n  },\n  \"5ddbdcd3\": {\n    \"title\": \"Frontal Eye Fields (FEF)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eFrontal Eye Fields (FEF)\u003c/b\u003e are a region of the prefrontal cortex (Brodmann area 8) responsible for planning and initiating voluntary, saccadic eye movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the middle frontal gyrus of the frontal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Controls voluntary, conjugate eye movements to the \u003cmark\u003econtralateral\u003c/mark\u003e side. For example, the left FEF drives the eyes to the right.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e The FEF projects to the contralateral paramedian pontine reticular formation (PPRF), the brainstem\u0027s horizontal gaze center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDestructive Lesion (e.g., stroke):\u003c/b\u003e Causes a temporary gaze deviation \u003cmark\u003e\u003cu\u003etoward\u003c/u\u003e the side of the lesion\u003c/mark\u003e. This is because the contralateral, intact FEF is unopposed and drives the eyes toward the damaged side.\u003cbr\u003e - \u003cb\u003eIrritative Lesion (e.g., seizure):\u003c/b\u003e Causes the eyes to deviate \u003cmark\u003e\u003cu\u003eaway\u003c/u\u003e from the side of the lesion\u003c/mark\u003e, as the hyperactive FEF drives the eyes to the contralateral side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction of eye deviation is a key localizing sign. Remember: FEF lesion \u003d eyes look \u003cb\u003etoward\u003c/b\u003e the \u0027bad\u0027 side. PPRF lesion \u003d eyes look \u003cb\u003eaway\u003c/b\u003e from the \u0027bad\u0027 side.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eFrontal Eye Fields\u003c/b\u003e are the cortical command center for voluntary eye movements, with each hemisphere driving the eyes to the opposite side; a destructive lesion here results in the unopposed action of the healthy hemisphere, causing the eyes to \u0027look at the lesion\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left FEF] --Activates--\u003e B(Right PPRF); B --\u003e C(Gaze to the Right); D[Right FEF] --Activates--\u003e E(Left PPRF); E --\u003e F(Gaze to the Left);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"0405ada3\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"saccadic_eye_movements\"\n      },\n      {\n        \"type\": \"destructive_lesion_causes\",\n        \"to\": \"ipsilateral_gaze_deviation\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"pprf\"\n      }\n    ]\n  },\n  \"0405ada3\": {\n    \"title\": \"Frontal Lobe\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eFrontal Lobe\u003c/b\u003e is the largest of the four major lobes of the cerebral cortex in the brain of mammals, located at the front of each cerebral hemisphere. It is responsible for higher-level executive functions, motor control, and speech production.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Motor Cortex (Precentral Gyrus):\u003c/b\u003e Controls voluntary movements of the contralateral side of the body. Organized somatotopically (motor homunculus).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePremotor Cortex \u0026 Supplementary Motor Area:\u003c/b\u003e Involved in planning and sequencing movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[5ddbdcd3|Frontal Eye Fields (FEF)]]:\u003c/b\u003e Control voluntary eye movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[a3bbace2|Broca\u0027s Area]]:\u003c/b\u003e Located in the inferior frontal gyrus of the dominant hemisphere, responsible for speech production.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrefrontal Cortex:\u003c/b\u003e The large anterior portion of the frontal lobe responsible for \u003cmark\u003eexecutive functions\u003c/mark\u003e: planning, decision-making, working memory, personality expression, and moderating social behavior.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Damage to the frontal lobe can cause contralateral paralysis ([[830c856c|ACA stroke]] -\u003e leg; [[143bb23d|MCA stroke]] -\u003e arm/face), expressive aphasia (Broca\u0027s), and profound changes in personality and social conduct (frontal lobe syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Frontal lobe lesions are classically associated with personality changes, disinhibition, and deficits in executive function.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eFrontal Lobe\u003c/b\u003e is the brain\u0027s \u0027CEO,\u0027 orchestrating voluntary movement, producing language, and governing the complex executive functions that define personality and guide goal-directed behavior.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"a1b198f9\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"primary_motor_cortex\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"5ddbdcd3\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"a3bbace2\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9409,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"414154aa\": {\n    \"title\": \"F"
      }, {
        "text": "ever\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pathophysiology\",\n      \"In"
      }, {
        "text": "fectious Disease\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Thermoregulation\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFever\u003c/b\u003e (pyrexia) is an elevation of body"
      }, {
        "text": " temperature that exceeds the normal daily variation, occurring in conjunction with an increase in the hypothalamic set point. It is a common"
      }, {
        "text": ", coordinated response to infection or inflammation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:"
      }, {
        "text": "\u003c/b\u003e Exogenous pyrogens (e.g., bacterial LPS) induce immune cells to release endogenous pyrogens (cytokines like IL-1, IL-"
      }, {
        "text": "6, TNF-Œ±). These cytokines increase the synthesis of \u003cmark\u003eprostaglandin E\u003csub\u003e2\u003c/sub\u003e (PGE\u003csub\u003e2\u003c/sub\u003e"
      }, {
        "text": ")\u003c/mark\u003e in the hypothalamus. PGE\u003csub\u003e2\u003c/sub\u003e then acts on the anterior hypothalamus to \u003cmark\u003eraise the therm"
      }, {
        "text": "oregulatory set point\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Heat Production:\u003c/b\u003e The body responds to the new, higher set point by initiating"
      }, {
        "text": " heat-generating mechanisms, such as shivering and peripheral vasoconstriction, until the blood temperature matches the new set point.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e Ant"
      }, {
        "text": "ipyretics like NSAIDs and acetaminophen work by inhibiting COX enzymes, thereby \u003cmark\u003edecreasing PGE\u003csub\u003e2\u003c/sub\u003e synthesis\u003c/mark\u003e"
      }, {
        "text": " and lowering the hypothalamic set point back toward normal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFever vs. Heat Stroke:\u003c/b\u003e This is a critical distinction. In fever,"
      }, {
        "text": " the hypothalamic set point is elevated. In [[heat_stroke|heat stroke]], the set point is normal, but the body\u0027s heat-"
      }, {
        "text": "dissipating mechanisms are overwhelmed. Therefore, antipyretics are ineffective for heat stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The central mediator of fever is PGE\u003csub\u003e2\u003c/sub\u003e acting on the hypothalamus. This is the target of antipyretic"
      }, {
        "text": " drugs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFever\u003c/b\u003e is not a failure of thermoregulation but"
      }, {
        "text": " a deliberate resetting of the body\u0027s thermostat by the hypothalamus, orchestrated by PGE\u003csub\u003e2\u003c/sub\u003e in response to inflammation, a"
      }, {
        "text": " process that is pharmacologically reversed by inhibiting prostaglandin synthesis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Infection/Inflammation] --\u003e B(Cytokine Release); B --\u003e C(‚Üë PGE2 in Hypothalamus); C --\u003e"
      }, {
        "text": " D(‚Üë Hypothalamic Set Point); D --\u003e E(Heat Conservation/Production); E --\u003e F(F"
      }, {
        "text": "ever);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_mediated_by\","
      }, {
        "text": "\n        \"to\": \"prostaglandin_e2\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"heat_stroke\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_treated_by\",\n        \"to\": \"nsaids\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"c88383fe\": {\n    \"title\": \"Finger Ag"
      }, {
        "text": "nosia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Cognitive Deficit\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFinger agnosia\u003c/b\u003e is a specific neurological deficit characterized"
      }, {
        "text": " by the inability to name, identify, or recognize one\u0027s own or another person\u0027s fingers. It is a component"
      }, {
        "text": " of Gerstmann syndrome.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocalization:\u003c/b\u003e Finger agnosia is a key"
      }, {
        "text": " localizing sign for a lesion in the \u003cmark\u003edominant angular gyrus\u003c/mark\u003e of the parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Syndrome:\u003c/b\u003e It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eGerstmann Syndrome Tetrad:\u003c/b\u003e The full syndrome includes \u003cb\u003eFinger Agnosia\u003c/b\u003e, "
      }, {
        "text": "\u003cb\u003e[[13d6bca7|Agraphia]]\u003c/b\u003e (inability to write), \u003cb\u003e[[85"
      }, {
        "text": "58c64b|Acalculia]]\u003c/b\u003e (inability to perform calculations), and \u003cb\u003eLeft-Right Dis"
      }, {
        "text": "orientation\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e These symptoms often result from a stroke in the territory of the [["
      }, {
        "text": "143bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The combination of finger agnosia with any of the other elements of the Gerstmann tetrad is a strong"
      }, {
        "text": " indicator of a lesion in the dominant (usually left) parietal lobe.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFinger agnos"
      }, {
        "text": "ia\u003c/b\u003e is a bizarre and highly specific neurological sign that, along with its partners in Gerstmann syndrome, points directly"
      }, {
        "text": " to a lesion in the dominant angular gyrus, a critical association area for language, calculation, and body schema.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \""
      }, {
        "text": "to\": \"38f3ed1f\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"953e1306\": {\n    \""
      }, {
        "text": "title\": \"Flaccid Paralysis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFlaccid paralysis\u003c/b\u003e is a clinical manifestation of neurological disease characterized by extreme"
      }, {
        "text": " weakness of muscles and loss of muscle tone. It is the hallmark sign of a \u003cu\u003elower motor neuron (LMN) lesion\u003c/u\u003e"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results from damage to the L"
      }, {
        "text": "MNs in the anterior horn of the spinal cord or the peripheral nerves, which disrupts the final common pathway for muscle contraction. The"
      }, {
        "text": " muscle is deprived of all input.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated LMN Signs:\u003c/b\u003e Flaccid paralysis is accompanied by other L"
      }, {
        "text": "MN signs:\u003cbr\u003e - \u003cb\u003eHypotonia:\u003c/b\u003e Decreased muscle tone.\u003cbr\u003e - \u003cb\u003eHyporeflex"
      }, {
        "text": "ia/Areflexia:\u003c/b\u003e Diminished or absent deep tendon reflexes.\u003cbr\u003e - \u003cb\u003e[[519"
      }, {
        "text": "8afd0|Fasciculations]]:\u003c/b\u003e Involuntary muscle twitches.\u003cbr\u003e - \u003cb\u003eSevere Muscle [["
      }, {
        "text": "0c2b4642|Atrophy]]:\u003c/b\u003e Pronounced muscle wasting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e [["
      }, {
        "text": "ed52e40b|Guillain-Barr√© syndrome]], poliomyelitis, spinal muscular atrophy, [[4ed"
      }, {
        "text": "629f9|ALS]] (as part of the mixed UMN/LMN picture), and peripheral nerve trauma"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eBotulism:\u003c/b\u003e A classic cause of descending flaccid paralysis due to inhibition of acetylcholine release by"
      }, {
        "text": " [[84b10400|botulinum toxin]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e D"
      }, {
        "text": "ifferentiate from spastic paralysis, which is caused by UMN lesions and is characterized by hypertonia and hyperreflexia.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFlaccid paralysis\u003c/b\u003e is the clinical sign of a \u0027"
      }, {
        "text": "disconnected\u0027 muscle, resulting from a lower motor neuron lesion that severs the final neural command line, leading to a limp"
      }, {
        "text": ", wasted, and areflexic state.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_"
      }, {
        "text": "lesion\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \""
      }, {
        "text": "to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_symptom_of\",\n        \"to\": \"poliomyelitis\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"spastic_paralysis\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"b8ce0d03\": {\n    \"title\": \""
      }, {
        "text": "Focal Aware Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFocal aware seizures\u003c/b\u003e, formerly known as simple partial seizures, are seizures"
      }, {
        "text": " that originate within a localized network in one cerebral hemisphere and occur \u003cu\u003ewithout\u003c/u\u003e any impairment of consciousness or awareness.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e Consciousness and awareness are fully preserved throughout the event. The patient"
      }, {
        "text": " can recall the event afterward.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e The manifestations depend on the location of the seizure focus in the brain.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eMotor:\u003c/b\u003e Jerking movements (clonus) of a single limb or one side of the face"
      }, {
        "text": " (e.g., Jacksonian march).\u003cbr\u003e - \u003cb\u003eSensory:\u003c/b\u003e Paresthesias (ting"
      }, {
        "text": "ling) or other sensory phenomena.\u003cbr\u003e - \u003cb\u003eAutonomic:\u003c/b\u003e Epigastric rising sensation, sweating, pil"
      }, {
        "text": "oerection.\u003cbr\u003e - \u003cb\u003ePsychic:\u003c/b\u003e D√©j√† vu, fear, or other emotional experiences.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAura:"
      }, {
        "text": "\u003c/b\u003e A focal aware seizure can serve as an \u0027aura\u0027 or warning before a more significant seizure, such as a focal impaired"
      }, {
        "text": " awareness seizure or a secondary generalized tonic-clonic seizure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The defining characteristic is the preservation"
      }, {
        "text": " of consciousness. If a patient describes a seizure event in detail (e.g., \u0027my right hand started shaking,"
      }, {
        "text": " but I was fully awake\u0027), it is a focal aware seizure.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFocal aware seizures\u003c/b\u003e"
      }, {
        "text": " are localized electrical storms in the brain that produce motor, sensory, or emotional symptoms without affecting consciousness, often serving as a"
      }, {
        "text": " prelude or \u0027aura\u0027 to a larger seizure.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"953ad620\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to"
      }, {
        "text": "\": \"00be40b6\"\n      }\n    ]\n  },\n  \"00be40b6"
      }, {
        "text": "\": {\n    \"title\": \"Focal Impaired Awareness Seizures\",\n    \"primaryType\": \"disease\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eFocal impaired awareness seizures\u003c/b\u003e, formerly known as complex partial seizures, are seizures that originate within a localized network in one cerebral hemisphere and are"
      }, {
        "text": " characterized by an alteration or loss of consciousness or awareness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Feature:\u003c/b\u003e Impairment of consciousness. The patient may appear awake but is unresponsive or responds inappropriately. There is typically"
      }, {
        "text": " amnesia for the event.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Most commonly originate in the \u003cmark\u003etemporal lobe\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAutomat"
      }, {
        "text": "isms:\u003c/b\u003e Often accompanied by stereotyped, purposeless movements called automatisms, such as lip smacking, chewing, or f"
      }, {
        "text": "umbling with clothing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAura:\u003c/b\u003e May be preceded by an aura (a focal aware seizure), such"
      }, {
        "text": " as an epigastric rising sensation, fear, or an olfactory hallucination.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostictal State:\u003c/b\u003e Follow"
      }, {
        "text": "ed by a period of confusion, drowsiness, or other neurological deficits (e.g., Todd\u0027s paralysis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A patient who stares blankly, is unresponsive, and performs repetitive, automatic behaviors like lip smacking is the classic presentation of a focal impaired awareness seizure"
      }, {
        "text": ", most likely of temporal lobe origin.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFocal impaired awareness seizures\u003c/b\u003e are temporal"
      }, {
        "text": " lobe-originating seizures that temporarily disconnect a person\u0027s consciousness, leaving them in a dream-like state where they may"
      }, {
        "text": " perform automatic behaviors (automatisms) for which they have no memory.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"953ad620\"\n      },\n      {\n        \"type\": \"d"
      }, {
        "text": "ifferentiated_from\",\n        \"to\": \"b8ce0d03\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"most_commonly_originate_in\",\n        \"to\": \"temporal_lobe\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"953ad620\": {\n    \"title\": \"Focal Seizures"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003e\u003cb\u003eFocal seizures\u003c/b\u003e (formerly partial seizures) are seizures that originate within a localized network in one cerebral hemisphere."
      }, {
        "text": " Their clinical manifestations depend on the specific area of the cortex involved.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes"
      }, {
        "text": ":\u003c/b\u003e Classified based on the level of consciousness during the event:\u003cbr\u003e - \u003cb\u003e[[b8ce0d03|F"
      }, {
        "text": "ocal Aware Seizure]]:\u003c/b\u003e Consciousness is fully maintained.\u003cbr\u003e - \u003cb\u003e[[00be40b6|F"
      }, {
        "text": "ocal Impaired Awareness Seizure]]:\u003c/b\u003e Consciousness is altered or lost.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary Generalization:\u003c/b\u003e A focal seizure can spread"
      }, {
        "text": " to involve both hemispheres, evolving into a bilateral tonic-clonic seizure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Often"
      }, {
        "text": " caused by a structural brain lesion, such as a tumor, scar tissue from a previous stroke or trauma, or a developmental malformation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": ":\u003c/b\u003e Typically treated with \u003cmark\u003enarrow-spectrum anticonvulsants\u003c/mark\u003e like [[eddd2bc5"
      }, {
        "text": "|carbamazepine]] or [[5aea213f|phenytoin]], although broad-spectrum agents are also effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The initial symptoms of a seizure (the aura) can help localize its origin. For example, an"
      }, {
        "text": " olfactory hallucination (e.g., smelling burning rubber) points to a temporal lobe onset.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eFocal seizures\u003c/b\u003e are the result of an electrical fire starting in one specific part of the brain,"
      }, {
        "text": " with the resulting symptoms providing a direct clue to the location of the seizure\u0027s origin.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"64c08e92\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"b8ce0d03\"\n      },\n      {\n        \"type\": \"includes\",\n        \""
      }, {
        "text": "to\": \"00be40b6\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"narrow_spectrum_anticonvulsants\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"0569a9e3\": {\n    \"title\": \"For"
      }, {
        "text": "amen of Magendie\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eForamen of Magendie\u003c/b\u003e, or median aperture, is a single opening in"
      }, {
        "text": " the midline of the roof of the fourth ventricle. It is one of the three apertures that allow cerebrospinal fluid (CSF) to exit"
      }, {
        "text": " the ventricular system and enter the subarachnoid space.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eLocation:\u003c/b\u003e Midline of the posterior roof of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Allows CSF to flow from the fourth ventricle into"
      }, {
        "text": " the \u003cmark\u003ecisterna magna\u003c/mark\u003e, a large CSF cistern in the subarachnoid space located posterior to the medulla"
      }, {
        "text": " and inferior to the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePaired Foramina:\u003c/b\u003e It works in conjunction with the two lateral [["
      }, {
        "text": "098c1e45|foramina of Luschka]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Obst"
      }, {
        "text": "ruction of the foramina of Magendie and Luschka (e.g., by a tumor, inflammation, or congenital malformation like"
      }, {
        "text": " [[b96a6a07|Chiari malformation]]) blocks CSF outflow from the ventricles, causing \u003c"
      }, {
        "text": "mark\u003enon-communicating hydrocephalus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the three exits from"
      }, {
        "text": " the fourth ventricle: two lateral foramina of \u003cb\u003eL\u003c/b\u003euschka and one \u003cb\u003em\u003c/b\u003eedian foramen"
      }, {
        "text": " of \u003cb\u003eM\u003c/b\u003eagendie.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eForamen of Magendie"
      }, {
        "text": "\u003c/b\u003e is the central drain of the fourth ventricle, allowing CSF to escape into the subarachnoid space; its blockage leads"
      }, {
        "text": " to a dangerous backup of fluid and hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Fourth"
      }, {
        "text": " Ventricle] --\u003e B(Foramen of Magendie); B --\u003e C(Subarachnoid Space/"
      }, {
        "text": "Cisterna Magna);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_an_aperture_of\",\n        \"to\": \"fourth_ventricle\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"allows_csf_flow_to\",\n        \"to\": \"subarachnoid_space\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to\": \"0"
      }, {
        "text": "bc2f200\"\n      }\n    ]\n  },\n  \"eea1b84"
      }, {
        "text": "1\": {\n    \"title\": \"Interventricular Foramen (of Monro)\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\","
      }, {
        "text": "\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e"
      }, {
        "text": "The \u003cb\u003eInterventricular Foramen\u003c/b\u003e, also known as the foramen of Monro, are two short conduits that connect the paired"
      }, {
        "text": " lateral ventricles with the third ventricle at the midline of the brain, allowing for the passage of cerebrospinal fluid (CSF).\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Situated at the junction of the anterior and body"
      }, {
        "text": " portions of the lateral ventricles, connecting them to the anterior part of the third ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Allows"
      }, {
        "text": " CSF produced in the lateral ventricles to flow into the third ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Obstruction of one"
      }, {
        "text": " or both foramina can lead to \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e. A common cause of obstruction is a \u003cmark\u003ecolloid"
      }, {
        "text": " cyst\u003c/mark\u003e of the third ventricle, which can act as a ball-valve, causing intermittent obstruction and positional headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging"
      }, {
        "text": ":\u003c/b\u003e Blockage of a foramen of Monro will lead to enlargement of the ipsilateral lateral ventricle, while the third and"
      }, {
        "text": " fourth ventricles remain normal in size.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with positional headaches that are relieved by lying"
      }, {
        "text": " down, who has an enlarged lateral ventricle on imaging, should be evaluated for a colloid cyst obstructing the foramen of Monro."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eForamen of Monro\u003c/b\u003e is the crucial channel that"
      }, {
        "text": " allows CSF to drain from each lateral ventricle into the third ventricle; its blockage, often by a colloid cyst, leads to a buildup"
      }, {
        "text": " of pressure in the affected lateral ventricle.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Ventricles"
      }, {
        "text": "] --Foramen of Monro--\u003e B(Third Ventricle);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"1cb9c975\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"connects\",\n        \"to\": \"lateral_ventricles\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"connects\",\n        \"to\": \"third_ventricle\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"obstruction_causes\",\n        \"to\": \"0bc2f200\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"098c1e45\": {\n    \"title\": \""
      }, {
        "text": "Foramina of Luschka\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eForamina of Luschka\u003c/b\u003e, or"
      }, {
        "text": " lateral apertures, are two openings on the lateral aspects of the fourth ventricle. They are part of the three apertures that allow cerebrospinal fluid"
      }, {
        "text": " (CSF) to exit the ventricular system and enter the subarachnoid space.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eLocation:\u003c/b\u003e Paired openings located on the lateral recesses of the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Allow CSF"
      }, {
        "text": " to flow from the fourth ventricle into the subarachnoid space, specifically into the cerebellopontine angle cistern."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePaired with:\u003c/b\u003e Works in conjunction with the single, midline [[0569a9e3|foramen of Magend"
      }, {
        "text": "ie]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Obstruction of the foramina of Luschka and Magendie (e"
      }, {
        "text": ".g., by a tumor, inflammation, or congenital malformation like [[96ec2121|D"
      }, {
        "text": "andy-Walker malformation]]) blocks CSF outflow from the ventricles, causing \u003cmark\u003enon-communicating hydrocephalus\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the three exits from the fourth ventricle: two \u003cb\u003eL\u003c/b\u003eateral foramina of \u003cb\u003eL\u003c/b\u003euschka and one "
      }, {
        "text": "\u003cb\u003em\u003c/b\u003eedian foramen of \u003cb\u003eM\u003c/b\u003eagendie.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eForamina of Luschka\u003c/b\u003e are the paired lateral drains of the fourth ventricle, essential"
      }, {
        "text": " for allowing CSF to escape into the subarachnoid space; their blockage results in a dangerous buildup of fluid and pressure"
      }, {
        "text": " within the entire ventricular system.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Fourth Ventricle] --\u003e B("
      }, {
        "text": "Foramina of Luschka); B --\u003e C(Subarachnoid Space/Cerebellopontine Angle);\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_an_aperture_"
      }, {
        "text": "of\",\n        \"to\": \"fourth_ventricle\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"allows_csf_flow_to\",\n        \"to\": \"subarachnoid_space\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to\": \"0"
      }, {
        "text": "bc2f200\"\n      }\n    ]\n  },\n  \"fc5e9480\": {\n    \""
      }, {
        "text": "title\": \"Frataxin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Bi"
      }, {
        "text": "ochemistry\",\n      \"Genetics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Neurodegenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFrataxin\u003c/b\u003e is"
      }, {
        "text": " a mitochondrial protein that is essential for the synthesis of iron-sulfur clusters and for regulating mitochondrial iron homeostasis. A deficiency of"
      }, {
        "text": " frataxin is the underlying cause of [[39bc1763|Friedreich ataxia]].\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Plays a critical role in mitochondrial iron metabolism and the assembly of iron-sulfur cluster"
      }, {
        "text": "-containing proteins, which are essential for the electron transport chain and other enzymatic reactions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetic Basis:\u003c/b\u003e The"
      }, {
        "text": " gene for frataxin (\u003ci\u003eFXN\u003c/i\u003e) is located on chromosome 9. In [[39bc1763"
      }, {
        "text": "|Friedreich ataxia]], there is an expansion of a \u003cmark\u003eGAA trinucleotide repeat\u003c/mark\u003e in an"
      }, {
        "text": " intron of this gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The GAA repeat expansion leads to reduced transcription of the \u003ci\u003eFXN\u003c/i\u003e gene"
      }, {
        "text": ", resulting in a deficiency of the frataxin protein. This leads to mitochondrial iron overload, oxidative stress, and impaired"
      }, {
        "text": " mitochondrial function, particularly in high-energy-demand tissues.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected Tissues:\u003c/b\u003e The deficiency of frataxin particularly"
      }, {
        "text": " affects neurons (especially in the cerebellum, dorsal root ganglia, and corticospinal tracts), cardiomyocytes, and pancreatic Œ≤-cells.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Frataxin deficiency ‚Üí Mitochondrial dysfunction ‚Üí [[39bc1763|Friedreich ataxia]]. Remember"
      }, {
        "text": " the GAA repeat and the key systems affected: nervous system (ataxia), heart (hypertrophic cardiomyopathy), and pancreas"
      }, {
        "text": " (diabetes).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFrataxin\u003c/b\u003e is a vital mitochondrial protein for"
      }, {
        "text": " iron management; its deficiency, caused by a GAA trinucleotide repeat expansion, leads to mitochondrial iron overload and oxidative damage"
      }, {
        "text": ", culminating in the multisystem neurodegenerative disorder, Friedreich ataxia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[G"
      }, {
        "text": "AA Repeat Expansion in FXN Gene] --\u003e B(‚Üì Frataxin Protein); B --\u003e C(Mitochondrial Iron"
      }, {
        "text": " Overload \u0026 Oxidative Stress); C --\u003e D(Cell Death in Neurons, Cardiomyocytes, Pancreatic Œ≤-cells); D --\u003e E"
      }, {
        "text": "(Friedreich Ataxia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "deficiency_causes\",\n        \"to\": \"39bc1763\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_involved_in\",\n        \"to\": \"mitochondrial_iron"
      }, {
        "text": "_metabolism\"\n      },\n      {\n        \"type\": \"gene_has_repeat_expansion_in\",\n        \""
      }, {
        "text": "to\": \"39bc1763\"\n      }\n    ]\n  },\n  \"1"
      }, {
        "text": "e7ec644\": {\n    \"title\": \"Free Nerve Endings\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Hist"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Sensory Receptors\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eFree nerve endings\u003c/b\u003e are unencapsulated, branching terminations of sensory nerve fibers found throughout the body"
      }, {
        "text": ", particularly in the skin, cornea, and pulp of teeth. They are the most common type of nerve ending and are responsible for detecting"
      }, {
        "text": " pain (nociception) and temperature (thermoception).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure"
      }, {
        "text": ":\u003c/b\u003e Simple, unencapsulated dendritic endings of sensory neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediate the sensations"
      }, {
        "text": " of \u003cmark\u003epain and temperature\u003c/mark\u003e. They are also involved in crude touch.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFiber Types:\u003c/b\u003e The"
      }, {
        "text": " signals are transmitted by two main types of nerve fibers:\u003cbr\u003e - \u003cb\u003eAŒ¥ fibers:\u003c/b\u003e Thinly myelinated, fast"
      }, {
        "text": "-conducting fibers that transmit sharp, well-localized \u0027fast\u0027 pain and cold sensation.\u003cbr\u003e - \u003cb\u003eC fibers"
      }, {
        "text": ":\u003c/b\u003e Unmyelinated, slow-conducting fibers that transmit dull, aching, poorly-localized \u0027slow\u0027 pain"
      }, {
        "text": " and warmth sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Abundant in the epidermis and cornea, but also found in most other body"
      }, {
        "text": " tissues.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate free nerve endings with the primary sensations of pain and temperature, and"
      }, {
        "text": " remember the two different fiber types (fast AŒ¥ and slow C) that carry these signals.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eFree nerve endings\u003c/b\u003e are the body\u0027s primary detectors for noxious and thermal stimuli, acting as simple but crucial"
      }, {
        "text": " sensors that alert the nervous system to potential or actual tissue damage through the sensations of pain and temperature.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"sensory_receptor\"\n      },\n      {\n        \"type\": \"detects"
      }, {
        "text": "\",\n        \"to\": \"pain\"\n      },\n      {\n        \"type\": \"detects\","
      }, {
        "text": "\n        \"to\": \"temperature\"\n      },\n      {\n        \"type\": \"transmits_signals_via\",\n        "
      }, {
        "text": "\"to\": \"a_delta_fibers\"\n      },\n      {\n        \"type\": \"trans"
      }, {
        "text": "mits_signals_via\",\n        \"to\": \"c_fibers\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"d72bc844\": {\n    \"title\": \"Fried Egg Cells\",\n    \"primaryType\":"
      }, {
        "text": " \"pathology\",\n    \"tags\": [\n      \"Neuropathology\",\n      \"Oncology\",\n      \"Histology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " term \u003cb\u003e\\\"fried egg\\\" cells\u003c/b\u003e is a classic histological description for the appearance of cells in an \u003cmark\u003eoligodendroglioma"
      }, {
        "text": "\u003c/mark\u003e. These cells have a round, central nucleus (the \u0027yolk\u0027) surrounded by a clear halo of cytoplasm ("
      }, {
        "text": "the \u0027egg white\u0027).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Round cells"
      }, {
        "text": " with a dark, central nucleus and a clear cytoplasmic halo. This appearance is an artifact of tissue processing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Tumor"
      }, {
        "text": ":\u003c/b\u003e The pathognomonic histological feature of an \u003cmark\u003eoligodendroglioma\u003c/mark\u003e, a primary"
      }, {
        "text": " CNS tumor derived from [[a24f9747|oligodendrocytes]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Features of"
      }, {
        "text": " Oligodendroglioma:\u003c/b\u003e These tumors often have a delicate network of branching capillaries, described as a \u0027chicken-wire\u0027 pattern,"
      }, {
        "text": " and are frequently calcified.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther \u0027Fried Egg\u0027 Appearances:\u003c/b\u003e The term is also used to"
      }, {
        "text": " describe other cells in pathology, such as koilocytes in HPV infection and the cells of a seminoma. In the context of neuropath"
      }, {
        "text": "ology, it refers to oligodendroglioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A brain tumor biopsy showing \u0027"
      }, {
        "text": "fried egg\u0027 cells and a \u0027chicken-wire\u0027 capillary pattern is diagnostic for an oligodendroglioma.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e\u0027fried egg\u0027 appearance\u003c/b\u003e is the memorable histological signature"
      }, {
        "text": " of an oligodendroglioma, created by a processing artifact that leaves the tumor cells with a clear cytoplasm surrounding a central nucleus"
      }, {
        "text": ", resembling a sunny-side-up egg.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_histological_feature_of\",\n        \"to\": \"oligodend"
      }, {
        "text": "roglioma\"\n      },\n      {\n        \"type\": \"is_a_histological_feature_of\","
      }, {
        "text": "\n        \"to\": \"seminoma\"\n      },\n      {\n        \"type\": \"is_a_histological_"
      }, {
        "text": "feature_of\",\n        \"to\": \"koilocytes\"\n      }\n    ]\n  },\n"
      }, {
        "text": "  \"39bc1763\": {\n    \"title\": \"Friedreich Ataxia\",\n    \"primary"
      }, {
        "text": "Type\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n"
      }, {
        "text": "      \"Cardiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neuro"
      }, {
        "text": "degenerative Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFriedreich ataxia"
      }, {
        "text": "\u003c/b\u003e is an autosomal recessive neurodegenerative disorder characterized by progressive gait and limb ataxia, dysarthria, and loss of proprio"
      }, {
        "text": "ception and vibration sense. It is the most common hereditary ataxia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGen"
      }, {
        "text": "etics:\u003c/b\u003e Caused by an expansion of a \u003cmark\u003eGAA trinucleotide repeat\u003c/mark\u003e in an"
      }, {
        "text": " intron of the \u003ci\u003eFXN\u003c/i\u003e gene on chromosome 9. This leads to reduced expression of the mitochondrial protein \u003cmark\u003e[["
      }, {
        "text": "fc5e9480|frataxin]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Fr"
      }, {
        "text": "ataxin deficiency causes mitochondrial iron overload and oxidative stress, leading to degeneration of multiple spinal cord tracts (dorsal columns, cortic"
      }, {
        "text": "ospinal, spinocerebellar), dorsal root ganglia, and the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Manifestations:\u003c/b\u003e Progressive gait and"
      }, {
        "text": " limb [[9767fd6b|ataxia]], dysarthria, loss of deep tendon reflexes (due"
      }, {
        "text": " to dorsal root ganglia degeneration), and an extensor plantar response (Babinski sign, due to corticospinal tract damage"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Manifestations:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCardiac:\u003c/b\u003e \u003cmark\u003eHypertrophic cardiomyopathy\u003c/mark"
      }, {
        "text": "\u003e is the most common cause of death.\u003cbr\u003e - \u003cb\u003eEndocrine:\u003c/b\u003e Diabetes mellitus.\u003cbr\u003e - \u003cb\u003eS"
      }, {
        "text": "keletal:\u003c/b\u003e Kyphoscoliosis and foot deformities (\u003cmark\u003epes cavus\u003c/mark\u003e, hammer toes).\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic for Friedreich Ataxia: \u003cb\u003eF\u003c/b\u003erataxin is deficient, \u003cb\u003eA\u003c/b\u003etax"
      }, {
        "text": "ic (G\u003cb\u003eAA\u003c/b\u003e), \u003cb\u003eA\u003c/b\u003eutosomal recessive. The combination of neurological symptoms (ataxia, loss"
      }, {
        "text": " of reflexes) with hypertrophic cardiomyopathy and skeletal deformities is classic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFried"
      }, {
        "text": "reich ataxia\u003c/b\u003e is a multisystem disorder caused by a GAA repeat expansion leading to frataxin deficiency and mitochondrial dysfunction, which manifests"
      }, {
        "text": " as a devastating combination of progressive neurodegeneration (ataxia), hypertrophic cardiomyopathy, and diabetes.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[GAA Repeat Expansion] --\u003e B(‚Üì Frataxin); B --\u003e C(Mitochondrial Dysfunction);"
      }, {
        "text": " C --\u003e D(Spinal Cord \u0026 Cerebellar Degeneration); D --\u003e E(Ataxia); C --\u003e F(Card"
      }, {
        "text": "iomyocyte Damage); F --\u003e G(Hypertrophic Cardiomyopathy); C --\u003e H(Pancreatic Œ≤-cell Damage); H --\u003e I("
      }, {
        "text": "Diabetes Mellitus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused"
      }, {
        "text": "_by_deficiency_of\",\n        \"to\": \"fc5e9480\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"has_inheritance_pattern\",\n        \"to\": \"autosomal_recessive\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_associated_with\",\n        \"to\": \"hypertrophic_cardiomyopathy\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"presents_with\",\n        \"to\": \"9767fd6b\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"5ddbdcd3\": {\n    \"title\": \""
      }, {
        "text": "Frontal Eye Fields (FEF)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n"
      }, {
        "text": "    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eFrontal Eye Fields ("
      }, {
        "text": "FEF)\u003c/b\u003e are a region of the prefrontal cortex (Brodmann area 8) responsible for planning and initiating"
      }, {
        "text": " voluntary, saccadic eye movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Located in the middle"
      }, {
        "text": " frontal gyrus of the frontal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Controls voluntary, conjugate eye movements to the \u003cmark\u003econtralateral\u003c/"
      }, {
        "text": "mark\u003e side. For example, the left FEF drives the eyes to the right.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e The FE"
      }, {
        "text": "F projects to the contralateral paramedian pontine reticular formation (PPRF), the brainstem\u0027s horizontal gaze center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ion Effects:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDestructive Lesion (e.g., stroke):\u003c/b\u003e Causes a temporary"
      }, {
        "text": " gaze deviation \u003cmark\u003e\u003cu\u003etoward\u003c/u\u003e the side of the lesion\u003c/mark\u003e. This is because the contralateral, intact"
      }, {
        "text": " FEF is unopposed and drives the eyes toward the damaged side.\u003cbr\u003e - \u003cb\u003eIrritative Lesion (e.g"
      }, {
        "text": "., seizure):\u003c/b\u003e Causes the eyes to deviate \u003cmark\u003e\u003cu\u003eaway\u003c/u\u003e from the side of the lesion\u003c/mark\u003e,"
      }, {
        "text": " as the hyperactive FEF drives the eyes to the contralateral side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction"
      }, {
        "text": " of eye deviation is a key localizing sign. Remember: FEF lesion \u003d eyes look \u003cb\u003etoward\u003c/b\u003e the \u0027"
      }, {
        "text": "bad\u0027 side. PPRF lesion \u003d eyes look \u003cb\u003eaway\u003c/b\u003e from the \u0027bad\u0027 side.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eFrontal Eye Fields\u003c/b\u003e are the cortical command center for voluntary eye movements, with each hemisphere driving"
      }, {
        "text": " the eyes to the opposite side; a destructive lesion here results in the unopposed action of the healthy hemisphere, causing the eyes to \u0027"
      }, {
        "text": "look at the lesion\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Left FEF] --"
      }, {
        "text": "Activates--\u003e B(Right PPRF); B --\u003e C(Gaze to the Right); D[Right FEF] --"
      }, {
        "text": "Activates--\u003e E(Left PPRF); E --\u003e F(Gaze to the Left);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"040"
      }, {
        "text": "5ada3\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"s"
      }, {
        "text": "accadic_eye_movements\"\n      },\n      {\n        \"type\": \"destructive_lesion_causes\","
      }, {
        "text": "\n        \"to\": \"ipsilateral_gaze_deviation\"\n      },\n      {\n        \"type\": \"projects"
      }, {
        "text": "_to\",\n        \"to\": \"pprf\"\n      }\n    ]\n  },\n  \"04"
      }, {
        "text": "05ada3\": {\n    \"title\": \"Frontal Lobe\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eFrontal Lobe\u003c/b\u003e is"
      }, {
        "text": " the largest of the four major lobes of the cerebral cortex in the brain of mammals, located at the front of each cerebral hemisphere. It is responsible"
      }, {
        "text": " for higher-level executive functions, motor control, and speech production.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary"
      }, {
        "text": " Motor Cortex (Precentral Gyrus):\u003c/b\u003e Controls voluntary movements of the contralateral side of the body. Organized somatotopically (motor"
      }, {
        "text": " homunculus).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePremotor Cortex \u0026 Supplementary Motor Area:\u003c/b\u003e Involved in planning and sequencing movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[["
      }, {
        "text": "5ddbdcd3|Frontal Eye Fields (FEF)]]:\u003c/b\u003e Control voluntary eye movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[a"
      }, {
        "text": "3bbace2|Broca\u0027s Area]]:\u003c/b\u003e Located in the inferior frontal gyrus of the dominant hemisphere,"
      }, {
        "text": " responsible for speech production.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrefrontal Cortex:\u003c/b\u003e The large anterior portion of the frontal lobe responsible for \u003c"
      }, {
        "text": "mark\u003eexecutive functions\u003c/mark\u003e: planning, decision-making, working memory, personality expression, and moderating social behavior.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Damage to the frontal lobe can cause contralateral paralysis ([[830c856c"
      }, {
        "text": "|ACA stroke]] -\u003e leg; [[143bb23d|MCA stroke]] -\u003e arm/face),"
      }, {
        "text": " expressive aphasia (Broca\u0027s), and profound changes in personality and social conduct (frontal lobe syndrome).\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Frontal lobe lesions are classically associated with personality changes, disinhibition, and deficits in executive function"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eFrontal Lobe\u003c/b\u003e is the brain\u0027s \u0027CEO"
      }, {
        "text": ",\u0027 orchestrating voluntary movement, producing language, and governing the complex executive functions that define personality and guide goal-directed behavior.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "part_of\",\n        \"to\": \"a1b198f9\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"contains\",\n        \"to\": \"primary_motor_cortex\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"contains\",\n        \"to\": \"5ddbdcd3\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"a3bbace"
      }, {
        "text": "2\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"4c1bee62\",\n    \"letter\": \"F\",\n    \"term\": \"Frontal lobe syndrome\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Frontal lobe syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"5fff42cd\",\n    \"letter\": \"F\",\n    \"term\": \"Frontotemporal dementia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Frontotemporal dementia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0facc404\",\n        \"letter\": \"F\",\n        \"term\": \"symptoms and histologic findings\",\n        \"pages\": [\n          \"535\"\n        ],\n        \"context\": \"Frontotemporal dementia \u003e symptoms and histologic findings\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b187d387\",\n    \"letter\": \"F\",\n    \"term\": \"Funduscopic examination\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Funduscopic examination\",\n    \"sub_entries\": [\n      {\n        \"id\": \"dc2e1448\",\n        \"letter\": \"F\",\n        \"term\": \"with glaucoma\",\n        \"pages\": [\n          \"551\"\n        ],\n        \"context\": \"Funduscopic examination \u003e with glaucoma\"\n      },\n      {\n        \"id\": \"9bb1d7fa\",\n        \"letter\": \"F\",\n        \"term\": \"with retinal disorders\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"Funduscopic examination \u003e with retinal disorders\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5aa5cb91\",\n    \"letter\": \"G\",\n    \"term\": \"GABA (Œ≥-aminobutyric acid)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"GABA (Œ≥-aminobutyric acid)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a42507b2\",\n        \"letter\": \"G\",\n        \"term\": \"basal ganglia and\",\n        \"pages\": [\n          \"511\"\n        ],\n        \"context\": \"GABA (Œ≥-aminobutyric acid) \u003e basal ganglia and\"\n      },\n      {\n        \"id\": \"643d9b10\",\n        \"letter\": \"G\",\n        \"term\": \"multiple sclerosis treatment\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"GABA (Œ≥-aminobutyric acid) \u003e multiple sclerosis treatment\"\n      },\n      {\n        \"id\": \"5df72cfe\",\n        \"letter\": \"G\",\n        \"term\": \"synthesis and change with diseases\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"GABA (Œ≥-aminobutyric acid) \u003e synthesis and change with diseases\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c032a9b2\",\n    \"letter\": \"G\",\n    \"term\": \"GABAA action\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"GABAA action\",\n    \"sub_entries\": [\n      {\n        \"id\": \"9eab749f\",\n        \"letter\": \"G\",\n        \"term\": \"barbiturates\",\n        \"pages\": [\n          \"561\"\n        ],\n        \"context\": \"GABAA action \u003e barbiturates\"\n      },\n      {\n        \"id\": \"130e4649\",\n        \"letter\": \"G\",\n        \"term\": \"benzodiazepine effects\",\n        \"pages\": [\n          \"562\"\n        ],\n        \"context\": \"GABAA action \u003e benzodiazepine effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"57eb8e27\",\n    \"letter\": \"G\",\n    \"term\": \"Gabapentin\",\n    \"pages\": [\n      \"560\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Gabapentin\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f608d2b0\",\n    \"letter\": \"G\",\n    \"term\": \"Gabapentinoids, mechanism and\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Gabapentinoids, mechanism and\",\n    \"sub_entries\": [\n      {\n        \"id\": \"d1245946\",\n        \"letter\": \"G\",\n        \"term\": \"adverse effects\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Gabapentinoids, mechanism and \u003e adverse effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5b6bd754\",\n    \"letter\": \"G\",\n    \"term\": \"Gag reflex\",\n    \"pages\": [\n      \"519\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Gag reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"5ad54943\",\n    \"letter\": \"G\",\n    \"term\": \"Gait disturbance\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Gait disturbance\",\n    \"sub_entries\": [\n      {\n        \"id\": \"67163b5e\",\n        \"letter\": \"G\",\n        \"term\": \"Friedreich ataxia\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Gait disturbance \u003e Friedreich ataxia\"\n      },\n      {\n        \"id\": \"dd379552\",\n        \"letter\": \"G\",\n        \"term\": \"hydrocephalus\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Gait disturbance \u003e hydrocephalus\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5e7a2664\",\n    \"letter\": \"G\",\n    \"term\": \"Galant reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Galant reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f65cf0b9\",\n    \"letter\": \"G\",\n    \"term\": \"Galantamine\",\n    \"pages\": [\n      \"239\",\n      \"564\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Galantamine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"bd9c9b17\",\n    \"letter\": \"G\",\n    \"term\": \"Gaze palsy, upward/vertical\",\n    \"pages\": [\n      \"542\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Gaze palsy, upward/vertical\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2e7554b7\",\n    \"letter\": \"G\",\n    \"term\": \"Generalized seizures\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Generalized seizures\",\n    \"sub_entries\": [\n      {\n        \"id\": \"cbac79c2\",\n        \"letter\": \"G\",\n        \"term\": \"anticonvulsants for\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Generalized seizures \u003e anticonvulsants for\"\n      },\n      {\n        \"id\": \"54a24cbe\",\n        \"letter\": \"G\",\n        \"term\": \"types of\",\n        \"pages\": [\n          \"531\"\n        ],\n        \"context\": \"Generalized seizures \u003e types of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"f42f6526\",\n    \"letter\": \"G\",\n    \"term\": \"Geriatric patients\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Geriatric patients\",\n    \"sub_entries\": [\n      {\n        \"id\": \"2e37e715\",\n        \"letter\": \"G\",\n        \"term\": \"aging-related hearing loss\",\n        \"pages\": [\n          \"548\"\n        ],\n        \"context\": \"Geriatric patients \u003e aging-related hearing loss\"\n      },\n      {\n        \"id\": \"e25f2266\",\n        \"letter\": \"G\",\n        \"term\": \"aneurysm risk\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Geriatric patients \u003e aneurysm risk\"\n      },\n      {\n        \"id\": \"ce1cf94f\",\n        \"letter\": \"G\",\n        \"term\": \"causes of seizures\",\n        \"pages\": [\n          \"531\"\n        ],\n        \"context\": \"Geriatric patients \u003e causes of seizures\"\n      },\n      {\n        \"id\": \"05d875c5\",\n        \"letter\": \"G\",\n        \"term\": \"impaired accommodation in\",\n        \"pages\": [\n          \"550\"\n        ],\n        \"context\": \"Geriatric patients \u003e impaired accommodation in\"\n      },\n      {\n        \"id\": \"b20a7586\",\n        \"letter\": \"G\",\n        \"term\": \"recurrent lobar hemorrhagic stroke\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Geriatric patients \u003e recurrent lobar hemorrhagic stroke\"\n      }\n    ]\n  },\n  {\n    \"id\": \"38f3ed1f\",\n    \"letter\": \"G\",\n    \"term\": \"Gerstmann syndrome\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Gerstmann syndrome\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2506
    }, {
      "text": "```json\n{\n  \"4c1bee62\": {\n    \"title\": \"Frontal Lobe Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFrontal lobe syndrome\u003c/b\u003e refers to a clinical syndrome resulting from damage to the prefrontal cortex of the [[0405ada3|frontal lobe]], leading to profound changes in personality, social behavior, and executive function.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by lesions affecting the prefrontal cortex, such as traumatic brain injury (e.g., Phineas Gage), tumors, stroke, or neurodegenerative diseases like [[5fff42cd|frontotemporal dementia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Features:\u003c/b\u003e The specific symptoms depend on the area of the prefrontal cortex affected:\u003cbr\u003e - \u003cb\u003eDisinhibition:\u003c/b\u003e Damage to the orbitofrontal cortex leads to impulsive, socially inappropriate behavior, poor judgment, and emotional lability.\u003cbr\u003e - \u003cb\u003eApathy:\u003c/b\u003e Damage to the medial frontal cortex can cause abulia (lack of motivation) or akinetic mutism.\u003cbr\u003e - \u003cb\u003eExecutive Dysfunction:\u003c/b\u003e Damage to the dorsolateral prefrontal cortex impairs planning, problem-solving, working memory, and concentration.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimitive Reflexes:\u003c/b\u003e Lesions can lead to the re-emergence of primitive reflexes (e.g., grasp, rooting) due to loss of cortical inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a dramatic personality change, becoming impulsive and socially inappropriate after a head injury, is a classic presentation of frontal lobe syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFrontal lobe syndrome\u003c/b\u003e is the clinical manifestation of damage to the brain\u0027s \u0027CEO,\u0027 the prefrontal cortex, resulting in a loss of executive control and a breakdown of the personality and social filters that govern appropriate behavior.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"0405ada3\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"5fff42cd\"\n      }\n    ]\n  },\n  \"5fff42cd\": {\n    \"title\": \"Frontotemporal Dementia (FTD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFrontotemporal Dementia (FTD)\u003c/b\u003e, formerly known as Pick disease, is a group of neurodegenerative disorders characterized by the progressive atrophy of the frontal and/or temporal lobes. It is a common cause of early-onset dementia (before age 65).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Variants:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eBehavioral Variant (bvFTD):\u003c/b\u003e The most common form. Presents with early and prominent changes in \u003cmark\u003epersonality, social conduct, and behavior\u003c/mark\u003e (e.g., apathy, disinhibition, compulsive behaviors). This is a classic [[4c1bee62|frontal lobe syndrome]].\u003cbr\u003e - \u003cb\u003ePrimary Progressive Aphasia (PPA):\u003c/b\u003e Presents with a progressive decline in language abilities.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistopathology:\u003c/b\u003e Characterized by the presence of intracellular inclusions. In some cases, these are hyperphosphorylated tau proteins forming round aggregates known as \u003cmark\u003ePick bodies\u003c/mark\u003e. In other cases, the inclusions are ubiquitinated TDP-43 protein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI or CT shows focal atrophy of the frontal and/or temporal lobes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Alzheimer\u0027s:\u003c/b\u003e FTD is distinguished from [[77ae6148|Alzheimer disease]] by the early prominence of behavioral or language deficits, with relative sparing of memory and visuospatial skills in the initial stages.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient in their 50s or 60s with a dramatic change in personality (e.g., becoming socially inappropriate or apathetic) but with preserved memory is the classic vignette for behavioral variant FTD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFrontotemporal Dementia\u003c/b\u003e is a neurodegenerative disease that selectively attacks the frontal and temporal lobes, leading to a devastating loss of personality, social grace, and language, while initially sparing the memory functions typically lost in Alzheimer\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Frontal \u0026 Temporal Lobe Atrophy] --\u003e B{FTD Variants}; B --\u003e C(Behavioral Variant - Personality Change); B --\u003e D(Primary Progressive Aphasia - Language Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"has_histological_finding\",\n        \"to\": \"pick_bodies\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"4c1bee62\"\n      }\n    ]\n  },\n  \"b187d387\": {\n    \"title\": \"Funduscopic Examination\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Diagnostics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003efunduscopic examination\u003c/b\u003e (or ophthalmoscopy) is a routine part of a physical exam that involves visualizing the fundus of the eye, which includes the retina, optic disc, macula, and retinal vessels. It provides a direct, non-invasive view of the central nervous system\u0027s vasculature and parenchyma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e Used to detect and evaluate a wide range of ocular and systemic diseases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Structures Visualized:\u003c/b\u003e Optic disc, retinal arteries and veins, macula, and fovea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFindings in Glaucoma:\u003c/b\u003e In [[3ce6c035|glaucoma]], the exam may reveal \u003cmark\u003eoptic disc cupping\u003c/mark\u003e, which is an enlargement of the cup-to-disc ratio due to the loss of optic nerve fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFindings in Retinal Disorders:\u003c/b\u003e Can identify numerous pathologies, including:\u003cbr\u003e - [[73b00ab0|Diabetic retinopathy]]: Microaneurysms, hemorrhages, exudates, neovascularization.\u003cbr\u003e - [[549b012e|Hypertensive retinopathy]]: AV nicking, cotton-wool spots, hemorrhages.\u003cbr\u003e - [[c63255c8|Macular degeneration]]: [[3f8bff66|Drusen]] (dry) or hemorrhage (wet).\u003cbr\u003e - [[3334840f|CRAO]]: Cherry-red spot.\u003cbr\u003e - [[b69e35b5|CRVO]]: \u0027Blood and thunder\u0027 appearance.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePapilledema:\u003c/b\u003e Swelling of the optic disc with blurred margins, a sign of increased intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to recognize the classic funduscopic findings of common systemic diseases like diabetes and hypertension, as well as ophthalmologic emergencies like CRAO and papilledema.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003efunduscopic examination\u003c/b\u003e is a powerful diagnostic tool, offering a unique \u0027window\u0027 into the health of both the eye and the body\u0027s microvasculature, revealing signs of diseases ranging from glaucoma and diabetes to life-threatening increased intracranial pressure.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        \"type\": \"is_used_to_diagnose\",\n        \"to\": \"papilledema\"\n      }\n    ]\n  },\n  \"5aa5cb91\": {\n    \"title\": \"GABA (Œ≥-Aminobutyric Acid)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGamma-aminobutyric acid (GABA)\u003c/b\u003e is the primary \u003ci\u003einhibitory neurotransmitter\u003c/i\u003e in the mature central nervous system. Its principal role is to reduce neuronal excitability throughout the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized from glutamate by the enzyme glutamate decarboxylase, which requires vitamin B\u003csub\u003e6\u003c/sub\u003e (pyridoxine) as a cofactor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGABA\u003csub\u003eA\u003c/sub\u003e:\u003c/b\u003e An ionotropic receptor (ligand-gated Cl\u003csup\u003e-\u003c/sup\u003e channel). Binding of GABA causes an influx of Cl\u003csup\u003e-\u003c/sup\u003e, leading to hyperpolarization of the neuron.\u003cbr\u003e - \u003cb\u003eGABA\u003csub\u003eB\u003c/sub\u003e:\u003c/b\u003e A metabotropic receptor (G protein-coupled). Activation opens K\u003csup\u003e+\u003c/sup\u003e channels and closes Ca\u003csup\u003e2+\u003c/sup\u003e channels, also leading to hyperpolarization.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e The GABA\u003csub\u003eA\u003c/sub\u003e receptor is a major target for many CNS depressant drugs, including [[14464617|benzodiazepines]], [[52564aea|barbiturates]], and alcohol. [[1ddc3f08|Baclofen]] is a GABA\u003csub\u003eB\u003c/sub\u003e agonist used to treat spasticity in [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e A deficiency of GABA is implicated in [[d1c786e9|anxiety disorders]] and [[64c08e92|epilepsy]]. A profound loss of GABAergic neurons in the striatum is the hallmark of [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that GABA is the main \u0027brake\u0027 of the CNS. Drugs that enhance GABA\u0027s effect are depressants, while a loss of GABAergic neurons leads to hyperkinetic disorders like Huntington\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGABA\u003c/b\u003e is the brain\u0027s universal inhibitory signal, acting primarily through GABA\u003csub\u003eA\u003c/sub\u003e receptors to open chloride channels and quiet neuronal firing, a mechanism that is therapeutically enhanced by anxiolytics and sedatives.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Glutamate] --Glutamate Decarboxylase (B6)--\u003e B(GABA); B --\u003e C(Binds to GABA Receptors); C --\u003e D(‚Üë Cl- influx or ‚Üë K+ efflux); D --\u003e E(Hyperpolarization); E --\u003e F(Inhibition of Neuron);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_the_primary\",\n        \"to\": \"inhibitory_neurotransmitter\"\n      },\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        \"type\": \"is_decreased_in\",\n        \"to\": \"d1c786e9\"\n      },\n      {\n        \"type\": \"receptor_is_target_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"receptor_is_target_of\",\n        \"to\": \"52564aea\"\n      }\n    ]\n  },\n  \"c032a9b2\": {\n    \"title\": \"GABA-A Receptor Action\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurophysiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"General Principles\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGABA\u003csub\u003eA\u003c/sub\u003e receptor\u003c/b\u003e is an ionotropic receptor and ligand-gated chloride channel that is the primary target for the inhibitory neurotransmitter GABA. Its action is allosterically modulated by several classes of drugs, including benzodiazepines and barbiturates.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e A pentameric transmembrane protein that forms a central chloride (Cl\u003csup\u003e-\u003c/sup\u003e) ion channel.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGABA Action:\u003c/b\u003e When GABA binds to the receptor, the channel opens, allowing Cl\u003csup\u003e-\u003c/sup\u003e to flow into the neuron, causing hyperpolarization and making it less likely to fire an action potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[14464617|Benzodiazepine]] Action:\u003c/b\u003e Bind to an allosteric site on the receptor and increase the \u003cmark\u003e\u003cu\u003efrequency\u003c/u\u003e\u003c/mark\u003e of channel opening in the presence of GABA.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[52564aea|Barbiturate]] Action:\u003c/b\u003e Bind to a different allosteric site and increase the \u003cmark\u003e\u003cu\u003eduration\u003c/u\u003e\u003c/mark\u003e of channel opening in the presence of GABA. At high concentrations, barbiturates can directly open the channel even without GABA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e \u003cb\u003eFre\u003c/b\u003enzodiazepines increase \u003cb\u003efre\u003c/b\u003equency. Barbi\u003cb\u003edurates\u003c/b\u003e increase \u003cb\u003eduration\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The different mechanisms of action explain the different safety profiles. Benzodiazepines have a ceiling effect on CNS depression because they require GABA to be present. Barbiturates do not, making their overdose much more likely to be fatal.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eGABA\u003csub\u003eA\u003c/sub\u003e receptor\u0027s\u003c/b\u003e inhibitory action is fine-tuned by allosteric modulators: benzodiazepines make the chloride channel open more often, while barbiturates make it stay open longer, with both leading to enhanced CNS depression.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[GABA] --\u003e B(Binds to GABA-A Receptor); B --\u003e C(Cl- Channel Opens); D[Benzodiazepines] --Increase Frequency--\u003e C; E[Barbiturates] --Increase Duration--\u003e C;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_receptor_for\",\n        \"to\": \"5aa5cb91\"\n      },\n      {\n        \"type\": \"is_modulated_by\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"is_modulated_by\",\n        \"to\": \"52564aea\"\n      }\n    ]\n  },\n  \"57eb8e27\": {\n    \"title\": \"Gabapentin\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGabapentin\u003c/b\u003e is an anticonvulsant medication that is structurally related to the neurotransmitter GABA. Despite its name, it does not act on GABA receptors but is primarily used for the treatment of neuropathic pain and as an adjunctive therapy for focal seizures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The primary mechanism is believed to be the inhibition of voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels, specifically by binding to the Œ±\u003csub\u003e2\u003c/sub\u003eŒ¥-1 subunit. This reduces the release of excitatory neurotransmitters like glutamate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNeuropathic Pain:\u003c/b\u003e First-line agent for various types of neuropathic pain, including diabetic neuropathy and postherpetic neuralgia.\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e Used as an adjunctive therapy for [[953ad620|focal seizures]].\u003cbr\u003e - \u003cb\u003eOther:\u003c/b\u003e Also used for [[919caff2|restless legs syndrome]] and fibromyalgia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e It is a gabapentinoid, along with pregabalin, which shares a similar mechanism and clinical use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are sedation, dizziness, and ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Do not be fooled by the name; gabapentin does not work on GABA receptors. Its main use is for neuropathic pain, not as a primary anticonvulsant.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGabapentin\u003c/b\u003e is a widely prescribed medication for neuropathic pain that works by inhibiting calcium channels to dampen the release of excitatory neurotransmitters, despite its name misleadingly suggesting a direct interaction with the GABA system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"f608d2b0\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"953ad620\"\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"voltage_gated_calcium_channels\"\n      }\n    ]\n  },\n  \"f608d2b0\": {\n    \"title\": \"Gabapentinoids\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGabapentinoids\u003c/b\u003e are a class of drugs that includes [[57eb8e27|gabapentin]] and pregabalin. They are structurally related to GABA but exert their effects by binding to voltage-gated calcium channels, not GABA receptors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to the Œ±\u003csub\u003e2\u003c/sub\u003eŒ¥-1 subunit of presynaptic voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels in the CNS. This binding reduces the influx of calcium into the presynaptic terminal, which in turn decreases the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgents:\u003c/b\u003e [[57eb8e27|Gabapentin]] and Pregabalin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used for \u003cmark\u003eneuropathic pain\u003c/mark\u003e (e.g., diabetic neuropathy, postherpetic neuralgia), fibromyalgia, and as adjunctive therapy for [[953ad620|focal seizures]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common dose-dependent side effects are \u003cmark\u003esedation, dizziness, and ataxia\u003c/mark\u003e. Peripheral edema can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key mechanism is the inhibition of presynaptic calcium channels, leading to reduced neurotransmitter release. This is a distinct mechanism from most other anticonvulsants.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGabapentinoids\u003c/b\u003e are a class of drugs that calm hyperexcitable neurons by \u0027turning down the volume\u0027 on neurotransmitter release, achieved by blocking presynaptic calcium channels, making them effective for both neuropathic pain and seizures.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Gabapentinoid] --\u003e B(Binds to Œ±2Œ¥-1 subunit of Ca2+ channel); B --\u003e C(‚Üì Ca2+ Influx); C --\u003e D(‚Üì Release of Excitatory Neurotransmitters); D --\u003e E(Analgesia \u0026 Anticonvulsant Effect);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"57eb8e27\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"pregabalin\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"voltage_gated_calcium_channels\"\n      }\n    ]\n  },\n  \"5b6bd754\": {\n    \"title\": \"Gag Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGag Reflex\u003c/b\u003e is a protective reflex involving a bilateral contraction of the pharyngeal muscles, elicited by touching the posterior pharynx, tonsils, or base of the tongue. It serves to prevent foreign objects from entering the throat.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e Tests the integrity of a brainstem reflex arc involving cranial nerves IX and X.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Limb (Sensation):\u003c/b\u003e The touch sensation from the posterior pharynx is carried by the \u003cmark\u003eglossopharyngeal nerve (CN IX)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb (Motor):\u003c/b\u003e The motor response (elevation of the palate, contraction of the pharyngeal muscles) is carried out by the \u003cmark\u003evagus nerve (CN X)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e An absent or diminished gag reflex indicates a lesion in either CN IX, CN X, or the medulla oblongata. It is a sign of \u003cmark\u003ebulbar dysfunction\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e A diminished gag reflex is seen in [[901f3180|bulbar palsy]] and brainstem strokes like the \u003cmark\u003elateral medullary syndrome\u003c/mark\u003e (which affects the nucleus ambiguus, the motor nucleus for CN IX and X).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple pathway: Sensation \u0027in\u0027 via CN IX, motor action \u0027out\u0027 via CN X.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eGag Reflex\u003c/b\u003e is a crucial brainstem reflex that relies on CN IX to sense a stimulus in the throat and CN X to execute the protective muscular contraction, making its absence a key indicator of lower cranial nerve or medullary pathology.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Touch Posterior Pharynx] --\u003e B(Afferent: CN IX); B --\u003e C(Medulla); C --\u003e D(Efferent: CN X); D --\u003e E(Pharyngeal Muscle Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\": \"glossopharyngeal_nerve\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"901f3180\"\n      },\n      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"lateral_medullary_syndrome\"\n      }\n    ]\n  },\n  \"5ad54943\": {\n    \"title\": \"Gait Disturbance\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Gait Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGait disturbance\u003c/b\u003e is an abnormality in the manner of walking. The pattern of the gait abnormality can provide important clues to the location and nature of the underlying neurological or musculoskeletal pathology.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAtaxic Gait:\u003c/b\u003e Unsteady and wide-based, often described as \u0027drunken.\u0027 Caused by cerebellar dysfunction ([[39bc1763|Friedreich ataxia]], alcohol intoxication) or sensory ataxia ([[71daebd6|tabes dorsalis]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpastic Gait:\u003c/b\u003e Stiff, shuffling, with feet scraping the floor. Seen in UMN lesions (e.g., cerebral palsy, spinal cord injury).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSteppage Gait (Foot Drop):\u003c/b\u003e Inability to dorsiflex the foot, causing the patient to lift the leg high to avoid tripping. Caused by common peroneal nerve palsy or L5 radiculopathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParkinsonian Gait:\u003c/b\u003e Shuffling with short steps (festinating), stooped posture, and difficulty initiating movement. Seen in [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[eb32eb82|Gait Apraxia]] (\u0027Magnetic Gait\u0027):\u003c/b\u003e Feet appear \u0027stuck to the floor.\u0027 The patient has difficulty initiating steps despite normal motor power. A classic sign of [[7c59030e|normal pressure hydrocephalus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Be able to recognize the descriptions of different gait patterns and associate them with their classic underlying causes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGait disturbance\u003c/b\u003e is a highly informative neurological sign, with the specific pattern of walking‚Äîbe it ataxic, spastic, shuffling, or magnetic‚Äîoffering a window into the location of the underlying pathology, from the peripheral nerves to the cerebellum and cerebral cortex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"39bc1763\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"7c59030e\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"eb32eb82\"\n      }\n    ]\n  },\n  \"5e7a2664\": {\n    \"title\": \"Galant Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGalant reflex\u003c/b\u003e, also known as the truncal incurvation reflex, is a primitive reflex found in newborns. It is elicited by stroking the skin along one side of the infant\u0027s spine, which causes the infant to laterally flex their lower body toward the stimulated side.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e The infant is held in ventral suspension (face down). The examiner strokes the skin along one side of the spine from the shoulder to the hip.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response:\u003c/b\u003e The infant\u0027s trunk and hips curve toward the side of the stimulus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Present at birth and typically disappears by 4 to 6 months of age.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is one of several primitive reflexes tested in the newborn neurological exam to assess brainstem and spinal cord integrity. An absent or asymmetric response may indicate a spinal cord lesion or other neurological injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Galant reflex is a normal finding in a newborn. Its persistence beyond 6 months or its absence at birth can be a sign of CNS dysfunction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eGalant reflex\u003c/b\u003e is a primitive spinal reflex in newborns that demonstrates the integrity of the spinal cord arc, where a unilateral tactile stimulus triggers a corresponding lateral flexion of the trunk.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex\"\n      }\n    ]\n  },\n  \"f65cf0b9\": {\n    \"title\": \"Galantamine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGalantamine\u003c/b\u003e is a reversible [[0835ea01|cholinesterase inhibitor]] used for the symptomatic treatment of mild to moderate [[77ae6148|Alzheimer disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Reversibly inhibits acetylcholinesterase (AChE), increasing the concentration of [[6a005559|acetylcholine]] in the brain. It also has a secondary action as a positive allosteric modulator of nicotinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRationale for Use:\u003c/b\u003e [[77ae6148|Alzheimer disease]] is associated with a significant loss of cholinergic neurons, and galantamine aims to enhance the function of the remaining neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Provides modest, symptomatic improvement in cognitive function in some patients with mild to moderate [[77ae6148|Alzheimer disease]]. It does not alter the course of the underlying disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Primarily cholinergic side effects, including nausea, vomiting, diarrhea, and dizziness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Agents:\u003c/b\u003e [[47d0372e|Donepezil]] and rivastigmine are other cholinesterase inhibitors used for Alzheimer\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Along with donepezil and rivastigmine, galantamine is a first-line symptomatic treatment for Alzheimer\u0027s, based on the cholinergic hypothesis of the disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGalantamine\u003c/b\u003e is a cholinesterase inhibitor that provides a modest cognitive boost in Alzheimer\u0027s disease by increasing acetylcholine levels, thereby supporting the function of the brain\u0027s dwindling cholinergic system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0835ea01\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"bd9c9b17\": {\n    \"title\": \"Upward Gaze Palsy\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eUpward gaze palsy\u003c/b\u003e (or vertical gaze palsy) is the inability to voluntarily move the eyes upward. It is the hallmark sign of \u003cmark\u003eParinaud syndrome\u003c/mark\u003e (dorsal midbrain syndrome).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the dorsal midbrain, specifically compressing the superior colliculus and the vertical gaze center located there.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e The primary component of Parinaud syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Palsy.\u003c/b\u003e\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils react poorly to light but constrict to accommodation.\u003cbr\u003e3. \u003cb\u003e[[3db2e75e|Convergence-Retraction Nystagmus]]:\u003c/b\u003e Jerky movements of the eyes on attempted upgaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e In children, a \u003cmark\u003epinealoma\u003c/mark\u003e is the classic cause. In adults, causes include stroke of the midbrain or hydrocephalus causing pressure on the tectum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The inability to look up, especially in a child or young adult, should immediately raise suspicion for a pineal region tumor causing Parinaud syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eUpward gaze palsy\u003c/b\u003e is a definitive localizing sign, pointing to a lesion in the dorsal midbrain that has disrupted the vertical gaze center, and is the most prominent feature of Parinaud syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"parinaud_syndrome\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"pinealoma\"\n      }\n    ]\n  },\n  \"2e7554b7\": {\n    \"title\": \"Generalized Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGeneralized seizures\u003c/b\u003e are a type of seizure that originates at some point within, and rapidly engages, bilaterally distributed neural networks. Consciousness is typically impaired from the onset.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes of Generalized Seizures:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eTonic-Clonic (Grand Mal):\u003c/b\u003e The most well-known type. Begins with a tonic phase (stiffening) followed by a clonic phase (rhythmic jerking). Associated with loss of consciousness and a postictal state.\u003cbr\u003e - \u003cb\u003e[[a0c128f4|Absence (Petit Mal)]]:\u003c/b\u003e Brief episodes of staring and impaired awareness, with a 3 Hz spike-and-wave EEG pattern.\u003cbr\u003e - \u003cb\u003eMyoclonic:\u003c/b\u003e Sudden, brief, shock-like muscle jerks.\u003cbr\u003e - \u003cb\u003e[[ed7a236f|Atonic (\u0027Drop\u0027 Seizures)]]:\u003c/b\u003e Sudden loss of muscle tone, causing a fall.\u003cbr\u003e - \u003cb\u003eTonic:\u003c/b\u003e Sustained muscle stiffening.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Require \u003cmark\u003e[[4dff096f|broad-spectrum anticonvulsants]]\u003c/mark\u003e that are effective against multiple seizure types, such as [[valproic_acid|valproic acid]], [[08d19a8f|lamotrigine]], or [[2341f9c0|levetiracetam]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindicated Drugs:\u003c/b\u003e Narrow-spectrum agents like [[eddd2bc5|carbamazepine]] and [[5aea213f|phenytoin]] can worsen certain generalized seizures, particularly absence and myoclonic seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature of generalized seizures is the immediate involvement of both hemispheres, leading to an abrupt loss of consciousness at the start of the event.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGeneralized seizures\u003c/b\u003e represent a widespread electrical storm involving both cerebral hemispheres from the outset, leading to an immediate loss of consciousness and diverse motor manifestations, requiring treatment with broad-spectrum anticonvulsants.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"ed7a236f\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"4dff096f\"\n      }\n    ]\n  },\n  \"f42f6526\": {\n    \"title\": \"Geriatric Patients (Neurological Considerations)\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Geriatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Geriatrics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGeriatric patients\u003c/b\u003e experience a number of age-related physiological changes and have a different spectrum of neurological diseases compared to younger adults. These considerations are critical for diagnosis and management.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCommon Neurological Conditions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eStroke:\u003c/b\u003e Incidence increases dramatically with age. [[c5da3c57|Ischemic stroke]] is the most common cause of seizures in the elderly.\u003cbr\u003e - \u003cb\u003eDementia:\u003c/b\u003e [[77ae6148|Alzheimer disease]] and [[99420dce|vascular dementia]] are highly prevalent.\u003cbr\u003e - \u003cb\u003e[[58c8ea03|Parkinson Disease]]:\u003c/b\u003e A neurodegenerative movement disorder of older age.\u003cbr\u003e - \u003cb\u003eHearing Loss:\u003c/b\u003e [[presbycusis|Presbycusis]] (age-related sensorineural hearing loss) is extremely common.\u003cbr\u003e - \u003cb\u003eVision Changes:\u003c/b\u003e [[85f03b02|Cataracts]], [[c63255c8|age-related macular degeneration]], and [[presbyopia]] (loss of accommodation) are nearly universal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAneurysm Risk:\u003c/b\u003e The risk of both [[a9f6d703|saccular aneurysm]] rupture and [[70b266c8|intraparenchymal hemorrhage]] (from CAA or hypertension) increases with age.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When presented with an elderly patient with a new neurological symptom, the differential diagnosis is heavily weighted towards stroke, neurodegeneration, and malignancy. Also, be mindful of polypharmacy and altered drug metabolism in this population.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neurology of \u003cb\u003egeriatric patients\u003c/b\u003e is dominated by the \u0027D\u0027s\u0027‚Äî\u003cb\u003eD\u003c/b\u003eegeneration (Alzheimer\u0027s, Parkinson\u0027s), \u003cb\u003eD\u003c/b\u003eeprivation of blood flow (stroke), and \u003cb\u003eD\u003c/b\u003eecreased sensory function (presbycusis, macular degeneration)‚Äîrequiring a distinct diagnostic approach compared to younger populations.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"has_increased_risk_for\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"has_increased_risk_for\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"has_increased_risk_for\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"commonly_experiences\",\n        \"to\": \"presbycusis\"\n      }\n    ]\n  },\n  \"38f3ed1f\": {\n    \"title\": \"Gerstmann Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGerstmann syndrome\u003c/b\u003e is a neurological disorder characterized by a specific tetrad of cognitive deficits, resulting from a lesion in the dominant (usually left) inferior parietal lobule, specifically the angular gyrus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e \u003cmark\u003eDominant inferior parietal lobule\u003c/mark\u003e (angular gyrus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Tetrad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[13d6bca7|Agraphia]]:\u003c/b\u003e Inability to write.\u003cbr\u003e2. \u003cb\u003e[[8558c64b|Acalculia]]:\u003c/b\u003e Inability to perform simple mathematical calculations.\u003cbr\u003e3. \u003cb\u003e[[c88383fe|Finger Agnosia]]:\u003c/b\u003e Inability to identify or distinguish one\u0027s own fingers.\u003cbr\u003e4. \u003cb\u003eLeft-Right Disorientation:\u003c/b\u003e Inability to distinguish left from right.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by a [[c5da3c57|stroke]] in the territory of the \u003cmark\u003e[[143bb23d|Middle Cerebral Artery (MCA)]]\u003c/mark\u003e that supplies the dominant parietal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of all four components of this tetrad is highly specific for a lesion in the dominant angular gyrus. If you see a patient who can\u0027t write, do math, or tell their fingers apart, think Gerstmann syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGerstmann syndrome\u003c/b\u003e is a unique cognitive syndrome where a single lesion in the dominant angular gyrus disrupts a cluster of seemingly unrelated higher-order functions‚Äîwriting, calculation, finger identification, and left-right orientation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion in Dominant Angular Gyrus] --\u003e B(Gerstmann Syndrome); B --\u003e C(Agraphia); B --\u003e D(Acalculia); B --\u003e E(Finger Agnosia); B --\u003e F(Left-Right Disorientation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"13d6bca7\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"8558c64b\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"c88383fe\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9816,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"4c1bee62\": {\n    \"title\": \"Frontal L"
      }, {
        "text": "obe Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eFrontal lobe syndrome\u003c/b\u003e refers to a clinical syndrome resulting from damage"
      }, {
        "text": " to the prefrontal cortex of the [[0405ada3|frontal lobe]], leading to profound changes in personality, social behavior, and"
      }, {
        "text": " executive function.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by lesions"
      }, {
        "text": " affecting the prefrontal cortex, such as traumatic brain injury (e.g., Phineas Gage), tumors, stroke, or neurodegenerative diseases like"
      }, {
        "text": " [[5fff42cd|frontotemporal dementia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Features:\u003c/b\u003e The specific symptoms depend on the area"
      }, {
        "text": " of the prefrontal cortex affected:\u003cbr\u003e - \u003cb\u003eDisinhibition:\u003c/b\u003e Damage to the orbitofrontal cortex leads to impulsive"
      }, {
        "text": ", socially inappropriate behavior, poor judgment, and emotional lability.\u003cbr\u003e - \u003cb\u003eApathy:\u003c/b\u003e Damage to the medial frontal"
      }, {
        "text": " cortex can cause abulia (lack of motivation) or akinetic mutism.\u003cbr\u003e - \u003cb\u003eExecutive Dysfunction:\u003c/b\u003e Damage"
      }, {
        "text": " to the dorsolateral prefrontal cortex impairs planning, problem-solving, working memory, and concentration.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimitive"
      }, {
        "text": " Reflexes:\u003c/b\u003e Lesions can lead to the re-emergence of primitive reflexes (e.g., grasp, rooting)"
      }, {
        "text": " due to loss of cortical inhibition.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a dramatic personality change, becoming impulsive"
      }, {
        "text": " and socially inappropriate after a head injury, is a classic presentation of frontal lobe syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eFrontal lobe syndrome\u003c/b\u003e is the clinical manifestation of damage to the brain\u0027s \u0027CEO,\u0027"
      }, {
        "text": " the prefrontal cortex, resulting in a loss of executive control and a breakdown of the personality and social filters that govern appropriate"
      }, {
        "text": " behavior.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_caused_by_lesion_in\",\n        \"to\": \"0405ada3\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\":"
      }, {
        "text": " \"5fff42cd\"\n      }\n    ]\n  },\n  \"5fff42cd\": {"
      }, {
        "text": "\n    \"title\": \"Frontotemporal Dementia (FTD)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Geriatrics"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eFrontotemporal Dementia (FTD)\u003c/b\u003e, formerly known as Pick disease, is a group of neurodegenerative disorders"
      }, {
        "text": " characterized by the progressive atrophy of the frontal and/or temporal lobes. It is a common cause of early-onset dementia ("
      }, {
        "text": "before age 65).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Variants:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eBehavioral Variant (bvFTD):\u003c/b\u003e The most common form. Presents with early and prominent"
      }, {
        "text": " changes in \u003cmark\u003epersonality, social conduct, and behavior\u003c/mark\u003e (e.g., apathy, disinhibition, compulsive"
      }, {
        "text": " behaviors). This is a classic [[4c1bee62|frontal lobe syndrome]].\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Primary Progressive Aphasia (PPA):\u003c/b\u003e Presents with a progressive decline in language abilities.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistopathology"
      }, {
        "text": ":\u003c/b\u003e Characterized by the presence of intracellular inclusions. In some cases, these are hyperphosphorylated tau proteins forming round"
      }, {
        "text": " aggregates known as \u003cmark\u003ePick bodies\u003c/mark\u003e. In other cases, the inclusions are ubiquitinated TDP-4"
      }, {
        "text": "3 protein.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI or CT shows focal atrophy of the frontal and/or temporal lobes.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eDifferentiation from Alzheimer\u0027s:\u003c/b\u003e FTD is distinguished from [[77ae6148|Alz"
      }, {
        "text": "heimer disease]] by the early prominence of behavioral or language deficits, with relative sparing of memory and visuospatial skills in the initial"
      }, {
        "text": " stages.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient in their 50s or 60s with"
      }, {
        "text": " a dramatic change in personality (e.g., becoming socially inappropriate or apathetic) but with preserved memory is the classic vignette"
      }, {
        "text": " for behavioral variant FTD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFrontotemporal Dementia\u003c/b\u003e is a"
      }, {
        "text": " neurodegenerative disease that selectively attacks the frontal and temporal lobes, leading to a devastating loss of personality, social grace, and language"
      }, {
        "text": ", while initially sparing the memory functions typically lost in Alzheimer\u0027s disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Frontal \u0026 Temporal Lobe Atrophy] --\u003e B{FTD Variants}; B --\u003e C("
      }, {
        "text": "Behavioral Variant - Personality Change); B --\u003e D(Primary Progressive Aphasia - Language Loss);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"differentiated"
      }, {
        "text": "_from\",\n        \"to\": \"77ae6148\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"has_histological_finding\",\n        \"to\": \"pick_bodies\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"causes\",\n        \"to\": \"4c1bee62\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"b187d387\": {\n    \"title\": \"Fundusc"
      }, {
        "text": "opic Examination\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ophthalmology\",\n      "
      }, {
        "text": "\"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Diagnostics\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003efunduscopic examination\u003c/b\u003e (or ophthalmoscopy) is a"
      }, {
        "text": " routine part of a physical exam that involves visualizing the fundus of the eye, which includes the retina, optic disc, mac"
      }, {
        "text": "ula, and retinal vessels. It provides a direct, non-invasive view of the central nervous system\u0027s vasculature and parenchyma"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e Used to detect and evaluate a wide range of ocular"
      }, {
        "text": " and systemic diseases.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Structures Visualized:\u003c/b\u003e Optic disc, retinal arteries and veins, macula, and f"
      }, {
        "text": "ovea.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFindings in Glaucoma:\u003c/b\u003e In [[3ce6c035|glaucoma]], the exam"
      }, {
        "text": " may reveal \u003cmark\u003eoptic disc cupping\u003c/mark\u003e, which is an enlargement of the cup-to-disc ratio due"
      }, {
        "text": " to the loss of optic nerve fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFindings in Retinal Disorders:\u003c/b\u003e Can identify numerous pathologies, including:\u003c"
      }, {
        "text": "br\u003e - [[73b00ab0|Diabetic retinopathy]]: Microaneurysms, hemorrhages,"
      }, {
        "text": " exudates, neovascularization.\u003cbr\u003e - [[549b012e|Hypertensive retinopathy]]: AV"
      }, {
        "text": " nicking, cotton-wool spots, hemorrhages.\u003cbr\u003e - [[c63255c8|Mac"
      }, {
        "text": "ular degeneration]]: [[3f8bff66|Drusen]] (dry) or hemorrhage (wet).\u003cbr\u003e - [["
      }, {
        "text": "3334840f|CRAO]]: Cherry-red spot.\u003cbr\u003e - [[b6"
      }, {
        "text": "9e35b5|CRVO]]: \u0027Blood and thunder\u0027 appearance.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePapilledema:"
      }, {
        "text": "\u003c/b\u003e Swelling of the optic disc with blurred margins, a sign of increased intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Be able to recognize the classic funduscopic findings of common systemic diseases like diabetes and hypertension, as well as ophthalmologic"
      }, {
        "text": " emergencies like CRAO and papilledema.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003efunduscopic examination\u003c/b\u003e is"
      }, {
        "text": " a powerful diagnostic tool, offering a unique \u0027window\u0027 into the health of both the eye and the body\u0027s microvas"
      }, {
        "text": "culature, revealing signs of diseases ranging from glaucoma and diabetes to life-threatening increased intracranial pressure.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_used_to_diagnose\","
      }, {
        "text": "\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"is_used_"
      }, {
        "text": "to_diagnose\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_used_to_diagnose\",\n        \"to\": \"papilledema\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"5aa5cb91\": {\n    \"title\": \"GABA (Œ≥"
      }, {
        "text": "-Aminobutyric Acid)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGamma-aminobutyric acid (GABA)"
      }, {
        "text": "\u003c/b\u003e is the primary \u003ci\u003einhibitory neurotransmitter\u003c/i\u003e in the mature central nervous system. Its principal role is to reduce"
      }, {
        "text": " neuronal excitability throughout the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synt"
      }, {
        "text": "hesized from glutamate by the enzyme glutamate decarboxylase, which requires vitamin B\u003csub\u003e6\u003c/sub\u003e (pyridoxine) as a"
      }, {
        "text": " cofactor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGABA\u003csub\u003eA\u003c/sub\u003e:\u003c/b\u003e An ionotropic receptor"
      }, {
        "text": " (ligand-gated Cl\u003csup\u003e-\u003c/sup\u003e channel). Binding of GABA causes an influx of Cl\u003csup\u003e-\u003c/sup\u003e, leading"
      }, {
        "text": " to hyperpolarization of the neuron.\u003cbr\u003e - \u003cb\u003eGABA\u003csub\u003eB\u003c/sub\u003e:\u003c/b\u003e A metabotropic receptor"
      }, {
        "text": " (G protein-coupled). Activation opens K\u003csup\u003e+\u003c/sup\u003e channels and closes Ca\u003csup\u003e2+\u003c/sup\u003e channels, also leading to hyperpolarization."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e The GABA\u003csub\u003eA\u003c/sub\u003e receptor is a major target for many CNS depressant drugs, including [["
      }, {
        "text": "14464617|benzodiazepines]], [[52564aea|barbiturates]], and alcohol"
      }, {
        "text": ". [[1ddc3f08|Baclofen]] is a GABA\u003csub\u003eB\u003c/sub\u003e agonist used to treat spasticity in"
      }, {
        "text": " [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e A deficiency of GABA is implicated in [["
      }, {
        "text": "d1c786e9|anxiety disorders]] and [[64c08e92|epilepsy]]. A"
      }, {
        "text": " profound loss of GABAergic neurons in the striatum is the hallmark of [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that GABA is the main \u0027brake\u0027 of the CNS. Drugs that enhance GABA\u0027s effect"
      }, {
        "text": " are depressants, while a loss of GABAergic neurons leads to hyperkinetic disorders like Huntington\u0027s.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eGABA\u003c/b\u003e is the brain\u0027s universal inhibitory signal, acting primarily through GABA"
      }, {
        "text": "\u003csub\u003eA\u003c/sub\u003e receptors to open chloride channels and quiet neuronal firing, a mechanism that is therapeutically enhanced by anxiolytics and sed"
      }, {
        "text": "atives.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Glutamate] --Glutamate Decarboxylase (B"
      }, {
        "text": "6)--\u003e B(GABA); B --\u003e C(Binds to GABA Receptors); C --\u003e D(‚Üë"
      }, {
        "text": " Cl- influx or ‚Üë K+ efflux); D --\u003e E(Hyperpolarization); E --\u003e F(Inhibition of"
      }, {
        "text": " Neuron);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_the_primary"
      }, {
        "text": "\",\n        \"to\": \"inhibitory_neurotransmitter\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_decreased_in\",\n        \"to\": \"ffd7e743\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_decreased_in\",\n        \"to\": \"d1c786e"
      }, {
        "text": "9\"\n      },\n      {\n        \"type\": \"receptor_is_target_of\",\n        \"to\": \"1"
      }, {
        "text": "4464617\"\n      },\n      {\n        \"type\": \"receptor_is_"
      }, {
        "text": "target_of\",\n        \"to\": \"52564aea\"\n      }\n    ]\n  },\n  \"c"
      }, {
        "text": "032a9b2\": {\n    \"title\": \"GABA-A Receptor Action\",\n    \"primary"
      }, {
        "text": "Type\": \"physiology\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurophysiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"General Principles\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eGABA\u003csub\u003eA\u003c/sub\u003e receptor\u003c/b\u003e is an ionotropic receptor and ligand-gated chloride channel that is"
      }, {
        "text": " the primary target for the inhibitory neurotransmitter GABA. Its action is allosterically modulated by several classes of drugs, including benzodiazep"
      }, {
        "text": "ines and barbiturates.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e A pentameric transmembrane"
      }, {
        "text": " protein that forms a central chloride (Cl\u003csup\u003e-\u003c/sup\u003e) ion channel.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGABA Action:\u003c/b\u003e When"
      }, {
        "text": " GABA binds to the receptor, the channel opens, allowing Cl\u003csup\u003e-\u003c/sup\u003e to flow into the neuron, causing hyperpolarization and making"
      }, {
        "text": " it less likely to fire an action potential.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[14464617|Benzodiazepine"
      }, {
        "text": "]] Action:\u003c/b\u003e Bind to an allosteric site on the receptor and increase the \u003cmark\u003e\u003cu\u003efrequency\u003c/u\u003e\u003c/mark\u003e of channel"
      }, {
        "text": " opening in the presence of GABA.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[52564aea|Barbiturate]] Action:\u003c/b\u003e Bind to a"
      }, {
        "text": " different allosteric site and increase the \u003cmark\u003e\u003cu\u003eduration\u003c/u\u003e\u003c/mark\u003e of channel opening in the presence of GABA. At high"
      }, {
        "text": " concentrations, barbiturates can directly open the channel even without GABA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e \u003cb\u003eFre\u003c/b\u003enz"
      }, {
        "text": "odiazepines increase \u003cb\u003efre\u003c/b\u003equency. Barbi\u003cb\u003edurates\u003c/b\u003e increase \u003cb\u003eduration\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The different mechanisms of action explain the different safety profiles. Benzodiazepines have a ceiling effect on CNS depression because they require GABA to be"
      }, {
        "text": " present. Barbiturates do not, making their overdose much more likely to be fatal.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eGABA\u003csub\u003eA\u003c/sub\u003e receptor\u0027s\u003c/b\u003e inhibitory action is fine-tuned by all"
      }, {
        "text": "osteric modulators: benzodiazepines make the chloride channel open more often, while barbiturates make it stay open longer, with"
      }, {
        "text": " both leading to enhanced CNS depression.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[GABA] --\u003e B(B"
      }, {
        "text": "inds to GABA-A Receptor); B --\u003e C(Cl- Channel Opens); D[Benzodiazepines] --Increase"
      }, {
        "text": " Frequency--\u003e C; E[Barbiturates] --Increase Duration--\u003e C;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_receptor_for\",\n        \"to\": \"5aa5cb9"
      }, {
        "text": "1\"\n      },\n      {\n        \"type\": \"is_modulated_by\",\n        \"to"
      }, {
        "text": "\": \"14464617\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_modulated_by\",\n        \"to\": \"52564aea\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"57eb8e27\": {\n    \"title\": \"Gabapentin\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Ant"
      }, {
        "text": "iconvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGab"
      }, {
        "text": "apentin\u003c/b\u003e is an anticonvulsant medication that is structurally related to the neurotransmitter GABA. Despite its name, it does"
      }, {
        "text": " not act on GABA receptors but is primarily used for the treatment of neuropathic pain and as an adjunctive therapy for focal seizures"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The primary mechanism is believed"
      }, {
        "text": " to be the inhibition of voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels, specifically by binding to the Œ±\u003csub\u003e2\u003c/sub\u003e"
      }, {
        "text": "Œ¥-1 subunit. This reduces the release of excitatory neurotransmitters like glutamate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Neuropathic Pain:\u003c/b\u003e First-line agent for various types of neuropathic pain, including diabetic neuropathy and postherpetic neuralgia.\u003cbr\u003e"
      }, {
        "text": " - \u003cb\u003eSeizures:\u003c/b\u003e Used as an adjunctive therapy for [[953ad620|focal seizures]]."
      }, {
        "text": "\u003cbr\u003e - \u003cb\u003eOther:\u003c/b\u003e Also used for [[919caff2|restless legs syndrome]]"
      }, {
        "text": " and fibromyalgia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e It is a gabapentinoid, along with pregabalin, which shares"
      }, {
        "text": " a similar mechanism and clinical use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are sedation, dizziness, and ataxia"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Do not be fooled by the name; gabapentin does not work on GABA receptors. Its main"
      }, {
        "text": " use is for neuropathic pain, not as a primary anticonvulsant.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eGabapentin\u003c/b\u003e is a widely prescribed medication for neuropathic pain that works by inhibiting calcium channels to dampen the release of excitatory neurotransmitters, despite"
      }, {
        "text": " its name misleadingly suggesting a direct interaction with the GABA system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"f608d2b0\"\n      },\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"treats\",\n        \"to\": \"953ad620\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"inhibits\",\n        \"to\": \"voltage_gated_calcium_channels"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"f608d2b0\": {\n    \"title\": \"Gab"
      }, {
        "text": "apentinoids\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eGabapentinoids\u003c/b\u003e are a class of drugs that includes [[57eb8e27|gab"
      }, {
        "text": "apentin]] and pregabalin. They are structurally related to GABA but exert their effects by binding to voltage-gated calcium"
      }, {
        "text": " channels, not GABA receptors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind"
      }, {
        "text": " to the Œ±\u003csub\u003e2\u003c/sub\u003eŒ¥-1 subunit of presynaptic voltage-gated Ca\u003csup\u003e2+\u003c/sup\u003e channels in"
      }, {
        "text": " the CNS. This binding reduces the influx of calcium into the presynaptic terminal, which in turn decreases the release of excitatory neurotransmitters such"
      }, {
        "text": " as glutamate, norepinephrine, and substance P.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgents:\u003c/b\u003e [[57eb8e27|"
      }, {
        "text": "Gabapentin]] and Pregabalin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used for \u003cmark\u003eneuropathic pain\u003c/"
      }, {
        "text": "mark\u003e (e.g., diabetic neuropathy, postherpetic neuralgia), fibromyalgia, and as adjunctive therapy for [[95"
      }, {
        "text": "3ad620|focal seizures]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common dose-dependent"
      }, {
        "text": " side effects are \u003cmark\u003esedation, dizziness, and ataxia\u003c/mark\u003e. Peripheral edema can also occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The key mechanism is the inhibition of presynaptic calcium channels, leading to reduced neurotransmitter release. This is a distinct"
      }, {
        "text": " mechanism from most other anticonvulsants.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGabapentinoids\u003c/b\u003e are a"
      }, {
        "text": " class of drugs that calm hyperexcitable neurons by \u0027turning down the volume\u0027 on neurotransmitter release, achieved by blocking"
      }, {
        "text": " presynaptic calcium channels, making them effective for both neuropathic pain and seizures.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Gabap"
      }, {
        "text": "entinoid] --\u003e B(Binds to Œ±2Œ¥-1 subunit of Ca2+ channel); B --\u003e C(‚Üì"
      }, {
        "text": " Ca2+ Influx); C --\u003e D(‚Üì Release of Excitatory Neurotransmitters); D --\u003e E("
      }, {
        "text": "Analgesia \u0026 Anticonvulsant Effect);\"\n    },\n    \"connections\": [\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"57eb8e27\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"includes\",\n        \"to\": \"pregabalin\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"inhibits\",\n        \"to\": \"voltage_gated_calcium_channels"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"5b6bd754\": {\n    \"title"
      }, {
        "text": "\": \"Gag Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003eThe \u003cb\u003eGag Reflex\u003c/b\u003e is a protective reflex involving a bilateral contraction of the pharyngeal muscles, elicited"
      }, {
        "text": " by touching the posterior pharynx, tonsils, or base of the tongue. It serves to prevent foreign objects from entering the throat"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e Tests the integrity of a brainstem reflex arc"
      }, {
        "text": " involving cranial nerves IX and X.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Limb (Sensation):\u003c/b\u003e The touch sensation from the posterior pharynx is carried by the"
      }, {
        "text": " \u003cmark\u003eglossopharyngeal nerve (CN IX)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfferent Limb (Motor):\u003c/b\u003e The motor"
      }, {
        "text": " response (elevation of the palate, contraction of the pharyngeal muscles) is carried out by the \u003cmark\u003evagus nerve (CN X)\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e An absent or diminished gag reflex indicates a lesion in either CN IX, CN X, or the medulla"
      }, {
        "text": " oblongata. It is a sign of \u003cmark\u003ebulbar dysfunction\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e A"
      }, {
        "text": " diminished gag reflex is seen in [[901f3180|bulbar palsy]] and brainstem strokes"
      }, {
        "text": " like the \u003cmark\u003elateral medullary syndrome\u003c/mark\u003e (which affects the nucleus ambiguus, the motor nucleus for CN IX and"
      }, {
        "text": " X).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the simple pathway: Sensation \u0027in\u0027 via CN IX, motor"
      }, {
        "text": " action \u0027out\u0027 via CN X.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eG"
      }, {
        "text": "ag Reflex\u003c/b\u003e is a crucial brainstem reflex that relies on CN IX to sense a stimulus in the throat and CN X to execute"
      }, {
        "text": " the protective muscular contraction, making its absence a key indicator of lower cranial nerve or medullary pathology.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Touch Posterior Pharynx] --\u003e B(Afferent: CN IX); B --\u003e C(Med"
      }, {
        "text": "ulla); C --\u003e D(Efferent: CN X); D --\u003e E(Pharyngeal Muscle Contraction);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"afferent_limb_is\",\n        \"to\": \"gloss"
      }, {
        "text": "opharyngeal_nerve\"\n      },\n      {\n        \"type\": \"efferent_limb_is\",\n        "
      }, {
        "text": "\"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "absent_in\",\n        \"to\": \"901f3180\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_absent_in\",\n        \"to\": \"lateral_med"
      }, {
        "text": "ullary_syndrome\"\n      }\n    ]\n  },\n  \"5ad54943\": {\n    \"title\":"
      }, {
        "text": " \"Gait Disturbance\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Geriatrics\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Gait Disorders"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGait disturbance\u003c/b\u003e is"
      }, {
        "text": " an abnormality in the manner of walking. The pattern of the gait abnormality can provide important clues to the location and nature of the underlying neurological or"
      }, {
        "text": " musculoskeletal pathology.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAtaxic Gait:\u003c/b\u003e Unsteady and"
      }, {
        "text": " wide-based, often described as \u0027drunken.\u0027 Caused by cerebellar dysfunction ([[39bc1763|Friedreich ataxia"
      }, {
        "text": "]], alcohol intoxication) or sensory ataxia ([[71daebd6|tabes dorsalis]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpastic Gait:\u003c/b\u003e St"
      }, {
        "text": "iff, shuffling, with feet scraping the floor. Seen in UMN lesions (e.g., cerebral palsy, spinal"
      }, {
        "text": " cord injury).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSteppage Gait (Foot Drop):\u003c/b\u003e Inability to dorsiflex the foot, causing the patient"
      }, {
        "text": " to lift the leg high to avoid tripping. Caused by common peroneal nerve palsy or L5 radiculopathy.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePark"
      }, {
        "text": "insonian Gait:\u003c/b\u003e Shuffling with short steps (festinating), stooped posture, and difficulty initiating movement. Seen"
      }, {
        "text": " in [[58c8ea03|Parkinson disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[eb32eb82|Gait Ap"
      }, {
        "text": "raxia]] (\u0027Magnetic Gait\u0027):\u003c/b\u003e Feet appear \u0027stuck to the floor.\u0027 The patient has difficulty initiating steps despite"
      }, {
        "text": " normal motor power. A classic sign of [[7c59030e|normal pressure hydrocephalus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Be able to recognize the descriptions of different gait patterns and associate them with their classic underlying causes.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGait disturbance\u003c/b\u003e is a highly informative neurological sign, with"
      }, {
        "text": " the specific pattern of walking‚Äîbe it ataxic, spastic, shuffling, or magnetic‚Äîoffering a window"
      }, {
        "text": " into the location of the underlying pathology, from the peripheral nerves to the cerebellum and cerebral cortex.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "symptom_of\",\n        \"to\": \"39bc1763\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \""
      }, {
        "text": "7c59030e\"\n      },\n      {\n        \"type\": \"is_a_symptom"
      }, {
        "text": "_of\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"eb32eb82\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"5e7a2664\": {\n    \"title\": \"Galant Reflex\",\n    \""
      }, {
        "text": "primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Physical"
      }, {
        "text": " Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eGalant reflex\u003c/b\u003e, also known as the truncal incurvation reflex, is a primitive reflex found"
      }, {
        "text": " in newborns. It is elicited by stroking the skin along one side of the infant\u0027s spine, which causes the infant to laterally"
      }, {
        "text": " flex their lower body toward the stimulated side.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElic"
      }, {
        "text": "itation:\u003c/b\u003e The infant is held in ventral suspension (face down). The examiner strokes the skin along one side of the"
      }, {
        "text": " spine from the shoulder to the hip.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response:\u003c/b\u003e The infant\u0027s trunk and hips curve toward"
      }, {
        "text": " the side of the stimulus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Present at birth and typically disappears by 4 to 6 months of age.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is one of several primitive reflexes tested in the newborn neurological exam to assess brainstem and spinal cord integrity"
      }, {
        "text": ". An absent or asymmetric response may indicate a spinal cord lesion or other neurological injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The Gal"
      }, {
        "text": "ant reflex is a normal finding in a newborn. Its persistence beyond 6 months or its absence at birth can be a sign of CNS"
      }, {
        "text": " dysfunction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eGalant reflex\u003c/b\u003e is a primitive"
      }, {
        "text": " spinal reflex in newborns that demonstrates the integrity of the spinal cord arc, where a unilateral tactile stimulus triggers a corresponding lateral flexion"
      }, {
        "text": " of the trunk.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"f65cf0b9\": {\n    \"title\": \"Galantamine\",\n    \"primaryType\": \""
      }, {
        "text": "drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Geriatrics\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eGalantamine\u003c/b\u003e is a reversible [[0835ea01|cholinesterase inhibitor"
      }, {
        "text": "]] used for the symptomatic treatment of mild to moderate [[77ae6148|Alzheimer disease]].\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Reversibly inhibits acetylcholinesterase (AChE),"
      }, {
        "text": " increasing the concentration of [[6a005559|acetylcholine]] in the brain. It also has a"
      }, {
        "text": " secondary action as a positive allosteric modulator of nicotinic receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRationale for Use:\u003c/b\u003e [[77ae6148|"
      }, {
        "text": "Alzheimer disease]] is associated with a significant loss of cholinergic neurons, and galantamine aims to enhance the function of the remaining neurons"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Provides modest, symptomatic improvement in cognitive function in some patients with mild to moderate [[77"
      }, {
        "text": "ae6148|Alzheimer disease]]. It does not alter the course of the underlying disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Adverse Effects:\u003c/b\u003e Primarily cholinergic side effects, including nausea, vomiting, diarrhea, and dizziness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Agents:\u003c/b\u003e [["
      }, {
        "text": "47d0372e|Donepezil]] and rivastigmine are other cholinesterase inhibitors used for Alzheimer"
      }, {
        "text": "\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Along with donepezil and rivastigmine, galantamine is a first"
      }, {
        "text": "-line symptomatic treatment for Alzheimer\u0027s, based on the cholinergic hypothesis of the disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Galantamine\u003c/b\u003e is a cholinesterase inhibitor that provides a modest cognitive boost in Alzheimer\u0027s disease by increasing acetylcholine"
      }, {
        "text": " levels, thereby supporting the function of the brain\u0027s dwindling cholinergic system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0"
      }, {
        "text": "835ea01\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"77ae"
      }, {
        "text": "6148\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\":"
      }, {
        "text": " \"6a005559\"\n      }\n    ]\n  },\n  \"bd9"
      }, {
        "text": "c9b17\": {\n    \"title\": \"Upward Gaze Palsy\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eUpward gaze palsy\u003c/b\u003e (or vertical gaze palsy) is the inability to voluntarily move the eyes upward."
      }, {
        "text": " It is the hallmark sign of \u003cmark\u003eParinaud syndrome\u003c/mark\u003e (dorsal midbrain syndrome).\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the dorsal"
      }, {
        "text": " midbrain, specifically compressing the superior colliculus and the vertical gaze center located there.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e The"
      }, {
        "text": " primary component of Parinaud syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Pals"
      }, {
        "text": "y.\u003c/b\u003e\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils react poorly to light but"
      }, {
        "text": " constrict to accommodation.\u003cbr\u003e3. \u003cb\u003e[[3db2e75e|Convergence-Retraction N"
      }, {
        "text": "ystagmus]]:\u003c/b\u003e Jerky movements of the eyes on attempted upgaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e In"
      }, {
        "text": " children, a \u003cmark\u003epinealoma\u003c/mark\u003e is the classic cause. In adults, causes include stroke of"
      }, {
        "text": " the midbrain or hydrocephalus causing pressure on the tectum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The inability to look"
      }, {
        "text": " up, especially in a child or young adult, should immediately raise suspicion for a pineal region tumor causing Parinaud syndrome.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eUpward gaze palsy\u003c/b\u003e is a definitive localizing sign, pointing to"
      }, {
        "text": " a lesion in the dorsal midbrain that has disrupted the vertical gaze center, and is the most prominent feature of Parinaud syndrome.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_sign_of\",\n        \"to\": \"parinaud_syndrome\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to"
      }, {
        "text": "\": \"pinealoma\"\n      }\n    ]\n  },\n  \"2e7554"
      }, {
        "text": "b7\": {\n    \"title\": \"Generalized Seizures\",\n    \"primaryType\": \"disease\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Se"
      }, {
        "text": "izures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGeneralized seizures\u003c/b\u003e"
      }, {
        "text": " are a type of seizure that originates at some point within, and rapidly engages, bilaterally distributed neural networks. Consciousness is typically"
      }, {
        "text": " impaired from the onset.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes of Generalized Seizures:\u003c/b\u003e\u003cbr"
      }, {
        "text": "\u003e - \u003cb\u003eTonic-Clonic (Grand Mal):\u003c/b\u003e The most well-known type. Begins with a tonic"
      }, {
        "text": " phase (stiffening) followed by a clonic phase (rhythmic jerking). Associated with loss of consciousness and a"
      }, {
        "text": " postictal state.\u003cbr\u003e - \u003cb\u003e[[a0c128f4|Absence (Petit Mal)]"
      }, {
        "text": "]:\u003c/b\u003e Brief episodes of staring and impaired awareness, with a 3 Hz spike-and-wave EEG pattern.\u003cbr\u003e - \u003cb\u003eMy"
      }, {
        "text": "oclonic:\u003c/b\u003e Sudden, brief, shock-like muscle jerks.\u003cbr\u003e - \u003cb\u003e[[ed7a"
      }, {
        "text": "236f|Atonic (\u0027Drop\u0027 Seizures)]]:\u003c/b\u003e Sudden loss of muscle tone, causing a"
      }, {
        "text": " fall.\u003cbr\u003e - \u003cb\u003eTonic:\u003c/b\u003e Sustained muscle stiffening.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Require"
      }, {
        "text": " \u003cmark\u003e[[4dff096f|broad-spectrum anticonvulsants]]\u003c/mark\u003e that"
      }, {
        "text": " are effective against multiple seizure types, such as [[valproic_acid|valproic acid]], [[08d"
      }, {
        "text": "19a8f|lamotrigine]], or [[2341f9c0|levetiracetam]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindicated Drugs:\u003c/b\u003e Narrow-spectrum agents like [[eddd2bc5|carbamazepine]] and [[5aea"
      }, {
        "text": "213f|phenytoin]] can worsen certain generalized seizures, particularly absence and myoclonic seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The key feature of generalized seizures is the immediate involvement of both hemispheres, leading to an abrupt loss of consciousness at"
      }, {
        "text": " the start of the event.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGeneralized seizures\u003c/b\u003e represent a widespread electrical storm involving"
      }, {
        "text": " both cerebral hemispheres from the outset, leading to an immediate loss of consciousness and diverse motor manifestations, requiring treatment with broad-spectrum anticonvulsants"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"a0c128f4\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"ed7a236f"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\":"
      }, {
        "text": " \"4dff096f\"\n      }\n    ]\n  },\n  \"f42f"
      }, {
        "text": "6526\": {\n    \"title\": \"Geriatric Patients (Neurological Considerations)\",\n    \"primary"
      }, {
        "text": "Type\": \"concept\",\n    \"tags\": [\n      \"Geriatrics\",\n      \"Neurology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Geriatrics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eGeriatric patients\u003c/b\u003e experience a number of age-related physiological changes and have a different spectrum of neurological diseases"
      }, {
        "text": " compared to younger adults. These considerations are critical for diagnosis and management.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Common Neurological Conditions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eStroke:\u003c/b\u003e Incidence increases dramatically with age. [[c5"
      }, {
        "text": "da3c57|Ischemic stroke]] is the most common cause of seizures in the elderly.\u003cbr\u003e - \u003cb\u003eD"
      }, {
        "text": "ementia:\u003c/b\u003e [[77ae6148|Alzheimer disease]] and [[99420d"
      }, {
        "text": "ce|vascular dementia]] are highly prevalent.\u003cbr\u003e - \u003cb\u003e[[58c8ea03|Park"
      }, {
        "text": "inson Disease]]:\u003c/b\u003e A neurodegenerative movement disorder of older age.\u003cbr\u003e - \u003cb\u003eHearing Loss:\u003c/b\u003e [[pres"
      }, {
        "text": "bycusis|Presbycusis]] (age-related sensorineural hearing loss) is extremely common.\u003cbr\u003e - \u003cb\u003eVision"
      }, {
        "text": " Changes:\u003c/b\u003e [[85f03b02|Cataracts]], [[c63255c8|age"
      }, {
        "text": "-related macular degeneration]], and [[presbyopia]] (loss of accommodation) are nearly universal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eA"
      }, {
        "text": "neurysm Risk:\u003c/b\u003e The risk of both [[a9f6d703|saccular aneurysm]] rupture and [[70"
      }, {
        "text": "b266c8|intraparenchymal hemorrhage]] (from CAA or hypertension) increases with age."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When presented with an elderly patient with a new neurological symptom, the differential diagnosis is"
      }, {
        "text": " heavily weighted towards stroke, neurodegeneration, and malignancy. Also, be mindful of polypharmacy and altered drug metabolism in"
      }, {
        "text": " this population.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neurology of \u003cb\u003egeriatric patients\u003c/b\u003e is dominated"
      }, {
        "text": " by the \u0027D\u0027s\u0027‚Äî\u003cb\u003eD\u003c/b\u003eegeneration (Alzheimer\u0027s, Parkinson\u0027s), \u003cb\u003eD\u003c/b\u003eep"
      }, {
        "text": "rivation of blood flow (stroke), and \u003cb\u003eD\u003c/b\u003eecreased sensory function (presbycusis, macular"
      }, {
        "text": " degeneration)‚Äîrequiring a distinct diagnostic approach compared to younger populations.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"has_increased_risk_for\",\n        \"to\": \"c"
      }, {
        "text": "5da3c57\"\n      },\n      {\n        \"type\": \"has_increased_risk_for\",\n        \"to"
      }, {
        "text": "\": \"77ae6148\"\n      },\n      {\n        \"type\": \"has_"
      }, {
        "text": "increased_risk_for\",\n        \"to\": \"58c8ea03\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"commonly_experiences\",\n        \"to\": \"presbycusis\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"38f3ed1f\": {\n    \"title\":"
      }, {
        "text": " \"Gerstmann Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Lesions\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGerstmann syndrome\u003c/b\u003e is a neurological disorder characterized by a"
      }, {
        "text": " specific tetrad of cognitive deficits, resulting from a lesion in the dominant (usually left) inferior parietal lobule, specifically the angular gyrus.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e \u003cmark\u003eDominant inferior"
      }, {
        "text": " parietal lobule\u003c/mark\u003e (angular gyrus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Tetrad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[["
      }, {
        "text": "13d6bca7|Agraphia]]:\u003c/b\u003e Inability to write.\u003cbr\u003e2. \u003cb\u003e[[8"
      }, {
        "text": "558c64b|Acalculia]]:\u003c/b\u003e Inability to perform simple mathematical calculations.\u003cbr\u003e3. \u003cb\u003e"
      }, {
        "text": "[[c88383fe|Finger Agnosia]]:\u003c/b\u003e Inability to identify or distinguish one\u0027s own fingers.\u003cbr\u003e"
      }, {
        "text": "4. \u003cb\u003eLeft-Right Disorientation:\u003c/b\u003e Inability to distinguish left from right.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most"
      }, {
        "text": " commonly caused by a [[c5da3c57|stroke]] in the territory of the \u003cmark\u003e[["
      }, {
        "text": "143bb23d|Middle Cerebral Artery (MCA)]]\u003c/mark\u003e that supplies the dominant parietal lobe"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of all four components of this tetrad is highly specific for a"
      }, {
        "text": " lesion in the dominant angular gyrus. If you see a patient who can\u0027t write, do math, or tell"
      }, {
        "text": " their fingers apart, think Gerstmann syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGerstmann syndrome\u003c/b\u003e is a unique"
      }, {
        "text": " cognitive syndrome where a single lesion in the dominant angular gyrus disrupts a cluster of seemingly unrelated higher-order functions‚Äîwriting"
      }, {
        "text": ", calculation, finger identification, and left-right orientation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Les"
      }, {
        "text": "ion in Dominant Angular Gyrus] --\u003e B(Gerstmann Syndrome); B --\u003e C(Agraphia); B --\u003e D("
      }, {
        "text": "Acalculia); B --\u003e E(Finger Agnosia); B --\u003e F(Left-Right Disorientation);\"\n"
      }, {
        "text": "    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_les"
      }, {
        "text": "ion_in\",\n        \"to\": \"26efa771\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"13d6bca7\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"includes\",\n        \"to\": \"8558c64b\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"c88383fe\""
      }, {
        "text": "\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"83146d36\",\n    \"letter\": \"W\",\n    \"term\": \"Weakness\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Weakness\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1b0f9086\",\n        \"letter\": \"W\",\n        \"term\": \"motor neuron signs\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Weakness \u003e motor neuron signs\"\n      },\n      {\n        \"id\": \"89576592\",\n        \"letter\": \"W\",\n        \"term\": \"spinal cord lesions\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Weakness \u003e spinal cord lesions\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7053478e\",\n    \"letter\": \"W\",\n    \"term\": \"Weber syndrome\",\n    \"pages\": [\n      \"526\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Weber syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"17c628e2\",\n    \"letter\": \"W\",\n    \"term\": \"Werdnig-Hoffmann disease\",\n    \"pages\": [\n      \"544\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Werdnig-Hoffmann disease\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2c4a6130\",\n    \"letter\": \"W\",\n    \"term\": \"Wernicke (receptive) aphasia\",\n    \"pages\": [\n      \"526\",\n      \"529\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Wernicke (receptive) aphasia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"404a6050\",\n    \"letter\": \"W\",\n    \"term\": \"Wernicke-Korsakoff syndrome\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Wernicke-Korsakoff syndrome\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7c07cfe8\",\n        \"letter\": \"W\",\n        \"term\": \"brain lesions with\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Wernicke-Korsakoff syndrome \u003e brain lesions with\"\n      }\n    ]\n  },\n  {\n    \"id\": \"a3d13743\",\n    \"letter\": \"W\",\n    \"term\": \"White matter\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"White matter\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b587d492\",\n        \"letter\": \"W\",\n        \"term\": \"demyelinating disorders\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"White matter \u003e demyelinating disorders\"\n      },\n      {\n        \"id\": \"d84f654f\",\n        \"letter\": \"W\",\n        \"term\": \"multiple sclerosis\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"White matter \u003e multiple sclerosis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b0fbf22a\",\n    \"letter\": \"W\",\n    \"term\": \"Work of breathing\",\n    \"pages\": [\n      \"682\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Work of breathing\",\n    \"sub_entries\": [\n      {\n        \"id\": \"fe1ab340\",\n        \"letter\": \"W\",\n        \"term\": \"‚ÄúWorst headache of my life‚Äù\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Work of breathing \u003e ‚ÄúWorst headache of my life‚Äù\"\n      }\n    ]\n  },\n  {\n    \"id\": \"e622320e\",\n    \"letter\": \"X\",\n    \"term\": \"Xanthelasma\",\n    \"pages\": [\n      \"305\",\n      \"559\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Xanthelasma\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"5edd272c\",\n    \"letter\": \"Z\",\n    \"term\": \"Zaleplon\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Zaleplon\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f38d516a\",\n    \"letter\": \"Z\",\n    \"term\": \"Zolpidem\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Zolpidem\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"d64b8bec\",\n    \"letter\": \"A\",\n    \"term\": \"Œ±-agonists\",\n    \"pages\": [\n      \"568\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Œ±-agonists\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"bc6647e5\",\n    \"letter\": \"A\",\n    \"term\": \"Œ±2-agonists\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Œ±2-agonists\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e6f6371e\",\n        \"letter\": \"A\",\n        \"term\": \"muscle spasm treatment\",\n        \"pages\": [\n          \"567\"\n        ],\n        \"context\": \"Œ±2-agonists \u003e muscle spasm treatment\"\n      }\n    ]\n  },\n  {\n    \"id\": \"10535992\",\n    \"letter\": \"B\",\n    \"term\": \"Œ≤-blockers\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Œ≤-blockers\",\n    \"sub_entries\": [\n      {\n        \"id\": \"3ca1fcb0\",\n        \"letter\": \"B\",\n        \"term\": \"glaucoma therapy\",\n        \"pages\": [\n          \"244\",\n          \"568\"\n        ],\n        \"context\": \"Œ≤-blockers \u003e glaucoma therapy\"\n      },\n      {\n        \"id\": \"bd4131bc\",\n        \"letter\": \"B\",\n        \"term\": \"migraine headaches\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Œ≤-blockers \u003e migraine headaches\"\n      }\n    ]\n  },\n  {\n    \"id\": \"00e48ea3\",\n    \"letter\": \"B\",\n    \"term\": \"Œ≤-interferon\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Œ≤-interferon\",\n    \"sub_entries\": [\n      {\n        \"id\": \"242b1163\",\n        \"letter\": \"B\",\n        \"term\": \"multiple sclerosis treatment\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Œ≤-interferon \u003e multiple sclerosis treatment\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1893
    }, {
      "text": "```json\n{\n  \"83146d36\": {\n    \"title\": \"Weakness (Motor Neuron Signs)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWeakness\u003c/b\u003e, or paresis, is a reduction in the force exerted by one or more muscles. In neurology, the pattern of weakness and associated signs helps distinguish between an upper motor neuron (UMN) lesion and a lower motor neuron (LMN) lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eUpper Motor Neuron (UMN) Weakness:\u003c/b\u003e Caused by a lesion in the corticospinal tract (e.g., stroke, spinal cord injury). It is characterized by \u003cmark\u003espastic paralysis\u003c/mark\u003e, hyperreflexia, increased tone, and a positive Babinski sign. Weakness is often more pronounced in extensors of the upper limb and flexors of the lower limb.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Motor Neuron (LMN) Weakness:\u003c/b\u003e Caused by a lesion of the anterior horn cells, nerve roots, or peripheral nerves. It is characterized by \u003cmark\u003eflaccid paralysis\u003c/mark\u003e, hyporeflexia, decreased tone, significant muscle atrophy, and fasciculations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Cord Lesions:\u003c/b\u003e The pattern of weakness depends on the tracts involved. For example, an [[b48b54d7|anterior spinal artery occlusion]] causes bilateral LMN weakness at the level of the lesion and UMN weakness below it.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of both UMN and LMN signs in the same patient is the hallmark of [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe character of muscle \u003cb\u003eweakness\u003c/b\u003e is a powerful localizing tool: spasticity and hyperreflexia point to an upper motor neuron lesion, while flaccidity, atrophy, and fasciculations indicate a lower motor neuron lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"spinal_cord_lesion\"\n      }\n    ]\n  },\n  \"7053478e\": {\n    \"title\": \"Weber Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Stroke\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWeber syndrome\u003c/b\u003e, also known as medial midbrain syndrome, is a brainstem stroke syndrome caused by an infarct in the anterior midbrain, affecting the cerebral peduncle and the fibers of the oculomotor nerve (CN III).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e Caused by occlusion of the paramedian branches of the \u003cmark\u003eposterior cerebral artery (PCA)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Damaged:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eCerebral Peduncle:\u003c/b\u003e Contains the descending corticospinal and corticobulbar tracts.\u003cbr\u003e2. \u003cb\u003eOculomotor Nerve (CN III) Fibers:\u003c/b\u003e Emerge from the midbrain between the cerebral peduncles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A classic crossed deficit:\u003cbr\u003e - \u003cmark\u003eIpsilateral CN III palsy:\u003c/mark\u003e The eye is deviated \u0027down and out,\u0027 with ptosis and a dilated pupil.\u003cbr\u003e - \u003cmark\u003eContralateral Hemiplegia/Hemiparesis:\u003c/mark\u003e Weakness of the arm and leg due to corticospinal tract damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of an ipsilateral CN III palsy and contralateral hemiplegia is pathognomonic for Weber syndrome and localizes the lesion to the anterior midbrain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWeber syndrome\u003c/b\u003e is a classic midbrain stroke syndrome that \u0027knocks out\u0027 the oculomotor nerve and the corticospinal tract on one side, resulting in the tell-tale combination of an ipsilateral \u0027down and out\u0027 eye and contralateral body paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PCA Branch Occlusion] --\u003e B(Anterior Midbrain Infarct); B --\u003e C(Ipsilateral CN III Palsy); B --\u003e D(Contralateral Hemiplegia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"brainstem_syndrome\"\n      },\n      {\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"b6a2cc31\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"fdfd22ca\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"hemiplegia\"\n      }\n    ]\n  },\n  \"17c628e2\": {\n    \"title\": \"Werdnig-Hoffmann Disease (SMA Type 1)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWerdnig-Hoffmann disease\u003c/b\u003e, also known as Spinal Muscular Atrophy (SMA) Type 1, is the most severe form of SMA. It is an autosomal recessive disorder characterized by the degeneration of anterior horn cells in the spinal cord, leading to progressive, symmetric muscle weakness and atrophy.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal recessive mutation or deletion in the \u003ci\u003eSMN1\u003c/i\u003e (Survival Motor Neuron 1) gene on chromosome 5.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The SMN protein is essential for the survival of lower motor neurons. Its deficiency leads to apoptosis of anterior horn cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Onset is before 6 months of age. Presents as a \u003cmark\u003e\\\"floppy baby\\\"\u003c/mark\u003e with profound, symmetric hypotonia and flaccid weakness, which is more pronounced proximally than distally. Tongue fasciculations are a characteristic finding.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Milestones:\u003c/b\u003e Infants are never able to sit unsupported.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Without treatment, death from respiratory failure typically occurs before age 2.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Polio:\u003c/b\u003e The pathology (destruction of anterior horn cells) is similar to poliomyelitis, but the cause is genetic, not infectious.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A \u0027floppy infant\u0027 with tongue fasciculations and absent deep tendon reflexes is the classic presentation for Werdnig-Hoffmann disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWerdnig-Hoffmann disease (SMA Type 1)\u003c/b\u003e is a devastating genetic disorder that selectively destroys lower motor neurons, resulting in a \u0027floppy baby\u0027 with progressive paralysis that ultimately leads to respiratory failure in early childhood.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"spinal_muscular_atrophy\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"smn1_gene\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"953e1306\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"hypotonia\"\n      }\n    ]\n  },\n  \"2c4a6130\": {\n    \"title\": \"Wernicke\u0027s Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWernicke\u0027s aphasia\u003c/b\u003e, also known as receptive aphasia, is a language disorder characterized by fluent but meaningless speech and severely impaired language comprehension. It is caused by a lesion in Wernicke\u0027s area.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e \u003cmark\u003eSuperior temporal gyrus\u003c/mark\u003e of the dominant (usually left) hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply:\u003c/b\u003e Supplied by the inferior division of the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFluency:\u003c/b\u003e Speech is fluent and grammatically correct but is nonsensical and contains paraphasic errors and neologisms (made-up words). This is often described as a \u003cmark\u003e\\\"word salad.\\\"\u003c/mark\u003e\u003cbr\u003e - \u003cb\u003eComprehension:\u003c/b\u003e Auditory and reading comprehension are severely impaired.\u003cbr\u003e - \u003cb\u003eRepetition:\u003c/b\u003e Impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Awareness:\u003c/b\u003e Patients are typically unaware of their deficit (anosognosia) and do not become frustrated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Mnemonic: \u003cb\u003eW\u003c/b\u003eernicke\u0027s is \u003cb\u003eW\u003c/b\u003eordy but makes no sense. A lesion in the temporal lobe can also affect the optic radiations (Meyer\u0027s loop), so Wernicke\u0027s aphasia is often associated with a contralateral superior quadrantanopia (\u0027pie in the sky\u0027).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWernicke\u0027s aphasia\u003c/b\u003e is a disorder of language comprehension, where the ability to produce fluent speech is preserved but the content is meaningless, leaving the patient adrift in a sea of incomprehensible language, both incoming and outgoing.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion in Wernicke\u0027s Area] --\u003e B(Impaired Comprehension); B --\u003e C(Fluent but nonsensical speech); A --Spares--\u003e D(Broca\u0027s Area); D --\u003e E(Intact Fluency);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"wernicke_area\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"7f6ed344\"\n      }\n    ]\n  },\n  \"404a6050\": {\n    \"title\": \"Wernicke-Korsakoff Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Nutrition\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cognitive Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWernicke-Korsakoff syndrome\u003c/b\u003e is a spectrum of neurological disease caused by severe thiamine (vitamin B\u003csub\u003e1\u003c/sub\u003e) deficiency. It consists of an acute, reversible phase (Wernicke encephalopathy) and a chronic, often irreversible phase (Korsakoff syndrome).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly seen in the context of \u003cmark\u003echronic alcohol use disorder\u003c/mark\u003e, which leads to poor nutrition, impaired absorption, and altered metabolism of thiamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke Encephalopathy (Acute):\u003c/b\u003e A medical emergency characterized by the classic triad of:\u003cbr\u003e1. \u003cb\u003eEncephalopathy\u003c/b\u003e (confusion, disorientation)\u003cbr\u003e2. \u003cb\u003eOphthalmoplegia\u003c/b\u003e (nystagmus, CN VI palsy, gaze palsies)\u003cbr\u003e3. \u003cb\u003eGait Ataxia\u003c/b\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eKorsakoff Syndrome (Chronic):\u003c/b\u003e Characterized by profound \u003cmark\u003eanterograde and retrograde amnesia\u003c/mark\u003e with \u003cmark\u003econfabulation\u003c/mark\u003e (making up stories to fill in memory gaps). Personality changes are also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Involves damage to the \u003cmark\u003emammillary bodies\u003c/mark\u003e, medial thalamus, and periaqueductal gray matter. Atrophy and hemorrhage in the mammillary bodies are classic findings.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Immediate administration of high-dose IV thiamine. \u003cu\u003eThiamine must be given before glucose\u003c/u\u003e, as glucose administration can precipitate or worsen the encephalopathy by rapidly depleting the remaining thiamine stores.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the triad for Wernicke\u0027s: \u003cb\u003eCAN O\u0027\u003c/b\u003e beer (\u003cb\u003eC\u003c/b\u003eonfusion, \u003cb\u003eA\u003c/b\u003etaxia, \u003cb\u003eN\u003c/b\u003eystagmus, \u003cb\u003eO\u003c/b\u003ephthalmoplegia). Always give thiamine before glucose to an alcoholic or malnourished patient.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWernicke-Korsakoff syndrome\u003c/b\u003e is a preventable neurological catastrophe of thiamine deficiency, progressing from an acute, reversible triad of confusion, ataxia, and ophthalmoplegia to a chronic, irreversible state of profound amnesia and confabulation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thiamine (B1) Deficiency] --\u003e B(Wernicke Encephalopathy - Acute); B --\u003e C(Confusion, Ataxia, Ophthalmoplegia); B --Untreated--\u003e D(Korsakoff Syndrome - Chronic); D --\u003e E(Amnesia, Confabulation); F[Lesion in Mammillary Bodies/Thalamus] \u003c--\u003e D;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"thiamine_deficiency\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"alcohol_use_disorder\"\n      },\n      {\n        \"type\": \"involves_lesion_in\",\n        \"to\": \"f02cfaa1\"\n      }\n    ]\n  },\n  \"a3d13743\": {\n    \"title\": \"White Matter\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Central Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWhite matter\u003c/b\u003e is one of the two components of the central nervous system, consisting mainly of myelinated axons bundled into tracts. Its white appearance is due to the high lipid content of the myelin sheaths.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Primarily composed of myelinated axons, as well as the glial cells that produce the myelin ([[a24f9747|oligodendrocytes]] in the CNS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Transmits nerve signals between different areas of gray matter within the CNS. It forms the communication pathways of the brain and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e In the brain, white matter is generally located deep to the cerebral cortex. In the spinal cord, it surrounds the central butterfly-shaped gray matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDemyelinating Disorders:\u003c/b\u003e Diseases that selectively damage the white matter by destroying myelin are known as demyelinating disorders. The classic example is \u003cmark\u003e[[45dd6d19|multiple sclerosis]]\u003c/mark\u003e, which is characterized by the formation of demyelinating plaques in the CNS white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDysmyelinating Disorders:\u003c/b\u003e Genetic disorders involving the defective formation of myelin (leukodystrophies) also primarily affect the white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Lesions described as being in the \u0027white matter\u0027 on an MRI should immediately bring demyelinating or dysmyelinating disorders to mind.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWhite matter\u003c/b\u003e constitutes the \u0027wiring\u0027 of the central nervous system, a vast network of myelinated axons that provides the high-speed communication infrastructure connecting different processing centers; its integrity is essential for normal neurological function and is the primary target in demyelinating diseases like MS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"myelinated_axons\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"f17ad9a5\"\n      }\n    ]\n  },\n  \"b0fbf22a\": {\n    \"title\": \"Work of Breathing\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pulmonology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Respiratory\",\n      \"Physiology\",\n      \"Lung Mechanics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ework of breathing\u003c/b\u003e is the energy expended to inhale and exhale air. It is the work done by the respiratory muscles to overcome the elastic recoil of the lungs and chest wall, as well as the airway resistance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents of Work:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eElastic Work:\u003c/b\u003e Work required to overcome the elastic forces of the lung and chest wall during inspiration.\u003cbr\u003e2. \u003cb\u003eResistive Work:\u003c/b\u003e Work required to overcome the resistance to airflow in the airways.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIncreased Work in Disease:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eRestrictive Lung Diseases (e.g., fibrosis):\u003c/b\u003e Increased elastic work due to stiff, non-compliant lungs. Patients adopt a rapid, shallow breathing pattern to minimize this work.\u003cbr\u003e - \u003cb\u003eObstructive Lung Diseases (e.g., asthma, COPD):\u003c/b\u003e Increased resistive work due to narrowed airways. Patients adopt a slow, deep breathing pattern to minimize this work.\u003c/li\u003e\u003cli\u003e\u003cb\u003e\u0027Worst Headache of My Life\u0027:\u003c/b\u003e This phrase is the classic description of a [[63f8b05f|subarachnoid hemorrhage]] and is \u003cu\u003enot related\u003c/u\u003e to the work of breathing. The index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand how different lung diseases affect the work of breathing and lead to characteristic breathing patterns. Fibrosis \u003d stiff lungs \u003d high elastic work. Asthma \u003d narrow airways \u003d high resistive work.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ework of breathing\u003c/b\u003e represents the metabolic cost of ventilation, a balance between overcoming the stiffness of the respiratory system and the resistance of the airways, which is pathologically increased in both restrictive and obstructive lung diseases.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_increased_in\",\n        \"to\": \"restrictive_lung_disease\"\n      },\n      {\n        \"type\": \"is_increased_in\",\n        \"to\": \"obstructive_lung_disease\"\n      }\n    ]\n  },\n  \"e622320e\": {\n    \"title\": \"Xanthelasma\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Cardiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"Lipid-Related Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eXanthelasma\u003c/b\u003e (or xanthelasma palpebrarum) is a sharply demarcated, yellowish deposit of cholesterol underneath the skin, usually on or around the eyelids. It is the most common type of xanthoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Soft, yellowish, flat plaques that typically occur on the medial aspects of the upper and lower eyelids.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Composed of lipid-laden macrophages (foam cells) in the dermis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e While they can be idiopathic, xanthelasmas are often a sign of \u003cmark\u003ehyperlipidemia\u003c/mark\u003e, particularly hypercholesterolemia. Their presence should prompt a lipid panel evaluation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Can be seen in familial hypercholesterolemia and other dyslipidemias. Also associated with primary biliary cholangitis, which can cause hypercholesterolemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Xanthelasma is a cutaneous marker for potential underlying hyperlipidemia and increased cardiovascular risk.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eXanthelasma\u003c/b\u003e are benign but cosmetically significant cholesterol deposits on the eyelids that serve as an important external clue to an internal problem‚Äîhyperlipidemia‚Äîand the associated risk of atherosclerotic disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"xanthoma\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"hyperlipidemia\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"familial_hypercholesterolemia\"\n      }\n    ]\n  },\n  \"5edd272c\": {\n    \"title\": \"Zaleplon\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eZaleplon\u003c/b\u003e is a non-benzodiazepine hypnotic agent, known as a \u0027Z-drug,\u0027 used for the short-term treatment of insomnia, particularly for difficulty with sleep onset.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a positive allosteric modulator at the benzodiazepine (BZ\u003csub\u003e1\u003c/sub\u003e) subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, enhancing the inhibitory effects of GABA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-benzodiazepine hypnotic (\u0027Z-drug\u0027), along with zolpidem and eszopiclone.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003every short half-life\u003c/mark\u003e (approximately 1 hour), making it effective for initiating sleep without causing significant next-day sedation or \u0027hangover\u0027 effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used for patients who have trouble \u003cmark\u003efalling asleep\u003c/mark\u003e. It can be taken later in the night if needed, as long as the patient has at least 4 hours remaining for sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Dizziness, headache. Risk of anterograde amnesia and complex sleep behaviors is lower than with longer-acting agents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e Effects can be reversed by \u003cmark\u003eflumazenil\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Zaleplon\u0027s ultra-short half-life is its defining feature, making it ideal for sleep-onset insomnia without affecting the rest of the night\u0027s sleep or the next day.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eZaleplon\u003c/b\u003e is a \u0027Z-drug\u0027 hypnotic with an exceptionally short duration of action, designed to help patients fall asleep quickly without lingering sedative effects, making it a \u0027hit-and-run\u0027 solution for sleep-onset insomnia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"non_benzodiazepine_hypnotic\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n  },\n  \"f38d516a\": {\n    \"title\": \"Zolpidem\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eZolpidem\u003c/b\u003e (trade name Ambien) is a widely prescribed non-benzodiazepine hypnotic agent, or \u0027Z-drug,\u0027 used for the short-term treatment of insomnia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a positive allosteric modulator at the benzodiazepine (BZ\u003csub\u003e1\u003c/sub\u003e) subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, enhancing the inhibitory effects of GABA to induce sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-benzodiazepine hypnotic (\u0027Z-drug\u0027), along with zaleplon and eszopiclone.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a rapid onset and a relatively short half-life (2-3 hours), making it effective for sleep-onset insomnia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ataxia, headaches, confusion. It is particularly known for causing \u003cmark\u003eanterograde amnesia\u003c/mark\u003e and \u003cmark\u003ecomplex sleep-related behaviors\u003c/mark\u003e (e.g., sleepwalking, sleep-driving, sleep-eating), especially at higher doses or when combined with alcohol.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e Effects can be reversed by \u003cmark\u003eflumazenil\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Zolpidem is the prototypical \u0027Z-drug.\u0027 Remember its association with bizarre sleep-related behaviors and the fact that its overdose is treated with flumazenil, just like benzodiazepines.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eZolpidem\u003c/b\u003e is a popular hypnotic that promotes sleep by selectively enhancing GABAergic inhibition, but its use is shadowed by the risk of inducing complex and potentially dangerous sleep-related behaviors for which the user has no memory.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"non_benzodiazepine_hypnotic\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"overdose_treated_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n  },\n  \"d64b8bec\": {\n    \"title\": \"Œ±-Agonists (Ophthalmic)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eŒ±-Adrenergic agonists\u003c/b\u003e are a class of sympathomimetic drugs used topically in ophthalmology to treat glaucoma by lowering intraocular pressure (IOP) or to cause mydriasis for examination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-Agonists (e.g., [[2fcee185|brimonidine]], [[c1f67280|apraclonidine]]):\u003c/b\u003e The primary class used for glaucoma.\u003cbr\u003e - \u003cb\u003eMechanism:\u003c/b\u003e They have a dual mechanism: they \u003cmark\u003edecrease aqueous humor synthesis\u003c/mark\u003e by acting on the ciliary body and \u003cmark\u003eincrease uveoscleral outflow\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eUse:\u003c/b\u003e Long-term management of open-angle glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eŒ±\u003csub\u003e1\u003c/sub\u003e-Agonists (e.g., phenylephrine):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMechanism:\u003c/b\u003e Stimulates the pupillary dilator muscle, causing \u003cmark\u003emydriasis\u003c/mark\u003e (pupil dilation).\u003cbr\u003e - \u003cb\u003eUse:\u003c/b\u003e Used to dilate the pupil for funduscopic examination. \u003cu\u003eContraindicated in angle-closure glaucoma\u003c/u\u003e as mydriasis can further narrow the angle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-selective Agonists (e.g., [[583587cd|epinephrine]]):\u003c/b\u003e Have both Œ± and Œ≤ effects. The Œ±\u003csub\u003e1\u003c/sub\u003e effect decreases aqueous humor production via vasoconstriction of ciliary body vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For glaucoma treatment, think Œ±\u003csub\u003e2\u003c/sub\u003e-agonists (brimonidine, apraclonidine) which decrease aqueous production. For pupillary dilation, think Œ±\u003csub\u003e1\u003c/sub\u003e-agonists (phenylephrine).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eOphthalmic \u003cb\u003eŒ±-agonists\u003c/b\u003e modulate aqueous humor dynamics and pupillary size; Œ±\u003csub\u003e2\u003c/sub\u003e-agonists are the workhorses for glaucoma by reducing fluid production, while Œ±\u003csub\u003e1\u003c/sub\u003e-agonists are used to dilate the pupil for examination.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"2fcee185\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"c1f67280\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"phenylephrine\"\n      }\n    ]\n  },\n  \"bc6647e5\": {\n    \"title\": \"Œ±2-Agonists\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Autonomic\",\n      \"Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-Adrenergic agonists\u003c/b\u003e are a class of sympatholytic drugs that act on presynaptic Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the central and peripheral nervous systems to reduce sympathetic outflow.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stimulate presynaptic Œ±\u003csub\u003e2\u003c/sub\u003e-receptors, which are autoreceptors that provide negative feedback. This inhibits the release of norepinephrine from the nerve terminal, leading to a decrease in sympathetic tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Agents (e.g., Clonidine, Methyldopa):\u003c/b\u003e Used as antihypertensives. They act on central Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the brainstem to reduce sympathetic outflow to the heart and blood vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOphthalmic Agents (e.g., [[2fcee185|brimonidine]], [[c1f67280|apraclonidine]]):\u003c/b\u003e Used for glaucoma. They act on Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the ciliary body to decrease aqueous humor production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle Relaxants (e.g., Tizanidine):\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-agonist used as an antispasmodic to treat spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e-agonists are \u0027sympatho-\u003cu\u003elytic\u003c/u\u003e\u0027 despite being agonists. They stimulate an inhibitory autoreceptor, effectively putting the brakes on the sympathetic nervous system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-Agonists\u003c/b\u003e paradoxically reduce sympathetic activity by stimulating an inhibitory \u0027off-switch\u0027 on presynaptic nerve terminals, a mechanism harnessed to treat conditions of sympathetic excess like hypertension and glaucoma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Œ±2-Agonist] --\u003e B(Stimulates Presynaptic Œ±2-Receptor); B --\u003e C(‚Üì Norepinephrine Release); C --\u003e D(‚Üì Sympathetic Tone);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"clonidine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"2fcee185\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"sympatholytic\"\n      }\n    ]\n  },\n  \"10535992\": {\n    \"title\": \"Œ≤-Blockers (Ophthalmic)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eŒ≤-Blockers\u003c/b\u003e (beta-adrenergic antagonists) are a first-line therapy for open-angle glaucoma, administered as topical eye drops to reduce intraocular pressure (IOP).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Block Œ≤-adrenergic receptors on the ciliary epithelium. This \u003cmark\u003edecreases the production of aqueous humor\u003c/mark\u003e, thereby lowering IOP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgents:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNon-selective (Œ≤\u003csub\u003e1\u003c/sub\u003e and Œ≤\u003csub\u003e2\u003c/sub\u003e):\u003c/b\u003e \u003cmark\u003eTimolol\u003c/mark\u003e, carteolol.\u003cbr\u003e - \u003cb\u003eŒ≤\u003csub\u003e1\u003c/sub\u003e-selective:\u003c/b\u003e \u003cmark\u003e[[43508d57|Betaxolol]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e First-line treatment for [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects are minimal (e.g., stinging). However, systemic absorption can occur, leading to the same side effects as systemic beta-blockers: bradycardia, hypotension, fatigue, and bronchoconstriction (especially with non-selective agents).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Use non-selective beta-blockers with caution in patients with \u003cmark\u003easthma, COPD\u003c/mark\u003e, bradycardia, or heart failure. Œ≤\u003csub\u003e1\u003c/sub\u003e-selective agents like [[43508d57|betaxolol]] are safer in patients with pulmonary disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For migraine prophylaxis, systemic beta-blockers like propranolol are used. For glaucoma, topical beta-blockers like timolol are used. The mechanism in glaucoma is decreased aqueous humor production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eTopical \u003cb\u003eŒ≤-blockers\u003c/b\u003e are a mainstay of glaucoma therapy, working by \u0027turning down the tap\u0027 on aqueous humor production in the ciliary body, but their potential for systemic absorption requires caution in patients with cardiac or pulmonary disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Topical Œ≤-Blocker] --\u003e B(Blocks Œ≤-Receptors on Ciliary Epithelium); B --\u003e C(‚Üì Aqueous Humor Production); C --\u003e D(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"timolol\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"43508d57\"\n      },\n      {\n        \"type\": \"is_used_for_prophylaxis_of\",\n        \"to\": \"c8833bae\"\n      }\n    ]\n  },\n  \"00e48ea3\": {\n    \"title\": \"Interferon-Œ≤\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Multiple Sclerosis Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eInterferon-Œ≤ (IFN-Œ≤)\u003c/b\u003e is a cytokine of the interferon family that is used as a first-line disease-modifying therapy for the treatment of relapsing forms of [[45dd6d19|multiple sclerosis (MS)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism in MS is not fully understood, but IFN-Œ≤ has both antiviral and immunomodulatory effects. It is thought to work by shifting the cytokine profile from a pro-inflammatory (Th1) to an anti-inflammatory (Th2) state, and by reducing the migration of inflammatory cells across the blood-brain barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A cornerstone of treatment for relapsing-remitting [[45dd6d19|multiple sclerosis]]. It reduces the frequency and severity of clinical relapses and can slow the accumulation of lesions on MRI.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Administered by subcutaneous or intramuscular injection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are \u003cmark\u003eflu-like symptoms\u003c/mark\u003e (fever, chills, myalgias) that occur shortly after injection. Injection site reactions are also common. Depression and elevated liver enzymes can occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e IFN-Œ≤ is a classic disease-modifying drug for MS. Remember its immunomodulatory role and the characteristic flu-like side effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eInterferon-Œ≤\u003c/b\u003e is an immunomodulatory cytokine used to treat multiple sclerosis, which helps to quell the autoimmune attack on myelin by shifting the immune response towards a less inflammatory state, thereby reducing the frequency of relapses.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"cytokine\"\n      },\n      {\n        \"type\": \"has_adverse_effect\",\n        \"to\": \"flu_like_symptoms\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 8961,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"83146d36\": {\n    \"title\": \"Weakness ("
      }, {
        "text": "Motor Neuron Signs)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWeakness\u003c/b\u003e, or paresis, is a reduction in the force exerted"
      }, {
        "text": " by one or more muscles. In neurology, the pattern of weakness and associated signs helps distinguish between an upper motor neuron ("
      }, {
        "text": "UMN) lesion and a lower motor neuron (LMN) lesion.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eUpper Motor Neuron (UMN) Weakness:\u003c/b\u003e Caused by a lesion in the corticospinal tract"
      }, {
        "text": " (e.g., stroke, spinal cord injury). It is characterized by \u003cmark\u003espastic paralysis\u003c/mark\u003e,"
      }, {
        "text": " hyperreflexia, increased tone, and a positive Babinski sign. Weakness is often more pronounced in extensors of"
      }, {
        "text": " the upper limb and flexors of the lower limb.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Motor Neuron (LMN) Weakness:\u003c/b\u003e Caused by a lesion"
      }, {
        "text": " of the anterior horn cells, nerve roots, or peripheral nerves. It is characterized by \u003cmark\u003eflaccid paralysis\u003c/mark\u003e, hyp"
      }, {
        "text": "oreflexia, decreased tone, significant muscle atrophy, and fasciculations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Cord Lesions:\u003c/b\u003e The"
      }, {
        "text": " pattern of weakness depends on the tracts involved. For example, an [[b48b54d7|anterior spinal"
      }, {
        "text": " artery occlusion]] causes bilateral LMN weakness at the level of the lesion and UMN weakness below it.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The presence of both UMN and LMN signs in the same patient is the hallmark of [[4"
      }, {
        "text": "ed629f9|Amyotrophic Lateral Sclerosis (ALS)]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe character of muscle \u003cb\u003eweakness\u003c/b\u003e is a powerful localizing tool: spasticity and"
      }, {
        "text": " hyperreflexia point to an upper motor neuron lesion, while flaccidity, atrophy, and fasciculations indicate a lower motor neuron lesion"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_les"
      }, {
        "text": "ion\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        "
      }, {
        "text": "\"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_caused_by\",\n        \"to\": \"spinal_cord_lesion\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"7053478e\": {\n    \"title\": \"Weber Syndrome"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      "
      }, {
        "text": "\"Stroke\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWeber syndrome\u003c/b\u003e, also known as medial midbrain syndrome, is a brain"
      }, {
        "text": "stem stroke syndrome caused by an infarct in the anterior midbrain, affecting the cerebral peduncle and the fibers of the oculomotor nerve ("
      }, {
        "text": "CN III).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e Caused by occlusion"
      }, {
        "text": " of the paramedian branches of the \u003cmark\u003eposterior cerebral artery (PCA)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructures Damaged:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e1. \u003cb\u003eCerebral Peduncle:\u003c/b\u003e Contains the descending corticospinal and corticobulbar tracts.\u003c"
      }, {
        "text": "br\u003e2. \u003cb\u003eOculomotor Nerve (CN III) Fibers:\u003c/b\u003e Emerge from the midbrain between"
      }, {
        "text": " the cerebral peduncles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e A classic crossed deficit:\u003cbr\u003e - \u003cmark\u003eIpsilateral CN"
      }, {
        "text": " III palsy:\u003c/mark\u003e The eye is deviated \u0027down and out,\u0027 with ptosis and a dilated pupil.\u003cbr\u003e - \u003cmark\u003eCont"
      }, {
        "text": "ralateral Hemiplegia/Hemiparesis:\u003c/mark\u003e Weakness of the arm and leg due to cortic"
      }, {
        "text": "ospinal tract damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of an ipsilateral CN III palsy and contralateral"
      }, {
        "text": " hemiplegia is pathognomonic for Weber syndrome and localizes the lesion to the anterior midbrain.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWeber syndrome\u003c/b\u003e is a classic midbrain stroke syndrome that \u0027kn"
      }, {
        "text": "ocks out\u0027 the oculomotor nerve and the corticospinal tract on one side, resulting in the tell-tale combination of an ipsilateral \u0027"
      }, {
        "text": "down and out\u0027 eye and contralateral body paralysis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PCA"
      }, {
        "text": " Branch Occlusion] --\u003e B(Anterior Midbrain Infarct); B --\u003e C(Ipsilateral CN III Palsy);"
      }, {
        "text": " B --\u003e D(Contralateral Hemiplegia);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"brainstem_syndrome\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"b"
      }, {
        "text": "6a2cc31\"\n      },\n      {\n        \"type\": \"presents_with\","
      }, {
        "text": "\n        \"to\": \"fdfd22ca\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"hemiplegia\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "17c628e2\": {\n    \"title\": \"Werdnig-Hoffmann Disease (SMA"
      }, {
        "text": " Type 1)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\","
      }, {
        "text": "\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWerdnig-Hoffmann disease\u003c/b\u003e,"
      }, {
        "text": " also known as Spinal Muscular Atrophy (SMA) Type 1, is the most severe form of SMA. It is an autosomal recessive disorder"
      }, {
        "text": " characterized by the degeneration of anterior horn cells in the spinal cord, leading to progressive, symmetric muscle weakness and atrophy.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal recessive mutation or deletion in the \u003ci\u003eSMN1\u003c/i\u003e"
      }, {
        "text": " (Survival Motor Neuron 1) gene on chromosome 5.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The SMN protein"
      }, {
        "text": " is essential for the survival of lower motor neurons. Its deficiency leads to apoptosis of anterior horn cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e On"
      }, {
        "text": "set is before 6 months of age. Presents as a \u003cmark\u003e\\\"floppy baby\\\"\u003c/mark\u003e with profound,"
      }, {
        "text": " symmetric hypotonia and flaccid weakness, which is more pronounced proximally than distally. Tongue fasciculations are a"
      }, {
        "text": " characteristic finding.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Milestones:\u003c/b\u003e Infants are never able to sit unsupported.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Without"
      }, {
        "text": " treatment, death from respiratory failure typically occurs before age 2.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Polio:\u003c/b\u003e The pathology"
      }, {
        "text": " (destruction of anterior horn cells) is similar to poliomyelitis, but the cause is genetic, not infectious.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A \u0027floppy infant\u0027 with tongue fasciculations and absent deep tendon reflexes is the classic presentation for"
      }, {
        "text": " Werdnig-Hoffmann disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWerdnig"
      }, {
        "text": "-Hoffmann disease (SMA Type 1)\u003c/b\u003e is a devastating genetic disorder that selectively destroys lower motor neurons, resulting"
      }, {
        "text": " in a \u0027floppy baby\u0027 with progressive paralysis that ultimately leads to respiratory failure in early childhood.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        "
      }, {
        "text": "\"to\": \"spinal_muscular_atrophy\"\n      },\n      {\n        \"type\": \"is_caused"
      }, {
        "text": "_by_mutation_in\",\n        \"to\": \"smn1_gene\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"presents_with\",\n        \"to\": \"953e1306\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"presents_with\",\n        \"to\": \"hypotonia\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"2c4a6130\": {\n    \"title"
      }, {
        "text": "\": \"Wernicke\u0027s Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Pathology\",\n      \"Stroke\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWernicke\u0027s aphasia\u003c/b\u003e, also known as receptive"
      }, {
        "text": " aphasia, is a language disorder characterized by fluent but meaningless speech and severely impaired language comprehension. It is caused by a lesion in"
      }, {
        "text": " Wernicke\u0027s area.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e \u003c"
      }, {
        "text": "mark\u003eSuperior temporal gyrus\u003c/mark\u003e of the dominant (usually left) hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply"
      }, {
        "text": ":\u003c/b\u003e Supplied by the inferior division of the [[143bb23d|Middle Cerebral Artery (MCA"
      }, {
        "text": ")]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFluency:\u003c/b\u003e Speech is fluent and grammat"
      }, {
        "text": "ically correct but is nonsensical and contains paraphasic errors and neologisms (made-up words). This is often described as a"
      }, {
        "text": " \u003cmark\u003e\\\"word salad.\\\"\u003c/mark\u003e\u003cbr\u003e - \u003cb\u003eComprehension:\u003c/b\u003e Auditory and reading"
      }, {
        "text": " comprehension are severely impaired.\u003cbr\u003e - \u003cb\u003eRepetition:\u003c/b\u003e Impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Awareness:\u003c/b\u003e Patients are typically"
      }, {
        "text": " unaware of their deficit (anosognosia) and do not become frustrated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e M"
      }, {
        "text": "nemonic: \u003cb\u003eW\u003c/b\u003eernicke\u0027s is \u003cb\u003eW\u003c/b\u003eordy but makes no sense. A lesion in the temporal"
      }, {
        "text": " lobe can also affect the optic radiations (Meyer\u0027s loop), so Wernicke\u0027s aphasia is often associated with a contralateral superior"
      }, {
        "text": " quadrantanopia (\u0027pie in the sky\u0027).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWern"
      }, {
        "text": "icke\u0027s aphasia\u003c/b\u003e is a disorder of language comprehension, where the ability to produce fluent speech is preserved but"
      }, {
        "text": " the content is meaningless, leaving the patient adrift in a sea of incomprehensible language, both incoming and outgoing.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Lesion in Wernicke\u0027s Area] --\u003e B(Impaired Comprehension); B"
      }, {
        "text": " --\u003e C(Fluent but nonsensical speech); A --Spares--\u003e D(Broca\u0027s Area); D --\u003e E"
      }, {
        "text": "(Intact Fluency);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"wernicke_area"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"1"
      }, {
        "text": "43bb23d\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to"
      }, {
        "text": "\": \"7f6ed344\"\n      }\n    ]\n  },\n  \"404"
      }, {
        "text": "a6050\": {\n    \"title\": \"Wernicke-Korsakoff Syndrome\",\n    "
      }, {
        "text": "\"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Psychiatry\",\n      \"Nutrition"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Cognitive Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWernicke"
      }, {
        "text": "-Korsakoff syndrome\u003c/b\u003e is a spectrum of neurological disease caused by severe thiamine (vitamin B\u003csub\u003e1\u003c/sub\u003e) deficiency."
      }, {
        "text": " It consists of an acute, reversible phase (Wernicke encephalopathy) and a chronic, often irreversible phase (K"
      }, {
        "text": "orsakoff syndrome).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most"
      }, {
        "text": " commonly seen in the context of \u003cmark\u003echronic alcohol use disorder\u003c/mark\u003e, which leads to poor nutrition, impaired absorption, and altered"
      }, {
        "text": " metabolism of thiamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eWernicke Encephalopathy (Acute):\u003c/b\u003e A medical emergency characterized by the"
      }, {
        "text": " classic triad of:\u003cbr\u003e1. \u003cb\u003eEncephalopathy\u003c/b\u003e (confusion, disorientation)\u003cbr\u003e2. \u003cb\u003eOphthalm"
      }, {
        "text": "oplegia\u003c/b\u003e (nystagmus, CN VI palsy, gaze palsies)\u003cbr\u003e3. \u003cb\u003eGait At"
      }, {
        "text": "axia\u003c/b\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eKorsakoff Syndrome (Chronic):\u003c/b\u003e Characterized by profound \u003cmark\u003eanterograde and"
      }, {
        "text": " retrograde amnesia\u003c/mark\u003e with \u003cmark\u003econfabulation\u003c/mark\u003e (making up stories to fill in memory gaps). Personality"
      }, {
        "text": " changes are also common.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Involves damage to the \u003cmark\u003emammillary bodies\u003c/"
      }, {
        "text": "mark\u003e, medial thalamus, and periaqueductal gray matter. Atrophy and hemorrhage in the mammillary bodies are"
      }, {
        "text": " classic findings.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Immediate administration of high-dose IV thiamine. \u003cu\u003eThiamine must"
      }, {
        "text": " be given before glucose\u003c/u\u003e, as glucose administration can precipitate or worsen the encephalopathy by rapidly depleting the remaining thiamine stores.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Remember the triad for Wernicke\u0027s: \u003cb\u003eCAN O\u0027\u003c/b\u003e beer (\u003cb\u003e"
      }, {
        "text": "C\u003c/b\u003eonfusion, \u003cb\u003eA\u003c/b\u003etaxia, \u003cb\u003eN\u003c/b\u003eystagmus, \u003cb\u003eO\u003c/b\u003ephthalm"
      }, {
        "text": "oplegia). Always give thiamine before glucose to an alcoholic or malnourished patient.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Wernicke-Korsakoff syndrome\u003c/b\u003e is a preventable neurological catastrophe of thiamine deficiency, progressing from an acute, reversible triad"
      }, {
        "text": " of confusion, ataxia, and ophthalmoplegia to a chronic, irreversible state of profound amnesia and confabulation.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Thiamine (B1) Deficiency] --\u003e B(Wernicke Encephalopathy -"
      }, {
        "text": " Acute); B --\u003e C(Confusion, Ataxia, Ophthalmoplegia); B --Untreated--\u003e D(Korsakoff Syndrome - Chronic); D"
      }, {
        "text": " --\u003e E(Amnesia, Confabulation); F[Lesion in Mammillary Bodies/Thalamus]"
      }, {
        "text": " \u003c--\u003e D;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused"
      }, {
        "text": "_by\",\n        \"to\": \"thiamine_deficiency\"\n      },\n      {\n        \"type\": \"is_associated"
      }, {
        "text": "_with\",\n        \"to\": \"alcohol_use_disorder\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"involves_lesion_in\",\n        \"to\": \"f02cfaa1\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"a3d13743\": {\n    \"title\": \""
      }, {
        "text": "White Matter\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \""
      }, {
        "text": "Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Central Nervous System\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eWhite matter\u003c/b\u003e is one of the two components of the central nervous system, consisting mainly of myelinated axons bundled"
      }, {
        "text": " into tracts. Its white appearance is due to the high lipid content of the myelin sheaths.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Primarily composed of myelinated axons, as well as the glial cells that produce"
      }, {
        "text": " the myelin ([[a24f9747|oligodendrocytes]] in the CNS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Trans"
      }, {
        "text": "mits nerve signals between different areas of gray matter within the CNS. It forms the communication pathways of the brain and spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:"
      }, {
        "text": "\u003c/b\u003e In the brain, white matter is generally located deep to the cerebral cortex. In the spinal cord, it surrounds the central"
      }, {
        "text": " butterfly-shaped gray matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDemyelinating Disorders:\u003c/b\u003e Diseases that selectively damage the white matter by"
      }, {
        "text": " destroying myelin are known as demyelinating disorders. The classic example is \u003cmark\u003e[[45dd6d"
      }, {
        "text": "19|multiple sclerosis]]\u003c/mark\u003e, which is characterized by the formation of demyelinating plaques in the CNS"
      }, {
        "text": " white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDysmyelinating Disorders:\u003c/b\u003e Genetic disorders involving the defective formation of myelin (leukodyst"
      }, {
        "text": "rophies) also primarily affect the white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Lesions described as being in"
      }, {
        "text": " the \u0027white matter\u0027 on an MRI should immediately bring demyelinating or dysmyelinating disorders to mind.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWhite matter\u003c/b\u003e constitutes the \u0027wiring\u0027 of the central nervous system, a"
      }, {
        "text": " vast network of myelinated axons that provides the high-speed communication infrastructure connecting different processing centers; its integrity is essential for normal neurological"
      }, {
        "text": " function and is the primary target in demyelinating diseases like MS.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_component_of\",\n        \"to\": \"central_nervous_system"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\":"
      }, {
        "text": " \"myelinated_axons\"\n      },\n      {\n        \"type\": \"is_affected_in"
      }, {
        "text": "\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"is_affected_"
      }, {
        "text": "in\",\n        \"to\": \"f17ad9a5\"\n      }\n    ]\n  },\n  \"b0"
      }, {
        "text": "fbf22a\": {\n    \"title\": \"Work of Breathing\",\n    \"primaryType\": \"physiology"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pulmonology\",\n      \"Physiology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Respiratory\",\n      \"Physiology\",\n      \"Lung"
      }, {
        "text": " Mechanics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ework of breathing\u003c/b\u003e is the energy"
      }, {
        "text": " expended to inhale and exhale air. It is the work done by the respiratory muscles to overcome the elastic recoil of the lungs"
      }, {
        "text": " and chest wall, as well as the airway resistance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents"
      }, {
        "text": " of Work:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eElastic Work:\u003c/b\u003e Work required to overcome the elastic forces of the lung"
      }, {
        "text": " and chest wall during inspiration.\u003cbr\u003e2. \u003cb\u003eResistive Work:\u003c/b\u003e Work required to overcome the resistance"
      }, {
        "text": " to airflow in the airways.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIncreased Work in Disease:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eRestrictive Lung"
      }, {
        "text": " Diseases (e.g., fibrosis):\u003c/b\u003e Increased elastic work due to stiff, non-compliant lungs. Patients adopt a rapid"
      }, {
        "text": ", shallow breathing pattern to minimize this work.\u003cbr\u003e - \u003cb\u003eObstructive Lung Diseases (e.g., asthma"
      }, {
        "text": ", COPD):\u003c/b\u003e Increased resistive work due to narrowed airways. Patients adopt a slow, deep breathing pattern to minimize this work.\u003c/li\u003e\u003cli\u003e\u003cb\u003e\u0027"
      }, {
        "text": "Worst Headache of My Life\u0027:\u003c/b\u003e This phrase is the classic description of a [[63f8b05f"
      }, {
        "text": "|subarachnoid hemorrhage]] and is \u003cu\u003enot related\u003c/u\u003e to the work of breathing. The index entry is likely"
      }, {
        "text": " a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand how different lung diseases affect the work of breathing and lead"
      }, {
        "text": " to characteristic breathing patterns. Fibrosis \u003d stiff lungs \u003d high elastic work. Asthma \u003d narrow airways \u003d high resistive work.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003ework of breathing\u003c/b\u003e represents the metabolic cost of ventilation, a"
      }, {
        "text": " balance between overcoming the stiffness of the respiratory system and the resistance of the airways, which is pathologically increased in both restrictive and obstructive lung diseases.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_increased_"
      }, {
        "text": "in\",\n        \"to\": \"restrictive_lung_disease\"\n      },\n      {\n        \"type\": \"is_increased"
      }, {
        "text": "_in\",\n        \"to\": \"obstructive_lung_disease\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"e622320e\": {\n    \"title\": \"Xanthelasma\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Cardiology\",\n      \"Endocrinology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connect"
      }, {
        "text": "ive Tissue\",\n      \"Dermatology\",\n      \"Lipid-Related Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eXanthelasma\u003c/b\u003e (or xanthelasma palpebr"
      }, {
        "text": "arum) is a sharply demarcated, yellowish deposit of cholesterol underneath the skin, usually on or around the eyelids. It is the"
      }, {
        "text": " most common type of xanthoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e Soft"
      }, {
        "text": ", yellowish, flat plaques that typically occur on the medial aspects of the upper and lower eyelids.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Composed of lipid"
      }, {
        "text": "-laden macrophages (foam cells) in the dermis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e While they can be idiopathic"
      }, {
        "text": ", xanthelasmas are often a sign of \u003cmark\u003ehyperlipidemia\u003c/mark\u003e, particularly hypercholesterolemia."
      }, {
        "text": " Their presence should prompt a lipid panel evaluation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Can be seen in familial hypercholesterolemia and"
      }, {
        "text": " other dyslipidemias. Also associated with primary biliary cholangitis, which can cause hypercholesterolemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Xanthelasma is a cutaneous marker for potential underlying hyperlipidemia and increased cardiovascular risk.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eXanthelasma\u003c/b\u003e are benign but cosmetically significant cholesterol deposits on the eyelids that serve as an"
      }, {
        "text": " important external clue to an internal problem‚Äîhyperlipidemia‚Äîand the associated risk of atherosclerotic disease.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"xanthoma\"\n      },\n      {\n        \"type\": \"is_a_sign_of"
      }, {
        "text": "\",\n        \"to\": \"hyperlipidemia\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "associated_with\",\n        \"to\": \"familial_hypercholesterolemia\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"5edd272c\": {\n    \"title\": \"Zaleplon\",\n    \"primaryType"
      }, {
        "text": "\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep"
      }, {
        "text": " Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eZaleplon\u003c/b\u003e is a non-benzodiazepine hypnotic agent, known as a \u0027Z"
      }, {
        "text": "-drug,\u0027 used for the short-term treatment of insomnia, particularly for difficulty with sleep onset.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a positive allosteric modulator at the benzodiazepine (BZ"
      }, {
        "text": "\u003csub\u003e1\u003c/sub\u003e) subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, enhancing the inhibitory effects of GABA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass"
      }, {
        "text": ":\u003c/b\u003e Non-benzodiazepine hypnotic (\u0027Z-drug\u0027), along with zolpidem and eszopiclone.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmac"
      }, {
        "text": "okinetics:\u003c/b\u003e Has a \u003cmark\u003every short half-life\u003c/mark\u003e (approximately 1 hour), making it effective"
      }, {
        "text": " for initiating sleep without causing significant next-day sedation or \u0027hangover\u0027 effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used"
      }, {
        "text": " for patients who have trouble \u003cmark\u003efalling asleep\u003c/mark\u003e. It can be taken later in the night if needed, as long as the"
      }, {
        "text": " patient has at least 4 hours remaining for sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Dizziness, headache."
      }, {
        "text": " Risk of anterograde amnesia and complex sleep behaviors is lower than with longer-acting agents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e"
      }, {
        "text": " Effects can be reversed by \u003cmark\u003eflumazenil\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Z"
      }, {
        "text": "aleplon\u0027s ultra-short half-life is its defining feature, making it ideal for sleep-onset insomnia without"
      }, {
        "text": " affecting the rest of the night\u0027s sleep or the next day.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eZale"
      }, {
        "text": "plon\u003c/b\u003e is a \u0027Z-drug\u0027 hypnotic with an exceptionally short duration of action, designed to help patients fall asleep quickly without lingering"
      }, {
        "text": " sedative effects, making it a \u0027hit-and-run\u0027 solution for sleep-onset insomnia.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"non_benzodiazepine_hypnotic\"\n      },\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts"
      }, {
        "text": "_on\",\n        \"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"over"
      }, {
        "text": "dose_treated_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"f38d516a\": {\n    \"title\": \"Zolpidem\",\n    "
      }, {
        "text": "\"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eZolpidem\u003c/b\u003e (trade name Ambien) is a widely"
      }, {
        "text": " prescribed non-benzodiazepine hypnotic agent, or \u0027Z-drug,\u0027 used for the short-term treatment of insomnia.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a positive allosteric modulator at"
      }, {
        "text": " the benzodiazepine (BZ\u003csub\u003e1\u003c/sub\u003e) subtype of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, enhancing the inhibitory effects of GABA"
      }, {
        "text": " to induce sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-benzodiazepine hypnotic (\u0027Z-drug\u0027), along with z"
      }, {
        "text": "aleplon and eszopiclone.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a rapid onset and a relatively short half-life (2"
      }, {
        "text": "-3 hours), making it effective for sleep-onset insomnia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ataxia, headaches"
      }, {
        "text": ", confusion. It is particularly known for causing \u003cmark\u003eanterograde amnesia\u003c/mark\u003e and \u003cmark\u003ecomplex sleep-"
      }, {
        "text": "related behaviors\u003c/mark\u003e (e.g., sleepwalking, sleep-driving, sleep-eating), especially at higher doses or"
      }, {
        "text": " when combined with alcohol.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntidote:\u003c/b\u003e Effects can be reversed by \u003cmark\u003eflumazenil"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Zolpidem is the prototypical \u0027Z-drug.\u0027 Remember its"
      }, {
        "text": " association with bizarre sleep-related behaviors and the fact that its overdose is treated with flumazenil, just like benzodiazepines.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eZolpidem\u003c/b\u003e is a popular hypnotic that promotes sleep by selectively"
      }, {
        "text": " enhancing GABAergic inhibition, but its use is shadowed by the risk of inducing complex and potentially dangerous sleep-related behaviors for"
      }, {
        "text": " which the user has no memory.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"non_benzodiazep"
      }, {
        "text": "ine_hypnotic\"\n      },\n      {\n        \"type\": \"treats\",\n        \""
      }, {
        "text": "to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_on\",\n        "
      }, {
        "text": "\"to\": \"gaba_a_receptor\"\n      },\n      {\n        \"type\": \"over"
      }, {
        "text": "dose_treated_by\",\n        \"to\": \"flumazenil\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"d64b8bec\": {\n    \"title\": \"Œ±-Agonists ("
      }, {
        "text": "Ophthalmic)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eŒ±-Ad"
      }, {
        "text": "renergic agonists\u003c/b\u003e are a class of sympathomimetic drugs used topically in ophthalmology to treat glaucoma by lowering intra"
      }, {
        "text": "ocular pressure (IOP) or to cause mydriasis for examination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eŒ±"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e-Agonists (e.g., [[2fcee185|brimonidine]],"
      }, {
        "text": " [[c1f67280|apraclonidine]]):\u003c/b\u003e The primary class used for glaucoma.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eMechanism:\u003c/b\u003e They have a dual mechanism: they \u003cmark\u003edecrease aqueous humor synthesis\u003c/mark\u003e by"
      }, {
        "text": " acting on the ciliary body and \u003cmark\u003eincrease uveoscleral outflow\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eUse"
      }, {
        "text": ":\u003c/b\u003e Long-term management of open-angle glaucoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eŒ±\u003csub\u003e1\u003c/sub\u003e-Agonists ("
      }, {
        "text": "e.g., phenylephrine):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMechanism:\u003c/b\u003e Stimulates the pupillary dilator muscle, causing \u003c"
      }, {
        "text": "mark\u003emydriasis\u003c/mark\u003e (pupil dilation).\u003cbr\u003e - \u003cb\u003eUse:\u003c/b\u003e Used to"
      }, {
        "text": " dilate the pupil for funduscopic examination. \u003cu\u003eContraindicated in angle-closure glaucoma\u003c/u\u003e as mydriasis can further"
      }, {
        "text": " narrow the angle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-selective Agonists (e.g., [[583587"
      }, {
        "text": "cd|epinephrine]]):\u003c/b\u003e Have both Œ± and Œ≤ effects. The Œ±\u003csub\u003e1\u003c/sub\u003e effect decreases aqueous humor production"
      }, {
        "text": " via vasoconstriction of ciliary body vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For glaucoma treatment, think Œ±\u003csub\u003e2\u003c/sub\u003e-agonists ("
      }, {
        "text": "brimonidine, apraclonidine) which decrease aqueous production. For pupillary dilation, think Œ±\u003csub\u003e1\u003c/sub\u003e"
      }, {
        "text": "-agonists (phenylephrine).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eOphthalmic "
      }, {
        "text": "\u003cb\u003eŒ±-agonists\u003c/b\u003e modulate aqueous humor dynamics and pupillary size; Œ±\u003csub\u003e2\u003c/sub\u003e-agonists are the work"
      }, {
        "text": "horses for glaucoma by reducing fluid production, while Œ±\u003csub\u003e1\u003c/sub\u003e-agonists are used to dilate the pupil for examination.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n"
      }, {
        "text": "        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"2fcee185\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "includes\",\n        \"to\": \"c1f67280\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"phenylephrine\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"bc6647e5\": {\n    \"title\": \"Œ±2-Agonists\","
      }, {
        "text": "\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Autonomic\",\n      \"Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Autonomic Drugs\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-Adrenergic agonists\u003c/b\u003e are a class of sympatholytic"
      }, {
        "text": " drugs that act on presynaptic Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the central and peripheral nervous systems to reduce sympathetic outflow.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Stimulate presynaptic Œ±\u003csub\u003e2\u003c/sub\u003e-receptors,"
      }, {
        "text": " which are autoreceptors that provide negative feedback. This inhibits the release of norepinephrine from the nerve terminal, leading to a decrease in sympathetic"
      }, {
        "text": " tone.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Agents (e.g., Clonidine, Methyldopa):\u003c/b\u003e Used as antihypertensives."
      }, {
        "text": " They act on central Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the brainstem to reduce sympathetic outflow to the heart and blood vessels.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eOphthalmic Agents (e.g., [[2fcee185|brimonidine]], [[c"
      }, {
        "text": "1f67280|apraclonidine]]):\u003c/b\u003e Used for glaucoma. They act on Œ±\u003csub\u003e2\u003c/sub\u003e-receptors in the"
      }, {
        "text": " ciliary body to decrease aqueous humor production.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMuscle Relaxants (e.g., Tizanidine):\u003c/b\u003e A"
      }, {
        "text": " centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-agonist used as an antispasmodic to treat spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember that Œ±\u003csub\u003e2\u003c/sub\u003e-agonists are \u0027sympatho-\u003cu\u003elytic\u003c/u\u003e\u0027 despite"
      }, {
        "text": " being agonists. They stimulate an inhibitory autoreceptor, effectively putting the brakes on the sympathetic nervous system.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-Agonists\u003c/b\u003e paradoxically reduce sympathetic activity by stimulating an inhibitory \u0027"
      }, {
        "text": "off-switch\u0027 on presynaptic nerve terminals, a mechanism harnessed to treat conditions of sympathetic excess like hypertension and glaucoma.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Œ±2-Agonist] --\u003e B(Stimulates Presynaptic Œ±2-Re"
      }, {
        "text": "ceptor); B --\u003e C(‚Üì Norepinephrine Release); C --\u003e D(‚Üì Sympathetic Tone);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"includes\",\n        \"to\": \"clonidine\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"includes\",\n        \"to\": \"2fcee185\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"sympatholytic\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"10535992\": {\n    \"title\": \"Œ≤-Block"
      }, {
        "text": "ers (Ophthalmic)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Ophthalmology\",\n      \"Autonomic\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eŒ≤-Blockers\u003c/b\u003e (beta-adrenergic antagonists"
      }, {
        "text": ") are a first-line therapy for open-angle glaucoma, administered as topical eye drops to reduce intraocular pressure (IOP).\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Block Œ≤-adrenergic receptors on the ciliary epithelium"
      }, {
        "text": ". This \u003cmark\u003edecreases the production of aqueous humor\u003c/mark\u003e, thereby lowering IOP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAgents:"
      }, {
        "text": "\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNon-selective (Œ≤\u003csub\u003e1\u003c/sub\u003e and Œ≤\u003csub\u003e2\u003c/sub\u003e):\u003c/b\u003e \u003cmark\u003eTimolol\u003c/"
      }, {
        "text": "mark\u003e, carteolol.\u003cbr\u003e - \u003cb\u003eŒ≤\u003csub\u003e1\u003c/sub\u003e-selective:\u003c/b\u003e \u003cmark\u003e[[435"
      }, {
        "text": "08d57|Betaxolol]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e First-line treatment"
      }, {
        "text": " for [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e O"
      }, {
        "text": "cular side effects are minimal (e.g., stinging). However, systemic absorption can occur, leading to the same side"
      }, {
        "text": " effects as systemic beta-blockers: bradycardia, hypotension, fatigue, and bronchoconstriction (especially with non-selective agents"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Use non-selective beta-blockers with caution in patients with \u003cmark\u003easthma,"
      }, {
        "text": " COPD\u003c/mark\u003e, bradycardia, or heart failure. Œ≤\u003csub\u003e1\u003c/sub\u003e-selective agents like [[43508d"
      }, {
        "text": "57|betaxolol]] are safer in patients with pulmonary disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For"
      }, {
        "text": " migraine prophylaxis, systemic beta-blockers like propranolol are used. For glaucoma, topical beta-blockers like timolol are used. The"
      }, {
        "text": " mechanism in glaucoma is decreased aqueous humor production.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eTopical \u003cb\u003eŒ≤-block"
      }, {
        "text": "ers\u003c/b\u003e are a mainstay of glaucoma therapy, working by \u0027turning down the tap\u0027 on aqueous humor production in the ciliary body, but their potential"
      }, {
        "text": " for systemic absorption requires caution in patients with cardiac or pulmonary disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Topical Œ≤-Blocker] --\u003e B(Blocks Œ≤-Receptors on Ciliary Epithelium); B --\u003e C(‚Üì Aqueous"
      }, {
        "text": " Humor Production); C --\u003e D(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"includes\",\n        \"to\": \"timolol\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"43508d5"
      }, {
        "text": "7\"\n      },\n      {\n        \"type\": \"is_used_for_prophylaxis_of\",\n        \"to\":"
      }, {
        "text": " \"c8833bae\"\n      }\n    ]\n  },\n  \"00e4"
      }, {
        "text": "8ea3\": {\n    \"title\": \"Interferon-Œ≤\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Immunology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Multiple Sclerosis Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eInterferon-Œ≤ (IFN-Œ≤)\u003c/b\u003e is a cytokine of the interferon family that is used as a first"
      }, {
        "text": "-line disease-modifying therapy for the treatment of relapsing forms of [[45dd6d19|multiple"
      }, {
        "text": " sclerosis (MS)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The"
      }, {
        "text": " exact mechanism in MS is not fully understood, but IFN-Œ≤ has both antiviral and immunomodulatory effects. It is"
      }, {
        "text": " thought to work by shifting the cytokine profile from a pro-inflammatory (Th1) to an anti-inflammatory (Th2)"
      }, {
        "text": " state, and by reducing the migration of inflammatory cells across the blood-brain barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A"
      }, {
        "text": " cornerstone of treatment for relapsing-remitting [[45dd6d19|multiple sclerosis]]. It reduces the frequency and severity"
      }, {
        "text": " of clinical relapses and can slow the accumulation of lesions on MRI.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Administered by subcutaneous or intramuscular"
      }, {
        "text": " injection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are \u003cmark\u003eflu-like symptoms\u003c/mark"
      }, {
        "text": "\u003e (fever, chills, myalgias) that occur shortly after injection. Injection site reactions are also common. Depression and"
      }, {
        "text": " elevated liver enzymes can occur.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e IFN-Œ≤ is a classic disease-modifying drug"
      }, {
        "text": " for MS. Remember its immunomodulatory role and the characteristic flu-like side effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eInterferon-Œ≤\u003c/b\u003e is an immunomodulatory cytokine used to treat multiple sclerosis, which"
      }, {
        "text": " helps to quell the autoimmune attack on myelin by shifting the immune response towards a less inflammatory state, thereby reducing the frequency of"
      }, {
        "text": " relapses.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"cytokine\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"has_adverse_effect\",\n        \"to\": \"flu_like_s"
      }, {
        "text": "ymptoms\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"b7b619f2\",\n    \"letter\": \"V\",\n    \"term\": \"VHL gene\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"VHL gene\",\n    \"sub_entries\": [\n      {\n        \"id\": \"b22c5865\",\n        \"letter\": \"V\",\n        \"term\": \"deletion of\",\n        \"pages\": [\n          \"539\"\n        ],\n        \"context\": \"VHL gene \u003e deletion of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c3b254c8\",\n    \"letter\": \"V\",\n    \"term\": \"Vibration sense\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vibration sense\",\n    \"sub_entries\": [\n      {\n        \"id\": \"88a4e62a\",\n        \"letter\": \"V\",\n        \"term\": \"high-frequency\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Vibration sense \u003e high-frequency\"\n      },\n      {\n        \"id\": \"a7d0f3da\",\n        \"letter\": \"V\",\n        \"term\": \"low-frequency\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Vibration sense \u003e low-frequency\"\n      },\n      {\n        \"id\": \"2422927c\",\n        \"letter\": \"V\",\n        \"term\": \"thalamic relay of\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Vibration sense \u003e thalamic relay of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5aced400\",\n    \"letter\": \"V\",\n    \"term\": \"Vision disturbances\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vision disturbances\",\n    \"sub_entries\": [\n      {\n        \"id\": \"363bd4ca\",\n        \"letter\": \"V\",\n        \"term\": \"and\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Vision disturbances \u003e and\"\n      },\n      {\n        \"id\": \"f555d033\",\n        \"letter\": \"V\",\n        \"term\": \"glaucoma\",\n        \"pages\": [\n          \"551\"\n        ],\n        \"context\": \"Vision disturbances \u003e glaucoma\"\n      }\n    ]\n  },\n  {\n    \"id\": \"67790093\",\n    \"letter\": \"V\",\n    \"term\": \"Vision, thalamic relay for\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vision, thalamic relay for\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a12351b0\",\n    \"letter\": \"V\",\n    \"term\": \"Visual cortex\",\n    \"pages\": [\n      \"508\",\n      \"555\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Visual cortex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ff289b3a\",\n    \"letter\": \"V\",\n    \"term\": \"Visual field defects\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Visual field defects\",\n    \"sub_entries\": [\n      {\n        \"id\": \"195b2480\",\n        \"letter\": \"V\",\n        \"term\": \"hypertension\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Visual field defects \u003e hypertension\"\n      },\n      {\n        \"id\": \"b84a55cc\",\n        \"letter\": \"V\",\n        \"term\": \"saccular aneurysms and\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Visual field defects \u003e saccular aneurysms and\"\n      },\n      {\n        \"id\": \"06969160\",\n        \"letter\": \"V\",\n        \"term\": \"types of\",\n        \"pages\": [\n          \"557\"\n        ],\n        \"context\": \"Visual field defects \u003e types of\"\n      },\n      {\n        \"id\": \"014ae867\",\n        \"letter\": \"V\",\n        \"term\": \"with stroke\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Visual field defects \u003e with stroke\"\n      }\n    ]\n  },\n  {\n    \"id\": \"21e10649\",\n    \"letter\": \"V\",\n    \"term\": \"Vitamin A (retinol)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vitamin A (retinol)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c6d96fca\",\n        \"letter\": \"V\",\n        \"term\": \"hypertension\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Vitamin A (retinol) \u003e hypertension\"\n      }\n    ]\n  },\n  {\n    \"id\": \"784e2484\",\n    \"letter\": \"V\",\n    \"term\": \"Vitamin B12 (cobalamin)\",\n    \"pages\": [\n      \"66\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vitamin B12 (cobalamin)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"6ef15b9e\",\n        \"letter\": \"V\",\n        \"term\": \"and\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Vitamin B12 (cobalamin) \u003e and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ae1e474d\",\n    \"letter\": \"V\",\n    \"term\": \"Vitamin B9 (folate)\",\n    \"pages\": [\n      \"66\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vitamin B9 (folate)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"6a5adebf\",\n        \"letter\": \"V\",\n        \"term\": \"depletion with anticonvulsants\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Vitamin B9 (folate) \u003e depletion with anticonvulsants\"\n      }\n    ]\n  },\n  {\n    \"id\": \"36e0b01f\",\n    \"letter\": \"V\",\n    \"term\": \"Voluntary movement\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Voluntary movement\",\n    \"sub_entries\": [\n      {\n        \"id\": \"744210bf\",\n        \"letter\": \"V\",\n        \"term\": \"basal ganglia and\",\n        \"pages\": [\n          \"511\"\n        ],\n        \"context\": \"Voluntary movement \u003e basal ganglia and\"\n      },\n      {\n        \"id\": \"3addc447\",\n        \"letter\": \"V\",\n        \"term\": \"spinal tracts for\",\n        \"pages\": [\n          \"522\"\n        ],\n        \"context\": \"Voluntary movement \u003e spinal tracts for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"8b927b54\",\n    \"letter\": \"V\",\n    \"term\": \"Vomiting\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vomiting\",\n    \"sub_entries\": [\n      {\n        \"id\": \"9ca3a077\",\n        \"letter\": \"V\",\n        \"term\": \"area postrema and\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Vomiting \u003e area postrema and\"\n      },\n      {\n        \"id\": \"c979eb05\",\n        \"letter\": \"V\",\n        \"term\": \"chemotherapy-induced\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Vomiting \u003e chemotherapy-induced\"\n      },\n      {\n        \"id\": \"b0204aad\",\n        \"letter\": \"V\",\n        \"term\": \"in stroke\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Vomiting \u003e in stroke\"\n      }\n    ]\n  },\n  {\n    \"id\": \"74b651ab\",\n    \"letter\": \"V\",\n    \"term\": \"Vomiting center\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vomiting center\",\n    \"sub_entries\": [\n      {\n        \"id\": \"d9d30711\",\n        \"letter\": \"V\",\n        \"term\": \"location and function\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Vomiting center \u003e location and function\"\n      },\n      {\n        \"id\": \"9a61319f\",\n        \"letter\": \"V\",\n        \"term\": \"receptors input for\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Vomiting center \u003e receptors input for\"\n      }\n    ]\n  },\n  {\n    \"id\": \"274cb033\",\n    \"letter\": \"V\",\n    \"term\": \"Von Hippel-Lindau disease\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Von Hippel-Lindau disease\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a39a8978\",\n        \"letter\": \"V\",\n        \"term\": \"genetics and presentation\",\n        \"pages\": [\n          \"539\"\n        ],\n        \"context\": \"Von Hippel-Lindau disease \u003e genetics and presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"1d7d392c\",\n    \"letter\": \"W\",\n    \"term\": \"Wallenberg syndrome\",\n    \"pages\": [\n      \"527\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Wallenberg syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"6772c663\",\n    \"letter\": \"W\",\n    \"term\": \"Watershed areas/regions\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Watershed areas/regions\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f1610c17\",\n        \"letter\": \"W\",\n        \"term\": \"anterior spinal artery\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Watershed areas/regions \u003e anterior spinal artery\"\n      },\n      {\n        \"id\": \"1883ddd4\",\n        \"letter\": \"W\",\n        \"term\": \"cerebral arteries\",\n        \"pages\": [\n          \"513\"\n        ],\n        \"context\": \"Watershed areas/regions \u003e cerebral arteries\"\n      },\n      {\n        \"id\": \"84ce0086\",\n        \"letter\": \"W\",\n        \"term\": \"ischemic stroke\",\n        \"pages\": [\n          \"525\"\n        ],\n        \"context\": \"Watershed areas/regions \u003e ischemic stroke\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2883
    }, {
      "text": "```json\n{\n  \"b7b619f2\": {\n    \"title\": \"VHL Gene\",\n    \"primaryType\": \"gene\",\n    \"tags\": [\n      \"Genetics\",\n      \"Oncology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Tumor Suppressor Genes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVHL gene\u003c/b\u003e (von Hippel-Lindau tumor suppressor) is a gene on chromosome 3 that encodes the pVHL protein. Germline mutations or deletions of this gene cause [[274cb033|von Hippel-Lindau disease]], an autosomal dominant syndrome characterized by the development of numerous benign and malignant tumors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of pVHL:\u003c/b\u003e The VHL protein is part of a ubiquitin ligase complex that targets hypoxia-inducible factor 1Œ± (HIF-1Œ±) for degradation in the presence of oxygen.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Loss of VHL function leads to the stabilization and accumulation of HIF-1Œ±, even under normoxic conditions. HIF-1Œ± then acts as a transcription factor, upregulating genes involved in angiogenesis (e.g., VEGF) and cell growth, promoting tumor formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Tumors (Mnemonic HARP):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eH\u003c/b\u003eemangioblastomas (retina, cerebellum, brainstem, spine)\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003engiomatosis\u003cbr\u003e - \u003cb\u003eR\u003c/b\u003eenal cell carcinoma (bilateral, clear cell type)\u003cbr\u003e - \u003cb\u003eP\u003c/b\u003eheochromocytoma\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e VHL is a classic tumor suppressor gene. Its inactivation leads to a \u0027pseudo-hypoxic\u0027 state where angiogenic factors are constitutively active, driving the growth of highly vascular tumors like hemangioblastomas and renal cell carcinoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVHL gene\u003c/b\u003e acts as the oxygen sensor for a major growth pathway; its inactivation tricks the cell into thinking it\u0027s hypoxic, leading to the uncontrolled production of blood vessels and the formation of the highly vascular tumors characteristic of von Hippel-Lindau disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Normal Oxygen] --\u003e B(pVHL); B --\u003e C(Degradation of HIF-1Œ±); C --x D(Angiogenesis); E[VHL Deletion] --x B; E --\u003e F(HIF-1Œ± Accumulation); F --\u003e D;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"mutation_causes\",\n        \"to\": \"274cb033\"\n      },\n      {\n        \"type\": \"is_a\",\n        \"to\": \"tumor_suppressor_gene\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"hif_1_alpha\"\n      }\n    ]\n  },\n  \"c3b254c8\": {\n    \"title\": \"Vibration Sense\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVibration sense\u003c/b\u003e (pallesthesia) is the ability to perceive a vibratory stimulus, typically tested using a tuning fork. It is a sensory modality transmitted by large, myelinated nerve fibers via the dorsal column-medial lemniscus pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Sensation is detected by mechanoreceptors in the skin and deeper tissues:\u003cbr\u003e - \u003cb\u003ePacinian corpuscles:\u003c/b\u003e Detect high-frequency vibration.\u003cbr\u003e - \u003cb\u003eMeissner\u0027s corpuscles:\u003c/b\u003e Detect low-frequency vibration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Pathway:\u003c/b\u003e The signal travels via large, myelinated AŒ≤ fibers through the peripheral nerves to the spinal cord, where it ascends ipsilaterally in the \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e. After synapsing and decussating in the medulla, it travels via the medial lemniscus to the VPL nucleus of the [[afc0a64b|thalamus]] and then to the somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Loss of vibration sense is often one of the earliest signs of peripheral neuropathy (e.g., in diabetes) and dorsal column pathology.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Impaired vibration sense is a key finding in [[6f5bea90|subacute combined degeneration]] (vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency), [[71daebd6|tabes dorsalis]] (neurosyphilis), and [[39bc1763|Friedreich ataxia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Vibration and proprioception travel together in the dorsal columns. A patient with loss of vibration sense will likely also have a positive Romberg sign.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVibration sense\u003c/b\u003e is a critical component of the neurological exam that specifically tests the integrity of the large myelinated fibers of the dorsal column-medial lemniscus pathway, making it a sensitive indicator of both peripheral neuropathy and spinal cord disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_transmitted_by\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"is_detected_by\",\n        \"to\": \"pacinian_corpuscles\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"71daebd6\"\n      }\n    ]\n  },\n  \"5aced400\": {\n    \"title\": \"Vision Disturbances\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVision disturbances\u003c/b\u003e are a broad category of symptoms affecting sight, which can range from blurred vision to complete blindness. They can be caused by pathology anywhere along the visual pathway, from the cornea to the occipital cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eRefractive Errors:\u003c/b\u003e Blurred vision correctable with lenses (e.g., myopia, hyperopia, [[18cff34e|astigmatism]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedia Opacities:\u003c/b\u003e Clouding of the normally clear parts of the eye, such as [[85f03b02|cataracts]] (lens) or vitreous hemorrhage.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[3ce6c035|Glaucoma]]:\u003c/b\u003e A group of diseases that damage the optic nerve, typically causing progressive peripheral vision loss. [[9c80344d|Acute angle-closure glaucoma]] causes sudden, painful vision loss with halos around lights.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinal Disorders:\u003c/b\u003e Include [[c63255c8|macular degeneration]] (central vision loss), [[73b00ab0|diabetic retinopathy]], and retinal detachment (\u0027curtain\u0027 over vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[ff289b3a|Visual Field Defects]]:\u003c/b\u003e Patterns of vision loss that help localize lesions along the optic pathway (e.g., [[6c3a980e|bitemporal hemianopia]] from chiasmal compression).\u003c/li\u003e\u003cli\u003e\u003cb\u003eIncreased Intracranial Hypertension:\u003c/b\u003e Can cause [[papilledema]] and transient visual obscurations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The nature of the vision disturbance provides crucial diagnostic clues. Is it painful or painless? Transient or persistent? Affecting central or peripheral vision? Monocular or binocular?\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVision disturbances\u003c/b\u003e are a key neurological and ophthalmological symptom, and a careful history of their characteristics‚Äîsuch as timing, location in the visual field, and associated symptoms‚Äîis essential for localizing the underlying pathology along the complex visual pathway.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"ff289b3a\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"7c4e7c74\"\n      }\n    ]\n  },\n  \"67790093\": {\n    \"title\": \"Thalamic Relay for Vision\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Neurophysiology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ethalamic relay for vision\u003c/b\u003e is the process by which visual information from the retina is processed and relayed to the primary visual cortex. This function is performed by the \u003cmark\u003eLateral Geniculate Nucleus (LGN)\u003c/mark\u003e of the [[afc0a64b|thalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e The Lateral Geniculate Nucleus (LGN) is a specific sensory relay nucleus in the [[afc0a64b|thalamus]]. Mnemonic: \u003cb\u003eL\u003c/b\u003eGN for \u003cb\u003eL\u003c/b\u003eight.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e The LGN receives major sensory input from retinal ganglion cells via the optic tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSegregation of Input:\u003c/b\u003e Information from the ipsilateral and contralateral eyes remains segregated in different layers of the LGN.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Neurons of the LGN project to the primary [[a12351b0|visual cortex]] (Brodmann area 17) in the occipital lobe via the optic radiation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that all sensory pathways (except olfaction) have a thalamic relay. For vision, this relay is the LGN. For hearing, it\u0027s the Medial Geniculate Nucleus (MGN).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eLateral Geniculate Nucleus\u003c/b\u003e of the thalamus serves as the essential processing and relay station for vision, receiving organized input from the retina and projecting it faithfully to the visual cortex for conscious perception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Retina] --\u003e B(Optic Tract); B --\u003e C(Lateral Geniculate Nucleus - LGN); C --\u003e D(Optic Radiation); D --\u003e E(Primary Visual Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_performed_by\",\n        \"to\": \"lateral_geniculate_nucleus\"\n      },\n      {\n        \"type\": \"is_a_function_of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"sends_output_to\",\n        \"to\": \"a12351b0\"\n      }\n    ]\n  },\n  \"a12351b0\": {\n    \"title\": \"Visual Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVisual Cortex\u003c/b\u003e is the region of the [[a1b198f9|cerebral cortex]] located in the occipital lobe that is responsible for processing visual information. It is divided into the primary visual cortex (V1) and higher-order visual association areas.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Visual Cortex (V1):\u003c/b\u003e Located in the calcarine sulcus of the occipital lobe (Brodmann area 17). It receives direct input from the \u003cmark\u003eLateral Geniculate Nucleus (LGN)\u003c/mark\u003e of the [[afc0a64b|thalamus]] via the optic radiation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinotopic Organization:\u003c/b\u003e V1 is organized retinotopically, meaning that adjacent points on the retina are mapped to adjacent points in the cortex. The macula, responsible for central, high-acuity vision, has a disproportionately large representation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood Supply:\u003c/b\u003e Primarily supplied by the \u003cmark\u003e[[b6a2cc31|Posterior Cerebral Artery (PCA)]]\u003c/mark\u003e. The macular region often has a dual blood supply from the Middle Cerebral Artery (MCA), which can lead to \u0027macular sparing\u0027 in a PCA stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e A lesion of the primary visual cortex causes a contralateral \u003cmark\u003ehomonymous hemianopia\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Motility:\u003c/b\u003e The visual cortex is involved in voluntary eye movements, sending signals to the [[5ddbdcd3|frontal eye fields]] to direct gaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A stroke in the PCA territory classically causes a contralateral homonymous hemianopia with macular sparing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVisual Cortex\u003c/b\u003e is the brain\u0027s final destination for visual processing, where raw data from the thalamus is transformed into the coherent images we perceive, with a significant portion of its real estate dedicated to the high-resolution input from the macula.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[LGN of Thalamus] --\u003e B(Optic Radiation); B --\u003e C(Primary Visual Cortex - V1); C --\u003e D(Visual Association Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"occipital_lobe\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"lateral_geniculate_nucleus\"\n      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"b6a2cc31\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"homonymous_hemianopia\"\n      }\n    ]\n  },\n  \"ff289b3a\": {\n    \"title\": \"Visual Field Defects\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual Pathway\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVisual field defects\u003c/b\u003e are patterns of vision loss in specific areas of the visual field. The nature of the defect provides crucial information for localizing a lesion along the visual pathway, from the retina to the occipital cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOptic Nerve Lesion:\u003c/b\u003e Monocular vision loss (anopia) in the ipsilateral eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOptic Chiasm Lesion:\u003c/b\u003e \u003cmark\u003e[[6c3a980e|Bitemporal hemianopia]]\u003c/mark\u003e (tunnel vision), caused by compression of the decussating nasal fibers (e.g., from a [[5f3188bd|pituitary adenoma]] or [[bd802d22|AComA aneurysm]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOptic Tract Lesion:\u003c/b\u003e Contralateral homonymous hemianopia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTemporal Lobe Lesion (Meyer\u0027s Loop):\u003c/b\u003e Contralateral superior quadrantanopia (\u0027pie in the sky\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eParietal Lobe Lesion (Dorsal Optic Radiation):\u003c/b\u003e Contralateral inferior quadrantanopia (\u0027pie on the floor\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOccipital Lobe Lesion (Visual Cortex):\u003c/b\u003e Contralateral homonymous hemianopia, often with \u003cmark\u003emacular sparing\u003c/mark\u003e due to dual blood supply from the MCA and PCA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIncreased Intracranial Hypertension:\u003c/b\u003e Can cause an enlarged blind spot due to papilledema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Systematically tracing the visual pathway and knowing where fibers cross is key to solving these problems. Nasal fibers cross at the chiasm; temporal fibers do not.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVisual field defects\u003c/b\u003e are a direct neuroanatomical map; the specific pattern of \u0027what\u0027s missing\u0027 in a patient\u0027s vision allows for precise localization of a lesion along the highly organized visual pathway.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"6c3a980e\"\n      }\n    ]\n  },\n  \"21e10649\": {\n    \"title\": \"Vitamin A (Retinol)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Nutrition\",\n      \"Dermatology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVitamin A (Retinol)\u003c/b\u003e is a fat-soluble vitamin essential for vision, immune function, reproduction, and cellular differentiation. It exists in several forms, including retinol, retinal, and retinoic acid.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction (Vision):\u003c/b\u003e Retinal is a component of the visual pigment rhodopsin in photoreceptor cells of the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficiency:\u003c/b\u003e Can cause \u003cmark\u003enight blindness (nyctalopia)\u003c/mark\u003e, xerophthalmia (dry eyes), Bitot spots (keratin debris on conjunctiva), and corneal degeneration (keratomalacia). Also leads to immunosuppression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxicity (Hypervitaminosis A):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAcute:\u003c/b\u003e Nausea, vomiting, vertigo, and blurred vision.\u003cbr\u003e - \u003cb\u003eChronic:\u003c/b\u003e Alopecia, dry skin, hepatotoxicity, arthralgias, and \u003cmark\u003e[[7c4e7c74|idiopathic intracranial hypertension]]\u003c/mark\u003e (pseudotumor cerebri).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTeratogenicity:\u003c/b\u003e Vitamin A is highly teratogenic (especially the synthetic retinoid isotretinoin), causing birth defects. It is contraindicated in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the dual risk of Vitamin A: deficiency causes night blindness, while excess can cause pseudotumor cerebri and is a potent teratogen.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVitamin A\u003c/b\u003e is crucial for vision, but its levels must be tightly regulated, as both deficiency and excess can lead to significant pathology, ranging from night blindness to increased intracranial pressure and severe birth defects.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_essential_for\",\n        \"to\": \"vision\"\n      },\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"night_blindness\"\n      },\n      {\n        \"type\": \"excess_causes\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"is_a\",\n        \"to\": \"teratogen\"\n      }\n    ]\n  },\n  \"784e2484\": {\n    \"title\": \"Vitamin B12 (Cobalamin)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Nutrition\",\n      \"Hematology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVitamin B\u003csub\u003e12\u003c/sub\u003e (Cobalamin)\u003c/b\u003e is a water-soluble vitamin that is a crucial cofactor for two key enzymatic reactions: the conversion of homocysteine to methionine and the conversion of methylmalonyl-CoA to succinyl-CoA. Its deficiency leads to megaloblastic anemia and severe neurological dysfunction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Cofactor for methionine synthase (regenerates THF and converts homocysteine to methionine) and methylmalonyl-CoA mutase (involved in odd-chain fatty acid metabolism).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficiency Causes:\u003c/b\u003e Pernicious anemia (most common), malabsorption (e.g., Crohn\u0027s disease, gastric bypass), insufficient intake (strict vegans), or infection with the fish tapeworm \u003ci\u003eDiphyllobothrium latum\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHematologic Manifestations:\u003c/b\u003e Megaloblastic anemia (due to impaired DNA synthesis from folate trapping).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Manifestations:\u003c/b\u003e Deficiency causes \u003cmark\u003e[[6f5bea90|Subacute Combined Degeneration (SCD)]]\u003c/mark\u003e of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSCD Pathology:\u003c/b\u003e Demyelination of the \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e (loss of proprioception/vibration), \u003cmark\u003elateral corticospinal tracts\u003c/mark\u003e (spastic paresis), and spinocerebellar tracts (ataxia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Neurological symptoms of B\u003csub\u003e12\u003c/sub\u003e deficiency can occur \u003cu\u003ewithout\u003c/u\u003e anemia. Administration of folate alone to a B\u003csub\u003e12\u003c/sub\u003e-deficient patient can correct the anemia but will worsen the neurological symptoms. Always check B\u003csub\u003e12\u003c/sub\u003e levels in a patient with megaloblastic anemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVitamin B\u003csub\u003e12\u003c/sub\u003e deficiency\u003c/b\u003e is a dual-system threat, causing megaloblastic anemia by trapping folate and, more insidiously, causing irreversible neurological damage through subacute combined degeneration of the spinal cord by disrupting myelin synthesis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vitamin B12 Deficiency] --\u003e B(‚Üì Methionine Synthase Activity); B --\u003e C(Folate Trap -\u003e Megaloblastic Anemia); A --\u003e D(‚Üë Methylmalonyl-CoA); D --\u003e E(Abnormal Fatty Acid Synthesis); E --\u003e F(Myelin Damage); F --\u003e G(Subacute Combined Degeneration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"megaloblastic_anemia\"\n      },\n      {\n        \"type\": \"is_a_cofactor_for\",\n        \"to\": \"methionine_synthase\"\n      },\n      {\n        \"type\": \"is_a_cofactor_for\",\n        \"to\": \"methylmalonyl_coa_mutase\"\n      }\n    ]\n  },\n  \"ae1e474d\": {\n    \"title\": \"Vitamin B9 (Folate)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Nutrition\",\n      \"Hematology\",\n      \"Embryology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVitamin B\u003csub\u003e9\u003c/sub\u003e (Folate)\u003c/b\u003e is a water-soluble vitamin that, in its active form tetrahydrofolate (THF), is essential for one-carbon transfer reactions, which are critical for the synthesis of nitrogenous bases in DNA and RNA.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e THF is a cofactor for the synthesis of thymidine, purines (adenine, guanine), and methionine. It is essential for DNA synthesis and repair.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficiency Causes:\u003c/b\u003e Insufficient dietary intake (e.g., alcoholism, elderly), malabsorption, or increased demand (e.g., pregnancy, hemolytic anemia). Certain drugs can also cause deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug-Induced Deficiency:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMethotrexate:\u003c/b\u003e Inhibits dihydrofolate reductase.\u003cbr\u003e - \u003cb\u003eTrimethoprim:\u003c/b\u003e Inhibits bacterial dihydrofolate reductase.\u003cbr\u003e - \u003cb\u003e[[5aea213f|Phenytoin]] and other anticonvulsants:\u003c/b\u003e Can interfere with folate absorption and metabolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Manifestations:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMegaloblastic Anemia:\u003c/b\u003e Impaired DNA synthesis in hematopoietic precursors leads to large, fragile red blood cells. Hypersegmented neutrophils are seen.\u003cbr\u003e - \u003cb\u003eNeural Tube Defects:\u003c/b\u003e Maternal folate deficiency is a major risk factor for neural tube defects (e.g., spina bifida, anencephaly) in the developing fetus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Folate deficiency causes megaloblastic anemia but, unlike B\u003csub\u003e12\u003c/sub\u003e deficiency, it does \u003cu\u003enot\u003c/u\u003e cause neurological symptoms. Both deficiencies will have elevated homocysteine, but only B\u003csub\u003e12\u003c/sub\u003e deficiency will have elevated methylmalonic acid.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eFolate\u003c/b\u003e is indispensable for DNA synthesis, and its deficiency manifests as megaloblastic anemia and a high risk of neural tube defects, highlighting the critical need for supplementation in pregnancy and caution with drugs like anticonvulsants that can deplete its levels.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"megaloblastic_anemia\"\n      },\n      {\n        \"type\": \"deficiency_is_risk_factor_for\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"levels_can_be_depleted_by\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"deficiency_differentiated_from_b12_by\",\n        \"to\": \"absence_of_neurological_symptoms\"\n      }\n    ]\n  },\n  \"36e0b01f\": {\n    \"title\": \"Voluntary Movement\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Motor System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVoluntary movement\u003c/b\u003e is a complex process initiated in the cerebral cortex and executed through the coordinated action of upper and lower motor neurons, with continuous modulation from the [[ed462927|basal ganglia]] and cerebellum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInitiation:\u003c/b\u003e The decision to move originates in the prefrontal and premotor cortices. The primary motor cortex then executes the command.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExecution Pathway:\u003c/b\u003e The primary pathway is the \u003cmark\u003e[[fb0a5fdc|corticospinal tract]]\u003c/mark\u003e. Upper motor neurons (UMNs) from the motor cortex descend and synapse on lower motor neurons (LMNs) in the spinal cord, which in turn innervate the muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eModulation by Basal Ganglia:\u003c/b\u003e The [[ed462927|basal ganglia]] are crucial for selecting the appropriate motor program and suppressing unwanted movements. They act via feedback loops to the cortex through the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eModulation by Cerebellum:\u003c/b\u003e The cerebellum coordinates the timing and force of movements, ensuring they are smooth and accurate. It corrects for errors in real-time.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the roles of the different motor system components: Cortex \u003d Command, Corticospinal Tract \u003d Conduit, Basal Ganglia \u003d Gatekeeper, Cerebellum \u003d Coordinator, LMN \u003d Final Common Pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVoluntary movement\u003c/b\u003e is not a simple command but a symphony conducted by the motor cortex, with the basal ganglia selecting the piece and the cerebellum ensuring the timing and harmony, all played out through the corticospinal tracts and peripheral nerves.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cortex] --Command--\u003e B(Corticospinal Tract); B --\u003e C(LMNs); C --\u003e D(Muscle Contraction); E(Basal Ganglia) --Modulates--\u003e A; F(Cerebellum) --Modulates--\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"corticospinal_tracts\"\n      },\n      {\n        \"type\": \"is_modulated_by\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"is_modulated_by\",\n        \"to\": \"bebe58d4\"\n      }\n    ]\n  },\n  \"8b927b54\": {\n    \"title\": \"Vomiting\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Gastroenterology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVomiting\u003c/b\u003e (emesis) is the forceful expulsion of the contents of the stomach through the mouth. It is a complex reflex coordinated by the vomiting center in the brainstem, which receives inputs from multiple sources.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVomiting Center:\u003c/b\u003e The central coordinator is the \u003cmark\u003enucleus tractus solitarius (NTS)\u003c/mark\u003e in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Inputs to Vomiting Center:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[93f70f8e|Chemoreceptor Trigger Zone (CTZ)]]:\u003c/b\u003e The [[5dd343d3|area postrema]] in the fourth ventricle, which lies outside the blood-brain barrier and detects emetogenic substances in the blood (e.g., chemotherapy, toxins). Rich in D\u003csub\u003e2\u003c/sub\u003e and 5-HT\u003csub\u003e3\u003c/sub\u003e receptors.\u003cbr\u003e2. \u003cb\u003eGI Tract:\u003c/b\u003e Vagal afferents from the GI tract respond to irritation or distension.\u003cbr\u003e3. \u003cb\u003eVestibular System:\u003c/b\u003e Input from the vestibular system mediates motion sickness.\u003cbr\u003e4. \u003cb\u003eCNS:\u003c/b\u003e Higher cortical centers can trigger vomiting in response to sights, smells, or emotional distress.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke:\u003c/b\u003e Vomiting can be a prominent symptom of brainstem or cerebellar strokes, particularly those affecting the vestibular nuclei (e.g., lateral medullary syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The CTZ is a key pharmacological target. 5-HT\u003csub\u003e3\u003c/sub\u003e antagonists (ondansetron) are effective for chemotherapy-induced vomiting, while antihistamines and anticholinergics are effective for motion sickness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVomiting\u003c/b\u003e is a protective reflex orchestrated by the brainstem\u0027s vomiting center, which integrates a wide array of inputs‚Äîfrom blood-borne toxins detected by the CTZ to vestibular signals of motion sickness‚Äîto trigger the forceful emptying of the stomach.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CTZ] --\u003e E(Vomiting Center - NTS); B[GI Tract - Vagal Afferents] --\u003e E; C[Vestibular System] --\u003e E; D[CNS] --\u003e E; E --\u003e F(Vomiting);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_coordinated_by\",\n        \"to\": \"74b651ab\"\n      },\n      {\n        \"type\": \"is_triggered_by\",\n        \"to\": \"93f70f8e\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"c5da3c57\"\n      }\n    ]\n  },\n  \"74b651ab\": {\n    \"title\": \"Vomiting Center\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003evomiting center\u003c/b\u003e is a functionally defined area in the medulla oblongata that coordinates the complex motor act of vomiting. The core of this center is the \u003cmark\u003enucleus tractus solitarius (NTS)\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Nucleus tractus solitarius (NTS) in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Integrates afferent signals from various sources and generates the efferent output for the vomiting reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Inputs:\u003c/b\u003e\u003cbr\u003e - From the [[93f70f8e|chemoreceptor trigger zone (CTZ)]] (detects blood-borne emetics).\u003cbr\u003e - From the GI tract via the vagus nerve (detects irritation).\u003cbr\u003e - From the vestibular system (mediates motion sickness).\u003cbr\u003e - From higher CNS centers (psychogenic vomiting).\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e The NTS is rich in various neurotransmitter receptors, including neurokinin-1 (NK-1), which binds substance P.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e NK-1 receptor antagonists (e.g., aprepitant) are potent antiemetics that act directly on the vomiting center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While the CTZ is the \u0027detector\u0027 for blood-borne toxins, the NTS is the \u0027coordinator\u0027 of the vomiting reflex itself.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003evomiting center\u003c/b\u003e, centered on the nucleus tractus solitarius, is the brainstem\u0027s command post for emesis, integrating signals of distress from the gut, blood, and vestibular system to orchestrate the forceful expulsion of stomach contents.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CTZ] --\u003e B(Vomiting Center - NTS); C[GI Tract] --\u003e B; D[Vestibular System] --\u003e B; B --\u003e E(Efferent Signals to Diaphragm, Abdominal Muscles, etc.); E --\u003e F(Vomiting);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"nucleus_tractus_solitarius\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"93f70f8e\"\n      },\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"nk1_receptor_antagonists\"\n      }\n    ]\n  },\n  \"274cb033\": {\n    \"title\": \"Von Hippel-Lindau Disease\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Genetics\",\n      \"Oncology\",\n      \"Neurology\",\n      \"Nephrology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVon Hippel-Lindau (VHL) disease\u003c/b\u003e is an autosomal dominant neurocutaneous disorder caused by a mutation in the \u003ci\u003eVHL\u003c/i\u003e tumor suppressor gene on chromosome 3. It is characterized by the development of numerous benign and malignant tumors in various organs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal dominant inheritance of a mutated \u003ci\u003eVHL\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The VHL protein normally degrades hypoxia-inducible factor 1Œ± (HIF-1Œ±). Loss of VHL function leads to accumulation of HIF-1Œ±, which promotes angiogenesis and cell growth, leading to tumor formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCharacteristic Tumors (Mnemonic HARP):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eH\u003c/b\u003eemangioblastomas: Highly vascular tumors of the retina, cerebellum, brainstem, and spine.\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003engiomatosis: Formation of angiomas.\u003cbr\u003e - \u003cb\u003eR\u003c/b\u003eenal Cell Carcinoma: Bilateral, clear cell type.\u003cbr\u003e - \u003cb\u003eP\u003c/b\u003eheochromocytoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Tumors:\u003c/b\u003e Can also cause endolymphatic sac tumors (leading to hearing loss) and cysts in the kidney and pancreas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with cerebellar hemangioblastomas and bilateral renal cell carcinoma is the classic presentation. The hemangioblastomas can produce erythropoietin, leading to secondary polycythemia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVon Hippel-Lindau disease\u003c/b\u003e is a hereditary cancer syndrome driven by a faulty \u0027oxygen sensor\u0027 (VHL protein), leading to a pseudo-hypoxic state that fuels the growth of highly vascular tumors, most notably hemangioblastomas and renal cell carcinomas.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[VHL Gene Mutation] --\u003e B(Loss of pVHL function); B --\u003e C(Accumulation of HIF-1Œ±); C --\u003e D(‚Üë Angiogenesis \u0026 Cell Growth); D --\u003e E(Tumor Formation - Hemangioblastoma, RCC, etc.);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous_disorder\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"b7b619f2\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"hemangioblastoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"renal_cell_carcinoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"pheochromocytoma\"\n      }\n    ]\n  },\n  \"1d7d392c\": {\n    \"title\": \"Wallenberg Syndrome (Lateral Medullary Syndrome)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Stroke\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWallenberg syndrome\u003c/b\u003e, or lateral medullary syndrome, is a brainstem stroke syndrome caused by an infarct in the lateral medulla oblongata, typically due to occlusion of the posterior inferior cerebellar artery (PICA).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e Posterior Inferior Cerebellar Artery (PICA). Less commonly, occlusion of the vertebral artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation (Mnemonic \u0027Don\u0027t PICA lame horse that can\u0027t eat\u0027):\u003c/b\u003e A complex constellation of crossed findings:\u003cbr\u003e - \u003cb\u003eVestibular nuclei:\u003c/b\u003e Vertigo, nystagmus, nausea/vomiting.\u003cbr\u003e - \u003cb\u003eInferior cerebellar peduncle:\u003c/b\u003e Ipsilateral [[9767fd6b|ataxia]] and dysmetria.\u003cbr\u003e - \u003cb\u003eSpinothalamic tract:\u003c/b\u003e Contralateral loss of pain and temperature sensation in the body.\u003cbr\u003e - \u003cb\u003eSpinal trigeminal nucleus:\u003c/b\u003e Ipsilateral loss of pain and temperature sensation in the face.\u003cbr\u003e - \u003cb\u003eNucleus ambiguus (CN IX, X):\u003c/b\u003e \u003cmark\u003eDysphagia, hoarseness, diminished gag reflex\u003c/mark\u003e. (The \u0027lame horse that can\u0027t eat\u0027).\u003cbr\u003e - \u003cb\u003eSympathetic tract:\u003c/b\u003e Ipsilateral [[c19010a3|Horner syndrome]] (ptosis, miosis, anhidrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of dysphagia and hoarseness is the key feature that distinguishes a lateral medullary (PICA) stroke from a lateral pontine (AICA) stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWallenberg syndrome\u003c/b\u003e is a classic brainstem stroke that creates a striking pattern of ipsilateral cranial nerve deficits (including dysphagia and Horner\u0027s) and ataxia, combined with contralateral body sensory loss, all due to an infarct in the PICA territory of the lateral medulla.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PICA Occlusion] --\u003e B(Lateral Medullary Infarct); B --\u003e C(Ipsilateral CN Deficits - V, IX, X); B --\u003e D(Ipsilateral Ataxia); B --\u003e E(Ipsilateral Horner\u0027s); B --\u003e F(Contralateral Body Pain/Temp Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"brainstem_syndrome\"\n      },\n      {\n        \"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"posterior_inferior_cerebellar_artery\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"f0207c17\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"c19010a3\"\n      }\n    ]\n  },\n  \"6772c663\": {\n    \"title\": \"Watershed Areas\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eWatershed areas\u003c/b\u003e are regions of the brain that receive a dual blood supply from the most distal branches of two adjacent major cerebral arteries. These zones are particularly vulnerable to ischemia in the setting of systemic hypoperfusion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e During a state of systemic hypotension (e.g., shock, cardiac arrest), blood pressure may be insufficient to perfuse these distal \u0027border zones,\u0027 leading to a \u003cmark\u003ewatershed infarct\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Watershed Zones:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eACA-MCA Watershed:\u003c/b\u003e Located between the anterior and middle cerebral artery territories. Infarction here can cause weakness of the proximal arm and leg, sparing the hand and foot, sometimes called \u003cmark\u003e\u0027man-in-a-barrel\u0027 syndrome\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eMCA-PCA Watershed:\u003c/b\u003e Located between the middle and posterior cerebral artery territories. Infarction can cause higher-order visual processing deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterior Spinal Artery:\u003c/b\u003e The territory of the anterior spinal artery, particularly in the mid-thoracic region (T4-T8), is also a watershed area, making it vulnerable to ischemia during aortic surgery or severe hypotension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who suffers a hypotensive episode and subsequently develops bilateral proximal limb weakness (\u0027man-in-a-barrel\u0027) has likely sustained an ACA-MCA watershed stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWatershed areas\u003c/b\u003e are the \u0027no-man\u0027s land\u0027 of cerebral circulation, the border territories at the farthest reach of the major arteries, making them the first to suffer ischemic damage when systemic blood pressure falls too low.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_vulnerable_to\",\n        \"to\": \"hypoperfusion\"\n      },\n      {\n        \"type\": \"are_located_between\",\n        \"to\": \"e51a7691\"\n      },\n      {\n        \"type\": \"infarction_can_cause\",\n        \"to\": \"man_in_a_barrel_syndrome\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10249,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"b7b619f2\": {\n    \"title"
      }, {
        "text": "\": \"VHL Gene\",\n    \"primaryType\": \"gene\",\n    \"tags\": [\n      \"Gen"
      }, {
        "text": "etics\",\n      \"Oncology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Tumor Suppressor Genes\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVHL gene\u003c/b\u003e (von Hippel-Lindau tumor"
      }, {
        "text": " suppressor) is a gene on chromosome 3 that encodes the pVHL protein. Germline mutations or deletions of this gene cause"
      }, {
        "text": " [[274cb033|von Hippel-Lindau disease]], an autosomal dominant syndrome characterized by the"
      }, {
        "text": " development of numerous benign and malignant tumors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of pVHL:"
      }, {
        "text": "\u003c/b\u003e The VHL protein is part of a ubiquitin ligase complex that targets hypoxia-inducible factor 1Œ± (HIF-1Œ±) for"
      }, {
        "text": " degradation in the presence of oxygen.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Loss of VHL function leads to the stabilization and"
      }, {
        "text": " accumulation of HIF-1Œ±, even under normoxic conditions. HIF-1Œ± then acts as a transcription factor, up"
      }, {
        "text": "regulating genes involved in angiogenesis (e.g., VEGF) and cell growth, promoting tumor formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Tumors (Mnemonic HARP):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eH\u003c/b\u003eemangioblastomas (ret"
      }, {
        "text": "ina, cerebellum, brainstem, spine)\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003engiomatosis\u003cbr\u003e - \u003cb\u003eR"
      }, {
        "text": "\u003c/b\u003eenal cell carcinoma (bilateral, clear cell type)\u003cbr\u003e - \u003cb\u003eP\u003c/b\u003eheochromocytoma\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e VHL is a classic tumor suppressor gene. Its inactivation leads to a \u0027pseudo-hyp"
      }, {
        "text": "oxic\u0027 state where angiogenic factors are constitutively active, driving the growth of highly vascular tumors like hemangioblastomas and"
      }, {
        "text": " renal cell carcinoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVHL gene\u003c/b\u003e acts"
      }, {
        "text": " as the oxygen sensor for a major growth pathway; its inactivation tricks the cell into thinking it\u0027s hypoxic, leading to the"
      }, {
        "text": " uncontrolled production of blood vessels and the formation of the highly vascular tumors characteristic of von Hippel-Lindau disease.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Normal Oxygen] --\u003e B(pVHL); B --\u003e C(Deg"
      }, {
        "text": "radation of HIF-1Œ±); C --x D(Angiogenesis); E[VHL Deletion] --"
      }, {
        "text": "x B; E --\u003e F(HIF-1Œ± Accumulation); F --\u003e D;\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"mutation_causes\",\n        \"to\": \"274cb03"
      }, {
        "text": "3\"\n      },\n      {\n        \"type\": \"is_a\",\n        \"to\": \"tumor_"
      }, {
        "text": "suppressor_gene\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"h"
      }, {
        "text": "if_1_alpha\"\n      }\n    ]\n  },\n  \"c3b254c8"
      }, {
        "text": "\": {\n    \"title\": \"Vibration Sense\",\n    \"primaryType\": \"physiology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neurophysiology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sens"
      }, {
        "text": "ory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVibration sense\u003c/b\u003e (pall"
      }, {
        "text": "esthesia) is the ability to perceive a vibratory stimulus, typically tested using a tuning fork. It is a sensory modality transmitted"
      }, {
        "text": " by large, myelinated nerve fibers via the dorsal column-medial lemniscus pathway.\u003c/p\u003e\",\n      \"atAGlance\":"
      }, {
        "text": " \"\u003cul\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Sensation is detected by mechanoreceptors in the skin and deeper tissues:\u003cbr\u003e - \u003cb\u003eP"
      }, {
        "text": "acinian corpuscles:\u003c/b\u003e Detect high-frequency vibration.\u003cbr\u003e - \u003cb\u003eMeissner\u0027s corpuscles:\u003c/b\u003e Detect low-"
      }, {
        "text": "frequency vibration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Pathway:\u003c/b\u003e The signal travels via large, myelinated AŒ≤ fibers through the peripheral"
      }, {
        "text": " nerves to the spinal cord, where it ascends ipsilaterally in the \u003cmark\u003e[[e7f5cbbe"
      }, {
        "text": "|dorsal columns]]\u003c/mark\u003e. After synapsing and decussating in the medulla, it travels via the medial"
      }, {
        "text": " lemniscus to the VPL nucleus of the [[afc0a64b|thalamus]] and then to the som"
      }, {
        "text": "atosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Loss of vibration sense is often one of the earliest signs of peripheral"
      }, {
        "text": " neuropathy (e.g., in diabetes) and dorsal column pathology.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Impaired vibration sense is a"
      }, {
        "text": " key finding in [[6f5bea90|subacute combined degeneration]] (vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency), [[7"
      }, {
        "text": "1daebd6|tabes dorsalis]] (neurosyphilis), and [[39bc176"
      }, {
        "text": "3|Friedreich ataxia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Vibration and proprioception travel together in the dorsal columns"
      }, {
        "text": ". A patient with loss of vibration sense will likely also have a positive Romberg sign.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eVibration sense\u003c/b\u003e is a critical component of the neurological exam that specifically tests the integrity of the large"
      }, {
        "text": " myelinated fibers of the dorsal column-medial lemniscus pathway, making it a sensitive indicator of both peripheral neuropathy and spinal"
      }, {
        "text": " cord disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_transmitted_by\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_detected_by\",\n        \"to\": \"pacinian_corpuscles\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"6"
      }, {
        "text": "f5bea90\"\n      },\n      {\n        \"type\": \"is_impaired_in"
      }, {
        "text": "\",\n        \"to\": \"71daebd6\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"5aced400\": {\n    \"title\": \"Vision Disturbances\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Symptoms\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVision disturbances\u003c/b\u003e are a broad"
      }, {
        "text": " category of symptoms affecting sight, which can range from blurred vision to complete blindness. They can be caused by pathology anywhere along the visual"
      }, {
        "text": " pathway, from the cornea to the occipital cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Refractive Errors:\u003c/b\u003e Blurred vision correctable with lenses (e.g., myopia, hyperopia, [[18c"
      }, {
        "text": "ff34e|astigmatism]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedia Opacities:\u003c/b\u003e Clouding of the normally clear"
      }, {
        "text": " parts of the eye, such as [[85f03b02|cataracts]] (lens) or vitreous hemorrhage"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[3ce6c035|Glaucoma]]:\u003c/b\u003e A group of diseases that damage"
      }, {
        "text": " the optic nerve, typically causing progressive peripheral vision loss. [[9c80344d|Acute angle-closure glaucoma]] causes"
      }, {
        "text": " sudden, painful vision loss with halos around lights.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinal Disorders:\u003c/b\u003e Include [[c632"
      }, {
        "text": "55c8|macular degeneration]] (central vision loss), [[73b00ab0|diabetic retinopathy]],"
      }, {
        "text": " and retinal detachment (\u0027curtain\u0027 over vision).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[ff289b3a|Visual Field Defects"
      }, {
        "text": "]]:\u003c/b\u003e Patterns of vision loss that help localize lesions along the optic pathway (e.g., [[6c3a9"
      }, {
        "text": "80e|bitemporal hemianopia]] from chiasmal compression).\u003c/li\u003e\u003cli\u003e\u003cb\u003eIncreased Intracranial Hypertension"
      }, {
        "text": ":\u003c/b\u003e Can cause [[papilledema]] and transient visual obscurations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " nature of the vision disturbance provides crucial diagnostic clues. Is it painful or painless? Transient or persistent? Affecting central or peripheral vision? Monocular"
      }, {
        "text": " or binocular?\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVision disturbances\u003c/b\u003e are a key neurological"
      }, {
        "text": " and ophthalmological symptom, and a careful history of their characteristics‚Äîsuch as timing, location in the visual field, and associated"
      }, {
        "text": " symptoms‚Äîis essential for localizing the underlying pathology along the complex visual pathway.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        \""
      }, {
        "text": "to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"can"
      }, {
        "text": "_be_caused_by\",\n        \"to\": \"ff289b3a\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"can_be_caused_by\",\n        \"to\": \"7c4e7"
      }, {
        "text": "c74\"\n      }\n    ]\n  },\n  \"67790093\": {\n    \"title"
      }, {
        "text": "\": \"Thalamic Relay for Vision\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroanatomy\",\n      \"Neurophysiology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\","
      }, {
        "text": "\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003ethalamic relay for vision\u003c/b\u003e is the process by which visual information from the retina is processed and relayed to the primary"
      }, {
        "text": " visual cortex. This function is performed by the \u003cmark\u003eLateral Geniculate Nucleus (LGN)\u003c/mark\u003e of the [["
      }, {
        "text": "afc0a64b|thalamus]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eStructure:\u003c/b\u003e The Lateral Geniculate Nucleus (LGN) is a specific sensory relay nucleus in the [[afc0a64"
      }, {
        "text": "b|thalamus]]. Mnemonic: \u003cb\u003eL\u003c/b\u003eGN for \u003cb\u003eL\u003c/b\u003eight.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Input:\u003c/b\u003e The LGN receives major sensory input from retinal ganglion cells via the optic tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSegregation of"
      }, {
        "text": " Input:\u003c/b\u003e Information from the ipsilateral and contralateral eyes remains segregated in different layers of the LGN.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Neur"
      }, {
        "text": "ons of the LGN project to the primary [[a12351b0|visual cortex]] (B"
      }, {
        "text": "rodmann area 17) in the occipital lobe via the optic radiation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " that all sensory pathways (except olfaction) have a thalamic relay. For vision, this relay is the LGN. For"
      }, {
        "text": " hearing, it\u0027s the Medial Geniculate Nucleus (MGN).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eLateral Geniculate Nucleus\u003c/b\u003e of the thalamus serves as the essential processing and relay station for vision, receiving organized"
      }, {
        "text": " input from the retina and projecting it faithfully to the visual cortex for conscious perception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Retina] --\u003e B(Optic Tract); B --\u003e C(Lateral Geniculate Nucleus - LGN); C --\u003e D(Opt"
      }, {
        "text": "ic Radiation); D --\u003e E(Primary Visual Cortex);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_performed_by\",\n        \"to\": \"lateral_geniculate_nucleus\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_function_of\",\n        \"to\": \"afc0a64b"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"sends_output_to\",\n        \"to\":"
      }, {
        "text": " \"a12351b0\"\n      }\n    ]\n  },\n  \"a12351b0\":"
      }, {
        "text": " {\n    \"title\": \"Visual Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\":"
      }, {
        "text": " [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVisual Cortex\u003c/b\u003e is the region of the [[a1b198"
      }, {
        "text": "f9|cerebral cortex]] located in the occipital lobe that is responsible for processing visual information. It is divided"
      }, {
        "text": " into the primary visual cortex (V1) and higher-order visual association areas.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Visual Cortex (V1):\u003c/b\u003e Located in the calcarine sulcus of the occipital lobe ("
      }, {
        "text": "Brodmann area 17). It receives direct input from the \u003cmark\u003eLateral Geniculate Nucleus (LGN)\u003c/"
      }, {
        "text": "mark\u003e of the [[afc0a64b|thalamus]] via the optic radiation.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Retinotopic Organization:\u003c/b\u003e V1 is organized retinotopically, meaning that adjacent points on the retina are mapped to adjacent points in"
      }, {
        "text": " the cortex. The macula, responsible for central, high-acuity vision, has a disproportionately large representation."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood Supply:\u003c/b\u003e Primarily supplied by the \u003cmark\u003e[[b6a2cc31|Poster"
      }, {
        "text": "ior Cerebral Artery (PCA)]]\u003c/mark\u003e. The macular region often has a dual blood supply from the Middle Cerebral Artery (MCA),"
      }, {
        "text": " which can lead to \u0027macular sparing\u0027 in a PCA stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e A lesion of the primary"
      }, {
        "text": " visual cortex causes a contralateral \u003cmark\u003ehomonymous hemianopia\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcular Motility:\u003c/b\u003e The visual cortex"
      }, {
        "text": " is involved in voluntary eye movements, sending signals to the [[5ddbdcd3|frontal eye fields]] to direct"
      }, {
        "text": " gaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A stroke in the PCA territory classically causes a contralateral homonymous hemianopia with macular"
      }, {
        "text": " sparing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVisual Cortex\u003c/b\u003e is the brain\u0027s final destination"
      }, {
        "text": " for visual processing, where raw data from the thalamus is transformed into the coherent images we perceive, with a significant portion of its"
      }, {
        "text": " real estate dedicated to the high-resolution input from the macula.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[LGN of Thalamus] --\u003e B(Optic Radiation); B --\u003e C(Primary Visual Cortex -"
      }, {
        "text": " V1); C --\u003e D(Visual Association Cortex);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_located_in\",\n        \"to\": \"occipital_lobe\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"receives_input_from\",\n        \"to\": \"lateral_geniculate_nucleus\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_supplied_by\",\n        \"to\": \"b6a2cc31"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \""
      }, {
        "text": "homonymous_hemianopia\"\n      }\n    ]\n  },\n  \"ff289b3a\": {"
      }, {
        "text": "\n    \"title\": \"Visual Field Defects\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual Pathway\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVisual field defects\u003c/b\u003e are patterns of vision loss in specific areas of the visual field."
      }, {
        "text": " The nature of the defect provides crucial information for localizing a lesion along the visual pathway, from the retina to the occip"
      }, {
        "text": "ital cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOptic Nerve Lesion:\u003c/b\u003e Mon"
      }, {
        "text": "ocular vision loss (anopia) in the ipsilateral eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOptic Chiasm Lesion:"
      }, {
        "text": "\u003c/b\u003e \u003cmark\u003e[[6c3a980e|Bitemporal hemianopia]]\u003c/mark\u003e (tunnel"
      }, {
        "text": " vision), caused by compression of the decussating nasal fibers (e.g., from a [[5f318"
      }, {
        "text": "8bd|pituitary adenoma]] or [[bd802d22|AComA aneurysm]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOptic Tract"
      }, {
        "text": " Lesion:\u003c/b\u003e Contralateral homonymous hemianopia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTemporal Lobe Lesion (Meyer\u0027s Loop"
      }, {
        "text": "):\u003c/b\u003e Contralateral superior quadrantanopia (\u0027pie in the sky\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eParietal Lobe Lesion (D"
      }, {
        "text": "orsal Optic Radiation):\u003c/b\u003e Contralateral inferior quadrantanopia (\u0027pie on the floor\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOcc"
      }, {
        "text": "ipital Lobe Lesion (Visual Cortex):\u003c/b\u003e Contralateral homonymous hemianopia, often with \u003cmark\u003emacular sparing\u003c/"
      }, {
        "text": "mark\u003e due to dual blood supply from the MCA and PCA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eIncreased Intracranial Hypertension:\u003c/b\u003e Can cause"
      }, {
        "text": " an enlarged blind spot due to papilledema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Systematically tracing the visual pathway and"
      }, {
        "text": " knowing where fibers cross is key to solving these problems. Nasal fibers cross at the chiasm; temporal fibers do"
      }, {
        "text": " not.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVisual field defects\u003c/b\u003e are a direct neuroanatom"
      }, {
        "text": "ical map; the specific pattern of \u0027what\u0027s missing\u0027 in a patient\u0027s vision allows for precise localization of a lesion along the highly"
      }, {
        "text": " organized visual pathway.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"can_be_caused_by\",\n        \"to\": \"c5da3c5"
      }, {
        "text": "7\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        "
      }, {
        "text": "\"to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"can_"
      }, {
        "text": "be_caused_by\",\n        \"to\": \"7c4e7c74\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"6c3a980"
      }, {
        "text": "e\"\n      }\n    ]\n  },\n  \"21e10649\": {\n    \"title\": \""
      }, {
        "text": "Vitamin A (Retinol)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      "
      }, {
        "text": "\"Nutrition\",\n      \"Dermatology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Phys"
      }, {
        "text": "iology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVitamin A (Retinol)\u003c/b\u003e is a fat-"
      }, {
        "text": "soluble vitamin essential for vision, immune function, reproduction, and cellular differentiation. It exists in several forms, including retinol, retinal, and ret"
      }, {
        "text": "inoic acid.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction (Vision):\u003c/b\u003e Retinal is a component"
      }, {
        "text": " of the visual pigment rhodopsin in photoreceptor cells of the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficiency:\u003c/b\u003e Can cause \u003c"
      }, {
        "text": "mark\u003enight blindness (nyctalopia)\u003c/mark\u003e, xerophthalmia (dry eyes), Bitot spots (keratin debris"
      }, {
        "text": " on conjunctiva), and corneal degeneration (keratomalacia). Also leads to immunosuppression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eToxicity ("
      }, {
        "text": "Hypervitaminosis A):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAcute:\u003c/b\u003e Nausea, vomiting, vertigo, and blurred vision.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eChronic:\u003c/b\u003e Alopecia, dry skin, hepatotoxicity, arthralgias, and \u003c"
      }, {
        "text": "mark\u003e[[7c4e7c74|idiopathic intracranial hypertension]]\u003c/mark\u003e (pseudotumor cerebri).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eTeratogenicity:\u003c/b\u003e Vitamin A is highly teratogenic (especially the synthetic retinoid isotretinoin),"
      }, {
        "text": " causing birth defects. It is contraindicated in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the dual risk of Vitamin"
      }, {
        "text": " A: deficiency causes night blindness, while excess can cause pseudotumor cerebri and is a potent teratogen.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVitamin A\u003c/b\u003e is crucial for vision, but its levels must be tightly regulated,"
      }, {
        "text": " as both deficiency and excess can lead to significant pathology, ranging from night blindness to increased intracranial pressure and severe birth defects.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_essential"
      }, {
        "text": "_for\",\n        \"to\": \"vision\"\n      },\n      {\n        \"type\": \"def"
      }, {
        "text": "iciency_causes\",\n        \"to\": \"night_blindness\"\n      },\n      {\n        \"type\": \"excess"
      }, {
        "text": "_causes\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_a\",\n        \"to\": \"teratogen\"\n      }\n    ]\n  },\n  \"7"
      }, {
        "text": "84e2484\": {\n    \"title\": \"Vitamin B12 (Cobalamin)\",\n    "
      }, {
        "text": "\"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Nutrition\",\n      \"Hematology\",\n"
      }, {
        "text": "      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVitamin B\u003csub\u003e12\u003c/sub\u003e (Cobalamin)\u003c/b\u003e is a"
      }, {
        "text": " water-soluble vitamin that is a crucial cofactor for two key enzymatic reactions: the conversion of homocysteine to methionine and the"
      }, {
        "text": " conversion of methylmalonyl-CoA to succinyl-CoA. Its deficiency leads to megaloblastic anemia and severe neurological dysfunction.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Cofactor for methionine synthase (regenerates THF and converts homocysteine to methionine) and methyl"
      }, {
        "text": "malonyl-CoA mutase (involved in odd-chain fatty acid metabolism).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficiency Causes:\u003c/b\u003e Pern"
      }, {
        "text": "icious anemia (most common), malabsorption (e.g., Crohn\u0027s disease, gastric bypass), insufficient intake (strict"
      }, {
        "text": " vegans), or infection with the fish tapeworm \u003ci\u003eDiphyllobothrium latum\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHemat"
      }, {
        "text": "ologic Manifestations:\u003c/b\u003e Megaloblastic anemia (due to impaired DNA synthesis from folate trapping).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Manifestations"
      }, {
        "text": ":\u003c/b\u003e Deficiency causes \u003cmark\u003e[[6f5bea90|Subacute Combined Degeneration (SCD)]]\u003c/"
      }, {
        "text": "mark\u003e of the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSCD Pathology:\u003c/b\u003e Demyelination of the \u003cmark\u003e[[e7f5cb"
      }, {
        "text": "be|dorsal columns]]\u003c/mark\u003e (loss of proprioception/vibration), \u003cmark\u003elateral corticospinal tracts\u003c/mark\u003e ("
      }, {
        "text": "spastic paresis), and spinocerebellar tracts (ataxia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Neurological symptoms of B\u003csub\u003e12\u003c/sub\u003e"
      }, {
        "text": " deficiency can occur \u003cu\u003ewithout\u003c/u\u003e anemia. Administration of folate alone to a B\u003csub\u003e12\u003c/sub\u003e-deficient patient can correct"
      }, {
        "text": " the anemia but will worsen the neurological symptoms. Always check B\u003csub\u003e12\u003c/sub\u003e levels in a patient with megaloblastic anemia.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVitamin B\u003csub\u003e12\u003c/sub\u003e deficiency\u003c/b\u003e is a dual-system"
      }, {
        "text": " threat, causing megaloblastic anemia by trapping folate and, more insidiously, causing irreversible neurological damage through subacute combined degeneration of"
      }, {
        "text": " the spinal cord by disrupting myelin synthesis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vitamin B12 Deficiency] --\u003e B("
      }, {
        "text": "‚Üì Methionine Synthase Activity); B --\u003e C(Folate Trap -\u003e Megaloblastic Anemia); A --\u003e D(‚Üë Methyl"
      }, {
        "text": "malonyl-CoA); D --\u003e E(Abnormal Fatty Acid Synthesis); E --\u003e F(Myelin Damage); F --\u003e G(Subacute Combined"
      }, {
        "text": " Degeneration);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"deficiency_"
      }, {
        "text": "causes\",\n        \"to\": \"6f5bea90\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"deficiency_causes\",\n        \"to\": \"megaloblastic_anemia\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a_cofactor_for\",\n        \"to\": \""
      }, {
        "text": "methionine_synthase\"\n      },\n      {\n        \"type\": \"is_a_cofactor"
      }, {
        "text": "_for\",\n        \"to\": \"methylmalonyl_coa_mutase\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "ae1e474d\": {\n    \"title\": \"Vitamin B9 (Folate)\",\n    \"primary"
      }, {
        "text": "Type\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Nutrition\",\n      \"Hematology\",\n      \""
      }, {
        "text": "Embryology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVitamin B\u003csub\u003e9\u003c/sub\u003e (Folate)\u003c/b\u003e is"
      }, {
        "text": " a water-soluble vitamin that, in its active form tetrahydrofolate (THF), is essential for one-carbon transfer"
      }, {
        "text": " reactions, which are critical for the synthesis of nitrogenous bases in DNA and RNA.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e THF is a cofactor for the synthesis of thymidine, purines (adenine, guanine), and methionine"
      }, {
        "text": ". It is essential for DNA synthesis and repair.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeficiency Causes:\u003c/b\u003e Insufficient dietary intake (e"
      }, {
        "text": ".g., alcoholism, elderly), malabsorption, or increased demand (e.g., pregnancy, hemolytic anemia). Certain"
      }, {
        "text": " drugs can also cause deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDrug-Induced Deficiency:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMethotrexate:"
      }, {
        "text": "\u003c/b\u003e Inhibits dihydrofolate reductase.\u003cbr\u003e - \u003cb\u003eTrimethoprim:\u003c/b\u003e Inhibits bacterial dihydrofolate reductase.\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003e[[5aea213f|Phenytoin]] and other anticonvulsants:\u003c/b\u003e Can interfere with folate absorption"
      }, {
        "text": " and metabolism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Manifestations:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMegaloblastic Anemia:\u003c/b\u003e Imp"
      }, {
        "text": "aired DNA synthesis in hematopoietic precursors leads to large, fragile red blood cells. Hypersegmented neutrophils are seen.\u003cbr\u003e - \u003cb\u003eNeural"
      }, {
        "text": " Tube Defects:\u003c/b\u003e Maternal folate deficiency is a major risk factor for neural tube defects (e.g., spina bifida"
      }, {
        "text": ", anencephaly) in the developing fetus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Folate deficiency causes megaloblastic anemia but"
      }, {
        "text": ", unlike B\u003csub\u003e12\u003c/sub\u003e deficiency, it does \u003cu\u003enot\u003c/u\u003e cause neurological symptoms. Both deficiencies will have elevated homocysteine,"
      }, {
        "text": " but only B\u003csub\u003e12\u003c/sub\u003e deficiency will have elevated methylmalonic acid.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eFolate\u003c/b\u003e is indispensable for DNA synthesis, and its deficiency manifests as megaloblastic anemia and a high"
      }, {
        "text": " risk of neural tube defects, highlighting the critical need for supplementation in pregnancy and caution with drugs like anticonvulsants that can"
      }, {
        "text": " deplete its levels.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"deficiency_causes\",\n        \"to\": \"megaloblastic_anemia\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"deficiency_is_risk_factor_for\",\n        \""
      }, {
        "text": "to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"levels_can_be_dep"
      }, {
        "text": "leted_by\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"deficiency_differentiated_from_b12_by\",\n        \"to\": \"absence_of_neurological_symptoms"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"36e0b01f\": {\n    \"title\":"
      }, {
        "text": " \"Voluntary Movement\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "physiology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Anatomy and Physiology\",\n      \"Motor System\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eVoluntary movement\u003c/b\u003e is a complex process initiated in the cerebral cortex and executed through the coordinated action of upper"
      }, {
        "text": " and lower motor neurons, with continuous modulation from the [[ed462927|basal ganglia]] and cerebellum"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInitiation:\u003c/b\u003e The decision to move originates in the pre"
      }, {
        "text": "frontal and premotor cortices. The primary motor cortex then executes the command.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExecution Pathway:\u003c/b\u003e The primary pathway"
      }, {
        "text": " is the \u003cmark\u003e[[fb0a5fdc|corticospinal tract]]\u003c/mark\u003e. Upper motor neurons (UMN"
      }, {
        "text": "s) from the motor cortex descend and synapse on lower motor neurons (LMNs) in the spinal cord, which in"
      }, {
        "text": " turn innervate the muscles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eModulation by Basal Ganglia:\u003c/b\u003e The [[ed462927|"
      }, {
        "text": "basal ganglia]] are crucial for selecting the appropriate motor program and suppressing unwanted movements. They act via feedback loops to the cortex"
      }, {
        "text": " through the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eModulation by Cerebellum:\u003c/b\u003e The cerebellum coordinates the timing and force of movements, ensuring they"
      }, {
        "text": " are smooth and accurate. It corrects for errors in real-time.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the roles"
      }, {
        "text": " of the different motor system components: Cortex \u003d Command, Corticospinal Tract \u003d Conduit, Basal Ganglia \u003d Gate"
      }, {
        "text": "keeper, Cerebellum \u003d Coordinator, LMN \u003d Final Common Pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVoluntary"
      }, {
        "text": " movement\u003c/b\u003e is not a simple command but a symphony conducted by the motor cortex, with the basal ganglia selecting the piece and"
      }, {
        "text": " the cerebellum ensuring the timing and harmony, all played out through the corticospinal tracts and peripheral nerves.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Cortex] --Command--\u003e B(Corticospinal Tract); B --\u003e C(L"
      }, {
        "text": "MNs); C --\u003e D(Muscle Contraction); E(Basal Ganglia) --Modulates--\u003e A; F(Cerebellum) --"
      }, {
        "text": "Modulates--\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_controlled"
      }, {
        "text": "_by\",\n        \"to\": \"corticospinal_tracts\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_modulated_by\",\n        \"to\": \"ed462927"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_modulated_by\",\n        \"to\":"
      }, {
        "text": " \"bebe58d4\"\n      }\n    ]\n  },\n  \"8b927b"
      }, {
        "text": "54\": {\n    \"title\": \"Vomiting\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Gastroenterology\",\n      \"Neurology\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVom"
      }, {
        "text": "iting\u003c/b\u003e (emesis) is the forceful expulsion of the contents of the stomach through the mouth. It is a complex reflex"
      }, {
        "text": " coordinated by the vomiting center in the brainstem, which receives inputs from multiple sources.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eV"
      }, {
        "text": "omiting Center:\u003c/b\u003e The central coordinator is the \u003cmark\u003enucleus tractus solitarius (NTS)\u003c/mark\u003e in"
      }, {
        "text": " the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Inputs to Vomiting Center:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[9"
      }, {
        "text": "3f70f8e|Chemoreceptor Trigger Zone (CTZ)]]:\u003c/b\u003e The [[5dd34"
      }, {
        "text": "3d3|area postrema]] in the fourth ventricle, which lies outside the blood-brain barrier and detects em"
      }, {
        "text": "etogenic substances in the blood (e.g., chemotherapy, toxins). Rich in D\u003csub\u003e2\u003c/sub\u003e and 5-"
      }, {
        "text": "HT\u003csub\u003e3\u003c/sub\u003e receptors.\u003cbr\u003e2. \u003cb\u003eGI Tract:\u003c/b\u003e Vagal afferents from the GI tract respond"
      }, {
        "text": " to irritation or distension.\u003cbr\u003e3. \u003cb\u003eVestibular System:\u003c/b\u003e Input from the vestibular system mediates motion sickness.\u003cbr\u003e4. "
      }, {
        "text": "\u003cb\u003eCNS:\u003c/b\u003e Higher cortical centers can trigger vomiting in response to sights, smells, or emotional distress.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke"
      }, {
        "text": ":\u003c/b\u003e Vomiting can be a prominent symptom of brainstem or cerebellar strokes, particularly those affecting the vestibular nuclei (e.g., lateral"
      }, {
        "text": " medullary syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The CTZ is a key pharmacological target. 5-HT\u003csub\u003e3\u003c/sub\u003e antagonists ("
      }, {
        "text": "ondansetron) are effective for chemotherapy-induced vomiting, while antihistamines and anticholinergics are effective for motion"
      }, {
        "text": " sickness.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVomiting\u003c/b\u003e is a protective reflex orchestrated"
      }, {
        "text": " by the brainstem\u0027s vomiting center, which integrates a wide array of inputs‚Äîfrom blood-borne toxins detected by the CTZ to vestibular"
      }, {
        "text": " signals of motion sickness‚Äîto trigger the forceful emptying of the stomach.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[CTZ] --\u003e E(Vomiting Center - NTS); B[GI Tract - Vagal Affer"
      }, {
        "text": "ents] --\u003e E; C[Vestibular System] --\u003e E; D[CNS] --\u003e E; E --\u003e F"
      }, {
        "text": "(Vomiting);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_coordinated_"
      }, {
        "text": "by\",\n        \"to\": \"74b651ab\"\n      },\n      {\n        \"type\": \"is_triggered"
      }, {
        "text": "_by\",\n        \"to\": \"93f70f8e\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"c5"
      }, {
        "text": "da3c57\"\n      }\n    ]\n  },\n  \"74b651"
      }, {
        "text": "ab\": {\n    \"title\": \"Vomiting Center\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003evomiting center\u003c/b\u003e is a functionally defined"
      }, {
        "text": " area in the medulla oblongata that coordinates the complex motor act of vomiting. The core of this center is the \u003cmark\u003enucleus"
      }, {
        "text": " tractus solitarius (NTS)\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Nucleus tractus solitarius (NTS) in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Integrates affer"
      }, {
        "text": "ent signals from various sources and generates the efferent output for the vomiting reflex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAfferent Inputs:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - From the [[93f70f8e|chemoreceptor trigger zone (CTZ)]] ("
      }, {
        "text": "detects blood-borne emetics).\u003cbr\u003e - From the GI tract via the vagus nerve (detects irritation)."
      }, {
        "text": "\u003cbr\u003e - From the vestibular system (mediates motion sickness).\u003cbr\u003e - From higher CNS centers (psych"
      }, {
        "text": "ogenic vomiting).\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e The NTS is rich in various neurotransmitter receptors, including neurokinin-"
      }, {
        "text": "1 (NK-1), which binds substance P.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e NK-1 receptor antagonists (e"
      }, {
        "text": ".g., aprepitant) are potent antiemetics that act directly on the vomiting center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While"
      }, {
        "text": " the CTZ is the \u0027detector\u0027 for blood-borne toxins, the NTS is the \u0027coordinator\u0027 of the vomiting reflex itself"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003evomiting center\u003c/b\u003e, centered on the nucleus tractus solitarius,"
      }, {
        "text": " is the brainstem\u0027s command post for emesis, integrating signals of distress from the gut, blood, and vestibular"
      }, {
        "text": " system to orchestrate the forceful expulsion of stomach contents.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[CT"
      }, {
        "text": "Z] --\u003e B(Vomiting Center - NTS); C[GI Tract] --\u003e B; D[Vest"
      }, {
        "text": "ibular System] --\u003e B; B --\u003e E(Efferent Signals to Diaphragm, Abdominal Muscles, etc.); E"
      }, {
        "text": " --\u003e F(Vomiting);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_"
      }, {
        "text": "in\",\n        \"to\": \"medulla_oblongata\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_composed_of\",\n        \"to\": \"nucleus_tractus_solitarius\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"receives_input_from\",\n        \"to\": \"93f70"
      }, {
        "text": "f8e\"\n      },\n      {\n        \"type\": \"is_target_of\",\n        \"to\": \"nk"
      }, {
        "text": "1_receptor_antagonists\"\n      }\n    ]\n  },\n  \"274cb0"
      }, {
        "text": "33\": {\n    \"title\": \"Von Hippel-Lindau Disease\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Genetics\",\n      \"Oncology\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Nephrology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVon Hippel-Lindau (VHL) disease"
      }, {
        "text": "\u003c/b\u003e is an autosomal dominant neurocutaneous disorder caused by a mutation in the \u003ci\u003eVHL\u003c/i\u003e tumor suppressor gene on chromosome 3. It is characterized by"
      }, {
        "text": " the development of numerous benign and malignant tumors in various organs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Genetics:\u003c/b\u003e Autosomal dominant inheritance of a mutated \u003ci\u003eVHL\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The"
      }, {
        "text": " VHL protein normally degrades hypoxia-inducible factor 1Œ± (HIF-1Œ±). Loss of VHL function leads to accumulation"
      }, {
        "text": " of HIF-1Œ±, which promotes angiogenesis and cell growth, leading to tumor formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCharacteristic Tumors (Mnemonic HARP):"
      }, {
        "text": "\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eH\u003c/b\u003eemangioblastomas: Highly vascular tumors of the retina, cerebellum, brainstem, and spine"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003engiomatosis: Formation of angiomas.\u003cbr\u003e - \u003cb\u003eR\u003c/b\u003eenal"
      }, {
        "text": " Cell Carcinoma: Bilateral, clear cell type.\u003cbr\u003e - \u003cb\u003eP\u003c/b\u003eheochromocytoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther"
      }, {
        "text": " Tumors:\u003c/b\u003e Can also cause endolymphatic sac tumors (leading to hearing loss) and cysts in the kidney"
      }, {
        "text": " and pancreas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with cerebellar hemangioblastomas and bilateral renal cell carcinoma is the"
      }, {
        "text": " classic presentation. The hemangioblastomas can produce erythropoietin, leading to secondary polycythemia.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVon Hippel-Lindau disease\u003c/b\u003e is a hereditary cancer syndrome driven"
      }, {
        "text": " by a faulty \u0027oxygen sensor\u0027 (VHL protein), leading to a pseudo-hypoxic state that fuels the growth of highly"
      }, {
        "text": " vascular tumors, most notably hemangioblastomas and renal cell carcinomas.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[VHL Gene"
      }, {
        "text": " Mutation] --\u003e B(Loss of pVHL function); B --\u003e C(Accumulation of HIF-1Œ±);"
      }, {
        "text": " C --\u003e D(‚Üë Angiogenesis \u0026 Cell Growth); D --\u003e E(Tumor Formation - Hemangioblastoma"
      }, {
        "text": ", RCC, etc.);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"neurocutaneous_disorder\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"b7b6"
      }, {
        "text": "19f2\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"hemang"
      }, {
        "text": "ioblastoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to"
      }, {
        "text": "\": \"renal_cell_carcinoma\"\n      },\n      {\n        \"type\": \"presents_with\",\n        "
      }, {
        "text": "\"to\": \"pheochromocytoma\"\n      }\n    ]\n  },\n  \"1d7d3"
      }, {
        "text": "92c\": {\n    \"title\": \"Wallenberg Syndrome (Lateral Medullary Syndrome)\",\n    \"primary"
      }, {
        "text": "Type\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Stroke\",\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Brainstem Syndromes\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eWallenberg syndrome\u003c/b\u003e, or lateral medullary syndrome, is a brainstem stroke syndrome caused by an"
      }, {
        "text": " infarct in the lateral medulla oblongata, typically due to occlusion of the posterior inferior cerebellar artery (PICA).\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e Posterior Inferior Cerebellar Artery (PICA). Less commonly, occlusion"
      }, {
        "text": " of the vertebral artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation (Mnemonic \u0027Don\u0027t PICA lame horse that can\u0027t eat"
      }, {
        "text": "\u0027):\u003c/b\u003e A complex constellation of crossed findings:\u003cbr\u003e - \u003cb\u003eVestibular nuclei:\u003c/b\u003e Vertigo, nystagmus, nausea"
      }, {
        "text": "/vomiting.\u003cbr\u003e - \u003cb\u003eInferior cerebellar peduncle:\u003c/b\u003e Ipsilateral [[9767fd"
      }, {
        "text": "6b|ataxia]] and dysmetria.\u003cbr\u003e - \u003cb\u003eSpinothalamic tract:\u003c/b\u003e Cont"
      }, {
        "text": "ralateral loss of pain and temperature sensation in the body.\u003cbr\u003e - \u003cb\u003eSpinal trigeminal nucleus:"
      }, {
        "text": "\u003c/b\u003e Ipsilateral loss of pain and temperature sensation in the face.\u003cbr\u003e - \u003cb\u003eNucleus ambiguus (CN"
      }, {
        "text": " IX, X):\u003c/b\u003e \u003cmark\u003eDysphagia, hoarseness, diminished gag reflex\u003c/mark\u003e. (The"
      }, {
        "text": " \u0027lame horse that can\u0027t eat\u0027).\u003cbr\u003e - \u003cb\u003eSympathetic tract:\u003c/b\u003e Ipsilateral [["
      }, {
        "text": "c19010a3|Horner syndrome]] (ptosis, miosis, anhidrosis).\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of dysphagia and hoarseness is the key feature that distinguishes a lateral medullary ("
      }, {
        "text": "PICA) stroke from a lateral pontine (AICA) stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eWallenberg syndrome\u003c/b\u003e is a classic brainstem stroke that creates a striking pattern of ipsilateral cranial nerve deficits (including"
      }, {
        "text": " dysphagia and Horner\u0027s) and ataxia, combined with contralateral body sensory loss, all due to an infarct in the P"
      }, {
        "text": "ICA territory of the lateral medulla.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[PICA Occlusion] --\u003e B(Lateral"
      }, {
        "text": " Medullary Infarct); B --\u003e C(Ipsilateral CN Deficits - V, IX, X); B --\u003e D(I"
      }, {
        "text": "psilateral Ataxia); B --\u003e E(Ipsilateral Horner\u0027s); B --\u003e F(Contralateral Body Pain"
      }, {
        "text": "/Temp Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"brainstem_syndrome\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by_occlusion_of\",\n        \"to\": \"posterior_infer"
      }, {
        "text": "ior_cerebellar_artery\"\n      },\n      {\n        \"type\": \"presents_with"
      }, {
        "text": "\",\n        \"to\": \"f0207c17\"\n      },\n      {\n        \"type\": \"presents"
      }, {
        "text": "_with\",\n        \"to\": \"c19010a3\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"6772c663\": {\n    \"title\": \"Watershed Areas\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebrovascular\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Cerebral Vasculature\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eWatershed areas\u003c/b\u003e are regions of the brain that receive a dual blood supply from the most distal branches of two"
      }, {
        "text": " adjacent major cerebral arteries. These zones are particularly vulnerable to ischemia in the setting of systemic hypoperfusion.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e During a state of systemic hypotension (e.g., shock"
      }, {
        "text": ", cardiac arrest), blood pressure may be insufficient to perfuse these distal \u0027border zones,\u0027 leading to a \u003cmark\u003ewaters"
      }, {
        "text": "hed infarct\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Watershed Zones:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eACA-MCA Watershed"
      }, {
        "text": ":\u003c/b\u003e Located between the anterior and middle cerebral artery territories. Infarction here can cause weakness of the proximal arm and leg"
      }, {
        "text": ", sparing the hand and foot, sometimes called \u003cmark\u003e\u0027man-in-a-barrel\u0027 syndrome\u003c/mark\u003e"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003eMCA-PCA Watershed:\u003c/b\u003e Located between the middle and posterior cerebral artery territories. Infarction can"
      }, {
        "text": " cause higher-order visual processing deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAnterior Spinal Artery:\u003c/b\u003e The territory of the anterior spinal artery,"
      }, {
        "text": " particularly in the mid-thoracic region (T4-T8), is also a watershed area, making it vulnerable"
      }, {
        "text": " to ischemia during aortic surgery or severe hypotension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who suffers a hypotensive episode"
      }, {
        "text": " and subsequently develops bilateral proximal limb weakness (\u0027man-in-a-barrel\u0027) has likely sustained an ACA-MCA watershed stroke"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eWatershed areas\u003c/b\u003e are the \u0027no-man\u0027s land"
      }, {
        "text": "\u0027 of cerebral circulation, the border territories at the farthest reach of the major arteries, making them the first to suffer ischemic"
      }, {
        "text": " damage when systemic blood pressure falls too low.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"are_vulnerable_to\",\n        \"to\": \"hypoperfusion\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"are_located_between\",\n        \"to\": \"e51a7"
      }, {
        "text": "691\"\n      },\n      {\n        \"type\": \"infarction_can_cause\",\n        \""
      }, {
        "text": "to\": \"man_in_a_barrel_syndrome\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"5e9c9023\",\n    \"letter\": \"V\",\n    \"term\": \"Ventral anterior nucleus (thalamus)\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventral anterior nucleus (thalamus)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"718c1a2c\",\n    \"letter\": \"V\",\n    \"term\": \"Ventral lateral nucleus (thalamus)\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventral lateral nucleus (thalamus)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"6dcf9281\",\n    \"letter\": \"V\",\n    \"term\": \"Ventral optic radiation (Meyer loop)\",\n    \"pages\": [\n      \"557\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventral optic radiation (Meyer loop)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2ae957b8\",\n    \"letter\": \"V\",\n    \"term\": \"Ventral posterolateral nucleus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventral posterolateral nucleus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e7bc3767\",\n        \"letter\": \"V\",\n        \"term\": \"(thalamus)\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Ventral posterolateral nucleus \u003e (thalamus)\"\n      }\n    ]\n  },\n  {\n    \"id\": \"23ac314a\",\n    \"letter\": \"V\",\n    \"term\": \"Ventral posteromedial nucleus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventral posteromedial nucleus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f83e847a\",\n        \"letter\": \"V\",\n        \"term\": \"(thalamus)\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Ventral posteromedial nucleus \u003e (thalamus)\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ddf80249\",\n    \"letter\": \"V\",\n    \"term\": \"Ventral tegmentum\",\n    \"pages\": [\n      \"505\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventral tegmentum\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1cb9c975\",\n    \"letter\": \"V\",\n    \"term\": \"Ventricular system (CNS)\",\n    \"pages\": [\n      \"515\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventricular system (CNS)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e970dcf9\",\n    \"letter\": \"V\",\n    \"term\": \"Ventriculomegaly (brain)\",\n    \"pages\": [\n      \"536\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventriculomegaly (brain)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"d662ec5d\",\n    \"letter\": \"V\",\n    \"term\": \"Ventromedial nucleus (hypothalamus)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Ventromedial nucleus (hypothalamus)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"085c69ee\",\n        \"letter\": \"V\",\n        \"term\": \"satiety\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Ventromedial nucleus (hypothalamus) \u003e satiety\"\n      }\n    ]\n  },\n  {\n    \"id\": \"38100c31\",\n    \"letter\": \"V\",\n    \"term\": \"Verapamil\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Verapamil\",\n    \"sub_entries\": [\n      {\n        \"id\": \"c6598a3d\",\n        \"letter\": \"V\",\n        \"term\": \"headache therapy\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Verapamil \u003e headache therapy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"09dd109e\",\n    \"letter\": \"V\",\n    \"term\": \"Vertical gaze palsy\",\n    \"pages\": [\n      \"542\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vertical gaze palsy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"5603962d\",\n    \"letter\": \"V\",\n    \"term\": \"Vertigo\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vertigo\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f930a2f1\",\n        \"letter\": \"V\",\n        \"term\": \"peripheral vs central\",\n        \"pages\": [\n          \"548\"\n        ],\n        \"context\": \"Vertigo \u003e peripheral vs central\"\n      }\n    ]\n  },\n  {\n    \"id\": \"07b0a9dd\",\n    \"letter\": \"V\",\n    \"term\": \"Vesicular monoamine transporter\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vesicular monoamine transporter\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ce09365c\",\n        \"letter\": \"V\",\n        \"term\": \"(VMAT)\",\n        \"pages\": [\n          \"564\"\n        ],\n        \"context\": \"Vesicular monoamine transporter \u003e (VMAT)\"\n      }\n    ]\n  },\n  {\n    \"id\": \"11946667\",\n    \"letter\": \"V\",\n    \"term\": \"Vestibular schwannomas\",\n    \"pages\": [\n      \"539\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vestibular schwannomas\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"6fded3e7\",\n    \"letter\": \"V\",\n    \"term\": \"Vestibulocochlear (CNVIII), function\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vestibulocochlear (CNVIII), function\",\n    \"sub_entries\": [\n      {\n        \"id\": \"640db7fe\",\n        \"letter\": \"V\",\n        \"term\": \"and type\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Vestibulocochlear (CNVIII), function \u003e and type\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1776
    }, {
      "text": "```json\n{\n  \"5e9c9023\": {\n    \"title\": \"Ventral Anterior (VA) Nucleus of Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Anterior (VA) nucleus\u003c/b\u003e is a motor nucleus of the [[afc0a64b|thalamus]]. It is part of the [[ed462927|basal ganglia]]-thalamocortical motor loop, involved in the planning and initiation of movement.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the ventral nuclear group of the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor planning.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives major input from the \u003cmark\u003eglobus pallidus internus (GPi)\u003c/mark\u003e, which is the main output nucleus of the [[ed462927|basal ganglia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the premotor cortex and supplementary motor area.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e The VA nucleus, along with the [[718c1a2c|ventral lateral (VL) nucleus]], receives inhibitory signals from the GPi. The direct and indirect pathways of the basal ganglia modulate this inhibition to either facilitate or suppress movement by disinhibiting or inhibiting the VA/VL nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the VA and VL nuclei as the motor relay stations of the thalamus, receiving input from the basal ganglia and cerebellum and projecting to the motor cortices.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVentral Anterior nucleus\u003c/b\u003e of the thalamus is a key node in the motor circuit, acting as a gate that is controlled by inhibitory inputs from the basal ganglia to regulate the flow of information to the premotor cortex for movement planning.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basal Ganglia - GPi] --Inhibitory--\u003e B(VA Nucleus); B --Excitatory--\u003e C(Premotor Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"globus_pallidus_internus\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"premotor_cortex\"\n      }\n    ]\n  },\n  \"718c1a2c\": {\n    \"title\": \"Ventral Lateral (VL) Nucleus of Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Lateral (VL) nucleus\u003c/b\u003e is a motor nucleus of the [[afc0a64b|thalamus]] that plays a crucial role in coordinating and modulating motor activity by relaying information from the [[ed462927|basal ganglia]] and cerebellum to the motor cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the ventral nuclear group of the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor coordination and modulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives input from two major motor control centers:\u003cbr\u003e - From the \u003cmark\u003eglobus pallidus internus (GPi)\u003c/mark\u003e of the [[ed462927|basal ganglia]].\u003cbr\u003e - From the contralateral \u003cmark\u003e[[c819d97b|dentate nucleus]]\u003c/mark\u003e of the [[bebe58d4|cerebellum]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects primarily to the \u003cmark\u003eprimary motor cortex\u003c/mark\u003e and premotor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway Integration:\u003c/b\u003e The VL nucleus is a key site where inputs from both the basal ganglia (for movement selection) and the cerebellum (for movement coordination) are integrated before being sent to the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the VA and VL nuclei as the motor relay stations of the thalamus. The VL is particularly important as it integrates both basal ganglia and cerebellar inputs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVentral Lateral nucleus\u003c/b\u003e of the thalamus is the primary motor integration and relay center, funneling processed information from both the basal ganglia and cerebellum to the motor cortex to ensure that movements are both well-chosen and well-executed.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basal Ganglia] --\u003e C(VL Nucleus); B[Cerebellum] --\u003e C; C --\u003e D(Motor Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"primary_motor_cortex\"\n      }\n    ]\n  },\n  \"6dcf9281\": {\n    \"title\": \"Ventral Optic Radiation (Meyer\u0027s Loop)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Visual Pathway\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Optic Radiation\u003c/b\u003e, commonly known as \u003cb\u003eMeyer\u0027s loop\u003c/b\u003e, is the inferior bundle of nerve fibers that projects from the lateral geniculate nucleus (LGN) of the thalamus to the primary visual cortex. It takes a characteristic looping path through the temporal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Originates in the LGN, sweeps anteriorly and inferiorly into the \u003cmark\u003etemporal lobe\u003c/mark\u003e around the inferior horn of the lateral ventricle, and then projects posteriorly to the inferior portion of the primary visual cortex (lingual gyrus), below the calcarine sulcus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisual Field Information:\u003c/b\u003e It carries information from the \u003cmark\u003einferior retina\u003c/mark\u003e, which corresponds to the \u003cmark\u003esuperior visual field\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e A lesion of Meyer\u0027s loop causes a contralateral \u003cmark\u003esuperior quadrantanopia\u003c/mark\u003e (a \u0027pie in the sky\u0027 visual field defect).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[09c8409d|dorsal optic radiation]] travels through the parietal lobe and carries information from the superior retina (inferior visual field).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003ePITS\u003c/b\u003e: \u003cb\u003eP\u003c/b\u003earietal lesion \u003d \u003cb\u003eI\u003c/b\u003enferior field defect, \u003cb\u003eT\u003c/b\u003eemporal lesion \u003d \u003cb\u003eS\u003c/b\u003euperior field defect. A lesion in the temporal lobe affecting Meyer\u0027s loop causes a \u0027pie in the sky\u0027 defect.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eMeyer\u0027s loop\u003c/b\u003e is the inferior, looping visual pathway that takes a detour through the temporal lobe to carry information about the superior visual world; a lesion here characteristically \u0027takes a pie out of the sky\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Inferior Retina] --\u003e B(LGN); B --\u003e C(Meyer\u0027s Loop); C --\u003e D(Through Temporal Lobe); D --\u003e E(Primary Visual Cortex); F[Lesion in Meyer\u0027s Loop] --\u003e G(Contralateral Superior Quadrantanopia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"optic_radiation\"\n      },\n      {\n        \"type\": \"travels_through\",\n        \"to\": \"temporal_lobe\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"superior_quadrantanopia\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"09c8409d\"\n      }\n    ]\n  },\n  \"2ae957b8\": {\n    \"title\": \"Ventral Posterolateral (VPL) Nucleus of Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Posterolateral (VPL) nucleus\u003c/b\u003e is a primary sensory relay nucleus in the [[afc0a64b|thalamus]]. It receives somatosensory information from the body and limbs and projects it to the primary somatosensory cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the ventral posterior complex of the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Relays sensory information for \u003cmark\u003evibration, proprioception, pain, temperature, and fine touch\u003c/mark\u003e from the body and limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives input from two major ascending sensory pathways:\u003cbr\u003e - The \u003cmark\u003e[[f19bc454|medial lemniscus]]\u003c/mark\u003e (carrying proprioception, vibration, fine touch).\u003cbr\u003e - The \u003cmark\u003e[[07eecef1|spinothalamic tract]]\u003c/mark\u003e (carrying pain, temperature, crude touch).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the primary somatosensory cortex in the postcentral gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[23ac314a|ventral posteromedial (VPM) nucleus]] receives sensory information from the face. Mnemonic: V\u003cb\u003ePL\u003c/b\u003e for \u003cb\u003eP\u003c/b\u003eain/\u003cb\u003eP\u003c/b\u003eroprioception from \u003cb\u003eL\u003c/b\u003eimbs; V\u003cb\u003ePM\u003c/b\u003e for sensation from the \u003cb\u003eM\u003c/b\u003eouth/\u003cb\u003eM\u003c/b\u003eug.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion in the VPL nucleus (e.g., from a thalamic stroke) will cause contralateral sensory loss in the body and limbs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVPL nucleus\u003c/b\u003e of the thalamus is the central processing hub for all somatosensory information from the body, receiving inputs from both the spinothalamic and dorsal column pathways before relaying them to the cortex for conscious perception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Spinothalamic Tract] --\u003e C(VPL Nucleus); B[Medial Lemniscus] --\u003e C; C --\u003e D(Primary Somatosensory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"07eecef1\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"f19bc454\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"23ac314a\"\n      }\n    ]\n  },\n  \"23ac314a\": {\n    \"title\": \"Ventral Posteromedial (VPM) Nucleus of Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Posteromedial (VPM) nucleus\u003c/b\u003e is a primary sensory relay nucleus in the [[afc0a64b|thalamus]]. It receives somatosensory information from the face and head, as well as taste information, and projects it to the primary somatosensory cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the ventral posterior complex of the [[afc0a64b|thalamus]], medial to the VPL nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Relays sensory information for \u003cmark\u003evibration, proprioception, pain, temperature, and fine touch\u003c/mark\u003e from the face, as well as taste.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives input from:\u003cbr\u003e - The \u003cmark\u003etrigeminal lemniscus\u003c/mark\u003e (carrying somatosensation from the contralateral face via the trigeminal nerve).\u003cbr\u003e - The \u003cmark\u003esolitary tract\u003c/mark\u003e (carrying taste information).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the primary somatosensory cortex (for facial sensation) and the gustatory cortex (for taste).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[2ae957b8|ventral posterolateral (VPL) nucleus]] receives sensory information from the body and limbs. Mnemonic: V\u003cb\u003ePM\u003c/b\u003e for sensation from the \u003cb\u003eM\u003c/b\u003eouth/\u003cb\u003eM\u003c/b\u003eug.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion in the VPM nucleus will cause contralateral sensory loss in the face.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVPM nucleus\u003c/b\u003e of the thalamus is the specific relay station for all sensory information from the face and for taste, processing these inputs before sending them to the cortex for perception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Lemniscus] --\u003e C(VPM Nucleus); B[Solitary Tract - Taste] --\u003e C; C --\u003e D(Somatosensory \u0026 Gustatory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"trigeminal_nerve\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"solitary_tract\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"2ae957b8\"\n      }\n    ]\n  },\n  \"ddf80249\": {\n    \"title\": \"Ventral Tegmental Area (VTA)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Psychiatry\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Tegmental Area (VTA)\u003c/b\u003e is a group of neurons located in the midbrain that is the origin of the major dopaminergic pathways of the mesolimbic and mesocortical systems. It is a central component of the brain\u0027s reward circuitry.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Midbrain, medial to the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e The neurons of the VTA synthesize and release \u003cmark\u003e[[90adc821|dopamine]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProjections:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMesolimbic Pathway:\u003c/b\u003e Projects to the nucleus accumbens. This pathway is crucial for reward, motivation, and pleasure, and is the primary circuit involved in \u003cmark\u003eaddiction\u003c/mark\u003e. Hyperactivity is implicated in the positive symptoms of schizophrenia.\u003cbr\u003e - \u003cb\u003eMesocortical Pathway:\u003c/b\u003e Projects to the prefrontal cortex. This pathway is involved in cognition and executive function. Hypoactivity is implicated in the negative symptoms of schizophrenia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e The VTA and its projections are the primary targets of addictive drugs, which increase dopamine release in the nucleus accumbens. It is also a key area in the pathophysiology of schizophrenia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The VTA is the starting point for the \u0027reward\u0027 and \u0027cognitive\u0027 dopamine pathways. Differentiate it from the substantia nigra, which is the starting point for the \u0027motor\u0027 (nigrostriatal) dopamine pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVentral Tegmental Area\u003c/b\u003e is the wellspring of the brain\u0027s dopamine-driven reward system, launching the mesolimbic pathway that is fundamental to motivation, pleasure, and the hijacked neural circuitry of addiction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[VTA]; A --Mesolimbic Pathway--\u003e B(Nucleus Accumbens - Reward); A --Mesocortical Pathway--\u003e C(Prefrontal Cortex - Cognition);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \"is_origin_of\",\n        \"to\": \"mesolimbic_pathway\"\n      },\n      {\n        \"type\": \"is_origin_of\",\n        \"to\": \"mesocortical_pathway\"\n      },\n      {\n        \"type\": \"produces\",\n        \"to\": \"90adc821\"\n      }\n    ]\n  },\n  \"1cb9c975\": {\n    \"title\": \"Ventricular System (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eventricular system\u003c/b\u003e is a set of four interconnected, cerebrospinal fluid (CSF)-filled cavities within the brain. It is responsible for the production, circulation, and removal of CSF.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Two lateral ventricles, the third ventricle, and the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Flow Pathway:\u003c/b\u003e\u003cbr\u003e1. Lateral ventricles ‚Üí [[eea1b841|Foramen of Monro]] ‚Üí\u003cbr\u003e2. Third ventricle ‚Üí [[8a30e721|Cerebral aqueduct]] ‚Üí\u003cbr\u003e3. Fourth ventricle ‚Üí [[098c1e45|Foramina of Luschka]] (lateral) \u0026 [[0569a9e3|Foramen of Magendie]] (medial) ‚Üí\u003cbr\u003e4. Subarachnoid space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Production:\u003c/b\u003e [[7109d8b6|CSF]] is produced by the [[ae65e9c7|choroid plexus]] located within all four ventricles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Reabsorption:\u003c/b\u003e CSF is reabsorbed into the venous circulation via the [[b7b67074|arachnoid granulations]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Obstruction of this system at any point leads to \u003cmark\u003e[[0bc2f200|hydrocephalus]]\u003c/mark\u003e, an accumulation of CSF that increases intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the path of CSF flow and the sites of potential obstruction. For example, stenosis of the cerebral aqueduct is a common cause of non-communicating hydrocephalus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eventricular system\u003c/b\u003e is the brain\u0027s internal plumbing, a network of cavities that produces and circulates cerebrospinal fluid, with narrow passages like the cerebral aqueduct acting as critical choke points where blockages can lead to hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Ventricles] --Foramen of Monro--\u003e B[Third Ventricle]; B --Cerebral Aqueduct--\u003e C[Fourth Ventricle]; C --Foramina of Luschka \u0026 Magendie--\u003e D[Subarachnoid Space];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"circulates\",\n        \"to\": \"7109d8b6\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"ae65e9c7\"\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to\": \"0bc2f200\"\n      }\n    ]\n  },\n  \"e970dcf9\": {\n    \"title\": \"Ventriculomegaly\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Radiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVentriculomegaly\u003c/b\u003e is a descriptive term for the enlargement of the cerebral ventricles, as seen on neuroimaging. It can be a sign of [[0bc2f200|hydrocephalus]] or it can be a compensatory change due to brain atrophy.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[0bc2f200|Hydrocephalus]]:\u003c/b\u003e In true hydrocephalus, ventriculomegaly is caused by an increased volume of cerebrospinal fluid (CSF) due to obstruction of flow (non-communicating) or impaired reabsorption (communicating). This leads to \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[7efdb0ef|Hydrocephalus Ex Vacuo]]:\u003c/b\u003e This is ventriculomegaly that occurs secondary to a loss of brain parenchyma (atrophy). The ventricles enlarge to fill the space left by the missing brain tissue. In this case, the intracranial pressure is \u003cmark\u003enormal\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging Differentiation:\u003c/b\u003e\u003cbr\u003e - In true hydrocephalus, the ventricles are enlarged, often out of proportion to the cortical sulci.\u003cbr\u003e - In hydrocephalus ex vacuo, both the ventricles and the cortical sulci are enlarged, indicating diffuse brain atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e True hydrocephalus can be caused by aqueductal stenosis, tumors, or post-meningitic scarring. Hydrocephalus ex vacuo is seen in neurodegenerative diseases like [[77ae6148|Alzheimer disease]] and [[ffd7e743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When you see enlarged ventricles on a brain scan, always check the sulci. Wide sulci suggest atrophy (hydrocephalus ex vacuo). Normal or effaced sulci suggest true hydrocephalus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVentriculomegaly\u003c/b\u003e is simply \u0027big ventricles\u0027 on a scan; the crucial diagnostic step is to determine if this is due to a high-pressure fluid backup (true hydrocephalus) or a passive expansion into space created by brain atrophy (hydrocephalus ex vacuo).\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"7efdb0ef\"\n      },\n      {\n        \"type\": \"is_seen_in\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"d662ec5d\": {\n    \"title\": \"Ventromedial Nucleus of Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentromedial Nucleus\u003c/b\u003e is a region of the [[89e86633|hypothalamus]] that acts as the primary \u003cmark\u003esatiety center\u003c/mark\u003e of the brain, responsible for signaling the feeling of fullness and inhibiting hunger.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediates \u003cb\u003esatiety\u003c/b\u003e. Mnemonic: The \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003eM\u003c/b\u003eedial nucleus makes you feel \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003euch full.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e It is stimulated by hormones that signal energy sufficiency, such as \u003cmark\u003eleptin\u003c/mark\u003e (released from adipose tissue).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e Destruction of the ventromedial nucleus (e.g., by a craniopharyngioma or trauma) leads to the loss of the satiety signal. This results in \u003cmark\u003ehyperphagia\u003c/mark\u003e (excessive eating) and profound obesity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[lateral_hypothalamic_nucleus|lateral nucleus of the hypothalamus]] is the hunger center. A lesion there causes anorexia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the functional pairing: Ventromedial \u003d Satiety (lesion -\u003e get very fat). Lateral \u003d Hunger (lesion -\u003e get very lean).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVentromedial Nucleus of the hypothalamus\u003c/b\u003e is the brain\u0027s \u0027off switch\u0027 for eating; its stimulation by hormones like leptin signals fullness, and its destruction leads to unchecked hunger and obesity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Leptin/Satiety Signals] --\u003e B(Ventromedial Nucleus); B --Inhibits--\u003e C(Hunger Drive); D[Lesion of VMN] --x C; D --\u003e E(Hyperphagia \u0026 Obesity);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"mediates\",\n        \"to\": \"satiety\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"hyperphagia\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\": \"lateral_hypothalamic_nucleus\"\n      }\n    ]\n  },\n  \"38100c31\": {\n    \"title\": \"Verapamil\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Cardiovascular\",\n      \"Pharmacology\",\n      \"Calcium Channel Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVerapamil\u003c/b\u003e is a non-dihydropyridine \u003ci\u003ecalcium channel blocker\u003c/i\u003e that exerts its effects primarily on the heart, causing decreased heart rate and contractility. It is used to treat hypertension, angina, arrhythmias, and for the prophylaxis of cluster headaches.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks L-type voltage-gated calcium channels in cardiac myocytes and nodal tissue, as well as in vascular smooth muscle. Its effects are more pronounced on the heart than on peripheral vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiac Effects:\u003c/b\u003e Decreases heart rate (negative chronotropy) by slowing conduction through the SA and AV nodes. Decreases contractility (negative inotropy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Effects:\u003c/b\u003e Causes vasodilation, but less so than dihydropyridine calcium channel blockers (e.g., amlodipine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Headache:\u003c/b\u003e It is the \u003cmark\u003efirst-line prophylactic\u003c/mark\u003e treatment for [[21760f80|cluster headaches]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effect is \u003cmark\u003econstipation\u003c/mark\u003e. It can also cause bradycardia, AV block, and worsening of heart failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember verapamil as the non-dihydropyridine CCB with the most prominent cardiac effects and the classic side effect of constipation. It is the drug of choice for preventing cluster headaches.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVerapamil\u003c/b\u003e is a heart-focused calcium channel blocker that slows the heart and reduces its force of contraction, but it also has a unique and important role as the primary prophylactic agent for the excruciatingly painful cluster headache.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"calcium_channel_blocker\"\n      },\n      {\n        \"type\": \"is_used_for_prophylaxis_of\",\n        \"to\": \"21760f80\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"constipation\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"bradycardia\"\n      }\n    ]\n  },\n  \"09dd109e\": {\n    \"title\": \"Vertical Gaze Palsy\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVertical gaze palsy\u003c/b\u003e is the inability to voluntarily move the eyes up (upward gaze palsy) or down (downward gaze palsy). An upward gaze palsy is the hallmark sign of \u003cmark\u003eParinaud syndrome\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the dorsal midbrain, specifically compressing the superior colliculus and the rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF), which is the vertical gaze center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e The primary component of Parinaud syndrome (dorsal midbrain syndrome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eParinaud Syndrome Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Palsy.\u003c/b\u003e\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils react poorly to light but constrict to accommodation.\u003cbr\u003e3. \u003cb\u003e[[3db2e75e|Convergence-Retraction Nystagmus]]:\u003c/b\u003e Jerky movements of the eyes on attempted upgaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e In children, a \u003cmark\u003epinealoma\u003c/mark\u003e is the classic cause. In adults, causes include stroke of the midbrain or hydrocephalus causing pressure on the tectum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The inability to look up, especially in a child or young adult, should immediately raise suspicion for a pineal region tumor causing Parinaud syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003evertical gaze palsy\u003c/b\u003e, particularly an inability to look up, is a definitive localizing sign, pointing to a lesion in the dorsal midbrain that has disrupted the vertical gaze center, and is the most prominent feature of Parinaud syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"parinaud_syndrome\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"dorsal_midbrain\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"pinealoma\"\n      }\n    ]\n  },\n  \"5603962d\": {\n    \"title\": \"Vertigo\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVertigo\u003c/b\u003e is a subtype of [[71d3f0e1|dizziness]] characterized by a false sensation of movement, either of the self or the environment, often described as \u0027spinning.\u0027 It is a cardinal symptom of vestibular system dysfunction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePeripheral Vertigo:\u003c/b\u003e Caused by a problem in the inner ear or vestibular nerve (CN VIII).\u003cbr\u003e - \u003cb\u003eCharacteristics:\u003c/b\u003e Sudden onset, intense spinning sensation, often associated with nausea/vomiting, tinnitus, and hearing loss. Nystagmus is typically horizontal or torsional and is suppressed by visual fixation.\u003cbr\u003e - \u003cb\u003eCauses:\u003c/b\u003e Benign paroxysmal positional vertigo (BPPV), vestibular neuritis, [[menieres_disease|M√©ni√®re disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[350f1c8b|Central Vertigo]]:\u003c/b\u003e Caused by a problem in the brainstem or cerebellum.\u003cbr\u003e - \u003cb\u003eCharacteristics:\u003c/b\u003e More subtle, less intense vertigo. Nystagmus can be in any direction, including \u003cmark\u003epurely vertical\u003c/mark\u003e, and is \u003cu\u003enot\u003c/u\u003e suppressed by visual fixation. Often accompanied by other neurological signs (e.g., diplopia, dysarthria, ataxia).\u003cbr\u003e - \u003cb\u003eCauses:\u003c/b\u003e Stroke (e.g., Wallenberg syndrome), [[45dd6d19|multiple sclerosis]], tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The direction of nystagmus and the presence of other neurological signs are key to differentiating central from peripheral vertigo. Purely vertical nystagmus is a red flag for a central cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVertigo\u003c/b\u003e is the illusion of motion that signals a mismatch in the vestibular system; distinguishing between a benign peripheral cause (like BPPV) and a dangerous central cause (like a brainstem stroke) is a critical diagnostic challenge guided by the characteristics of the nystagmus and associated neurological findings.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"71d3f0e1\"\n      },\n      {\n        \"type\": \"can_be\",\n        \"to\": \"peripheral_vertigo\"\n      },\n      {\n        \"type\": \"can_be\",\n        \"to\": \"350f1c8b\"\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"menieres_disease\"\n      }\n    ]\n  },\n  \"07b0a9dd\": {\n    \"title\": \"Vesicular Monoamine Transporter (VMAT)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVesicular Monoamine Transporter (VMAT)\u003c/b\u003e is a transport protein located on the membrane of synaptic vesicles in monoaminergic neurons. Its function is to transport monoamine neurotransmitters (such as dopamine, norepinephrine, serotonin, and histamine) from the cytoplasm into the vesicles for storage and subsequent release.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Packages monoamines into presynaptic vesicles, protecting them from degradation by monoamine oxidase (MAO) in the cytoplasm and making them available for synaptic release.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacological Inhibition:\u003c/b\u003e VMAT can be inhibited by certain drugs.\u003cbr\u003e - \u003cb\u003eReserpine (irreversible):\u003c/b\u003e An old antihypertensive drug that depletes monoamine stores, leading to profound depression and hypotension.\u003cbr\u003e - \u003cb\u003eTetrabenazine \u0026 Deutetrabenazine (reversible):\u003c/b\u003e VMAT2 inhibitors used to treat the chorea associated with [[ffd7e743|Huntington disease]] by depleting dopamine stores.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e By controlling the amount of neurotransmitter available for release, VMAT plays a crucial role in modulating monoaminergic neurotransmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e VMAT inhibitors like tetrabenazine are used to treat hyperkinetic movement disorders (e.g., Huntington\u0027s chorea) by reducing the amount of dopamine that can be released into the synapse.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVesicular Monoamine Transporter (VMAT)\u003c/b\u003e acts as the \u0027loading dock\u0027 for monoamine neurotransmitters, packaging them into vesicles for release; inhibiting this transporter effectively depletes the brain\u0027s supply of these neurotransmitters, a mechanism used to treat hyperkinetic movement disorders.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Monoamines in Cytoplasm] --VMAT--\u003e B(Storage in Synaptic Vesicles); C[Tetrabenazine] --Inhibits--\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"transports\",\n        \"to\": \"monoamines\"\n      },\n      {\n        \"type\": \"is_inhibited_by\",\n        \"to\": \"tetrabenazine\"\n      },\n      {\n        \"type\": \"is_inhibited_by\",\n        \"to\": \"reserpine\"\n      }\n    ]\n  },\n  \"11946667\": {\n    \"title\": \"Vestibular Schwannoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003evestibular schwannoma\u003c/b\u003e, also known as an acoustic neuroma, is a benign tumor arising from the Schwann cells of the vestibular portion of the vestibulocochlear nerve (CN VIII). It is typically located at the cerebellopontine angle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCell of Origin:\u003c/b\u003e Arises from Schwann cells, which myelinate peripheral nerves. The tumor is S-100 positive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found at the \u003cmark\u003ecerebellopontine angle\u003c/mark\u003e, the space between the cerebellum and the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms are due to compression of CN VIII and adjacent structures.\u003cbr\u003e - \u003cb\u003eCN VIII:\u003c/b\u003e \u003cmark\u003eUnilateral sensorineural hearing loss\u003c/mark\u003e and \u003cmark\u003etinnitus\u003c/mark\u003e are the most common presenting symptoms. Vertigo is less common.\u003cbr\u003e - \u003cb\u003eCN VII:\u003c/b\u003e Facial weakness or paralysis.\u003cbr\u003e - \u003cb\u003eCN V:\u003c/b\u003e Facial numbness or paresthesias.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBilateral Schwannomas:\u003c/b\u003e The presence of bilateral vestibular schwannomas is pathognomonic for \u003cmark\u003eNeurofibromatosis Type 2 (NF-2)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An adult with insidious, unilateral hearing loss and tinnitus should be evaluated for a vestibular schwannoma. If the schwannomas are bilateral, the diagnosis is NF-2.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003evestibular schwannoma\u003c/b\u003e is a benign tumor of the myelin-forming cells of the eighth cranial nerve, which classically presents with unilateral hearing loss and tinnitus due to its growth in the confined space of the cerebellopontine angle, where it also endangers adjacent cranial nerves.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Schwannoma] --Grows at Cerebellopontine Angle--\u003e B(Compresses Nerves); B --\u003e C(CN VIII -\u003e Hearing Loss, Tinnitus); B --\u003e D(CN VII -\u003e Facial Palsy); B --\u003e E(CN V -\u003e Facial Numbness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"schwannoma\"\n      },\n      {\n        \"type\": \"is_located_at\",\n        \"to\": \"cerebellopontine_angle\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"neurofibromatosis_type_2\"\n      },\n      {\n        \"type\": \"compresses\",\n        \"to\": \"vestibulocochlear_nerve\"\n      }\n    ]\n  },\n  \"6fded3e7\": {\n    \"title\": \"Vestibulocochlear Nerve (CN VIII)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVestibulocochlear Nerve (CN VIII)\u003c/b\u003e is a purely sensory cranial nerve that transmits sound and equilibrium (balance) information from the inner ear to the brainstem.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e It has two distinct components:\u003cbr\u003e1. \u003cb\u003eCochlear Nerve:\u003c/b\u003e Transmits auditory information from the hair cells of the [[001c359f|cochlea]].\u003cbr\u003e2. \u003cb\u003eVestibular Nerve:\u003c/b\u003e Transmits information about linear and rotational acceleration from the utricle, saccule, and semicircular canals of the vestibular apparatus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e The nerve travels from the inner ear through the internal auditory meatus to enter the brainstem at the cerebellopontine angle (at the pontomedullary junction).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Hearing and balance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e Damage to CN VIII can cause sensorineural hearing loss, tinnitus, vertigo, and nystagmus. A common cause of a lesion is a [[11946667|vestibular schwannoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that CN VIII travels with CN VII through the internal auditory meatus. Therefore, a lesion in this location (e.g., a schwannoma) can present with symptoms related to both nerves (e.g., hearing loss and facial palsy).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVestibulocochlear Nerve\u003c/b\u003e is the composite nerve for hearing and balance, carrying two distinct streams of sensory information from the inner ear to the brainstem; its dysfunction leads to the characteristic symptoms of hearing loss, tinnitus, and vertigo.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a\",\n        \"to\": \"sensory_cranial_nerve\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"cochlear_nerve\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"vestibular_nerve\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"sensorineural_hearing_loss\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"5603962d\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9972,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"5e9c9023\": {\n    \"title"
      }, {
        "text": "\": \"Ventral Anterior (VA) Nucleus of Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Anterior (VA) nucleus"
      }, {
        "text": "\u003c/b\u003e is a motor nucleus of the [[afc0a64b|thalamus]]. It is part of the [["
      }, {
        "text": "ed462927|basal ganglia]]-thalamocortical motor loop, involved in the"
      }, {
        "text": " planning and initiation of movement.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the ventral"
      }, {
        "text": " nuclear group of the [[afc0a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor"
      }, {
        "text": " planning.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives major input from the \u003cmark\u003eglobus pallidus internus ("
      }, {
        "text": "GPi)\u003c/mark\u003e, which is the main output nucleus of the [[ed462927|basal ganglia"
      }, {
        "text": "]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the premotor cortex and supplementary motor area.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e The VA nucleus"
      }, {
        "text": ", along with the [[718c1a2c|ventral lateral (VL) nucleus]], receives inhibitory"
      }, {
        "text": " signals from the GPi. The direct and indirect pathways of the basal ganglia modulate this inhibition to either facilitate or suppress movement by"
      }, {
        "text": " disinhibiting or inhibiting the VA/VL nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the VA and VL nuclei as"
      }, {
        "text": " the motor relay stations of the thalamus, receiving input from the basal ganglia and cerebellum and projecting to the motor cortices.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVentral Anterior nucleus\u003c/b\u003e of the thalamus is a key node"
      }, {
        "text": " in the motor circuit, acting as a gate that is controlled by inhibitory inputs from the basal ganglia to regulate the flow of information"
      }, {
        "text": " to the premotor cortex for movement planning.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Basal Ganglia -"
      }, {
        "text": " GPi] --Inhibitory--\u003e B(VA Nucleus); B --Excitatory--\u003e C(Premotor Cortex"
      }, {
        "text": ");\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \""
      }, {
        "text": "to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"receives_"
      }, {
        "text": "input_from\",\n        \"to\": \"globus_pallidus_internus\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"projects_to\",\n        \"to\": \"premotor_cortex\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"718c1a2c\": {\n    \"title\": \"V"
      }, {
        "text": "entral Lateral (VL) Nucleus of Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Lateral (VL) nucleus"
      }, {
        "text": "\u003c/b\u003e is a motor nucleus of the [[afc0a64b|thalamus]] that plays a crucial role in coordinating"
      }, {
        "text": " and modulating motor activity by relaying information from the [[ed462927|basal ganglia]] and cerebellum to the"
      }, {
        "text": " motor cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the ventral nuclear group of the [[afc0"
      }, {
        "text": "a64b|thalamus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Motor coordination and modulation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput"
      }, {
        "text": ":\u003c/b\u003e Receives input from two major motor control centers:\u003cbr\u003e - From the \u003cmark\u003eglobus pallidus internus (GPi"
      }, {
        "text": ")\u003c/mark\u003e of the [[ed462927|basal ganglia]].\u003cbr\u003e - From the contralateral"
      }, {
        "text": " \u003cmark\u003e[[c819d97b|dentate nucleus]]\u003c/mark\u003e of the [[be"
      }, {
        "text": "be58d4|cerebellum]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects primarily to the \u003cmark\u003eprimary motor cortex\u003c/mark\u003e and"
      }, {
        "text": " premotor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway Integration:\u003c/b\u003e The VL nucleus is a key site where inputs from both the basal ganglia (for movement"
      }, {
        "text": " selection) and the cerebellum (for movement coordination) are integrated before being sent to the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the VA and VL nuclei as the motor relay stations of the thalamus. The VL is particularly important as it integrates both"
      }, {
        "text": " basal ganglia and cerebellar inputs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVentral Lateral nucleus"
      }, {
        "text": "\u003c/b\u003e of the thalamus is the primary motor integration and relay center, funneling processed information from both the basal ganglia and"
      }, {
        "text": " cerebellum to the motor cortex to ensure that movements are both well-chosen and well-executed.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Basal Ganglia] --\u003e C(VL Nucleus); B[Cerebellum] --\u003e C;"
      }, {
        "text": " C --\u003e D(Motor Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_"
      }, {
        "text": "of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"receives_input_from\",\n        \"to\": \"ed462927"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\":"
      }, {
        "text": " \"bebe58d4\"\n      },\n      {\n        \"type\": \"projects_to\","
      }, {
        "text": "\n        \"to\": \"primary_motor_cortex\"\n      }\n    ]\n  },\n  \"6"
      }, {
        "text": "dcf9281\": {\n    \"title\": \"Ventral Optic Radiation (Meyer\u0027s Loop)\",\n    \"primaryType"
      }, {
        "text": "\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ophthalmology\",\n      \"USMLE"
      }, {
        "text": "\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Visual Pathway\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Ventral Optic Radiation\u003c/b\u003e, commonly known as \u003cb\u003eMeyer\u0027s loop\u003c/b\u003e, is the inferior bundle of nerve"
      }, {
        "text": " fibers that projects from the lateral geniculate nucleus (LGN) of the thalamus to the primary visual cortex. It takes"
      }, {
        "text": " a characteristic looping path through the temporal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Origin"
      }, {
        "text": "ates in the LGN, sweeps anteriorly and inferiorly into the \u003cmark\u003etemporal lobe\u003c/mark\u003e around the inferior horn"
      }, {
        "text": " of the lateral ventricle, and then projects posteriorly to the inferior portion of the primary visual cortex (lingual gyrus), below"
      }, {
        "text": " the calcarine sulcus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisual Field Information:\u003c/b\u003e It carries information from the \u003cmark\u003einfer"
      }, {
        "text": "ior retina\u003c/mark\u003e, which corresponds to the \u003cmark\u003esuperior visual field\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect"
      }, {
        "text": ":\u003c/b\u003e A lesion of Meyer\u0027s loop causes a contralateral \u003cmark\u003esuperior quadrantanopia\u003c/mark\u003e (a \u0027"
      }, {
        "text": "pie in the sky\u0027 visual field defect).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[09c8409d"
      }, {
        "text": "|dorsal optic radiation]] travels through the parietal lobe and carries information from the superior retina (inferior visual field).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the mnemonic \u003cb\u003ePITS\u003c/b\u003e: \u003cb\u003eP\u003c/b\u003earietal lesion \u003d \u003cb\u003eI\u003c/b\u003enferior field"
      }, {
        "text": " defect, \u003cb\u003eT\u003c/b\u003eemporal lesion \u003d \u003cb\u003eS\u003c/b\u003euperior field defect. A lesion in the temporal lobe affecting"
      }, {
        "text": " Meyer\u0027s loop causes a \u0027pie in the sky\u0027 defect.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Meyer\u0027s loop\u003c/b\u003e is the inferior, looping visual pathway that takes a detour through the temporal lobe to carry information about"
      }, {
        "text": " the superior visual world; a lesion here characteristically \u0027takes a pie out of the sky\u0027.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Inferior Retina] --\u003e B(LGN); B --\u003e C(Meyer\u0027s Loop); C"
      }, {
        "text": " --\u003e D(Through Temporal Lobe); D --\u003e E(Primary Visual Cortex); F[Lesion in Meyer\u0027s Loop] --\u003e G"
      }, {
        "text": "(Contralateral Superior Quadrantanopia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_"
      }, {
        "text": "of\",\n        \"to\": \"optic_radiation\"\n      },\n      {\n        \"type\": \"travels_"
      }, {
        "text": "through\",\n        \"to\": \"temporal_lobe\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "lesion_causes\",\n        \"to\": \"superior_quadrantanopia\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_counterpart_to\",\n        \"to\": \"09c8409d\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"2ae957b8\": {\n    \"title\": \""
      }, {
        "text": "Ventral Posterolateral (VPL) Nucleus of Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \""
      }, {
        "text": "Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Posterolateral (V"
      }, {
        "text": "PL) nucleus\u003c/b\u003e is a primary sensory relay nucleus in the [[afc0a64b|thalamus]]. It receives"
      }, {
        "text": " somatosensory information from the body and limbs and projects it to the primary somatosensory cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the ventral posterior complex of the [[afc0a64b|thalamus]].\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Relays sensory information for \u003cmark\u003evibration, proprioception, pain, temperature, and fine touch"
      }, {
        "text": "\u003c/mark\u003e from the body and limbs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives input from two major ascending sensory pathways:\u003cbr\u003e - The"
      }, {
        "text": " \u003cmark\u003e[[f19bc454|medial lemniscus]]\u003c/mark\u003e (carrying proprioception, vibration"
      }, {
        "text": ", fine touch).\u003cbr\u003e - The \u003cmark\u003e[[07eecef1|spinothalamic tract]]\u003c/mark\u003e ("
      }, {
        "text": "carrying pain, temperature, crude touch).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the primary somatosensory cortex in the post"
      }, {
        "text": "central gyrus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[23ac314a|ventral poster"
      }, {
        "text": "omedial (VPM) nucleus]] receives sensory information from the face. Mnemonic: V\u003cb\u003ePL\u003c/b\u003e for \u003cb\u003eP"
      }, {
        "text": "\u003c/b\u003eain/\u003cb\u003eP\u003c/b\u003eroprioception from \u003cb\u003eL\u003c/b\u003eimbs; V\u003cb\u003ePM\u003c/b\u003e for sensation from the"
      }, {
        "text": " \u003cb\u003eM\u003c/b\u003eouth/\u003cb\u003eM\u003c/b\u003eug.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion in the VPL nucleus ("
      }, {
        "text": "e.g., from a thalamic stroke) will cause contralateral sensory loss in the body and limbs.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eVPL nucleus\u003c/b\u003e of the thalamus is the central processing hub for all somatosensory information from the body,"
      }, {
        "text": " receiving inputs from both the spinothalamic and dorsal column pathways before relaying them to the cortex for conscious perception.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Spinothalamic Tract] --\u003e C(VPL Nucleus); B[Medial Lemniscus] --\u003e C"
      }, {
        "text": "; C --\u003e D(Primary Somatosensory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_part_of\",\n        \"to\": \"afc0a64b\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"receives_input_from\",\n        \"to\": \"07eecef1\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"f1"
      }, {
        "text": "9bc454\"\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        "
      }, {
        "text": "\"to\": \"23ac314a\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "23ac314a\": {\n    \"title\": \"Ventral Posteromedial (VPM)"
      }, {
        "text": " Nucleus of Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      "
      }, {
        "text": "\"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVentral Posteromedial (VPM"
      }, {
        "text": ") nucleus\u003c/b\u003e is a primary sensory relay nucleus in the [[afc0a64b|thalamus]]."
      }, {
        "text": " It receives somatosensory information from the face and head, as well as taste information, and projects it to the primary somatos"
      }, {
        "text": "ensory cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the ventral posterior complex of the [[afc0"
      }, {
        "text": "a64b|thalamus]], medial to the VPL nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Relays sensory"
      }, {
        "text": " information for \u003cmark\u003evibration, proprioception, pain, temperature, and fine touch\u003c/mark\u003e from the face"
      }, {
        "text": ", as well as taste.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives input from:\u003cbr\u003e - The \u003cmark\u003etr"
      }, {
        "text": "igeminal lemniscus\u003c/mark\u003e (carrying somatosensation from the contralateral face via the trigeminal nerve).\u003cbr\u003e - The \u003cmark\u003e"
      }, {
        "text": "solitary tract\u003c/mark\u003e (carrying taste information).\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the primary somatosensory cortex ("
      }, {
        "text": "for facial sensation) and the gustatory cortex (for taste).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[2ae"
      }, {
        "text": "957b8|ventral posterolateral (VPL) nucleus]] receives sensory information from the body and limbs. Mnemonic: V\u003cb\u003ePM"
      }, {
        "text": "\u003c/b\u003e for sensation from the \u003cb\u003eM\u003c/b\u003eouth/\u003cb\u003eM\u003c/b\u003eug.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion in the VPM nucleus"
      }, {
        "text": " will cause contralateral sensory loss in the face.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "VPM nucleus\u003c/b\u003e of the thalamus is the specific relay station for all sensory information from the face and for taste,"
      }, {
        "text": " processing these inputs before sending them to the cortex for perception.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigem"
      }, {
        "text": "inal Lemniscus] --\u003e C(VPM Nucleus); B[Solitary Tract - Taste] --\u003e C; C --\u003e D"
      }, {
        "text": "(Somatosensory \u0026 Gustatory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_"
      }, {
        "text": "of\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"receives_input_from\",\n        \"to\": \"trigeminal_nerve\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"receives_input_from\",\n        \"to\": \"solitary_tract\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_counterpart_to\",\n        \"to\":"
      }, {
        "text": " \"2ae957b8\"\n      }\n    ]\n  },\n  \"ddf80"
      }, {
        "text": "249\": {\n    \"title\": \"Ventral Tegmental Area (VTA)\",\n    \"primary"
      }, {
        "text": "Type\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Psychiatry\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eVentral Tegmental Area (VTA)\u003c/b\u003e is a group of neurons located in the midbrain that"
      }, {
        "text": " is the origin of the major dopaminergic pathways of the mesolimbic and mesocortical systems. It is"
      }, {
        "text": " a central component of the brain\u0027s reward circuitry.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:"
      }, {
        "text": "\u003c/b\u003e Midbrain, medial to the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter:\u003c/b\u003e The neurons of the VTA synthesize"
      }, {
        "text": " and release \u003cmark\u003e[[90adc821|dopamine]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePro"
      }, {
        "text": "jections:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMesolimbic Pathway:\u003c/b\u003e Projects to the nucleus accumbens."
      }, {
        "text": " This pathway is crucial for reward, motivation, and pleasure, and is the primary circuit involved in \u003cmark\u003eaddiction\u003c/mark\u003e. Hyper"
      }, {
        "text": "activity is implicated in the positive symptoms of schizophrenia.\u003cbr\u003e - \u003cb\u003eMesocortical Pathway:\u003c/b\u003e Projects to the prefrontal cortex."
      }, {
        "text": " This pathway is involved in cognition and executive function. Hypoactivity is implicated in the negative symptoms of schizophrenia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Relevance:\u003c/b\u003e The VTA and its projections are the primary targets of addictive drugs, which increase dopamine release in the nucleus accumbens. It"
      }, {
        "text": " is also a key area in the pathophysiology of schizophrenia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The VTA is the"
      }, {
        "text": " starting point for the \u0027reward\u0027 and \u0027cognitive\u0027 dopamine pathways. Differentiate it from the substantia nigra, which is the starting"
      }, {
        "text": " point for the \u0027motor\u0027 (nigrostriatal) dopamine pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eV"
      }, {
        "text": "entral Tegmental Area\u003c/b\u003e is the wellspring of the brain\u0027s dopamine-driven reward system, launching the mesolimbic pathway"
      }, {
        "text": " that is fundamental to motivation, pleasure, and the hijacked neural circuitry of addiction.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "VTA]; A --Mesolimbic Pathway--\u003e B(Nucleus Accumbens - Reward); A --Mesocortical Pathway--\u003e C"
      }, {
        "text": "(Prefrontal Cortex - Cognition);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_"
      }, {
        "text": "of\",\n        \"to\": \"midbrain\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_origin_of\",\n        \"to\": \"mesolimbic_pathway\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_origin_of\",\n        \"to\": \"mesocortical_pathway\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"produces\",\n        \"to\": \"90adc821\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"1cb9c975\": {\n    \"title\": \""
      }, {
        "text": "Ventricular System (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Anatomy and Physiology\",\n      \"Ventricular System\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eventricular system\u003c/b\u003e is a set of four interconnected, cerebrospinal fluid ("
      }, {
        "text": "CSF)-filled cavities within the brain. It is responsible for the production, circulation, and removal of CSF.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Two lateral ventricles, the third ventricle, and the fourth ventricle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF"
      }, {
        "text": " Flow Pathway:\u003c/b\u003e\u003cbr\u003e1. Lateral ventricles ‚Üí [[eea1b841|Foramen of"
      }, {
        "text": " Monro]] ‚Üí\u003cbr\u003e2. Third ventricle ‚Üí [[8a30e721|Cerebral aqueduct]] ‚Üí\u003cbr"
      }, {
        "text": "\u003e3. Fourth ventricle ‚Üí [[098c1e45|Foramina of Luschka]] ("
      }, {
        "text": "lateral) \u0026 [[0569a9e3|Foramen of Magendie]] (medial) ‚Üí\u003c"
      }, {
        "text": "br\u003e4. Subarachnoid space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Production:\u003c/b\u003e [[7109d8"
      }, {
        "text": "b6|CSF]] is produced by the [[ae65e9c7|choroid plexus]] located within all"
      }, {
        "text": " four ventricles.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Reabsorption:\u003c/b\u003e CSF is reabsorbed into the venous circulation via the [[b"
      }, {
        "text": "7b67074|arachnoid granulations]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Obstruction of this"
      }, {
        "text": " system at any point leads to \u003cmark\u003e[[0bc2f200|hydrocephalus]]\u003c/mark\u003e,"
      }, {
        "text": " an accumulation of CSF that increases intracranial pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the path of CSF flow and the"
      }, {
        "text": " sites of potential obstruction. For example, stenosis of the cerebral aqueduct is a common cause of non-communicating hydrocephalus."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eventricular system\u003c/b\u003e is the brain\u0027s internal plumbing,"
      }, {
        "text": " a network of cavities that produces and circulates cerebrospinal fluid, with narrow passages like the cerebral aqueduct acting as critical choke"
      }, {
        "text": " points where blockages can lead to hydrocephalus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lateral Ventricles] --"
      }, {
        "text": "Foramen of Monro--\u003e B[Third Ventricle]; B --Cerebral Aqueduct--\u003e C[Fourth Ventricle]; C --"
      }, {
        "text": "Foramina of Luschka \u0026 Magendie--\u003e D[Subarachnoid Space];\"\n    },\n    \"connections\": ["
      }, {
        "text": "\n      {\n        \"type\": \"circulates\",\n        \"to\": \"7109d8b6\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"ae65e9c7\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"obstruction_causes\",\n        \"to\": \"0"
      }, {
        "text": "bc2f200\"\n      }\n    ]\n  },\n  \"e970dcf"
      }, {
        "text": "9\": {\n    \"title\": \"Ventriculomegaly\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Radiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Hydrocephalus\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVentriculomegaly\u003c/b\u003e is a"
      }, {
        "text": " descriptive term for the enlargement of the cerebral ventricles, as seen on neuroimaging. It can be a sign of [["
      }, {
        "text": "0bc2f200|hydrocephalus]] or it can be a compensatory change due to brain atrophy.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[0bc2f200|Hydrocephalus]]:\u003c/b\u003e In"
      }, {
        "text": " true hydrocephalus, ventriculomegaly is caused by an increased volume of cerebrospinal fluid (CSF) due to obstruction of"
      }, {
        "text": " flow (non-communicating) or impaired reabsorption (communicating). This leads to \u003cmark\u003eincreased intracranial pressure\u003c/mark\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[7efdb0ef|Hydrocephalus Ex Vacuo]]:\u003c/b\u003e This is ventriculomegaly that"
      }, {
        "text": " occurs secondary to a loss of brain parenchyma (atrophy). The ventricles enlarge to fill the space left by the missing"
      }, {
        "text": " brain tissue. In this case, the intracranial pressure is \u003cmark\u003enormal\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging Differentiation:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - In true hydrocephalus, the ventricles are enlarged, often out of proportion to the cortical sulci.\u003c"
      }, {
        "text": "br\u003e - In hydrocephalus ex vacuo, both the ventricles and the cortical sulci are enlarged, indicating diffuse brain atrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses"
      }, {
        "text": ":\u003c/b\u003e True hydrocephalus can be caused by aqueductal stenosis, tumors, or post-meningitic scarring. Hydrocephalus ex vacuo is"
      }, {
        "text": " seen in neurodegenerative diseases like [[77ae6148|Alzheimer disease]] and [[ffd7e"
      }, {
        "text": "743|Huntington disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e When you see enlarged ventricles on a brain"
      }, {
        "text": " scan, always check the sulci. Wide sulci suggest atrophy (hydrocephalus ex vacuo). Normal or effaced sulci suggest true"
      }, {
        "text": " hydrocephalus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVentriculomegaly\u003c/b\u003e is simply"
      }, {
        "text": " \u0027big ventricles\u0027 on a scan; the crucial diagnostic step is to determine if this is due to a high-pressure fluid"
      }, {
        "text": " backup (true hydrocephalus) or a passive expansion into space created by brain atrophy (hydrocephalus ex vacuo).\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \""
      }, {
        "text": "to\": \"0bc2f200\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_sign_of\",\n        \"to\": \"7efdb0ef\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_seen_in\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"d662ec5d\": {\n    \"title\": \"Ventromedial Nucle"
      }, {
        "text": "us of Hypothalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Physiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology"
      }, {
        "text": "\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Ventromedial Nucleus\u003c/b\u003e is a region of the [[89e86633|hypothalamus]] that acts"
      }, {
        "text": " as the primary \u003cmark\u003esatiety center\u003c/mark\u003e of the brain, responsible for signaling the feeling of fullness and"
      }, {
        "text": " inhibiting hunger.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Mediates \u003cb\u003esatiety\u003c/b\u003e. M"
      }, {
        "text": "nemonic: The \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003eM\u003c/b\u003eedial nucleus makes you feel \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM"
      }, {
        "text": "\u003c/b\u003euch full.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e It is stimulated by hormones that signal energy sufficiency, such as \u003cmark\u003eleptin\u003c/mark\u003e ("
      }, {
        "text": "released from adipose tissue).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effect:\u003c/b\u003e Destruction of the ventromedial nucleus (e.g., by"
      }, {
        "text": " a craniopharyngioma or trauma) leads to the loss of the satiety signal. This results in \u003cmark\u003ehyperph"
      }, {
        "text": "agia\u003c/mark\u003e (excessive eating) and profound obesity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e The [[lateral_hypothalamic"
      }, {
        "text": "_nucleus|lateral nucleus of the hypothalamus]] is the hunger center. A lesion there causes anorexia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember the functional pairing: Ventromedial \u003d Satiety (lesion -\u003e get very fat). Lateral \u003d Hunger"
      }, {
        "text": " (lesion -\u003e get very lean).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVent"
      }, {
        "text": "romedial Nucleus of the hypothalamus\u003c/b\u003e is the brain\u0027s \u0027off switch\u0027 for eating; its stimulation by hormones"
      }, {
        "text": " like leptin signals fullness, and its destruction leads to unchecked hunger and obesity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Leptin/Satiety Signals] --\u003e B(Ventromedial Nucleus); B --Inhibits--\u003e C(Hunger Drive"
      }, {
        "text": "); D[Lesion of VMN] --x C; D --\u003e E(Hyperphagia \u0026 Obesity);\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \""
      }, {
        "text": "89e86633\"\n      },\n      {\n        \"type\": \"mediates\","
      }, {
        "text": "\n        \"to\": \"satiety\"\n      },\n      {\n        \"type\": \"lesion"
      }, {
        "text": "_causes\",\n        \"to\": \"hyperphagia\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_counterpart_to\",\n        \"to\": \"lateral_hypothalamic_nucleus\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"38100c31\": {\n    \"title\":"
      }, {
        "text": " \"Verapamil\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Cardiology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Card"
      }, {
        "text": "iovascular\",\n      \"Pharmacology\",\n      \"Calcium Channel Blockers\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVerapamil\u003c/b\u003e is a non-dihydropyridine "
      }, {
        "text": "\u003ci\u003ecalcium channel blocker\u003c/i\u003e that exerts its effects primarily on the heart, causing decreased heart rate and contractility. It is"
      }, {
        "text": " used to treat hypertension, angina, arrhythmias, and for the prophylaxis of cluster headaches.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e Blocks L-type voltage-gated calcium channels in cardiac myocytes and nodal tissue, as well as in vascular"
      }, {
        "text": " smooth muscle. Its effects are more pronounced on the heart than on peripheral vessels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCardiac Effects:\u003c/b\u003e Decre"
      }, {
        "text": "ases heart rate (negative chronotropy) by slowing conduction through the SA and AV nodes. Decreases contractility (negative in"
      }, {
        "text": "otropy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Effects:\u003c/b\u003e Causes vasodilation, but less so than dihydropyridine calcium"
      }, {
        "text": " channel blockers (e.g., amlodipine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Headache:\u003c/b\u003e It is the \u003cmark\u003efirst"
      }, {
        "text": "-line prophylactic\u003c/mark\u003e treatment for [[21760f80|cluster headaches]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The"
      }, {
        "text": " most common side effect is \u003cmark\u003econstipation\u003c/mark\u003e. It can also cause bradycardia, AV block, and worsening"
      }, {
        "text": " of heart failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember verapamil as the non-dihydropyridine CC"
      }, {
        "text": "B with the most prominent cardiac effects and the classic side effect of constipation. It is the drug of choice for preventing cluster headaches.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eVerapamil\u003c/b\u003e is a heart-focused calcium channel blocker that slows the heart and"
      }, {
        "text": " reduces its force of contraction, but it also has a unique and important role as the primary prophylactic agent for the excruciatingly"
      }, {
        "text": " painful cluster headache.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"calcium_channel_blocker\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_used_for_prophylaxis_of\","
      }, {
        "text": "\n        \"to\": \"21760f80\"\n      },\n      {\n        \"type\": \"causes_ad"
      }, {
        "text": "verse_effect\",\n        \"to\": \"constipation\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"causes_adverse_effect\",\n        \"to\": \"bradycardia\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"09dd109e\": {\n    \"title\": \"Vertical Gaze Pals"
      }, {
        "text": "y\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eVertical gaze palsy\u003c/b\u003e is the inability to voluntarily move the eyes up (upward gaze palsy) or down (down"
      }, {
        "text": "ward gaze palsy). An upward gaze palsy is the hallmark sign of \u003cmark\u003eParinaud syndrome\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the dorsal midbrain, specifically compressing the superior"
      }, {
        "text": " colliculus and the rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF), which is the vertical"
      }, {
        "text": " gaze center.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndrome:\u003c/b\u003e The primary component of Parinaud syndrome (dorsal midbrain syndrome).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eParinaud Syndrome Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eUpward Gaze Palsy."
      }, {
        "text": "\u003c/b\u003e\u003cbr\u003e2. \u003cb\u003ePupillary Light-Near Dissociation:\u003c/b\u003e Pupils react poorly to light but const"
      }, {
        "text": "rict to accommodation.\u003cbr\u003e3. \u003cb\u003e[[3db2e75e|Convergence-Retraction N"
      }, {
        "text": "ystagmus]]:\u003c/b\u003e Jerky movements of the eyes on attempted upgaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e In"
      }, {
        "text": " children, a \u003cmark\u003epinealoma\u003c/mark\u003e is the classic cause. In adults, causes include stroke of the midbrain or hydro"
      }, {
        "text": "cephalus causing pressure on the tectum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The inability to look up, especially in"
      }, {
        "text": " a child or young adult, should immediately raise suspicion for a pineal region tumor causing Parinaud syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eA \u003cb\u003evertical gaze palsy\u003c/b\u003e, particularly an inability to look up, is a definitive localizing"
      }, {
        "text": " sign, pointing to a lesion in the dorsal midbrain that has disrupted the vertical gaze center, and is the most prominent feature of Par"
      }, {
        "text": "inaud syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"parinaud_syndrome\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to"
      }, {
        "text": "\": \"dorsal_midbrain\"\n      },\n      {\n        \"type\": \"can_be_caused_"
      }, {
        "text": "by\",\n        \"to\": \"pinealoma\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "5603962d\": {\n    \"title\": \"Vertigo\",\n    \"primaryType\":"
      }, {
        "text": " \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Otology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVertigo\u003c/b\u003e is a subtype"
      }, {
        "text": " of [[71d3f0e1|dizziness]] characterized by a false sensation of movement, either of the self"
      }, {
        "text": " or the environment, often described as \u0027spinning.\u0027 It is a cardinal symptom of vestibular system dysfunction.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePeripheral Vertigo:\u003c/b\u003e Caused by a problem in the inner ear or vestibular"
      }, {
        "text": " nerve (CN VIII).\u003cbr\u003e - \u003cb\u003eCharacteristics:\u003c/b\u003e Sudden onset, intense spinning sensation, often associated with nausea/"
      }, {
        "text": "vomiting, tinnitus, and hearing loss. Nystagmus is typically horizontal or torsional and is suppressed by visual fixation.\u003cbr\u003e - \u003cb\u003eCauses"
      }, {
        "text": ":\u003c/b\u003e Benign paroxysmal positional vertigo (BPPV), vestibular neuritis, [[menieres_disease|M√©n"
      }, {
        "text": "i√®re disease]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[350f1c8b|Central Vertigo]]:\u003c/b\u003e Caused by a problem in the brain"
      }, {
        "text": "stem or cerebellum.\u003cbr\u003e - \u003cb\u003eCharacteristics:\u003c/b\u003e More subtle, less intense vertigo. Nystagmus can"
      }, {
        "text": " be in any direction, including \u003cmark\u003epurely vertical\u003c/mark\u003e, and is \u003cu\u003enot\u003c/u\u003e suppressed by visual fixation."
      }, {
        "text": " Often accompanied by other neurological signs (e.g., diplopia, dysarthria, ataxia).\u003cbr\u003e - \u003cb\u003eCauses:\u003c/b\u003e Stroke ("
      }, {
        "text": "e.g., Wallenberg syndrome), [[45dd6d19|multiple sclerosis]], tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The direction of nystagmus and the presence of other neurological signs are key to differentiating central from peripheral vertigo. Purely vertical n"
      }, {
        "text": "ystagmus is a red flag for a central cause.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVertigo\u003c/b\u003e is the"
      }, {
        "text": " illusion of motion that signals a mismatch in the vestibular system; distinguishing between a benign peripheral cause (like BPPV) and a dangerous"
      }, {
        "text": " central cause (like a brainstem stroke) is a critical diagnostic challenge guided by the characteristics of the nystagmus and associated"
      }, {
        "text": " neurological findings.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"71d3f0e1\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"can_be\",\n        \"to\": \"peripheral_vertigo\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"can_be\",\n        \"to\": \"350f1c8b\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\":"
      }, {
        "text": " \"menieres_disease\"\n      }\n    ]\n  },\n  \"07b0a9dd"
      }, {
        "text": "\": {\n    \"title\": \"Vesicular Monoamine Transporter (VMAT)\",\n    \"primaryType\": \""
      }, {
        "text": "molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Bi"
      }, {
        "text": "ochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eVesicular Monoamine Transporter (VMAT)\u003c/b\u003e is a transport protein located on the membrane"
      }, {
        "text": " of synaptic vesicles in monoaminergic neurons. Its function is to transport monoamine neurotransmitters (such as dopamine, norepinephrine, serotonin"
      }, {
        "text": ", and histamine) from the cytoplasm into the vesicles for storage and subsequent release.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": ":\u003c/b\u003e Packages monoamines into presynaptic vesicles, protecting them from degradation by monoamine oxidase (MAO) in the cytoplasm and making"
      }, {
        "text": " them available for synaptic release.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacological Inhibition:\u003c/b\u003e VMAT can be inhibited by certain drugs.\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eReserpine (irreversible):\u003c/b\u003e An old antihypertensive drug that depletes monoamine stores, leading to profound"
      }, {
        "text": " depression and hypotension.\u003cbr\u003e - \u003cb\u003eTetrabenazine \u0026 Deutetrabenazine (reversible):\u003c/b\u003e VMAT2"
      }, {
        "text": " inhibitors used to treat the chorea associated with [[ffd7e743|Huntington disease]] by depleting dopamine stores."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e By controlling the amount of neurotransmitter available for release, VMAT plays a crucial role in modulating"
      }, {
        "text": " monoaminergic neurotransmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e VMAT inhibitors like tetrabenazine are used to treat hyperkinetic movement"
      }, {
        "text": " disorders (e.g., Huntington\u0027s chorea) by reducing the amount of dopamine that can be released into the synapse.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVesicular Monoamine Transporter (VMAT)\u003c/b\u003e acts as the \u0027"
      }, {
        "text": "loading dock\u0027 for monoamine neurotransmitters, packaging them into vesicles for release; inhibiting this transporter effectively depletes the brain\u0027s supply"
      }, {
        "text": " of these neurotransmitters, a mechanism used to treat hyperkinetic movement disorders.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Mono"
      }, {
        "text": "amines in Cytoplasm] --VMAT--\u003e B(Storage in Synaptic Vesicles); C[Tetrabenazine] --"
      }, {
        "text": "Inhibits--\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"transports\","
      }, {
        "text": "\n        \"to\": \"monoamines\"\n      },\n      {\n        \"type\": \"is_inhibited_by\",\n        \""
      }, {
        "text": "to\": \"tetrabenazine\"\n      },\n      {\n        \"type\": \"is_inhibited"
      }, {
        "text": "_by\",\n        \"to\": \"reserpine\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"11946667\": {\n    \"title\": \"Vestibular Schwannoma\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Ot"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eA \u003cb\u003evestibular schwannoma\u003c/b\u003e, also known as an acoustic neuroma, is a"
      }, {
        "text": " benign tumor arising from the Schwann cells of the vestibular portion of the vestibulocochlear nerve (CN VIII). It is"
      }, {
        "text": " typically located at the cerebellopontine angle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCell"
      }, {
        "text": " of Origin:\u003c/b\u003e Arises from Schwann cells, which myelinate peripheral nerves. The tumor is S-100 positive"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found at the \u003cmark\u003ecerebellopontine angle\u003c/mark\u003e, the"
      }, {
        "text": " space between the cerebellum and the pons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Symptoms are due to compression of CN VIII and adjacent structures"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003eCN VIII:\u003c/b\u003e \u003cmark\u003eUnilateral sensorineural hearing loss\u003c/mark\u003e and \u003cmark\u003etinnitus\u003c/"
      }, {
        "text": "mark\u003e are the most common presenting symptoms. Vertigo is less common.\u003cbr\u003e - \u003cb\u003eCN VII:\u003c/b\u003e Facial"
      }, {
        "text": " weakness or paralysis.\u003cbr\u003e - \u003cb\u003eCN V:\u003c/b\u003e Facial numbness or paresthesias.\u003c/li\u003e\u003cli\u003e\u003cb\u003eB"
      }, {
        "text": "ilateral Schwannomas:\u003c/b\u003e The presence of bilateral vestibular schwannomas is pathognomonic for \u003cmark\u003eNeurofibromatosis Type 2 (NF"
      }, {
        "text": "-2)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An adult with insidious, unilateral hearing loss and tinnitus should"
      }, {
        "text": " be evaluated for a vestibular schwannoma. If the schwannomas are bilateral, the diagnosis is NF-2."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003evestibular schwannoma\u003c/b\u003e is a benign tumor of"
      }, {
        "text": " the myelin-forming cells of the eighth cranial nerve, which classically presents with unilateral hearing loss and tinnitus due to its growth"
      }, {
        "text": " in the confined space of the cerebellopontine angle, where it also endangers adjacent cranial nerves.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Schwannoma] --Grows at Cerebellopontine Angle--\u003e B(Compresses N"
      }, {
        "text": "erves); B --\u003e C(CN VIII -\u003e Hearing Loss, Tinnitus); B --\u003e D(CN VII -\u003e Facial Pals"
      }, {
        "text": "y); B --\u003e E(CN V -\u003e Facial Numbness);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"schwannoma\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_located_at\",\n        \"to\": \"cerebell"
      }, {
        "text": "opontine_angle\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to"
      }, {
        "text": "\": \"neurofibromatosis_type_2\"\n      },\n      {\n        \"type\": \"comp"
      }, {
        "text": "resses\",\n        \"to\": \"vestibulocochlear_nerve\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"6fded3e7\": {\n    \"title\": \"Vestibulocochlear Nerve"
      }, {
        "text": " (CN VIII)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Ot"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVestibulocochlear Nerve (CN VIII)\u003c/b\u003e is a purely"
      }, {
        "text": " sensory cranial nerve that transmits sound and equilibrium (balance) information from the inner ear to the brainstem.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e It has two distinct components:\u003cbr\u003e1. \u003cb\u003eCochlear Nerve"
      }, {
        "text": ":\u003c/b\u003e Transmits auditory information from the hair cells of the [[001c359f|cochlea]]."
      }, {
        "text": "\u003cbr\u003e2. \u003cb\u003eVestibular Nerve:\u003c/b\u003e Transmits information about linear and rotational acceleration from the utricle"
      }, {
        "text": ", saccule, and semicircular canals of the vestibular apparatus.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e The nerve travels from the inner ear through"
      }, {
        "text": " the internal auditory meatus to enter the brainstem at the cerebellopontine angle (at the pontomedullary junction).\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eFunction:\u003c/b\u003e Hearing and balance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e Damage to CN VIII can cause sensorineural hearing loss,"
      }, {
        "text": " tinnitus, vertigo, and nystagmus. A common cause of a lesion is a [[11946667|"
      }, {
        "text": "vestibular schwannoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that CN VIII travels with CN VII through the internal auditory meatus."
      }, {
        "text": " Therefore, a lesion in this location (e.g., a schwannoma) can present with symptoms related to both nerves"
      }, {
        "text": " (e.g., hearing loss and facial palsy).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003e"
      }, {
        "text": "Vestibulocochlear Nerve\u003c/b\u003e is the composite nerve for hearing and balance, carrying two distinct streams of sensory information from the inner ear to"
      }, {
        "text": " the brainstem; its dysfunction leads to the characteristic symptoms of hearing loss, tinnitus, and vertigo.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a\",\n        \"to\": \"sensory"
      }, {
        "text": "_cranial_nerve\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \""
      }, {
        "text": "to\": \"cochlear_nerve\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "composed_of\",\n        \"to\": \"vestibular_nerve\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"lesion_causes\",\n        \"to\": \"sensorineural_hearing_loss\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"5603962d\""
      }, {
        "text": "\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"a2cba303\",\n    \"letter\": \"G\",\n    \"term\": \"Ghrelin\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Ghrelin\",\n    \"sub_entries\": [\n      {\n        \"id\": \"4387462a\",\n        \"letter\": \"G\",\n        \"term\": \"hypothalamus effects of\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Ghrelin \u003e hypothalamus effects of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"88fffc48\",\n    \"letter\": \"G\",\n    \"term\": \"Glatiramer\",\n    \"pages\": [\n      \"537\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Glatiramer\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"3ce6c035\",\n    \"letter\": \"G\",\n    \"term\": \"Glaucoma\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Glaucoma\",\n    \"sub_entries\": [\n      {\n        \"id\": \"6fdec791\",\n        \"letter\": \"G\",\n        \"term\": \"therapy\",\n        \"pages\": [\n          \"568\"\n        ],\n        \"context\": \"Glaucoma \u003e therapy\"\n      },\n      {\n        \"id\": \"1901f125\",\n        \"letter\": \"G\",\n        \"term\": \"types and treatment\",\n        \"pages\": [\n          \"551\"\n        ],\n        \"context\": \"Glaucoma \u003e types and treatment\"\n      }\n    ]\n  },\n  {\n    \"id\": \"0bd25f41\",\n    \"letter\": \"G\",\n    \"term\": \"Glial cells\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Glial cells\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1bd0430d\",\n        \"letter\": \"G\",\n        \"term\": \"of CNS\",\n        \"pages\": [\n          \"503\"\n        ],\n        \"context\": \"Glial cells \u003e of CNS\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b6bbd0bc\",\n    \"letter\": \"G\",\n    \"term\": \"Glioblastoma\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Glioblastoma\",\n    \"sub_entries\": [\n      {\n        \"id\": \"bf27bca8\",\n        \"letter\": \"G\",\n        \"term\": \"description and histology\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Glioblastoma \u003e description and histology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"22421548\",\n    \"letter\": \"G\",\n    \"term\": \"Global aphasia\",\n    \"pages\": [\n      \"529\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Global aphasia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"21112945\",\n    \"letter\": \"G\",\n    \"term\": \"Globose nucleus\",\n    \"pages\": [\n      \"510\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Globose nucleus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"59e71dea\",\n    \"letter\": \"G\",\n    \"term\": \"Globus pallidus externus\",\n    \"pages\": [\n      \"511\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Globus pallidus externus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"97e2c817\",\n    \"letter\": \"G\",\n    \"term\": \"Glossopharyngeal nerve (CN IX)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Glossopharyngeal nerve (CN IX)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"08a53893\",\n        \"letter\": \"G\",\n        \"term\": \"function and type\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Glossopharyngeal nerve (CN IX) \u003e function and type\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7072f130\",\n    \"letter\": \"G\",\n    \"term\": \"Glucose\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Glucose\",\n    \"sub_entries\": [\n      {\n        \"id\": \"21d346a5\",\n        \"letter\": \"G\",\n        \"term\": \"blood-brain barrier and\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Glucose \u003e blood-brain barrier and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5ef5ca57\",\n    \"letter\": \"G\",\n    \"term\": \"GNAQ gene mutation\",\n    \"pages\": [\n      \"539\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"GNAQ gene mutation\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"d25e69be\",\n    \"letter\": \"G\",\n    \"term\": \"Gonadotropin-releasing hormone\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Gonadotropin-releasing hormone\",\n    \"sub_entries\": [\n      {\n        \"id\": \"bd510a5e\",\n        \"letter\": \"G\",\n        \"term\": \"neurons producing\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Gonadotropin-releasing hormone \u003e neurons producing\"\n      }\n    ]\n  },\n  {\n    \"id\": \"39f6b128\",\n    \"letter\": \"G\",\n    \"term\": \"Grand mal (tonic-clonic) seizures\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Grand mal (tonic-clonic) seizures\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e8720ceb\",\n    \"letter\": \"G\",\n    \"term\": \"Guillain-Barr√© syndrome\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Guillain-Barr√© syndrome\",\n    \"sub_entries\": [\n      {\n        \"id\": \"06a7581e\",\n        \"letter\": \"G\",\n        \"term\": \"peripheral nerves in\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Guillain-Barr√© syndrome \u003e peripheral nerves in\"\n      }\n    ]\n  },\n  {\n    \"id\": \"248af9f9\",\n    \"letter\": \"G\",\n    \"term\": \"Gustatory pathway\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Gustatory pathway\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1856
    }, {
      "text": "```json\n{\n  \"a2cba303\": {\n    \"title\": \"Ghrelin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Gastroenterology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Appetite Regulation\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGhrelin\u003c/b\u003e is a peptide hormone, primarily produced by ghrelinergic cells in the gastrointestinal tract (mainly the stomach), that is known as the \\\"hunger hormone.\\\" It acts on the [[89e86633|hypothalamus]] to stimulate appetite.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Stimulates appetite (orexigenic effect), increases food intake, and promotes fat storage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSite of Production:\u003c/b\u003e Primarily the stomach.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegulation:\u003c/b\u003e Ghrelin levels \u003cmark\u003eincrease before meals\u003c/mark\u003e and decrease after meals. Levels are also increased during fasting and in Prader-Willi syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypothalamic Effects:\u003c/b\u003e Acts on the arcuate nucleus of the [[89e86633|hypothalamus]] to stimulate orexigenic neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart:\u003c/b\u003e Its effects are opposed by satiety hormones like leptin and PYY.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember \u0027\u003cb\u003eGh\u003c/b\u003erelin makes you hun\u003cb\u003egh\u003c/b\u003ery.\u0027 Its levels are paradoxically low in obesity (except in Prader-Willi syndrome) and increase with weight loss, contributing to the difficulty of maintaining weight loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGhrelin\u003c/b\u003e is the primary hormonal signal for hunger, released from the stomach to act on the hypothalamus, driving the physiological urge to eat.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Empty Stomach] --\u003e B(‚Üë Ghrelin Secretion); B --\u003e C(Hypothalamus); C --\u003e D(‚Üë Appetite);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"stimulates\",\n        \"to\": \"appetite\"\n      },\n      {\n        \"type\": \"is_produced_by\",\n        \"to\": \"stomach\"\n      }\n    ]\n  },\n  \"88fffc48\": {\n    \"title\": \"Glatiramer Acetate\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Multiple Sclerosis Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlatiramer acetate\u003c/b\u003e is an immunomodulatory drug used as a disease-modifying therapy for the treatment of relapsing forms of [[45dd6d19|multiple sclerosis (MS)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a synthetic polypeptide, a random polymer of four amino acids found in myelin basic protein (glutamic acid, lysine, alanine, tyrosine). It is thought to act as a \u0027decoy\u0027 for the immune system, diverting the autoimmune response away from myelin. It may also promote the development of anti-inflammatory T-helper 2 (Th2) cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A first-line therapy for relapsing-remitting [[45dd6d19|multiple sclerosis]]. It reduces the frequency of relapses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Administered by subcutaneous injection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are injection site reactions (pain, redness, swelling). A characteristic, though benign, side effect is a post-injection reaction consisting of flushing, chest pain, palpitations, and shortness of breath, which is transient and self-limited.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Glatiramer acetate is a key disease-modifying therapy for MS. Remember its proposed mechanism as a \u0027myelin decoy\u0027 and its characteristic post-injection reaction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlatiramer acetate\u003c/b\u003e is a unique MS therapy that acts as an immunological decoy, mimicking myelin basic protein to redirect the autoimmune attack away from the patient\u0027s own myelin sheath, thereby reducing the frequency of inflammatory relapses.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"immunomodulator\"\n      }\n    ]\n  },\n  \"3ce6c035\": {\n    \"title\": \"Glaucoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Glaucoma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlaucoma\u003c/b\u003e is a group of eye conditions that damage the optic nerve, often characterized by an increase in intraocular pressure (IOP). If untreated, it leads to progressive, irreversible vision loss, typically beginning with the peripheral visual field.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Damage to the optic nerve head (optic neuropathy) from a combination of elevated IOP and vascular insufficiency. This leads to apoptosis of retinal ganglion cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[5ea7b741|Open-Angle Glaucoma]]:\u003c/b\u003e The most common type. The drainage angle for aqueous humor is open, but the trabecular meshwork is dysfunctional, leading to a slow, progressive increase in IOP. It is asymptomatic in early stages.\u003cbr\u003e - \u003cb\u003e[[9c80344d|Angle-Closure Glaucoma]]:\u003c/b\u003e The drainage angle is physically obstructed by the iris. Can be acute (a painful ophthalmologic emergency) or chronic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Findings:\u003c/b\u003e Progressive, bilateral (though often asymmetric) loss of peripheral vision (\u0027tunnel vision\u0027). Fundoscopy shows \u003cmark\u003eoptic disc cupping\u003c/mark\u003e (an increased cup-to-disc ratio).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapy:\u003c/b\u003e Treatment is aimed at lowering IOP. Medications either \u003cmark\u003edecrease aqueous humor production\u003c/mark\u003e (Œ≤-blockers, Œ±\u003csub\u003e2\u003c/sub\u003e-agonists, carbonic anhydrase inhibitors) or \u003cmark\u003eincrease aqueous humor outflow\u003c/mark\u003e (prostaglandin analogs, cholinomimetics).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Open-angle glaucoma is a chronic, silent disease causing peripheral vision loss. Acute angle-closure glaucoma is a painful emergency with a red eye and a fixed, mid-dilated pupil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlaucoma\u003c/b\u003e is a progressive optic neuropathy, not just high eye pressure, that silently steals peripheral vision by damaging the optic nerve; its management revolves around lowering intraocular pressure to slow the disease\u0027s progression.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë IOP] --\u003e B(Compression \u0026 Ischemia of Optic Nerve Head); B --\u003e C(Retinal Ganglion Cell Death); C --\u003e D(Optic Atrophy \u0026 Cupping); D --\u003e E(Progressive Peripheral Vision Loss);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"optic_neuropathy\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5ea7b741\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"9c80344d\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"glaucoma_drugs\"\n      }\n    ]\n  },\n  \"0bd25f41\": {\n    \"title\": \"Glial Cells\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlial cells\u003c/b\u003e (or neuroglia) are non-neuronal cells in the nervous system that do not produce electrical impulses but serve to maintain homeostasis, form myelin, and provide support and protection for neurons.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCNS Glial Cells (derived from neuroectoderm):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[8192f595|Astrocytes]]:\u003c/b\u003e Most abundant; provide structural support, form the blood-brain barrier, and regulate the chemical environment.\u003cbr\u003e - \u003cb\u003e[[a24f9747|Oligodendrocytes]]:\u003c/b\u003e Myelinate axons in the CNS. One oligodendrocyte myelinates multiple axons.\u003cbr\u003e - \u003cb\u003e[[3a777d5f|Ependymal Cells]]:\u003c/b\u003e Line the ventricles and produce CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Glial Cell (derived from mesoderm):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMicroglia:\u003c/b\u003e The resident macrophages of the CNS; act as phagocytic scavenger cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePNS Glial Cells (derived from neural crest):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSchwann Cells:\u003c/b\u003e Myelinate axons in the PNS. One Schwann cell myelinates one segment of one axon.\u003cbr\u003e - \u003cb\u003eSatellite Cells:\u003c/b\u003e Surround neuron cell bodies in ganglia, providing support.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the cell of origin for common CNS tumors: Astrocytes ‚Üí Astrocytoma/[[b6bbd0bc|Glioblastoma]]; Oligodendrocytes ‚Üí Oligodendroglioma; Ependymal cells ‚Üí [[14365ef4|Ependymoma]]; Schwann cells ‚Üí [[03ecb69e|Schwannoma]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlial cells\u003c/b\u003e are the essential support staff of the nervous system, performing a vast array of functions from myelination and immune defense to metabolic support, without which neurons could not function or survive.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"a24f9747\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"microglia\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"schwann_cells\"\n      }\n    ]\n  },\n  \"b6bbd0bc\": {\n    \"title\": \"Glioblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e (formerly known as glioblastoma multiforme or GBM) is the most common and most aggressive primary malignant brain tumor in adults. It is a Grade IV astrocytoma with a very poor prognosis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCell of Origin:\u003c/b\u003e Arises from [[8192f595|astrocytes]]. It is GFAP-positive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Typically arises in the cerebral hemispheres. It is known for its ability to cross the corpus callosum, creating a \u003cmark\u003e\\\"butterfly glioma\\\"\u003c/mark\u003e appearance on imaging.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e On contrast-enhanced MRI, it classically appears as a \u003cmark\u003ering-enhancing lesion\u003c/mark\u003e with central necrosis and surrounding vasogenic edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e The two key histological features are:\u003cbr\u003e1. \u003cb\u003ePseudopalisading necrosis:\u003c/b\u003e Tumor cells line up along the edges of a central area of necrosis.\u003cbr\u003e2. \u003cb\u003eMicrovascular proliferation:\u003c/b\u003e Endothelial cell proliferation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e Highly malignant and infiltrative, with a median survival of about 1 year despite aggressive treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of a ring-enhancing \u0027butterfly\u0027 lesion in an adult and histology showing pseudopalisading necrosis is pathognomonic for glioblastoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e is the most devastating primary brain tumor, characterized by its aggressive infiltration, central necrosis surrounded by pseudopalisading tumor cells, and its ominous ability to spread across the brain\u0027s midline as a \u0027butterfly glioma\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Astrocyte] --Mutations (e.g., EGFR, PTEN)--\u003e B(Glioblastoma); B --\u003e C(Rapid Growth \u0026 Infiltration); C --\u003e D(Central Necrosis \u0026 Vascular Proliferation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"astrocytoma\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"has_histological_finding\",\n        \"to\": \"pseudopalisading_necrosis\"\n      },\n      {\n        \"type\": \"expresses_marker\",\n        \"to\": \"fb50d450\"\n      }\n    ]\n  },\n  \"22421548\": {\n    \"title\": \"Global Aphasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Stroke\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlobal aphasia\u003c/b\u003e is the most severe form of aphasia, characterized by profound impairment of all language modalities, including speech production, comprehension, repetition, reading, and writing.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a large lesion that damages both [[a3bbace2|Broca\u0027s area]] and [[wernicke_area|Wernicke\u0027s area]], as well as the arcuate fasciculus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e Classically caused by a large \u003cmark\u003e[[143bb23d|Middle Cerebral Artery (MCA)]] stroke\u003c/mark\u003e in the dominant (usually left) hemisphere, affecting both the superior and inferior divisions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFluency:\u003c/b\u003e Nonfluent. Speech is absent or reduced to a few stereotyped words or sounds.\u003cbr\u003e - \u003cb\u003eComprehension:\u003c/b\u003e Severely impaired.\u003cbr\u003e - \u003cb\u003eRepetition:\u003c/b\u003e Severely impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs:\u003c/b\u003e Due to the large size of the lesion, it is almost always accompanied by a dense \u003cmark\u003econtralateral hemiplegia\u003c/mark\u003e (face and arm \u003e leg) and sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a sudden onset of right-sided paralysis who is mute or can only utter a few words and cannot follow any commands has global aphasia from a massive left MCA stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlobal aphasia\u003c/b\u003e represents a catastrophic loss of language function, resulting from a massive stroke that wipes out the entire language center of the dominant hemisphere, leaving the patient unable to produce or comprehend speech.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Large Dominant MCA Stroke] --\u003e B(Damage to Broca\u0027s Area, Wernicke\u0027s Area, \u0026 Arcuate Fasciculus); B --\u003e C(Global Aphasia); C --\u003e D(Impaired Fluency, Comprehension, \u0026 Repetition);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"a3bbace2\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"wernicke_area\"\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \"143bb23d\"\n      }\n    ]\n  },\n  \"21112945\": {\n    \"title\": \"Globose Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cerebellum\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebellum\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGlobose Nucleus\u003c/b\u003e is one of the four deep cerebellar nuclei, located medial to the emboliform nucleus. Together with the emboliform nucleus, it forms the interposed nucleus, which is involved in coordinating limb movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Deep within the white matter of the [[bebe58d4|cerebellum]], part of the interposed nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The interposed nuclei (emboliform + globose) are involved in coordinating agonist-antagonist muscle pairs during voluntary movements of the \u003cmark\u003edistal limbs\u003c/mark\u003e. They receive input from the intermediate zone of the cerebellar cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Projects to the contralateral red nucleus, contributing to the rubrospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e The deep cerebellar nuclei from lateral to medial are \\\"\u003cb\u003eD\u003c/b\u003eon\u0027t \u003cb\u003eE\u003c/b\u003eat \u003cb\u003eG\u003c/b\u003ereasy \u003cb\u003eF\u003c/b\u003eoods\\\" (\u003cb\u003eD\u003c/b\u003eentate, \u003cb\u003eE\u003c/b\u003emboliform, \u003cb\u003eG\u003c/b\u003elobose, \u003cb\u003eF\u003c/b\u003eastigial).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While less commonly tested than the dentate or fastigial nuclei, remember that the interposed nuclei (emboliform and globose) are involved in modulating limb movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eGlobose Nucleus\u003c/b\u003e, along with the emboliform nucleus, forms the interposed nucleus, a cerebellar relay that helps ensure the accuracy and coordination of ongoing movements in the distal limbs.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_cerebellar_nuclei\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"forms_interposed_nucleus_with\",\n        \"to\": \"3eccefd4\"\n      }\n    ]\n  },\n  \"59e71dea\": {\n    \"title\": \"Globus Pallidus Externus (GPe)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Basal Ganglia\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGlobus Pallidus Externus (GPe)\u003c/b\u003e is the outer segment of the globus pallidus, a key component of the [[ed462927|basal ganglia]]. It is a crucial relay nucleus within the \u003cmark\u003eindirect pathway\u003c/mark\u003e of the basal ganglia motor circuit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction in Indirect Pathway:\u003c/b\u003e The GPe is a central player in the \u0027no-go\u0027 or indirect pathway, which acts to suppress unwanted movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e\u003cbr\u003e1. The striatum sends inhibitory (GABAergic) signals to the GPe.\u003cbr\u003e2. The GPe normally tonically inhibits the subthalamic nucleus (STN).\u003cbr\u003e3. When the GPe is inhibited by the striatum, it stops inhibiting the STN.\u003cbr\u003e4. The disinhibited STN then excites the globus pallidus internus (GPi), which in turn inhibits the thalamus, suppressing movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives inhibitory input from the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Sends inhibitory output to the subthalamic nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The GPe is the pivotal relay in the indirect pathway. Remember its role: it is inhibited by the striatum, which leads to the disinhibition of the subthalamic nucleus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eGlobus Pallidus Externus\u003c/b\u003e is the linchpin of the basal ganglia\u0027s indirect \u0027no-go\u0027 pathway; its inhibition by the striatum is the first step in a cascade that ultimately suppresses unwanted motor programs.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Striatum] --(-)--\u003e B(GPe); B --(-)--\u003e C(Subthalamic Nucleus); C --(+)--\u003e D(GPi); D --(-)--\u003e E(Thalamus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"globus_pallidus\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"is_a_key_component_of\",\n        \"to\": \"indirect_pathway_basal_ganglia\"\n      }\n    ]\n  },\n  \"97e2c817\": {\n    \"title\": \"Glossopharyngeal Nerve (CN IX)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cranial Nerves\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGlossopharyngeal Nerve (CN IX)\u003c/b\u003e is a mixed cranial nerve that carries motor, parasympathetic, general sensory, and special sensory (taste) fibers. It is primarily involved in functions related to the pharynx and tongue.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction Type:\u003c/b\u003e Both motor and sensory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Function:\u003c/b\u003e Innervates the stylopharyngeus muscle, which elevates the pharynx and larynx during swallowing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Function:\u003c/b\u003e Provides preganglionic parasympathetic fibers to the otic ganglion, which then innervate the parotid gland for salivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Sensory Function:\u003c/b\u003e Provides sensation from the posterior one-third of the tongue, tonsils, upper pharynx, and the middle ear cavity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpecial Sensory Function:\u003c/b\u003e Transmits taste sensation from the posterior one-third of the tongue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisceral Sensory Function:\u003c/b\u003e Carries afferent signals from the carotid sinus (baroreceptors) and carotid body (chemoreceptors).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion:\u003c/b\u003e An isolated CN IX lesion is rare. It would result in loss of the \u003cmark\u003egag reflex\u003c/mark\u003e (afferent limb), loss of sensation and taste from the posterior tongue, and dysfunction of the parotid gland.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The gag reflex is a key test for CN IX (afferent) and CN X (efferent). Remember: CN IX \u0027senses\u0027 the gag, CN X \u0027acts\u0027 on it.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eGlossopharyngeal Nerve\u003c/b\u003e is a multifunctional nerve of the throat, responsible for the complex tasks of swallowing, salivating, tasting from the back of the tongue, and monitoring blood pressure and oxygen from the critical carotid sensors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_afferent_limb_of\",\n        \"to\": \"5b6bd754\"\n      },\n      {\n        \"type\": \"provides_taste_to\",\n        \"to\": \"posterior_tongue\"\n      },\n      {\n        \"type\": \"receives_sensory_input_from\",\n        \"to\": \"carotid_sinus\"\n      },\n      {\n        \"type\": \"receives_sensory_input_from\",\n        \"to\": \"carotid_body\"\n      }\n    ]\n  },\n  \"7072f130\": {\n    \"title\": \"Glucose (CNS Context)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Neurophysiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlucose\u003c/b\u003e is a simple sugar that is the primary source of energy for the brain. Due to the brain\u0027s high metabolic demand and inability to store significant amounts of glycogen, it requires a continuous supply of glucose from the blood.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier Transport:\u003c/b\u003e Glucose is a polar molecule and cannot diffuse freely across the lipid membranes of the [[dd47b9cc|blood-brain barrier]]. It requires facilitated diffusion via specific \u003cmark\u003ecarrier-mediated transporters\u003c/mark\u003e, primarily GLUT1.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEnergy Metabolism:\u003c/b\u003e Neurons are highly dependent on aerobic metabolism of glucose to produce the ATP necessary to maintain ion gradients and synaptic transmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypoglycemia:\u003c/b\u003e A low blood glucose level can rapidly lead to neurological dysfunction, including confusion, seizures, coma, and irreversible brain damage, as the brain is starved of its essential fuel.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperglycemia:\u003c/b\u003e Chronic high blood glucose, as in diabetes, can damage cerebral microvasculature and contribute to cognitive decline and an increased risk of stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that both glucose and amino acids require specific carrier-mediated transport to cross the blood-brain barrier. The brain\u0027s absolute dependence on a steady supply of glucose makes hypoglycemia a neurological emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlucose\u003c/b\u003e is the brain\u0027s obligatory fuel, and its entry into the CNS is tightly controlled by GLUT1 transporters at the blood-brain barrier, highlighting the brain\u0027s extreme vulnerability to hypoglycemia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"crosses_via_transporters\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_primary_energy_source_for\",\n        \"to\": \"a584135d\"\n      },\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"hypoglycemic_encephalopathy\"\n      }\n    ]\n  },\n  \"5ef5ca57\": {\n    \"title\": \"GNAQ Gene Mutation\",\n    \"primaryType\": \"genetics\",\n    \"tags\": [\n      \"Genetics\",\n      \"Neurology\",\n      \"Dermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eGNAQ gene mutation\u003c/b\u003e is a genetic alteration in the gene encoding the G\u003csub\u003eŒ±q\u003c/sub\u003e protein, a subunit of a heterotrimeric G protein. Somatic mutations in this gene are the cause of [[1c42ff26|Sturge-Weber syndrome]] and uveal melanoma.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGene Product:\u003c/b\u003e The GNAQ gene codes for the G\u003csub\u003eq\u003c/sub\u003e alpha subunit, which is involved in signal transduction pathways that activate phospholipase C.\u003c/li\u003e\u003cli\u003e\u003cb\u003eType of Mutation:\u003c/b\u003e The mutation seen in [[1c42ff26|Sturge-Weber syndrome]] is a \u003cmark\u003esomatic mosaic mutation\u003c/mark\u003e. This means it occurs after conception, is not inherited, and affects only a subset of the body\u0027s cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Disorder:\u003c/b\u003e The primary neurological disorder associated with this mutation is \u003cmark\u003e[[1c42ff26|Sturge-Weber syndrome]]\u003c/mark\u003e (encephalotrigeminal angiomatosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology in Sturge-Weber:\u003c/b\u003e The somatic mutation in neural crest derivatives is thought to cause the development of the characteristic vascular malformations (facial port-wine stain, leptomeningeal angioma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate the somatic GNAQ mutation with Sturge-Weber syndrome. The fact that it\u0027s a somatic mutation explains why the disorder is not inherited and why its manifestations can be patchy or mosaic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA post-zygotic \u003cb\u003esomatic GNAQ gene mutation\u003c/b\u003e is the underlying genetic event that gives rise to the vascular malformations of Sturge-Weber syndrome, explaining its sporadic occurrence and mosaic pattern of involvement.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"1c42ff26\"\n      },\n      {\n        \"type\": \"is_a\",\n        \"to\": \"somatic_mutation\"\n      }\n    ]\n  },\n  \"d25e69be\": {\n    \"title\": \"Gonadotropin-Releasing Hormone (GnRH)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Reproductive\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-Pituitary Axis\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGonadotropin-releasing hormone (GnRH)\u003c/b\u003e is a tropic peptide hormone synthesized and released from GnRH neurons within the [[89e86633|hypothalamus]]. It is the primary driver of the hypothalamic-pituitary-gonadal axis, controlling reproduction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Stimulates the [[76ba7f2e|anterior pituitary]] to secrete the gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePulsatile Release:\u003c/b\u003e GnRH must be released in a \u003cmark\u003epulsatile\u003c/mark\u003e fashion to be effective. Continuous, non-pulsatile administration paradoxically leads to the downregulation of GnRH receptors on the pituitary, suppressing FSH and LH release.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacologic Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePulsatile administration\u003c/b\u003e of GnRH analogs (e.g., gonadorelin) is used to treat infertility.\u003cbr\u003e - \u003cb\u003eContinuous administration\u003c/b\u003e of GnRH analogs (e.g., leuprolide) is used to suppress gonadal function in conditions like prostate cancer, endometriosis, and precocious puberty.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKallmann Syndrome:\u003c/b\u003e A genetic disorder characterized by the failure of GnRH-producing neurons to migrate to the hypothalamus, resulting in hypogonadotropic hypogonadism and anosmia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The distinction between pulsatile (stimulatory) and continuous (inhibitory) GnRH action is a critical and frequently tested concept.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGnRH\u003c/b\u003e is the master regulator of the reproductive axis, whose unique requirement for pulsatile release allows for a pharmacological paradox: it can be used to either stimulate fertility (pulsatile) or induce a state of medical castration (continuous).\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --Pulsatile GnRH--\u003e B(Anterior Pituitary); B --\u003e C(FSH \u0026 LH Release); C --\u003e D(Gonads);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_produced_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"stimulates_release_of\",\n        \"to\": \"fsh\"\n      },\n      {\n        \"type\": \"stimulates_release_of\",\n        \"to\": \"lh\"\n      },\n      {\n        \"type\": \"is_deficient_in\",\n        \"to\": \"kallmann_syndrome\"\n      }\n    ]\n  },\n  \"39f6b128\": {\n    \"title\": \"Tonic-Clonic Seizure (Grand Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etonic-clonic seizure\u003c/b\u003e, formerly known as a grand mal seizure, is a type of [[2e7554b7|generalized seizure]] that involves a loss of consciousness and violent muscle contractions. It is the most dramatic and widely recognized type of seizure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhases:\u003c/b\u003e Characterized by two distinct phases:\u003cbr\u003e1. \u003cb\u003eTonic Phase:\u003c/b\u003e A sudden stiffening of the body, arms, and legs, causing the person to fall. The patient may cry out as air is forced out of the lungs. Lasts 10-20 seconds.\u003cbr\u003e2. \u003cb\u003eClonic Phase:\u003c/b\u003e Rhythmic, convulsive jerking of the limbs. The patient may bite their tongue or have urinary/fecal incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostictal State:\u003c/b\u003e Following the seizure, there is a period of confusion, drowsiness, headache, and muscle soreness that can last for hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be primary (idiopathic generalized epilepsy) or secondary to a focal seizure that spreads to both hemispheres (focal to bilateral tonic-clonic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute management involves ensuring patient safety. Long-term prevention requires [[4dff096f|broad-spectrum anticonvulsants]] like [[valproic_acid|valproic acid]] or [[2341f9c0|levetiracetam]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of a postictal state is a key feature that helps distinguish a tonic-clonic seizure from syncope.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003etonic-clonic seizure\u003c/b\u003e is a global cerebral electrical storm that manifests as a dramatic sequence of body stiffening (tonic phase) followed by rhythmic convulsions (clonic phase), culminating in a prolonged postictal state of confusion and exhaustion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"2e7554b7\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"4dff096f\"\n      },\n      {\n        \"type\": \"is_followed_by\",\n        \"to\": \"postictal_state\"\n      }\n    ]\n  },\n  \"e8720ceb\": {\n    \"title\": \"Guillain-Barr√© Syndrome (GBS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelinating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGuillain-Barr√© Syndrome (GBS)\u003c/b\u003e is an acute, immune-mediated polyneuropathy characterized by rapidly progressive, symmetric muscle weakness and areflexia. The most common form is [[ed52e40b|acute inflammatory demyelinating polyneuropathy (AIDP)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e An autoimmune response, often triggered by a preceding infection, leads to demyelination and/or axonal damage of peripheral nerves. \u003cmark\u003eMolecular mimicry\u003c/mark\u003e is the proposed mechanism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTriggers:\u003c/b\u003e Classically associated with an antecedent gastrointestinal infection with \u003cmark\u003e\u003ci\u003eCampylobacter jejuni\u003c/i\u003e\u003c/mark\u003e. Also associated with other infections (CMV, EBV, Zika) and, rarely, vaccinations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapidly progressive, symmetric \u003cmark\u003eascending paralysis\u003c/mark\u003e, typically starting in the legs and moving up. Deep tendon reflexes are diminished or absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Life-threatening complications include \u003cmark\u003erespiratory failure\u003c/mark\u003e from diaphragmatic weakness and autonomic dysfunction (e.g., cardiac arrhythmias, blood pressure instability).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Lumbar puncture reveals the classic finding of \u003cmark\u003e[[a0f3ce4c|albuminocytologic dissociation]]\u003c/mark\u003e in the CSF (high protein, normal cell count). Nerve conduction studies show evidence of demyelination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is supportive (especially respiratory support). Disease-modifying therapies include plasmapheresis or intravenous immunoglobulin (IVIG). Steroids are \u003cu\u003enot\u003c/u\u003e effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e \u0027Ascending paralysis\u0027 after a diarrheal illness + \u0027high protein, normal cells\u0027 in CSF \u003d Guillain-Barr√© Syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGuillain-Barr√© Syndrome\u003c/b\u003e is an acute autoimmune assault on the peripheral nervous system, triggered by a recent infection, that causes a rapidly ascending paralysis which can threaten breathing and autonomic stability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Antecedent Infection] --Molecular Mimicry--\u003e B(Autoimmune Attack on Peripheral Nerves); B --\u003e C(Demyelination of Schwann Cells); C --\u003e D(Ascending Paralysis \u0026 Areflexia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"f17ad9a5\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"campylobacter_jejuni\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"a0f3ce4c\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"schwann_cells\"\n      }\n    ]\n  },\n  \"248af9f9\": {\n    \"title\": \"Gustatory Pathway\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003egustatory pathway\u003c/b\u003e is the neural pathway that transmits the sensation of taste from the taste buds on the tongue to the cerebral cortex for conscious perception.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePeripheral Receptors:\u003c/b\u003e Taste buds on the tongue detect the five basic tastes: sweet, sour, salty, bitter, and umami.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst-Order Neurons (Cranial Nerves):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[dea9755f|Facial Nerve (CN VII)]]\u003c/b\u003e (via chorda tympani): Transmits taste from the \u003cmark\u003eanterior two-thirds\u003c/mark\u003e of the tongue.\u003cbr\u003e - \u003cb\u003e[[97e2c817|Glossopharyngeal Nerve (CN IX)]]:\u003c/b\u003e Transmits taste from the \u003cmark\u003eposterior one-third\u003c/mark\u003e of the tongue.\u003cbr\u003e - \u003cb\u003e[[vagus_nerve|Vagus Nerve (CN X)]]:\u003c/b\u003e Transmits taste from the epiglottis and pharynx.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Relay:\u003c/b\u003e All three cranial nerves project to the \u003cmark\u003esolitary nucleus\u003c/mark\u003e (gustatory nucleus) in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e Second-order neurons ascend from the solitary nucleus to the \u003cmark\u003e[[23ac314a|ventral posteromedial (VPM) nucleus]]\u003c/mark\u003e of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Destination:\u003c/b\u003e Third-order neurons project from the VPM to the gustatory cortex, located in the insula and frontal operculum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the cranial nerve innervation for taste: 7 for the front, 9 for the back. The central pathway is Solitary Nucleus ‚Üí VPM of Thalamus ‚Üí Cortex.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003egustatory pathway\u003c/b\u003e is a three-neuron chain that carries taste information from the tongue via cranial nerves VII, IX, and X to the solitary nucleus, then relays through the VPM of the thalamus before reaching the cortex for the conscious perception of flavor.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Taste Buds] --\u003e B{CN VII, IX, X}; B --\u003e C(Solitary Nucleus - Medulla); C --\u003e D(VPM Nucleus - Thalamus); D --\u003e E(Gustatory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_cranial_nerve\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"involves_cranial_nerve\",\n        \"to\": \"97e2c817\"\n      },\n      {\n        \"type\": \"involves_cranial_nerve\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"relays_in\",\n        \"to\": \"23ac314a\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9627,
      "parts": [{
        "text": "```json\n{\n"
      }, {
        "text": "  \"a2cba303\": {\n    \"title\": \"Gh"
      }, {
        "text": "relin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"G"
      }, {
        "text": "astroenterology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Appetite Regulation\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGhrelin\u003c/b\u003e is a peptide hormone, primarily produced by gh"
      }, {
        "text": "relinergic cells in the gastrointestinal tract (mainly the stomach), that is known as the \\\"hunger hormone.\\\" It acts"
      }, {
        "text": " on the [[89e86633|hypothalamus]] to stimulate appetite.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Stimulates appetite (orexigenic effect), increases food intake,"
      }, {
        "text": " and promotes fat storage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSite of Production:\u003c/b\u003e Primarily the stomach.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegulation:\u003c/b\u003e Gh"
      }, {
        "text": "relin levels \u003cmark\u003eincrease before meals\u003c/mark\u003e and decrease after meals. Levels are also increased during fasting and in"
      }, {
        "text": " Prader-Willi syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypothalamic Effects:\u003c/b\u003e Acts on the arcuate nucleus of"
      }, {
        "text": " the [[89e86633|hypothalamus]] to stimulate orexigenic neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounter"
      }, {
        "text": "part:\u003c/b\u003e Its effects are opposed by satiety hormones like leptin and PYY.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " \u0027\u003cb\u003eGh\u003c/b\u003erelin makes you hun\u003cb\u003egh\u003c/b\u003ery.\u0027 Its levels are paradoxically low in obesity (except"
      }, {
        "text": " in Prader-Willi syndrome) and increase with weight loss, contributing to the difficulty of maintaining weight loss.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGhrelin\u003c/b\u003e is the primary hormonal signal for hunger, released"
      }, {
        "text": " from the stomach to act on the hypothalamus, driving the physiological urge to eat.\u003c/p\u003e\",\n      \"mermaid\": \"graph"
      }, {
        "text": " TD; A[Empty Stomach] --\u003e B(‚Üë Ghrelin Secretion); B --\u003e C(Hypothalamus); C --\u003e"
      }, {
        "text": " D(‚Üë Appetite);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"acts"
      }, {
        "text": "_on\",\n        \"to\": \"89e86633\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"stimulates\",\n        \"to\": \"appetite\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_produced_by\",\n        \"to\": \"stomach\"\n      }\n    ]\n  },\n  \"8"
      }, {
        "text": "8fffc48\": {\n    \"title\": \"Glatiramer Acetate\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Immun"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Pharmacology\",\n      \"Multiple Sclerosis Therapy\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlatiramer acetate\u003c/b\u003e is an immunomodulatory drug used"
      }, {
        "text": " as a disease-modifying therapy for the treatment of relapsing forms of [[45dd6d19|multiple sclerosis ("
      }, {
        "text": "MS)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e It is a synthetic polypeptide"
      }, {
        "text": ", a random polymer of four amino acids found in myelin basic protein (glutamic acid, lysine, alanine, tyrosine). It is thought"
      }, {
        "text": " to act as a \u0027decoy\u0027 for the immune system, diverting the autoimmune response away from myelin. It may also promote"
      }, {
        "text": " the development of anti-inflammatory T-helper 2 (Th2) cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A"
      }, {
        "text": " first-line therapy for relapsing-remitting [[45dd6d19|multiple sclerosis]]. It reduces the frequency of"
      }, {
        "text": " relapses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Administered by subcutaneous injection.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The"
      }, {
        "text": " most common side effects are injection site reactions (pain, redness, swelling). A characteristic, though benign, side effect is a post-injection reaction consisting"
      }, {
        "text": " of flushing, chest pain, palpitations, and shortness of breath, which is transient and self-limited.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Glatiramer acetate is a key disease-modifying therapy for MS. Remember its proposed mechanism as a \u0027"
      }, {
        "text": "myelin decoy\u0027 and its characteristic post-injection reaction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlatiramer acetate"
      }, {
        "text": "\u003c/b\u003e is a unique MS therapy that acts as an immunological decoy, mimicking myelin basic protein to redirect the autoimmune attack away from the patient"
      }, {
        "text": "\u0027s own myelin sheath, thereby reducing the frequency of inflammatory relapses.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"immunomod"
      }, {
        "text": "ulator\"\n      }\n    ]\n  },\n  \"3ce6c035\": {\n    \"title"
      }, {
        "text": "\": \"Glaucoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Glaucoma\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlaucoma\u003c/b\u003e is a group of eye conditions"
      }, {
        "text": " that damage the optic nerve, often characterized by an increase in intraocular pressure (IOP). If untreated, it leads"
      }, {
        "text": " to progressive, irreversible vision loss, typically beginning with the peripheral visual field.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Damage to the optic nerve head (optic neuropathy) from a combination of elevated IOP and vascular insufficiency. This"
      }, {
        "text": " leads to apoptosis of retinal ganglion cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[5ea7"
      }, {
        "text": "b741|Open-Angle Glaucoma]]:\u003c/b\u003e The most common type. The drainage angle for aqueous humor is open, but the"
      }, {
        "text": " trabecular meshwork is dysfunctional, leading to a slow, progressive increase in IOP. It is asymptomatic in early stages.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[9c80344d|Angle-Closure Glaucoma]]:\u003c/b\u003e The drainage angle"
      }, {
        "text": " is physically obstructed by the iris. Can be acute (a painful ophthalmologic emergency) or chronic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Findings"
      }, {
        "text": ":\u003c/b\u003e Progressive, bilateral (though often asymmetric) loss of peripheral vision (\u0027tunnel vision\u0027). Fundoscopy shows \u003cmark\u003eoptic"
      }, {
        "text": " disc cupping\u003c/mark\u003e (an increased cup-to-disc ratio).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTherapy:\u003c/b\u003e Treatment"
      }, {
        "text": " is aimed at lowering IOP. Medications either \u003cmark\u003edecrease aqueous humor production\u003c/mark\u003e (Œ≤-blockers, Œ±"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e-agonists, carbonic anhydrase inhibitors) or \u003cmark\u003eincrease aqueous humor outflow\u003c/mark\u003e ("
      }, {
        "text": "prostaglandin analogs, cholinomimetics).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Open-angle glaucoma is a chronic"
      }, {
        "text": ", silent disease causing peripheral vision loss. Acute angle-closure glaucoma is a painful emergency with a red eye and a fixed"
      }, {
        "text": ", mid-dilated pupil.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlaucoma\u003c/b\u003e"
      }, {
        "text": " is a progressive optic neuropathy, not just high eye pressure, that silently steals peripheral vision by damaging the optic nerve; its"
      }, {
        "text": " management revolves around lowering intraocular pressure to slow the disease\u0027s progression.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[‚Üë IOP] --\u003e B(Compression \u0026 Ischemia of Optic Nerve Head); B --\u003e C(Retinal Ganglion Cell"
      }, {
        "text": " Death); C --\u003e D(Optic Atrophy \u0026 Cupping); D --\u003e E(Progressive Peripheral Vision Loss);\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"optic"
      }, {
        "text": "_neuropathy\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5"
      }, {
        "text": "ea7b741\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"9c80"
      }, {
        "text": "344d\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n"
      }, {
        "text": "        \"to\": \"glaucoma_drugs\"\n      }\n    ]\n  },\n  \"0"
      }, {
        "text": "bd25f41\": {\n    \"title\": \"Glial Cells\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eGlial cells\u003c/b\u003e (or neuroglia) are non-neuronal cells in the nervous system that do"
      }, {
        "text": " not produce electrical impulses but serve to maintain homeostasis, form myelin, and provide support and protection for neurons.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCNS Glial Cells (derived from neuroectoderm):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[8"
      }, {
        "text": "192f595|Astrocytes]]:\u003c/b\u003e Most abundant; provide structural support, form the blood-brain barrier, and"
      }, {
        "text": " regulate the chemical environment.\u003cbr\u003e - \u003cb\u003e[[a24f9747|Oligodendrocytes]]:\u003c/b\u003e My"
      }, {
        "text": "elinate axons in the CNS. One oligodendrocyte myelinates multiple axons.\u003cbr\u003e - \u003cb\u003e[[3a777"
      }, {
        "text": "d5f|Ependymal Cells]]:\u003c/b\u003e Line the ventricles and produce CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCNS Glial Cell"
      }, {
        "text": " (derived from mesoderm):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eMicroglia:\u003c/b\u003e The resident macrophages of the CNS;"
      }, {
        "text": " act as phagocytic scavenger cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePNS Glial Cells (derived from neural crest):\u003c/b\u003e\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eSchwann Cells:\u003c/b\u003e Myelinate axons in the PNS. One Schwann cell myelinates one segment of one axon.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eSatellite Cells:\u003c/b\u003e Surround neuron cell bodies in ganglia, providing support.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know"
      }, {
        "text": " the cell of origin for common CNS tumors: Astrocytes ‚Üí Astrocytoma/[[b6bbd0bc"
      }, {
        "text": "|Glioblastoma]]; Oligodendrocytes ‚Üí Oligodendroglioma; Ependymal cells ‚Üí [[1436"
      }, {
        "text": "5ef4|Ependymoma]]; Schwann cells ‚Üí [[03ecb69e|Schwannoma"
      }, {
        "text": "]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlial cells\u003c/b\u003e are the essential support staff of"
      }, {
        "text": " the nervous system, performing a vast array of functions from myelination and immune defense to metabolic support, without which neurons could"
      }, {
        "text": " not function or survive.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"8192f595\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"a24f974"
      }, {
        "text": "7\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"microglia"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"schwann_"
      }, {
        "text": "cells\"\n      }\n    ]\n  },\n  \"b6bbd0bc\": {\n    \"title\": \"Glioblastoma"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"On"
      }, {
        "text": "cology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e (formerly known as glioblastoma multiforme or GBM) is the most common and"
      }, {
        "text": " most aggressive primary malignant brain tumor in adults. It is a Grade IV astrocytoma with a very poor prognosis.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCell of Origin:\u003c/b\u003e Arises from [[8192f595|ast"
      }, {
        "text": "rocytes]]. It is GFAP-positive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Typically arises in the cerebral hemispheres. It is known"
      }, {
        "text": " for its ability to cross the corpus callosum, creating a \u003cmark\u003e\\\"butterfly glioma\\\"\u003c/mark\u003e appearance on imaging"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e On contrast-enhanced MRI, it classically appears as a \u003cmark\u003ering-enhancing lesion"
      }, {
        "text": "\u003c/mark\u003e with central necrosis and surrounding vasogenic edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e The two key histological features are:\u003c"
      }, {
        "text": "br\u003e1. \u003cb\u003ePseudopalisading necrosis:\u003c/b\u003e Tumor cells line up along the edges of a central area"
      }, {
        "text": " of necrosis.\u003cbr\u003e2. \u003cb\u003eMicrovascular proliferation:\u003c/b\u003e Endothelial cell proliferation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis"
      }, {
        "text": ":\u003c/b\u003e Highly malignant and infiltrative, with a median survival of about 1 year despite aggressive treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The combination of a ring-enhancing \u0027butterfly\u0027 lesion in an adult and histology showing pseudopalisading necrosis is pathognomonic for glioblastoma"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlioblastoma\u003c/b\u003e is the most devastating primary brain tumor,"
      }, {
        "text": " characterized by its aggressive infiltration, central necrosis surrounded by pseudopalisading tumor cells, and its ominous ability to spread across the brain"
      }, {
        "text": "\u0027s midline as a \u0027butterfly glioma\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[A"
      }, {
        "text": "strocyte] --Mutations (e.g., EGFR, PTEN)--\u003e B(Glioblastoma); B"
      }, {
        "text": " --\u003e C(Rapid Growth \u0026 Infiltration); C --\u003e D(Central Necrosis \u0026 Vascular Proliferation);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ast"
      }, {
        "text": "rocytoma\"\n      },\n      {\n        \"type\": \"arises_from\",\n        \""
      }, {
        "text": "to\": \"8192f595\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "has_histological_finding\",\n        \"to\": \"pseudopalisading_necrosis\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"expresses_marker\",\n        \"to\": \"fb50d450\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"22421548\": {\n    \"title\": \"Global A"
      }, {
        "text": "phasia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Stroke\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Aphasia\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGlobal aphasia\u003c/b\u003e is the most severe form of aphasia, characterized by profound"
      }, {
        "text": " impairment of all language modalities, including speech production, comprehension, repetition, reading, and writing.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a large lesion that damages both [[a3bbace"
      }, {
        "text": "2|Broca\u0027s area]] and [[wernicke_area|Wernicke\u0027s area]], as well as the arc"
      }, {
        "text": "uate fasciculus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Territory:\u003c/b\u003e Classically caused by a large \u003cmark\u003e[[1"
      }, {
        "text": "43bb23d|Middle Cerebral Artery (MCA)]] stroke\u003c/mark\u003e in the dominant (usually left) hemisphere, affecting both"
      }, {
        "text": " the superior and inferior divisions.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFluency:\u003c/b\u003e Nonfluent"
      }, {
        "text": ". Speech is absent or reduced to a few stereotyped words or sounds.\u003cbr\u003e - \u003cb\u003eComprehension:\u003c/b\u003e Sever"
      }, {
        "text": "ely impaired.\u003cbr\u003e - \u003cb\u003eRepetition:\u003c/b\u003e Severely impaired.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs:\u003c/b\u003e Due"
      }, {
        "text": " to the large size of the lesion, it is almost always accompanied by a dense \u003cmark\u003econtralateral hemiplegia\u003c/mark"
      }, {
        "text": "\u003e (face and arm \u003e leg) and sensory loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a sudden"
      }, {
        "text": " onset of right-sided paralysis who is mute or can only utter a few words and cannot follow any commands has global aphasia from"
      }, {
        "text": " a massive left MCA stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlobal aphasia\u003c/b\u003e represents"
      }, {
        "text": " a catastrophic loss of language function, resulting from a massive stroke that wipes out the entire language center of the dominant hemisphere, leaving the patient unable to produce"
      }, {
        "text": " or comprehend speech.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Large Dominant MCA Stroke] --\u003e B(Damage"
      }, {
        "text": " to Broca\u0027s Area, Wernicke\u0027s Area, \u0026 Arcuate Fasciculus); B --\u003e C(Global"
      }, {
        "text": " Aphasia); C --\u003e D(Impaired Fluency, Comprehension, \u0026 Repetition);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6"
      }, {
        "text": "bc9a567\"\n      },\n      {\n        \"type\": \"is_caused_by_les"
      }, {
        "text": "ion_in\",\n        \"to\": \"a3bbace2\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_caused_by_lesion_in\",\n        \"to\": \"wernicke_area\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_caused_by_stroke_in\",\n        \"to\": \""
      }, {
        "text": "143bb23d\"\n      }\n    ]\n  },\n  \"21112"
      }, {
        "text": "945\": {\n    \"title\": \"Globose Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"Cerebellum\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cerebellum\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGlobose Nucle"
      }, {
        "text": "us\u003c/b\u003e is one of the four deep cerebellar nuclei, located medial to the emboliform nucleus. Together with the emboliform nucleus, it forms the interposed"
      }, {
        "text": " nucleus, which is involved in coordinating limb movements.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Deep"
      }, {
        "text": " within the white matter of the [[bebe58d4|cerebellum]], part of the interposed nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The"
      }, {
        "text": " interposed nuclei (emboliform + globose) are involved in coordinating agonist-antagonist muscle pairs during voluntary movements of the \u003c"
      }, {
        "text": "mark\u003edistal limbs\u003c/mark\u003e. They receive input from the intermediate zone of the cerebellar cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput"
      }, {
        "text": ":\u003c/b\u003e Projects to the contralateral red nucleus, contributing to the rubrospinal tract.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMnemonic:\u003c/b\u003e The"
      }, {
        "text": " deep cerebellar nuclei from lateral to medial are \\\"\u003cb\u003eD\u003c/b\u003eon\u0027t \u003cb\u003eE\u003c/b\u003eat \u003cb\u003eG\u003c/b\u003e"
      }, {
        "text": "reasy \u003cb\u003eF\u003c/b\u003eoods\\\" (\u003cb\u003eD\u003c/b\u003eentate, \u003cb\u003eE\u003c/b\u003emboliform, \u003cb\u003eG\u003c/b\u003elob"
      }, {
        "text": "ose, \u003cb\u003eF\u003c/b\u003eastigial).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e While less commonly tested than the dent"
      }, {
        "text": "ate or fastigial nuclei, remember that the interposed nuclei (emboliform and globose) are involved in modulating limb movements."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eGlobose Nucleus\u003c/b\u003e, along with the emboliform nucleus, forms the"
      }, {
        "text": " interposed nucleus, a cerebellar relay that helps ensure the accuracy and coordination of ongoing movements in the distal limbs.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"deep_cerebellar_nuclei\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_located_in\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"forms_interposed_nucleus_with\",\n        \"to\": \"3eccefd4\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"59e71dea\": {\n    \"title\": \"Globus Pallidus Externus ("
      }, {
        "text": "GPe)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      "
      }, {
        "text": "\"Basal Ganglia\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGlobus Pallidus"
      }, {
        "text": " Externus (GPe)\u003c/b\u003e is the outer segment of the globus pallidus, a key component of the [[ed"
      }, {
        "text": "462927|basal ganglia]]. It is a crucial relay nucleus within the \u003cmark\u003eindirect pathway\u003c/mark\u003e of"
      }, {
        "text": " the basal ganglia motor circuit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction in Indirect Pathway:\u003c/b\u003e The GPe is"
      }, {
        "text": " a central player in the \u0027no-go\u0027 or indirect pathway, which acts to suppress unwanted movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e1. The striatum sends inhibitory (GABAergic) signals to the GPe.\u003cbr\u003e2. The GPe normally"
      }, {
        "text": " tonically inhibits the subthalamic nucleus (STN).\u003cbr\u003e3. When the GPe is inhibited by the stri"
      }, {
        "text": "atum, it stops inhibiting the STN.\u003cbr\u003e4. The disinhibited STN then excites the globus pallidus intern"
      }, {
        "text": "us (GPi), which in turn inhibits the thalamus, suppressing movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives inhibitory input"
      }, {
        "text": " from the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e Sends inhibitory output to the subthalamic nucleus.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The GPe is the pivotal relay in the indirect pathway. Remember its role: it is inhibited by the striatum"
      }, {
        "text": ", which leads to the disinhibition of the subthalamic nucleus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eGlobus Pallidus Externus\u003c/b\u003e is the linchpin of the basal ganglia\u0027s indirect \u0027"
      }, {
        "text": "no-go\u0027 pathway; its inhibition by the striatum is the first step in a cascade that ultimately suppresses unwanted motor programs"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Striatum] --(-)--\u003e B(GPe); B --"
      }, {
        "text": "(-)--\u003e C(Subthalamic Nucleus); C --(+)--\u003e D(GPi); D --(-)--\u003e E"
      }, {
        "text": "(Thalamus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"globus_pallidus\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_key_component_of\",\n        \"to\": \"indirect_pathway_bas"
      }, {
        "text": "al_ganglia\"\n      }\n    ]\n  },\n  \"97e2c817"
      }, {
        "text": "\": {\n    \"title\": \"Glossopharyngeal Nerve (CN IX)\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"Cranial Nerves\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eGlossopharyngeal Nerve (CN"
      }, {
        "text": " IX)\u003c/b\u003e is a mixed cranial nerve that carries motor, parasympathetic, general sensory, and special sensory (taste) fibers."
      }, {
        "text": " It is primarily involved in functions related to the pharynx and tongue.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction"
      }, {
        "text": " Type:\u003c/b\u003e Both motor and sensory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Function:\u003c/b\u003e Innervates the stylopharyngeus muscle, which"
      }, {
        "text": " elevates the pharynx and larynx during swallowing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Function:\u003c/b\u003e Provides preganglionic parasympathetic fibers to the ot"
      }, {
        "text": "ic ganglion, which then innervate the parotid gland for salivation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Sensory Function:\u003c/b\u003e Provides"
      }, {
        "text": " sensation from the posterior one-third of the tongue, tonsils, upper pharynx, and the middle ear cavity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpecial Sensory Function:"
      }, {
        "text": "\u003c/b\u003e Transmits taste sensation from the posterior one-third of the tongue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisceral Sensory Function:\u003c/b\u003e"
      }, {
        "text": " Carries afferent signals from the carotid sinus (baroreceptors) and carotid body (chemoreceptors).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ion:\u003c/b\u003e An isolated CN IX lesion is rare. It would result in loss of the \u003cmark\u003egag reflex\u003c/mark\u003e ("
      }, {
        "text": "afferent limb), loss of sensation and taste from the posterior tongue, and dysfunction of the parotid gland.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e The gag reflex is a key test for CN IX (afferent) and CN X (efferent)."
      }, {
        "text": " Remember: CN IX \u0027senses\u0027 the gag, CN X \u0027acts\u0027 on it.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eGlossopharyngeal Nerve\u003c/b\u003e is a multifunctional nerve of the throat, responsible for the complex"
      }, {
        "text": " tasks of swallowing, salivating, tasting from the back of the tongue, and monitoring blood pressure and oxygen from the critical"
      }, {
        "text": " carotid sensors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_afferent_limb_of\",\n        \"to\": \"5b6bd"
      }, {
        "text": "754\"\n      },\n      {\n        \"type\": \"provides_taste_to\",\n        \"to\": \"posterior"
      }, {
        "text": "_tongue\"\n      },\n      {\n        \"type\": \"receives_sensory_input_from\",\n        "
      }, {
        "text": "\"to\": \"carotid_sinus\"\n      },\n      {\n        \"type\": \"receives"
      }, {
        "text": "_sensory_input_from\",\n        \"to\": \"carotid_body\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"7072f130\": {\n    \"title\": \"Glucose"
      }, {
        "text": " (CNS Context)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Biochemistry\",\n      \"Neurophysiology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eGlucose\u003c/b\u003e is a simple sugar that is the primary source of energy for the brain. Due to the brain\u0027s high metabolic demand"
      }, {
        "text": " and inability to store significant amounts of glycogen, it requires a continuous supply of glucose from the blood.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier Transport:\u003c/b\u003e Glucose is a polar molecule and cannot diffuse freely across the lipid membranes of the [[dd"
      }, {
        "text": "47b9cc|blood-brain barrier]]. It requires facilitated diffusion via specific \u003cmark\u003ecarrier-mediated transporters"
      }, {
        "text": "\u003c/mark\u003e, primarily GLUT1.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEnergy Metabolism:\u003c/b\u003e Neurons are highly dependent on aerobic metabolism of glucose to"
      }, {
        "text": " produce the ATP necessary to maintain ion gradients and synaptic transmission.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypoglycemia:\u003c/b\u003e A low blood glucose level can"
      }, {
        "text": " rapidly lead to neurological dysfunction, including confusion, seizures, coma, and irreversible brain damage, as the brain is starved of its"
      }, {
        "text": " essential fuel.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHyperglycemia:\u003c/b\u003e Chronic high blood glucose, as in diabetes, can damage cerebral micro"
      }, {
        "text": "vasculature and contribute to cognitive decline and an increased risk of stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " that both glucose and amino acids require specific carrier-mediated transport to cross the blood-brain barrier. The brain\u0027s absolute"
      }, {
        "text": " dependence on a steady supply of glucose makes hypoglycemia a neurological emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGlucose"
      }, {
        "text": "\u003c/b\u003e is the brain\u0027s obligatory fuel, and its entry into the CNS is tightly controlled by GLUT1 transporters at the blood-brain barrier"
      }, {
        "text": ", highlighting the brain\u0027s extreme vulnerability to hypoglycemia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"crosses_via_transporters\",\n        \"to\": \""
      }, {
        "text": "dd47b9cc\"\n      },\n      {\n        \"type\": \"is_primary_energy_source_for\","
      }, {
        "text": "\n        \"to\": \"a584135d\"\n      },\n      {\n        \"type\": \"deficiency_"
      }, {
        "text": "causes\",\n        \"to\": \"hypoglycemic_encephalopathy\"\n      }\n    ]\n  },\n  \"5ef"
      }, {
        "text": "5ca57\": {\n    \"title\": \"GNAQ Gene Mutation\",\n    \"primaryType\":"
      }, {
        "text": " \"genetics\",\n    \"tags\": [\n      \"Genetics\",\n      \"Neurology\",\n      \"D"
      }, {
        "text": "ermatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eA \u003cb\u003eGNAQ gene mutation\u003c/b\u003e is a genetic alteration in the gene encoding the G\u003csub\u003e"
      }, {
        "text": "Œ±q\u003c/sub\u003e protein, a subunit of a heterotrimeric G protein. Somatic mutations in this gene are the"
      }, {
        "text": " cause of [[1c42ff26|Sturge-Weber syndrome]] and uveal melanoma.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGene Product:\u003c/b\u003e The GNAQ gene codes for the G\u003csub\u003eq\u003c/sub\u003e alpha subunit,"
      }, {
        "text": " which is involved in signal transduction pathways that activate phospholipase C.\u003c/li\u003e\u003cli\u003e\u003cb\u003eType of Mutation:\u003c/b\u003e The mutation seen"
      }, {
        "text": " in [[1c42ff26|Sturge-Weber syndrome]] is a \u003cmark\u003esomatic mosaic"
      }, {
        "text": " mutation\u003c/mark\u003e. This means it occurs after conception, is not inherited, and affects only a subset of the body\u0027s cells."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Disorder:\u003c/b\u003e The primary neurological disorder associated with this mutation is \u003cmark\u003e[[1c42ff26|"
      }, {
        "text": "Sturge-Weber syndrome]]\u003c/mark\u003e (encephalotrigeminal angiomatosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology in"
      }, {
        "text": " Sturge-Weber:\u003c/b\u003e The somatic mutation in neural crest derivatives is thought to cause the development of the characteristic vascular mal"
      }, {
        "text": "formations (facial port-wine stain, leptomeningeal angioma).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate"
      }, {
        "text": " the somatic GNAQ mutation with Sturge-Weber syndrome. The fact that it\u0027s a somatic mutation explains why the"
      }, {
        "text": " disorder is not inherited and why its manifestations can be patchy or mosaic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA"
      }, {
        "text": " post-zygotic \u003cb\u003esomatic GNAQ gene mutation\u003c/b\u003e is the underlying genetic event that gives rise to the vascular"
      }, {
        "text": " malformations of Sturge-Weber syndrome, explaining its sporadic occurrence and mosaic pattern of involvement.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"1"
      }, {
        "text": "c42ff26\"\n      },\n      {\n        \"type\": \"is_a\",\n        \"to\": \"somatic"
      }, {
        "text": "_mutation\"\n      }\n    ]\n  },\n  \"d25e69be\": {\n    \"title\": \""
      }, {
        "text": "Gonadotropin-Releasing Hormone (GnRH)\",\n    \"primaryType\": \"molecule\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Endocrinology\",\n      \"Reproductive\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Hypothalamic-"
      }, {
        "text": "Pituitary Axis\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGonadotropin-re"
      }, {
        "text": "leasing hormone (GnRH)\u003c/b\u003e is a tropic peptide hormone synthesized and released from GnRH neurons within the [[89e866"
      }, {
        "text": "33|hypothalamus]]. It is the primary driver of the hypothalamic-pituitary-gonadal axis, controlling reproduction"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Stimulates the [[76ba7"
      }, {
        "text": "f2e|anterior pituitary]] to secrete the gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePulsatile Release:\u003c/b\u003e GnRH must be released in a \u003cmark\u003epulsatile\u003c/mark\u003e fashion"
      }, {
        "text": " to be effective. Continuous, non-pulsatile administration paradoxically leads to the downregulation of GnRH receptors on the pituitary"
      }, {
        "text": ", suppressing FSH and LH release.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacologic Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePulsatile administration"
      }, {
        "text": "\u003c/b\u003e of GnRH analogs (e.g., gonadorelin) is used to treat infertility.\u003cbr\u003e - \u003cb\u003eContinuous"
      }, {
        "text": " administration\u003c/b\u003e of GnRH analogs (e.g., leuprolide) is used to suppress gonadal function in conditions like prostate"
      }, {
        "text": " cancer, endometriosis, and precocious puberty.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKallmann Syndrome:\u003c/b\u003e A genetic disorder characterized by the"
      }, {
        "text": " failure of GnRH-producing neurons to migrate to the hypothalamus, resulting in hypogonadotropic hypogonadism and anosmia."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The distinction between pulsatile (stimulatory) and continuous (inhibitory) Gn"
      }, {
        "text": "RH action is a critical and frequently tested concept.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGn"
      }, {
        "text": "RH\u003c/b\u003e is the master regulator of the reproductive axis, whose unique requirement for pulsatile release allows for a pharmacological paradox: it"
      }, {
        "text": " can be used to either stimulate fertility (pulsatile) or induce a state of medical castration (continuous).\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Hypothalamus] --Pulsatile GnRH--\u003e B(Anterior Pituitary); B --\u003e C("
      }, {
        "text": "FSH \u0026 LH Release); C --\u003e D(Gonads);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_produced_by\",\n        \"to\": \"89e86633\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"stimulates_release_of\",\n        \"to\": \"fsh\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"stimulates_release_of\",\n        \"to\": \"lh\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_deficient_in\",\n        \"to\": \"kallmann_syndrome\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"39f6b128\": {\n    \"title\":"
      }, {
        "text": " \"Tonic-Clonic Seizure (Grand Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Se"
      }, {
        "text": "izures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etonic"
      }, {
        "text": "-clonic seizure\u003c/b\u003e, formerly known as a grand mal seizure, is a type of [[2e7554"
      }, {
        "text": "b7|generalized seizure]] that involves a loss of consciousness and violent muscle contractions. It is the most dramatic and widely"
      }, {
        "text": " recognized type of seizure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhases:\u003c/b\u003e Characterized by two distinct phases:\u003cbr\u003e"
      }, {
        "text": "1. \u003cb\u003eTonic Phase:\u003c/b\u003e A sudden stiffening of the body, arms, and legs, causing the person"
      }, {
        "text": " to fall. The patient may cry out as air is forced out of the lungs. Lasts 10-20 seconds.\u003cbr"
      }, {
        "text": "\u003e2. \u003cb\u003eClonic Phase:\u003c/b\u003e Rhythmic, convulsive jerking of the limbs. The patient may bite their"
      }, {
        "text": " tongue or have urinary/fecal incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostictal State:\u003c/b\u003e Following the seizure, there is a period"
      }, {
        "text": " of confusion, drowsiness, headache, and muscle soreness that can last for hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be primary"
      }, {
        "text": " (idiopathic generalized epilepsy) or secondary to a focal seizure that spreads to both hemispheres (focal to bilateral tonic-clonic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": ":\u003c/b\u003e Acute management involves ensuring patient safety. Long-term prevention requires [[4dff096f|broad-spectrum anticon"
      }, {
        "text": "vulsants]] like [[valproic_acid|valproic acid]] or [[2341f9"
      }, {
        "text": "c0|levetiracetam]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of a postictal state is"
      }, {
        "text": " a key feature that helps distinguish a tonic-clonic seizure from syncope.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA"
      }, {
        "text": " \u003cb\u003etonic-clonic seizure\u003c/b\u003e is a global cerebral electrical storm that manifests as a dramatic sequence of body stiffening ("
      }, {
        "text": "tonic phase) followed by rhythmic convulsions (clonic phase), culminating in a prolonged postictal state of confusion and exhaustion.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"2e7554b7\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"4dff096f\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_followed_by\",\n        \"to\": \"postictal_state\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"e8720ceb\": {\n    \"title\":"
      }, {
        "text": " \"Guillain-Barr√© Syndrome (GBS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \""
      }, {
        "text": "Neurology\",\n      \"Immunology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Demyelin"
      }, {
        "text": "ating Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eGuillain-Barr√©"
      }, {
        "text": " Syndrome (GBS)\u003c/b\u003e is an acute, immune-mediated polyneuropathy characterized by rapidly progressive, symmetric muscle weakness and"
      }, {
        "text": " areflexia. The most common form is [[ed52e40b|acute inflammatory demyelinating polyneuropathy (AID"
      }, {
        "text": "P)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e An autoimmune response"
      }, {
        "text": ", often triggered by a preceding infection, leads to demyelination and/or axonal damage of peripheral nerves. \u003cmark\u003eMolecular"
      }, {
        "text": " mimicry\u003c/mark\u003e is the proposed mechanism.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTriggers:\u003c/b\u003e Classically associated with an antecedent gastro"
      }, {
        "text": "intestinal infection with \u003cmark\u003e\u003ci\u003eCampylobacter jejuni\u003c/i\u003e\u003c/mark\u003e. Also associated with other infections (CMV, EBV, Zika"
      }, {
        "text": ") and, rarely, vaccinations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Rapidly progressive, symmetric \u003cmark\u003eascending paralysis\u003c/mark\u003e,"
      }, {
        "text": " typically starting in the legs and moving up. Deep tendon reflexes are diminished or absent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Life"
      }, {
        "text": "-threatening complications include \u003cmark\u003erespiratory failure\u003c/mark\u003e from diaphragmatic weakness and autonomic dysfunction (e.g., cardiac"
      }, {
        "text": " arrhythmias, blood pressure instability).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Lumbar puncture reveals the classic finding of \u003cmark\u003e[["
      }, {
        "text": "a0f3ce4c|albuminocytologic dissociation]]\u003c/mark\u003e in the CSF (high protein, normal cell"
      }, {
        "text": " count). Nerve conduction studies show evidence of demyelination.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Management is supportive (especially respiratory support). Disease"
      }, {
        "text": "-modifying therapies include plasmapheresis or intravenous immunoglobulin (IVIG). Steroids are \u003cu\u003enot\u003c/u\u003e effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e \u0027Ascending paralysis\u0027 after a diarrheal illness + \u0027high protein, normal cells\u0027 in CSF \u003d"
      }, {
        "text": " Guillain-Barr√© Syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eGuillain-Barr√© Syndrome\u003c/b\u003e is an"
      }, {
        "text": " acute autoimmune assault on the peripheral nervous system, triggered by a recent infection, that causes a rapidly ascending paralysis which can threaten"
      }, {
        "text": " breathing and autonomic stability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Antecedent Infection] --Molecular"
      }, {
        "text": " Mimicry--\u003e B(Autoimmune Attack on Peripheral Nerves); B --\u003e C(Demyelination of Schwann Cells); C --\u003e D(Asc"
      }, {
        "text": "ending Paralysis \u0026 Areflexia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"f17ad9a5\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_associated_with\",\n        \"to\": \"campylobacter_jejuni\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"a0f3ce4c\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"schwann_cells\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"248af9f9\": {\n    \"title\": \"Gustatory Pathway\",\n    \""
      }, {
        "text": "primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003egustatory pathway\u003c/b\u003e is the neural pathway that transmits the sensation of taste from the taste"
      }, {
        "text": " buds on the tongue to the cerebral cortex for conscious perception.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePeripheral"
      }, {
        "text": " Receptors:\u003c/b\u003e Taste buds on the tongue detect the five basic tastes: sweet, sour, salty, bitter, and umami.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "First-Order Neurons (Cranial Nerves):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[dea9755"
      }, {
        "text": "f|Facial Nerve (CN VII)]]\u003c/b\u003e (via chorda tympani): Transmits taste from the \u003c"
      }, {
        "text": "mark\u003eanterior two-thirds\u003c/mark\u003e of the tongue.\u003cbr\u003e - \u003cb\u003e[[97e2c817|"
      }, {
        "text": "Glossopharyngeal Nerve (CN IX)]]:\u003c/b\u003e Transmits taste from the \u003cmark\u003eposterior one-third\u003c/mark"
      }, {
        "text": "\u003e of the tongue.\u003cbr\u003e - \u003cb\u003e[[vagus_nerve|Vagus Nerve (CN X)]]:"
      }, {
        "text": "\u003c/b\u003e Transmits taste from the epiglottis and pharynx.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Relay:\u003c/b\u003e All three cranial nerves project"
      }, {
        "text": " to the \u003cmark\u003esolitary nucleus\u003c/mark\u003e (gustatory nucleus) in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTh"
      }, {
        "text": "alamic Relay:\u003c/b\u003e Second-order neurons ascend from the solitary nucleus to the \u003cmark\u003e[[23ac31"
      }, {
        "text": "4a|ventral posteromedial (VPM) nucleus]]\u003c/mark\u003e of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCort"
      }, {
        "text": "ical Destination:\u003c/b\u003e Third-order neurons project from the VPM to the gustatory cortex, located in the insula and frontal"
      }, {
        "text": " operculum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the cranial nerve innervation for taste: 7 for the"
      }, {
        "text": " front, 9 for the back. The central pathway is Solitary Nucleus ‚Üí VPM of Thalamus ‚Üí Cortex"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003egustatory pathway\u003c/b\u003e is a three-neuron"
      }, {
        "text": " chain that carries taste information from the tongue via cranial nerves VII, IX, and X to the solitary nucleus, then relays"
      }, {
        "text": " through the VPM of the thalamus before reaching the cortex for the conscious perception of flavor.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Taste Buds] --\u003e B{CN VII, IX, X}; B --\u003e C(Solitary Nucleus -"
      }, {
        "text": " Medulla); C --\u003e D(VPM Nucleus - Thalamus); D --\u003e E(Gustatory Cortex);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"involves_cranial_nerve\",\n        "
      }, {
        "text": "\"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"in"
      }, {
        "text": "volves_cranial_nerve\",\n        \"to\": \"97e2c817\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"involves_cranial_nerve\",\n        "
      }, {
        "text": "\"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"relays"
      }, {
        "text": "_in\",\n        \"to\": \"23ac314a\"\n      }\n    ]\n  "
      }, {
        "text": "}\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"bccd13b6\",\n    \"letter\": \"T\",\n    \"term\": \"Tuberoinfundibular pathway\",\n    \"pages\": [\n      \"509\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tuberoinfundibular pathway\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"83302339\",\n    \"letter\": \"T\",\n    \"term\": \"Tuberous sclerosis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Tuberous sclerosis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"005375ab\",\n        \"letter\": \"T\",\n        \"term\": \"characteristics of\",\n        \"pages\": [\n          \"539\"\n        ],\n        \"context\": \"Tuberous sclerosis \u003e characteristics of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"07be978a\",\n    \"letter\": \"U\",\n    \"term\": \"Uncal transtentorial herniation\",\n    \"pages\": [\n      \"543\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Uncal transtentorial herniation\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"503fcb39\",\n    \"letter\": \"U\",\n    \"term\": \"Upper extremities\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Upper extremities\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ad86f224\",\n        \"letter\": \"U\",\n        \"term\": \"syringomyelia effects on\",\n        \"pages\": [\n          \"502\"\n        ],\n        \"context\": \"Upper extremities \u003e syringomyelia effects on\"\n      }\n    ]\n  },\n  {\n    \"id\": \"726ba7d4\",\n    \"letter\": \"U\",\n    \"term\": \"Upper motor neuron\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Upper motor neuron\",\n    \"sub_entries\": [\n      {\n        \"id\": \"3b13f3e4\",\n        \"letter\": \"U\",\n        \"term\": \"Babinski sign in adults\",\n        \"pages\": [\n          \"523\"\n        ],\n        \"context\": \"Upper motor neuron \u003e Babinski sign in adults\"\n      },\n      {\n        \"id\": \"b2036ff9\",\n        \"letter\": \"U\",\n        \"term\": \"effects of injury\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Upper motor neuron \u003e effects of injury\"\n      },\n      {\n        \"id\": \"697f60f0\",\n        \"letter\": \"U\",\n        \"term\": \"facial nerve lesion\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Upper motor neuron \u003e facial nerve lesion\"\n      },\n      {\n        \"id\": \"cc12cc60\",\n        \"letter\": \"U\",\n        \"term\": \"facial paralysis\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Upper motor neuron \u003e facial paralysis\"\n      },\n      {\n        \"id\": \"67a29a16\",\n        \"letter\": \"U\",\n        \"term\": \"in amyotrophic lateral sclerosis\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Upper motor neuron \u003e in amyotrophic lateral sclerosis\"\n      },\n      {\n        \"id\": \"d9b5c17c\",\n        \"letter\": \"U\",\n        \"term\": \"in cerebral palsy\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Upper motor neuron \u003e in cerebral palsy\"\n      },\n      {\n        \"id\": \"6e70b547\",\n        \"letter\": \"U\",\n        \"term\": \"lesion signs\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Upper motor neuron \u003e lesion signs\"\n      },\n      {\n        \"id\": \"c9677c86\",\n        \"letter\": \"U\",\n        \"term\": \"pathways of\",\n        \"pages\": [\n          \"522\"\n        ],\n        \"context\": \"Upper motor neuron \u003e pathways of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"f72d0292\",\n    \"letter\": \"U\",\n    \"term\": \"Uveitis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Uveitis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ae2b9102\",\n        \"letter\": \"U\",\n        \"term\": \"glaucoma\",\n        \"pages\": [\n          \"551\"\n        ],\n        \"context\": \"Uveitis \u003e glaucoma\"\n      },\n      {\n        \"id\": \"ea9d6e1e\",\n        \"letter\": \"U\",\n        \"term\": \"types of\",\n        \"pages\": [\n          \"553\"\n        ],\n        \"context\": \"Uveitis \u003e types of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"534e796f\",\n    \"letter\": \"V\",\n    \"term\": \"Vagal nuclei\",\n    \"pages\": [\n      \"516\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vagal nuclei\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"7c12e7a3\",\n    \"letter\": \"V\",\n    \"term\": \"Vagus nerve (CN X)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Vagus nerve (CN X)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e3f73a23\",\n        \"letter\": \"V\",\n        \"term\": \"functions of\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Vagus nerve (CN X) \u003e functions of\"\n      },\n      {\n        \"id\": \"7e2dcd48\",\n        \"letter\": \"V\",\n        \"term\": \"lesions of\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Vagus nerve (CN X) \u003e lesions of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"0d37e045\",\n    \"letter\": \"V\",\n    \"term\": \"Valproate\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Valproate\",\n    \"sub_entries\": [\n      {\n        \"id\": \"87ff6aa7\",\n        \"letter\": \"V\",\n        \"term\": \"mechanism and adverse effects\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Valproate \u003e mechanism and adverse effects\"\n      },\n      {\n        \"id\": \"e8a5be76\",\n        \"letter\": \"V\",\n        \"term\": \"migraine headaches\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Valproate \u003e migraine headaches\"\n      }\n    ]\n  },\n  {\n    \"id\": \"99420dce\",\n    \"letter\": \"V\",\n    \"term\": \"Vascular dementia\",\n    \"pages\": [\n      \"535\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vascular dementia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4017bec5\",\n    \"letter\": \"V\",\n    \"term\": \"Vasculitides\",\n    \"pages\": [\n      \"479\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vasculitides\",\n    \"sub_entries\": [\n      {\n        \"id\": \"9df55e99\",\n        \"letter\": \"V\",\n        \"term\": \"intraparenchymal hemorrhage\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Vasculitides \u003e intraparenchymal hemorrhage\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d94a9e61\",\n    \"letter\": \"V\",\n    \"term\": \"Vasogenic edema (cerebral)\",\n    \"pages\": [\n      \"525\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vasogenic edema (cerebral)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"43bf4ead\",\n    \"letter\": \"V\",\n    \"term\": \"Vecuronium\",\n    \"pages\": [\n      \"566\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vecuronium\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"66656d8b\",\n    \"letter\": \"V\",\n    \"term\": \"Vegetative state\",\n    \"pages\": [\n      \"529\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Vegetative state\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"067666cd\",\n    \"letter\": \"V\",\n    \"term\": \"Venous sinus thrombosis (dural)\",\n    \"pages\": [\n      \"514\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Venous sinus thrombosis (dural)\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2418
    }, {
      "text": "```json\n{\n  \"bccd13b6\": {\n    \"title\": \"Tuberoinfundibular Pathway\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Endocrinology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Dopaminergic Pathways\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTuberoinfundibular Pathway\u003c/b\u003e is one of the four major dopaminergic pathways in the brain. It consists of dopamine-releasing neurons that project from the arcuate nucleus of the [[89e86633|hypothalamus]] to the median eminence, where dopamine is released into the hypophyseal portal system to act on the anterior pituitary.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The primary role of this pathway is the \u003cmark\u003etonic inhibition of prolactin secretion\u003c/mark\u003e from the anterior pituitary lactotrophs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e [[90adc821|Dopamine]] released into the portal system binds to D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs, inhibiting the synthesis and release of prolactin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance (Pharmacology):\u003c/b\u003e This pathway is significantly affected by \u003cmark\u003edopamine D\u003csub\u003e2\u003c/sub\u003e receptor antagonists\u003c/mark\u003e (i.e., most antipsychotic drugs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAntipsychotic Side Effect:\u003c/b\u003e Blockade of D\u003csub\u003e2\u003c/sub\u003e receptors in this pathway removes the normal inhibition of prolactin, leading to \u003cmark\u003ehyperprolactinemia\u003c/mark\u003e. This can cause galactorrhea, gynecomastia, amenorrhea, and sexual dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Hyperprolactinemia is a classic side effect of typical and some atypical antipsychotics. Remember that dopamine normally \u0027puts the brakes\u0027 on prolactin; blocking dopamine releases the brake.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTuberoinfundibular Pathway\u003c/b\u003e is the neuroendocrine link through which the hypothalamus controls prolactin, with dopamine acting as the primary inhibitory signal; its blockade by antipsychotic drugs predictably leads to hyperprolactinemia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus] --Dopamine--\u003e B(Anterior Pituitary); B --Inhibits--\u003e C(Prolactin Release);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"57f4719b\"\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"prolactin\"\n      },\n      {\n        \"type\": \"is_blocked_by\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"blockade_causes\",\n        \"to\": \"hyperprolactinemia\"\n      }\n    ]\n  },\n  \"83302339\": {\n    \"title\": \"Tuberous Sclerosis Complex\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Genetics\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTuberous Sclerosis Complex (TSC)\u003c/b\u003e is an autosomal dominant neurocutaneous disorder characterized by the growth of numerous benign hamartomas in multiple organs, including the brain, skin, heart, kidneys, and lungs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal dominant inheritance with variable expressivity. Caused by a mutation in the tumor suppressor genes \u003ci\u003eTSC1\u003c/i\u003e (encoding hamartin) or \u003ci\u003eTSC2\u003c/i\u003e (encoding tuberin).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Hamartin and tuberin normally form a complex that inhibits mTOR (mammalian target of rapamycin), a key regulator of cell growth and proliferation. Loss of function leads to unregulated cell growth and hamartoma formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features (Mnemonic HAMARTOMAS):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eH\u003c/b\u003eamartomas in CNS and skin\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003engiofibromas (facial)\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eitral regurgitation\u003cbr\u003e - \u003cb\u003eA\u003c/b\u003esh-leaf spots (hypopigmented macules)\u003cbr\u003e - Cardiac \u003cb\u003eR\u003c/b\u003ehabdomyoma (most common cardiac tumor in children)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003euberous Sclerosis\u003cbr\u003e - Autosomal d\u003cb\u003eO\u003c/b\u003eminant\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eental retardation (intellectual disability)\u003cbr\u003e - Renal \u003cb\u003eA\u003c/b\u003engiomyolipoma\u003cbr\u003e - \u003cb\u003eS\u003c/b\u003eeizures (infantile spasms are common), \u003cb\u003eS\u003c/b\u003ehagreen patches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Manifestations:\u003c/b\u003e Cortical tubers and subependymal giant cell astrocytomas (SEGAs) are common brain hamartomas, leading to seizures and intellectual disability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of skin findings (ash-leaf spots, angiofibromas) and neurological symptoms (seizures, developmental delay) in a child is classic for TSC. Cardiac rhabdomyoma in an infant is also highly suggestive.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTuberous Sclerosis\u003c/b\u003e is a genetic disorder of cellular growth control, caused by mutations in mTOR pathway inhibitors, which manifests as a widespread development of benign hamartomas, classically presenting with the triad of skin lesions, seizures, and intellectual disability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[TSC1/TSC2 Mutation] --\u003e B(Loss of Hamartin/Tuberin); B --x C(Inhibition of mTOR); C --\u003e D(Unregulated Cell Growth); D --\u003e E(Hamartoma Formation in Multiple Organs);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous_disorder\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"tsc1_gene\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"tsc2_gene\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"seizures\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"ash_leaf_spots\"\n      }\n    ]\n  },\n  \"07be978a\": {\n    \"title\": \"Uncal Transtentorial Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eUncal transtentorial herniation\u003c/b\u003e is a subtype of downward brain herniation where the uncus, the innermost part of the temporal lobe, is forced medially and downward through the tentorial notch, compressing the adjacent midbrain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by an expanding mass lesion in the middle cranial fossa, such as an [[a61683ae|epidural hematoma]], subdural hematoma, or temporal lobe tumor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEarly Signs (Ipsilateral CN III Compression):\u003c/b\u003e The herniating uncus first compresses the ipsilateral [[68c66997|oculomotor nerve (CN III)]]. This affects the superficial parasympathetic fibers, causing a fixed, dilated pupil (\u003cmark\u003e\\\"blown pupil\\\"\u003c/mark\u003e). This is followed by paralysis of the extraocular muscles innervated by CN III, leading to a \u0027down and out\u0027 gaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLater Signs (Brainstem Compression):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eContralateral Cerebral Peduncle Compression:\u003c/b\u003e Leads to \u003cmark\u003eipsilateral hemiparesis\u003c/mark\u003e (a false localizing sign known as Kernohan\u0027s notch phenomenon).\u003cbr\u003e - \u003cb\u003eBrainstem Compression:\u003c/b\u003e Can lead to altered consciousness, coma, and Duret hemorrhages.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePCA Compression:\u003c/b\u003e The ipsilateral posterior cerebral artery can also be compressed, leading to a contralateral homonymous hemianopia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a head injury who develops a unilateral \u0027blown pupil\u0027 is the classic presentation of uncal herniation. This is a neurosurgical emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eUncal herniation\u003c/b\u003e is a life-threatening event where the temporal lobe is squeezed against the brainstem, classically heralded by a \u0027blown pupil\u0027 from oculomotor nerve compression, which can rapidly progress to coma and death if the underlying pressure is not relieved.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Expanding Temporal Lobe Mass] --\u003e B(Uncus Herniates Medially); B --Compresses--\u003e C(Ipsilateral CN III); C --\u003e D(Ipsilateral Blown Pupil); B --Compresses--\u003e E(Ipsilateral Cerebral Peduncle); E --\u003e F(Contralateral Hemiparesis); B --Compresses--\u003e G(Contralateral Cerebral Peduncle - Kernohan\u0027s Notch); G --\u003e H(Ipsilateral Hemiparesis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"8c0728b7\"\n      },\n      {\n        \"type\": \"compresses\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"compresses\",\n        \"to\": \"cerebral_peduncle\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"6ab4b0f2\"\n      }\n    ]\n  },\n  \"503fcb39\": {\n    \"title\": \"Upper Extremities (Neurological Innervation)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eupper extremities\u003c/b\u003e receive their motor and sensory innervation primarily from the brachial plexus, which is formed by the ventral rami of the spinal nerves C5, C6, C7, C8, and T1.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBrachial Plexus:\u003c/b\u003e A complex network of nerves that gives rise to the major peripheral nerves of the upper limb (musculocutaneous, axillary, radial, median, and ulnar nerves).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Homunculus:\u003c/b\u003e The motor and sensory control of the upper limb is represented on the lateral aspect of the precentral and postcentral gyri, respectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply (Cortex):\u003c/b\u003e The cortical areas for the arm and hand are supplied by the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Cord Tracts:\u003c/b\u003e Motor commands descend via the corticospinal tracts. Sensation ascends via the dorsal columns (proprioception/vibration) and spinothalamic tracts (pain/temperature).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSyringomyelia:\u003c/b\u003e A syrinx (fluid-filled cavity) in the cervical spinal cord classically damages the decussating spinothalamic fibers at the anterior white commissure, leading to a \u003cmark\u003e\u0027cape-like\u0027\u003c/mark\u003e bilateral loss of pain and temperature sensation in the upper extremities.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the motor and sensory deficits associated with lesions of the brachial plexus and its terminal branches.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neurological control of the \u003cb\u003eupper extremities\u003c/b\u003e is a complex system involving the brachial plexus for peripheral innervation and specific, well-defined areas of the cerebral cortex and spinal cord, making the pattern of deficits a reliable guide for lesion localization.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"brachial_plexus\"\n      },\n      {\n        \"type\": \"cortical_area_supplied_by\",\n        \"to\": \"143bb23d\"\n      },\n      {\n        \"type\": \"is_affected_by\",\n        \"to\": \"syringomyelia\"\n      }\n    ]\n  },\n  \"726ba7d4\": {\n    \"title\": \"Upper Motor Neuron (UMN)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Motor System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eAn \u003cb\u003eupper motor neuron (UMN)\u003c/b\u003e is a neuron whose cell body is located in the motor cortex of the brain and whose axon descends to synapse on a lower motor neuron (or an interneuron) in the brainstem or spinal cord. UMNs constitute the descending motor pathways, such as the corticospinal and corticobulbar tracts.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e UMNs initiate, control, and modulate voluntary movement. They provide both excitatory and inhibitory input to LMNs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN Lesion:\u003c/b\u003e Damage to UMNs or their descending tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN Lesion Signs:\u003c/b\u003e Result from a loss of descending inhibition on the spinal reflex arcs. Signs include:\u003cbr\u003e - \u003cb\u003eSpastic Paralysis/Paresis:\u003c/b\u003e Increased muscle tone.\u003cbr\u003e - \u003cb\u003eHyperreflexia:\u003c/b\u003e Exaggerated deep tendon reflexes.\u003cbr\u003e - \u003cb\u003e[[ca51f29a|Clasp-knife spasticity]]\u003c/b\u003e.\u003cbr\u003e - \u003cb\u003ePositive [[8947da55|Babinski sign]]:\u003c/b\u003e Upgoing toe.\u003cbr\u003e - \u003cb\u003eMild (Disuse) Atrophy:\u003c/b\u003e No significant muscle wasting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of UMN Lesions:\u003c/b\u003e [[c5da3c57|Stroke]], [[45dd6d19|multiple sclerosis]], traumatic brain or spinal cord injury, [[171ca00b|cerebral palsy]], and [[4ed629f9|amyotrophic lateral sclerosis (ALS)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFacial Paralysis:\u003c/b\u003e A UMN lesion (e.g., stroke) causes \u003cmark\u003econtralateral lower facial weakness\u003c/mark\u003e, sparing the forehead, due to bilateral UMN innervation of the upper face.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that UMN signs are \u0027hyper\u0027 (hyperreflexia, hypertonia) and the Babinski sign is \u0027up\u0027. This contrasts with LMN signs, which are \u0027hypo\u0027 (hyporeflexia, hypotonia, atrophy).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eAn \u003cb\u003eupper motor neuron\u003c/b\u003e is the \u0027commander\u0027 of voluntary movement, originating in the brain; a lesion to it cuts off the regulatory descending control, leading to a \u0027released\u0027 and hyperactive state in the spinal reflexes, manifesting as spasticity and hyperreflexia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"fb0a5fdc\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"spastic_paralysis\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"8947da55\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4ed629f9\"\n      }\n    ]\n  },\n  \"f72d0292\": {\n    \"title\": \"Uveitis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Immunology\",\n      \"Rheumatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Inflammatory Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eUveitis\u003c/b\u003e is inflammation of the uvea, the middle, pigmented, vascular layer of the eye, which is composed of the iris, ciliary body, and choroid.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassification by Location:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnterior Uveitis (Iritis/Iridocyclitis):\u003c/b\u003e Most common type. Inflammation of the iris and ciliary body. Presents with eye pain, redness (ciliary flush), photophobia, and blurred vision. Inflammatory cells may be seen in the anterior chamber (hypopyon).\u003cbr\u003e - \u003cb\u003eIntermediate Uveitis:\u003c/b\u003e Inflammation of the vitreous.\u003cbr\u003e - \u003cb\u003ePosterior Uveitis (Choroiditis/Retinitis):\u003c/b\u003e Inflammation of the choroid and/or retina. Often presents with floaters and painless vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Associations:\u003c/b\u003e Uveitis is strongly associated with systemic inflammatory and autoimmune diseases. Anterior uveitis is classically associated with \u003cmark\u003eHLA-B27-associated spondyloarthropathies\u003c/mark\u003e (e.g., ankylosing spondylitis, reactive arthritis). Other causes include sarcoidosis, inflammatory bowel disease, and juvenile idiopathic arthritis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInfectious Causes:\u003c/b\u003e Can be caused by infections such as syphilis, tuberculosis, toxoplasmosis, and herpesviruses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to [[3ce6c035|glaucoma]], [[85f03b02|cataracts]], and macular edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with low back pain and stiffness (ankylosing spondylitis) who develops a painful red eye has anterior uveitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eUveitis\u003c/b\u003e is an intraocular inflammation that often serves as an ocular \u0027window\u0027 to systemic disease, with anterior uveitis being a classic manifestation of HLA-B27-associated spondyloarthropathies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_inflammation_of\",\n        \"to\": \"uvea\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"ankylosing_spondylitis\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"sarcoidosis\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"3ce6c035\"\n      }\n    ]\n  },\n  \"534e796f\": {\n    \"title\": \"Vagal Nuclei\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003evagal nuclei\u003c/b\u003e are three main nuclei in the medulla oblongata that are associated with the [[vagus_nerve|vagus nerve (CN X)]], controlling its diverse motor, sensory, and parasympathetic functions.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[2f9dde44|Dorsal Motor Nucleus]]:\u003c/b\u003e The primary source of \u003cmark\u003eparasympathetic\u003c/mark\u003e preganglionic fibers of the vagus nerve. It innervates the viscera of the thorax and abdomen (heart, lungs, GI tract up to the splenic flexure).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNucleus Ambiguus:\u003c/b\u003e A \u003cmark\u003emotor\u003c/mark\u003e nucleus that provides branchial motor fibers to the muscles of the pharynx and larynx (via CN IX and X). It is essential for swallowing and phonation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNucleus Solitarius (Solitary Tract Nucleus):\u003c/b\u003e A \u003cmark\u003esensory\u003c/mark\u003e nucleus. It receives general visceral sensory information from the GI tract, baroreceptors, and chemoreceptors (via CN IX and X), as well as special sensory (taste) information from the epiglottis (via CN X).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Lesions in the lateral medulla (e.g., [[1d7d392c|Wallenberg syndrome]]) can damage these nuclei, leading to dysphagia, hoarseness (nucleus ambiguus), and autonomic dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the three functions and their corresponding nuclei: Parasympathetic (Dorsal Motor), Motor to pharynx/larynx (Ambiguus), and Sensory/Taste (Solitarius).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe diverse functions of the vagus nerve are neatly segregated among its three medullary nuclei: the \u003cb\u003edorsal motor nucleus\u003c/b\u003e for parasympathetic outflow, the \u003cb\u003enucleus ambiguus\u003c/b\u003e for motor control of swallowing and speech, and the \u003cb\u003enucleus solitarius\u003c/b\u003e for visceral and taste sensation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vagus Nerve - CN X]; A --\u003e B(Dorsal Motor Nucleus - Parasympathetic); A --\u003e C(Nucleus Ambiguus - Motor); A --\u003e D(Nucleus Solitarius - Sensory);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"are_nuclei_of\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"2f9dde44\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"nucleus_ambiguus\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"nucleus_solitarius\"\n      }\n    ]\n  },\n  \"7c12e7a3\": {\n    \"title\": \"Vagus Nerve (CN X)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Autonomic\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVagus Nerve (CN X)\u003c/b\u003e is a mixed cranial nerve with extensive motor, sensory, and parasympathetic functions. It is the longest cranial nerve, \u0027wandering\u0027 (Latin: \u003ci\u003evagus\u003c/i\u003e) from the brainstem to the abdomen.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction Type:\u003c/b\u003e Both motor and sensory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Function:\u003c/b\u003e Innervates most muscles of the pharynx and larynx, responsible for swallowing and phonation (speech). A lesion causes a hoarse voice and dysphagia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Function:\u003c/b\u003e Provides preganglionic parasympathetic innervation to nearly all thoracic and abdominal viscera up to the splenic flexure, slowing the heart rate, causing bronchoconstriction, and increasing GI motility and secretion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Sensory Function:\u003c/b\u003e Sensation from the pharynx, larynx, and a small area around the external auditory meatus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisceral Sensory Function:\u003c/b\u003e Transmits sensory information (e.g., stretch, chemoreception) from the aortic arch baroreceptors and chemoreceptors, and from the thoracic and abdominal viscera.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Signs:\u003c/b\u003e A unilateral lesion causes \u003cmark\u003euvula deviation \u003cu\u003eaway\u003c/u\u003e from the side of the lesion\u003c/mark\u003e, a hoarse voice, dysphagia, and loss of the efferent limb of the [[5b6bd754|gag reflex]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vagus nerve is the workhorse of the parasympathetic nervous system. Remember its key motor functions in the pharynx/larynx and its role in the gag reflex (efferent limb).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVagus Nerve\u003c/b\u003e is the primary conduit of the parasympathetic nervous system to the trunk, regulating vital organ functions, while also providing the motor control for speech and swallowing; its unilateral paralysis is clinically evident by the uvula pointing away from the weak side.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"contains_nuclei\",\n        \"to\": \"534e796f\"\n      },\n      {\n        \"type\": \"is_efferent_limb_of\",\n        \"to\": \"5b6bd754\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"f0207c17\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"uvula_deviation\"\n      }\n    ]\n  },\n  \"0d37e045\": {\n    \"title\": \"Valproate (Valproic Acid)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eValproate\u003c/b\u003e (valproic acid) is a broad-spectrum anticonvulsant medication that is also used as a mood stabilizer and for migraine prophylaxis. It has multiple mechanisms of action.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e1. Increases CNS levels of [[5aa5cb91|GABA]] by inhibiting GABA transaminase.\u003cbr\u003e2. Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels.\u003cbr\u003e3. Blocks T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e A first-line agent for \u003cmark\u003egeneralized tonic-clonic seizures\u003c/mark\u003e. Also effective for [[a0c128f4|absence]] and myoclonic seizures.\u003cbr\u003e - \u003cb\u003eBipolar Disorder:\u003c/b\u003e Used as a mood stabilizer.\u003cbr\u003e - \u003cb\u003e[[c8833bae|Migraine]] Prophylaxis.\u003c/b\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e GI distress, weight gain, tremor, and hair loss. The most serious side effects are \u003cmark\u003ehepatotoxicity\u003c/mark\u003e (can be fatal, requires LFT monitoring) and \u003cmark\u003epancreatitis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTeratogenicity:\u003c/b\u003e It is a potent teratogen, highly associated with an increased risk of \u003cmark\u003eneural tube defects\u003c/mark\u003e (e.g., spina bifida). It is contraindicated in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Valproate is a great broad-spectrum AED, but its use is limited by its significant side effect profile, especially hepatotoxicity and teratogenicity.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eValproate\u003c/b\u003e is a powerful, multi-mechanism anticonvulsant and mood stabilizer, but its clinical utility is significantly constrained by its black box warnings for hepatotoxicity, pancreatitis, and its high risk of causing neural tube defects in pregnancy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"4dff096f\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"2e7554b7\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"a0c128f4\"\n      },\n      {\n        \"type\": \"is_used_for_prophylaxis_of\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"is_a\",\n        \"to\": \"teratogen\"\n      }\n    ]\n  },\n  \"99420dce\": {\n    \"title\": \"Vascular Dementia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVascular dementia\u003c/b\u003e is the second most common cause of dementia, resulting from cognitive decline due to cerebrovascular disease, typically involving multiple ischemic strokes or chronic ischemia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by brain damage from cerebrovascular disease. This can be from multiple large-vessel strokes, a single strategic infarct in a critical area (e.g., thalamus), or, most commonly, multiple small, subcortical \u003cmark\u003elacunar infarcts\u003c/mark\u003e (multi-infarct dementia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e The risk factors are the same as for stroke: \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, hyperlipidemia, and smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The hallmark is a \u003cmark\u003estepwise decline\u003c/mark\u003e in cognitive function, where the patient\u0027s condition deteriorates abruptly with each new ischemic event, followed by periods of stability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Signs:\u003c/b\u003e Unlike Alzheimer\u0027s, vascular dementia is often accompanied by \u003cmark\u003efocal neurological deficits\u003c/mark\u003e corresponding to the locations of the infarcts (e.g., hemiparesis, visual field defects, dysarthria).\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e MRI or CT of the brain shows evidence of multiple cortical and/or subcortical infarcts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with a history of hypertension and multiple strokes who presents with a stepwise decline in cognition and focal neurological signs has vascular dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVascular dementia\u003c/b\u003e is a cognitive decline driven by cerebrovascular \u0027hits\u0027 to the brain, characterized by a stepwise deterioration that mirrors the occurrence of new ischemic events and is often accompanied by focal neurological signs.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension \u0026 other vascular risk factors] --\u003e B(Cerebrovascular Disease); B --\u003e C(Multiple Infarcts); C --\u003e D(Stepwise Cognitive Decline); D --\u003e E(Vascular Dementia);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bb316ca0\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertension\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"77ae6148\"\n      }\n    ]\n  },\n  \"4017bec5\": {\n    \"title\": \"Vasculitides (CNS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Rheumatology\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eCentral nervous system (CNS) vasculitis\u003c/b\u003e is inflammation of the blood vessel walls within the brain, spinal cord, and meninges. It can be a primary disorder confined to the CNS or a secondary manifestation of a systemic vasculitis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary CNS Vasculitis:\u003c/b\u003e A rare disorder where vasculitis is restricted to the CNS without evidence of systemic involvement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary CNS Vasculitis:\u003c/b\u003e CNS involvement can occur in systemic vasculitides, such as polyarteritis nodosa, granulomatosis with polyangiitis, and eosinophilic granulomatosis with polyangiitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Inflammation of the vessel walls can lead to stenosis, occlusion, or aneurysm formation, resulting in ischemic or hemorrhagic events.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Highly variable. Can present with diffuse encephalopathy, headaches, seizures, or multifocal [[c5da3c57|ischemic strokes]] or [[70b266c8|intraparenchymal hemorrhages]] occurring over time in different vascular territories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Can be challenging. Angiography may show characteristic \u0027beading\u0027 (alternating areas of stenosis and dilation). Brain biopsy is the gold standard for diagnosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Consider CNS vasculitis in a patient, especially a younger one, who presents with multiple strokes in different vascular territories that are not explained by a cardioembolic source.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eCNS vasculitis\u003c/b\u003e is an inflammatory attack on the brain\u0027s blood vessels that can cause a wide array of neurological symptoms by producing multiple, scattered ischemic and hemorrhagic lesions over time.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        \"type\": \"can_be_secondary_to\",\n        \"to\": \"systemic_vasculitis\"\n      }\n    ]\n  },\n  \"d94a9e61\": {\n    \"title\": \"Vasogenic Edema (Cerebral)\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVasogenic edema\u003c/b\u003e is the most common type of [[aa00bdef|cerebral edema]], characterized by the accumulation of fluid in the \u003ci\u003eextracellular\u003c/i\u003e space of the brain. It is caused by a breakdown of the tight endothelial junctions that form the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Disruption of the [[dd47b9cc|blood-brain barrier]] allows plasma proteins and fluid to leak from the intravascular space into the interstitial space of the brain, particularly affecting the white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Commonly seen in conditions that disrupt the BBB, such as \u003cmark\u003ebrain tumors\u003c/mark\u003e, abscesses, inflammation, trauma, and the later stages of [[c5da3c57|ischemic stroke]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e On imaging (CT/MRI), vasogenic edema appears as white matter hypodensity (CT) or hyperintensity (T2/FLAIR MRI) that often follows the finger-like projections of the white matter tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContrast with Cytotoxic Edema:\u003c/b\u003e [[8e51aa24|Cytotoxic edema]] is intracellular swelling due to cellular energy failure and occurs early in ischemia. Vasogenic edema is extracellular and occurs later.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The ring-enhancing lesion of a [[b6bbd0bc|glioblastoma]] or abscess is often surrounded by extensive vasogenic edema, which contributes significantly to the mass effect.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVasogenic edema\u003c/b\u003e is the result of a \u0027leaky\u0027 blood-brain barrier, causing fluid to pour into the brain\u0027s extracellular space, a common and significant contributor to mass effect in brain tumors and late-stage strokes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tumor/Inflammation/Late Stroke] --\u003e B(Disruption of Blood-Brain Barrier); B --\u003e C(Leakage of Plasma Fluid \u0026 Proteins); C --\u003e D(Accumulation in Extracellular Space); D --\u003e E(Vasogenic Edema);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"aa00bdef\"\n      },\n      {\n        \"type\": \"is_caused_by_disruption_of\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"is_seen_with\",\n        \"to\": \"be057cfc\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"8e51aa24\"\n      }\n    ]\n  },\n  \"43bf4ead\": {\n    \"title\": \"Vecuronium\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVecuronium\u003c/b\u003e is an intermediate-acting, non-depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e of the aminosteroid class. It is used to provide skeletal muscle relaxation during surgery and mechanical ventilation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing [[6a005559|acetylcholine]] from binding and causing muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-depolarizing neuromuscular blocker, similar to rocuronium and pancuronium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Primarily metabolized by the liver and excreted in bile and urine. Its duration of action can be prolonged in patients with hepatic or renal failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Unlike some other neuromuscular blockers (e.g., atracurium), it does not cause histamine release and is hemodynamically stable.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The neuromuscular blockade can be reversed by [[0835ea01|acetylcholinesterase inhibitors]] (e.g., neostigmine) combined with an antimuscarinic (e.g., glycopyrolate), or by sugammadex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Vecuronium and rocuronium are workhorse non-depolarizing blockers in anesthesia. Remember that their effects are reversed by increasing the amount of acetylcholine at the synapse with an acetylcholinesterase inhibitor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVecuronium\u003c/b\u003e is a standard non-depolarizing muscle relaxant that provides predictable paralysis for surgery by competitively blocking acetylcholine receptors, with the advantage of being hemodynamically stable.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"0835ea01\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        \"to\": \"liver\"\n      }\n    ]\n  },\n  \"66656d8b\": {\n    \"title\": \"Persistent Vegetative State\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Critical Care\",\n      \"Medical Ethics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Coma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003epersistent vegetative state (PVS)\u003c/b\u003e is a disorder of consciousness in which a patient with severe brain damage is in a state of partial arousal rather than true awareness. It is characterized by the return of sleep-wake cycles and autonomic functions, but a complete lack of cognitive function or awareness of the environment.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results from severe, diffuse damage to the cerebral hemispheres (cortex and white matter), with relative preservation of the brainstem and diencephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients appear to be awake (eyes are open and may track objects) but are not aware. They have intact sleep-wake cycles and can breathe spontaneously. They may have primitive reflexes (e.g., startle, grasp) but show no purposeful, voluntary behaviors or evidence of language comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Coma:\u003c/b\u003e In a [[d36eed18|coma]], the patient is unarousable and their eyes are closed. In PVS, the patient is arousable (has sleep-wake cycles) and their eyes are open.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Locked-in Syndrome:\u003c/b\u003e In locked-in syndrome, the patient is fully conscious and aware but is quadriplegic and cannot speak.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e If the state persists for more than a few months, the chance of significant recovery is very low. The term \u0027persistent\u0027 is used after 1 month, and \u0027permanent\u0027 after 3 months (anoxic injury) or 12 months (traumatic injury).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to identifying PVS is the dissociation between arousal (awake, open eyes) and awareness (no cognitive function).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003epersistent vegetative state\u003c/b\u003e is a devastating outcome of severe brain injury where the \u0027wakefulness\u0027 centers of the brainstem are preserved, but the \u0027awareness\u0027 centers of the cortex are lost, leaving a patient who is \u0027awake but not aware\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_disorder_of\",\n        \"to\": \"consciousness\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"d36eed18\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"locked_in_syndrome\"\n      }\n    ]\n  },\n  \"067666cd\": {\n    \"title\": \"Dural Venous Sinus Thrombosis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Hematology\",\n      \"Cerebrovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDural venous sinus thrombosis (DVST)\u003c/b\u003e, or cerebral venous thrombosis, is the formation of a blood clot in the [[21f1c955|dural venous sinuses]], which are the primary drainage channels for the brain. This obstruction of venous outflow can lead to increased intracranial pressure and venous infarction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Thrombosis of a sinus impedes venous drainage, leading to venous congestion and increased intracranial pressure. It can also cause back-pressure in cortical veins, leading to hemorrhagic venous infarcts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Associated with \u003cmark\u003ehypercoagulable states\u003c/mark\u003e. These include inherited thrombophilias (e.g., [[514c69e0|Factor V Leiden]]), oral contraceptive use, pregnancy and the postpartum period, malignancy, and certain infections (e.g., mastoiditis, sinusitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Highly variable. The most common symptom is a severe headache that can be acute or subacute. Other signs include seizures, focal neurological deficits (that may not conform to a single arterial territory), and signs of increased ICP (papilledema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e The imaging modality of choice is an \u003cmark\u003eMRI with magnetic resonance venography (MRV)\u003c/mark\u003e, which can directly visualize the lack of flow or the thrombus within the sinus (e.g., the \u0027empty delta sign\u0027 in the superior sagittal sinus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The primary treatment is anticoagulation (e.g., with heparin), even in the presence of hemorrhagic infarction, to prevent thrombus propagation and promote recanalization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Suspect DVST in a young patient, especially a woman who is pregnant, postpartum, or on OCPs, who presents with a severe headache and/or stroke-like symptoms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDural venous sinus thrombosis\u003c/b\u003e is a \u0027stroke on the venous side,\u0027 where a clot in the brain\u0027s drainage system causes a pressure backup, leading to headaches, seizures, and potentially hemorrhagic infarcts, often in the setting of a hypercoagulable state.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypercoagulable State] --\u003e B(Thrombus in Dural Sinus); B --\u003e C(Obstruction of Venous Outflow); C --\u003e D(‚Üë Intracranial Pressure); C --\u003e E(Venous Infarction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_thrombosis_of\",\n        \"to\": \"21f1c955\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypercoagulable_state\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"514c69e0\"\n      },\n      {\n        \"type\": \"is_diagnosed_by\",\n        \"to\": \"mr_venography\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10423,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"bccd13b6\": {\n    \"title\": \"Tub"
      }, {
        "text": "eroinfundibular Pathway\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Endocrinology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"D"
      }, {
        "text": "opaminergic Pathways\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTuberoinfundibular Pathway"
      }, {
        "text": "\u003c/b\u003e is one of the four major dopaminergic pathways in the brain. It consists of dopamine-releasing neurons that project"
      }, {
        "text": " from the arcuate nucleus of the [[89e86633|hypothalamus]] to the median"
      }, {
        "text": " eminence, where dopamine is released into the hypophyseal portal system to act on the anterior pituitary.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The primary role of this pathway is the \u003cmark\u003etonic inhibition of prol"
      }, {
        "text": "actin secretion\u003c/mark\u003e from the anterior pituitary lactotrophs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e [[90adc8"
      }, {
        "text": "21|Dopamine]] released into the portal system binds to D\u003csub\u003e2\u003c/sub\u003e receptors on lactotrophs, inhibiting the"
      }, {
        "text": " synthesis and release of prolactin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance (Pharmacology):\u003c/b\u003e This pathway is significantly affected by \u003c"
      }, {
        "text": "mark\u003edopamine D\u003csub\u003e2\u003c/sub\u003e receptor antagonists\u003c/mark\u003e (i.e., most antipsychotic drugs).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eAntipsychotic Side Effect:\u003c/b\u003e Blockade of D\u003csub\u003e2\u003c/sub\u003e receptors in this pathway removes the normal inhibition"
      }, {
        "text": " of prolactin, leading to \u003cmark\u003ehyperprolactinemia\u003c/mark\u003e. This can cause galactorrhea, gyne"
      }, {
        "text": "comastia, amenorrhea, and sexual dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Hyperprolactinemia is a classic"
      }, {
        "text": " side effect of typical and some atypical antipsychotics. Remember that dopamine normally \u0027puts the brakes\u0027 on prolactin; blocking dopamine"
      }, {
        "text": " releases the brake.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTuberoinfundibular Pathway\u003c/b\u003e is the"
      }, {
        "text": " neuroendocrine link through which the hypothalamus controls prolactin, with dopamine acting as the primary inhibitory signal; its blockade by antipsychotic drugs predictably"
      }, {
        "text": " leads to hyperprolactinemia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypothalamus]"
      }, {
        "text": " --Dopamine--\u003e B(Anterior Pituitary); B --Inhibits--\u003e C(Prolactin Release);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\","
      }, {
        "text": "\n        \"to\": \"57f4719b\"\n      },\n      {\n        \"type\": \"inhibits\","
      }, {
        "text": "\n        \"to\": \"prolactin\"\n      },\n      {\n        \"type\": \"is_blocked"
      }, {
        "text": "_by\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"blockade_"
      }, {
        "text": "causes\",\n        \"to\": \"hyperprolactinemia\"\n      }\n    ]\n  },\n  \"8"
      }, {
        "text": "3302339\": {\n    \"title\": \"Tuberous Sclerosis Complex\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Genetics"
      }, {
        "text": "\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTuberous Sclerosis Complex (TSC)\u003c/b\u003e is an autosomal dominant neurocutaneous disorder characterized by the"
      }, {
        "text": " growth of numerous benign hamartomas in multiple organs, including the brain, skin, heart, kidneys, and lungs.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal dominant inheritance with variable expressivity. Caused by a mutation in the"
      }, {
        "text": " tumor suppressor genes \u003ci\u003eTSC1\u003c/i\u003e (encoding hamartin) or \u003ci\u003eTSC2\u003c/i\u003e (encoding tuberin"
      }, {
        "text": ").\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Hamartin and tuberin normally form a complex that inhibits mTOR (mammalian target of rapamycin),"
      }, {
        "text": " a key regulator of cell growth and proliferation. Loss of function leads to unregulated cell growth and hamartoma formation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Features (Mnemonic HAMARTOMAS):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eH\u003c/b\u003eamartomas in CNS and skin\u003cbr\u003e - \u003cb\u003eA"
      }, {
        "text": "\u003c/b\u003engiofibromas (facial)\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eitral regurgitation\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eA\u003c/b\u003esh-leaf spots (hypopigmented macules)\u003cbr\u003e - Cardiac \u003cb\u003eR\u003c/b\u003ehab"
      }, {
        "text": "domyoma (most common cardiac tumor in children)\u003cbr\u003e - \u003cb\u003eT\u003c/b\u003euberous Sclerosis\u003cbr\u003e - Aut"
      }, {
        "text": "osomal d\u003cb\u003eO\u003c/b\u003eminant\u003cbr\u003e - \u003cb\u003eM\u003c/b\u003eental retardation (intellectual disability)\u003cbr\u003e - Renal"
      }, {
        "text": " \u003cb\u003eA\u003c/b\u003engiomyolipoma\u003cbr\u003e - \u003cb\u003eS\u003c/b\u003eeizures (infantile spasms are common), \u003cb\u003eS"
      }, {
        "text": "\u003c/b\u003ehagreen patches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Manifestations:\u003c/b\u003e Cortical tubers and subependymal giant cell astrocytomas (SEG"
      }, {
        "text": "As) are common brain hamartomas, leading to seizures and intellectual disability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination"
      }, {
        "text": " of skin findings (ash-leaf spots, angiofibromas) and neurological symptoms (seizures, developmental"
      }, {
        "text": " delay) in a child is classic for TSC. Cardiac rhabdomyoma in an infant is also highly suggestive.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eTuberous Sclerosis\u003c/b\u003e is a genetic disorder of cellular growth control, caused"
      }, {
        "text": " by mutations in mTOR pathway inhibitors, which manifests as a widespread development of benign hamartomas, classically presenting with the triad"
      }, {
        "text": " of skin lesions, seizures, and intellectual disability.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[TSC1/"
      }, {
        "text": "TSC2 Mutation] --\u003e B(Loss of Hamartin/Tuberin); B --x C(Inhibition of mTOR); C --\u003e"
      }, {
        "text": " D(Unregulated Cell Growth); D --\u003e E(Hamartoma Formation in Multiple Organs);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous_"
      }, {
        "text": "disorder\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to"
      }, {
        "text": "\": \"tsc1_gene\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        "
      }, {
        "text": "\"to\": \"tsc2_gene\"\n      },\n      {\n        \"type\": \"presents_"
      }, {
        "text": "with\",\n        \"to\": \"seizures\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"ash_leaf_spots\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"07be978a\": {\n    \"title\": \"Uncal Transtent"
      }, {
        "text": "orial Herniation\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Neurosurgery\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Herniation Syndromes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eUncal transtentorial herni"
      }, {
        "text": "ation\u003c/b\u003e is a subtype of downward brain herniation where the uncus, the innermost part of the temporal lobe, is forced med"
      }, {
        "text": "ially and downward through the tentorial notch, compressing the adjacent midbrain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Caused by an expanding mass lesion in the middle cranial fossa, such as an [[a61"
      }, {
        "text": "683ae|epidural hematoma]], subdural hematoma, or temporal lobe tumor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEarly"
      }, {
        "text": " Signs (Ipsilateral CN III Compression):\u003c/b\u003e The herniating uncus first compresses the ipsilateral [[68c"
      }, {
        "text": "66997|oculomotor nerve (CN III)]]. This affects the superficial parasympathetic fibers, causing"
      }, {
        "text": " a fixed, dilated pupil (\u003cmark\u003e\\\"blown pupil\\\"\u003c/mark\u003e). This is followed by paralysis of the extra"
      }, {
        "text": "ocular muscles innervated by CN III, leading to a \u0027down and out\u0027 gaze.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLater Signs (Brain"
      }, {
        "text": "stem Compression):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eContralateral Cerebral Peduncle Compression:\u003c/b\u003e Leads to \u003cmark\u003eipsilateral hem"
      }, {
        "text": "iparesis\u003c/mark\u003e (a false localizing sign known as Kernohan\u0027s notch phenomenon).\u003cbr\u003e - \u003cb\u003eBrain"
      }, {
        "text": "stem Compression:\u003c/b\u003e Can lead to altered consciousness, coma, and Duret hemorrhages.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePCA Compression:\u003c/b\u003e The"
      }, {
        "text": " ipsilateral posterior cerebral artery can also be compressed, leading to a contralateral homonymous hemianopia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A patient with a head injury who develops a unilateral \u0027blown pupil\u0027 is the classic presentation of uncal herniation. This is a neuro"
      }, {
        "text": "surgical emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eUncal herniation\u003c/b\u003e is a life"
      }, {
        "text": "-threatening event where the temporal lobe is squeezed against the brainstem, classically heralded by a \u0027blown pupil\u0027 from ocul"
      }, {
        "text": "omotor nerve compression, which can rapidly progress to coma and death if the underlying pressure is not relieved.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD;"
      }, {
        "text": " A[Expanding Temporal Lobe Mass] --\u003e B(Uncus Herniates Medially); B --Compresses--\u003e C(Ipsilateral CN"
      }, {
        "text": " III); C --\u003e D(Ipsilateral Blown Pupil); B --Compresses--\u003e E(Ipsilateral Cerebral"
      }, {
        "text": " Peduncle); E --\u003e F(Contralateral Hemiparesis); B --Compresses--\u003e G(Contralateral Cerebral Peduncle -"
      }, {
        "text": " Kernohan\u0027s Notch); G --\u003e H(Ipsilateral Hemiparesis);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"8c072"
      }, {
        "text": "8b7\"\n      },\n      {\n        \"type\": \"compresses\",\n        \"to\": \"6"
      }, {
        "text": "8c66997\"\n      },\n      {\n        \"type\": \"compresses\",\n"
      }, {
        "text": "        \"to\": \"cerebral_peduncle\"\n      },\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"6ab4b0f2\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "503fcb39\": {\n    \"title\": \"Upper Extremities (Neurological Innervation)\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003eupper extremities\u003c/b\u003e receive their motor and sensory innervation primarily from the brachial plexus, which is formed by the ventral rami of the spinal"
      }, {
        "text": " nerves C5, C6, C7, C8, and T1.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBrachial Plexus:\u003c/b\u003e A complex network of nerves that gives rise to the major peripheral"
      }, {
        "text": " nerves of the upper limb (musculocutaneous, axillary, radial, median, and ulnar nerves).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eMotor Homunculus:\u003c/b\u003e The motor and sensory control of the upper limb is represented on the lateral aspect of the precentral and"
      }, {
        "text": " postcentral gyri, respectively.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVascular Supply (Cortex):\u003c/b\u003e The cortical areas for the arm"
      }, {
        "text": " and hand are supplied by the [[143bb23d|Middle Cerebral Artery (MCA)]].\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eSpinal Cord Tracts:\u003c/b\u003e Motor commands descend via the corticospinal tracts. Sensation ascends via the dorsal"
      }, {
        "text": " columns (proprioception/vibration) and spinothalamic tracts (pain/temperature).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSyringomyelia:"
      }, {
        "text": "\u003c/b\u003e A syrinx (fluid-filled cavity) in the cervical spinal cord classically damages the decussating spinothalamic fibers"
      }, {
        "text": " at the anterior white commissure, leading to a \u003cmark\u003e\u0027cape-like\u0027\u003c/mark\u003e bilateral loss of pain and temperature sensation in the"
      }, {
        "text": " upper extremities.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the motor and sensory deficits associated with lesions of the brachial plexus and"
      }, {
        "text": " its terminal branches.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe neurological control of the \u003cb\u003eupper extremities\u003c/b\u003e is a complex"
      }, {
        "text": " system involving the brachial plexus for peripheral innervation and specific, well-defined areas of the cerebral cortex and spinal cord, making the"
      }, {
        "text": " pattern of deficits a reliable guide for lesion localization.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"brachial_plex"
      }, {
        "text": "us\"\n      },\n      {\n        \"type\": \"cortical_area_supplied_by\",\n        \"to\":"
      }, {
        "text": " \"143bb23d\"\n      },\n      {\n        \"type\": \"is_affected_by\","
      }, {
        "text": "\n        \"to\": \"syringomyelia\"\n      }\n    ]\n  },\n  \"7"
      }, {
        "text": "26ba7d4\": {\n    \"title\": \"Upper Motor Neuron (UMN)\",\n    \"primary"
      }, {
        "text": "Type\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Motor System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eAn \u003cb\u003eupper motor neuron (UMN)\u003c/b\u003e is a neuron whose cell body is located in the motor cortex of the brain and"
      }, {
        "text": " whose axon descends to synapse on a lower motor neuron (or an interneuron) in the brainstem or spinal cord."
      }, {
        "text": " UMNs constitute the descending motor pathways, such as the corticospinal and corticobulbar tracts.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e UMNs initiate, control, and modulate voluntary movement. They provide"
      }, {
        "text": " both excitatory and inhibitory input to LMNs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN Lesion:\u003c/b\u003e Damage to UMNs or"
      }, {
        "text": " their descending tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUMN Lesion Signs:\u003c/b\u003e Result from a loss of descending inhibition on the spinal reflex"
      }, {
        "text": " arcs. Signs include:\u003cbr\u003e - \u003cb\u003eSpastic Paralysis/Paresis:\u003c/b\u003e Increased muscle tone.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eHyperreflexia:\u003c/b\u003e Exaggerated deep tendon reflexes.\u003cbr\u003e - \u003cb\u003e[[ca"
      }, {
        "text": "51f29a|Clasp-knife spasticity]]\u003c/b\u003e.\u003cbr\u003e - \u003cb\u003ePositive [["
      }, {
        "text": "8947da55|Babinski sign]]:\u003c/b\u003e Upgoing toe.\u003cbr\u003e - \u003cb\u003eMild ("
      }, {
        "text": "Disuse) Atrophy:\u003c/b\u003e No significant muscle wasting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of UMN Lesions:\u003c/b\u003e [["
      }, {
        "text": "c5da3c57|Stroke]], [[45dd6d19|multiple sclerosis]], traumatic brain or"
      }, {
        "text": " spinal cord injury, [[171ca00b|cerebral palsy]], and [[4ed629f"
      }, {
        "text": "9|amyotrophic lateral sclerosis (ALS)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFacial Paralysis:\u003c/b\u003e A UMN lesion ("
      }, {
        "text": "e.g., stroke) causes \u003cmark\u003econtralateral lower facial weakness\u003c/mark\u003e, sparing the forehead, due"
      }, {
        "text": " to bilateral UMN innervation of the upper face.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that UMN signs are \u0027"
      }, {
        "text": "hyper\u0027 (hyperreflexia, hypertonia) and the Babinski sign is \u0027up\u0027. This contrasts with L"
      }, {
        "text": "MN signs, which are \u0027hypo\u0027 (hyporeflexia, hypotonia, atrophy).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eAn \u003cb\u003eupper motor neuron\u003c/b\u003e is the \u0027commander\u0027 of voluntary movement, originating in the brain"
      }, {
        "text": "; a lesion to it cuts off the regulatory descending control, leading to a \u0027released\u0027 and hyperactive state in the spinal reflexes"
      }, {
        "text": ", manifesting as spasticity and hyperreflexia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"fb0"
      }, {
        "text": "a5fdc\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \""
      }, {
        "text": "spastic_paralysis\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"8"
      }, {
        "text": "947da55\"\n      },\n      {\n        \"type\": \"is_damaged_in"
      }, {
        "text": "\",\n        \"to\": \"4ed629f9\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"f72d0292\": {\n    \"title\": \"Uveitis\",\n    \"primary"
      }, {
        "text": "Type\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Immunology\",\n      \"Rhe"
      }, {
        "text": "umatology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Ophthalmology\",\n      \"Inflammatory Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eUveitis\u003c/b\u003e is inflammation of the uvea, the middle"
      }, {
        "text": ", pigmented, vascular layer of the eye, which is composed of the iris, ciliary body, and choroid.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClassification by Location:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eAnterior Uveitis ("
      }, {
        "text": "Iritis/Iridocyclitis):\u003c/b\u003e Most common type. Inflammation of the iris and ciliary body. Presents with eye"
      }, {
        "text": " pain, redness (ciliary flush), photophobia, and blurred vision. Inflammatory cells may be seen in the anterior chamber (hyp"
      }, {
        "text": "opyon).\u003cbr\u003e - \u003cb\u003eIntermediate Uveitis:\u003c/b\u003e Inflammation of the vitreous.\u003cbr\u003e - \u003cb\u003ePosterior U"
      }, {
        "text": "veitis (Choroiditis/Retinitis):\u003c/b\u003e Inflammation of the choroid and/or retina. Often presents with float"
      }, {
        "text": "ers and painless vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSystemic Associations:\u003c/b\u003e Uveitis is strongly associated with systemic inflammatory and autoimmune"
      }, {
        "text": " diseases. Anterior uveitis is classically associated with \u003cmark\u003eHLA-B27-associated spondyloarthropathies\u003c/mark\u003e"
      }, {
        "text": " (e.g., ankylosing spondylitis, reactive arthritis). Other causes include sarcoidosis, inflammatory bowel disease, and juvenile"
      }, {
        "text": " idiopathic arthritis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInfectious Causes:\u003c/b\u003e Can be caused by infections such as syphilis, tuberculosis, tox"
      }, {
        "text": "oplasmosis, and herpesviruses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Can lead to [[3ce6c03"
      }, {
        "text": "5|glaucoma]], [[85f03b02|cataracts]], and macular edema.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A patient with low back pain and stiffness (ankylosing spondylitis) who develops a painful red eye has"
      }, {
        "text": " anterior uveitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eUveitis\u003c/b\u003e is an intra"
      }, {
        "text": "ocular inflammation that often serves as an ocular \u0027window\u0027 to systemic disease, with anterior uveitis being a classic manifestation of HLA"
      }, {
        "text": "-B27-associated spondyloarthropathies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_inflammation_of\",\n        \"to\": \"uvea\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"ankylosing_"
      }, {
        "text": "spondylitis\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n"
      }, {
        "text": "        \"to\": \"sarcoidosis\"\n      },\n      {\n        \"type\": \"can_cause"
      }, {
        "text": "\",\n        \"to\": \"3ce6c035\"\n      }\n    ]\n  },\n  \"5"
      }, {
        "text": "34e796f\": {\n    \"title\": \"Vagal Nuclei\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"An"
      }, {
        "text": "atomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003ev"
      }, {
        "text": "agal nuclei\u003c/b\u003e are three main nuclei in the medulla oblongata that are associated with the [[vagus_nerve|"
      }, {
        "text": "vagus nerve (CN X)]], controlling its diverse motor, sensory, and parasympathetic functions.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[2f9dde44|Dorsal Motor Nucleus]]:\u003c/b\u003e The primary source"
      }, {
        "text": " of \u003cmark\u003eparasympathetic\u003c/mark\u003e preganglionic fibers of the vagus nerve. It innervates the visc"
      }, {
        "text": "era of the thorax and abdomen (heart, lungs, GI tract up to the splenic flexure).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNucle"
      }, {
        "text": "us Ambiguus:\u003c/b\u003e A \u003cmark\u003emotor\u003c/mark\u003e nucleus that provides branchial motor fibers to the muscles"
      }, {
        "text": " of the pharynx and larynx (via CN IX and X). It is essential for swallowing and phonation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNucleus"
      }, {
        "text": " Solitarius (Solitary Tract Nucleus):\u003c/b\u003e A \u003cmark\u003esensory\u003c/mark\u003e nucleus. It receives general"
      }, {
        "text": " visceral sensory information from the GI tract, baroreceptors, and chemoreceptors (via CN IX and X), as well"
      }, {
        "text": " as special sensory (taste) information from the epiglottis (via CN X).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Les"
      }, {
        "text": "ions in the lateral medulla (e.g., [[1d7d392c|Wallenberg syndrome]])"
      }, {
        "text": " can damage these nuclei, leading to dysphagia, hoarseness (nucleus ambiguus), and autonomic dysfunction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Remember the three functions and their corresponding nuclei: Parasympathetic (Dorsal Motor), Motor to pharynx/larynx (Amb"
      }, {
        "text": "iguus), and Sensory/Taste (Solitarius).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " diverse functions of the vagus nerve are neatly segregated among its three medullary nuclei: the \u003cb\u003edorsal motor nucleus\u003c/b\u003e for"
      }, {
        "text": " parasympathetic outflow, the \u003cb\u003enucleus ambiguus\u003c/b\u003e for motor control of swallowing and speech, and the \u003cb\u003enucleus solitarius\u003c/b\u003e for visceral"
      }, {
        "text": " and taste sensation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vagus Nerve - CN X]; A"
      }, {
        "text": " --\u003e B(Dorsal Motor Nucleus - Parasympathetic); A --\u003e C(Nucleus Ambiguus - Motor); A"
      }, {
        "text": " --\u003e D(Nucleus Solitarius - Sensory);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"are_nuclei_of\",\n        \"to\": \"vagus_nerve\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"2f9dde44\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"nucleus_ambiguus\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"includes\",\n        \"to\": \"nucleus_solitarius\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"7c12e7a3\": {\n    \"title\": \"Vagus Nerve (CN X)\","
      }, {
        "text": "\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \""
      }, {
        "text": "Autonomic\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eVagus Nerve (CN X)\u003c/b\u003e"
      }, {
        "text": " is a mixed cranial nerve with extensive motor, sensory, and parasympathetic functions. It is the longest cranial nerve, \u0027"
      }, {
        "text": "wandering\u0027 (Latin: \u003ci\u003evagus\u003c/i\u003e) from the brainstem to the abdomen.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction Type:\u003c/b\u003e Both motor and sensory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Function:\u003c/b\u003e Innervates most"
      }, {
        "text": " muscles of the pharynx and larynx, responsible for swallowing and phonation (speech). A lesion causes a hoarse voice and dysph"
      }, {
        "text": "agia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParasympathetic Function:\u003c/b\u003e Provides preganglionic parasympathetic innervation to nearly all thoracic and abdominal visc"
      }, {
        "text": "era up to the splenic flexure, slowing the heart rate, causing bronchoconstriction, and increasing GI motility and secretion"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Sensory Function:\u003c/b\u003e Sensation from the pharynx, larynx, and a small area around the external auditory meatus.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eVisceral Sensory Function:\u003c/b\u003e Transmits sensory information (e.g., stretch, chemoreception) from the aortic"
      }, {
        "text": " arch baroreceptors and chemoreceptors, and from the thoracic and abdominal viscera.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Signs"
      }, {
        "text": ":\u003c/b\u003e A unilateral lesion causes \u003cmark\u003euvula deviation \u003cu\u003eaway\u003c/u\u003e from the side of the lesion\u003c/mark\u003e, a"
      }, {
        "text": " hoarse voice, dysphagia, and loss of the efferent limb of the [[5b6bd754|gag reflex]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The vagus nerve is the workhorse of the parasympathetic nervous system. Remember"
      }, {
        "text": " its key motor functions in the pharynx/larynx and its role in the gag reflex (efferent limb).\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eThe \u003cb\u003eVagus Nerve\u003c/b\u003e is the primary conduit of the parasympathetic nervous system to"
      }, {
        "text": " the trunk, regulating vital organ functions, while also providing the motor control for speech and swallowing; its unilateral paralysis is clinically"
      }, {
        "text": " evident by the uvula pointing away from the weak side.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"contains_nuclei\",\n        \"to\": \"5"
      }, {
        "text": "34e796f\"\n      },\n      {\n        \"type\": \"is_efferent"
      }, {
        "text": "_limb_of\",\n        \"to\": \"5b6bd754\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"lesion_causes\",\n        \"to\": \"f0207c17\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"lesion_causes\",\n        \"to\": \"uvula_deviation\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"0d37e045\": {\n    \""
      }, {
        "text": "title\": \"Valproate (Valproic Acid)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eValproate\u003c/b\u003e (valproic acid) is a broad-"
      }, {
        "text": "spectrum anticonvulsant medication that is also used as a mood stabilizer and for migraine prophylaxis. It has multiple mechanisms of action.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e1. Increases CNS"
      }, {
        "text": " levels of [[5aa5cb91|GABA]] by inhibiting GABA transaminase.\u003cbr\u003e2. Blocks"
      }, {
        "text": " voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels.\u003cbr\u003e3. Blocks T-type Ca\u003csup\u003e2+\u003c/sup\u003e channels."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e A first-line agent for \u003c"
      }, {
        "text": "mark\u003egeneralized tonic-clonic seizures\u003c/mark\u003e. Also effective for [[a0c128f4|absence"
      }, {
        "text": "]] and myoclonic seizures.\u003cbr\u003e - \u003cb\u003eBipolar Disorder:\u003c/b\u003e Used as a mood stabilizer.\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003e[[c8833bae|Migraine]] Prophylaxis.\u003c/b\u003e\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e GI"
      }, {
        "text": " distress, weight gain, tremor, and hair loss. The most serious side effects are \u003cmark\u003ehepatotoxicity\u003c/mark\u003e (can"
      }, {
        "text": " be fatal, requires LFT monitoring) and \u003cmark\u003epancreatitis\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTeratogenicity:\u003c/b\u003e"
      }, {
        "text": " It is a potent teratogen, highly associated with an increased risk of \u003cmark\u003eneural tube defects\u003c/mark\u003e (e.g"
      }, {
        "text": "., spina bifida). It is contraindicated in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Valproate is a great"
      }, {
        "text": " broad-spectrum AED, but its use is limited by its significant side effect profile, especially hepatotoxicity and teratogenicity.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eValproate\u003c/b\u003e is a powerful, multi-mechanism anticon"
      }, {
        "text": "vulsant and mood stabilizer, but its clinical utility is significantly constrained by its black box warnings for hepatotoxicity, pancreatitis, and its"
      }, {
        "text": " high risk of causing neural tube defects in pregnancy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"4"
      }, {
        "text": "dff096f\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"2"
      }, {
        "text": "e7554b7\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \""
      }, {
        "text": "a0c128f4\"\n      },\n      {\n        \"type\": \"is_used_for"
      }, {
        "text": "_prophylaxis_of\",\n        \"to\": \"c8833bae\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a\",\n        \"to\": \"teratogen\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"99420dce\": {\n    \"title\": \"Vascular Dementia\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Geriatrics\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eVascular dementia\u003c/b\u003e is the second most common cause of dementia, resulting from cognitive decline due to cerebro"
      }, {
        "text": "vascular disease, typically involving multiple ischemic strokes or chronic ischemia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEti"
      }, {
        "text": "ology:\u003c/b\u003e Caused by brain damage from cerebrovascular disease. This can be from multiple large-vessel strokes,"
      }, {
        "text": " a single strategic infarct in a critical area (e.g., thalamus), or, most commonly, multiple small,"
      }, {
        "text": " subcortical \u003cmark\u003elacunar infarcts\u003c/mark\u003e (multi-infarct dementia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk"
      }, {
        "text": " Factors:\u003c/b\u003e The risk factors are the same as for stroke: \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, hyperlipidemia, and"
      }, {
        "text": " smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The hallmark is a \u003cmark\u003estepwise decline\u003c/mark\u003e in cognitive function,"
      }, {
        "text": " where the patient\u0027s condition deteriorates abruptly with each new ischemic event, followed by periods of stability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Signs:\u003c/b\u003e Unlike Alzheimer\u0027s, vascular dementia is often accompanied by \u003cmark\u003efocal neurological deficits\u003c/mark\u003e corresponding"
      }, {
        "text": " to the locations of the infarcts (e.g., hemiparesis, visual field defects, dysarthria).\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging"
      }, {
        "text": ":\u003c/b\u003e MRI or CT of the brain shows evidence of multiple cortical and/or subcortical infarcts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " A patient with a history of hypertension and multiple strokes who presents with a stepwise decline in cognition and focal neurological signs has vascular"
      }, {
        "text": " dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVascular dementia\u003c/b\u003e is a cognitive decline driven"
      }, {
        "text": " by cerebrovascular \u0027hits\u0027 to the brain, characterized by a stepwise deterioration that mirrors the occurrence of new ischemic events and"
      }, {
        "text": " is often accompanied by focal neurological signs.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypertension \u0026"
      }, {
        "text": " other vascular risk factors] --\u003e B(Cerebrovascular Disease); B --\u003e C(Multiple Infarcts); C --\u003e D(Step"
      }, {
        "text": "wise Cognitive Decline); D --\u003e E(Vascular Dementia);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bb316"
      }, {
        "text": "ca0\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"c"
      }, {
        "text": "5da3c57\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\":"
      }, {
        "text": " \"hypertension\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"7"
      }, {
        "text": "7ae6148\"\n      }\n    ]\n  },\n  \"4017bec"
      }, {
        "text": "5\": {\n    \"title\": \"Vasculitides (CNS)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Rheumatology\",\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\","
      }, {
        "text": "\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eCentral nervous system (CNS) vasculitis\u003c/b\u003e is inflammation of the blood vessel walls within the brain, spinal"
      }, {
        "text": " cord, and meninges. It can be a primary disorder confined to the CNS or a secondary manifestation of a systemic vascul"
      }, {
        "text": "itis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary CNS Vasculitis:\u003c/b\u003e A rare disorder"
      }, {
        "text": " where vasculitis is restricted to the CNS without evidence of systemic involvement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary CNS Vasculitis:\u003c/b\u003e CNS"
      }, {
        "text": " involvement can occur in systemic vasculitides, such as polyarteritis nodosa, granulomatosis with polyangiitis, and eosinophilic granulomatosis"
      }, {
        "text": " with polyangiitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Inflammation of the vessel walls can lead to stenosis, occlusion, or aneurysm"
      }, {
        "text": " formation, resulting in ischemic or hemorrhagic events.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Highly variable. Can present with diffuse encephal"
      }, {
        "text": "opathy, headaches, seizures, or multifocal [[c5da3c57|ischemic strokes]] or [["
      }, {
        "text": "70b266c8|intraparenchymal hemorrhages]] occurring over time in different vascular territories.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e"
      }, {
        "text": " Can be challenging. Angiography may show characteristic \u0027beading\u0027 (alternating areas of stenosis and dilation). Brain biopsy is the"
      }, {
        "text": " gold standard for diagnosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Consider CNS vasculitis in a patient, especially a younger one, who"
      }, {
        "text": " presents with multiple strokes in different vascular territories that are not explained by a cardioembolic source.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eCNS vasculitis\u003c/b\u003e is an inflammatory attack on the brain\u0027s blood vessels that"
      }, {
        "text": " can cause a wide array of neurological symptoms by producing multiple, scattered ischemic and hemorrhagic lesions over time.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_cause\",\n        \"to\":"
      }, {
        "text": " \"c5da3c57\"\n      },\n      {\n        \"type\": \"can_cause"
      }, {
        "text": "\",\n        \"to\": \"70b266c8\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"can_be_secondary_to\",\n        \"to\": \"systemic_vasculitis"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"d94a9e61\": {\n    \"title"
      }, {
        "text": "\": \"Vasogenic Edema (Cerebral)\",\n    \"primaryType\": \"pathology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"C"
      }, {
        "text": "erebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVas"
      }, {
        "text": "ogenic edema\u003c/b\u003e is the most common type of [[aa00bdef|cerebral edema]], characterized by the accumulation of fluid"
      }, {
        "text": " in the \u003ci\u003eextracellular\u003c/i\u003e space of the brain. It is caused by a breakdown of the tight endothelial junctions that"
      }, {
        "text": " form the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Disruption of the [[dd47b9cc|blood-brain barrier]] allows plasma proteins and fluid to leak from the intravascular"
      }, {
        "text": " space into the interstitial space of the brain, particularly affecting the white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Commonly seen in conditions"
      }, {
        "text": " that disrupt the BBB, such as \u003cmark\u003ebrain tumors\u003c/mark\u003e, abscesses, inflammation, trauma, and the"
      }, {
        "text": " later stages of [[c5da3c57|ischemic stroke]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e On imaging"
      }, {
        "text": " (CT/MRI), vasogenic edema appears as white matter hypodensity (CT) or hyperintensity (T2/"
      }, {
        "text": "FLAIR MRI) that often follows the finger-like projections of the white matter tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContrast with Cyt"
      }, {
        "text": "otoxic Edema:\u003c/b\u003e [[8e51aa24|Cytotoxic edema]] is intracellular swelling due to cellular"
      }, {
        "text": " energy failure and occurs early in ischemia. Vasogenic edema is extracellular and occurs later.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " ring-enhancing lesion of a [[b6bbd0bc|glioblastoma]] or abscess is often surrounded by extensive"
      }, {
        "text": " vasogenic edema, which contributes significantly to the mass effect.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVasogenic edema"
      }, {
        "text": "\u003c/b\u003e is the result of a \u0027leaky\u0027 blood-brain barrier, causing fluid to pour into the brain\u0027s extracellular space, a"
      }, {
        "text": " common and significant contributor to mass effect in brain tumors and late-stage strokes.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tum"
      }, {
        "text": "or/Inflammation/Late Stroke] --\u003e B(Disruption of Blood-Brain Barrier); B --\u003e C(Leak"
      }, {
        "text": "age of Plasma Fluid \u0026 Proteins); C --\u003e D(Accumulation in Extracellular Space); D --\u003e E(Vasogenic Edema);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"aa00bdef\"\n      },\n      {\n        \"type\": \"is_caused_by_dis"
      }, {
        "text": "ruption_of\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_seen_with\",\n        \"to\": \"be057cfc\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"8e51"
      }, {
        "text": "aa24\"\n      }\n    ]\n  },\n  \"43bf4ead\": {\n    \"title\":"
      }, {
        "text": " \"Vecuronium\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      "
      }, {
        "text": "\"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eVecuronium\u003c/b\u003e is an intermediate-acting, non-depolarizing"
      }, {
        "text": " \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e of the aminosteroid class. It is used to provide skeletal muscle relaxation during"
      }, {
        "text": " surgery and mechanical ventilation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts"
      }, {
        "text": " as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing [[6a005559|acetyl"
      }, {
        "text": "choline]] from binding and causing muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-depolarizing neuromuscular blocker, similar to rocuronium and pancur"
      }, {
        "text": "onium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Primarily metabolized by the liver and excreted in bile and urine. Its duration of action can"
      }, {
        "text": " be prolonged in patients with hepatic or renal failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Unlike some other neuromuscular blockers ("
      }, {
        "text": "e.g., atracurium), it does not cause histamine release and is hemodynamically stable.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:"
      }, {
        "text": "\u003c/b\u003e The neuromuscular blockade can be reversed by [[0835ea01|acetylcholinesterase inhibitors]] (e.g., ne"
      }, {
        "text": "ostigmine) combined with an antimuscarinic (e.g., glycopyrolate), or by sug"
      }, {
        "text": "ammadex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Vecuronium and rocuronium are workhorse non-depolarizing blockers"
      }, {
        "text": " in anesthesia. Remember that their effects are reversed by increasing the amount of acetylcholine at the synapse with an acetylcholinesterase inhibitor.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eVecuronium\u003c/b\u003e is a standard non-depolarizing muscle relaxant that provides predictable"
      }, {
        "text": " paralysis for surgery by competitively blocking acetylcholine receptors, with the advantage of being hemodynamically stable.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"n"
      }, {
        "text": "ondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_reversed_by\",\n        \"to\": \"0835ea01\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_metabolized_by\",\n        \"to\": \"liver\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"66656d8b\": {\n    \"title\":"
      }, {
        "text": " \"Persistent Vegetative State\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology"
      }, {
        "text": "\",\n      \"Critical Care\",\n      \"Medical Ethics\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Coma\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003epersistent vegetative state ("
      }, {
        "text": "PVS)\u003c/b\u003e is a disorder of consciousness in which a patient with severe brain damage is in a state of partial arousal"
      }, {
        "text": " rather than true awareness. It is characterized by the return of sleep-wake cycles and autonomic functions, but a complete lack"
      }, {
        "text": " of cognitive function or awareness of the environment.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results"
      }, {
        "text": " from severe, diffuse damage to the cerebral hemispheres (cortex and white matter), with relative preservation of the brainstem and di"
      }, {
        "text": "encephalon.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients appear to be awake (eyes are open and may track objects) but are not"
      }, {
        "text": " aware. They have intact sleep-wake cycles and can breathe spontaneously. They may have primitive reflexes (e.g., start"
      }, {
        "text": "le, grasp) but show no purposeful, voluntary behaviors or evidence of language comprehension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Coma:\u003c/b\u003e In"
      }, {
        "text": " a [[d36eed18|coma]], the patient is unarousable and their eyes are closed. In P"
      }, {
        "text": "VS, the patient is arousable (has sleep-wake cycles) and their eyes are open.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferent"
      }, {
        "text": "iation from Locked-in Syndrome:\u003c/b\u003e In locked-in syndrome, the patient is fully conscious and aware but is quadri"
      }, {
        "text": "plegic and cannot speak.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrognosis:\u003c/b\u003e If the state persists for more than a few months, the"
      }, {
        "text": " chance of significant recovery is very low. The term \u0027persistent\u0027 is used after 1 month, and \u0027permanent\u0027"
      }, {
        "text": " after 3 months (anoxic injury) or 12 months (traumatic injury).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key"
      }, {
        "text": " to identifying PVS is the dissociation between arousal (awake, open eyes) and awareness (no cognitive function).\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eA \u003cb\u003epersistent vegetative state\u003c/b\u003e is a devastating outcome of severe brain injury where the \u0027"
      }, {
        "text": "wakefulness\u0027 centers of the brainstem are preserved, but the \u0027awareness\u0027 centers of the cortex are lost, leaving"
      }, {
        "text": " a patient who is \u0027awake but not aware\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_disorder_of\",\n        \"to\": \"consciousness\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"d"
      }, {
        "text": "36eed18\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n"
      }, {
        "text": "        \"to\": \"locked_in_syndrome\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "067666cd\": {\n    \"title\": \"Dural Venous Sinus Thrombosis\",\n    \"primary"
      }, {
        "text": "Type\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Hematology\",\n"
      }, {
        "text": "      \"Cerebrovascular\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eDural venous sinus thrombosis (DVST)\u003c/b\u003e, or cerebral venous thrombosis"
      }, {
        "text": ", is the formation of a blood clot in the [[21f1c955|dural venous sinuses"
      }, {
        "text": "]], which are the primary drainage channels for the brain. This obstruction of venous outflow can lead to increased intracranial pressure and venous"
      }, {
        "text": " infarction.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Thrombosis of a"
      }, {
        "text": " sinus impedes venous drainage, leading to venous congestion and increased intracranial pressure. It can also cause back-pressure in cortical"
      }, {
        "text": " veins, leading to hemorrhagic venous infarcts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Associated with \u003cmark\u003ehypercoagulable states\u003c/"
      }, {
        "text": "mark\u003e. These include inherited thrombophilias (e.g., [[514c69e0|Factor V Leiden]]),"
      }, {
        "text": " oral contraceptive use, pregnancy and the postpartum period, malignancy, and certain infections (e.g., mastoiditis, sinusitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Clinical Presentation:\u003c/b\u003e Highly variable. The most common symptom is a severe headache that can be acute or subacute. Other"
      }, {
        "text": " signs include seizures, focal neurological deficits (that may not conform to a single arterial territory), and signs of increased ICP (pap"
      }, {
        "text": "illedema).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e The imaging modality of choice is an \u003cmark\u003eMRI with magnetic resonance venography (MRV)\u003c/"
      }, {
        "text": "mark\u003e, which can directly visualize the lack of flow or the thrombus within the sinus (e.g., the \u0027empty delta"
      }, {
        "text": " sign\u0027 in the superior sagittal sinus).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e The primary treatment is anticoagulation (e.g., with heparin),"
      }, {
        "text": " even in the presence of hemorrhagic infarction, to prevent thrombus propagation and promote recanalization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Sus"
      }, {
        "text": "pect DVST in a young patient, especially a woman who is pregnant, postpartum, or on OCPs, who"
      }, {
        "text": " presents with a severe headache and/or stroke-like symptoms.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eDural"
      }, {
        "text": " venous sinus thrombosis\u003c/b\u003e is a \u0027stroke on the venous side,\u0027 where a clot in the brain\u0027s drainage system causes"
      }, {
        "text": " a pressure backup, leading to headaches, seizures, and potentially hemorrhagic infarcts, often in the setting of a hypercoagulable state.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"graph TD; A[Hypercoagulable State] --\u003e B(Throm"
      }, {
        "text": "bus in Dural Sinus); B --\u003e C(Obstruction of Venous Outflow); C --\u003e D(‚Üë"
      }, {
        "text": " Intracranial Pressure); C --\u003e E(Venous Infarction);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_thrombosis_of\",\n        \"to\": \"21f1c955\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypercoagulable"
      }, {
        "text": "_state\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\":"
      }, {
        "text": " \"514c69e0\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "diagnosed_by\",\n        \"to\": \"mr_venography\"\n      }\n    ]\n  }\n}"
      }, {
        "text": "\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"9b7ed3e2\",\n    \"letter\": \"T\",\n    \"term\": \"Tonic-clonic (grand mal) seizure\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tonic-clonic (grand mal) seizure\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e1f5066c\",\n    \"letter\": \"T\",\n    \"term\": \"Topiramate\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Topiramate\",\n    \"sub_entries\": [\n      {\n        \"id\": \"34e37a8b\",\n        \"letter\": \"T\",\n        \"term\": \"mechanism and adverse effects\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Topiramate \u003e mechanism and adverse effects\"\n      },\n      {\n        \"id\": \"63d9ea6e\",\n        \"letter\": \"T\",\n        \"term\": \"migraine headaches\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Topiramate \u003e migraine headaches\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7a598c51\",\n    \"letter\": \"T\",\n    \"term\": \"Touch\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Touch\",\n    \"sub_entries\": [\n      {\n        \"id\": \"bc4dd093\",\n        \"letter\": \"T\",\n        \"term\": \"deep static\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Touch \u003e deep static\"\n      },\n      {\n        \"id\": \"74ec8f7d\",\n        \"letter\": \"T\",\n        \"term\": \"fine/light\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Touch \u003e fine/light\"\n      }\n    ]\n  },\n  {\n    \"id\": \"79c57cfb\",\n    \"letter\": \"T\",\n    \"term\": \"TP53 gene\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"TP53 gene\",\n    \"sub_entries\": [\n      {\n        \"id\": \"69756a1d\",\n        \"letter\": \"T\",\n        \"term\": \"tPA, stroke treatment\",\n        \"pages\": [\n          \"525\"\n        ],\n        \"context\": \"TP53 gene \u003e tPA, stroke treatment\"\n      }\n    ]\n  },\n  {\n    \"id\": \"dead5320\",\n    \"letter\": \"T\",\n    \"term\": \"Tramadol\",\n    \"pages\": [\n      \"567\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tramadol\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"623ba776\",\n    \"letter\": \"T\",\n    \"term\": \"Transient ischemic attack\",\n    \"pages\": [\n      \"525\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Transient ischemic attack\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1835cfef\",\n    \"letter\": \"T\",\n    \"term\": \"Tremor\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Tremor\",\n    \"sub_entries\": [\n      {\n        \"id\": \"984f7d11\",\n        \"letter\": \"T\",\n        \"term\": \"intention\",\n        \"pages\": [\n          \"524\",\n          \"533\"\n        ],\n        \"context\": \"Tremor \u003e intention\"\n      },\n      {\n        \"id\": \"e4d86bbf\",\n        \"letter\": \"T\",\n        \"term\": \"resting\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Tremor \u003e resting\"\n      },\n      {\n        \"id\": \"ad0e4cca\",\n        \"letter\": \"T\",\n        \"term\": \"types of\",\n        \"pages\": [\n          \"533\"\n        ],\n        \"context\": \"Tremor \u003e types of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ff5777a9\",\n    \"letter\": \"T\",\n    \"term\": \"Triazolam\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Triazolam\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b79b3546\",\n    \"letter\": \"T\",\n    \"term\": \"Triceps reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Triceps reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e7bc7ac8\",\n    \"letter\": \"T\",\n    \"term\": \"Tricyclic antidepressants\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Tricyclic antidepressants\",\n    \"sub_entries\": [\n      {\n        \"id\": \"3831e234\",\n        \"letter\": \"T\",\n        \"term\": \"in multiple sclerosis treatment\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Tricyclic antidepressants \u003e in multiple sclerosis treatment\"\n      }\n    ]\n  },\n  {\n    \"id\": \"0eb45a0a\",\n    \"letter\": \"T\",\n    \"term\": \"Trigeminal nerve (CN V)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Trigeminal nerve (CN V)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"da3011f0\",\n        \"letter\": \"T\",\n        \"term\": \"functions of\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Trigeminal nerve (CN V) \u003e functions of\"\n      },\n      {\n        \"id\": \"b5c729c7\",\n        \"letter\": \"T\",\n        \"term\": \"lesion of\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Trigeminal nerve (CN V) \u003e lesion of\"\n      },\n      {\n        \"id\": \"ff1ede14\",\n        \"letter\": \"T\",\n        \"term\": \"neuralgia\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Trigeminal nerve (CN V) \u003e neuralgia\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5d7bde15\",\n    \"letter\": \"T\",\n    \"term\": \"Trihexyphenidyl\",\n    \"pages\": [\n      \"240\",\n      \"563\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Trihexyphenidyl\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"34ba2a7b\",\n    \"letter\": \"T\",\n    \"term\": \"Triptans\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Triptans\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7ae623d4\",\n        \"letter\": \"T\",\n        \"term\": \"effects\",\n        \"pages\": [\n          \"562\"\n        ],\n        \"context\": \"Triptans \u003e effects\"\n      },\n      {\n        \"id\": \"9e94bcd4\",\n        \"letter\": \"T\",\n        \"term\": \"for migraine headaches\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Triptans \u003e for migraine headaches\"\n      }\n    ]\n  },\n  {\n    \"id\": \"bba6093a\",\n    \"letter\": \"T\",\n    \"term\": \"Trochlear nerve (CN IV)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Trochlear nerve (CN IV)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e52a8344\",\n        \"letter\": \"T\",\n        \"term\": \"damage to\",\n        \"pages\": [\n          \"556\"\n        ],\n        \"context\": \"Trochlear nerve (CN IV) \u003e damage to\"\n      },\n      {\n        \"id\": \"bd5e59ba\",\n        \"letter\": \"T\",\n        \"term\": \"function and types\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Trochlear nerve (CN IV) \u003e function and types\"\n      },\n      {\n        \"id\": \"4af52a97\",\n        \"letter\": \"T\",\n        \"term\": \"ocular motility\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Trochlear nerve (CN IV) \u003e ocular motility\"\n      },\n      {\n        \"id\": \"302047a8\",\n        \"letter\": \"T\",\n        \"term\": \"palsy\",\n        \"pages\": [\n          \"558\"\n        ],\n        \"context\": \"Trochlear nerve (CN IV) \u003e palsy\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c72b32d9\",\n    \"letter\": \"T\",\n    \"term\": \"Truncal ataxia, with\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Truncal ataxia, with\",\n    \"sub_entries\": [\n      {\n        \"id\": \"166b9114\",\n        \"letter\": \"T\",\n        \"term\": \"medulloblastoma\",\n        \"pages\": [\n          \"542\"\n        ],\n        \"context\": \"Truncal ataxia, with \u003e medulloblastoma\"\n      }\n    ]\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2536
    }, {
      "text": "```json\n{\n  \"9b7ed3e2\": {\n    \"title\": \"Tonic-Clonic Seizure (Grand Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etonic-clonic seizure\u003c/b\u003e, formerly known as a grand mal seizure, is a type of [[2e7554b7|generalized seizure]] that involves a loss of consciousness and violent muscle contractions. It is the most dramatic and widely recognized type of seizure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhases:\u003c/b\u003e Characterized by two distinct phases:\u003cbr\u003e1. \u003cb\u003eTonic Phase:\u003c/b\u003e A sudden stiffening of the body, arms, and legs, causing the person to fall. The patient may cry out as air is forced out of the lungs. Lasts 10-20 seconds.\u003cbr\u003e2. \u003cb\u003eClonic Phase:\u003c/b\u003e Rhythmic, convulsive jerking of the limbs. The patient may bite their tongue or have urinary/fecal incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostictal State:\u003c/b\u003e Following the seizure, there is a period of confusion, drowsiness, headache, and muscle soreness that can last for hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be primary (idiopathic generalized epilepsy) or secondary to a focal seizure that spreads to both hemispheres (focal to bilateral tonic-clonic).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute management involves ensuring patient safety. Long-term prevention requires [[4dff096f|broad-spectrum anticonvulsants]] like [[valproic_acid|valproic acid]] or [[2341f9c0|levetiracetam]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of a postictal state is a key feature that helps distinguish a tonic-clonic seizure from syncope.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003etonic-clonic seizure\u003c/b\u003e is a global cerebral electrical storm that manifests as a dramatic sequence of body stiffening (tonic phase) followed by rhythmic convulsions (clonic phase), culminating in a prolonged postictal state of confusion and exhaustion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"2e7554b7\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"4dff096f\"\n      },\n      {\n        \"type\": \"is_followed_by\",\n        \"to\": \"postictal_state\"\n      }\n    ]\n  },\n  \"e1f5066c\": {\n    \"title\": \"Topiramate\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTopiramate\u003c/b\u003e is a broad-spectrum anticonvulsant medication with multiple mechanisms of action. It is used to treat various types of seizures and for the prophylaxis of migraine headaches.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Has several effects:\u003cbr\u003e1. Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels.\u003cbr\u003e2. Potentiates the inhibitory effect of GABA at GABA\u003csub\u003eA\u003c/sub\u003e receptors.\u003cbr\u003e3. Antagonizes glutamate receptors (AMPA/kainate).\u003cbr\u003e4. Weakly inhibits carbonic anhydrase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSeizures:\u003c/b\u003e Used for [[953ad620|focal seizures]] and primary [[2e7554b7|generalized tonic-clonic seizures]].\u003cbr\u003e - \u003cb\u003e[[c8833bae|Migraine]] Prophylaxis:\u003c/b\u003e A first-line agent for preventing migraine headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effects are somnolence, dizziness, and cognitive slowing (\u0027mental dulling\u0027 or \u0027word-finding difficulty\u0027). It can also cause weight loss and paresthesias.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSerious Adverse Effects:\u003c/b\u003e Due to its carbonic anhydrase inhibition, it can cause metabolic acidosis and increases the risk of \u003cmark\u003ecalcium phosphate kidney stones\u003c/mark\u003e. It can also precipitate acute [[9c80344d|angle-closure glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the unique side effect profile of topiramate: weight loss, cognitive slowing (\u0027dope-a-max\u0027), and kidney stones.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTopiramate\u003c/b\u003e is a multi-target anticonvulsant that is also effective for migraine prevention, but its utility is often limited by cognitive side effects and the risk of metabolic acidosis and kidney stones stemming from its carbonic anhydrase activity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"4dff096f\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_used_for_prophylaxis_of\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"kidney_stones\"\n      }\n    ]\n  },\n  \"7a598c51\": {\n    \"title\": \"Touch Sensation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTouch sensation\u003c/b\u003e (tactition) is the perception of pressure or distortion of the skin. It is mediated by various mechanoreceptors and transmitted to the brain via two distinct ascending pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFine/Light Touch:\u003c/b\u003e The ability to discriminate fine details of texture and shape (stereognosis).\u003cbr\u003e - \u003cb\u003eReceptors:\u003c/b\u003e Meissner\u0027s corpuscles (light touch, rapidly adapting), Merkel\u0027s discs (pressure, slowly adapting).\u003cbr\u003e - \u003cb\u003ePathway:\u003c/b\u003e Transmitted via the \u003cmark\u003e[[e7f5cbbe|dorsal column-medial lemniscus pathway]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCrude/Deep Static Touch:\u003c/b\u003e A non-discriminative sense of being touched or pressure.\u003cbr\u003e - \u003cb\u003eReceptors:\u003c/b\u003e Pacinian corpuscles (deep pressure/vibration), Ruffini corpuscles (stretch).\u003cbr\u003e - \u003cb\u003ePathway:\u003c/b\u003e Transmitted via the \u003cmark\u003e[[07eecef1|spinothalamic tract]]\u003c/mark\u003e (anterior portion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The dissociation of these pathways is clinically important. A lesion of the dorsal columns will impair fine touch and proprioception while leaving crude touch intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the two pathways for touch: Fine touch travels with proprioception and vibration in the dorsal columns. Crude touch travels with pain and temperature in the spinothalamic tract.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe sensation of \u003cb\u003etouch\u003c/b\u003e is not monolithic; it is divided into a high-fidelity \u0027fine touch\u0027 system that travels via the dorsal columns and a low-resolution \u0027crude touch\u0027 system that travels via the spinothalamic tract, a separation that allows for precise lesion localization.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_transmitted_by\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"is_transmitted_by\",\n        \"to\": \"07eecef1\"\n      },\n      {\n        \"type\": \"is_detected_by\",\n        \"to\": \"meissners_corpuscles\"\n      },\n      {\n        \"type\": \"is_detected_by\",\n        \"to\": \"pacinian_corpuscles\"\n      }\n    ]\n  },\n  \"79c57cfb\": {\n    \"title\": \"TP53 Gene\",\n    \"primaryType\": \"gene\",\n    \"tags\": [\n      \"Genetics\",\n      \"Oncology\",\n      \"Cell Biology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Tumor Suppressor Genes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTP53 gene\u003c/b\u003e is a critical \u003ci\u003etumor suppressor gene\u003c/i\u003e located on chromosome 17. It encodes the protein p53, often called the \\\"guardian of the genome,\\\" which plays a central role in regulating the cell cycle, initiating apoptosis, and preventing tumor formation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of p53:\u003c/b\u003e In response to DNA damage, p53 is activated and can:\u003cbr\u003e1. Halt the cell cycle at the G\u003csub\u003e1\u003c/sub\u003e/S checkpoint to allow for DNA repair.\u003cbr\u003e2. Induce [[1a804e11|apoptosis]] if the DNA damage is irreparable.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e p53 acts as a transcription factor, upregulating the expression of genes like \u003ci\u003eCDKN1A\u003c/i\u003e (which encodes p21, a cell cycle inhibitor) and pro-apoptotic genes like \u003ci\u003eBAX\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLi-Fraumeni Syndrome:\u003c/b\u003e A rare, autosomal dominant hereditary cancer syndrome caused by a germline mutation in one allele of the \u003ci\u003eTP53\u003c/i\u003e gene. It confers a very high lifetime risk of developing a wide range of malignancies, often at a young age (e.g., sarcomas, breast cancer, brain tumors, adrenocortical carcinomas).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatic Mutations:\u003c/b\u003e Somatic mutations in \u003ci\u003eTP53\u003c/i\u003e are the most common genetic alterations found in human cancers, occurring in over 50% of all tumors.\u003c/li\u003e\u003cli\u003e\u003cb\u003etPA (Tissue Plasminogen Activator):\u003c/b\u003e A thrombolytic drug used for [[c5da3c57|ischemic stroke]] treatment. It is \u003cu\u003enot related\u003c/u\u003e to the TP53 gene. The index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of p53 function is a key step in the development of most cancers. Remember its role as the \u0027guardian of the genome\u0027 that either pauses the cell cycle for repair or triggers cell suicide.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTP53 gene\u003c/b\u003e is the master regulator of cell cycle control and apoptosis; its inactivation removes the primary safeguard against genomic instability, paving the way for malignant transformation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[DNA Damage] --\u003e B(‚Üë p53); B --\u003e C(Cell Cycle Arrest - G1/S); B --\u003e D(Apoptosis); E[TP53 Mutation] --x B; E --\u003e F(Uncontrolled Cell Proliferation); F --\u003e G(Cancer);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a\",\n        \"to\": \"tumor_suppressor_gene\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"cell_cycle\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"1a804e11\"\n      },\n      {\n        \"type\": \"mutation_causes\",\n        \"to\": \"li_fraumeni_syndrome\"\n      }\n    ]\n  },\n  \"dead5320\": {\n    \"title\": \"Tramadol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTramadol\u003c/b\u003e is a centrally acting synthetic analgesic with a dual mechanism of action. It is used for the management of moderate to moderately severe pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e1. A very weak agonist at Œº-opioid receptors.\u003cbr\u003e2. Inhibits the reuptake of \u003cmark\u003eserotonin and norepinephrine\u003c/mark\u003e, which modulates pain pathways in the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for moderate pain when non-opioid analgesics are insufficient.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Similar to opioids, it can cause sedation, dizziness, nausea, and constipation. A major risk is that it \u003cmark\u003elowers the seizure threshold\u003c/mark\u003e and is contraindicated in patients with epilepsy or other seizure risk factors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSerotonin Syndrome:\u003c/b\u003e Due to its effect on serotonin reuptake, it can cause \u003cmark\u003eserotonin syndrome\u003c/mark\u003e when co-administered with other serotonergic drugs (e.g., SSRIs, MAOIs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the dual mechanism of tramadol. Its opioid effect is weak, but its inhibition of serotonin/norepinephrine reuptake contributes significantly to its analgesia and also to its unique side effect profile (seizures, serotonin syndrome).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTramadol\u003c/b\u003e is a unique analgesic that combines weak opioid activity with the properties of an SNRI antidepressant, but this dual action carries the distinct risks of lowering the seizure threshold and precipitating serotonin syndrome.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"analgesic\"\n      },\n      {\n        \"type\": \"acts_as\",\n        \"to\": \"weak_mu_opioid_agonist\"\n      },\n      {\n        \"type\": \"inhibits_reuptake_of\",\n        \"to\": \"serotonin\"\n      },\n      {\n        \"type\": \"inhibits_reuptake_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"lowers\",\n        \"to\": \"seizure_threshold\"\n      }\n    ]\n  },\n  \"623ba776\": {\n    \"title\": \"Transient Ischemic Attack (TIA)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cerebrovascular\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eTransient Ischemic Attack (TIA)\u003c/b\u003e is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, \u003cu\u003ewithout\u003c/u\u003e acute infarction. It is often referred to as a \\\"mini-stroke.\\\"\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDefinition:\u003c/b\u003e Traditionally defined as symptoms resolving within 24 hours. The modern, tissue-based definition is a transient episode of neurologic dysfunction without evidence of acute infarction on brain imaging (e.g., diffusion-weighted MRI).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The causes are the same as for [[c5da3c57|ischemic stroke]]: thrombosis, embolism (cardiac or artery-to-artery), or stenosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of focal neurological deficits that are temporary. A classic example is \u003cmark\u003e[[f0aac1c3|amaurosis fugax]]\u003c/mark\u003e (transient monocular blindness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A TIA is a major warning sign of an impending [[c5da3c57|stroke]]. The risk of stroke is highest in the first few days after a TIA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e Patients with a TIA require urgent evaluation to determine the cause and initiate secondary prevention strategies. This includes brain imaging, carotid imaging, and cardiac evaluation. Treatment involves antiplatelet therapy (e.g., [[09db7b12|aspirin]], [[22372d48|clopidogrel]]), statins, and management of vascular risk factors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Treat a TIA with the same urgency as a stroke. The goal is to prevent a future, permanent stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eTransient Ischemic Attack\u003c/b\u003e is a \u0027warning stroke\u0027 where neurological symptoms are temporary because blood flow is quickly restored, but it signals a high, imminent risk of a permanent stroke and necessitates immediate medical evaluation and preventive therapy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_warning_sign_for\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_a_form_of\",\n        \"to\": \"cerebral_ischemia\"\n      },\n      {\n        \"type\": \"can_present_as\",\n        \"to\": \"f0aac1c3\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \"to\": \"09db7b12\"\n      }\n    ]\n  },\n  \"1835cfef\": {\n    \"title\": \"Tremor\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etremor\u003c/b\u003e is an involuntary, rhythmic, oscillatory movement of a body part. It is classified based on its characteristics, particularly whether it occurs at rest or during action.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eResting Tremor:\u003c/b\u003e Occurs when the muscle is relaxed and supported against gravity. It is suppressed by voluntary movement. The classic example is the \u003cmark\u003e\\\"pill-rolling\\\" tremor\u003c/mark\u003e of [[58c8ea03|Parkinson disease]], caused by a lesion in the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostural Tremor:\u003c/b\u003e Occurs when holding a position against gravity (e.g., holding arms outstretched). The most common type is [[40039e56|essential tremor]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntention (Action) Tremor:\u003c/b\u003e Occurs during a purposeful, goal-directed movement and worsens as the target is approached. It is a sign of \u003cmark\u003ecerebellar dysfunction\u003c/mark\u003e (e.g., lesion of the cerebellar hemisphere or [[c819d97b|dentate nucleus]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAsterixis:\u003c/b\u003e Not a true tremor, but a negative myoclonus (\u0027flapping tremor\u0027) seen in metabolic encephalopathies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The timing of the tremor is the key to the diagnosis: At rest? Think Parkinson\u0027s. With action/posture? Think essential tremor. As you approach a target? Think cerebellum.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical classification of \u003cb\u003etremor\u003c/b\u003e‚Äîwhether it manifests at rest, with posture, or with intention‚Äîis a powerful diagnostic tool that points to distinct underlying pathologies in the basal ganglia, cerebellum, or other motor systems.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"9a9c9169\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"resting_tremor\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"intention_tremor\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"40039e56\"\n      }\n    ]\n  },\n  \"ff5777a9\": {\n    \"title\": \"Triazolam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTriazolam\u003c/b\u003e is a very short-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used for the short-term treatment of insomnia, particularly sleep-onset insomnia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A positive allosteric modulator of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It has a very rapid onset and a very short half-life (2-3 hours). Mnemonic for short-acting benzodiazepines: \u003cb\u003eATOM\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003elprazolam, \u003cb\u003eT\u003c/b\u003eriazolam, \u003cb\u003eO\u003c/b\u003exazepam, \u003cb\u003eM\u003c/b\u003eidazolam).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily for sleep-onset insomnia. Its short duration minimizes next-day \u0027hangover\u0027 effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Higher risk of anterograde amnesia and rebound insomnia upon discontinuation compared to longer-acting agents. High abuse potential due to its rapid onset and short duration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Triazolam is a good choice for a patient who has trouble falling asleep but not staying asleep. Its short half-life is its defining feature.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTriazolam\u003c/b\u003e is a fast-on, fast-off benzodiazepine hypnotic, ideal for initiating sleep but with a higher risk of rebound insomnia and dependence due to its short duration of action.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_on\",\n        \"to\": \"gaba_a_receptor\"\n      }\n    ]\n  },\n  \"b79b3546\": {\n    \"title\": \"Triceps Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTriceps reflex\u003c/b\u003e is a deep tendon reflex that causes extension of the elbow when the triceps brachii tendon is tapped. It is used to test the integrity of the \u003cmark\u003eC7 and C8\u003c/mark\u003e spinal nerve roots and the radial nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNerve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC7\u003c/b\u003e nerve root, with a contribution from C6 and C8. Mnemonic: C6, \u003cb\u003e7\u003c/b\u003e, 8, lay them straight.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the triceps tendon stretches the muscle. The afferent signal travels via the radial nerve to the C7/C8 spinal cord segments, synapses, and an efferent signal returns via the radial nerve to cause contraction of the triceps muscle and elbow extension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiminished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C7 root or a peripheral neuropathy affecting the radial nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the C7 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triceps reflex, along with sensation over the middle finger and strength of wrist flexion/finger extension, is a key part of the C7 neurological exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTriceps reflex\u003c/b\u003e is a standard part of the neurological exam that specifically assesses the C7 nerve root, providing a quick check on the integrity of the lower cervical spinal cord and the radial nerve.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Triceps Tendon] --\u003e B(Stretch Triceps Muscle); B --\u003e C(Afferent Signal via Radial N.); C --\u003e D[C7/C8 Spinal Cord]; D --\u003e E(Efferent Signal via Radial N.); E --\u003e F(Triceps Contraction/Elbow Extension);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c7_nerve_root\"\n      },\n      {\n        \"type\": \"tests_nerve_root\",\n        \"to\": \"c8_nerve_root\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"e7bc7ac8\": {\n    \"title\": \"Tricyclic Antidepressants (TCAs)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTricyclic antidepressants (TCAs)\u003c/b\u003e are a class of medications primarily used to treat depression, though their use has declined due to a significant side effect profile and the availability of safer alternatives. They are also used for neuropathic pain, migraine prophylaxis, and OCD.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Block the reuptake of \u003cmark\u003enorepinephrine (NE) and serotonin (5-HT)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Their side effects are due to blockade of multiple other receptors:\u003cbr\u003e - \u003cb\u003eAnticholinergic (muscarinic):\u003c/b\u003e Dry mouth, constipation, urinary retention, blurred vision, confusion.\u003cbr\u003e - \u003cb\u003eAntihistaminic (H\u003csub\u003e1\u003c/sub\u003e):\u003c/b\u003e Sedation, weight gain.\u003cbr\u003e - \u003cb\u003eAnti-adrenergic (Œ±\u003csub\u003e1\u003c/sub\u003e):\u003c/b\u003e Orthostatic hypotension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOverdose (Tri-C\u0027s):\u003c/b\u003e TCA overdose is life-threatening. Remember the Tri-C\u0027s: \u003cb\u003eC\u003c/b\u003eonvulsions, \u003cb\u003eC\u003c/b\u003eoma, \u003cb\u003eC\u003c/b\u003eardiotoxicity. Cardiotoxicity (QRS widening, ventricular arrhythmias) is due to Na\u003csup\u003e+\u003c/sup\u003e channel blockade and is the most common cause of death. Treat with sodium bicarbonate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Use:\u003c/b\u003e Tertiary amines like [[c6814506|amitriptyline]] are used for chronic neuropathic pain and migraine prophylaxis. Clomipramine is used for OCD. Some TCAs are used to treat pain in [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The wide range of receptor blockade explains the extensive side effect profile of TCAs. Cardiotoxicity in overdose is a critical, high-yield concept.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTricyclic antidepressants\u003c/b\u003e are \u0027dirty\u0027 drugs that, in addition to their therapeutic effect of blocking serotonin and norepinephrine reuptake, also block muscarinic, histaminic, and adrenergic receptors, leading to a broad and problematic side effect profile, especially life-threatening cardiotoxicity in overdose.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"inhibits_reuptake_of\",\n        \"to\": \"serotonin\"\n      },\n      {\n        \"type\": \"inhibits_reuptake_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"9a0f5ba6\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      }\n    ]\n  },\n  \"0eb45a0a\": {\n    \"title\": \"Trigeminal Nerve (CN V)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cranial Nerves\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTrigeminal Nerve (CN V)\u003c/b\u003e is the largest cranial nerve and is a mixed nerve, containing both sensory and motor fibers. It is the principal sensory nerve for the face and provides motor innervation to the muscles of mastication.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction Type:\u003c/b\u003e Both sensory and motor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThree Divisions:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eOphthalmic (V\u003csub\u003e1\u003c/sub\u003e):\u003c/b\u003e Sensory. Supplies the forehead, scalp, cornea, and upper eyelid.\u003cbr\u003e2. \u003cb\u003eMaxillary (V\u003csub\u003e2\u003c/sub\u003e):\u003c/b\u003e Sensory. Supplies the midface, lower eyelid, upper lip, and upper teeth.\u003cbr\u003e3. \u003cb\u003eMandibular (V\u003csub\u003e3\u003c/sub\u003e):\u003c/b\u003e Both sensory and motor. Provides sensation to the lower face, lower lip, lower teeth, and anterior two-thirds of the tongue (general sensation, not taste). Provides motor innervation to the \u003cmark\u003emuscles of mastication\u003c/mark\u003e (masseter, temporalis, pterygoids).\u003c/li\u003e\u003cli\u003e\u003cb\u003eReflexes:\u003c/b\u003e The afferent limb of the [[64663383|corneal reflex]] is carried by V\u003csub\u003e1\u003c/sub\u003e. The afferent and efferent limbs of the jaw jerk reflex are carried by V\u003csub\u003e3\u003c/sub\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e A lesion of CN V can cause facial numbness, weakness in chewing, and deviation of the jaw toward the side of the lesion upon opening.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTrigeminal Neuralgia:\u003c/b\u003e A condition characterized by recurrent, severe, lancinating pain in the distribution of one or more branches of CN V. Treated with [[eddd2bc5|carbamazepine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember V\u003csub\u003e3\u003c/sub\u003e is the only division with motor fibers (\u0027M\u0027 for Mandibular and Motor).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTrigeminal Nerve\u003c/b\u003e is the great sensory nerve of the face, with its three divisions mapping out distinct facial territories, and it also provides the crucial motor power for chewing via its mandibular branch.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Nerve - CN V]; A --\u003e B(V1 - Ophthalmic - Sensory); A --\u003e C(V2 - Maxillary - Sensory); A --\u003e D(V3 - Mandibular - Sensory \u0026 Motor); D --\u003e E(Muscles of Mastication);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_afferent_limb_of\",\n        \"to\": \"64663383\"\n      },\n      {\n        \"type\": \"innervates\",\n        \"to\": \"muscles_of_mastication\"\n      },\n      {\n        \"type\": \"pathology_causes\",\n        \"to\": \"trigeminal_neuralgia\"\n      }\n    ]\n  },\n  \"5d7bde15\": {\n    \"title\": \"Trihexyphenidyl\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTrihexyphenidyl\u003c/b\u003e is a centrally acting \u003ci\u003eantimuscarinic (anticholinergic) drug\u003c/i\u003e used to treat the symptoms of [[58c8ea03|Parkinson disease]] and drug-induced extrapyramidal symptoms.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at central muscarinic receptors, helping to restore the dopaminergic-cholinergic balance in the [[ed462927|basal ganglia]] that is disrupted in Parkinson\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Primarily effective for treating \u003cmark\u003etremor and rigidity\u003c/mark\u003e. It has little effect on bradykinesia. Often used in younger patients where tremor is the predominant symptom. Mnemonic: \u0027\u003cb\u003eTri\u003c/b\u003e to \u003cb\u003ePark\u003c/b\u003e my Mercedes-\u003cb\u003eBenz\u003c/b\u003e\u0027 (\u003cb\u003eTri\u003c/b\u003ehexyphenidyl and [[383f6fbe|Benztropine]] for \u003cb\u003ePark\u003c/b\u003einson\u0027s).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (EPS):\u003c/b\u003e Can be used to treat drug-induced parkinsonism and dystonia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Classic anticholinergic side effects: dry mouth, blurred vision, constipation, urinary retention, tachycardia, and confusion/delirium, especially in the elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Trihexyphenidyl and benztropine are the two main anticholinergics used for Parkinson\u0027s. They are most useful for tremor in younger patients.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTrihexyphenidyl\u003c/b\u003e is an anticholinergic agent that helps manage Parkinson\u0027s disease by reducing the relative overactivity of acetylcholine in the dopamine-depleted basal ganglia, thereby improving tremor and rigidity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"96e8bf39\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"extrapyramidal_symptoms\"\n      }\n    ]\n  },\n  \"34ba2a7b\": {\n    \"title\": \"Triptans\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTriptans\u003c/b\u003e (e.g., sumatriptan) are a class of drugs that are serotonin 5-HT\u003csub\u003e1B/1D\u003c/sub\u003e receptor agonists. They are a first-line therapy for the acute (abortive) treatment of moderate to severe [[c8833bae|migraine headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e1. Agonism at 5-HT\u003csub\u003e1B\u003c/sub\u003e receptors on cranial blood vessels causes \u003cmark\u003evasoconstriction\u003c/mark\u003e.\u003cbr\u003e2. Agonism at presynaptic 5-HT\u003csub\u003e1D\u003c/sub\u003e receptors on trigeminal nerve endings \u003cmark\u003einhibits the release of vasoactive neuropeptides\u003c/mark\u003e like CGRP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Acute treatment of [[c8833bae|migraines]] and [[21760f80|cluster headaches]]. They are \u003cu\u003enot\u003c/u\u003e used for prophylaxis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Tingling, paresthesias, dizziness, and a sensation of chest tightness or pressure (\u0027triptan sensations\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Due to their vasoconstrictive effects, they are contraindicated in patients with a history of \u003cmark\u003ecoronary artery disease\u003c/mark\u003e, uncontrolled hypertension, or stroke. They should not be used with ergotamines or within 2 weeks of MAOI use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Triptans are the go-to abortive therapy for migraines. Remember their 5-HT\u003csub\u003e1B/1D\u003c/sub\u003e agonist mechanism and their major contraindication in patients with cardiovascular disease due to the risk of [[dd3c9b1b|coronary vasospasm]].\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTriptans\u003c/b\u003e abort migraine attacks through a dual mechanism of constricting painfully dilated cranial vessels and inhibiting the release of inflammatory neuropeptides from the trigeminal nerve, but their vasoconstrictive nature makes them risky in patients with vascular disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Triptan] --\u003e B(5-HT1B/1D Agonist); B --\u003e C(Cranial Vasoconstriction); B --\u003e D(‚Üì CGRP Release); C \u0026 D --\u003e E(Migraine Relief);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"21760f80\"\n      },\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"serotonin_receptor\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"dd3c9b1b\"\n      }\n    ]\n  },\n  \"bba6093a\": {\n    \"title\": \"Trochlear Nerve (CN IV)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cranial Nerves\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTrochlear Nerve (CN IV)\u003c/b\u003e is a motor cranial nerve that provides innervation to a single extraocular muscle, the superior oblique. It is unique among cranial nerves in that it is the only one to exit from the dorsal aspect of the brainstem and to decussate completely.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Innervates the contralateral \u003cmark\u003esuperior oblique muscle\u003c/mark\u003e. The primary actions of this muscle are intorsion (internal rotation) and depression of the eyeball, especially when the eye is adducted.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Emerges from the dorsal midbrain, decussates, and then travels anteriorly to enter the orbit via the superior orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy:\u003c/b\u003e A lesion of the CN IV nucleus or nerve causes a \u003cmark\u003e[[de532715|trochlear nerve palsy]]\u003c/mark\u003e. Due to the decussation, a lesion of the nucleus affects the contralateral eye, while a lesion of the nerve after it has decussated affects the ipsilateral eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e The affected eye is hypertropic (elevated) and extorted. Patients present with vertical [[9914d433|diplopia]] that is worse when looking down and in (e.g., reading). They classically compensate by tilting their head \u003cu\u003eaway\u003c/u\u003e from the side of the palsied eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e: \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique is innervated by CN \u003cb\u003eIV\u003c/b\u003e. A patient with a head tilt and difficulty walking down stairs is a classic presentation for a CN IV palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTrochlear Nerve\u003c/b\u003e is the unique, crossed nerve for the superior oblique muscle; its paralysis leads to a characteristic vertical diplopia and a compensatory head tilt away from the affected eye.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"superior_oblique_muscle\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"de532715\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"709aa7c2\"\n      }\n    ]\n  },\n  \"c72b32d9\": {\n    \"title\": \"Truncal Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebellar Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTruncal ataxia\u003c/b\u003e is a type of [[9767fd6b|ataxia]] characterized by instability of the trunk, leading to a wide-based, unsteady gait and difficulty sitting or standing without support. It is a hallmark of midline cerebellar disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Caused by a lesion in the \u003cmark\u003ecerebellar vermis\u003c/mark\u003e or the [[644b8e4d|fastigial nucleus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients have a wide-based, lurching gait often described as a \u0027drunken sailor\u0027 gait. They may sway or fall when sitting or standing still, even with their eyes open.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRomberg Test:\u003c/b\u003e The Romberg test is typically negative, as the instability is present with both eyes open and closed (distinguishing it from sensory ataxia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e\u003cbr\u003e - In children, the most common cause is a \u003cmark\u003e[[16d613bb|medulloblastoma]]\u003c/mark\u003e located in the vermis.\u003cbr\u003e - In adults, the most common cause is cerebellar degeneration secondary to \u003cmark\u003echronic alcohol use disorder\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate truncal ataxia from limb ataxia. Truncal ataxia (midline lesion) affects gait and posture. Limb ataxia (hemispheric lesion) affects coordinated movements of the extremities, like the finger-to-nose test.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTruncal ataxia\u003c/b\u003e is a profound instability of the body\u0027s core, resulting from damage to the cerebellar vermis, which manifests as a characteristic wide-based, staggering gait independent of visual input.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"9767fd6b\"\n      },\n      {\n        \"type\": \"is_caused_by_lesion_in\",\n        \"to\": \"6e31977d\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"chronic_alcohol_use\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9889,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"9b7ed3e2\": {\n    \"title"
      }, {
        "text": "\": \"Tonic-Clonic Seizure (Grand Mal)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etonic-clonic seizure\u003c/b\u003e"
      }, {
        "text": ", formerly known as a grand mal seizure, is a type of [[2e7554b7|generalized seizure]]"
      }, {
        "text": " that involves a loss of consciousness and violent muscle contractions. It is the most dramatic and widely recognized type of seizure.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhases:\u003c/b\u003e Characterized by two distinct phases:\u003cbr\u003e1"
      }, {
        "text": ". \u003cb\u003eTonic Phase:\u003c/b\u003e A sudden stiffening of the body, arms, and legs, causing the person to fall."
      }, {
        "text": " The patient may cry out as air is forced out of the lungs. Lasts 10-20 seconds.\u003cbr\u003e2. \u003cb\u003eCl"
      }, {
        "text": "onic Phase:\u003c/b\u003e Rhythmic, convulsive jerking of the limbs. The patient may bite their tongue or have urinary"
      }, {
        "text": "/fecal incontinence.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostictal State:\u003c/b\u003e Following the seizure, there is a period of confusion, drowsiness"
      }, {
        "text": ", headache, and muscle soreness that can last for hours.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Can be primary (idi"
      }, {
        "text": "opathic generalized epilepsy) or secondary to a focal seizure that spreads to both hemispheres (focal to bilateral tonic-clonic).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Acute management involves ensuring patient safety. Long-term prevention requires [[4dff096"
      }, {
        "text": "f|broad-spectrum anticonvulsants]] like [[valproic_acid|valproic acid]] or"
      }, {
        "text": " [[2341f9c0|levetiracetam]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " presence of a postictal state is a key feature that helps distinguish a tonic-clonic seizure from syncope.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003etonic-clonic seizure\u003c/b\u003e is a global cerebral electrical"
      }, {
        "text": " storm that manifests as a dramatic sequence of body stiffening (tonic phase) followed by rhythmic convulsions (clonic phase),"
      }, {
        "text": " culminating in a prolonged postictal state of confusion and exhaustion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"2e75"
      }, {
        "text": "54b7\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\":"
      }, {
        "text": " \"4dff096f\"\n      },\n      {\n        \"type\": \"is_followed"
      }, {
        "text": "_by\",\n        \"to\": \"postictal_state\"\n      }\n    ]\n  },\n  \"e"
      }, {
        "text": "1f5066c\": {\n    \"title\": \"Topiramate\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Ant"
      }, {
        "text": "iconvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTopiramate\u003c/b\u003e is a broad"
      }, {
        "text": "-spectrum anticonvulsant medication with multiple mechanisms of action. It is used to treat various types of seizures and for"
      }, {
        "text": " the prophylaxis of migraine headaches.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Has"
      }, {
        "text": " several effects:\u003cbr\u003e1. Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels.\u003cbr\u003e2. Potentiates the"
      }, {
        "text": " inhibitory effect of GABA at GABA\u003csub\u003eA\u003c/sub\u003e receptors.\u003cbr\u003e3. Antagonizes glutamate receptors (AMPA/"
      }, {
        "text": "kainate).\u003cbr\u003e4. Weakly inhibits carbonic anhydrase.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eSeizures:\u003c/b\u003e Used for [[953ad620|focal seizures]] and"
      }, {
        "text": " primary [[2e7554b7|generalized tonic-clonic seizures]].\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "c8833bae|Migraine]] Prophylaxis:\u003c/b\u003e A first-line agent for preventing migraine headaches.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e The most common side effects are somnolence, dizziness, and cognitive slowing (\u0027mental dulling\u0027 or \u0027word-"
      }, {
        "text": "finding difficulty\u0027). It can also cause weight loss and paresthesias.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSerious Adverse Effects:\u003c/b\u003e Due to its"
      }, {
        "text": " carbonic anhydrase inhibition, it can cause metabolic acidosis and increases the risk of \u003cmark\u003ecalcium phosphate kidney stones\u003c/"
      }, {
        "text": "mark\u003e. It can also precipitate acute [[9c80344d|angle-closure glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Remember the unique side effect profile of topiramate: weight loss, cognitive slowing (\u0027dope-a-max\u0027), and kidney"
      }, {
        "text": " stones.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTopiramate\u003c/b\u003e is a multi-target"
      }, {
        "text": " anticonvulsant that is also effective for migraine prevention, but its utility is often limited by cognitive side effects and the risk of metabolic"
      }, {
        "text": " acidosis and kidney stones stemming from its carbonic anhydrase activity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"4dff096f\"\n      },\n      {\n        \"type\": \"treats\","
      }, {
        "text": "\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "used_for_prophylaxis_of\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"causes_adverse_effect\",\n        \"to\": \"kidney_stones\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"7a598c51\": {\n    \"title\": \"Touch"
      }, {
        "text": " Sensation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eTouch sensation\u003c/b\u003e (tactition) is the perception of pressure or distortion of the skin. It is mediated by various mechan"
      }, {
        "text": "oreceptors and transmitted to the brain via two distinct ascending pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFine/"
      }, {
        "text": "Light Touch:\u003c/b\u003e The ability to discriminate fine details of texture and shape (stereognosis).\u003cbr\u003e - \u003cb\u003eRe"
      }, {
        "text": "ceptors:\u003c/b\u003e Meissner\u0027s corpuscles (light touch, rapidly adapting), Merkel\u0027s discs (pressure, slowly"
      }, {
        "text": " adapting).\u003cbr\u003e - \u003cb\u003ePathway:\u003c/b\u003e Transmitted via the \u003cmark\u003e[[e7f5cb"
      }, {
        "text": "be|dorsal column-medial lemniscus pathway]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCrude/Deep Static"
      }, {
        "text": " Touch:\u003c/b\u003e A non-discriminative sense of being touched or pressure.\u003cbr\u003e - \u003cb\u003eReceptors:\u003c/b\u003e Pac"
      }, {
        "text": "inian corpuscles (deep pressure/vibration), Ruffini corpuscles (stretch).\u003cbr\u003e - \u003cb\u003ePathway:"
      }, {
        "text": "\u003c/b\u003e Transmitted via the \u003cmark\u003e[[07eecef1|spinothalamic tract]]\u003c/mark\u003e"
      }, {
        "text": " (anterior portion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e The dissociation of these pathways is clinically important. A lesion of the dorsal"
      }, {
        "text": " columns will impair fine touch and proprioception while leaving crude touch intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the"
      }, {
        "text": " two pathways for touch: Fine touch travels with proprioception and vibration in the dorsal columns. Crude touch travels with pain and temperature in the spin"
      }, {
        "text": "othalamic tract.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe sensation of \u003cb\u003etouch\u003c/b\u003e is not"
      }, {
        "text": " monolithic; it is divided into a high-fidelity \u0027fine touch\u0027 system that travels via the dorsal columns and a low"
      }, {
        "text": "-resolution \u0027crude touch\u0027 system that travels via the spinothalamic tract, a separation that allows for precise lesion"
      }, {
        "text": " localization.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_transmitted"
      }, {
        "text": "_by\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_transmitted_by\",\n        \"to\": \"07eecef1\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_detected_by\",\n        \"to\": \"meiss"
      }, {
        "text": "ners_corpuscles\"\n      },\n      {\n        \"type\": \"is_detected_by\",\n"
      }, {
        "text": "        \"to\": \"pacinian_corpuscles\"\n      }\n    ]\n  },\n  \"7"
      }, {
        "text": "9c57cfb\": {\n    \"title\": \"TP53 Gene\",\n    \"primaryType\": \"gene"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Genetics\",\n      \"Oncology\",\n      \"Cell Biology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Hematology and Oncology\",\n      \"Pathology\",\n      \"Tum"
      }, {
        "text": "or Suppressor Genes\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTP53 gene\u003c/b\u003e is"
      }, {
        "text": " a critical \u003ci\u003etumor suppressor gene\u003c/i\u003e located on chromosome 17. It encodes the protein p53, often"
      }, {
        "text": " called the \\\"guardian of the genome,\\\" which plays a central role in regulating the cell cycle, initiating apoptosis, and preventing"
      }, {
        "text": " tumor formation.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of p53:\u003c/b\u003e In"
      }, {
        "text": " response to DNA damage, p53 is activated and can:\u003cbr\u003e1. Halt the cell cycle at the G\u003csub\u003e"
      }, {
        "text": "1\u003c/sub\u003e/S checkpoint to allow for DNA repair.\u003cbr\u003e2. Induce [[1a804e1"
      }, {
        "text": "1|apoptosis]] if the DNA damage is irreparable.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e p53 acts as a"
      }, {
        "text": " transcription factor, upregulating the expression of genes like \u003ci\u003eCDKN1A\u003c/i\u003e (which encodes p21, a"
      }, {
        "text": " cell cycle inhibitor) and pro-apoptotic genes like \u003ci\u003eBAX\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLi-Fraumeni"
      }, {
        "text": " Syndrome:\u003c/b\u003e A rare, autosomal dominant hereditary cancer syndrome caused by a germline mutation in one allele of the \u003ci\u003eTP53\u003c/i\u003e"
      }, {
        "text": " gene. It confers a very high lifetime risk of developing a wide range of malignancies, often at a young age (e.g"
      }, {
        "text": "., sarcomas, breast cancer, brain tumors, adrenocortical carcinomas).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatic Mutations:\u003c/b\u003e Som"
      }, {
        "text": "atic mutations in \u003ci\u003eTP53\u003c/i\u003e are the most common genetic alterations found in human cancers, occurring in over 50% of all tumors"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003etPA (Tissue Plasminogen Activator):\u003c/b\u003e A thrombolytic drug used for [[c"
      }, {
        "text": "5da3c57|ischemic stroke]] treatment. It is \u003cu\u003enot related\u003c/u\u003e to the TP53 gene. The"
      }, {
        "text": " index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of p53 function is a key"
      }, {
        "text": " step in the development of most cancers. Remember its role as the \u0027guardian of the genome\u0027 that either pauses the cell cycle for"
      }, {
        "text": " repair or triggers cell suicide.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTP53 gene\u003c/b\u003e is"
      }, {
        "text": " the master regulator of cell cycle control and apoptosis; its inactivation removes the primary safeguard against genomic instability, paving the way for malignant"
      }, {
        "text": " transformation.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[DNA Damage] --\u003e B(‚Üë p53);"
      }, {
        "text": " B --\u003e C(Cell Cycle Arrest - G1/S); B --\u003e D(Apoptosis); E[TP53 Mutation] --"
      }, {
        "text": "x B; E --\u003e F(Uncontrolled Cell Proliferation); F --\u003e G(Cancer);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a\",\n        \"to\": \"tumor_"
      }, {
        "text": "suppressor_gene\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"cell_"
      }, {
        "text": "cycle\"\n      },\n      {\n        \"type\": \"induces\",\n        \"to\": \"1"
      }, {
        "text": "a804e11\"\n      },\n      {\n        \"type\": \"mutation_causes\",\n        \"to\": \"li"
      }, {
        "text": "_fraumeni_syndrome\"\n      }\n    ]\n  },\n  \"dead5320\": {\n    \""
      }, {
        "text": "title\": \"Tramadol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pharmacology\",\n      \"Analgesics\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTramadol\u003c/b\u003e is a centrally acting synthetic analgesic with a"
      }, {
        "text": " dual mechanism of action. It is used for the management of moderate to moderately severe pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Mechanism of Action:\u003c/b\u003e\u003cbr\u003e1. A very weak agonist at Œº-opioid receptors.\u003cbr\u003e2. Inhib"
      }, {
        "text": "its the reuptake of \u003cmark\u003eserotonin and norepinephrine\u003c/mark\u003e, which modulates pain pathways in the spinal"
      }, {
        "text": " cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for moderate pain when non-opioid analgesics are insufficient.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e"
      }, {
        "text": " Similar to opioids, it can cause sedation, dizziness, nausea, and constipation. A major risk is that it \u003cmark\u003elow"
      }, {
        "text": "ers the seizure threshold\u003c/mark\u003e and is contraindicated in patients with epilepsy or other seizure risk factors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSer"
      }, {
        "text": "otonin Syndrome:\u003c/b\u003e Due to its effect on serotonin reuptake, it can cause \u003cmark\u003eserotonin syndrome\u003c/"
      }, {
        "text": "mark\u003e when co-administered with other serotonergic drugs (e.g., SSRIs, MAOIs).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the dual mechanism of tramadol. Its opioid effect is weak, but its inhibition of serotonin/"
      }, {
        "text": "norepinephrine reuptake contributes significantly to its analgesia and also to its unique side effect profile (seizures, serotonin"
      }, {
        "text": " syndrome).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTramadol\u003c/b\u003e is a unique analgesic that combines"
      }, {
        "text": " weak opioid activity with the properties of an SNRI antidepressant, but this dual action carries the distinct risks of lowering the seizure threshold and precipitating serotonin syndrome"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"analgesic\"\n      },\n      {\n        \"type\": \"acts"
      }, {
        "text": "_as\",\n        \"to\": \"weak_mu_opioid_agonist\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"inhibits_reuptake_of\",\n        \"to\": \"serotonin\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"inhibits_reuptake_of\",\n        \""
      }, {
        "text": "to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"lowers\",\n        \"to\": \"seizure"
      }, {
        "text": "_threshold\"\n      }\n    ]\n  },\n  \"623ba776\": {\n    \"title\":"
      }, {
        "text": " \"Transient Ischemic Attack (TIA)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Cerebrovascular\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eTransient Ischemic Attack (TIA)\u003c/b\u003e is"
      }, {
        "text": " a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, \u003cu\u003ewithout\u003c/u\u003e acute infarction. It is often"
      }, {
        "text": " referred to as a \\\"mini-stroke.\\\"\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDefinition"
      }, {
        "text": ":\u003c/b\u003e Traditionally defined as symptoms resolving within 24 hours. The modern, tissue-based definition is a transient episode of neurologic"
      }, {
        "text": " dysfunction without evidence of acute infarction on brain imaging (e.g., diffusion-weighted MRI).\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The"
      }, {
        "text": " causes are the same as for [[c5da3c57|ischemic stroke]]: thrombosis, embolism (card"
      }, {
        "text": "iac or artery-to-artery), or stenosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden onset of focal neurological deficits that are"
      }, {
        "text": " temporary. A classic example is \u003cmark\u003e[[f0aac1c3|amaurosis fugax]]\u003c/mark\u003e"
      }, {
        "text": " (transient monocular blindness).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e A TIA is a major warning sign of an impending [["
      }, {
        "text": "c5da3c57|stroke]]. The risk of stroke is highest in the first few days after a TIA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement"
      }, {
        "text": ":\u003c/b\u003e Patients with a TIA require urgent evaluation to determine the cause and initiate secondary prevention strategies. This includes brain imaging,"
      }, {
        "text": " carotid imaging, and cardiac evaluation. Treatment involves antiplatelet therapy (e.g., [[09db7b"
      }, {
        "text": "12|aspirin]], [[22372d48|clopidogrel]]), statins"
      }, {
        "text": ", and management of vascular risk factors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Treat a TIA with the same urgency as a stroke. The"
      }, {
        "text": " goal is to prevent a future, permanent stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA "
      }, {
        "text": "\u003cb\u003eTransient Ischemic Attack\u003c/b\u003e is a \u0027warning stroke\u0027 where neurological symptoms are temporary because blood flow is quickly restored,"
      }, {
        "text": " but it signals a high, imminent risk of a permanent stroke and necessitates immediate medical evaluation and preventive therapy.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_warning_sign_for\",\n"
      }, {
        "text": "        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "form_of\",\n        \"to\": \"cerebral_ischemia\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"can_present_as\",\n        \"to\": \"f0aac1c3\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_treated_with\",\n        \"to\": \"09db7b12\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"1835cfef\": {\n    \"title\": \"Tremor\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA"
      }, {
        "text": " \u003cb\u003etremor\u003c/b\u003e is an involuntary, rhythmic, oscillatory movement of a body part. It is classified based on its characteristics"
      }, {
        "text": ", particularly whether it occurs at rest or during action.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eResting"
      }, {
        "text": " Tremor:\u003c/b\u003e Occurs when the muscle is relaxed and supported against gravity. It is suppressed by voluntary movement. The"
      }, {
        "text": " classic example is the \u003cmark\u003e\\\"pill-rolling\\\" tremor\u003c/mark\u003e of [[58c8ea0"
      }, {
        "text": "3|Parkinson disease]], caused by a lesion in the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePostural Tremor:\u003c/b\u003e Occurs when"
      }, {
        "text": " holding a position against gravity (e.g., holding arms outstretched). The most common type is [[40039"
      }, {
        "text": "e56|essential tremor]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eIntention (Action) Tremor:\u003c/b\u003e Occurs during a purposeful, goal"
      }, {
        "text": "-directed movement and worsens as the target is approached. It is a sign of \u003cmark\u003ecerebellar dysfunction\u003c/mark\u003e"
      }, {
        "text": " (e.g., lesion of the cerebellar hemisphere or [[c819d97b|dentate nucleus]])."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAsterixis:\u003c/b\u003e Not a true tremor, but a negative myoclonus (\u0027flapping tremor\u0027) seen"
      }, {
        "text": " in metabolic encephalopathies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The timing of the tremor is the key to the diagnosis"
      }, {
        "text": ": At rest? Think Parkinson\u0027s. With action/posture? Think essential tremor. As you approach a target? Think cerebellum"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe clinical classification of \u003cb\u003etremor\u003c/b\u003e‚Äîwhether it manifests"
      }, {
        "text": " at rest, with posture, or with intention‚Äîis a powerful diagnostic tool that points to distinct underlying pathologies in the basal"
      }, {
        "text": " ganglia, cerebellum, or other motor systems.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"9"
      }, {
        "text": "a9c9169\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"resting_"
      }, {
        "text": "tremor\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"intention"
      }, {
        "text": "_tremor\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \""
      }, {
        "text": "40039e56\"\n      }\n    ]\n  },\n  \"ff57"
      }, {
        "text": "77a9\": {\n    \"title\": \"Triazolam\",\n    \"primaryType\": \"drug\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Triazolam\u003c/b\u003e is a very short-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used for the short-term treatment of insomnia,"
      }, {
        "text": " particularly sleep-onset insomnia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A positive"
      }, {
        "text": " allosteric modulator of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It has a very rapid onset and a very short half-life (2-3 hours). M"
      }, {
        "text": "nemonic for short-acting benzodiazepines: \u003cb\u003eATOM\u003c/b\u003e (\u003cb\u003eA\u003c/b\u003elprazolam, \u003cb\u003eT\u003c/b\u003eriazolam, \u003cb\u003e"
      }, {
        "text": "O\u003c/b\u003exazepam, \u003cb\u003eM\u003c/b\u003eidazolam).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily for sleep-onset insomnia."
      }, {
        "text": " Its short duration minimizes next-day \u0027hangover\u0027 effects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Higher risk of anter"
      }, {
        "text": "ograde amnesia and rebound insomnia upon discontinuation compared to longer-acting agents. High abuse potential due to its rapid onset"
      }, {
        "text": " and short duration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Triazolam is a good choice for a patient who has"
      }, {
        "text": " trouble falling asleep but not staying asleep. Its short half-life is its defining feature.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eTriazolam\u003c/b\u003e is a fast-on, fast-off benzodiazepine hypnotic, ideal"
      }, {
        "text": " for initiating sleep but with a higher risk of rebound insomnia and dependence due to its short duration of action.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_"
      }, {
        "text": "on\",\n        \"to\": \"gaba_a_receptor\"\n      }\n    ]\n  },\n  \"b"
      }, {
        "text": "79b3546\": {\n    \"title\": \"Triceps Reflex\",\n    \"primaryType\": \""
      }, {
        "text": "physiology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003eThe \u003cb\u003eTriceps reflex\u003c/b\u003e is a deep tendon reflex that causes extension of the elbow when"
      }, {
        "text": " the triceps brachii tendon is tapped. It is used to test the integrity of the \u003cmark\u003eC7 and C8\u003c/"
      }, {
        "text": "mark\u003e spinal nerve roots and the radial nerve.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eN"
      }, {
        "text": "erve Roots:\u003c/b\u003e Primarily tests the \u003cb\u003eC7\u003c/b\u003e nerve root, with a contribution from C6 and C8. Mnemonic:"
      }, {
        "text": " C6, \u003cb\u003e7\u003c/b\u003e, 8, lay them straight.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Tapping the triceps tendon stretches"
      }, {
        "text": " the muscle. The afferent signal travels via the radial nerve to the C7/C8 spinal cord segments, synapses"
      }, {
        "text": ", and an efferent signal returns via the radial nerve to cause contraction of the triceps muscle and elbow extension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDim"
      }, {
        "text": "inished/Absent Reflex:\u003c/b\u003e Suggests a lower motor neuron lesion, such as a herniated disc compressing the C7 root"
      }, {
        "text": " or a peripheral neuropathy affecting the radial nerve.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExaggerated Reflex (Hyperreflexia):\u003c/b\u003e Suggests an upper"
      }, {
        "text": " motor neuron lesion, such as a stroke or spinal cord injury above the C7 level.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The"
      }, {
        "text": " triceps reflex, along with sensation over the middle finger and strength of wrist flexion/finger extension, is a key part"
      }, {
        "text": " of the C7 neurological exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTriceps reflex\u003c/b\u003e is a"
      }, {
        "text": " standard part of the neurological exam that specifically assesses the C7 nerve root, providing a quick check on the integrity of the lower"
      }, {
        "text": " cervical spinal cord and the radial nerve.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tap Triceps Tendon] --\u003e B("
      }, {
        "text": "Stretch Triceps Muscle); B --\u003e C(Afferent Signal via Radial N.); C --\u003e D[C7/C8 Spinal"
      }, {
        "text": " Cord]; D --\u003e E(Efferent Signal via Radial N.); E --\u003e F(Triceps Contraction/El"
      }, {
        "text": "bow Extension);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"tests_ner"
      }, {
        "text": "ve_root\",\n        \"to\": \"c7_nerve_root\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"tests_nerve_root\",\n        \"to\": \"c8_nerve_root\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \""
      }, {
        "text": "deep_tendon_reflex\"\n      }\n    ]\n  },\n  \"e7bc7ac"
      }, {
        "text": "8\": {\n    \"title\": \"Tricyclic Antidepressants (TCAs)\",\n    \"primaryType\":"
      }, {
        "text": " \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTric"
      }, {
        "text": "yclic antidepressants (TCAs)\u003c/b\u003e are a class of medications primarily used to treat depression, though their use has declined"
      }, {
        "text": " due to a significant side effect profile and the availability of safer alternatives. They are also used for neuropathic pain, migraine"
      }, {
        "text": " prophylaxis, and OCD.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Block"
      }, {
        "text": " the reuptake of \u003cmark\u003enorepinephrine (NE) and serotonin (5-HT)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "verse Effects:\u003c/b\u003e Their side effects are due to blockade of multiple other receptors:\u003cbr\u003e - \u003cb\u003eAnticholinergic ("
      }, {
        "text": "muscarinic):\u003c/b\u003e Dry mouth, constipation, urinary retention, blurred vision, confusion.\u003cbr\u003e - \u003cb\u003eAntihist"
      }, {
        "text": "aminic (H\u003csub\u003e1\u003c/sub\u003e):\u003c/b\u003e Sedation, weight gain.\u003cbr\u003e - \u003cb\u003eAnti-adrenergic (Œ±\u003csub\u003e1\u003c/sub\u003e):\u003c/b\u003e Orth"
      }, {
        "text": "ostatic hypotension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOverdose (Tri-C\u0027s):\u003c/b\u003e TCA overdose is life-threatening. Remember"
      }, {
        "text": " the Tri-C\u0027s: \u003cb\u003eC\u003c/b\u003eonvulsions, \u003cb\u003eC\u003c/b\u003eoma, \u003cb\u003eC\u003c/b\u003eard"
      }, {
        "text": "iotoxicity. Cardiotoxicity (QRS widening, ventricular arrhythmias) is due to Na\u003csup\u003e+\u003c/sup\u003e channel blockade and is"
      }, {
        "text": " the most common cause of death. Treat with sodium bicarbonate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Use:\u003c/b\u003e Tertiary amines like [[c"
      }, {
        "text": "6814506|amitriptyline]] are used for chronic neuropathic pain and migraine prophylaxis. Clomipramine is used for OCD"
      }, {
        "text": ". Some TCAs are used to treat pain in [[45dd6d19|multiple sclerosis]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The wide range of receptor blockade explains the extensive side effect profile of TCAs. Cardiotoxicity in"
      }, {
        "text": " overdose is a critical, high-yield concept.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTricyclic antidepressants\u003c/b\u003e"
      }, {
        "text": " are \u0027dirty\u0027 drugs that, in addition to their therapeutic effect of blocking serotonin and norepinephrine reuptake, also block"
      }, {
        "text": " muscarinic, histaminic, and adrenergic receptors, leading to a broad and problematic side effect profile, especially life"
      }, {
        "text": "-threatening cardiotoxicity in overdose.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"inhibits_reuptake_of\",\n        \"to\": \"seroton"
      }, {
        "text": "in\"\n      },\n      {\n        \"type\": \"inhibits_reuptake_of\",\n"
      }, {
        "text": "        \"to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"treats\",\n"
      }, {
        "text": "        \"to\": \"9a0f5ba6\"\n      },\n      {\n        \"type\": \"treat"
      }, {
        "text": "s\",\n        \"to\": \"neuropathic_pain\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"treats\",\n        \"to\": \"45dd6d19\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"0eb45a0a\": {\n    \"title\": \"Trigeminal Nerve (CN"
      }, {
        "text": " V)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"C"
      }, {
        "text": "ranial Nerves\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTrigeminal Nerve (CN V)\u003c/b\u003e is the"
      }, {
        "text": " largest cranial nerve and is a mixed nerve, containing both sensory and motor fibers. It is the principal sensory nerve for the face and provides"
      }, {
        "text": " motor innervation to the muscles of mastication.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction Type"
      }, {
        "text": ":\u003c/b\u003e Both sensory and motor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThree Divisions:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eOphthalmic (V\u003csub\u003e1\u003c/sub\u003e):\u003c/b\u003e"
      }, {
        "text": " Sensory. Supplies the forehead, scalp, cornea, and upper eyelid.\u003cbr\u003e2. \u003cb\u003eMaxillary (V\u003csub\u003e2\u003c/sub\u003e):\u003c/b\u003e"
      }, {
        "text": " Sensory. Supplies the midface, lower eyelid, upper lip, and upper teeth.\u003cbr\u003e3. \u003cb\u003eMandibular (V\u003csub\u003e3\u003c/sub\u003e):"
      }, {
        "text": "\u003c/b\u003e Both sensory and motor. Provides sensation to the lower face, lower lip, lower teeth, and anterior two-thirds of the tongue ("
      }, {
        "text": "general sensation, not taste). Provides motor innervation to the \u003cmark\u003emuscles of mastication\u003c/mark\u003e (mass"
      }, {
        "text": "eter, temporalis, pterygoids).\u003c/li\u003e\u003cli\u003e\u003cb\u003eReflexes:\u003c/b\u003e The afferent limb of the [["
      }, {
        "text": "64663383|corneal reflex]] is carried by V\u003csub\u003e1\u003c/sub\u003e. The afferent and"
      }, {
        "text": " efferent limbs of the jaw jerk reflex are carried by V\u003csub\u003e3\u003c/sub\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e A"
      }, {
        "text": " lesion of CN V can cause facial numbness, weakness in chewing, and deviation of the jaw toward the side of the lesion upon"
      }, {
        "text": " opening.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTrigeminal Neuralgia:\u003c/b\u003e A condition characterized by recurrent, severe, lancinating pain in the distribution"
      }, {
        "text": " of one or more branches of CN V. Treated with [[eddd2bc5|carbamazepine]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Remember V\u003csub\u003e3\u003c/sub\u003e is the only division with motor fibers (\u0027M\u0027 for Mandibular and Motor"
      }, {
        "text": ").\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTrigeminal Nerve\u003c/b\u003e is the great"
      }, {
        "text": " sensory nerve of the face, with its three divisions mapping out distinct facial territories, and it also provides the crucial motor power for"
      }, {
        "text": " chewing via its mandibular branch.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Trigeminal Nerve -"
      }, {
        "text": " CN V]; A --\u003e B(V1 - Ophthalmic - Sensory); A --\u003e C(V2 - Max"
      }, {
        "text": "illary - Sensory); A --\u003e D(V3 - Mandibular - Sensory \u0026 Motor); D --\u003e E(Muscles of Mastic"
      }, {
        "text": "ation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_afferent_limb_of\","
      }, {
        "text": "\n        \"to\": \"64663383\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"innervates\",\n        \"to\": \"muscles_of_mastication\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"pathology_causes\",\n        \"to\": \"trigeminal_neuralgia\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"5d7bde15\": {\n    \"title\": \"Trihexyphenidyl"
      }, {
        "text": "\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eTrihexyphenidyl\u003c/b\u003e is a centrally acting \u003ci\u003eantimuscarinic (anticholinergic) drug"
      }, {
        "text": "\u003c/i\u003e used to treat the symptoms of [[58c8ea03|Parkinson disease]] and drug-induced extra"
      }, {
        "text": "pyramidal symptoms.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts"
      }, {
        "text": " as a competitive antagonist at central muscarinic receptors, helping to restore the dopaminergic-cholinergic balance in the [["
      }, {
        "text": "ed462927|basal ganglia]] that is disrupted in Parkinson\u0027s disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Clinical Use (Parkinson\u0027s):\u003c/b\u003e Primarily effective for treating \u003cmark\u003etremor and rigidity\u003c/mark\u003e. It has"
      }, {
        "text": " little effect on bradykinesia. Often used in younger patients where tremor is the predominant symptom. Mnemonic: \u0027\u003cb\u003e"
      }, {
        "text": "Tri\u003c/b\u003e to \u003cb\u003ePark\u003c/b\u003e my Mercedes-\u003cb\u003eBenz\u003c/b\u003e\u0027 (\u003cb\u003eTri\u003c/b\u003ehexyphenidyl and [["
      }, {
        "text": "383f6fbe|Benztropine]] for \u003cb\u003ePark\u003c/b\u003einson\u0027s).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use (EPS):\u003c/b\u003e Can be used to treat drug-induced parkinsonism and dystonia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Classic"
      }, {
        "text": " anticholinergic side effects: dry mouth, blurred vision, constipation, urinary retention, tachycardia, and confusion/delirium, especially in the"
      }, {
        "text": " elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Trihexyphenidyl and benztropine are the two main anticholinergics used for"
      }, {
        "text": " Parkinson\u0027s. They are most useful for tremor in younger patients.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Trihexyphenidyl\u003c/b\u003e is an anticholinergic agent that helps manage Parkinson\u0027s disease by reducing the relative over"
      }, {
        "text": "activity of acetylcholine in the dopamine-depleted basal ganglia, thereby improving tremor and rigidity.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"96e8bf39\"\n      },\n      {\n        \"type\": \"treats"
      }, {
        "text": "\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n"
      }, {
        "text": "        \"to\": \"extrapyramidal_symptoms\"\n      }\n    ]\n  },\n  \"34"
      }, {
        "text": "ba2a7b\": {\n    \"title\": \"Triptans\",\n    \"primaryType\": \"drug\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      "
      }, {
        "text": "\"Headache Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTriptans\u003c/b\u003e ("
      }, {
        "text": "e.g., sumatriptan) are a class of drugs that are serotonin 5-HT\u003csub\u003e1B"
      }, {
        "text": "/1D\u003c/sub\u003e receptor agonists. They are a first-line therapy for the acute (abortive) treatment of moderate to severe"
      }, {
        "text": " [[c8833bae|migraine headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e1. Agonism at 5-HT\u003csub\u003e1B\u003c/sub\u003e receptors on cranial blood vessels causes \u003c"
      }, {
        "text": "mark\u003evasoconstriction\u003c/mark\u003e.\u003cbr\u003e2. Agonism at presynaptic 5-HT\u003csub\u003e"
      }, {
        "text": "1D\u003c/sub\u003e receptors on trigeminal nerve endings \u003cmark\u003einhibits the release of vasoactive neuropeptides\u003c/mark\u003e like"
      }, {
        "text": " CGRP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Acute treatment of [[c8833bae|migraines]] and [[2"
      }, {
        "text": "1760f80|cluster headaches]]. They are \u003cu\u003enot\u003c/u\u003e used for prophylaxis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:"
      }, {
        "text": "\u003c/b\u003e Tingling, paresthesias, dizziness, and a sensation of chest tightness or pressure (\u0027triptan sensations"
      }, {
        "text": "\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Due to their vasoconstrictive effects, they are contraindicated in patients with a history of \u003cmark\u003ecoronary"
      }, {
        "text": " artery disease\u003c/mark\u003e, uncontrolled hypertension, or stroke. They should not be used with ergotamines or within 2 weeks"
      }, {
        "text": " of MAOI use.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Triptans are the go-to abortive therapy for migraines"
      }, {
        "text": ". Remember their 5-HT\u003csub\u003e1B/1D\u003c/sub\u003e agonist mechanism and their major contraindication in patients with cardiovascular disease due"
      }, {
        "text": " to the risk of [[dd3c9b1b|coronary vasospasm]].\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eTriptans\u003c/b\u003e abort migraine attacks through a dual mechanism of constricting painfully dilated cranial"
      }, {
        "text": " vessels and inhibiting the release of inflammatory neuropeptides from the trigeminal nerve, but their vasoconstrictive nature makes them risky"
      }, {
        "text": " in patients with vascular disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Triptan] --\u003e B(5"
      }, {
        "text": "-HT1B/1D Agonist); B --\u003e C(Cranial Vasoconstriction); B --\u003e D"
      }, {
        "text": "(‚Üì CGRP Release); C \u0026 D --\u003e E(Migraine Relief);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"21760f80\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"acts_as_agonist_at\",\n        \"to\": \"ser"
      }, {
        "text": "otonin_receptor\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"dd"
      }, {
        "text": "3c9b1b\"\n      }\n    ]\n  },\n  \"bba6093"
      }, {
        "text": "a\": {\n    \"title\": \"Trochlear Nerve (CN IV)\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Cranial Nerves\",\n      \""
      }, {
        "text": "Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTrochlear Nerve (CN IV)\u003c/b\u003e is a motor"
      }, {
        "text": " cranial nerve that provides innervation to a single extraocular muscle, the superior oblique. It is unique among cranial nerves in that it is"
      }, {
        "text": " the only one to exit from the dorsal aspect of the brainstem and to decussate completely.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Innervates the contralateral \u003cmark\u003esuperior oblique muscle\u003c/mark\u003e. The primary actions of this"
      }, {
        "text": " muscle are intorsion (internal rotation) and depression of the eyeball, especially when the eye is adducted.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e Emerges from the dorsal midbrain, decussates, and then travels anteriorly to enter the orbit via the superior"
      }, {
        "text": " orbital fissure.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy:\u003c/b\u003e A lesion of the CN IV nucleus or nerve causes a \u003cmark\u003e[["
      }, {
        "text": "de532715|trochlear nerve palsy]]\u003c/mark\u003e. Due to the decussation, a"
      }, {
        "text": " lesion of the nucleus affects the contralateral eye, while a lesion of the nerve after it has decussated affects the ipsilateral eye."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy Presentation:\u003c/b\u003e The affected eye is hypertropic (elevated) and extorted. Patients"
      }, {
        "text": " present with vertical [[9914d433|diplopia]] that is worse when looking down and in"
      }, {
        "text": " (e.g., reading). They classically compensate by tilting their head \u003cu\u003eaway\u003c/u\u003e from the side of the pals"
      }, {
        "text": "ied eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3"
      }, {
        "text": "\u003c/sub\u003e: \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique is innervated by CN \u003cb\u003eIV\u003c/b\u003e. A"
      }, {
        "text": " patient with a head tilt and difficulty walking down stairs is a classic presentation for a CN IV palsy.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eThe \u003cb\u003eTrochlear Nerve\u003c/b\u003e is the unique, crossed nerve for the superior oblique muscle; its paralysis"
      }, {
        "text": " leads to a characteristic vertical diplopia and a compensatory head tilt away from the affected eye.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"innervates\",\n        \"to\": \"superior"
      }, {
        "text": "_oblique_muscle\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n"
      }, {
        "text": "        \"to\": \"de532715\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_part_of\",\n        \"to\": \"709aa7c2\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"c72b32d9\": {\n    \"title\": \"Trun"
      }, {
        "text": "cal Ataxia\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Cerebellar Disorders\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eTruncal ataxia\u003c/b\u003e is a type of [[9767fd6b|ataxia]] characterized by instability of"
      }, {
        "text": " the trunk, leading to a wide-based, unsteady gait and difficulty sitting or standing without support. It is a hallmark"
      }, {
        "text": " of midline cerebellar disease.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLesion Location:\u003c/b\u003e Ca"
      }, {
        "text": "used by a lesion in the \u003cmark\u003ecerebellar vermis\u003c/mark\u003e or the [[644b8"
      }, {
        "text": "e4d|fastigial nucleus]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients have a wide-based, l"
      }, {
        "text": "urching gait often described as a \u0027drunken sailor\u0027 gait. They may sway or fall when sitting or standing still,"
      }, {
        "text": " even with their eyes open.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRomberg Test:\u003c/b\u003e The Romberg test is typically negative, as the instability"
      }, {
        "text": " is present with both eyes open and closed (distinguishing it from sensory ataxia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e\u003cbr\u003e - In"
      }, {
        "text": " children, the most common cause is a \u003cmark\u003e[[16d613bb|medulloblastoma]]\u003c/mark"
      }, {
        "text": "\u003e located in the vermis.\u003cbr\u003e - In adults, the most common cause is cerebellar degeneration secondary to \u003cmark\u003echronic"
      }, {
        "text": " alcohol use disorder\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate truncal ataxia from limb ataxia. Truncal ataxia (mid"
      }, {
        "text": "line lesion) affects gait and posture. Limb ataxia (hemispheric lesion) affects coordinated movements of the extremities, like the"
      }, {
        "text": " finger-to-nose test.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTruncal ataxia"
      }, {
        "text": "\u003c/b\u003e is a profound instability of the body\u0027s core, resulting from damage to the cerebellar vermis, which manifests as a characteristic"
      }, {
        "text": " wide-based, staggering gait independent of visual input.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"9767fd6b\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by_lesion_in\",\n        \"to\": \"6e31977d\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_caused_by\",\n        \"to\": \"16d613bb\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \""
      }, {
        "text": "chronic_alcohol_use\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"14ca8706\",\n    \"letter\": \"T\",\n    \"term\": \"Temporal lobe\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Temporal lobe\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"0fef6159\",\n    \"letter\": \"T\",\n    \"term\": \"Tension headaches\",\n    \"pages\": [\n      \"532\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tension headaches\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e5846fa8\",\n    \"letter\": \"T\",\n    \"term\": \"Teratogenicity\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Teratogenicity\",\n    \"sub_entries\": [\n      {\n        \"id\": \"40762ec9\",\n        \"letter\": \"T\",\n        \"term\": \"with anticonvulsants\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Teratogenicity \u003e with anticonvulsants\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d6d5d92e\",\n    \"letter\": \"T\",\n    \"term\": \"Tetracaine\",\n    \"pages\": [\n      \"565\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tetracaine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f710cf40\",\n    \"letter\": \"T\",\n    \"term\": \"Tetracyclines\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Tetracyclines\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0e0e9cb5\",\n        \"letter\": \"T\",\n        \"term\": \"pseudotumor cerebri and\",\n        \"pages\": [\n          \"536\"\n        ],\n        \"context\": \"Tetracyclines \u003e pseudotumor cerebri and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"afc0a64b\",\n    \"letter\": \"T\",\n    \"term\": \"Thalamus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Thalamus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"65097f46\",\n        \"letter\": \"T\",\n        \"term\": \"functions and nuclei of\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Thalamus \u003e functions and nuclei of\"\n      },\n      {\n        \"id\": \"9846ace1\",\n        \"letter\": \"T\",\n        \"term\": \"limbic system and\",\n        \"pages\": [\n          \"509\"\n        ],\n        \"context\": \"Thalamus \u003e limbic system and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"91bfec7e\",\n    \"letter\": \"T\",\n    \"term\": \"Thrombotic stroke\",\n    \"pages\": [\n      \"525\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Thrombotic stroke\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e53c9136\",\n    \"letter\": \"T\",\n    \"term\": \"Thrush\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Thrush\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a8053874\",\n        \"letter\": \"T\",\n        \"term\": \"‚ÄúThunderclap headache‚Äù\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Thrush \u003e ‚ÄúThunderclap headache‚Äù\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5206aa83\",\n    \"letter\": \"T\",\n    \"term\": \"Tight junctions\",\n    \"pages\": [\n      \"482\",\n      \"506\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tight junctions\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ae28be6c\",\n    \"letter\": \"T\",\n    \"term\": \"Timolol\",\n    \"pages\": [\n      \"244\",\n      \"327\",\n      \"568\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Timolol\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"bfe17d7e\",\n    \"letter\": \"T\",\n    \"term\": \"Tizanidine\",\n    \"pages\": [\n      \"243\",\n      \"567\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tizanidine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"42e6a13b\",\n    \"letter\": \"T\",\n    \"term\": \"Tobacco smoking\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Tobacco smoking\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e9a41b04\",\n        \"letter\": \"T\",\n        \"term\": \"aneurism risks\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Tobacco smoking \u003e aneurism risks\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5f6eb15f\",\n    \"letter\": \"T\",\n    \"term\": \"Tolcapone\",\n    \"pages\": [\n      \"563\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tolcapone\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1761b409\",\n    \"letter\": \"T\",\n    \"term\": \"Tongue\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Tongue\",\n    \"sub_entries\": [\n      {\n        \"id\": \"42327290\",\n        \"letter\": \"T\",\n        \"term\": \"movement in swallowing\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Tongue \u003e movement in swallowing\"\n      }\n    ]\n  },\n  {\n    \"id\": \"dc458d4e\",\n    \"letter\": \"T\",\n    \"term\": \"Tonic seizure\",\n    \"pages\": [\n      \"531\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Tonic seizure\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1717
    }, {
      "text": "```json\n{\n  \"14ca8706\": {\n    \"title\": \"Temporal Lobe\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTemporal Lobe\u003c/b\u003e is one of the four major lobes of the cerebral cortex, located beneath the lateral fissure on both cerebral hemispheres. It is primarily involved in processing auditory information and is crucial for memory, emotion, and language comprehension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary Auditory Cortex:\u003c/b\u003e Located in the superior temporal gyrus, it is responsible for the perception of sound.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[wernicke_area|Wernicke\u0027s Area]]:\u003c/b\u003e Located in the posterior superior temporal gyrus of the dominant hemisphere, it is critical for the \u003cmark\u003ecomprehension of spoken and written language\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedial Temporal Lobe Structures:\u003c/b\u003e Contains key components of the limbic system:\u003cbr\u003e - \u003cb\u003e[[a0590674|Hippocampus]]:\u003c/b\u003e Essential for the formation of new long-term memories.\u003cbr\u003e - \u003cb\u003e[[d220fc3f|Amygdala]]:\u003c/b\u003e Central to processing emotions, particularly fear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisual Pathway:\u003c/b\u003e The inferior optic radiation, or \u003cmark\u003e[[6dcf9281|Meyer\u0027s loop]]\u003c/mark\u003e, passes through the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDominant Lobe:\u003c/b\u003e [[2c4a6130|Wernicke\u0027s aphasia]].\u003cbr\u003e - \u003cb\u003eMedial Lobe (bilateral):\u003c/b\u003e [[a62c0c9f|Anterograde amnesia]] (hippocampus), [[kluver_bucy_syndrome|Kl√ºver-Bucy syndrome]] (amygdala).\u003cbr\u003e - \u003cb\u003eMeyer\u0027s Loop:\u003c/b\u003e Contralateral superior quadrantanopia (\u0027pie in the sky\u0027).\u003cbr\u003e - \u003cb\u003eTemporal Lobe Epilepsy:\u003c/b\u003e The most common site for focal seizures, often presenting with auras (e.g., epigastric rising sensation, olfactory hallucinations).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTemporal Lobe\u003c/b\u003e is a multifaceted brain region that processes what we hear, allows us to understand language, forms new memories, and generates emotional responses, making it a hub for some of the most complex human cognitive functions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"a1b198f9\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"wernicke_area\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"a0590674\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"d220fc3f\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"6dcf9281\"\n      }\n    ]\n  },\n  \"0fef6159\": {\n    \"title\": \"Tension-Type Headaches\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Headaches\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTension-type headaches\u003c/b\u003e are the most common type of primary headache, characterized by a mild to moderate, bilateral, non-throbbing headache often described as a tight band around the head.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Bilateral, \u0027band-like\u0027 or pressing/tightening quality. The pain is typically mild to moderate in intensity and is not aggravated by routine physical activity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Unlike migraines, tension headaches are \u003cmark\u003e\u003cu\u003enot\u003c/u\u003e associated with nausea or vomiting\u003c/mark\u003e. Patients may have either photophobia (sensitivity to light) or phonophobia (sensitivity to sound), but not both.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDuration:\u003c/b\u003e Can last from 30 minutes to 7 days.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment (Acute):\u003c/b\u003e Simple analgesics like NSAIDs or acetaminophen are usually effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProphylaxis:\u003c/b\u003e For chronic tension-type headaches, [[c6814506|amitriptyline]] (a TCA) and behavioral therapy are common prophylactic strategies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating a tension headache from a migraine is the absence of severe, debilitating features. Tension headaches are bilateral, non-pulsating, and lack significant associated symptoms like nausea.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTension-type headaches\u003c/b\u003e are the common, \u0027featureless\u0027 headache, defined more by what they lack (unilaterality, pulsating quality, nausea, severe disability) than what they have, presenting as a simple, bilateral pressure or tightness.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primary_headache\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"is_treated_prophylactically_by\",\n        \"to\": \"c6814506\"\n      }\n    ]\n  },\n  \"e5846fa8\": {\n    \"title\": \"Teratogenicity of Anticonvulsants\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Obstetrics\",\n      \"Teratology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eMany \u003cb\u003eanticonvulsant\u003c/b\u003e (antiepileptic) drugs are known teratogens, meaning they can cause birth defects if taken during pregnancy. This poses a significant management challenge for women with epilepsy of childbearing age.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGeneral Risk:\u003c/b\u003e All anticonvulsants carry some risk, and the goal is to use the lowest effective dose of a single agent (monotherapy) if possible.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[0d37e045|Valproate]]:\u003c/b\u003e Has the \u003cmark\u003ehighest risk of teratogenicity\u003c/mark\u003e. It is strongly associated with an increased risk of \u003cmark\u003eneural tube defects\u003c/mark\u003e (e.g., spina bifida) due to its interference with folate metabolism. It can also cause other malformations and is associated with lower IQ in offspring.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[eddd2bc5|Carbamazepine]]:\u003c/b\u003e Also associated with neural tube defects.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[5aea213f|Phenytoin]]:\u003c/b\u003e Can cause Fetal Hydantoin Syndrome, characterized by craniofacial abnormalities (cleft lip/palate), hypoplastic nails and distal phalanges, and growth/intellectual disability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFolate Supplementation:\u003c/b\u003e High-dose folic acid supplementation is recommended for all women of childbearing potential who are taking anticonvulsants to reduce the risk of neural tube defects.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Valproate is the most notorious teratogen among the anticonvulsants, with a strong link to neural tube defects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eteratogenicity of anticonvulsants\u003c/b\u003e is a major clinical concern, with valproate carrying the highest risk, particularly for neural tube defects, necessitating careful counseling and high-dose folate supplementation for women with epilepsy who are planning a pregnancy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"is_highest_with\",\n        \"to\": \"0d37e045\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"neural_tube_defect\"\n      }\n    ]\n  },\n  \"d6d5d92e\": {\n    \"title\": \"Tetracaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTetracaine\u003c/b\u003e is a potent, long-acting, ester-type \u003ci\u003elocal anesthetic\u003c/i\u003e used for spinal anesthesia and topically for anesthesia of the eye, nose, or throat.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Ester local anesthetic. It is metabolized by plasma pseudocholinesterases.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a slow onset but a long duration of action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Commonly used for spinal anesthesia due to its long duration. Also used in topical formulations for ophthalmology and ENT procedures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e As an ester, it has a higher potential for allergic reactions (due to its metabolite, PABA) compared to amide anesthetics. Systemic toxicity can cause CNS excitation and cardiovascular collapse.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the classification of local anesthetics: Esters (one \u0027i\u0027 in the name, e.g., tetraca\u003cb\u003ei\u003c/b\u003ene, coca\u003cb\u003ei\u003c/b\u003ene) are metabolized in the plasma, while Amides (two \u0027i\u0027s, e.g., l\u003cb\u003ei\u003c/b\u003edoca\u003cb\u003ei\u003c/b\u003ene) are metabolized in the liver.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTetracaine\u003c/b\u003e is a long-acting ester anesthetic whose prolonged nerve-blocking effect makes it well-suited for spinal anesthesia, but its ester structure carries a risk of allergic reactions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        \"to\": \"pseudocholinesterase\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n  },\n  \"f710cf40\": {\n    \"title\": \"Tetracyclines\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTetracyclines\u003c/b\u003e (e.g., tetracycline, doxycycline, minocycline) are a class of broad-spectrum bacteriostatic antibiotics that inhibit protein synthesis by binding to the 30S ribosomal subunit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to the 30S ribosomal subunit and prevent the attachment of aminoacyl-tRNA to the A site.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Effective against a wide range of bacteria, including atypical organisms (\u003ci\u003eMycoplasma\u003c/i\u003e, \u003ci\u003eChlamydia\u003c/i\u003e), spirochetes (\u003ci\u003eBorrelia burgdorferi\u003c/i\u003e in Lyme disease), and rickettsial species. Also used for acne.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e GI distress, photosensitivity, and discoloration of teeth and inhibition of bone growth in children. They are teratogenic and should be avoided in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic Side Effect:\u003c/b\u003e Tetracyclines, particularly minocycline, are a known cause of \u003cmark\u003e[[7c4e7c74|idiopathic intracranial hypertension]]\u003c/mark\u003e (pseudotumor cerebri).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the major side effects: photosensitivity, teeth discoloration in kids, and teratogenicity. The association with pseudotumor cerebri is also a high-yield fact.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTetracyclines\u003c/b\u003e are broad-spectrum antibiotics that, in addition to their well-known side effects like photosensitivity and teeth staining, can also cause the neurological condition of idiopathic intracranial hypertension.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"antibiotic\"\n      },\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"bacterial_protein_synthesis\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"7c4e7c74\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"photosensitivity\"\n      }\n    ]\n  },\n  \"afc0a64b\": {\n    \"title\": \"Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eThalamus\u003c/b\u003e is a large, paired gray matter structure in the diencephalon, located superior to the brainstem. It serves as the primary relay and integration center for sensory information (except smell) on its way to the cerebral cortex, and also plays a crucial role in motor control, consciousness, sleep, and alertness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The major sensory relay station of the brain. All sensory input (except olfaction) synapses in the thalamus before being projected to the appropriate cortical area.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Nuclei and Functions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[2ae957b8|VPL]]:\u003c/b\u003e Relays sensation (pain, temp, proprioception, touch) from the body.\u003cbr\u003e - \u003cb\u003e[[23ac314a|VPM]]:\u003c/b\u003e Relays sensation from the face (via trigeminal nerve) and taste.\u003cbr\u003e - \u003cb\u003eLGN (Lateral Geniculate Nucleus):\u003c/b\u003e Relays visual information. Mnemonic: \u003cb\u003eL\u003c/b\u003eGN for \u003cb\u003eL\u003c/b\u003eight.\u003cbr\u003e - \u003cb\u003eMGN (Medial Geniculate Nucleus):\u003c/b\u003e Relays auditory information. Mnemonic: \u003cb\u003eM\u003c/b\u003eGN for \u003cb\u003eM\u003c/b\u003eusic.\u003cbr\u003e - \u003cb\u003eVA/VL:\u003c/b\u003e Relays motor information from the [[ed462927|basal ganglia]] and cerebellum to the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLimbic System Connection:\u003c/b\u003e The anterior nucleus of the thalamus is part of the Papez circuit, a component of the [[73ace357|limbic system]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e A thalamic stroke can cause \u003cmark\u003econtralateral sensory loss\u003c/mark\u003e of all modalities. It can also lead to [[714f15fc|central post-stroke pain syndrome]] (thalamic pain syndrome).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eThalamus\u003c/b\u003e acts as the brain\u0027s central switchboard, sorting and directing nearly all incoming sensory and motor signals to their appropriate cortical destinations, making it indispensable for perception, movement, and consciousness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sensory Input] --\u003e B(Thalamus); B --\u003e C(Cortex); D[Basal Ganglia/Cerebellum] --\u003e B;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"24a24d08\"\n      },\n      {\n        \"type\": \"is_a_relay_for\",\n        \"to\": \"sensory_system\"\n      },\n      {\n        \"type\": \"is_a_relay_for\",\n        \"to\": \"motor_system\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"714f15fc\"\n      }\n    ]\n  },\n  \"91bfec7e\": {\n    \"title\": \"Thrombotic Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cardiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ethrombotic stroke\u003c/b\u003e is a type of [[c5da3c57|ischemic stroke]] that occurs when a thrombus (blood clot) forms on an atherosclerotic plaque within a cerebral artery, obstructing blood flow.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Atherosclerosis leads to the formation of plaques in cerebral arteries. Rupture of one of these plaques can trigger local thrombus formation, leading to arterial occlusion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOnset:\u003c/b\u003e The onset of symptoms is often \u003cmark\u003egradual or stuttering\u003c/mark\u003e, developing over minutes to hours, as the thrombus grows to completely occlude the vessel. Patients may awaken from sleep with the deficit.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly occurs at arterial branch points, such as the carotid bifurcation or the origin of the [[143bb23d|middle cerebral artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e The risk factors are those for atherosclerosis: hypertension, hyperlipidemia, diabetes, and smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation from Embolic Stroke:\u003c/b\u003e [[6a805ecd|Embolic strokes]] typically have a sudden, maximal-at-onset presentation, whereas thrombotic strokes can have a more gradual onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with known risk factors for atherosclerosis who develops neurological deficits that progress over several hours is likely having a thrombotic stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ethrombotic stroke\u003c/b\u003e is a \u0027stroke from within,\u0027 where a clot forms directly on a pre-existing atherosclerotic plaque in a brain artery, gradually choking off blood flow and causing a stuttering or progressive onset of neurological symptoms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Atherosclerotic Plaque] --Rupture--\u003e B(Thrombus Formation); B --\u003e C(Occlusion of Cerebral Artery); C --\u003e D(Ischemic Stroke);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"atherosclerosis\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"6a805ecd\"\n      }\n    ]\n  },\n  \"e53c9136\": {\n    \"title\": \"Thrush (Oral Candidiasis)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Infectious Disease\",\n      \"Immunology\",\n      \"Oral Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Gastrointestinal\",\n      \"Pathology\",\n      \"Oral Cavity\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eThrush\u003c/b\u003e, or oral candidiasis, is a fungal infection of the mucous membranes of the mouth caused by an overgrowth of \u003ci\u003eCandida\u003c/i\u003e species, most commonly \u003ci\u003eCandida albicans\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by white, cottage cheese-like plaques on the tongue, buccal mucosa, and palate. These plaques can be \u003cmark\u003escraped off\u003c/mark\u003e, revealing an erythematous, sometimes bleeding, base.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Occurs in states of immunosuppression or disruption of normal oral flora. Common risk factors include infancy, use of inhaled corticosteroids (without rinsing), antibiotic therapy, and immunodeficiency (e.g., HIV/AIDS).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Usually clinical. Can be confirmed by a KOH preparation of a scraping, which will show pseudohyphae and budding yeasts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Topical antifungal agents like nystatin \u0027swish and swallow\u0027 or clotrimazole troches. Systemic fluconazole may be used for more severe or refractory cases.\u003c/li\u003e\u003cli\u003e\u003cb\u003e\u0027Thunderclap Headache\u0027:\u003c/b\u003e This term describes the sudden, severe headache of a [[63f8b05f|subarachnoid hemorrhage]] and is \u003cu\u003enot related\u003c/u\u003e to thrush. The index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The ability to scrape off the white plaques is a key feature that distinguishes thrush from oral hairy leukoplakia (seen in HIV, cannot be scraped off).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eThrush\u003c/b\u003e is a superficial \u003ci\u003eCandida\u003c/i\u003e infection of the mouth, presenting as white plaques that can be scraped off, and serves as a clinical indicator of either local or systemic immunosuppression.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"candida_albicans\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"immunosuppression\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"oral_hairy_leukoplakia\"\n      }\n    ]\n  },\n  \"5206aa83\": {\n    \"title\": \"Tight Junctions (CNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eIn the central nervous system, \u003cb\u003etight junctions\u003c/b\u003e (zonula occludens) are multiprotein junctional complexes that join the cerebral endothelial cells together, forming a continuous seal that is the primary structural component of the [[dd47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They severely restrict paracellular (between-cell) diffusion of solutes from the blood into the brain. This forces most substances to pass through the endothelial cells themselves (transcellular route), allowing for highly selective transport.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProteins:\u003c/b\u003e Composed of transmembrane proteins like claudins and occludins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier:\u003c/b\u003e The tight junctions of the non-fenestrated CNS capillary endothelium are the most critical element in forming the [[dd47b9cc|blood-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Disruption of tight junctions leads to a breakdown of the blood-brain barrier and the development of \u003cmark\u003evasogenic edema\u003c/mark\u003e. This can occur in response to inflammation, tumors, or ischemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of extensive tight junctions is the key feature that distinguishes CNS capillaries from the more permeable (\u0027fenestrated\u0027 or \u0027discontinuous\u0027) capillaries found in other parts of the body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTight junctions\u003c/b\u003e are the molecular \u0027mortar\u0027 that seals the gaps between cerebral endothelial cells, creating the formidable blood-brain barrier and forcing nearly all substances to undergo a highly regulated transcellular journey to enter the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_key_component_of\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        \"type\": \"are_composed_of\",\n        \"to\": \"claudins\"\n      },\n      {\n        \"type\": \"disruption_leads_to\",\n        \"to\": \"d94a9e61\"\n      }\n    ]\n  },\n  \"ae28be6c\": {\n    \"title\": \"Timolol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Ophthalmology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTimolol\u003c/b\u003e is a non-selective \u003ci\u003eŒ≤-adrenergic antagonist\u003c/i\u003e (beta-blocker) used topically as eye drops to reduce intraocular pressure (IOP) in the treatment of [[5ea7b741|open-angle glaucoma]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks both Œ≤\u003csub\u003e1\u003c/sub\u003e and Œ≤\u003csub\u003e2\u003c/sub\u003e adrenergic receptors on the ciliary epithelium. This \u003cmark\u003edecreases the production of aqueous humor\u003c/mark\u003e, thereby lowering IOP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-selective beta-blocker.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A first-line agent for [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Ocular side effects are minimal. Systemic absorption can occur, leading to bradycardia, hypotension, fatigue, and \u003cmark\u003ebronchoconstriction\u003c/mark\u003e (due to Œ≤\u003csub\u003e2\u003c/sub\u003e blockade).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Should be used with caution or avoided in patients with \u003cmark\u003easthma, COPD\u003c/mark\u003e, bradycardia, or severe heart failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Timolol is a classic first-line glaucoma drug. Its non-selective nature means you must consider the risk of bronchospasm in patients with reactive airway disease. In such patients, a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective agent like [[43508d57|betaxolol]] would be a safer choice.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTimolol\u003c/b\u003e is a highly effective topical beta-blocker for glaucoma that works by reducing aqueous humor production, but its non-selectivity requires caution due to the potential for systemic side effects, particularly bronchoconstriction in susceptible individuals.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Timolol] --\u003e B(Blocks Œ≤-Receptors on Ciliary Epithelium); B --\u003e C(‚Üì Aqueous Humor Production); C --\u003e D(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"10535992\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"3ce6c035\"\n      },\n      {\n        \"type\": \"decreases_production_of\",\n        \"to\": \"aqueous_humor\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"asthma\"\n      }\n    ]\n  },\n  \"bfe17d7e\": {\n    \"title\": \"Tizanidine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTizanidine\u003c/b\u003e is a centrally acting \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist\u003c/i\u003e that is used as a skeletal muscle relaxant (antispasmodic) to treat spasticity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as an Œ±\u003csub\u003e2\u003c/sub\u003e-agonist in the spinal cord. This enhances presynaptic inhibition of motor neurons, reducing the release of excitatory amino acids and thereby decreasing muscle spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Management of spasticity associated with [[45dd6d19|multiple sclerosis]], spinal cord injury, and [[171ca00b|cerebral palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Hypotension, sedation/somnolence, dry mouth, and dizziness. Hepatotoxicity is a rare but serious side effect, requiring monitoring of liver function tests.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Clonidine:\u003c/b\u003e Tizanidine is structurally and mechanistically related to clonidine (an antihypertensive), but it has a greater effect on muscle spasticity with less of an effect on blood pressure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Tizanidine is a muscle relaxant that works via the Œ±\u003csub\u003e2\u003c/sub\u003e-agonist mechanism, similar to clonidine. Remember its use for chronic spasticity and its potential to cause hypotension.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTizanidine\u003c/b\u003e reduces muscle spasticity by acting as an Œ±\u003csub\u003e2\u003c/sub\u003e-agonist in the spinal cord, which dampens the excitability of motor neurons, but its shared mechanism with clonidine means it also carries the risk of causing hypotension and sedation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bc6647e5\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"spasticity\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      }\n    ]\n  },\n  \"42e6a13b\": {\n    \"title\": \"Tobacco Smoking (Neurological Risks)\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Public Health\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Risk Factors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTobacco smoking\u003c/b\u003e is a major modifiable risk factor for a wide range of neurological diseases, primarily through its profound effects on the cardiovascular system and its direct neurotoxic and pro-inflammatory properties.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStroke:\u003c/b\u003e Smoking is a potent risk factor for both [[c5da3c57|ischemic stroke]] and [[63f8b05f|subarachnoid hemorrhage]]. It promotes atherosclerosis, increases blood pressure, and induces a hypercoagulable state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Aneurysms:\u003c/b\u003e Smoking is a significant risk factor for the formation and rupture of [[a9f6d703|saccular (berry) aneurysms]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDementia:\u003c/b\u003e Smoking increases the risk of both [[77ae6148|Alzheimer disease]] and [[99420dce|vascular dementia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMultiple Sclerosis:\u003c/b\u003e Smoking is associated with an increased risk of developing [[45dd6d19|MS]] and with a more rapid disease progression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with a stroke or subarachnoid hemorrhage, smoking should be identified as a key modifiable risk factor.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTobacco smoking\u003c/b\u003e is a powerful neurotoxin and vasculotoxin, accelerating atherosclerosis and promoting thrombosis, thereby dramatically increasing the risk of devastating neurological events like stroke and aneurysm rupture.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \"45dd6d19\"\n      }\n    ]\n  },\n  \"5f6eb15f\": {\n    \"title\": \"Tolcapone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTolcapone\u003c/b\u003e is a reversible inhibitor of catechol-O-methyltransferase (COMT) that is used as an adjunctive therapy with [[541cd176|levodopa/carbidopa]] for the treatment of [[58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits COMT, the enzyme that metabolizes levodopa. Unlike [[eb2da2bc|entacapone]], tolcapone acts in both the \u003cmark\u003eperiphery and the central nervous system\u003c/mark\u003e because it can cross the blood-brain barrier. This dual action increases the bioavailability of levodopa to the brain and also prevents the breakdown of dopamine within the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used with [[541cd176|levodopa/carbidopa]] to prolong the \u0027on\u0027 time and reduce \u0027off\u0027 time in patients with motor fluctuations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Potentiates levodopa side effects (dyskinesias, nausea). The most significant adverse effect is \u003cmark\u003ehepatotoxicity\u003c/mark\u003e, which can be fatal. Its use is limited due to this risk and requires regular monitoring of liver function tests.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the key difference between the COMT inhibitors: \u003cb\u003eT\u003c/b\u003eolcapone acts in \u003cb\u003eT\u003c/b\u003ewo places (CNS and periphery) and is toxic to the liver. \u003cb\u003eE\u003c/b\u003entacapone acts in the \u003cb\u003eE\u003c/b\u003endiphery (periphery) only.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTolcapone\u003c/b\u003e is a potent COMT inhibitor that works both centrally and peripherally to extend the action of levodopa, but its clinical use is severely restricted by the risk of life-threatening hepatotoxicity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Levodopa] --Peripheral COMT--\u003e B(3-O-methyldopa); C[Tolcapone] --x B; A --\u003e D(Crosses BBB); D --\u003e E[Dopamine in CNS]; E --Central COMT--\u003e F(3-MT); C --x F;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"comt_inhibitor\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"eb2da2bc\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"hepatotoxicity\"\n      }\n    ]\n  },\n  \"1761b409\": {\n    \"title\": \"Tongue\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Anatomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003etongue\u003c/b\u003e is a muscular organ in the mouth that is vital for gustation (taste), mastication (chewing), deglutition (swallowing), and articulation (speech). Its complex functions are controlled by multiple cranial nerves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMotor Innervation:\u003c/b\u003e All intrinsic and extrinsic muscles of the tongue are innervated by the \u003cmark\u003ehypoglossal nerve (CN XII)\u003c/mark\u003e, except for the palatoglossus muscle, which is innervated by the \u003cmark\u003evagus nerve (CN X)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Innervation (Anterior 2/3):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGeneral Sensation\u003c/b\u003e (touch, pain, temp): Mandibular division of the trigeminal nerve (CN V\u003csub\u003e3\u003c/sub\u003e).\u003cbr\u003e - \u003cb\u003eTaste (Special Sensation):\u003c/b\u003e Chorda tympani branch of the facial nerve (CN VII).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Innervation (Posterior 1/3):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGeneral Sensation \u0026 Taste:\u003c/b\u003e Glossopharyngeal nerve (CN IX).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSwallowing:\u003c/b\u003e Coordinated movement of the tongue, primarily by CN XII, is essential for the oral phase of swallowing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion of CN XII will cause the tongue to deviate \u003cu\u003etoward\u003c/u\u003e the side of the lesion upon protrusion (\u0027lick your wounds\u0027). Remember the different sensory nerves for the anterior vs. posterior tongue.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003etongue\u003c/b\u003e is a neurologically complex organ, with its motor function dominated by CN XII, while its sensory and taste functions are neatly divided between CN V, VII, and IX for the anterior and posterior portions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"motor_innervation_by\",\n        \"to\": \"hypoglossal_nerve\"\n      },\n      {\n        \"type\": \"sensory_innervation_by\",\n        \"to\": \"trigeminal_nerve_v3\"\n      },\n      {\n        \"type\": \"taste_innervation_by\",\n        \"to\": \"facial_nerve\"\n      },\n      {\n        \"type\": \"taste_and_sensory_innervation_by\",\n        \"to\": \"97e2c817\"\n      }\n    ]\n  },\n  \"dc458d4e\": {\n    \"title\": \"Tonic Seizure\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etonic seizure\u003c/b\u003e is a type of [[2e7554b7|generalized seizure]] characterized by a sudden, sustained increase in muscle tone, causing the body, arms, or legs to become stiff and rigid. Consciousness is typically impaired.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The seizure consists of a sudden, forceful, sustained contraction of muscles. If standing, the person will fall stiffly (\u0027like a tree falling\u0027). The eyes may roll back, and breathing may be temporarily arrested. The event is usually brief, lasting from a few seconds to a minute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTonic-Clonic Seizure:\u003c/b\u003e A tonic seizure is the initial phase of a [[39f6b128|generalized tonic-clonic seizure]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndromes:\u003c/b\u003e Tonic seizures are a common feature of severe epilepsy syndromes, particularly \u003cmark\u003eLennox-Gastaut syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Findings:\u003c/b\u003e The EEG typically shows a generalized, low-voltage fast activity or a flattening (desynchronization) of the background rhythm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate a tonic seizure (sustained stiffening) from a clonic seizure (rhythmic jerking) and an atonic seizure (sudden loss of tone).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003etonic seizure\u003c/b\u003e is a manifestation of a widespread neuronal discharge that locks the body\u0027s muscles into a state of rigid contraction, often seen as the initial \u0027stiffening\u0027 phase of a grand mal seizure or as a feature of severe epilepsy syndromes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"2e7554b7\"\n      },\n      {\n        \"type\": \"is_a_phase_of\",\n        \"to\": \"39f6b128\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"lennox_gastaut_syndrome\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9392,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"14ca8706\": {\n    \"title"
      }, {
        "text": "\": \"Temporal Lobe\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTemporal Lobe\u003c/b\u003e is one of the four major lobes"
      }, {
        "text": " of the cerebral cortex, located beneath the lateral fissure on both cerebral hemispheres. It is primarily involved in processing auditory information and"
      }, {
        "text": " is crucial for memory, emotion, and language comprehension.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePrimary"
      }, {
        "text": " Auditory Cortex:\u003c/b\u003e Located in the superior temporal gyrus, it is responsible for the perception of sound.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[["
      }, {
        "text": "wernicke_area|Wernicke\u0027s Area]]:\u003c/b\u003e Located in the posterior superior temporal gyrus of the dominant hemisphere, it is critical"
      }, {
        "text": " for the \u003cmark\u003ecomprehension of spoken and written language\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMedial Temporal Lobe Structures"
      }, {
        "text": ":\u003c/b\u003e Contains key components of the limbic system:\u003cbr\u003e - \u003cb\u003e[[a059067"
      }, {
        "text": "4|Hippocampus]]:\u003c/b\u003e Essential for the formation of new long-term memories.\u003cbr\u003e - \u003cb\u003e[[d"
      }, {
        "text": "220fc3f|Amygdala]]:\u003c/b\u003e Central to processing emotions, particularly fear.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVisual"
      }, {
        "text": " Pathway:\u003c/b\u003e The inferior optic radiation, or \u003cmark\u003e[[6dcf9281|Meyer\u0027s loop"
      }, {
        "text": "]]\u003c/mark\u003e, passes through the temporal lobe.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eDomin"
      }, {
        "text": "ant Lobe:\u003c/b\u003e [[2c4a6130|Wernicke\u0027s aphasia]]."
      }, {
        "text": "\u003cbr\u003e - \u003cb\u003eMedial Lobe (bilateral):\u003c/b\u003e [[a62c0c9f|An"
      }, {
        "text": "terograde amnesia]] (hippocampus), [[kluver_bucy_syndrome|Kl√ºver-Bucy syndrome"
      }, {
        "text": "]] (amygdala).\u003cbr\u003e - \u003cb\u003eMeyer\u0027s Loop:\u003c/b\u003e Contralateral superior quadrantan"
      }, {
        "text": "opia (\u0027pie in the sky\u0027).\u003cbr\u003e - \u003cb\u003eTemporal Lobe Epilepsy:\u003c/b\u003e The most common site for"
      }, {
        "text": " focal seizures, often presenting with auras (e.g., epigastric rising sensation, olfactory hallucinations).\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTemporal Lobe\u003c/b\u003e is a multifaceted brain region that processes"
      }, {
        "text": " what we hear, allows us to understand language, forms new memories, and generates emotional responses, making it a hub for"
      }, {
        "text": " some of the most complex human cognitive functions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_part_of\",\n        \"to\": \"a1b198"
      }, {
        "text": "f9\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"w"
      }, {
        "text": "ernicke_area\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"a059"
      }, {
        "text": "0674\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"d220"
      }, {
        "text": "fc3f\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \""
      }, {
        "text": "6dcf9281\"\n      }\n    ]\n  },\n  \"0fef6"
      }, {
        "text": "159\": {\n    \"title\": \"Tension-Type Headaches\",\n    \"primaryType\": \"disease"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pain Management\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Head"
      }, {
        "text": "aches\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTension-type"
      }, {
        "text": " headaches\u003c/b\u003e are the most common type of primary headache, characterized by a mild to moderate, bilateral, non-throbbing headache often"
      }, {
        "text": " described as a tight band around the head.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Bil"
      }, {
        "text": "ateral, \u0027band-like\u0027 or pressing/tightening quality. The pain is typically mild to moderate in intensity and is"
      }, {
        "text": " not aggravated by routine physical activity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Symptoms:\u003c/b\u003e Unlike migraines, tension headaches are \u003cmark\u003e\u003cu\u003e"
      }, {
        "text": "not\u003c/u\u003e associated with nausea or vomiting\u003c/mark\u003e. Patients may have either photophobia (sensitivity to light) or phonophobia (sensitivity to sound),"
      }, {
        "text": " but not both.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDuration:\u003c/b\u003e Can last from 30 minutes to 7 days.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": " (Acute):\u003c/b\u003e Simple analgesics like NSAIDs or acetaminophen are usually effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProphylaxis:\u003c/b\u003e For chronic"
      }, {
        "text": " tension-type headaches, [[c6814506|amitriptyline]] (a TCA) and behavioral therapy"
      }, {
        "text": " are common prophylactic strategies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key to differentiating a tension headache from a migraine is the absence"
      }, {
        "text": " of severe, debilitating features. Tension headaches are bilateral, non-pulsating, and lack significant associated symptoms like nausea."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTension-type headaches\u003c/b\u003e are the common, \u0027"
      }, {
        "text": "featureless\u0027 headache, defined more by what they lack (unilaterality, pulsating quality, nausea, severe disability"
      }, {
        "text": ") than what they have, presenting as a simple, bilateral pressure or tightness.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"primary_headache\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\":"
      }, {
        "text": " \"c8833bae\"\n      },\n      {\n        \"type\": \"is_treated_pro"
      }, {
        "text": "phylactically_by\",\n        \"to\": \"c6814506\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"e5846fa8\": {\n    \"title\": \"Teratogenicity of"
      }, {
        "text": " Anticonvulsants\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"Obstetrics\",\n      \"Teratology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anticonvulsants\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eMany \u003cb\u003eanticonvulsant\u003c/b\u003e ("
      }, {
        "text": "antiepileptic) drugs are known teratogens, meaning they can cause birth defects if taken during pregnancy. This poses"
      }, {
        "text": " a significant management challenge for women with epilepsy of childbearing age.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eGeneral Risk:\u003c/b\u003e All anticonvulsants carry some risk, and the goal is to use the lowest effective dose of a"
      }, {
        "text": " single agent (monotherapy) if possible.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[0d37e045|Valpro"
      }, {
        "text": "ate]]:\u003c/b\u003e Has the \u003cmark\u003ehighest risk of teratogenicity\u003c/mark\u003e. It is strongly associated with an increased risk of \u003cmark\u003eneural tube"
      }, {
        "text": " defects\u003c/mark\u003e (e.g., spina bifida) due to its interference with folate metabolism. It can"
      }, {
        "text": " also cause other malformations and is associated with lower IQ in offspring.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[eddd2bc5|Car"
      }, {
        "text": "bamazepine]]:\u003c/b\u003e Also associated with neural tube defects.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[5aea213f|Phenytoin]]:\u003c/b\u003e Can"
      }, {
        "text": " cause Fetal Hydantoin Syndrome, characterized by craniofacial abnormalities (cleft lip/palate), hypoplastic nails"
      }, {
        "text": " and distal phalanges, and growth/intellectual disability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFolate Supplementation:\u003c/b\u003e High-dose folic"
      }, {
        "text": " acid supplementation is recommended for all women of childbearing potential who are taking anticonvulsants to reduce the risk of neural tube defects."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Valproate is the most notorious teratogen among the anticonvulsants, with a strong"
      }, {
        "text": " link to neural tube defects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eteratogenicity of anticon"
      }, {
        "text": "vulsants\u003c/b\u003e is a major clinical concern, with valproate carrying the highest risk, particularly for neural tube defects, necessitating careful"
      }, {
        "text": " counseling and high-dose folate supplementation for women with epilepsy who are planning a pregnancy.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"f9"
      }, {
        "text": "1a0cfa\"\n      },\n      {\n        \"type\": \"is_highest_with\",\n        \"to\": \"0"
      }, {
        "text": "d37e045\"\n      },\n      {\n        \"type\": \"can_cause\","
      }, {
        "text": "\n        \"to\": \"neural_tube_defect\"\n      }\n    ]\n  },\n  \"d"
      }, {
        "text": "6d5d92e\": {\n    \"title\": \"Tetracaine\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTetracaine"
      }, {
        "text": "\u003c/b\u003e is a potent, long-acting, ester-type \u003ci\u003elocal anesthetic\u003c/i\u003e used for spinal anesthesia and topically for anesthesia"
      }, {
        "text": " of the eye, nose, or throat.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks"
      }, {
        "text": " voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass"
      }, {
        "text": ":\u003c/b\u003e Ester local anesthetic. It is metabolized by plasma pseudocholinesterases.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has"
      }, {
        "text": " a slow onset but a long duration of action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Commonly used for spinal anesthesia due to its long duration. Also used in"
      }, {
        "text": " topical formulations for ophthalmology and ENT procedures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e As an ester, it has a higher potential"
      }, {
        "text": " for allergic reactions (due to its metabolite, PABA) compared to amide anesthetics. Systemic toxicity can cause CNS excitation"
      }, {
        "text": " and cardiovascular collapse.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the classification of local anesthetics: Esters (one"
      }, {
        "text": " \u0027i\u0027 in the name, e.g., tetraca\u003cb\u003ei\u003c/b\u003ene, coca\u003cb\u003ei\u003c/b\u003ene)"
      }, {
        "text": " are metabolized in the plasma, while Amides (two \u0027i\u0027s, e.g., l\u003cb\u003ei\u003c/b\u003e"
      }, {
        "text": "doca\u003cb\u003ei\u003c/b\u003ene) are metabolized in the liver.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eTetracaine\u003c/b\u003e is a long-acting ester anesthetic whose prolonged nerve-blocking effect makes it well-suited for spinal anesthesia,"
      }, {
        "text": " but its ester structure carries a risk of allergic reactions.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        \""
      }, {
        "text": "to\": \"pseudocholinesterase\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \""
      }, {
        "text": "voltage_gated_sodium_channel\"\n      }\n    ]\n  },\n  \"f71"
      }, {
        "text": "0cf40\": {\n    \"title\": \"Tetracyclines\",\n    \"primaryType\": \"drug\",\n"
      }, {
        "text": "    \"tags\": [\n      \"Pharmacology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Ad"
      }, {
        "text": "verse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTetracycl"
      }, {
        "text": "ines\u003c/b\u003e (e.g., tetracycline, doxycycline, minocycline) are a class of broad-spectrum bacteri"
      }, {
        "text": "ostatic antibiotics that inhibit protein synthesis by binding to the 30S ribosomal subunit.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Bind to the 30S ribosomal subunit and prevent the attachment of aminoacyl-tRNA to the A"
      }, {
        "text": " site.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Effective against a wide range of bacteria, including atypical organisms (\u003ci\u003eMycoplasma\u003c/i\u003e"
      }, {
        "text": ", \u003ci\u003eChlamydia\u003c/i\u003e), spirochetes (\u003ci\u003eBorrelia burgdorferi\u003c/i\u003e in Lyme disease), and ricketts"
      }, {
        "text": "ial species. Also used for acne.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e GI distress, photosensitivity, and discoloration"
      }, {
        "text": " of teeth and inhibition of bone growth in children. They are teratogenic and should be avoided in pregnancy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurologic"
      }, {
        "text": " Side Effect:\u003c/b\u003e Tetracyclines, particularly minocycline, are a known cause of \u003cmark\u003e[[7c"
      }, {
        "text": "4e7c74|idiopathic intracranial hypertension]]\u003c/mark\u003e (pseudotumor cerebri).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the major side effects: photosensitivity, teeth discoloration in kids, and teratogenicity. The"
      }, {
        "text": " association with pseudotumor cerebri is also a high-yield fact.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTetracycl"
      }, {
        "text": "ines\u003c/b\u003e are broad-spectrum antibiotics that, in addition to their well-known side effects like photosensitivity and teeth staining, can"
      }, {
        "text": " also cause the neurological condition of idiopathic intracranial hypertension.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"antibiotic\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"inhibits\",\n        \"to\": \"bacterial_protein_synthesis\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"7c"
      }, {
        "text": "4e7c74\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\":"
      }, {
        "text": " \"photosensitivity\"\n      }\n    ]\n  },\n  \"afc0a64b\": {\n    \"title\": \""
      }, {
        "text": "Thalamus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Thalamus\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003eThe \u003cb\u003eThalamus\u003c/b\u003e is a large, paired gray matter structure in the di"
      }, {
        "text": "encephalon, located superior to the brainstem. It serves as the primary relay and integration center for sensory information (except smell"
      }, {
        "text": ") on its way to the cerebral cortex, and also plays a crucial role in motor control, consciousness, sleep, and alertness"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The major sensory relay station of the brain. All"
      }, {
        "text": " sensory input (except olfaction) synapses in the thalamus before being projected to the appropriate cortical area.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Nuclei and Functions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[2ae957b8|VPL]]:"
      }, {
        "text": "\u003c/b\u003e Relays sensation (pain, temp, proprioception, touch) from the body.\u003cbr\u003e - \u003cb\u003e[[23"
      }, {
        "text": "ac314a|VPM]]:\u003c/b\u003e Relays sensation from the face (via trigeminal nerve) and taste.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eLGN (Lateral Geniculate Nucleus):\u003c/b\u003e Relays visual information. Mnemonic: "
      }, {
        "text": "\u003cb\u003eL\u003c/b\u003eGN for \u003cb\u003eL\u003c/b\u003eight.\u003cbr\u003e - \u003cb\u003eMGN (Medial Geniculate Nucleus):\u003c/b\u003e Rel"
      }, {
        "text": "ays auditory information. Mnemonic: \u003cb\u003eM\u003c/b\u003eGN for \u003cb\u003eM\u003c/b\u003eusic.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "VA/VL:\u003c/b\u003e Relays motor information from the [[ed462927|basal ganglia]] and"
      }, {
        "text": " cerebellum to the motor cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLimbic System Connection:\u003c/b\u003e The anterior nucleus of the thalamus is part of the Pape"
      }, {
        "text": "z circuit, a component of the [[73ace357|limbic system]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions"
      }, {
        "text": ":\u003c/b\u003e A thalamic stroke can cause \u003cmark\u003econtralateral sensory loss\u003c/mark\u003e of all modalities. It"
      }, {
        "text": " can also lead to [[714f15fc|central post-stroke pain syndrome]] (thalamic pain syndrome"
      }, {
        "text": ").\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eThalamus\u003c/b\u003e acts as the brain"
      }, {
        "text": "\u0027s central switchboard, sorting and directing nearly all incoming sensory and motor signals to their appropriate cortical destinations, making it indispensable"
      }, {
        "text": " for perception, movement, and consciousness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sensory Input"
      }, {
        "text": "] --\u003e B(Thalamus); B --\u003e C(Cortex); D[Basal Ganglia/Cerebellum] --\u003e B;\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \""
      }, {
        "text": "24a24d08\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_relay_for\",\n        \"to\": \"sensory_system\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_a_relay_for\",\n        \"to\": \"motor_system\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"lesion_causes\",\n        \"to\": \"714f15fc\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"91bfec7e\": {\n    \"title\":"
      }, {
        "text": " \"Thrombotic Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \""
      }, {
        "text": "Neurology\",\n      \"Cardiology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath"
      }, {
        "text": "\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003ethrombotic stroke\u003c/b\u003e is a type"
      }, {
        "text": " of [[c5da3c57|ischemic stroke]] that occurs when a thrombus (blood clot) forms on"
      }, {
        "text": " an atherosclerotic plaque within a cerebral artery, obstructing blood flow.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Atherosclerosis leads to the formation of plaques in cerebral arteries. Rupture of one of these plaques can trigger local"
      }, {
        "text": " thrombus formation, leading to arterial occlusion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOnset:\u003c/b\u003e The onset of symptoms is often \u003cmark\u003egradual or stutter"
      }, {
        "text": "ing\u003c/mark\u003e, developing over minutes to hours, as the thrombus grows to completely occlude the vessel. Patients may awaken"
      }, {
        "text": " from sleep with the deficit.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly occurs at arterial branch points, such as the carotid"
      }, {
        "text": " bifurcation or the origin of the [[143bb23d|middle cerebral artery (MCA)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk"
      }, {
        "text": " Factors:\u003c/b\u003e The risk factors are those for atherosclerosis: hypertension, hyperlipidemia, diabetes, and smoking.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferent"
      }, {
        "text": "iation from Embolic Stroke:\u003c/b\u003e [[6a805ecd|Embolic strokes]] typically have a sudden, maximal-"
      }, {
        "text": "at-onset presentation, whereas thrombotic strokes can have a more gradual onset.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient"
      }, {
        "text": " with known risk factors for atherosclerosis who develops neurological deficits that progress over several hours is likely having a thrombotic stroke.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003ethrombotic stroke\u003c/b\u003e is a \u0027stroke from within,\u0027 where"
      }, {
        "text": " a clot forms directly on a pre-existing atherosclerotic plaque in a brain artery, gradually choking off blood flow and causing a stutter"
      }, {
        "text": "ing or progressive onset of neurological symptoms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Atherosclerotic"
      }, {
        "text": " Plaque] --Rupture--\u003e B(Thrombus Formation); B --\u003e C(Occlusion of Cerebral Artery); C --\u003e"
      }, {
        "text": " D(Ischemic Stroke);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by\",\n        \"to\": \"atherosclerosis\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"differentiated_from\",\n        \"to\": \"6a805ecd\"\n      }\n    "
      }, {
        "text": "]\n  },\n  \"e53c9136\": {\n    \"title\": \"Thrush (Oral Candid"
      }, {
        "text": "iasis)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Infectious Disease\",\n      \"Immun"
      }, {
        "text": "ology\",\n      \"Oral Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"G"
      }, {
        "text": "astrointestinal\",\n      \"Pathology\",\n      \"Oral Cavity\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eThrush\u003c/b\u003e, or oral candidiasis, is a fungal infection of the mucous membranes of the mouth caused by an"
      }, {
        "text": " overgrowth of \u003ci\u003eCandida\u003c/i\u003e species, most commonly \u003ci\u003eCandida albicans\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by white, cottage cheese-like plaques on the tongue, buccal"
      }, {
        "text": " mucosa, and palate. These plaques can be \u003cmark\u003escraped off\u003c/mark\u003e, revealing an erythematous, sometimes"
      }, {
        "text": " bleeding, base.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Occurs in states of immunosuppression or disruption of normal oral flora. Common risk factors include"
      }, {
        "text": " infancy, use of inhaled corticosteroids (without rinsing), antibiotic therapy, and immunodeficiency (e.g., HIV/AIDS).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Usually clinical. Can be confirmed by a KOH preparation of a scraping, which will show pseudohyphae and budding"
      }, {
        "text": " yeasts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Topical antifungal agents like nystatin \u0027swish and swallow\u0027 or clotrimazole tro"
      }, {
        "text": "ches. Systemic fluconazole may be used for more severe or refractory cases.\u003c/li\u003e\u003cli\u003e\u003cb\u003e\u0027Thunderclap Headache"
      }, {
        "text": "\u0027:\u003c/b\u003e This term describes the sudden, severe headache of a [[63f8b05f|subarachnoid hemorrhage"
      }, {
        "text": "]] and is \u003cu\u003enot related\u003c/u\u003e to thrush. The index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e The ability to scrape off the white plaques is a key feature that distinguishes thrush from oral hairy leukoplakia ("
      }, {
        "text": "seen in HIV, cannot be scraped off).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eThrush\u003c/b\u003e"
      }, {
        "text": " is a superficial \u003ci\u003eCandida\u003c/i\u003e infection of the mouth, presenting as white plaques that can be scraped off, and"
      }, {
        "text": " serves as a clinical indicator of either local or systemic immunosuppression.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"candida_albicans\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\":"
      }, {
        "text": " \"immunosuppression\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \""
      }, {
        "text": "to\": \"oral_hairy_leukoplakia\"\n      }\n    ]\n  },\n  \"5"
      }, {
        "text": "206aa83\": {\n    \"title\": \"Tight Junctions (CNS)\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"Phys"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Blood-Brain Barrier\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eIn the central nervous system, \u003cb\u003etight junctions\u003c/b\u003e (zonula occludens) are multip"
      }, {
        "text": "rotein junctional complexes that join the cerebral endothelial cells together, forming a continuous seal that is the primary structural component of the [[dd"
      }, {
        "text": "47b9cc|blood-brain barrier]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:"
      }, {
        "text": "\u003c/b\u003e They severely restrict paracellular (between-cell) diffusion of solutes from the blood into the brain. This forces most"
      }, {
        "text": " substances to pass through the endothelial cells themselves (transcellular route), allowing for highly selective transport.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProteins:\u003c/b\u003e Com"
      }, {
        "text": "posed of transmembrane proteins like claudins and occludins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBlood-Brain Barrier:\u003c/b\u003e The tight"
      }, {
        "text": " junctions of the non-fenestrated CNS capillary endothelium are the most critical element in forming the [[dd47b9cc|blood"
      }, {
        "text": "-brain barrier]].\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Disruption of tight junctions leads to a breakdown of the blood-brain barrier and"
      }, {
        "text": " the development of \u003cmark\u003evasogenic edema\u003c/mark\u003e. This can occur in response to inflammation, tumors, or ischemia"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of extensive tight junctions is the key feature that distinguishes CNS capillaries from the more permeable (\u0027"
      }, {
        "text": "fenestrated\u0027 or \u0027discontinuous\u0027) capillaries found in other parts of the body.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eTight junctions\u003c/b\u003e are the molecular \u0027mortar\u0027 that seals the gaps between cerebral endothelial cells, creating"
      }, {
        "text": " the formidable blood-brain barrier and forcing nearly all substances to undergo a highly regulated transcellular journey to enter the brain.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_key_component_of\",\n        \"to\": \"dd47b9cc\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"are_composed_of\",\n        \"to\": \"claudins\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"disruption_leads_to\",\n        \"to\": \"d94a9"
      }, {
        "text": "e61\"\n      }\n    ]\n  },\n  \"ae28be6c\": {\n    \"title"
      }, {
        "text": "\": \"Timolol\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Ophthalmology\",\n      \"Cardiology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Glaucoma Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTim"
      }, {
        "text": "olol\u003c/b\u003e is a non-selective \u003ci\u003eŒ≤-adrenergic antagonist\u003c/i\u003e (beta-blocker) used topically as eye"
      }, {
        "text": " drops to reduce intraocular pressure (IOP) in the treatment of [[5ea7b741|open-angle glaucoma]]."
      }, {
        "text": "\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks both Œ≤\u003csub\u003e1\u003c/sub\u003e and Œ≤\u003csub\u003e2"
      }, {
        "text": "\u003c/sub\u003e adrenergic receptors on the ciliary epithelium. This \u003cmark\u003edecreases the production of aqueous humor\u003c/mark\u003e, thereby"
      }, {
        "text": " lowering IOP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-selective beta-blocker.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e A"
      }, {
        "text": " first-line agent for [[5ea7b741|open-angle glaucoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e O"
      }, {
        "text": "cular side effects are minimal. Systemic absorption can occur, leading to bradycardia, hypotension, fatigue, and \u003cmark\u003ebron"
      }, {
        "text": "choconstriction\u003c/mark\u003e (due to Œ≤\u003csub\u003e2\u003c/sub\u003e blockade).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Should be used with caution or"
      }, {
        "text": " avoided in patients with \u003cmark\u003easthma, COPD\u003c/mark\u003e, bradycardia, or severe heart failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e Timolol is a classic first-line glaucoma drug. Its non-selective nature means you must consider the risk of bronch"
      }, {
        "text": "ospasm in patients with reactive airway disease. In such patients, a Œ≤\u003csub\u003e1\u003c/sub\u003e-selective agent like [[4"
      }, {
        "text": "3508d57|betaxolol]] would be a safer choice.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Timolol\u003c/b\u003e is a highly effective topical beta-blocker for glaucoma that works by reducing aqueous humor production, but its non-select"
      }, {
        "text": "ivity requires caution due to the potential for systemic side effects, particularly bronchoconstriction in susceptible individuals.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Timolol] --\u003e B(Blocks Œ≤-Receptors on Ciliary Epithelium); B --\u003e C"
      }, {
        "text": "(‚Üì Aqueous Humor Production); C --\u003e D(‚Üì Intraocular Pressure);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"10535"
      }, {
        "text": "992\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \""
      }, {
        "text": "3ce6c035\"\n      },\n      {\n        \"type\": \"decreases_production_of\",\n        \"to"
      }, {
        "text": "\": \"aqueous_humor\"\n      },\n      {\n        \"type\": \"is_contraindicated_in"
      }, {
        "text": "\",\n        \"to\": \"asthma\"\n      }\n    ]\n  },\n  \"bfe1"
      }, {
        "text": "7d7e\": {\n    \"title\": \"Tizanidine\",\n    \"primaryType\": \"drug\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTizan"
      }, {
        "text": "idine\u003c/b\u003e is a centrally acting \u003ci\u003eŒ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist\u003c/i\u003e that is used as a skeletal muscle relaxant ("
      }, {
        "text": "antispasmodic) to treat spasticity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action"
      }, {
        "text": ":\u003c/b\u003e Acts as an Œ±\u003csub\u003e2\u003c/sub\u003e-agonist in the spinal cord. This enhances presynaptic inhibition of motor neurons"
      }, {
        "text": ", reducing the release of excitatory amino acids and thereby decreasing muscle spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Management"
      }, {
        "text": " of spasticity associated with [[45dd6d19|multiple sclerosis]], spinal cord injury, and [["
      }, {
        "text": "171ca00b|cerebral palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Hypotension, sedation"
      }, {
        "text": "/somnolence, dry mouth, and dizziness. Hepatotoxicity is a rare but serious side effect, requiring monitoring of liver function tests"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Clonidine:\u003c/b\u003e Tizanidine is structurally and mechanistically related to clonidine (an antihy"
      }, {
        "text": "pertensive), but it has a greater effect on muscle spasticity with less of an effect on blood pressure.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Tizanidine is a muscle relaxant that works via the Œ±\u003csub\u003e2\u003c/sub\u003e-agonist mechanism"
      }, {
        "text": ", similar to clonidine. Remember its use for chronic spasticity and its potential to cause hypotension.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eTizanidine\u003c/b\u003e reduces muscle spasticity by acting as an Œ±\u003csub\u003e2\u003c/sub\u003e-agonist in the spinal"
      }, {
        "text": " cord, which dampens the excitability of motor neurons, but its shared mechanism with clonidine means it also carries the"
      }, {
        "text": " risk of causing hypotension and sedation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"af72aab5\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"bc6647"
      }, {
        "text": "e5\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \""
      }, {
        "text": "spasticity\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \""
      }, {
        "text": "45dd6d19\"\n      }\n    ]\n  },\n  \"42e6a"
      }, {
        "text": "13b\": {\n    \"title\": \"Tobacco Smoking (Neurological Risks)\",\n    \"primaryType\": \""
      }, {
        "text": "concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Public Health\",\n      \"Card"
      }, {
        "text": "iology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Risk Factors\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eTobacco smoking\u003c/b\u003e is a major modifiable risk factor for a wide range of neurological diseases, primarily through its profound"
      }, {
        "text": " effects on the cardiovascular system and its direct neurotoxic and pro-inflammatory properties.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eStroke:\u003c/b\u003e Smoking is a potent risk factor for both [[c5da3c57|ischemic stroke]] and [["
      }, {
        "text": "63f8b05f|subarachnoid hemorrhage]]. It promotes atherosclerosis, increases blood pressure, and induces"
      }, {
        "text": " a hypercoagulable state.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCerebral Aneurysms:\u003c/b\u003e Smoking is a significant risk factor for the formation"
      }, {
        "text": " and rupture of [[a9f6d703|saccular (berry) aneurysms]].\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eDementia:\u003c/b\u003e Smoking increases the risk of both [[77ae6148|Alzheimer disease]] and [[99"
      }, {
        "text": "420dce|vascular dementia]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eMultiple Sclerosis:\u003c/b\u003e Smoking is associated with an increased risk of developing [["
      }, {
        "text": "45dd6d19|MS]] and with a more rapid disease progression.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In"
      }, {
        "text": " a patient with a stroke or subarachnoid hemorrhage, smoking should be identified as a key modifiable risk factor."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTobacco smoking\u003c/b\u003e is a powerful neurotoxin and vascul"
      }, {
        "text": "otoxin, accelerating atherosclerosis and promoting thrombosis, thereby dramatically increasing the risk of devastating neurological events like stroke and aneurysm rupture.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "risk_factor_for\",\n        \"to\": \"c5da3c57\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_risk_factor_for\",\n        \"to\": \""
      }, {
        "text": "a9f6d703\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_risk_factor_for\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_risk_factor_for\",\n        \"to\": \"45dd6"
      }, {
        "text": "d19\"\n      }\n    ]\n  },\n  \"5f6eb15f\": {\n    \"title\": \""
      }, {
        "text": "Tolcapone\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology"
      }, {
        "text": "\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n"
      }, {
        "text": "      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTolcapone\u003c/b\u003e is a reversible inhibitor of catechol-O"
      }, {
        "text": "-methyltransferase (COMT) that is used as an adjunctive therapy with [[541cd176|levod"
      }, {
        "text": "opa/carbidopa]] for the treatment of [[58c8ea03|Parkinson disease]].\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibits COMT, the"
      }, {
        "text": " enzyme that metabolizes levodopa. Unlike [[eb2da2bc|entacapone]], tolcapone acts in"
      }, {
        "text": " both the \u003cmark\u003eperiphery and the central nervous system\u003c/mark\u003e because it can cross the blood-brain barrier. This"
      }, {
        "text": " dual action increases the bioavailability of levodopa to the brain and also prevents the breakdown of dopamine within the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use"
      }, {
        "text": ":\u003c/b\u003e Used with [[541cd176|levodopa/carbidopa]] to prolong the \u0027"
      }, {
        "text": "on\u0027 time and reduce \u0027off\u0027 time in patients with motor fluctuations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Pot"
      }, {
        "text": "entiates levodopa side effects (dyskinesias, nausea). The most significant adverse effect is \u003cmark\u003ehepatotoxicity\u003c/"
      }, {
        "text": "mark\u003e, which can be fatal. Its use is limited due to this risk and requires regular monitoring of liver function tests.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the key difference between the COMT inhibitors: \u003cb\u003eT\u003c/b\u003eolcapone acts in"
      }, {
        "text": " \u003cb\u003eT\u003c/b\u003ewo places (CNS and periphery) and is toxic to the liver. \u003cb\u003eE\u003c/b\u003entacapone acts in the "
      }, {
        "text": "\u003cb\u003eE\u003c/b\u003endiphery (periphery) only.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTol"
      }, {
        "text": "capone\u003c/b\u003e is a potent COMT inhibitor that works both centrally and peripherally to extend the action of levodopa, but its clinical"
      }, {
        "text": " use is severely restricted by the risk of life-threatening hepatotoxicity.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lev"
      }, {
        "text": "odopa] --Peripheral COMT--\u003e B(3-O-methyldopa); C[Tolcapone] --"
      }, {
        "text": "x B; A --\u003e D(Crosses BBB); D --\u003e E[Dopamine in CNS]; E --Central COMT--\u003e F(3"
      }, {
        "text": "-MT); C --x F;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"comt_inhibitor\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"differentiated_from\",\n        \"to\": \"eb2da2bc\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"hepatotoxicity"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"1761b409\": {\n    \"title"
      }, {
        "text": "\": \"Tongue\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"An"
      }, {
        "text": "atomy\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003etongue\u003c/b\u003e is a muscular organ in the mouth"
      }, {
        "text": " that is vital for gustation (taste), mastication (chewing), deglutition (swallowing), and articulation"
      }, {
        "text": " (speech). Its complex functions are controlled by multiple cranial nerves.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Motor Innervation:\u003c/b\u003e All intrinsic and extrinsic muscles of the tongue are innervated by the \u003cmark\u003ehypoglossal nerve (CN XII)\u003c/"
      }, {
        "text": "mark\u003e, except for the palatoglossus muscle, which is innervated by the \u003cmark\u003evagus nerve (CN X"
      }, {
        "text": ")\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Innervation (Anterior 2/3):\u003c/b\u003e\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eGeneral Sensation\u003c/b\u003e (touch, pain, temp): Mandibular division of the trigeminal nerve (CN V"
      }, {
        "text": "\u003csub\u003e3\u003c/sub\u003e).\u003cbr\u003e - \u003cb\u003eTaste (Special Sensation):\u003c/b\u003e Chorda tympani branch of the facial nerve (CN"
      }, {
        "text": " VII).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSensory Innervation (Posterior 1/3):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eGeneral Sensation \u0026"
      }, {
        "text": " Taste:\u003c/b\u003e Glossopharyngeal nerve (CN IX).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSwallowing:\u003c/b\u003e Coordinated movement of the tongue,"
      }, {
        "text": " primarily by CN XII, is essential for the oral phase of swallowing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A lesion of"
      }, {
        "text": " CN XII will cause the tongue to deviate \u003cu\u003etoward\u003c/u\u003e the side of the lesion upon protrusion (\u0027lick your wounds\u0027). Remember"
      }, {
        "text": " the different sensory nerves for the anterior vs. posterior tongue.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003etongue\u003c/b\u003e is a neurologically complex organ, with its motor function dominated by CN XII, while its sensory and"
      }, {
        "text": " taste functions are neatly divided between CN V, VII, and IX for the anterior and posterior portions.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"motor_innervation_by\",\n        \"to\":"
      }, {
        "text": " \"hypoglossal_nerve\"\n      },\n      {\n        \"type\": \"sensory_innervation_by\",\n"
      }, {
        "text": "        \"to\": \"trigeminal_nerve_v3\"\n      },\n      {\n        \"type\": \"taste"
      }, {
        "text": "_innervation_by\",\n        \"to\": \"facial_nerve\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"taste_and_sensory_innervation_by\",\n        \"to\": \"9"
      }, {
        "text": "7e2c817\"\n      }\n    ]\n  },\n  \"dc458d"
      }, {
        "text": "4e\": {\n    \"title\": \"Tonic Seizure\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Se"
      }, {
        "text": "izures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003etonic seizure\u003c/b\u003e is a type"
      }, {
        "text": " of [[2e7554b7|generalized seizure]] characterized by a sudden, sustained increase in muscle tone,"
      }, {
        "text": " causing the body, arms, or legs to become stiff and rigid. Consciousness is typically impaired.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The seizure consists of a sudden, forceful, sustained contraction of muscles"
      }, {
        "text": ". If standing, the person will fall stiffly (\u0027like a tree falling\u0027). The eyes may roll back, and breathing"
      }, {
        "text": " may be temporarily arrested. The event is usually brief, lasting from a few seconds to a minute.\u003c/li\u003e\u003cli\u003e\u003cb\u003eT"
      }, {
        "text": "onic-Clonic Seizure:\u003c/b\u003e A tonic seizure is the initial phase of a [[39f6b1"
      }, {
        "text": "28|generalized tonic-clonic seizure]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndromes:\u003c/b\u003e Tonic seizures are a common feature of severe"
      }, {
        "text": " epilepsy syndromes, particularly \u003cmark\u003eLennox-Gastaut syndrome\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEEG Findings:\u003c/b\u003e The"
      }, {
        "text": " EEG typically shows a generalized, low-voltage fast activity or a flattening (desynchronization) of the background rhythm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Differentiate a tonic seizure (sustained stiffening) from a clonic seizure (rhythmic jerking) and an atonic seizure ("
      }, {
        "text": "sudden loss of tone).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003etonic seizure\u003c/b\u003e is a manifestation"
      }, {
        "text": " of a widespread neuronal discharge that locks the body\u0027s muscles into a state of rigid contraction, often seen as the initial \u0027"
      }, {
        "text": "stiffening\u0027 phase of a grand mal seizure or as a feature of severe epilepsy syndromes.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"2e7554b7\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "phase_of\",\n        \"to\": \"39f6b128\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"lennox"
      }, {
        "text": "_gastaut_syndrome\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"381bfc50\",\n    \"letter\": \"S\",\n    \"term\": \"Superior rectus muscle\",\n    \"pages\": [\n      \"555\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Superior rectus muscle\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ad2b0b65\",\n    \"letter\": \"S\",\n    \"term\": \"Suprachiasmatic nucleus, circadian\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Suprachiasmatic nucleus, circadian\",\n    \"sub_entries\": [\n      {\n        \"id\": \"197b70bc\",\n        \"letter\": \"S\",\n        \"term\": \"rhythm\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Suprachiasmatic nucleus, circadian \u003e rhythm\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b2594742\",\n    \"letter\": \"S\",\n    \"term\": \"Supraoptic nucleus\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Supraoptic nucleus\",\n    \"sub_entries\": [\n      {\n        \"id\": \"90436a57\",\n        \"letter\": \"S\",\n        \"term\": \"secretions of\",\n        \"pages\": [\n          \"331\",\n          \"508\"\n        ],\n        \"context\": \"Supraoptic nucleus \u003e secretions of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6a781682\",\n    \"letter\": \"S\",\n    \"term\": \"Survival motor neuron protein\",\n    \"pages\": [\n      \"544\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Survival motor neuron protein\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"deaa4d25\",\n    \"letter\": \"S\",\n    \"term\": \"Suvorexant\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Suvorexant\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1e6ae46b\",\n    \"letter\": \"S\",\n    \"term\": \"Swallowing\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Swallowing\",\n    \"sub_entries\": [\n      {\n        \"id\": \"99fe4c46\",\n        \"letter\": \"S\",\n        \"term\": \"motor innervation\",\n        \"pages\": [\n          \"516\",\n          \"519\"\n        ],\n        \"context\": \"Swallowing \u003e motor innervation\"\n      },\n      {\n        \"id\": \"62227bcb\",\n        \"letter\": \"S\",\n        \"term\": \"tongue movement in\",\n        \"pages\": [\n          \"364\",\n          \"519\"\n        ],\n        \"context\": \"Swallowing \u003e tongue movement in\"\n      }\n    ]\n  },\n  {\n    \"id\": \"789bda92\",\n    \"letter\": \"S\",\n    \"term\": \"Sympathetic nervous system\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sympathetic nervous system\",\n    \"sub_entries\": [\n      {\n        \"id\": \"62568712\",\n        \"letter\": \"S\",\n        \"term\": \"denervation of face\",\n        \"pages\": [\n          \"555\"\n        ],\n        \"context\": \"Sympathetic nervous system \u003e denervation of face\"\n      }\n    ]\n  },\n  {\n    \"id\": \"fb50d450\",\n    \"letter\": \"S\",\n    \"term\": \"Synaptophysin\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Synaptophysin\",\n    \"sub_entries\": [\n      {\n        \"id\": \"643422df\",\n        \"letter\": \"S\",\n        \"term\": \"tumor identification\",\n        \"pages\": [\n          \"223\",\n          \"542\"\n        ],\n        \"context\": \"Synaptophysin \u003e tumor identification\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d2b8e10c\",\n    \"letter\": \"S\",\n    \"term\": \"Syringomyelia\",\n    \"pages\": [\n      \"502\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Syringomyelia\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"71daebd6\",\n    \"letter\": \"T\",\n    \"term\": \"Tabes dorsalis\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Tabes dorsalis\",\n    \"sub_entries\": [\n      {\n        \"id\": \"340f44ad\",\n        \"letter\": \"T\",\n        \"term\": \"spinal cord lesions with\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Tabes dorsalis \u003e spinal cord lesions with\"\n      }\n    ]\n  },\n  {\n    \"id\": \"bda79225\",\n    \"letter\": \"T\",\n    \"term\": \"Tardive dyskinesia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Tardive dyskinesia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a4b67950\",\n        \"letter\": \"T\",\n        \"term\": \"treatment\",\n        \"pages\": [\n          \"564\"\n        ],\n        \"context\": \"Tardive dyskinesia \u003e treatment\"\n      }\n    ]\n  },\n  {\n    \"id\": \"e3ce6784\",\n    \"letter\": \"T\",\n    \"term\": \"Taste\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Taste\",\n    \"sub_entries\": [\n      {\n        \"id\": \"9f879463\",\n        \"letter\": \"T\",\n        \"term\": \"cortical stroke\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Taste \u003e cortical stroke\"\n      },\n      {\n        \"id\": \"efd51ae8\",\n        \"letter\": \"T\",\n        \"term\": \"cranial nerve lesions\",\n        \"pages\": [\n          \"546\"\n        ],\n        \"context\": \"Taste \u003e cranial nerve lesions\"\n      },\n      {\n        \"id\": \"40b89894\",\n        \"letter\": \"T\",\n        \"term\": \"cranial nerve nuclei\",\n        \"pages\": [\n          \"516\"\n        ],\n        \"context\": \"Taste \u003e cranial nerve nuclei\"\n      },\n      {\n        \"id\": \"0f03dd3f\",\n        \"letter\": \"T\",\n        \"term\": \"cranial nerves and\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Taste \u003e cranial nerves and\"\n      },\n      {\n        \"id\": \"af30d5d7\",\n        \"letter\": \"T\",\n        \"term\": \"thalamic nuclei\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Taste \u003e thalamic nuclei\"\n      }\n    ]\n  },\n  {\n    \"id\": \"75929e32\",\n    \"letter\": \"T\",\n    \"term\": \"Telencephalon\",\n    \"pages\": [\n      \"500\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Telencephalon\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e6deda1b\",\n    \"letter\": \"T\",\n    \"term\": \"Temazepam\",\n    \"pages\": [\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Temazepam\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b8b42fc5\",\n    \"letter\": \"T\",\n    \"term\": \"Temperature sensation, receptors\",\n    \"pages\": [\n      \"504\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Temperature sensation, receptors\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2121
    }, {
      "text": "```json\n{\n  \"381bfc50\": {\n    \"title\": \"Superior Rectus Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSuperior Rectus\u003c/b\u003e is one of the six extraocular muscles responsible for moving the eye. Its primary action is elevation, but it also contributes to adduction and intorsion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e It is innervated by the superior division of the \u003cmark\u003eoculomotor nerve (CN III)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Action:\u003c/b\u003e Elevation (moving the eye upward).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary Actions:\u003c/b\u003e Adduction (moving the eye medially) and intorsion (rotating the top of the eye toward the nose).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTesting:\u003c/b\u003e The function of the superior rectus is best isolated by having the patient look \u003cmark\u003eup and out\u003c/mark\u003e (abducted position).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion:\u003c/b\u003e Weakness of the superior rectus due to a [[fdfd22ca|CN III palsy]] contributes to the characteristic \u0027down and out\u0027 position of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e. The superior rectus is one of the \u0027rest\u0027 innervated by CN III. To test it, have the patient look up and out.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSuperior Rectus muscle\u003c/b\u003e is the primary elevator of the eye, controlled by the oculomotor nerve, and its function is clinically isolated by having the patient look in an abducted, upward direction.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"68c66997\"\n      },\n      {\n        \"type\": \"action_is\",\n        \"to\": \"elevation_of_eye\"\n      }\n    ]\n  },\n  \"ad2b0b65\": {\n    \"title\": \"Suprachiasmatic Nucleus (SCN)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSuprachiasmatic Nucleus (SCN)\u003c/b\u003e is a tiny region in the anterior [[89e86633|hypothalamus]], situated directly above the optic chiasm. It functions as the central \u0027master clock\u0027 of the body, responsible for controlling [[0ab894d6|circadian rhythms]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The SCN is the primary pacemaker of the circadian timing system, regulating the sleep-wake cycle, body temperature, and hormone secretion over a near-24-hour period.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e It receives direct input from photosensitive ganglion cells in the retina via the \u003cmark\u003eretinohypothalamic tract\u003c/mark\u003e. This light information is used to entrain (synchronize) the internal clock to the external day-night cycle.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e The SCN projects to various brain regions, including the pineal gland. It regulates the pineal gland\u0027s production of \u003cmark\u003emelatonin\u003c/mark\u003e, with secretion increasing in darkness and decreasing in light.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e Destruction of the SCN results in the loss of circadian rhythms, leading to a disorganized sleep-wake pattern.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The SCN is the anatomical basis for the body\u0027s internal clock. Remember its location above the optic chiasm, which is perfectly positioned to receive light cues.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSuprachiasmatic Nucleus\u003c/b\u003e is the brain\u0027s master timekeeper, a small hypothalamic nucleus that uses light as its primary cue to synchronize the body\u0027s myriad physiological and behavioral circadian rhythms with the 24-hour solar day.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Light] --\u003e B(Retina); B --\u003e C(Suprachiasmatic Nucleus - SCN); C --\u003e D(Pineal Gland); D --\u003e E(Melatonin Secretion); E --\u003e F(Regulation of Circadian Rhythms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"controls\",\n        \"to\": \"0ab894d6\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"retina\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"pineal_gland\"\n      }\n    ]\n  },\n  \"b2594742\": {\n    \"title\": \"Supraoptic Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Endocrinology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Hypothalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSupraoptic Nucleus\u003c/b\u003e is a nucleus of magnocellular neurosecretory cells in the [[89e86633|hypothalamus]]. It is the primary site of synthesis for \u003cmark\u003eantidiuretic hormone (ADH)\u003c/mark\u003e, also known as vasopressin.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Anterior hypothalamus, situated superior to the optic chiasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Synthesizes ADH. It also synthesizes a smaller amount of oxytocin.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Axons from the supraoptic nucleus (and the paraventricular nucleus) form the hypothalamo-hypophyseal tract, which descends to the posterior pituitary (neurohypophysis). The hormones are transported down these axons and stored in the posterior pituitary for later release into the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegulation:\u003c/b\u003e The neurons of the supraoptic nucleus are osmoreceptors that are stimulated by increased plasma osmolality, triggering the release of ADH.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Damage to the supraoptic nucleus or the hypothalamo-hypophyseal tract can lead to \u003cmark\u003ecentral diabetes insipidus\u003c/mark\u003e, a condition of ADH deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the primary products of the hypothalamic nuclei: \u003cb\u003eS\u003c/b\u003eupraoptic nucleus makes \u003cb\u003eA\u003c/b\u003eDH. \u003cb\u003eP\u003c/b\u003earaventricular nucleus makes \u003cb\u003eO\u003c/b\u003exytocin. (\u003cb\u003eSA-PO\u003c/b\u003e).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSupraoptic Nucleus\u003c/b\u003e is the brain\u0027s primary osmosensor and ADH factory, responsible for synthesizing the hormone that controls the body\u0027s water balance, which is then shipped down to the posterior pituitary for storage and release.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Supraoptic Nucleus] --Synthesizes--\u003e B(ADH); B --Axonal Transport--\u003e C(Posterior Pituitary); C --Release--\u003e D(Bloodstream);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"synthesizes\",\n        \"to\": \"290a966b\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"posterior_pituitary\"\n      },\n      {\n        \"type\": \"damage_to_causes\",\n        \"to\": \"central_diabetes_insipidus\"\n      }\n    ]\n  },\n  \"6a781682\": {\n    \"title\": \"Survival Motor Neuron (SMN) Protein\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Genetics\",\n      \"Neurology\",\n      \"Molecular Biology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSurvival Motor Neuron (SMN) protein\u003c/b\u003e is a protein that is essential for the survival and function of motor neurons. A deficiency of this protein, due to a genetic mutation, is the cause of spinal muscular atrophy (SMA).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The SMN protein is ubiquitously expressed and plays a critical role in the assembly of small nuclear ribonucleoproteins (snRNPs), which are essential components of the spliceosome. It is crucial for the proper splicing of pre-mRNA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetic Basis:\u003c/b\u003e Humans have two nearly identical genes that code for the SMN protein: \u003ci\u003eSMN1\u003c/i\u003e and \u003ci\u003eSMN2\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Muscular Atrophy (SMA):\u003c/b\u003e Caused by a homozygous deletion or mutation of the \u003ci\u003eSMN1\u003c/i\u003e gene. The severity of the disease is then modified by the number of copies of the \u003ci\u003eSMN2\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSMN2 Gene:\u003c/b\u003e The \u003ci\u003eSMN2\u003c/i\u003e gene differs from \u003ci\u003eSMN1\u003c/i\u003e by a single nucleotide, which causes it to be inefficiently spliced, producing only a small amount of full-length, functional SMN protein. More copies of \u003ci\u003eSMN2\u003c/i\u003e lead to more functional protein and a milder disease phenotype.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Deficiency of SMN protein leads to the selective death of lower motor neurons (anterior horn cells) in the spinal cord, resulting in progressive muscle weakness and atrophy. The most severe form is [[17c628e2|Werdnig-Hoffmann disease (SMA Type 1)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e SMA is a disease of defective pre-mRNA splicing due to SMN protein deficiency. The number of \u003ci\u003eSMN2\u003c/i\u003e copies determines the severity of the disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSMN protein\u003c/b\u003e is a vital housekeeping protein for RNA splicing, and its deficiency in spinal muscular atrophy leads to the specific and devastating loss of lower motor neurons, highlighting their unique vulnerability to splicing defects.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[SMN1 Gene Deletion] --\u003e B(‚Üì SMN Protein); B --\u003e C(Defective snRNP Assembly/Splicing); C --\u003e D(Apoptosis of Lower Motor Neurons); D --\u003e E(Spinal Muscular Atrophy);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \"spinal_muscular_atrophy\"\n      },\n      {\n        \"type\": \"is_involved_in\",\n        \"to\": \"rna_splicing\"\n      },\n      {\n        \"type\": \"is_deficient_in\",\n        \"to\": \"17c628e2\"\n      }\n    ]\n  },\n  \"deaa4d25\": {\n    \"title\": \"Suvorexant\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSuvorexant\u003c/b\u003e is a novel hypnotic agent used for the treatment of insomnia. It has a unique mechanism of action, acting as a dual orexin receptor antagonist.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks the binding of the wake-promoting neuropeptides orexin-A and orexin-B to their receptors, OX1R and OX2R. This suppresses the wake drive and promotes sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrexin System:\u003c/b\u003e The orexin (or hypocretin) system, originating in the lateral hypothalamus, is a central promoter of wakefulness. A deficiency of orexin is the cause of narcolepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Treatment of insomnia characterized by difficulties with both sleep onset and sleep maintenance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effect is somnolence (next-day drowsiness). It can also cause abnormal sleep-related activities and symptoms similar to narcolepsy, such as cataplexy-like symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Contraindicated in patients with narcolepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Suvorexant is the prototype of the orexin receptor antagonist class. Remember its unique \u0027sleep-permissive\u0027 mechanism of blocking the wakefulness-promoting orexin system, which contrasts with the CNS-depressant mechanisms of GABAergic hypnotics.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSuvorexant\u003c/b\u003e promotes sleep not by actively sedating the brain, but by \u0027turning off the lights\u0027‚Äîblocking the orexin system, the brain\u0027s primary wakefulness-promoting signal.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Orexin] --\u003e B(Orexin Receptors); B --\u003e C(Wakefulness); D[Suvorexant] --Antagonizes--\u003e B;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"hypnotic_drug\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"acts_as_antagonist_at\",\n        \"to\": \"orexin_receptor\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n        \"to\": \"narcolepsy\"\n      }\n    ]\n  },\n  \"1e6ae46b\": {\n    \"title\": \"Swallowing (Deglutition)\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Physiology\",\n      \"Neurology\",\n      \"Gastroenterology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSwallowing\u003c/b\u003e (deglutition) is a complex reflex process that moves food or liquid from the mouth, through the pharynx, and into the esophagus. It involves a coordinated sequence of voluntary and involuntary muscle contractions controlled by several cranial nerves and the brainstem swallowing center.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhases of Swallowing:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eOral Phase (Voluntary):\u003c/b\u003e The [[1761b409|tongue]] (CN XII) pushes the food bolus toward the pharynx.\u003cbr\u003e2. \u003cb\u003ePharyngeal Phase (Involuntary):\u003c/b\u003e The soft palate elevates (CN X) to close off the nasopharynx, the epiglottis covers the larynx, and the pharyngeal constrictor muscles (CN IX, X) propel the bolus downward.\u003cbr\u003e3. \u003cb\u003eEsophageal Phase (Involuntary):\u003c/b\u003e Peristalsis, controlled by the vagus nerve and enteric nervous system, moves the bolus down the esophagus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Innervation:\u003c/b\u003e The motor control of swallowing is primarily mediated by the \u003cmark\u003enucleus ambiguus\u003c/mark\u003e in the medulla, which provides efferent fibers for CN IX and X. The hypoglossal nucleus (CN XII) controls the tongue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDysphagia:\u003c/b\u003e Difficulty swallowing. Oropharyngeal dysphagia (difficulty initiating a swallow) often points to a neurological cause, such as a brainstem stroke, [[4ed629f9|ALS]], or myasthenia gravis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The motor act of swallowing is a complex interplay of cranial nerves, with CN IX and X (from the nucleus ambiguus) being the key players in the pharyngeal phase.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSwallowing\u003c/b\u003e is a precisely choreographed neuromuscular reflex, initiated voluntarily but completed involuntarily, that depends on the integrity of the lower cranial nerves and their brainstem control centers to safely transport food from the mouth to the esophagus while protecting the airway.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"97e2c817\"\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"7c12e7a3\"\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \"to\": \"hypoglossal_nerve\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"f0207c17\"\n      }\n    ]\n  },\n  \"789bda92\": {\n    \"title\": \"Sympathetic Nervous System\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Autonomic Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSympathetic Nervous System (SNS)\u003c/b\u003e is a division of the [[4f0ade90|autonomic nervous system]] that prepares the body for \u0027fight or flight\u0027 responses. It originates in the thoracolumbar region of the spinal cord and has widespread effects on multiple organ systems.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Preganglionic neurons originate in the intermediolateral cell column of the spinal cord from T1 to L2.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuron Structure:\u003c/b\u003e Characterized by short preganglionic fibers and long postganglionic fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePreganglionic:\u003c/b\u003e [[6a005559|Acetylcholine]] (acting on nicotinic receptors in the sympathetic ganglia).\u003cbr\u003e - \u003cb\u003ePostganglionic:\u003c/b\u003e Norepinephrine (acting on adrenergic receptors), with the exception of sweat glands (ACh on muscarinic receptors) and the adrenal medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdrenal Medulla:\u003c/b\u003e Acts as a modified sympathetic ganglion. Preganglionic fibers release ACh, stimulating chromaffin cells to release epinephrine and norepinephrine into the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDenervation of Face:\u003c/b\u003e Disruption of the sympathetic pathway to the head (e.g., from a Pancoast tumor or carotid dissection) results in [[c19010a3|Horner syndrome]] (ptosis, miosis, anhidrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the thoracolumbar origin (T1-L2) and the \u0027short pre, long post\u0027 structure of sympathetic neurons.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSympathetic Nervous System\u003c/b\u003e is the body\u0027s rapid response system for stress, orchestrating the \u0027fight or flight\u0027 state through a widespread network of norepinephrine-releasing neurons originating from the thoracolumbar spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Spinal Cord T1-L2] --Short Preganglionic Fiber (ACh)--\u003e B(Sympathetic Ganglion); B --Long Postganglionic Fiber (NE)--\u003e C(Target Organ);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_division_of\",\n        \"to\": \"4f0ade90\"\n      },\n      {\n        \"type\": \"disruption_of_causes\",\n        \"to\": \"c19010a3\"\n      },\n      {\n        \"type\": \"releases\",\n        \"to\": \"norepinephrine\"\n      }\n    ]\n  },\n  \"fb50d450\": {\n    \"title\": \"Synaptophysin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Histology\",\n      \"Pathology\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Tumor Markers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSynaptophysin\u003c/b\u003e is a glycoprotein found in the membrane of presynaptic vesicles in neurons and neuroendocrine cells. It is widely used as an immunohistochemical marker to identify tumors of neuronal or neuroendocrine origin.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Involved in the regulation of synaptic vesicle exocytosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImmunohistochemistry:\u003c/b\u003e An antibody against synaptophysin is used in pathology to stain tissues. A positive stain indicates that the cells are of neuronal or neuroendocrine lineage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTumors Staining Positive for Synaptophysin:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNeuronal Tumors:\u003c/b\u003e Neuroblastoma, ganglioneuroma.\u003cbr\u003e - \u003cb\u003eNeuroendocrine Tumors:\u003c/b\u003e Small cell lung carcinoma, carcinoid tumors, pheochromocytoma, [[16d613bb|medulloblastoma]].\u003cbr\u003e - \u003cb\u003eOther CNS Tumors:\u003c/b\u003e Can be positive in some CNS tumors with neuronal differentiation, like [[16d613bb|medulloblastoma]] and central neurocytoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Neuroendocrine Markers:\u003c/b\u003e Often used in a panel with other markers like chromogranin A and neuron-specific enolase (NSE).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e If a tumor biopsy is described as \u0027small, round, blue cells\u0027 and stains positive for synaptophysin, think of a neuroendocrine tumor like small cell lung cancer or a neuroblastoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSynaptophysin\u003c/b\u003e is a key protein of synaptic vesicles, and its detection by immunohistochemistry serves as a reliable molecular fingerprint for identifying tumors that arise from either neurons or neuroendocrine cells.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_marker_for\",\n        \"to\": \"neuroendocrine_tumors\"\n      },\n      {\n        \"type\": \"is_a_marker_for\",\n        \"to\": \"neuronal_tumors\"\n      },\n      {\n        \"type\": \"is_positive_in\",\n        \"to\": \"16d613bb\"\n      },\n      {\n        \"type\": \"is_positive_in\",\n        \"to\": \"small_cell_lung_carcinoma\"\n      }\n    ]\n  },\n  \"d2b8e10c\": {\n    \"title\": \"Syringomyelia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSyringomyelia\u003c/b\u003e is a chronic, progressive disorder characterized by the formation of a fluid-filled, gliosis-lined cavity (a syrinx) within the central canal of the spinal cord. This cyst expands over time, compressing and damaging surrounding nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly occurs in the cervical and upper thoracic spinal cord (C8-T1).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The expanding syrinx first damages the \u003cmark\u003eanterior white commissure\u003c/mark\u003e, where the spinothalamic tract fibers for pain and temperature decussate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Presentation:\u003c/b\u003e This leads to a bilateral, \u0027cape-like\u0027 loss of \u003cmark\u003epain and temperature sensation\u003c/mark\u003e across the upper back and arms, with preservation of touch, vibration, and proprioception (which travel in the spared dorsal columns).\u003c/li\u003e\u003cli\u003e\u003cb\u003eProgression:\u003c/b\u003e As the syrinx enlarges, it can compress the anterior horns, causing lower motor neuron signs (weakness, atrophy, fasciculations) in the hands. It can also affect the lateral horn, causing a [[c19010a3|Horner syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition:\u003c/b\u003e Strongly associated with \u003cmark\u003e[[b96a6a07|Chiari I malformations]]\u003c/mark\u003e. Can also be post-traumatic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with bilateral loss of pain and temperature in the upper extremities, often with a history of burns or cuts on the hands that they did not feel, is the classic vignette for syringomyelia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSyringomyelia\u003c/b\u003e is a cystic expansion of the central spinal cord that selectively destroys the crossing spinothalamic fibers first, creating a unique sensory dissociation with a \u0027cape-like\u0027 loss of pain and temperature while sparing other sensations.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Syrinx Formation] --Expands--\u003e B(Compresses Anterior White Commissure); B --\u003e C(Damage to Crossing Spinothalamic Fibers); C --\u003e D(Bilateral \u0027Cape-like\u0027 Loss of Pain \u0026 Temperature);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"spinal_cord_lesion\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"b96a6a07\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"anterior_white_commissure\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cape_like_sensory_loss\"\n      }\n    ]\n  },\n  \"71daebd6\": {\n    \"title\": \"Tabes Dorsalis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTabes dorsalis\u003c/b\u003e is a slow, progressive degeneration of the dorsal (posterior) columns and dorsal roots of the spinal cord. It is a manifestation of tertiary neurosyphilis, occurring years to decades after the initial infection with \u003ci\u003eTreponema pallidum\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Demyelination and degeneration of the \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e and dorsal nerve roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSensory [[9767fd6b|Ataxia]]:\u003c/b\u003e Loss of proprioception leads to a wide-based gait and a positive [[47a0f3d1|Romberg sign]].\u003cbr\u003e - \u003cb\u003eLancinating Pains:\u003c/b\u003e Brief, severe, stabbing pains in the legs or trunk.\u003cbr\u003e - \u003cb\u003eAreflexia:\u003c/b\u003e Loss of deep tendon reflexes (e.g., [[87d19a70|Achilles]], patellar) due to dorsal root damage.\u003cbr\u003e - \u003cb\u003e[[08cb577f|Argyll Robertson Pupils]]:\u003c/b\u003e Pupils that accommodate but do not react to light.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e \u003cmark\u003e[[cfbd9f68|Charcot joints]]\u003c/mark\u003e (neuropathic arthropathy) can develop due to the loss of pain and position sense, leading to repeated joint trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of sensory ataxia, lancinating pains, areflexia, and Argyll Robertson pupils is pathognomonic for tabes dorsalis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTabes dorsalis\u003c/b\u003e is the neurological legacy of untreated syphilis, a devastating degeneration of the dorsal columns and roots that robs the patient of their sense of position and reflexes, leading to a characteristic ataxic gait and lancinating pains.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Tertiary Syphilis] --\u003e B(Degeneration of Dorsal Columns \u0026 Roots); B --\u003e C(Loss of Proprioception \u0026 Vibration); C --\u003e D(Sensory Ataxia \u0026 +Romberg); B --\u003e E(Loss of DTRs); B --\u003e F(Lancinating Pains);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_manifestation_of\",\n        \"to\": \"neurosyphilis\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cfbd9f68\"\n      }\n    ]\n  },\n  \"bda79225\": {\n    \"title\": \"Tardive Dyskinesia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTardive dyskinesia (TD)\u003c/b\u003e is a potentially irreversible movement disorder characterized by involuntary, repetitive body movements. It is a delayed-onset extrapyramidal side effect of long-term use of dopamine receptor-blocking agents, particularly antipsychotics.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by prolonged exposure to dopamine antagonists, especially \u003cmark\u003efirst-generation (typical) antipsychotics\u003c/mark\u003e. The risk increases with duration of treatment and age.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact mechanism is unknown, but it is thought to involve upregulation and supersensitivity of postsynaptic dopamine receptors in the nigrostriatal pathway after chronic blockade.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by stereotyped, involuntary movements, most commonly affecting the orofacial region. Classic signs include \u003cmark\u003elip smacking, chewing, grimacing, and tongue protrusions\u003c/mark\u003e (\u0027fly-catching\u0027 movements). It can also involve choreoathetoid movements of the limbs and trunk.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e The first step is to stop or reduce the dose of the offending agent if possible, or switch to an atypical antipsychotic with a lower risk (e.g., clozapine). The movements may be irreversible. Treatment options include [[07b0a9dd|VMAT2 inhibitors]] like valbenazine and deutetrabenazine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e \u0027Tardive\u0027 means delayed. This is a long-term complication of antipsychotic use. A patient on haloperidol for many years who develops new, involuntary facial movements has tardive dyskinesia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTardive dyskinesia\u003c/b\u003e is the cruel, delayed consequence of long-term dopamine blockade, where the brain\u0027s attempt to compensate by upregulating dopamine receptors leads to the emergence of persistent, involuntary, and often disfiguring orofacial movements.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"9a9c9169\"\n      },\n      {\n        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"antipsychotics\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"07b0a9dd\"\n      }\n    ]\n  },\n  \"e3ce6784\": {\n    \"title\": \"Taste Pathway\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003etaste (gustatory) pathway\u003c/b\u003e is the neural pathway that transmits the sensation of taste from the taste buds on the tongue to the cerebral cortex for conscious perception.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePeripheral Receptors:\u003c/b\u003e Taste buds on the tongue detect the five basic tastes: sweet, sour, salty, bitter, and umami.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst-Order Neurons (Cranial Nerves):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[dea9755f|Facial Nerve (CN VII)]]\u003c/b\u003e (via chorda tympani): Transmits taste from the \u003cmark\u003eanterior two-thirds\u003c/mark\u003e of the tongue.\u003cbr\u003e - \u003cb\u003e[[97e2c817|Glossopharyngeal Nerve (CN IX)]]:\u003c/b\u003e Transmits taste from the \u003cmark\u003eposterior one-third\u003c/mark\u003e of the tongue.\u003cbr\u003e - \u003cb\u003e[[vagus_nerve|Vagus Nerve (CN X)]]:\u003c/b\u003e Transmits taste from the epiglottis and pharynx.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Relay:\u003c/b\u003e All three cranial nerves project to the \u003cmark\u003esolitary nucleus\u003c/mark\u003e (gustatory nucleus) in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e Second-order neurons ascend from the solitary nucleus to the \u003cmark\u003e[[23ac314a|ventral posteromedial (VPM) nucleus]]\u003c/mark\u003e of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Destination:\u003c/b\u003e Third-order neurons project from the VPM to the gustatory cortex, located in the insula and frontal operculum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the cranial nerve innervation for taste: 7 for the front, 9 for the back. The central pathway is Solitary Nucleus ‚Üí VPM of Thalamus ‚Üí Cortex.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003egustatory pathway\u003c/b\u003e is a three-neuron chain that carries taste information from the tongue via cranial nerves VII, IX, and X to the solitary nucleus, then relays through the VPM of the thalamus before reaching the cortex for the conscious perception of flavor.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Taste Buds] --\u003e B{CN VII, IX, X}; B --\u003e C(Solitary Nucleus - Medulla); C --\u003e D(VPM Nucleus - Thalamus); D --\u003e E(Gustatory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"248af9f9\"\n      },\n      {\n        \"type\": \"involves_cranial_nerve\",\n        \"to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"involves_cranial_nerve\",\n        \"to\": \"97e2c817\"\n      },\n      {\n        \"type\": \"relays_in\",\n        \"to\": \"23ac314a\"\n      }\n    ]\n  },\n  \"75929e32\": {\n    \"title\": \"Telencephalon\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTelencephalon\u003c/b\u003e is the most rostral of the five secondary brain vesicles that develop from the embryonic neural tube. It undergoes massive growth and differentiation to form the major structures of the adult cerebrum.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Arises from the anterior part of the forebrain (prosencephalon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivatives:\u003c/b\u003e The telencephalon develops into the two \u003cmark\u003ecerebral hemispheres\u003c/mark\u003e, which include the cerebral cortex, the underlying white matter, and the \u003cmark\u003e[[ed462927|basal ganglia]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavities within the developing telencephalon expand to become the paired \u003cmark\u003elateral ventricles\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDevelopmental Abnormalities:\u003c/b\u003e Failure of the telencephalon to properly divide into two hemispheres results in \u003cmark\u003eholoprosencephaly\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the developmental lineage: Prosencephalon ‚Üí Telencephalon (cerebral hemispheres, basal ganglia) and Diencephalon (thalamus, hypothalamus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eTelencephalon\u003c/b\u003e is the embryonic foundation of the cerebrum, undergoing an explosive growth process to form the highly convoluted cerebral hemispheres that are the seat of all higher cognitive functions.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Prosencephalon - Forebrain] --\u003e B(Telencephalon); B --\u003e C(Cerebral Hemispheres); B --\u003e D(Basal Ganglia); B --\u003e E(Lateral Ventricles);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"develops_from\",\n        \"to\": \"prosencephalon\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"cerebral_hemispheres\"\n      },\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"malformation_of_leads_to\",\n        \"to\": \"holoprosencephaly\"\n      }\n    ]\n  },\n  \"e6deda1b\": {\n    \"title\": \"Temazepam\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTemazepam\u003c/b\u003e is an intermediate-acting \u003ci\u003ebenzodiazepine\u003c/i\u003e used for the short-term treatment of insomnia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A positive allosteric modulator of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the \u003cu\u003efrequency\u003c/u\u003e of chloride channel opening.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is one of the benzodiazepines that undergoes metabolism \u003cmark\u003e\u0027Outside The Liver\u0027\u003c/mark\u003e (OTL - Oxazepam, Temazepam, Lorazepam). It is metabolized via conjugation, not by the cytochrome P450 system, making it a safer choice for patients with liver disease and the elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used for insomnia, particularly for sleep-maintenance insomnia due to its intermediate duration of action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dizziness, dependence, and withdrawal. Less next-day \u0027hangover\u0027 effect than long-acting benzodiazepines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027OTL\u0027 benzodiazepines (Oxazepam, Temazepam, Lorazepam) as the ones that are safe to use in patients with liver failure because they bypass phase I (P450) metabolism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTemazepam\u003c/b\u003e is an intermediate-acting benzodiazepine for insomnia whose primary clinical advantage lies in its metabolic pathway, which bypasses the cytochrome P450 system, making it a safer hypnotic choice for patients with liver disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"insomnia\"\n      },\n      {\n        \"type\": \"is_metabolized_outside_liver_p450\",\n        \"to\": \"true\"\n      }\n    ]\n  },\n  \"b8b42fc5\": {\n    \"title\": \"Temperature Sensation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTemperature sensation\u003c/b\u003e (thermoception) is the ability to sense differences in temperature. It is detected by specialized thermoreceptors in the skin and transmitted to the brain via the spinothalamic tract.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eReceptors:\u003c/b\u003e Mediated by \u003cmark\u003e[[1e7ec644|free nerve endings]]\u003c/mark\u003e in the skin, which contain specific transient receptor potential (TRP) channels that are sensitive to different temperature ranges (e.g., TRPV1 for heat, TRPM8 for cold).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFiber Types:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCold\u003c/b\u003e sensation is transmitted by fast, thinly myelinated \u003cmark\u003eAŒ¥ fibers\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eWarmth\u003c/b\u003e sensation is transmitted by slow, unmyelinated \u003cmark\u003eC fibers\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural Pathway:\u003c/b\u003e The signal travels to the spinal cord, synapses in the dorsal horn, decussates at the \u003cmark\u003eanterior white commissure\u003c/mark\u003e, and ascends in the contralateral \u003cmark\u003e[[07eecef1|spinothalamic tract]]\u003c/mark\u003e to the VPL nucleus of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Loss of temperature sensation is a key finding in lesions of the spinothalamic tract. A classic example is [[d2b8e10c|syringomyelia]], which causes a bilateral \u0027cape-like\u0027 loss of pain and temperature sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that pain and temperature travel together in the spinothalamic tract. A sensory exam that shows loss of temperature sensation but preserved vibration sense points to a lesion affecting the spinothalamic tract while sparing the dorsal columns.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTemperature sensation\u003c/b\u003e is a critical protective sense mediated by free nerve endings and transmitted via the spinothalamic tract; its selective loss is a powerful localizing sign for specific spinal cord lesions like syringomyelia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_detected_by\",\n        \"to\": \"1e7ec644\"\n      },\n      {\n        \"type\": \"is_transmitted_by\",\n        \"to\": \"07eecef1\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to\": \"d2b8e10c\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9868,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"381bfc50\": {\n    \"title\": \"Superior"
      }, {
        "text": " Rectus Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSuperior Rectus\u003c/b\u003e is one of the six extraocular muscles responsible"
      }, {
        "text": " for moving the eye. Its primary action is elevation, but it also contributes to adduction and intorsion.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e It is innervated by the superior division"
      }, {
        "text": " of the \u003cmark\u003eoculomotor nerve (CN III)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimary Action:\u003c/b\u003e Elevation ("
      }, {
        "text": "moving the eye upward).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary Actions:\u003c/b\u003e Adduction (moving the eye medially) and intorsion (rotating"
      }, {
        "text": " the top of the eye toward the nose).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTesting:\u003c/b\u003e The function of the superior rectus is best isolated"
      }, {
        "text": " by having the patient look \u003cmark\u003eup and out\u003c/mark\u003e (abducted position).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion:\u003c/b\u003e Weak"
      }, {
        "text": "ness of the superior rectus due to a [[fdfd22ca|CN III palsy]] contributes to the"
      }, {
        "text": " characteristic \u0027down and out\u0027 position of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic (SO"
      }, {
        "text": "\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e. The superior rectus is one of the \u0027rest\u0027 inn"
      }, {
        "text": "ervated by CN III. To test it, have the patient look up and out.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eSuperior Rectus muscle\u003c/b\u003e is the primary elevator of the eye, controlled by the ocul"
      }, {
        "text": "omotor nerve, and its function is clinically isolated by having the patient look in an abducted, upward direction.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "innervated_by\",\n        \"to\": \"68c66997\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"action_is\",\n        \"to\": \"elevation_of_eye\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"ad2b0b65\": {\n    \"title\": \"Su"
      }, {
        "text": "prachiasmatic Nucleus (SCN)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "anatomy\",\n      \"Physiology\",\n      \"Endocrinology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Hyp"
      }, {
        "text": "othalamus\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSuprach"
      }, {
        "text": "iasmatic Nucleus (SCN)\u003c/b\u003e is a tiny region in the anterior [[89e8663"
      }, {
        "text": "3|hypothalamus]], situated directly above the optic chiasm. It functions as the central \u0027master clock\u0027 of the body"
      }, {
        "text": ", responsible for controlling [[0ab894d6|circadian rhythms]].\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The SCN is the primary pacemaker of the circadian timing system, regulating"
      }, {
        "text": " the sleep-wake cycle, body temperature, and hormone secretion over a near-24-hour period.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e It"
      }, {
        "text": " receives direct input from photosensitive ganglion cells in the retina via the \u003cmark\u003eretinohypothalamic tract"
      }, {
        "text": "\u003c/mark\u003e. This light information is used to entrain (synchronize) the internal clock to the external day-night cycle."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eOutput:\u003c/b\u003e The SCN projects to various brain regions, including the pineal gland. It regulates the pineal gland\u0027"
      }, {
        "text": "s production of \u003cmark\u003emelatonin\u003c/mark\u003e, with secretion increasing in darkness and decreasing in light.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions"
      }, {
        "text": ":\u003c/b\u003e Destruction of the SCN results in the loss of circadian rhythms, leading to a disorganized sleep-wake pattern.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e The SCN is the anatomical basis for the body\u0027s internal clock. Remember its location above the optic chiasm,"
      }, {
        "text": " which is perfectly positioned to receive light cues.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSu"
      }, {
        "text": "prachiasmatic Nucleus\u003c/b\u003e is the brain\u0027s master timekeeper, a small hypothalamic nucleus that uses light as its primary cue"
      }, {
        "text": " to synchronize the body\u0027s myriad physiological and behavioral circadian rhythms with the 24-hour solar day.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Light] --\u003e B(Retina); B --\u003e C(Suprachiasmatic Nucleus -"
      }, {
        "text": " SCN); C --\u003e D(Pineal Gland); D --\u003e E(Melatonin Secretion); E --\u003e F(Regulation"
      }, {
        "text": " of Circadian Rhythms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"controls\",\n        \"to\": \"0ab894d6\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"retina\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"regulates\",\n        \"to\": \"pineal_gland\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"b2594742\": {\n    \"title\": \""
      }, {
        "text": "Supraoptic Nucleus\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \""
      }, {
        "text": "Endocrinology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Hypothalamus\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSupraoptic Nucleus\u003c/b\u003e is a nucleus"
      }, {
        "text": " of magnocellular neurosecretory cells in the [[89e86633|hypothalamus]]. It"
      }, {
        "text": " is the primary site of synthesis for \u003cmark\u003eantidiuretic hormone (ADH)\u003c/mark\u003e, also known as vasopressin.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Anterior hypothalamus, situated superior to the optic chiasm.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:"
      }, {
        "text": "\u003c/b\u003e Synthesizes ADH. It also synthesizes a smaller amount of oxytocin.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e Ax"
      }, {
        "text": "ons from the supraoptic nucleus (and the paraventricular nucleus) form the hypothalamo-hypophyseal tract, which descends"
      }, {
        "text": " to the posterior pituitary (neurohypophysis). The hormones are transported down these axons and stored in the posterior pituitary for later"
      }, {
        "text": " release into the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegulation:\u003c/b\u003e The neurons of the supraoptic nucleus are osmoreceptors that are"
      }, {
        "text": " stimulated by increased plasma osmolality, triggering the release of ADH.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Damage to the supraoptic nucleus or"
      }, {
        "text": " the hypothalamo-hypophyseal tract can lead to \u003cmark\u003ecentral diabetes insipidus\u003c/mark\u003e, a condition of AD"
      }, {
        "text": "H deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the primary products of the hypothalamic nuclei: \u003cb\u003eS\u003c/b\u003eupra"
      }, {
        "text": "optic nucleus makes \u003cb\u003eA\u003c/b\u003eDH. \u003cb\u003eP\u003c/b\u003earaventricular nucleus makes \u003cb\u003eO\u003c/b\u003exytocin. (\u003cb\u003e"
      }, {
        "text": "SA-PO\u003c/b\u003e).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSupraoptic Nucleus\u003c/b\u003e"
      }, {
        "text": " is the brain\u0027s primary osmosensor and ADH factory, responsible for synthesizing the hormone that controls the body\u0027s water balance,"
      }, {
        "text": " which is then shipped down to the posterior pituitary for storage and release.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sup"
      }, {
        "text": "raoptic Nucleus] --Synthesizes--\u003e B(ADH); B --Axonal Transport--\u003e C(Posterior Pituitary); C --"
      }, {
        "text": "Release--\u003e D(Bloodstream);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part"
      }, {
        "text": "_of\",\n        \"to\": \"89e86633\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"synthesizes\",\n        \"to\": \"290a966b\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"projects_to\",\n        \"to\": \"posterior_pituitary\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"damage_to_causes\",\n        \"to\": \"central_diabetes_insipidus"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"6a781682\": {\n    \""
      }, {
        "text": "title\": \"Survival Motor Neuron (SMN) Protein\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Genetics\",\n      \"Neurology\",\n      \"Molecular Biology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor"
      }, {
        "text": " Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSurvival Motor Neuron"
      }, {
        "text": " (SMN) protein\u003c/b\u003e is a protein that is essential for the survival and function of motor neurons. A deficiency of"
      }, {
        "text": " this protein, due to a genetic mutation, is the cause of spinal muscular atrophy (SMA).\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The SMN protein is ubiquitously expressed and plays a critical role in the assembly of small nuclear ribonucle"
      }, {
        "text": "oproteins (snRNPs), which are essential components of the spliceosome. It is crucial for the proper splicing of pre"
      }, {
        "text": "-mRNA.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGenetic Basis:\u003c/b\u003e Humans have two nearly identical genes that code for the SMN protein: \u003ci\u003eSMN"
      }, {
        "text": "1\u003c/i\u003e and \u003ci\u003eSMN2\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Muscular Atrophy (SMA):\u003c/b\u003e Ca"
      }, {
        "text": "used by a homozygous deletion or mutation of the \u003ci\u003eSMN1\u003c/i\u003e gene. The severity of the disease is then"
      }, {
        "text": " modified by the number of copies of the \u003ci\u003eSMN2\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSMN2 Gene:\u003c/b\u003e The"
      }, {
        "text": " \u003ci\u003eSMN2\u003c/i\u003e gene differs from \u003ci\u003eSMN1\u003c/i\u003e by a single nucleotide, which causes it to be inefficient"
      }, {
        "text": "ly spliced, producing only a small amount of full-length, functional SMN protein. More copies of \u003ci\u003eSMN2\u003c/i\u003e lead to more"
      }, {
        "text": " functional protein and a milder disease phenotype.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Deficiency of SMN protein leads to the selective"
      }, {
        "text": " death of lower motor neurons (anterior horn cells) in the spinal cord, resulting in progressive muscle weakness and atrophy. The"
      }, {
        "text": " most severe form is [[17c628e2|Werdnig-Hoffmann disease (SMA Type"
      }, {
        "text": " 1)]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e SMA is a disease of defective pre-mRNA splicing due to SMN protein"
      }, {
        "text": " deficiency. The number of \u003ci\u003eSMN2\u003c/i\u003e copies determines the severity of the disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003eThe \u003cb\u003eSMN protein\u003c/b\u003e is a vital housekeeping protein for RNA splicing, and its deficiency in spinal muscular atrophy leads to the"
      }, {
        "text": " specific and devastating loss of lower motor neurons, highlighting their unique vulnerability to splicing defects.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[SMN1 Gene Deletion] --\u003e B(‚Üì SMN Protein); B --\u003e C(Defective snR"
      }, {
        "text": "NP Assembly/Splicing); C --\u003e D(Apoptosis of Lower Motor Neurons); D --\u003e E(Spinal Muscular Atrophy);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"deficiency_causes\",\n        \"to\": \""
      }, {
        "text": "spinal_muscular_atrophy\"\n      },\n      {\n        \"type\": \"is_involved_"
      }, {
        "text": "in\",\n        \"to\": \"rna_splicing\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_deficient_in\",\n        \"to\": \"17c628e2\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"deaa4d25\": {\n    \"title\": \"Suvorexant\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Sedative-Hypnotics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eSuvorexant\u003c/b\u003e is a novel hypnotic agent used for the treatment of insomnia. It has a unique mechanism of action, acting"
      }, {
        "text": " as a dual orexin receptor antagonist.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks"
      }, {
        "text": " the binding of the wake-promoting neuropeptides orexin-A and orexin-B to their receptors, OX1"
      }, {
        "text": "R and OX2R. This suppresses the wake drive and promotes sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOrexin System:\u003c/b\u003e The ore"
      }, {
        "text": "xin (or hypocretin) system, originating in the lateral hypothalamus, is a central promoter of wakefulness. A deficiency of orexin is"
      }, {
        "text": " the cause of narcolepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Treatment of insomnia characterized by difficulties with both sleep onset and sleep"
      }, {
        "text": " maintenance.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e The most common side effect is somnolence (next-day drowsiness"
      }, {
        "text": "). It can also cause abnormal sleep-related activities and symptoms similar to narcolepsy, such as cataplexy-like symptoms.\u003c/li\u003e\u003cli\u003e\u003cb\u003eContra"
      }, {
        "text": "indications:\u003c/b\u003e Contraindicated in patients with narcolepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Suvorexant is the prototype"
      }, {
        "text": " of the orexin receptor antagonist class. Remember its unique \u0027sleep-permissive\u0027 mechanism of blocking the wakefulness-"
      }, {
        "text": "promoting orexin system, which contrasts with the CNS-depressant mechanisms of GABAergic hypnotics.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eSuvorexant\u003c/b\u003e promotes sleep not by actively sedating the brain, but by \u0027"
      }, {
        "text": "turning off the lights\u0027‚Äîblocking the orexin system, the brain\u0027s primary wakefulness-promoting signal.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Orexin] --\u003e B(Orexin Receptors); B --\u003e C(Wakefulness"
      }, {
        "text": "); D[Suvorexant] --Antagonizes--\u003e B;\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"hypnotic_drug"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"insomnia"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"acts_as_antagonist_at\",\n        \"to\": \"ore"
      }, {
        "text": "xin_receptor\"\n      },\n      {\n        \"type\": \"is_contraindicated_in\",\n"
      }, {
        "text": "        \"to\": \"narcolepsy\"\n      }\n    ]\n  },\n  \"1e6ae"
      }, {
        "text": "46b\": {\n    \"title\": \"Swallowing (Deglutition)\",\n    \"primaryType\": \"physiology"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Physiology\",\n      \"Neurology\",\n      \"Gastroenter"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Cranial Nerves\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eSwallowing\u003c/b\u003e (deglutition) is a complex reflex process that moves food or"
      }, {
        "text": " liquid from the mouth, through the pharynx, and into the esophagus. It involves a coordinated sequence of voluntary and involuntary muscle"
      }, {
        "text": " contractions controlled by several cranial nerves and the brainstem swallowing center.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePh"
      }, {
        "text": "ases of Swallowing:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eOral Phase (Voluntary):\u003c/b\u003e The [[176"
      }, {
        "text": "1b409|tongue]] (CN XII) pushes the food bolus toward the pharynx.\u003cbr\u003e2. \u003cb\u003ePh"
      }, {
        "text": "aryngeal Phase (Involuntary):\u003c/b\u003e The soft palate elevates (CN X) to close off the nasopharynx, the ep"
      }, {
        "text": "iglottis covers the larynx, and the pharyngeal constrictor muscles (CN IX, X) propel the bolus downward"
      }, {
        "text": ".\u003cbr\u003e3. \u003cb\u003eEsophageal Phase (Involuntary):\u003c/b\u003e Peristalsis, controlled by the vag"
      }, {
        "text": "us nerve and enteric nervous system, moves the bolus down the esophagus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMotor Innervation:\u003c/b\u003e The motor"
      }, {
        "text": " control of swallowing is primarily mediated by the \u003cmark\u003enucleus ambiguus\u003c/mark\u003e in the medulla, which provides eff"
      }, {
        "text": "erent fibers for CN IX and X. The hypoglossal nucleus (CN XII) controls the tongue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDys"
      }, {
        "text": "phagia:\u003c/b\u003e Difficulty swallowing. Oropharyngeal dysphagia (difficulty initiating a swallow) often points to a neurological cause,"
      }, {
        "text": " such as a brainstem stroke, [[4ed629f9|ALS]], or myasthenia gravis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The motor act of swallowing is a complex interplay of cranial nerves, with CN IX and X (from"
      }, {
        "text": " the nucleus ambiguus) being the key players in the pharyngeal phase.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eSwallowing\u003c/b\u003e is a precisely choreographed neuromuscular reflex, initiated voluntarily but completed involuntarily, that depends on the integrity"
      }, {
        "text": " of the lower cranial nerves and their brainstem control centers to safely transport food from the mouth to the esophagus while protecting the airway.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_controlled"
      }, {
        "text": "_by\",\n        \"to\": \"97e2c817\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_controlled_by\",\n        \"to\": \"7c12e7"
      }, {
        "text": "a3\"\n      },\n      {\n        \"type\": \"is_controlled_by\",\n        \""
      }, {
        "text": "to\": \"hypoglossal_nerve\"\n      },\n      {\n        \"type\": \"is_impaired_in"
      }, {
        "text": "\",\n        \"to\": \"f0207c17\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "789bda92\": {\n    \"title\": \"Sympathetic Nervous System\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Autonomic Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eSympathetic Nervous System (SNS)\u003c/b\u003e is a division of the [[4f0ade90|autonomic nervous system"
      }, {
        "text": "]] that prepares the body for \u0027fight or flight\u0027 responses. It originates in the thoracolumbar region of the spinal cord and has widespread"
      }, {
        "text": " effects on multiple organ systems.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Preganglionic neurons originate in the intermedi"
      }, {
        "text": "olateral cell column of the spinal cord from T1 to L2.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuron Structure:\u003c/b\u003e Characterized by short pre"
      }, {
        "text": "ganglionic fibers and long postganglionic fibers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurotransmitters:\u003c/b\u003e\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003ePreganglionic:\u003c/b\u003e [[6a005559|Acetylcholine]] (acting on nicotin"
      }, {
        "text": "ic receptors in the sympathetic ganglia).\u003cbr\u003e - \u003cb\u003ePostganglionic:\u003c/b\u003e Norepinephrine (acting on adrenergic receptors),"
      }, {
        "text": " with the exception of sweat glands (ACh on muscarinic receptors) and the adrenal medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAd"
      }, {
        "text": "renal Medulla:\u003c/b\u003e Acts as a modified sympathetic ganglion. Preganglionic fibers release ACh, stimulating chromaffin cells to release epinephrine"
      }, {
        "text": " and norepinephrine into the bloodstream.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDenervation of Face:\u003c/b\u003e Disruption of the sympathetic pathway to the head"
      }, {
        "text": " (e.g., from a Pancoast tumor or carotid dissection) results in [[c19010"
      }, {
        "text": "a3|Horner syndrome]] (ptosis, miosis, anhidrosis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the thor"
      }, {
        "text": "acolumbar origin (T1-L2) and the \u0027short pre, long post\u0027 structure of sympathetic neurons.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSympathetic Nervous System\u003c/b\u003e is the body\u0027s rapid"
      }, {
        "text": " response system for stress, orchestrating the \u0027fight or flight\u0027 state through a widespread network of norepinephrine-releasing neurons originating"
      }, {
        "text": " from the thoracolumbar spinal cord.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Spinal Cord T"
      }, {
        "text": "1-L2] --Short Preganglionic Fiber (ACh)--\u003e B(Sympathetic Ganglion); B"
      }, {
        "text": " --Long Postganglionic Fiber (NE)--\u003e C(Target Organ);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_division_of\",\n        \"to\": \"4f0ade9"
      }, {
        "text": "0\"\n      },\n      {\n        \"type\": \"disruption_of_causes\",\n        \"to\":"
      }, {
        "text": " \"c19010a3\"\n      },\n      {\n        \"type\": \"releases\",\n        \"to\": \"nore"
      }, {
        "text": "pinephrine\"\n      }\n    ]\n  },\n  \"fb50d450\": {\n    \"title"
      }, {
        "text": "\": \"Synaptophysin\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Hist"
      }, {
        "text": "ology\",\n      \"Pathology\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Tum"
      }, {
        "text": "or Markers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSynaptophysin\u003c/b\u003e is a glycoprotein"
      }, {
        "text": " found in the membrane of presynaptic vesicles in neurons and neuroendocrine cells. It is widely used as an immunohistochemical marker to"
      }, {
        "text": " identify tumors of neuronal or neuroendocrine origin.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Involved"
      }, {
        "text": " in the regulation of synaptic vesicle exocytosis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImmunohistochemistry:\u003c/b\u003e An antibody against synaptophysin is used"
      }, {
        "text": " in pathology to stain tissues. A positive stain indicates that the cells are of neuronal or neuroendocrine lineage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTum"
      }, {
        "text": "ors Staining Positive for Synaptophysin:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eNeuronal Tumors:\u003c/b\u003e Neuro"
      }, {
        "text": "blastoma, ganglioneuroma.\u003cbr\u003e - \u003cb\u003eNeuroendocrine Tumors:\u003c/b\u003e Small cell lung carcinoma, carcin"
      }, {
        "text": "oid tumors, pheochromocytoma, [[16d613bb|medulloblastoma]].\u003cbr\u003e - \u003cb\u003eOther"
      }, {
        "text": " CNS Tumors:\u003c/b\u003e Can be positive in some CNS tumors with neuronal differentiation, like [[16d613bb"
      }, {
        "text": "|medulloblastoma]] and central neurocytoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Neuroendocrine Markers:\u003c/b\u003e Often used in a"
      }, {
        "text": " panel with other markers like chromogranin A and neuron-specific enolase (NSE).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e If a tumor biopsy is described as \u0027small, round, blue cells\u0027 and stains positive for synaptophysin, think"
      }, {
        "text": " of a neuroendocrine tumor like small cell lung cancer or a neuroblastoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Synaptophysin\u003c/b\u003e is a key protein of synaptic vesicles, and its detection by immunohistochemistry serves as a reliable molecular"
      }, {
        "text": " fingerprint for identifying tumors that arise from either neurons or neuroendocrine cells.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_marker_for\",\n        \"to\": \"neuro"
      }, {
        "text": "endocrine_tumors\"\n      },\n      {\n        \"type\": \"is_a_marker_for"
      }, {
        "text": "\",\n        \"to\": \"neuronal_tumors\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_positive_in\",\n        \"to\": \"16d613bb\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_positive_in\",\n        \"to\": \"small_cell_lung_carcinoma\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"d2b8e10c\": {\n    \"title\": \"Syringomyelia\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \""
      }, {
        "text": "Pathology\",\n      \"Neurosurgery\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSyringomyelia\u003c/b\u003e is a chronic, progressive disorder characterized by the formation"
      }, {
        "text": " of a fluid-filled, gliosis-lined cavity (a syrinx) within the central canal of the spinal cord. This"
      }, {
        "text": " cyst expands over time, compressing and damaging surrounding nerve fibers.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:"
      }, {
        "text": "\u003c/b\u003e Most commonly occurs in the cervical and upper thoracic spinal cord (C8-T1).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophys"
      }, {
        "text": "iology:\u003c/b\u003e The expanding syrinx first damages the \u003cmark\u003eanterior white commissure\u003c/mark\u003e, where the spinoth"
      }, {
        "text": "alamic tract fibers for pain and temperature decussate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Presentation:\u003c/b\u003e This leads to a bilateral"
      }, {
        "text": ", \u0027cape-like\u0027 loss of \u003cmark\u003epain and temperature sensation\u003c/mark\u003e across the upper back and arms"
      }, {
        "text": ", with preservation of touch, vibration, and proprioception (which travel in the spared dorsal columns).\u003c/li\u003e\u003cli\u003e\u003cb\u003eProg"
      }, {
        "text": "ression:\u003c/b\u003e As the syrinx enlarges, it can compress the anterior horns, causing lower motor neuron signs (weakness,"
      }, {
        "text": " atrophy, fasciculations) in the hands. It can also affect the lateral horn, causing a [[c19010a3|"
      }, {
        "text": "Horner syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Condition:\u003c/b\u003e Strongly associated with \u003cmark\u003e[[b96a6a0"
      }, {
        "text": "7|Chiari I malformations]]\u003c/mark\u003e. Can also be post-traumatic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " patient with bilateral loss of pain and temperature in the upper extremities, often with a history of burns or cuts on the hands that they did"
      }, {
        "text": " not feel, is the classic vignette for syringomyelia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Syringomyelia\u003c/b\u003e is a cystic expansion of the central spinal cord that selectively destroys the crossing spinothalamic fibers"
      }, {
        "text": " first, creating a unique sensory dissociation with a \u0027cape-like\u0027 loss of pain and temperature while sparing other sensations.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Syrinx Formation] --Expands--\u003e B(Compresses Anterior White Commissure); B"
      }, {
        "text": " --\u003e C(Damage to Crossing Spinothalamic Fibers); C --\u003e D(Bilateral \u0027Cape-like\u0027 Loss of"
      }, {
        "text": " Pain \u0026 Temperature);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"spinal_cord_lesion\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_associated_with\",\n        \"to\": \"b96a6a"
      }, {
        "text": "07\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"anterior_"
      }, {
        "text": "white_commissure\"\n      },\n      {\n        \"type\": \"causes\",\n        \"to\": \"cape"
      }, {
        "text": "_like_sensory_loss\"\n      }\n    ]\n  },\n  \"71daebd"
      }, {
        "text": "6\": {\n    \"title\": \"Tabes Dorsalis\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neurology\",\n      \"Infectious Disease\",\n      \"Pathology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n"
      }, {
        "text": "      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eTabes dorsalis\u003c/b\u003e is a slow, progressive degeneration of the dorsal (posterior) columns and dorsal roots of the spinal cord"
      }, {
        "text": ". It is a manifestation of tertiary neurosyphilis, occurring years to decades after the initial infection with \u003ci\u003eTreponema"
      }, {
        "text": " pallidum\u003c/i\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Demyelination and"
      }, {
        "text": " degeneration of the \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e and dorsal nerve"
      }, {
        "text": " roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eSensory [[9767fd6b"
      }, {
        "text": "|Ataxia]]:\u003c/b\u003e Loss of proprioception leads to a wide-based gait and a positive [[47a0"
      }, {
        "text": "f3d1|Romberg sign]].\u003cbr\u003e - \u003cb\u003eLancinating Pains:\u003c/b\u003e Brief, severe,"
      }, {
        "text": " stabbing pains in the legs or trunk.\u003cbr\u003e - \u003cb\u003eAreflexia:\u003c/b\u003e Loss of deep tendon reflexes (e"
      }, {
        "text": ".g., [[87d19a70|Achilles]], patellar) due to dorsal root damage"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003e[[08cb577f|Argyll Robertson Pupils]]:\u003c/b\u003e Pupils that accommodate"
      }, {
        "text": " but do not react to light.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e \u003cmark\u003e[[cfbd9f68|Charcot joints"
      }, {
        "text": "]]\u003c/mark\u003e (neuropathic arthropathy) can develop due to the loss of pain and position sense, leading to repeated joint"
      }, {
        "text": " trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The combination of sensory ataxia, lancinating pains, areflexia, and Argy"
      }, {
        "text": "ll Robertson pupils is pathognomonic for tabes dorsalis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eTabes dorsalis\u003c/b\u003e is the neurological legacy of untreated syphilis, a devastating degeneration of the dorsal columns and roots that ro"
      }, {
        "text": "bs the patient of their sense of position and reflexes, leading to a characteristic ataxic gait and lancinating pains.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"graph TD; A[Tertiary Syphilis] --\u003e B(Degeneration of Dorsal Columns \u0026 Roots);"
      }, {
        "text": " B --\u003e C(Loss of Proprioception \u0026 Vibration); C --\u003e D(Sensory Ataxia \u0026 +Romberg);"
      }, {
        "text": " B --\u003e E(Loss of DTRs); B --\u003e F(Lancinating Pains);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_manifestation_of\",\n        "
      }, {
        "text": "\"to\": \"neurosyphilis\"\n      },\n      {\n        \"type\": \"damages\","
      }, {
        "text": "\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"presents_with\",\n"
      }, {
        "text": "        \"to\": \"08cb577f\"\n      },\n      {\n        \"type\": \"causes\",\n        "
      }, {
        "text": "\"to\": \"cfbd9f68\"\n      }\n    ]\n  },\n  \"b"
      }, {
        "text": "da79225\": {\n    \"title\": \"Tardive Dyskinesia\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Neurology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Adverse Effects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTardive"
      }, {
        "text": " dyskinesia (TD)\u003c/b\u003e is a potentially irreversible movement disorder characterized by involuntary, repetitive body movements. It is a delayed"
      }, {
        "text": "-onset extrapyramidal side effect of long-term use of dopamine receptor-blocking agents, particularly antipsychotics.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by prolonged exposure to dopamine antagonists"
      }, {
        "text": ", especially \u003cmark\u003efirst-generation (typical) antipsychotics\u003c/mark\u003e. The risk increases with duration of treatment and age"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact mechanism is unknown, but it is thought to involve upregulation and supers"
      }, {
        "text": "ensitivity of postsynaptic dopamine receptors in the nigrostriatal pathway after chronic blockade.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " Characterized by stereotyped, involuntary movements, most commonly affecting the orofacial region. Classic signs include \u003cmark\u003elip"
      }, {
        "text": " smacking, chewing, grimacing, and tongue protrusions\u003c/mark\u003e (\u0027fly-catching\u0027 movements). It can also involve chore"
      }, {
        "text": "oathetoid movements of the limbs and trunk.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e The first step is to stop or"
      }, {
        "text": " reduce the dose of the offending agent if possible, or switch to an atypical antipsychotic with a lower risk (e.g., clozapine). The"
      }, {
        "text": " movements may be irreversible. Treatment options include [[07b0a9dd|VMAT2 inhibitors]] like val"
      }, {
        "text": "benazine and deutetrabenazine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e \u0027Tardive\u0027 means delayed."
      }, {
        "text": " This is a long-term complication of antipsychotic use. A patient on haloperidol for many years who develops new"
      }, {
        "text": ", involuntary facial movements has tardive dyskinesia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTardive dys"
      }, {
        "text": "kinesia\u003c/b\u003e is the cruel, delayed consequence of long-term dopamine blockade, where the brain\u0027s attempt to compensate by"
      }, {
        "text": " upregulating dopamine receptors leads to the emergence of persistent, involuntary, and often disfiguring orofacial movements.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_a_type_of\",\n        \"to\": \"9a9c9169\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_an_adverse_effect_of\",\n        \"to\": \"antipsych"
      }, {
        "text": "otics\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to"
      }, {
        "text": "\": \"07b0a9dd\"\n      }\n    ]\n  },\n  \"e3"
      }, {
        "text": "ce6784\": {\n    \"title\": \"Taste Pathway\",\n    \"primaryType\": \"physiology\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cranial Nerves\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003etaste (gustatory) pathway\u003c/b\u003e is the neural pathway that transmits the sensation of taste from the taste buds on"
      }, {
        "text": " the tongue to the cerebral cortex for conscious perception.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePeripheral"
      }, {
        "text": " Receptors:\u003c/b\u003e Taste buds on the tongue detect the five basic tastes: sweet, sour, salty, bitter, and"
      }, {
        "text": " umami.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFirst-Order Neurons (Cranial Nerves):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "dea9755f|Facial Nerve (CN VII)]]\u003c/b\u003e (via chorda tympani): Transmits taste"
      }, {
        "text": " from the \u003cmark\u003eanterior two-thirds\u003c/mark\u003e of the tongue.\u003cbr\u003e - \u003cb\u003e[[97e2c817|"
      }, {
        "text": "Glossopharyngeal Nerve (CN IX)]]:\u003c/b\u003e Transmits taste from the \u003cmark\u003eposterior one-third\u003c/mark\u003e of the tongue"
      }, {
        "text": ".\u003cbr\u003e - \u003cb\u003e[[vagus_nerve|Vagus Nerve (CN X)]]:\u003c/b\u003e Transmits taste from the ep"
      }, {
        "text": "iglottis and pharynx.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Relay:\u003c/b\u003e All three cranial nerves project to the \u003cmark\u003esol"
      }, {
        "text": "itary nucleus\u003c/mark\u003e (gustatory nucleus) in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e Second"
      }, {
        "text": "-order neurons ascend from the solitary nucleus to the \u003cmark\u003e[[23ac314a|ventral poster"
      }, {
        "text": "omedial (VPM) nucleus]]\u003c/mark\u003e of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Destination:\u003c/b\u003e Third"
      }, {
        "text": "-order neurons project from the VPM to the gustatory cortex, located in the insula and frontal operculum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the cranial nerve innervation for taste: 7 for the front, 9 for the back. The"
      }, {
        "text": " central pathway is Solitary Nucleus ‚Üí VPM of Thalamus ‚Üí Cortex.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003egustatory pathway\u003c/b\u003e is a three-neuron chain that carries taste information from the tongue"
      }, {
        "text": " via cranial nerves VII, IX, and X to the solitary nucleus, then relays through the VPM of the thalamus before"
      }, {
        "text": " reaching the cortex for the conscious perception of flavor.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Taste Buds"
      }, {
        "text": "] --\u003e B{CN VII, IX, X}; B --\u003e C(Solitary Nucleus - Medulla); C --\u003e D(V"
      }, {
        "text": "PM Nucleus - Thalamus); D --\u003e E(Gustatory Cortex);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_synonymous_with\",\n        \"to\": \"248af9f9"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"involves_cranial_nerve\",\n        \""
      }, {
        "text": "to\": \"dea9755f\"\n      },\n      {\n        \"type\": \"invol"
      }, {
        "text": "ves_cranial_nerve\",\n        \"to\": \"97e2c817\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"relays_in\",\n        \"to\": \"23ac314a\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"75929e32\": {\n    \"title\":"
      }, {
        "text": " \"Telencephalon\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Em"
      }, {
        "text": "bryology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Brain Development\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eTelencephalon\u003c/b\u003e is the most rostral of"
      }, {
        "text": " the five secondary brain vesicles that develop from the embryonic neural tube. It undergoes massive growth and differentiation to form the major structures of the adult cerebr"
      }, {
        "text": "um.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEmbryonic Origin:\u003c/b\u003e Arises from the anterior part"
      }, {
        "text": " of the forebrain (prosencephalon).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdult Derivatives:\u003c/b\u003e The telencephalon develops into the two"
      }, {
        "text": " \u003cmark\u003ecerebral hemispheres\u003c/mark\u003e, which include the cerebral cortex, the underlying white matter, and the \u003cmark\u003e[[ed"
      }, {
        "text": "462927|basal ganglia]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Cavity:\u003c/b\u003e The cavities"
      }, {
        "text": " within the developing telencephalon expand to become the paired \u003cmark\u003elateral ventricles\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDevelopment"
      }, {
        "text": "al Abnormalities:\u003c/b\u003e Failure of the telencephalon to properly divide into two hemispheres results in \u003cmark\u003eholoprosence"
      }, {
        "text": "phaly\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the developmental lineage: Prosencephalon ‚Üí Telencephalon ("
      }, {
        "text": "cerebral hemispheres, basal ganglia) and Diencephalon (thalamus, hypothalamus).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe \u003cb\u003eTelencephalon\u003c/b\u003e is the embryonic foundation of the cerebrum, undergoing an explosive growth"
      }, {
        "text": " process to form the highly convoluted cerebral hemispheres that are the seat of all higher cognitive functions.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Prosencephalon - Forebrain] --\u003e B(Telencephalon); B --\u003e C(Cerebral Hemispheres);"
      }, {
        "text": " B --\u003e D(Basal Ganglia); B --\u003e E(Lateral Ventricles);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"develops_from\",\n        \"to\": \"prosencephalon\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"develops_into\",\n        \"to\": \"cerebral_hemispheres\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"develops_into\",\n        \"to\": \"ed46"
      }, {
        "text": "2927\"\n      },\n      {\n        \"type\": \"malformation_of_leads_to\",\n        \""
      }, {
        "text": "to\": \"holoprosencephaly\"\n      }\n    ]\n  },\n  \"e6"
      }, {
        "text": "deda1b\": {\n    \"title\": \"Temazepam\",\n    \"primaryType\": \"drug\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Sedative-Hypnotics\"\n    "
      }, {
        "text": "],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eTemazepam\u003c/b\u003e is an intermediate-acting"
      }, {
        "text": " \u003ci\u003ebenzodiazepine\u003c/i\u003e used for the short-term treatment of insomnia.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e A positive allosteric modulator of the GABA\u003csub\u003eA\u003c/sub\u003e receptor, increasing the "
      }, {
        "text": "\u003cu\u003efrequency\u003c/u\u003e of chloride channel opening.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It is one of the benzodiazepines that undergoes"
      }, {
        "text": " metabolism \u003cmark\u003e\u0027Outside The Liver\u0027\u003c/mark\u003e (OTL - Oxazepam, Temazepam, Lorazepam)."
      }, {
        "text": " It is metabolized via conjugation, not by the cytochrome P450 system, making it a safer choice for patients with liver disease and"
      }, {
        "text": " the elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Primarily used for insomnia, particularly for sleep-maintenance insomnia due to its intermediate duration"
      }, {
        "text": " of action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Sedation, dizziness, dependence, and withdrawal. Less next-day \u0027"
      }, {
        "text": "hangover\u0027 effect than long-acting benzodiazepines.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027OTL\u0027 benzodiazep"
      }, {
        "text": "ines (Oxazepam, Temazepam, Lorazepam) as the ones that are safe to use in patients with liver failure"
      }, {
        "text": " because they bypass phase I (P450) metabolism.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTemazepam\u003c/b\u003e is an"
      }, {
        "text": " intermediate-acting benzodiazepine for insomnia whose primary clinical advantage lies in its metabolic pathway, which bypasses the cytochrome P450 system, making it"
      }, {
        "text": " a safer hypnotic choice for patients with liver disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"144"
      }, {
        "text": "64617\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \""
      }, {
        "text": "insomnia\"\n      },\n      {\n        \"type\": \"is_metabolized_outside_liver"
      }, {
        "text": "_p450\",\n        \"to\": \"true\"\n      }\n    ]\n  },\n  \"b8"
      }, {
        "text": "b42fc5\": {\n    \"title\": \"Temperature Sensation\",\n    \"primaryType\": \"physiology"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n"
      }, {
        "text": "      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Temperature sensation\u003c/b\u003e (thermoception) is the ability to sense differences in temperature. It is detected by specialized thermoreceptors in the skin and transmitted"
      }, {
        "text": " to the brain via the spinothalamic tract.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eRe"
      }, {
        "text": "ceptors:\u003c/b\u003e Mediated by \u003cmark\u003e[[1e7ec644|free nerve endings]]\u003c/mark"
      }, {
        "text": "\u003e in the skin, which contain specific transient receptor potential (TRP) channels that are sensitive to different temperature ranges (e"
      }, {
        "text": ".g., TRPV1 for heat, TRPM8 for cold).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFiber Types:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eCold"
      }, {
        "text": "\u003c/b\u003e sensation is transmitted by fast, thinly myelinated \u003cmark\u003eAŒ¥ fibers\u003c/mark\u003e.\u003cbr\u003e - \u003cb\u003eWarm"
      }, {
        "text": "th\u003c/b\u003e sensation is transmitted by slow, unmyelinated \u003cmark\u003eC fibers\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeural"
      }, {
        "text": " Pathway:\u003c/b\u003e The signal travels to the spinal cord, synapses in the dorsal horn, decussates at the \u003cmark\u003eanterior white commissure"
      }, {
        "text": "\u003c/mark\u003e, and ascends in the contralateral \u003cmark\u003e[[07eecef1|spinothalamic tract]]"
      }, {
        "text": "\u003c/mark\u003e to the VPL nucleus of the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Loss of temperature sensation is a key"
      }, {
        "text": " finding in lesions of the spinothalamic tract. A classic example is [[d2b8e10c|"
      }, {
        "text": "syringomyelia]], which causes a bilateral \u0027cape-like\u0027 loss of pain and temperature sensation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember that pain and temperature travel together in the spinothalamic tract. A sensory exam that shows"
      }, {
        "text": " loss of temperature sensation but preserved vibration sense points to a lesion affecting the spinothalamic tract while sparing the dorsal columns.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eTemperature sensation\u003c/b\u003e is a critical protective sense mediated by free nerve endings and"
      }, {
        "text": " transmitted via the spinothalamic tract; its selective loss is a powerful localizing sign for specific spinal cord lesions like"
      }, {
        "text": " syringomyelia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_detected_by\",\n        \"to\": \"1e7ec644\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_transmitted_by\",\n        \"to\": \""
      }, {
        "text": "07eecef1\"\n      },\n      {\n        \"type\": \"is_impaired_in\",\n        \"to"
      }, {
        "text": "\": \"d2b8e10c\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"644fc3b4\",\n    \"letter\": \"S\",\n    \"term\": \"Striatum\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Striatum\",\n    \"sub_entries\": [\n      {\n        \"id\": \"066e575e\",\n        \"letter\": \"S\",\n        \"term\": \"functions of\",\n        \"pages\": [\n          \"511\"\n        ],\n        \"context\": \"Striatum \u003e functions of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c5da3c57\",\n    \"letter\": \"S\",\n    \"term\": \"Stroke\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Stroke\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0a12374b\",\n        \"letter\": \"S\",\n        \"term\": \"central poststroke pain\",\n        \"pages\": [\n          \"529\"\n        ],\n        \"context\": \"Stroke \u003e central poststroke pain\"\n      },\n      {\n        \"id\": \"8c2905c7\",\n        \"letter\": \"S\",\n        \"term\": \"hemorrhagic intraparenchymal\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Stroke \u003e hemorrhagic intraparenchymal\"\n      },\n      {\n        \"id\": \"9f618c9c\",\n        \"letter\": \"S\",\n        \"term\": \"ischemic, types of\",\n        \"pages\": [\n          \"525\"\n        ],\n        \"context\": \"Stroke \u003e ischemic, types of\"\n      },\n      {\n        \"id\": \"63d0d365\",\n        \"letter\": \"S\",\n        \"term\": \"lesion area and symptoms\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Stroke \u003e lesion area and symptoms\"\n      }\n    ]\n  },\n  {\n    \"id\": \"fd52a8b8\",\n    \"letter\": \"S\",\n    \"term\": \"Sturge-Weber syndrome\",\n    \"pages\": [\n      \"539\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Sturge-Weber syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"61af7d03\",\n    \"letter\": \"S\",\n    \"term\": \"Sturge-Weber syndrome,\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sturge-Weber syndrome,\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a018a735\",\n        \"letter\": \"S\",\n        \"term\": \"presentation\",\n        \"pages\": [\n          \"539\"\n        ],\n        \"context\": \"Sturge-Weber syndrome, \u003e presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6f5bea90\",\n    \"letter\": \"S\",\n    \"term\": \"Subacute combined degeneration,\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Subacute combined degeneration,\",\n    \"sub_entries\": [\n      {\n        \"id\": \"de28f828\",\n        \"letter\": \"S\",\n        \"term\": \"67\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Subacute combined degeneration, \u003e 67\"\n      }\n    ]\n  },\n  {\n    \"id\": \"63f8b05f\",\n    \"letter\": \"S\",\n    \"term\": \"Subarachnoid hemorrhage\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Subarachnoid hemorrhage\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8a680168\",\n        \"letter\": \"S\",\n        \"term\": \"aneurysms\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Subarachnoid hemorrhage \u003e aneurysms\"\n      },\n      {\n        \"id\": \"fad44e88\",\n        \"letter\": \"S\",\n        \"term\": \"cause and effects of\",\n        \"pages\": [\n          \"528\"\n        ],\n        \"context\": \"Subarachnoid hemorrhage \u003e cause and effects of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"7fca15b0\",\n    \"letter\": \"S\",\n    \"term\": \"Subarachnoid space\",\n    \"pages\": [\n      \"506\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Subarachnoid space\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8aaeb0d8\",\n    \"letter\": \"S\",\n    \"term\": \"Subdural hematomas\",\n    \"pages\": [\n      \"528\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Subdural hematomas\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8a695458\",\n    \"letter\": \"S\",\n    \"term\": \"Subgaleal hemorrhage\",\n    \"pages\": [\n      \"527\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Subgaleal hemorrhage\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f6299199\",\n    \"letter\": \"S\",\n    \"term\": \"Substance P\",\n    \"pages\": [\n      \"532\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Substance P\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c4cae1ab\",\n    \"letter\": \"S\",\n    \"term\": \"Subthalamic nucleus, lesions\",\n    \"pages\": [\n      \"524\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Subthalamic nucleus, lesions\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"92e3a9e8\",\n    \"letter\": \"S\",\n    \"term\": \"Succinylcholine\",\n    \"pages\": [\n      \"566\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Succinylcholine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b63c57d8\",\n    \"letter\": \"S\",\n    \"term\": \"Sucking reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Sucking reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e4aa616b\",\n    \"letter\": \"S\",\n    \"term\": \"Sumatriptan\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sumatriptan\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f225986e\",\n        \"letter\": \"S\",\n        \"term\": \"cluster headaches\",\n        \"pages\": [\n          \"532\"\n        ],\n        \"context\": \"Sumatriptan \u003e cluster headaches\"\n      },\n      {\n        \"id\": \"68bcb06d\",\n        \"letter\": \"S\",\n        \"term\": \"effects\",\n        \"pages\": [\n          \"562\"\n        ],\n        \"context\": \"Sumatriptan \u003e effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"09252a1b\",\n    \"letter\": \"S\",\n    \"term\": \"Superior oblique muscle\",\n    \"pages\": [\n      \"555\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Superior oblique muscle\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1994
    }, {
      "text": "```json\n{\n  \"644fc3b4\": {\n    \"title\": \"Striatum\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Basal Ganglia\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eStriatum\u003c/b\u003e is a major component of the [[ed462927|basal ganglia]], composed of the [[3fa071ef|caudate nucleus]] and the putamen. It serves as the primary input nucleus for the basal ganglia, receiving extensive excitatory input from the cerebral cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Caudate nucleus and putamen.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The striatum is the main input station of the [[ed462927|basal ganglia]]. It receives glutamatergic (excitatory) input from the cortex and dopaminergic input from the substantia nigra pars compacta. It then projects inhibitory (GABAergic) signals to the output nuclei of the basal ganglia (GPi/SNr).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctional Division:\u003c/b\u003e\u003cbr\u003e - The \u003cb\u003eputamen\u003c/b\u003e is primarily involved in the motor loop.\u003cbr\u003e - The \u003cb\u003e[[3fa071ef|caudate nucleus]]\u003c/b\u003e is more involved in cognitive and associative loops.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Degeneration of the striatum is the hallmark of \u003cmark\u003e[[ffd7e743|Huntington disease]]\u003c/mark\u003e, leading to chorea and dementia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the striatum (caudate + putamen) is the \u0027input\u0027 part of the basal ganglia. Its degeneration in Huntington\u0027s disease leads to a loss of inhibitory output, causing the characteristic hyperkinetic movements.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eStriatum\u003c/b\u003e is the gateway to the basal ganglia, receiving cortical commands for movement and cognition and initiating the direct (\u0027go\u0027) and indirect (\u0027no-go\u0027) pathways that ultimately shape motor output.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cortex] --Glutamate--\u003e B(Striatum); C[Substantia Nigra] --Dopamine--\u003e B; B --GABA--\u003e D(Globus Pallidus \u0026 SNr);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"3fa071ef\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"putamen\"\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"ffd7e743\"\n      }\n    ]\n  },\n  \"c5da3c57\": {\n    \"title\": \"Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Cerebrovascular\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003estroke\u003c/b\u003e, or cerebrovascular accident (CVA), is a medical condition in which poor blood flow to the brain results in cell death. There are two main types of stroke: ischemic, due to lack of blood flow, and hemorrhagic, due to bleeding.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIschemic Stroke (~85%):\u003c/b\u003e Caused by obstruction of a cerebral artery.\u003cbr\u003e - \u003cb\u003e[[91bfec7e|Thrombotic]]:\u003c/b\u003e A clot forms locally on an atherosclerotic plaque.\u003cbr\u003e - \u003cb\u003e[[6a805ecd|Embolic]]:\u003c/b\u003e A clot travels from a distant site (e.g., heart in atrial fibrillation).\u003cbr\u003e - \u003cb\u003eLacunar:\u003c/b\u003e Occlusion of small, penetrating arteries, often due to hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHemorrhagic Stroke (~15%):\u003c/b\u003e Caused by rupture of a blood vessel.\u003cbr\u003e - \u003cb\u003e[[70b266c8|Intraparenchymal]]:\u003c/b\u003e Bleeding into the brain tissue, often from rupture of Charcot-Bouchard microaneurysms due to hypertension.\u003cbr\u003e - \u003cb\u003e[[63f8b05f|Subarachnoid]]:\u003c/b\u003e Bleeding into the subarachnoid space, often from a ruptured berry aneurysm.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation:\u003c/b\u003e Sudden onset of focal neurological deficits. The specific symptoms depend on the \u003cmark\u003elesion area and affected vascular territory\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Immediate non-contrast head CT is crucial to differentiate ischemic from hemorrhagic stroke, as this guides acute management.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute Treatment:\u003c/b\u003e For ischemic stroke, thrombolysis with tPA (tissue plasminogen activator) may be an option if within the therapeutic window (typically 3-4.5 hours).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e [[714f15fc|Central post-stroke pain]] is a potential chronic complication, especially after a thalamic stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003estroke\u003c/b\u003e is a \u0027brain attack\u0027 that causes neurological deficits corresponding to the affected vascular territory; the immediate priority is to distinguish ischemic from hemorrhagic types with a CT scan, as the acute treatments are diametrically opposed.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"ischemic_stroke\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hemorrhagic_stroke\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"714f15fc\"\n      }\n    ]\n  },\n  \"fd52a8b8\": {\n    \"title\": \"Sturge-Weber Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e, also known as encephalotrigeminal angiomatosis, is a rare, congenital neurocutaneous disorder characterized by a facial capillary malformation (port-wine stain) and an associated vascular malformation of the brain and eye.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Caused by a somatic mosaic mutation in the \u003ci\u003e[[5ef5ca57|GNAQ]]\u003c/i\u003e gene. It is \u003cu\u003enot\u003c/u\u003e inherited.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eFacial Port-Wine Stain:\u003c/b\u003e A capillary malformation in the distribution of the ophthalmic (V\u003csub\u003e1\u003c/sub\u003e) and sometimes maxillary (V\u003csub\u003e2\u003c/sub\u003e) branches of the trigeminal nerve.\u003cbr\u003e2. \u003cb\u003eLeptomeningeal Angioma:\u003c/b\u003e An abnormal collection of blood vessels on the surface of the brain, typically ipsilateral to the facial lesion. This can lead to \u003cmark\u003eseizures\u003c/mark\u003e (most common neurological symptom), intellectual disability, and focal neurological deficits.\u003cbr\u003e3. \u003cb\u003eGlaucoma:\u003c/b\u003e Increased intraocular pressure, often ipsilateral to the facial lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Skull X-rays or CT scans may show characteristic \u0027tram-track\u0027 calcifications, which represent calcification of the cortex underlying the leptomeningeal angioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with a port-wine stain on their face, seizures, and intellectual disability is the classic presentation of Sturge-Weber syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e is a congenital vascular disorder that \u0027stains\u0027 the face with a port-wine birthmark and the underlying brain with a leptomeningeal angioma, leading to a triad of dermatological, neurological (seizures), and ophthalmological (glaucoma) problems.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Somatic GNAQ Mutation] --\u003e B(Vascular Malformation); B --\u003e C(Facial Port-Wine Stain); B --\u003e D(Leptomeningeal Angioma); D --\u003e E(Seizures); B --\u003e F(Ocular Involvement); F --\u003e G(Glaucoma);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"1c42ff26\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous_disorder\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"5ef5ca57\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"port_wine_stain\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"seizures\"\n      }\n    ]\n  },\n  \"61af7d03\": {\n    \"title\": \"Sturge-Weber Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e, also known as encephalotrigeminal angiomatosis, is a rare, congenital neurocutaneous disorder characterized by a facial capillary malformation (port-wine stain) and an associated vascular malformation of the brain and eye.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Caused by a somatic mosaic mutation in the \u003ci\u003e[[5ef5ca57|GNAQ]]\u003c/i\u003e gene. It is \u003cu\u003enot\u003c/u\u003e inherited.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eFacial Port-Wine Stain:\u003c/b\u003e A capillary malformation in the distribution of the ophthalmic (V\u003csub\u003e1\u003c/sub\u003e) and sometimes maxillary (V\u003csub\u003e2\u003c/sub\u003e) branches of the trigeminal nerve.\u003cbr\u003e2. \u003cb\u003eLeptomeningeal Angioma:\u003c/b\u003e An abnormal collection of blood vessels on the surface of the brain, typically ipsilateral to the facial lesion. This can lead to \u003cmark\u003eseizures\u003c/mark\u003e (most common neurological symptom), intellectual disability, and focal neurological deficits.\u003cbr\u003e3. \u003cb\u003eGlaucoma:\u003c/b\u003e Increased intraocular pressure, often ipsilateral to the facial lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Skull X-rays or CT scans may show characteristic \u0027tram-track\u0027 calcifications, which represent calcification of the cortex underlying the leptomeningeal angioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with a port-wine stain on their face, seizures, and intellectual disability is the classic presentation of Sturge-Weber syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e is a congenital vascular disorder that \u0027stains\u0027 the face with a port-wine birthmark and the underlying brain with a leptomeningeal angioma, leading to a triad of dermatological, neurological (seizures), and ophthalmological (glaucoma) problems.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Somatic GNAQ Mutation] --\u003e B(Vascular Malformation); B --\u003e C(Facial Port-Wine Stain); B --\u003e D(Leptomeningeal Angioma); D --\u003e E(Seizures); B --\u003e F(Ocular Involvement); F --\u003e G(Glaucoma);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"1c42ff26\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous_disorder\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"5ef5ca57\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"port_wine_stain\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"seizures\"\n      }\n    ]\n  },\n  \"6f5bea90\": {\n    \"title\": \"Subacute Combined Degeneration (SCD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Hematology\",\n      \"Nutrition\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSubacute Combined Degeneration (SCD)\u003c/b\u003e is a neurological complication of severe [[784e2484|vitamin B\u003csub\u003e12\u003c/sub\u003e (cobalamin) deficiency]]. It is characterized by the progressive demyelination of specific tracts in the spinal cord.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency leads to an accumulation of methylmalonic acid, which is thought to be toxic to myelin. This results in demyelination of three main spinal cord tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected Tracts:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[e7f5cbbe|Dorsal Columns]]:\u003c/b\u003e Causes loss of proprioception and vibration sense, leading to sensory ataxia and a positive Romberg sign.\u003cbr\u003e2. \u003cb\u003eLateral Corticospinal Tracts:\u003c/b\u003e Causes upper motor neuron signs, such as spastic paresis and hyperreflexia.\u003cbr\u003e3. \u003cb\u003eSpinocerebellar Tracts:\u003c/b\u003e Contributes to ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with a combination of sensory ataxia (from dorsal column loss) and spastic weakness (from corticospinal tract loss).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Findings:\u003c/b\u003e Often accompanied by megaloblastic anemia, but neurological symptoms can precede or occur in the absence of hematological changes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The \u0027combined\u0027 in the name refers to the combination of damage to both ascending (dorsal columns) and descending (corticospinal) tracts. Remember that folate supplementation can correct the anemia of B\u003csub\u003e12\u003c/sub\u003e deficiency but will not stop (and may worsen) the progression of SCD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSubacute Combined Degeneration\u003c/b\u003e is the devastating neurological consequence of vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency, where demyelination of both the dorsal and lateral columns of the spinal cord leads to a crippling combination of sensory ataxia and spastic weakness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Vitamin B12 Deficiency] --\u003e B(‚Üë Methylmalonic Acid); B --\u003e C(Myelin Damage); C --\u003e D(Demyelination of Spinal Cord Tracts); D --\u003e E(Dorsal Columns -\u003e Sensory Ataxia); D --\u003e F(Corticospinal Tracts -\u003e Spastic Paresis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"784e2484\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"damages\",\n        \"to\": \"corticospinal_tracts\"\n      }\n    ]\n  },\n  \"63f8b05f\": {\n    \"title\": \"Subarachnoid Hemorrhage (SAH)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003esubarachnoid hemorrhage (SAH)\u003c/b\u003e is bleeding into the subarachnoid space, the area between the arachnoid mater and the pia mater that is normally filled with cerebrospinal fluid. It is a type of hemorrhagic stroke and a medical emergency.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The most common cause of non-traumatic SAH is the rupture of a saccular \u003cmark\u003e[[a9f6d703|berry aneurysm]]\u003c/mark\u003e (~85% of cases). Other causes include trauma (most common overall), arteriovenous malformations, and vasculitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by the sudden onset of a severe, explosive headache, classically described as the \u003cmark\u003e\\\"worst headache of my life\\\"\u003c/mark\u003e or a \u0027thunderclap headache.\u0027 May be accompanied by nausea, vomiting, loss of consciousness, and nuchal rigidity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eNon-contrast head CT:\u003c/b\u003e The initial test of choice. Shows hyperdense (white) blood in the sulci and basal cisterns.\u003cbr\u003e2. \u003cb\u003eLumbar Puncture:\u003c/b\u003e Performed if the CT is negative but clinical suspicion is high. The classic finding is \u003cmark\u003exanthochromia\u003c/mark\u003e (yellowish discoloration of the CSF due to bilirubin from RBC breakdown), which appears several hours after the bleed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eRebleeding:\u003c/b\u003e High risk in the first 24 hours.\u003cbr\u003e - \u003cb\u003eVasospasm:\u003c/b\u003e Narrowing of cerebral arteries 3-10 days after the bleed, which can cause ischemic stroke. Nimodipine (a calcium channel blocker) is used to prevent this.\u003cbr\u003e - \u003cb\u003eHydrocephalus:\u003c/b\u003e Blood can obstruct CSF reabsorption at the arachnoid granulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e \u0027Worst headache of my life\u0027 \u003d Subarachnoid hemorrhage. The first step is a non-contrast CT. If negative, the next step is a lumbar puncture.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003esubarachnoid hemorrhage\u003c/b\u003e is a neurovascular catastrophe, most often from a ruptured berry aneurysm, that announces itself with a \u0027thunderclap headache\u0027 and carries the dual threats of rebleeding and delayed ischemic stroke from vasospasm.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Ruptured Berry Aneurysm] --\u003e B(Bleeding into Subarachnoid Space); B --\u003e C(Sudden ‚Üë ICP); C --\u003e D(Worst Headache of My Life);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"hemorrhagic_stroke\"\n      },\n      {\n        \"type\": \"is_caused_by_rupture_of\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"thunderclap_headache\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"vasospasm\"\n      }\n    ]\n  },\n  \"7fca15b0\": {\n    \"title\": \"Subarachnoid Space\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003esubarachnoid space\u003c/b\u003e is the anatomical space between the [[46e279b9|arachnoid mater]] and the pia mater. It is filled with cerebrospinal fluid (CSF) and contains the major arteries and veins of the brain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eContents:\u003c/b\u003e Cerebrospinal fluid (CSF), major cerebral arteries (forming the [[e22300e8|Circle of Willis]]), and bridging veins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The CSF within this space provides a buoyant cushion for the brain, protecting it from trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Circulation:\u003c/b\u003e CSF enters the subarachnoid space from the fourth ventricle via the foramina of Luschka and Magendie and is reabsorbed into the dural venous sinuses via the [[b7b67074|arachnoid granulations]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[63f8b05f|Subarachnoid Hemorrhage]]:\u003c/b\u003e Bleeding into this space, typically from a ruptured aneurysm.\u003cbr\u003e - \u003cb\u003eMeningitis:\u003c/b\u003e Inflammation of the meninges, with inflammatory cells found in the CSF of the subarachnoid space.\u003cbr\u003e - \u003cb\u003eLumbar Puncture:\u003c/b\u003e A needle is inserted into the lumbar subarachnoid space (lumbar cistern) to sample CSF.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the major blood vessels of the brain run through the subarachnoid space, which is why a ruptured aneurysm bleeds into this space.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003esubarachnoid space\u003c/b\u003e is the CSF-filled \u0027moat\u0027 surrounding the brain, providing a protective fluid buffer and serving as the conduit for the brain\u0027s major blood vessels, but also making it the site of devastating hemorrhages and infections.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \"46e279b9\"\n      },\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \"pia_mater\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"7109d8b6\"\n      },\n      {\n        \"type\": \"is_site_of\",\n        \"to\": \"63f8b05f\"\n      }\n    ]\n  },\n  \"8aaeb0d8\": {\n    \"title\": \"Subdural Hematoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Trauma\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003esubdural hematoma (SDH)\u003c/b\u003e is a collection of blood that forms between the inner layer of the dura mater and the arachnoid mater. It is typically caused by the tearing of bridging veins that cross the subdural space.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Usually caused by head trauma, often with acceleration-deceleration forces that shear the bridging veins. It is common in the \u003cmark\u003eelderly\u003c/mark\u003e (due to brain atrophy, which stretches the veins) and in infants (shaken baby syndrome). Chronic alcohol use is also a risk factor.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Venous bleeding leads to a slower accumulation of blood compared to an epidural hematoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Can be acute, subacute, or chronic. Symptoms may be insidious and fluctuating, including headache, confusion, somnolence, and focal neurological deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e A non-contrast head CT shows a hyperdense (acute) or hypodense (chronic), \u003cmark\u003ecrescent-shaped\u003c/mark\u003e blood collection that \u003cmark\u003ecrosses suture lines\u003c/mark\u003e but is limited by dural reflections (e.g., falx cerebri).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Crescent shape that crosses suture lines \u003d Subdural hematoma. Lentiform shape that does not cross suture lines \u003d [[a61683ae|Epidural hematoma]]. The classic patient is an elderly individual with a history of a fall who presents with gradual cognitive decline.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003esubdural hematoma\u003c/b\u003e is a low-pressure venous bleed from torn bridging veins, which slowly spreads in a crescent shape over the brain\u0027s surface and is classically seen in the elderly after minor head trauma due to age-related brain atrophy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Head Trauma] --\u003e B(Tearing of Bridging Veins); B --\u003e C(Venous Bleeding into Subdural Space); C --\u003e D(Crescent-shaped Hematoma); D --\u003e E(Compression of Brain);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"intracranial_hemorrhage\"\n      },\n      {\n        \"type\": \"is_caused_by_tearing_of\",\n        \"to\": \"bridging_veins\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a61683ae\"\n      },\n      {\n        \"type\": \"is_common_in\",\n        \"to\": \"elderly\"\n      }\n    ]\n  },\n  \"8a695458\": {\n    \"title\": \"Subgaleal Hemorrhage\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Obstetrics\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neonatal Injuries\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003esubgaleal hemorrhage\u003c/b\u003e is a rare but potentially lethal extracranial hemorrhage in a newborn, where blood accumulates in the potential space between the cranial periosteum and the galea aponeurosis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Caused by the rupture of emissary veins, which connect the dural sinuses with the scalp veins. It is a severe complication of difficult operative vaginal deliveries, especially \u003cmark\u003evacuum extraction\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The subgaleal space is large and can accommodate a significant portion of the infant\u0027s total blood volume, leading to severe hemorrhagic shock.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with a diffuse, fluctuant, boggy swelling of the scalp that \u003cmark\u003ecrosses suture lines\u003c/mark\u003e and can shift with gravity. The infant may show signs of hypovolemic shock (tachycardia, pallor, poor perfusion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Hypovolemic shock, coagulopathy, and death.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A newborn with a rapidly expanding, boggy scalp swelling that crosses suture lines after a difficult vacuum delivery should raise immediate concern for a subgaleal hemorrhage, a life-threatening emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003esubgaleal hemorrhage\u003c/b\u003e is a dangerous neonatal bleed into the vast potential space under the scalp aponeurosis, capable of causing rapid and massive blood loss and hypovolemic shock, most often as a complication of vacuum-assisted delivery.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"46ca72c2\"\n      },\n      {\n        \"type\": \"is_caused_by_rupture_of\",\n        \"to\": \"emissary_veins\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"vacuum_extraction\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"hypovolemic_shock\"\n      }\n    ]\n  },\n  \"f6299199\": {\n    \"title\": \"Substance P\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSubstance P\u003c/b\u003e is a neuropeptide of the tachykinin family that functions as a neurotransmitter and neuromodulator. It is strongly associated with the transmission of pain signals and the inflammatory response.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e A key mediator in the perception of \u003cmark\u003epain\u003c/mark\u003e. It is released from the peripheral terminals of sensory nerve fibers (nociceptors) in response to noxious stimuli and in the dorsal horn of the spinal cord to transmit pain signals to higher centers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptor:\u003c/b\u003e It acts on the \u003cmark\u003eneurokinin-1 (NK-1) receptor\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Migraine:\u003c/b\u003e Along with [[24d36d58|CGRP]], substance P is one of the vasoactive neuropeptides released from trigeminal nerve endings during a [[c8833bae|migraine]] attack, contributing to neurogenic inflammation and pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Vomiting:\u003c/b\u003e Substance P acting on NK-1 receptors in the brainstem (vomiting center) is a key mediator of the vomiting reflex, particularly in delayed chemotherapy-induced nausea and vomiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e NK-1 receptor antagonists (e.g., aprepitant) are used as antiemetics. Topical [[e4b8298b|capsaicin]] works by depleting substance P from peripheral nerve endings to produce analgesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate Substance P with pain transmission in the spinal cord and its role in both migraine and emesis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSubstance P\u003c/b\u003e is the primary neuropeptide for pain signaling, released by nociceptive neurons to transmit pain information centrally, and its blockade is a therapeutic strategy for both pain and emesis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Noxious Stimulus] --\u003e B(Nociceptor); B --Releases Substance P--\u003e C(Dorsal Horn Neuron); C --\u003e D(Ascending Pain Pathway);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_mediator_of\",\n        \"to\": \"pain\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to\": \"vomiting\"\n      },\n      {\n        \"type\": \"is_depleted_by\",\n        \"to\": \"e4b8298b\"\n      }\n    ]\n  },\n  \"c4cae1ab\": {\n    \"title\": \"Subthalamic Nucleus Lesions\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Basal Ganglia Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA lesion of the \u003cb\u003esubthalamic nucleus (STN)\u003c/b\u003e, a component of the [[ed462927|basal ganglia]], results in a hyperkinetic movement disorder known as \u003cmark\u003ehemiballismus\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of STN:\u003c/b\u003e The STN is the key excitatory nucleus in the \u003cmark\u003eindirect pathway\u003c/mark\u003e of the basal ganglia. It provides excitatory (glutamatergic) input to the globus pallidus internus (GPi), which in turn inhibits the thalamus to suppress unwanted movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Pathophysiology:\u003c/b\u003e A lesion of the STN (typically a lacunar stroke) removes this excitatory drive to the GPi. This leads to reduced inhibitory output from the GPi to the thalamus. The resulting disinhibition of the thalamus causes excessive cortical excitation and involuntary movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation (Hemiballismus):\u003c/b\u003e Characterized by wild, violent, flinging movements of the limbs on \u003cmark\u003eone side of the body (contralateral to the lesion)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Contralateral hemiballismus is the classic, pathognomonic sign of a lesion in the subthalamic nucleus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA lesion in the \u003cb\u003esubthalamic nucleus\u003c/b\u003e effectively \u0027cuts the brakes\u0027 of the indirect pathway, leading to a profound disinhibition of the thalamus and the explosive, uncontrolled, flinging movements of contralateral hemiballismus.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Lesion of Subthalamic Nucleus] --x B(Excitation of GPi); B --x C(Inhibition of Thalamus); C --\u003e D(Disinhibition of Thalamus); D --\u003e E(Contralateral Hemiballismus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"hemiballismus\"\n      },\n      {\n        \"type\": \"is_a_lesion_of\",\n        \"to\": \"subthalamic_nucleus\"\n      },\n      {\n        \"type\": \"disrupts\",\n        \"to\": \"indirect_pathway_basal_ganglia\"\n      }\n    ]\n  },\n  \"92e3a9e8\": {\n    \"title\": \"Succinylcholine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSuccinylcholine\u003c/b\u003e is the only depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e in clinical use. It induces paralysis by causing persistent depolarization of the motor endplate.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Phase I):\u003c/b\u003e Acts as a nicotinic ACh receptor agonist. It binds to the receptor, causing initial depolarization which leads to transient muscle twitching (\u003cmark\u003efasciculations\u003c/mark\u003e). Because it is not degraded by acetylcholinesterase, it remains bound, keeping the membrane depolarized and preventing repolarization, leading to flaccid paralysis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Phase II):\u003c/b\u003e With prolonged exposure, the receptor becomes desensitized, and the membrane repolarizes but remains unresponsive to ACh.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for rapid sequence intubation due to its \u003cmark\u003efast onset\u003c/mark\u003e (~1 min) and \u003cmark\u003eshort duration\u003c/mark\u003e (~5-10 min).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Rapidly hydrolyzed by plasma pseudocholinesterase (butyrylcholinesterase).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e\u003cbr\u003e - \u003cmark\u003eMalignant Hyperthermia:\u003c/mark\u003e A life-threatening hypermetabolic state in genetically susceptible individuals.\u003cbr\u003e - \u003cmark\u003eHyperkalemia:\u003c/mark\u003e Can cause a dangerous increase in serum potassium, especially in patients with burns, crush injuries, or neuromuscular diseases, due to upregulation of ACh receptors.\u003cbr\u003e - Bradycardia or tachycardia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The initial muscle fasciculations are the key clinical feature that distinguishes succinylcholine from non-depolarizing blockers. Its potential to cause malignant hyperthermia and severe hyperkalemia are high-yield adverse effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSuccinylcholine\u003c/b\u003e is a unique neuromuscular blocker that paralyzes muscles by overstimulating them into a state of persistent depolarization, offering a rapid onset and offset ideal for intubation but carrying the serious risks of malignant hyperthermia and life-threatening hyperkalemia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Succinylcholine] --\u003e B(Binds Nicotinic ACh Receptor); B --\u003e C(Phase I: Depolarization); C --\u003e D(Fasciculations); D --\u003e E(Flaccid Paralysis);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"a518f249\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"malignant_hyperthermia\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"hyperkalemia\"\n      },\n      {\n        \"type\": \"is_metabolized_by\",\n        \"to\": \"pseudocholinesterase\"\n      }\n    ]\n  },\n  \"b63c57d8\": {\n    \"title\": \"Sucking Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003esucking reflex\u003c/b\u003e is a primitive reflex present in infants that allows for feeding. It is characterized by a sucking motion when the roof of the mouth is stimulated.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e Elicited by placing a gloved finger or pacifier into the infant\u0027s mouth and touching the palate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response:\u003c/b\u003e The infant will begin to suck rhythmically.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Present at birth and is strongest in the first few months. It is gradually replaced by voluntary sucking and typically disappears by 4 months of age.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is one of several primitive reflexes tested in the newborn neurological exam to assess brainstem function and development. A weak or absent sucking reflex can be a sign of prematurity or neurological impairment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRe-emergence:\u003c/b\u003e The reappearance of the sucking reflex in an adult is an abnormal finding known as a frontal release sign, indicating damage to the [[0405ada3|frontal lobe]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The sucking reflex is a normal, essential reflex for feeding in a newborn. Its persistence or re-emergence in an older child or adult is pathological.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003esucking reflex\u003c/b\u003e is an innate, brainstem-mediated survival reflex in infants that ensures feeding, which is later suppressed by the maturing frontal lobes; its reappearance in adulthood is a sign of frontal lobe pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex\"\n      },\n      {\n        \"type\": \"re-emergence_indicates\",\n        \"to\": \"frontal_lobe_damage\"\n      }\n    ]\n  },\n  \"e4aa616b\": {\n    \"title\": \"Sumatriptan\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSumatriptan\u003c/b\u003e is the prototypical drug in the \u003ci\u003etriptan\u003c/i\u003e class, acting as a serotonin 5-HT\u003csub\u003e1B/1D\u003c/sub\u003e receptor agonist. It is a first-line therapy for the acute (abortive) treatment of moderate to severe [[c8833bae|migraine]] and [[21760f80|cluster headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e\u003cbr\u003e1. Agonism at 5-HT\u003csub\u003e1B\u003c/sub\u003e receptors on cranial blood vessels causes \u003cmark\u003evasoconstriction\u003c/mark\u003e, counteracting the vasodilation thought to contribute to migraine pain.\u003cbr\u003e2. Agonism at presynaptic 5-HT\u003csub\u003e1D\u003c/sub\u003e receptors on trigeminal nerve endings \u003cmark\u003einhibits the release of vasoactive neuropeptides\u003c/mark\u003e like CGRP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Acute treatment of [[c8833bae|migraines]] (with or without aura) and [[21760f80|cluster headaches]]. It is \u003cu\u003enot\u003c/u\u003e for prophylaxis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Paresthesias, dizziness, and \u0027triptan sensations\u0027 (a feeling of tightness or pressure in the chest, neck, or throat).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Due to its vasoconstrictive effects, it is contraindicated in patients with a history of \u003cmark\u003ecoronary artery disease\u003c/mark\u003e, uncontrolled hypertension, or stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Sumatriptan is the classic abortive agent for migraines and cluster headaches. Its vasoconstrictive properties are both part of its mechanism and the source of its major contraindications.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSumatriptan\u003c/b\u003e provides rapid relief from migraine and cluster headaches by constricting cranial vessels and blocking pain peptide release, but this powerful vasoconstriction makes it unsafe for patients with underlying cardiovascular disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sumatriptan] --\u003e B(5-HT1B/1D Agonist); B --\u003e C(Cranial Vasoconstriction); B --\u003e D(‚Üì CGRP Release); C \u0026 D --\u003e E(Migraine/Cluster Headache Relief);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"34ba2a7b\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"c8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"21760f80\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"dd3c9b1b\"\n      }\n    ]\n  },\n  \"09252a1b\": {\n    \"title\": \"Superior Oblique Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSuperior Oblique\u003c/b\u003e is one of the six extraocular muscles. It is unique in that it passes through a fibrocartilaginous pulley, the trochlea, before inserting on the eyeball, and it is innervated by the [[bba6093a|trochlear nerve (CN IV)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInnervation:\u003c/b\u003e Innervated by the contralateral \u003cmark\u003e[[bba6093a|trochlear nerve (CN IV)]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eActions:\u003c/b\u003e Its primary action is \u003cmark\u003eintorsion\u003c/mark\u003e (internal rotation of the top of the eye toward the nose). Its secondary action is depression (especially in adduction), and its tertiary action is abduction.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTesting:\u003c/b\u003e The depressing action of the superior oblique is best isolated by having the patient look \u003cmark\u003edown and in\u003c/mark\u003e (adducted position).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy:\u003c/b\u003e A [[de532715|CN IV palsy]] results in weakness of the superior oblique. The eye becomes extorted and elevated (hypertropia). This causes vertical [[9914d433|diplopia]] that is worse when looking down and medially (e.g., reading or going down stairs). Patients compensate by tilting their head away from the affected side.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the mnemonic (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e: \u003cb\u003eS\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique is innervated by CN \u003cb\u003eIV\u003c/b\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSuperior Oblique muscle\u003c/b\u003e, controlled by the trochlear nerve, is the eye\u0027s primary intortor and is crucial for looking down and in; its paralysis leads to a characteristic vertical diplopia and a compensatory head tilt.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"bba6093a\"\n      },\n      {\n        \"type\": \"action_is\",\n        \"to\": \"intorsion_of_eye\"\n      },\n      {\n        \"type\": \"paralysis_causes\",\n        \"to\": \"de532715\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 10325,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"644fc3b4\": {\n    \"title\": \"Stri"
      }, {
        "text": "atum\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Bas"
      }, {
        "text": "al Ganglia\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eStriatum\u003c/b\u003e is a major component of the [[ed4"
      }, {
        "text": "62927|basal ganglia]], composed of the [[3fa071ef|caudate nucleus"
      }, {
        "text": "]] and the putamen. It serves as the primary input nucleus for the basal ganglia, receiving extensive excitatory input from the cerebral"
      }, {
        "text": " cortex.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComponents:\u003c/b\u003e Caudate nucleus and putamen.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The striatum is the main input station of the [[ed462927|"
      }, {
        "text": "basal ganglia]]. It receives glutamatergic (excitatory) input from the cortex and dopaminergic input"
      }, {
        "text": " from the substantia nigra pars compacta. It then projects inhibitory (GABAergic) signals to the output nuclei of the basal ganglia ("
      }, {
        "text": "GPi/SNr).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunctional Division:\u003c/b\u003e\u003cbr\u003e - The \u003cb\u003eputamen\u003c/b\u003e is primarily"
      }, {
        "text": " involved in the motor loop.\u003cbr\u003e - The \u003cb\u003e[[3fa071ef|caudate nucleus]]\u003c/b\u003e is more"
      }, {
        "text": " involved in cognitive and associative loops.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e Degeneration of the striatum is the hallmark of \u003c"
      }, {
        "text": "mark\u003e[[ffd7e743|Huntington disease]]\u003c/mark\u003e, leading to chorea and dementia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember that the striatum (caudate + putamen) is the \u0027input\u0027 part of the basal ganglia."
      }, {
        "text": " Its degeneration in Huntington\u0027s disease leads to a loss of inhibitory output, causing the characteristic hyperkinetic movements.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eStriatum\u003c/b\u003e is the gateway to the basal ganglia, receiving cortical"
      }, {
        "text": " commands for movement and cognition and initiating the direct (\u0027go\u0027) and indirect (\u0027no-go\u0027) pathways that ultimately shape motor"
      }, {
        "text": " output.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Cortex] --Glutamate--\u003e B"
      }, {
        "text": "(Striatum); C[Substantia Nigra] --Dopamine--\u003e B; B --GABA--\u003e"
      }, {
        "text": " D(Globus Pallidus \u0026 SNr);\"\n    },\n    \"connections\": [\n      {\n        \"type"
      }, {
        "text": "\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_composed_of\",\n        \"to\": \"3fa071ef\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"put"
      }, {
        "text": "amen\"\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"ffd7e743"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"c5da3c57\": {\n    \"title\":"
      }, {
        "text": " \"Stroke\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"C"
      }, {
        "text": "erebrovascular\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003estroke\u003c/b\u003e, or cerebrovascular accident ("
      }, {
        "text": "CVA), is a medical condition in which poor blood flow to the brain results in cell death. There are two main types of"
      }, {
        "text": " stroke: ischemic, due to lack of blood flow, and hemorrhagic, due to bleeding.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eIschemic Stroke (~85%):\u003c/b\u003e Caused by obstruction of a cerebral artery.\u003cbr\u003e - \u003cb\u003e[[9"
      }, {
        "text": "1bfec7e|Thrombotic]]:\u003c/b\u003e A clot forms locally on an atherosclerotic plaque.\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003e[[6a805ecd|Embolic]]:\u003c/b\u003e A clot travels from a distant site (e.g., heart"
      }, {
        "text": " in atrial fibrillation).\u003cbr\u003e - \u003cb\u003eLacunar:\u003c/b\u003e Occlusion of small, penetrating arteries, often due"
      }, {
        "text": " to hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHemorrhagic Stroke (~15%):\u003c/b\u003e Caused by rupture of a blood vessel.\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003e[[70b266c8|Intraparenchymal]]:\u003c/b\u003e Bleeding into the brain tissue"
      }, {
        "text": ", often from rupture of Charcot-Bouchard microaneurysms due to hypertension.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "[[63f8b05f|Subarachnoid]]:\u003c/b\u003e Bleeding into the subarachnoid space, often from a"
      }, {
        "text": " ruptured berry aneurysm.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation:\u003c/b\u003e Sudden onset of focal neurological deficits. The specific symptoms depend on the \u003c"
      }, {
        "text": "mark\u003elesion area and affected vascular territory\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Immediate non-contrast head CT is crucial to differentiate"
      }, {
        "text": " ischemic from hemorrhagic stroke, as this guides acute management.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAcute Treatment:\u003c/b\u003e For ischemic stroke, thrombolysis with"
      }, {
        "text": " tPA (tissue plasminogen activator) may be an option if within the therapeutic window (typically 3-4.5 hours)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e [[714f15fc|Central post-stroke pain]] is a potential"
      }, {
        "text": " chronic complication, especially after a thalamic stroke.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003estroke\u003c/b\u003e is a \u0027"
      }, {
        "text": "brain attack\u0027 that causes neurological deficits corresponding to the affected vascular territory; the immediate priority is to distinguish ischemic from hemorrhagic types"
      }, {
        "text": " with a CT scan, as the acute treatments are diametrically opposed.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"includes\",\n        \"to\": \"ischemic_stroke\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"hemorrhagic_stroke\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"714f15fc\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"fd52a8b8\": {\n    \"title\":"
      }, {
        "text": " \"Sturge-Weber Syndrome\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Dermatology\",\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neuro"
      }, {
        "text": "cutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome"
      }, {
        "text": "\u003c/b\u003e, also known as encephalotrigeminal angiomatosis, is a rare, congenital neurocutaneous disorder characterized by a facial"
      }, {
        "text": " capillary malformation (port-wine stain) and an associated vascular malformation of the brain and eye.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Caused by a somatic mosaic mutation in the \u003ci\u003e[[5ef"
      }, {
        "text": "5ca57|GNAQ]]\u003c/i\u003e gene. It is \u003cu\u003enot\u003c/u\u003e inherited.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic"
      }, {
        "text": " Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eFacial Port-Wine Stain:\u003c/b\u003e A capillary malformation in the distribution"
      }, {
        "text": " of the ophthalmic (V\u003csub\u003e1\u003c/sub\u003e) and sometimes maxillary (V\u003csub\u003e2\u003c/sub\u003e) branches of the trigeminal"
      }, {
        "text": " nerve.\u003cbr\u003e2. \u003cb\u003eLeptomeningeal Angioma:\u003c/b\u003e An abnormal collection of blood vessels on"
      }, {
        "text": " the surface of the brain, typically ipsilateral to the facial lesion. This can lead to \u003cmark\u003eseizures\u003c/mark\u003e"
      }, {
        "text": " (most common neurological symptom), intellectual disability, and focal neurological deficits.\u003cbr\u003e3. \u003cb\u003eGlaucoma:\u003c/b\u003e Increased"
      }, {
        "text": " intraocular pressure, often ipsilateral to the facial lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e Skull X-rays or CT scans may show characteristic \u0027tram"
      }, {
        "text": "-track\u0027 calcifications, which represent calcification of the cortex underlying the leptomeningeal angioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e A child with a port-wine stain on their face, seizures, and intellectual disability is the classic presentation of Stur"
      }, {
        "text": "ge-Weber syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e is a congenital vascular"
      }, {
        "text": " disorder that \u0027stains\u0027 the face with a port-wine birthmark and the underlying brain with a leptomeningeal angioma,"
      }, {
        "text": " leading to a triad of dermatological, neurological (seizures), and ophthalmological (glaucoma) problems.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Somatic GNAQ Mutation] --\u003e B(Vascular Malformation); B --\u003e C("
      }, {
        "text": "Facial Port-Wine Stain); B --\u003e D(Leptomeningeal Angioma); D --\u003e E(Seizures); B --\u003e F"
      }, {
        "text": "(Ocular Involvement); F --\u003e G(Glaucoma);\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_synonymous_with\",\n        \"to\": \"1c42ff26\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous_disorder"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\":"
      }, {
        "text": " \"5ef5ca57\"\n      },\n      {\n        \"type\": \"presents_with"
      }, {
        "text": "\",\n        \"to\": \"port_wine_stain\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"presents_with\",\n        \"to\": \"seizures\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"61af7d03\": {\n    \"title\": \"Sturge-Weber Syndrome"
      }, {
        "text": "\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neuro"
      }, {
        "text": "cutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e, also"
      }, {
        "text": " known as encephalotrigeminal angiomatosis, is a rare, congenital neurocutaneous disorder characterized by a facial capillary"
      }, {
        "text": " malformation (port-wine stain) and an associated vascular malformation of the brain and eye.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Caused by a somatic mosaic mutation in the \u003ci\u003e[[5"
      }, {
        "text": "ef5ca57|GNAQ]]\u003c/i\u003e gene. It is \u003cu\u003enot\u003c/u\u003e inherited.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic"
      }, {
        "text": " Triad:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eFacial Port-Wine Stain:\u003c/b\u003e A capillary malformation in"
      }, {
        "text": " the distribution of the ophthalmic (V\u003csub\u003e1\u003c/sub\u003e) and sometimes maxillary (V\u003csub\u003e2\u003c/sub\u003e) branches of the"
      }, {
        "text": " trigeminal nerve.\u003cbr\u003e2. \u003cb\u003eLeptomeningeal Angioma:\u003c/b\u003e An abnormal collection"
      }, {
        "text": " of blood vessels on the surface of the brain, typically ipsilateral to the facial lesion. This can lead to \u003cmark"
      }, {
        "text": "\u003eseizures\u003c/mark\u003e (most common neurological symptom), intellectual disability, and focal neurological deficits.\u003cbr\u003e3"
      }, {
        "text": ". \u003cb\u003eGlaucoma:\u003c/b\u003e Increased intraocular pressure, often ipsilateral to the facial lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging"
      }, {
        "text": ":\u003c/b\u003e Skull X-rays or CT scans may show characteristic \u0027tram-track\u0027 calcifications, which represent calcification"
      }, {
        "text": " of the cortex underlying the leptomeningeal angioma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A child with a port-wine stain on their"
      }, {
        "text": " face, seizures, and intellectual disability is the classic presentation of Sturge-Weber syndrome.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eSturge-Weber syndrome\u003c/b\u003e is a congenital vascular disorder that \u0027stains\u0027 the face with a port-wine birth"
      }, {
        "text": "mark and the underlying brain with a leptomeningeal angioma, leading to a triad of dermatological, neurological ("
      }, {
        "text": "seizures), and ophthalmological (glaucoma) problems.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A[Somatic GNAQ Mutation] --\u003e B(Vascular Malformation); B --\u003e C(Facial Port-Wine Stain); B --\u003e"
      }, {
        "text": " D(Leptomeningeal Angioma); D --\u003e E(Seizures); B --\u003e F(O"
      }, {
        "text": "cular Involvement); F --\u003e G(Glaucoma);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_synonymous_with\",\n        \"to\": \"1c42ff26\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous"
      }, {
        "text": "_disorder\"\n      },\n      {\n        \"type\": \"is_caused_by_mutation_"
      }, {
        "text": "in\",\n        \"to\": \"5ef5ca57\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"presents_with\",\n        \"to\": \"port_wine_stain\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"seizures\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"6f5bea90\": {\n    \"title\":"
      }, {
        "text": " \"Subacute Combined Degeneration (SCD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Hematology\",\n      \"Nutrition\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSubacute Combined Degeneration (SCD)\u003c/b\u003e is a neurological"
      }, {
        "text": " complication of severe [[784e2484|vitamin B\u003csub\u003e12\u003c/sub\u003e (cobalamin) deficiency]]."
      }, {
        "text": " It is characterized by the progressive demyelination of specific tracts in the spinal cord.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency leads to an accumulation of methylmalonic acid,"
      }, {
        "text": " which is thought to be toxic to myelin. This results in demyelination of three main spinal cord tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAffected"
      }, {
        "text": " Tracts:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003e[[e7f5cbbe|Dorsal Columns]]:"
      }, {
        "text": "\u003c/b\u003e Causes loss of proprioception and vibration sense, leading to sensory ataxia and a positive Romberg sign.\u003cbr\u003e2. \u003cb\u003eLateral"
      }, {
        "text": " Corticospinal Tracts:\u003c/b\u003e Causes upper motor neuron signs, such as spastic paresis and hyperreflexia.\u003cbr\u003e3. "
      }, {
        "text": "\u003cb\u003eSpinocerebellar Tracts:\u003c/b\u003e Contributes to ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients present with a combination"
      }, {
        "text": " of sensory ataxia (from dorsal column loss) and spastic weakness (from corticospinal tract loss).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated"
      }, {
        "text": " Findings:\u003c/b\u003e Often accompanied by megaloblastic anemia, but neurological symptoms can precede or occur in the absence of hematological changes"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The \u0027combined\u0027 in the name refers to the combination of damage to both"
      }, {
        "text": " ascending (dorsal columns) and descending (corticospinal) tracts. Remember that folate supplementation can correct the anemia of"
      }, {
        "text": " B\u003csub\u003e12\u003c/sub\u003e deficiency but will not stop (and may worsen) the progression of SCD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eSubacute Combined Degeneration\u003c/b\u003e is the devastating neurological consequence of vitamin B\u003csub\u003e12\u003c/sub\u003e deficiency, where"
      }, {
        "text": " demyelination of both the dorsal and lateral columns of the spinal cord leads to a crippling combination of sensory ataxia and spastic weakness.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"graph TD; A[Vitamin B12 Deficiency] --\u003e B(‚Üë Methylmalonic Acid);"
      }, {
        "text": " B --\u003e C(Myelin Damage); C --\u003e D(Demyelination of Spinal Cord Tracts); D --\u003e E(Dors"
      }, {
        "text": "al Columns -\u003e Sensory Ataxia); D --\u003e F(Corticospinal Tracts -\u003e Spastic Paresis);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by\","
      }, {
        "text": "\n        \"to\": \"784e2484\"\n      },\n      {\n        \"type\": \"damages\",\n"
      }, {
        "text": "        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "damages\",\n        \"to\": \"corticospinal_tracts\"\n      }\n    ]\n  },"
      }, {
        "text": "\n  \"63f8b05f\": {\n    \"title\": \"Subarachnoid Hem"
      }, {
        "text": "orrhage (SAH)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Neurosurgery\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"C"
      }, {
        "text": "erebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA "
      }, {
        "text": "\u003cb\u003esubarachnoid hemorrhage (SAH)\u003c/b\u003e is bleeding into the subarachnoid space, the area between the arach"
      }, {
        "text": "noid mater and the pia mater that is normally filled with cerebrospinal fluid. It is a type of hemorrhagic stroke and a medical emergency.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e The most common cause of non-traumatic SAH is the"
      }, {
        "text": " rupture of a saccular \u003cmark\u003e[[a9f6d703|berry aneurysm]]\u003c/mark\u003e"
      }, {
        "text": " (~85% of cases). Other causes include trauma (most common overall), arteriovenous malformations, and vascul"
      }, {
        "text": "itis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Characterized by the sudden onset of a severe, explosive headache, classically described as the \u003c"
      }, {
        "text": "mark\u003e\\\"worst headache of my life\\\"\u003c/mark\u003e or a \u0027thunderclap headache.\u0027 May be accompanied by nausea, vomiting, loss"
      }, {
        "text": " of consciousness, and nuchal rigidity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003eNon-contrast head CT:"
      }, {
        "text": "\u003c/b\u003e The initial test of choice. Shows hyperdense (white) blood in the sulci and basal cisterns.\u003cbr\u003e2. \u003cb\u003eLum"
      }, {
        "text": "bar Puncture:\u003c/b\u003e Performed if the CT is negative but clinical suspicion is high. The classic finding is \u003cmark\u003exanthochromia\u003c/mark\u003e"
      }, {
        "text": " (yellowish discoloration of the CSF due to bilirubin from RBC breakdown), which appears several hours after the bleed.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e"
      }, {
        "text": "\u003cbr\u003e - \u003cb\u003eRebleeding:\u003c/b\u003e High risk in the first 24 hours.\u003cbr\u003e - \u003cb\u003eVasosp"
      }, {
        "text": "asm:\u003c/b\u003e Narrowing of cerebral arteries 3-10 days after the bleed, which can cause ischemic stroke. N"
      }, {
        "text": "imodipine (a calcium channel blocker) is used to prevent this.\u003cbr\u003e - \u003cb\u003eHydrocephalus:\u003c/b\u003e Blood"
      }, {
        "text": " can obstruct CSF reabsorption at the arachnoid granulations.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e \u0027Worst headache of my life\u0027 \u003d"
      }, {
        "text": " Subarachnoid hemorrhage. The first step is a non-contrast CT. If negative, the next step is a"
      }, {
        "text": " lumbar puncture.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003esubarachnoid hemorrhage\u003c/b\u003e"
      }, {
        "text": " is a neurovascular catastrophe, most often from a ruptured berry aneurysm, that announces itself with a \u0027thunderclap headache\u0027 and carries"
      }, {
        "text": " the dual threats of rebleeding and delayed ischemic stroke from vasospasm.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Ruptured Berry Aneurysm] --\u003e B(Bleeding into Subarachnoid Space); B --\u003e C"
      }, {
        "text": "(Sudden ‚Üë ICP); C --\u003e D(Worst Headache of My Life);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"hemorrhagic_stroke"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_caused_by_rupture_of\",\n        \"to"
      }, {
        "text": "\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"thunderclap_headache\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"can_cause\",\n        \"to\": \"vasospasm\"\n      }\n    ]\n  },\n  \"7"
      }, {
        "text": "fca15b0\": {\n    \"title\": \"Subarachnoid Space\",\n    \"primaryType\": \"anatomy\","
      }, {
        "text": "\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Meninges\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003esubarachnoid"
      }, {
        "text": " space\u003c/b\u003e is the anatomical space between the [[46e279b9|arachnoid mater]] and"
      }, {
        "text": " the pia mater. It is filled with cerebrospinal fluid (CSF) and contains the major arteries and veins of the brain.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eContents:\u003c/b\u003e Cerebrospinal fluid (CSF), major cerebral arteries (forming the [[e"
      }, {
        "text": "22300e8|Circle of Willis]]), and bridging veins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The CSF within"
      }, {
        "text": " this space provides a buoyant cushion for the brain, protecting it from trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCSF Circulation:\u003c/b\u003e CSF enters the subarachn"
      }, {
        "text": "oid space from the fourth ventricle via the foramina of Luschka and Magendie and is reabsorbed into the d"
      }, {
        "text": "ural venous sinuses via the [[b7b67074|arachnoid granulations]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Significance:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[63f8b05f|Subarachnoid Hemorrhage]]:"
      }, {
        "text": "\u003c/b\u003e Bleeding into this space, typically from a ruptured aneurysm.\u003cbr\u003e - \u003cb\u003eMeningitis:\u003c/b\u003e Inflammation of the mening"
      }, {
        "text": "es, with inflammatory cells found in the CSF of the subarachnoid space.\u003cbr\u003e - \u003cb\u003eLumbar Puncture"
      }, {
        "text": ":\u003c/b\u003e A needle is inserted into the lumbar subarachnoid space (lumbar cistern) to sample CSF.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember that the major blood vessels of the brain run through the subarachnoid space,"
      }, {
        "text": " which is why a ruptured aneurysm bleeds into this space.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003esubarachnoid"
      }, {
        "text": " space\u003c/b\u003e is the CSF-filled \u0027moat\u0027 surrounding the brain, providing a protective fluid buffer and serving as the conduit"
      }, {
        "text": " for the brain\u0027s major blood vessels, but also making it the site of devastating hemorrhages and infections.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_between\",\n        \"to\": \""
      }, {
        "text": "46e279b9\"\n      },\n      {\n        \"type\": \"is_located"
      }, {
        "text": "_between\",\n        \"to\": \"pia_mater\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"contains\",\n        \"to\": \"7109d8b6\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"is_site_of\",\n        \"to\": \"63f8b05f\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"8aaeb0d8\": {\n    \"title"
      }, {
        "text": "\": \"Subdural Hematoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Neurosurgery\",\n      \"Trauma\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Trauma\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003esubdural hemat"
      }, {
        "text": "oma (SDH)\u003c/b\u003e is a collection of blood that forms between the inner layer of the dura mater and the arach"
      }, {
        "text": "noid mater. It is typically caused by the tearing of bridging veins that cross the subdural space.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Usually caused by head trauma, often with acceleration-deceleration forces that"
      }, {
        "text": " shear the bridging veins. It is common in the \u003cmark\u003eelderly\u003c/mark\u003e (due to brain atrophy,"
      }, {
        "text": " which stretches the veins) and in infants (shaken baby syndrome). Chronic alcohol use is also a risk factor.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e Venous bleeding leads to a slower accumulation of blood compared to an epidural hematoma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Can be acute, subacute, or chronic. Symptoms may be insidious and fluctuating, including headache, confusion"
      }, {
        "text": ", somnolence, and focal neurological deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eImaging:\u003c/b\u003e A non-contrast head CT shows a hyper"
      }, {
        "text": "dense (acute) or hypodense (chronic), \u003cmark\u003ecrescent-shaped\u003c/mark\u003e blood collection that \u003c"
      }, {
        "text": "mark\u003ecrosses suture lines\u003c/mark\u003e but is limited by dural reflections (e.g., falx cerebri)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Crescent shape that crosses suture lines \u003d Subdural hematoma. Lentiform shape that"
      }, {
        "text": " does not cross suture lines \u003d [[a61683ae|Epidural hematoma]]. The classic patient is an elderly individual"
      }, {
        "text": " with a history of a fall who presents with gradual cognitive decline.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA "
      }, {
        "text": "\u003cb\u003esubdural hematoma\u003c/b\u003e is a low-pressure venous bleed from torn bridging veins, which slowly spreads in a crescent shape over the brain"
      }, {
        "text": "\u0027s surface and is classically seen in the elderly after minor head trauma due to age-related brain atrophy.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Head Trauma] --\u003e B(Tearing of Bridging Veins); B"
      }, {
        "text": " --\u003e C(Venous Bleeding into Subdural Space); C --\u003e D(Crescent-shaped Hematoma); D --\u003e E"
      }, {
        "text": "(Compression of Brain);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"intracranial_hemorrhage\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_caused_by_tearing_of\",\n        \"to\": \"bridging_veins\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a61683ae"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_common_in\",\n        \"to\": \"elderly"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"8a695458\": {\n    \"title\": \""
      }, {
        "text": "Subgaleal Hemorrhage\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ped"
      }, {
        "text": "iatrics\",\n      \"Obstetrics\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    "
      }, {
        "text": "\"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \""
      }, {
        "text": "Neonatal Injuries\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003esubgale"
      }, {
        "text": "al hemorrhage\u003c/b\u003e is a rare but potentially lethal extracranial hemorrhage in a newborn, where blood accumulates in the potential space between the cranial"
      }, {
        "text": " periosteum and the galea aponeurosis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eE"
      }, {
        "text": "tiology:\u003c/b\u003e Caused by the rupture of emissary veins, which connect the dural sinuses with the scalp veins"
      }, {
        "text": ". It is a severe complication of difficult operative vaginal deliveries, especially \u003cmark\u003evacuum extraction\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The"
      }, {
        "text": " subgaleal space is large and can accommodate a significant portion of the infant\u0027s total blood volume, leading to severe"
      }, {
        "text": " hemorrhagic shock.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Presents with a diffuse, fluctuant, boggy swelling of the scalp"
      }, {
        "text": " that \u003cmark\u003ecrosses suture lines\u003c/mark\u003e and can shift with gravity. The infant may show signs of hyp"
      }, {
        "text": "ovolemic shock (tachycardia, pallor, poor perfusion).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e Hypovolemic shock, coag"
      }, {
        "text": "ulopathy, and death.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A newborn with a rapidly expanding, boggy scalp"
      }, {
        "text": " swelling that crosses suture lines after a difficult vacuum delivery should raise immediate concern for a subgaleal hemorrhage, a life"
      }, {
        "text": "-threatening emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003esubgaleal hemorrhage"
      }, {
        "text": "\u003c/b\u003e is a dangerous neonatal bleed into the vast potential space under the scalp aponeurosis, capable of causing rapid and"
      }, {
        "text": " massive blood loss and hypovolemic shock, most often as a complication of vacuum-assisted delivery.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"46ca72c2\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by_rupture_of\",\n        \"to\": \"emissary_veins"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_complication_of\",\n        "
      }, {
        "text": "\"to\": \"vacuum_extraction\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"hyp"
      }, {
        "text": "ovolemic_shock\"\n      }\n    ]\n  },\n  \"f629919"
      }, {
        "text": "9\": {\n    \"title\": \"Substance P\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroscience\",\n      \"Pharmacology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \""
      }, {
        "text": "Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSubstance P\u003c/b\u003e is a neurope"
      }, {
        "text": "ptide of the tachykinin family that functions as a neurotransmitter and neuromodulator. It is strongly associated with the"
      }, {
        "text": " transmission of pain signals and the inflammatory response.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e A"
      }, {
        "text": " key mediator in the perception of \u003cmark\u003epain\u003c/mark\u003e. It is released from the peripheral terminals of sensory nerve fibers (noc"
      }, {
        "text": "iceptors) in response to noxious stimuli and in the dorsal horn of the spinal cord to transmit pain signals to higher"
      }, {
        "text": " centers.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptor:\u003c/b\u003e It acts on the \u003cmark\u003eneurokinin-1 (NK-"
      }, {
        "text": "1) receptor\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Migraine:\u003c/b\u003e Along with [[24d36d"
      }, {
        "text": "58|CGRP]], substance P is one of the vasoactive neuropeptides released from trigeminal nerve endings"
      }, {
        "text": " during a [[c8833bae|migraine]] attack, contributing to neurogenic inflammation and pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole in Vom"
      }, {
        "text": "iting:\u003c/b\u003e Substance P acting on NK-1 receptors in the brainstem (vomiting center) is a key mediator of"
      }, {
        "text": " the vomiting reflex, particularly in delayed chemotherapy-induced nausea and vomiting.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e NK-1 receptor"
      }, {
        "text": " antagonists (e.g., aprepitant) are used as antiemetics. Topical [[e4b829"
      }, {
        "text": "8b|capsaicin]] works by depleting substance P from peripheral nerve endings to produce analgesia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Associate Substance P with pain transmission in the spinal cord and its role in both migraine and emesis.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003e\u003cb\u003eSubstance P\u003c/b\u003e is the primary neuropeptide for pain signaling, released by noc"
      }, {
        "text": "iceptive neurons to transmit pain information centrally, and its blockade is a therapeutic strategy for both pain and emesis.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"graph TD; A[Noxious Stimulus] --\u003e B(Nociceptor"
      }, {
        "text": "); B --Releases Substance P--\u003e C(Dorsal Horn Neuron); C --\u003e D(Ascending Pain Pathway);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_mediator_of\",\n        \""
      }, {
        "text": "to\": \"pain\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n        \"to"
      }, {
        "text": "\": \"c8833bae\"\n      },\n      {\n        \"type\": \"is_implicated_in\",\n"
      }, {
        "text": "        \"to\": \"vomiting\"\n      },\n      {\n        \"type\": \"is_depleted_by\","
      }, {
        "text": "\n        \"to\": \"e4b8298b\"\n      }\n    ]\n  },\n  \"c"
      }, {
        "text": "4cae1ab\": {\n    \"title\": \"Subthalamic Nucleus Lesions\",\n    \"primaryType\":"
      }, {
        "text": " \"pathology\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Basal Ganglia Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eA lesion of the \u003cb\u003esubthalamic nucleus (STN)\u003c/b\u003e, a component of the [["
      }, {
        "text": "ed462927|basal ganglia]], results in a hyperkinetic movement disorder known as \u003cmark\u003e"
      }, {
        "text": "hemiballismus\u003c/mark\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction of STN:\u003c/b\u003e The STN"
      }, {
        "text": " is the key excitatory nucleus in the \u003cmark\u003eindirect pathway\u003c/mark\u003e of the basal ganglia. It provides excitatory ("
      }, {
        "text": "glutamatergic) input to the globus pallidus internus (GPi), which in turn inhibits the thalam"
      }, {
        "text": "us to suppress unwanted movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Pathophysiology:\u003c/b\u003e A lesion of the STN (typically"
      }, {
        "text": " a lacunar stroke) removes this excitatory drive to the GPi. This leads to reduced inhibitory output from the GPi to"
      }, {
        "text": " the thalamus. The resulting disinhibition of the thalamus causes excessive cortical excitation and involuntary movements.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation (Hemiballismus):\u003c/b\u003e Characterized by wild, violent, flinging movements of the limbs on \u003cmark\u003eone side of the body ("
      }, {
        "text": "contralateral to the lesion)\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Contralateral hemiballismus is"
      }, {
        "text": " the classic, pathognomonic sign of a lesion in the subthalamic nucleus.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eA lesion in the \u003cb\u003esubthalamic nucleus\u003c/b\u003e effectively \u0027cuts the brakes\u0027 of the indirect pathway,"
      }, {
        "text": " leading to a profound disinhibition of the thalamus and the explosive, uncontrolled, flinging movements of contralateral hemiballismus.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"graph TD; A[Lesion of Subthalamic Nucleus] --x B(Excitation of G"
      }, {
        "text": "Pi); B --x C(Inhibition of Thalamus); C --\u003e D(Disinhibition of Thalamus); D"
      }, {
        "text": " --\u003e E(Contralateral Hemiballismus);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes"
      }, {
        "text": "\",\n        \"to\": \"hemiballismus\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_a_lesion_of\",\n        \"to\": \"subthalamic_nucleus\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"disrupts\",\n        \"to\": \"indirect_pathway"
      }, {
        "text": "_basal_ganglia\"\n      }\n    ]\n  },\n  \"92e3a"
      }, {
        "text": "9e8\": {\n    \"title\": \"Succinylcholine\",\n    \"primaryType\": \"drug\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neu"
      }, {
        "text": "romuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSuccinylcholine\u003c/b\u003e is the"
      }, {
        "text": " only depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e in clinical use. It induces paralysis by causing persistent depolarization of the motor"
      }, {
        "text": " endplate.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Phase I):\u003c/b\u003e Acts"
      }, {
        "text": " as a nicotinic ACh receptor agonist. It binds to the receptor, causing initial depolarization which leads to transient muscle twitching (\u003c"
      }, {
        "text": "mark\u003efasciculations\u003c/mark\u003e). Because it is not degraded by acetylcholinesterase, it remains bound, keeping"
      }, {
        "text": " the membrane depolarized and preventing repolarization, leading to flaccid paralysis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action (Phase II):\u003c/b\u003e With"
      }, {
        "text": " prolonged exposure, the receptor becomes desensitized, and the membrane repolarizes but remains unresponsive to ACh.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use"
      }, {
        "text": ":\u003c/b\u003e Used for rapid sequence intubation due to its \u003cmark\u003efast onset\u003c/mark\u003e (~1 min) and \u003cmark\u003eshort duration"
      }, {
        "text": "\u003c/mark\u003e (~5-10 min).\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Rapidly hydrolyzed by plasma pseudocholinesterase ("
      }, {
        "text": "butyrylcholinesterase).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e\u003cbr\u003e - \u003cmark\u003eMalignant Hyperther"
      }, {
        "text": "mia:\u003c/mark\u003e A life-threatening hypermetabolic state in genetically susceptible individuals.\u003cbr\u003e - \u003cmark\u003eHyperkalemia:\u003c/mark\u003e"
      }, {
        "text": " Can cause a dangerous increase in serum potassium, especially in patients with burns, crush injuries, or neuromuscular diseases, due to upregulation of ACh"
      }, {
        "text": " receptors.\u003cbr\u003e - Bradycardia or tachycardia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The initial muscle fasciculations are the key"
      }, {
        "text": " clinical feature that distinguishes succinylcholine from non-depolarizing blockers. Its potential to cause malignant hyperthermia and severe"
      }, {
        "text": " hyperkalemia are high-yield adverse effects.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSuccinylcholine\u003c/b\u003e is a unique neuromuscular"
      }, {
        "text": " blocker that paralyzes muscles by overstimulating them into a state of persistent depolarization, offering a rapid onset and offset ideal for int"
      }, {
        "text": "ubation but carrying the serious risks of malignant hyperthermia and life-threatening hyperkalemia.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD"
      }, {
        "text": "; A[Succinylcholine] --\u003e B(Binds Nicotinic ACh Receptor); B --\u003e C(Phase I:"
      }, {
        "text": " Depolarization); C --\u003e D(Fasciculations); D --\u003e E(Flaccid Paralysis);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"a"
      }, {
        "text": "518f249\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"malign"
      }, {
        "text": "ant_hyperthermia\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\":"
      }, {
        "text": " \"hyperkalemia\"\n      },\n      {\n        \"type\": \"is_metabolized_by"
      }, {
        "text": "\",\n        \"to\": \"pseudocholinesterase\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "b63c57d8\": {\n    \"title\": \"Sucking Reflex\",\n    \"primaryType\": \"physiology"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Physical Exam"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003esucking reflex\u003c/b\u003e is a primitive reflex present in infants that allows"
      }, {
        "text": " for feeding. It is characterized by a sucking motion when the roof of the mouth is stimulated.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e Elicited by placing a gloved finger or pacifier into the infant\u0027s mouth and"
      }, {
        "text": " touching the palate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response:\u003c/b\u003e The infant will begin to suck rhythmically.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline"
      }, {
        "text": ":\u003c/b\u003e Present at birth and is strongest in the first few months. It is gradually replaced by voluntary sucking and typically disappears by"
      }, {
        "text": " 4 months of age.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is one of several primitive reflexes tested in the newborn"
      }, {
        "text": " neurological exam to assess brainstem function and development. A weak or absent sucking reflex can be a sign of prematurity or"
      }, {
        "text": " neurological impairment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRe-emergence:\u003c/b\u003e The reappearance of the sucking reflex in an adult is an"
      }, {
        "text": " abnormal finding known as a frontal release sign, indicating damage to the [[0405ada3|frontal lobe]].\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The sucking reflex is a normal, essential reflex for feeding in a newborn. Its persistence or re-emergence in an older"
      }, {
        "text": " child or adult is pathological.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003esucking reflex\u003c/b\u003e is an"
      }, {
        "text": " innate, brainstem-mediated survival reflex in infants that ensures feeding, which is later suppressed by the maturing frontal lobes; its reapp"
      }, {
        "text": "earance in adulthood is a sign of frontal lobe pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"re-emergence_indicates\",\n        \"to\": \"frontal_"
      }, {
        "text": "lobe_damage\"\n      }\n    ]\n  },\n  \"e4aa616b\": {\n    \"title\":"
      }, {
        "text": " \"Sumatriptan\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Headache Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eSumatriptan\u003c/b\u003e is the prototypical drug in the \u003ci\u003etriptan\u003c/i\u003e class, acting as a serotonin "
      }, {
        "text": "5-HT\u003csub\u003e1B/1D\u003c/sub\u003e receptor agonist. It is a first-line therapy for the acute ("
      }, {
        "text": "abortive) treatment of moderate to severe [[c8833bae|migraine]] and [[217"
      }, {
        "text": "60f80|cluster headaches]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e\u003cbr\u003e1. Agonism at 5-HT\u003csub\u003e1B\u003c/sub\u003e receptors on cranial"
      }, {
        "text": " blood vessels causes \u003cmark\u003evasoconstriction\u003c/mark\u003e, counteracting the vasodilation thought to contribute to migraine pain.\u003cbr\u003e2."
      }, {
        "text": " Agonism at presynaptic 5-HT\u003csub\u003e1D\u003c/sub\u003e receptors on trigeminal nerve endings \u003cmark\u003einhibits the release of"
      }, {
        "text": " vasoactive neuropeptides\u003c/mark\u003e like CGRP.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Acute treatment of [[c8833bae|mig"
      }, {
        "text": "raines]] (with or without aura) and [[21760f80|cluster headaches]]. It is "
      }, {
        "text": "\u003cu\u003enot\u003c/u\u003e for prophylaxis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Paresthesias, dizziness, and \u0027triptan sensations"
      }, {
        "text": "\u0027 (a feeling of tightness or pressure in the chest, neck, or throat).\u003c/li\u003e\u003cli\u003e\u003cb\u003eContraindications:\u003c/b\u003e Due"
      }, {
        "text": " to its vasoconstrictive effects, it is contraindicated in patients with a history of \u003cmark\u003ecoronary artery disease\u003c/mark\u003e,"
      }, {
        "text": " uncontrolled hypertension, or stroke.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Sumatriptan is the classic abortive agent for migraines"
      }, {
        "text": " and cluster headaches. Its vasoconstrictive properties are both part of its mechanism and the source of its major contraindications."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSumatriptan\u003c/b\u003e provides rapid relief from migraine and"
      }, {
        "text": " cluster headaches by constricting cranial vessels and blocking pain peptide release, but this powerful vasoconstriction makes it unsafe for patients with underlying"
      }, {
        "text": " cardiovascular disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sumatriptan] --\u003e B("
      }, {
        "text": "5-HT1B/1D Agonist); B --\u003e C(Cranial Vasoconstriction); B --\u003e D"
      }, {
        "text": "(‚Üì CGRP Release); C \u0026 D --\u003e E(Migraine/Cluster Headache Relief);\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"34ba2"
      }, {
        "text": "a7b\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"c"
      }, {
        "text": "8833bae\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"217"
      }, {
        "text": "60f80\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"dd"
      }, {
        "text": "3c9b1b\"\n      }\n    ]\n  },\n  \"09252a"
      }, {
        "text": "1b\": {\n    \"title\": \"Superior Oblique Muscle\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \""
      }, {
        "text": "Anatomy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSuperior"
      }, {
        "text": " Oblique\u003c/b\u003e is one of the six extraocular muscles. It is unique in that it passes through a fibrocartilaginous pulley,"
      }, {
        "text": " the trochlea, before inserting on the eyeball, and it is innervated by the [[bba609"
      }, {
        "text": "3a|trochlear nerve (CN IV)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eInn"
      }, {
        "text": "ervation:\u003c/b\u003e Innervated by the contralateral \u003cmark\u003e[[bba6093a|trochlear nerve (CN IV)]]\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eActions:\u003c/b\u003e Its primary action is \u003cmark\u003eintorsion\u003c/mark\u003e (internal rotation of the top"
      }, {
        "text": " of the eye toward the nose). Its secondary action is depression (especially in adduction), and its tertiary action is abduction"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eTesting:\u003c/b\u003e The depressing action of the superior oblique is best isolated by having the patient look \u003cmark\u003edown"
      }, {
        "text": " and in\u003c/mark\u003e (adducted position).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePalsy:\u003c/b\u003e A [[de532715"
      }, {
        "text": "|CN IV palsy]] results in weakness of the superior oblique. The eye becomes extorted and elevated (hypertropia)."
      }, {
        "text": " This causes vertical [[9914d433|diplopia]] that is worse when looking down and med"
      }, {
        "text": "ially (e.g., reading or going down stairs). Patients compensate by tilting their head away from the affected side.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e Remember the mnemonic (SO\u003csub\u003e4\u003c/sub\u003eLR\u003csub\u003e6\u003c/sub\u003e)\u003csub\u003e3\u003c/sub\u003e: \u003cb\u003eS"
      }, {
        "text": "\u003c/b\u003euperior \u003cb\u003eO\u003c/b\u003eblique is innervated by CN \u003cb\u003eIV\u003c/b\u003e.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSuperior Oblique muscle\u003c/b\u003e, controlled by the trochlear nerve, is the eye"
      }, {
        "text": "\u0027s primary intortor and is crucial for looking down and in; its paralysis leads to a characteristic vertical diplopia and a"
      }, {
        "text": " compensatory head tilt.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"extraocular_muscle\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_innervated_by\",\n        \"to\": \"bba6093a\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"action_is\",\n        \"to\": \"intorsion_"
      }, {
        "text": "of_eye\"\n      },\n      {\n        \"type\": \"paralysis_causes\",\n        \"to\": \"de"
      }, {
        "text": "532715\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"e6820b7f\",\n    \"letter\": \"S\",\n    \"term\": \"Spinal muscular atrophy\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinal muscular atrophy\",\n    \"sub_entries\": [\n      {\n        \"id\": \"2222e439\",\n        \"letter\": \"S\",\n        \"term\": \"presentation\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Spinal muscular atrophy \u003e presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c757e185\",\n    \"letter\": \"S\",\n    \"term\": \"Spinal nerves\",\n    \"pages\": [\n      \"520\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinal nerves\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"76044e89\",\n    \"letter\": \"S\",\n    \"term\": \"Spinal reflexes/nerve roots, clinical\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinal reflexes/nerve roots, clinical\",\n    \"sub_entries\": [\n      {\n        \"id\": \"a465390c\",\n        \"letter\": \"S\",\n        \"term\": \"reflexes\",\n        \"pages\": [\n          \"523\"\n        ],\n        \"context\": \"Spinal reflexes/nerve roots, clinical \u003e reflexes\"\n      }\n    ]\n  },\n  {\n    \"id\": \"8aa8156f\",\n    \"letter\": \"S\",\n    \"term\": \"Spinal tract anatomy/function,\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinal tract anatomy/function,\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f9da2936\",\n        \"letter\": \"S\",\n        \"term\": \"ascending tracts\",\n        \"pages\": [\n          \"522\"\n        ],\n        \"context\": \"Spinal tract anatomy/function, \u003e ascending tracts\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5468da40\",\n    \"letter\": \"S\",\n    \"term\": \"Spinocerebellar tracts\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinocerebellar tracts\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ffb36bc0\",\n        \"letter\": \"S\",\n        \"term\": \"diseases of\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Spinocerebellar tracts \u003e diseases of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"07eecef1\",\n    \"letter\": \"S\",\n    \"term\": \"Spinothalamic tracts\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinothalamic tracts\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f39666b4\",\n        \"letter\": \"S\",\n        \"term\": \"Brown-S√©quard syndrome\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Spinothalamic tracts \u003e Brown-S√©quard syndrome\"\n      },\n      {\n        \"id\": \"229bd7bb\",\n        \"letter\": \"S\",\n        \"term\": \"in anterior spinal artery occlusion\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Spinothalamic tracts \u003e in anterior spinal artery occlusion\"\n      },\n      {\n        \"id\": \"5f426a47\",\n        \"letter\": \"S\",\n        \"term\": \"location and functions\",\n        \"pages\": [\n          \"522\"\n        ],\n        \"context\": \"Spinothalamic tracts \u003e location and functions\"\n      },\n      {\n        \"id\": \"eb64bc34\",\n        \"letter\": \"S\",\n        \"term\": \"organization of\",\n        \"pages\": [\n          \"521\"\n        ],\n        \"context\": \"Spinothalamic tracts \u003e organization of\"\n      },\n      {\n        \"id\": \"0b478020\",\n        \"letter\": \"S\",\n        \"term\": \"syringomyelia\",\n        \"pages\": [\n          \"502\"\n        ],\n        \"context\": \"Spinothalamic tracts \u003e syringomyelia\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c271838c\",\n    \"letter\": \"S\",\n    \"term\": \"Spongiform cortex\",\n    \"pages\": [\n      \"535\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Spongiform cortex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"05e4a508\",\n    \"letter\": \"S\",\n    \"term\": \"Stapes (ossicles)\",\n    \"pages\": [\n      \"547\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Stapes (ossicles)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"769ef31b\",\n    \"letter\": \"S\",\n    \"term\": \"Startle myoclonus\",\n    \"pages\": [\n      \"535\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Startle myoclonus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"676a6271\",\n    \"letter\": \"S\",\n    \"term\": \"Status epilepticus\",\n    \"pages\": [\n      \"531\",\n      \"562\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Status epilepticus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"adc34ee4\",\n    \"letter\": \"S\",\n    \"term\": \"Steroids\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Steroids\",\n    \"sub_entries\": [\n      {\n        \"id\": \"4ae61586\",\n        \"letter\": \"S\",\n        \"term\": \"multiple sclerosis treatment\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Steroids \u003e multiple sclerosis treatment\"\n      }\n    ]\n  },\n  {\n    \"id\": \"86d263e9\",\n    \"letter\": \"S\",\n    \"term\": \"Stevens-Johnson syndrome\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Stevens-Johnson syndrome\",\n    \"sub_entries\": [\n      {\n        \"id\": \"42241714\",\n        \"letter\": \"S\",\n        \"term\": \"with anticonvulsants\",\n        \"pages\": [\n          \"560\"\n        ],\n        \"context\": \"Stevens-Johnson syndrome \u003e with anticonvulsants\"\n      }\n    ]\n  },\n  {\n    \"id\": \"cdcda821\",\n    \"letter\": \"S\",\n    \"term\": \"Strabismus\",\n    \"pages\": [\n      \"552\",\n      \"555\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Strabismus\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4da30f12\",\n    \"letter\": \"S\",\n    \"term\": \"Streptococcus pneumoniae\",\n    \"pages\": [\n      \"134\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Streptococcus pneumoniae\",\n    \"sub_entries\": [\n      {\n        \"id\": \"54014012\",\n        \"letter\": \"S\",\n        \"term\": \"otitis media\",\n        \"pages\": [\n          \"547\"\n        ],\n        \"context\": \"Streptococcus pneumoniae \u003e otitis media\"\n      }\n    ]\n  },\n  {\n    \"id\": \"0c4b0065\",\n    \"letter\": \"S\",\n    \"term\": \"Stretch receptors\",\n    \"pages\": [\n      \"504\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Stretch receptors\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2098
    }, {
      "text": "```json\n{\n  \"e6820b7f\": {\n    \"title\": \"Spinal Muscular Atrophy (SMA)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Genetics\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal Muscular Atrophy (SMA)\u003c/b\u003e is an autosomal recessive disorder characterized by the degeneration of anterior horn cells (lower motor neurons) in the spinal cord, leading to progressive muscle weakness and atrophy. It is caused by a deficiency of the [[6a781682|Survival Motor Neuron (SMN) protein]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal recessive deletion or mutation of the \u003ci\u003eSMN1\u003c/i\u003e gene. Disease severity is inversely correlated with the number of copies of a second gene, \u003ci\u003eSMN2\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Deficiency of the SMN protein, which is critical for snRNP assembly and pre-mRNA splicing, leads to apoptosis of lower motor neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Pure \u003cmark\u003elower motor neuron\u003c/mark\u003e signs. Presents with symmetric, progressive muscle weakness (proximal \u003e distal) and atrophy, hypotonia, and absent deep tendon reflexes. Sensation and cognition are intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e Classified by age of onset and severity. Type 1 ([[17c628e2|Werdnig-Hoffmann disease]]) is the most severe, with onset in infancy and death from respiratory failure by age 2 if untreated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The classic presentation of SMA Type 1 is a \u0027floppy baby\u0027 with symmetric weakness, tongue fasciculations, and areflexia. The underlying defect is in pre-mRNA splicing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpinal Muscular Atrophy\u003c/b\u003e is a devastating lower motor neuron disease caused by a genetic defect in the SMN protein, essential for neuronal survival, leading to progressive, symmetric muscle wasting and weakness that is most severe in infants.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_deficiency_of\",\n        \"to\": \"6a781682\"\n      },\n      {\n        \"type\": \"is_a\",\n        \"to\": \"lower_motor_neuron_disease\"\n      },\n      {\n        \"type\": \"includes_subtype\",\n        \"to\": \"17c628e2\"\n      }\n    ]\n  },\n  \"c757e185\": {\n    \"title\": \"Spinal Nerves\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal nerves\u003c/b\u003e are 31 pairs of mixed nerves that emerge from the spinal cord and are a fundamental part of the peripheral nervous system. Each nerve is formed by the union of a dorsal (sensory) root and a ventral (motor) root.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e 31 pairs: 8 cervical (C1-C8), 12 thoracic (T1-T12), 5 lumbar (L1-L5), 5 sacral (S1-S5), and 1 coccygeal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExit from Vertebral Canal:\u003c/b\u003e C1-C7 nerves exit \u003cu\u003eabove\u003c/u\u003e their corresponding vertebra. The C8 nerve exits between C7 and T1. All subsequent nerves (T1 and below) exit \u003cu\u003ebelow\u003c/u\u003e their corresponding vertebra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They carry motor, sensory, and autonomic signals between the spinal cord and the body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDermatomes and Myotomes:\u003c/b\u003e Each spinal nerve innervates a specific area of skin (dermatome) and a specific group of muscles (myotome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Extent of Spinal Cord:\u003c/b\u003e In adults, the spinal cord ends at the L1-L2 vertebral level (conus medullaris). The nerve roots below this level form the [[1c4d7e8f|cauda equina]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Knowing the vertebral exit pattern is important for localizing nerve root compression. For example, a herniated disc between L4 and L5 will typically compress the L5 nerve root.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpinal nerves\u003c/b\u003e are the vital conduits connecting the spinal cord to the periphery, with each of the 31 pairs carrying a mix of motor and sensory fibers to a specific segment of the body, forming the basis of the dermatomal and myotomal maps.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"peripheral_nervous_system\"\n      },\n      {\n        \"type\": \"form\",\n        \"to\": \"brachial_plexus\"\n      },\n      {\n        \"type\": \"form\",\n        \"to\": \"lumbosacral_plexus\"\n      }\n    ]\n  },\n  \"76044e89\": {\n    \"title\": \"Spinal Reflexes\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal reflexes\u003c/b\u003e are involuntary and nearly instantaneous movements that are mediated by a reflex arc at the level of the spinal cord, without requiring input from the brain. Testing these reflexes is a fundamental part of the neurological examination.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eReflex Arc Components:\u003c/b\u003e A sensory receptor, an afferent neuron, an integration center (spinal cord), an efferent neuron, and an effector (muscle).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeep Tendon Reflexes (DTRs):\u003c/b\u003e Monosynaptic stretch reflexes that test the integrity of specific spinal nerve roots.\u003cbr\u003e - \u003cb\u003e[[87d19a70|Achilles]]:\u003c/b\u003e S1, S2\u003cbr\u003e - \u003cb\u003ePatellar:\u003c/b\u003e L2, L3, L4\u003cbr\u003e - \u003cb\u003e[[f36cfe18|Biceps]] \u0026 [[ac55d026|Brachioradialis]]:\u003c/b\u003e C5, C6\u003cbr\u003e - \u003cb\u003e[[b79b3546|Triceps]]:\u003c/b\u003e C7, C8\u003c/li\u003e\u003cli\u003e\u003cb\u003eSuperficial Reflexes:\u003c/b\u003e Polysynaptic reflexes.\u003cbr\u003e - \u003cb\u003e[[ce2052d6|Anal wink]]:\u003c/b\u003e S3, S4\u003cbr\u003e - \u003cb\u003e[[cd09cad7|Cremasteric]]:\u003c/b\u003e L1, L2\u003c/li\u003e\u003cli\u003e\u003cb\u003eInterpretation:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHyporeflexia/Areflexia (Diminished/Absent):\u003c/b\u003e Suggests a lower motor neuron lesion (e.g., nerve root compression, peripheral neuropathy).\u003cbr\u003e - \u003cb\u003eHyperreflexia (Exaggerated):\u003c/b\u003e Suggests an upper motor neuron lesion (e.g., stroke, spinal cord injury).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The state of the spinal reflexes is a key differentiator between UMN and LMN lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpinal reflexes\u003c/b\u003e are the spinal cord\u0027s automatic responses to sensory stimuli, providing a rapid and reliable clinical tool to assess the integrity of specific nerve roots and to distinguish between upper and lower motor neuron pathologies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Stimulus] --\u003e B(Sensory Receptor); B --\u003e C(Afferent Neuron); C --\u003e D(Spinal Cord); D --\u003e E(Efferent Neuron); E --\u003e F(Effector Muscle); F --\u003e G(Response);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"2915ead0\"\n      },\n      {\n        \"type\": \"are_used_to_test\",\n        \"to\": \"c757e185\"\n      },\n      {\n        \"type\": \"are_diminished_in\",\n        \"to\": \"lower_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"are_exaggerated_in\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      }\n    ]\n  },\n  \"8aa8156f\": {\n    \"title\": \"Spinal Tracts\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal tracts\u003c/b\u003e are bundles of myelinated nerve fibers (white matter) that run up and down the spinal cord, carrying information between the brain and the periphery. They are functionally segregated into ascending (sensory) and descending (motor) pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAscending (Sensory) Tracts:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[e7f5cbbe|Dorsal Columns]]:\u003c/b\u003e Carry fine touch, vibration, and proprioception. Ascend ipsilaterally and decussate in the medulla.\u003cbr\u003e - \u003cb\u003e[[07eecef1|Spinothalamic Tract]]:\u003c/b\u003e Carries pain, temperature, and crude touch. Decussates at the level of the spinal cord in the anterior white commissure and ascends contralaterally.\u003cbr\u003e - \u003cb\u003e[[5468da40|Spinocerebellar Tracts]]:\u003c/b\u003e Carry unconscious proprioceptive information to the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDescending (Motor) Tracts:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[fb0a5fdc|Corticospinal Tract]]:\u003c/b\u003e The primary pathway for voluntary motor control. Descends from the motor cortex and decussates in the medullary pyramids to control the contralateral body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Localization:\u003c/b\u003e The distinct pathways and decussation points of these tracts are crucial for localizing spinal cord lesions. For example, [[4792bc68|Brown-S√©quard syndrome]] (hemisection) causes a characteristic pattern of ipsilateral and contralateral deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Master the three major tracts: Dorsal Columns, Spinothalamic, and Corticospinal. Know what they carry, where they are located in the cord, and where they decussate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003espinal tracts\u003c/b\u003e are the information superhighways of the spinal cord, with anatomically and functionally distinct ascending and descending lanes that allow for precise clinical localization of lesions based on the pattern of sensory and motor deficits.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"07eecef1\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"fb0a5fdc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"5468da40\"\n      }\n    ]\n  },\n  \"5468da40\": {\n    \"title\": \"Spinocerebellar Tracts\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003espinocerebellar tracts\u003c/b\u003e are ascending sensory pathways that transmit unconscious proprioceptive information from the muscles and joints to the cerebellum. This information is crucial for the cerebellum\u0027s role in coordinating movement and maintaining balance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Carry unconscious proprioception (information about muscle stretch and tension) to the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor Tracts:\u003c/b\u003e Includes the dorsal spinocerebellar tract, ventral spinocerebellar tract, and others.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e These tracts are primarily ipsilateral. Information from one side of the body is transmitted to the ipsilateral cerebellar hemisphere.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Damage to the spinocerebellar tracts contributes to the [[9767fd6b|ataxia]] seen in certain neurological disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Diseases:\u003c/b\u003e These tracts are notably affected in \u003cmark\u003e[[39bc1763|Friedreich ataxia]]\u003c/mark\u003e, a hereditary ataxia where their degeneration contributes to the characteristic gait and limb ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the spinocerebellar tracts (unconscious proprioception to the cerebellum) from the dorsal columns (conscious proprioception to the cerebral cortex).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003espinocerebellar tracts\u003c/b\u003e are the cerebellum\u0027s private lines of communication with the body, providing a continuous, unconscious stream of proprioceptive data that is essential for real-time motor coordination and balance.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"transmits\",\n        \"to\": \"unconscious_proprioception\"\n      },\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"bebe58d4\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"39bc1763\"\n      }\n    ]\n  },\n  \"07eecef1\": {\n    \"title\": \"Spinothalamic Tract\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSpinothalamic Tract\u003c/b\u003e (also known as the anterolateral system) is a major ascending sensory pathway that transmits information about \u003cu\u003epain, temperature, and crude touch\u003c/u\u003e from the body to the thalamus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Transmits nociceptive, thermal, and non-discriminative tactile information.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e A three-neuron chain:\u003cbr\u003e1. \u003cb\u003eFirst-order neuron:\u003c/b\u003e From peripheral receptors to the dorsal horn of the spinal cord, where it synapses.\u003cbr\u003e2. \u003cb\u003eSecond-order neuron:\u003c/b\u003e \u003cmark\u003eDecussates (crosses)\u003c/mark\u003e at the level of the spinal cord in the \u003cmark\u003eanterior white commissure\u003c/mark\u003e, then ascends in the contralateral anterolateral funiculus.\u003cbr\u003e3. \u003cb\u003eThird-order neuron:\u003c/b\u003e From the VPL nucleus of the thalamus to the primary somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopy:\u003c/b\u003e The tract is organized somatotopically, with fibers from the sacral levels located most laterally and cervical fibers most medially.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e A lesion of the spinothalamic tract causes \u003cmark\u003econtralateral\u003c/mark\u003e loss of pain and temperature sensation beginning 1-2 segments below the level of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndromes:\u003c/b\u003e Damaged in [[4792bc68|Brown-S√©quard syndrome]] (contralateral loss), [[b48b54d7|anterior spinal artery occlusion]] (bilateral loss), and [[d2b8e10c|syringomyelia]] (bilateral loss at the level of the syrinx).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The key feature is its decussation at the spinal cord level. This contrasts with the dorsal columns, which decussate in the medulla.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSpinothalamic Tract\u003c/b\u003e is the essential pathway for pain and temperature sensation, characterized by its immediate decussation in the spinal cord, which results in contralateral sensory loss when the tract is damaged.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Receptor] --\u003e B(1st Order Neuron); B --\u003e C(Synapse in Dorsal Horn); C --Decussation--\u003e D(2nd Order Neuron); D --\u003e E(Ascends Contralaterally); E --\u003e F(Synapse in Thalamus); F --\u003e G(3rd Order Neuron); G --\u003e H(Somatosensory Cortex);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"transmits\",\n        \"to\": \"pain_and_temperature_sensation\"\n      },\n      {\n        \"type\": \"decussates_at\",\n        \"to\": \"anterior_white_commissure\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"d2b8e10c\"\n      }\n    ]\n  },\n  \"c271838c\": {\n    \"title\": \"Spongiform Cortex\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neuropathology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Dementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpongiform cortex\u003c/b\u003e, or spongiform encephalopathy, is the pathognomonic histological finding in prion diseases, such as [[86fe59ba|Creutzfeldt-Jakob disease (CJD)]]. It is characterized by the presence of numerous microscopic vacuoles in the neuropil of the cerebral cortex, giving it a sponge-like appearance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e On H\u0026E stain, the gray matter shows diffuse, small, empty-looking vacuoles in the neuropil, which can coalesce into larger cysts.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The vacuoles are the result of extensive neuronal loss, astrogliosis, and the accumulation of abnormal, protease-resistant prion protein (PrP\u003csup\u003eSc\u003c/sup\u003e) aggregates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Feature:\u003c/b\u003e This vacuolation occurs \u003cmark\u003ewithout a significant inflammatory infiltrate\u003c/mark\u003e, which is a key feature distinguishing prion diseases from viral encephalitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Disease:\u003c/b\u003e The hallmark of all prion diseases, including [[86fe59ba|CJD]], kuru, and bovine spongiform encephalopathy (\u0027mad cow disease\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The term \u0027spongiform encephalopathy\u0027 is synonymous with prion disease. A brain biopsy showing vacuolation without inflammation is diagnostic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003espongiform cortex\u003c/b\u003e is the devastating microscopic endpoint of prion disease, where the accumulation of misfolded proteins leads to widespread neuronal death, leaving behind a brain riddled with empty vacuoles, resembling a sponge.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"86fe59ba\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"prion_disease\"\n      }\n    ]\n  },\n  \"05e4a508\": {\n    \"title\": \"Stapes\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy and Physiology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003estapes\u003c/b\u003e is the smallest of the three auditory ossicles in the middle ear. It is also the smallest bone in the human body. Its function is to transmit sound vibrations from the incus to the oval window of the inner ear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAnatomy:\u003c/b\u003e Shaped like a stirrup (Latin: \u003ci\u003estapes\u003c/i\u003e). It consists of a head (which articulates with the incus), two crura (limbs), and a footplate (which fits into the oval window).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e As the final bone in the ossicular chain, it acts like a piston, pushing on the oval window to create pressure waves in the fluid of the [[001c359f|cochlea]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eStapedius Muscle:\u003c/b\u003e The stapes is attached to the stapedius muscle, which is innervated by the [[dea9755f|facial nerve (CN VII)]]. This muscle contracts in response to loud noises (acoustic reflex), stiffening the ossicular chain to protect the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOtosclerosis:\u003c/b\u003e A condition where abnormal bone growth fixes the stapes footplate to the oval window, preventing it from vibrating. This is a common cause of progressive [[2b500647|conductive hearing loss]].\u003cbr\u003e - \u003cb\u003eFacial Nerve Palsy:\u003c/b\u003e Paralysis of the stapedius muscle can cause hyperacusis (sensitivity to loud sounds).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the stapes as the final link in the mechanical amplification of sound in the middle ear. Its fixation in otosclerosis is a classic cause of conductive hearing loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003estapes\u003c/b\u003e is the tiny, piston-like bone that bridges the middle and inner ear, converting the amplified vibrations of the ossicles into the hydraulic waves within the cochlea that are necessary for hearing.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"auditory_ossicle\"\n      },\n      {\n        \"type\": \"is_affected_in\",\n        \"to\": \"otosclerosis\"\n      },\n      {\n        \"type\": \"is_stabilized_by\",\n        \"to\": \"stapedius_muscle\"\n      }\n    ]\n  },\n  \"769ef31b\": {\n    \"title\": \"Startle Myoclonus\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eStartle myoclonus\u003c/b\u003e is a type of myoclonus (sudden, brief, shock-like muscle jerks) that is elicited by an unexpected sensory stimulus, such as a loud noise, a sudden touch, or a bright light.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e An exaggerated, involuntary jerking response to a surprising stimulus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e It is a characteristic and highly suggestive feature of \u003cmark\u003e[[86fe59ba|Creutzfeldt-Jakob disease (CJD)]]\u003c/mark\u003e, a rapidly progressive prion disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in other encephalopathies, such as anoxic brain injury, and in certain genetic epilepsy syndromes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e In the context of a rapidly progressive dementia, the presence of startle myoclonus is a strong clinical clue that points toward a diagnosis of CJD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with rapidly progressing dementia who exhibits sudden, violent jerks in response to the examiner clapping their hands has startle myoclonus, a classic sign of CJD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eStartle myoclonus\u003c/b\u003e is an exaggerated, reflexive jerk to a surprise stimulus, which, when seen in a patient with rapid cognitive decline, is a near-pathognomonic sign of the profound cortical and subcortical irritability caused by Creutzfeldt-Jakob disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"myoclonus\"\n      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"86fe59ba\"\n      }\n    ]\n  },\n  \"676a6271\": {\n    \"title\": \"Status Epilepticus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Emergency Medicine\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eStatus epilepticus\u003c/b\u003e is a neurological emergency defined as a single continuous epileptic seizure lasting longer than 5 minutes, or two or more seizures occurring without a complete recovery of consciousness in between.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A failure of the mechanisms that normally terminate a seizure, leading to a state of prolonged, self-sustaining neuronal firing. This can cause excitotoxic neuronal injury, metabolic derangements, and cardiorespiratory compromise.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e Can be convulsive (e.g., continuous tonic-clonic seizures) or non-convulsive (e.g., continuous absence or focal impaired awareness seizures). Convulsive status epilepticus is the most life-threatening.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e This is a medical emergency requiring rapid intervention to stop the seizure and prevent brain damage.\u003cbr\u003e1. \u003cb\u003eInitial Therapy (0-5 min):\u003c/b\u003e Stabilize the patient (Airway, Breathing, Circulation).\u003cbr\u003e2. \u003cb\u003eFirst-line Therapy (5-20 min):\u003c/b\u003e IV \u003cmark\u003e[[14464617|benzodiazepines]]\u003c/mark\u003e (e.g., lorazepam, [[e14063c3|diazepam]]).\u003cbr\u003e3. \u003cb\u003eSecond-line Therapy (20-40 min):\u003c/b\u003e IV anticonvulsants like fosphenytoin, [[5aea213f|phenytoin]], [[0d37e045|valproic acid]], or [[2341f9c0|levetiracetam]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The first-line drug for terminating status epilepticus is an IV benzodiazepine. Remember the ABCs (Airway, Breathing, Circulation) are always the first step in any emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eStatus epilepticus\u003c/b\u003e is a brain \u0027stuck in a seizure,\u0027 a dangerous state of unrelenting neuronal firing that requires immediate treatment with IV benzodiazepines to prevent permanent neurological damage and systemic complications.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Seizure \u003e 5 min] --\u003e B(Status Epilepticus); B --\u003e C(Administer IV Benzodiazepine); C --Failure--\u003e D(Administer IV Anticonvulsant);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_complication_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \"to\": \"14464617\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \"to\": \"5aea213f\"\n      }\n    ]\n  },\n  \"adc34ee4\": {\n    \"title\": \"Steroids (Neurological Use)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Immunology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Immunomodulators\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSteroids\u003c/b\u003e (specifically, glucocorticoids like prednisone or methylprednisolone) are potent anti-inflammatory and immunosuppressive agents used in neurology to treat a variety of inflammatory and autoimmune conditions of the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Broad anti-inflammatory effects, including inhibiting phospholipase A\u003csub\u003e2\u003c/sub\u003e, suppressing the transcription of pro-inflammatory cytokines, and inducing apoptosis in lymphocytes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Multiple Sclerosis:\u003c/b\u003e High-dose IV steroids (e.g., methylprednisolone) are the \u003cmark\u003efirst-line treatment for acute relapses\u003c/mark\u003e of [[45dd6d19|multiple sclerosis]]. They shorten the duration and severity of the relapse but do not affect the long-term course of the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Vasogenic Edema:\u003c/b\u003e Dexamethasone is used to reduce vasogenic edema associated with brain tumors and abscesses by stabilizing the blood-brain barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Uses:\u003c/b\u003e Used in other autoimmune neurological conditions like myasthenia gravis crisis and inflammatory myopathies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Long-term use can cause Cushing\u0027s syndrome, osteoporosis, hyperglycemia, and immunosuppression. Acute high-dose therapy can cause psychosis (\u0027steroid psychosis\u0027), insomnia, and hyperglycemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For an acute MS flare, the answer is high-dose steroids. For long-term disease modification in MS, other agents like interferon-Œ≤ or glatiramer are used.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn neurology, high-dose \u003cb\u003esteroids\u003c/b\u003e act as a powerful \u0027fire extinguisher\u0027 for acute inflammatory events, most notably for shortening the duration of a multiple sclerosis relapse by rapidly suppressing the autoimmune attack on myelin.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"45dd6d19\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"vasogenic_edema\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"glucocorticoid\"\n      }\n    ]\n  },\n  \"86d263e9\": {\n    \"title\": \"Stevens-Johnson Syndrome (SJS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Immunology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connective Tissue\",\n      \"Dermatology\",\n      \"Drug Reactions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eStevens-Johnson Syndrome (SJS)\u003c/b\u003e is a severe, immune-mediated mucocutaneous reaction, most often triggered by medications. It is characterized by extensive necrosis and detachment of the epidermis. It is considered a less severe form of Toxic Epidermal Necrolysis (TEN), with SJS involving \u003c10% of the body surface area.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A delayed-type (Type IV) hypersensitivity reaction where drug-specific cytotoxic T cells and NK cells induce widespread apoptosis of keratinocytes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Begins with a prodrome of fever and flu-like symptoms, followed by the abrupt onset of an erythematous, morbilliform rash and mucosal lesions. The rash progresses to form bullae and sloughing of the skin. \u003cmark\u003eMucosal involvement\u003c/mark\u003e (oral, ocular, genital) is a hallmark.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCausative Drugs:\u003c/b\u003e The most commonly implicated drugs are \u003cmark\u003eanticonvulsants\u003c/mark\u003e (especially [[08d19a8f|lamotrigine]], [[eddd2bc5|carbamazepine]], [[5aea213f|phenytoin]]), \u003cmark\u003eallopurinol\u003c/mark\u003e, and \u003cmark\u003esulfonamides\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNikolsky\u0027s Sign:\u003c/b\u003e A positive Nikolsky\u0027s sign (slight rubbing of the skin results in exfoliation) is often present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e This is a medical emergency requiring immediate withdrawal of the offending drug and supportive care in a burn unit.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient who recently started a new drug (especially an anticonvulsant or allopurinol) and develops a fever, rash, and painful mucosal erosions has SJS until proven otherwise.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eStevens-Johnson Syndrome\u003c/b\u003e is a catastrophic drug-induced hypersensitivity reaction where the immune system attacks the skin and mucous membranes, causing them to blister and peel off as if the patient has been severely burned.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"type_iv_hypersensitivity\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"allopurinol\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"sulfonamides\"\n      }\n    ]\n  },\n  \"cdcda821\": {\n    \"title\": \"Strabismus\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Eye Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eStrabismus\u003c/b\u003e is a condition in which the eyes do not properly align with each other when looking at an object. This misalignment can be constant or intermittent.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTerminology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eEsotropia:\u003c/b\u003e Inward turning of the eye.\u003cbr\u003e - \u003cb\u003eExotropia:\u003c/b\u003e Outward turning of the eye.\u003cbr\u003e - \u003cb\u003eHypertropia:\u003c/b\u003e Upward deviation of the eye.\u003cbr\u003e - \u003cb\u003eHypotropia:\u003c/b\u003e Downward deviation of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Can be due to extraocular muscle weakness, refractive error (accommodative esotropia), or a problem with the innervating cranial nerves (paralytic strabismus, e.g., [[01c1b782|CN VI palsy]] causing esotropia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications in Children:\u003c/b\u003e If not corrected during the critical period of visual development, the brain may suppress the image from the deviating eye to avoid [[9914d433|diplopia]]. This can lead to the development of \u003cmark\u003e[[a4a401c7|amblyopia]]\u003c/mark\u003e (\u0027lazy eye\u0027), a permanent reduction in visual acuity in that eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e The cover-uncover test is used to detect strabismus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLeukocoria:\u003c/b\u003e The presence of a white pupillary reflex (leukocoria) in a child with strabismus is a red flag for [[63b964af|retinoblastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The primary concern with strabismus in a child is the risk of developing amblyopia. Early detection and treatment (e.g., glasses, patching, surgery) are crucial to prevent permanent vision loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eStrabismus\u003c/b\u003e is a misalignment of the eyes that, in children, poses a significant threat to vision development by potentially leading to amblyopia if the brain learns to ignore the input from the deviating eye.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"a4a401c7\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"cranial_nerve_palsy\"\n      },\n      {\n        \"type\": \"can_be_a_sign_of\",\n        \"to\": \"63b964af\"\n      }\n    ]\n  },\n  \"4da30f12\": {\n    \"title\": \"Streptococcus pneumoniae\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Microbiology\",\n      \"Infectious Disease\",\n      \"Pulmonology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003ci\u003e\u003cb\u003eStreptococcus pneumoniae\u003c/b\u003e\u003c/i\u003e (pneumococcus) is a gram-positive, lancet-shaped diplococcus that is a major cause of community-acquired pneumonia, meningitis, otitis media, and sinusitis.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e Gram-positive, Œ±-hemolytic, lancet-shaped diplococcus. It is catalase-negative and optochin-sensitive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVirulence Factor:\u003c/b\u003e Its most important virulence factor is its \u003cmark\u003epolysaccharide capsule\u003c/mark\u003e, which is antiphagocytic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiseases (Meningitis):\u003c/b\u003e The \u003cmark\u003emost common cause of bacterial meningitis\u003c/mark\u003e in adults, children, and the elderly (excluding neonates).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiseases (Other):\u003c/b\u003e The most common cause of community-acquired pneumonia (lobar pneumonia with \u0027rusty\u0027 sputum), [[a03641af|otitis media]] in children, and sinusitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors for Invasive Disease:\u003c/b\u003e Patients who are \u003cmark\u003easplenic\u003c/mark\u003e (e.g., sickle cell disease, splenectomy) are at high risk for overwhelming sepsis because the spleen is critical for clearing encapsulated organisms.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrevention:\u003c/b\u003e Vaccination with pneumococcal conjugate (PCV) and polysaccharide (PPSV) vaccines is highly effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember \u003ci\u003eS. pneumoniae\u003c/i\u003e as the #1 cause of MOPS: \u003cb\u003eM\u003c/b\u003eeningitis, \u003cb\u003eO\u003c/b\u003etitis media, \u003cb\u003eP\u003c/b\u003eneumonia, and \u003cb\u003eS\u003c/b\u003einusitis.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003ci\u003e\u003cb\u003eStreptococcus pneumoniae\u003c/b\u003e\u003c/i\u003e is a formidable encapsulated bacterium that is the leading cause of several common and serious respiratory tract and CNS infections, with its polysaccharide capsule being the key to both its virulence and the target of effective vaccines.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"meningitis\"\n      },\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"a03641af\"\n      },\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"pneumonia\"\n      },\n      {\n        \"type\": \"has_virulence_factor\",\n        \"to\": \"polysaccharide_capsule\"\n      }\n    ]\n  },\n  \"0c4b0065\": {\n    \"title\": \"Stretch Receptors\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory Receptors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eStretch receptors\u003c/b\u003e are a type of mechanoreceptor that respond to the stretching of the tissue in which they are located. They are crucial for proprioception and the regulation of various physiological processes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMuscle Spindles:\u003c/b\u003e Located within skeletal muscles, they are stretch receptors that detect changes in muscle length. They are the sensory component of the \u003cmark\u003edeep tendon reflex\u003c/mark\u003e (e.g., patellar reflex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGolgi Tendon Organs (GTOs):\u003c/b\u003e Located in tendons, they detect changes in muscle tension. They have an inhibitory function to protect muscles from excessive force.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBaroreceptors:\u003c/b\u003e Stretch receptors located in the walls of the carotid sinus and aortic arch. They detect changes in blood pressure by sensing the stretch of the arterial wall.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePulmonary Stretch Receptors:\u003c/b\u003e Located in the smooth muscle of the airways, they are involved in the Hering-Breuer reflex, which terminates inhalation to prevent over-inflation of the lungs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The muscle spindle is the key receptor for the monosynaptic deep tendon reflex, a fundamental component of the neurological exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eStretch receptors\u003c/b\u003e are the body\u0027s internal strain gauges, providing the central nervous system with continuous feedback on the state of muscles, tendons, and blood vessels, which is essential for motor control and autonomic regulation.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"mechanoreceptor\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"muscle_spindle\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"golgi_tendon_organ\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"baroreceptors\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9637,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"e6820b7f\": {\n    \"title\": \"Sp"
      }, {
        "text": "inal Muscular Atrophy (SMA)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Genetics\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron"
      }, {
        "text": " Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal Muscular Atrophy (SMA"
      }, {
        "text": ")\u003c/b\u003e is an autosomal recessive disorder characterized by the degeneration of anterior horn cells (lower motor neurons) in the spinal cord, leading to progressive"
      }, {
        "text": " muscle weakness and atrophy. It is caused by a deficiency of the [[6a781682|Survival"
      }, {
        "text": " Motor Neuron (SMN) protein]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:"
      }, {
        "text": "\u003c/b\u003e Autosomal recessive deletion or mutation of the \u003ci\u003eSMN1\u003c/i\u003e gene. Disease severity is inversely correlated with the number of copies"
      }, {
        "text": " of a second gene, \u003ci\u003eSMN2\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Deficiency of the SMN protein"
      }, {
        "text": ", which is critical for snRNP assembly and pre-mRNA splicing, leads to apoptosis of lower motor neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e Pure \u003cmark\u003elower motor neuron\u003c/mark\u003e signs. Presents with symmetric, progressive muscle weakness (prox"
      }, {
        "text": "imal \u003e distal) and atrophy, hypotonia, and absent deep tendon reflexes. Sensation and cognition are intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e Classified"
      }, {
        "text": " by age of onset and severity. Type 1 ([[17c628e2|Werdnig-Hoff"
      }, {
        "text": "mann disease]]) is the most severe, with onset in infancy and death from respiratory failure by age 2 if untreated.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e The classic presentation of SMA Type 1 is a \u0027floppy baby\u0027 with symmetric weakness, tongue"
      }, {
        "text": " fasciculations, and areflexia. The underlying defect is in pre-mRNA splicing.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eSpinal Muscular Atrophy\u003c/b\u003e is a devastating lower motor neuron disease caused by a genetic defect in the SMN protein,"
      }, {
        "text": " essential for neuronal survival, leading to progressive, symmetric muscle wasting and weakness that is most severe in infants.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_def"
      }, {
        "text": "iciency_of\",\n        \"to\": \"6a781682\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_a\",\n        \"to\": \"lower_motor_neuron_disease\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"includes_subtype\",\n        \"to\": \"17c628e2\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"c757e185\": {\n    \"title\": \"Spinal Nerves\","
      }, {
        "text": "\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Peripheral Nervous System\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eSpinal nerves\u003c/b\u003e are 31 pairs of mixed nerves that emerge from the spinal cord and"
      }, {
        "text": " are a fundamental part of the peripheral nervous system. Each nerve is formed by the union of a dorsal (sensory) root and a ventral ("
      }, {
        "text": "motor) root.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e 31 pairs:"
      }, {
        "text": " 8 cervical (C1-C8), 12 thoracic (T1-T12), 5"
      }, {
        "text": " lumbar (L1-L5), 5 sacral (S1-S5), and 1 coccygeal."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eExit from Vertebral Canal:\u003c/b\u003e C1-C7 nerves exit \u003cu\u003eabove\u003c/u\u003e their corresponding vertebra"
      }, {
        "text": ". The C8 nerve exits between C7 and T1. All subsequent nerves (T1 and below) exit \u003cu\u003ebelow\u003c/u\u003e their"
      }, {
        "text": " corresponding vertebra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They carry motor, sensory, and autonomic signals between the spinal cord and the"
      }, {
        "text": " body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDermatomes and Myotomes:\u003c/b\u003e Each spinal nerve innervates a specific area of"
      }, {
        "text": " skin (dermatome) and a specific group of muscles (myotome).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Extent of Spinal Cord:\u003c/b\u003e In"
      }, {
        "text": " adults, the spinal cord ends at the L1-L2 vertebral level (conus medullaris). The nerve"
      }, {
        "text": " roots below this level form the [[1c4d7e8f|cauda equina]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Knowing the vertebral exit pattern is important for localizing nerve root compression. For example, a herniated"
      }, {
        "text": " disc between L4 and L5 will typically compress the L5 nerve root.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "\u003cb\u003eSpinal nerves\u003c/b\u003e are the vital conduits connecting the spinal cord to the periphery, with each of the 31 pairs carrying"
      }, {
        "text": " a mix of motor and sensory fibers to a specific segment of the body, forming the basis of the dermatomal and myotomal maps"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_part_of\",\n        \"to\": \"peripheral_nervous_system\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"form\",\n        \"to\": \"brachial_plexus\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"form\",\n        \"to\": \"lumbosacral_plexus\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"76044e89\": {\n    \"title\": \""
      }, {
        "text": "Spinal Reflexes\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neuro"
      }, {
        "text": "physiology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eSpinal reflexes\u003c/b\u003e are involuntary and nearly instantaneous movements that are mediated by a reflex arc at the level"
      }, {
        "text": " of the spinal cord, without requiring input from the brain. Testing these reflexes is a fundamental part of the neurological examination.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eReflex Arc Components:\u003c/b\u003e A sensory receptor, an afferent neuron, an"
      }, {
        "text": " integration center (spinal cord), an efferent neuron, and an effector (muscle).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDeep Tendon Reflexes (DTRs):"
      }, {
        "text": "\u003c/b\u003e Monosynaptic stretch reflexes that test the integrity of specific spinal nerve roots.\u003cbr\u003e - \u003cb\u003e[[87d"
      }, {
        "text": "19a70|Achilles]]:\u003c/b\u003e S1, S2\u003cbr\u003e - \u003cb\u003ePatellar:\u003c/b\u003e L2"
      }, {
        "text": ", L3, L4\u003cbr\u003e - \u003cb\u003e[[f36cfe18|Biceps]] \u0026 [[ac"
      }, {
        "text": "55d026|Brachioradialis]]:\u003c/b\u003e C5, C6\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "b79b3546|Triceps]]:\u003c/b\u003e C7, C8\u003c/li\u003e\u003cli\u003e\u003cb\u003eSuperficial Reflexes:"
      }, {
        "text": "\u003c/b\u003e Polysynaptic reflexes.\u003cbr\u003e - \u003cb\u003e[[ce2052d6|Anal wink]]:\u003c/b\u003e S3"
      }, {
        "text": ", S4\u003cbr\u003e - \u003cb\u003e[[cd09cad7|Cremasteric]]:\u003c/b\u003e L1, L2\u003c/li\u003e\u003cli\u003e\u003cb\u003eInterpretation"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eHyporeflexia/Areflexia (Diminished/Absent):\u003c/b\u003e Suggest"
      }, {
        "text": "s a lower motor neuron lesion (e.g., nerve root compression, peripheral neuropathy).\u003cbr\u003e - \u003cb\u003eHyperreflexia (Exaggerated"
      }, {
        "text": "):\u003c/b\u003e Suggests an upper motor neuron lesion (e.g., stroke, spinal cord injury).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The state of the spinal reflexes is a key differentiator between UMN and LMN lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eSpinal reflexes\u003c/b\u003e are the spinal cord\u0027s automatic responses to sensory stimuli, providing a rapid and reliable clinical"
      }, {
        "text": " tool to assess the integrity of specific nerve roots and to distinguish between upper and lower motor neuron pathologies.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Stimulus] --\u003e B(Sensory Receptor); B --\u003e C(Afferent Neuron); C"
      }, {
        "text": " --\u003e D(Spinal Cord); D --\u003e E(Efferent Neuron); E --\u003e F(Effector Muscle); F"
      }, {
        "text": " --\u003e G(Response);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_syn"
      }, {
        "text": "onymous_with\",\n        \"to\": \"2915ead0\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"are_used_to_test\",\n        \"to\": \"c757e185\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"are_diminished_in\",\n        \"to\": \"lower"
      }, {
        "text": "_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"are_exaggerated_in\",\n        "
      }, {
        "text": "\"to\": \"upper_motor_neuron_lesion\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"8aa8156f\": {\n    \"title\": \"Spinal Tracts\",\n    \"primaryType\": \""
      }, {
        "text": "anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eSpinal tracts\u003c/b\u003e are bundles of myelinated nerve fibers (white matter) that run up"
      }, {
        "text": " and down the spinal cord, carrying information between the brain and the periphery. They are functionally segregated into ascending (sensory) and descending ("
      }, {
        "text": "motor) pathways.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAscending (Sensory) Tracts:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[e7f5cbbe|Dorsal Columns]]:\u003c/b\u003e Carry fine touch, vibration"
      }, {
        "text": ", and proprioception. Ascend ipsilaterally and decussate in the medulla.\u003cbr\u003e - \u003cb\u003e[[0"
      }, {
        "text": "7eecef1|Spinothalamic Tract]]:\u003c/b\u003e Carries pain, temperature, and crude touch. Decussates at"
      }, {
        "text": " the level of the spinal cord in the anterior white commissure and ascends contralaterally.\u003cbr\u003e - \u003cb\u003e[[5"
      }, {
        "text": "468da40|Spinocerebellar Tracts]]:\u003c/b\u003e Carry unconscious proprioceptive information to the cerebellum."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eDescending (Motor) Tracts:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[fb0a5fdc|Corticospinal Tract]]:"
      }, {
        "text": "\u003c/b\u003e The primary pathway for voluntary motor control. Descends from the motor cortex and decussates in the medullary pyramids to"
      }, {
        "text": " control the contralateral body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Localization:\u003c/b\u003e The distinct pathways and decussation points of these tracts are"
      }, {
        "text": " crucial for localizing spinal cord lesions. For example, [[4792bc68|Brown-S√©qu"
      }, {
        "text": "ard syndrome]] (hemisection) causes a characteristic pattern of ipsilateral and contralateral deficits.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Master"
      }, {
        "text": " the three major tracts: Dorsal Columns, Spinothalamic, and Corticospinal. Know what they carry, where"
      }, {
        "text": " they are located in the cord, and where they decussate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003espinal tracts\u003c/b\u003e are the information superhighways of the spinal cord, with anatomically and functionally distinct ascending and"
      }, {
        "text": " descending lanes that allow for precise clinical localization of lesions based on the pattern of sensory and motor deficits.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"e"
      }, {
        "text": "7f5cbbe\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"0"
      }, {
        "text": "7eecef1\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"fb0a5fdc\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"5468da40\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "5468da40\": {\n    \"title\": \"Spinocerebellar Tracts\",\n    "
      }, {
        "text": "\"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"An"
      }, {
        "text": "atomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003espinocerebellar tracts\u003c/b\u003e are ascending sensory pathways that transmit unconscious proprioceptive information from the muscles"
      }, {
        "text": " and joints to the cerebellum. This information is crucial for the cerebellum\u0027s role in coordinating movement and maintaining balance.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Carry unconscious proprioception (information about muscle stretch and tension) to the cerebellum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMajor"
      }, {
        "text": " Tracts:\u003c/b\u003e Includes the dorsal spinocerebellar tract, ventral spinocerebellar tract, and others.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway"
      }, {
        "text": ":\u003c/b\u003e These tracts are primarily ipsilateral. Information from one side of the body is transmitted to the ipsilateral cerebellar hemisphere.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e Damage to the spinocerebellar tracts contributes to the [[9767fd6b"
      }, {
        "text": "|ataxia]] seen in certain neurological disorders.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Diseases:\u003c/b\u003e These tracts are notably affected in \u003c"
      }, {
        "text": "mark\u003e[[39bc1763|Friedreich ataxia]]\u003c/mark\u003e, a hereditary ataxia where their degeneration contributes"
      }, {
        "text": " to the characteristic gait and limb ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the spinocerebellar tracts ("
      }, {
        "text": "unconscious proprioception to the cerebellum) from the dorsal columns (conscious proprioception to the cerebral cortex).\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe \u003cb\u003espinocerebellar tracts\u003c/b\u003e are the cerebellum\u0027s private lines of communication with"
      }, {
        "text": " the body, providing a continuous, unconscious stream of proprioceptive data that is essential for real-time motor coordination and balance.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"8aa8156f\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"transmits\",\n        \"to\": \"unconscious_proprioception\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"projects_to\",\n        \"to\": \"bebe58d"
      }, {
        "text": "4\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to"
      }, {
        "text": "\": \"39bc1763\"\n      }\n    ]\n  },\n  \"07eecef1\": {\n    "
      }, {
        "text": "\"title\": \"Spinothalamic Tract\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSpinothalamic Tract\u003c/b\u003e (also known"
      }, {
        "text": " as the anterolateral system) is a major ascending sensory pathway that transmits information about \u003cu\u003epain, temperature, and crude touch"
      }, {
        "text": "\u003c/u\u003e from the body to the thalamus.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Trans"
      }, {
        "text": "mits nociceptive, thermal, and non-discriminative tactile information.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathway:\u003c/b\u003e A three-neuron"
      }, {
        "text": " chain:\u003cbr\u003e1. \u003cb\u003eFirst-order neuron:\u003c/b\u003e From peripheral receptors to the dorsal horn of the spinal cord,"
      }, {
        "text": " where it synapses.\u003cbr\u003e2. \u003cb\u003eSecond-order neuron:\u003c/b\u003e \u003cmark\u003eDecussates (crosses)\u003c/"
      }, {
        "text": "mark\u003e at the level of the spinal cord in the \u003cmark\u003eanterior white commissure\u003c/mark\u003e, then ascends in"
      }, {
        "text": " the contralateral anterolateral funiculus.\u003cbr\u003e3. \u003cb\u003eThird-order neuron:\u003c/b\u003e From the VPL nucleus"
      }, {
        "text": " of the thalamus to the primary somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopy:\u003c/b\u003e The tract is organized som"
      }, {
        "text": "atotopically, with fibers from the sacral levels located most laterally and cervical fibers most medially.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLes"
      }, {
        "text": "ions:\u003c/b\u003e A lesion of the spinothalamic tract causes \u003cmark\u003econtralateral\u003c/mark\u003e loss of pain and"
      }, {
        "text": " temperature sensation beginning 1-2 segments below the level of the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Syndromes:\u003c/b\u003e Dam"
      }, {
        "text": "aged in [[4792bc68|Brown-S√©quard syndrome]] (contralateral loss), [[b4"
      }, {
        "text": "8b54d7|anterior spinal artery occlusion]] (bilateral loss), and [[d2b8e"
      }, {
        "text": "10c|syringomyelia]] (bilateral loss at the level of the syrinx).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The key feature is its decussation at the spinal cord level. This contrasts with the dorsal columns"
      }, {
        "text": ", which decussate in the medulla.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eSpinothalamic Tract\u003c/b\u003e"
      }, {
        "text": " is the essential pathway for pain and temperature sensation, characterized by its immediate decussation in the spinal cord, which results"
      }, {
        "text": " in contralateral sensory loss when the tract is damaged.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Re"
      }, {
        "text": "ceptor] --\u003e B(1st Order Neuron); B --\u003e C(Synapse in Dorsal Horn); C --Dec"
      }, {
        "text": "ussation--\u003e D(2nd Order Neuron); D --\u003e E(Ascends Contralaterally); E --\u003e F(Syn"
      }, {
        "text": "apse in Thalamus); F --\u003e G(3rd Order Neuron); G --\u003e H(Somatosensory Cortex);\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"transmits\",\n        \"to\": \"pain_and_temperature_sensation\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"decussates_at\",\n        \"to\": \"anterior_white_commissure\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"4"
      }, {
        "text": "792bc68\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \""
      }, {
        "text": "d2b8e10c\"\n      }\n    ]\n  },\n  \"c2718"
      }, {
        "text": "38c\": {\n    \"title\": \"Spongiform Cortex\",\n    \"primaryType\": \"pathology\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuropathology\",\n      \"Infectious Disease\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"D"
      }, {
        "text": "ementia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpongiform cortex\u003c/b\u003e,"
      }, {
        "text": " or spongiform encephalopathy, is the pathognomonic histological finding in prion diseases, such as [[86fe"
      }, {
        "text": "59ba|Creutzfeldt-Jakob disease (CJD)]]. It is characterized by the presence of numerous microscopic"
      }, {
        "text": " vacuoles in the neuropil of the cerebral cortex, giving it a sponge-like appearance.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eAppearance:\u003c/b\u003e On H\u0026E stain, the gray matter shows diffuse, small, empty-looking vacuoles in the neuropil, which"
      }, {
        "text": " can coalesce into larger cysts.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The vacuoles are the result of extensive neuronal loss,"
      }, {
        "text": " astrogliosis, and the accumulation of abnormal, protease-resistant prion protein (PrP\u003csup\u003eSc\u003c/sup\u003e) aggregates.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Feature:\u003c/b\u003e This vacuolation occurs \u003cmark\u003ewithout a significant inflammatory infiltrate\u003c/mark\u003e, which is a key feature distinguishing prion"
      }, {
        "text": " diseases from viral encephalitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Disease:\u003c/b\u003e The hallmark of all prion diseases, including [[86fe"
      }, {
        "text": "59ba|CJD]], kuru, and bovine spongiform encephalopathy (\u0027mad cow disease\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The term \u0027spongiform encephalopathy\u0027 is synonymous with prion disease. A brain biopsy showing vacu"
      }, {
        "text": "olation without inflammation is diagnostic.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003espongiform cortex\u003c/b\u003e is the"
      }, {
        "text": " devastating microscopic endpoint of prion disease, where the accumulation of misfolded proteins leads to widespread neuronal death, leaving behind a brain"
      }, {
        "text": " riddled with empty vacuoles, resembling a sponge.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"86fe59ba"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        "
      }, {
        "text": "\"to\": \"prion_disease\"\n      }\n    ]\n  },\n  \"05e"
      }, {
        "text": "4a508\": {\n    \"title\": \"Stapes\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Otology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Anatomy and Physiology\""
      }, {
        "text": "\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003estapes\u003c/b\u003e is"
      }, {
        "text": " the smallest of the three auditory ossicles in the middle ear. It is also the smallest bone in the human body. Its function is to transmit sound"
      }, {
        "text": " vibrations from the incus to the oval window of the inner ear.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eAnatomy:\u003c/b\u003e Shaped like a stirrup (Latin: \u003ci\u003estapes\u003c/i\u003e). It consists of a head ("
      }, {
        "text": "which articulates with the incus), two crura (limbs), and a footplate (which fits into the oval window).\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Function:\u003c/b\u003e As the final bone in the ossicular chain, it acts like a piston, pushing on the oval window to"
      }, {
        "text": " create pressure waves in the fluid of the [[001c359f|cochlea]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSt"
      }, {
        "text": "apedius Muscle:\u003c/b\u003e The stapes is attached to the stapedius muscle, which is innervated by the [["
      }, {
        "text": "dea9755f|facial nerve (CN VII)]]. This muscle contracts in response to loud noises (acoustic reflex), stiff"
      }, {
        "text": "ening the ossicular chain to protect the inner ear.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eOtosclerosis"
      }, {
        "text": ":\u003c/b\u003e A condition where abnormal bone growth fixes the stapes footplate to the oval window, preventing it from vibrating."
      }, {
        "text": " This is a common cause of progressive [[2b500647|conductive hearing loss]].\u003cbr\u003e - \u003cb\u003eFac"
      }, {
        "text": "ial Nerve Palsy:\u003c/b\u003e Paralysis of the stapedius muscle can cause hyperacusis (sensitivity to loud sounds).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Remember the stapes as the final link in the mechanical amplification of sound in the middle ear. Its fixation in ot"
      }, {
        "text": "osclerosis is a classic cause of conductive hearing loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003estapes\u003c/b\u003e"
      }, {
        "text": " is the tiny, piston-like bone that bridges the middle and inner ear, converting the amplified vibrations of the ossicles into"
      }, {
        "text": " the hydraulic waves within the cochlea that are necessary for hearing.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"auditory_ossicle\"\n      },\n      {\n        \"type\": \"is_affected"
      }, {
        "text": "_in\",\n        \"to\": \"otosclerosis\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "is_stabilized_by\",\n        \"to\": \"stapedius_muscle\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"769ef31b\": {\n    \"title\": \"Startle Myoclonus\",\n    \"primary"
      }, {
        "text": "Type\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eStartle myoclonus\u003c/b\u003e is a type of myoclonus (sudden, brief"
      }, {
        "text": ", shock-like muscle jerks) that is elicited by an unexpected sensory stimulus, such as a loud noise, a sudden touch"
      }, {
        "text": ", or a bright light.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e An exaggerated, involuntary jer"
      }, {
        "text": "king response to a surprising stimulus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e It is a characteristic and highly suggestive feature of \u003c"
      }, {
        "text": "mark\u003e[[86fe59ba|Creutzfeldt-Jakob disease (CJD)]]\u003c/mark\u003e,"
      }, {
        "text": " a rapidly progressive prion disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Causes:\u003c/b\u003e Can also be seen in other encephalopathies, such as an"
      }, {
        "text": "oxic brain injury, and in certain genetic epilepsy syndromes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e In the context of a rapidly"
      }, {
        "text": " progressive dementia, the presence of startle myoclonus is a strong clinical clue that points toward a diagnosis of CJD.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "USMLE Tip:\u003c/b\u003e A patient with rapidly progressing dementia who exhibits sudden, violent jerks in response to the examiner clapping"
      }, {
        "text": " their hands has startle myoclonus, a classic sign of CJD.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eStartle myoclonus\u003c/b\u003e is an exaggerated, reflexive jerk to a surprise stimulus, which, when seen"
      }, {
        "text": " in a patient with rapid cognitive decline, is a near-pathognomonic sign of the profound cortical and subcortical irritability caused"
      }, {
        "text": " by Creutzfeldt-Jakob disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections"
      }, {
        "text": "\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"myoclonus\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\":"
      }, {
        "text": " \"86fe59ba\"\n      }\n    ]\n  },\n  \"676a6"
      }, {
        "text": "271\": {\n    \"title\": \"Status Epilepticus\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Emergency Medicine\",\n      \"Critical Care\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n"
      }, {
        "text": "      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Status epilepticus\u003c/b\u003e is a neurological emergency defined as a single continuous epileptic seizure lasting longer than 5 minutes, or two"
      }, {
        "text": " or more seizures occurring without a complete recovery of consciousness in between.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e A failure of the mechanisms that normally terminate a seizure, leading to a state of prolonged, self-sustaining neuronal firing"
      }, {
        "text": ". This can cause excitotoxic neuronal injury, metabolic derangements, and cardiorespiratory compromise.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e Can"
      }, {
        "text": " be convulsive (e.g., continuous tonic-clonic seizures) or non-convulsive (e.g., continuous"
      }, {
        "text": " absence or focal impaired awareness seizures). Convulsive status epilepticus is the most life-threatening.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e This"
      }, {
        "text": " is a medical emergency requiring rapid intervention to stop the seizure and prevent brain damage.\u003cbr\u003e1. \u003cb\u003eInitial Therapy"
      }, {
        "text": " (0-5 min):\u003c/b\u003e Stabilize the patient (Airway, Breathing, Circulation).\u003cbr\u003e2. \u003cb\u003eFirst"
      }, {
        "text": "-line Therapy (5-20 min):\u003c/b\u003e IV \u003cmark\u003e[[14464617|benz"
      }, {
        "text": "odiazepines]]\u003c/mark\u003e (e.g., lorazepam, [[e14063c3|diazepam]])."
      }, {
        "text": "\u003cbr\u003e3. \u003cb\u003eSecond-line Therapy (20-40 min):\u003c/b\u003e IV anticonvulsants like"
      }, {
        "text": " fosphenytoin, [[5aea213f|phenytoin]], [[0d37e045|valproic acid]],"
      }, {
        "text": " or [[2341f9c0|levetiracetam]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The first"
      }, {
        "text": "-line drug for terminating status epilepticus is an IV benzodiazepine. Remember the ABCs (Airway, Breathing, Circulation)"
      }, {
        "text": " are always the first step in any emergency.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eStatus epilepticus\u003c/b\u003e is"
      }, {
        "text": " a brain \u0027stuck in a seizure,\u0027 a dangerous state of unrelenting neuronal firing that requires immediate treatment with IV benzodiazepines to prevent"
      }, {
        "text": " permanent neurological damage and systemic complications.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Seizure \u003e 5 min] --\u003e B(Status"
      }, {
        "text": " Epilepticus); B --\u003e C(Administer IV Benzodiazepine); C --Failure--\u003e D(Administer IV Ant"
      }, {
        "text": "iconvulsant);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "complication_of\",\n        \"to\": \"64c08e92\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_treated_with\",\n        \"to\": \"144646"
      }, {
        "text": "17\"\n      },\n      {\n        \"type\": \"is_treated_with\",\n        \""
      }, {
        "text": "to\": \"5aea213f\"\n      }\n    ]\n  },\n  \"adc3"
      }, {
        "text": "4ee4\": {\n    \"title\": \"Steroids (Neurological Use)\",\n    \"primaryType\": \""
      }, {
        "text": "drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Immunology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pharmacology\",\n      \"Immunomodulators\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eSteroids\u003c/b\u003e (specifically, glucocorticoids like prednisone or methylprednisolone) are potent anti-inflammatory and"
      }, {
        "text": " immunosuppressive agents used in neurology to treat a variety of inflammatory and autoimmune conditions of the nervous system.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Broad anti-inflammatory effects, including inhibiting phospholipase A\u003csub\u003e"
      }, {
        "text": "2\u003c/sub\u003e, suppressing the transcription of pro-inflammatory cytokines, and inducing apoptosis in lymphocytes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Multiple Sclerosis:"
      }, {
        "text": "\u003c/b\u003e High-dose IV steroids (e.g., methylprednisolone) are the \u003cmark\u003efirst-line treatment for"
      }, {
        "text": " acute relapses\u003c/mark\u003e of [[45dd6d19|multiple sclerosis]]. They shorten the duration and"
      }, {
        "text": " severity of the relapse but do not affect the long-term course of the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUse in Vasogenic Edema:\u003c/b\u003e D"
      }, {
        "text": "examethasone is used to reduce vasogenic edema associated with brain tumors and abscesses by stabilizing the blood-brain barrier.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther"
      }, {
        "text": " Uses:\u003c/b\u003e Used in other autoimmune neurological conditions like myasthenia gravis crisis and inflammatory myopathies.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects"
      }, {
        "text": ":\u003c/b\u003e Long-term use can cause Cushing\u0027s syndrome, osteoporosis, hyperglycemia, and immunosuppression. Acute high-"
      }, {
        "text": "dose therapy can cause psychosis (\u0027steroid psychosis\u0027), insomnia, and hyperglycemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e For"
      }, {
        "text": " an acute MS flare, the answer is high-dose steroids. For long-term disease modification in MS, other agents"
      }, {
        "text": " like interferon-Œ≤ or glatiramer are used.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eIn"
      }, {
        "text": " neurology, high-dose \u003cb\u003esteroids\u003c/b\u003e act as a powerful \u0027fire extinguisher\u0027 for acute inflammatory events, most"
      }, {
        "text": " notably for shortening the duration of a multiple sclerosis relapse by rapidly suppressing the autoimmune attack on myelin.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"4"
      }, {
        "text": "5dd6d19\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"vasogenic_"
      }, {
        "text": "edema\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"glucocorticoid\"\n      }\n    ]\n  },\n  \"86d"
      }, {
        "text": "263e9\": {\n    \"title\": \"Stevens-Johnson Syndrome (SJS)\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Dermatology\",\n      \"Immunology\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Musculoskeletal, Skin, and Connect"
      }, {
        "text": "ive Tissue\",\n      \"Dermatology\",\n      \"Drug Reactions\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eStevens-Johnson Syndrome (SJS)\u003c/b\u003e is a severe, immune-mediated mucocutaneous reaction,"
      }, {
        "text": " most often triggered by medications. It is characterized by extensive necrosis and detachment of the epidermis. It is considered a less severe form of Toxic"
      }, {
        "text": " Epidermal Necrolysis (TEN), with SJS involving \u003c10% of the body surface area.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A delayed-type (Type IV) hypersensitivity reaction where drug-specific cytotoxic T cells"
      }, {
        "text": " and NK cells induce widespread apoptosis of keratinocytes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Begins with a prodrome of fever and"
      }, {
        "text": " flu-like symptoms, followed by the abrupt onset of an erythematous, morbilliform rash and mucosal lesions. The rash"
      }, {
        "text": " progresses to form bullae and sloughing of the skin. \u003cmark\u003eMucosal involvement\u003c/mark\u003e (oral"
      }, {
        "text": ", ocular, genital) is a hallmark.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCausative Drugs:\u003c/b\u003e The most commonly implicated drugs are \u003cmark\u003eant"
      }, {
        "text": "iconvulsants\u003c/mark\u003e (especially [[08d19a8f|lamotrigine]], [["
      }, {
        "text": "eddd2bc5|carbamazepine]], [[5aea213f|phenytoin]]), \u003cmark\u003eall"
      }, {
        "text": "opurinol\u003c/mark\u003e, and \u003cmark\u003esulfonamides\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNikolsky\u0027s Sign:\u003c/b\u003e A positive"
      }, {
        "text": " Nikolsky\u0027s sign (slight rubbing of the skin results in exfoliation) is often present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:"
      }, {
        "text": "\u003c/b\u003e This is a medical emergency requiring immediate withdrawal of the offending drug and supportive care in a burn unit.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " A patient who recently started a new drug (especially an anticonvulsant or allopurinol) and develops a fever"
      }, {
        "text": ", rash, and painful mucosal erosions has SJS until proven otherwise.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Stevens-Johnson Syndrome\u003c/b\u003e is a catastrophic drug-induced hypersensitivity reaction where the immune system attacks the skin and mucous membranes, causing them"
      }, {
        "text": " to blister and peel off as if the patient has been severely burned.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\","
      }, {
        "text": "\n        \"to\": \"type_iv_hypersensitivity\"\n      },\n      {\n        \"type\": \"is_caused_"
      }, {
        "text": "by\",\n        \"to\": \"f91a0cfa\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_caused_by\",\n        \"to\": \"allopurinol\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_caused_by\",\n        \"to\": \"sulfonamides\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"cdcda821\": {\n    \"title\": \"Strabismus\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      "
      }, {
        "text": "\"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Eye Movement Disorders\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eStrabismus\u003c/b\u003e is a condition in which the eyes do"
      }, {
        "text": " not properly align with each other when looking at an object. This misalignment can be constant or intermittent.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTerminology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eEsotropia:\u003c/b\u003e Inward turning of the eye.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003eExotropia:\u003c/b\u003e Outward turning of the eye.\u003cbr\u003e - \u003cb\u003eHypert"
      }, {
        "text": "ropia:\u003c/b\u003e Upward deviation of the eye.\u003cbr\u003e - \u003cb\u003eHypotropia:\u003c/b\u003e Downward deviation of the eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Causes:\u003c/b\u003e Can be due to extraocular muscle weakness, refractive error (accommodative esotropia), or a problem"
      }, {
        "text": " with the innervating cranial nerves (paralytic strabismus, e.g., [[01c1"
      }, {
        "text": "b782|CN VI palsy]] causing esotropia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications in Children:\u003c/b\u003e If not"
      }, {
        "text": " corrected during the critical period of visual development, the brain may suppress the image from the deviating eye to avoid [[9"
      }, {
        "text": "914d433|diplopia]]. This can lead to the development of \u003cmark\u003e[[a4a"
      }, {
        "text": "401c7|amblyopia]]\u003c/mark\u003e (\u0027lazy eye\u0027), a permanent reduction in visual acuity in"
      }, {
        "text": " that eye.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e The cover-uncover test is used to detect strabismus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLeuk"
      }, {
        "text": "ocoria:\u003c/b\u003e The presence of a white pupillary reflex (leukocoria) in a child with strabismus is"
      }, {
        "text": " a red flag for [[63b964af|retinoblastoma]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " The primary concern with strabismus in a child is the risk of developing amblyopia. Early detection and treatment ("
      }, {
        "text": "e.g., glasses, patching, surgery) are crucial to prevent permanent vision loss.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eStrabismus\u003c/b\u003e is a misalignment of the eyes that, in children, poses a significant threat to vision development by"
      }, {
        "text": " potentially leading to amblyopia if the brain learns to ignore the input from the deviating eye.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"can_cause\",\n        \"to"
      }, {
        "text": "\": \"a4a401c7\"\n      },\n      {\n        \"type\": \"can"
      }, {
        "text": "_be_caused_by\",\n        \"to\": \"cranial_nerve_palsy\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"can_be_a_sign_of\",\n        \"to\": \"63b96"
      }, {
        "text": "4af\"\n      }\n    ]\n  },\n  \"4da30f12\": {\n    \"title"
      }, {
        "text": "\": \"Streptococcus pneumoniae\",\n    \"primaryType\": \"microbe\",\n    \"tags\": [\n      \"Microbiology"
      }, {
        "text": "\",\n      \"Infectious Disease\",\n      \"Pulmonology\",\n      \"Neurology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Infections\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003ci\u003e"
      }, {
        "text": "\u003cb\u003eStreptococcus pneumoniae\u003c/b\u003e\u003c/i\u003e (pneumococcus) is a gram-positive, lancet-shaped diplococcus that"
      }, {
        "text": " is a major cause of community-acquired pneumonia, meningitis, otitis media, and sinusitis.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMicrobiology:\u003c/b\u003e Gram-positive, Œ±-hemolytic, lancet-shaped diplococcus."
      }, {
        "text": " It is catalase-negative and optochin-sensitive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVirulence Factor:\u003c/b\u003e Its most important virulence factor is its"
      }, {
        "text": " \u003cmark\u003epolysaccharide capsule\u003c/mark\u003e, which is antiphagocytic.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiseases (Mening"
      }, {
        "text": "itis):\u003c/b\u003e The \u003cmark\u003emost common cause of bacterial meningitis\u003c/mark\u003e in adults, children, and the elderly ("
      }, {
        "text": "excluding neonates).\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiseases (Other):\u003c/b\u003e The most common cause of community-acquired pneumonia (lo"
      }, {
        "text": "bar pneumonia with \u0027rusty\u0027 sputum), [[a03641af|otitis media]] in children, and sinusitis.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Risk Factors for Invasive Disease:\u003c/b\u003e Patients who are \u003cmark\u003easplenic\u003c/mark\u003e (e.g.,"
      }, {
        "text": " sickle cell disease, splenectomy) are at high risk for overwhelming sepsis because the spleen is critical for clearing encapsulated organisms.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrevention:\u003c/b\u003e Vaccination"
      }, {
        "text": " with pneumococcal conjugate (PCV) and polysaccharide (PPSV) vaccines is highly effective.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " \u003ci\u003eS. pneumoniae\u003c/i\u003e as the #1 cause of MOPS: \u003cb\u003eM\u003c/b\u003eeningitis, \u003cb\u003e"
      }, {
        "text": "O\u003c/b\u003etitis media, \u003cb\u003eP\u003c/b\u003eneumonia, and \u003cb\u003eS\u003c/b\u003einusitis.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003ci\u003e\u003cb\u003eStreptococcus pneumoniae\u003c/b\u003e\u003c/i\u003e is a formidable encapsulated bacterium that is"
      }, {
        "text": " the leading cause of several common and serious respiratory tract and CNS infections, with its polysaccharide capsule being the key to both its virulence and the"
      }, {
        "text": " target of effective vaccines.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_cause_of\",\n        \"to\": \"meningitis\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"a03641af\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\":"
      }, {
        "text": " \"pneumonia\"\n      },\n      {\n        \"type\": \"has_virulence_factor\",\n        \"to"
      }, {
        "text": "\": \"polysaccharide_capsule\"\n      }\n    ]\n  },\n  \"0c4b"
      }, {
        "text": "0065\": {\n    \"title\": \"Stretch Receptors\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Anatomy\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Sensory Receptors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Stretch receptors\u003c/b\u003e are a type of mechanoreceptor that respond to the stretching of the tissue in which they are located. They are crucial"
      }, {
        "text": " for proprioception and the regulation of various physiological processes.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMuscle Sp"
      }, {
        "text": "indles:\u003c/b\u003e Located within skeletal muscles, they are stretch receptors that detect changes in muscle length. They are the sensory"
      }, {
        "text": " component of the \u003cmark\u003edeep tendon reflex\u003c/mark\u003e (e.g., patellar reflex).\u003c/li\u003e\u003cli\u003e\u003cb\u003eGolgi Tendon Org"
      }, {
        "text": "ans (GTOs):\u003c/b\u003e Located in tendons, they detect changes in muscle tension. They have an inhibitory function to"
      }, {
        "text": " protect muscles from excessive force.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBaroreceptors:\u003c/b\u003e Stretch receptors located in the walls of the carotid sinus"
      }, {
        "text": " and aortic arch. They detect changes in blood pressure by sensing the stretch of the arterial wall.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePulmonary Stretch"
      }, {
        "text": " Receptors:\u003c/b\u003e Located in the smooth muscle of the airways, they are involved in the Hering-Breuer reflex"
      }, {
        "text": ", which terminates inhalation to prevent over-inflation of the lungs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The muscle spindle is the key"
      }, {
        "text": " receptor for the monosynaptic deep tendon reflex, a fundamental component of the neurological exam.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eStretch receptors\u003c/b\u003e are the body\u0027s internal strain gauges, providing the central nervous system with continuous feedback on"
      }, {
        "text": " the state of muscles, tendons, and blood vessels, which is essential for motor control and autonomic regulation.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"mechanoreceptor\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"muscle_spindle\"\n      },\n      {\n        \"type\": \"includes\",\n"
      }, {
        "text": "        \"to\": \"golgi_tendon_organ\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"baroreceptors\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"6ab72a5a\",\n    \"letter\": \"S\",\n    \"term\": \"Sleep\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sleep\",\n    \"sub_entries\": [\n      {\n        \"id\": \"1929d714\",\n        \"letter\": \"S\",\n        \"term\": \"architecture\",\n        \"pages\": [\n          \"507\"\n        ],\n        \"context\": \"Sleep \u003e architecture\"\n      },\n      {\n        \"id\": \"52831a36\",\n        \"letter\": \"S\",\n        \"term\": \"physiology and stages\",\n        \"pages\": [\n          \"507\"\n        ],\n        \"context\": \"Sleep \u003e physiology and stages\"\n      },\n      {\n        \"id\": \"cf210f8e\",\n        \"letter\": \"S\",\n        \"term\": \"stages of\",\n        \"pages\": [\n          \"333\",\n          \"507\"\n        ],\n        \"context\": \"Sleep \u003e stages of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"90066c64\",\n    \"letter\": \"S\",\n    \"term\": \"SMN1 mutation\",\n    \"pages\": [\n      \"544\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"SMN1 mutation\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"63593303\",\n    \"letter\": \"S\",\n    \"term\": \"SNc (substantia nigra pars compacta)\",\n    \"pages\": [\n      \"505\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"SNc (substantia nigra pars compacta)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8c2c618d\",\n    \"letter\": \"S\",\n    \"term\": \"SNRIs (serotonin-norepinephrine\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"SNRIs (serotonin-norepinephrine\",\n    \"sub_entries\": [\n      {\n        \"id\": \"380b6803\",\n        \"letter\": \"S\",\n        \"term\": \"snRNP assembly\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"SNRIs (serotonin-norepinephrine \u003e snRNP assembly\"\n      }\n    ]\n  },\n  {\n    \"id\": \"beaf3c5e\",\n    \"letter\": \"S\",\n    \"term\": \"SOD1 mutations\",\n    \"pages\": [\n      \"544\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"SOD1 mutations\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"ed7d43ca\",\n    \"letter\": \"S\",\n    \"term\": \"Somatosensory cortex\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Somatosensory cortex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"cc214e1b\",\n    \"letter\": \"S\",\n    \"term\": \"Sonic hedgehog (SHH)\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sonic hedgehog (SHH)\",\n    \"sub_entries\": [\n      {\n        \"id\": \"0bac65d5\",\n        \"letter\": \"S\",\n        \"term\": \"basal plate development\",\n        \"pages\": [\n          \"500\"\n        ],\n        \"context\": \"Sonic hedgehog (SHH) \u003e basal plate development\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ce5eeda6\",\n    \"letter\": \"S\",\n    \"term\": \"Spasmolytics\",\n    \"pages\": [\n      \"567\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Spasmolytics\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b511bc97\",\n    \"letter\": \"S\",\n    \"term\": \"Spastic paresis\",\n    \"pages\": [\n      \"543\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Spastic paresis\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"fbd9a4e5\",\n    \"letter\": \"S\",\n    \"term\": \"Spasticity\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Spasticity\",\n    \"sub_entries\": [\n      {\n        \"id\": \"899efbb5\",\n        \"letter\": \"S\",\n        \"term\": \"motor neuron lesions and\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Spasticity \u003e motor neuron lesions and\"\n      }\n    ]\n  },\n  {\n    \"id\": \"805115af\",\n    \"letter\": \"S\",\n    \"term\": \"Special senses\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Special senses\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f2291e24\",\n        \"letter\": \"S\",\n        \"term\": \"otology\",\n        \"pages\": [\n          \"547\"\n        ],\n        \"context\": \"Special senses \u003e otology\"\n      }\n    ]\n  },\n  {\n    \"id\": \"63014ebc\",\n    \"letter\": \"S\",\n    \"term\": \"Spina bifida occulta\",\n    \"pages\": [\n      \"501\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Spina bifida occulta\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"377937be\",\n    \"letter\": \"S\",\n    \"term\": \"Spinal cord\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinal cord\",\n    \"sub_entries\": [\n      {\n        \"id\": \"ae826fac\",\n        \"letter\": \"S\",\n        \"term\": \"lesions and syndromes of\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Spinal cord \u003e lesions and syndromes of\"\n      },\n      {\n        \"id\": \"fb9cf6d8\",\n        \"letter\": \"S\",\n        \"term\": \"lower extent\",\n        \"pages\": [\n          \"520\"\n        ],\n        \"context\": \"Spinal cord \u003e lower extent\"\n      },\n      {\n        \"id\": \"b108e4b8\",\n        \"letter\": \"S\",\n        \"term\": \"reflexes and nerve roots\",\n        \"pages\": [\n          \"523\"\n        ],\n        \"context\": \"Spinal cord \u003e reflexes and nerve roots\"\n      },\n      {\n        \"id\": \"4aa9103c\",\n        \"letter\": \"S\",\n        \"term\": \"tracts and functions of\",\n        \"pages\": [\n          \"522\"\n        ],\n        \"context\": \"Spinal cord \u003e tracts and functions of\"\n      },\n      {\n        \"id\": \"a30fb4f5\",\n        \"letter\": \"S\",\n        \"term\": \"tracts in\",\n        \"pages\": [\n          \"521\"\n        ],\n        \"context\": \"Spinal cord \u003e tracts in\"\n      }\n    ]\n  },\n  {\n    \"id\": \"84a88b78\",\n    \"letter\": \"S\",\n    \"term\": \"Spinal cord lesions/syndromes\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinal cord lesions/syndromes\",\n    \"sub_entries\": [\n      {\n        \"id\": \"3e13b8cf\",\n        \"letter\": \"S\",\n        \"term\": \"causes of\",\n        \"pages\": [\n          \"544\"\n        ],\n        \"context\": \"Spinal cord lesions/syndromes \u003e causes of\"\n      },\n      {\n        \"id\": \"c5f9c74e\",\n        \"letter\": \"S\",\n        \"term\": \"in multiple sclerosis\",\n        \"pages\": [\n          \"537\"\n        ],\n        \"context\": \"Spinal cord lesions/syndromes \u003e in multiple sclerosis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"692e674f\",\n    \"letter\": \"S\",\n    \"term\": \"Spinal dysraphism types\",\n    \"pages\": [\n      \"501\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Spinal dysraphism types\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2220
    }, {
      "text": "```json\n{\n  \"6ab72a5a\": {\n    \"title\": \"Sleep\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sleep\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSleep\u003c/b\u003e is a naturally recurring state of mind and body, characterized by altered consciousness, relatively inhibited sensory activity, reduced muscle activity, and inhibition of nearly all voluntary muscles during REM sleep. It is divided into distinct stages that cycle throughout the night.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSleep Architecture:\u003c/b\u003e The cyclical pattern of sleep stages over the course of a night. A normal adult cycles through the stages approximately every 90 minutes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-REM (NREM) Sleep:\u003c/b\u003e Divided into three stages (N1, N2, N3).\u003cbr\u003e - \u003cb\u003eN1:\u003c/b\u003e Light sleep.\u003cbr\u003e - \u003cb\u003eN2:\u003c/b\u003e Deeper sleep, characterized by \u003cmark\u003esleep spindles and K-complexes\u003c/mark\u003e on EEG.\u003cbr\u003e - \u003cb\u003eN3:\u003c/b\u003e Deepest, slow-wave sleep. Important for physical restoration. Sleepwalking, night terrors, and bedwetting occur during N3.\u003c/li\u003e\u003cli\u003e\u003cb\u003eREM Sleep:\u003c/b\u003e Characterized by rapid eye movements, muscle atonia, and dreaming. EEG resembles the awake state (\u0027paradoxical sleep\u0027). Important for memory consolidation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e The sleep-wake cycle is regulated by the [[ad2b0b65|suprachiasmatic nucleus (SCN)]] of the hypothalamus, which controls the release of melatonin. Growth hormone is primarily released during N3 sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the EEG waveforms for each stage: N2 (sleep spindles, K-complexes), N3 (delta waves), REM (beta waves, looks like awake EEG). Remember that benzodiazepines and alcohol suppress REM and N3 sleep.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSleep\u003c/b\u003e is an active and highly structured physiological process, cycling through distinct NREM and REM stages, each with unique neural activity and functions, from physical repair in deep NREM sleep to memory consolidation during REM sleep.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Awake] --\u003e B(NREM Stage 1); B --\u003e C(NREM Stage 2); C --\u003e D(NREM Stage 3); D --\u003e C; C --\u003e E(REM Sleep); E --\u003e A;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"ad2b0b65\"\n      },\n      {\n        \"type\": \"includes_stage\",\n        \"to\": \"rem_sleep\"\n      },\n      {\n        \"type\": \"includes_stage\",\n        \"to\": \"nrem_sleep\"\n      }\n    ]\n  },\n  \"90066c64\": {\n    \"title\": \"SMN1 Gene Mutation\",\n    \"primaryType\": \"genetics\",\n    \"tags\": [\n      \"Genetics\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA mutation in the \u003cb\u003eSurvival Motor Neuron 1 (SMN1) gene\u003c/b\u003e is the genetic cause of [[e6820b7f|spinal muscular atrophy (SMA)]], an autosomal recessive disorder characterized by the degeneration of lower motor neurons.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGene Function:\u003c/b\u003e The \u003ci\u003eSMN1\u003c/i\u003e gene produces the full-length, functional [[6a781682|SMN protein]], which is critical for the assembly of spliceosomes and proper pre-mRNA splicing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMutation Type:\u003c/b\u003e In \u003e95% of SMA cases, there is a homozygous deletion of the \u003ci\u003eSMN1\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Loss of the \u003ci\u003eSMN1\u003c/i\u003e gene leads to a profound deficiency of SMN protein, causing apoptosis of anterior horn cells (lower motor neurons) in the spinal cord.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole of SMN2:\u003c/b\u003e Humans have a nearly identical gene, \u003ci\u003eSMN2\u003c/i\u003e, which can also produce SMN protein. However, due to a single nucleotide difference, \u003ci\u003eSMN2\u003c/i\u003e is inefficiently spliced and produces mostly a truncated, non-functional protein. The number of \u003ci\u003eSMN2\u003c/i\u003e copies a person has determines the severity of SMA, as more copies can partially compensate for the lack of \u003ci\u003eSMN1\u003c/i\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e SMA is a disease of defective pre-mRNA splicing caused by an \u003ci\u003eSMN1\u003c/i\u003e mutation. The number of \u003ci\u003eSMN2\u003c/i\u003e copies acts as a disease modifier.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA homozygous \u003cb\u003eSMN1 gene mutation\u003c/b\u003e is the root cause of spinal muscular atrophy, leading to a deficiency in a protein essential for RNA splicing and the subsequent death of lower motor neurons, with the disease\u0027s severity being modulated by the number of \u0027backup\u0027 \u003ci\u003eSMN2\u003c/i\u003e gene copies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[SMN1 Gene Deletion] --\u003e B(No functional SMN protein from SMN1); C[SMN2 Gene] --\u003e D(Small amount of functional SMN protein); B \u0026 D --\u003e E(Overall SMN Protein Deficiency); E --\u003e F(Lower Motor Neuron Death); F --\u003e G(Spinal Muscular Atrophy);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"causes\",\n        \"to\": \"e6820b7f\"\n      },\n      {\n        \"type\": \"encodes\",\n        \"to\": \"6a781682\"\n      }\n    ]\n  },\n  \"63593303\": {\n    \"title\": \"Substantia Nigra Pars Compacta (SNc)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Basal Ganglia\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003esubstantia nigra pars compacta (SNc)\u003c/b\u003e is a nucleus in the midbrain that is a key component of the [[ed462927|basal ganglia]]. It is composed of dopaminergic neurons that project to the striatum, forming the nigrostriatal pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Part of the substantia nigra in the midbrain. Its neurons contain neuromelanin, giving it a dark appearance on gross section.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The SNc provides [[90adc821|dopamine]] to the striatum (caudate and putamen). This dopaminergic input modulates the activity of the direct and indirect pathways of the basal ganglia to facilitate the initiation of voluntary movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptor Effects:\u003c/b\u003e Dopamine from the SNc \u003cmark\u003eexcites\u003c/mark\u003e the direct pathway via D\u003csub\u003e1\u003c/sub\u003e receptors and \u003cmark\u003einhibits\u003c/mark\u003e the indirect pathway via D\u003csub\u003e2\u003c/sub\u003e receptors. The net effect is to facilitate movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The hallmark of \u003cmark\u003e[[58c8ea03|Parkinson disease]]\u003c/mark\u003e is the progressive loss of dopaminergic neurons in the SNc. This leads to a dopamine deficit in the striatum, causing the characteristic motor symptoms of bradykinesia, rigidity, and tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology in Parkinson\u0027s:\u003c/b\u003e Surviving neurons in the SNc of Parkinson\u0027s patients often contain eosinophilic intracytoplasmic inclusions called \u003cmark\u003eLewy bodies\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of dopaminergic neurons in the substantia nigra pars compacta is the fundamental pathology of Parkinson disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003esubstantia nigra pars compacta\u003c/b\u003e is the dopamine-producing powerhouse of the motor system; its degeneration in Parkinson\u0027s disease starves the basal ganglia of dopamine, leading to a profound impairment in the ability to initiate and control movement.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[SNc] --Dopamine--\u003e B(Striatum); B --\u003e C(Modulation of Direct/Indirect Pathways); C --\u003e D(Facilitation of Movement); A --x Degeneration in Parkinson\u0027s Disease;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"substantia_nigra\"\n      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed462927\"\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"produces\",\n        \"to\": \"90adc821\"\n      }\n    ]\n  },\n  \"8c2c618d\": {\n    \"title\": \"Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSerotonin-norepinephrine reuptake inhibitors (SNRIs)\u003c/b\u003e are a class of antidepressant medications that work by blocking the reuptake of both serotonin and norepinephrine. They are used to treat depression, anxiety disorders, and neuropathic pain.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAgents:\u003c/b\u003e Venlafaxine, desvenlafaxine, duloxetine, levomilnacipran.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibit the serotonin transporter (SERT) and the norepinephrine transporter (NET), increasing the synaptic levels of both neurotransmitters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - Major depressive disorder.\u003cbr\u003e - [[d1c786e9|Anxiety disorders]] (e.g., GAD, panic disorder).\u003cbr\u003e - \u003cmark\u003eNeuropathic pain\u003c/mark\u003e (e.g., diabetic neuropathy) and fibromyalgia (especially duloxetine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Similar to SSRIs (e.g., nausea, sexual dysfunction). The norepinephrine effects can cause increased blood pressure and heart rate, which should be monitored.\u003c/li\u003e\u003cli\u003e\u003cb\u003esnRNP Assembly:\u003c/b\u003e This is a function of the [[6a781682|SMN protein]] and is \u003cu\u003enot related\u003c/u\u003e to SNRIs. The index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e SNRIs are a good choice for patients with depression and comorbid neuropathic pain or fibromyalgia. Duloxetine is specifically approved for these pain indications.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSNRIs\u003c/b\u003e are dual-action antidepressants that boost both serotonin and norepinephrine, making them effective not only for depression but also for treating chronic pain syndromes by modulating descending pain pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"antidepressant\"\n      },\n      {\n        \"type\": \"inhibits_reuptake_of\",\n        \"to\": \"serotonin\"\n      },\n      {\n        \"type\": \"inhibits_reuptake_of\",\n        \"to\": \"norepinephrine\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"9a0f5ba6\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"neuropathic_pain\"\n      }\n    ]\n  },\n  \"beaf3c5e\": {\n    \"title\": \"SOD1 Mutations\",\n    \"primaryType\": \"genetics\",\n    \"tags\": [\n      \"Genetics\",\n      \"Neurology\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eMutations in the \u003cb\u003eSOD1 (superoxide dismutase 1) gene\u003c/b\u003e are the most common known cause of familial \u003cmark\u003e[[4ed629f9|amyotrophic lateral sclerosis (ALS)]]\u003c/mark\u003e, accounting for about 20% of familial cases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGene Product:\u003c/b\u003e The \u003ci\u003eSOD1\u003c/i\u003e gene encodes the enzyme copper-zinc superoxide dismutase, which is a ubiquitous antioxidant enzyme that catalyzes the dismutation of superoxide radicals into oxygen and hydrogen peroxide.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact mechanism is not fully understood, but it is believed to be a \u003cmark\u003etoxic gain-of-function\u003c/mark\u003e mutation rather than a loss of enzymatic activity. The mutant SOD1 protein is prone to misfolding and aggregation, which may be toxic to motor neurons through various mechanisms, including oxidative stress, mitochondrial dysfunction, and excitotoxicity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInheritance:\u003c/b\u003e Familial ALS due to SOD1 mutations is typically inherited in an autosomal dominant pattern.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e While only a small fraction of all ALS cases are familial, the discovery of SOD1 mutations provided a crucial first insight into the molecular pathogenesis of the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate SOD1 mutations with familial ALS. The mechanism is thought to be a toxic gain-of-function, not a simple loss of antioxidant capacity.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSOD1 mutations\u003c/b\u003e are a key genetic cause of familial ALS, where a toxic gain-of-function in this antioxidant enzyme leads to the selective death of motor neurons, highlighting the role of protein misfolding and oxidative stress in the disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[SOD1 Mutation] --\u003e B(Misfolded SOD1 Protein); B --\u003e C(Toxic Gain-of-Function); C --\u003e D(Oxidative Stress \u0026 Aggregation); D --\u003e E(Motor Neuron Death); E --\u003e F(Familial ALS);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"encodes\",\n        \"to\": \"superoxide_dismutase_1\"\n      }\n    ]\n  },\n  \"ed7d43ca\": {\n    \"title\": \"Somatosensory Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eprimary somatosensory cortex\u003c/b\u003e (S1) is the main cortical area for processing tactile information from the body. It is located in the postcentral gyrus of the parietal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Postcentral gyrus of the parietal lobe (Brodmann areas 1, 2, and 3).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Receives and processes sensory information from the contralateral side of the body, including touch, pressure, pain, temperature, vibration, and proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives its primary input from the \u003cmark\u003eventral posterior nucleus (VPN)\u003c/mark\u003e of the [[afc0a64b|thalamus]], which is composed of the [[2ae957b8|VPL]] (for the body) and [[23ac314a|VPM]] (for the face) nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopic Organization (Sensory Homunculus):\u003c/b\u003e The cortex is organized somatotopically, with different body parts represented in specific areas. The face and hands have a disproportionately large representation due to their high sensory acuity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e A lesion in the primary somatosensory cortex causes contralateral sensory loss (e.g., numbness, paresthesias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the location (postcentral gyrus) and the somatotopic organization (homunculus), with the leg represented medially (supplied by ACA) and the arm/face represented laterally (supplied by MCA).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003esomatosensory cortex\u003c/b\u003e is the brain\u0027s primary \u0027touch map,\u0027 a highly organized region in the parietal lobe that receives all tactile information from the thalamus and translates it into our conscious perception of sensation from the contralateral body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamus - VPL/VPM] --\u003e B(Primary Somatosensory Cortex); B --\u003e C(Conscious Perception of Sensation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"parietal_lobe\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"is_organized_as\",\n        \"to\": \"sensory_homunculus\"\n      }\n    ]\n  },\n  \"cc214e1b\": {\n    \"title\": \"Sonic Hedgehog (SHH) Signaling Pathway\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Embryology\",\n      \"Neuroscience\",\n      \"Developmental Biology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSonic hedgehog (SHH)\u003c/b\u003e signaling pathway is a crucial signaling pathway in embryonic development, particularly for patterning the central nervous system. The SHH protein is a signaling molecule (morphogen) that acts in a concentration-dependent manner.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction in Neurodevelopment:\u003c/b\u003e Secreted by the underlying \u003cmark\u003enotochord\u003c/mark\u003e, SHH acts as a ventralizing signal for the neural tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVentralization:\u003c/b\u003e High concentrations of SHH induce the formation of the \u003cmark\u003e[[253e3efb|basal plate]]\u003c/mark\u003e, which gives rise to motor neurons in the ventral horn of the spinal cord and motor nuclei of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart Signal:\u003c/b\u003e The dorsalizing signal is \u003cmark\u003e[[869535a9|Bone Morphogenetic Protein (BMP)]]\u003c/mark\u003e, which is secreted by the ectoderm and induces the formation of the [[43be7a6e|alar plate]] (sensory neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHoloprosencephaly:\u003c/b\u003e Mutations in the SHH pathway are a cause of holoprosencephaly, a severe birth defect where the forebrain fails to divide into two hemispheres.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the source and effect: SHH from the notochord (floor) induces the ventral/motor basal plate. BMP from the ectoderm (roof) induces the dorsal/sensory alar plate.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSonic hedgehog\u003c/b\u003e is the key \u0027ventralizing\u0027 morphogen in the developing nervous system, secreted from the notochord to instruct the ventral neural tube to become the motor [[253e3efb|basal plate]], thereby establishing the fundamental motor-sensory axis of the CNS.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Notochord] --Secretes--\u003e B(SHH); B --Induces--\u003e C(Ventral Neural Tube); C --\u003e D(Basal Plate); D --\u003e E(Motor Neurons);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"induces_development_of\",\n        \"to\": \"253e3efb\"\n      },\n      {\n        \"type\": \"is_counteracted_by\",\n        \"to\": \"869535a9\"\n      },\n      {\n        \"type\": \"is_secreted_by\",\n        \"to\": \"notochord\"\n      },\n      {\n        \"type\": \"mutation_in_pathway_causes\",\n        \"to\": \"holoprosencephaly\"\n      }\n    ]\n  },\n  \"ce5eeda6\": {\n    \"title\": \"Spasmolytics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpasmolytics\u003c/b\u003e, or skeletal muscle relaxants, are a group of drugs used to alleviate symptoms associated with muscle spasticity or acute muscle spasms by acting either on the central nervous system or directly on the muscle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBaclofen:\u003c/b\u003e A GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist that acts on the spinal cord to suppress hyperactive reflexes. Used for spasticity in [[45dd6d19|multiple sclerosis]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCyclobenzaprine:\u003c/b\u003e A centrally acting muscle relaxant, structurally related to TCAs. Used for acute muscle spasms from musculoskeletal conditions. Has significant anticholinergic side effects and causes sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTizanidine:\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist that inhibits motor neuron activity. Used for spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDantrolene:\u003c/b\u003e Acts directly on skeletal muscle by blocking Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum (inhibits ryanodine receptor). Used to treat malignant hyperthermia and neuroleptic malignant syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the uses: [[1ddc3f08|baclofen]] and tizanidine for chronic spasticity (MS, spinal cord injury), cyclobenzaprine for acute muscle strain, and [[d67a204d|dantrolene]] for life-threatening hyperthermic syndromes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpasmolytics\u003c/b\u003e reduce muscle hyperactivity through diverse mechanisms, ranging from central GABAergic and adrenergic modulation (baclofen, tizanidine) to direct interference with muscle contraction machinery (dantrolene), the latter being crucial for treating hyperthermic emergencies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"cyclobenzaprine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d67a204d\"\n      }\n    ]\n  },\n  \"b511bc97\": {\n    \"title\": \"Spastic Paresis\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpastic paresis\u003c/b\u003e is a form of muscle weakness (paresis) combined with spasticity (increased muscle tone). It is a hallmark sign of an \u003cu\u003eupper motor neuron (UMN) lesion\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Results from damage to the descending corticospinal tracts, which leads to a loss of inhibitory modulation on spinal reflex arcs. This results in hypertonia and hyperreflexia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients have weakness, but their muscles are stiff and resistant to passive movement (spasticity). Deep tendon reflexes are exaggerated, and a positive [[8947da55|Babinski sign]] is present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGait:\u003c/b\u003e A spastic gait is often seen, where the legs are stiff and the feet are dragged or circumducted.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e Any UMN lesion can cause spastic paresis, including [[c5da3c57|stroke]], spinal cord injury, [[45dd6d19|multiple sclerosis]], and [[171ca00b|cerebral palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Spastic paresis is a key component of the UMN syndrome. Contrast it with the flaccid paralysis seen in LMN lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpastic paresis\u003c/b\u003e is a paradoxical state of weakness combined with stiffness, resulting from an upper motor neuron lesion that removes the brain\u0027s inhibitory control over spinal reflexes, leading to hyperactive and poorly controlled muscle tone.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is_characterized_by\",\n        \"to\": \"spasticity\"\n      },\n      {\n        \"type\": \"is_contrasted_with\",\n        \"to\": \"953e1306\"\n      }\n    ]\n  },\n  \"fbd9a4e5\": {\n    \"title\": \"Spasticity\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpasticity\u003c/b\u003e is a motor disorder characterized by a velocity-dependent increase in muscle tone (hypertonia) and exaggerated deep tendon reflexes (hyperreflexia). It is a component of the upper motor neuron (UMN) syndrome.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by damage to the descending motor pathways (e.g., corticospinal tract) that provide inhibitory input to spinal motor neurons. The loss of this inhibition leads to hyperexcitability of the stretch reflex arc.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e Increased muscle tone, hyperreflexia, clonus, and a positive [[8947da55|Babinski sign]]. A specific type of spasticity is \u003cmark\u003e[[ca51f29a|clasp-knife spasticity]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Seen in UMN lesions such as [[c5da3c57|stroke]], spinal cord injury, [[45dd6d19|multiple sclerosis]], and [[171ca00b|cerebral palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Can be managed with physical therapy and spasmolytic medications like [[1ddc3f08|baclofen]], tizanidine, or [[14464617|benzodiazepines]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Spasticity is a key sign that localizes a lesion to the upper motor neuron.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpasticity\u003c/b\u003e is a state of muscular hypertonia resulting from the disinhibition of spinal reflexes after an upper motor neuron injury, leading to stiff, overactive muscles.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"ca51f29a\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"af72aab5\"\n      }\n    ]\n  },\n  \"805115af\": {\n    \"title\": \"Special Senses\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"General Principles\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003especial senses\u003c/b\u003e are the senses that have specialized organs devoted to them. They include vision, hearing (audition), balance (equilibrium), taste (gustation), and smell (olfaction).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVision:\u003c/b\u003e Detected by photoreceptors in the retina; transmitted by the optic nerve (CN II).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHearing \u0026 Balance:\u003c/b\u003e Detected by hair cells in the [[001c359f|cochlea]] and vestibular apparatus, respectively; transmitted by the [[6fded3e7|vestibulocochlear nerve (CN VIII)]]. The field of study is [[c5a1d2fc|otology]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTaste:\u003c/b\u003e Detected by taste buds; transmitted by CN VII, IX, and X.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSmell:\u003c/b\u003e Detected by olfactory receptors in the nasal epithelium; transmitted by the olfactory nerve (CN I). It is the only sense that does not relay through the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Senses:\u003c/b\u003e This contrasts with the general senses (somatic senses), which include touch, temperature, pain, and proprioception, whose receptors are distributed throughout the body.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the cranial nerves associated with each special sense.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003especial senses\u003c/b\u003e are our sophisticated sensory systems for perceiving the external world, each with a dedicated organ and a specific cranial nerve pathway to the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"vision\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hearing\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"taste\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"smell\"\n      }\n    ]\n  },\n  \"63014ebc\": {\n    \"title\": \"Spina Bifida Occulta\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpina bifida occulta\u003c/b\u003e is the mildest and most common form of spina bifida, a type of neural tube defect. It is characterized by a failure of the vertebral arches to fuse, typically in the lumbosacral region, without herniation of the spinal cord or meninges.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A failure of the caudal neuropore to close completely, resulting in a bony defect of the vertebral arch. The spinal cord and meninges remain in their normal position.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e It is often asymptomatic and discovered incidentally on imaging. The term \u0027occulta\u0027 means hidden.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCutaneous Signs:\u003c/b\u003e The site of the bony defect may be marked by a patch of hair, a dimple, a birthmark, or a lipoma on the overlying skin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Deficits:\u003c/b\u003e Usually, there are no neurological deficits. Rarely, it can be associated with a tethered cord syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A tuft of hair or a dimple over the lower back in an otherwise asymptomatic infant is the classic presentation of spina bifida occulta.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpina bifida occulta\u003c/b\u003e is a \u0027hidden\u0027 neural tube defect where the only sign of the underlying vertebral anomaly is often a small patch of hair or a dimple on the lower back, with the spinal cord itself being unaffected.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"spina_bifida\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      }\n    ]\n  },\n  \"377937be\": {\n    \"title\": \"Spinal Cord\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003espinal cord\u003c/b\u003e is a long, thin, tubular structure made up of nervous tissue, which extends from the medulla oblongata in the brainstem to the lumbar region of the vertebral column. It is the main pathway for information connecting the brain and peripheral nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Composed of central gray matter (containing neuron cell bodies) surrounded by outer white matter (containing myelinated axon tracts).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Extent:\u003c/b\u003e In adults, the spinal cord terminates at the L1-L2 vertebral level as the \u003cmark\u003econus medullaris\u003c/mark\u003e. The nerve roots below this form the [[1c4d7e8f|cauda equina]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Tracts:\u003c/b\u003e Contains major ascending (sensory) and descending (motor) tracts, including the [[fb0a5fdc|corticospinal tracts]], [[e7f5cbbe|dorsal columns]], and [[07eecef1|spinothalamic tracts]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Reflexes:\u003c/b\u003e Mediates reflexes independently of the brain via reflex arcs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions/Syndromes:\u003c/b\u003e Damage to the spinal cord results in specific syndromes based on the location and extent of the lesion (e.g., [[4792bc68|Brown-S√©quard syndrome]], [[b48b54d7|anterior spinal artery syndrome]], [[d2b8e10c|syringomyelia]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understanding the cross-sectional anatomy of the spinal cord, including the location of the major tracts and their decussation points, is essential for localizing lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003espinal cord\u003c/b\u003e is the critical information highway of the body, containing precisely organized tracts that carry motor commands down from the brain and sensory information up to it, while also managing local reflexes independently.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"central_nervous_system\"\n      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"8aa8156f\"\n      },\n      {\n        \"type\": \"mediates\",\n        \"to\": \"76044e89\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"84a88b78\"\n      }\n    ]\n  },\n  \"84a88b78\": {\n    \"title\": \"Spinal Cord Lesions/Syndromes\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal cord lesions/syndromes\u003c/b\u003e are distinct patterns of neurological deficits that result from damage to specific areas or tracts within the spinal cord. The clinical presentation allows for precise anatomical localization of the lesion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[4792bc68|Brown-S√©quard Syndrome]]:\u003c/b\u003e Hemisection of the cord. Ipsilateral UMN signs and loss of proprioception/vibration below the lesion; contralateral loss of pain/temperature below the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[b48b54d7|Anterior Spinal Artery Syndrome]]:\u003c/b\u003e Infarct of the anterior 2/3 of the cord. Bilateral loss of motor function and pain/temperature below the lesion, with \u003cmark\u003espared dorsal columns\u003c/mark\u003e (proprioception/vibration).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[d2b8e10c|Syringomyelia]]:\u003c/b\u003e Cystic lesion of the central canal. Causes a bilateral, \u0027cape-like\u0027 loss of pain and temperature in the upper extremities (damage to anterior white commissure).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[6f5bea90|Subacute Combined Degeneration]]:\u003c/b\u003e Due to B\u003csub\u003e12\u003c/sub\u003e deficiency. Demyelination of dorsal columns, lateral corticospinal tracts, and spinocerebellar tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[71daebd6|Tabes Dorsalis]]:\u003c/b\u003e Tertiary syphilis. Degeneration of dorsal columns and dorsal roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[45dd6d19|Multiple Sclerosis]]:\u003c/b\u003e Can cause random, asymmetric demyelinating plaques anywhere in the spinal cord white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e These syndromes are a classic test of your knowledge of spinal cord tract anatomy and function. Draw out the cross-section and trace the pathways to solve problems.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe predictable organization of the spinal cord\u0027s tracts means that specific patterns of injury, or \u003cb\u003espinal cord syndromes\u003c/b\u003e, produce highly characteristic and localizable clinical deficits, making them a favorite topic for testing neuroanatomical knowledge.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"b48b54d7\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d2b8e10c\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"6f5bea90\"\n      }\n    ]\n  },\n  \"692e674f\": {\n    \"title\": \"Spinal Dysraphism\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal dysraphism\u003c/b\u003e refers to a group of congenital malformations of the spinal cord and vertebral column resulting from the incomplete closure of the neural tube during embryonic development (neurulation). These are also known as neural tube defects of the spine.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the caudal (posterior) neuropore to close during the 4th week of gestation. Associated with maternal folate deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[63014ebc|Spina Bifida Occulta]]:\u003c/b\u003e Mildest form. Failure of vertebral arch fusion, with no herniation of neural tissue. Often asymptomatic, may have an overlying skin dimple or tuft of hair.\u003cbr\u003e - \u003cb\u003eMeningocele:\u003c/b\u003e Herniation of the meninges (but not the spinal cord) through the bony defect, forming a CSF-filled sac.\u003cbr\u003e - \u003cb\u003eMyelomeningocele:\u003c/b\u003e Most severe form. Herniation of both the meninges and the spinal cord through the defect. Almost always associated with neurological deficits below the level of the lesion and a [[b96a6a07|Chiari II malformation]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Detected prenatally by elevated maternal serum alpha-fetoprotein (AFP) and ultrasound.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the types based on what is herniating: Occulta \u003d nothing, Meningocele \u003d meninges only, Myelomeningocele \u003d meninges + spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpinal dysraphism\u003c/b\u003e is a spectrum of birth defects resulting from failed closure of the spinal neural tube, ranging from the hidden bony defect of spina bifida occulta to the devastating paralysis associated with a myelomeningocele.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"63014ebc\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"meningocele\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"myelomeningocele\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9514,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"6ab72a5a\": {\n    \"title"
      }, {
        "text": "\": \"Sleep\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sleep\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSleep\u003c/b\u003e is a naturally recurring state of mind and body, characterized by altered"
      }, {
        "text": " consciousness, relatively inhibited sensory activity, reduced muscle activity, and inhibition of nearly all voluntary muscles during REM sleep. It is divided into distinct"
      }, {
        "text": " stages that cycle throughout the night.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSleep Architecture:\u003c/b\u003e The cyclical"
      }, {
        "text": " pattern of sleep stages over the course of a night. A normal adult cycles through the stages approximately every 90 minutes."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eNon-REM (NREM) Sleep:\u003c/b\u003e Divided into three stages (N1, N2, N3"
      }, {
        "text": ").\u003cbr\u003e - \u003cb\u003eN1:\u003c/b\u003e Light sleep.\u003cbr\u003e - \u003cb\u003eN2:\u003c/b\u003e De"
      }, {
        "text": "eper sleep, characterized by \u003cmark\u003esleep spindles and K-complexes\u003c/mark\u003e on EEG.\u003cbr\u003e - \u003cb\u003eN"
      }, {
        "text": "3:\u003c/b\u003e Deepest, slow-wave sleep. Important for physical restoration. Sleepwalking, night terrors, and bed"
      }, {
        "text": "wetting occur during N3.\u003c/li\u003e\u003cli\u003e\u003cb\u003eREM Sleep:\u003c/b\u003e Characterized by rapid eye movements, muscle atonia, and"
      }, {
        "text": " dreaming. EEG resembles the awake state (\u0027paradoxical sleep\u0027). Important for memory consolidation.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiology:\u003c/b\u003e The sleep"
      }, {
        "text": "-wake cycle is regulated by the [[ad2b0b65|suprachiasmatic nucleus (SCN)]"
      }, {
        "text": "] of the hypothalamus, which controls the release of melatonin. Growth hormone is primarily released during N3 sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e Know the EEG waveforms for each stage: N2 (sleep spindles, K-complexes), N"
      }, {
        "text": "3 (delta waves), REM (beta waves, looks like awake EEG). Remember that benzodiazepines and alcohol suppress REM and"
      }, {
        "text": " N3 sleep.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSleep\u003c/b\u003e is an active and highly"
      }, {
        "text": " structured physiological process, cycling through distinct NREM and REM stages, each with unique neural activity and functions, from physical repair"
      }, {
        "text": " in deep NREM sleep to memory consolidation during REM sleep.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A"
      }, {
        "text": "[Awake] --\u003e B(NREM Stage 1); B --\u003e C(NREM Stage 2); C --\u003e D(NREM Stage "
      }, {
        "text": "3); D --\u003e C; C --\u003e E(REM Sleep); E --\u003e A;\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"is_regulated_by\",\n        \"to\": \"ad2b0b6"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"includes_stage\",\n        \"to\": \"rem"
      }, {
        "text": "_sleep\"\n      },\n      {\n        \"type\": \"includes_stage\",\n        \"to\":"
      }, {
        "text": " \"nrem_sleep\"\n      }\n    ]\n  },\n  \"90066c"
      }, {
        "text": "64\": {\n    \"title\": \"SMN1 Gene Mutation\",\n    \"primaryType\": \"genetics\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Genetics\",\n      \"Neurology\",\n      \"Pediatrics\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA mutation in the "
      }, {
        "text": "\u003cb\u003eSurvival Motor Neuron 1 (SMN1) gene\u003c/b\u003e is the genetic cause of [[e6820"
      }, {
        "text": "b7f|spinal muscular atrophy (SMA)]], an autosomal recessive disorder characterized by the degeneration of lower motor neurons.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGene Function:\u003c/b\u003e The \u003ci\u003eSMN1\u003c/i\u003e gene produces the full-length,"
      }, {
        "text": " functional [[6a781682|SMN protein]], which is critical for the assembly of spliceosomes and"
      }, {
        "text": " proper pre-mRNA splicing.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMutation Type:\u003c/b\u003e In \u003e95% of SMA cases, there is a homozygous deletion of"
      }, {
        "text": " the \u003ci\u003eSMN1\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Loss of the \u003ci\u003eSMN1\u003c/i\u003e"
      }, {
        "text": " gene leads to a profound deficiency of SMN protein, causing apoptosis of anterior horn cells (lower motor neurons) in the spinal cord"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eRole of SMN2:\u003c/b\u003e Humans have a nearly identical gene, \u003ci\u003eSMN2\u003c/i\u003e,"
      }, {
        "text": " which can also produce SMN protein. However, due to a single nucleotide difference, \u003ci\u003eSMN2\u003c/i\u003e is"
      }, {
        "text": " inefficiently spliced and produces mostly a truncated, non-functional protein. The number of \u003ci\u003eSMN2\u003c/i\u003e copies a"
      }, {
        "text": " person has determines the severity of SMA, as more copies can partially compensate for the lack of \u003ci\u003eSMN1\u003c/i\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e SMA is a disease of defective pre-mRNA splicing caused by an \u003ci\u003eSMN1\u003c/i\u003e mutation"
      }, {
        "text": ". The number of \u003ci\u003eSMN2\u003c/i\u003e copies acts as a disease modifier.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eA homozygous \u003cb\u003eSMN1 gene mutation\u003c/b\u003e is the root cause of spinal muscular atrophy, leading to a deficiency in"
      }, {
        "text": " a protein essential for RNA splicing and the subsequent death of lower motor neurons, with the disease\u0027s severity being modulated by the number of \u0027"
      }, {
        "text": "backup\u0027 \u003ci\u003eSMN2\u003c/i\u003e gene copies.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[SM"
      }, {
        "text": "N1 Gene Deletion] --\u003e B(No functional SMN protein from SMN1); C[SMN2 Gene]"
      }, {
        "text": " --\u003e D(Small amount of functional SMN protein); B \u0026 D --\u003e E(Overall SMN Protein Deficiency); E --\u003e"
      }, {
        "text": " F(Lower Motor Neuron Death); F --\u003e G(Spinal Muscular Atrophy);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"causes\",\n        \"to\": \"e6820b7f\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"encodes\",\n        \"to\": \"6a781682\"\n"
      }, {
        "text": "      }\n    ]\n  },\n  \"63593303\": {\n    \"title\": \""
      }, {
        "text": "Substantia Nigra Pars Compacta (SNc)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Neuroanatomy\",\n      \"Basal Ganglia\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Basal Ganglia\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003esubstantia nigra pars compacta (SNc)\u003c/b\u003e is a nucleus in the midbrain that is a key"
      }, {
        "text": " component of the [[ed462927|basal ganglia]]. It is composed of dopaminergic neurons that project"
      }, {
        "text": " to the striatum, forming the nigrostriatal pathway.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Part of the substantia nigra in the midbrain. Its neurons contain neuromelanin, giving it a dark appearance"
      }, {
        "text": " on gross section.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The SNc provides [[90adc821|dopamine"
      }, {
        "text": "]] to the striatum (caudate and putamen). This dopaminergic input modulates the activity of the direct and indirect pathways of the basal ganglia"
      }, {
        "text": " to facilitate the initiation of voluntary movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReceptor Effects:\u003c/b\u003e Dopamine from the SNc \u003cmark\u003eexc"
      }, {
        "text": "ites\u003c/mark\u003e the direct pathway via D\u003csub\u003e1\u003c/sub\u003e receptors and \u003cmark\u003einhibits\u003c/mark\u003e the indirect"
      }, {
        "text": " pathway via D\u003csub\u003e2\u003c/sub\u003e receptors. The net effect is to facilitate movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e The hallmark"
      }, {
        "text": " of \u003cmark\u003e[[58c8ea03|Parkinson disease]]\u003c/mark\u003e is the progressive loss"
      }, {
        "text": " of dopaminergic neurons in the SNc. This leads to a dopamine deficit in the striatum, causing the characteristic"
      }, {
        "text": " motor symptoms of bradykinesia, rigidity, and tremor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology in Parkinson\u0027s:\u003c/b\u003e Surv"
      }, {
        "text": "iving neurons in the SNc of Parkinson\u0027s patients often contain eosinophilic intracytoplasmic inclusions called \u003cmark\u003eLewy bodies\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Loss of dopaminergic neurons in the substantia nigra pars compacta is the fundamental"
      }, {
        "text": " pathology of Parkinson disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003esubstantia nigra pars"
      }, {
        "text": " compacta\u003c/b\u003e is the dopamine-producing powerhouse of the motor system; its degeneration in Parkinson\u0027s disease starves the basal"
      }, {
        "text": " ganglia of dopamine, leading to a profound impairment in the ability to initiate and control movement.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "SNc] --Dopamine--\u003e B(Striatum); B --\u003e C(Modulation of Direct/Indirect Pathways); C"
      }, {
        "text": " --\u003e D(Facilitation of Movement); A --x Degeneration in Parkinson\u0027s Disease;\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"substantia_nigra\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_part_of\",\n        \"to\": \"ed"
      }, {
        "text": "462927\"\n      },\n      {\n        \"type\": \"degenerates_in\",\n        \"to\": \"5"
      }, {
        "text": "8c8ea03\"\n      },\n      {\n        \"type\": \"produces\",\n        \"to\": \"90adc"
      }, {
        "text": "821\"\n      }\n    ]\n  },\n  \"8c2c618d\": {\n    \""
      }, {
        "text": "title\": \"Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Psychiatry\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Antidepressants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Serotonin-norepinephrine reuptake inhibitors (SNRIs)\u003c/b\u003e are a class of antidepressant medications that work by blocking"
      }, {
        "text": " the reuptake of both serotonin and norepinephrine. They are used to treat depression, anxiety disorders, and neuropathic pain.\u003c/p\u003e\",\n      \""
      }, {
        "text": "atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAgents:\u003c/b\u003e Venlafaxine, desvenlafaxine, duloxetine"
      }, {
        "text": ", levomilnacipran.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Inhibit the serotonin transporter (SERT) and the norepinephrine transporter (NET"
      }, {
        "text": "), increasing the synaptic levels of both neurotransmitters.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e\u003cbr\u003e - Major depressive disorder.\u003c"
      }, {
        "text": "br\u003e - [[d1c786e9|Anxiety disorders]] (e.g., GAD,"
      }, {
        "text": " panic disorder).\u003cbr\u003e - \u003cmark\u003eNeuropathic pain\u003c/mark\u003e (e.g., diabetic neuropathy"
      }, {
        "text": ") and fibromyalgia (especially duloxetine).\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Similar to SSRIs (e.g., nausea, sexual"
      }, {
        "text": " dysfunction). The norepinephrine effects can cause increased blood pressure and heart rate, which should be monitored.\u003c/li\u003e\u003cli\u003e\u003cb\u003esnR"
      }, {
        "text": "NP Assembly:\u003c/b\u003e This is a function of the [[6a781682|SMN protein]] and"
      }, {
        "text": " is \u003cu\u003enot related\u003c/u\u003e to SNRIs. The index entry is likely a processing error.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e SNRIs are a good choice for patients with depression and comorbid neuropathic pain or fibromyalgia. Duloxetine is specifically"
      }, {
        "text": " approved for these pain indications.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSNRIs\u003c/b\u003e are dual"
      }, {
        "text": "-action antidepressants that boost both serotonin and norepinephrine, making them effective not only for depression but also for treating chronic pain syndromes"
      }, {
        "text": " by modulating descending pain pathways.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"antidepressant\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"inhibits_reuptake_of\",\n        \"to\": \"serotonin\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"inhibits_reuptake_of\",\n        \"to\": \"norepinephrine\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"treats\",\n        \"to\": \"9a0f5"
      }, {
        "text": "ba6\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"neu"
      }, {
        "text": "ropathic_pain\"\n      }\n    ]\n  },\n  \"beaf3c5e\": {\n    \"title"
      }, {
        "text": "\": \"SOD1 Mutations\",\n    \"primaryType\": \"genetics\",\n    \"tags\": [\n      \"Gen"
      }, {
        "text": "etics\",\n      \"Neurology\",\n      \"Biochemistry\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      "
      }, {
        "text": "\"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eMutations in the \u003cb\u003eSOD"
      }, {
        "text": "1 (superoxide dismutase 1) gene\u003c/b\u003e are the most common known cause of familial \u003cmark\u003e[[4"
      }, {
        "text": "ed629f9|amyotrophic lateral sclerosis (ALS)]]\u003c/mark\u003e, accounting for about 20% of familial"
      }, {
        "text": " cases.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGene Product:\u003c/b\u003e The \u003ci\u003eSOD1\u003c/i\u003e"
      }, {
        "text": " gene encodes the enzyme copper-zinc superoxide dismutase, which is a ubiquitous antioxidant enzyme that catalyzes the dismutation of superoxide radicals into oxygen"
      }, {
        "text": " and hydrogen peroxide.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact mechanism is not fully understood, but it is believed"
      }, {
        "text": " to be a \u003cmark\u003etoxic gain-of-function\u003c/mark\u003e mutation rather than a loss of enzymatic activity. The mutant"
      }, {
        "text": " SOD1 protein is prone to misfolding and aggregation, which may be toxic to motor neurons through various mechanisms, including oxidative stress, mitochondrial dysfunction"
      }, {
        "text": ", and excitotoxicity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInheritance:\u003c/b\u003e Familial ALS due to SOD1 mutations is typically inherited in"
      }, {
        "text": " an autosomal dominant pattern.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e While only a small fraction of all ALS cases are familial, the discovery"
      }, {
        "text": " of SOD1 mutations provided a crucial first insight into the molecular pathogenesis of the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate"
      }, {
        "text": " SOD1 mutations with familial ALS. The mechanism is thought to be a toxic gain-of-function, not a simple"
      }, {
        "text": " loss of antioxidant capacity.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSOD1 mutations\u003c/b\u003e are a key"
      }, {
        "text": " genetic cause of familial ALS, where a toxic gain-of-function in this antioxidant enzyme leads to the selective death of motor neurons, highlighting the role"
      }, {
        "text": " of protein misfolding and oxidative stress in the disease.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[SOD1 Mutation"
      }, {
        "text": "] --\u003e B(Misfolded SOD1 Protein); B --\u003e C(Toxic Gain-of-Function); C --\u003e D(Ox"
      }, {
        "text": "idative Stress \u0026 Aggregation); D --\u003e E(Motor Neuron Death); E --\u003e F(Familial ALS);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_cause_of\",\n        \"to\": \"4"
      }, {
        "text": "ed629f9\"\n      },\n      {\n        \"type\": \"encodes\",\n        \"to\": \"superoxide"
      }, {
        "text": "_dismutase_1\"\n      }\n    ]\n  },\n  \"ed7d4"
      }, {
        "text": "3ca\": {\n    \"title\": \"Somatosensory Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003eprimary somatosensory cortex\u003c/b\u003e (S1) is the main cortical area for processing tactile information from the body. It is located in the"
      }, {
        "text": " postcentral gyrus of the parietal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e"
      }, {
        "text": " Postcentral gyrus of the parietal lobe (Brodmann areas 1, 2, and 3).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:"
      }, {
        "text": "\u003c/b\u003e Receives and processes sensory information from the contralateral side of the body, including touch, pressure, pain, temperature, vibration"
      }, {
        "text": ", and proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives its primary input from the \u003cmark\u003eventral posterior"
      }, {
        "text": " nucleus (VPN)\u003c/mark\u003e of the [[afc0a64b|thalamus]], which is composed of the [["
      }, {
        "text": "2ae957b8|VPL]] (for the body) and [[23ac314a|"
      }, {
        "text": "VPM]] (for the face) nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopic Organization (Sensory Homunculus):\u003c/b\u003e The cortex"
      }, {
        "text": " is organized somatotopically, with different body parts represented in specific areas. The face and hands have a disproportionately large representation due"
      }, {
        "text": " to their high sensory acuity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions:\u003c/b\u003e A lesion in the primary somatosensory cortex causes contralateral"
      }, {
        "text": " sensory loss (e.g., numbness, paresthesias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the location"
      }, {
        "text": " (postcentral gyrus) and the somatotopic organization (homunculus), with the leg represented medially (supplied by ACA"
      }, {
        "text": ") and the arm/face represented laterally (supplied by MCA).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003esomatosensory cortex\u003c/b\u003e is the brain\u0027s primary \u0027touch map,\u0027 a highly organized region in the parietal lobe that receives all"
      }, {
        "text": " tactile information from the thalamus and translates it into our conscious perception of sensation from the contralateral body.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Thalamus - VPL/VPM] --\u003e B(Primary Somatosensory Cortex); B"
      }, {
        "text": " --\u003e C(Conscious Perception of Sensation);\"\n    },\n    \"connections\": [\n      {\n        \"type\":"
      }, {
        "text": " \"is_located_in\",\n        \"to\": \"parietal_lobe\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"receives_input_from\",\n        \"to\": \"afc0a64b\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_organized_as\",\n        \"to\": \"sensory_homunculus\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"cc214e1b\": {\n    \"title\": \"Sonic"
      }, {
        "text": " Hedgehog (SHH) Signaling Pathway\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Em"
      }, {
        "text": "bryology\",\n      \"Neuroscience\",\n      \"Developmental Biology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Embryology\",\n      \""
      }, {
        "text": "Neural Development\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eSonic hedgehog"
      }, {
        "text": " (SHH)\u003c/b\u003e signaling pathway is a crucial signaling pathway in embryonic development, particularly for patterning the central nervous system."
      }, {
        "text": " The SHH protein is a signaling molecule (morphogen) that acts in a concentration-dependent manner.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eFunction in Neurodevelopment:\u003c/b\u003e Secreted by the underlying \u003cmark\u003enotochord\u003c/mark"
      }, {
        "text": "\u003e, SHH acts as a ventralizing signal for the neural tube.\u003c/li\u003e\u003cli\u003e\u003cb\u003eVentralization:\u003c/b\u003e High concentrations of SHH induce the formation of"
      }, {
        "text": " the \u003cmark\u003e[[253e3efb|basal plate]]\u003c/mark\u003e, which gives rise to motor"
      }, {
        "text": " neurons in the ventral horn of the spinal cord and motor nuclei of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCounterpart Signal:\u003c/b\u003e The dorsal"
      }, {
        "text": "izing signal is \u003cmark\u003e[[869535a9|Bone Morphogenetic Protein (BMP)]]\u003c/"
      }, {
        "text": "mark\u003e, which is secreted by the ectoderm and induces the formation of the [[43be7a6e|alar"
      }, {
        "text": " plate]] (sensory neurons).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHoloprosencephaly:\u003c/b\u003e Mutations in the SHH pathway"
      }, {
        "text": " are a cause of holoprosencephaly, a severe birth defect where the forebrain fails to divide into two hemispheres"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the source and effect: SHH from the notochord (floor)"
      }, {
        "text": " induces the ventral/motor basal plate. BMP from the ectoderm (roof) induces the dorsal/sensory alar plate.\u003c/li\u003e\u003c/ul\u003e\",\n      "
      }, {
        "text": "\"takeAway\": \"\u003cp\u003e\u003cb\u003eSonic hedgehog\u003c/b\u003e is the key \u0027ventralizing\u0027 morphogen in the developing nervous"
      }, {
        "text": " system, secreted from the notochord to instruct the ventral neural tube to become the motor [[253e3efb|"
      }, {
        "text": "basal plate]], thereby establishing the fundamental motor-sensory axis of the CNS.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Notochord] --Secretes--\u003e B(SHH); B --Induces--\u003e C"
      }, {
        "text": "(Ventral Neural Tube); C --\u003e D(Basal Plate); D --\u003e E(Motor Neurons);\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"induces_development_of\",\n        \"to"
      }, {
        "text": "\": \"253e3efb\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "counteracted_by\",\n        \"to\": \"869535a9\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_secreted_by\",\n        \"to\": \"notochord"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"mutation_in_pathway_causes\",\n        \"to\": \"holop"
      }, {
        "text": "rosencephaly\"\n      }\n    ]\n  },\n  \"ce5eeda6\": {\n    \"title\":"
      }, {
        "text": " \"Spasmolytics\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \""
      }, {
        "text": "Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eSpasmolytics\u003c/b\u003e, or skeletal muscle relaxants, are a group of drugs used"
      }, {
        "text": " to alleviate symptoms associated with muscle spasticity or acute muscle spasms by acting either on the central nervous system or directly on"
      }, {
        "text": " the muscle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBaclofen:\u003c/b\u003e A GABA\u003csub\u003eB"
      }, {
        "text": "\u003c/sub\u003e receptor agonist that acts on the spinal cord to suppress hyperactive reflexes. Used for spasticity in [[45"
      }, {
        "text": "dd6d19|multiple sclerosis]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCyclobenzaprine:\u003c/b\u003e A centrally"
      }, {
        "text": " acting muscle relaxant, structurally related to TCAs. Used for acute muscle spasms from musculoskeletal conditions. Has significant antichol"
      }, {
        "text": "inergic side effects and causes sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTizanidine:\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist that inhibits"
      }, {
        "text": " motor neuron activity. Used for spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDantrolene:\u003c/b\u003e Acts directly on skeletal muscle by blocking"
      }, {
        "text": " Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum (inhibits ryanodine receptor). Used to treat malignant"
      }, {
        "text": " hyperthermia and neuroleptic malignant syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the uses: [["
      }, {
        "text": "1ddc3f08|baclofen]] and tizanidine for chronic spasticity (MS, spinal"
      }, {
        "text": " cord injury), cyclobenzaprine for acute muscle strain, and [[d67a204d|dantrolene]] for life"
      }, {
        "text": "-threatening hyperthermic syndromes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpasmolytics\u003c/b\u003e reduce"
      }, {
        "text": " muscle hyperactivity through diverse mechanisms, ranging from central GABAergic and adrenergic modulation (baclofen, tizanidine) to direct"
      }, {
        "text": " interference with muscle contraction machinery (dantrolene), the latter being crucial for treating hyperthermic emergencies.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        "
      }, {
        "text": "\"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"includes\",\n        \""
      }, {
        "text": "to\": \"cyclobenzaprine\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"d67a204d\"\n      }\n    ]\n  },\n  \"b"
      }, {
        "text": "511bc97\": {\n    \"title\": \"Spastic Paresis\",\n    \"primaryType"
      }, {
        "text": "\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Motor"
      }, {
        "text": " Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpastic pares"
      }, {
        "text": "is\u003c/b\u003e is a form of muscle weakness (paresis) combined with spasticity (increased muscle tone). It is a hallmark"
      }, {
        "text": " sign of an \u003cu\u003eupper motor neuron (UMN) lesion\u003c/u\u003e.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophys"
      }, {
        "text": "iology:\u003c/b\u003e Results from damage to the descending corticospinal tracts, which leads to a loss of inhibitory modulation on spinal"
      }, {
        "text": " reflex arcs. This results in hypertonia and hyperreflexia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients have weakness"
      }, {
        "text": ", but their muscles are stiff and resistant to passive movement (spasticity). Deep tendon reflexes are exaggerated, and a"
      }, {
        "text": " positive [[8947da55|Babinski sign]] is present.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGait:\u003c/b\u003e A"
      }, {
        "text": " spastic gait is often seen, where the legs are stiff and the feet are dragged or circumducted.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses:\u003c/b\u003e"
      }, {
        "text": " Any UMN lesion can cause spastic paresis, including [[c5da3c57|stroke]], spinal"
      }, {
        "text": " cord injury, [[45dd6d19|multiple sclerosis]], and [[171ca00b|cere"
      }, {
        "text": "bral palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Spastic paresis is a key component of the UMN syndrome. Contrast it with the fl"
      }, {
        "text": "accid paralysis seen in LMN lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpastic"
      }, {
        "text": " paresis\u003c/b\u003e is a paradoxical state of weakness combined with stiffness, resulting from an upper motor neuron lesion that removes the brain"
      }, {
        "text": "\u0027s inhibitory control over spinal reflexes, leading to hyperactive and poorly controlled muscle tone.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to"
      }, {
        "text": "\": \"upper_motor_neuron_lesion\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_characterized_by\",\n        \"to\": \"spasticity\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"is_contrasted_with\",\n        \"to\": \"953e1306\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"fbd9a4e5\": {\n    \"title\": \"Spasticity\",\n    \""
      }, {
        "text": "primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Motor Neuron Diseases\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eSpasticity\u003c/b\u003e is a motor disorder characterized by a velocity-dependent increase in muscle tone ("
      }, {
        "text": "hypertonia) and exaggerated deep tendon reflexes (hyperreflexia). It is a component of the upper motor neuron ("
      }, {
        "text": "UMN) syndrome.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by damage"
      }, {
        "text": " to the descending motor pathways (e.g., corticospinal tract) that provide inhibitory input to spinal motor neurons. The"
      }, {
        "text": " loss of this inhibition leads to hyperexcitability of the stretch reflex arc.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Signs:\u003c/b\u003e Increased"
      }, {
        "text": " muscle tone, hyperreflexia, clonus, and a positive [[8947da55|Babinski"
      }, {
        "text": " sign]]. A specific type of spasticity is \u003cmark\u003e[[ca51f29a|clasp-knife"
      }, {
        "text": " spasticity]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Seen in UMN lesions such as [[c5da3c5"
      }, {
        "text": "7|stroke]], spinal cord injury, [[45dd6d19|multiple sclerosis]], and [[171ca00b"
      }, {
        "text": "|cerebral palsy]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Can be managed with physical therapy and spasmolytic medications like [[1"
      }, {
        "text": "ddc3f08|baclofen]], tizanidine, or [[1446461"
      }, {
        "text": "7|benzodiazepines]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Spasticity is a key sign that localizes a"
      }, {
        "text": " lesion to the upper motor neuron.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpasticity\u003c/b\u003e"
      }, {
        "text": " is a state of muscular hypertonia resulting from the disinhibition of spinal reflexes after an upper motor neuron injury, leading to stiff"
      }, {
        "text": ", overactive muscles.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_sign_of\",\n        \"to\": \"upper_motor_neuron_"
      }, {
        "text": "lesion\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"ca"
      }, {
        "text": "51f29a\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\":"
      }, {
        "text": " \"af72aab5\"\n      }\n    ]\n  },\n  \"805115af"
      }, {
        "text": "\": {\n    \"title\": \"Special Senses\",\n    \"primaryType\": \"concept\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"General"
      }, {
        "text": " Principles\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003especial senses\u003c/b\u003e"
      }, {
        "text": " are the senses that have specialized organs devoted to them. They include vision, hearing (audition), balance (equilibrium), taste"
      }, {
        "text": " (gustation), and smell (olfaction).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVision:\u003c/b\u003e"
      }, {
        "text": " Detected by photoreceptors in the retina; transmitted by the optic nerve (CN II).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHearing \u0026 Balance:\u003c/b\u003e Detected by hair"
      }, {
        "text": " cells in the [[001c359f|cochlea]] and vestibular apparatus, respectively; transmitted by the [[6f"
      }, {
        "text": "ded3e7|vestibulocochlear nerve (CN VIII)]]. The field of study is [[c5a"
      }, {
        "text": "1d2fc|otology]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eTaste:\u003c/b\u003e Detected by taste buds; transmitted by CN VII,"
      }, {
        "text": " IX, and X.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSmell:\u003c/b\u003e Detected by olfactory receptors in the nasal epithelium; transmitted by the olfactory nerve ("
      }, {
        "text": "CN I). It is the only sense that does not relay through the thalamus.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGeneral Senses:\u003c/b\u003e This"
      }, {
        "text": " contrasts with the general senses (somatic senses), which include touch, temperature, pain, and proprioception, whose receptors are distributed throughout the body.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the cranial nerves associated with each special sense.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003especial senses\u003c/b\u003e are our sophisticated sensory systems for perceiving the external world, each with a"
      }, {
        "text": " dedicated organ and a specific cranial nerve pathway to the brain.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"vision\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"hearing\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"taste\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"includes\",\n        \"to\": \"smell\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"63014ebc\": {\n    \"title\": \"Spina Bifida Occ"
      }, {
        "text": "ulta\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Pediatrics"
      }, {
        "text": "\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpina bifida occulta\u003c/b\u003e is the mildest and"
      }, {
        "text": " most common form of spina bifida, a type of neural tube defect. It is characterized by a failure of the vertebral arches to fuse"
      }, {
        "text": ", typically in the lumbosacral region, without herniation of the spinal cord or meninges.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e A failure of the caudal neuropore to close completely, resulting"
      }, {
        "text": " in a bony defect of the vertebral arch. The spinal cord and meninges remain in their normal position.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " It is often asymptomatic and discovered incidentally on imaging. The term \u0027occulta\u0027 means hidden.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCut"
      }, {
        "text": "aneous Signs:\u003c/b\u003e The site of the bony defect may be marked by a patch of hair, a dimple, a birth"
      }, {
        "text": "mark, or a lipoma on the overlying skin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurological Deficits:\u003c/b\u003e Usually, there are no neurological deficits."
      }, {
        "text": " Rarely, it can be associated with a tethered cord syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A tuft of hair or"
      }, {
        "text": " a dimple over the lower back in an otherwise asymptomatic infant is the classic presentation of spina bifida occulta."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSpina bifida occulta\u003c/b\u003e is a \u0027hidden\u0027 neural tube defect where"
      }, {
        "text": " the only sign of the underlying vertebral anomaly is often a small patch of hair or a dimple on the lower back, with"
      }, {
        "text": " the spinal cord itself being unaffected.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"spina_bifida"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"neural_tube_defect\"\n      }\n    ]\n  },\n  \"377"
      }, {
        "text": "937be\": {\n    \"title\": \"Spinal Cord\",\n    \"primaryType\": \"anatomy\",\n    \""
      }, {
        "text": "tags\": [\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],"
      }, {
        "text": "\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003espinal cord\u003c/b\u003e is a long, thin"
      }, {
        "text": ", tubular structure made up of nervous tissue, which extends from the medulla oblongata in the brainstem to the lumbar region of the vertebral column."
      }, {
        "text": " It is the main pathway for information connecting the brain and peripheral nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Structure:\u003c/b\u003e Composed of central gray matter (containing neuron cell bodies) surrounded by outer white matter (containing myelinated axon"
      }, {
        "text": " tracts).\u003c/li\u003e\u003cli\u003e\u003cb\u003eLower Extent:\u003c/b\u003e In adults, the spinal cord terminates at the L1-L2 vertebral"
      }, {
        "text": " level as the \u003cmark\u003econus medullaris\u003c/mark\u003e. The nerve roots below this form the [[1c"
      }, {
        "text": "4d7e8f|cauda equina]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Tracts:\u003c/b\u003e Contains major ascending ("
      }, {
        "text": "sensory) and descending (motor) tracts, including the [[fb0a5fdc|corticospinal tracts]],"
      }, {
        "text": " [[e7f5cbbe|dorsal columns]], and [[07eecef1|spinothalamic tracts]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eSp"
      }, {
        "text": "inal Reflexes:\u003c/b\u003e Mediates reflexes independently of the brain via reflex arcs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesions/Syndromes:\u003c/b\u003e Damage"
      }, {
        "text": " to the spinal cord results in specific syndromes based on the location and extent of the lesion (e.g., [[4"
      }, {
        "text": "792bc68|Brown-S√©quard syndrome]], [[b48b54d7|anterior"
      }, {
        "text": " spinal artery syndrome]], [[d2b8e10c|syringomyelia]]).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Understanding the cross-sectional anatomy of the spinal cord, including the location of the major tracts and their decussation points, is essential for local"
      }, {
        "text": "izing lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003espinal cord\u003c/b\u003e is the critical"
      }, {
        "text": " information highway of the body, containing precisely organized tracts that carry motor commands down from the brain and sensory information up to it"
      }, {
        "text": ", while also managing local reflexes independently.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_part_of\",\n        \"to\": \"central_nervous_system\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"contains\",\n        \"to\": \"8aa8156"
      }, {
        "text": "f\"\n      },\n      {\n        \"type\": \"mediates\",\n        \"to\": \"7"
      }, {
        "text": "6044e89\"\n      },\n      {\n        \"type\": \"lesion_causes"
      }, {
        "text": "\",\n        \"to\": \"84a88b78\"\n      }\n    ]\n  },\n  \"8"
      }, {
        "text": "4a88b78\": {\n    \"title\": \"Spinal Cord Lesions/Syndromes\",\n    \"primary"
      }, {
        "text": "Type\": \"concept\",\n    \"tags\": [\n      \"Neurology\",\n      \"Pathology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Pathology\",\n      \"Spinal Cord Lesions\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSpinal cord lesions/syndromes\u003c/b\u003e are distinct patterns of neurological"
      }, {
        "text": " deficits that result from damage to specific areas or tracts within the spinal cord. The clinical presentation allows for precise anatomical localization of the lesion.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[4792bc68|Brown-S√©quard"
      }, {
        "text": " Syndrome]]:\u003c/b\u003e Hemisection of the cord. Ipsilateral UMN signs and loss of proprioception/vibration below the lesion; contralateral"
      }, {
        "text": " loss of pain/temperature below the lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[b48b54d7|Anterior Spinal Ar"
      }, {
        "text": "tery Syndrome]]:\u003c/b\u003e Infarct of the anterior 2/3 of the cord. Bilateral loss of motor function and pain"
      }, {
        "text": "/temperature below the lesion, with \u003cmark\u003espared dorsal columns\u003c/mark\u003e (proprioception/vibration).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[d2"
      }, {
        "text": "b8e10c|Syringomyelia]]:\u003c/b\u003e Cystic lesion of the central canal. Causes a bilateral,"
      }, {
        "text": " \u0027cape-like\u0027 loss of pain and temperature in the upper extremities (damage to anterior white commissure).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[6"
      }, {
        "text": "f5bea90|Subacute Combined Degeneration]]:\u003c/b\u003e Due to B\u003csub\u003e12\u003c/sub\u003e deficiency. Demyelination of dorsal"
      }, {
        "text": " columns, lateral corticospinal tracts, and spinocerebellar tracts.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[71daebd6|Tab"
      }, {
        "text": "es Dorsalis]]:\u003c/b\u003e Tertiary syphilis. Degeneration of dorsal columns and dorsal roots.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[45dd6d19|"
      }, {
        "text": "Multiple Sclerosis]]:\u003c/b\u003e Can cause random, asymmetric demyelinating plaques anywhere in the spinal cord white matter.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e These syndromes are a classic test of your knowledge of spinal cord tract anatomy and function. Draw out the cross-section and"
      }, {
        "text": " trace the pathways to solve problems.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe predictable organization of the spinal cord\u0027"
      }, {
        "text": "s tracts means that specific patterns of injury, or \u003cb\u003espinal cord syndromes\u003c/b\u003e, produce highly characteristic and localizable clinical"
      }, {
        "text": " deficits, making them a favorite topic for testing neuroanatomical knowledge.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"4792bc68\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"b48b"
      }, {
        "text": "54d7\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\":"
      }, {
        "text": " \"d2b8e10c\"\n      },\n      {\n        \"type\": \"includes\","
      }, {
        "text": "\n        \"to\": \"6f5bea90\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"692e674f\": {\n    \"title\": \"Spinal Dysraphism\",\n    \"primaryType"
      }, {
        "text": "\": \"disease\",\n    \"tags\": [\n      \"Embryology\",\n      \"Pediatrics\",\n      \"Neu"
      }, {
        "text": "rology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Embryology\",\n      \"Neural Tube Defects\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eSpinal dysraphism\u003c/b\u003e refers to a group of congenital malformations of the spinal cord and vertebral"
      }, {
        "text": " column resulting from the incomplete closure of the neural tube during embryonic development (neurulation). These are also known as neural tube defects of"
      }, {
        "text": " the spine.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the caudal ("
      }, {
        "text": "posterior) neuropore to close during the 4th week of gestation. Associated with maternal folate deficiency.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Types:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[63014ebc|Spina Bifida Occulta]]:\u003c/b\u003e Mild"
      }, {
        "text": "est form. Failure of vertebral arch fusion, with no herniation of neural tissue. Often asymptomatic, may have an overlying skin dim"
      }, {
        "text": "ple or tuft of hair.\u003cbr\u003e - \u003cb\u003eMeningocele:\u003c/b\u003e Herniation of the meninges ("
      }, {
        "text": "but not the spinal cord) through the bony defect, forming a CSF-filled sac.\u003cbr\u003e - \u003cb\u003eMy"
      }, {
        "text": "elomeningocele:\u003c/b\u003e Most severe form. Herniation of both the meninges and the spinal cord through the defect"
      }, {
        "text": ". Almost always associated with neurological deficits below the level of the lesion and a [[b96a6a07|Chiari II malformation]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Detected prenatally by elevated maternal serum alpha-fetoprotein (AFP) and ultrasound.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Differentiate the types based on what is herniating: Occulta \u003d nothing, Meningocele \u003d meninges only"
      }, {
        "text": ", Myelomeningocele \u003d meninges + spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eSpinal dysraphism\u003c/b\u003e is a spectrum of birth defects resulting from failed closure of the spinal neural tube, ranging from the"
      }, {
        "text": " hidden bony defect of spina bifida occulta to the devastating paralysis associated with a myelomeningocele.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "is_a_type_of\",\n        \"to\": \"neural_tube_defect\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"63014ebc\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"meningocele\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"myelomeningoce"
      }, {
        "text": "le\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"f844c0eb\",\n    \"letter\": \"S\",\n    \"term\": \"Satiety/hunger regulation\",\n    \"pages\": [\n      \"508\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Satiety/hunger regulation\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"5b8cd0c3\",\n    \"letter\": \"S\",\n    \"term\": \"Schizophrenia\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Schizophrenia\",\n    \"sub_entries\": [\n      {\n        \"id\": \"f3ef4119\",\n        \"letter\": \"S\",\n        \"term\": \"neurotransmitter changes with\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Schizophrenia \u003e neurotransmitter changes with\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c65a8909\",\n    \"letter\": \"S\",\n    \"term\": \"Schwann cells\",\n    \"pages\": [\n      \"503\",\n      \"538\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Schwann cells\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"03ecb69e\",\n    \"letter\": \"S\",\n    \"term\": \"Schwannomas\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Schwannomas\",\n    \"sub_entries\": [\n      {\n        \"id\": \"559f50e6\",\n        \"letter\": \"S\",\n        \"term\": \"characteristics and histology\",\n        \"pages\": [\n          \"540\"\n        ],\n        \"context\": \"Schwannomas \u003e characteristics and histology\"\n      },\n      {\n        \"id\": \"0e125ce0\",\n        \"letter\": \"S\",\n        \"term\": \"in neurofibromatosis\",\n        \"pages\": [\n          \"539\"\n        ],\n        \"context\": \"Schwannomas \u003e in neurofibromatosis\"\n      }\n    ]\n  },\n  {\n    \"id\": \"cca074cc\",\n    \"letter\": \"S\",\n    \"term\": \"Seizures\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Seizures\",\n    \"sub_entries\": [\n      {\n        \"id\": \"aedaf958\",\n        \"letter\": \"S\",\n        \"term\": \"benzodiazepine withdrawal\",\n        \"pages\": [\n          \"562\"\n        ],\n        \"context\": \"Seizures \u003e benzodiazepine withdrawal\"\n      },\n      {\n        \"id\": \"f3e8786b\",\n        \"letter\": \"S\",\n        \"term\": \"febrile\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Seizures \u003e febrile\"\n      },\n      {\n        \"id\": \"eff946f6\",\n        \"letter\": \"S\",\n        \"term\": \"types and phases of\",\n        \"pages\": [\n          \"531\"\n        ],\n        \"context\": \"Seizures \u003e types and phases of\"\n      }\n    ]\n  },\n  {\n    \"id\": \"fe2db5f3\",\n    \"letter\": \"S\",\n    \"term\": \"Selective dorsal rhizotomy\",\n    \"pages\": [\n      \"545\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Selective dorsal rhizotomy\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"227f8980\",\n    \"letter\": \"S\",\n    \"term\": \"Selegiline\",\n    \"pages\": [\n      \"563\",\n      \"593\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Selegiline\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"4b693ef1\",\n    \"letter\": \"S\",\n    \"term\": \"Sensorineural hearing loss\",\n    \"pages\": [\n      \"312\",\n      \"548\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Sensorineural hearing loss\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1c324451\",\n    \"letter\": \"S\",\n    \"term\": \"Sensory cortex\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sensory cortex\",\n    \"sub_entries\": [\n      {\n        \"id\": \"118b0203\",\n        \"letter\": \"S\",\n        \"term\": \"stroke effects in\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Sensory cortex \u003e stroke effects in\"\n      },\n      {\n        \"id\": \"82cb33ec\",\n        \"letter\": \"S\",\n        \"term\": \"topographic representation\",\n        \"pages\": [\n          \"513\"\n        ],\n        \"context\": \"Sensory cortex \u003e topographic representation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"e60ae264\",\n    \"letter\": \"S\",\n    \"term\": \"Sensory loss\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sensory loss\",\n    \"sub_entries\": [\n      {\n        \"id\": \"439eb52f\",\n        \"letter\": \"S\",\n        \"term\": \"Brown-S√©quard syndrome\",\n        \"pages\": [\n          \"545\"\n        ],\n        \"context\": \"Sensory loss \u003e Brown-S√©quard syndrome\"\n      },\n      {\n        \"id\": \"c9b494a4\",\n        \"letter\": \"S\",\n        \"term\": \"stroke effects\",\n        \"pages\": [\n          \"526\"\n        ],\n        \"context\": \"Sensory loss \u003e stroke effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"c50d4c25\",\n    \"letter\": \"S\",\n    \"term\": \"Sensory modalities/pathways,\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sensory modalities/pathways,\",\n    \"sub_entries\": [\n      {\n        \"id\": \"769b0588\",\n        \"letter\": \"S\",\n        \"term\": \"thalamus in\",\n        \"pages\": [\n          \"508\"\n        ],\n        \"context\": \"Sensory modalities/pathways, \u003e thalamus in\"\n      }\n    ]\n  },\n  {\n    \"id\": \"6d676aba\",\n    \"letter\": \"S\",\n    \"term\": \"Sensory receptors, fiber type, location\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Sensory receptors, fiber type, location\",\n    \"sub_entries\": [\n      {\n        \"id\": \"3d8ad660\",\n        \"letter\": \"S\",\n        \"term\": \"and modality\",\n        \"pages\": [\n          \"504\"\n        ],\n        \"context\": \"Sensory receptors, fiber type, location \u003e and modality\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5d3c2089\",\n    \"letter\": \"S\",\n    \"term\": \"Serotonin\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Serotonin\",\n    \"sub_entries\": [\n      {\n        \"id\": \"adc84b9a\",\n        \"letter\": \"S\",\n        \"term\": \"synthesis and change with diseases\",\n        \"pages\": [\n          \"505\"\n        ],\n        \"context\": \"Serotonin \u003e synthesis and change with diseases\"\n      },\n      {\n        \"id\": \"25b095ff\",\n        \"letter\": \"S\",\n        \"term\": \"vomiting center input\",\n        \"pages\": [\n          \"506\"\n        ],\n        \"context\": \"Serotonin \u003e vomiting center input\"\n      }\n    ]\n  },\n  {\n    \"id\": \"b9835e21\",\n    \"letter\": \"S\",\n    \"term\": \"Sevoflurane\",\n    \"pages\": [\n      \"565\",\n      \"566\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Sevoflurane\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"b7950295\",\n    \"letter\": \"S\",\n    \"term\": \"Skeletal muscle relaxants\",\n    \"pages\": [\n      \"567\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Skeletal muscle relaxants\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 2227
    }, {
      "text": "```json\n{\n  \"f844c0eb\": {\n    \"title\": \"Satiety and Hunger Regulation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Endocrinology\",\n      \"Neurophysiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Appetite Regulation\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSatiety and hunger regulation\u003c/b\u003e is a complex neurohormonal process, primarily controlled by the [[89e86633|hypothalamus]], which integrates peripheral signals from the gut and adipose tissue to balance energy intake and expenditure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypothalamic Centers:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[lateral_hypothalamic_nucleus|Lateral Hypothalamus]]:\u003c/b\u003e The \u003cmark\u003ehunger center\u003c/mark\u003e. Stimulation induces hunger. A lesion leads to anorexia. Mnemonic: A lesion to the \u003cb\u003eL\u003c/b\u003eateral nucleus makes you \u003cb\u003eL\u003c/b\u003eean.\u003cbr\u003e - \u003cb\u003e[[d662ec5d|Ventromedial Hypothalamus]]:\u003c/b\u003e The \u003cmark\u003esatiety center\u003c/mark\u003e. Stimulation induces satiety. A lesion leads to hyperphagia and obesity. Mnemonic: A lesion to the \u003cb\u003eV\u003c/b\u003eentro\u003cb\u003eM\u003c/b\u003eedial nucleus makes you \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003eassive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey Hormones:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLeptin:\u003c/b\u003e A satiety hormone released from adipose tissue. It acts on the hypothalamus to suppress appetite.\u003cbr\u003e - \u003cb\u003e[[a2cba303|Ghrelin]]:\u003c/b\u003e A hunger hormone released from the stomach. It acts on the hypothalamus to stimulate appetite.\u003cbr\u003e - \u003cb\u003eInsulin:\u003c/b\u003e Acts as a satiety signal in the CNS.\u003cbr\u003e - \u003cb\u003ePYY, CCK:\u003c/b\u003e Gut hormones that act as short-term satiety signals.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the roles of the lateral and ventromedial hypothalamus and the primary functions of leptin (satiety) and ghrelin (hunger).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe regulation of hunger and satiety is a delicate balance orchestrated by the hypothalamus, which weighs the \u0027eat now\u0027 signal from ghrelin against the \u0027stop eating\u0027 signals from leptin and other gut hormones to maintain energy homeostasis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Leptin] --\u003e B(Ventromedial Hypothalamus); B --\u003e C(Satiety); D[Ghrelin] --\u003e E(Lateral Hypothalamus); E --\u003e F(Hunger);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"leptin\"\n      },\n      {\n        \"type\": \"is_regulated_by\",\n        \"to\": \"a2cba303\"\n      }\n    ]\n  },\n  \"5b8cd0c3\": {\n    \"title\": \"Schizophrenia\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Neurology\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Pathology\",\n      \"Psychotic Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSchizophrenia\u003c/b\u003e is a chronic, severe mental disorder that affects how a person thinks, feels, and behaves. It is characterized by a breakdown in the relation between thought, emotion, and behavior, leading to faulty perception, inappropriate actions and feelings, and withdrawal from reality into fantasy and delusion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Changes:\u003c/b\u003e The primary hypothesis involves \u003cmark\u003eexcessive dopaminergic activity\u003c/mark\u003e in the brain. Specifically, the \u003cmark\u003emesolimbic pathway\u003c/mark\u003e is thought to be hyperactive (causing positive symptoms), while the \u003cmark\u003emesocortical pathway\u003c/mark\u003e is thought to be hypoactive (causing negative and cognitive symptoms).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePositive Symptoms:\u003c/b\u003e Hallucinations (especially auditory), delusions, disorganized speech and behavior.\u003cbr\u003e - \u003cb\u003eNegative Symptoms:\u003c/b\u003e Flat affect, anhedonia, avolition (apathy), alogia (poverty of speech).\u003cbr\u003e - \u003cb\u003eCognitive Symptoms:\u003c/b\u003e Impaired executive function, attention, and working memory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Requires ‚â•2 characteristic symptoms for at least 1 month, with continuous signs of disturbance for at least 6 months.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Antipsychotic medications, which primarily act as dopamine D\u003csub\u003e2\u003c/sub\u003e receptor antagonists, are the mainstay of treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The dopamine hypothesis is key. Positive symptoms are due to too much dopamine in the mesolimbic pathway, while negative symptoms are due to too little dopamine in the mesocortical pathway.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSchizophrenia\u003c/b\u003e is a complex disorder of thought and perception fundamentally linked to dysregulated dopamine signaling, with an excess in the mesolimbic pathway driving psychosis and a deficit in the mesocortical pathway contributing to negative symptoms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Dopamine in Mesolimbic Pathway] --\u003e B(Positive Symptoms); C[‚Üì Dopamine in Mesocortical Pathway] --\u003e D(Negative Symptoms);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"psychotic_disorder\"\n      },\n      {\n        \"type\": \"involves_dysregulation_of\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"antipsychotics\"\n      }\n    ]\n  },\n  \"c65a8909\": {\n    \"title\": \"Schwann Cells\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSchwann cells\u003c/b\u003e are the principal glial cells of the peripheral nervous system (PNS). Their main function is to myelinate the axons of peripheral nerves, which is essential for rapid, saltatory conduction of nerve impulses.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Derived from the [[14c6f2a7|neural crest]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Myelinate axons in the PNS. A single Schwann cell myelinates \u003cmark\u003eonly one segment of a single axon\u003c/mark\u003e. They also provide support for unmyelinated axons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegeneration:\u003c/b\u003e Schwann cells play a crucial role in the regeneration of damaged peripheral nerves by forming a \u0027regeneration tube\u0027 (band of B√ºngner) that guides the regrowing axon.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[ed52e40b|Guillain-Barr√© Syndrome]]:\u003c/b\u003e An autoimmune attack on Schwann cells and their myelin.\u003cbr\u003e - \u003cb\u003e[[c3f13d85|Charcot-Marie-Tooth Disease]]:\u003c/b\u003e A group of hereditary neuropathies often involving mutations in genes related to Schwann cell/myelin function.\u003cbr\u003e - \u003cb\u003e[[03ecb69e|Schwannoma]]:\u003c/b\u003e A benign tumor of Schwann cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison to Oligodendrocytes:\u003c/b\u003e [[a24f9747|Oligodendrocytes]] myelinate axons in the CNS. One oligodendrocyte can myelinate multiple axons, and they do not effectively support regeneration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the \u0027one-to-one\u0027 rule for Schwann cells: one cell per axon segment. This is a key difference from oligodendrocytes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSchwann cells\u003c/b\u003e are the dedicated myelinators of the peripheral nervous system, wrapping individual axon segments to ensure fast nerve conduction and, crucially, providing the supportive scaffold necessary for nerve regeneration after injury.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0bd25f41\"\n      },\n      {\n        \"type\": \"myelinates_axons_in\",\n        \"to\": \"peripheral_nervous_system\"\n      },\n      {\n        \"type\": \"is_damaged_in\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"is_cell_of_origin_for\",\n        \"to\": \"03ecb69e\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a24f9747\"\n      }\n    ]\n  },\n  \"03ecb69e\": {\n    \"title\": \"Schwannoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Oncology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eschwannoma\u003c/b\u003e is a benign, encapsulated tumor that arises from [[c65a8909|Schwann cells]], the myelin-forming cells of the peripheral nervous system. The most common type is the [[11946667|vestibular schwannoma]] (acoustic neuroma).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCell of Origin:\u003c/b\u003e Arises from [[c65a8909|Schwann cells]]. The tumor cells are \u003cmark\u003eS-100 positive\u003c/mark\u003e on immunohistochemistry.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Can occur on any peripheral or cranial nerve (except CN I and II, which are myelinated by oligodendrocytes). Most commonly affects the vestibular branch of CN VIII at the \u003cmark\u003ecerebellopontine angle\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Characterized by a biphasic pattern:\u003cbr\u003e - \u003cb\u003eAntoni A:\u003c/b\u003e Dense, hypercellular areas with spindle cells arranged in palisading patterns (Verocay bodies).\u003cbr\u003e - \u003cb\u003eAntoni B:\u003c/b\u003e Hypocellular, myxoid areas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 2 (NF-2):\u003c/b\u003e The presence of \u003cmark\u003ebilateral vestibular schwannomas\u003c/mark\u003e is pathognomonic for NF-2, an autosomal dominant disorder caused by a mutation in the \u003ci\u003eNF2\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A tumor at the cerebellopontine angle that is S-100 positive is a schwannoma. If bilateral, the diagnosis is NF-2.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eschwannoma\u003c/b\u003e is a benign tumor of Schwann cells, most famously occurring as a vestibular schwannoma at the cerebellopontine angle, and is histologically identified by its biphasic Antoni A and B patterns and S-100 positivity.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"arises_from\",\n        \"to\": \"c65a8909\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"neurofibromatosis_type_2\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"11946667\"\n      },\n      {\n        \"type\": \"expresses_marker\",\n        \"to\": \"s100\"\n      }\n    ]\n  },\n  \"cca074cc\": {\n    \"title\": \"Seizures\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eseizure\u003c/b\u003e is a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain. [[64c08e92|Epilepsy]] is a disease characterized by a predisposition to recurrent, unprovoked seizures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhases:\u003c/b\u003e A seizure may have an ictal phase (the event itself) and a postictal phase (a period of confusion or drowsiness after the seizure). An aura may precede the seizure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassification:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[953ad620|Focal Seizures]]:\u003c/b\u003e Originate in one hemisphere. Can be aware or have impaired awareness.\u003cbr\u003e - \u003cb\u003e[[2e7554b7|Generalized Seizures]]:\u003c/b\u003e Involve both hemispheres from the outset. Include tonic-clonic, absence, myoclonic, and atonic types.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[12108f05|Febrile Seizures]]:\u003c/b\u003e Common in children aged 6 months to 5 years, triggered by fever. Simple febrile seizures are benign and do not constitute epilepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStatus Epilepticus:\u003c/b\u003e A seizure lasting \u003e5 minutes or recurrent seizures without recovery in between. This is a medical emergency. First-line treatment is IV [[14464617|benzodiazepines]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eWithdrawal:\u003c/b\u003e Abrupt cessation of CNS depressants, particularly alcohol and [[14464617|benzodiazepines]], is a common cause of provoked seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The clinical description of the seizure is key to its classification, which in turn guides the choice of anticonvulsant medication.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eseizure\u003c/b\u003e is a \u0027short circuit\u0027 in the brain\u0027s electrical activity, and its classification into focal or generalized types based on its origin and spread is the cornerstone of diagnosis and treatment.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \"to\": \"64c08e92\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"953ad620\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"2e7554b7\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"12108f05\"\n      },\n      {\n        \"type\": \"can_be_caused_by_withdrawal_from\",\n        \"to\": \"14464617\"\n      }\n    ]\n  },\n  \"fe2db5f3\": {\n    \"title\": \"Selective Dorsal Rhizotomy\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Neurosurgery\",\n      \"Pediatrics\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Surgical Procedures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSelective dorsal rhizotomy (SDR)\u003c/b\u003e is a neurosurgical procedure used to reduce spasticity in the lower limbs, most commonly in children with spastic diplegic [[171ca00b|cerebral palsy]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGoal:\u003c/b\u003e To permanently reduce muscle spasticity and improve gait and motor function.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProcedure:\u003c/b\u003e Involves surgically identifying and sectioning (cutting) a portion of the dorsal (sensory) nerve roots in the lumbosacral spine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Spasticity is caused by a hyperexcitable stretch reflex arc. By cutting the sensory nerve rootlets that are firing abnormally, the procedure interrupts the afferent limb of the reflex arc, thereby reducing the spastic motor response.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Selection:\u003c/b\u003e Typically performed in children with spastic diplegic [[171ca00b|cerebral palsy]] who have good underlying muscle strength but whose function is limited by spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the rationale for SDR: it targets the sensory (afferent) side of the spinal reflex arc to reduce the motor (efferent) output that causes spasticity.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSelective dorsal rhizotomy\u003c/b\u003e is a neurosurgical procedure that alleviates spasticity by selectively cutting the sensory nerve rootlets that are sending abnormal signals, effectively turning down the \u0027volume\u0027 on the hyperactive stretch reflexes that cause muscle stiffness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Stretched Muscle] --\u003e B(Sensory Afferent - Dorsal Root); B --x C(Selective Dorsal Rhizotomy); C --x D(Spinal Cord); D --x E(Motor Efferent); E --x F(Spastic Contraction);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"spasticity\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"171ca00b\"\n      },\n      {\n        \"type\": \"involves_sectioning_of\",\n        \"to\": \"dorsal_nerve_roots\"\n      }\n    ]\n  },\n  \"227f8980\": {\n    \"title\": \"Selegiline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSelegiline\u003c/b\u003e is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B). It is used in the treatment of [[58c8ea03|Parkinson disease]] and, in a transdermal patch formulation, for major depressive disorder.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Selectively and irreversibly inhibits MAO-B, the enzyme that primarily metabolizes [[90adc821|dopamine]] in the brain. This increases the levels of dopamine in the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Used as an adjunct to [[541cd176|levodopa/carbidopa]] to help with motor fluctuations (\u0027wearing-off\u0027 phenomenon) by prolonging the effect of dopamine. It can also be used as monotherapy in early disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelectivity:\u003c/b\u003e At standard doses, it is selective for MAO-B over MAO-A (which metabolizes serotonin and norepinephrine). This reduces the risk of hypertensive crisis (\u0027cheese effect\u0027) compared to non-selective MAOIs. However, at high doses, it can lose its selectivity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Insomnia (as it can be metabolized to amphetamine-like substances), confusion, and hallucinations. Risk of serotonin syndrome if combined with serotonergic drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Selegiline and rasagiline are the two main MAO-B inhibitors for Parkinson\u0027s. Their mechanism is to prevent the breakdown of dopamine in the brain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSelegiline\u003c/b\u003e helps in Parkinson\u0027s disease by selectively blocking MAO-B, the enzyme that degrades dopamine in the brain, thereby preserving the limited dopamine supply and extending the effectiveness of levodopa therapy.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Dopamine] --MAO-B--\u003e B(DOPAC - Inactive); C[Selegiline] --x B;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"mao_b_inhibitor\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"9a0f5ba6\"\n      },\n      {\n        \"type\": \"inhibits_breakdown_of\",\n        \"to\": \"90adc821\"\n      }\n    ]\n  },\n  \"4b693ef1\": {\n    \"title\": \"Sensorineural Hearing Loss\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Otology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSensorineural hearing loss (SNHL)\u003c/b\u003e is a type of hearing impairment that results from damage to the inner ear (cochlea) or to the nerve pathways from the inner ear to the brain (vestibulocochlear nerve, CN VIII).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by damage to the sensory hair cells in the cochlea or to the auditory nerve itself. This impairs the transduction of sound vibrations into neural signals or the transmission of those signals to the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[presbycusis|Presbycusis]]:\u003c/b\u003e Age-related hearing loss (most common cause).\u003cbr\u003e - \u003cb\u003eNoise-induced hearing loss:\u003c/b\u003e Damage to hair cells from excessive noise exposure.\u003cbr\u003e - \u003cb\u003eOtotoxic drugs:\u003c/b\u003e Aminoglycosides, loop diuretics, cisplatin.\u003cbr\u003e - \u003cb\u003e[[11946667|Vestibular schwannoma]]:\u003c/b\u003e Tumor compressing CN VIII.\u003cbr\u003e - \u003cb\u003eCongenital infections:\u003c/b\u003e e.g., CMV.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTuning Fork Tests:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eRinne Test:\u003c/b\u003e \u003cmark\u003eNormal\u003c/mark\u003e. Air conduction (AC) is greater than bone conduction (BC) in both ears, but hearing is diminished overall in the affected ear.\u003cbr\u003e - \u003cb\u003eWeber Test:\u003c/b\u003e Sound \u003cmark\u003elateralizes to the unaffected (good) ear\u003c/mark\u003e, because the damaged nerve cannot transmit the sound signal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the tuning fork results: In SNHL, the Weber test lateralizes to the good ear, and the Rinne test is normal (AC \u003e BC).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSensorineural hearing loss\u003c/b\u003e is a \u0027wiring problem\u0027 of the ear, where damage to the delicate hair cells of the cochlea or the auditory nerve prevents sound from being properly converted into or transmitted as a neural signal, in contrast to the \u0027plumbing problem\u0027 of conductive hearing loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"hearing_loss\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"2b500647\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"presbycusis\"\n      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"11946667\"\n      }\n    ]\n  },\n  \"1c324451\": {\n    \"title\": \"Sensory Cortex\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Cerebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eprimary somatosensory cortex\u003c/b\u003e (S1) is the main cortical area for processing tactile information from the body. It is located in the postcentral gyrus of the parietal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Postcentral gyrus of the parietal lobe (Brodmann areas 1, 2, and 3).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Receives and processes sensory information from the contralateral side of the body, including touch, pressure, pain, temperature, vibration, and proprioception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives its primary input from the \u003cmark\u003eventral posterior nucleus (VPN)\u003c/mark\u003e of the [[afc0a64b|thalamus]], which is composed of the [[2ae957b8|VPL]] (for the body) and [[23ac314a|VPM]] (for the face) nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopic Organization (Sensory Homunculus):\u003c/b\u003e The cortex is organized somatotopically, with different body parts represented in specific areas. The face and hands have a disproportionately large representation due to their high sensory acuity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Effects:\u003c/b\u003e A lesion in the primary somatosensory cortex causes contralateral sensory loss (e.g., numbness, paresthesias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the location (postcentral gyrus) and the somatotopic representation (homunculus), with the leg represented medially (supplied by ACA) and the arm/face represented laterally (supplied by MCA).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003esomatosensory cortex\u003c/b\u003e is the brain\u0027s primary \u0027touch map,\u0027 a highly organized region in the parietal lobe that receives all tactile information from the thalamus and translates it into our conscious perception of sensation from the contralateral body.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Thalamus - VPL/VPM] --\u003e B(Primary Somatosensory Cortex); B --\u003e C(Conscious Perception of Sensation);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"ed7d43ca\"\n      },\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"parietal_lobe\"\n      },\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"afc0a64b\"\n      },\n      {\n        \"type\": \"is_organized_as\",\n        \"to\": \"sensory_homunculus\"\n      }\n    ]\n  },\n  \"e60ae264\": {\n    \"title\": \"Sensory Loss\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSensory loss\u003c/b\u003e is a deficit in one or more of the sensory modalities (e.g., touch, pain, temperature, vibration, proprioception). The pattern of sensory loss is a critical clue for localizing lesions within the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePeripheral Neuropathy:\u003c/b\u003e Typically causes a \u0027glove and stocking\u0027 pattern of sensory loss, affecting the distal extremities first.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiculopathy:\u003c/b\u003e Sensory loss in a dermatomal pattern.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinal Cord Lesions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[4792bc68|Brown-S√©quard Syndrome]]:\u003c/b\u003e Ipsilateral loss of proprioception/vibration and contralateral loss of pain/temperature below the lesion.\u003cbr\u003e - \u003cb\u003e[[d2b8e10c|Syringomyelia]]:\u003c/b\u003e \u0027Cape-like\u0027 bilateral loss of pain/temperature in the upper extremities.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Lesions:\u003c/b\u003e Often cause \u0027crossed\u0027 sensory loss (e.g., ipsilateral face, contralateral body), as seen in lateral medullary or pontine syndromes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Lesions:\u003c/b\u003e Cause contralateral sensory loss of all modalities in the face, arm, and leg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCortical Lesions:\u003c/b\u003e Cause contralateral sensory loss, often with deficits in discriminative sensation (e.g., graphesthesia, stereognosis). Stroke effects depend on the vascular territory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating between a dorsal column pattern (loss of vibration/proprioception) and a spinothalamic pattern (loss of pain/temperature) is fundamental to localizing CNS lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe specific pattern of \u003cb\u003esensory loss\u003c/b\u003e‚Äîwhether it follows a dermatome, a \u0027glove and stocking\u0027 distribution, or a dissociated pattern in the spinal cord‚Äîprovides a precise roadmap for pinpointing the location of a neurological lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"4792bc68\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"peripheral_neuropathy\"\n      }\n    ]\n  },\n  \"c50d4c25\": {\n    \"title\": \"Sensory Pathways\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSensory pathways\u003c/b\u003e (or ascending tracts) are neural pathways in the spinal cord and brainstem that transmit somatosensory information from the periphery to the cerebral cortex for conscious perception. The two main pathways are the dorsal column-medial lemniscus system and the spinothalamic tract.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDorsal Column-Medial Lemniscus Pathway:\u003c/b\u003e Transmits \u003cmark\u003efine touch, vibration, and proprioception\u003c/mark\u003e. It ascends ipsilaterally in the dorsal columns and decussates in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinothalamic Tract (Anterolateral System):\u003c/b\u003e Transmits \u003cmark\u003epain, temperature, and crude touch\u003c/mark\u003e. It decussates at the level of the spinal cord and ascends contralaterally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e Both major pathways synapse in the \u003cmark\u003eventral posterior nucleus (VPL/VPM)\u003c/mark\u003e of the thalamus before projecting to the somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Application:\u003c/b\u003e The different decussation points of these two pathways are the basis for the dissociated sensory loss seen in spinal cord syndromes like Brown-S√©quard.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Master the functions and decussation points of the two main sensory pathways. Dorsal columns \u003d fine touch/proprioception, crosses in medulla. Spinothalamic \u003d pain/temp, crosses in spinal cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe body\u0027s sensory information travels to the brain on two main, segregated highways: the \u003cb\u003edorsal column pathway\u003c/b\u003e for fine, discriminative sensations and the \u003cb\u003espinothalamic pathway\u003c/b\u003e for crude, vital sensations like pain and temperature, with their different crossing points being key to neurological diagnosis.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"dorsal_column_medial_lemniscus_pathway\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"07eecef1\"\n      },\n      {\n        \"type\": \"relay_in\",\n        \"to\": \"afc0a64b\"\n      }\n    ]\n  },\n  \"6d676aba\": {\n    \"title\": \"Sensory Receptors\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSensory receptors\u003c/b\u003e are specialized neurons or cells that transduce sensory stimuli (e.g., touch, temperature, light) into electrical signals (action potentials) that can be interpreted by the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanoreceptors (Touch, Pressure, Vibration):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[1e7ec644|Free Nerve Endings]]:\u003c/b\u003e Pain, temperature, crude touch.\u003cbr\u003e - \u003cb\u003eMeissner\u0027s Corpuscles:\u003c/b\u003e Fine/light touch, low-frequency vibration. Rapidly adapting.\u003cbr\u003e - \u003cb\u003ePacinian Corpuscles:\u003c/b\u003e Deep pressure, high-frequency vibration. Rapidly adapting.\u003cbr\u003e - \u003cb\u003eMerkel\u0027s Discs:\u003c/b\u003e Deep static touch (shapes, edges), pressure. Slowly adapting.\u003cbr\u003e - \u003cb\u003eRuffini Corpuscles:\u003c/b\u003e Stretch, slippage of objects. Slowly adapting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProprioceptors:\u003c/b\u003e Muscle spindles (muscle stretch) and Golgi tendon organs (muscle tension).\u003c/li\u003e\u003cli\u003e\u003cb\u003eThermoreceptors:\u003c/b\u003e [[1e7ec644|Free nerve endings]] that detect temperature.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNociceptors:\u003c/b\u003e [[1e7ec644|Free nerve endings]] that detect pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFiber Types:\u003c/b\u003e Different receptors are associated with different nerve fiber types, which determines the speed of conduction (e.g., large, myelinated AŒ≤ fibers for fine touch vs. small, unmyelinated C fibers for slow pain).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know which receptors are rapidly adapting (Meissner, Pacinian - sense changes) versus slowly adapting (Merkel, Ruffini - sense sustained stimuli).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSensory receptors\u003c/b\u003e are the body\u0027s diverse array of biological transducers, each exquisitely tuned to a specific type of physical or chemical energy, converting the stimuli of the outside world into the electrical language of the nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"1e7ec644\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"meissners_corpuscles\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"pacinian_corpuscles\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"merkels_discs\"\n      }\n    ]\n  },\n  \"5d3c2089\": {\n    \"title\": \"Serotonin (5-HT)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psychiatry\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSerotonin\u003c/b\u003e (5-hydroxytryptamine, 5-HT) is a monoamine neurotransmitter that plays a wide-ranging role in modulating mood, sleep, appetite, and cognition. Its dysregulation is implicated in numerous psychiatric disorders.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e Synthesized from the amino acid tryptophan. The majority of the body\u0027s serotonin is produced in the gut, but in the CNS, it is produced in the \u003cmark\u003eraphe nuclei\u003c/mark\u003e of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Involved in the regulation of mood, sleep, anxiety, appetite, and libido.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e A deficiency of serotonin is implicated in \u003cmark\u003e[[9a0f5ba6|depression]]\u003c/mark\u003e and \u003cmark\u003e[[d1c786e9|anxiety disorders]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology:\u003c/b\u003e The serotonin system is a major target for psychotropic drugs.\u003cbr\u003e - \u003cb\u003eSSRIs (e.g., fluoxetine):\u003c/b\u003e Block the reuptake of serotonin, increasing its synaptic levels. First-line for depression and anxiety.\u003cbr\u003e - \u003cb\u003e[[8c2c618d|SNRIs]]:\u003c/b\u003e Block reuptake of both serotonin and norepinephrine.\u003cbr\u003e - \u003cb\u003eTCAs:\u003c/b\u003e Also block serotonin and norepinephrine reuptake.\u003cbr\u003e - \u003cb\u003eMAOIs:\u003c/b\u003e Inhibit the breakdown of serotonin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSerotonin Syndrome:\u003c/b\u003e A potentially life-threatening condition caused by excessive serotonergic activity (e.g., from combining serotonergic drugs). Presents with a triad of autonomic hyperactivity, altered mental status, and neuromuscular abnormalities (clonus, hyperreflexia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVomiting Center Input:\u003c/b\u003e 5-HT\u003csub\u003e3\u003c/sub\u003e receptors in the [[93f70f8e|chemoreceptor trigger zone (CTZ)]] and GI tract are involved in the vomiting reflex. 5-HT\u003csub\u003e3\u003c/sub\u003e antagonists (e.g., ondansetron) are potent antiemetics.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSerotonin\u003c/b\u003e is a key neuromodulator for mood and well-being, with its deficiency being a central hypothesis for depression, making the enhancement of serotonergic transmission the primary mechanism of action for the most widely prescribed antidepressants.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_deficient_in\",\n        \"to\": \"9a0f5ba6\"\n      },\n      {\n        \"type\": \"is_deficient_in\",\n        \"to\": \"d1c786e9\"\n      },\n      {\n        \"type\": \"is_synthesized_in\",\n        \"to\": \"raphe_nuclei\"\n      },\n      {\n        \"type\": \"excess_causes\",\n        \"to\": \"serotonin_syndrome\"\n      }\n    ]\n  },\n  \"b9835e21\": {\n    \"title\": \"Sevoflurane\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSevoflurane\u003c/b\u003e is a sweet-smelling, non-flammable, halogenated ether used as a volatile inhaled general anesthetic for the induction and maintenance of anesthesia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is unknown, but it is thought to enhance the activity of inhibitory neurotransmitter receptors (like GABA\u003csub\u003eA\u003c/sub\u003e) and inhibit excitatory receptors (like NMDA).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It has a \u003cmark\u003elow blood:gas partition coefficient\u003c/mark\u003e (0.65), which means it has low solubility in blood. This results in a \u003cmark\u003erapid onset\u003c/mark\u003e of anesthesia and a \u003cmark\u003erapid recovery\u003c/mark\u003e upon discontinuation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e It is one of the most commonly used volatile anesthetics, especially in pediatrics, because its non-pungent nature makes it suitable for \u003cmark\u003einhalation induction\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes dose-dependent respiratory depression and myocardial depression (hypotension). It can trigger \u003cmark\u003emalignant hyperthermia\u003c/mark\u003e in susceptible individuals. It can be nephrotoxic at low fresh gas flow rates due to the formation of Compound A, but this is rarely clinically significant.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Sevoflurane is known for its rapid induction and recovery and its suitability for inhalation induction, especially in children. Contrast its rapid kinetics with older agents like halothane, which had high blood solubility and thus slow induction.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSevoflurane\u003c/b\u003e is a modern, widely used inhaled anesthetic favored for its rapid and smooth induction, particularly in children, a property directly related to its low solubility in blood.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"inhaled_anesthetic\"\n      },\n      {\n        \"type\": \"can_trigger\",\n        \"to\": \"malignant_hyperthermia\"\n      },\n      {\n        \"type\": \"has_property\",\n        \"to\": \"low_blood_gas_solubility\"\n      }\n    ]\n  },\n  \"b7950295\": {\n    \"title\": \"Skeletal Muscle Relaxants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSkeletal muscle relaxants\u003c/b\u003e are a group of drugs used to alleviate symptoms associated with muscle spasticity or acute muscle spasms by acting either on the central nervous system or directly on the muscle.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBaclofen:\u003c/b\u003e A GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist that acts on the spinal cord to suppress hyperactive reflexes. Used for spasticity in [[45dd6d19|multiple sclerosis]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCyclobenzaprine:\u003c/b\u003e A centrally acting muscle relaxant, structurally related to TCAs. Used for acute muscle spasms from musculoskeletal conditions. Has significant anticholinergic side effects and causes sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTizanidine:\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist that inhibits motor neuron activity. Used for spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDantrolene:\u003c/b\u003e Acts directly on skeletal muscle by blocking Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum (inhibits ryanodine receptor). \u003cu\u003eUsed to treat malignant hyperthermia and neuroleptic malignant syndrome\u003c/u\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the uses: [[1ddc3f08|baclofen]] and tizanidine for chronic spasticity (MS, spinal cord injury), cyclobenzaprine for acute muscle strain, and [[d67a204d|dantrolene]] for life-threatening hyperthermic syndromes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSkeletal muscle relaxants\u003c/b\u003e reduce muscle hyperactivity through diverse mechanisms, ranging from central GABAergic and adrenergic modulation (baclofen, tizanidine) to direct interference with muscle contraction machinery (dantrolene), the latter being crucial for treating hyperthermic emergencies.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"af72aab5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"cyclobenzaprine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"d67a204d\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9983,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"f844c0eb\": {\n    \"title"
      }, {
        "text": "\": \"Satiety and Hunger Regulation\",\n    \"primaryType\": \"physiology\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Endocrinology\",\n      \"Neurophysiology\",\n      \"USMLE\"\n    ],\n    \"classification"
      }, {
        "text": "Path\": [\n      \"Endocrine\",\n      \"Physiology\",\n      \"Appetite Regulation\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSatiety and hunger regulation\u003c/b\u003e is a complex neurohormonal process,"
      }, {
        "text": " primarily controlled by the [[89e86633|hypothalamus]], which integrates peripheral signals from the gut"
      }, {
        "text": " and adipose tissue to balance energy intake and expenditure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHyp"
      }, {
        "text": "othalamic Centers:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[lateral_hypothalamic_nucleus|Lateral Hypothalamus]]:"
      }, {
        "text": "\u003c/b\u003e The \u003cmark\u003ehunger center\u003c/mark\u003e. Stimulation induces hunger. A lesion leads to anorexia. Mnemonic: A"
      }, {
        "text": " lesion to the \u003cb\u003eL\u003c/b\u003eateral nucleus makes you \u003cb\u003eL\u003c/b\u003eean.\u003cbr\u003e - \u003cb\u003e[[d6"
      }, {
        "text": "62ec5d|Ventromedial Hypothalamus]]:\u003c/b\u003e The \u003cmark\u003esatiety center\u003c/mark\u003e. Stimulation induces"
      }, {
        "text": " satiety. A lesion leads to hyperphagia and obesity. Mnemonic: A lesion to the \u003cb\u003eV\u003c/b\u003eentro"
      }, {
        "text": "\u003cb\u003eM\u003c/b\u003eedial nucleus makes you \u003cb\u003eV\u003c/b\u003eery \u003cb\u003eM\u003c/b\u003eassive.\u003c/li\u003e\u003cli\u003e\u003cb\u003eKey"
      }, {
        "text": " Hormones:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eLeptin:\u003c/b\u003e A satiety hormone released from adipose tissue. It acts"
      }, {
        "text": " on the hypothalamus to suppress appetite.\u003cbr\u003e - \u003cb\u003e[[a2cba303|Ghrelin]]:\u003c/b\u003e"
      }, {
        "text": " A hunger hormone released from the stomach. It acts on the hypothalamus to stimulate appetite.\u003cbr\u003e - \u003cb\u003eInsulin:\u003c/b\u003e Acts"
      }, {
        "text": " as a satiety signal in the CNS.\u003cbr\u003e - \u003cb\u003ePYY, CCK:\u003c/b\u003e Gut hormones that act as short"
      }, {
        "text": "-term satiety signals.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know the roles of the lateral and ventromedial hypothalamus"
      }, {
        "text": " and the primary functions of leptin (satiety) and ghrelin (hunger).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003eThe regulation of hunger and satiety is a delicate balance orchestrated by the hypothalamus, which weighs the \u0027"
      }, {
        "text": "eat now\u0027 signal from ghrelin against the \u0027stop eating\u0027 signals from leptin and other gut hormones to maintain energy"
      }, {
        "text": " homeostasis.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Leptin] --\u003e B(Ventromedial Hypothalamus);"
      }, {
        "text": " B --\u003e C(Satiety); D[Ghrelin] --\u003e E(Lateral Hypothalamus); E"
      }, {
        "text": " --\u003e F(Hunger);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_regulated_by\",\n        \"to\": \"89e86633\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_regulated_by\",\n        \"to\": \"leptin\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "regulated_by\",\n        \"to\": \"a2cba303\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"5b8cd0c3\": {\n    \"title\": \"Schizophrenia\",\n    \""
      }, {
        "text": "primaryType\": \"disease\",\n    \"tags\": [\n      \"Psychiatry\",\n      \"Neurology\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Psychiatry\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Psychotic Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSchizophrenia"
      }, {
        "text": "\u003c/b\u003e is a chronic, severe mental disorder that affects how a person thinks, feels, and behaves. It is characterized by a breakdown"
      }, {
        "text": " in the relation between thought, emotion, and behavior, leading to faulty perception, inappropriate actions and feelings, and withdrawal from reality into"
      }, {
        "text": " fantasy and delusion.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eNeurotransmitter Changes:\u003c/b\u003e The primary"
      }, {
        "text": " hypothesis involves \u003cmark\u003eexcessive dopaminergic activity\u003c/mark\u003e in the brain. Specifically, the \u003cmark\u003emes"
      }, {
        "text": "olimbic pathway\u003c/mark\u003e is thought to be hyperactive (causing positive symptoms), while the \u003cmark\u003emes"
      }, {
        "text": "ocortical pathway\u003c/mark\u003e is thought to be hypoactive (causing negative and cognitive symptoms).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSymptoms"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003ePositive Symptoms:\u003c/b\u003e Hallucinations (especially auditory), delusions, disorganized speech and"
      }, {
        "text": " behavior.\u003cbr\u003e - \u003cb\u003eNegative Symptoms:\u003c/b\u003e Flat affect, anhedonia, avolition (apathy), al"
      }, {
        "text": "ogia (poverty of speech).\u003cbr\u003e - \u003cb\u003eCognitive Symptoms:\u003c/b\u003e Impaired executive function, attention, and working"
      }, {
        "text": " memory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Requires ‚â•2 characteristic symptoms for at least 1 month, with continuous signs of disturbance for at least 6 months"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e Antipsychotic medications, which primarily act as dopamine D\u003csub\u003e2\u003c/sub\u003e receptor antagonists, are the"
      }, {
        "text": " mainstay of treatment.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The dopamine hypothesis is key. Positive symptoms are due to too"
      }, {
        "text": " much dopamine in the mesolimbic pathway, while negative symptoms are due to too little dopamine in the mesocortical pathway.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSchizophrenia\u003c/b\u003e is a complex disorder of thought and perception"
      }, {
        "text": " fundamentally linked to dysregulated dopamine signaling, with an excess in the mesolimbic pathway driving psychosis and a deficit in the mesocortical pathway"
      }, {
        "text": " contributing to negative symptoms.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[‚Üë Dopamine in Mesolimbic Pathway]"
      }, {
        "text": " --\u003e B(Positive Symptoms); C[‚Üì Dopamine in Mesocortical Pathway] --\u003e D(Negative Symptoms);\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\","
      }, {
        "text": "\n        \"to\": \"psychotic_disorder\"\n      },\n      {\n        \"type\": \"involves_dysregulation_"
      }, {
        "text": "of\",\n        \"to\": \"90adc821\"\n      },\n      {\n        \"type\": \"is"
      }, {
        "text": "_treated_by\",\n        \"to\": \"antipsychotics\"\n      }\n    ]\n  },\n  \"c"
      }, {
        "text": "65a8909\": {\n    \"title\": \"Schwann Cells\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Gl"
      }, {
        "text": "ial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSchwann cells"
      }, {
        "text": "\u003c/b\u003e are the principal glial cells of the peripheral nervous system (PNS). Their main function is to myelinate the axons of peripheral"
      }, {
        "text": " nerves, which is essential for rapid, saltatory conduction of nerve impulses.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eOrigin:\u003c/b\u003e Derived from the [[14c6f2a7|neural crest]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e My"
      }, {
        "text": "elinate axons in the PNS. A single Schwann cell myelinates \u003cmark\u003eonly one segment of a single axon\u003c/mark\u003e. They"
      }, {
        "text": " also provide support for unmyelinated axons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRegeneration:\u003c/b\u003e Schwann cells play a crucial role in the regeneration"
      }, {
        "text": " of damaged peripheral nerves by forming a \u0027regeneration tube\u0027 (band of B√ºngner) that guides the regrowing axon.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ology:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[ed52e40b|Guillain-Barr√© Syndrome"
      }, {
        "text": "]]:\u003c/b\u003e An autoimmune attack on Schwann cells and their myelin.\u003cbr\u003e - \u003cb\u003e[[c3f13d85|Charcot-"
      }, {
        "text": "Marie-Tooth Disease]]:\u003c/b\u003e A group of hereditary neuropathies often involving mutations in genes related to Schwann cell/myelin function.\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003e[[03ecb69e|Schwannoma]]:\u003c/b\u003e A benign tumor of Schwann cells.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComparison"
      }, {
        "text": " to Oligodendrocytes:\u003c/b\u003e [[a24f9747|Oligodendrocytes]] myelinate axons in the CNS."
      }, {
        "text": " One oligodendrocyte can myelinate multiple axons, and they do not effectively support regeneration.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " Remember the \u0027one-to-one\u0027 rule for Schwann cells: one cell per axon segment. This is a key difference from oligodend"
      }, {
        "text": "rocytes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSchwann cells\u003c/b\u003e are the dedicated myelinators"
      }, {
        "text": " of the peripheral nervous system, wrapping individual axon segments to ensure fast nerve conduction and, crucially, providing the supportive scaffold necessary for nerve"
      }, {
        "text": " regeneration after injury.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"0bd25f4"
      }, {
        "text": "1\"\n      },\n      {\n        \"type\": \"myelinates_axons_in\",\n        \"to"
      }, {
        "text": "\": \"peripheral_nervous_system\"\n      },\n      {\n        \"type\": \"is_damaged"
      }, {
        "text": "_in\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"is_cell_of_origin_for\",\n        \"to\": \"03ecb69e\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"a24f974"
      }, {
        "text": "7\"\n      }\n    ]\n  },\n  \"03ecb69e\": {\n    \"title\": \"Schwann"
      }, {
        "text": "oma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"On"
      }, {
        "text": "cology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eschwannoma\u003c/b\u003e is a benign, encapsulated tumor that"
      }, {
        "text": " arises from [[c65a8909|Schwann cells]], the myelin-forming cells of the peripheral nervous system."
      }, {
        "text": " The most common type is the [[11946667|vestibular schwannoma]] (acoustic neuroma).\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eCell of Origin:\u003c/b\u003e Arises from [[c65a8909"
      }, {
        "text": "|Schwann cells]]. The tumor cells are \u003cmark\u003eS-100 positive\u003c/mark\u003e on immunohistochemistry.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation"
      }, {
        "text": ":\u003c/b\u003e Can occur on any peripheral or cranial nerve (except CN I and II, which are myelinated by oligodendrocytes). Most"
      }, {
        "text": " commonly affects the vestibular branch of CN VIII at the \u003cmark\u003ecerebellopontine angle\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eHistology:\u003c/b\u003e Characterized by a biphasic pattern:\u003cbr\u003e - \u003cb\u003eAntoni A:\u003c/b\u003e Dense, hyper"
      }, {
        "text": "cellular areas with spindle cells arranged in palisading patterns (Verocay bodies).\u003cbr\u003e - \u003cb\u003eAntoni B:\u003c/b\u003e Hyp"
      }, {
        "text": "ocellular, myxoid areas.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeurofibromatosis Type 2 (NF-2):\u003c/b\u003e The"
      }, {
        "text": " presence of \u003cmark\u003ebilateral vestibular schwannomas\u003c/mark\u003e is pathognomonic for NF-2,"
      }, {
        "text": " an autosomal dominant disorder caused by a mutation in the \u003ci\u003eNF2\u003c/i\u003e gene.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " tumor at the cerebellopontine angle that is S-100 positive is a schwannoma. If bilateral, the"
      }, {
        "text": " diagnosis is NF-2.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eschwannoma\u003c/b\u003e is a"
      }, {
        "text": " benign tumor of Schwann cells, most famously occurring as a vestibular schwannoma at the cerebellopontine angle,"
      }, {
        "text": " and is histologically identified by its biphasic Antoni A and B patterns and S-100 positivity.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"ar"
      }, {
        "text": "ises_from\",\n        \"to\": \"c65a8909\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"neurofibromatosis_type"
      }, {
        "text": "_2\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"1"
      }, {
        "text": "1946667\"\n      },\n      {\n        \"type\": \"expresses_marker"
      }, {
        "text": "\",\n        \"to\": \"s100\"\n      }\n    ]\n  },\n  \"cca"
      }, {
        "text": "074cc\": {\n    \"title\": \"Seizures\",\n    \"primaryType\": \"disease"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurology\",\n      \"Epilepsy\",\n      \"US"
      }, {
        "text": "MLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"Seizures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003eA \u003cb\u003eseizure\u003c/b\u003e is a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous"
      }, {
        "text": " neuronal activity in the brain. [[64c08e92|Epilepsy]] is a disease characterized by a predisposition to recurrent,"
      }, {
        "text": " unprovoked seizures.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePhases:\u003c/b\u003e A seizure may"
      }, {
        "text": " have an ictal phase (the event itself) and a postictal phase (a period of confusion or drowsiness after the seizure"
      }, {
        "text": "). An aura may precede the seizure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassification:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[953"
      }, {
        "text": "ad620|Focal Seizures]]:\u003c/b\u003e Originate in one hemisphere. Can be aware or have impaired awareness.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[2e7554b7|Generalized Seizures]]:\u003c/b\u003e Involve both hemispheres from"
      }, {
        "text": " the outset. Include tonic-clonic, absence, myoclonic, and atonic types.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[["
      }, {
        "text": "12108f05|Febrile Seizures]]:\u003c/b\u003e Common in children aged 6 months to 5"
      }, {
        "text": " years, triggered by fever. Simple febrile seizures are benign and do not constitute epilepsy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStatus Epilepticus:"
      }, {
        "text": "\u003c/b\u003e A seizure lasting \u003e5 minutes or recurrent seizures without recovery in between. This is a medical emergency. First-line treatment is IV"
      }, {
        "text": " [[14464617|benzodiazepines]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eWithdrawal:\u003c/b\u003e Abrupt cessation"
      }, {
        "text": " of CNS depressants, particularly alcohol and [[14464617|benzodiazepines]], is a common"
      }, {
        "text": " cause of provoked seizures.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The clinical description of the seizure is key to its classification,"
      }, {
        "text": " which in turn guides the choice of anticonvulsant medication.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003e"
      }, {
        "text": "seizure\u003c/b\u003e is a \u0027short circuit\u0027 in the brain\u0027s electrical activity, and its classification into focal or generalized types"
      }, {
        "text": " based on its origin and spread is the cornerstone of diagnosis and treatment.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_symptom_of\",\n        \""
      }, {
        "text": "to\": \"64c08e92\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "includes\",\n        \"to\": \"953ad620\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"2e7554b7\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"12108f0"
      }, {
        "text": "5\"\n      },\n      {\n        \"type\": \"can_be_caused_by_withdrawal_from\",\n        \"to"
      }, {
        "text": "\": \"14464617\"\n      }\n    ]\n  },\n  \"fe"
      }, {
        "text": "2db5f3\": {\n    \"title\": \"Selective Dorsal Rhizotomy\",\n    \"primaryType\": \"concept"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neurosurgery\",\n      \"Pediatrics\",\n      \"Neurology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmac"
      }, {
        "text": "ology\",\n      \"Surgical Procedures\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSelective dorsal rhiz"
      }, {
        "text": "otomy (SDR)\u003c/b\u003e is a neurosurgical procedure used to reduce spasticity in the lower limbs, most commonly in children with sp"
      }, {
        "text": "astic diplegic [[171ca00b|cerebral palsy]].\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGoal:\u003c/b\u003e To permanently reduce muscle spasticity and improve gait and motor function.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProcedure:\u003c/b\u003e"
      }, {
        "text": " Involves surgically identifying and sectioning (cutting) a portion of the dorsal (sensory) nerve roots in the l"
      }, {
        "text": "umbosacral spine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMechanism:\u003c/b\u003e Spasticity is caused by a hyperexcitable stretch"
      }, {
        "text": " reflex arc. By cutting the sensory nerve rootlets that are firing abnormally, the procedure interrupts the afferent limb of the reflex arc, thereby"
      }, {
        "text": " reducing the spastic motor response.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePatient Selection:\u003c/b\u003e Typically performed in children with spastic diplegic"
      }, {
        "text": " [[171ca00b|cerebral palsy]] who have good underlying muscle strength but whose function is limited"
      }, {
        "text": " by spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the rationale for SDR: it targets the sensory ("
      }, {
        "text": "afferent) side of the spinal reflex arc to reduce the motor (efferent) output that causes spasticity.\u003c/li\u003e\u003c/ul\u003e\","
      }, {
        "text": "\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSelective dorsal rhizotomy\u003c/b\u003e is a neurosurgical procedure that alleviates spasticity by selectively cutting the"
      }, {
        "text": " sensory nerve rootlets that are sending abnormal signals, effectively turning down the \u0027volume\u0027 on the hyperactive stretch reflexes that cause muscle"
      }, {
        "text": " stiffness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Stretched Muscle] --\u003e B(Sensory Aff"
      }, {
        "text": "erent - Dorsal Root); B --x C(Selective Dorsal Rhizotomy); C --x D(Spinal"
      }, {
        "text": " Cord); D --x E(Motor Efferent); E --x F(Spastic Contraction);\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"treats\",\n        \"to\": \"spasticity\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"treats\",\n        \"to\": \"171ca00b\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"involves_sectioning_of\",\n        \"to\": \"d"
      }, {
        "text": "orsal_nerve_roots\"\n      }\n    ]\n  },\n  \"227f89"
      }, {
        "text": "80\": {\n    \"title\": \"Selegiline\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Pharmacology\",\n      \"Neurology\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],"
      }, {
        "text": "\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Park"
      }, {
        "text": "inson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSelegiline"
      }, {
        "text": "\u003c/b\u003e is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B). It is used in the treatment of [["
      }, {
        "text": "58c8ea03|Parkinson disease]] and, in a transdermal patch formulation, for major depressive disorder.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Selectively and irreversibly inhibits MAO-B,"
      }, {
        "text": " the enzyme that primarily metabolizes [[90adc821|dopamine]] in the brain. This increases"
      }, {
        "text": " the levels of dopamine in the striatum.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Used as an"
      }, {
        "text": " adjunct to [[541cd176|levodopa/carbidopa]] to help with motor fluctuations (\u0027"
      }, {
        "text": "wearing-off\u0027 phenomenon) by prolonging the effect of dopamine. It can also be used as monotherapy in early disease"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eSelectivity:\u003c/b\u003e At standard doses, it is selective for MAO-B over MAO-A ("
      }, {
        "text": "which metabolizes serotonin and norepinephrine). This reduces the risk of hypertensive crisis (\u0027cheese effect\u0027) compared to non-selective MAOIs"
      }, {
        "text": ". However, at high doses, it can lose its selectivity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Insomnia ("
      }, {
        "text": "as it can be metabolized to amphetamine-like substances), confusion, and hallucinations. Risk of serotonin syndrome if combined with seroton"
      }, {
        "text": "ergic drugs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Selegiline and rasagiline are the two main MAO-B inhibitors for"
      }, {
        "text": " Parkinson\u0027s. Their mechanism is to prevent the breakdown of dopamine in the brain.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eSelegiline\u003c/b\u003e helps in Parkinson\u0027s disease by selectively blocking MAO-B, the enzyme that degrades"
      }, {
        "text": " dopamine in the brain, thereby preserving the limited dopamine supply and extending the effectiveness of levodopa therapy.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"graph TD; A[Dopamine] --MAO-B--\u003e B(DOPAC - Inactive); C"
      }, {
        "text": "[Selegiline] --x B;\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"mao_b_inhibitor\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"treats\",\n        \"to\": \"9a0f5ba6\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"inhibits_breakdown_of\",\n        \"to\": \"90adc821"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"4b693ef1\": {\n    \"title"
      }, {
        "text": "\": \"Sensorineural Hearing Loss\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Otology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Otology\",\n      \"Pathology\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSensorineural hearing loss (SNHL)\u003c/b\u003e is a type"
      }, {
        "text": " of hearing impairment that results from damage to the inner ear (cochlea) or to the nerve pathways from the inner ear to the brain (vest"
      }, {
        "text": "ibulocochlear nerve, CN VIII).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophys"
      }, {
        "text": "iology:\u003c/b\u003e Caused by damage to the sensory hair cells in the cochlea or to the auditory nerve itself. This"
      }, {
        "text": " impairs the transduction of sound vibrations into neural signals or the transmission of those signals to the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCommon Causes:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[presbycusis|Presbycusis]]:\u003c/b\u003e Age-related hearing loss (most"
      }, {
        "text": " common cause).\u003cbr\u003e - \u003cb\u003eNoise-induced hearing loss:\u003c/b\u003e Damage to hair cells from excessive noise exposure.\u003cbr\u003e"
      }, {
        "text": " - \u003cb\u003eOtotoxic drugs:\u003c/b\u003e Aminoglycosides, loop diuretics, cisplatin.\u003cbr\u003e - \u003cb\u003e[[1"
      }, {
        "text": "1946667|Vestibular schwannoma]]:\u003c/b\u003e Tumor compressing CN VIII.\u003cbr\u003e - \u003cb\u003eCong"
      }, {
        "text": "enital infections:\u003c/b\u003e e.g., CMV.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTuning Fork Tests:\u003c/b\u003e\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eRinne Test:\u003c/b\u003e \u003cmark\u003eNormal\u003c/mark\u003e. Air conduction (AC) is greater than bone conduction (BC) in both"
      }, {
        "text": " ears, but hearing is diminished overall in the affected ear.\u003cbr\u003e - \u003cb\u003eWeber Test:\u003c/b\u003e Sound \u003cmark\u003elateral"
      }, {
        "text": "izes to the unaffected (good) ear\u003c/mark\u003e, because the damaged nerve cannot transmit the sound signal.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Remember the tuning fork results: In SNHL, the Weber test lateralizes to the good ear, and the Rinne test is normal ("
      }, {
        "text": "AC \u003e BC).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSensorineural hearing loss\u003c/b\u003e is a \u0027wiring"
      }, {
        "text": " problem\u0027 of the ear, where damage to the delicate hair cells of the cochlea or the auditory nerve prevents sound from being properly"
      }, {
        "text": " converted into or transmitted as a neural signal, in contrast to the \u0027plumbing problem\u0027 of conductive hearing loss.\u003c/p\u003e\",\n      \""
      }, {
        "text": "mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_type_of\",\n        \"to\": \"hearing_loss\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"differentiated_from\",\n        \"to\": \"2b500647\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_caused_by\",\n        \"to\": \"presbycusis\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"is_caused_by\",\n        \"to\": \"1"
      }, {
        "text": "1946667\"\n      }\n    ]\n  },\n  \"1c32"
      }, {
        "text": "4451\": {\n    \"title\": \"Sensory Cortex\",\n    \"primaryType\": \"anatomy"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"C"
      }, {
        "text": "erebral Cortex\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eprimary"
      }, {
        "text": " somatosensory cortex\u003c/b\u003e (S1) is the main cortical area for processing tactile information from the body. It is located in the post"
      }, {
        "text": "central gyrus of the parietal lobe.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Post"
      }, {
        "text": "central gyrus of the parietal lobe (Brodmann areas 1, 2, and 3).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Rece"
      }, {
        "text": "ives and processes sensory information from the contralateral side of the body, including touch, pressure, pain, temperature, vibration, and proprio"
      }, {
        "text": "ception.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInput:\u003c/b\u003e Receives its primary input from the \u003cmark\u003eventral posterior nucleus (VPN)\u003c/"
      }, {
        "text": "mark\u003e of the [[afc0a64b|thalamus]], which is composed of the [[2"
      }, {
        "text": "ae957b8|VPL]] (for the body) and [[23ac314a"
      }, {
        "text": "|VPM]] (for the face) nuclei.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSomatotopic Organization (Sensory Homunculus):\u003c/b\u003e The"
      }, {
        "text": " cortex is organized somatotopically, with different body parts represented in specific areas. The face and hands have a disproportionately large representation due"
      }, {
        "text": " to their high sensory acuity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStroke Effects:\u003c/b\u003e A lesion in the primary somatosensory cortex causes contralateral"
      }, {
        "text": " sensory loss (e.g., numbness, paresthesias).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the location"
      }, {
        "text": " (postcentral gyrus) and the somatotopic representation (homunculus), with the leg represented medially (supplied by ACA"
      }, {
        "text": ") and the arm/face represented laterally (supplied by MCA).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe "
      }, {
        "text": "\u003cb\u003esomatosensory cortex\u003c/b\u003e is the brain\u0027s primary \u0027touch map,\u0027 a highly organized region in the parietal lobe that receives"
      }, {
        "text": " all tactile information from the thalamus and translates it into our conscious perception of sensation from the contralateral body.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"graph TD; A[Thalamus - VPL/VPM] --\u003e B(Primary Somatosensory Cortex); B --\u003e C"
      }, {
        "text": "(Conscious Perception of Sensation);\"\n    },\n    \"connections\": [\n      {\n        \"type\":"
      }, {
        "text": " \"is_synonymous_with\",\n        \"to\": \"ed7d43ca\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"is_located_in\",\n        \"to\": \"parietal_lobe\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"receives_input_from\",\n        \"to\": \"afc0a64b"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_organized_as\",\n        \"to\": \"sens"
      }, {
        "text": "ory_homunculus\"\n      }\n    ]\n  },\n  \"e60ae264\": {\n    \"title"
      }, {
        "text": "\": \"Sensory Loss\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Symptoms\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eSensory loss\u003c/b\u003e is a deficit in one or more of the sensory modalities (e.g., touch, pain, temperature"
      }, {
        "text": ", vibration, proprioception). The pattern of sensory loss is a critical clue for localizing lesions within the nervous system.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePeripheral Neuropathy:\u003c/b\u003e Typically causes a \u0027glove and stocking\u0027 pattern of sensory loss, affecting"
      }, {
        "text": " the distal extremities first.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRadiculopathy:\u003c/b\u003e Sensory loss in a dermatomal pattern.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSp"
      }, {
        "text": "inal Cord Lesions:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[4792bc68|Brown-S√©qu"
      }, {
        "text": "ard Syndrome]]:\u003c/b\u003e Ipsilateral loss of proprioception/vibration and contralateral loss of pain/temperature below the lesion.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[d2b8e10c|Syringomyelia]]:\u003c/b\u003e \u0027Cape-like\u0027 bilateral"
      }, {
        "text": " loss of pain/temperature in the upper extremities.\u003c/li\u003e\u003cli\u003e\u003cb\u003eBrainstem Lesions:\u003c/b\u003e Often cause \u0027crossed\u0027 sensory loss"
      }, {
        "text": " (e.g., ipsilateral face, contralateral body), as seen in lateral medullary or pontine syndromes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic"
      }, {
        "text": " Lesions:\u003c/b\u003e Cause contralateral sensory loss of all modalities in the face, arm, and leg.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCort"
      }, {
        "text": "ical Lesions:\u003c/b\u003e Cause contralateral sensory loss, often with deficits in discriminative sensation (e.g., graphesthesia, stere"
      }, {
        "text": "ognosis). Stroke effects depend on the vascular territory.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiating between a dorsal column pattern"
      }, {
        "text": " (loss of vibration/proprioception) and a spinothalamic pattern (loss of pain/temperature) is fundamental"
      }, {
        "text": " to localizing CNS lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe specific pattern of \u003cb\u003esensory loss\u003c/b\u003e‚Äî"
      }, {
        "text": "whether it follows a dermatome, a \u0027glove and stocking\u0027 distribution, or a dissociated pattern in the spinal cord‚Äîprovides"
      }, {
        "text": " a precise roadmap for pinpointing the location of a neurological lesion.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_a_feature_of\",\n        \"to\":"
      }, {
        "text": " \"4792bc68\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_feature_of\",\n        \"to\": \"c5da3c57\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_feature_of\",\n        \"to\": \"peripheral_neuropathy"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"c50d4c25\": {\n    \"title\":"
      }, {
        "text": " \"Sensory Pathways\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \""
      }, {
        "text": "Neuroanatomy\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eSensory pathways\u003c/b\u003e (or ascending tracts) are neural pathways in the spinal cord and brainstem that transmit som"
      }, {
        "text": "atosensory information from the periphery to the cerebral cortex for conscious perception. The two main pathways are the dorsal column-medial lemniscus system"
      }, {
        "text": " and the spinothalamic tract.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDorsal Column-Medial Lemn"
      }, {
        "text": "iscus Pathway:\u003c/b\u003e Transmits \u003cmark\u003efine touch, vibration, and proprioception\u003c/mark\u003e. It ascends ipsilaterally in the dorsal"
      }, {
        "text": " columns and decussates in the medulla.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSpinothalamic Tract (Anterolateral System):\u003c/b\u003e Transmits \u003c"
      }, {
        "text": "mark\u003epain, temperature, and crude touch\u003c/mark\u003e. It decussates at the level of the spinal cord and"
      }, {
        "text": " ascends contralaterally.\u003c/li\u003e\u003cli\u003e\u003cb\u003eThalamic Relay:\u003c/b\u003e Both major pathways synapse in the \u003cmark\u003eventral posterior nucleus (V"
      }, {
        "text": "PL/VPM)\u003c/mark\u003e of the thalamus before projecting to the somatosensory cortex.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Application:\u003c/b\u003e The different decussation points of these two pathways are the basis for the dissociated sensory loss seen in spinal"
      }, {
        "text": " cord syndromes like Brown-S√©quard.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Master the functions and decussation points of the two main sensory"
      }, {
        "text": " pathways. Dorsal columns \u003d fine touch/proprioception, crosses in medulla. Spinothalamic \u003d pain/temp, crosses in spinal"
      }, {
        "text": " cord.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe body\u0027s sensory information travels to the brain on"
      }, {
        "text": " two main, segregated highways: the \u003cb\u003edorsal column pathway\u003c/b\u003e for fine, discriminative sensations and the \u003cb\u003espinothalamic"
      }, {
        "text": " pathway\u003c/b\u003e for crude, vital sensations like pain and temperature, with their different crossing points being key to neurological diagnosis.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"dorsal_column_medial_lemniscus_pathway\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"includes\",\n        \"to\": \"07eecef1\"\n      },\n      {\n        \"type\": \"relay_"
      }, {
        "text": "in\",\n        \"to\": \"afc0a64b\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"6d676aba\": {\n    \"title\": \"Sensory Receptors\",\n    "
      }, {
        "text": "\"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Hist"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Sensory System\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eSensory receptors\u003c/b\u003e are specialized neurons or cells that transduce sensory stimuli (e.g., touch, temperature"
      }, {
        "text": ", light) into electrical signals (action potentials) that can be interpreted by the nervous system.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanoreceptors (Touch, Pressure, Vibration):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[1"
      }, {
        "text": "e7ec644|Free Nerve Endings]]:\u003c/b\u003e Pain, temperature, crude touch.\u003cbr\u003e - \u003cb\u003eMe"
      }, {
        "text": "issner\u0027s Corpuscles:\u003c/b\u003e Fine/light touch, low-frequency vibration. Rapidly adapting.\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003ePacinian Corpuscles:\u003c/b\u003e Deep pressure, high-frequency vibration. Rapidly adapting.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "Merkel\u0027s Discs:\u003c/b\u003e Deep static touch (shapes, edges), pressure. Slowly adapting.\u003cbr\u003e - \u003cb\u003eR"
      }, {
        "text": "uffini Corpuscles:\u003c/b\u003e Stretch, slippage of objects. Slowly adapting.\u003c/li\u003e\u003cli\u003e\u003cb\u003eProprioceptors:\u003c/b\u003e Muscle"
      }, {
        "text": " spindles (muscle stretch) and Golgi tendon organs (muscle tension).\u003c/li\u003e\u003cli\u003e\u003cb\u003eThermoreceptors:\u003c/b\u003e [[1e7ec644|"
      }, {
        "text": "Free nerve endings]] that detect temperature.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNociceptors:\u003c/b\u003e [[1e7ec644|Free nerve"
      }, {
        "text": " endings]] that detect pain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFiber Types:\u003c/b\u003e Different receptors are associated with different nerve fiber types, which determines"
      }, {
        "text": " the speed of conduction (e.g., large, myelinated AŒ≤ fibers for fine touch vs. small, unmyelinated C"
      }, {
        "text": " fibers for slow pain).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Know which receptors are rapidly adapting (Meissner, Pac"
      }, {
        "text": "inian - sense changes) versus slowly adapting (Merkel, Ruffini - sense sustained stimuli).\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eSensory receptors\u003c/b\u003e are the body\u0027s diverse array of biological transducers, each exquisitely tuned to a"
      }, {
        "text": " specific type of physical or chemical energy, converting the stimuli of the outside world into the electrical language of the nervous system.\u003c/p"
      }, {
        "text": "\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"1e7ec644\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "includes\",\n        \"to\": \"meissners_corpuscles\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"pacinian_corpuscles\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"merkels_discs\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"5d3c2089\": {\n    \"title\": \"Serotonin ("
      }, {
        "text": "5-HT)\",\n    \"primaryType\": \"molecule\",\n    \"tags\": [\n      \"Neuroscience\",\n      \"Psych"
      }, {
        "text": "iatry\",\n      \"Pharmacology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\":"
      }, {
        "text": " [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Neurotransmitters\"\n    ],\n    "
      }, {
        "text": "\"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSerotonin\u003c/b\u003e (5-hydroxytryptamine, 5-HT"
      }, {
        "text": ") is a monoamine neurotransmitter that plays a wide-ranging role in modulating mood, sleep, appetite, and cognition. Its"
      }, {
        "text": " dysregulation is implicated in numerous psychiatric disorders.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSynthesis:\u003c/b\u003e"
      }, {
        "text": " Synthesized from the amino acid tryptophan. The majority of the body\u0027s serotonin is produced in the gut, but in"
      }, {
        "text": " the CNS, it is produced in the \u003cmark\u003eraphe nuclei\u003c/mark\u003e of the brainstem.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Involved"
      }, {
        "text": " in the regulation of mood, sleep, anxiety, appetite, and libido.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathology:\u003c/b\u003e A deficiency"
      }, {
        "text": " of serotonin is implicated in \u003cmark\u003e[[9a0f5ba6|depression]]\u003c/mark\u003e and \u003c"
      }, {
        "text": "mark\u003e[[d1c786e9|anxiety disorders]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacology"
      }, {
        "text": ":\u003c/b\u003e The serotonin system is a major target for psychotropic drugs.\u003cbr\u003e - \u003cb\u003eSSRIs (e.g., flu"
      }, {
        "text": "oxetine):\u003c/b\u003e Block the reuptake of serotonin, increasing its synaptic levels. First-line for depression and anxiety.\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "8c2c618d|SNRIs]]:\u003c/b\u003e Block reuptake of both serotonin and norepinephrine.\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eTCAs:\u003c/b\u003e Also block serotonin and norepinephrine reuptake.\u003cbr\u003e - \u003cb\u003eMAOIs:\u003c/b\u003e"
      }, {
        "text": " Inhibit the breakdown of serotonin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSerotonin Syndrome:\u003c/b\u003e A potentially life-threatening condition caused by excessive seroton"
      }, {
        "text": "ergic activity (e.g., from combining serotonergic drugs). Presents with a triad of autonomic hyperactivity, altered mental status, and neuromuscular abnormalities"
      }, {
        "text": " (clonus, hyperreflexia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eVomiting Center Input:\u003c/b\u003e 5-HT\u003csub\u003e"
      }, {
        "text": "3\u003c/sub\u003e receptors in the [[93f70f8e|chemoreceptor trigger zone (CTZ)]]"
      }, {
        "text": " and GI tract are involved in the vomiting reflex. 5-HT\u003csub\u003e3\u003c/sub\u003e antagonists (e.g., ondansetron"
      }, {
        "text": ") are potent antiemetics.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSerotonin\u003c/b\u003e is a key"
      }, {
        "text": " neuromodulator for mood and well-being, with its deficiency being a central hypothesis for depression, making the enhancement of seroton"
      }, {
        "text": "ergic transmission the primary mechanism of action for the most widely prescribed antidepressants.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_deficient_in\",\n        \"to\": \"9a0f5ba6"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"is_deficient_in\",\n        \"to\":"
      }, {
        "text": " \"d1c786e9\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "synthesized_in\",\n        \"to\": \"raphe_nuclei\"\n      },\n      {\n        \"type\": \""
      }, {
        "text": "excess_causes\",\n        \"to\": \"serotonin_syndrome\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"b9835e21\": {\n    \"title\": \"Sevoflurane\",\n    "
      }, {
        "text": "\"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anest"
      }, {
        "text": "hesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\":"
      }, {
        "text": " \"\u003cp\u003e\u003cb\u003eSevoflurane\u003c/b\u003e is a sweet-smelling, non-flammable, halogenated ether"
      }, {
        "text": " used as a volatile inhaled general anesthetic for the induction and maintenance of anesthesia.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e The exact mechanism is unknown, but it is thought to enhance the activity of inhibitory neurotransmitter receptors (like"
      }, {
        "text": " GABA\u003csub\u003eA\u003c/sub\u003e) and inhibit excitatory receptors (like NMDA).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e It has a \u003cmark\u003elow blood"
      }, {
        "text": ":gas partition coefficient\u003c/mark\u003e (0.65), which means it has low solubility in blood. This results in a"
      }, {
        "text": " \u003cmark\u003erapid onset\u003c/mark\u003e of anesthesia and a \u003cmark\u003erapid recovery\u003c/mark\u003e upon discontinuation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e"
      }, {
        "text": " It is one of the most commonly used volatile anesthetics, especially in pediatrics, because its non-pungent nature makes it suitable for \u003c"
      }, {
        "text": "mark\u003einhalation induction\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Causes dose-dependent respiratory depression and myocardial depression (hyp"
      }, {
        "text": "otension). It can trigger \u003cmark\u003emalignant hyperthermia\u003c/mark\u003e in susceptible individuals. It can be"
      }, {
        "text": " nephrotoxic at low fresh gas flow rates due to the formation of Compound A, but this is rarely clinically significant."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Sevoflurane is known for its rapid induction and recovery and its suitability for inhalation induction, especially"
      }, {
        "text": " in children. Contrast its rapid kinetics with older agents like halothane, which had high blood solubility and thus slow induction"
      }, {
        "text": ".\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSevoflurane\u003c/b\u003e is a modern, widely used inhaled anesthetic"
      }, {
        "text": " favored for its rapid and smooth induction, particularly in children, a property directly related to its low solubility in blood.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n"
      }, {
        "text": "        \"to\": \"inhaled_anesthetic\"\n      },\n      {\n        \"type\": \"can"
      }, {
        "text": "_trigger\",\n        \"to\": \"malignant_hyperthermia\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"has_property\",\n        \"to\": \"low_blood_gas_solubility\"\n      }\n    ]"
      }, {
        "text": "\n  },\n  \"b7950295\": {\n    \"title\": \"Skeletal Muscle"
      }, {
        "text": " Relaxants\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special S"
      }, {
        "text": "enses\",\n      \"Pharmacology\",\n      \"Skeletal Muscle Relaxants\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSkeletal muscle relaxants\u003c/b\u003e are a group of drugs used to alleviate"
      }, {
        "text": " symptoms associated with muscle spasticity or acute muscle spasms by acting either on the central nervous system or directly on the muscle"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eBaclofen:\u003c/b\u003e A GABA\u003csub\u003eB\u003c/sub\u003e receptor agonist that"
      }, {
        "text": " acts on the spinal cord to suppress hyperactive reflexes. Used for spasticity in [[45dd6d1"
      }, {
        "text": "9|multiple sclerosis]] and spinal cord injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCyclobenzaprine:\u003c/b\u003e A centrally acting muscle relaxant,"
      }, {
        "text": " structurally related to TCAs. Used for acute muscle spasms from musculoskeletal conditions. Has significant anticholinergic side effects and causes"
      }, {
        "text": " sedation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTizanidine:\u003c/b\u003e A centrally acting Œ±\u003csub\u003e2\u003c/sub\u003e-adrenergic agonist that inhibits motor neuron"
      }, {
        "text": " activity. Used for spasticity.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDantrolene:\u003c/b\u003e Acts directly on skeletal muscle by blocking"
      }, {
        "text": " Ca\u003csup\u003e2+\u003c/sup\u003e release from the sarcoplasmic reticulum (inhibits ryanodine receptor). \u003cu\u003eUsed to treat"
      }, {
        "text": " malignant hyperthermia and neuroleptic malignant syndrome\u003c/u\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate the uses: [["
      }, {
        "text": "1ddc3f08|baclofen]] and tizanidine for chronic spasticity (MS, spinal"
      }, {
        "text": " cord injury), cyclobenzaprine for acute muscle strain, and [[d67a204d|d"
      }, {
        "text": "antrolene]] for life-threatening hyperthermic syndromes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSkeletal"
      }, {
        "text": " muscle relaxants\u003c/b\u003e reduce muscle hyperactivity through diverse mechanisms, ranging from central GABAergic and adrenergic modulation (baclofen, t"
      }, {
        "text": "izanidine) to direct interference with muscle contraction machinery (dantrolene), the latter being crucial for treating hyperthermic emergencies"
      }, {
        "text": ".\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \""
      }, {
        "text": "type\": \"is_synonymous_with\",\n        \"to\": \"af72aab5\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"includes\",\n        \"to\": \"1ddc3f08\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"includes\",\n        \"to\": \"cyclobenzaprine\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"tizanidine\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"d67a204d\"\n      }"
      }, {
        "text": "\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"63b964af\",\n    \"letter\": \"R\",\n    \"term\": \"Retinoblastoma\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Retinoblastoma\",\n    \"sub_entries\": [\n      {\n        \"id\": \"e2a9e68a\",\n        \"letter\": \"R\",\n        \"term\": \"cause and presentation\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"Retinoblastoma \u003e cause and presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"9a30f7f0\",\n    \"letter\": \"R\",\n    \"term\": \"Retinopathy\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Retinopathy\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8bea9ce4\",\n        \"letter\": \"R\",\n        \"term\": \"diabetic\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"Retinopathy \u003e diabetic\"\n      },\n      {\n        \"id\": \"29f1fee8\",\n        \"letter\": \"R\",\n        \"term\": \"hemorrhage\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"Retinopathy \u003e hemorrhage\"\n      },\n      {\n        \"id\": \"d9905f4c\",\n        \"letter\": \"R\",\n        \"term\": \"retinitis\",\n        \"pages\": [\n          \"553\"\n        ],\n        \"context\": \"Retinopathy \u003e retinitis\"\n      },\n      {\n        \"id\": \"681eb6b3\",\n        \"letter\": \"R\",\n        \"term\": \"vein occlusion\",\n        \"pages\": [\n          \"552\"\n        ],\n        \"context\": \"Retinopathy \u003e vein occlusion\"\n      }\n    ]\n  },\n  {\n    \"id\": \"06a2b849\",\n    \"letter\": \"R\",\n    \"term\": \"Retinopathy of prematurity\",\n    \"pages\": [\n      \"206\",\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Retinopathy of prematurity\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f48498a3\",\n    \"letter\": \"R\",\n    \"term\": \"Rhegmatogenous retinal detachment\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Rhegmatogenous retinal detachment\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"53ec4490\",\n    \"letter\": \"R\",\n    \"term\": \"Riluzole\",\n    \"pages\": [\n      \"544\",\n      \"564\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Riluzole\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"072343f1\",\n    \"letter\": \"R\",\n    \"term\": \"Rivastigmine\",\n    \"pages\": [\n      \"239\",\n      \"564\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Rivastigmine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"1166bed5\",\n    \"letter\": \"R\",\n    \"term\": \"Rocuronium\",\n    \"pages\": [\n      \"566\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Rocuronium\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"47a0f3d1\",\n    \"letter\": \"R\",\n    \"term\": \"Romberg sign\",\n    \"pages\": [\n      \"544\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Romberg sign\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"10476fc2\",\n    \"letter\": \"R\",\n    \"term\": \"Rooting reflex\",\n    \"pages\": [\n      \"523\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Rooting reflex\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"16a1a322\",\n    \"letter\": \"R\",\n    \"term\": \"Ropinirole\",\n    \"pages\": [\n      \"563\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ropinirole\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"52e3038a\",\n    \"letter\": \"R\",\n    \"term\": \"Ropivacaine\",\n    \"pages\": [\n      \"565\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ropivacaine\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"c04f05c0\",\n    \"letter\": \"R\",\n    \"term\": \"Rosenthal fibers\",\n    \"pages\": [\n      \"542\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Rosenthal fibers\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"3c284a14\",\n    \"letter\": \"R\",\n    \"term\": \"Ruffini corpuscles\",\n    \"pages\": [\n      \"504\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Ruffini corpuscles\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a1647fb2\",\n    \"letter\": \"S\",\n    \"term\": \"Saccular aneurysms\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Saccular aneurysms\",\n    \"sub_entries\": [\n      {\n        \"id\": \"7eb9abe9\",\n        \"letter\": \"S\",\n        \"term\": \"presentation\",\n        \"pages\": [\n          \"530\"\n        ],\n        \"context\": \"Saccular aneurysms \u003e presentation\"\n      }\n    ]\n  },\n  {\n    \"id\": \"8e14cc0d\",\n    \"letter\": \"S\",\n    \"term\": \"Satellite cells\",\n    \"pages\": [\n      \"503\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Satellite cells\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1676
    }, {
      "text": "```json\n{\n  \"63b964af\": {\n    \"title\": \"Retinoblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Oncology\",\n      \"Pediatrics\",\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinoblastoma\u003c/b\u003e is the most common primary intraocular malignancy in children. It is a malignant tumor arising from the immature cells of the retina, caused by mutations in the \u003ci\u003eRB1\u003c/i\u003e tumor suppressor gene.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Caused by two inactivating mutations (\u0027two hits\u0027) in the \u003ci\u003eRB1\u003c/i\u003e gene on chromosome 13. It can be sporadic (two acquired somatic mutations in one retinal cell) or hereditary (one inherited germline mutation and one acquired somatic mutation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHereditary Form:\u003c/b\u003e Patients with the hereditary form (autosomal dominant inheritance pattern) are at high risk for \u003cmark\u003ebilateral retinoblastoma\u003c/mark\u003e and have a significantly increased risk of developing secondary malignancies, most notably \u003cmark\u003eosteosarcoma\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The most common presenting sign is \u003cmark\u003eleukocoria\u003c/mark\u003e (a white pupillary reflex, \u0027cat\u0027s eye reflex\u0027) instead of the normal red reflex. [[cdcda821|Strabismus]] (eye misalignment) is the second most common sign.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Characterized by small, round, blue cells forming Flexner-Wintersteiner rosettes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Leukocoria in a child is retinoblastoma until proven otherwise. Remember the \u0027two-hit\u0027 hypothesis of tumor suppressor genes, for which retinoblastoma is the classic example.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinoblastoma\u003c/b\u003e is a pediatric eye cancer driven by the inactivation of the RB1 tumor suppressor gene, which classically presents as a \u0027white pupil\u0027 (leukocoria) and, in its hereditary form, carries a lifelong risk of secondary cancers like osteosarcoma.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_mutation_in\",\n        \"to\": \"rb1_gene\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"912babcc\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"cdcda821\"\n      },\n      {\n        \"type\": \"hereditary_form_increases_risk_of\",\n        \"to\": \"osteosarcoma\"\n      }\n    ]\n  },\n  \"9a30f7f0\": {\n    \"title\": \"Retinopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinopathy\u003c/b\u003e is a general term for any non-inflammatory disease of the retina. It is most often used to describe damage to the retinal blood vessels, which can lead to vision impairment or blindness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[73b00ab0|Diabetic Retinopathy]]:\u003c/b\u003e A microvascular complication of diabetes. Can be nonproliferative (microaneurysms, hemorrhages, exudates) or proliferative (neovascularization).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[549b012e|Hypertensive Retinopathy]]:\u003c/b\u003e Retinal vascular damage from chronic hypertension. Signs include arteriolar narrowing, AV nicking, cotton-wool spots, and hemorrhages.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[06a2b849|Retinopathy of Prematurity]]:\u003c/b\u003e Abnormal blood vessel development in the retina of premature infants.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinal Vein/Artery Occlusion:\u003c/b\u003e Blockage of retinal vessels leading to ischemia or hemorrhage. [[b69e35b5|CRVO]] has a \u0027blood and thunder\u0027 appearance. [[3334840f|CRAO]] has a \u0027cherry-red spot\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinitis:\u003c/b\u003e This term implies inflammation of the retina (e.g., CMV retinitis), and is distinct from the non-inflammatory vasculopathies typically referred to as \u0027retinopathy\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The funduscopic exam is key to differentiating the types of retinopathy. Be able to recognize the classic findings for diabetic, hypertensive, and vascular occlusive retinopathies.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinopathy\u003c/b\u003e is a broad term for retinal disease, most commonly referring to the vascular damage caused by systemic conditions like diabetes and hypertension, which manifest with characteristic and diagnostic findings on funduscopic examination.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"549b012e\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"06a2b849\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"b69e35b5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"3334840f\"\n      }\n    ]\n  },\n  \"06a2b849\": {\n    \"title\": \"Retinopathy of Prematurity (ROP)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Ophthalmology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinopathy of Prematurity (ROP)\u003c/b\u003e is a potentially blinding eye disorder that primarily affects premature infants. It is caused by abnormal development of retinal blood vessels, leading to neovascularization and potential retinal detachment.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology (Two Phases):\u003c/b\u003e\u003cbr\u003e1. \u003cb\u003ePhase 1 (Hyperoxic):\u003c/b\u003e Premature birth exposes the immature retina to a relatively hyperoxic environment compared to the uterus. Supplemental oxygen therapy further increases this. High oxygen levels suppress VEGF, causing a cessation of normal retinal vessel growth.\u003cbr\u003e2. \u003cb\u003ePhase 2 (Hypoxic):\u003c/b\u003e As the avascular peripheral retina develops and becomes metabolically active, it becomes hypoxic. This triggers a massive, unregulated overproduction of VEGF, leading to neovascularization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e The primary risk factors are \u003cmark\u003eprematurity\u003c/mark\u003e (low gestational age) and \u003cmark\u003elow birth weight\u003c/mark\u003e. The use of supplemental oxygen is a major contributing factor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e The new, abnormal vessels are fragile and can bleed. They can also form fibrous scar tissue that pulls on the retina, leading to \u003cmark\u003etractional retinal detachment\u003c/mark\u003e and blindness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eScreening \u0026 Treatment:\u003c/b\u003e All high-risk premature infants undergo regular screening eye exams. Treatment for severe ROP includes laser photocoagulation or anti-VEGF injections to ablate the avascular retina and reduce the stimulus for neovascularization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember the biphasic oxygen-dependent pathophysiology: initial hyperoxia stops normal vessel growth, and subsequent hypoxia drives abnormal vessel growth.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinopathy of Prematurity\u003c/b\u003e is a disease of vascular dysregulation, where the premature retina\u0027s normal, orderly vessel growth is disrupted by the oxygen-rich extrauterine environment, leading to a delayed, chaotic neovascularization that can detach the retina and cause blindness.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Premature Birth + O2 Therapy] --\u003e B(Phase 1: Hyperoxia); B --\u003e C(‚Üì VEGF -\u003e Cessation of normal vessel growth); C --\u003e D(Avascular Peripheral Retina); D --\u003e E(Phase 2: Hypoxia); E --\u003e F(‚Üë‚Üë VEGF); F --\u003e G(Neovascularization); G --\u003e H(Retinal Detachment);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"9a30f7f0\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"prematurity\"\n      },\n      {\n        \"type\": \"is_mediated_by\",\n        \"to\": \"vegf\"\n      },\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"retinal_detachment\"\n      }\n    ]\n  },\n  \"f48498a3\": {\n    \"title\": \"Rhegmatogenous Retinal Detachment\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003erhegmatogenous retinal detachment\u003c/b\u003e is the most common type of retinal detachment, occurring when a tear or break in the retina allows liquefied vitreous humor to seep into the subretinal space, separating the neurosensory retina from the underlying retinal pigment epithelium (RPE).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The process is initiated by a \u003cmark\u003efull-thickness retinal tear\u003c/mark\u003e. This is often preceded by a posterior vitreous detachment (PVD), where the aging vitreous gel shrinks and pulls away from the retina, sometimes tearing it in the process.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Myopia (nearsightedness), older age, previous cataract surgery, and eye trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients often report a sudden onset of \u003cmark\u003ephotopsia\u003c/mark\u003e (flashes of light) and a shower of \u003cmark\u003efloaters\u003c/mark\u003e (corresponding to the PVD and retinal tear). This is followed by a progressive, painless peripheral visual field loss, often described as a \u003cmark\u003e\\\"curtain\\\"\u003c/mark\u003e or shadow moving across the vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Fundoscopic examination reveals a detached, gray, undulating retina. The retinal tear may also be visible.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e This is a surgical emergency to prevent permanent vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Flashes, floaters, and a curtain-like vision loss are the classic triad for a rhegmatogenous retinal detachment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003erhegmatogenous retinal detachment\u003c/b\u003e is a mechanical separation of the retina caused by a tear, which allows vitreous fluid to get underneath and lift the retina off its underlying blood supply, a process heralded by the classic symptoms of flashes and floaters.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Posterior Vitreous Detachment] --\u003e B(Retinal Tear); B --\u003e C(Liquefied Vitreous Enters Subretinal Space); C --\u003e D(Separation of Retina from RPE); D --\u003e E(Retinal Detachment);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"retinal_detachment\"\n      },\n      {\n        \"type\": \"is_preceded_by\",\n        \"to\": \"posterior_vitreous_detachment\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"photopsia_and_floaters\"\n      }\n    ]\n  },\n  \"53ec4490\": {\n    \"title\": \"Riluzole\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRiluzole\u003c/b\u003e is a neuroprotective drug that is the primary disease-modifying therapy for [[4ed629f9|amyotrophic lateral sclerosis (ALS)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e The exact mechanism is not fully understood, but it is believed to work by \u003cmark\u003edecreasing glutamate excitotoxicity\u003c/mark\u003e. It is thought to inhibit glutamate release and block postsynaptic NMDA and kainate receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used to treat [[4ed629f9|amyotrophic lateral sclerosis (ALS)]]. It has been shown to modestly prolong survival and/or the time to tracheostomy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfficacy:\u003c/b\u003e The benefit is modest, typically extending survival by only a few months. It does not reverse or halt the disease process.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, dizziness, and elevated liver enzymes (hepatotoxicity), requiring monitoring of LFTs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Riluzole is the main drug associated with the treatment of ALS. Remember its proposed mechanism of reducing glutamate excitotoxicity. Mnemonic: Ri-\u003cb\u003eLOU\u003c/b\u003e-zole for \u003cb\u003eLou\u003c/b\u003e Gehrig\u0027s disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRiluzole\u003c/b\u003e is a neuroprotective agent that offers a modest survival benefit in ALS by mitigating glutamate-mediated excitotoxicity, one of the proposed mechanisms of motor neuron death in the disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"decreases\",\n        \"to\": \"glutamate_excitotoxicity\"\n      }\n    ]\n  },\n  \"072343f1\": {\n    \"title\": \"Rivastigmine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Geriatrics\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRivastigmine\u003c/b\u003e is a reversible [[0835ea01|cholinesterase inhibitor]] used for the symptomatic treatment of mild to moderate [[77ae6148|Alzheimer disease]] and dementia associated with [[58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Reversibly inhibits both acetylcholinesterase (AChE) and butyrylcholinesterase, leading to increased levels of [[6a005559|acetylcholine]] in the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRationale for Use:\u003c/b\u003e [[77ae6148|Alzheimer disease]] is associated with a significant loss of cholinergic neurons. Rivastigmine aims to enhance the function of the remaining neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Provides modest, symptomatic improvement in cognitive function in some patients with mild to moderate dementia. It does not alter the course of the underlying disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Available as an oral capsule and a transdermal patch. The patch formulation may have better gastrointestinal tolerability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Primarily cholinergic side effects, including nausea, vomiting, diarrhea, and dizziness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Along with [[47d0372e|donepezil]] and galantamine, rivastigmine is a first-line symptomatic treatment for Alzheimer\u0027s, based on the cholinergic hypothesis of the disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRivastigmine\u003c/b\u003e is a cholinesterase inhibitor that helps manage the cognitive symptoms of Alzheimer\u0027s and Parkinson\u0027s dementia by boosting acetylcholine levels, available in both oral and transdermal forms to improve tolerability.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0835ea01\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"77ae6148\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"parkinson_disease_dementia\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\": \"6a005559\"\n      }\n    ]\n  },\n  \"1166bed5\": {\n    \"title\": \"Rocuronium\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuromuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRocuronium\u003c/b\u003e is an intermediate-acting, non-depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e of the aminosteroid class. It is widely used to provide skeletal muscle relaxation for endotracheal intubation and surgery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing [[6a005559|acetylcholine]] from binding and causing muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003erapid onset\u003c/mark\u003e of action, making it a common alternative to succinylcholine for rapid sequence intubation when succinylcholine is contraindicated.\u003c/li\u003e\u003cli\u003e\u003cb\u003eMetabolism:\u003c/b\u003e Primarily eliminated unchanged by the liver (biliary excretion). Its duration can be prolonged in patients with hepatic failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally hemodynamically stable with minimal histamine release.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:\u003c/b\u003e The blockade can be reversed by [[0835ea01|acetylcholinesterase inhibitors]] (e.g., neostigmine) or, more rapidly and completely, by \u003cmark\u003esugammadex\u003c/mark\u003e, a specific binding agent for rocuronium and vecuronium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Rocuronium is a popular non-depolarizing blocker because of its rapid onset. Know that its reversal can be achieved with either traditional cholinesterase inhibitors or the specific reversal agent, sugammadex.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRocuronium\u003c/b\u003e is a fast-acting, non-depolarizing muscle relaxant that provides a safe and effective alternative to succinylcholine for rapid sequence intubation, with the added advantage of being reversible by the specific agent sugammadex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"0835ea01\"\n      },\n      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"sugammadex\"\n      }\n    ]\n  },\n  \"47a0f3d1\": {\n    \"title\": \"Romberg Sign\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Sensory Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eRomberg sign\u003c/b\u003e is a clinical sign of sensory ataxia, elicited by having a patient stand with their feet together and then close their eyes. A positive sign is a significant worsening of unsteadiness or a loss of balance with eye closure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e The test is used to differentiate sensory ataxia from cerebellar ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiology of Balance:\u003c/b\u003e Balance is maintained by three sensory inputs: proprioception (position sense), vestibular input, and vision. At least two of these three must be intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePositive Romberg Sign:\u003c/b\u003e A positive sign indicates a deficit in \u003cmark\u003eproprioception\u003c/mark\u003e. The patient is able to compensate for the proprioceptive loss by using visual input. When the eyes are closed, this compensation is removed, and the unsteadiness becomes apparent.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e A positive Romberg sign points to a lesion in the \u003cmark\u003e[[e7f5cbbe|dorsal columns]]\u003c/mark\u003e of the spinal cord or in the peripheral nerves. It is a classic finding in [[71daebd6|tabes dorsalis]] (neurosyphilis) and [[6f5bea90|subacute combined degeneration]] (B\u003csub\u003e12\u003c/sub\u003e deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNegative Romberg Sign:\u003c/b\u003e If a patient is unsteady with their eyes open and this does not significantly worsen with eye closure, the ataxia is likely cerebellar in origin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A positive Romberg test is a test of proprioception, \u003cu\u003enot\u003c/u\u003e cerebellar function.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eRomberg sign\u003c/b\u003e is a simple yet elegant test that unmasks a deficit in proprioception by removing the visual compensation the patient relies on to maintain balance, thereby pointing to a lesion in the dorsal columns or peripheral nerves.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"sensory_ataxia\"\n      },\n      {\n        \"type\": \"indicates_lesion_in\",\n        \"to\": \"e7f5cbbe\"\n      },\n      {\n        \"type\": \"is_positive_in\",\n        \"to\": \"71daebd6\"\n      },\n      {\n        \"type\": \"is_positive_in\",\n        \"to\": \"6f5bea90\"\n      }\n    ]\n  },\n  \"10476fc2\": {\n    \"title\": \"Rooting Reflex\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003erooting reflex\u003c/b\u003e is a primitive reflex present in newborns that helps them find the breast or bottle to begin feeding. It is elicited by stroking the corner of the infant\u0027s mouth or cheek.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eElicitation:\u003c/b\u003e Gently stroke the infant\u0027s cheek near the corner of the mouth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response:\u003c/b\u003e The infant will turn their head toward the side of the stimulus and open their mouth in an attempt to suck.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Present at birth and typically disappears by 4 months of age as it becomes a voluntary action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e It is one of several primitive reflexes tested in the newborn neurological exam to assess brainstem function and development. Its absence may indicate CNS depression or injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRe-emergence:\u003c/b\u003e The reappearance of the rooting reflex in an adult is an abnormal finding known as a frontal release sign, indicating damage to the [[0405ada3|frontal lobe]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The rooting reflex is a normal, adaptive reflex in a newborn. Its persistence beyond infancy or its re-emergence in an adult is pathological.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003erooting reflex\u003c/b\u003e is an innate, automatic head-turning and mouth-opening response in infants that facilitates breastfeeding, which is normally suppressed by the maturing frontal lobes after a few months of life.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"primitive_reflex\"\n      },\n      {\n        \"type\": \"re-emergence_indicates\",\n        \"to\": \"frontal_lobe_damage\"\n      }\n    ]\n  },\n  \"16a1a322\": {\n    \"title\": \"Ropinirole\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRopinirole\u003c/b\u003e is a non-ergot \u003ci\u003edopamine agonist\u003c/i\u003e used for the treatment of [[58c8ea03|Parkinson disease]] and restless legs syndrome.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Directly stimulates dopamine D\u003csub\u003e2\u003c/sub\u003e and D\u003csub\u003e3\u003c/sub\u003e receptors in the brain, mimicking the effect of dopamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-ergot dopamine agonist, along with pramipexole. These are preferred over older ergot derivatives like [[d24a5ff0|bromocriptine]] due to a better side effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Used as monotherapy in younger patients to delay the need for levodopa, or as an adjunct to levodopa in older patients to reduce motor fluctuations (\u0027off\u0027 time).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Other):\u003c/b\u003e A first-line treatment for moderate to severe [[919caff2|restless legs syndrome]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, postural hypotension, somnolence (including sudden-onset \u0027sleep attacks\u0027), and hallucinations. A notable side effect is \u003cmark\u003eimpulse control disorders\u003c/mark\u003e (e.g., pathological gambling, compulsive shopping).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Ropinirole and pramipexole are the main non-ergot dopamine agonists. Remember their use in both Parkinson\u0027s and restless legs syndrome, and be aware of the unique side effect of impulse control disorders.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRopinirole\u003c/b\u003e is a non-ergot dopamine agonist that directly stimulates dopamine receptors to compensate for the deficiency in Parkinson\u0027s disease, but its use can be complicated by CNS side effects, including the unusual development of impulse control disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"c36650bd\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"919caff2\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"impulse_control_disorder\"\n      }\n    ]\n  },\n  \"52e3038a\": {\n    \"title\": \"Ropivacaine\",\n    \"primaryType\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRopivacaine\u003c/b\u003e is a long-acting, amide-type \u003ci\u003elocal anesthetic\u003c/i\u003e. It is structurally similar to [[181a22b1|bupivacaine]] but is associated with a lower risk of cardiotoxicity.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic (has two \u0027i\u0027s in its name).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long duration of action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used for regional anesthesia, including epidural, spinal, and peripheral nerve blocks for surgery and postoperative pain control.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdvantage over Bupivacaine:\u003c/b\u003e It is less cardiotoxic than [[181a22b1|bupivacaine]], making it a safer choice, especially for techniques that carry a higher risk of systemic absorption. It also produces a greater degree of motor block relative to sensory block (\u0027motor-sensory separation\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Ropivacaine is the \u0027safer bupivacaine.\u0027 It offers a similar long duration of action with a reduced risk of life-threatening cardiac arrhythmias.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRopivacaine\u003c/b\u003e is a long-acting amide local anesthetic that provides effective regional anesthesia with a better cardiovascular safety profile than its predecessor, bupivacaine.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_safer_than\",\n        \"to\": \"181a22b1\"\n      },\n      {\n        \"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n  },\n  \"c04f05c0\": {\n    \"title\": \"Rosenthal Fibers\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neuropathology\",\n      \"Oncology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRosenthal fibers\u003c/b\u003e are thick, elongated, eosinophilic (pink), corkscrew-shaped protein aggregates found in the cytoplasm of astrocytes. They are a characteristic histological finding in certain slow-growing glial processes and tumors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e On H\u0026E stain, they appear as bright pink, irregular, rope-like or \u0027corkscrew\u0027 inclusions within astrocytic processes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComposition:\u003c/b\u003e Composed of aggregates of intermediate filament proteins, including glial fibrillary acidic protein (GFAP), along with heat shock proteins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e They are the histological hallmark of a \u003cmark\u003epilocytic astrocytoma\u003c/mark\u003e, the most common primary brain tumor in children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Conditions:\u003c/b\u003e Can also be seen in areas of long-standing gliosis and in Alexander disease, a rare leukodystrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of Rosenthal fibers in a biopsy of a pediatric cerebellar cystic tumor is diagnostic for pilocytic astrocytoma.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRosenthal fibers\u003c/b\u003e are distinctive eosinophilic, corkscrew-shaped inclusions that are the microscopic signature of a pilocytic astrocytoma, representing aggregates of glial proteins within the tumor cells.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"208cebcd\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"pilocytic_astrocytoma\"\n      },\n      {\n        \"type\": \"is_found_in\",\n        \"to\": \"8192f595\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n        \"to\": \"fb50d450\"\n      }\n    ]\n  },\n  \"3c284a14\": {\n    \"title\": \"Ruffini Corpuscles\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sensory Receptors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRuffini corpuscles\u003c/b\u003e (or Ruffini endings) are slowly adapting mechanoreceptors found in the skin and joint capsules that are sensitive to sustained pressure and skin stretch.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure:\u003c/b\u003e Spindle-shaped, encapsulated receptors located in the deep dermis and subcutaneous tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They respond to \u003cmark\u003esustained pressure and skin stretch\u003c/mark\u003e. They are also thought to contribute to the perception of warmth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdaptation:\u003c/b\u003e They are \u003cmark\u003eslowly adapting\u003c/mark\u003e, meaning they continue to fire action potentials as long as the stimulus is present. This allows for the perception of constant stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e They contribute to our ability to perceive the shape of objects held in the hand and to sense finger position and movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate slowly adapting receptors (Ruffini, Merkel) from rapidly adapting receptors (Pacinian, Meissner). Slowly adapting receptors are good for sensing static properties like pressure and shape, while rapidly adapting receptors are good for sensing dynamic properties like vibration and texture changes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRuffini corpuscles\u003c/b\u003e are the skin\u0027s stretch detectors, slowly adapting mechanoreceptors that provide continuous information about sustained pressure and the distortion of the skin, crucial for proprioception and grip control.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"6d676aba\"\n      },\n      {\n        \"type\": \"detects\",\n        \"to\": \"pressure_and_stretch\"\n      },\n      {\n        \"type\": \"is_a\",\n        \"to\": \"slowly_adapting_receptor\"\n      }\n    ]\n  },\n  \"a1647fb2\": {\n    \"title\": \"Saccular Aneurysms\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSaccular aneurysms\u003c/b\u003e, also known as berry aneurysms, are thin-walled, sac-like outpouchings of a cerebral artery, typically located at arterial branch points within the [[e22300e8|Circle of Willis]]. Their rupture is the most common cause of non-traumatic [[63f8b05f|subarachnoid hemorrhage]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found at the junction of the [[bd802d22|anterior communicating artery (AComA)]] with the anterior cerebral artery. The second most common site is the junction of the posterior communicating artery (PComA) with the internal carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Believed to form due to a congenital weakness in the vessel wall at arterial bifurcations, which is exacerbated over time by hemodynamic stress from hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Increased incidence in patients with \u003cmark\u003eAutosomal Dominant Polycystic Kidney Disease (ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, and Marfan syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation:\u003c/b\u003e Usually asymptomatic until rupture. Rupture causes a [[63f8b05f|subarachnoid hemorrhage]], presenting with a sudden, explosive \u003cmark\u003e\\\"worst headache of my life.\\\"\u003c/mark\u003e A large, unruptured aneurysm can cause symptoms by compressing adjacent structures (e.g., a PComA aneurysm compressing CN III).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient with ADPKD who develops a sudden, severe headache should be immediately evaluated for a ruptured saccular aneurysm.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSaccular aneurysms\u003c/b\u003e are silent vascular time bombs located at the branch points of the Circle of Willis; their rupture leads to a devastating subarachnoid hemorrhage, classically presenting as a \u0027thunderclap headache\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Arterial Bifurcation in Circle of Willis] --\u003e B(Congenital Wall Weakness); B --Hypertension--\u003e C(Saccular Aneurysm Formation); C --\u003e D{Rupture}; D --\u003e E[Subarachnoid Hemorrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"a9f6d703\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"a7f97d7f\"\n      },\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"63f8b05f\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"autosomal_dominant_polycystic_kidney_disease\"\n      }\n    ]\n  },\n  \"8e14cc0d\": {\n    \"title\": \"Satellite Cells (PNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSatellite cells\u003c/b\u003e are a type of glial cell found in the peripheral nervous system (PNS). They form a thin sheath around the cell bodies of neurons located in the peripheral ganglia (e.g., dorsal root ganglia, autonomic ganglia).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Derived from the [[14c6f2a7|neural crest]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Surround neuronal cell bodies within PNS ganglia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They provide structural support and regulate the chemical microenvironment of the neurons they surround, similar to the role of [[8192f595|astrocytes]] in the CNS. They help control the extracellular environment by absorbing neurotransmitters and supplying nutrients to the neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Relevance:\u003c/b\u003e Can be involved in neuropathic pain states and may be affected by viral infections like Herpes Simplex Virus, which establishes latency in sensory ganglia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate satellite cells with the support of neuronal cell bodies in the PNS, just as astrocytes support neurons in the CNS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSatellite cells\u003c/b\u003e are the dedicated support cells for neuronal cell bodies in the peripheral nervous system, acting as a protective and homeostatic buffer around the ganglia.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"0bd25f41\"\n      },\n      {\n        \"type\": \"surrounds\",\n        \"to\": \"pns_neuronal_cell_bodies\"\n      },\n      {\n        \"type\": \"is_analogous_to\",\n        \"to\": \"8192f595\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9114,
      "parts": [{
        "text": "```json\n"
      }, {
        "text": "{\n  \"63b964af\": {\n    \"title"
      }, {
        "text": "\": \"Retinoblastoma\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"On"
      }, {
        "text": "cology\",\n      \"Pediatrics\",\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"USMLE"
      }, {
        "text": "\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"Tumors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003e"
      }, {
        "text": "Retinoblastoma\u003c/b\u003e is the most common primary intraocular malignancy in children. It is a malignant tumor arising from the immature"
      }, {
        "text": " cells of the retina, caused by mutations in the \u003ci\u003eRB1\u003c/i\u003e tumor suppressor gene.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Caused by two inactivating mutations (\u0027two hits\u0027) in the \u003ci\u003eRB1"
      }, {
        "text": "\u003c/i\u003e gene on chromosome 13. It can be sporadic (two acquired somatic mutations in one retinal cell) or hereditary"
      }, {
        "text": " (one inherited germline mutation and one acquired somatic mutation).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHereditary Form:\u003c/b\u003e Patients with the"
      }, {
        "text": " hereditary form (autosomal dominant inheritance pattern) are at high risk for \u003cmark\u003ebilateral retinoblastoma\u003c/mark\u003e and have"
      }, {
        "text": " a significantly increased risk of developing secondary malignancies, most notably \u003cmark\u003eosteosarcoma\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Presentation:\u003c/b\u003e The most common presenting sign is \u003cmark\u003eleukocoria\u003c/mark\u003e (a white pupillary reflex,"
      }, {
        "text": " \u0027cat\u0027s eye reflex\u0027) instead of the normal red reflex. [[cdcda821|Strabismus]]"
      }, {
        "text": " (eye misalignment) is the second most common sign.\u003c/li\u003e\u003cli\u003e\u003cb\u003eHistology:\u003c/b\u003e Characterized by small, round"
      }, {
        "text": ", blue cells forming Flexner-Wintersteiner rosettes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Leukocoria in"
      }, {
        "text": " a child is retinoblastoma until proven otherwise. Remember the \u0027two-hit\u0027 hypothesis of tumor suppressor genes, for"
      }, {
        "text": " which retinoblastoma is the classic example.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinoblastoma\u003c/b\u003e"
      }, {
        "text": " is a pediatric eye cancer driven by the inactivation of the RB1 tumor suppressor gene, which classically presents as a \u0027white pupil"
      }, {
        "text": "\u0027 (leukocoria) and, in its hereditary form, carries a lifelong risk of secondary cancers like osteosarcoma.\u003c/p\u003e\",\n      "
      }, {
        "text": "\"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_caused_by_mutation"
      }, {
        "text": "_in\",\n        \"to\": \"rb1_gene\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"presents_with\",\n        \"to\": \"912babcc\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"presents_with\",\n        \"to\": \"cdcda821\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"hereditary_form_increases_risk_of\",\n        \"to\": \"osteosar"
      }, {
        "text": "coma\"\n      }\n    ]\n  },\n  \"9a30f7f0\": {\n    \"title\":"
      }, {
        "text": " \"Retinopathy\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinopathy\u003c/b\u003e is a general term for any non-"
      }, {
        "text": "inflammatory disease of the retina. It is most often used to describe damage to the retinal blood vessels, which can lead to vision impairment"
      }, {
        "text": " or blindness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[73b00ab0|Di"
      }, {
        "text": "abetic Retinopathy]]:\u003c/b\u003e A microvascular complication of diabetes. Can be nonproliferative (microaneurysms, hemorrhages, exud"
      }, {
        "text": "ates) or proliferative (neovascularization).\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[549b012e|Hypertensive Retinopathy]]:\u003c/b\u003e"
      }, {
        "text": " Retinal vascular damage from chronic hypertension. Signs include arteriolar narrowing, AV nicking, cotton-wool spots, and"
      }, {
        "text": " hemorrhages.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[06a2b849|Retinopathy of Prematurity]]:\u003c/b\u003e Abnormal"
      }, {
        "text": " blood vessel development in the retina of premature infants.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinal Vein/Artery Occlusion:\u003c/b\u003e Block"
      }, {
        "text": "age of retinal vessels leading to ischemia or hemorrhage. [[b69e35b5|CRVO]] has"
      }, {
        "text": " a \u0027blood and thunder\u0027 appearance. [[3334840f|CRAO]] has a \u0027cherry"
      }, {
        "text": "-red spot\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRetinitis:\u003c/b\u003e This term implies inflammation of the retina (e.g., CMV"
      }, {
        "text": " retinitis), and is distinct from the non-inflammatory vasculopathies typically referred to as \u0027retinopathy\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e The funduscopic exam is key to differentiating the types of retinopathy. Be able to recognize the classic"
      }, {
        "text": " findings for diabetic, hypertensive, and vascular occlusive retinopathies.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinopathy"
      }, {
        "text": "\u003c/b\u003e is a broad term for retinal disease, most commonly referring to the vascular damage caused by systemic conditions like diabetes and hypertension, which manifest with characteristic"
      }, {
        "text": " and diagnostic findings on funduscopic examination.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"includes\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"549b012e\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"06a2b84"
      }, {
        "text": "9\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"b6"
      }, {
        "text": "9e35b5\"\n      },\n      {\n        \"type\": \"includes\",\n        \""
      }, {
        "text": "to\": \"3334840f\"\n      }\n    ]\n  },\n  \""
      }, {
        "text": "06a2b849\": {\n    \"title\": \"Retinopathy of Prematurity ("
      }, {
        "text": "ROP)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Ophthalmology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \""
      }, {
        "text": "definition\": \"\u003cp\u003e\u003cb\u003eRetinopathy of Prematurity (ROP)\u003c/b\u003e is a potentially blinding eye disorder that"
      }, {
        "text": " primarily affects premature infants. It is caused by abnormal development of retinal blood vessels, leading to neovascularization and potential retinal"
      }, {
        "text": " detachment.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology (Two Phases):\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e1. \u003cb\u003ePhase 1 (Hyperoxic):\u003c/b\u003e Premature birth exposes the immature retina to a relatively hyper"
      }, {
        "text": "oxic environment compared to the uterus. Supplemental oxygen therapy further increases this. High oxygen levels suppress VEGF, causing a cessation of normal retinal vessel growth"
      }, {
        "text": ".\u003cbr\u003e2. \u003cb\u003ePhase 2 (Hypoxic):\u003c/b\u003e As the avascular peripheral retina develops and becomes"
      }, {
        "text": " metabolically active, it becomes hypoxic. This triggers a massive, unregulated overproduction of VEGF, leading to neovascularization."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e The primary risk factors are \u003cmark\u003eprematurity\u003c/mark\u003e (low gestational age) and \u003cmark\u003elow"
      }, {
        "text": " birth weight\u003c/mark\u003e. The use of supplemental oxygen is a major contributing factor.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComplications:\u003c/b\u003e The"
      }, {
        "text": " new, abnormal vessels are fragile and can bleed. They can also form fibrous scar tissue that pulls on the retina, leading"
      }, {
        "text": " to \u003cmark\u003etractional retinal detachment\u003c/mark\u003e and blindness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eScreening \u0026 Treatment:\u003c/b\u003e All high"
      }, {
        "text": "-risk premature infants undergo regular screening eye exams. Treatment for severe ROP includes laser photocoagulation or anti-VEGF injections"
      }, {
        "text": " to ablate the avascular retina and reduce the stimulus for neovascularization.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Remember"
      }, {
        "text": " the biphasic oxygen-dependent pathophysiology: initial hyperoxia stops normal vessel growth, and subsequent hypoxia drives abnormal vessel growth."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinopathy of Prematurity\u003c/b\u003e is a disease"
      }, {
        "text": " of vascular dysregulation, where the premature retina\u0027s normal, orderly vessel growth is disrupted by the oxygen-rich extra"
      }, {
        "text": "uterine environment, leading to a delayed, chaotic neovascularization that can detach the retina and cause blindness.\u003c/p\u003e\",\n      \"mermaid\": \""
      }, {
        "text": "graph TD; A[Premature Birth + O2 Therapy] --\u003e B(Phase 1: Hyperoxia); B --\u003e"
      }, {
        "text": " C(‚Üì VEGF -\u003e Cessation of normal vessel growth); C --\u003e D(Avascular Peripheral Retina); D --\u003e E("
      }, {
        "text": "Phase 2: Hypoxia); E --\u003e F(‚Üë‚Üë VEGF); F --\u003e G(Neovascularization); G --\u003e H(Retinal Detachment"
      }, {
        "text": ");\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type"
      }, {
        "text": "_of\",\n        \"to\": \"9a30f7f0\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_associated_with\",\n        \"to\": \"prematurity\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_mediated_by\",\n        \"to\": \"vegf\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"can_cause\",\n        \"to\": \"retinal_detachment"
      }, {
        "text": "\"\n      }\n    ]\n  },\n  \"f48498a3\": {\n    \"title\":"
      }, {
        "text": " \"Rhegmatogenous Retinal Detachment\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology"
      }, {
        "text": "\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content"
      }, {
        "text": "\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003erhegmatogenous retinal detachment\u003c/b\u003e is the most common type of retinal detachment, occurring"
      }, {
        "text": " when a tear or break in the retina allows liquefied vitreous humor to seep into the subretinal space, separating the neuro"
      }, {
        "text": "sensory retina from the underlying retinal pigment epithelium (RPE).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Pathophysiology:\u003c/b\u003e The process is initiated by a \u003cmark\u003efull-thickness retinal tear\u003c/mark\u003e. This is"
      }, {
        "text": " often preceded by a posterior vitreous detachment (PVD), where the aging vitreous gel shrinks and pulls away from the retina,"
      }, {
        "text": " sometimes tearing it in the process.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Myopia (nearsightedness), older age, previous"
      }, {
        "text": " cataract surgery, and eye trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients often report a sudden onset of \u003cmark\u003e"
      }, {
        "text": "photopsia\u003c/mark\u003e (flashes of light) and a shower of \u003cmark\u003efloaters\u003c/mark\u003e (corresponding"
      }, {
        "text": " to the PVD and retinal tear). This is followed by a progressive, painless peripheral visual field loss, often described as a \u003c"
      }, {
        "text": "mark\u003e\\\"curtain\\\"\u003c/mark\u003e or shadow moving across the vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDiagnosis:\u003c/b\u003e Fundoscopic examination reveals"
      }, {
        "text": " a detached, gray, undulating retina. The retinal tear may also be visible.\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e This is a surgical emergency to"
      }, {
        "text": " prevent permanent vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Flashes, floaters, and a curtain-like vision"
      }, {
        "text": " loss are the classic triad for a rhegmatogenous retinal detachment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eA \u003cb\u003erhegmatogenous retinal detachment\u003c/b\u003e is a mechanical separation of the retina caused by a tear,"
      }, {
        "text": " which allows vitreous fluid to get underneath and lift the retina off its underlying blood supply, a process heralded by the classic symptoms"
      }, {
        "text": " of flashes and floaters.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Posterior Vitreous Detachment] --\u003e"
      }, {
        "text": " B(Retinal Tear); B --\u003e C(Liquefied Vitreous Enters Subretinal Space); C --\u003e D("
      }, {
        "text": "Separation of Retina from RPE); D --\u003e E(Retinal Detachment);\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"retinal"
      }, {
        "text": "_detachment\"\n      },\n      {\n        \"type\": \"is_preceded_by\",\n        \"to"
      }, {
        "text": "\": \"posterior_vitreous_detachment\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"photopsia_and_floaters\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"53ec4490\": {\n    \"title\": \"Riluzole\",\n    \"primaryType\": \"drug"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neuro"
      }, {
        "text": "degenerative Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRiluzole"
      }, {
        "text": "\u003c/b\u003e is a neuroprotective drug that is the primary disease-modifying therapy for [[4ed629f9"
      }, {
        "text": "|amyotrophic lateral sclerosis (ALS)]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism"
      }, {
        "text": " of Action:\u003c/b\u003e The exact mechanism is not fully understood, but it is believed to work by \u003cmark\u003edecreasing glutamate excit"
      }, {
        "text": "otoxicity\u003c/mark\u003e. It is thought to inhibit glutamate release and block postsynaptic NMDA and kainate receptors.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use"
      }, {
        "text": ":\u003c/b\u003e Used to treat [[4ed629f9|amyotrophic lateral sclerosis (ALS)]]. It has"
      }, {
        "text": " been shown to modestly prolong survival and/or the time to tracheostomy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEfficacy:\u003c/b\u003e The benefit"
      }, {
        "text": " is modest, typically extending survival by only a few months. It does not reverse or halt the disease process.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:"
      }, {
        "text": "\u003c/b\u003e Nausea, dizziness, and elevated liver enzymes (hepatotoxicity), requiring monitoring of LFTs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Riluzole is the main drug associated with the treatment of ALS. Remember its proposed mechanism of reducing glutamate excitotoxicity. M"
      }, {
        "text": "nemonic: Ri-\u003cb\u003eLOU\u003c/b\u003e-zole for \u003cb\u003eLou\u003c/b\u003e Gehrig\u0027s disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eRiluzole\u003c/b\u003e is a neuroprotective agent that offers a modest survival benefit in ALS by mitigating"
      }, {
        "text": " glutamate-mediated excitotoxicity, one of the proposed mechanisms of motor neuron death in the disease.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"treats\",\n        \"to\":"
      }, {
        "text": " \"4ed629f9\"\n      },\n      {\n        \"type\": \"decreases\","
      }, {
        "text": "\n        \"to\": \"glutamate_excitotoxicity\"\n      }\n    ]\n  },\n  \"0"
      }, {
        "text": "72343f1\": {\n    \"title\": \"Rivastigmine\",\n    \"primaryType\": \"drug\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      \"Geriatrics\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Neurodegenerative Disease Therapy\"\n    ],\n    \"content\": {\n"
      }, {
        "text": "      \"definition\": \"\u003cp\u003e\u003cb\u003eRivastigmine\u003c/b\u003e is a reversible [[0835ea01|cholinesterase inhibitor]] used"
      }, {
        "text": " for the symptomatic treatment of mild to moderate [[77ae6148|Alzheimer disease]] and dementia associated with [["
      }, {
        "text": "58c8ea03|Parkinson disease]].\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of"
      }, {
        "text": " Action:\u003c/b\u003e Reversibly inhibits both acetylcholinesterase (AChE) and butyrylcholinesterase,"
      }, {
        "text": " leading to increased levels of [[6a005559|acetylcholine]] in the brain.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRationale"
      }, {
        "text": " for Use:\u003c/b\u003e [[77ae6148|Alzheimer disease]] is associated with a significant loss of cholinergic"
      }, {
        "text": " neurons. Rivastigmine aims to enhance the function of the remaining neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Provides"
      }, {
        "text": " modest, symptomatic improvement in cognitive function in some patients with mild to moderate dementia. It does not alter the course of the underlying"
      }, {
        "text": " disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdministration:\u003c/b\u003e Available as an oral capsule and a transdermal patch. The patch formulation may"
      }, {
        "text": " have better gastrointestinal tolerability.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Primarily cholinergic side effects, including nausea, vomiting,"
      }, {
        "text": " diarrhea, and dizziness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Along with [[47d0372e|donepezil]] and gal"
      }, {
        "text": "antamine, rivastigmine is a first-line symptomatic treatment for Alzheimer\u0027s, based on the cholinergic hypothesis of the disease."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRivastigmine\u003c/b\u003e is a cholinesterase inhibitor that helps manage"
      }, {
        "text": " the cognitive symptoms of Alzheimer\u0027s and Parkinson\u0027s dementia by boosting acetylcholine levels, available in both oral and transdermal forms"
      }, {
        "text": " to improve tolerability.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_type_of\",\n        \"to\": \"0835ea01\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"77ae6"
      }, {
        "text": "148\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"park"
      }, {
        "text": "inson_disease_dementia\"\n      },\n      {\n        \"type\": \"increases_levels_of\",\n        \"to\":"
      }, {
        "text": " \"6a005559\"\n      }\n    ]\n  },\n  \"1166"
      }, {
        "text": "bed5\": {\n    \"title\": \"Rocuronium\",\n    \"primaryType\": \"drug\",\n    "
      }, {
        "text": "\"tags\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\",\n      \"Neu"
      }, {
        "text": "romuscular Blockers\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRocuronium\u003c/b\u003e"
      }, {
        "text": " is an intermediate-acting, non-depolarizing \u003ci\u003eneuromuscular blocking agent\u003c/i\u003e of the aminosteroid class. It is widely"
      }, {
        "text": " used to provide skeletal muscle relaxation for endotracheal intubation and surgery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action"
      }, {
        "text": ":\u003c/b\u003e Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing [[6a005559"
      }, {
        "text": "|acetylcholine]] from binding and causing muscle contraction.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a \u003cmark\u003erapid"
      }, {
        "text": " onset\u003c/mark\u003e of action, making it a common alternative to succinylcholine for rapid sequence intubation when succinylcholine is contraindicated.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Metabolism:\u003c/b\u003e Primarily eliminated unchanged by the liver (biliary excretion). Its duration can be prolonged in patients with hepatic"
      }, {
        "text": " failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Generally hemodynamically stable with minimal histamine release.\u003c/li\u003e\u003cli\u003e\u003cb\u003eReversal:"
      }, {
        "text": "\u003c/b\u003e The blockade can be reversed by [[0835ea01|acetylcholinesterase inhibitors]] (e."
      }, {
        "text": "g., neostigmine) or, more rapidly and completely, by \u003cmark\u003esugammadex\u003c/mark\u003e, a specific binding"
      }, {
        "text": " agent for rocuronium and vecuronium.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Rocuronium is a popular non"
      }, {
        "text": "-depolarizing blocker because of its rapid onset. Know that its reversal can be achieved with either traditional cholinesterase inhibitors or the"
      }, {
        "text": " specific reversal agent, sugammadex.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRocuronium"
      }, {
        "text": "\u003c/b\u003e is a fast-acting, non-depolarizing muscle relaxant that provides a safe and effective alternative to succinylcholine for rapid"
      }, {
        "text": " sequence intubation, with the added advantage of being reversible by the specific agent sugammadex.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    "
      }, {
        "text": "},\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\","
      }, {
        "text": "\n        \"to\": \"nondepolarizing_neuromuscular_blocker\"\n      },\n      {\n        \"type"
      }, {
        "text": "\": \"is_reversed_by\",\n        \"to\": \"0835ea01\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_reversed_by\",\n        \"to\": \"sug"
      }, {
        "text": "ammadex\"\n      }\n    ]\n  },\n  \"47a0f3d1\": {\n    \"title\":"
      }, {
        "text": " \"Romberg Sign\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Sensory Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eThe \u003cb\u003eRomberg sign\u003c/b\u003e is a clinical sign of sensory ataxia, elicited by having a patient stand with their"
      }, {
        "text": " feet together and then close their eyes. A positive sign is a significant worsening of unsteadiness or a loss of balance with"
      }, {
        "text": " eye closure.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePurpose:\u003c/b\u003e The test is used to differentiate sensory"
      }, {
        "text": " ataxia from cerebellar ataxia.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiology of Balance:\u003c/b\u003e Balance is maintained by three sensory inputs: proprioception (position"
      }, {
        "text": " sense), vestibular input, and vision. At least two of these three must be intact.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePositive Romberg Sign:\u003c/b\u003e A"
      }, {
        "text": " positive sign indicates a deficit in \u003cmark\u003eproprioception\u003c/mark\u003e. The patient is able to compensate for the proprio"
      }, {
        "text": "ceptive loss by using visual input. When the eyes are closed, this compensation is removed, and the unsteadiness becomes apparent.\u003c/li\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Associated Conditions:\u003c/b\u003e A positive Romberg sign points to a lesion in the \u003cmark\u003e[[e7f5cb"
      }, {
        "text": "be|dorsal columns]]\u003c/mark\u003e of the spinal cord or in the peripheral nerves. It is a classic finding in [[71"
      }, {
        "text": "daebd6|tabes dorsalis]] (neurosyphilis) and [[6f5bea90|subacute"
      }, {
        "text": " combined degeneration]] (B\u003csub\u003e12\u003c/sub\u003e deficiency).\u003c/li\u003e\u003cli\u003e\u003cb\u003eNegative Romberg Sign:\u003c/b\u003e If a patient is unsteady"
      }, {
        "text": " with their eyes open and this does not significantly worsen with eye closure, the ataxia is likely cerebellar in origin.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip"
      }, {
        "text": ":\u003c/b\u003e A positive Romberg test is a test of proprioception, \u003cu\u003enot\u003c/u\u003e cerebellar function.\u003c/li\u003e\u003c/ul\u003e\",\n      \""
      }, {
        "text": "takeAway\": \"\u003cp\u003eThe \u003cb\u003eRomberg sign\u003c/b\u003e is a simple yet elegant test that unmasks a deficit in proprioception by"
      }, {
        "text": " removing the visual compensation the patient relies on to maintain balance, thereby pointing to a lesion in the dorsal columns or peripheral nerves.\u003c/p\u003e\",\n"
      }, {
        "text": "      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_sign_of\",\n        \"to\": \"sensory_ataxia\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"indicates_lesion_in\",\n        \"to\": \"e7f5cbbe\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_positive_in\",\n        \"to\": \"71daebd"
      }, {
        "text": "6\"\n      },\n      {\n        \"type\": \"is_positive_in\",\n        \"to"
      }, {
        "text": "\": \"6f5bea90\"\n      }\n    ]\n  },\n  \"104"
      }, {
        "text": "76fc2\": {\n    \"title\": \"Rooting Reflex\",\n    \"primaryType\": \"physiology"
      }, {
        "text": "\",\n    \"tags\": [\n      \"Pediatrics\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology"
      }, {
        "text": "\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eroot"
      }, {
        "text": "ing reflex\u003c/b\u003e is a primitive reflex present in newborns that helps them find the breast or bottle to begin feeding. It is elicited"
      }, {
        "text": " by stroking the corner of the infant\u0027s mouth or cheek.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Elicitation:\u003c/b\u003e Gently stroke the infant\u0027s cheek near the corner of the mouth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNormal Response"
      }, {
        "text": ":\u003c/b\u003e The infant will turn their head toward the side of the stimulus and open their mouth in an attempt to suck."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eTimeline:\u003c/b\u003e Present at birth and typically disappears by 4 months of age as it becomes a voluntary action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Significance:\u003c/b\u003e It is one of several primitive reflexes tested in the newborn neurological exam to assess brainstem function and development. Its"
      }, {
        "text": " absence may indicate CNS depression or injury.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRe-emergence:\u003c/b\u003e The reappearance of the rooting reflex in an adult is"
      }, {
        "text": " an abnormal finding known as a frontal release sign, indicating damage to the [[0405ada3|frontal lobe]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The rooting reflex is a normal, adaptive reflex in a newborn. Its persistence beyond"
      }, {
        "text": " infancy or its re-emergence in an adult is pathological.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe"
      }, {
        "text": " \u003cb\u003erooting reflex\u003c/b\u003e is an innate, automatic head-turning and mouth-opening response in infants that facilitates breastfeeding"
      }, {
        "text": ", which is normally suppressed by the maturing frontal lobes after a few months of life.\u003c/p\u003e\",\n      \"mermaid\":"
      }, {
        "text": " \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \""
      }, {
        "text": "to\": \"primitive_reflex\"\n      },\n      {\n        \"type\": \"re-emergence_"
      }, {
        "text": "indicates\",\n        \"to\": \"frontal_lobe_damage\"\n      }\n    ]\n  },\n  \"1"
      }, {
        "text": "6a1a322\": {\n    \"title\": \"Ropinirole\",\n    \"primaryType"
      }, {
        "text": "\": \"drug\",\n    \"tags\": [\n      \"Pharmacology\",\n      \"Neurology\",\n      "
      }, {
        "text": "\"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\","
      }, {
        "text": "\n      \"Pharmacology\",\n      \"Parkinson Disease Therapy\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eRopinirole\u003c/b\u003e is a non-ergot \u003ci\u003edopamine agonist\u003c/i\u003e used"
      }, {
        "text": " for the treatment of [[58c8ea03|Parkinson disease]] and restless legs syndrome.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Directly stimulates dopamine D\u003csub\u003e2\u003c/sub\u003e and D\u003csub\u003e3\u003c/sub\u003e receptors in the brain, mimicking"
      }, {
        "text": " the effect of dopamine.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Non-ergot dopamine agonist, along with pramipexole. These"
      }, {
        "text": " are preferred over older ergot derivatives like [[d24a5ff0|bromocriptine]] due to a better side"
      }, {
        "text": " effect profile.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use (Parkinson\u0027s):\u003c/b\u003e Used as monotherapy in younger patients to delay the need"
      }, {
        "text": " for levodopa, or as an adjunct to levodopa in older patients to reduce motor fluctuations (\u0027off\u0027 time).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Use (Other):\u003c/b\u003e A first-line treatment for moderate to severe [[919caff2|restless legs syndrome]]."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdverse Effects:\u003c/b\u003e Nausea, postural hypotension, somnolence (including sudden-onset \u0027sleep attacks\u0027),"
      }, {
        "text": " and hallucinations. A notable side effect is \u003cmark\u003eimpulse control disorders\u003c/mark\u003e (e.g., pathological gambling, compulsive"
      }, {
        "text": " shopping).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Ropinirole and pramipexole are the main non-ergot dopamine agonists."
      }, {
        "text": " Remember their use in both Parkinson\u0027s and restless legs syndrome, and be aware of the unique side effect of impulse control disorders.\u003c/li\u003e"
      }, {
        "text": "\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRopinirole\u003c/b\u003e is a non-ergot dopamine agonist that directly stimulates"
      }, {
        "text": " dopamine receptors to compensate for the deficiency in Parkinson\u0027s disease, but its use can be complicated by CNS side effects,"
      }, {
        "text": " including the unusual development of impulse control disorders.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n"
      }, {
        "text": "      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"c36"
      }, {
        "text": "650bd\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"58c"
      }, {
        "text": "8ea03\"\n      },\n      {\n        \"type\": \"treats\",\n        \"to\": \"919"
      }, {
        "text": "caff2\"\n      },\n      {\n        \"type\": \"causes_adverse_effect\",\n        \"to\": \"impulse"
      }, {
        "text": "_control_disorder\"\n      }\n    ]\n  },\n  \"52e3038"
      }, {
        "text": "a\": {\n    \"title\": \"Ropivacaine\",\n    \"primaryType\": \"drug\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pharmacology\",\n      \"Anesthesiology\",\n      \"USMLE\"\n    "
      }, {
        "text": "],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pharmacology\","
      }, {
        "text": "\n      \"Anesthetics\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRopivacaine\u003c/b\u003e"
      }, {
        "text": " is a long-acting, amide-type \u003ci\u003elocal anesthetic\u003c/i\u003e. It is structurally similar to [[181"
      }, {
        "text": "a22b1|bupivacaine]] but is associated with a lower risk of cardiotoxicity.\u003c/p\u003e\","
      }, {
        "text": "\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eMechanism of Action:\u003c/b\u003e Blocks voltage-gated Na\u003csup\u003e+\u003c/sup\u003e channels in nerve"
      }, {
        "text": " membranes, preventing the generation and conduction of nerve impulses.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClass:\u003c/b\u003e Amide local anesthetic (has two \u0027i"
      }, {
        "text": "\u0027s in its name).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePharmacokinetics:\u003c/b\u003e Has a long duration of action.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Use:\u003c/b\u003e Used"
      }, {
        "text": " for regional anesthesia, including epidural, spinal, and peripheral nerve blocks for surgery and postoperative pain control.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdv"
      }, {
        "text": "antage over Bupivacaine:\u003c/b\u003e It is less cardiotoxic than [[181a22b1|"
      }, {
        "text": "bupivacaine]], making it a safer choice, especially for techniques that carry a higher risk of systemic absorption. It"
      }, {
        "text": " also produces a greater degree of motor block relative to sensory block (\u0027motor-sensory separation\u0027).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Ropivacaine"
      }, {
        "text": " is the \u0027safer bupivacaine.\u0027 It offers a similar long duration of action with a reduced risk of life"
      }, {
        "text": "-threatening cardiac arrhythmias.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRopivacaine\u003c/b\u003e is a long"
      }, {
        "text": "-acting amide local anesthetic that provides effective regional anesthesia with a better cardiovascular safety profile than its predecessor, bupivacaine.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"local_anesthetics\"\n      },\n      {\n        \"type\": \"is_sa"
      }, {
        "text": "fer_than\",\n        \"to\": \"181a22b1\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"blocks_channel\",\n        \"to\": \"voltage_gated_sodium_channel\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"c04f05c0\": {\n    \"title\": \"Rosenthal Fib"
      }, {
        "text": "ers\",\n    \"primaryType\": \"pathology\",\n    \"tags\": [\n      \"Neuropathology\",\n      \"On"
      }, {
        "text": "cology\",\n      \"Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology"
      }, {
        "text": " and Special Senses\",\n      \"Pathology\",\n      \"Brain Tumors\"\n    ],\n    \""
      }, {
        "text": "content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRosenthal fibers\u003c/b\u003e are thick, elongated, eosinophilic (pink"
      }, {
        "text": "), corkscrew-shaped protein aggregates found in the cytoplasm of astrocytes. They are a characteristic histological finding in certain slow-growing glial processes"
      }, {
        "text": " and tumors.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eAppearance:\u003c/b\u003e On H\u0026E stain, they"
      }, {
        "text": " appear as bright pink, irregular, rope-like or \u0027corkscrew\u0027 inclusions within astrocytic processes.\u003c/li\u003e\u003cli\u003e\u003cb\u003eComposition"
      }, {
        "text": ":\u003c/b\u003e Composed of aggregates of intermediate filament proteins, including glial fibrillary acidic protein (GFAP), along with heat"
      }, {
        "text": " shock proteins.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e They are the histological hallmark of a \u003cmark\u003epilocytic ast"
      }, {
        "text": "rocytoma\u003c/mark\u003e, the most common primary brain tumor in children.\u003c/li\u003e\u003cli\u003e\u003cb\u003eOther Conditions:\u003c/b\u003e Can also be seen"
      }, {
        "text": " in areas of long-standing gliosis and in Alexander disease, a rare leukodystrophy.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e The presence of Rosenthal fibers in a biopsy of a pediatric cerebellar cystic tumor is diagnostic for pilocytic astrocytoma."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRosenthal fibers\u003c/b\u003e are distinctive eosinophilic, corkscrew-shaped inclusions that are"
      }, {
        "text": " the microscopic signature of a pilocytic astrocytoma, representing aggregates of glial proteins within the tumor cells.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous"
      }, {
        "text": "_with\",\n        \"to\": \"208cebcd\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_hallmark_of\",\n        \"to\": \"pilocytic_astrocytoma\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_found_in\",\n        \"to\": \"819"
      }, {
        "text": "2f595\"\n      },\n      {\n        \"type\": \"is_composed_of\",\n"
      }, {
        "text": "        \"to\": \"fb50d450\"\n      }\n    ]\n  },\n  \"3"
      }, {
        "text": "c284a14\": {\n    \"title\": \"Ruffini Corpuscles\",\n    \"primaryType\":"
      }, {
        "text": " \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"Histology\","
      }, {
        "text": "\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \""
      }, {
        "text": "Anatomy and Physiology\",\n      \"Sensory Receptors\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eRuffini corpuscles\u003c/b\u003e (or Ruffini endings) are slowly adapting mechanoreceptors found in the skin and joint"
      }, {
        "text": " capsules that are sensitive to sustained pressure and skin stretch.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eStructure"
      }, {
        "text": ":\u003c/b\u003e Spindle-shaped, encapsulated receptors located in the deep dermis and subcutaneous tissue.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e They respond"
      }, {
        "text": " to \u003cmark\u003esustained pressure and skin stretch\u003c/mark\u003e. They are also thought to contribute to the perception of warmth"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eAdaptation:\u003c/b\u003e They are \u003cmark\u003eslowly adapting\u003c/mark\u003e, meaning they continue to fire action"
      }, {
        "text": " potentials as long as the stimulus is present. This allows for the perception of constant stimuli.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Significance:\u003c/b\u003e They contribute"
      }, {
        "text": " to our ability to perceive the shape of objects held in the hand and to sense finger position and movement.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e Differentiate slowly adapting receptors (Ruffini, Merkel) from rapidly adapting receptors (Pacinian, Meissner). Slowly"
      }, {
        "text": " adapting receptors are good for sensing static properties like pressure and shape, while rapidly adapting receptors are good for sensing dynamic properties like vibration and"
      }, {
        "text": " texture changes.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRuffini corpuscles\u003c/b\u003e are the"
      }, {
        "text": " skin\u0027s stretch detectors, slowly adapting mechanoreceptors that provide continuous information about sustained pressure and the distortion of the skin, crucial"
      }, {
        "text": " for proprioception and grip control.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"6d676aba"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"detects\",\n        \"to\": \"pressure_and_stretch\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_a\",\n        \"to\": \"slowly_adapting_receptor\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"a1647fb2\": {\n    \"title\":"
      }, {
        "text": " \"Saccular Aneurysms\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neu"
      }, {
        "text": "rology\",\n      \"Neurosurgery\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": ["
      }, {
        "text": "\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Cerebrovascular Disease"
      }, {
        "text": "\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eSaccular aneurys"
      }, {
        "text": "ms\u003c/b\u003e, also known as berry aneurysms, are thin-walled, sac-like outpouchings of a"
      }, {
        "text": " cerebral artery, typically located at arterial branch points within the [[e22300e8|Circle of Willis"
      }, {
        "text": "]]. Their rupture is the most common cause of non-traumatic [[63f8b05f|subarachnoid hemorrhage]].\u003c/"
      }, {
        "text": "p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Most commonly found at the junction of the [["
      }, {
        "text": "bd802d22|anterior communicating artery (AComA)]] with the anterior cerebral artery. The"
      }, {
        "text": " second most common site is the junction of the posterior communicating artery (PComA) with the internal carotid artery.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePath"
      }, {
        "text": "ophysiology:\u003c/b\u003e Believed to form due to a congenital weakness in the vessel wall at arterial bifurcations, which is exacerbated over"
      }, {
        "text": " time by hemodynamic stress from hypertension.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Increased incidence in patients with \u003cmark\u003eAutosomal Dominant Polycystic Kidney"
      }, {
        "text": " Disease (ADPKD)\u003c/mark\u003e, Ehlers-Danlos syndrome, and Marfan syndrome.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePresentation"
      }, {
        "text": ":\u003c/b\u003e Usually asymptomatic until rupture. Rupture causes a [[63f8b05f|subarachnoid hemorrhage]],"
      }, {
        "text": " presenting with a sudden, explosive \u003cmark\u003e\\\"worst headache of my life.\\\"\u003c/mark\u003e A large, unruptured aneurysm can cause"
      }, {
        "text": " symptoms by compressing adjacent structures (e.g., a PComA aneurysm compressing CN III).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A"
      }, {
        "text": " patient with ADPKD who develops a sudden, severe headache should be immediately evaluated for a ruptured saccular aneurysm.\u003c/li\u003e\u003c/ul\u003e"
      }, {
        "text": "\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSaccular aneurysms\u003c/b\u003e are silent vascular time bombs located"
      }, {
        "text": " at the branch points of the Circle of Willis; their rupture leads to a devastating subarachnoid hemorrhage, classically presenting as"
      }, {
        "text": " a \u0027thunderclap headache\u0027.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Arterial Bif"
      }, {
        "text": "urcation in Circle of Willis] --\u003e B(Congenital Wall Weakness); B --Hypertension--\u003e C(S"
      }, {
        "text": "accular Aneurysm Formation); C --\u003e D{Rupture}; D --\u003e E[Subarachnoid Hem"
      }, {
        "text": "orrhage];\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_"
      }, {
        "text": "synonymous_with\",\n        \"to\": \"a9f6d703\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"is_a_type_of\",\n        \"to\": \"a7f9"
      }, {
        "text": "7d7f\"\n      },\n      {\n        \"type\": \"rupture_causes\",\n        \"to\": \"63"
      }, {
        "text": "f8b05f\"\n      },\n      {\n        \"type\": \"is_associated_with"
      }, {
        "text": "\",\n        \"to\": \"autosomal_dominant_polycystic_kidney_disease\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"8e14cc0d\": {\n    \"title\":"
      }, {
        "text": " \"Satellite Cells (PNS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \""
      }, {
        "text": "Histology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Glial Cells\"\n    ],\n    \"content\": {\n      "
      }, {
        "text": "\"definition\": \"\u003cp\u003e\u003cb\u003eSatellite cells\u003c/b\u003e are a type of glial cell found in the peripheral nervous system (PNS)."
      }, {
        "text": " They form a thin sheath around the cell bodies of neurons located in the peripheral ganglia (e.g., dorsal root ganglia,"
      }, {
        "text": " autonomic ganglia).\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eOrigin:\u003c/b\u003e Derived from the [[1"
      }, {
        "text": "4c6f2a7|neural crest]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e Surround neuronal cell bodies within PNS ganglia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e"
      }, {
        "text": " They provide structural support and regulate the chemical microenvironment of the neurons they surround, similar to the role of [[8192f595|"
      }, {
        "text": "astrocytes]] in the CNS. They help control the extracellular environment by absorbing neurotransmitters and supplying nutrients to the neurons.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Relevance:\u003c/b\u003e Can be involved in neuropathic pain states and may be affected by viral infections like Herpes Simplex Virus,"
      }, {
        "text": " which establishes latency in sensory ganglia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Associate satellite cells with the support of neuronal cell bodies in the"
      }, {
        "text": " PNS, just as astrocytes support neurons in the CNS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eSatellite cells\u003c/b\u003e are the dedicated"
      }, {
        "text": " support cells for neuronal cell bodies in the peripheral nervous system, acting as a protective and homeostatic buffer around the ganglia.\u003c/"
      }, {
        "text": "p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is"
      }, {
        "text": "_a_type_of\",\n        \"to\": \"0bd25f41\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"surrounds\",\n        \"to\": \"pns_neuronal_cell_bodies\"\n      "
      }, {
        "text": "},\n      {\n        \"type\": \"is_analogous_to\",\n        \"to\": \"8"
      }, {
        "text": "192f595\"\n      }\n    ]\n  }\n}\n```"
      }]
    }, {
      "text": "```json\n[\n  {\n    \"id\": \"e617dfab\",\n    \"letter\": \"R\",\n    \"term\": \"Recklinghausen disease\",\n    \"pages\": [\n      \"539\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Recklinghausen disease\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f5dfa5c6\",\n    \"letter\": \"R\",\n    \"term\": \"Reflexes\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Reflexes\",\n    \"sub_entries\": [\n      {\n        \"id\": \"2bd3b1f4\",\n        \"letter\": \"R\",\n        \"term\": \"cranial nerves\",\n        \"pages\": [\n          \"519\"\n        ],\n        \"context\": \"Reflexes \u003e cranial nerves\"\n      },\n      {\n        \"id\": \"5f0ef9f2\",\n        \"letter\": \"R\",\n        \"term\": \"grading of\",\n        \"pages\": [\n          \"523\"\n        ],\n        \"context\": \"Reflexes \u003e grading of\"\n      },\n      {\n        \"id\": \"d98b2042\",\n        \"letter\": \"R\",\n        \"term\": \"motor neuron signs\",\n        \"pages\": [\n          \"543\"\n        ],\n        \"context\": \"Reflexes \u003e motor neuron signs\"\n      },\n      {\n        \"id\": \"54d730f4\",\n        \"letter\": \"R\",\n        \"term\": \"primitive\",\n        \"pages\": [\n          \"523\"\n        ],\n        \"context\": \"Reflexes \u003e primitive\"\n      },\n      {\n        \"id\": \"29dcd24c\",\n        \"letter\": \"R\",\n        \"term\": \"spinal (clinical)\",\n        \"pages\": [\n          \"523\"\n        ],\n        \"context\": \"Reflexes \u003e spinal (clinical)\"\n      }\n    ]\n  },\n  {\n    \"id\": \"d720eaaf\",\n    \"letter\": \"R\",\n    \"term\": \"Refractive errors (vision)\",\n    \"pages\": [\n      \"549\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Refractive errors (vision)\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"8a1f3476\",\n    \"letter\": \"R\",\n    \"term\": \"Relative afferent pupillary defect\",\n    \"pages\": [\n      \"554\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Relative afferent pupillary defect\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"2821b1d1\",\n    \"letter\": \"R\",\n    \"term\": \"REM (rapid eye movement) sleep\",\n    \"pages\": [\n      \"507\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"REM (rapid eye movement) sleep\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"63b44bb7\",\n    \"letter\": \"R\",\n    \"term\": \"REM sleep behavior disorder\",\n    \"pages\": [\n      \"507\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"REM sleep behavior disorder\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"e4f62793\",\n    \"letter\": \"R\",\n    \"term\": \"Respiratory failure\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Respiratory failure\",\n    \"sub_entries\": [\n      {\n        \"id\": \"53a74de8\",\n        \"letter\": \"R\",\n        \"term\": \"disorders\",\n        \"pages\": [\n          \"538\"\n        ],\n        \"context\": \"Respiratory failure \u003e disorders\"\n      }\n    ]\n  },\n  {\n    \"id\": \"5dc2069f\",\n    \"letter\": \"R\",\n    \"term\": \"Resting tremor\",\n    \"pages\": [\n      \"533\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Resting tremor\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"919caff2\",\n    \"letter\": \"R\",\n    \"term\": \"Restless legs syndrome\",\n    \"pages\": [\n      \"533\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Restless legs syndrome\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"7e0e7c86\",\n    \"letter\": \"R\",\n    \"term\": \"Reticular activating system, lesion\",\n    \"pages\": [],\n    \"type\": \"main_entry\",\n    \"context\": \"Reticular activating system, lesion\",\n    \"sub_entries\": [\n      {\n        \"id\": \"8ccc17b9\",\n        \"letter\": \"R\",\n        \"term\": \"effects\",\n        \"pages\": [\n          \"524\"\n        ],\n        \"context\": \"Reticular activating system, lesion \u003e effects\"\n      }\n    ]\n  },\n  {\n    \"id\": \"ae06ecfa\",\n    \"letter\": \"R\",\n    \"term\": \"Retinal artery occlusion\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Retinal artery occlusion\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"38c092f9\",\n    \"letter\": \"R\",\n    \"term\": \"Retinal detachment\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Retinal detachment\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"a52e7422\",\n    \"letter\": \"R\",\n    \"term\": \"Retinal disorders\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Retinal disorders\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"0b8cd9eb\",\n    \"letter\": \"R\",\n    \"term\": \"Retinal vein occlusion\",\n    \"pages\": [\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Retinal vein occlusion\",\n    \"sub_entries\": []\n  },\n  {\n    \"id\": \"f7063b6e\",\n    \"letter\": \"R\",\n    \"term\": \"Retinitis pigmentosa\",\n    \"pages\": [\n      \"92\",\n      \"552\"\n    ],\n    \"type\": \"main_entry\",\n    \"context\": \"Retinitis pigmentosa\",\n    \"sub_entries\": []\n  }\n]\n```\n\ncontinue",
      "role": "user",
      "tokenCount": 1731
    }, {
      "text": "```json\n{\n  \"e617dfab\": {\n    \"title\": \"Recklinghausen Disease (Neurofibromatosis Type 1)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Genetics\",\n      \"Oncology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRecklinghausen disease\u003c/b\u003e is the eponym for \u003cb\u003eNeurofibromatosis Type 1 (NF-1)\u003c/b\u003e, an autosomal dominant neurocutaneous disorder characterized by the growth of tumors along nerves and the presence of skin and eye findings.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Autosomal dominant mutation in the \u003ci\u003eNF1\u003c/i\u003e tumor suppressor gene on chromosome \u003cb\u003e17\u003c/b\u003e. Mnemonic: 17 letters in \u0027von Recklinghausen\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The NF1 gene encodes neurofibromin, a negative regulator of the RAS signaling pathway. Loss of function leads to uncontrolled cell growth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Features (Mnemonic CICLOPSS):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003eaf√©-au-lait spots: Hyperpigmented macules with smooth borders (\u0027coast of California\u0027).\u003cbr\u003e - \u003cb\u003eI\u003c/b\u003entellectual disability (learning disabilities are common).\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003eutaneous neurofibromas: Benign nerve sheath tumors.\u003cbr\u003e - \u003cb\u003eL\u003c/b\u003eisch nodules: Pigmented hamartomas in the iris.\u003cbr\u003e - \u003cb\u003eO\u003c/b\u003eptic gliomas.\u003cbr\u003e - \u003cb\u003eP\u003c/b\u003eheochromocytomas.\u003cbr\u003e - \u003cb\u003eS\u003c/b\u003eeizures / \u003cb\u003eS\u003c/b\u003ephenoid dysplasia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of ‚â•6 caf√©-au-lait spots and cutaneous neurofibromas is highly suggestive of NF-1.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRecklinghausen disease (NF-1)\u003c/b\u003e is a multisystem genetic disorder caused by a faulty tumor suppressor gene, leading to a characteristic constellation of skin findings (caf√©-au-lait spots, neurofibromas), eye findings (Lisch nodules), and an increased risk of various tumors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"neurofibromatosis_type_1\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"neurocutaneous_disorder\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"cbb4285c\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"lisch_nodules\"\n      }\n    ]\n  },\n  \"f5dfa5c6\": {\n    \"title\": \"Reflexes\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eReflexes\u003c/b\u003e are involuntary and nearly instantaneous movements in response to a stimulus, mediated by a neural pathway called a reflex arc. They are fundamental to the neurological examination for assessing the integrity of the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eSpinal (Clinical) Reflexes:\u003c/b\u003e Test specific spinal nerve roots.\u003cbr\u003e - \u003cb\u003eDeep Tendon Reflexes (DTRs):\u003c/b\u003e Monosynaptic stretch reflexes (e.g., patellar, Achilles).\u003cbr\u003e - \u003cb\u003eSuperficial Reflexes:\u003c/b\u003e Polysynaptic (e.g., cremasteric, anal wink).\u003c/li\u003e\u003cli\u003e\u003cb\u003eCranial Nerve Reflexes:\u003c/b\u003e Test brainstem integrity.\u003cbr\u003e - \u003cb\u003ePupillary Light Reflex:\u003c/b\u003e CN II (afferent), CN III (efferent).\u003cbr\u003e - \u003cb\u003eCorneal Reflex:\u003c/b\u003e CN V\u003csub\u003e1\u003c/sub\u003e (afferent), CN VII (efferent).\u003cbr\u003e - \u003cb\u003eGag Reflex:\u003c/b\u003e CN IX (afferent), CN X (efferent).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimitive Reflexes:\u003c/b\u003e Present in infants (e.g., Moro, rooting, Babinski) and disappear as the CNS matures. Their re-emergence in adults indicates frontal lobe damage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eGrading of DTRs:\u003c/b\u003e A scale from 0 (absent) to 4+ (clonus). 2+ is normal. Hyporeflexia (0, 1+) suggests an LMN lesion. Hyperreflexia (3+, 4+) suggests a UMN lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The state of the reflexes is a primary tool for differentiating between upper and lower motor neuron lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe testing of \u003cb\u003ereflexes\u003c/b\u003e, from the simple knee-jerk to complex cranial nerve reflexes, provides a direct and objective assessment of the functional integrity of specific pathways throughout the central and peripheral nervous system.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \"to\": \"2915ead0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"76044e89\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"cranial_nerve_reflexes\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"primitive_reflexes\"\n      }\n    ]\n  },\n  \"d720eaaf\": {\n    \"title\": \"Refractive Errors\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Refractive Errors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRefractive errors\u003c/b\u003e are a group of common vision problems that occur when the shape of the eye prevents light from focusing directly on the retina, resulting in blurred vision. They are corrected with eyeglasses, contact lenses, or surgery.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[myopia|Myopia]] (Nearsightedness):\u003c/b\u003e Light focuses \u003cu\u003ein front of\u003c/u\u003e the retina, either because the eyeball is too long or the lens/cornea system is too powerful. Distant objects are blurry. Corrected with a \u003cmark\u003econcave (-)\u003c/mark\u003e lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[62a81479|Hyperopia]] (Farsightedness):\u003c/b\u003e Light focuses \u003cu\u003ebehind\u003c/u\u003e the retina, either because the eyeball is too short or the lens/cornea system is too weak. Near objects are blurry. Corrected with a \u003cmark\u003econvex (+)\u003c/mark\u003e lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[18cff34e|Astigmatism]]:\u003c/b\u003e The cornea or lens has an irregular, non-spherical curvature, causing light to focus at multiple points. Vision is blurred at all distances. Corrected with a \u003cmark\u003ecylindrical\u003c/mark\u003e lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[presbyopia|Presbyopia]]:\u003c/b\u003e Age-related loss of accommodation, making it difficult to focus on near objects. Caused by stiffening of the lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the basic optics: Myopia needs a diverging (concave) lens to move the focal point back. Hyperopia needs a converging (convex) lens to move the focal point forward.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRefractive errors\u003c/b\u003e are a mismatch between the eye\u0027s focusing power and its length, leading to blurred vision that is correctable by using lenses to precisely adjust the path of light so it lands perfectly on the retina.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"myopia\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"62a81479\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"18cff34e\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"presbyopia\"\n      }\n    ]\n  },\n  \"8a1f3476\": {\n    \"title\": \"Relative Afferent Pupillary Defect (RAPD)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual Pathway\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eRelative Afferent Pupillary Defect (RAPD)\u003c/b\u003e, also known as a Marcus Gunn pupil, is a clinical sign indicating a decreased response to light in the afferent pathway of the pupillary light reflex in one eye relative to the other. It is detected using the swinging flashlight test.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by a unilateral or asymmetric lesion of the afferent visual pathway, anterior to the optic chiasm (i.e., in the retina or optic nerve).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSwinging Flashlight Test:\u003c/b\u003e A light is swung back and forth between the two eyes. In a normal individual, both pupils will remain constricted. In a patient with an RAPD in the right eye, when the light is swung from the normal left eye to the abnormal right eye, both pupils will paradoxically \u003cmark\u003edilate\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExplanation:\u003c/b\u003e The affected eye perceives the bright light as if it were dim, so the direct response is weak. When the light swings from the good eye (which caused strong bilateral constriction) to the bad eye, the weaker signal from the bad eye is not enough to maintain the constriction, and both pupils dilate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Cause:\u003c/b\u003e The most common cause is a lesion of the optic nerve, such as \u003cmark\u003e[[98a63a59|optic neuritis]]\u003c/mark\u003e (often seen in [[45dd6d19|multiple sclerosis]]). Other causes include severe retinal disease or [[3334840f|central retinal artery occlusion]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An RAPD is a sign of an afferent pathway problem, not an efferent (CN III) problem. The pupils themselves are capable of constricting; the problem is that the brain isn\u0027t receiving a strong enough \u0027light on\u0027 signal from the affected eye.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eRelative Afferent Pupillary Defect\u003c/b\u003e is a subtle but crucial sign of unilateral optic nerve or retinal disease, unmasked by the swinging flashlight test, where the pupils paradoxically dilate when light is shone into the affected eye because the \u0027light signal\u0027 it sends to the brain is weaker than the consensual signal it was just receiving from the healthy eye.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\": \"optic_nerve_lesion\"\n      },\n      {\n        \"type\": \"is_a_classic_sign_of\",\n        \"to\": \"98a63a59\"\n      },\n      {\n        \"type\": \"is_detected_by\",\n        \"to\": \"swinging_flashlight_test\"\n      }\n    ]\n  },\n  \"2821b1d1\": {\n    \"title\": \"REM Sleep\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Sleep\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRapid Eye Movement (REM) sleep\u003c/b\u003e is a unique stage of sleep characterized by random rapid movement of the eyes, accompanied by low muscle tone throughout the body, and the propensity of the sleeper to dream vividly.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEEG Pattern:\u003c/b\u003e EEG shows low-voltage, high-frequency, sawtooth waves, which resembles the EEG of an awake, active brain. This is why it is often called \u003cmark\u003e\u0027paradoxical sleep\u0027\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiological Changes:\u003c/b\u003e Characterized by rapid eye movements, muscle atonia (paralysis of major voluntary muscles), and variable heart rate and respiration. Penile/clitoral tumescence also occurs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e Believed to be crucial for memory consolidation, emotional processing, and brain development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDreaming:\u003c/b\u003e The majority of vivid, story-like dreaming occurs during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[63b44bb7|REM Sleep Behavior Disorder]]:\u003c/b\u003e A parasomnia where the normal muscle atonia of REM sleep is absent, causing individuals to physically act out their dreams.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e REM sleep increases in duration and frequency in the later part of the night. Alcohol and benzodiazepines are known to suppress REM sleep.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eREM sleep\u003c/b\u003e is a paradoxical state where the brain is highly active, as if awake, yet the body is almost completely paralyzed, creating the ideal stage for vivid dreaming without the risk of physical enactment.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_stage_of\",\n        \"to\": \"6ab72a5a\"\n      },\n      {\n        \"type\": \"is_dysregulated_in\",\n        \"to\": \"63b44bb7\"\n      },\n      {\n        \"type\": \"is_suppressed_by\",\n        \"to\": \"alcohol\"\n      },\n      {\n        \"type\": \"is_suppressed_by\",\n        \"to\": \"14464617\"\n      }\n    ]\n  },\n  \"63b44bb7\": {\n    \"title\": \"REM Sleep Behavior Disorder (RBD)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"Psychiatry\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder (RBD)\u003c/b\u003e is a parasomnia characterized by the loss of normal muscle atonia during REM sleep, leading to the physical enactment of vivid, often violent or action-filled dreams.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the brainstem mechanisms (particularly in the pons) that normally induce muscle paralysis during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may shout, punch, kick, or jump out of bed during sleep, corresponding to the content of their dreams. This can result in injury to the patient or their bed partner.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e RBD is a very strong predictor of future neurodegenerative disease, particularly \u003cmark\u003eŒ±-synucleinopathies\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Diseases:\u003c/b\u003e A majority of patients with idiopathic RBD will eventually develop [[58c8ea03|Parkinson disease]], [[db2f16e5|Lewy body dementia]], or multiple system atrophy, often years or decades after the onset of RBD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An older male patient who reports acting out violent dreams and has injured his spouse during sleep should raise immediate suspicion for REM Sleep Behavior Disorder, which should be considered a prodromal sign of Parkinson disease or Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder\u003c/b\u003e is more than just a sleep disturbance; it is a critical early warning sign of an underlying Œ±-synucleinopathy, where the failure to paralyze muscles during dreaming precedes the onset of motor and cognitive symptoms of diseases like Parkinson\u0027s by many years.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"parasomnia\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n        \"to\": \"db2f16e5\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"alpha_synucleinopathies\"\n      }\n    ]\n  },\n  \"e4f62793\": {\n    \"title\": \"Respiratory Failure\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Pulmonology\",\n      \"Critical Care\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Respiratory\",\n      \"Pathology\",\n      \"General\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRespiratory failure\u003c/b\u003e is a condition in which the respiratory system fails in one or both of its gas exchange functions: oxygenation and carbon dioxide elimination. It is classified as hypoxemic or hypercapnic.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypoxemic Respiratory Failure (Type 1):\u003c/b\u003e Characterized by low PaO\u003csub\u003e2\u003c/sub\u003e with a normal or low PaCO\u003csub\u003e2\u003c/sub\u003e. Caused by V/Q mismatch or shunting (e.g., pneumonia, ARDS, pulmonary embolism).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypercapnic Respiratory Failure (Type 2):\u003c/b\u003e Characterized by high PaCO\u003csub\u003e2\u003c/sub\u003e (with or without hypoxemia). Caused by inadequate alveolar ventilation (\u0027can\u0027t breathe\u0027) due to decreased respiratory drive, neuromuscular weakness, or increased dead space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuromuscular Causes:\u003c/b\u003e Several neurological disorders can lead to hypercapnic respiratory failure by weakening the muscles of respiration (diaphragm, intercostals).\u003cbr\u003e - \u003cb\u003e[[ed52e40b|Guillain-Barr√© Syndrome]]:\u003c/b\u003e Ascending paralysis can involve the diaphragm.\u003cbr\u003e - \u003cb\u003e[[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]:\u003c/b\u003e Progressive weakness of respiratory muscles is the usual cause of death.\u003cbr\u003e - \u003cb\u003eMyasthenia Gravis:\u003c/b\u003e A myasthenic crisis can cause acute respiratory failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with a known neuromuscular disorder, monitoring respiratory function (e.g., with vital capacity or negative inspiratory force measurements) is critical to anticipate and manage impending respiratory failure.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRespiratory failure\u003c/b\u003e in the context of neurological disease is typically a hypercapnic failure, a \u0027pump problem\u0027 where the muscles of breathing are too weak to adequately ventilate the lungs, leading to a buildup of carbon dioxide.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"ed52e40b\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \"to\": \"myasthenia_gravis\"\n      }\n    ]\n  },\n  \"5dc2069f\": {\n    \"title\": \"Resting Tremor\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eresting tremor\u003c/b\u003e is an involuntary, rhythmic, oscillatory movement that occurs when a body part is relaxed and completely supported against gravity. It is characteristically suppressed or diminished by voluntary movement.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDescription:\u003c/b\u003e A tremor that is present at rest. It often has a low frequency (4-6 Hz).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e The hallmark and often the first symptom of \u003cmark\u003e[[58c8ea03|Parkinson disease]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParkinsonian Tremor:\u003c/b\u003e Typically starts asymmetrically in one hand and has a characteristic \u003cmark\u003e\\\"pill-rolling\\\"\u003c/mark\u003e quality (a circular movement of the thumb and index finger).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by dysfunction in the [[ed462927|basal ganglia]], specifically the loss of dopaminergic neurons in the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It is crucial to differentiate a resting tremor from other types:\u003cbr\u003e - \u003cb\u003e[[40039e56|Essential Tremor]]:\u003c/b\u003e A postural and action tremor that is absent at rest.\u003cbr\u003e - \u003cb\u003eIntention Tremor:\u003c/b\u003e A tremor that worsens on goal-directed movement, indicative of a cerebellar lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A tremor that is present when the patient\u0027s hands are in their lap but disappears when they reach for an object is a resting tremor, and the most likely diagnosis is Parkinson disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eresting tremor\u003c/b\u003e is the classic \u0027pill-rolling\u0027 tremor of Parkinson disease, a sign of basal ganglia dysfunction that is uniquely present when the limb is at rest and paradoxically improves with voluntary action.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"1835cfef\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"40039e56\"\n      },\n      {\n        \"type\": \"differentiated_from\",\n        \"to\": \"intention_tremor\"\n      }\n    ]\n  },\n  \"919caff2\": {\n    \"title\": \"Restless Legs Syndrome (RLS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRestless Legs Syndrome (RLS)\u003c/b\u003e, also known as Willis-Ekbom disease, is a sensorimotor disorder characterized by an irresistible urge to move the legs, which is typically accompanied by or caused by uncomfortable and unpleasant sensations in the legs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDiagnostic Criteria (URGE):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eU\u003c/b\u003erge to move the legs.\u003cbr\u003e - \u003cb\u003eR\u003c/b\u003eest worsens the symptoms.\u003cbr\u003e - \u003cb\u003eG\u003c/b\u003eetting up and moving provides relief.\u003cbr\u003e - \u003cb\u003eE\u003c/b\u003evening and night are when symptoms are worse.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact cause is unknown, but it is strongly linked to \u003cmark\u003eiron deficiency\u003c/mark\u003e in the central nervous system (even with normal peripheral iron stores) and dysfunction of the dopaminergic system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary Causes:\u003c/b\u003e Can be secondary to iron deficiency anemia, pregnancy, end-stage renal disease, and [[5bc4bd07|diabetes mellitus]] (peripheral neuropathy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFirst-line:\u003c/b\u003e Address any underlying iron deficiency. Lifestyle modifications.\u003cbr\u003e - \u003cb\u003ePharmacotherapy:\u003c/b\u003e [[c36650bd|Dopamine agonists]] (e.g., pramipexole, [[16a1a322|ropinirole]]) or [[f608d2b0|gabapentinoids]] (gabapentin, pregabalin) are first-line agents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A patient complaining of an \u0027uncomfortable, creepy-crawly\u0027 sensation in their legs at night that is only relieved by getting up and walking is the classic presentation of RLS. The first step in workup is to check iron studies (ferritin).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRestless Legs Syndrome\u003c/b\u003e is a sensorimotor disorder driven by CNS iron deficiency and dopaminergic dysfunction, which creates an overwhelming urge to move the legs, particularly during periods of rest in the evening.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"iron_deficiency\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"5bc4bd07\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"c36650bd\"\n      },\n      {\n        \"type\": \"is_treated_by\",\n        \"to\": \"f608d2b0\"\n      }\n    ]\n  },\n  \"7e0e7c86\": {\n    \"title\": \"Reticular Activating System (RAS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": [\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      \"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eReticular Activating System (RAS)\u003c/b\u003e is a diffuse network of neurons located in the brainstem tegmentum that projects widely to the thalamus and cerebral cortex. It plays a crucial role in regulating wakefulness, arousal, and consciousness.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e A network of nuclei within the reticular formation of the brainstem (midbrain, pons, medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The RAS is the \u0027on switch\u0027 for the brain. It filters incoming sensory stimuli and projects to the cortex (via the thalamus) to maintain a state of alertness and consciousness.\u003c/li\u003e\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Damage to the RAS can lead to a profound reduction in arousal and wakefulness, resulting in \u003cmark\u003e[[d36eed18|coma]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of Damage:\u003c/b\u003e Lesions can be structural (e.g., brainstem stroke, hemorrhage, tumor, herniation) or metabolic/toxic (e.g., drug overdose, hypoglycemia, hypoxia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Consciousness is maintained by either two functioning cerebral hemispheres or one functioning brainstem (specifically the RAS). Therefore, coma can result from either bilateral hemispheric damage or a focal brainstem lesion affecting the RAS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eReticular Activating System\u003c/b\u003e is the brain\u0027s arousal center, a brainstem network that constantly bombards the cortex with activating signals to maintain consciousness; its failure leads to the profound unconsciousness of coma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A[Sensory Input] --\u003e B(Reticular Activating System); B --\u003e C(Thalamus); C --\u003e D(Cerebral Cortex); D --\u003e E(Arousal/Consciousness);\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_located_in\",\n        \"to\": \"582d8572\"\n      },\n      {\n        \"type\": \"regulates\",\n        \"to\": \"consciousness\"\n      },\n      {\n        \"type\": \"lesion_causes\",\n        \"to\": \"d36eed18\"\n      }\n    ]\n  },\n  \"ae06ecfa\": {\n    \"title\": \"Retinal Artery Occlusion\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinal artery occlusion\u003c/b\u003e is the blockage of the central retinal artery or one of its branches, leading to acute ischemia of the inner retina and sudden, painless vision loss. It is considered an ocular stroke.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[3334840f|Central Retinal Artery Occlusion (CRAO)]]:\u003c/b\u003e Blockage of the main retinal artery. Causes severe, profound vision loss affecting the entire visual field.\u003cbr\u003e - \u003cb\u003eBranch Retinal Artery Occlusion (BRAO):\u003c/b\u003e Blockage of a smaller branch. Causes a sectoral visual field defect.\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an embolus from an atherosclerotic plaque in the ipsilateral carotid artery or from the heart (e.g., atrial fibrillation). Giant cell arteritis is an important cause to consider in the elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, monocular vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e Classic findings include a \u003cmark\u003epale, edematous retina\u003c/mark\u003e and a \u003cmark\u003e\\\"cherry-red spot\\\"\u003c/mark\u003e at the macula in CRAO. In BRAO, the findings are localized to a sector of the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The \u0027cherry-red spot\u0027 is pathognomonic for CRAO. This is an ophthalmologic emergency requiring immediate evaluation for stroke risk factors.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eretinal artery occlusion\u003c/b\u003e is an ischemic stroke of the eye, where an embolus lodges in the retinal circulation, causing sudden, painless blindness and the classic fundoscopic sign of a cherry-red spot on a pale retina.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"3334840f\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"branch_retinal_artery_occlusion\"\n      },\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"ischemic_stroke\"\n      }\n    ]\n  },\n  \"38c092f9\": {\n    \"title\": \"Retinal Detachment\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eretinal detachment\u003c/b\u003e is a serious eye condition where the neurosensory retina separates from the underlying retinal pigment epithelium (RPE), depriving the photoreceptors of their blood supply from the choroid.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[f48498a3|Rhegmatogenous]]:\u003c/b\u003e Most common. Caused by a full-thickness retinal tear that allows liquefied vitreous to seep underneath the retina.\u003cbr\u003e - \u003cb\u003eTractional:\u003c/b\u003e Scar tissue (e.g., from proliferative diabetic retinopathy) contracts and pulls the retina off.\u003cbr\u003e - \u003cb\u003eExudative:\u003c/b\u003e Fluid accumulates under the retina without a tear, due to inflammation or vascular leakage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The classic symptoms are a sudden onset of \u003cmark\u003ephotopsia\u003c/mark\u003e (flashes of light), a shower of \u003cmark\u003efloaters\u003c/mark\u003e, and a progressive peripheral visual field defect described as a \u003cmark\u003e\\\"curtain\\\"\u003c/mark\u003e or shadow. This is a painless event.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Myopia, older age, previous cataract surgery, and eye trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e This is a surgical emergency. The goal is to reattach the retina as soon as possible to prevent permanent vision loss, especially if the macula is still attached.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of flashes, floaters, and a curtain-like vision loss is the classic presentation of a rhegmatogenous retinal detachment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eretinal detachment\u003c/b\u003e is the separation of the retina from its vital choroidal blood supply, a sight-threatening emergency often heralded by the premonitory symptoms of light flashes and floaters.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"f48498a3\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"tractional_retinal_detachment\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"exudative_retinal_detachment\"\n      }\n    ]\n  },\n  \"a52e7422\": {\n    \"title\": \"Retinal Disorders\",\n    \"primaryType\": \"concept\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinal disorders\u003c/b\u003e are a group of conditions affecting the retina, the light-sensitive tissue at the back of the eye. These disorders can be vascular, degenerative, or inflammatory and are a major cause of vision loss.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eVascular Retinopathies:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[73b00ab0|Diabetic Retinopathy]]:\u003c/b\u003e Microaneurysms, hemorrhages, neovascularization.\u003cbr\u003e - \u003cb\u003e[[549b012e|Hypertensive Retinopathy]]:\u003c/b\u003e AV nicking, cotton-wool spots.\u003cbr\u003e - \u003cb\u003e[[ae06ecfa|Retinal Artery Occlusion]]:\u003c/b\u003e Cherry-red spot.\u003cbr\u003e - \u003cb\u003e[[0b8cd9eb|Retinal Vein Occlusion]]:\u003c/b\u003e \u0027Blood and thunder\u0027 hemorrhages.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegenerative Disorders:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[c63255c8|Age-related Macular Degeneration]]:\u003c/b\u003e Drusen, central vision loss.\u003cbr\u003e - \u003cb\u003e[[f7063b6e|Retinitis Pigmentosa]]:\u003c/b\u003e Peripheral vision loss, night blindness, bone spicule pigmentation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructural Disorders:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[38c092f9|Retinal Detachment]]:\u003c/b\u003e Flashes, floaters, \u0027curtain\u0027 of vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInflammatory Disorders:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eRetinitis:\u003c/b\u003e Inflammation of the retina, often infectious (e.g., CMV retinitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Funduscopic examination is key to diagnosing retinal disorders. Be able to recognize the classic appearance of each of these conditions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinal disorders\u003c/b\u003e are a diverse group of sight-threatening conditions, each with a characteristic funduscopic appearance that reflects the underlying vascular, degenerative, or inflammatory pathology.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"c63255c8\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"38c092f9\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"ae06ecfa\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"0b8cd9eb\"\n      }\n    ]\n  },\n  \"0b8cd9eb\": {\n    \"title\": \"Retinal Vein Occlusion\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eretinal vein occlusion\u003c/b\u003e is the blockage of the central retinal vein or one of its branches, leading to venous stasis, retinal hemorrhage, and edema.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[b69e35b5|Central Retinal Vein Occlusion (CRVO)]]:\u003c/b\u003e Blockage of the main retinal vein at the optic nerve head. Affects the entire retina.\u003cbr\u003e - \u003cb\u003e[[0f0fbfa0|Branch Retinal Vein Occlusion (BRVO)]]:\u003c/b\u003e Blockage of a smaller branch, typically at an AV crossing. Affects a quadrant of the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Strongly associated with systemic vascular diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, and hyperlipidemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, unilateral blurring or loss of vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The classic appearance is a \u003cmark\u003e\\\"blood and thunder\\\"\u003c/mark\u003e fundus, with widespread (CRVO) or sectoral (BRVO) retinal hemorrhages, venous dilation, and cotton-wool spots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from retinal artery occlusion. Vein occlusion \u003d hemorrhagic, \u0027blood and thunder\u0027. Artery occlusion \u003d ischemic, \u0027cherry-red spot\u0027.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eretinal vein occlusion\u003c/b\u003e is a vascular \u0027plumbing backup\u0027 in the eye, where a thrombus obstructs venous outflow, causing a dramatic, hemorrhagic retinopathy and vision loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"b69e35b5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"0f0fbfa0\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"hypertension\"\n      }\n    ]\n  },\n  \"f7063b6e\": {\n    \"title\": \"Retinitis Pigmentosa\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"Pathology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinitis pigmentosa (RP)\u003c/b\u003e is a group of inherited retinal dystrophies characterized by the progressive degeneration of photoreceptor cells (primarily rods) and the retinal pigment epithelium (RPE), leading to progressive vision loss.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Genetically heterogeneous, with autosomal dominant, autosomal recessive, and X-linked inheritance patterns described.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary defect is in the rods, leading to their progressive death. Cone degeneration follows later in the disease course.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The classic initial symptom is \u003cmark\u003enight blindness (nyctalopia)\u003c/mark\u003e due to rod dysfunction. This is followed by a progressive loss of the \u003cmark\u003eperipheral visual field\u003c/mark\u003e, leading to \u0027tunnel vision.\u0027 Central vision is typically spared until late in the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The classic triad of findings includes:\u003cbr\u003e1. \u003cb\u003eBone spicule-like pigmentation\u003c/b\u003e in the mid-periphery of the retina.\u003cbr\u003e2. \u003cb\u003eArteriolar attenuation\u003c/b\u003e (narrowing of retinal vessels).\u003cbr\u003e3. \u003cb\u003eOptic disc pallor\u003c/b\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Can be a feature of systemic syndromes like Usher syndrome (RP and deafness) and abetalipoproteinemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young patient complaining of difficulty seeing at night and bumping into things in their peripheral vision, with bone spicules on fundoscopy, is the classic presentation of retinitis pigmentosa.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinitis pigmentosa\u003c/b\u003e is a hereditary retinal dystrophy that begins with the death of rod photoreceptors, causing an insidious onset of night blindness and a slow constriction of the visual field, leaving the patient with \u0027tunnel vision\u0027 in advanced stages.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"retinal_dystrophy\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"night_blindness\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \"peripheral_vision_loss\"\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"abetalipoproteinemia\"\n      }\n    ]\n  }\n}\n```",
      "role": "model",
      "finishReason": "STOP",
      "tokenCount": 9466,
      "parts": [{
        "text": "```json\n{\n  "
      }, {
        "text": "\"e617dfab\": {\n    \"title\": \"Re"
      }, {
        "text": "cklinghausen Disease (Neurofibromatosis Type 1)\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Neurology\",\n      \"Dermatology\",\n      \"Genetics\",\n      \"Oncology"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special"
      }, {
        "text": " Senses\",\n      \"Pathology\",\n      \"Neurocutaneous Disorders\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRecklinghausen disease\u003c/b\u003e is the eponym for \u003cb\u003eNeurofibromatosis Type"
      }, {
        "text": " 1 (NF-1)\u003c/b\u003e, an autosomal dominant neurocutaneous disorder characterized by the growth of tumors along nerves and"
      }, {
        "text": " the presence of skin and eye findings.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:"
      }, {
        "text": "\u003c/b\u003e Autosomal dominant mutation in the \u003ci\u003eNF1\u003c/i\u003e tumor suppressor gene on chromosome \u003cb\u003e17\u003c/b\u003e. M"
      }, {
        "text": "nemonic: 17 letters in \u0027von Recklinghausen\u0027.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The NF1 gene encodes"
      }, {
        "text": " neurofibromin, a negative regulator of the RAS signaling pathway. Loss of function leads to uncontrolled cell growth.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical"
      }, {
        "text": " Features (Mnemonic CICLOPSS):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003eaf√©-au-lait spots"
      }, {
        "text": ": Hyperpigmented macules with smooth borders (\u0027coast of California\u0027).\u003cbr\u003e - \u003cb\u003eI\u003c/b\u003entel"
      }, {
        "text": "lectual disability (learning disabilities are common).\u003cbr\u003e - \u003cb\u003eC\u003c/b\u003eutaneous neurofibromas: Ben"
      }, {
        "text": "ign nerve sheath tumors.\u003cbr\u003e - \u003cb\u003eL\u003c/b\u003eisch nodules: Pigmented hamartomas in the iris.\u003cbr\u003e - "
      }, {
        "text": "\u003cb\u003eO\u003c/b\u003eptic gliomas.\u003cbr\u003e - \u003cb\u003eP\u003c/b\u003eheochromocytomas.\u003cbr\u003e - \u003cb\u003eS\u003c/b\u003ee"
      }, {
        "text": "izures / \u003cb\u003eS\u003c/b\u003ephenoid dysplasia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The presence of ‚â•6 caf√©"
      }, {
        "text": "-au-lait spots and cutaneous neurofibromas is highly suggestive of NF-1.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eRecklinghausen disease (NF-1)\u003c/b\u003e is a multisystem genetic disorder caused by a faulty"
      }, {
        "text": " tumor suppressor gene, leading to a characteristic constellation of skin findings (caf√©-au-lait spots, neurofibromas), eye"
      }, {
        "text": " findings (Lisch nodules), and an increased risk of various tumors.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },"
      }, {
        "text": "\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous_with\",\n        \""
      }, {
        "text": "to\": \"neurofibromatosis_type_1\"\n      },\n      {\n        \"type\": \"is_a_"
      }, {
        "text": "type_of\",\n        \"to\": \"neurocutaneous_disorder\"\n      },\n      {\n        \"type\": \"p"
      }, {
        "text": "resents_with\",\n        \"to\": \"cbb4285c\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"presents_with\",\n        \"to\": \"lisch_nodules\"\n      }"
      }, {
        "text": "\n    ]\n  },\n  \"f5dfa5c6\": {\n    \"title\": \"Reflexes\",\n    \""
      }, {
        "text": "primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \"Physical Exam\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and"
      }, {
        "text": " Physiology\",\n      \"Spinal Cord\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003c"
      }, {
        "text": "p\u003e\u003cb\u003eReflexes\u003c/b\u003e are involuntary and nearly instantaneous movements in response to a stimulus, mediated by a neural pathway called a reflex arc. They"
      }, {
        "text": " are fundamental to the neurological examination for assessing the integrity of the nervous system.\u003c/p\u003e\",\n      \"atAGlance\": \""
      }, {
        "text": "\u003cul\u003e\u003cli\u003e\u003cb\u003eSpinal (Clinical) Reflexes:\u003c/b\u003e Test specific spinal nerve roots.\u003cbr\u003e - \u003cb\u003eDeep"
      }, {
        "text": " Tendon Reflexes (DTRs):\u003c/b\u003e Monosynaptic stretch reflexes (e.g., patellar, Achilles).\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eSuperficial Reflexes:\u003c/b\u003e Polysynaptic (e.g., cremasteric, anal wink).\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eCranial Nerve Reflexes:\u003c/b\u003e Test brainstem integrity.\u003cbr\u003e - \u003cb\u003ePupillary Light Reflex:\u003c/b\u003e CN"
      }, {
        "text": " II (afferent), CN III (efferent).\u003cbr\u003e - \u003cb\u003eCorneal Reflex:\u003c/b\u003e CN V"
      }, {
        "text": "\u003csub\u003e1\u003c/sub\u003e (afferent), CN VII (efferent).\u003cbr\u003e - \u003cb\u003eGag Reflex:\u003c/b\u003e CN"
      }, {
        "text": " IX (afferent), CN X (efferent).\u003c/li\u003e\u003cli\u003e\u003cb\u003ePrimitive Reflexes:\u003c/b\u003e Present in infants (e.g., Moro"
      }, {
        "text": ", rooting, Babinski) and disappear as the CNS matures. Their re-emergence in adults indicates frontal lobe damage"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eGrading of DTRs:\u003c/b\u003e A scale from 0 (absent) to 4+"
      }, {
        "text": " (clonus). 2+ is normal. Hyporeflexia (0, 1+) suggests an LMN lesion"
      }, {
        "text": ". Hyperreflexia (3+, 4+) suggests a UMN lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The state"
      }, {
        "text": " of the reflexes is a primary tool for differentiating between upper and lower motor neuron lesions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\":"
      }, {
        "text": " \"\u003cp\u003eThe testing of \u003cb\u003ereflexes\u003c/b\u003e, from the simple knee-jerk to complex cranial nerve reflexes, provides a direct"
      }, {
        "text": " and objective assessment of the functional integrity of specific pathways throughout the central and peripheral nervous system.\u003c/p\u003e\",\n      \"mermaid"
      }, {
        "text": "\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \"is_synonymous"
      }, {
        "text": "_with\",\n        \"to\": \"2915ead0\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"76044e89\"\n      },\n      {\n        \"type\": \"includes"
      }, {
        "text": "\",\n        \"to\": \"cranial_nerve_reflexes\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"primitive_reflexes\"\n      }\n    ]\n"
      }, {
        "text": "  },\n  \"d720eaaf\": {\n    \"title\": \"Refractive Errors\",\n    \"primaryType\": \""
      }, {
        "text": "disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Physiology\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Ref"
      }, {
        "text": "ractive Errors\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRefractive errors"
      }, {
        "text": "\u003c/b\u003e are a group of common vision problems that occur when the shape of the eye prevents light from focusing directly on the retina,"
      }, {
        "text": " resulting in blurred vision. They are corrected with eyeglasses, contact lenses, or surgery.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e[[myopia|Myopia]] (Nearsightedness):\u003c/b\u003e Light focuses \u003cu\u003ein front of\u003c/u\u003e the retina,"
      }, {
        "text": " either because the eyeball is too long or the lens/cornea system is too powerful. Distant objects are blurry. Corrected with"
      }, {
        "text": " a \u003cmark\u003econcave (-)\u003c/mark\u003e lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[62a81479|Hyperopia]] (F"
      }, {
        "text": "arsightedness):\u003c/b\u003e Light focuses \u003cu\u003ebehind\u003c/u\u003e the retina, either because the eyeball is too short or the lens"
      }, {
        "text": "/cornea system is too weak. Near objects are blurry. Corrected with a \u003cmark\u003econvex (+)\u003c/mark\u003e lens.\u003c/li\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003e[[18cff34e|Astigmatism]]:\u003c/b\u003e The cornea or lens has an irregular, non-spherical curvature"
      }, {
        "text": ", causing light to focus at multiple points. Vision is blurred at all distances. Corrected with a \u003cmark\u003ecylindrical\u003c/mark\u003e lens."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[presbyopia|Presbyopia]]:\u003c/b\u003e Age-related loss of accommodation, making it difficult to focus on"
      }, {
        "text": " near objects. Caused by stiffening of the lens.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Understand the basic optics"
      }, {
        "text": ": Myopia needs a diverging (concave) lens to move the focal point back. Hyperopia needs a converging (convex) lens to move the focal"
      }, {
        "text": " point forward.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRefractive errors\u003c/b\u003e are a mismatch between the"
      }, {
        "text": " eye\u0027s focusing power and its length, leading to blurred vision that is correctable by using lenses to precisely adjust the path"
      }, {
        "text": " of light so it lands perfectly on the retina.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {"
      }, {
        "text": "\n        \"type\": \"includes\",\n        \"to\": \"myopia\"\n      },\n      {\n"
      }, {
        "text": "        \"type\": \"includes\",\n        \"to\": \"62a81479\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"18cff34e\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"includes\",\n        \"to\": \"presbyopia\"\n      }\n"
      }, {
        "text": "    ]\n  },\n  \"8a1f3476\": {\n    \"title\": \""
      }, {
        "text": "Relative Afferent Pupillary Defect (RAPD)\",\n    \"primaryType\": \"finding\",\n    \"tags\": [\n"
      }, {
        "text": "      \"Ophthalmology\",\n      \"Neurology\",\n      \"Physical Exam\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalmology\",\n      \"Visual"
      }, {
        "text": " Pathway\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA \u003cb\u003eRelative Afferent Pupillary Def"
      }, {
        "text": "ect (RAPD)\u003c/b\u003e, also known as a Marcus Gunn pupil, is a clinical sign indicating a decreased response to"
      }, {
        "text": " light in the afferent pathway of the pupillary light reflex in one eye relative to the other. It is detected using"
      }, {
        "text": " the swinging flashlight test.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Ca"
      }, {
        "text": "used by a unilateral or asymmetric lesion of the afferent visual pathway, anterior to the optic chiasm (i.e.,"
      }, {
        "text": " in the retina or optic nerve).\u003c/li\u003e\u003cli\u003e\u003cb\u003eSwinging Flashlight Test:\u003c/b\u003e A light is swung back and forth between the two eyes."
      }, {
        "text": " In a normal individual, both pupils will remain constricted. In a patient with an RAPD in the right eye, when"
      }, {
        "text": " the light is swung from the normal left eye to the abnormal right eye, both pupils will paradoxically \u003cmark\u003edilate\u003c/"
      }, {
        "text": "mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eExplanation:\u003c/b\u003e The affected eye perceives the bright light as if it were dim, so the direct"
      }, {
        "text": " response is weak. When the light swings from the good eye (which caused strong bilateral constriction) to the bad eye,"
      }, {
        "text": " the weaker signal from the bad eye is not enough to maintain the constriction, and both pupils dilate.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic"
      }, {
        "text": " Cause:\u003c/b\u003e The most common cause is a lesion of the optic nerve, such as \u003cmark\u003e[[98a6"
      }, {
        "text": "3a59|optic neuritis]]\u003c/mark\u003e (often seen in [[45dd6d19|multiple sclerosis]])."
      }, {
        "text": " Other causes include severe retinal disease or [[3334840f|central retinal artery occlusion]].\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e"
      }, {
        "text": " An RAPD is a sign of an afferent pathway problem, not an efferent (CN III) problem. The"
      }, {
        "text": " pupils themselves are capable of constricting; the problem is that the brain isn\u0027t receiving a strong enough \u0027light on"
      }, {
        "text": "\u0027 signal from the affected eye.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eRelative Afferent Pupillary"
      }, {
        "text": " Defect\u003c/b\u003e is a subtle but crucial sign of unilateral optic nerve or retinal disease, unmasked by the swinging flashlight test, where the pupils paradox"
      }, {
        "text": "ically dilate when light is shone into the affected eye because the \u0027light signal\u0027 it sends to the brain is weaker"
      }, {
        "text": " than the consensual signal it was just receiving from the healthy eye.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_sign_of\",\n        \"to\":"
      }, {
        "text": " \"optic_nerve_lesion\"\n      },\n      {\n        \"type\": \"is_a"
      }, {
        "text": "_classic_sign_of\",\n        \"to\": \"98a63a59\"\n      },\n"
      }, {
        "text": "      {\n        \"type\": \"is_detected_by\",\n        \"to\": \"swinging_flashlight_test\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"2821b1d1\": {\n    \"title\": \"REM"
      }, {
        "text": " Sleep\",\n    \"primaryType\": \"physiology\",\n    \"tags\": [\n      \"Neurophysiology\",\n      \""
      }, {
        "text": "Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Anatomy and Physiology\",\n      \"Sleep\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp"
      }, {
        "text": "\u003e\u003cb\u003eRapid Eye Movement (REM) sleep\u003c/b\u003e is a unique stage of sleep characterized by random rapid movement of the eyes, accompanied"
      }, {
        "text": " by low muscle tone throughout the body, and the propensity of the sleeper to dream vividly.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eEEG Pattern:\u003c/b\u003e EEG shows low-voltage, high-frequency, sawtooth waves, which resembles"
      }, {
        "text": " the EEG of an awake, active brain. This is why it is often called \u003cmark\u003e\u0027paradoxical sleep\u0027"
      }, {
        "text": "\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePhysiological Changes:\u003c/b\u003e Characterized by rapid eye movements, muscle atonia (paralysis of major"
      }, {
        "text": " voluntary muscles), and variable heart rate and respiration. Penile/clitoral tumescence also occurs.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e"
      }, {
        "text": " Believed to be crucial for memory consolidation, emotional processing, and brain development.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDreaming:\u003c/b\u003e The"
      }, {
        "text": " majority of vivid, story-like dreaming occurs during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003e[[63b44bb7|REM Sleep Behavior Disorder"
      }, {
        "text": "]]:\u003c/b\u003e A parasomnia where the normal muscle atonia of REM sleep is absent, causing individuals to physically act out their dreams.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUS"
      }, {
        "text": "MLE Tip:\u003c/b\u003e REM sleep increases in duration and frequency in the later part of the night. Alcohol and benzodiazepines are"
      }, {
        "text": " known to suppress REM sleep.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eREM sleep\u003c/b\u003e is a paradoxical state where"
      }, {
        "text": " the brain is highly active, as if awake, yet the body is almost completely paralyzed, creating the ideal stage for vivid dreaming"
      }, {
        "text": " without the risk of physical enactment.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_a_stage_of\",\n        \"to\": \"6ab72a"
      }, {
        "text": "5a\"\n      },\n      {\n        \"type\": \"is_dysregulated_in\",\n        \"to\": \"6"
      }, {
        "text": "3b44bb7\"\n      },\n      {\n        \"type\": \"is_suppressed_by\",\n        \"to"
      }, {
        "text": "\": \"alcohol\"\n      },\n      {\n        \"type\": \"is_suppressed_by\",\n"
      }, {
        "text": "        \"to\": \"14464617\"\n      }\n    ]\n  },\n  \"6"
      }, {
        "text": "3b44bb7\": {\n    \"title\": \"REM Sleep Behavior Disorder (RBD)\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Neurology\",\n      \"Sleep Medicine\",\n      \"Psychiatry\",\n      \""
      }, {
        "text": "USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n"
      }, {
        "text": "      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder (RBD)\u003c/b\u003e is a parasomnia characterized by the loss of normal"
      }, {
        "text": " muscle atonia during REM sleep, leading to the physical enactment of vivid, often violent or action-filled dreams.\u003c/p\u003e\",\n      \"at"
      }, {
        "text": "AGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Failure of the brainstem mechanisms (particularly in the pons) that normally"
      }, {
        "text": " induce muscle paralysis during REM sleep.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Patients may shout, punch, kick, or jump"
      }, {
        "text": " out of bed during sleep, corresponding to the content of their dreams. This can result in injury to the patient or their"
      }, {
        "text": " bed partner.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic Association:\u003c/b\u003e RBD is a very strong predictor of future neurodegenerative disease, particularly \u003cmark\u003eŒ±"
      }, {
        "text": "-synucleinopathies\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Diseases:\u003c/b\u003e A majority of patients with idiopathic RBD will eventually develop [["
      }, {
        "text": "58c8ea03|Parkinson disease]], [[db2f16e5|Lewy body dementia"
      }, {
        "text": "]], or multiple system atrophy, often years or decades after the onset of RBD.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e An"
      }, {
        "text": " older male patient who reports acting out violent dreams and has injured his spouse during sleep should raise immediate suspicion for REM Sleep Behavior Disorder,"
      }, {
        "text": " which should be considered a prodromal sign of Parkinson disease or Lewy body dementia.\u003c/li\u003e\u003c/ul\u003e\",\n      \"take"
      }, {
        "text": "Away\": \"\u003cp\u003e\u003cb\u003eREM Sleep Behavior Disorder\u003c/b\u003e is more than just a sleep disturbance; it is a critical early warning"
      }, {
        "text": " sign of an underlying Œ±-synucleinopathy, where the failure to paralyze muscles during dreaming precedes the onset of motor and cognitive symptoms"
      }, {
        "text": " of diseases like Parkinson\u0027s by many years.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \""
      }, {
        "text": "connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to"
      }, {
        "text": "\": \"parasomnia\"\n      },\n      {\n        \"type\": \"is_a_prodromal_sign_of\",\n"
      }, {
        "text": "        \"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"is_a_prod"
      }, {
        "text": "romal_sign_of\",\n        \"to\": \"db2f16e5\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"alpha_syn"
      }, {
        "text": "ucleinopathies\"\n      }\n    ]\n  },\n  \"e4f62793"
      }, {
        "text": "\": {\n    \"title\": \"Respiratory Failure\",\n    \"primaryType\": \"disease\",\n    \"tags"
      }, {
        "text": "\": [\n      \"Pulmonology\",\n      \"Critical Care\",\n      \"Neurology\",\n      \"USMLE\"\n    ],\n"
      }, {
        "text": "    \"classificationPath\": [\n      \"Respiratory\",\n      \"Pathology\",\n      \"General\"\n    ],\n    \"content\":"
      }, {
        "text": " {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRespiratory failure\u003c/b\u003e is a condition in which the respiratory system fails in one or both of its gas"
      }, {
        "text": " exchange functions: oxygenation and carbon dioxide elimination. It is classified as hypoxemic or hypercapnic.\u003c/p\u003e\",\n      \"atAGlance"
      }, {
        "text": "\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eHypoxemic Respiratory Failure (Type 1):\u003c/b\u003e Characterized by low PaO\u003csub\u003e2\u003c/sub\u003e with"
      }, {
        "text": " a normal or low PaCO\u003csub\u003e2\u003c/sub\u003e. Caused by V/Q mismatch or shunting (e.g., pneumonia"
      }, {
        "text": ", ARDS, pulmonary embolism).\u003c/li\u003e\u003cli\u003e\u003cb\u003eHypercapnic Respiratory Failure (Type 2):\u003c/b\u003e Characterized by high PaCO"
      }, {
        "text": "\u003csub\u003e2\u003c/sub\u003e (with or without hypoxemia). Caused by inadequate alveolar ventilation (\u0027can\u0027t breathe\u0027) due"
      }, {
        "text": " to decreased respiratory drive, neuromuscular weakness, or increased dead space.\u003c/li\u003e\u003cli\u003e\u003cb\u003eNeuromuscular Causes:\u003c/b\u003e Several neurological disorders"
      }, {
        "text": " can lead to hypercapnic respiratory failure by weakening the muscles of respiration (diaphragm, intercostals).\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "ed52e40b|Guillain-Barr√© Syndrome]]:\u003c/b\u003e Ascending paralysis can involve the diaphragm.\u003cbr\u003e - \u003cb\u003e"
      }, {
        "text": "[[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]]:\u003c/b\u003e Progressive weakness of respiratory muscles is"
      }, {
        "text": " the usual cause of death.\u003cbr\u003e - \u003cb\u003eMyasthenia Gravis:\u003c/b\u003e A myasthenic crisis can cause"
      }, {
        "text": " acute respiratory failure.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e In a patient with a known neuromuscular disorder, monitoring respiratory function"
      }, {
        "text": " (e.g., with vital capacity or negative inspiratory force measurements) is critical to anticipate and manage impending respiratory failure."
      }, {
        "text": "\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRespiratory failure\u003c/b\u003e in the context of neurological disease is typically"
      }, {
        "text": " a hypercapnic failure, a \u0027pump problem\u0027 where the muscles of breathing are too weak to adequately ventilate the lungs"
      }, {
        "text": ", leading to a buildup of carbon dioxide.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"can_be_caused_by\",\n        \"to\": \"ed52e40b"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"can_be_caused_by\",\n        \""
      }, {
        "text": "to\": \"4ed629f9\"\n      },\n      {\n        \"type\": \"can_be_"
      }, {
        "text": "caused_by\",\n        \"to\": \"myasthenia_gravis\"\n      }\n    ]\n  "
      }, {
        "text": "},\n  \"5dc2069f\": {\n    \"title\": \"Resting Tremor\",\n    "
      }, {
        "text": "\"primaryType\": \"finding\",\n    \"tags\": [\n      \"Neurology\",\n      \"Movement Disorders"
      }, {
        "text": "\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      "
      }, {
        "text": "\"Pathology\",\n      \"Movement Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA"
      }, {
        "text": " \u003cb\u003eresting tremor\u003c/b\u003e is an involuntary, rhythmic, oscillatory movement that occurs when a body part is relaxed and completely supported against"
      }, {
        "text": " gravity. It is characteristically suppressed or diminished by voluntary movement.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003e"
      }, {
        "text": "Description:\u003c/b\u003e A tremor that is present at rest. It often has a low frequency (4-6 Hz).\u003c/li\u003e\u003cli\u003e\u003cb\u003eClassic"
      }, {
        "text": " Association:\u003c/b\u003e The hallmark and often the first symptom of \u003cmark\u003e[[58c8ea03|Parkinson disease"
      }, {
        "text": "]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eParkinsonian Tremor:\u003c/b\u003e Typically starts asymmetrically in one hand and has"
      }, {
        "text": " a characteristic \u003cmark\u003e\\\"pill-rolling\\\"\u003c/mark\u003e quality (a circular movement of the thumb and index finger)."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e Caused by dysfunction in the [[ed462927|bas"
      }, {
        "text": "al ganglia]], specifically the loss of dopaminergic neurons in the substantia nigra.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDifferentiation:\u003c/b\u003e It"
      }, {
        "text": " is crucial to differentiate a resting tremor from other types:\u003cbr\u003e - \u003cb\u003e[[40039e56|Essential Trem"
      }, {
        "text": "or]]:\u003c/b\u003e A postural and action tremor that is absent at rest.\u003cbr\u003e - \u003cb\u003eIntention Tremor:\u003c/b\u003e A tremor that"
      }, {
        "text": " worsens on goal-directed movement, indicative of a cerebellar lesion.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A tremor that is present when"
      }, {
        "text": " the patient\u0027s hands are in their lap but disappears when they reach for an object is a resting tremor, and the"
      }, {
        "text": " most likely diagnosis is Parkinson disease.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA \u003cb\u003eresting tremor\u003c/b\u003e is the"
      }, {
        "text": " classic \u0027pill-rolling\u0027 tremor of Parkinson disease, a sign of basal ganglia dysfunction that is uniquely present when the limb"
      }, {
        "text": " is at rest and paradoxically improves with voluntary action.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"is_a_type_of\",\n        \"to\": \"183"
      }, {
        "text": "5cfef\"\n      },\n      {\n        \"type\": \"is_a_hallmark_of\",\n        "
      }, {
        "text": "\"to\": \"58c8ea03\"\n      },\n      {\n        \"type\": \"d"
      }, {
        "text": "ifferentiated_from\",\n        \"to\": \"40039e56\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"differentiated_from\",\n        \"to\": \"intention_tremor\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"919caff2\": {\n    \"title\": \"Restless Legs Syndrome ("
      }, {
        "text": "RLS)\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Neurology\","
      }, {
        "text": "\n      \"Sleep Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      "
      }, {
        "text": "\"Neurology and Special Senses\",\n      \"Pathology\",\n      \"Sleep Disorders\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRestless Legs Syndrome (RLS)\u003c/b\u003e,"
      }, {
        "text": " also known as Willis-Ekbom disease, is a sensorimotor disorder characterized by an irresistible urge to move the legs, which"
      }, {
        "text": " is typically accompanied by or caused by uncomfortable and unpleasant sensations in the legs.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eDiagnostic"
      }, {
        "text": " Criteria (URGE):\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eU\u003c/b\u003erge to move the legs.\u003cbr\u003e - \u003cb\u003eR\u003c/b\u003eest"
      }, {
        "text": " worsens the symptoms.\u003cbr\u003e - \u003cb\u003eG\u003c/b\u003eetting up and moving provides relief.\u003cbr\u003e - \u003cb\u003eE"
      }, {
        "text": "\u003c/b\u003evening and night are when symptoms are worse.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The exact cause is unknown, but it is strongly"
      }, {
        "text": " linked to \u003cmark\u003eiron deficiency\u003c/mark\u003e in the central nervous system (even with normal peripheral iron stores) and dysfunction of"
      }, {
        "text": " the dopaminergic system.\u003c/li\u003e\u003cli\u003e\u003cb\u003eSecondary Causes:\u003c/b\u003e Can be secondary to iron deficiency anemia, pregnancy, end"
      }, {
        "text": "-stage renal disease, and [[5bc4bd07|diabetes mellitus]] (peripheral neuropathy).\u003c/li\u003e\u003cli\u003e\u003cb\u003eTreatment"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003eFirst-line:\u003c/b\u003e Address any underlying iron deficiency. Lifestyle modifications.\u003cbr\u003e - \u003cb\u003ePharmacotherapy"
      }, {
        "text": ":\u003c/b\u003e [[c36650bd|Dopamine agonists]] (e.g., pramipexole, [["
      }, {
        "text": "16a1a322|ropinirole]]) or [[f608d2b0|gab"
      }, {
        "text": "apentinoids]] (gabapentin, pregabalin) are first-line agents.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:"
      }, {
        "text": "\u003c/b\u003e A patient complaining of an \u0027uncomfortable, creepy-crawly\u0027 sensation in their legs at night that is only"
      }, {
        "text": " relieved by getting up and walking is the classic presentation of RLS. The first step in workup is to check iron"
      }, {
        "text": " studies (ferritin).\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRestless Legs Syndrome\u003c/b\u003e"
      }, {
        "text": " is a sensorimotor disorder driven by CNS iron deficiency and dopaminergic dysfunction, which creates an overwhelming urge to move the legs,"
      }, {
        "text": " particularly during periods of rest in the evening.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\":"
      }, {
        "text": " [\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \"iron_deficiency\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"is_associated_with\",\n        \"to\": \""
      }, {
        "text": "5bc4bd07\"\n      },\n      {\n        \"type\": \"is_treated_by"
      }, {
        "text": "\",\n        \"to\": \"c36650bd\"\n      },\n      {\n        \""
      }, {
        "text": "type\": \"is_treated_by\",\n        \"to\": \"f608d2b0\""
      }, {
        "text": "\n      }\n    ]\n  },\n  \"7e0e7c86\": {\n    \"title"
      }, {
        "text": "\": \"Reticular Activating System (RAS)\",\n    \"primaryType\": \"anatomy\",\n    \"tags\": ["
      }, {
        "text": "\n      \"Neuroanatomy\",\n      \"Physiology\",\n      \"USMLE\"\n    ],\n    \""
      }, {
        "text": "classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Anatomy and Physiology\",\n      "
      }, {
        "text": "\"Brainstem\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eThe \u003cb\u003eReticular Activating System"
      }, {
        "text": " (RAS)\u003c/b\u003e is a diffuse network of neurons located in the brainstem tegmentum that projects widely to the thalamus and cerebral"
      }, {
        "text": " cortex. It plays a crucial role in regulating wakefulness, arousal, and consciousness.\u003c/p\u003e\",\n      \"atAG"
      }, {
        "text": "lance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eLocation:\u003c/b\u003e A network of nuclei within the reticular formation of the brainstem (mid"
      }, {
        "text": "brain, pons, medulla).\u003c/li\u003e\u003cli\u003e\u003cb\u003eFunction:\u003c/b\u003e The RAS is the \u0027on switch\u0027 for the brain. It filters"
      }, {
        "text": " incoming sensory stimuli and projects to the cortex (via the thalamus) to maintain a state of alertness and consciousness.\u003c/li\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eLesion Effects:\u003c/b\u003e Damage to the RAS can lead to a profound reduction in arousal and wakefulness, resulting in \u003c"
      }, {
        "text": "mark\u003e[[d36eed18|coma]]\u003c/mark\u003e.\u003c/li\u003e\u003cli\u003e\u003cb\u003eCauses of Damage:\u003c/b\u003e Les"
      }, {
        "text": "ions can be structural (e.g., brainstem stroke, hemorrhage, tumor, herniation) or metabolic/toxic (e.g., drug"
      }, {
        "text": " overdose, hypoglycemia, hypoxia).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Consciousness is maintained by either two functioning cerebral hemispheres or one"
      }, {
        "text": " functioning brainstem (specifically the RAS). Therefore, coma can result from either bilateral hemispheric damage or a focal brainstem lesion affecting"
      }, {
        "text": " the RAS.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eThe \u003cb\u003eReticular Activating System"
      }, {
        "text": "\u003c/b\u003e is the brain\u0027s arousal center, a brainstem network that constantly bombards the cortex with activating signals to maintain consciousness"
      }, {
        "text": "; its failure leads to the profound unconsciousness of coma.\u003c/p\u003e\",\n      \"mermaid\": \"graph TD; A["
      }, {
        "text": "Sensory Input] --\u003e B(Reticular Activating System); B --\u003e C(Thalamus); C --\u003e D"
      }, {
        "text": "(Cerebral Cortex); D --\u003e E(Arousal/Consciousness);\"\n    },\n    \"connections\": [\n      {\n"
      }, {
        "text": "        \"type\": \"is_located_in\",\n        \"to\": \"582d8572\"\n      },\n      "
      }, {
        "text": "{\n        \"type\": \"regulates\",\n        \"to\": \"consciousness\"\n      },\n      {"
      }, {
        "text": "\n        \"type\": \"lesion_causes\",\n        \"to\": \"d36eed18\"\n      "
      }, {
        "text": "}\n    ]\n  },\n  \"ae06ecfa\": {\n    \"title\": \"Retinal Artery Occlusion\","
      }, {
        "text": "\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      "
      }, {
        "text": "\"Emergency Medicine\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neu"
      }, {
        "text": "rology and Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n"
      }, {
        "text": "    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinal artery occlusion\u003c/b\u003e is the blockage of the"
      }, {
        "text": " central retinal artery or one of its branches, leading to acute ischemia of the inner retina and sudden, painless vision loss."
      }, {
        "text": " It is considered an ocular stroke.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes:\u003c/b\u003e\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[3334840f|Central Retinal Artery Occlusion (C"
      }, {
        "text": "RAO)]]:\u003c/b\u003e Blockage of the main retinal artery. Causes severe, profound vision loss affecting the entire visual field.\u003cbr\u003e - \u003cb\u003eBranch"
      }, {
        "text": " Retinal Artery Occlusion (BRAO):\u003c/b\u003e Blockage of a smaller branch. Causes a sectoral visual field defect"
      }, {
        "text": ".\u003c/li\u003e\u003cli\u003e\u003cb\u003eEtiology:\u003c/b\u003e Most commonly caused by an embolus from an atherosclerotic plaque in the ips"
      }, {
        "text": "ilateral carotid artery or from the heart (e.g., atrial fibrillation). Giant cell arteritis is an important cause to consider in the"
      }, {
        "text": " elderly.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless, monocular vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e Classic"
      }, {
        "text": " findings include a \u003cmark\u003epale, edematous retina\u003c/mark\u003e and a \u003cmark\u003e\\\"cherry-red spot"
      }, {
        "text": "\\\"\u003c/mark\u003e at the macula in CRAO. In BRAO, the findings are localized to a sector of"
      }, {
        "text": " the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The \u0027cherry-red spot\u0027 is pathognomonic for CRAO."
      }, {
        "text": " This is an ophthalmologic emergency requiring immediate evaluation for stroke risk factors.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003eA "
      }, {
        "text": "\u003cb\u003eretinal artery occlusion\u003c/b\u003e is an ischemic stroke of the eye, where an embolus lodges in the retinal circulation, causing sudden,"
      }, {
        "text": " painless blindness and the classic fundoscopic sign of a cherry-red spot on a pale retina.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n"
      }, {
        "text": "    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"3334840f\""
      }, {
        "text": "\n      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"branch_retinal"
      }, {
        "text": "_artery_occlusion\"\n      },\n      {\n        \"type\": \"is_a_type"
      }, {
        "text": "_of\",\n        \"to\": \"ischemic_stroke\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"38c092f9\": {\n    \"title\": \"Retinal Detachment\",\n    \"primaryType\":"
      }, {
        "text": " \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Emergency Medicine\",\n      \"USMLE\"\n"
      }, {
        "text": "    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"Ophthalm"
      }, {
        "text": "ology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003eA"
      }, {
        "text": " \u003cb\u003eretinal detachment\u003c/b\u003e is a serious eye condition where the neurosensory retina separates from the underlying retinal pigment epithelium ("
      }, {
        "text": "RPE), depriving the photoreceptors of their blood supply from the choroid.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e"
      }, {
        "text": "\u003cb\u003eTypes:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[f48498a3|Rhegmatogenous"
      }, {
        "text": "]]:\u003c/b\u003e Most common. Caused by a full-thickness retinal tear that allows liquefied vitreous to seep underneath the retina.\u003cbr\u003e - \u003cb\u003eT"
      }, {
        "text": "ractional:\u003c/b\u003e Scar tissue (e.g., from proliferative diabetic retinopathy) contracts and pulls the retina off.\u003cbr\u003e - \u003cb\u003eExud"
      }, {
        "text": "ative:\u003c/b\u003e Fluid accumulates under the retina without a tear, due to inflammation or vascular leakage.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e The"
      }, {
        "text": " classic symptoms are a sudden onset of \u003cmark\u003ephotopsia\u003c/mark\u003e (flashes of light), a shower"
      }, {
        "text": " of \u003cmark\u003efloaters\u003c/mark\u003e, and a progressive peripheral visual field defect described as a \u003cmark\u003e\\\"cur"
      }, {
        "text": "tain\\\"\u003c/mark\u003e or shadow. This is a painless event.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Myopia,"
      }, {
        "text": " older age, previous cataract surgery, and eye trauma.\u003c/li\u003e\u003cli\u003e\u003cb\u003eManagement:\u003c/b\u003e This is a surgical emergency. The"
      }, {
        "text": " goal is to reattach the retina as soon as possible to prevent permanent vision loss, especially if the macula is still"
      }, {
        "text": " attached.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e The triad of flashes, floaters, and a curtain-like vision"
      }, {
        "text": " loss is the classic presentation of a rhegmatogenous retinal detachment.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003c"
      }, {
        "text": "p\u003eA \u003cb\u003eretinal detachment\u003c/b\u003e is the separation of the retina from its vital choroidal blood supply, a"
      }, {
        "text": " sight-threatening emergency often heralded by the premonitory symptoms of light flashes and floaters.\u003c/p\u003e\",\n      \"mermaid\": \"\""
      }, {
        "text": "\n    },\n    \"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"f"
      }, {
        "text": "48498a3\"\n      },\n      {\n        \"type\": \"includes\",\n        "
      }, {
        "text": "\"to\": \"tractional_retinal_detachment\"\n      },\n      {\n        \"type\":"
      }, {
        "text": " \"includes\",\n        \"to\": \"exudative_retinal_detachment\"\n      }\n    ]\n  },\n  "
      }, {
        "text": "\"a52e7422\": {\n    \"title\": \"Retinal Disorders\",\n    \"primaryType\": \""
      }, {
        "text": "concept\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Pathology\",\n      \"USMLE\""
      }, {
        "text": "\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses\",\n      \"O"
      }, {
        "text": "phthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinal disorders"
      }, {
        "text": "\u003c/b\u003e are a group of conditions affecting the retina, the light-sensitive tissue at the back of the eye. These disorders can be"
      }, {
        "text": " vascular, degenerative, or inflammatory and are a major cause of vision loss.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e"
      }, {
        "text": "\u003cli\u003e\u003cb\u003eVascular Retinopathies:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[73b00ab0|Di"
      }, {
        "text": "abetic Retinopathy]]:\u003c/b\u003e Microaneurysms, hemorrhages, neovascularization.\u003cbr\u003e - \u003cb\u003e[[5"
      }, {
        "text": "49b012e|Hypertensive Retinopathy]]:\u003c/b\u003e AV nicking, cotton-wool spots.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[ae06ecfa|Retinal Artery Occlusion]]:\u003c/b\u003e Cherry-red spot.\u003c"
      }, {
        "text": "br\u003e - \u003cb\u003e[[0b8cd9eb|Retinal Vein Occlusion]]:\u003c/b\u003e \u0027Blood and"
      }, {
        "text": " thunder\u0027 hemorrhages.\u003c/li\u003e\u003cli\u003e\u003cb\u003eDegenerative Disorders:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[c632"
      }, {
        "text": "55c8|Age-related Macular Degeneration]]:\u003c/b\u003e Drusen, central vision loss.\u003cbr\u003e - \u003cb\u003e[["
      }, {
        "text": "f7063b6e|Retinitis Pigmentosa]]:\u003c/b\u003e Peripheral vision loss, night blindness, bone sp"
      }, {
        "text": "icule pigmentation.\u003c/li\u003e\u003cli\u003e\u003cb\u003eStructural Disorders:\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[38c092f9|Retinal Detachment]]:"
      }, {
        "text": "\u003c/b\u003e Flashes, floaters, \u0027curtain\u0027 of vision loss.\u003c/li\u003e\u003cli\u003e\u003cb\u003eInflammatory Disorders:\u003c/b\u003e\u003cbr\u003e -"
      }, {
        "text": " \u003cb\u003eRetinitis:\u003c/b\u003e Inflammation of the retina, often infectious (e.g., CMV retinitis).\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE"
      }, {
        "text": " Tip:\u003c/b\u003e Funduscopic examination is key to diagnosing retinal disorders. Be able to recognize the classic appearance of each of"
      }, {
        "text": " these conditions.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinal disorders\u003c/b\u003e are a diverse group of sight"
      }, {
        "text": "-threatening conditions, each with a characteristic funduscopic appearance that reflects the underlying vascular, degenerative, or inflammatory pathology.\u003c/p\u003e\","
      }, {
        "text": "\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        \"type\": \""
      }, {
        "text": "includes\",\n        \"to\": \"73b00ab0\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"c63255c8\"\n      },\n      {\n        "
      }, {
        "text": "\"type\": \"includes\",\n        \"to\": \"38c092f9\"\n      },"
      }, {
        "text": "\n      {\n        \"type\": \"includes\",\n        \"to\": \"ae06ecfa\"\n"
      }, {
        "text": "      },\n      {\n        \"type\": \"includes\",\n        \"to\": \"0b8cd9"
      }, {
        "text": "eb\"\n      }\n    ]\n  },\n  \"0b8cd9eb\": {\n    \"title\": \"Retinal Ve"
      }, {
        "text": "in Occlusion\",\n    \"primaryType\": \"disease\",\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Path"
      }, {
        "text": "ology\",\n      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and"
      }, {
        "text": " Special Senses\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {\n      \"definition"
      }, {
        "text": "\": \"\u003cp\u003eA \u003cb\u003eretinal vein occlusion\u003c/b\u003e is the blockage of the central retinal vein or one of its branches, leading"
      }, {
        "text": " to venous stasis, retinal hemorrhage, and edema.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eTypes"
      }, {
        "text": ":\u003c/b\u003e\u003cbr\u003e - \u003cb\u003e[[b69e35b5|Central Retinal Vein Occlusion (CRVO)]]:"
      }, {
        "text": "\u003c/b\u003e Blockage of the main retinal vein at the optic nerve head. Affects the entire retina.\u003cbr\u003e - \u003cb\u003e[[0"
      }, {
        "text": "f0fbfa0|Branch Retinal Vein Occlusion (BRVO)]]:\u003c/b\u003e Blockage of a smaller branch,"
      }, {
        "text": " typically at an AV crossing. Affects a quadrant of the retina.\u003c/li\u003e\u003cli\u003e\u003cb\u003eRisk Factors:\u003c/b\u003e Strongly associated with systemic vascular"
      }, {
        "text": " diseases like \u003cmark\u003ehypertension\u003c/mark\u003e, diabetes mellitus, and hyperlipidemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e Sudden, painless,"
      }, {
        "text": " unilateral blurring or loss of vision.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The classic appearance is a \u003cmark\u003e\\\"blood and thunder\\\"\u003c/mark\u003e"
      }, {
        "text": " fundus, with widespread (CRVO) or sectoral (BRVO) retinal hemorrhages, venous dilation, and cotton-wool"
      }, {
        "text": " spots.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e Differentiate from retinal artery occlusion. Vein occlusion \u003d hemorrhagic, \u0027"
      }, {
        "text": "blood and thunder\u0027. Artery occlusion \u003d ischemic, \u0027cherry-red spot\u0027.\u003c/li\u003e\u003c/ul\u003e\",\n      \"takeAway\": \"\u003cp\u003e"
      }, {
        "text": "A \u003cb\u003eretinal vein occlusion\u003c/b\u003e is a vascular \u0027plumbing backup\u0027 in the eye, where a thrombus obstruct"
      }, {
        "text": "s venous outflow, causing a dramatic, hemorrhagic retinopathy and vision loss.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    "
      }, {
        "text": "\"connections\": [\n      {\n        \"type\": \"includes\",\n        \"to\": \"b69"
      }, {
        "text": "e35b5\"\n      },\n      {\n        \"type\": \"includes\",\n        \"to"
      }, {
        "text": "\": \"0f0fbfa0\"\n      },\n      {\n        \"type\": \"is_associated"
      }, {
        "text": "_with\",\n        \"to\": \"hypertension\"\n      }\n    ]\n  },\n  \"f7063b6"
      }, {
        "text": "e\": {\n    \"title\": \"Retinitis Pigmentosa\",\n    \"primaryType\": \"disease\","
      }, {
        "text": "\n    \"tags\": [\n      \"Ophthalmology\",\n      \"Genetics\",\n      \"Pathology\",\n"
      }, {
        "text": "      \"USMLE\"\n    ],\n    \"classificationPath\": [\n      \"Neurology and Special Senses"
      }, {
        "text": "\",\n      \"Ophthalmology\",\n      \"Retinal Disorders\"\n    ],\n    \"content\": {"
      }, {
        "text": "\n      \"definition\": \"\u003cp\u003e\u003cb\u003eRetinitis pigmentosa (RP)\u003c/b\u003e is a group of inherited retinal dystroph"
      }, {
        "text": "ies characterized by the progressive degeneration of photoreceptor cells (primarily rods) and the retinal pigment epithelium (RPE), leading to progressive"
      }, {
        "text": " vision loss.\u003c/p\u003e\",\n      \"atAGlance\": \"\u003cul\u003e\u003cli\u003e\u003cb\u003eGenetics:\u003c/b\u003e Genetically heterogeneous, with autosomal"
      }, {
        "text": " dominant, autosomal recessive, and X-linked inheritance patterns described.\u003c/li\u003e\u003cli\u003e\u003cb\u003ePathophysiology:\u003c/b\u003e The primary defect is in"
      }, {
        "text": " the rods, leading to their progressive death. Cone degeneration follows later in the disease course.\u003c/li\u003e\u003cli\u003e\u003cb\u003eClinical Presentation:\u003c/b\u003e"
      }, {
        "text": " The classic initial symptom is \u003cmark\u003enight blindness (nyctalopia)\u003c/mark\u003e due to rod dysfunction. This is followed by a"
      }, {
        "text": " progressive loss of the \u003cmark\u003eperipheral visual field\u003c/mark\u003e, leading to \u0027tunnel vision.\u0027 Central vision is typically spared"
      }, {
        "text": " until late in the disease.\u003c/li\u003e\u003cli\u003e\u003cb\u003eFundoscopy:\u003c/b\u003e The classic triad of findings includes:\u003cbr\u003e1. "
      }, {
        "text": "\u003cb\u003eBone spicule-like pigmentation\u003c/b\u003e in the mid-periphery of the retina.\u003cbr\u003e2. "
      }, {
        "text": "\u003cb\u003eArteriolar attenuation\u003c/b\u003e (narrowing of retinal vessels).\u003cbr\u003e3. \u003cb\u003eOptic disc pallor\u003c/b\u003e."
      }, {
        "text": "\u003c/li\u003e\u003cli\u003e\u003cb\u003eAssociated Conditions:\u003c/b\u003e Can be a feature of systemic syndromes like Usher syndrome (RP and deafness) and ab"
      }, {
        "text": "etalipoproteinemia.\u003c/li\u003e\u003cli\u003e\u003cb\u003eUSMLE Tip:\u003c/b\u003e A young patient complaining of difficulty seeing at night and bumping"
      }, {
        "text": " into things in their peripheral vision, with bone spicules on fundoscopy, is the classic presentation of retinitis pigmentosa.\u003c/li\u003e\u003c/ul\u003e\",\n"
      }, {
        "text": "      \"takeAway\": \"\u003cp\u003e\u003cb\u003eRetinitis pigmentosa\u003c/b\u003e is a hereditary retinal dystrophy that begins with the death of rod"
      }, {
        "text": " photoreceptors, causing an insidious onset of night blindness and a slow constriction of the visual field, leaving the patient with \u0027"
      }, {
        "text": "tunnel vision\u0027 in advanced stages.\u003c/p\u003e\",\n      \"mermaid\": \"\"\n    },\n    \"connections\": [\n      {\n        "
      }, {
        "text": "\"type\": \"is_a_type_of\",\n        \"to\": \"retinal_dystrophy"
      }, {
        "text": "\"\n      },\n      {\n        \"type\": \"presents_with\",\n        \"to\": \""
      }, {
        "text": "night_blindness\"\n      },\n      {\n        \"type\": \"presents_with\",\n        "
      }, {
        "text": "\"to\": \"peripheral_vision_loss\"\n      },\n      {\n        \"type\": \"is_"
      }, {
        "text": "associated_with\",\n        \"to\": \"abetalipoproteinemia\"\n      }\n    ]\n  "
      }, {
        "text": "}\n}\n```"
      }]
    }],
    "pendingInputs": [{
      "text": "",
      "role": "user"
    }]
  }
}